Citrus Sinensis ID: 008220

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570---
Protein Sequence
MNPYGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Secondary Structure (PSIPRED)
cccccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEccEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEccccccEEEcccccccccccHHHHHccccccccccccccccccccccccccHHHHccccccccccHHcHHHHHHHHHccccccccccHHHHHHHHHHHcccHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHcccccccccccccccccHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHcccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccEEEEEccccEEEEEEccccccccHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEEccccHccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHccccccccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHEEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEcccEEEEccccHHHHccccccccEEcccccccccccEEEEEEEEEEccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHccccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHccHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccccccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHccccEEEccccccHHHHHHEEHHccEEEEEcccHHHHHHcccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
mnpyglkpneqrsfrFVRKTQVLLSSKYGLQFFtlnskmglkvlepntcirgccssqsiplhlppssytllspiargaESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCkldhpglakfvaahakppnymFFFEFYESRNLAEklhveewspSVDQVLMIAAQLAKALQYLHNLgivhrdvkpanvlldrnlcphladFGLAEYRENLKEISLKnwrssgkptggfhkknmvGTLIYMAPEILKKeihseksdvysfGISINelltgvvpytdlrAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRcwdgnphnrpsfsdIALELDLVLEHRKslkeedlcagksyvtyddklinsgnnmhtyhesinwtaqgehsskkashAAESDVKLWLESANDaltyypvlswgsfatcgrretmedthflmphmynqkeihmfgifdghrgsaaAEFSARALPGflqnlgsttrpTDALLEAFIRTDVAFRNELDSLrkskrvvqkdwhpgCTAIAALIVRNRLfvanagdcrailcrgghpfalsRVRQEFWL
Flexible Loop (DISEMBL)
mnpyglkpneqrsfrfvRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLknwrssgkptggfhkknmvGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKslkeedlcagksYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDslrkskrvvqkdwhpGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Low Complexity Region (SEG)
MNPYGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGehsskkashaaesDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Disordered region (IsUnstruct)
*************FRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWT*****************VKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF**
Disordered Region (DISOPRED)
*********************************************************SIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL**************************************************************************TYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPG*****************AFIRTDVAFRNELD************WHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Disordered Region (DISEMBL)
MNPYGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWT****************DVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Disordered Region (DISPRO)
*NPYGLKPNEQRSFRFV*********************************RGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR*********************************************************************************************MP****QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNPYGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEFWL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	573	2.2.26 [Sep-21-2011]
Q940A2	658	Protein kinase and PP2C-l	yes	no	0.912	0.794	0.678	0.0
Q5JJY4	657	Protein kinase and PP2C-l	yes	no	0.905	0.789	0.650	0.0
Q55GU0	916	Probable serine/threonine	yes	no	0.415	0.259	0.329	4e-34
Q2MHE4	390	Serine/threonine-protein	no	no	0.424	0.623	0.330	8e-33
Q54IP4	653	Dual specificity protein	no	no	0.436	0.382	0.308	2e-28
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.427	0.150	0.303	6e-28
Q5UQG7	1651	Putative serine/threonine	N/A	no	0.438	0.152	0.326	8e-28
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.429	0.148	0.313	5e-27
Q66L42	940	Mitogen-activated protein	yes	no	0.445	0.271	0.302	4e-26
Q54U31	744	Dual specificity protein	no	no	0.431	0.331	0.305	5e-26

>sp|Q940A2|P2C31_ARATH Protein kinase and PP2C-like domain-containing protein OS=Arabidopsis thaliana GN=At2g40860/At2g40870 PE=2 SV=1

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/532 (67%), Positives = 438/532 (82%), Gaps = 9/532 (1%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1   MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES  LAEKLHVEEWS
Sbjct: 61  LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+DQVL+I   LAKALQYLHN GIVHRDVKPANVLLD    P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P  
Sbjct: 241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD----DKLINSGNNMHTYHESINWT 394
           RPS  ++ LEL+ + E  +  ++  L    S    D    D + NSG+    Y +++NW 
Sbjct: 301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGD----YRDTVNWF 356

Query: 395 AQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMY 454
           +QGE  SKK+S +   DVKLW  S ++   Y PV+S GSFATCGRRE+MEDTHF++PHM 
Sbjct: 357 SQGECLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMC 416

Query: 455 NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELD 514
           N++ IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+   +AL +AF+RTD+AFR ELD
Sbjct: 417 NEESIHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFRQELD 475

Query: 515 SLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+
Sbjct: 476 SHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSK 527

Arabidopsis thaliana (taxid: 3702)
EC: 3EC: .EC: 1EC: .EC: 3EC: .EC: 1EC: 6

>sp|Q5JJY4|P2C04_ORYSJ Protein kinase and PP2C-like domain-containing protein OS=Oryza sativa subsp. japonica GN=Os01g0541900 PE=2 SV=1

 Score =  726 bits (1875), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/535 (65%), Positives = 422/535 (78%), Gaps = 16/535 (2%)

Query: 39  MGLKVL--EPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKK 96
           MG++V   E N C+RGCC S +IPLHLPPSS++LLSPIA+G+ES VYEA L G +VA KK
Sbjct: 1   MGVEVPPEESNRCVRGCCRSAAIPLHLPPSSFSLLSPIAKGSESTVYEARLGGERVAAKK 60

Query: 97  PILSTSEELDNFHKELQLL-----CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           P+LSTS++LD FH +LQLL      +LDHPGLA+ VAAHA+PPNY+ FF+F+E  NLA+K
Sbjct: 61  PVLSTSDDLDKFHYQLQLLWWVLPIELDHPGLARLVAAHARPPNYLMFFDFFEPPNLADK 120

Query: 152 LHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
           +HVEEW+PSV QV+ IA  LAKALQYL+ LGIVHRD+KPAN+L+D++  PHLADFGLA Y
Sbjct: 121 IHVEEWNPSVQQVVTIATDLAKALQYLNILGIVHRDIKPANILIDKDFHPHLADFGLAMY 180

Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
           ++++K +S++NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K+IH+EKSDVYSF ISINEL
Sbjct: 181 QKDIKHVSVENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDIHTEKSDVYSFAISINEL 240

Query: 272 LTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRC 331
           LTGVVPYTDLRAEAQAHTVLEM YTEQQLTAA+VS GLRP LA  E G P S+LSLIQRC
Sbjct: 241 LTGVVPYTDLRAEAQAHTVLEMTYTEQQLTAAIVSQGLRPALALPESGAPPSLLSLIQRC 300

Query: 332 WDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESI 391
           WD +P  RPSF DI  EL ++ +H       + C   S  +  +K  N    +H Y E++
Sbjct: 301 WDSDPQQRPSFKDITEELKIIEKHIAV----NSC---SLASPANKSQNGNTEVHHYQEAL 353

Query: 392 NWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMP 451
           +W  QGE  +K   +  +S V  W +  + +  Y P LSWGSFATCGRRETMEDTHF++P
Sbjct: 354 SWLNQGELFAK--GNKLDSTVDHWSDIFDQSSKYCPTLSWGSFATCGRRETMEDTHFMLP 411

Query: 452 HMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRN 511
           HM  +K++H FGIFDGHRGSAAAEFS RA+PGFL+   S T PTDAL EAF+RTD+AFR 
Sbjct: 412 HMSEEKDLHAFGIFDGHRGSAAAEFSVRAVPGFLKQFNSNTSPTDALTEAFVRTDIAFRE 471

Query: 512 ELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           EL   +KSKR+ QK+WHPGCTA+ ALIVRN+LFVANAGDCRAIL R G PF ++R
Sbjct: 472 ELILHQKSKRITQKNWHPGCTAVTALIVRNKLFVANAGDCRAILNRAGEPFPMTR 526

Oryza sativa subsp. japonica (taxid: 39947)

EC: 3

EC: .

EC: 1

EC: .

EC: 3

EC: .

EC: 1

EC: 6

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  146 bits (369), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 146/279 (52%), Gaps = 41/279 (14%)

Query: 72  SPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLLCKLDHPGLAKF 126
           S +  G   VVY+    G  VA+K+  +  +E+++N     F KEL +L +L HP +   
Sbjct: 666 SKLGEGTFGVVYKGLWRGSSVAIKQ--IKINEDVNNQVLEEFRKELTILSRLRHPNIVLL 723

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
           +AA   PPN  F  E+    +L + LH ++   ++     +A Q+A+ + YLH  G++HR
Sbjct: 724 MAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHR 783

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+K  N+LLD ++   + DFGL++ +    E++    +S G P             I+M+
Sbjct: 784 DIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMT----KSIGSP-------------IWMS 826

Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           PE+L  E ++EK DVY+FGI + EL TG +PY+ L +               QL  AV +
Sbjct: 827 PELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSV--------------QLALAVTT 872

Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             LRP + +     P  +  LIQ CW  +P  RPSF++I
Sbjct: 873 KSLRPPIPN---AWPYQLSHLIQACWHQDPLKRPSFTEI 908

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  142 bits (358), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 142/284 (50%), Gaps = 41/284 (14%)

Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTSEEL------DNFHKELQLLCKLDHPGLAKFV 127
            A GA S +Y      R VAVK   + T +E         F  E+ LL +L HP + +F+
Sbjct: 92  FASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFI 151

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
           AA  KPP Y    E+    NL   L+ +E +S S++ VL +A  +++ ++YLH+ G++HR
Sbjct: 152 AACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHR 211

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+K  N+LL+  +   +ADFG +      +E                 K NM GT  +MA
Sbjct: 212 DLKSNNLLLNDEMRVKVADFGTSCLETQCREA----------------KGNM-GTYRWMA 254

Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           PE++K++ ++ K DVYSFGI + EL T ++P+  +              T  Q   AV  
Sbjct: 255 PEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGM--------------TPVQAAFAVAE 300

Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
              RP L +       ++  LI+RCW  NP  RP FS+I   L+
Sbjct: 301 KNERPPLPA---SCQPALAHLIKRCWSENPSKRPDFSNIVAVLE 341

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1

 Score =  127 bits (320), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 137/285 (48%), Gaps = 35/285 (12%)

Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLA 124
           SY   + +  GA   VY+  + G++VA+KK   +  EE  ++ F KE+ L+ KL +P L 
Sbjct: 173 SYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEENTMNEFKKEVSLMAKLRNPHLL 232

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQYLHNL 181
            F+ A   P +     E     ++   L  +E +    +  + ++IA      + +LH  
Sbjct: 233 LFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVLGMTWLHAS 292

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+H D+KPAN+L+D+N    +ADFGL++Y                KP          G+
Sbjct: 293 NILHLDLKPANLLVDQNWVVKVADFGLSKYM---------------KPDSKDKLLGQAGS 337

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            +YMAPE+L  + +  K DV+SF I + ELLT   PY  L +            +  QL 
Sbjct: 338 PLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYS------------SYPQLV 385

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
             VV+   RPI+       P  +  L+ RCWD  P  RPSF++I+
Sbjct: 386 EGVVNKKNRPIIPDY---FPTRLKDLLARCWDHYPSRRPSFAEIS 427

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  126 bits (316), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 137/287 (47%), Gaps = 42/287 (14%)

Query: 74   IARGAESVVYEATLDGRKVAVKKPI---LSTSEELDNFHKELQLLCKLDHPGLAKFVAAH 130
            I  G+  +V+     G  VAVKK +   LS ++ L+ F  E+  L +L H  +  F+ A 
Sbjct: 1370 IGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLE-FRAEMAFLSELKHSNIVTFIGAC 1428

Query: 131  AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--NLGIVHRDV 188
             K PN     E+    NL + L   +   +    L +    A  + YLH  N  IVHRD+
Sbjct: 1429 IKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDI 1488

Query: 189  KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
            KPAN+L+D +    +ADFG A  +E+   ++                    GT  + APE
Sbjct: 1489 KPANILVDEHFNVKIADFGFARIKEDNTTMT------------------RCGTPCWTAPE 1530

Query: 249  ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
            +++ E + EK+DV+SFG+ + E+LTG  P+             E N+ +  L   ++ GG
Sbjct: 1531 VIRGEKYCEKADVFSFGVVMWEVLTGKEPFA------------ECNFMKVSLD--ILEGG 1576

Query: 309  LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
             RPI+ S     P     LI++CW    H RP+ +++  +L L+ E 
Sbjct: 1577 -RPIIPS---DCPHEFAKLIKKCWHAKAHKRPTMTEVVQQLMLITEQ 1619

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1

 Score =  125 bits (314), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 144/288 (50%), Gaps = 37/288 (12%)

Query: 70   LLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFV 127
             +  +  G    V++A   G +VAVKK + S  T +   NF +E+  +  L HP +  F+
Sbjct: 795  FMESLGSGGSGEVFKAMWKGTEVAVKKLVNSNITKDAERNFKQEIHRMTSLRHPNVVLFM 854

Query: 128  AAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
            AA  +PPN     EF    +L + L    V E  P +   + IA Q AK + +LH+  IV
Sbjct: 855  AASTRPPNMCIVMEFMSLGSLYDLLGNELVTEIPPVLR--IRIAYQAAKGMHFLHSSDIV 912

Query: 185  HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
            HRD+K  N+LLD      ++DFGL + ++N K          GK +    K++ V ++ +
Sbjct: 913  HRDLKSLNLLLDSKWNVKVSDFGLTKIKDNNK----------GKSS---TKEDSVCSIQW 959

Query: 245  MAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
             APE+L  K++I    +DVYSFGI + EL+T + PY  L   A A               
Sbjct: 960  TAPEVLSEKQDIDYILADVYSFGIIMWELMTRLRPYIGLSPAAIA--------------V 1005

Query: 303  AVVSGGLRPILASLELGLPAS-ILSLIQRCWDGNPHNRPSFSDIALEL 349
            AV+   LRP +   ++ L +S  + L+  CW  +   RPSF +I  +L
Sbjct: 1006 AVIRDNLRPEIQEEDINLMSSDYVELVNICWHKDTMIRPSFLEIMTKL 1053

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  122 bits (307), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 38/284 (13%)

Query: 74   IARGAESVVYEATLDGRKVAVK--KPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAH 130
            +  GA   V++ T  G +VAVK   P  + +++++ NF  E++++  L HP +  F+AA 
Sbjct: 792  LGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRVMTTLRHPNVVLFMAAS 851

Query: 131  AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLHNLGIVHRDV 188
             KPP      EF    +L + L   E  P +   L   IA Q +K + +LH+ GI HRD+
Sbjct: 852  TKPPKMCIVMEFMALGSLHDLLK-NELIPDIPFALKVKIAYQASKGMHFLHSSGITHRDL 910

Query: 189  KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
            K  N+LLD      ++DFGL +++ ++K I               + +   GT+ + APE
Sbjct: 911  KSLNLLLDIKWNVKVSDFGLTKFKSDVKSI---------------NPEKFAGTIQWTAPE 955

Query: 249  ILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
            IL   +E+    SDVYSFGI + EL+T   PY  +   A A +V+  NY           
Sbjct: 956  ILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNY----------- 1004

Query: 307  GGLRPILAS-LELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
               RP+++  L   +    + L+  CW  +P  RP+F +I   L
Sbjct: 1005 ---RPVISDQLRSEVAPEYIELLTSCWHFDPTIRPTFLEIMTRL 1045

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2

 Score =  120 bits (300), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 94/311 (30%), Positives = 138/311 (44%), Gaps = 56/311 (18%)

Query: 57  QSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE----LDNFHKEL 112
           Q IP H       L   I  G    VY A   G +VAVK   L    +     +   +E 
Sbjct: 91  QEIPFH----ELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDPAVTAEQVRQEA 146

Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
           +L   L HP +     A   PPN     E+     L+  L      P V  ++  A Q+A
Sbjct: 147 RLFGALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGRRVPPHV--LVNWAVQVA 204

Query: 173 KALQYLHN---LGIVHRDVKPANVLLDRNLCPH--------LADFGLAEYRENLKEISLK 221
           + + YLHN   + I+HRD+K  N+L+   +  H        + DFGLA           +
Sbjct: 205 RGMNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLA-----------R 253

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
            W  +        K +  GT  +MAPE+++  + S+ SDV+SFG+ + ELLTG VPY ++
Sbjct: 254 EWHKT-------TKMSAAGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREI 306

Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
            A A A+ V  MN    +LT  + S              P     L++ CWD +PH RP 
Sbjct: 307 DALAVAYGVA-MN----KLTLPIPS------------TCPEPFARLLEECWDPDPHGRPD 349

Query: 342 FSDIALELDLV 352
           F  I  +L+++
Sbjct: 350 FGSILKQLEVI 360

Activates the JUN N-terminal pathway.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1

 Score =  119 bits (299), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 143/285 (50%), Gaps = 38/285 (13%)

Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G+   VY+    G++VAVK P        EL +F  E++++ K+ HP +  F+ A  
Sbjct: 283 LGQGSFGSVYKGKCRGQEVAVKIPRKQKLSLYELTSFRHEVKIMSKIFHPNVVLFLGACT 342

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKALQYLHNLG-IVHRDV 188
           +        E  ++ +L + LH +      S+ + + +A   A  + +LH +  IVH D+
Sbjct: 343 QSGKMQIVTELCQT-DLEKLLHNDRTKKEFSLFRRMQMAKDAALGMNWLHGITRIVHNDL 401

Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K AN+L+D NL   + DFG ++ +E  +                F  K   GT ++MAPE
Sbjct: 402 KTANLLVDINLRVKVTDFGFSQIKEGEE----------------FQDKAAKGTPLWMAPE 445

Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           ++    ++EK+DVYSFGI + E+LT   PY+        H   ++ +       A+ +  
Sbjct: 446 VMMGNPYNEKADVYSFGIILWEILTKEAPYS-------HHKDYDIFFN------AICNEK 492

Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
            RP + +  L    S+  LIQ CWD NP NRPSFS+I   L+ +L
Sbjct: 493 ERPPIPADTL---PSLRHLIQTCWDHNPQNRPSFSEILFRLNEIL 534

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	573
225440175	659	PREDICTED: protein kinase and PP2C-like	0.921	0.801	0.765	0.0
225440177	669	PREDICTED: protein kinase and PP2C-like	0.921	0.789	0.747	0.0
224139662	661	predicted protein [Populus trichocarpa]	0.919	0.797	0.767	0.0
255570496	657	protein kinase, putative [Ricinus commun	0.917	0.800	0.757	0.0
357439937	654	Protein kinase and PP2C-like domain-cont	0.910	0.798	0.695	0.0
356500335	658	PREDICTED: protein kinase and PP2C-like	0.919	0.800	0.695	0.0
297827721	661	kinase family protein [Arabidopsis lyrat	0.910	0.789	0.682	0.0
30688440	658	putative protein phosphatase 2C 31 [Arab	0.912	0.794	0.678	0.0
312281615	654	unnamed protein product [Thellungiella h	0.912	0.799	0.676	0.0
449505991	654	PREDICTED: protein kinase and PP2C-like	0.904	0.792	0.682	0.0

>gi|225440175|ref|XP_002283436.1| PREDICTED: protein kinase and PP2C-like domain-containing protein isoform 1 [Vitis vinifera] gi|297741696|emb|CBI32828.3| unnamed protein product [Vitis vinifera]

 Score =  859 bits (2220), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/528 (76%), Positives = 465/528 (88%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MG+++++PNTC RGCCSS+SIPL LP S Y+LLSPIARGAESVVYEA LDG+KVAVKKPI
Sbjct: 1   MGVEIVQPNTCFRGCCSSESIPLCLPSSFYSLLSPIARGAESVVYEACLDGKKVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTS+++D FHKELQLLCKLDHPG+AK VAAHAKPPNYMFFFEFYES NLA+KLHVEEWS
Sbjct: 61  LSTSQDIDKFHKELQLLCKLDHPGIAKLVAAHAKPPNYMFFFEFYESGNLADKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P +DQ  MI  QLA+ALQYLHNLGI+HRDVKPANVLLD+   PHLADFGLAEY+ +LK++
Sbjct: 121 PGIDQAFMITVQLARALQYLHNLGIIHRDVKPANVLLDKKFYPHLADFGLAEYKADLKQV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           S +NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFG+SINELLTGVVPY
Sbjct: 181 STENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGVSINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTAAV S GLRP+LA LE   PA +LSLIQRCWD NP N
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAVASEGLRPVLAGLESAAPARLLSLIQRCWDANPQN 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RPSF +I +ELD +LEHRK++KE++   G+  +   D+ IN   N+ TY ESINW AQGE
Sbjct: 301 RPSFDEIVMELDPILEHRKTVKEKENILGEPSIFPADQHINDATNLRTYQESINWVAQGE 360

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
           + SK AS  A+S V++W +S+ND LTY P+LSWGSFATCGRRETMEDTHFLMP+M+N+++
Sbjct: 361 NFSKIASSVADSSVEMWFDSSNDPLTYRPILSWGSFATCGRRETMEDTHFLMPNMFNEED 420

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           IH+FGIFDGHRG+AAAEFSARALPG+L+ LGS + P DALLEAF++TDVAFRNELDS RK
Sbjct: 421 IHVFGIFDGHRGAAAAEFSARALPGYLKTLGSRSSPADALLEAFVKTDVAFRNELDSCRK 480

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           SK V+QKDWHPGCTA+AALIVRN+LFVANAGDCR ILCR G  FALS+
Sbjct: 481 SKGVIQKDWHPGCTAVAALIVRNKLFVANAGDCRTILCRAGCAFALSK 528

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225440177|ref|XP_002283443.1| PREDICTED: protein kinase and PP2C-like domain-containing protein isoform 2 [Vitis vinifera]

 Score =  842 bits (2176), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/538 (74%), Positives = 463/538 (86%), Gaps = 10/538 (1%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MG+++++PNTC RGCCSS+SIPL LP S Y+LLSPIARGAESVVYEA LDG+KVAVKKPI
Sbjct: 1   MGVEIVQPNTCFRGCCSSESIPLCLPSSFYSLLSPIARGAESVVYEACLDGKKVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLL----------CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           LSTS+++D FHKELQLL            LDHPG+AK VAAHAKPPNYMFFFEFYES NL
Sbjct: 61  LSTSQDIDKFHKELQLLWSTFLSFCLFFFLDHPGIAKLVAAHAKPPNYMFFFEFYESGNL 120

Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
           A+KLHVEEWSP +DQ  MI  QLA+ALQYLHNLGI+HRDVKPANVLLD+   PHLADFGL
Sbjct: 121 ADKLHVEEWSPGIDQAFMITVQLARALQYLHNLGIIHRDVKPANVLLDKKFYPHLADFGL 180

Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
           AEY+ +LK++S +NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFG+SI
Sbjct: 181 AEYKADLKQVSTENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGVSI 240

Query: 269 NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI 328
           NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV S GLRP+LA LE   PA +LSLI
Sbjct: 241 NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVASEGLRPVLAGLESAAPARLLSLI 300

Query: 329 QRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYH 388
           QRCWD NP NRPSF +I +ELD +LEHRK++KE++   G+  +   D+ IN   N+ TY 
Sbjct: 301 QRCWDANPQNRPSFDEIVMELDPILEHRKTVKEKENILGEPSIFPADQHINDATNLRTYQ 360

Query: 389 ESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHF 448
           ESINW AQGE+ SK AS  A+S V++W +S+ND LTY P+LSWGSFATCGRRETMEDTHF
Sbjct: 361 ESINWVAQGENFSKIASSVADSSVEMWFDSSNDPLTYRPILSWGSFATCGRRETMEDTHF 420

Query: 449 LMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVA 508
           LMP+M+N+++IH+FGIFDGHRG+AAAEFSARALPG+L+ LGS + P DALLEAF++TDVA
Sbjct: 421 LMPNMFNEEDIHVFGIFDGHRGAAAAEFSARALPGYLKTLGSRSSPADALLEAFVKTDVA 480

Query: 509 FRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           FRNELDS RKSK V+QKDWHPGCTA+AALIVRN+LFVANAGDCR ILCR G  FALS+
Sbjct: 481 FRNELDSCRKSKGVIQKDWHPGCTAVAALIVRNKLFVANAGDCRTILCRAGCAFALSK 538

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139662|ref|XP_002323217.1| predicted protein [Populus trichocarpa] gi|222867847|gb|EEF04978.1| predicted protein [Populus trichocarpa]

 Score =  840 bits (2171), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/528 (76%), Positives = 457/528 (86%), Gaps = 1/528 (0%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MGL+++EPN+CIRGCC+S SIPLHLPPSSYTLLSPIA+GAESVVY A LDGRKVAVKKPI
Sbjct: 1   MGLEIVEPNSCIRGCCTSNSIPLHLPPSSYTLLSPIAKGAESVVYGAVLDGRKVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTSE++D FHKELQLLCKLDHPG+AK VAAHAKPPNYMFFFEFYES NL+EKLHVEEWS
Sbjct: 61  LSTSEDIDKFHKELQLLCKLDHPGIAKLVAAHAKPPNYMFFFEFYESGNLSEKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++DQVLMI  QLAKALQYLHN  IVHRDVKPAN+LLD NLCPHLADFGLAEY++NLK +
Sbjct: 121 PNMDQVLMITVQLAKALQYLHNHEIVHRDVKPANILLDENLCPHLADFGLAEYQKNLKGV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           SL+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 SLENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGISINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTA+VVSG LRP LA L  G  ASILSLIQRCWD NP N
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTASVVSGKLRPALAGLGSGASASILSLIQRCWDDNPQN 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RPSF+DI LELD +LE RK    +D    K  +++ D+  +S  N+ TY E INW+ QGE
Sbjct: 301 RPSFTDILLELDPILESRKKSIGKDFSLDKYSISHGDQPADSAKNLTTYQEIINWSTQGE 360

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
             S KA  A +S +++WL+ +N  L Y P+LSWGSFATCG+RETMEDTHFLMPHM N+K+
Sbjct: 361 ILS-KAPPAVDSSLRIWLDCSNVGLAYRPILSWGSFATCGKRETMEDTHFLMPHMCNEKD 419

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           IH FGIFDGHRG+AAAEFSARALPGFLQ+ GS + P +AL+EAF+ TD AFRNELD+ RK
Sbjct: 420 IHAFGIFDGHRGAAAAEFSARALPGFLQSTGSASSPRNALVEAFVSTDAAFRNELDTHRK 479

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S+RVVQKDWHPGCTAI ALIV N+LFVANAGDC+ ILCR G  + LS+
Sbjct: 480 SRRVVQKDWHPGCTAIVALIVTNKLFVANAGDCKTILCRAGKAYPLSK 527

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255570496|ref|XP_002526206.1| protein kinase, putative [Ricinus communis] gi|223534484|gb|EEF36185.1| protein kinase, putative [Ricinus communis]

 Score =  827 bits (2136), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/528 (75%), Positives = 450/528 (85%), Gaps = 2/528 (0%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MG++++EPNTCIRGCCSS SIPLHLPPS YTLLSPIARG ESVVYE  LDGR+VAVKKPI
Sbjct: 1   MGVEIMEPNTCIRGCCSSNSIPLHLPPSCYTLLSPIARGGESVVYEGILDGRRVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTSE++D FHKELQLLC LDHPG+A+  AAHAKPPNYMFFFE YES NLA KLHVEEWS
Sbjct: 61  LSTSEDIDKFHKELQLLCTLDHPGIARLAAAHAKPPNYMFFFELYESGNLAGKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+DQVL I+ QLAKALQYLHN GIVHRDVKPANVLLDRNLC HLADFGLAEYR+NLK +
Sbjct: 121 PSIDQVLRISIQLAKALQYLHNQGIVHRDVKPANVLLDRNLCAHLADFGLAEYRKNLKGV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           S++NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 SMENWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHTEKSDVYSFGISINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTAAVVSG LRP LA  E G  AS+LSLIQRCWD NP  
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGNLRPALAGPESGASASMLSLIQRCWDENPQI 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RPSF +I LEL  VLEH+     E+   G+S +   D+L +  N +  + ESINW+ QGE
Sbjct: 301 RPSFDNIVLELSTVLEHKLKTMGENQAGGESTI-LQDQLSDGANKVQIFRESINWSTQGE 359

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
             SKK S A    ++ WL+S+ND L Y+PVLSWGSFATCG+RETMED HFLMPHM ++K+
Sbjct: 360 ELSKKVSLAVNLGLRNWLDSSNDPLAYHPVLSWGSFATCGKRETMEDRHFLMPHMCDEKD 419

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           IH+FGIFDGHRG+AAAEFSA+A+PGFL++L   T P  AL E FI TD+AFRNELDS RK
Sbjct: 420 IHVFGIFDGHRGAAAAEFSAQAMPGFLRSLAFVTSPKSALFEVFISTDLAFRNELDSHRK 479

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S RV+QKDWHPGCTAIAALIVR++LF+ANAGDCR+ILCR G  F+LS+
Sbjct: 480 S-RVIQKDWHPGCTAIAALIVRDKLFIANAGDCRSILCRSGRAFSLSK 526

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357439937|ref|XP_003590246.1| Protein kinase and PP2C-like domain-containing protein [Medicago truncatula] gi|355479294|gb|AES60497.1| Protein kinase and PP2C-like domain-containing protein [Medicago truncatula]

 Score =  800 bits (2066), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/528 (69%), Positives = 444/528 (84%), Gaps = 6/528 (1%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           +G +++EPNTCIRGCC+S SIPLHLPPSSY LL PIARGAESVVYE TL+G KVAVKKPI
Sbjct: 2   VGKEIVEPNTCIRGCCTSSSIPLHLPPSSYELLFPIARGAESVVYEGTLNGDKVAVKKPI 61

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LS S+ ++NFHK+LQLLCKLDHPG+A  +AAHAKPPNYMFFF+ YES NL  KLHVEEW+
Sbjct: 62  LSLSQHINNFHKQLQLLCKLDHPGIATLIAAHAKPPNYMFFFKLYESSNLGHKLHVEEWA 121

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P+V+  LMI  QLAKALQYLHNLGI+HRDVKP+N+LLD NLCPHL DFGLAEY+ ++K +
Sbjct: 122 PTVNDALMITMQLAKALQYLHNLGILHRDVKPSNILLDINLCPHLTDFGLAEYKSDIKGV 181

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           SL+NW+SSGKPTGGFHKKNMVGTL+YMAPEILKKE+H+EKSDVYSFGISINELLTGVVPY
Sbjct: 182 SLENWKSSGKPTGGFHKKNMVGTLVYMAPEILKKELHTEKSDVYSFGISINELLTGVVPY 241

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTAAVVS GLRP+LAS ELG+P+ ++S+I++CWD NP +
Sbjct: 242 TDLRAEAQAHTVLEMNYTEQQLTAAVVSDGLRPVLASEELGIPSRLVSMIRKCWDANPKS 301

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RPSF DI  ELD ++EHRK  K ED+      ++  D+L++      TY ESI+W+AQGE
Sbjct: 302 RPSFDDIVKELDFIMEHRKVKKVEDMHIRPCNLSV-DQLVDK-----TYQESISWSAQGE 355

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
             ++  S + +S  + W ES ++   Y P+LSWGS+ATCGRRE MEDTHF++PH++N+K+
Sbjct: 356 LLARNTSSSTDSGFRTWCESYDEPFAYRPILSWGSYATCGRREAMEDTHFILPHVFNEKD 415

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           ++ FGIFDGHRG+AAAEFS+RA+P  LQ LG  T P +AL+EAF+RTD AFR EL S RK
Sbjct: 416 VYAFGIFDGHRGAAAAEFSSRAVPAVLQTLGFKTSPANALVEAFLRTDTAFRKELASYRK 475

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S R +QKDWHPGCTAIAA++  N+LFVAN+GDCRAIL R G+P ALS+
Sbjct: 476 SNRCIQKDWHPGCTAIAAIVSGNKLFVANSGDCRAILYRAGNPIALSK 523

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500335|ref|XP_003518988.1| PREDICTED: protein kinase and PP2C-like domain-containing protein-like [Glycine max]

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/528 (69%), Positives = 440/528 (83%), Gaps = 1/528 (0%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MG+++LEPNTCIRGCC+S SIPLHLPPSSYTLLSPIARG+ESVVYE TLDG +VAVKKPI
Sbjct: 1   MGIEILEPNTCIRGCCTSPSIPLHLPPSSYTLLSPIARGSESVVYEGTLDGTRVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTSE+++ FHKELQLLCKLDHPG+A  +AAHAKPPNYMFFF+ +ES NLA+KLHVEEW 
Sbjct: 61  LSTSEDINKFHKELQLLCKLDHPGIATPIAAHAKPPNYMFFFKLFESPNLAQKLHVEEWI 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P+++  LMIA QLAKALQYLHNLGIVHRDVKPAN+LLD+NLCPHL DFGLAEY+ +LK +
Sbjct: 121 PTLNDALMIAMQLAKALQYLHNLGIVHRDVKPANILLDKNLCPHLTDFGLAEYKNDLKRV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           S +NW+SSGKPTGGFHKKNMVGTLIYMAPEIL+KE+H+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 STENWKSSGKPTGGFHKKNMVGTLIYMAPEILRKELHTEKSDVYSFGISINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLR EAQAHTVLEMNYTEQQLTAAVVS GLRP+LA+ +LG+P+ +LS+I++CWD +P+N
Sbjct: 241 TDLRTEAQAHTVLEMNYTEQQLTAAVVSDGLRPVLAAEDLGIPSRLLSMIKKCWDADPNN 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RP+F DI  ELDLV+EH K  K ED+   + Y  +  +     ++   Y ES +W  +GE
Sbjct: 301 RPAFDDIVEELDLVMEHGKLKKAEDIHI-RPYNLHVVQPAGKTDHFKAYQESFSWFTRGE 359

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
             ++ AS A +S +    ES++    Y+P +SWGS+ATCGRRETMEDTHF++PH+ ++K+
Sbjct: 360 LLARSASSANDSGLITRCESSDKPSAYHPTMSWGSYATCGRRETMEDTHFILPHICDEKD 419

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
            + FGIFDGHRG+AAA FS+RA+P  LQ       P +AL EAFI+TD AFR ELDS RK
Sbjct: 420 AYAFGIFDGHRGAAAAAFSSRAVPAVLQTSDFMGSPANALAEAFIKTDAAFRKELDSYRK 479

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S R +QKDWHPGCTAIA LIVRN+LFVAN GDCR ILCR G+P ALS+
Sbjct: 480 SNRCIQKDWHPGCTAIAILIVRNKLFVANIGDCRVILCRAGNPIALSK 527

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297827721|ref|XP_002881743.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297327582|gb|EFH58002.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  762 bits (1968), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/536 (68%), Positives = 440/536 (82%), Gaps = 14/536 (2%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1   MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTS++LD FH+ LQLLC LDHPG+AK +AAHAKPPNYMFFFE YES  LAEKLHVEEWS
Sbjct: 61  LSTSDDLDKFHRNLQLLCNLDHPGVAKLLAAHAKPPNYMFFFELYESGTLAEKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+DQVL+I   LAKALQYLHN GIVHRDVKPANVLLD    P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLVITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +L+NWRSSGKPTGGFHKKNMVGTLIYMAPE+L+K++++EKSD+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPELLRKDMYTEKSDIYSFGILINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTAA+VS GLRP LA   L LP ++LSLIQ CW+ +P  
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAIVSSGLRPALAETGLHLPKNLLSLIQNCWEADPSK 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDK-----LINSGNNMHTYHESINW 393
           RPS  ++ LEL+ + E  +  K++     K+Y +  D      + NSG     Y + +NW
Sbjct: 301 RPSSDNVGLELESIWEQVRG-KQQGHLLEKTYNSQSDTDGADIIKNSGE----YRDIVNW 355

Query: 394 TAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM 453
           ++QGE  SKK+S +   DVKLW  S +D  +Y PV+S GSFATCGRRE+MEDTHFLMPHM
Sbjct: 356 SSQGECLSKKSSVSTVFDVKLWSTSIDDPSSYVPVISCGSFATCGRRESMEDTHFLMPHM 415

Query: 454 YNQKEIHMFGIFDGHRG---SAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFR 510
            N++ IH+F IFDGHRG   + AAEFSA+ LPG +Q+L ST+   +AL +AF+RTD+AFR
Sbjct: 416 CNEESIHLFAIFDGHRGIPTATAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFR 474

Query: 511 NELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
            ELDS R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+
Sbjct: 475 QELDSHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSK 530

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30688440|ref|NP_850336.1| putative protein phosphatase 2C 31 [Arabidopsis thaliana] gi|75249489|sp|Q940A2.1|P2C31_ARATH RecName: Full=Protein kinase and PP2C-like domain-containing protein; Includes: RecName: Full=Probable serine/threonine protein kinase At2g40860; Includes: RecName: Full=Probable protein phosphatase 2C 31; Short=AtPP2C31 gi|15810225|gb|AAL07230.1| unknown protein [Arabidopsis thaliana] gi|22136688|gb|AAM91663.1| unknown protein [Arabidopsis thaliana] gi|330254797|gb|AEC09891.1| putative protein phosphatase 2C 31 [Arabidopsis thaliana]

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/532 (67%), Positives = 438/532 (82%), Gaps = 9/532 (1%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1   MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES  LAEKLHVEEWS
Sbjct: 61  LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+DQVL+I   LAKALQYLHN GIVHRDVKPANVLLD    P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P  
Sbjct: 241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD----DKLINSGNNMHTYHESINWT 394
           RPS  ++ LEL+ + E  +  ++  L    S    D    D + NSG+    Y +++NW 
Sbjct: 301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGD----YRDTVNWF 356

Query: 395 AQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMY 454
           +QGE  SKK+S +   DVKLW  S ++   Y PV+S GSFATCGRRE+MEDTHF++PHM 
Sbjct: 357 SQGECLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMC 416

Query: 455 NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELD 514
           N++ IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+   +AL +AF+RTD+AFR ELD
Sbjct: 417 NEESIHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFRQELD 475

Query: 515 SLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           S R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+
Sbjct: 476 SHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSK 527

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|312281615|dbj|BAJ33673.1| unnamed protein product [Thellungiella halophila]

 Score =  748 bits (1930), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/528 (67%), Positives = 428/528 (81%), Gaps = 5/528 (0%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           M ++++EPNTCIRGCC+S+SIPLHL PSS+TL SPIARG+ESVVYEA LDGR+VA KKP+
Sbjct: 1   MVMEIVEPNTCIRGCCTSESIPLHLSPSSFTLRSPIARGSESVVYEAILDGRRVAAKKPV 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTS++LD FH+ LQLLC LDHPGLAK +AAHAKPPNYMFFFE YES  LAEKLHVEEWS
Sbjct: 61  LSTSDDLDKFHRHLQLLCNLDHPGLAKLLAAHAKPPNYMFFFELYESGTLAEKLHVEEWS 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+DQVLMI  QLAKALQ LHN GIVHRDVKPANVLLD  L P+LADFGLAEY+++L+E+
Sbjct: 121 PSIDQVLMITLQLAKALQNLHNNGIVHRDVKPANVLLDEKLSPYLADFGLAEYKKDLREV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +L NWRSSGKPTGGF+KKNMVGTLIYMAPEIL+KE+ +EKSD+YSFGI INELLTGVVPY
Sbjct: 181 NLHNWRSSGKPTGGFYKKNMVGTLIYMAPEILRKEMFTEKSDIYSFGILINELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLRAEAQAHTVLEMNYTEQQLTAA+VS GLRP LA     +P S+LSLIQ+CW  +P  
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAIVSSGLRPALAETGFHVPKSLLSLIQKCWGADPSK 300

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
           RPS  ++ LEL+ + E  +  ++       + ++  DK   +      Y + INW++QG+
Sbjct: 301 RPSLDNVVLELESLWEQEREKQQ----GQTNSISRSDKDGEAIKITGEYRDDINWSSQGQ 356

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
             SKK   +    +K+W  S +D+  Y   +S GSFATCGRRE+MEDTHFLMPHM N++ 
Sbjct: 357 CLSKKLFLSTVPGLKMWSSSTDDSSRYVTRVSCGSFATCGRRESMEDTHFLMPHMCNEEN 416

Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+   +AL +AFIRTD+AFR+ELDS R+
Sbjct: 417 IHLFAIFDGHRGAAAAEFSAQVLPGLIQSLSSTS-TGEALSQAFIRTDLAFRHELDSHRQ 475

Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           SKRV QKD HPGCTAIA+L+V N+LFVAN GD RAILCR GH FALS+
Sbjct: 476 SKRVSQKDLHPGCTAIASLLVDNKLFVANVGDSRAILCRAGHSFALSK 523

Source: Thellungiella halophila

Species: Eutrema halophilum

Genus: Eutrema

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449505991|ref|XP_004162623.1| PREDICTED: protein kinase and PP2C-like domain-containing protein-like [Cucumis sativus]

 Score =  744 bits (1921), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/533 (68%), Positives = 431/533 (80%), Gaps = 15/533 (2%)

Query: 39  MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
           MGL++++PNTCIRGCCS+ SIPLHL PS++TLLSPIARG ES VYE  LDGRKVAVKKPI
Sbjct: 1   MGLEIMDPNTCIRGCCSTNSIPLHLQPSAFTLLSPIARGGESTVYEGRLDGRKVAVKKPI 60

Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           LSTSEELD FHKELQLLC+LDHPG+ K VAA+AKPPNYMFFFE+YES NLAEKLHVEEW+
Sbjct: 61  LSTSEELDKFHKELQLLCELDHPGIVKLVAANAKPPNYMFFFEYYESPNLAEKLHVEEWN 120

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS++QVLMI  +LAK LQYLHNLGIVHRDVKPANVLLD++L P+LADFGLA +++ LKE+
Sbjct: 121 PSINQVLMITLELAKTLQYLHNLGIVHRDVKPANVLLDKDLHPYLADFGLAIHQKYLKEV 180

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           S +NW+SSGKPTGGF+KK+MVGTLIYMAPEIL+KEIH++ SDVYSFGI +NELLTGVVPY
Sbjct: 181 SAENWKSSGKPTGGFYKKSMVGTLIYMAPEILRKEIHTDLSDVYSFGILMNELLTGVVPY 240

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
           TDLR EAQAHTVLEMNYTEQ LTAA+VS GLRP L S E G P+ +LSLIQ CWD NP N
Sbjct: 241 TDLRTEAQAHTVLEMNYTEQLLTAAIVSDGLRPALPSDESGTPSRLLSLIQSCWDANPKN 300

Query: 339 RPSFSDIALELDLVLEHRKSLK-----EEDLCAGKSYVTYDDKLINSGNNMHTYHESINW 393
           RPSFSDI ++L+ + E RKSL+     + DLC          +L ++  +   Y E INW
Sbjct: 301 RPSFSDIVMDLESIWESRKSLESVSSGQLDLCG---------RLSDANEHDCAYREEINW 351

Query: 394 TAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM 453
           + QGEH S+K S      +  WL+ + D L Y P LS GSF+T G RETMED+HFL+PH 
Sbjct: 352 SNQGEHCSQKFS-GDRCGLNEWLDHSTDQLAYRPTLSCGSFSTRGMRETMEDSHFLLPHF 410

Query: 454 YNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNEL 513
            + + IH FGIFDGHRG+AAAEFSA+A+PGFLQ   ST  P D L+EAF++TD+ FR EL
Sbjct: 411 CSDENIHAFGIFDGHRGAAAAEFSAQAIPGFLQRAFSTRSPADVLMEAFVKTDIEFRKEL 470

Query: 514 DSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           +  RKSK++ QKDWHPGCTA+ ALIVR++LF ANAGDCRAILCR G P  LS+
Sbjct: 471 EFFRKSKKLKQKDWHPGCTAVVALIVRDKLFAANAGDCRAILCRAGDPIVLSK 523

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	573
TAIR|locus:2058495	658	AT2G40860 [Arabidopsis thalian	0.919	0.800	0.668	4.9e-195
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.279	0.174	0.323	7.2e-27
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.246	0.268	0.331	2.7e-25
TAIR|locus:2102802	475	AT3G46930 [Arabidopsis thalian	0.251	0.303	0.317	1.5e-24
DICTYBASE|DDB_G0290451	710	shkE "SHK subfamily protein ki	0.467	0.377	0.297	3.5e-24
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.432	0.566	0.310	8.1e-23
TAIR|locus:2084193	411	AT3G01490 [Arabidopsis thalian	0.200	0.279	0.396	1.3e-22
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.471	0.375	0.296	1.7e-22
TAIR|locus:2170106	385	AT5G50000 [Arabidopsis thalian	0.200	0.298	0.404	1.9e-22
DICTYBASE|DDB_G0281343	744	shkD "SHK subfamily protein ki	0.455	0.350	0.304	4e-22

TAIR|locus:2058495 AT2G40860 [Arabidopsis thaliana (taxid:3702)]

 Score = 1889 (670.0 bits), Expect = 4.9e-195, P = 4.9e-195
 Identities = 353/528 (66%), Positives = 427/528 (80%)

Query:    39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
             M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct:     1 MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60

Query:    99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
             LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES  LAEKLHVEEWS
Sbjct:    61 LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120

Query:   159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
             PS+DQVL+I   LAKALQYLHN GIVHRDVKPANVLLD    P+LADFGLAEY++NL+E+
Sbjct:   121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180

Query:   219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct:   181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240

Query:   279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P  
Sbjct:   241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300

Query:   339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGX 398
             RPS  ++ LEL+ + E  +  ++  L    S    D    +   N   Y +++NW +QG 
Sbjct:   301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGDYRDTVNWFSQGE 360

Query:   399 XXXXXXXXXXXXDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
                         DVKLW  S ++   Y PV+S GSFATCGRRE+MEDTHF++PHM N++ 
Sbjct:   361 CLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMCNEES 420

Query:   459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
             IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+   +AL +AF+RTD+AFR ELDS R+
Sbjct:   421 IHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTSAG-EALSQAFVRTDLAFRQELDSHRQ 479

Query:   519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
             SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+
Sbjct:   480 SKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSK 527

GO:0003824 "catalytic activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004722 "protein serine/threonine phosphatase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 237 (88.5 bits), Expect = 7.2e-27, Sum P(3) = 7.2e-27
 Identities = 54/167 (32%), Positives = 90/167 (53%)

Query:    66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPG 122
             S   + S +  G   VVY+    G  VA+K+  ++    ++ L+ F KEL +L +L HP 
Sbjct:   660 SELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPN 719

Query:   123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
             +   +AA   PPN  F  E+    +L + LH ++   ++     +A Q+A+ + YLH  G
Sbjct:   720 IVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSG 779

Query:   183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
             ++HRD+K  N+LLD ++   + DFGL++    LK  S +  +S G P
Sbjct:   780 VIHRDIKSLNLLLDEHMNVKICDFGLSK----LKSKSTEMTKSIGSP 822

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 205 (77.2 bits), Expect = 2.7e-25, Sum P(3) = 2.7e-25
 Identities = 52/157 (33%), Positives = 84/157 (53%)

Query:    75 ARGAESVVYEATLDGRKVAVKKPILSTSEELDN----------FHKELQLLCKLDHPGLA 124
             A G  S +Y    + + VAVK  +++  ++ DN          F KE+ LL +L HP + 
Sbjct:   214 AHGLYSRLYHGKYEDKAVAVK--LITVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVI 271

Query:   125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
             KFV A+  PP Y    ++    +L   LH  E  S  + +++  A  +A+ ++Y+H+  I
Sbjct:   272 KFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRI 331

Query:   184 VHRDVKPANVLLDRNLCPHLADFGLA---EYRENLKE 217
             +HRD+KP NVL+D      +ADFG+A   EY + L +
Sbjct:   332 IHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLAD 368

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)]

 Score = 183 (69.5 bits), Expect = 1.5e-24, Sum P(3) = 1.5e-24
 Identities = 52/164 (31%), Positives = 84/164 (51%)

Query:    75 ARGAESVVYEATLDGRKVAVKKPILSTSEELDN----------FHKELQLLCKLDHPGLA 124
             A G  S +Y    +G+ VA+K  I++  E+ D+          F  E  LL +L HP + 
Sbjct:   168 AHGKYSQIYHGEYEGKAVALK--IITAPEDSDDIFLGARLEKEFIVEATLLSRLSHPNVV 225

Query:   125 KFVAAHAKPPNYMFFFEFYESRNLAEKLH-VEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
             KFV  +          E+    +L   LH +E+ S  ++Q++     +AK ++Y+H+  I
Sbjct:   226 KFVGVNT---GNCIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREI 282

Query:   184 VHRDVKPANVLLDRNLCPHLADFGLA---EYRENLKE-ISLKNW 223
             VH+D+KP NVL+D +    +ADFG+A   EY + L + I    W
Sbjct:   283 VHQDLKPENVLIDNDFHLKIADFGIACEEEYCDVLGDNIGTYRW 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009644 "response to high light intensity" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

DICTYBASE|DDB_G0290451 shkE "SHK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 306 (112.8 bits), Expect = 3.5e-24, P = 3.5e-24
 Identities = 91/306 (29%), Positives = 155/306 (50%)

Query:    55 SSQSIPLHLPPSSYTL---LSPIARGAESVVYEATLDGRKVAVKKPILST-SE-ELDNFH 109
             S  S P  +PP           +  GA   VY+AT  G+KVAVK P   T SE EL +F 
Sbjct:   221 SRHSGPPEIPPEEIKFDVKTDLLGGGAYGKVYKATCRGKKVAVKVPKKQTLSESELKSFK 280

Query:   110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-VDQVLMIA 168
              E++++ ++ HP +   + A  KP   M   E  ++ +L + +H  E  P  + + + + 
Sbjct:   281 NEVEIMKQIFHPNVVLCLGACTKPGKVMIVSELMQT-DLEKLIHSSEVEPPPLYERMKMC 339

Query:   169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
                A  + +LH +  I+HRD+K AN+++ ++    + DFG ++  +    +S        
Sbjct:   340 LDAALGINWLHGICNIIHRDLKLANLMISKDKTVKIGDFGFSQVIKTGTTLS-------- 391

Query:   228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
                    +K   GT +YMAPE++ K   +EK+DVYSFG+ + E+ T      +L  E   
Sbjct:   392 ------DQKGPKGTALYMAPEVMMKHEFNEKADVYSFGLILYEMAT----CEELFPE--- 438

Query:   288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
             ++ ++  Y       A+ +  LRP +       P S+ +LIQ+CWD +P+ RPSF+++  
Sbjct:   439 YSEIDPFYD------AICNKKLRPPIPD---SFPKSLKTLIQKCWDHDPNKRPSFNEVTQ 489

Query:   348 ELDLVL 353
              ++ VL
Sbjct:   490 RMNEVL 495

GO:0051219 "phosphoprotein binding" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 247 (92.0 bits), Expect = 8.1e-23, Sum P(2) = 8.1e-23
 Identities = 85/274 (31%), Positives = 130/274 (47%)

Query:    23 LLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVV 82
             LL S  GL +    S    K + P   I   C  +  P  L  S+  +   I +G+   +
Sbjct:   122 LLKSHGGLSYGQNGSHFEPKPVPPP--IPKKCDWEIEPAELDFSNAAM---IGKGSFGEI 176

Query:    83 YEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139
              +A   G  VAVK+ + S S++   + +F  E+ LL KL HP + +F+ A  +    M  
Sbjct:   177 VKAYWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLI 236

Query:   140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDR 197
              E+    +L + L  E+   +    +  A  +A+ + YLHN    I+HRD+KP NVLL  
Sbjct:   237 TEYLRGGDLHQYLK-EKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVN 295

Query:   198 NLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH 255
             +   HL   DFGL+      K I ++N     K TG        G+  YMAPE+ K   +
Sbjct:   296 SSADHLKVGDFGLS------KLIKVQNSHDVYKMTGE------TGSYRYMAPEVFKHRRY 343

Query:   256 SEKSDVYSFGISINELLTGVVPYTDLRA-EAQAH 288
              +K DV+SF + + E+L G  P+ +    EA  H
Sbjct:   344 DKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKH 377

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)]

 Score = 189 (71.6 bits), Expect = 1.3e-22, Sum P(3) = 1.3e-22
 Identities = 52/131 (39%), Positives = 69/131 (52%)

Query:   164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
             V+ ++  LA+ L YLH+  IVHRDVK  N+LLD++    +ADFG+A       E S  N 
Sbjct:   230 VIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIADFGVARL-----EASNPN- 283

Query:   224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                   TG        GTL YMAPE+L    ++ K DVYSFGI + E+    +PY DL  
Sbjct:   284 ----DMTGE------TGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 333

Query:   284 EAQAHTVLEMN 294
                   V+  N
Sbjct:   334 SEVTSAVVRQN 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 291 (107.5 bits), Expect = 1.7e-22, P = 1.7e-22
 Identities = 88/297 (29%), Positives = 146/297 (49%)

Query:    74 IARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132
             + +G +  VY+  L DG  VAVKK      E L+ F  E+ LL +++H  + K +    +
Sbjct:   396 LGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLE 455

Query:   133 PPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHN---LGIVHRD 187
                 +  +EF  +RNL + LH   E++  S +  L IA ++A AL YLH+   + I HRD
Sbjct:   456 TEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRD 515

Query:   188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMA 246
             VK  N+LLD      ++DFG++      + +++ +           H   +V GT+ Y+ 
Sbjct:   516 VKSTNILLDEKHRAKVSDFGIS------RSVAIDDT----------HLTTIVQGTIGYVD 559

Query:   247 PEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA-EAQAHTVLEMNYTEQQLTAAVV 305
             PE L+    + KSDVYSFG+ + ELLTG  P + LR  E +      +          ++
Sbjct:   560 PEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEIL 619

Query:   306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
                ++      E+    ++  L +RC   N  +RP+  D+ +ELD +   RK  + +
Sbjct:   620 DARIKEECDREEV---LAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQ 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)]

 Score = 191 (72.3 bits), Expect = 1.9e-22, Sum P(3) = 1.9e-22
 Identities = 53/131 (40%), Positives = 68/131 (51%)

Query:   164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
             V+ +A  LA+ L YLH+  IVHRDVK  N+LLD+     +ADFG+A       E S  N 
Sbjct:   204 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARV-----EASNPN- 257

Query:   224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                   TG        GTL YMAPE+L    ++ K DVYSFGI + E+    +PY DL  
Sbjct:   258 ----DMTGE------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLTF 307

Query:   284 EAQAHTVLEMN 294
                   V+  N
Sbjct:   308 SEVTSAVVRQN 318

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009506 "plasmodesma" evidence=IDA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

DICTYBASE|DDB_G0281343 shkD "SHK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 288 (106.4 bits), Expect = 4.0e-22, P = 4.0e-22
 Identities = 91/299 (30%), Positives = 148/299 (49%)

Query:    60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE--ELDNFHKELQLLCK 117
             P  + P        + +G+   VY+    G++VAVK P        EL +F  E++++ K
Sbjct:   269 PPEILPEEIDRTDFLGQGSFGSVYKGKCRGQEVAVKIPRKQKLSLYELTSFRHEVKIMSK 328

Query:   118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKAL 175
             + HP +  F+ A  +        E  ++ +L + LH +      S+ + + +A   A  +
Sbjct:   329 IFHPNVVLFLGACTQSGKMQIVTELCQT-DLEKLLHNDRTKKEFSLFRRMQMAKDAALGM 387

Query:   176 QYLHNLG-IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
              +LH +  IVH D+K AN+L+D NL   + DFG ++ +E  +E               F 
Sbjct:   388 NWLHGITRIVHNDLKTANLLVDINLRVKVTDFGFSQIKEG-EE---------------FQ 431

Query:   235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
              K   GT ++MAPE++    ++EK+DVYSFGI + E+LT   PY+        H   ++ 
Sbjct:   432 DKAAKGTPLWMAPEVMMGNPYNEKADVYSFGIILWEILTKEAPYSH-------HKDYDIF 484

Query:   295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
             +       A+ +   RP + +  L  P S+  LIQ CWD NP NRPSFS+I   L+ +L
Sbjct:   485 FN------AICNEKERPPIPADTL--P-SLRHLIQTCWDHNPQNRPSFSEILFRLNEIL 534

GO:0051219 "phosphoprotein binding" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q5JJY4	P2C04_ORYSJ	3, ., 1, ., 3, ., 1, 6	0.6504	0.9057	0.7899	yes	no
Q940A2	P2C31_ARATH	3, ., 1, ., 3, ., 1, 6	0.6785	0.9127	0.7948	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_XVI0076 hypothetical protein (662 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	573
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-32
cd00143	254	cd00143, PP2Cc, Serine/threonine phosphatases, fam	5e-30
smart00332	252	smart00332, PP2Cc, Serine/threonine phosphatases,	2e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-28
pfam00481	252	pfam00481, PP2C, Protein phosphatase 2C	4e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-24
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-19
PLN03145	365	PLN03145, PLN03145, Protein phosphatase 2c; Provis	7e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
COG0631	262	COG0631, PTC1, Serine/threonine protein phosphatas	4e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
PTZ00224	381	PTZ00224, PTZ00224, protein phosphatase 2C; Provis	2e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-08
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	7e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-07
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  177 bits (452), Expect = 7e-52
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 36/281 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           Y +L  +  G+   VY A     G+ VA+K        ++ +   +E+++L KL HP + 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           +               E+ E  +L + L  +    S D+      Q+  AL+YLH+ GIV
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+LLD +    LADFGLA      +++             G      VGT  Y
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLA------RQL-----------DPGEKLTTFVGTPEY 162

Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           MAPE+L  + + +  D++S G+ + ELLTG  P+                  +Q L    
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFK 207

Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             G  +P     E  +      LI++    +P  R +  + 
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  172 bits (439), Expect = 7e-50
 Identities = 87/285 (30%), Positives = 130/285 (45%), Gaps = 38/285 (13%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHP 121
           Y LL  +  G+   VY+A     G+ VAVK  IL    E     +    E+++L +L HP
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVK--ILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + + + A     +     E+ E  +L + L       S D+   IA Q+ + L+YLH+ 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           GI+HRD+KP N+LLD N    +ADFGLA+             +SS   T        VGT
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL----------KSSSSLTT------FVGT 161

Query: 242 LIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             YMAPE+L     +  K DV+S G+ + ELLTG  P++            E    + QL
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG-----------ENILDQLQL 210

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              ++   L         G       LI++C + +P  RP+  +I
Sbjct: 211 IRRILGPPLEFDEPKWSSG-SEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  166 bits (423), Expect = 3e-48
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 71/277 (25%)

Query: 74  IARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH 130
           +  G    VY A     G+KVA+K      +S  L+   +E+++L KL+HP + K     
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
               +     E+ E  +L + L   E   S D++L I  Q+ + L+YLH+ GI+HRD+KP
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 191 ANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
            N+LLD  N    LADFGL++   + K +                 K +VGT  YMAPE+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLL----------------KTIVGTPAYMAPEV 164

Query: 250 LK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           L  K  +SEKSD++S G+                       + E+               
Sbjct: 165 LLGKGYYSEKSDIWSLGV----------------------ILYELP-------------- 188

Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                          +  LI++    +P  RPS  +I
Sbjct: 189 --------------ELKDLIRKMLQKDPEKRPSAKEI 211

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (415), Expect = 2e-46
 Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 55/296 (18%)

Query: 69  TLLSPIARGAESVVYEATLDGR------KVAVKKPILSTSE-ELDNFHKELQLLCKLDHP 121
           TL   +  GA   VY+  L G+      +VAVK      SE +++ F +E +++ KLDHP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K +    +        E+ E  +L   L       S+  +L  A Q+A+ ++YL + 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-------YRENLKEISLKNWRSSGKPTGGFH 234
             +HRD+   N L+  NL   ++DFGL+        YR+   ++ ++ W           
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-W----------- 169

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
                     MAPE LK+   + KSDV+SFG+ + E+ T G  PY  +            
Sbjct: 170 ----------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM------------ 207

Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
             + +++   + +G   P   +     P  +  L+ +CW  +P +RP+FS++   L
Sbjct: 208 --SNEEVLEYLKNGYRLPQPPN----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  161 bits (410), Expect = 9e-46
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 56/297 (18%)

Query: 69  TLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSE-ELDNFHKELQLLCKLDHP 121
           TL   +  GA   VY+ TL G+       VAVK      SE +++ F +E +++ KLDHP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHN 180
            + K +    +    M   E+    +L + L        S+  +L  A Q+A+ ++YL +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKPTGGF 233
              +HRD+   N L+  NL   ++DFGL+        Y+    ++ ++ W          
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR-W---------- 170

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
                      MAPE LK+   + KSDV+SFG+ + E+ T G  PY  +           
Sbjct: 171 -----------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM----------- 208

Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
              +  ++   +  G   P   +     P  +  L+ +CW  +P +RP+FS++   L
Sbjct: 209 ---SNAEVLEYLKKGYRLPKPPN----CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (402), Expect = 1e-44
 Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 58/298 (19%)

Query: 69  TLLSPIARGAESVVYEATLDGR------KVAVKK-PILSTSEELDNFHKELQLLCKLDHP 121
            L   +  GA   VY+ TL G       KVAVK     ++ EE + F +E  ++ KL HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + + +    +        E+    +L + L       ++  +L +A Q+AK ++YL + 
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKPTGGFH 234
             VHRD+   N L+  NL   ++DFGL+        YR+         W           
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW----------- 170

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
                     MAPE LK    + KSDV+SFG+ + E+ T G  PY  +  E         
Sbjct: 171 ----------MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------- 211

Query: 294 NYTEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                ++   +  G    RP         P  +  L+ +CW  +P +RP+FS++  +L
Sbjct: 212 -----EVLELLEDGYRLPRPENC------PDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  153 bits (389), Expect = 1e-42
 Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 55/297 (18%)

Query: 73  PIARGAESVVYEATLDG-----RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKF 126
            +  GA   VY+  L G      +VAVK      SE E  +F KE +++ KL HP + + 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKL------HVEEWSP--SVDQVLMIAAQLAKALQYL 178
           +    +        E+ E  +L + L               S+  +L  A Q+AK ++YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
            +   VHRD+   N L+  +L   ++DFGL+    +                  +++K  
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD----------------DDYYRKKT 165

Query: 239 VGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
            G L   +MAPE LK  I + KSDV+SFG+ + E+ T G  PY  L              
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------ 213

Query: 296 TEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
             +++   +  G    +P         P  +  L+  CW  +P +RP+FS++   L+
Sbjct: 214 --EEVLEYLRKGYRLPKPEYC------PDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  146 bits (372), Expect = 2e-40
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 44/291 (15%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           + +L  I +G    VY+A     G++VA+K   L + E+ +    E+Q+L K  HP + K
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
           +  ++ K        EF    +L + L     + +  Q+  +  +L K L+YLH+ GI+H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+K AN+LL  +    L DFGL+       ++S    R             MVGT  +M
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLS------AQLSDTKAR-----------NTMVGTPYWM 164

Query: 246 APEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           APE++  + +  K+D++S GI+  EL  G  PY++L        +  +        A   
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL------PPMKALFK-----IATNG 213

Query: 306 SGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
             GLR P   S E          +++C   NP  RP+    A +L   L+H
Sbjct: 214 PPGLRNPEKWSDEF------KDFLKKCLQKNPEKRPT----AEQL---LKH 251

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (348), Expect = 6e-37
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)

Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPG 122
            +T    + RG+   VY A     G  +AVK   LS  + EEL+   +E+++L  L HP 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 123 LAKFVAAHAKPPNYMF--FFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQ 176
           + ++  +           F E+    +L+  L     + E    V +      Q+ + L 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE---PVIRKY--TRQILEGLA 115

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+ GIVHRD+K AN+L+D +    LADFG A      K +                  
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA------KRLGDIETGEGTGS------- 162

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
            + GT  +MAPE+++ E +   +D++S G ++ E+ TG  P+++L     A         
Sbjct: 163 -VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--------- 212

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
              L     SG    I       L       +++C   +P  RP+    A EL   L+H
Sbjct: 213 ---LYKIGSSGEPPEIPE----HLSEEAKDFLRKCLRRDPKKRPT----ADEL---LQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  136 bits (341), Expect = 4e-35
 Identities = 92/380 (24%), Positives = 157/380 (41%), Gaps = 29/380 (7%)

Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG- 122
           SY +L  +  G+   VY A  D + VA+K   K + S S+E++ F +E+Q+L  L+HP  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
           + K         +     E+ +  +L + L        +   + L I AQ+  AL+YLH+
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 181 LGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
            GI+HRD+KP N+LLDR+     L DFGLA+   +    S                   V
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL----------PSTSV 169

Query: 240 GTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
           GT  YMAPE+L        S  SD++S GI++ ELLTG+ P+   +  +     L++   
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
                         P+  S    +  +   L+++    +P NR   S  +     +L H 
Sbjct: 230 L------PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL--SSSSDLSHDLLAHL 281

Query: 357 KSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWL 416
           K  + +     K   +   +L    +         +    G       S+ ++      +
Sbjct: 282 KLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGV 341

Query: 417 ESANDALTYYPVLSWGSFAT 436
            S+    +   + +  S  +
Sbjct: 342 SSSPHNSSSLLLSTASSKRS 361

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  130 bits (329), Expect = 3e-34
 Identities = 72/292 (24%), Positives = 136/292 (46%), Gaps = 42/292 (14%)

Query: 68  YTLLSPIARGAESVVY--EATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y ++  I +G+   VY      DG+   +K+  LS  + +E ++   E+++L KL+HP +
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS---PSVDQVLMIAAQLAKALQYLHN 180
            K+  +  +        E+ +  +L++K+  ++        +Q+L    QL  AL+YLH+
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+KP N+ L  N    L DFG+++   +  +                  K +VG
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD----------------LAKTVVG 165

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           T  Y++PE+ + + ++ KSD++S G  + EL T   P+       +   +LE       L
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-------EGENLLE-------L 211

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
              ++ G   PI +       + + +L+      +P  RPS + I L+   +
Sbjct: 212 ALKILKGQYPPIPSQ----YSSELRNLVSSLLQKDPEERPSIAQI-LQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 33/224 (14%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGL 123
           Y L   I RGA  VVY+      G  VA+K+  L     E L +  +E+ LL  L HP +
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLA------EKLHVEEWSPSVDQVLMIAAQLAKALQY 177
            K++ +     +     E+ E+ +L               +  V QVL       + L Y
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLAY 114

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH  G++HRD+K AN+L  ++    LADFG+A      K   +    +S           
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDDAS----------- 158

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           +VGT  +MAPE+++    S  SD++S G ++ ELLTG  PY DL
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  124 bits (313), Expect = 4e-32
 Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 44/291 (15%)

Query: 70  LLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKF 126
            +  + +G+  VVY+      G+  A+KK  +    E      +EL+ L   + P + K 
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIV 184
             A  K        E+ +  +LA+ L  V +    V  +  IA Q+ K L YLH    I+
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV--LAYIARQILKGLDYLHTKRHII 122

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP+N+L++      +ADFG++           K   ++      F     VGT+ Y
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGIS-----------KVLENTLDQCNTF-----VGTVTY 166

Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           M+PE ++ E +S  +D++S G+++ E   G  P+      +    +  +           
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---- 222

Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
               L     S E          I  C   +P  RPS    A EL   L+H
Sbjct: 223 ----LPAEEFSPEF------RDFISACLQKDPKKRPS----AAEL---LQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|238083 cd00143, PP2Cc, Serine/threonine phosphatases, family 2C, catalytic domain; The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity

 Score =  118 bits (297), Expect = 5e-30
 Identities = 50/141 (35%), Positives = 69/141 (48%), Gaps = 14/141 (9%)

Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL------ 485
           G     G R+T ED   + P++ N+    +FG+FDGH G AA EF+++ L   L      
Sbjct: 4   GVSDKGGDRKTNEDAVVIKPNLNNED-GGLFGVFDGHGGHAAGEFASKLLVEELLEELEE 62

Query: 486 QNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFV 545
               S     +AL +AF+R D     E        R        G TA+ ALI  N+L+V
Sbjct: 63  TLTLSEEDIEEALRKAFLRADEEILEEAQDEPDDARS-------GTTAVVALIRGNKLYV 115

Query: 546 ANAGDCRAILCRGGHPFALSR 566
           AN GD RA+LCR G    L++
Sbjct: 116 ANVGDSRAVLCRNGEAVQLTK 136

Length = 254

>gnl|CDD|214625 smart00332, PP2Cc, Serine/threonine phosphatases, family 2C, catalytic domain

 Score =  116 bits (292), Expect = 2e-29
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 19/145 (13%)

Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
             L +G  +  G R+ MED H + P +        FG+FDGH GS AA+F ++ LP  L 
Sbjct: 7   LGLRYGLSSMQGVRKPMEDAHVITPDL--SDSGGFFGVFDGHGGSEAAKFLSKNLPEILA 64

Query: 487 NL-----GSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN 541
                         +AL +AF+ TD             + + + +   G TA+ ALI  N
Sbjct: 65  EELIKEKDELEDVEEALRKAFLSTD------------EEILEELEALSGSTAVVALISGN 112

Query: 542 RLFVANAGDCRAILCRGGHPFALSR 566
           +L+VAN GD RA+LCR G    L+ 
Sbjct: 113 KLYVANVGDSRAVLCRNGKAVQLTE 137

The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity. Length = 252

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  114 bits (289), Expect = 1e-28
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 15/218 (6%)

Query: 73  PIARGAESVVYEATL--DGRKVAVKKPILSTS----EELDNF-HKELQLLCKLD-HPGLA 124
            I  G+ S V  A      ++ A+K  IL       E+   +   E ++L +L+ HPG+ 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIK--ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           K         N  F  E+  +  L + +  +  S         AA++  AL+YLH+ GI+
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGII 124

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLK---NWRSSGKPTGGFHKKNMVG 240
           HRD+KP N+LLD+++   + DFG A+    N    S K       S          + VG
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           T  Y++PE+L ++   + SD+++ G  I ++LTG  P+
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  114 bits (287), Expect = 2e-28
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 14/212 (6%)

Query: 74  IARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           I++GA   V+ A     G   A+K   K  +    ++D    E  +L +   P + K   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
           +     N     E+    +LA  L     S   D   +  A++  AL+YLH+ GI+HRD+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           KP N+L+D N    L DFGL++         L   R           K +VGT  Y+APE
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKV-------GLVR-RQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           ++  + HS+  D +S G  + E L G+ P+  
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)

Query: 69  TLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHP 121
             +  +  G    V     D      G +VAVK    S  E+   +F +E+++L  LDH 
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            + K+  V       +     E+  S +L + L       ++ ++L+ ++Q+ K + YL 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +   +HRD+   N+L++      ++DFGLA      K +         K  G        
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLA------KVLPEDKDYYYVKEPGES------ 174

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-----GVVPYTDLRAEAQAHTVLEMN 294
             + + APE L+    S  SDV+SFG+++ EL T        P   LR    A   +   
Sbjct: 175 -PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM--- 230

Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
               +L   +  G   P   S     P  +  L++ CW+  P +RPSF+D+ L +D + 
Sbjct: 231 -IVTRLLELLKEGERLPRPPS----CPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215938 pfam00481, PP2C, Protein phosphatase 2C

 Score =  109 bits (275), Expect = 4e-27
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 14/141 (9%)

Query: 432 GSFATCGRRETMEDTHFLMPHMYN---QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
           G     G R+ MED H    ++     +     F +FDGH GS AA+++ + L   L   
Sbjct: 4   GGPRMQGFRKFMEDAHIAGKNLNASSGKDSFGFFAVFDGHGGSQAAKYAGKHLETILALR 63

Query: 489 GS--TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVA 546
            S  T    DAL ++F+  D   R        S     +D   G TA+ ALI   +L+VA
Sbjct: 64  RSFLTLDKLDALRKSFLEADEELR--------SDAANHEDLSSGSTAVVALIRGQKLYVA 115

Query: 547 NAGDCRAILCRGGHPF-ALSR 566
           N GD RA+LCR G+    L+ 
Sbjct: 116 NVGDSRAVLCRNGNAIKQLTE 136

Protein phosphatase 2C is a Mn++ or Mg++ dependent protein serine/threonine phosphatase. Length = 252

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 5e-27
 Identities = 60/223 (26%), Positives = 116/223 (52%), Gaps = 22/223 (9%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + +L  +  G+   VY+A     G+ VA+K  ++   E+L    KE+ +L + D P
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSP 58

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K+  ++ K  +     E+  + ++++ + +   + + +++  I  Q  K L+YLH+ 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
             +HRD+K  N+LL+      LADFG+                 SG+ T    K+N ++G
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGV-----------------SGQLTDTMAKRNTVIG 161

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
           T  +MAPE++++  ++ K+D++S GI+  E+  G  PY+D+  
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/228 (25%), Positives = 109/228 (47%), Gaps = 24/228 (10%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD 119
             P   Y  L  I  GA   VY+AT    G++VA+KK  L   +  +    E+ ++    
Sbjct: 15  GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCK 73

Query: 120 HPGLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           HP +  +  ++    + ++   E+ +  +L + +       +  Q+  +  ++ + L+YL
Sbjct: 74  HPNIVDYYDSY-LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+K  N+LL ++    LADFG A       +++               + ++
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA------AQLT----------KEKSKRNSV 176

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
           VGT  +MAPE++K++ +  K D++S GI   E+  G  PY     LRA
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (271), Expect = 2e-26
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 32/217 (14%)

Query: 74  IARGAESVVYEA--TLDGR----KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           + +G+   V        G+    KV  KK I+   E       E  +L +++HP + K  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59

Query: 128 AAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVH 185
            A  +    ++   E+     L    H+ +    S ++    AA++  AL+YLH+LGI++
Sbjct: 60  YAF-QTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116

Query: 186 RDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           RD+KP N+LLD   ++   L DFGLA      KE+S          + G       GT  
Sbjct: 117 RDLKPENILLDADGHIK--LTDFGLA------KELS----------SEGSRTNTFCGTPE 158

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           Y+APE+L  + + +  D +S G+ + E+LTG  P+  
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 40/291 (13%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           +      L + I +G    V      G+KVAVK  +   S     F  E  ++  L HP 
Sbjct: 3   INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKC-LKDDSTAAQAFLAEASVMTTLRHPN 61

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV-DQVLMIAAQLAKALQYLHNL 181
           L + +    +        E+    +L + L     +     Q L  A  + + ++YL   
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             VHRD+   NVL+  +L   ++DFGLA      KE S       G+ +G    K     
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQ------GQDSGKLPVK----- 164

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + APE L+++  S KSDV+SFGI + E+ + G VPY  +                + +
Sbjct: 165 --WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PLKDV 208

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
              V   G R  + + E G P  +  +++ CW+ +P  RP+F  +  +L L
Sbjct: 209 VPHVEK-GYR--MEAPE-GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  105 bits (265), Expect = 1e-25
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 49/210 (23%)

Query: 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLA 204
           E+ ++EE     + +  I  QL  AL   HN       ++HRD+KPAN+ LD N    L 
Sbjct: 98  ERKYIEE-----EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152

Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSF 264
           DFGLA      K +                 K  VGT  YM+PE L    + EKSD++S 
Sbjct: 153 DFGLA------KIL----------GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSL 196

Query: 265 GISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA--SLELGLPA 322
           G  I EL     P+T                 + QL + +  G  R I    S EL    
Sbjct: 197 GCLIYELCALSPPFT--------------ARNQLQLASKIKEGKFRRIPYRYSSELN--- 239

Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLV 352
               +I+   + +P  RPS  ++ L+L L+
Sbjct: 240 ---EVIKSMLNVDPDKRPSTEEL-LQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (261), Expect = 4e-25
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 58/294 (19%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPIL-----STSEELDNFHKELQLLCKLDHPGLAKF 126
           +  G+   VYE     DG   AVK+  L     +  E +    +E+ LL KL HP + ++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
           +    +  N   F E     +LA KL  +  S     + +   Q+   L+YLH+   VHR
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+K AN+L+D N    LADFG+A+                         K+  G+  +MA
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFA-----------------KSFKGSPYWMA 169

Query: 247 PE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           PE I ++  +   +D++S G ++ E+ TG  P                 +++ +  AAV 
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP-----------------WSQLEGVAAVF 212

Query: 306 ----SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
               S  L PI   L       IL  +QR    +P  RP+    A EL   LEH
Sbjct: 213 KIGRSKELPPIPDHLSDEAKDFILKCLQR----DPSLRPT----AAEL---LEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 78/320 (24%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS---TSEELDNFHKEL 112
           LP    TL+  + +G+  +VYE    G        +VA+K   ++   +  E   F  E 
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRERIEFLNEA 60

Query: 113 QLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKL--HVEE-------WSPSV 161
            ++ + +   + +   V +  +P   +   E     +L   L     E         P++
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EYRENL 215
            + + +AA++A  + YL     VHRD+   N ++  +L   + DFG+       +Y    
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---- 174

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT 273
                  +R  GK           G L   +MAPE LK  + + KSDV+SFG+ + E+ T
Sbjct: 175 -------YRKGGK-----------GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQR 330
               PY  L  E              ++   V+ GG    P         P  +L L++ 
Sbjct: 217 LAEQPYQGLSNE--------------EVLKFVIDGGHLDLPE------NCPDKLLELMRM 256

Query: 331 CWDGNPHNRPSFSDIALELD 350
           CW  NP  RP+F +I   L 
Sbjct: 257 CWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (257), Expect = 1e-24
 Identities = 88/302 (29%), Positives = 124/302 (41%), Gaps = 59/302 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEEL--DNFHKELQLLCKLD 119
            P   +TL   +  G    V+E    +  +VA+K  IL + + L   +F KE+Q L +L 
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK--ILKSDDLLKQQDFQKEVQALKRLR 60

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYL 178
           H  L    A  +         E  E  +L   L   E     V  ++ +A Q+A+ + YL
Sbjct: 61  HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAE------YRENLKEISLKNWRSSGKPTGG 232
                +HRD+   N+L+  +L   +ADFGLA       Y  + K+I  K           
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK----------- 169

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
                      + APE       S KSDV+SFGI + E+ T G VPY             
Sbjct: 170 -----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG----------- 207

Query: 292 EMNYTE--QQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
            MN  E   Q+TA     G R P  A      P  I  ++  CW   P +RPSF  +  E
Sbjct: 208 -MNNHEVYDQITA-----GYRMPCPAK----CPQEIYKIMLECWAAEPEDRPSFKALREE 257

Query: 349 LD 350
           LD
Sbjct: 258 LD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  103 bits (258), Expect = 1e-24
 Identities = 74/312 (23%), Positives = 132/312 (42%), Gaps = 63/312 (20%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEE--LDNFHKELQ 113
             P S+   ++ + RG    V+ A         G  + + K +  T +E     F +EL 
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 114 LLCKLDHPGLAKFVA-AHAKPPNYMFFFEFYESRNL-----AEKLHVEEWSP---SVDQV 164
           +  KL H  + + +       P+YM   E+ +  +L     A K   E+  P   S  Q 
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMIL-EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EYRENLKEI 218
           + +  Q+A  + +L N   VHRD+   N L+       ++   L+      EY       
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY------- 172

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                         +  +N +  L ++APE ++++  S KSDV+SFG+ + E+ T G +P
Sbjct: 173 --------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218

Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           +  L              +++++   + +G L   +     G P+ +  L+ RCW  NP 
Sbjct: 219 FYGL--------------SDEEVLNRLQAGKLELPVPE---GCPSRLYKLMTRCWAVNPK 261

Query: 338 NRPSFSDIALEL 349
           +RPSFS++   L
Sbjct: 262 DRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 88/291 (30%), Positives = 128/291 (43%), Gaps = 51/291 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           +P  S  L   +  G    V+  T +G  KVAVK  KP    +   + F +E Q++ KL 
Sbjct: 3   IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP---GTMSPEAFLQEAQIMKKLR 59

Query: 120 HPGLAKFVAAHA----KPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKA 174
           H    K V  +A    + P Y+   E+    +L + L   E     + Q++ +AAQ+A+ 
Sbjct: 60  HD---KLVQLYAVCSEEEPIYIVT-EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           + YL +   +HRD+   N+L+  NL   +ADFGLA     L E      R   K    F 
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAK----FP 167

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
            K       + APE       + KSDV+SFGI + E++T G VPY  +        VLE 
Sbjct: 168 IK-------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQ 216

Query: 294 NYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                      V  G R P         P  +  L+ +CWD +P  RP+F 
Sbjct: 217 -----------VERGYRMPRPP----NCPEELYDLMLQCWDKDPEERPTFE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (254), Expect = 4e-24
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 48/292 (16%)

Query: 74  IARGAESVVYEA-TLD-GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G    VY A  LD G  +AVK+  +  ++   +     E+++L  L HP L K+   
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI---AAQLAKALQYLHNLGIVHR 186
                    F E+     L E L        +    +I     QL + L YLH+ GIVHR
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+KPAN+ LD N    L DFG A       ++      ++         +++ GT  YMA
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCA------VKLK----NNTTTMGEEV--QSLAGTPAYMA 171

Query: 247 PEILKKEIHSEK---SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           PE++           +D++S G  + E+ TG  P+++L               E Q+   
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------------NEFQIMFH 218

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           V +G   PI  SL+L         + RC + +P  RP+    A EL   L+H
Sbjct: 219 VGAGHKPPIPDSLQLSPEG--KDFLDRCLESDPKKRPT----ASEL---LQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (251), Expect = 8e-24
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 41/199 (20%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           K   K+  +     + N   E ++L +L+HP L               ++ F +  N+  
Sbjct: 31  KYMNKQKCVEK-GSVRNVLNERRILQELNHPFLVNL------------WYSFQDEENMYL 77

Query: 151 KL----------HVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            +          H+ +    S +QV     ++  AL+YLH+ GI+HRD+KP N+LLD   
Sbjct: 78  VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG 137

Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
             H+ DF +A                    T         GT  YMAPE+L ++ +S   
Sbjct: 138 HVHITDFNIA-----------TKVTPDTLTTS------TSGTPGYMAPEVLCRQGYSVAV 180

Query: 260 DVYSFGISINELLTGVVPY 278
           D +S G++  E L G  PY
Sbjct: 181 DWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  100 bits (252), Expect = 1e-23
 Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 62/307 (20%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRK-------VAVKK-PILSTSEELDNFHKELQL 114
           +P  S TLL  +  GA   VYE    GR        VAVK  P   + ++  +F  E  +
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ--------VLM 166
           + K +H  + + +    +        E     +L  K  + E  P  ++        +L 
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL--KSFLRENRPRPERPSSLTMKDLLF 120

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLADFGLAEYRENLKEISL 220
            A  +AK  +YL     +HRD+   N LL    C        +ADFG+A      ++I  
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMA------RDI-- 169

Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
             +R+S    GG   + M+  + +M PE     I + K+DV+SFG+ + E+ + G +PY 
Sbjct: 170 --YRASYYRKGG---RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223

Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGLPASILSLIQRCWDGNPHN 338
               +     V+E           V  GG L P       G P  +  ++  CW   P +
Sbjct: 224 GRTNQ----EVMEF----------VTGGGRLDP-----PKGCPGPVYRIMTDCWQHTPED 264

Query: 339 RPSFSDI 345
           RP+F+ I
Sbjct: 265 RPNFATI 271

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 28/227 (12%)

Query: 66  SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPG 122
             Y L+  I  GA +VVY A    +  KVA+K+  L      +D   KE+Q + + +HP 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA---KALQYLH 179
           + K+  +            +    +L + +        +D+ + IA  L    K L+YLH
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI-IATVLKEVLKGLEYLH 119

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFG----LAEYRENLKEISLKNWRSSGKPTGGFHK 235
           + G +HRD+K  N+LL  +    +ADFG    LA+  +  +++                +
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----------------R 163

Query: 236 KNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDL 281
           K  VGT  +MAPE++++   +  K+D++SFGI+  EL TG  PY+  
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 29/223 (13%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPG 122
             +TLL  I +G+   VY+A      + VA+K   L    +E+++  +E+Q L +   P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           + K+  +  K        E+       +L +   ++E       +  I  ++   L+YLH
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-----TYIAFILREVLLGLEYLH 115

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-M 238
             G +HRD+K AN+LL       LADFG+                 SG+ T    K+N  
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV-----------------SGQLTSTMSKRNTF 158

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           VGT  +MAPE++K+  + EK+D++S GI+  EL  G  P +DL
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 70/255 (27%), Positives = 118/255 (46%), Gaps = 37/255 (14%)

Query: 90  RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149
            KVA+K  +   S   + F  E  L+ +L HP L +  A   + P Y+   E+ E+ +L 
Sbjct: 31  TKVAIKS-LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIIT-EYMENGSLV 88

Query: 150 EKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
           + L   E    ++++++ +AAQ+A+ + ++     +HRD++ AN+L+   LC  +ADFGL
Sbjct: 89  DFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGL 148

Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
           A   E+ +  +    R   K    F  K       + APE +     + KSDV+SFGI +
Sbjct: 149 ARLIEDNEYTA----REGAK----FPIK-------WTAPEAINYGTFTIKSDVWSFGILL 193

Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
            E++T G +PY  +    +    LE  Y   +                     P  +  L
Sbjct: 194 TEIVTYGRIPYPGMT-NPEVIQNLERGYRMPRPD-----------------NCPEELYEL 235

Query: 328 IQRCWDGNPHNRPSF 342
           ++ CW   P  RP+F
Sbjct: 236 MRLCWKEKPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           Y +L  I  GA  +V++A     G  VA+KK  L   E    +   +E++ L    HP +
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K +        ++   E Y   +L+E L  EE      QV      L K + Y+H  GI
Sbjct: 62  VKLLDVFPHGSGFVLVME-YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KPAN+L+  +    +ADFGLA  R            S  +P    H+   V T  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLA--RLF----------SEEEPRLYSHQ---VATRW 165

Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
           Y APE+L     +    D+++ G    ELL G 
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 70/217 (32%), Positives = 101/217 (46%), Gaps = 29/217 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDHP 121
           Y  ++ I  G    VY+A     G  VA+KK  +    E + F     +E++LL KL HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHP 58

Query: 122 ---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
               L + V +  K   YM F E+ +  +L   L   E   +  Q+     QL + LQYL
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVF-EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+ GI+HRD+K +N+L++ +    LADFGLA              R+S   T      N 
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK---------RNSADYT------NR 161

Query: 239 VGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
           V TL Y  PE+L        + D++S G  + EL  G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
           Y  L  I  G   VVY+A   L G  VA+KK  L    E       +E++LL +L+HP +
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K +       +    FEF ++ +L + +   +       +     QL + L + H+ GI
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++      LADFGLA              RS G P   +   + V T  
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLA--------------RSFGSPVRPY--THYVVTRW 163

Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
           Y APE+L   + +S   D++S G    ELL+  
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 21/223 (9%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   Y L+  I  G    VY+A     G  VA+K   L   ++ +   +E+ +L +  HP
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHP 60

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  +  ++ +        E+    +L +   V     S  Q+  +  +  K L YLH  
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           G +HRD+K AN+LL  +    LADFG++       +++     +  K      +K+ +GT
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS------AQLT----ATIAK------RKSFIGT 164

Query: 242 LIYMAPEILKKEIHS---EKSDVYSFGISINELLTGVVPYTDL 281
             +MAPE+   E       K D+++ GI+  EL     P  DL
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 9e-22
 Identities = 75/228 (32%), Positives = 114/228 (50%), Gaps = 31/228 (13%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILST-SEELDNFHKELQLLCKLDH-- 120
           S Y  L  I RGA   VY       GR VA+K   L T  +++ +  +E+ LL +L    
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 121 -PGLAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K P      E+ E    R L +   + E   SV     I  ++  AL+
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALK 115

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H +G++HRD+K AN+L+       L DFG+A     L + S K  RS+          
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSK--RST---------- 160

Query: 237 NMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
             VGT  +MAPE I + + +  K+D++S GI+I E+ TG  PY+D+ A
Sbjct: 161 -FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 9e-22
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 30/223 (13%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE---------LDNFHKELQLLCKLDHPG 122
           I  G+   VY       G  +AVK+  L +            LD   +E+ LL +L H  
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQYL 178
           + +++ +     +   F E+    ++A  L+     EE       V     Q+ K L YL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-----TLVRNFVRQILKGLNYL 122

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           HN GI+HRD+K AN+L+D      ++DFG          IS K   +S        + ++
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFG----------ISKKLEANSLSTKTNGARPSL 172

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
            G++ +MAPE++K+  ++ K+D++S G  + E+LTG  P+ D 
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 20/170 (11%)

Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           E ++L + +HP + K      K   Y++   E+     L   L  +             A
Sbjct: 43  EKEILEECNHPFIVKLYRTF-KDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA 100

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
            +  A +YLHN GI++RD+KP N+LLD N    L DFG A      K++       SG+ 
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFA------KKL------KSGQK 148

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
           T  F      GT  Y+APEI+  + +    D +S GI + ELLTG  P+ 
Sbjct: 149 TWTF-----CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 39/278 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
           + +L+ I +G+  VV++     D R  A+K+  LS     +      E ++L KLD   +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
            ++  +           E+ E+ +L + L ++   P   DQV     Q+   L +LH+  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+K  N+ LD      + D G+A      K +S                  +VGT 
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVA------KLLSDNT----------NFANTIVGTP 165

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y++PE+ + + ++EKSDV++ G+ + E  TG  P+    A  Q   +L+          
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILK---------- 212

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
            ++ G   P+           +  LI +C   +   RP
Sbjct: 213 -IIRGVFPPVSQ----MYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 38/263 (14%)

Query: 92  VAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           VAVK   L +   S+ +D+F KE  ++  LDH  L +        P  M   E     +L
Sbjct: 26  VAVK--CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSL 82

Query: 149 AEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
            ++L  +      +  +   A Q+A  ++YL +   +HRD+   N+LL  +    + DFG
Sbjct: 83  LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG 142

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
           L       ++    ++          H K       + APE L+    S  SDV+ FG++
Sbjct: 143 LMRALPQNED----HYVME------EHLKV---PFAWCAPESLRTRTFSHASDVWMFGVT 189

Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
           + E+ T G  P+  L        + +     ++L         RP     +      I +
Sbjct: 190 LWEMFTYGEEPWAGLSGSQILKKI-DKEG--ERLE--------RPEACPQD------IYN 232

Query: 327 LIQRCWDGNPHNRPSFSDIALEL 349
           ++ +CW  NP +RP+F+ +   L
Sbjct: 233 VMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 49/288 (17%)

Query: 68  YTLLSPIARGA--ESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y  +  + +GA  E+ +Y  T D   V  K+  L+  + +E  +   E+ +L  L HP +
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKL------HVEEWSPSVDQVLMIAAQLAKALQY 177
             +          +   E+     L +K+        EE     + VL    Q+  A+ Y
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-----EMVLWYLFQIVSAVSY 116

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           +H  GI+HRD+K  N+ L +     L DFG++      K +           +     + 
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS------KILG----------SEYSMAET 160

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           +VGT  YM+PE+ +   ++ KSD+++ G  + ELLT       L+    A   L      
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-------LKRTFDATNPLN----- 208

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             L   +V G   P+++     L    +SL+      +P  RP+  ++
Sbjct: 209 --LVVKIVQGNYTPVVSVYSSEL----ISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 79/297 (26%), Positives = 131/297 (44%), Gaps = 43/297 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLD--GRK---VAVK--KPILSTSEELDNFHKELQLL 115
           + PS  T+   I  G    V    L   G+K   VA+K  K   S  + LD F  E  ++
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIM 59

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            + DHP + +      K    M   E+ E+ +L + L   +   +V Q++ +   +A  +
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
           +YL  +  VHRD+   N+L++ NL   ++DFGL+   E+ +          GK P     
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK---GGKIP----- 171

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
                  + + APE +     +  SDV+SFGI + E+++ G  PY D+            
Sbjct: 172 -------IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM------------ 212

Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
             + Q +  AV  G   P      +  P+++  L+  CW  + + RP+FS I   LD
Sbjct: 213 --SNQDVIKAVEDGYRLPP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 81/307 (26%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKK-PI--LSTSEELDNFHKELQLLCKLDHPG 122
           + +   I +G  SVVY+A   LDGR VA+KK  I  +  ++   +  KE+ LL +LDHP 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA-------------- 168
           + K++A+            F E+  L     V E + + D   MI               
Sbjct: 64  VIKYLAS------------FIENNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTI 108

Query: 169 ----AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
                QL  AL+++H+  I+HRD+KPANV +       L D GL  +             
Sbjct: 109 WKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF------------- 155

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP-YTDLRA 283
            S K T        VGT  YM+PE + +  ++ KSD++S G  + E+     P Y D   
Sbjct: 156 FSSKTTAAHSL---VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--- 209

Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRCWDGNPHN 338
                   +MN     L   +      P        LPA   S     L+ RC + +P  
Sbjct: 210 --------KMNLYS--LCKKIEKCDYPP--------LPADHYSEELRDLVSRCINPDPEK 251

Query: 339 RPSFSDI 345
           RP  S +
Sbjct: 252 RPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 31/273 (11%)

Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST+E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L          ++L+ A+Q+ K ++YL +   VHRD+   N+L++      + DF
Sbjct: 93  SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDF 152

Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      R  G+             + + APE L +   S  SDV+SFG+
Sbjct: 153 GLTKVLPQDKEYYKV--REPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 199

Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV-------SGGLRPILASLELG 319
            + EL T    Y+D ++ +     + M   ++Q    V        + G  P       G
Sbjct: 200 VLYELFT----YSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA----PPG 250

Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            PA I ++++ CW+ +P  RPSFS++AL+++ +
Sbjct: 251 CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 9e-21
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 23/229 (10%)

Query: 65  PSSYTLLSPIARGAESVVYEA-TLD-GRKVAVKK-PI----LSTSEELDNFHKELQLLCK 117
           P+++     + +GA   VY    +D GR++AVK+ P       T +E++    E+QLL  
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQ 176
           L H  + ++            F E+    ++ +   ++ +    + V      Q+ + ++
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKD--QLKAYGALTETVTRKYTRQILEGVE 118

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+  IVHRD+K AN+L D      L DFG ++         L+   SSG  TG    K
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RLQTICSSG--TG---MK 165

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           ++ GT  +M+PE++  E +  K+DV+S G ++ E+LT   P+ +  A A
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 46/286 (16%)

Query: 74  IARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDN----FHKELQLLCKLDHPGLAK 125
           +  GA S  Y+A     G  +AVK    + +TS E +       KE++L+ +L+HP + +
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM-IAAQLAKALQYLHNLGIV 184
            + A  +  ++  F E+    +++  L   ++    + V++    QL + L YLH   I+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 185 HRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG-GFHKKNMVG 240
           HRDVK AN+L+D   + L   +ADFG A              R + K TG G  +  ++G
Sbjct: 126 HRDVKGANLLIDSTGQRL--RIADFGAAA-------------RLAAKGTGAGEFQGQLLG 170

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           T+ +MAPE+L+ E +    DV+S G  I E+ T   P+      A+ H+          L
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHS------NHLAL 219

Query: 301 TAAVVSG-GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              + S      I   L  GL    L    RC +  P +RP   ++
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTL----RCLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 45/298 (15%)

Query: 69  TLLSPIARGAESVVYEATLDGRK-----VAVKK-PILSTSEELDNFHKELQLLCKLDHPG 122
           TL   I  G    VY+      +     VAVK     ++    + F +E  ++ + DHP 
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K +    + P ++   E      L   L V ++S  +  +++ + QL+ AL YL +  
Sbjct: 69  IVKLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
            VHRD+   NVL+    C  L DFGL+ Y E+                   + K   G L
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-----------------YYKASKGKL 170

Query: 243 --IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              +MAPE +     +  SDV+ FG+ + E+L  GV P+  +               +  
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV---------------KNN 215

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357
                +  G R  +       P ++ SL+ +CW  +P  RP F+++  +L  +L+  K
Sbjct: 216 DVIGRIENGERLPMPPN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.2 bits (221), Expect = 6e-20
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 36/287 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           PS  TL+  I  G   +V+    L+ RKVA+K  I   +   ++F +E Q++ KL HP L
Sbjct: 3   PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKL 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            +      +       FEF E   L++ L  +    S + +L +   + + + YL +  +
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+   N L+  N    ++DFG+           L +  +S   T  F  K       
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTR-------FVLDDQYTSSTGTK-FPVK------- 166

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + +PE+     +S KSDV+SFG+ + E+ + G  PY + R+ ++   V+E      +L  
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSE---VVETINAGFRL-- 220

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                  +P LA        S+  L+Q CW   P +RPSFS +  +L
Sbjct: 221 ------YKPRLA------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 51/288 (17%)

Query: 74  IARGAESVVYEATL-DGRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHA 131
           I +G    VY+  L    +VAVK    +   +L   F +E ++L + DHP + K +    
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
           +        E     +L   L  ++   +V ++L ++   A  ++YL +   +HRD+   
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122

Query: 192 NVLLDRNLCPHLADFGLAEYREN--------LKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           N L+  N    ++DFG++   E         LK+I +K                      
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---------------------- 160

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L    ++ +SDV+S+GI + E  + G  PY                 + QQ   
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP--------------GMSNQQTRE 206

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
            + SG   P         P  I  L+ +CW  +P NRPSFS+I  EL 
Sbjct: 207 RIESGYRMPA----PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 31/226 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILSTSE-ELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   L  +E E+++  +E+ +L + D
Sbjct: 2   PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K        E+     + +L E   ++E      Q+  I  ++ K L 
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 115

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K ANVLL  +    LADFG+A                 G+ T    K+
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 158

Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 44/276 (15%)

Query: 82  VYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139
           VYE         VAVK  +   + E++ F KE  ++ ++ HP L + +    + P +   
Sbjct: 22  VYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80

Query: 140 FEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
            EF    NL + L     +   +V  + M A Q++ A++YL     +HRD+   N L+  
Sbjct: 81  TEFMTYGNLLDYLRECNRQEVNAVVLLYM-ATQISSAMEYLEKKNFIHRDLAARNCLVGE 139

Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
           N    +ADFGL+          +     +      F  K       + APE L     S 
Sbjct: 140 NHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIK-------WTAPESLAYNKFSI 184

Query: 258 KSDVYSFGISINELLT-GVVPY--TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
           KSDV++FG+ + E+ T G+ PY   DL   +Q + +LE  Y  +           RP   
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYRME-----------RP--- 227

Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
               G P  +  L++ CW  NP +RPSF++I    +
Sbjct: 228 ---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 42/285 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           +P  S  L+  +  G    V+  T +G  KVAVK  KP   + E   +F +E Q++ KL 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLR 59

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
           H  L +  A  ++ P Y+   E+    +L + L   E     +  ++ +AAQ+A  + Y+
Sbjct: 60  HDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
             +  +HRD++ AN+L+   L   +ADFGLA   E+ +  +    R   K    F  K  
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA----RQGAK----FPIK-- 168

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
                + APE       + KSDV+SFGI + EL+T G VPY  +        VLE     
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREVLEQ---- 215

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
                  V  G R          P S+  L+ +CW  +P  RP+F
Sbjct: 216 -------VERGYR---MPCPQDCPISLHELMLQCWKKDPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A     G   A K   + + EEL++F  E+ +L +  HP
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHP 62

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +     A+          EF +   L   +   E   +  Q+  +  Q+ +AL +LH+ 
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    LADFG          +S KN  +  K      +   +GT
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFG----------VSAKNKSTLQK------RDTFIGT 166

Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
             +MAPE++  E   +     K+D++S GI++ EL     P+ +L
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           +P  S  L   +  G    V+ AT +   KVAVK  KP    S  ++ F  E  ++  L 
Sbjct: 3   IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQ 59

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
           H  L K  A   K P Y+   EF    +L + L  +E S   + +++  +AQ+A+ + ++
Sbjct: 60  HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
                +HRD++ AN+L+  +L   +ADFGLA   E+ +  +    R   K    F  K  
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA----REGAK----FPIK-- 168

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
                + APE +     + KSDV+SFGI + E++T G +PY  + +  +    LE  Y  
Sbjct: 169 -----WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM 222

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            +                     P  + +++ RCW   P  RP+F
Sbjct: 223 PRPENC-----------------PEELYNIMMRCWKNRPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 38/288 (13%)

Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I +G    VY  TL   DG+K+  AVK    ++  EE++ F KE  ++    HP +   +
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 128 AAHAKPPNY-MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
                     +    + +  +L   +  E  +P+V  ++    Q+AK ++YL +   VHR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+   N +LD +    +ADFGLA      ++I  K + S    TG    K  V    +MA
Sbjct: 123 DLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGA---KLPVK---WMA 170

Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
            E L+ +  + KSDV+SFG+ + EL+T G  PY D+ +      +L+             
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ------------- 217

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
             G R  L   E   P  +  ++  CW   P  RP+FS++   ++ + 
Sbjct: 218 --GRR--LLQPEY-CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 29/225 (12%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDH 120
           P   +T L  I +G+   VY+   +  K  V   I+   E   E+++  +E+ +L + D 
Sbjct: 2   PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 121 PGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           P + ++  ++ K        E+     + +L +   +EE       +  I  ++ K L Y
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE-----TYIATILREILKGLDY 116

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH+   +HRD+K ANVLL       LADFG+A                 G+ T    K+N
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVA-----------------GQLTDTQIKRN 159

Query: 238 -MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
             VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P +DL
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 63/283 (22%), Positives = 133/283 (46%), Gaps = 39/283 (13%)

Query: 68  YTLLSPIARGA--ESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y  +  I  G+  ++++ ++  DG++  +K+  +S  + +E +   KE+ +L  + HP +
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
            ++  +  +  N     ++ E  +L +K++ +       DQ+L    Q+  AL+++H+  
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+K  N+ L ++    L DFG+A    +  E++                +  +GT 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA----------------RTCIGTP 165

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y++PEI +   ++ KSD+++ G  + E+ T       L+   +A  +       + L  
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCT-------LKHAFEAGNM-------KNLVL 211

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            ++ G   P+ +     L   +  L +R    NP +RPS + I
Sbjct: 212 KIIRGSYPPVSSHYSYDLRNLVSQLFKR----NPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 82/310 (26%), Positives = 136/310 (43%), Gaps = 61/310 (19%)

Query: 88  DGRKVAVKKPIL---STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF-FEF 142
           DG K+     +L   ++  +  +F  EL++LCKL  HP +   + A  +   Y++   E+
Sbjct: 26  DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGA-CENRGYLYIAIEY 84

Query: 143 YESRNLAE---KLHVEEWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
               NL +   K  V E  P            +  Q+L  A+ +A  +QYL     +HRD
Sbjct: 85  APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRD 144

Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YM 245
           +   NVL+  NL   +ADFGL+   E                    + K  +G L   +M
Sbjct: 145 LAARNVLVGENLASKIADFGLSRGEE-------------------VYVKKTMGRLPVRWM 185

Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           A E L   +++ KSDV+SFG+ + E+++ G  PY  +   A+ +  L   Y  ++     
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRMEK----- 239

Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDL 364
                 P     E      +  L+++CW   P+ RP F+ I+++L  +LE RK+     L
Sbjct: 240 ------PRNCDDE------VYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMAL 287

Query: 365 CAGKSYVTYD 374
               +Y   D
Sbjct: 288 FENFTYAGID 297

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 43/290 (14%)

Query: 74  IARGAESVVYEA-TLDGRKVAVKKPILSTSEEL------DNFHKELQLLCKLDHPGLAKF 126
           + +GA   VY   T  G+ +AVK+  L TS  L      +   +E+ LL  L H  + ++
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGIVH 185
           +           F EF    +++  L    + P  + V      Q+   + YLHN  +VH
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+K  NV+L  N    L DFG A     L  + L    S+         K+M GT  +M
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCAR---RLAWVGLHGTHSN-------MLKSMHGTPYWM 175

Query: 246 APEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           APE++ +  +  KSD++S G ++ E+ TG  P   +                 +L A   
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----------------DRLAAMFY 219

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
            G  R ++  L     A+ +  +  C   + H RPS    AL+L   L H
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQL---LRH 262

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 63/297 (21%)

Query: 82  VYEATL---DGR--KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFV------A 128
           V E  L   DG   KVAVK  K  + T  E++ F  E   +   DHP + K +      +
Sbjct: 15  VMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74

Query: 129 AHAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
           +  K P  M    F +  +L       +L        +  +L     +A  ++YL N   
Sbjct: 75  SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL- 242
           +HRD+   N +L  ++   +ADFGL+      K+I           +G ++++  +  + 
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLS------KKIY----------SGDYYRQGRIAKMP 178

Query: 243 -IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             ++A E L   +++ KSDV++FG+++ E+ T G  PY       + H + +        
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY----PGVENHEIYDY------- 227

Query: 301 TAAVVSGGLRPILASLELGLPASILS----LIQRCWDGNPHNRPSFSDIALELDLVL 353
               +  G R       L  P   L     L+  CW  +P +RP+F+ +   L+ +L
Sbjct: 228 ----LRHGNR-------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 21/190 (11%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           K+  K  I+   +  ++   E ++L  + HP L     +     N     E+     L  
Sbjct: 32  KILSKAKIVKLKQV-EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFS 90

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
               +            AAQ+  AL+YLH+L IV+RD+KP N+LLD +    + DFG A 
Sbjct: 91  -HLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA- 148

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                K +  + +              + GT  Y+APEI+  + + +  D ++ GI I E
Sbjct: 149 -----KRVKGRTY-------------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYE 190

Query: 271 LLTGVVPYTD 280
           +L G  P+ D
Sbjct: 191 MLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215603 PLN03145, PLN03145, Protein phosphatase 2c; Provisional

 Score = 88.0 bits (218), Expect = 7e-19
 Identities = 61/179 (34%), Positives = 89/179 (49%), Gaps = 21/179 (11%)

Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM---YN 455
           HSS   + A++  V+  L   N    + PV+  G++A  G R +MED +  + +    + 
Sbjct: 35  HSSLVKTPASDISVENELTFENMDTEFIPVVRSGAWADIGSRSSMEDVYICVDNFMSDFG 94

Query: 456 QKEIH-----MFGIFDGHRGSAAAEFSARALPGFL-QNLGSTTRPTDALLEAFIRTDVAF 509
            K         +G+FDGH G  AA+F+   LP F+ ++          +  AF++TD AF
Sbjct: 95  LKNSEDGPSAFYGVFDGHGGKHAADFACYHLPRFIVEDEDFPREIEKVVSSAFLQTDTAF 154

Query: 510 RN--ELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
                LD+   S          G TA+AAL+V   L VANAGDCRA+LCR G    +SR
Sbjct: 155 AEACSLDASLAS----------GTTALAALVVGRSLVVANAGDCRAVLCRRGKAIEMSR 203

Length = 365

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 43/285 (15%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           + +L  + +G+   VY+     D +  A+K+  L   + +E ++   E+++L  ++HP +
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLHN 180
             +  A           E+    +L++ +   +    +    ++  I  QL + LQ LH 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K AN+LL  N    + D G++                  K       K  +G
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGIS------------------KVLKKNMAKTQIG 163

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           T  YMAPE+ K   +S KSD++S G  + E+ T   P+       +A ++ ++ Y     
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-------EARSMQDLRYK---- 212

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              V  G   PI       L   I S++Q      P  RP+   I
Sbjct: 213 ---VQRGKYPPIPPIYSQDLQNFIRSMLQV----KPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.5 bits (214), Expect = 8e-19
 Identities = 69/307 (22%), Positives = 136/307 (44%), Gaps = 55/307 (17%)

Query: 68  YTLLSPIARGAESVVYEATL-----DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
           +TL   + +G    V EA L       +KVAVK  K  + +S +++ F +E   + + DH
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 121 PGLAKF--VAAHAKP----PNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVLMIAA 169
           P + K   V+  ++     P  M    F +  +L       ++  E ++  +  ++    
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
            +A  ++YL +   +HRD+   N +L+ N+   +ADFGL+      K+I           
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS------KKIY---------- 164

Query: 230 TGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
           +G ++++     L   ++A E L   +++  SDV++FG+++ E++T G  PY  +     
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224

Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            + +++ N  +Q                         +  L+ +CW   P  RPSF  + 
Sbjct: 225 YNYLIKGNRLKQPPDC------------------LEDVYELMCQCWSPEPKCRPSFQHLR 266

Query: 347 LELDLVL 353
            +L+L+ 
Sbjct: 267 DQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 68  YTLLSPIARGAESVVYE----ATLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKLD 119
           Y +L  +  GA  VV +    AT  G  VA+KK     SE+ ++  K    E+++L +L 
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKAT--GEIVAIKK--FKESEDDEDVKKTALREVKVLRQLR 58

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQ 176
           H  +     A  +       FE+ E R L   L + E SP     D V     QL +A+ 
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVE-RTL---LELLEASPGGLPPDAVRSYIWQLLQAIA 114

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y H+  I+HRD+KP N+L+  +    L DFG A           +  R+           
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFA-----------RALRARPAS----PLT 159

Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
           + V T  Y APE+L  + +  K  DV++ G  + ELL G
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 73/286 (25%), Positives = 117/286 (40%), Gaps = 50/286 (17%)

Query: 74  IARGAESVVYEATL-DGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G    V++ TL D   VAVK       +EL   F  E ++L + DHP + K +    
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
           +        E     +    L  ++      Q++  A   A  + YL +   +HRD+   
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122

Query: 192 NVLLDRNLCPHLADFGLAEYREN-------LKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           N L+  N    ++DFG++   ++       LK+I +K                      +
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK----------------------W 160

Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            APE L    +S +SDV+S+GI + E  + GV PY  +  + QA   +E  Y        
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVEKGYR------- 212

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                      S     P  +  ++QRCWD  P NRP FS++  EL
Sbjct: 213 ----------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 23/222 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILSTSE-ELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   L  +E E+++  +E+ +L + D
Sbjct: 2   PEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            P + K+  ++ K        E+    +  + L    +     Q+  +  ++ K L YLH
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF--QIATMLKEILKGLDYLH 118

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +   +HRD+K ANVLL       LADFG+A     L +  +K             +   V
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIK-------------RNTFV 162

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           GT  +MAPE++++  +  K+D++S GI+  EL  G  P +D+
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 54/263 (20%)

Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           G K +V+K IL          +ELQ++ +   P +  F  A     N     EF +  +L
Sbjct: 41  GAKSSVRKQIL----------RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90

Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFG 207
            ++++ +     V+ +  IA  + + L YL+N   I+HRD+KP+N+L++      L DFG
Sbjct: 91  -DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
           ++   E +  I+                   VGT  YM+PE ++   ++ KSDV+S GIS
Sbjct: 150 VSG--ELINSIA----------------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191

Query: 268 INELLTGVVPYT----DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS 323
           I EL  G  P+     D   +     +L++               L+ I+      LP+S
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDL---------------LQQIVQEPPPRLPSS 236

Query: 324 ILS-----LIQRCWDGNPHNRPS 341
                    +  C   +P  RP+
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 58/295 (19%)

Query: 100 STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF-FEFYESRNLAE---KLHV 154
           ++ ++  +F  EL++LCKL  HP +   + A  +   Y++   E+    NL +   K  V
Sbjct: 46  ASKDDHRDFAGELEVLCKLGHHPNIINLLGA-CEHRGYLYLAIEYAPHGNLLDFLRKSRV 104

Query: 155 EEWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
            E  P            S  Q+L  AA +A+ + YL     +HRD+   N+L+  N    
Sbjct: 105 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164

Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSD 260
           +ADFGL+  +E                    + K  +G L   +MA E L   +++  SD
Sbjct: 165 IADFGLSRGQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSD 205

Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           V+S+G+ + E+++ G  PY  +   A+ +  L   Y  ++                  L 
Sbjct: 206 VWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLN 247

Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
               +  L+++CW   P+ RPSF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 302

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 62/185 (33%), Positives = 88/185 (47%), Gaps = 38/185 (20%)

Query: 167 IAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           IA    KAL YL   L I+HRDVKP+N+LLDRN    L DFG++    +    S+   R 
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRD 167

Query: 226 SG-KPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           +G +P              YMAPE +    ++ +  +SDV+S GI++ E+ TG  PY   
Sbjct: 168 AGCRP--------------YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-- 211

Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA-SLELGLPASILSLIQRCWDGNPHNRP 340
                     + N    QLT  VV G   PIL+ S E     S ++ I  C   +   RP
Sbjct: 212 ----------KWNSVFDQLT-QVVKGD-PPILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Query: 341 SFSDI 345
            + ++
Sbjct: 260 KYKEL 264

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 42/288 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           +P  S  L   + +G    V+  T +G  KVA+K  KP     E    F +E Q++ KL 
Sbjct: 3   IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLR 59

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
           H  L    A  ++ P Y+   EF    +L + L   +     + Q++ +AAQ+A  + Y+
Sbjct: 60  HDKLVPLYAVVSEEPIYIVT-EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
             +  +HRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K          
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK---------- 168

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
                + APE       + KSDV+SFGI + EL+T G VPY  +                
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------------VN 209

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           +++   V  G   P       G P S+  L++ CW  +P  RP+F  I
Sbjct: 210 REVLEQVERGYRMPC----PQGCPESLHELMKLCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 43/281 (15%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G   +VY A       ++A+K+     S  +   H+E+ L   L H  + +++ + +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA---AQLAKALQYLHNLGIVHRDV 188
           +   +  F E     +L+  L   +W P  D    I     Q+ + L+YLH+  IVHRD+
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134

Query: 189 KPANVLLD--RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           K  NVL++    +   ++DFG ++    +   +                +   GTL YMA
Sbjct: 135 KGDNVLVNTYSGVV-KISDFGTSKRLAGINPCT----------------ETFTGTLQYMA 177

Query: 247 PEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           PE++ K    +   +D++S G +I E+ TG  P+ +L  E Q               AA+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL-GEPQ---------------AAM 221

Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              G+  I   +   L A   + I RC++ +P  R S  D+
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 20/172 (11%)

Query: 109 HKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           H E ++L ++ HP + +               E+     L   L       S    L  A
Sbjct: 49  HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYA 107

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           +++  AL+YLH+  IV+RD+KP N+LLD+     L DFG A      K++  + W     
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA------KKLRDRTW----- 156

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                    + GT  Y+APE+++ + H++  D ++ GI I E+L G  P+ D
Sbjct: 157 --------TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 83/310 (26%), Positives = 123/310 (39%), Gaps = 59/310 (19%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELD---NFH--KELQLLCKLDH 120
           Y     +  G  +VVY+A     GR VA+KK  L   +E     NF   +E++LL +L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P +   +       N    FEF E+ +L + +  +    +   +        + L+YLH+
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM-- 238
             I+HRD+KP N+L+  +    LADFGLA              RS G P      + M  
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLA--------------RSFGSP-----NRKMTH 161

Query: 239 -VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPY----TDLR---------- 282
            V T  Y APE+L     +    D++S G    ELL   VP+    +D+           
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALG 220

Query: 283 ----AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
                     T L  +Y E +             L  +        L L+QR    NP+ 
Sbjct: 221 TPTEENWPGVTSL-PDYVEFKPFPP-------TPLKQIFPAASDDALDLLQRLLTLNPNK 272

Query: 339 RPSFSDIALE 348
           R +    ALE
Sbjct: 273 RITARQ-ALE 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 58/282 (20%)

Query: 100 STSEELDNFHKELQLLCKLDHPGLAKFVAA--HAKPPNYMFFFEFYES------------ 145
           ++S EL +   E  LL +++HP + K   A     P   +  +  Y S            
Sbjct: 42  ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVG 101

Query: 146 ---------RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
                    RN +   + +E + ++  ++  A Q+++ +QYL  + +VHRD+   NVL+ 
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161

Query: 197 RNLCPHLADFGLAEYRENLKEIS-LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH 255
                 ++DFGL+  R+  +E S +K  RS G+             + +MA E L   I+
Sbjct: 162 EGRKMKISDFGLS--RDVYEEDSYVK--RSKGRI-----------PVKWMAIESLFDHIY 206

Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
           + +SDV+SFG+ + E++T G  PY  +  E +   +L+  Y  +           RP   
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKTGYRME-----------RPENC 254

Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
           S E      + +L+  CW   P  RP+F+DI+ EL+ ++   
Sbjct: 255 SEE------MYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           +P  S  L   + +G    V+  T +G  +VA+K  KP   + E    F +E Q++ KL 
Sbjct: 3   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLR 59

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
           H  L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+
Sbjct: 60  HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
             +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K          
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---------- 168

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
                + APE       + KSDV+SFGI + EL T G VPY  +                
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VN 209

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +++   V  G   P         P S+  L+ +CW   P  RP+F
Sbjct: 210 REVLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 86.0 bits (213), Expect = 4e-18
 Identities = 84/301 (27%), Positives = 126/301 (41%), Gaps = 52/301 (17%)

Query: 73  PIARGAESVVYEAT--LDGRKVAVKK------PILSTSEELDNFHKELQLLCKLDHPGLA 124
           PI  GA  VV+  T   DG++VA+KK       ++S         +EL++LC   H  + 
Sbjct: 7   PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF----RELKMLCFFKHDNVL 62

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEK-LH---VEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    +PP+   F E Y    L +  LH   V     S D V +   Q+ + L+YLH+
Sbjct: 63  SALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
            GI+HRD+KP N+L++ N    + DFGLA   E               P    H    V 
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---------------PDESKHMTQEVV 166

Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPY------------TDLRAEAQA 287
           T  Y APEIL    H +   D++S G    ELL   + +            TDL      
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP-- 224

Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGL--PAS--ILSLIQRCWDGNPHNRPSFS 343
            ++  M    +   A ++ G  +P    +   L   A+   + L+ R    +P  R S +
Sbjct: 225 -SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283

Query: 344 D 344
           D
Sbjct: 284 D 284

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.9 bits (210), Expect = 5e-18
 Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 17/169 (10%)

Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
            E  +L +++HP + K   A           +F    +L  +L  +E   + + V    A
Sbjct: 47  MERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA 105

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           +LA AL +LH+LGI++RD+KP N+LLD      L DFGL+           K      K 
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-----------KESIDHEKK 154

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              F      GT+ YMAPE++ +  H++ +D +SFG+ + E+LTG +P+
Sbjct: 155 AYSF-----CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
           Y  L  +  G   VVY+A     G  VA+KK  L   EE      L    +E+ LL +L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP + K +            FE+ +  +L + L       S + +  I  QL + L Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +  I+HRD+KP N+L++R+    LADFGLA              R+ G P   +  +  V
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA--------------RAFGIPLRTYTHE--V 159

Query: 240 GTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
            TL Y APEIL    H   + D++S G    E++TG
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 56/267 (20%)

Query: 107 NFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE---KLHVEEWSP--- 159
           +F  EL++LCKL  HP +   + A           E+    NL +   K  V E  P   
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100

Query: 160 ---------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
                    S  Q+L  AA +A+ + YL     +HRD+   N+L+  N    +ADFGL+ 
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISI 268
            +E                    + K  +G L   +MA E L   +++  SDV+S+G+ +
Sbjct: 161 GQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201

Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
            E+++ G  PY  +   A+ +  L   Y  ++                  L     +  L
Sbjct: 202 WEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLNCDDEVYDL 243

Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLE 354
           +++CW   P+ RPSF+ I + L+ +LE
Sbjct: 244 MRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.2 bits (216), Expect = 8e-18
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 27/217 (12%)

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMF-FFEFYESRNLAEKLHVEEWSPSVDQV-L 165
           F +E  L  +L HP +   + +   PP  +F  FE+   R L E L  +   P+ +   L
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPH--LADFGLAEYRENLKEISLKN 222
           M   Q+  AL   HN GIVHRD+KP N+++    + PH  + DFG+      +++  +  
Sbjct: 85  M--LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142

Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
              + +         ++GT  Y APE L+ E  +  SD+Y++G+   E LTG       +
Sbjct: 143 LTRTTE---------VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG-------Q 186

Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
              Q  +V E+ Y  QQL+   VS  L P +A   LG
Sbjct: 187 RVVQGASVAEILY--QQLSPVDVS--LPPWIAGHPLG 219

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 44/240 (18%)

Query: 64  PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL-STSEELDNFHKELQLLCKL-D 119
           P   + L+  I  G    VY+A     G+ VA+K  I+    +E +   +E  +L K  +
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSN 61

Query: 120 HPGLAKFVAAHAKPPNYM------FFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQ 170
           HP +A F  A  K              E        +L + L  +      + +  I  +
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
             + L YLH   ++HRD+K  N+LL +N    L DFG++     L         + G+  
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS---AQLD-------STLGR-- 169

Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSE---------KSDVYSFGISINELLTGVVPYTDL 281
               +   +GT  +MAPE+    I  +         +SDV+S GI+  EL  G  P  D+
Sbjct: 170 ----RNTFIGTPYWMAPEV----IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 22/218 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P S       I  G+  +V  AT    GR+VAVKK  L   +  +    E+ ++    HP
Sbjct: 17  PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +  +++          EF E   L +   V     + +Q+  +   + KAL +LH  
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGL-AEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           G++HRD+K  ++LL  +    L+DFG  A+  + +                   +K++VG
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-----------------RKSLVG 177

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           T  +MAPE++ +  +  + D++S GI + E++ G  PY
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 46/288 (15%)

Query: 67  SYTLLSPIARGA--ESVVYEATLDGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPG 122
           +Y  +  + +G+  E  +     DG++  +KK  L  ++  E     +E QLL +L HP 
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 123 LAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLH 179
           +  +  +       ++    F E  +L  KL  +  +  P  +QV+    Q+A ALQYLH
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLH 119

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              I+HRD+K  NV L R     + D G+A   EN  +++                  ++
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA----------------STLI 163

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT  YM+PE+   + ++ KSDV++ G  + E+ T       L+    A    +MN     
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-------LK---HAFNAKDMN----S 209

Query: 300 LTAAVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           L   ++ G L P+    S ELG       LI       P  RPS   I
Sbjct: 210 LVYRIIEGKLPPMPKDYSPELG------ELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 78/283 (27%), Positives = 118/283 (41%), Gaps = 37/283 (13%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +  +S  LL  +  G    V+E   +    VAVK  +   + +  +F  E Q++ KL HP
Sbjct: 3   IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT-LKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A            E  +  +L E L         + Q++ +AAQ+A  + YL  
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD+   NVL+  N    +ADFGLA     +KE  +   R   K    F  K    
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARV---IKE-DIYEAREGAK----FPIK---- 169

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       S KSDV+SFGI + E++T G +PY                 T  +
Sbjct: 170 ---WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP--------------GMTNAE 212

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P       G P  +  ++  CW  +P +RP+F
Sbjct: 213 VLQQVDQGYRMPCPP----GCPKELYDIMLDCWKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
           +V E    +++V+  +AQ+   + +LH++ IV+RD+KP NVLLD      L+D GLA   
Sbjct: 86  NVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--- 142

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
                + LK+    GK           GT  YMAPEILK+E +S   D ++ G SI E++
Sbjct: 143 -----VELKD----GKTI-----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188

Query: 273 TGVVPYTDLRAEAQAHTVLE 292
            G  P+ D + +     +  
Sbjct: 189 AGRTPFKDHKEKVAKEELKR 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 36/253 (14%)

Query: 101 TSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           T ++  +F  E  ++ + DHP +     V   +KP   M   E+ E+ +L   L   +  
Sbjct: 45  TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP--VMIVTEYMENGSLDAFLRKHDGQ 102

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
            +V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+    
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---- 158

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                     P   +  +     + + APE +     +  SDV+S+GI + E+++ G  P
Sbjct: 159 ---------DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y ++              + Q +  A+  G   P      +  PA++  L+  CW  + +
Sbjct: 210 YWEM--------------SNQDVIKAIEEGYRLPA----PMDCPAALHQLMLDCWQKDRN 251

Query: 338 NRPSFSDIALELD 350
            RP F  I   LD
Sbjct: 252 ERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 71  LSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDN-FHKELQLLCKLDHPGLAKFV 127
           L  +  G   VV +      G+ +AVK   L  +E +     +EL +L K + P +  F 
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVL-MIAAQLAKALQYLHN-LGIV 184
            A     +     E+ +  +L + L  V+   P  +++L  IA  + K L YLH    I+
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEKHKII 123

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRDVKP+N+L++      L DFG+                 SG+      K   VGT  Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGV-----------------SGQLVNSLAKTF-VGTSSY 165

Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           MAPE ++   +S KSD++S G+S+ EL TG  PY
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 25/235 (10%)

Query: 66  SSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHK---ELQLLCKLDH 120
             +  +  + +G    V+   L G  +  A+K        + +   +   E ++L  LDH
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP----SVDQVLMIAAQLAKALQ 176
           P L    A+           ++     L   L  +   P    S +     AA++  AL+
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALE 117

Query: 177 YLHNLGIVHRDVKPANVLL---------DRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           YLH LGIV+RD+KP N+LL         D +L            +   K     +  S  
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 228 KPT----GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             T      F   + VGT  Y+APE++  + H    D ++ GI + E+L G  P+
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 67/289 (23%), Positives = 110/289 (38%), Gaps = 44/289 (15%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           + P   T L  +  G   VV      G+     K I   S   D F +E +++ KL H  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L +      K        E+  +  L   L          Q+L +   + + + YL +  
Sbjct: 61  LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT- 241
            +HRD+   N L+D   C  ++DFGL+ Y      +    + SS            VG+ 
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY------VLDDEYTSS------------VGSK 162

Query: 242 --LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298
             + +  PE+L     S KSDV++FG+ + E+ + G +PY                +   
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE--------------RFNNS 208

Query: 299 QLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           +    V  G    RP LAS        + +++  CW      RP+F  +
Sbjct: 209 ETVEKVSQGLRLYRPHLAS------EKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 38/281 (13%)

Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAA- 129
           I RG    V+   L  D   VAVK    +   +L   F +E ++L +  HP + + +   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
             K P Y+   E  +  +    L  E     V +++ +    A  ++YL +   +HRD+ 
Sbjct: 63  TQKQPIYIVM-ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
             N L+       ++DFG++   E+    S          TGG  +  +  T    APE 
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYAS----------TGGMKQIPVKWT----APEA 167

Query: 250 LKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           L    +S +SDV+SFGI + E  + G VPY +L              + QQ   A+  G 
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANL--------------SNQQTREAIEQGV 213

Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
             P         P ++  L++RCW+ +P  RPSFS +  EL
Sbjct: 214 RLPCPELC----PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 40/284 (14%)

Query: 68  YTLLSPIARGAESVVY--EATLDGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGL 123
           Y ++  I  G+   +Y  +A  D     +K+  L+    +E +   KE+ LL K+ HP +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
             F A+  +        E+ +  +L ++++ +     S DQ+L    Q++  L+++H+  
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 183 IVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           I+HRD+K  N+ L +N +   L DFG+A    +  E++                   VGT
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA----------------YTCVGT 165

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
             Y++PEI +   ++ K+D++S G  + EL T   P+             E N    QL 
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-------------EGN-NLHQLV 211

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             +  G   PI           + SLI + +  +P +RPS + I
Sbjct: 212 LKICQGYFAPI----SPNFSRDLRSLISQLFKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 44/287 (15%)

Query: 65  PSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           PS  T +  +  G   VV+      + KVA+K  I   +   ++F +E +++ KL HP L
Sbjct: 3   PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKL 61

Query: 124 AKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +   V    KP       EF E+  L   L   +   S D +L +   + + ++YL   
Sbjct: 62  VQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             +HRD+   N L+       ++DFG+  Y  + +  S     SSG     F  K     
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-----SSG---AKFPVK----- 166

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             +  PE+     +S KSDV+SFG+ + E+ T G +P+                 +  ++
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE--------------KKSNYEV 210

Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              +  G    RP LAS+      ++  ++  CW   P  RP+F+++
Sbjct: 211 VEMISRGFRLYRPKLASM------TVYEVMYSCWHEKPEGRPTFAEL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 40/297 (13%)

Query: 65  PSSYTLLSPIARGAESVVYEATLD--GRK---VAVK--KPILSTSEELDNFHKELQLLCK 117
           PS  T    I  G    V+   L   GRK   VA+K  KP  +  +  D F  E  ++ +
Sbjct: 4   PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQ 62

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
             H  + +      K    M   E+ E+  L + L   +   S  Q++ +   +A  ++Y
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           L ++  VHRD+   N+L++ NL   ++DFGL+   E+  E +     S GK         
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT--SGGKI-------- 172

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
               + + APE +     +  SDV+SFGI + E+++ G  PY D+              +
Sbjct: 173 ---PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------------S 215

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
             ++  A+  G   P      +  P+++  L+ +CW  +   RP F DI   LD +L
Sbjct: 216 NHEVMKAINDGFRLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 60/197 (30%), Positives = 82/197 (41%), Gaps = 39/197 (19%)

Query: 167 IAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           IA  + KAL+YLH  L ++HRDVKP+NVL++RN    L DFG+                 
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI----------------- 150

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE----KSDVYSFGISINELLTGVVPYTDL 281
           SG       K    G   YMAPE +  E++ +    KSDV+S GI++ EL TG  PY   
Sbjct: 151 SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY--- 207

Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
                  T        QQL   V      P L              + +C   N   RP+
Sbjct: 208 ---DSWKTPF------QQLKQVV--EEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN 254

Query: 342 FSDIALELDLVLEHRKS 358
           + ++ L+      H   
Sbjct: 255 YPEL-LQHPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 24/200 (12%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
             Y +L  +  G    VY+A     GR VA+KK ++    E D F     +E+++L KL 
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN--EKDGFPITALREIKILKKLK 65

Query: 120 HPGLAKFV-------AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
           HP +   +           +    ++    Y   +L+  L       +  Q+     QL 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTG 231
           + + YLH   I+HRD+K AN+L+D      +ADFGLA  Y               G   G
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP-------NPKGGGGG 178

Query: 232 GFHK-KNMVGTLIYMAPEIL 250
           G  K  N+V T  Y  PE+L
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 44/241 (18%)

Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLM 166
           E QLL KLDHP + KF A+  +   +    E+ E R+L  KL    H  +     +QV  
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCE 110

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
              QL   + Y+H   I+HRD+K  N+ L  NL   + DFG++       +++       
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA------- 162

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
                        GT  YM+PE LK + +  KSD++S G  + E+               
Sbjct: 163 ---------TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM--------------- 198

Query: 287 AHTVLEMNYTEQQLTAAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
               L   +  Q   + V+    G  P   SL       + S++Q   + +P  RPS ++
Sbjct: 199 --CCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253

Query: 345 I 345
           I
Sbjct: 254 I 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 40/272 (14%)

Query: 92  VAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VAVK      +    ++F KE+++L +L  P +A+ +      P      E+ E+ +L +
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 151 KL--HVEE--------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
            L  HV E         S S   +L +A Q+A  ++YL +L  VHRD+   N L+ +N  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168

Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             +ADFG+   R NL   S   +R  G+             + +MA E +     + KSD
Sbjct: 169 IKIADFGM--SR-NL--YSSDYYRVQGRA---------PLPIRWMAWESVLLGKFTTKSD 214

Query: 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL---TAAVVSGGLRPILASLE 317
           V++FG+++ E+LT            Q +  L    T+QQ+            R I     
Sbjct: 215 VWAFGVTLWEILT--------LCREQPYEHL----TDQQVIENAGHFFRDDGRQIYLPRP 262

Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
              P  I  L+  CW  +  +RP+F +I L L
Sbjct: 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 39/270 (14%)

Query: 89  GRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYE 144
           G +VAVK  KP  S    + +  KE+++L  L H  + K+  +             EF  
Sbjct: 33  GEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
           S +L E L   +   ++ Q L  A Q+ K + YL +   VHRD+   NVL++      + 
Sbjct: 92  SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151

Query: 205 DFGLAEYRENLKE-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE---KSD 260
           DFGL +  E  KE  ++K+   S               + + APE L   I S+    SD
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDS--------------PVFWYAPECL---IQSKFYIASD 194

Query: 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA----VVSGGLR-PILAS 315
           V+SFG+++ ELLT    Y D  +      +  +  T  Q+T      V+  G R P   +
Sbjct: 195 VWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPN 250

Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                P  +  L+++CW+  P  R +F ++
Sbjct: 251 ----CPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 44/281 (15%)

Query: 77  GAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQLLCKL-DHPGLAKF 126
           GA   V EAT  G        KVAVK  KP   +SE  +    EL+++  L +H  +   
Sbjct: 46  GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMSHLGNHENIVNL 104

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHNLGIVH 185
           + A       +   E+    +L   L  +  S  +++ +L  + Q+AK + +L +   +H
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+   NVLL       + DFGLA  R+ + +    N+   G         N    + +M
Sbjct: 165 RDLAARNVLLTHGKIVKICDFGLA--RDIMND---SNYVVKG---------NARLPVKWM 210

Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           APE +   +++ +SDV+S+GI + E+ + G  PY  +  +++ + +++  Y   Q     
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ----- 265

Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 P  A      PA I  +++ CWD +P  RP+F  I
Sbjct: 266 ------PEHA------PAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPI--LSTSEELDNFHKELQLLCKLDHP 121
           + Y  L P+  GA  +V  A   L G+ VA+KK +   ST       ++EL+LL  L H 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +         P   ++F       +L   L          Q  +   Q+ + L+Y+H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY--QILRGLKYVHSA 127

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           G+VHRD+KP+N+L++ N    + DFGLA  ++                         V T
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP-------------------QMTGYVST 168

Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
             Y APEI L  + +  + D++S G    E+L G
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.7 bits (199), Expect = 8e-17
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 45/279 (16%)

Query: 83  YEATLD--GRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYM 137
           Y+   D  G  VAVK       ++    + KE+ +L  L H  + K+    +        
Sbjct: 25  YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84

Query: 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
              E+    +L + L   +   ++ Q+L+ A Q+ + + YLH+   +HRD+   NVLLD 
Sbjct: 85  LIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142

Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKEI 254
           +    + DFGLA      K +          P G  +   +++    + + A E LK+  
Sbjct: 143 DRLVKIGDFGLA------KAV----------PEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
            S  SDV+SFG+++ ELLT          +       EM   +Q     V       ++ 
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKK-----FEEMIGPKQGQMTVV------RLIE 235

Query: 315 SLELGL--------PASILSLIQRCWDGNPHNRPSFSDI 345
            LE G+        P  +  L++ CW+     RP+F  +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A      V     ++ T   EEL+++  E+ +L   DHP
Sbjct: 3   PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 62

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A     N     EF     +   +   E   +  Q+ ++  Q  +AL YLH  
Sbjct: 63  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+L   +    LADFG          +S KN R+  +      + + +GT
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG----------VSAKNTRTIQR------RDSFIGT 166

Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
             +MAPE++  E   +     K+DV+S GI++ E+     P+ +L
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 17/145 (11%)

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
           +V E      + +  AAQ+   L++LH   IV+RD+KP NVLLD +    ++D GLA   
Sbjct: 86  NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--- 142

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
                + LK     GK   G       GT  YMAPE+L+ E++    D ++ G ++ E++
Sbjct: 143 -----VELK----GGKKIKGR-----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188

Query: 273 TGVVPYTDLRAEAQAHTVLEMNYTE 297
            G  P+   + + +   +       
Sbjct: 189 AGRSPFRQRKEKVEKEELKRRTLEM 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 46/286 (16%)

Query: 65  PSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           PS  T L  +  G   VV+     G   VA+K  I   +   D+F +E +++ KL HP L
Sbjct: 3   PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKM-IREGAMSEDDFIEEAKVMMKLSHPNL 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            +      K        E+  +  L   L   +     + +L + + + +A++YL + G 
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT-- 241
           +HRD+   N L+  +    ++DFGLA Y      +    + SS             GT  
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY------VLDDQYTSSQ------------GTKF 163

Query: 242 -LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + +  PE+      S KSDV+SFG+ + E+ + G +PY                ++  +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE--------------RFSNSE 209

Query: 300 LTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +  +V +G    RP LA      P  + +++  CW   P +RP+F 
Sbjct: 210 VVESVSAGYRLYRPKLA------PTEVYTIMYSCWHEKPEDRPAFK 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.4 bits (202), Expect = 9e-17
 Identities = 71/230 (30%), Positives = 100/230 (43%), Gaps = 51/230 (22%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
           Y LL PI  GA  VV  A     GRKVA+KK      + +D     +E++LL  L H  +
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 124 AKFVAAHA--KPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQY 177
              +      +PP+   F + Y    L E  LH    SP   + D +     Q+ + L+Y
Sbjct: 62  ---IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118

Query: 178 LHNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           LH+  ++HRD+KP+N+L++ N    +C    DFGLA              R         
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKIC----DFGLA--------------RGVD--PDED 158

Query: 234 HKKNM---VGTLIYMAPEIL------KKEIHSEKSDVYSFGISINELLTG 274
            K  +   V T  Y APE+L       K I     D++S G    ELLT 
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAI-----DIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 84/297 (28%), Positives = 124/297 (41%), Gaps = 61/297 (20%)

Query: 74  IARGAESVVYEATL-----DGR---KVAVKKPIL---STSEELDNFHKELQLLCKLDHPG 122
           +  GA   VYE T       G    +VAVK   L   +T +E   F KE  L+   +HP 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKT--LRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSP---SVDQVLMIAAQLAKALQ 176
           + K +             E  E  +L   L    VE + P   ++ ++L I   +AK   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 177 YLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
           YL  +  +HRD+   N L+     D +    + DFGLA      ++I  K+         
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA------RDI-YKS--------- 164

Query: 232 GFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
            +++K   G L   +MAPE L     + +SDV+SFG+ + E+LT G  PY  L       
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL------- 217

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                    Q++   V +GG    L   E   P  I  L+  CW  +P  RP+F  I
Sbjct: 218 -------NNQEVLQHVTAGGR---LQKPEN-CPDKIYQLMTNCWAQDPSERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 69/209 (33%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAH 130
           +  G    VY+A   L  R +AVK   L  + EL      EL++L K D P +  F  A 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGIVHRDVK 189
                     EF +  +L     + E       VL  IA  + K L YL +L I+HRDVK
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPE------HVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
           P+N+L++      L DFG++   + +  I+                K  VGT  YMAPE 
Sbjct: 123 PSNMLVNTRGQVKLCDFGVS--TQLVNSIA----------------KTYVGTNAYMAPER 164

Query: 250 LKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +  E +   SDV+S GIS  EL  G  PY
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 44/244 (18%)

Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLM 166
           E++ L  LDH  + +++           F E+    ++   L      EE       V  
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRF 112

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
              Q+ + L YLH+ GI+HRD+K  N+L+D +    ++DFG+++  +++           
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI----------- 161

Query: 227 GKPTGGFHKKNMVGTLIYMAPEI--LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
                     +M G++ +MAPE+     + +S K D++S G  + E+  G  P++D    
Sbjct: 162 ---YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD---- 214

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLR---PILASLELGLPASILSLIQRCWDGNPHNRPS 341
                       E+ + A    G  R   PI   + + L    L  +  C+  NP NRP+
Sbjct: 215 ------------EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262

Query: 342 FSDI 345
             ++
Sbjct: 263 AREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 37/219 (16%)

Query: 71  LSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQ-LLCKLDHPGLA 124
           L PI++GA   VY A     G   A+K   K  +    ++ N   E   ++ + + P +A
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLH 179
           K   +           E+    + A  +       E+W           A++   ++ LH
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW------AKQYIAEVVLGVEDLH 114

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
             GI+HRD+KP N+L+D+     L DFGL+                      G   K  V
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--------------------NGLENKKFV 154

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           GT  Y+APE +      + SD +S G  I E L G  P+
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 37/240 (15%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
             + ++  I RGA   V+       G+  A+K   K  +    ++ +   E  +L   D 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 121 PGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKAL 175
           P + K   +     +     E+    +  NL  +  V  EE            A+L  AL
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIAELVLAL 114

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLA---------EYRENLKEISLKNWR 224
             +H LG +HRD+KP N+L+D     H  LADFGL          EY  N     L   R
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF--R 170

Query: 225 SSGKPTGGFHKKNM------VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            +       HK+        VGT  Y+APE+L+   +  + D +S G+ + E+L G  P+
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.8 bits (196), Expect = 2e-16
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   V+ A     G++VA+K+  L    + +    E+ ++ +L +P
Sbjct: 17  PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP 76

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  F+ +           E+    +L +   V E      Q+  +  +  +AL++LH  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQALEFLHAN 134

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  NVLL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 178

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
             +MAPE++ ++ +  K D++S GI   E++ G  PY +   LRA
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+K+  L    + +    E+ ++ +  HP
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP 76

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 178

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
             +MAPE++ ++ +  K D++S GI   E++ G  PY +   LRA
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 88/323 (27%), Positives = 136/323 (42%), Gaps = 92/323 (28%)

Query: 68  YTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNF---------HKELQLL 115
           Y +L  + +GA  +V++A +D      VA+KK I       D F          +E+  L
Sbjct: 9   YEILQKLGKGAYGIVWKA-IDRRTKEVVALKK-IF------DAFRNATDAQRTFREIMFL 60

Query: 116 CKL-DHPGLAKFVAAHAKPPN----YMFFFEFYES-------RNLAEKLHVEEWSPSVDQ 163
            +L DHP + K +    K  N    Y+ F E+ E+        N+ E +H          
Sbjct: 61  QELGDHPNIVKLLNVI-KAENDKDIYLVF-EYMETDLHAVIRANILEDVHKR-------- 110

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----EYRENLKEIS 219
              I  QL KAL+Y+H+  ++HRD+KP+N+LL+ +    LADFGLA    E  EN +   
Sbjct: 111 --YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VV 276
           L ++               V T  Y APEIL       K  D++S G  + E+L G  + 
Sbjct: 169 LTDY---------------VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Query: 277 PYTDLRAEAQAHTV--LE--MNYTE---QQLTAAVVSGGLRPILAS--------LELGLP 321
           P T         T+  LE  +        +   ++ S     +L S        L+  LP
Sbjct: 214 PGTS--------TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP 265

Query: 322 ---ASILSLIQRCWDGNPHNRPS 341
                 L L+++    NP+ R +
Sbjct: 266 KASDDALDLLKKLLVFNPNKRLT 288

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 55/275 (20%)

Query: 88  DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
            G++V V    L           F +E  ++ +LDHP + + +      P  M   E   
Sbjct: 20  SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAP 78

Query: 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
              L + L      P  D +  +A Q+A  + YL +   VHRD+   NVLL       ++
Sbjct: 79  LGPLLKYLKKRREIPVSD-LKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKIS 137

Query: 205 DFGLA--------EYRENLKEISLKNWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIH 255
           DFG++         YR            ++G+ P            L + APE +     
Sbjct: 138 DFGMSRALGAGSDYYRA----------TTAGRWP------------LKWYAPECINYGKF 175

Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
           S KSDV+S+G+++ E  + G  PY +++       V+ M           +  G R  L 
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAM-----------LESGER--LP 218

Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
             E   P  I S++  CW   P +RP+FS++    
Sbjct: 219 RPE-ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLC 116
             P   +T L  I  G+   VY A        VA+KK   S   ++E+  +  KE++ L 
Sbjct: 11  DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +L HP   ++   + +        E Y   + ++ L V +      ++  I     + L 
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVME-YCLGSASDILEVHKKPLQEVEIAAICHGALQGLA 129

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K  N+LL       LADFG A         SL +      P   F   
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSA---------SLVS------PANSF--- 171

Query: 237 NMVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
             VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A
Sbjct: 172 --VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 26/222 (11%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKK----PILSTSEELDNFHKELQLLCKLD 119
           +++ +   I RG  S VY AT  LDG  VA+KK     ++      D   KE+ LL +L+
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLN 60

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQ--VLMIAAQLAKALQ 176
           HP + K+ A+  +        E  ++ +L+  + H ++    + +  V     QL  AL+
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++H+  ++HRD+KPANV +       L D GL  +              S K T      
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------------FSSKTTAA---H 164

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           ++VGT  YM+PE + +  ++ KSD++S G  + E+     P+
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 66/316 (20%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEEL-DNFHKELQ 113
           H+   +  L   +  GA   V+           D   VAVK    + S +   +F +E +
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---------VEEWSP----S 160
           LL    H  + KF     +    +  FE+ E  +L + L              SP    +
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI-S 219
           + Q+L IA Q+A  + YL +   VHRD+   N L+  +L   + DFG++      +++ +
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RDVYT 174

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
              +R  G             T++   +M PE +     + +SDV+SFG+ + E+ T G 
Sbjct: 175 TDYYRVGGH------------TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            P+  L        V+E           +  G L  RP         P+ +  ++  CW 
Sbjct: 223 QPWYGL----SNEEVIEC----------ITQGRLLQRP------RTCPSEVYDIMLGCWK 262

Query: 334 GNPHNRPSFSDIALEL 349
            +P  R +  DI   L
Sbjct: 263 RDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 31/216 (14%)

Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILS-------TSEELDNFHKELQLLCKLDH 120
           Y  +  + RGA  +V+   L  RK   K  I+        T +E      E Q+L  L H
Sbjct: 2   YEKIRVVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH 58

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYL 178
           P + ++     +    M   E+     LAE +           D +L    Q+  AL ++
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLALHHV 117

Query: 179 HNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           H   I+HRD+K  N+LLD++ +   + DFG++      K +S K+   +           
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGIS------KILSSKSKAYT----------- 160

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
           +VGT  Y++PE+ + + +++KSD+++ G  + EL +
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 40/264 (15%)

Query: 91  KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           KVAVK  KP    +  +  F +E  L+  L H  L +  A   K        E+    +L
Sbjct: 32  KVAVKTLKP---GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88

Query: 149 AEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
            + L  +E     + +++  +AQ+A+ + Y+     +HRD++ ANVL+  +L   +ADFG
Sbjct: 89  LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG 148

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
           LA   E+ +  +    R   K    F  K       + APE +     + KSDV+SFGI 
Sbjct: 149 LARVIEDNEYTA----REGAK----FPIK-------WTAPEAINFGSFTIKSDVWSFGIL 193

Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
           + E++T G +PY    + +   + L+  Y   ++                    P  +  
Sbjct: 194 LYEIVTYGKIPYPG-MSNSDVMSALQRGYRMPRMENC-----------------PDELYD 235

Query: 327 LIQRCWDGNPHNRPSFSDIALELD 350
           +++ CW      RP+F  +   LD
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 59/184 (32%), Positives = 85/184 (46%), Gaps = 27/184 (14%)

Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-----YRENL 215
           VD   M  A+   AL+YLHN GIVHRD+KP N+L+       L DFGL++        NL
Sbjct: 100 VDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
            E  ++      K T  F  K + GT  Y+APE++ ++ + +  D ++ GI + E L G 
Sbjct: 160 YEGHIE------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
           VP+                 T ++L   V+S  +       +  LPA    LI R    N
Sbjct: 214 VPF--------------FGDTPEELFGQVISDDI--EWPEGDEALPADAQDLISRLLRQN 257

Query: 336 PHNR 339
           P  R
Sbjct: 258 PLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 44/287 (15%)

Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
              TL   I  G    V +    G+KVAVK   +        F +E  ++ KL H  L +
Sbjct: 6   QKLTLGEIIGEGEFGAVLQGEYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVR 63

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
            +        Y+   E     NL   L        SV Q+L  +  +A+ ++YL +  +V
Sbjct: 64  LLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+   N+L+  +    ++DFGLA        +      +S  P              +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR-------VGSMGVDNSKLPVK------------W 163

Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            APE LK +  S KSDV+S+G+ + E+ + G  PY  +              + +++   
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--------------SLKEVKEC 209

Query: 304 VVSG-GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
           V  G  + P       G PA +  L+  CW+  P  RPSF  +  +L
Sbjct: 210 VEKGYRMEP-----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A            ++ T   EEL+++  E+++L   +HP
Sbjct: 10  PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP 69

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A           EF     +   +   +   +  Q+ +I  Q+ +ALQYLH++
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  NVLL  +    LADFG          +S KN ++  +      + + +GT
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFG----------VSAKNVKTLQR------RDSFIGT 173

Query: 242 LIYMAPEI-----LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
             +MAPE+     +K   +  K+D++S GI++ E+     P+ +L
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 25/226 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
           P   YT    I +GA   VY A +D   G++VA+K+  L    + +    E+ ++ +  +
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN 75

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P +  ++ ++          E+    +L +   V E      Q+  +  +  +AL +LH+
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALDFLHS 133

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVG
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVG 177

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
           T  +MAPE++ ++ +  K D++S GI   E++ G  PY +   LRA
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 23/225 (10%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 179

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
             +MAPE++ ++ +  K D++S GI   E++ G  PY +   LRA
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 39/216 (18%)

Query: 149 AEKLHVEEWSPSVDQVL-MIAAQLAKALQYL-HNLGIVHRDVKPANVLLDRNLCPHLADF 206
            +KL      P  + +L  +   + KAL YL    G++HRDVKP+N+LLD +    L DF
Sbjct: 100 LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159

Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSE---KSDVY 262
           G+                 SG+      K    G   YMAPE I   + + +   ++DV+
Sbjct: 160 GI-----------------SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVW 202

Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA 322
           S GIS+ EL TG  PY             +   TE ++   ++     P       G   
Sbjct: 203 SLGISLVELATGQFPY-------------KNCKTEFEVLTKILQ--EEPPSLPPNEGFSP 247

Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
              S +  C   +   RP + ++ L+   +  +  +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYREL-LQHPFIRRYETA 282

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 25/231 (10%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS-----TSEELDNFHKELQLLCK 117
           P+++ L   + +GA   VY       GR++AVK+         TS+E++    E+QLL  
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 118 LDHPGLAKFVAAHAKPPNYMF--FFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKA 174
           L H  + ++      P       F E     ++ ++L  + +    + V      Q+ + 
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEG 118

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           + YLH+  IVHRD+K AN+L D      L DFG ++    L+ I L           G  
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLS----------GTG 165

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
            K++ GT  +M+PE++  E +  K+D++S G ++ E+LT   P+ +  A A
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 36/254 (14%)

Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   EF E+  L   L   +   +
Sbjct: 45  TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT 104

Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL  +  VHRD+   N+L++ NL   ++DFGL+ + E+      
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED------ 158

Query: 221 KNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                +  PT      + +G  I   + APE +     +  SDV+S+GI + E+++ G  
Sbjct: 159 ----DTSDPT----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY D+  +        +N  EQ          L P      +  P ++  L+  CW  + 
Sbjct: 211 PYWDMSNQDV------INAIEQDYR-------LPP-----PMDCPTALHQLMLDCWQKDR 252

Query: 337 HNRPSFSDIALELD 350
           + RP F  I   LD
Sbjct: 253 NARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 70/306 (22%)

Query: 74  IARGAESVVYEATLDG-------RKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGL 123
           I +GA   V++A   G         VAVK  +L      D   +F +E  L+ + DHP +
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 124 AKF--VAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQV--------------- 164
            K   V A  KP      FE+    +L E L         S+                  
Sbjct: 71  VKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 165 ----LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
               L IA Q+A  + YL     VHRD+   N L+  N+   +ADFGL+         S 
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSA 183

Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
             +++S          N    + +M PE +    ++ +SDV+++G+ + E+ + G+ PY 
Sbjct: 184 DYYKASE---------NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
            +  E   + V + N                 +L+  +   P  + +L++ CW   P +R
Sbjct: 235 GMAHEEVIYYVRDGN-----------------VLSCPD-NCPLELYNLMRLCWSKLPSDR 276

Query: 340 PSFSDI 345
           PSF+ I
Sbjct: 277 PSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|223704 COG0631, PTC1, Serine/threonine protein phosphatase [Signal transduction mechanisms]

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 35/135 (25%), Positives = 53/135 (39%), Gaps = 7/135 (5%)

Query: 435 ATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTR 493
                R+  ED   + P+  N   + +F + DG  G AA E  S  A+    +    T  
Sbjct: 15  DVGTVRKHNEDAFLIKPN-ENGNLLLLFAVADGMGGHAAGEVASKLAVEALARLFDETNF 73

Query: 494 P--TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDC 551
               ++L E      +     +    +    V+     G T +  LI  N+L+VAN GD 
Sbjct: 74  NSLNESLEELLKEAILKANEAIAEEGQLNEDVRG---MGTTLVLLLIRGNKLYVANVGDS 130

Query: 552 RAILCRGGHPFALSR 566
           RA L R G    L+ 
Sbjct: 131 RAYLLRDGELKQLTE 145

Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 41/222 (18%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
           Y  L+ I  GA   VY+A     GR VA+KK  +  SEE      L    +E+ LL +L+
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----REIALLKQLE 56

Query: 120 ---HPGLAKFVAAHAKPPNY-----MFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQ 170
              HP + + +     P           FE  + ++LA  L    +     + +  +  Q
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKP 229
           L + + +LH+  IVHRD+KP N+L+  +    +ADFGLA  Y   +   S+         
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV--------- 166

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
                    V TL Y APE+L +  ++   D++S G    EL
Sbjct: 167 ---------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 28/223 (12%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELD-----NFHKELQLLCKL 118
           +++ +   I RG  S VY AT  LD + VA+KK  +   E +D     +  KE+ LL +L
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--VQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQ--VLMIAAQLAKAL 175
           +HP + K++ +  +        E  ++ +L++ + + ++    + +  V     QL  A+
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +++H+  ++HRD+KPANV +       L D GL  +              S K T     
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------------FSSKTTAA--- 163

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            ++VGT  YM+PE + +  ++ KSD++S G  + E+     P+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 43/275 (15%)

Query: 88  DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
           DG+ V V   +L    T    ++F KE++++ +L +P + + +             E+ E
Sbjct: 41  DGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 145 SRNLAEKLHVEEW-----------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
           + +L + L   E            S S+  +L +A Q+A  ++YL +L  VHRD+   N 
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160

Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
           L+  +    +ADFG++    NL   S   +R  G+          V  + +MA E +   
Sbjct: 161 LVGNHYTIKIADFGMS---RNL--YSGDYYRIQGRA---------VLPIRWMAWESILLG 206

Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL---TAAVVSGGLR 310
             +  SDV++FG+++ E+ T          + Q +++L    +++Q+   T        R
Sbjct: 207 KFTTASDVWAFGVTLWEMFT--------LCKEQPYSLL----SDEQVIENTGEFFRNQGR 254

Query: 311 PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            I  S     P+ +  L+ RCW  +  +RP+F+ I
Sbjct: 255 QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 64/287 (22%), Positives = 124/287 (43%), Gaps = 45/287 (15%)

Query: 73  PIARGAESVVYEA--TLDGRK----VAVKKPILSTSEELDN-FHKELQLLCKLDHPGLAK 125
            +  GA   VY+     +G K    VA+K     TS + +     E  ++  +DHP + +
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGI 183
            +             +      L +  +V     ++    ++    Q+AK + YL    +
Sbjct: 74  LLGI-CLSSQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL 130

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   NVL+       + DFGLA+    L ++  K + + G              + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAK----LLDVDEKEYHAEGGKV----------PIK 176

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E +   I++ KSDV+S+G+++ EL+T G  PY  + A  +   +LE     ++L  
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEKG---ERLP- 231

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                  +P + +++      +  ++ +CW  +  +RP+F ++  E 
Sbjct: 232 -------QPPICTID------VYMVLVKCWMIDAESRPTFKELINEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 77/319 (24%), Positives = 118/319 (36%), Gaps = 70/319 (21%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEEL-----DNFHKELQ 113
            +P S+   L  +  GA   VY+      + R  A    I +  E         F +E +
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-------------HVEEWSPS 160
           L+  L HP +   +    K       FE+    +L E L               E    S
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 161 VDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-------Y 211
           +D    L IA Q+A  ++YL +   VHRD+   N L+   L   ++DFGL+        Y
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
           R   K +    W                     M PE +     + +SD++SFG+ + E+
Sbjct: 181 RVQSKSLLPVRW---------------------MPPEAILYGKFTTESDIWSFGVVLWEI 219

Query: 272 LT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQR 330
            + G+ PY     +     V+EM  + Q L                    PA + +L+  
Sbjct: 220 FSYGLQPYYGFSNQ----EVIEMIRSRQLLPCPE--------------DCPARVYALMIE 261

Query: 331 CWDGNPHNRPSFSDIALEL 349
           CW+  P  RP F DI   L
Sbjct: 262 CWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 65/320 (20%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILSTSE-ELDNFHKELQL 114
           LP    TL  P+  GA   V +A   G         VAVK      +E +L +   E+++
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68

Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLM-- 166
           +  +  H  +   +    +        E+    NL + L       E  SP   +     
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
                    A Q+A+ +++L +   +HRD+   NVL+  +    +ADFGLA    ++  I
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---RDIHHI 185

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIY--MAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L    MAPE L   +++ +SDV+SFG+ + E+ T G 
Sbjct: 186 D-------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  +  E              +L   +  G    +P   + EL        L++ CW 
Sbjct: 233 SPYPGIPVE--------------ELFKLLKEGYRMEKPQNCTQEL------YHLMRDCWH 272

Query: 334 GNPHNRPSFSDIALELDLVL 353
             P  RP+F  +  +LD +L
Sbjct: 273 EVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 74  IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT    G++VAVKK  L   +  +    E+ ++    H  +     ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL YLHN G++HRD+K  
Sbjct: 90  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147

Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K++VGT  +MAPE++ 
Sbjct: 148 SILLTSDGRIKLSDFGFCA--QVSKEVP--------------KRKSLVGTPYWMAPEVIS 191

Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 43/226 (19%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  GRKVA+KK   P  S        ++EL+LL  +D
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMD 72

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLA----------EKLHVEEWSPSVDQVLMIAA 169
           H  +   +       +   F + Y   +L           +KL       S D +  +  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL-------SDDHIQFLVY 125

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+ + L+Y+H+ GI+HRD+KP+N+ ++ +    + DFGLA  R    E+           
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RHTDDEM----------- 172

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
           TG       V T  Y APEI+   +H  ++ D++S G  + ELLTG
Sbjct: 173 TG------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 42/111 (37%), Positives = 63/111 (56%), Gaps = 16/111 (14%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           ++++ AL++LH  GI++RD+KP N+LLD      L DFGL   +E++ E         G 
Sbjct: 107 SEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHE---------GT 155

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
            T  F      GT+ YMAPEIL +  H +  D +S G  + ++LTG  P+T
Sbjct: 156 VTHTF-----CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 70/226 (30%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK----------PILSTSEELDNFHKE 111
             + +  L+ I  G   +VY A  T  G  VA+KK          PI S         +E
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL--------RE 56

Query: 112 LQLLCKLDHPGLA--KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           + LL  L HP +   K V       +     E+ E ++LA  L       S  QV  +  
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLML 115

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           QL + LQYLH   I+HRD+K +N+LL    C  +ADFGLA              R+ G P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA--------------RTYGLP 161

Query: 230 TGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
                 K  V TL Y APE+L     ++   D+++ G  + ELL  
Sbjct: 162 AKPMTPK--VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)

Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK----ELQLLCKL 118
           P  YT L  +  GA   V  A     G KVA+KK  LS   + + F K    EL LL  +
Sbjct: 14  PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK--LSRPFQSEIFAKRAYRELTLLKHM 71

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFY----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
            H  +   +       +   F +FY      +   +K+     S   D+V  +  Q+   
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE--DKVQYLVYQMLCG 129

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L+Y+H+ GI+HRD+KP N+ ++ +    + DFGLA              R +     G+ 
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RHADAEMTGY- 174

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
               V T  Y APE++   +H  ++ D++S G  + E+LTG
Sbjct: 175 ----VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 2e-14
 Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDN-FHKELQLLCKLDHPG 122
           Y ++  I +G    VY A   +  R+VA+KK    LS +  L   F +E ++   L HPG
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 123 LAK-FVAAHAKPPNY--MFFFEFY----------ESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +   +       P Y  M + E Y          +  +L+++L  +    SV   L I  
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT---SVGAFLSIFH 120

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           ++   ++Y+H+ G++HRD+KP N+LL       + D+G A +++  +E  L       + 
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD--IDVDER 178

Query: 230 TGGFHKKNM------VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              +   +M      VGT  YMAPE L     SE +D+Y+ G+ + ++LT   PY
Sbjct: 179 NICYS--SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 48/122 (39%), Positives = 67/122 (54%), Gaps = 18/122 (14%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEI 218
           S D+V   + ++  AL++LH LGIV+RD+K  N+LLD      L DFGL+ E+    KE 
Sbjct: 103 SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVP 277
           +                 +  GT+ YMAPEI++ K  H +  D +S GI I ELLTG  P
Sbjct: 163 TY----------------SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Query: 278 YT 279
           +T
Sbjct: 207 FT 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 64/286 (22%)

Query: 91  KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PNYMFFFEF 142
           KVAVK  K  + T  E+++F  E   + + DHP + + +    +       P+ +    F
Sbjct: 28  KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87

Query: 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQ--------LAKALQYLHNLGIVHRDVKPANVL 194
            +  +L   L    +S   D    +  Q        +A  ++YL +   +HRD+   N +
Sbjct: 88  MKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCM 144

Query: 195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKK 252
           L+ N+   +ADFGL++   N                G ++++  +  +   ++A E L  
Sbjct: 145 LNENMNVCVADFGLSKKIYN----------------GDYYRQGRIAKMPVKWIAIESLAD 188

Query: 253 EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRP 311
            +++ KSDV+SFG+++ E+ T G  PY  +        + + N  +Q             
Sbjct: 189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ------------- 235

Query: 312 ILASLELGLPASIL----SLIQRCWDGNPHNRPSFSDIALELDLVL 353
                    P   L    SL+  CW  NP +RPSF  +  EL+  L
Sbjct: 236 ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 36/221 (16%)

Query: 67  SYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDH 120
            Y  L+ I  G   VVY A     G  VA+KK  L   +E + F     +E+ +L KL H
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKK--LKMEKEKEGFPITSLREINILLKLQH 63

Query: 121 P---GLAKFVAAHAKPPNYMF--FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
           P    + + V        YM   + E ++ ++L E +  + +  S  + LM+  QL   +
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLML--QLLSGV 119

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGGFH 234
            +LH+  I+HRD+K +N+LL+      + DFGLA EY   LK  +               
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ-------------- 165

Query: 235 KKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
              +V TL Y APE+L   + +S   D++S G    ELLT 
Sbjct: 166 ---LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 19/223 (8%)

Query: 66  SSYTLLSPIARGAESV-VYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPG 122
              TL+         V + +       VAVKK  L +   E+L    +E+    +L HP 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 123 LAKFVAAH-AKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           +  +V +       Y       +    +L +    E        +  I   +  AL Y+H
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAFILKDVLNALDYIH 118

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + G +HR VK +++LL  +    L+       R ++  I         +       K+ V
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL-----RYSVSMIKHGKR----QRVVHDFPKSSV 169

Query: 240 GTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTD 280
             L +++PE+L++ +   +EKSD+YS GI+  EL  G VP+ D
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + L+  I  G    VY+A     G   A+K   L   E+     +E+ ++    H 
Sbjct: 7   PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            +  +  ++ +        EF    +L +  HV    P S  Q+  ++ +  + L YLH+
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS 124

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-KNMV 239
            G +HRD+K AN+LL  N    LADFG+                 S + T    K K+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGV-----------------SAQITATIAKRKSFI 167

Query: 240 GTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           GT  +MAPE+    +K  +++  D+++ GI+  EL     P  DL
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 25/231 (10%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-----STSEELDNFHKELQLLCK 117
           P ++ L   + RGA   VY       GR++AVK+         TS+E++    E+QLL  
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60

Query: 118 LDHPGLAKFVAAHAKPPN--YMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKA 174
           L H  + ++      P       F E+    ++ ++L  + +    + V      Q+ + 
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQG 118

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           + YLH+  IVHRD+K AN+L D      L DFG ++    ++ I +           G  
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMS----------GTG 165

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
            K++ GT  +M+PE++  E +  K+DV+S   ++ E+LT   P+ +  A A
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQ 176
           +HP L +       P    F  EF    +L    H+++ S   D+      AA++  AL 
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM--FHIQK-SRRFDEARARFYAAEITSALM 110

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI++RD+K  NVLLD      LADFG+   +E +           GK T  F   
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGIFN---------GKTTSTF--- 156

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              GT  Y+APEIL++ ++    D ++ G+ + E+L G  P+
Sbjct: 157 --CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.5 bits (175), Expect = 7e-14
 Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 42/284 (14%)

Query: 68  YTLLSPIARGA--ESVVYEATLDGRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLA 124
           Y +L  +  G+   +++ +     +K A+K+  L  +S  +++  KE  LL K+ HP + 
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGI 183
            F  +     +     E+ +  +L +K+ ++       D +L    Q+   +Q++H   +
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+K  N+ L +N    L DFG A              R    P  G +    VGT  
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSA--------------RLLTSP--GAYACTYVGTPY 165

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           Y+ PEI +   ++ KSD++S G  + EL T   P+   +A +  + +L+           
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLILK----------- 211

Query: 304 VVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           V  G  +P+ +  S EL       SLI++ +  NP +RPS + I
Sbjct: 212 VCQGSYKPLPSHYSYELR------SLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 16/111 (14%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++   LQ+LH  GI++RD+K  NVLLD++    +ADFG+ +     + ++ +   S+ 
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKAST- 155

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                       GT  Y+APEILK + ++E  D +SFG+ + E+L G  P+
Sbjct: 156 ----------FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 29/209 (13%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFV-A 128
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA---QLAKALQYLHNLGIVH 185
            H +   Y+ F EF   ++L  K  ++    S   + +I +   QL + L + H+  ++H
Sbjct: 68  IHTENKLYLVF-EFL-HQDL--KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYTHE--VVTLWYR 167

Query: 246 APEI-LKKEIHSEKSDVYSFGISINELLT 273
           APEI L  + +S   D++S G    E++T
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 18/112 (16%)

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
           IA  + K L YLH+  I+HRD+KP+N+LL R     L DFG+                 S
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV-----------------S 152

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           G+           GT  YMAPE ++ + +S  SDV+S G+++ E+     P+
Sbjct: 153 GELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 59/190 (31%), Positives = 83/190 (43%), Gaps = 21/190 (11%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           KV  KK IL   EE     +   LL  + HP L     +        F  ++     L  
Sbjct: 26  KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 85

Query: 151 KLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
            L  E     P   +    AA++A AL YLH+L IV+RD+KP N+LLD      L DFGL
Sbjct: 86  HLQRERCFLEP---RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 142

Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
              +EN+            +  G        GT  Y+APE+L K+ +    D +  G  +
Sbjct: 143 C--KENI------------EHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 186

Query: 269 NELLTGVVPY 278
            E+L G+ P+
Sbjct: 187 YEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 63/271 (23%)

Query: 93  AVKKPILSTSEELDNFHKELQLLCK-LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE- 150
           A  K      + + +   E+ ++ + L HP + ++     +        +  E   L E 
Sbjct: 40  AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH 99

Query: 151 -------KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLDRNLCPH 202
                  K    E     +++  I  Q+  AL+YLH    IVHRD+ P N++L  +    
Sbjct: 100 FNSLKEKKQRFTE-----ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154

Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVY 262
           + DFGLA  ++   E  L +               +VGT++Y  PEI+K E + EK+DV+
Sbjct: 155 ITDFGLA--KQKQPESKLTS---------------VVGTILYSCPEIVKNEPYGEKADVW 197

Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA--VVSGGLRPILASLELGL 320
           +FG  + ++ T   P+                Y+   L+ A  +V     P        L
Sbjct: 198 AFGCILYQMCTLQPPF----------------YSTNMLSLATKIVEAVYEP--------L 233

Query: 321 PASILS-----LIQRCWDGNPHNRPSFSDIA 346
           P  + S     +I  C   +   RP    ++
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 21/196 (10%)

Query: 87  LDGR----KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142
           LDG+    KV  KK +L+  E+     +   LL  + HP L     +        F  +F
Sbjct: 18  LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77

Query: 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
                L   L  E   P   +    AA++A AL YLH++ IV+RD+KP N+LLD      
Sbjct: 78  VNGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136

Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVY 262
           L DFGL            K   +    T  F      GT  Y+APE+++K+ +    D +
Sbjct: 137 LTDFGLC-----------KEGIAQSDTTTTF-----CGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 263 SFGISINELLTGVVPY 278
             G  + E+L G+ P+
Sbjct: 181 CLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + KAL  LH  G++HRD+K  
Sbjct: 88  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145

Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K++VGT  +MAPE++ 
Sbjct: 146 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKSLVGTPYWMAPELIS 189

Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 54/283 (19%)

Query: 91  KVAVKKPILSTSE-ELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           KVAVK      +E +L +   E++++  +  H  +   + A  +        E+    NL
Sbjct: 52  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 149 AEKL---------------HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
            E L                V E   S   ++  A Q+A+ ++YL +   +HRD+   NV
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171

Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILK 251
           L+  +    +ADFGLA    ++  I              ++KK   G L   +MAPE L 
Sbjct: 172 LVTEDNVMKIADFGLA---RDIHHID-------------YYKKTTNGRLPVKWMAPEALF 215

Query: 252 KEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR 310
             I++ +SDV+SFG+ + E+ T G  PY  +  E     + E +  +            +
Sbjct: 216 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------------K 263

Query: 311 PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
           P   + EL +      +++ CW   P  RP+F  +  +LD +L
Sbjct: 264 PSNCTNELYM------MMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 2e-13
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 26/213 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPI--LSTSEELDNFHKELQLLCKL-DHPG 122
           Y ++  +  G    VY A     G  VA+KK      + EE  N  +E++ L KL +HP 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPN 59

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNL 181
           + K      +     F FE+ E  NL + +   +  P S   +  I  Q+ + L ++H  
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           G  HRD+KP N+L+       +ADFGLA      +EI     RS    T      + V T
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLA------REI-----RSRPPYT------DYVST 161

Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLT 273
             Y APEI L+   +S   D+++ G  + EL T
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)

Query: 65  PSSYTLLSPIARGAESVVYEATLDGR---KVAVKKPILSTSEEL--DNFHKELQLLCKLD 119
           P  Y  L  +  GA   V  A LD R   KVA+KK       EL     ++EL+LL  + 
Sbjct: 14  PDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           H  +   +       +   F +FY        +L + +  E+ S   D++  +  Q+ K 
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE--DRIQFLVYQMLKG 130

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L+Y+H  GI+HRD+KP N+ ++ +    + DFGLA              R +     G+ 
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RQTDSEMTGY- 175

Query: 235 KKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
               V T  Y APE++   +H ++  D++S G  + E+LTG
Sbjct: 176 ----VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           Y  +  I  G   VVY+A   L G  VA+KK  L T +E       +E+ LL +L+HP +
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 124 AK-FVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +     H++   Y+ F EF +  +L + +            +     QL + + Y H+ 
Sbjct: 61  VRLLDVVHSENKLYLVF-EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMVG 240
            ++HRD+KP N+L+DR     LADFGLA              R+ G P   + H+   V 
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA--------------RAFGVPVRTYTHE---VV 161

Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLT 273
           TL Y APEIL      S   D++S G    E++ 
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 57/188 (30%), Positives = 84/188 (44%), Gaps = 17/188 (9%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           KV  KK IL   E+     +   LL  L HP L     +        F  ++     L  
Sbjct: 26  KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF 85

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L  E       +    AA++A A+ YLH+L I++RD+KP N+LLD      L DFGL  
Sbjct: 86  HLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC- 143

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            +E ++           + T  F      GT  Y+APE+L+KE +    D +  G  + E
Sbjct: 144 -KEGVEP---------EETTSTF-----CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188

Query: 271 LLTGVVPY 278
           +L G+ P+
Sbjct: 189 MLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 16/111 (14%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++   LQ+LH  GI++RD+K  NVLLD      +ADFG+   +E +            
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC--KEGI------------ 147

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              GG       GT  Y+APEIL  + +    D ++ G+ + E+L G  P+
Sbjct: 148 --LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 37/187 (19%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+A+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+              
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID------------- 191

Query: 230 TGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
              ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T G  PY  +  E  
Sbjct: 192 ---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248

Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              + E +  +            +P   + EL +      +++ CW   P +RP+F  + 
Sbjct: 249 FKLLKEGHRMD------------KPANCTNELYM------MMRDCWHAIPSHRPTFKQLV 290

Query: 347 LELDLVL 353
            +LD +L
Sbjct: 291 EDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 17/120 (14%)

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
            +V +  A++  AL +LH LGI++RD+K  N+LLD      L DFGL+      KE    
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS------KEFL-- 156

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYT 279
                          +  GT+ YMAPE+++     H +  D +S G+   ELLTG  P+T
Sbjct: 157 -------AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 38/241 (15%)

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFY----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
            D  G  K+  A  +  NY   ++ Y      R   + L  E  + S   ++  + Q+A 
Sbjct: 193 QDMKGTVKY--ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVAN 250

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            +++L +   VHRD+   NVL+       + DFGLA  R+ +++    N+ S G      
Sbjct: 251 GMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRD---SNYISKG------ 299

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
              +    L +MAPE +   +++  SDV+SFGI + E+ T G  PY +L    Q +  ++
Sbjct: 300 ---STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356

Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
             Y   +           P  AS E      I  ++Q+CW+     RP FS +   +  +
Sbjct: 357 RGYRMAK-----------PAHASDE------IYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Query: 353 L 353
           L
Sbjct: 400 L 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 29/219 (13%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  L+P+  GA   V  A  T   +KVAVKK   P  S       + +EL+LL  + 
Sbjct: 14  PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMK 72

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F E Y   NL    L+  V+    S + V  +  QL + L+
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+ GI+HRD+KP+NV ++ +    + DFGLA              R +     G+   
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--------------RQADDEMTGY--- 175

Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
             V T  Y APEI+   +H  ++ D++S G  + ELL G
Sbjct: 176 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 21/190 (11%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           K   K+ IL   +++ +  +E  +L +L HP +   + +        F  EF     L  
Sbjct: 49  KCLKKREILKM-KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT 107

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L      P+ D      A+L  A +YLH+  I++RD+KP N+LLD      + DFG A 
Sbjct: 108 HLRKAGRFPN-DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA- 165

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                K++  + +   G P              Y+APE+++ + H +  D ++ G+ + E
Sbjct: 166 -----KKVPDRTFTLCGTPE-------------YLAPEVIQSKGHGKAVDWWTMGVLLYE 207

Query: 271 LLTGVVPYTD 280
            + G  P+ D
Sbjct: 208 FIAGYPPFFD 217

Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 75/321 (23%), Positives = 133/321 (41%), Gaps = 65/321 (20%)

Query: 63  LPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKEL 112
           L  +  TL  P+  G       AE++  +     + V V   +L   +T ++L +   E+
Sbjct: 9   LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM 68

Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--------- 162
           +++  +  H  +   + A  +        E+    NL E L      P +D         
Sbjct: 69  EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLP 127

Query: 163 -------QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    N+
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 188 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 232 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTHELYM------IMRECW 273

Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD VL
Sbjct: 274 HAVPSQRPTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)

Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
              Y  LS I  GA  +V  AT    G KVA+KK        +  F           E++
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIK 55

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LH--VEEWSPSVDQVLMIAAQ 170
           +L +  H  +   +    +PP++  F + Y  + L E  L+  ++    S D +     Q
Sbjct: 56  ILRRFKHENIIGILDI-IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ 114

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + + L+Y+H+  ++HRD+KP+N+LL+ N    + DFGLA        I+      +G  T
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA-------RIADPEHDHTGFLT 167

Query: 231 GGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                   V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 168 ------EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 16  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 74

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 177

Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 178 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 60/313 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKK-PILSTSEELDNFHKELQLL 115
           LP S+   +  +   A   +Y+  L        + VA+K    ++  ++   F +E  L+
Sbjct: 2   LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLM 61

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD------------- 162
            +L HP +   +    +       FE+    +L E L +   SP  D             
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMR--SPHSDVGCSSDEDGTVKS 119

Query: 163 -----QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
                  L IA Q+A  ++YL +   VH+D+   N+L+   L   ++D GL+      +E
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS------RE 173

Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
           I   ++           +   +  + +M PE +     S  SD++SFG+ + E+ + G+ 
Sbjct: 174 IYSADYYRV--------QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225

Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY     +     V+EM    Q L  +                 P  + SL+  CW   P
Sbjct: 226 PYYGFSNQ----EVIEMVRKRQLLPCSE--------------DCPPRMYSLMTECWQEGP 267

Query: 337 HNRPSFSDIALEL 349
             RP F DI   L
Sbjct: 268 SRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 47/191 (24%), Positives = 93/191 (48%), Gaps = 20/191 (10%)

Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           GR+VAVK   L   +  +    E+ ++    H  + +   ++          EF +   L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
            +   V +   + +Q+  +   + +AL YLH+ G++HRD+K  ++LL  +    L+DFG 
Sbjct: 106 TDI--VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF 163

Query: 209 -AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
            A+  +++ +                 +K++VGT  +MAPE++ +  +  + D++S GI 
Sbjct: 164 CAQISKDVPK-----------------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206

Query: 268 INELLTGVVPY 278
           + E++ G  PY
Sbjct: 207 VIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 25/206 (12%)

Query: 89  GRKVAVKKPIL-----STSEELDNFHKELQLLCKLDHPGLAKFVAA---HAKPPNYMFFF 140
           GR++A K+         TS+E+     E+QLL  L H  + ++       A+      F 
Sbjct: 27  GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK-TLTIFM 85

Query: 141 EFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
           E+    ++ ++L      + SV +      Q+ + + YLH+  IVHRD+K AN+L D   
Sbjct: 86  EYMPGGSVKDQLKAYGALTESVTR--KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG 143

Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              L DFG ++    L+ I +           G   +++ GT  +M+PE++  E +  K+
Sbjct: 144 NVKLGDFGASK---RLQTICMS----------GTGIRSVTGTPYWMSPEVISGEGYGRKA 190

Query: 260 DVYSFGISINELLTGVVPYTDLRAEA 285
           DV+S G ++ E+LT   P+ +  A A
Sbjct: 191 DVWSLGCTVVEMLTEKPPWAEYEAMA 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)

Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
           W   +D +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA    N  
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 217 EISLK-NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
              +K N R   K               +MAPE +   +++ +SDV+S+GI + E+ + G
Sbjct: 267 NYVVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311

Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  +   ++ + +++  Y   Q++        RP  A  E      I S+++ CW+ 
Sbjct: 312 KSPYPGILVNSKFYKMVKRGY---QMS--------RPDFAPPE------IYSIMKMCWNL 354

Query: 335 NPHNRPSFSDIA 346
            P  RP+FS I+
Sbjct: 355 EPTERPTFSQIS 366

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 73/285 (25%), Positives = 117/285 (41%), Gaps = 42/285 (14%)

Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
            LL  I +G    V      G KVAVK   +        F  E  ++ +L H  L + + 
Sbjct: 9   KLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 129 AHAKPPNYMFFF-EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHR 186
              +    ++   E+    +L + L     S    D +L  +  + +A++YL     VHR
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+   NVL+  +    ++DFGL       KE       SS + TG    K       + A
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTA 167

Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           PE L+++  S KSDV+SFGI + E+ + G VPY  +  +     V E  Y          
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD---- 222

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                        G P  +  ++++CW  +   RPSF  +  +L+
Sbjct: 223 -------------GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 48/267 (17%)

Query: 90  RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAA----HAKPPNYMFFFEFYE 144
            +V VK      SE ++    +E  LL  L H  +   +         P      + +  
Sbjct: 36  EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP---FVLYPYMN 92

Query: 145 SRNLAEKL----HVEEWSP---SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
             NL   L      E  +P   S  Q++ +A Q+A  + YLH  G++H+D+   N ++D 
Sbjct: 93  WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152

Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
            L   + D  L+      +++   ++   G         N    + +MA E L  + +S 
Sbjct: 153 ELQVKITDNALS------RDLFPMDYHCLG--------DNENRPVKWMALESLVNKEYSS 198

Query: 258 KSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
            SDV+SFG+ + EL+T G  PY ++     A   L+  Y   Q           PI    
Sbjct: 199 ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLAQ-----------PI---- 242

Query: 317 ELGLPASILSLIQRCWDGNPHNRPSFS 343
               P  + +++  CW  +P  RPSFS
Sbjct: 243 --NCPDELFAVMACCWALDPEERPSFS 267

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 19/116 (16%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           A++  AL  +H++G +HRDVKP N+LLD++    LADFG     +               
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-------------- 194

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHS----EKSDVYSFGISINELLTGVVPYTD 280
             G       VGT  Y++PE+LK +        + D +S G+ + E+L G  P+  
Sbjct: 195 -NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           YT +  I  G   VVY+      G+ VA+KK  L + EE       +E+ LL +L HP +
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA--AQLAKALQYLHNL 181
                   +       FEF  S +L + L        +D  L+ +   Q+ + + + H+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMVG 240
            ++HRD+KP N+L+D      LADFGLA              R+ G P   + H+   V 
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLA--------------RAFGIPVRVYTHE---VV 163

Query: 241 TLIYMAPEIL-KKEIHSEKSDVYSFGISINELLT 273
           TL Y APE+L     +S   D++S G    E+ T
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 42/120 (35%), Positives = 66/120 (55%), Gaps = 19/120 (15%)

Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLK 221
           +V + + ++  AL++LH LGI++RD+K  N+LLD N    L DFGL+ E+ E+  E    
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE---- 161

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYT 279
                          +  GT+ YMAP+I++     H +  D +S G+ + ELLTG  P+T
Sbjct: 162 ------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 60/188 (31%), Positives = 86/188 (45%), Gaps = 17/188 (9%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           KV  KK IL   E+     +   LL  + HP L     +        F  ++     L  
Sbjct: 26  KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF 85

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L  E   P   +    AA++A AL YLH+L I++RD+KP N+LLD      L DFGL  
Sbjct: 86  HLQRERSFPEP-RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC- 143

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            +E + E S        K T  F      GT  Y+APE+L+K+ +    D +  G  + E
Sbjct: 144 -KEGI-EHS--------KTTSTF-----CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYE 188

Query: 271 LLTGVVPY 278
           +L G+ P+
Sbjct: 189 MLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 27/139 (19%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE----------YREN--LK 216
           A+L  A++ +H +G +HRD+KP N+L+DR+    L DFGL            Y++    +
Sbjct: 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 217 EISLKNW-------RSSGKPTGGFHKK--------NMVGTLIYMAPEILKKEIHSEKSDV 261
           + S++         R   KP     K+        ++VGT  Y+APE+L +  +++  D 
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227

Query: 262 YSFGISINELLTGVVPYTD 280
           +S G+ + E+L G  P+  
Sbjct: 228 WSVGVILYEMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 41/192 (21%)

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 172

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
               +R  GK           G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 173 DY--YRKGGK-----------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  +              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 220 QPYQGM--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 259

Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 260 YNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 93  AVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           A+KK ++   ++++    E ++L    +HP L           N  F  E+    +L   
Sbjct: 27  ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLM-- 84

Query: 152 LHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            H++      + +    AA++   LQ+LH+ GIV+RD+K  N+LLD +    +ADFG+  
Sbjct: 85  FHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMC- 143

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                KE  L + ++              GT  Y+APEIL  + ++   D +SFG+ + E
Sbjct: 144 -----KENMLGDAKTC----------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYE 188

Query: 271 LLTGVVPYTDLRAEAQAHTV 290
           +L G  P+     E    ++
Sbjct: 189 MLIGQSPFHGHDEEELFQSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 22/205 (10%)

Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           YT++  +  G+E  V+ AT  G+   V   I      L     E  LL  ++HP + +  
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL----IEAMLLQNVNHPSVIRMK 123

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
                          Y S +L   L        +DQ L+I  Q+ + L+YLH   I+HRD
Sbjct: 124 DTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182

Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           VK  N+ ++      + D G A++                 P        + GT+   AP
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQF-----------------PVVAPAFLGLAGTVETNAP 225

Query: 248 EILKKEIHSEKSDVYSFGISINELL 272
           E+L ++ ++ K+D++S GI + E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 45/267 (16%)

Query: 92  VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           VAVK    ++     +FH+E +LL  L H  + KF     +    +  FE+ +  +L + 
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 152 LH--------VEEWSPSVD----QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
           L         + E +   +    Q+L IA Q+A  + YL +   VHRD+   N L+  NL
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157

Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFG++      +++   ++   G  T        +  + +M PE +     + +S
Sbjct: 158 LVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPIRWMPPESIMYRKFTTES 203

Query: 260 DVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL 318
           DV+S G+ + E+ T G  P+  L        + +    ++  T                 
Sbjct: 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC---------------- 247

Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDI 345
             P  +  L+  CW   PH R +  +I
Sbjct: 248 --PKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 37/189 (19%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++            
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID----------- 188

Query: 228 KPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE 284
                ++KK   G L   +MAPE L   +++ +SDV+SFGI + E+ T G  PY  +  E
Sbjct: 189 -----YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                + E +  +            +P   + EL +      L++ CW   P  RP+F  
Sbjct: 244 ELFKLLREGHRMD------------KPSNCTHELYM------LMRECWHAVPTQRPTFKQ 285

Query: 345 IALELDLVL 353
           +   LD VL
Sbjct: 286 LVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 18/186 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
           VKK +++  E++D    E  +  +  +HP L    +         F  E+    +L   +
Sbjct: 28  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
             +   P  +     +A+++ AL YLH  GI++RD+K  NVLLD      L D+G+   +
Sbjct: 88  QRQRKLPE-EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--K 144

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E L+          G  T  F      GT  Y+APEIL+ E +    D ++ G+ + E++
Sbjct: 145 EGLR---------PGDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 273 TGVVPY 278
            G  P+
Sbjct: 191 AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
            + Y  + PI RGA  +V  A       KVA+KK   +    +D     +E++LL  LDH
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH 63

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQ 176
             +   +     PP+   F + Y    L +  LH    S    S D       QL + L+
Sbjct: 64  ENVIA-IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  ++HRD+KP+N+LL+ N    + DFGLA              R++ +  G F  +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------------RTTSE-KGDFMTE 167

Query: 237 NMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
            +V T  Y APE +L    ++   DV+S G    ELL 
Sbjct: 168 YVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           Y +   I +G+  VV  A  T  G KVA+KK I    E + +  +   E++LL  L HP 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKK-INDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHV-----EEWSPSVDQVLMIAAQLAKALQ 176
           + + +     PP+   F + Y    L E  LH      ++ +P   Q  +   QL +AL+
Sbjct: 61  IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY--QLLRALK 117

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H   + HRD+KP N+L + +    + DFGLA    N              PT  F   
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN------------DTPTAIFW-T 164

Query: 237 NMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTG 274
           + V T  Y APE+       ++   D++S G    E+LTG
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 21/112 (18%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++ +A+  LH LG +HRD+KP N L+D +    L DFGL+                  
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS------------------ 148

Query: 228 KPTGGFHKKN-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              G     N +VG+  YMAPE+L+ + +    D +S G  + E L G  P+
Sbjct: 149 --KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 49/270 (18%)

Query: 92  VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL--- 148
           VAVK    ++     +F +E +LL  L H  + +F     +    +  FE+    +L   
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 149 -------AEKLHVEEWSP----SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
                  A+ L   E       ++ Q+L IA+Q+A  + YL +L  VHRD+   N L+ +
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157

Query: 198 NLCPHLADFGLAEYRENLKEI-SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS 256
            L   + DFG++      ++I S   +R  G        + M+  + +M PE +     +
Sbjct: 158 GLVVKIGDFGMS------RDIYSTDYYRVGG--------RTML-PIRWMPPESILYRKFT 202

Query: 257 EKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
            +SD++SFG+ + E+ T G  P+  L        + +    E+  T              
Sbjct: 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC------------- 249

Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                P  + +++Q CW   P  R    DI
Sbjct: 250 -----PPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 22/139 (15%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEI 218
           S  ++   AA++   L+++HN  +V+RD+KPAN+LLD +    ++D GLA ++       
Sbjct: 95  SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF------- 147

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVP 277
                 S  KP         VGT  YMAPE+L+K +  + S D +S G  + +LL G  P
Sbjct: 148 ------SKKKPHAS------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Query: 278 YTDLRAEAQAHTVLEMNYT 296
           +   + + + H +  M  T
Sbjct: 196 FRQHKTKDK-HEIDRMTLT 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 32/186 (17%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+A+ +++L +   +HRD+   N+LL  N    + DFGLA  R+  K+        +  P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA--RDIYKDPDYVRKGDARLP 238

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                       L +MAPE +  ++++ +SDV+SFG+ + E+ + G  PY  ++ + +  
Sbjct: 239 ------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
             L+               G R  + + E   P  I S++  CW  NP +RP+FS++   
Sbjct: 287 RRLKE--------------GTR--MRAPEYATP-EIYSIMLDCWHNNPEDRPTFSELVEI 329

Query: 349 LDLVLE 354
           L  +L+
Sbjct: 330 LGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 48/280 (17%)

Query: 89  GRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR + V   IL   +     ++F KE+++L +L  P + + +             E+ E+
Sbjct: 44  GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103

Query: 146 RNLAEKL---HVEEWS---------------PSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
            +L + L   H+++                  S   +L +A Q+A  ++YL +L  VHRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163

Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   N L+  NL   +ADFG++    NL   +   +R  G+          V  + +MA 
Sbjct: 164 LATRNCLVGENLTIKIADFGMS---RNL--YAGDYYRIQGRA---------VLPIRWMAW 209

Query: 248 EILKKEIHSEKSDVYSFGISINELLT--GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           E +     +  SDV++FG+++ E+L      PY +L  E       E  + +Q       
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEF-FRDQG------ 262

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               R +        P  +  L+ +CW  +   RPSFSDI
Sbjct: 263 ----RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 67/235 (28%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           P  ++ ++  I +G    VY+ T   DG   AVK   PI    EE++  +  LQ L   +
Sbjct: 20  PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP--N 77

Query: 120 HPGLAKFVAAHAKPPNYM-----FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           HP + KF     K    +        E     ++ E +             MI+  L  A
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 175 L---QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
           L   Q+LHN  I+HRDVK  N+LL       L DFG+                S+   + 
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV----------------SAQLTST 181

Query: 232 GFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVPYTDL 281
              +   VGT  +MAPE++  E   + S     DV+S GI+  EL  G  P  D+
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 25/191 (13%)

Query: 92  VAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF-FEFYESRN 147
           VA+K   K  +   +++D+   E ++L  ++HP       +  K  +Y++   EF     
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-KDESYLYLVLEFVIGGE 117

Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
               L   +  P+ D     AAQ+    +YL +L IV+RD+KP N+LLD++    + DFG
Sbjct: 118 FFTFLRRNKRFPN-DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
            A      K +  + +   G P              Y+APEIL    H + +D ++ GI 
Sbjct: 177 FA------KVVDTRTYTLCGTPE-------------YIAPEILLNVGHGKAADWWTLGIF 217

Query: 268 INELLTGVVPY 278
           I E+L G  P+
Sbjct: 218 IYEILVGCPPF 228

Length = 340

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 34/227 (14%)

Query: 66  SSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           S Y  L P+  G+  +V+ A +D    ++VAVKK +L+  + + +  +E++++ +LDH  
Sbjct: 5   SRYMDLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63

Query: 123 LAK-----FVAAHAKPPNYMFFFEF--------YESRNLAEKLHVEEWSPSVDQVLMIAA 169
           + K       +      +     E         Y   +LA  L  E+   S +   +   
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL--EQGPLSEEHARLFMY 121

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           QL + L+Y+H+  ++HRD+KPANV ++  +L   + DFGLA   +     S K + S G 
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSHKGYLSEG- 178

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
                     + T  Y +P +L    +  K+ D+++ G    E+LTG
Sbjct: 179 ----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 33/221 (14%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDN---FHKELQLLCKLDH 120
           S Y  +  I  GA  VV  A  T  G+KVA+KK I    +         +EL++L    H
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKK-IPHAFDVPTLAKRTLRELKILRHFKH 63

Query: 121 PGLAK----FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKAL 175
             +           A   +     +  ES +L   +H ++  P + + +     QL + L
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ--PLTEEHIRYFLYQLLRGL 120

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +Y+H+  ++HRD+KP+N+L++ +    + DFG+A      + +       S  PT   HK
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA------RGL-------SSSPTE--HK 165

Query: 236 KNM---VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELL 272
             M   V T  Y APE+L     ++   D++S G    E+L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 28/193 (14%)

Query: 89  GRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
           G+ VA+KK +   SE+     K    E+++L +L H  L   +    +       FEF +
Sbjct: 26  GQIVAIKKFL--ESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83

Query: 145 SRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
              L +   +E++   +D+  V     Q+ + +++ H+  I+HRD+KP N+L+ ++    
Sbjct: 84  HTVLDD---LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVK 140

Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DV 261
           L DFG A              R+   P  G    + V T  Y APE+L  +    ++ D+
Sbjct: 141 LCDFGFA--------------RTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184

Query: 262 YSFGISINELLTG 274
           ++ G  + E+LTG
Sbjct: 185 WAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           S Y  L+ I +G    V++A      + VA+KK ++   +E   F     +E+++L  L 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLK 69

Query: 120 HPGLAKFVA-AHAKP-------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           H  +   +     K         ++   FEF E  +LA  L  +    ++ ++  +   L
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
              L Y+H   I+HRD+K AN+L+ ++    LADFGLA              R+      
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA--------------RAFSLSKN 174

Query: 232 GFHKK--NMVGTLIYMAPEIL 250
               +  N V TL Y  PE+L
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 39/111 (35%), Positives = 62/111 (55%), Gaps = 16/111 (14%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++A  L +LH+ GI++RD+K  NV+LD      +ADFG+   +EN+           G
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC--KENIFG---------G 155

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           K T  F      GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+
Sbjct: 156 KTTRTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 63/256 (24%), Positives = 114/256 (44%), Gaps = 37/256 (14%)

Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE--------SRNLAEKLHVEEW 157
           ++F KE++++ +L  P + + +A            E+ E        SR+  ++   +  
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 158 SPSVD--QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
             ++    ++ +A Q+A  ++YL +L  VHRD+   N L+ +N    +ADFG++    NL
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS---RNL 180

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
              S   +R  G+          V  + +M+ E +     +  SDV++FG+++ E+LT  
Sbjct: 181 --YSGDYYRIQGRA---------VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229

Query: 276 --VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
              PY+ L  E       E  + +Q     +     +P L       P S+  L+  CW 
Sbjct: 230 KEQPYSQLSDEQVIENTGEF-FRDQGRQVYL----PKPALC------PDSLYKLMLSCWR 278

Query: 334 GNPHNRPSFSDIALEL 349
            N   RPSF +I   L
Sbjct: 279 RNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 37/190 (19%)

Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIYET 172

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
               +R  GK           G L   +MAPE LK  + +  SD++SFG+ + E+ +   
Sbjct: 173 DY--YRKGGK-----------GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
            PY  L  E     V++  Y +Q                      P  +  L++ CW  N
Sbjct: 220 QPYQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFN 261

Query: 336 PHNRPSFSDI 345
           P  RP+F +I
Sbjct: 262 PKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 17/188 (9%)

Query: 93  AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
            ++K  + +  E+ +   E  +L +++ P +     +   P        F     L   L
Sbjct: 25  TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
              E    + +     A+L  AL+ LH   +++RD+KP N+LLD      L DFGL +  
Sbjct: 85  Q-REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL- 142

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            N+K+    N                 GT  Y+APE+L    +++  D ++ G+ + E+L
Sbjct: 143 -NMKDDDKTN--------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187

Query: 273 TGVVPYTD 280
           TG+ P+ D
Sbjct: 188 TGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 19/211 (9%)

Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           Y +LS +  G+E  V+  T  G     KK I+          +E+ +L  + H  +   +
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLI 152

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHR 186
            A+            Y+        +V+   P  ++Q + I  +L +AL YLH  GI+HR
Sbjct: 153 HAYRWKSTVCMVMPKYKCDLFT---YVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           DVK  N+ LD      L DFG A           K       P          GTL   +
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAA----------CKLDAHPDTP----QCYGWSGTLETNS 255

Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           PE+L  + +  K+D++S G+ + E+    V 
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 16/127 (12%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++A  L +LH+ GI++RD+K  NV+LD      +ADFG+   +EN+ +          
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENMWD---------- 154

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
               G   K   GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+     +   
Sbjct: 155 ----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210

Query: 288 HTVLEMN 294
            +++E N
Sbjct: 211 QSIMEHN 217

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 25/195 (12%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK +L   E +  F +E  +L   + P + +   A     N     E+    +L   L+
Sbjct: 34  MKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
             E     D      A+L  A+  +H +G VHRD+KP NVL+DR     LADFG      
Sbjct: 94  RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG------ 147

Query: 214 NLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILK------KEIHSEKSDVYSFG 265
                      S+ + T       K  VGT  Y+APE+L       K  +  + D +S G
Sbjct: 148 -----------SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196

Query: 266 ISINELLTGVVPYTD 280
           +   E++ G  P+ +
Sbjct: 197 VIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHP 121
           Y  LS I  G+  VV++      G+ VA+KK +   SE+     K    E+++L +L HP
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHP 60

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            L   +    +       FE+ +   L E   +E+    V + L+  I  Q  +A+ + H
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNE---LEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
               +HRDVKP N+L+ +     L DFG A                      G    + V
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILT----------------GPGDDYTDYV 161

Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGV 275
            T  Y APE+L  +  +    DV++ G    ELLTG 
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 42/249 (16%)

Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D   +E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV E     
Sbjct: 41  DELLREANVMQQLDNPYIVRMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTE----- 94

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             +  +  Q++  ++YL     VHRD+   NVLL       ++DFGL+      K +   
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLS------KALGAD 148

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
                 K  G +  K       + APE +     S KSDV+SFG+ + E  + G  PY  
Sbjct: 149 ENYYKAKTHGKWPVK-------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201

Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
           ++     + V +M  + +++                    P  +  L++ CW      RP
Sbjct: 202 MK----GNEVTQMIESGERMECPQ--------------RCPPEMYDLMKLCWTYGVDERP 243

Query: 341 SFSDIALEL 349
            F+ + L L
Sbjct: 244 GFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|240318 PTZ00224, PTZ00224, protein phosphatase 2C; Provisional

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 37/129 (28%), Positives = 57/129 (44%), Gaps = 19/129 (14%)

Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST 491
            S    G RE+MED H     +Y   +   FG+FDGH     +++ ARA P  L+     
Sbjct: 25  ASACVNGYRESMEDAHL----LYLTDDWGFFGVFDGHVNDECSQYLARAWPQALEKEPEP 80

Query: 492 TRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGD 550
               + + E  +  D  +   +DS R+           G T    +I+++  L V N GD
Sbjct: 81  MTD-ERMEELCLEIDEEW---MDSGREG----------GSTGTFCVIMKDVHLQVGNVGD 126

Query: 551 CRAILCRGG 559
            R ++CR G
Sbjct: 127 SRVLVCRDG 135

Length = 381

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 39/120 (32%), Positives = 54/120 (45%), Gaps = 21/120 (17%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEI 218
           S  +V  I  QL +AL  LH   I+H D+K  NVL DR     +L D+GL          
Sbjct: 107 SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC--------- 157

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                +  G P+         GTL Y +PE +K   +    D ++ G+   ELLTG  P+
Sbjct: 158 -----KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 35/238 (14%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHPG 122
           Y  L PI  GA+ +V  A  T+ G  VAVKK   P  + +      ++EL LL  ++H  
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-KRAYRELVLLKCVNHKN 81

Query: 123 LAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKAL 175
           +   +       +   F + Y        NL + +H+E     +D   M  +  Q+   +
Sbjct: 82  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDHERMSYLLYQMLCGI 136

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           ++LH+ GI+HRD+KP+N+++  +    + DFGLA                       F  
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------TACTNFMM 179

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
              V T  Y APE++    + E  D++S G  + EL+ G V +       Q + V+E 
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 51/291 (17%)

Query: 71  LSPIARGAESVVYEA--TLDGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFV 127
           L  + +G    VY+      G  +A+K+  L   E + +    EL +L K   P +  F 
Sbjct: 6   LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYL---HNL 181
            A           E+ ++ +L +KL+    +      D +  I   + K L++L   HN 
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRDVKP NVL++ N    L DFG+                 SG       K N +G 
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGV-----------------SGNLVASLAKTN-IGC 164

Query: 242 LIYMAPEILKKE------IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
             YMAPE +K         ++ +SDV+S G+SI E+  G  PY     E  A+       
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIF----- 216

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              QL+A V   G  P L S   G        + +C +  P+ RP+++ + 
Sbjct: 217 --AQLSAIV--DGDPPTLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 37/230 (16%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
              Y  L PI  GA+ +V  A  T+ G+ VA+KK   P  + +     + +EL L+  ++
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVN 73

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLM--IAAQLA 172
           H  +   +       +   F + Y        NL + + ++     +D   M  +  Q+ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LDHERMSYLLYQML 128

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
             +++LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TS 171

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
           F     V T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 44/264 (16%)

Query: 100 STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VE 155
           +T +E   F +E+Q   +L+HP + + +    +   Y+   EF    +L   L     + 
Sbjct: 34  ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMV 93

Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRE 213
                 D +  +A ++A  L +LH    +H D+   N  L  +L   + D+GLA  +Y E
Sbjct: 94  AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-------LKKEIHSEKSDVYSFGI 266
           +       +                   L ++APE+       L  +  ++KS+++S G+
Sbjct: 154 DYYITKDCHAVP----------------LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197

Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
           ++ EL T    PY DL  E     VL+    EQ +         +P    L+L       
Sbjct: 198 TMWELFTAADQPYPDLSDE----QVLKQVVREQDIKLP------KP---QLDLKYSDRWY 244

Query: 326 SLIQRCWDGNPHNRPSFSDIALEL 349
            ++Q CW  +P  RP+  ++   L
Sbjct: 245 EVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 37/236 (15%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           P  ++ ++  I +G    V++     +G K AVK   PI    EE++  +  L+ L   D
Sbjct: 16  PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--D 73

Query: 120 HPGLAKFVAAHAKPP-----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           HP + KF   + K             E     ++ + +          +  +IA  L +A
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 175 L---QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
           L   Q+LH    +HRDVK  N+LL       L DFG+                 S + T 
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV-----------------SAQLTS 176

Query: 232 GFHKKNM-VGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDL 281
              ++N  VGT  +MAPE++  E      +  + DV+S GI+  EL  G  P  DL
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 24/215 (11%)

Query: 66  SSYTLLSPIARGAESVVYEATLDGRK--VAVKKPILSTSEELDNFH----KELQLLCKLD 119
           + + +L  +  GA  VV +      K  VA+KK     SEE +       +EL++L  L 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLK 58

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
              + +   A  +       FE+ E +N+ E L         ++V     QL KA+ + H
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVE-KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              IVHRD+KP N+L+  N    L DFG A    NL E S  N+               V
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFA---RNLSEGSNANY------------TEYV 162

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
            T  Y +PE+L    + +  D++S G  + EL  G
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 20/188 (10%)

Query: 93  AVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           A+KK ++   ++++    E ++L    ++P L           +  F  EF    +L   
Sbjct: 27  ALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLM-- 84

Query: 152 LHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            H+++     + +    AA++   LQ+LH+ GI++RD+K  NV+LDR+    +ADFG+  
Sbjct: 85  FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMC- 143

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            +EN+               G        GT  Y+APEIL+   ++   D +SFG+ + E
Sbjct: 144 -KENV--------------FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188

Query: 271 LLTGVVPY 278
           +L G  P+
Sbjct: 189 MLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 38/128 (29%), Positives = 66/128 (51%), Gaps = 18/128 (14%)

Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           +V+E +P   +       AQ+   L++LH   I++RD+KP NVLLD +    ++D GLA 
Sbjct: 86  NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA- 144

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                  + LK+ +S          K   GT  +MAPE+L+ E +    D ++ G+++ E
Sbjct: 145 -------VELKDGQSK--------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189

Query: 271 LLTGVVPY 278
           ++    P+
Sbjct: 190 MIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 34/206 (16%)

Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201
           + +    +E L  +E +   + +L  + Q+AK + +L +   +HRD+   N+LL      
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253

Query: 202 HLADFGLAEYRENLKEISLK-NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
            + DFGLA    N     +K N R   K               +MAPE +   +++ +SD
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESD 298

Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           V+S+GI + E+ + G  PY  +  +++ + +++  Y             L P  A     
Sbjct: 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-----------LSPECA----- 342

Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
            P+ +  +++ CWD +P  RP+F  I
Sbjct: 343 -PSEMYDIMKSCWDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 22/132 (16%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL---------AEYRENLKEIS 219
           A+   A+  +H LG +HRD+KP N+LLD      L+DFGL          E+   L    
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 220 LKNWRS-SGKP---TGGFH--KKN-------MVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
             N+     KP          K+N        VGT  Y+APE+  +  ++++ D +S G+
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 267 SINELLTGVVPY 278
            + E+L G  P+
Sbjct: 228 IMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 51/269 (18%)

Query: 93  AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
           A+K P L+  ++   F +E +LL  L H  + KF          +  FE+ +  +L + L
Sbjct: 42  ALKDPTLAARKD---FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 98

Query: 153 HVE--------EWSP-------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
                      +  P        + Q+L IA+Q+A  + YL +   VHRD+   N L+  
Sbjct: 99  RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158

Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
           NL   + DFG++      +++   ++   G  T        +  + +M PE +     + 
Sbjct: 159 NLLVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPIRWMPPESIMYRKFTT 204

Query: 258 KSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
           +SDV+SFG+ + E+ T G  P+  L        + +    E            RP +   
Sbjct: 205 ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE------------RPRVC-- 250

Query: 317 ELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               P  +  ++  CW   P  R +  +I
Sbjct: 251 ----PKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 38/258 (14%)

Query: 92  VAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           VA+K  +L    E    D   +E +++ +LD+P + + +    +    M   E      L
Sbjct: 25  VAIK--VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV-CEAEALMLVMEMASGGPL 81

Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
            + L  ++   +V  V+ +  Q++  ++YL     VHRD+   NVLL       ++DFGL
Sbjct: 82  NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGL 141

Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
           ++      + S    RS+GK             L + APE +     S +SDV+S+GI++
Sbjct: 142 SKALG--ADDSYYKARSAGK-----------WPLKWYAPECINFRKFSSRSDVWSYGITM 188

Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
            E  + G  PY  ++          M++ EQ         G R          P  + +L
Sbjct: 189 WEAFSYGQKPYKKMKGPEV------MSFIEQ---------GKR---LDCPAECPPEMYAL 230

Query: 328 IQRCWDGNPHNRPSFSDI 345
           ++ CW     +RP+F+ +
Sbjct: 231 MKDCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 17/116 (14%)

Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + +  AA++   L+ LH   IV+RD+KP N+LLD      ++D GLA        + +  
Sbjct: 103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPE 154

Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
               G+   G      VGT+ YMAPE++K E ++   D +  G  I E++ G  P+
Sbjct: 155 ----GETIRG-----RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 31/131 (23%)

Query: 160 SVDQVLM------------IAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADF 206
           S+DQVL             I+  + + L YL     I+HRDVKP+N+L++      L DF
Sbjct: 85  SLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 144

Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           G++    +    S+ N              + VGT  YM+PE L+   ++ +SD++S G+
Sbjct: 145 GVSGQLID----SMAN--------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186

Query: 267 SINELLTGVVP 277
           S+ E+  G  P
Sbjct: 187 SLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 34/231 (14%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLL 115
           L +    Y ++  I RGA   V        +      +LS  E +       F +E  ++
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQL 171
              + P + +   A           E+    +L   +      E+W+          A++
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK------FYTAEV 151

Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
             AL  +H++G++HRDVKP N+LLD++    LADFG     +                TG
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---------------TG 196

Query: 232 GFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPY 278
                  VGT  Y++PE+LK +     +  + D +S G+ + E+L G  P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.0 bits (155), Expect = 6e-11
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 27/213 (12%)

Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 76

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 179

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 17/117 (14%)

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
           ++ L  AA++   L+ LH    V+RD+KP N+LLD      ++D GLA            
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV----------- 150

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                 K   G   +  VGT+ YMAPE+L  + ++   D +  G  I E++ G  P+
Sbjct: 151 ------KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 32/188 (17%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+A+ +++L +   +HRD+   N+LL  N    + DFGLA              R   K 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA--------------RDIYKD 227

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                K +    L +MAPE +  ++++ +SDV+SFG+ + E+ + G  PY  ++   +  
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
             L+               G R  + + E   P  I  ++  CW G+P  RP+FS +   
Sbjct: 288 QRLK--------------DGTR--MRAPENATPE-IYRIMLACWQGDPKERPTFSALVEI 330

Query: 349 LDLVLEHR 356
           L  +L+  
Sbjct: 331 LGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 26/225 (11%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           ++K  +   E++ +   E  +L + D   + K   +     N     EF    ++   L 
Sbjct: 34  LRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----- 208
            ++ + S +      A+   A+  +H LG +HRD+KP N+LLD      L+DFGL     
Sbjct: 94  KKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152

Query: 209 ----AEYRENL-----KEISLKNWRSSGKPTGGFHKKN-------MVGTLIYMAPEILKK 252
                E+  NL      + S +N  S  K      KKN        VGT  Y+APE+  +
Sbjct: 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET--WKKNRRQLAYSTVGTPDYIAPEVFMQ 210

Query: 253 EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
             +++  D +S G+ + E+L G  P+     +     V  MN+ E
Sbjct: 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV--MNWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 78/301 (25%), Positives = 120/301 (39%), Gaps = 47/301 (15%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
           P   +  L  I  G+   VY AT       VAVKK   S   T+E+  +  KE++ L +L
Sbjct: 19  PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL 78

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            HP   ++   + K        E Y   + ++ L V +      ++  I     + L YL
Sbjct: 79  KHPNTIEYKGCYLKEHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+K  N+LL       LADFG A               S   P   F     
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSA---------------SKSSPANSF----- 177

Query: 239 VGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A +  + + + + 
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND- 236

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                          P L S E     S    +  C    P  RP+ +++ L  D V   
Sbjct: 237 --------------SPTLQSNE--WTDSFRGFVDYCLQKIPQERPASAEL-LRHDFVRRD 279

Query: 356 R 356
           R
Sbjct: 280 R 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 42/238 (17%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-P 121
           P   + L+  +  G    VY+   +   ++A  K +  T +E +   +E+ +L K  H  
Sbjct: 4   PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 63

Query: 122 GLAKFVAAHAK--PP----NYMFFFEFYES-------RNLAEKLHVEEWSPSVDQVLMIA 168
            +A +  A  K  PP          EF  +       +N       EEW      +  I 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW------IAYIC 117

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            ++ + L +LH   ++HRD+K  NVLL  N    L DFG++   +          R+ G+
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------RTVGR 167

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
                 +   +GT  +MAPE++  + + +     KSD++S GI+  E+  G  P  D+
Sbjct: 168 ------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 73/309 (23%), Positives = 122/309 (39%), Gaps = 53/309 (17%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
           P   ++ L  I  G+   VY A    +   VA+KK   S   ++E+  +  KE++ L KL
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            HP   ++   + +        E Y   + ++ L V +      ++  +     + L YL
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRDVK  N+LL       L DFG A               S   P   F     
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------SIMAPANXF----- 171

Query: 239 VGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A +  + + +   
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE- 230

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                          P L S          + +  C    P +RP+        +++L+H
Sbjct: 231 --------------SPALQSGHWS--EYFRNFVDSCLQKIPQDRPTS-------EVLLKH 267

Query: 356 RKSLKEEDL 364
           R  L+E   
Sbjct: 268 RFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+  A+ ++H+  ++HRD+K AN+LL  N    L DFG ++              +    
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----------TVSDD 200

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
            G    +   GT  Y+APEI +++ +S+K+D++S G+ + ELLT   P+     E   H 
Sbjct: 201 VG----RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256

Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
            L              +G   P+  S+   +   + +L+      +P  RPS
Sbjct: 257 TL--------------AGRYDPLPPSISPEMQEIVTALLS----SDPKRRPS 290

Length = 496

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 33/181 (18%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + YL  + +VHRD+   NVL+       + DFGLA     L +I    + + G  
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR----LLDIDETEYHADGGK 172

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                       + +MA E +     + +SDV+S+G+++ EL+T G  PY  +     A 
Sbjct: 173 V----------PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAR 218

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
            + ++    ++L         +P + +++      +  ++ +CW  +   RP F ++  E
Sbjct: 219 EIPDLLEKGERLP--------QPPICTID------VYMIMVKCWMIDSECRPRFRELVDE 264

Query: 349 L 349
            
Sbjct: 265 F 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 17/185 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 28  LKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS 87

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
            E    S D+     A++  AL YLH+  IV+RD+K  N++LD++    + DFGL   +E
Sbjct: 88  RERVF-SEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLC--KE 144

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
            +              T     K   GT  Y+APE+L+   +    D +  G+ + E++ 
Sbjct: 145 GI--------------TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 274 GVVPY 278
           G +P+
Sbjct: 191 GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)

Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 186

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 16/132 (12%)

Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           Q +  AA+++  L +LH  GI++RD+K  NV+LD      +ADFG+   +E++ +     
Sbjct: 102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMVD----- 154

Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
                    G   +   GT  Y+APEI+  + + +  D +++G+ + E+L G  P+    
Sbjct: 155 ---------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Query: 283 AEAQAHTVLEMN 294
            +    +++E N
Sbjct: 206 EDELFQSIMEHN 217

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLL-CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
           +KK +++  E++D    E  +     +HP L    +         F  EF    +L   +
Sbjct: 28  IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
             +   P  +     +A+++ AL +LH  GI++RD+K  NVLLD      L D+G+   +
Sbjct: 88  QRQRKLPE-EHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC--K 144

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E ++          G  T  F      GT  Y+APEIL+ E +    D ++ G+ + E++
Sbjct: 145 EGIRP---------GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 273 TGVVPY 278
            G  P+
Sbjct: 191 AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 24/136 (17%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           A++  A+  +H LG VHRD+KP NVLLD+N    LADFG       L+            
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-----SCLRL----------L 153

Query: 229 PTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
             G       VGT  Y++PEIL+     K  +  + D +S G+ + E+L G  P+    A
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY---A 210

Query: 284 EAQAHTVLE-MNYTEQ 298
           E+   T  + MN+ E 
Sbjct: 211 ESLVETYGKIMNHKEH 226

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 35/194 (18%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +   +L    Q+A+ +++L +   VHRD+   NVLL +     + DFGLA  R+ + +  
Sbjct: 235 TTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA--RDIMHD-- 290

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
             N+ S G         +    + +MAPE +   +++  SDV+S+GI + E+ + G  PY
Sbjct: 291 -SNYVSKG---------STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             +  ++  +  ++  Y   +   A                    +  ++ +CW+  P  
Sbjct: 341 PGMIVDSTFYNKIKSGYRMAKPDHA-----------------TQEVYDIMVKCWNSEPEK 383

Query: 339 RPSF---SDIALEL 349
           RPSF   SDI   L
Sbjct: 384 RPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 16/111 (14%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++  AL +LH  G+++RD+K  N+LLD      LADFG+   +E +           G
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMC--KEGILN---------G 150

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             T  F      GT  Y+APEIL++  +    D ++ G+ + E++ G  P+
Sbjct: 151 VTTTTF-----CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 75/319 (23%), Positives = 119/319 (37%), Gaps = 70/319 (21%)

Query: 56  SQSIPLHLPPSSYTLLSP------------------------IARGAESVVYEA--TLDG 89
           S ++PL LPP S +  S                         I  GA   VY+      G
Sbjct: 40  SLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTG 99

Query: 90  RKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
           R  A+K  I    E+       +E+++L  ++HP + K               EF +  +
Sbjct: 100 RLYALKV-IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158

Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           L E  H+ +     D    +A Q+   + YLH   IVHRD+KP+N+L++      +ADFG
Sbjct: 159 L-EGTHIADEQFLAD----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG 213

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK-----SDVY 262
           ++         ++    SS            VGT+ YM+PE +  +++         D++
Sbjct: 214 VSRILAQ----TMDPCNSS------------VGTIAYMSPERINTDLNHGAYDGYAGDIW 257

Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA 322
           S G+SI E   G  P+   R    A  +  +  ++     A  S   R            
Sbjct: 258 SLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR------------ 305

Query: 323 SILSLIQRCWDGNPHNRPS 341
                I  C    P  R S
Sbjct: 306 ---HFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 38/232 (16%)

Query: 68  YTLLSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           Y +   I RG    VY+A      DG++ A+KK      E+         +E+ LL +L 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 120 HPGLAKFVAAHAKPPN---YMFFFEFYESRNLAE--KLHVEEWSPSVDQ--VLMIAAQLA 172
           H  +   V    +  +   Y+ F ++ E  +L +  K H +    S+    V  +  Q+ 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLF-DYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPH----LADFGLAE-YRENLKEISLKNWRSSG 227
             + YLH+  ++HRD+KPAN+L+           + D GLA  +   LK +         
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL--------- 169

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVPY 278
                     +V T+ Y APE+L    H  K+ D+++ G    ELLT    +
Sbjct: 170 -----ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 22/223 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           ++K  +   E++ +   E  +L + D   + K   +     N     EF    ++   L 
Sbjct: 34  LRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----- 208
            ++ + + ++     A+   A+  +H LG +HRD+KP N+LLD      L+DFGL     
Sbjct: 94  KKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152

Query: 209 ----AEYRENLK-----EISLKNWRSSGKP-TGGFHKKNM----VGTLIYMAPEILKKEI 254
                E+  NL      + + +N  S  K  T   +++ +    VGT  Y+APE+  +  
Sbjct: 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212

Query: 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           +++  D +S G+ + E+L G  P+     +     V  MN+ E
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV--MNWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 38/111 (34%), Positives = 57/111 (51%), Gaps = 17/111 (15%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           A+L  AL++LH   IV+RD+KP N+LLD      L DFGL+  + NL +    N      
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTN------ 154

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPY 278
                      GT  Y+APE+L  E  +++  D +S G+ + E+  G  P+
Sbjct: 155 --------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   Y L+  +  G    VY+A     G   AVK   L   ++     +E+ ++ +  H 
Sbjct: 7   PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD-QVLMIAAQLAKALQYLHN 180
            +  +  ++          E+    +L +  HV    P  + Q+  +  +  + L YLH+
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS 124

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-KNMV 239
            G +HRD+K AN+LL  N    LADFG+A                  K T    K K+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVA-----------------AKITATIAKRKSFI 167

Query: 240 GTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDL 281
           GT  +MAPE+   E    +++  D+++ GI+  EL     P  DL
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 32/196 (16%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL  N    + DFGLA          
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---------- 226

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 227 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 283 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 325

Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 326 RPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 18/159 (11%)

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP L    A      +  F  E+    +L   +H + +S    + +  AA +   LQYLH
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFYAACVVLGLQYLH 118

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              IV+RD+K  N+LLD      +ADFGL   +E +           G  T  F      
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLC--KEGM---------GFGDRTSTF-----C 162

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           GT  ++APE+L +  ++   D +  G+ I E+L G  P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 69/249 (27%), Positives = 101/249 (40%), Gaps = 30/249 (12%)

Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLLCKLDHPG 122
           + +L  I RGA   V    L          IL+  E L       F +E  +L   D+  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           +     A     N     ++Y   +L   L   E     D      A++  A+  +H L 
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
            VHRD+KP N+L+D N    LADFG       LK +            G       VGT 
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-----SCLKLME----------DGTVQSSVAVGTP 167

Query: 243 IYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYT 296
            Y++PEIL+     K  +  + D +S G+ + E+L G  P+    AE+   T  + MN+ 
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224

Query: 297 EQ-QLTAAV 304
           E+ Q  A V
Sbjct: 225 ERFQFPAQV 233

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 33/222 (14%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDHP 121
           + ++  I  G    VY+A     G  VA+KK  +    E + F     +E+++L +L+H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKK--VRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 122 GLA--------KFVAAHAKPPNYMFFFEF-YESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
            +         K  A   K     F+  F Y   +L   L       S D +     QL 
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + L Y H    +HRD+K +N+LL+      LADFGLA                  +P   
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN----------SEESRPY-- 174

Query: 233 FHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
               N V TL Y  PE +L +E +    DV+S G  + EL T
Sbjct: 175 ---TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 21/218 (9%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKK--------PILSTSEELD----NFH--KELQLLCK 117
           +  G    V +A  TL G+ VA+KK         +    + +     +F   +EL+++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           + H  +   V  + +        +   S +L  K+   +   +  QV  I  Q+   L  
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMAS-DLK-KVVDRKIRLTESQVKCILLQILNGLNV 134

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH    +HRD+ PAN+ ++      +ADFGLA            +   + +       K 
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK- 193

Query: 238 MVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
            V TL Y APE+L   E +    D++S G    ELLTG
Sbjct: 194 -VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 20/193 (10%)

Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 20  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79

Query: 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
             L   L  E    + ++     A++  AL+YLH+  +V+RD+K  N++LD++    + D
Sbjct: 80  GELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 138

Query: 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG 265
           FGL   +E +              + G   K   GT  Y+APE+L+   +    D +  G
Sbjct: 139 FGLC--KEGI--------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182

Query: 266 ISINELLTGVVPY 278
           + + E++ G +P+
Sbjct: 183 VVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 17/111 (15%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++   L+ LH   IV+RD+KP N+LLD +    ++D GLA +    + I         
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--------- 158

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                   K  VGT+ YMAPE++K E ++   D ++ G  + E++ G  P+
Sbjct: 159 --------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 35/158 (22%)

Query: 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIA-------------AQLAKALQYLHNLGIV 184
            F+ F + R L     V E+ P  D V +++             A++  AL  +H++G +
Sbjct: 108 LFYAFQDDRYL---YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRDVKP N+LLD++    LADFG                       G       VGT  Y
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC---------------MKMNKEGMVRCDTAVGTPDY 209

Query: 245 MAPEILKKE----IHSEKSDVYSFGISINELLTGVVPY 278
           ++PE+LK +     +  + D +S G+ + E+L G  P+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           Y  +  I  G   VVY+A   +    +A+KK  L   +E       +E+ LL ++ H  +
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 124 AKFV-AAHAKPPNYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLH 179
            +     H++   Y+ F    E  +L  K H++   +++ +   +     Q+ + + Y H
Sbjct: 64  VRLQDVVHSEKRLYLVF----EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 180 NLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           +  ++HRD+KP N+L+DR      LADFGLA              R+ G P   F  +  
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLA--------------RAFGIPVRTFTHE-- 163

Query: 239 VGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLT 273
           V TL Y APEIL    H S   D++S G    E++ 
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 60/231 (25%), Positives = 91/231 (39%), Gaps = 47/231 (20%)

Query: 67  SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDH-P 121
           +Y  L  I  G    VY+A     G+ VA+KK  L   EE       +E+ LL  L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 122 GLAKFVAA-HAK----PPNYMFFFEFYES----------RNLAEKLHVEEWSPSVDQVLM 166
            + + +   H +     P+    FE+ +S          R     L          +  M
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPL-----PAKTIKSFM 116

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISLKNWRS 225
              QL K + + H  G++HRD+KP N+L+D+      +AD GL               R+
Sbjct: 117 Y--QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG--------------RA 160

Query: 226 SGKPTGGF-HKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
              P   + H+   + TL Y APE+L    H S   D++S G    E+   
Sbjct: 161 FSIPVKSYTHE---IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 31/229 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILS---TSEELDNFHKELQLLCK 117
           P   +T L  I  G+   VY A  D R    VA+KK   S   ++E+  +  KE++ L +
Sbjct: 23  PEKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           + HP   ++   + +        E Y   + ++ L V +      ++  I     + L Y
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH+  ++HRD+K  N+LL       LADFG A               S   P   F    
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---------------SIASPANSF---- 181

Query: 238 MVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
            VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A
Sbjct: 182 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 20/152 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKL-DHPG 122
           Y +L  I  G  S V +A     G+  A+K  K    + E+++N  +E+Q L +L  HP 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPN 59

Query: 123 LAKFVAAH--AKPPNYMFFFEFYESRNLAE-----KLHVEEWSPSVDQVLMIAAQLAKAL 175
           + + +      K       FE  +  NL E     K  + E      +V     QL K+L
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPE-----KRVKSYMYQLLKSL 113

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
            ++H  GI HRD+KP N+L+  +    LADFG
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 20/130 (15%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           A ++   L+++HN  +V+RD+KPAN+LLD +    ++D GLA       + S K   +S 
Sbjct: 103 ATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS- 155

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
                      VGT  YMAPE+L+K   +   +D +S G  + +LL G  P+   + + +
Sbjct: 156 -----------VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Query: 287 AHTVLEMNYT 296
            H +  M  T
Sbjct: 205 -HEIDRMTLT 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 38/236 (16%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKV-----AVKKPILSTSEELDNFHKELQLLCKL 118
           P   + L+  +  G    VY+    GR V     A  K +  T +E +    E+ +L K 
Sbjct: 14  PAGIFELVEVVGNGTYGQVYK----GRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY 69

Query: 119 DH-PGLAKFVAAHAK--PPNY----MFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQ 170
            H   +A +  A  K  PP +        EF  + ++ + + + +  +   D +  I  +
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + + L +LH   ++HRD+K  NVLL  N    L DFG          +S +  R+ G+  
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG----------VSAQLDRTVGR-- 177

Query: 231 GGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDL 281
               +   +GT  +MAPE++  +      +  +SD++S GI+  E+  G  P  D+
Sbjct: 178 ----RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)

Query: 67  SYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH-KELQLLCKLDHPGL 123
           ++  L  +  G  + VY+      G  VA+K+  L   E   +   +E+ L+ +L H  +
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKL--HVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +           M  FE+ + ++L + +  H    +   + V     QL K + + H  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+KP N+L+++     LADFGLA              R+ G P   F   N V T
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLA--------------RAFGIPVNTF--SNEVVT 163

Query: 242 LIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
           L Y AP++L     +S   D++S G  + E++TG
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 33/181 (18%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + YL    +VHRD+   NVL+       + DFGLA+    L     K + + G  
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK----LLGADEKEYHAEGGK 172

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                       + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++  
Sbjct: 173 V----------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEIS 221

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
           ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +E
Sbjct: 222 SILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELIIE 264

Query: 349 L 349
            
Sbjct: 265 F 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 23/255 (9%)

Query: 68  YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           Y L + + R   +  + AT       KV  K  +L+   +      EL  L   DH G+ 
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE--KLHVEEWSPSVD-QVLMIAAQLAKALQYLHNL 181
           K           +   E+    +L +  K  ++E  P  + +V ++  Q+  AL  +H+ 
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K AN+ L       L DFG +  ++    +SL    S              GT
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFS--KQYSDSVSLDVASS------------FCGT 234

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
             Y+APE+ +++ +S+K+D++S G+ + ELLT   P+   +  +Q   + ++ Y +    
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPF 291

Query: 302 AAVVSGGLRPILASL 316
              VS G++ +L  L
Sbjct: 292 PCPVSSGMKALLDPL 306

Length = 478

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 47/170 (27%), Positives = 73/170 (42%), Gaps = 35/170 (20%)

Query: 111 ELQLLCKLDHPGLAKFVAAHAKP-------PNYMFFFEFYESRNLAEKLHVEEWSP-SVD 162
           E +LL +L HP +   +             P Y      Y    L          P  + 
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL---------RPLGLA 260

Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNLCPHLADFGLAEYRENLKEISL 220
           QV  +A QL  A+ Y+H  GI+HRD+K  NVL++   ++C  L DFG A +         
Sbjct: 261 QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACF--------A 310

Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           +   S+    G      + GT+   APE+L  + ++   D++S G+ I E
Sbjct: 311 RGSWSTPFHYG------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 38/271 (14%)

Query: 83  YEATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
            +    G++V+V   +L +       F +   L+ +L H  L K      +  N M   E
Sbjct: 22  LDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE-E 80

Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201
           + +   L   LH E+ + S+   L +A QLA AL YL +  +VH +V   N+L+ R    
Sbjct: 81  YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR---- 136

Query: 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-- 259
               +GL E    +  I L +    G P     ++  V  + ++APE ++    S     
Sbjct: 137 ----YGLNE--GYVPFIKLSD---PGIPITVLSREERVERIPWIAPECIRNGQASLTIAA 187

Query: 260 DVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL 318
           D +SFG ++ E+ + G  P + L +  +          + +L          P+    EL
Sbjct: 188 DKWSFGTTLLEICSNGEEPLSTLSSSEK----ERFYQDQHRL----------PMPDCAEL 233

Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                  +LI +CW  +P  RPSF  I  +L
Sbjct: 234 A------NLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 67  SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPG 122
            Y  L  I  G    V++A        VA+K+  L   +E    +  +E+ LL +L H  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHN 180
           + +              FE+ + ++L +       +  P + +  M   QL K L + H+
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMF--QLLKGLAFCHS 117

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP N+L+++N    LADFGLA              R+ G P   +  +  V 
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLA--------------RAFGIPVRCYSAE--VV 161

Query: 241 TLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVP 277
           TL Y  P++L   +++S   D++S G    EL     P
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 18/186 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
           VKK ++   E++D    E  +  +   +P L    +            E+    +L   +
Sbjct: 28  VKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87

Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
             +   P  +     AA++  AL +LH  GI++RD+K  NVLLD +    L D+G+   +
Sbjct: 88  QRQRKLPE-EHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMC--K 144

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E L           G  T  F      GT  Y+APEIL+ E +    D ++ G+ + E++
Sbjct: 145 EGLG---------PGDTTSTF-----CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190

Query: 273 TGVVPY 278
            G  P+
Sbjct: 191 AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 57/243 (23%), Positives = 101/243 (41%), Gaps = 34/243 (13%)

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
           F  E  ++  +DHP L + +      P      +      L + +H  + +     +L  
Sbjct: 56  FMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             Q+AK + YL    +VHRD+   NVL+       + DFGLA     L E   K + + G
Sbjct: 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR----LLEGDEKEYNADG 170

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
                         + +MA E +     + +SDV+S+G++I EL+T G  PY  +    +
Sbjct: 171 GKM----------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-E 219

Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              +LE      Q           P + +++      +  ++ +CW  +  +RP F ++A
Sbjct: 220 IPDLLEKGERLPQ-----------PPICTID------VYMVMVKCWMIDADSRPKFKELA 262

Query: 347 LEL 349
            E 
Sbjct: 263 AEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 40/234 (17%)

Query: 70  LLSPIARGAESVV------YEATLDGRKVAVKKPIL-STSEELDNF-HKELQLLCKLDHP 121
           LL+ I RG E ++      Y+ T  G  V V++  L + + E+  F   EL +    +HP
Sbjct: 2   LLTVIGRGFEDLMTVNLARYKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHP 59

Query: 122 GL----AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKAL 175
            +    A F+A      N ++    + +   A+ L    +   + ++ +  I   + KAL
Sbjct: 60  NIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114

Query: 176 QYLHNLGIVHRDVKPANVL--LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            Y+H++G VHR VK +++L  +D  +        L+  R NL  I      + G+     
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDGKVY-------LSGLRSNLSMI------NHGQRLRVV 161

Query: 234 HK--KNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
           H   K  V  L +++PE+L++ +  +  KSD+YS GI+  EL  G VP+ D+ A
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 48/256 (18%)

Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-----HVEEWSPS 160
           + F  E  +  +L HP +   +    K       F +    +L E L     H +  S  
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 161 VDQV----------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            D+           + I  Q+A  +++L +  +VH+D+   NVL+   L   ++D GL  
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL-- 170

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           +RE       K   +S  P            + +M+PE +     S  SD++S+G+ + E
Sbjct: 171 FREVYAADYYKLMGNSLLP------------IRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218

Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           + + G+ PY                Y+ Q +   + +   R +L   +   PA + +L+ 
Sbjct: 219 VFSYGLQPYC--------------GYSNQDVIEMIRN---RQVLPCPD-DCPAWVYTLML 260

Query: 330 RCWDGNPHNRPSFSDI 345
            CW+  P  RP F DI
Sbjct: 261 ECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE---LDNFHKELQLLCKL---D 119
           Y  ++ I  GA   VY+A     G  VA+K   + T+E+   L    +E+ LL +L   D
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAFD 60

Query: 120 HPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS---VDQVLMIAAQLAKA 174
           HP + +   V A ++          +E  +   + ++++  P     + +  +  Q  + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L +LH   IVHRD+KP N+L+       LADFGLA          + + + +  P     
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTP----- 166

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
              +V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 167 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 17/185 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 28  LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
             E   S D+     A++  AL YLH+  +V+RD+K  N++LD++    + DFGL   +E
Sbjct: 88  -RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC--KE 144

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
            + +              G   K   GT  Y+APE+L+   +    D +  G+ + E++ 
Sbjct: 145 GISD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Query: 274 GVVPY 278
           G +P+
Sbjct: 191 GRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 36/240 (15%)

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
           F  E   L + DH  + +      +    M   E+  +  L   L   E      Q++ +
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG-LAEYRENLKEISLKNWRSS 226
              LA  ++YL  +G VH+ +    VL++ +L   ++ F  L E +      ++     S
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM-----S 167

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
           GK             +++ APE ++    S  SDV+SFGI + E+++ G  PY D+    
Sbjct: 168 GK-----------SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM---- 212

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                     + Q +  AV  G   P   +     P  +  L+  CW      RP FS I
Sbjct: 213 ----------SGQDVIKAVEDGFRLPAPRN----CPNLLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 19/113 (16%)

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK 221
           +L I   + +A+QYLH   I+HRD+K  N+ ++   ++C  L DFG A +  ++      
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINANKYY 241

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
            W                GT+   APE+L ++ +    D++S GI + E+ T 
Sbjct: 242 GW---------------AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 45/141 (31%), Positives = 66/141 (46%), Gaps = 31/141 (21%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----------AEYRENLKEI 218
           A+   A++ +H LG +HRD+KP N+L+DR     L+DFGL          A Y++ L+  
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 219 SLKNWRS--------------SGKPTGGFHKKN-------MVGTLIYMAPEILKKEIHSE 257
           S KN                 S K      KKN        VGT  Y+APEI  ++ + +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 258 KSDVYSFGISINELLTGVVPY 278
           + D +S G  + E L G  P+
Sbjct: 228 ECDWWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 47/275 (17%)

Query: 91  KVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149
           +V VK+  +S S +E   F +E Q    L H  L + +    +   Y+   EF    +L 
Sbjct: 24  QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83

Query: 150 EKLH----VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
             L      E  +P    +  +A ++A  L +LH    +H D+   N LL  +L   + D
Sbjct: 84  GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGD 143

Query: 206 FGLA--EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-------- 255
           +GL+  +Y+E+      + W                  L ++APE++  E+H        
Sbjct: 144 YGLSHNKYKEDYYVTPDQLWVP----------------LRWIAPELV-DEVHGNLLVVDQ 186

Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
           +++S+V+S G++I EL   G  PY  L  E     VL     EQQL         +P   
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYTVREQQLKLP------KPR-- 234

Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
            L+L L      ++Q CW   P  RPS  ++ L L
Sbjct: 235 -LKLPLSDRWYEVMQFCWL-QPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 44/228 (19%)

Query: 68  YTLLSPIARGAESVV----YEATLDGRKVAVKKPILSTSEE------------LDNF--H 109
           Y L+  + +GA  +V       T +   VA+KK     S++            L +F  H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD-QVLMIA 168
           K +  L  +D      F        N ++ +E     +L + +   +  P  D       
Sbjct: 62  KNITCLYDMDIVFPGNF--------NELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFI 111

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSG 227
            Q+   L+Y+H+  ++HRD+KP N+L++ +    + DFGLA  + EN  E +        
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG------- 164

Query: 228 KPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                      V T  Y APEI L  + +++  DV+S G  + ELL  
Sbjct: 165 ------FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)

Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 28  LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 88  RERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 144

Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 145 EGIKD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190

Query: 273 TGVVPY 278
            G +P+
Sbjct: 191 CGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 41/146 (28%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL---------AEY-------R 212
           A+L  A++ +H +G +HRD+KP N+L+DR+    L DFGL         ++Y       R
Sbjct: 108 AELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167

Query: 213 ENLKEISLK----------------NWRSSGKPTGGFHKK----NMVGTLIYMAPEILKK 252
           ++  + S +                  R++ +     H++    ++VGT  Y+APE+L +
Sbjct: 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQ-----HQRCLAHSLVGTPNYIAPEVLLR 222

Query: 253 EIHSEKSDVYSFGISINELLTGVVPY 278
             +++  D +S G+ + E+L G  P+
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 20/131 (15%)

Query: 151 KLHVEEW-SPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           K H+    +P  D+   +  AA+L   L+ L    IV+RD+KP N+LLD      ++D G
Sbjct: 88  KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLG 147

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
           LA       +I          P G    +  VGT+ YMAPE++  E ++   D +  G  
Sbjct: 148 LA------VQI----------PEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190

Query: 268 INELLTGVVPY 278
           I E++ G  P+
Sbjct: 191 IYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)

Query: 67  SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPG 122
           SY  L  +  G+ + VY+  + ++G+ VA+K  I    EE   F   +E  LL  L H  
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKV-IRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           +                FE+  + +L + +         + V +   QL + L Y+H   
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+KP N+L+       LADFGLA              R+   P+  +   N V TL
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLA--------------RAKSVPSHTY--SNEVVTL 167

Query: 243 IYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLR 282
            Y  P++L     +S   D++  G    E++ GV  +  ++
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 22/202 (10%)

Query: 76  RGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135
           RG  S         R +A  K + + S        E+  L +L+H  + K +    +   
Sbjct: 180 RGVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILK-IEEILRSEA 236

Query: 136 YMFFFEFYESRNLAEKLHVE--EW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
             +        +L   ++ E  +W   P + Q   I  QL  A++Y+H+  ++HRD+K  
Sbjct: 237 NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLE 296

Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           N+ L+ +    L DFG A   E  +E     W               VGT+   +PEIL 
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW---------------VGTVATNSPEILA 341

Query: 252 KEIHSEKSDVYSFGISINELLT 273
            + + E +D++S G+ + ++L+
Sbjct: 342 GDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 18/157 (11%)

Query: 71  LSPIARGAESVVYEATLDGRKVAVKKPILSTS---EELDN-FHK-----ELQLLCKLDHP 121
           +  I RGAE+ +Y     G K  +K  I        ELD    +     E +++ +    
Sbjct: 1   MKLIKRGAEAEIYLGDFLGIKAVIKWRI-PKRYRHPELDERIRRERTRREARIMSRARKA 59

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           G+         P N++   E+ E   L + ++       ++    I   + K    LH+ 
Sbjct: 60  GVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGK----LHSA 114

Query: 182 GIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKE 217
           GI+H D+  +N++L    +   L DFGLAE+ ++L++
Sbjct: 115 GIIHGDLTTSNMILSGGKIY--LIDFGLAEFSKDLED 149

Length = 211

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 22/170 (12%)

Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L   +  P  +++L  ++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVS 109

Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + + L YL     I+HRDVKP+N+L++      L DFG+                 SG
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----------------SG 152

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           +        + VGT  YM+PE L+   +S +SD++S G+S+ EL  G  P
Sbjct: 153 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 68  YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLD-- 119
           Y  ++ I  GA   V++A      GR VA+K+  + T EE   L    +E+ +L  L+  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 61

Query: 120 -HPGLAKF-----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
            HP + +      V+   +       FE  +         V E     + +  +  QL +
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L +LH+  +VHRD+KP N+L+  +    LADFGLA      +  S +   +S       
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMALTS------- 168

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
               +V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 169 ----VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 22/170 (12%)

Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 109

Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG+                 SG
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----------------SG 152

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           +        + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 153 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 21/231 (9%)

Query: 67  SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGL 123
           +Y  L  +  G  + VY+  + L    VA+K+  L   E       +E+ LL  L H  +
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                      +    FE Y  ++L + L     S ++  V +   QL + L Y H   +
Sbjct: 67  VTLHDIIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++      LADFGLA              R+   PT  +   N V TL 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLA--------------RAKSIPTKTY--SNEVVTLW 169

Query: 244 YMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
           Y  P+IL     +S + D++  G    E+ TG   +     E Q H +  +
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 25/171 (14%)

Query: 135 NYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
           NY++   ++Y   +L   L   E     D      A++  A+  +H L  VHRD+KP NV
Sbjct: 74  NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133

Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
           LLD N    LADFG       LK              G       VGT  Y++PEIL+  
Sbjct: 134 LLDMNGHIRLADFG-----SCLKMNQ----------DGTVQSSVAVGTPDYISPEILQAM 178

Query: 254 -----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQ 298
                 +  + D +S G+ + E+L G  P+    AE+   T  + MN+ E+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHEER 226

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 39/203 (19%)

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + L YLH  G +HR++K +++L+  +    L+  GL+         SL       K    
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLY------SLVRNGQKAKVVYD 163

Query: 233 FHKKNMVGTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTDL--------R 282
           F + +    L +++PE+L+++++  + KSD+YS GI+  EL TG VP+ D+        +
Sbjct: 164 FPQFS-TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222

Query: 283 AEAQAHTVLEMNYTEQQ--------------LTAAVVSGGLRPILASLELGLPAS----- 323
            +   ++ L++     +              +  +VV+ G+   + S  L  P+S     
Sbjct: 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282

Query: 324 -ILSLIQRCWDGNPHNRPSFSDI 345
              +L++ C   +P  RPS S +
Sbjct: 283 AFQNLVELCLQQDPEKRPSASSL 305

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 28/164 (17%)

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           KL HP + K +             E+ E +NL+E L    W    ++   IA  +AKAL+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW----ERRRKIAIGIAKALR 794

Query: 177 YLH---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           +LH   +  +V  ++ P  +++D    PHL    L      L     K + SS       
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG----LLCTDTKCFISSA------ 843

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                     Y+APE  + +  +EKSD+Y FG+ + ELLTG  P
Sbjct: 844 ----------YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 66  SSYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPG 122
           +SY  L  +  G+ + VY+  + ++G+ VA+K   + T E +     +E  LL  L H  
Sbjct: 5   TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-- 62

Query: 123 LAKFVAAH---AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            A  V  H          F FE+  + +LA+ +           V +   QL + L Y+H
Sbjct: 63  -ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              I+HRD+KP N+L+       LADFGLA              R+   P+  +  +  V
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLA--------------RAKSIPSQTYSSE--V 164

Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTG 274
            TL Y  P++L     +S   D++  G    E+L G
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 48/203 (23%), Positives = 97/203 (47%), Gaps = 41/203 (20%)

Query: 153 HVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           HV +   S+D   ++    Q+AK + YL    +VHR++   N+LL  +    +ADFG+A+
Sbjct: 98  HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157

Query: 211 --YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI-YMAPEILKKEIHSEKSDVYSFGIS 267
             Y ++ K                    +   T I +MA E +    ++ +SDV+S+G++
Sbjct: 158 LLYPDDKKYFY-----------------SEHKTPIKWMALESILFGRYTHQSDVWSYGVT 200

Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
           + E+++ G  PY  +R     H V ++    ++L         +P + +++      +  
Sbjct: 201 VWEMMSYGAEPYAGMR----PHEVPDLLEKGERLA--------QPQICTID------VYM 242

Query: 327 LIQRCWDGNPHNRPSFSDIALEL 349
           ++ +CW  + + RP+F ++A E 
Sbjct: 243 VMVKCWMIDENVRPTFKELANEF 265

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 39/222 (17%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           K   KK +L+ ++ + +   E  +L + D+  + K   +     N  F  ++    ++  
Sbjct: 32  KTLRKKDVLNRNQ-VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL-- 208
            L   E  P V     IA +L  A++ +H +G +HRD+KP N+L+D +    L DFGL  
Sbjct: 91  LLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149

Query: 209 --------------AEYRENLKEIS--------------LKNWRSSGKPTGGFHKK---- 236
                         +  R++  E S              LK            H++    
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ---HQRCLAH 206

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           ++VGT  Y+APE+L ++ +++  D +S G+ + E+L G  P+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 23/150 (15%)

Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTS---EELDN------FHKELQLLCKLDHPGLA 124
           IA+GAE+++Y     G K  +K+ +   S    ELD          E +LL +    G+ 
Sbjct: 2   IAKGAEAIIYLGDFLGLKAVIKERV-PKSYRHPELDERIRRERTRNEARLLSRARKAGVN 60

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGI 183
             V     P N     E+ E + L + +         D++L  I   + K    LH  GI
Sbjct: 61  TPVVYDVDPDNKTIVMEYIEGKPLKDVI-----EEGNDELLREIGRLVGK----LHKAGI 111

Query: 184 VHRDVKPANVLL-DRNLCPHLADFGLAEYR 212
           VH D+  +N+++ D  L   L DFGL +Y 
Sbjct: 112 VHGDLTTSNIIVRDDKLY--LIDFGLGKYS 139

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 21/212 (9%)

Query: 67  SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGL 123
           +Y  L  +  G  + V++  + L    VA+K+  L   E       +E+ LL  L H  +
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                           FE+ +S +L + L       S+  V +   QL + L Y H   I
Sbjct: 66  VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++      LADFGLA              R+   PT  +   N V TL 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA--------------RAKSVPTKTY--SNEVVTLW 168

Query: 244 YMAPEILKKEI-HSEKSDVYSFGISINELLTG 274
           Y  P++L     +S   D++  G  + E+ TG
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 53/234 (22%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT-LD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P  SY L + I  G+  VVYEA  +D   KVA+KK +     +    ++EL ++  L+H 
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----NRELLIMKNLNHI 119

Query: 122 GLAKF-------------------VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD 162
            +                      V     P     + + Y   N A  L +        
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-------- 171

Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLK 221
            V + + QL +AL Y+H+  I HRD+KP N+L+D       L DFG A   +NL      
Sbjct: 172 -VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA---KNL------ 221

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                     G    + + +  Y APE+ L    ++   D++S G  I E++ G
Sbjct: 222 --------LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 52.6 bits (127), Expect = 4e-07
 Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 18/146 (12%)

Query: 74  IARGAESVVYEATLDGRKVAVKKPILST--SEELDN------FHKELQLLCKLDHPGLAK 125
           I +GAE+ + +    GR   +K+ +       ELD          E +LL +    G+  
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
            V     P       E+   ++L + L       + + V  +   +AK    LH  GIVH
Sbjct: 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAK----LHKAGIVH 451

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEY 211
            D+  +N ++  +   +L DFGL +Y
Sbjct: 452 GDLTTSNFIVRDDRL-YLIDFGLGKY 476

Length = 535

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 41/146 (28%), Positives = 58/146 (39%), Gaps = 24/146 (16%)

Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           +++ L++ E     + V   AA++  AL  LH  GIV RD+ P N+LLD      L  F 
Sbjct: 76  ISKFLNIPE-----ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
                          W        G   +NM     Y APE+      +E  D +S G  
Sbjct: 131 --------------RWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAI 171

Query: 268 INELLTGVVPYTDLRAEAQAHTVLEM 293
           + ELLTG        +    HT L +
Sbjct: 172 LFELLTGKTLVECHPSGINTHTTLNI 197

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 9e-07
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 35/221 (15%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHP 121
            +Y  L  +  G+ + VY+    L G+ VA+K+ I    EE   F   +E  LL  L H 
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKH- 62

Query: 122 GLAKFVAAH---AKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKAL 175
             A  V  H            FE+ +  +L + +   +          V +   QL + L
Sbjct: 63  --ANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYM---DDCGGGLSMHNVRLFLFQLLRGL 116

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            Y H   ++HRD+KP N+L+       LADFGLA              R+   P+  +  
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLA--------------RAKSVPSKTY-- 160

Query: 236 KNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGV 275
            N V TL Y  P++L     +S   D++  G    E+ TG 
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 39/153 (25%), Positives = 62/153 (40%), Gaps = 21/153 (13%)

Query: 71  LSPIARGAESVVYEATLDGRKVAVKK--PILSTSEELDNFHK--------ELQLLCKLDH 120
           +  I +GAE+++Y     G    VK+  P      ELD   K        E ++L K   
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELD--EKLRRERTRREARILAKARE 58

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
            G+   +     P N +   E+ E   L + L         D +  +   + K    LH 
Sbjct: 59  AGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----EEARPDLLREVGRLVGK----LHK 110

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
            GIVH D+  +N++L      +  DFGL E+ +
Sbjct: 111 AGIVHGDLTTSNIIL-SGGRIYFIDFGLGEFSD 142

Length = 204

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 2/64 (3%)

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE--YRENLKEISLKNWRSS 226
           +++A AL YLH  GI+HRD+KP N+L+       L DFGL++      L  + +    S 
Sbjct: 111 SEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSM 170

Query: 227 GKPT 230
            KP 
Sbjct: 171 AKPK 174

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 59/277 (21%), Positives = 117/277 (42%), Gaps = 39/277 (14%)

Query: 80  SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139
           S +Y  T   R V  +    ++S+E + F ++      L HP + + +    +   Y+  
Sbjct: 14  SEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73

Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMI---AAQLAKALQYLHNLGIVHRDVKPANVLLD 196
           FE+ E  +L   L  E+W     Q+L++   A ++A  + ++H    +H D+   N  L 
Sbjct: 74  FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133

Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK----K 252
            +L   + D+G+   R     I  ++              +    L ++APE++      
Sbjct: 134 SDLTVKVGDYGIGPSRYKEDYIETED--------------DKCVPLRWLAPELVGEFHGG 179

Query: 253 EIHSEK---SDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
            I +E+   S+V++ G+++ EL      PY+ L      + V++    +QQ+        
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----DQQVKL------ 229

Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            +P    LEL        ++Q CW  +P  R +  ++
Sbjct: 230 FKP---QLELPYSERWYEVLQFCWL-SPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 17/148 (11%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           S+  V +   Q+ + L Y H   ++HRD+KP N+L++      LADFGLA          
Sbjct: 102 SMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA---------- 151

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPY 278
               R+   PT  +   N V TL Y  P++ L    +S + D++  G    E+ +G   +
Sbjct: 152 ----RAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
                E + H +  +  T  + T   +S
Sbjct: 206 PGSTVEDELHLIFRLLGTPTEETWPGIS 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 58/204 (28%)

Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFF--FEFYESRNLAEKLH--------VEEWSPS 160
           E+ ++ +L H  + +++       N   +   EF ++ +L+  +         +EE +  
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA-- 119

Query: 161 VDQVLMIAAQLAKALQYLHNLG-------IVHRDVKPANVLLDRNL-------------- 199
              ++ I  QL  AL Y HNL        ++HRD+KP N+ L   +              
Sbjct: 120 ---IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176

Query: 200 ---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS 256
                 + DFGL+      K I +++   S            VGT  Y +PE+L  E  S
Sbjct: 177 GRPIAKIGDFGLS------KNIGIESMAHS-----------CVGTPYYWSPELLLHETKS 219

Query: 257 --EKSDVYSFGISINELLTGVVPY 278
             +KSD+++ G  I EL +G  P+
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 22/109 (20%), Positives = 47/109 (43%), Gaps = 19/109 (17%)

Query: 239 VGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
           V  ++Y + ++L      ++ K D+YS G+ + E+ TG +P+ +L  +     ++  N +
Sbjct: 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS 240

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            +                 L L  P  I  +++ C   +   RP+  +I
Sbjct: 241 LK-----------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 19/148 (12%)

Query: 71  LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKE---LQLLCKLDHPGLAKFV 127
           +  +  G  + VY          +K  I  + E+  +  +E   LQLL +         V
Sbjct: 3   IKLLKGGLTNRVYLLGTKDEDYVLK--INPSREKGADREREVAILQLLAR--KGLPVPKV 58

Query: 128 AAHAKPPNYMF-FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---GI 183
            A  +   + +   E+ E   L E         S ++   IA QLA+ L  LH L    +
Sbjct: 59  LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVL 110

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEY 211
            H D+ P N+L+D      + D+  A Y
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 61/254 (24%), Positives = 94/254 (37%), Gaps = 55/254 (21%)

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL-----AEKLHVE-EWSPSV 161
           F +   L+ ++ H  LA       +    +   EF E   L      EK  V   W    
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--- 119

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
              + +A QLA AL YL +  +VH +V   N+LL R         GLAE      ++S  
Sbjct: 120 ---ITVAQQLASALSYLEDKNLVHGNVCAKNILLARL--------GLAEGTSPFIKLS-- 166

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINEL-LTGVVPYT 279
                G       ++  V  + ++APE +      S  +D +SFG ++ E+   G VP  
Sbjct: 167 ---DPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL- 222

Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP----ASILSLIQRCWDGN 335
                 +  T  E     ++                 +  LP      + +LI +C    
Sbjct: 223 ------KERTPSEKERFYEK-----------------KHRLPEPSCKELATLISQCLTYE 259

Query: 336 PHNRPSFSDIALEL 349
           P  RPSF  I  +L
Sbjct: 260 PTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 33/181 (18%)

Query: 110 KELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +E+ LL +L HP    L K   +HA    ++ F   Y   +L   +     S +  + + 
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFD--YAEHDLWHIIKFHRASKANKKPVQ 104

Query: 167 IAAQLAKAL--------QYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRE 213
           +   + K+L         YLH   ++HRD+KPAN+L+     +R     +AD G A    
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARL-- 161

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELL 272
                    + S  KP        +V T  Y APE+L    H  K+ D+++ G    ELL
Sbjct: 162 ---------FNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 273 T 273
           T
Sbjct: 211 T 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 33/181 (18%)

Query: 110 KELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +E+ LL +L HP    L K   +H+    ++ F   Y   +L   +     S +  + + 
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFD--YAEHDLWHIIKFHRASKANKKPMQ 104

Query: 167 IAAQLAKAL--------QYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRE 213
           +   + K+L         YLH   ++HRD+KPAN+L+     +R     +AD G A    
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARL-- 161

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELL 272
                    + S  KP        +V T  Y APE+L    H  K+ D+++ G    ELL
Sbjct: 162 ---------FNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 273 T 273
           T
Sbjct: 211 T 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 16/45 (35%), Positives = 28/45 (62%)

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
           I   +   L+Y+H  GI H D+KP N+++D N   ++ D+G+A +
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASH 175

Length = 294

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 16/30 (53%), Positives = 20/30 (66%)

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
           I  Q+  AL  LH+ GIVHRDVKP N++  
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS 289

Length = 566

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 29/137 (21%)

Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +LA+ L V     + +++  +  Q   AL+ LH      R  K  N+LL  +    L   
Sbjct: 2   SLADILEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDG--LLKLD 53

Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           G   ++               +P   F           MAPE+++ + ++EK+D+YS GI
Sbjct: 54  GSVAFKT----------PEQSRPDPYF-----------MAPEVIQGQSYTEKADIYSLGI 92

Query: 267 SINELLTGVVPYTDLRA 283
           ++ E L   +PY + R 
Sbjct: 93  TLYEALDYELPYNEERE 109

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 34/188 (18%)

Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           L +A QLA AL +L + G+ H +V   NVLL R                N   I L +  
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIRE---------EDRKTGNPPFIKLSD-- 151

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGV-VPYTDLR 282
             G       K+ ++  + ++ PE ++   + S  +D +SFG ++ E+ +G   P + L 
Sbjct: 152 -PGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210

Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           ++ +    L+      QL A        P    L         +LI +C D  P  RPSF
Sbjct: 211 SQKK----LQFYEDRHQLPA--------PKWTELA--------NLINQCMDYEPDFRPSF 250

Query: 343 SDIALELD 350
             I  +L+
Sbjct: 251 RAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 18/40 (45%), Positives = 26/40 (65%)

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
           Q+   L+ LH +GIVHRD+KP N+L+  +    + DFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	573
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
PLN03145	365	Protein phosphatase 2c; Provisional	99.95
KOG0697	379	consensus Protein phosphatase 1B (formerly 2C) [Si	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK14559	645	putative protein serine/threonine phosphatase; Pro	99.94
COG0631	262	PTC1 Serine/threonine protein phosphatase [Signal	99.93
PTZ00224	381	protein phosphatase 2C; Provisional	99.92
KOG0698	330	consensus Serine/threonine protein phosphatase [Si	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
PF00481	254	PP2C: Protein phosphatase 2C; InterPro: IPR001932	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0699	542	consensus Serine/threonine protein phosphatase [Si	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
smart00332	255	PP2Cc Serine/threonine phosphatases, family 2C, ca	99.82
cd00143	254	PP2Cc Serine/threonine phosphatases, family 2C, ca	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0700	390	consensus Protein phosphatase 2C/pyruvate dehydrog	99.8
smart00090	237	RIO RIO-like kinase.	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG1323	493	consensus Serine/threonine phosphatase [Signal tra	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
PF13672	212	PP2C_2: Protein phosphatase 2C; PDB: 2JFT_A 2JFS_A	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
KOG3087	229	consensus Serine/threonine protein kinase [General	99.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
smart00331	193	PP2C_SIG Sigma factor PP2C-like phosphatases.	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
KOG1379	330	consensus Serine/threonine protein phosphatase [Si	98.81
PRK09902	216	hypothetical protein; Provisional	98.81
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.67
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.42
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.32
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.09
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.95
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.94
TIGR02865	764	spore_II_E stage II sporulation protein E. Stage I	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.79
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.76
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.75
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.66
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.54
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.37
PRK05231	319	homoserine kinase; Provisional	97.35
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.31
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.28
PF07228	193	SpoIIE: Stage II sporulation protein E (SpoIIE); I	97.19
PLN02236	344	choline kinase	97.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.99
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.83

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-53  Score=407.44  Aligned_cols=258  Identities=27%  Similarity=0.387  Sum_probs=219.5

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-------HHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ..+.|.+.+.||.|+||.|-+|..  +++.||||++.....       .....+.+|+++|++|+|||||+++++|+.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456799999999999999999975  789999998643321       12334679999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC---CCCeEeeeecchh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEY  211 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~---~~~kL~Dfg~a~~  211 (573)
                      ..|+||||+.||+|.+++-..+ .+.++..+.+++|++.|+.|||++||+||||||+|||+..+   ..+||+|||+|++
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999997665 78889999999999999999999999999999999999876   7799999999987


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEA-QA  287 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~  287 (573)
                      ...                 +....+.||||.|.|||++.+..   +..++|||||||+||-+++|.+||.+..... ..
T Consensus       329 ~g~-----------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~  391 (475)
T KOG0615|consen  329 SGE-----------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK  391 (475)
T ss_pred             ccc-----------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence            653                 22467899999999999997654   3458899999999999999999998865444 55


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .++..+.+.               ..+..+..++++..+||.+||..||++|||+.|+++|+|+.-.
T Consensus       392 eQI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  392 EQILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             HHHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            555544433               2334566899999999999999999999999999999999743

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=414.75  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=227.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .+|...+.||+|+|+.||++++  +|+.||+|++..   ......+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999986  789999998643   34556788999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+|..++|..++. ....+++.+++.+++||+.||.|||+++|+|||||..|++++++.+|||+|||+|..++...    
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc----
Confidence            9999999999987 44589999999999999999999999999999999999999999999999999998876422    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  ....+.||||.|.|||++.....+..+||||+||+||-||+|++||...+..+....+....+.    
T Consensus       173 ------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----  236 (592)
T KOG0575|consen  173 ------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----  236 (592)
T ss_pred             ------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc----
Confidence                        2367899999999999999999999999999999999999999999998877777777655543    


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                     .|..++.++++||.++|+.||.+|||+++|+.|.++
T Consensus       237 ---------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  237 ---------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ---------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence                           345789999999999999999999999999999888

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-51  Score=388.47  Aligned_cols=262  Identities=26%  Similarity=0.368  Sum_probs=222.6

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-eEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YMF  138 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~l  138 (573)
                      +...+.+.++.||+|..|+||++++  +++.+|+|.+... ......++.+|+++++..+|||||++|+.|..+.. .++
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            3445788999999999999999998  5889999987544 44556789999999999999999999999999985 999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||++|+|.+++...+ ++++.....++.++++||.|||+ ++||||||||+||||+..|.|||||||.+..+.+.  
T Consensus       156 ~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999997664 79999999999999999999995 99999999999999999999999999999776531  


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.....         .....
T Consensus       233 ----------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---------~~~~~  287 (364)
T KOG0581|consen  233 ----------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---------PYLDI  287 (364)
T ss_pred             ----------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---------CCCCH
Confidence                            24678999999999999999999999999999999999999999987411         11122


Q ss_pred             HHHHHHHhcCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          298 QQLTAAVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      -++...++.+ ..   |.+|.+ +|+++++|+..||++||.+|||+.|+++|+|......
T Consensus       288 ~~Ll~~Iv~~-pp---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  288 FELLCAIVDE-PP---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHhcC-CC---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            2333333332 12   234444 9999999999999999999999999999998876433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=386.24  Aligned_cols=244  Identities=27%  Similarity=0.404  Sum_probs=214.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +..+.|++++.||+|+||.||+++.  +++.+|+|++...   ...+.+....|..+|..++||+||+++..|+++..+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            4467899999999999999999975  7889999975432   3356778899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|+||+.||.|...|.+++ .++++.++.++.+|+.||.|||+.|||||||||+|||+|.+|+++|+|||+|+....   
T Consensus       102 lVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~---  177 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK---  177 (357)
T ss_pred             EEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc---
Confidence            9999999999999998766 899999999999999999999999999999999999999999999999999974332   


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                   .+....+.+||+.|||||++.+..|+.++|.||||+++|||++|.+||...+.......+....   
T Consensus       178 -------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---  241 (357)
T KOG0598|consen  178 -------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---  241 (357)
T ss_pred             -------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---
Confidence                         1223566899999999999999999999999999999999999999999987777766665433   


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS  341 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt  341 (573)
                                     ++..+..++.+.++|++++|+.||++|..
T Consensus       242 ---------------~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  242 ---------------LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence                           12234458999999999999999999963

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-50  Score=386.82  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=217.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .+|.+.+.||+|+||+||+|++  ++..||||.+...  ..+..+.+..|+++|+.++|||||++++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5799999999999999999987  6789999987666  56677889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC------CCCeEeeeecchhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN------LCPHLADFGLAEYRENL  215 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~------~~~kL~Dfg~a~~~~~~  215 (573)
                      ||.||+|.++++..+ .++++.++.++.||+.||++||+++||||||||+|||++..      -.+||+|||+|+++.. 
T Consensus        90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-  167 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-  167 (429)
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-
Confidence            999999999998876 89999999999999999999999999999999999999875      3589999999998763 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      +....+.+|+|.|||||++..+.|+.|+|+||+|+++|++++|+.||...+..+....+.... 
T Consensus       168 ----------------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-  230 (429)
T KOG0595|consen  168 ----------------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-  230 (429)
T ss_pred             ----------------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-
Confidence                            223568899999999999999999999999999999999999999999877666655433222 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                     ..++..+..++..+.+|+...|+.+|..|.++.+-..+.
T Consensus       231 ---------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  231 ---------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             ---------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence                           222334446777788999999999999999988866554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-50  Score=369.88  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=215.8

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeee-ccccCCc-eE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVA-AHAKPPN-YM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~~  137 (573)
                      ....|+++++||+|.||+||++..  ++..+|.|.+...  +....+.+..|+.+|++|+|||||++++ .|..... ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            345799999999999999999976  7899999987654  3456778999999999999999999998 5555555 89


Q ss_pred             EEEEeccCCChhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          138 FFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHN--LG--IVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~--iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      +|||+|.+|+|...+.   ..+..+++..+|+++.|++.||..+|+  ..  |+||||||.||+++.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999885   345678999999999999999999999  44  9999999999999999999999999999


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      ++.....                ...+.+|||.||+||++.+.+|+.++||||+||++|||+.-.+||.+.+-.....+|
T Consensus       177 ~l~s~~t----------------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI  240 (375)
T KOG0591|consen  177 FLSSKTT----------------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI  240 (375)
T ss_pred             HhcchhH----------------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence            8875333                356789999999999999999999999999999999999999999987555555555


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .++.              +.|...   ..+|.++..||..|+..||+.||+.-.++..+..
T Consensus       241 ~qgd--------------~~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  241 EQGD--------------YPPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HcCC--------------CCCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            4433              322211   4689999999999999999999996666555444

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-49  Score=367.11  Aligned_cols=269  Identities=23%  Similarity=0.319  Sum_probs=220.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|+.+.++|+|+||+||+|++  +|+.||||++..+..  ...+...+|+++|++|+|||+|.|+++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            5799999999999999999986  789999998655433  234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      ||+. ++.+-+.......+.+.+.++++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..       
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-------  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-------  153 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-------
Confidence            9988 44455555556789999999999999999999999999999999999999999999999999987652       


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                               ++...+.++.|.||+|||.+.| ..|+.++||||+||++.||++|.+.|++..+..+...|.....+....
T Consensus       154 ---------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr  224 (396)
T KOG0593|consen  154 ---------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR  224 (396)
T ss_pred             ---------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence                     1223567899999999999987 789999999999999999999999999998888888776533222111


Q ss_pred             HHHHhc------CCCCCccccc------ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVS------GGLRPILASL------ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~------~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...+-.      |-.-|.++.+      -+.++.-+.+|++.||+.||++|++.+|++.|..+
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence            111111      1111211111      23567789999999999999999999999988755

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=393.00  Aligned_cols=264  Identities=24%  Similarity=0.389  Sum_probs=229.2

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..+|.+++.||+|+|++|++|+.  +++.||||++...   .......+..|-++|.+| .||.|++|+-.|++...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            46899999999999999999986  6899999974322   233456788899999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+||+++|+|.+++.+.+ .|++..++.++.||+.||+|||++|||||||||+|||+|.++++||+|||.|+.+......
T Consensus       152 vLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999999999999998876 8999999999999999999999999999999999999999999999999999988753332


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                      .. +.  ...........+++||..|++||++.....++.+|||+|||+||+|+.|.+||.+.+.-..+++|+...+.  
T Consensus       231 ~~-~~--~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~--  305 (604)
T KOG0592|consen  231 QE-NP--VDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE--  305 (604)
T ss_pred             cc-Cc--cCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc--
Confidence            11 10  01111111246789999999999999999999999999999999999999999999988888888876664  


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                       +++++++.+.+||+++|..||.+|+|+.+|.+|+.+
T Consensus       306 -----------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  306 -----------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             -----------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence                             356889999999999999999999999999988854

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=384.93  Aligned_cols=264  Identities=36%  Similarity=0.599  Sum_probs=226.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEECCee-EEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCC-ce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDGRK-VAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-NY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~  136 (573)
                      ..+......+.+.||.|+||+||+|.+.|+. ||+|++....  ....+.|.+|+.+|.+++|||||++++++.++. .+
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            5666677888888999999999999999988 9999865443  223668999999999999999999999999988 79


Q ss_pred             EEEEEeccCCChhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCceEEcCCC-CCeEeeeecchhhh
Q 008220          137 MFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLDRNL-CPHLADFGLAEYRE  213 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~  213 (573)
                      ++||||+++|+|.++++. ....++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++...
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            999999999999999987 3668999999999999999999999999 99999999999999998 99999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ...                ...+...||+.|||||++.  ...|+.++||||||++||||+||..||.+......     
T Consensus       196 ~~~----------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----  254 (362)
T KOG0192|consen  196 ISK----------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----  254 (362)
T ss_pred             ccc----------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence            211                1123368999999999999  56999999999999999999999999998755333     


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                               ...+...+.+|.++.   .+++.+..||++||..||..||++.+++..|..+.....
T Consensus       255 ---------~~~v~~~~~Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  255 ---------ASAVVVGGLRPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             ---------HHHHHhcCCCCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                     333444556665543   589999999999999999999999999999998887544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-48  Score=381.67  Aligned_cols=270  Identities=26%  Similarity=0.340  Sum_probs=231.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccC--CceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv  139 (573)
                      +.|+.+++||+|+||.||+|++  +|+.||+|++....  ........+|+.+|++|+||||++|.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            5699999999999999999987  68899999987765  33456678999999999999999999988776  689999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +|||+. +|.-++...+..|++.++..|++||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+++.....  
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~--  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS--  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC--
Confidence            999987 99999988888999999999999999999999999999999999999999999999999999997764221  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   ...+..+-|.||+|||++.|. .|+.++|+||.||||.||++|++.|.+.+..++...|+....++.
T Consensus       274 -------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  274 -------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             -------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence                         125667899999999999875 699999999999999999999999999999999999998877776


Q ss_pred             HHHHHHhc----CCCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          299 QLTAAVVS----GGLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       299 ~~~~~~~~----~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +..|.+..    ..++|      .+.+....++....+|+..+|..||.+|.||.+++++-++
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            66555211    11222      1122234688999999999999999999999999987665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-48  Score=355.79  Aligned_cols=238  Identities=25%  Similarity=0.351  Sum_probs=214.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..-++|++++.||.|+||.|.+++.  ++..+|+|++...   ..++.+...+|..+|+.+.||+++++++.|.+...+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            3446899999999999999999986  6889999986543   3456677889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||++||.|..++++.+ ++++..++.++.||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|+....   
T Consensus       121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            9999999999999998766 899999999999999999999999999999999999999999999999999987653   


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      ...+.||||.|+|||++...+|+.++|.|||||++|||+.|.+||.+.+......+|++.... 
T Consensus       197 ----------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-  259 (355)
T KOG0616|consen  197 ----------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-  259 (355)
T ss_pred             ----------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-
Confidence                            256789999999999999999999999999999999999999999998877777777665543 


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR  339 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  339 (573)
                                        .|..+++++++||+++|+.|-.+|
T Consensus       260 ------------------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 ------------------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------------------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                              356789999999999999999988

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=378.02  Aligned_cols=274  Identities=26%  Similarity=0.294  Sum_probs=225.8

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCC-CCccceeeeccccCC-c
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP-N  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~  135 (573)
                      .+..+||.++++||.|+||.||+|+.  ++..||||+.+.+  .-++ ..=.+|+..|++|+ ||||+++.+++.+.+ .
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            44568999999999999999999975  6889999975433  2222 22357999999998 999999999999888 9


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +++|||||+. +|.+++..++..|++..++.|++||++||+|+|++|++|||+||+|||+..+..+||+|||+|+.+...
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999999965 999999988889999999999999999999999999999999999999999999999999999876531


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 ..+.++-|.||+|||++. ...|+.+.|||++|||++|+.+-++.|.+.+...++.++.+..
T Consensus       164 p-----------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL  226 (538)
T KOG0661|consen  164 P-----------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL  226 (538)
T ss_pred             C-----------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence            1                 246788999999999875 5678999999999999999999999999999999988887655


Q ss_pred             ccHHHH--HH-HHhcC---CCCCc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQL--TA-AVVSG---GLRPI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~--~~-~~~~~---~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .++..-  .. .....   -..|.     +..+-.+.+.++.+||.+||.+||.+||||.|.++|+.+...
T Consensus       227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence            443221  11 11111   11111     122234588999999999999999999999999999876554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-47  Score=344.42  Aligned_cols=271  Identities=25%  Similarity=0.316  Sum_probs=225.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHH--HHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .+|...++||+|.||.||+|++  +|+.||||++...+..+  .....+|++.|+.++||||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5899999999999999999997  68999999987664442  2356799999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |++. +|..+++.....++..++..++.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.....    
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~----  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR----  156 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc----
Confidence            9976 99999988888899999999999999999999999999999999999999999999999999987753221    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  ..+..+-|.+|+|||.+.| ..|+..+||||.|||+.||+-|.+-|.+.++.++...+++.-.++...
T Consensus       157 ------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~  224 (318)
T KOG0659|consen  157 ------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD  224 (318)
T ss_pred             ------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence                        1234478999999999876 458999999999999999999999999999988888887654443221


Q ss_pred             HHH--------HhcCC-CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAA--------VVSGG-LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~--------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .+.        +.-.. ..+....+-...+.++.+|+.+||..||.+|+|+.|+++|.++..
T Consensus       225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            111        11111 111112223356788899999999999999999999999887754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=382.77  Aligned_cols=256  Identities=27%  Similarity=0.371  Sum_probs=221.3

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC----Ch-HHHHHHHHHHHHHHhCC-CCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS----TS-EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (573)
                      ....+|.+.+.||+|+||+|++|.+  ++..||+|.+...    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999986  6899999965442    11 23456778999999998 999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRE  213 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~  213 (573)
                      .+++||||+.||+|.+++.. ..++.+.+++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999988 5589999999999999999999999999999999999999999 999999999997653


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC-C-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-H-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .                ......+.+||+.|+|||++.+.. | +.++||||+||+||.|++|..||.+.+.......+.
T Consensus       173 ~----------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~  236 (370)
T KOG0583|consen  173 G----------------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR  236 (370)
T ss_pred             C----------------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            1                111356789999999999999877 7 478999999999999999999999976666655554


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCC-hHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGL-PASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ...+.                   .|..+ ++++.+|+++||..||.+|+|+.+|++|.|+...
T Consensus       237 ~~~~~-------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  237 KGEFK-------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             cCCcc-------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            43332                   34456 9999999999999999999999999999998763

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.7e-47  Score=376.54  Aligned_cols=275  Identities=25%  Similarity=0.338  Sum_probs=226.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .+..++|+++..||+|+||.||+|+.  +|..+|+|++..+.   ..+...+..|-++|....+|+||+|+..|++...+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45667999999999999999999974  79999999876543   34567788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ||||||++||++..+|.+.+ .++++.++.++.+++.||+.||+.|+|||||||+|+|||..|++||+|||++.-+....
T Consensus       217 YLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            99999999999999998776 89999999999999999999999999999999999999999999999999996443211


Q ss_pred             hhh-----------cccccCCCCC-----CC---------------CccccccccCcccCChhhhccCCCCchhhHHHHH
Q 008220          217 EIS-----------LKNWRSSGKP-----TG---------------GFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG  265 (573)
Q Consensus       217 ~~~-----------~~~~~~~~~~-----~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  265 (573)
                      ...           .........+     ..               .......+|||.|+|||++.+..|+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence            110           0000000000     00               0012346899999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---H
Q 008220          266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---F  342 (573)
Q Consensus       266 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~  342 (573)
                      ||+||||.|.+||...++.....+++.+.....           .|    ....+++++.|||.+||. ||++|..   +
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----------fP----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----------FP----EEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----------CC----CcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            999999999999999999999988876552211           01    123578999999999999 9999975   8


Q ss_pred             HHHHHHHHHHH
Q 008220          343 SDIALELDLVL  353 (573)
Q Consensus       343 ~ell~~l~~~~  353 (573)
                      +||-+|+|+--
T Consensus       440 ~EIK~HPfF~~  450 (550)
T KOG0605|consen  440 EEIKKHPFFKG  450 (550)
T ss_pred             HHHhcCCcccc
Confidence            88888887653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=379.45  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=223.9

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEECCe-eEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..+++++.+.+++++.||+|.||.||.|.+.+. .||+|.+... ....+.|.+|+.+|++|+|+|||++++++..+..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            345778888899999999999999999999776 9999986554 33446788999999999999999999999998899


Q ss_pred             EEEEEeccCCChhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ||||||++.|+|.++|.. .+..+...+.+.++.||++|++||+++++|||||.++||||+.++.+||+|||+|+...+.
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999999986 5567899999999999999999999999999999999999999999999999999954432


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ...               ......-+..|.|||.+....++.+||||||||+|||++| |+.||...........+.   
T Consensus       357 ~Y~---------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---  418 (468)
T KOG0197|consen  357 EYT---------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---  418 (468)
T ss_pred             cee---------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---
Confidence            111               1122234678999999999999999999999999999999 999999876666555443   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 .|...|    .|..+|+++.++|..||..+|++|||++.+...+..+..
T Consensus       419 -----------~GyRlp----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 -----------RGYRLP----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -----------ccCcCC----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                       232222    256899999999999999999999999998887777654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-47  Score=383.59  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=220.8

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      -|++++.||.|+.|.|-+|++  +|+.+|||++...   .......+.+|+-+|+.+.||||+++|+++++..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            489999999999999999987  8999999986544   22335678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |++||.|.+++-.++ ++++.++.+++.||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|....        
T Consensus        93 yv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--------  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--------  163 (786)
T ss_pred             ecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--------
Confidence            999999999998776 78899999999999999999999999999999999999999999999999996432        


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                               ++....+.||+|.|.|||++.|.+| +.++||||.|||||.||||..||++.+-.....++..+.+     
T Consensus       164 ---------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-----  229 (786)
T KOG0588|consen  164 ---------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-----  229 (786)
T ss_pred             ---------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----
Confidence                     2334678899999999999999988 6899999999999999999999997765555555444333     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                    ++|..+|+++.+||++||..||.+|.|.+||++|+|..
T Consensus       230 --------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  230 --------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             --------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence                          25678999999999999999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=367.66  Aligned_cols=261  Identities=28%  Similarity=0.452  Sum_probs=215.5

Q ss_pred             CCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC--ceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~  140 (573)
                      ..+|...+.||+|+||.||++.+.  +...|||.....+....+.+.+|+.+|++++|||||++++......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            357999999999999999999874  6999999876665555778999999999999999999999755544  699999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+++|+|.+++...+..++++.++.+.+||++||+|||++||+|+||||+|||++. ++.+||+|||++.......   
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~---  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG---  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc---
Confidence            999999999999877667999999999999999999999999999999999999999 7999999999987654200   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHHHhccccH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDL-RAEAQAHTVLEMNYTE  297 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~  297 (573)
                                ..........||+.|||||++... ...+++|||||||++.||+||+.||... .......         
T Consensus       173 ----------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~---------  233 (313)
T KOG0198|consen  173 ----------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL---------  233 (313)
T ss_pred             ----------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH---------
Confidence                      111123457899999999999853 3446999999999999999999999863 2111111         


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                           .+..+.   ..|.+|..+|+++.+||.+|+..||++||||.++++|++.....
T Consensus       234 -----~ig~~~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  234 -----LIGRED---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             -----HHhccC---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                 111122   23356678999999999999999999999999999999876643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=378.30  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=222.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ...|....+||+|+.|.||.++.  +++.||||++........+.+.+|+.+|+..+|+|||.+++.|...+.+|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            35799999999999999999976  6788999998888777788899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      ++||+|.|++...  .+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....     
T Consensus       352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-----  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-----  424 (550)
T ss_pred             cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-----
Confidence            9999999998654  589999999999999999999999999999999999999999999999999977653221     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 .+.+++|||.|||||++....|++++||||||++++||+-|++||-..++....+.+...         
T Consensus       425 -----------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n---------  484 (550)
T KOG0578|consen  425 -----------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---------  484 (550)
T ss_pred             -----------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---------
Confidence                       367899999999999999999999999999999999999999999765444333333211         


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                          +  .|.+. .+..+|+++++|+.+||+.||++|+++.|||+|+...
T Consensus       485 ----g--~P~lk-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  485 ----G--TPKLK-NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             ----C--CCCcC-CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence                1  22222 2457999999999999999999999999999999773

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-46  Score=351.09  Aligned_cols=282  Identities=25%  Similarity=0.371  Sum_probs=229.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeecc--CCChHHHHHHHHHHHHHHhCCCCccceeeecccc-----CCc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPI--LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-----PPN  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~~  135 (573)
                      ..+|..++.||.|+||.|+.+.+  +|+.||||++.  ..+.-..++..+|+++|++++|+||+.+++++..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            35677789999999999999987  68999999976  5566677888999999999999999999999865     346


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .|+|+|++ +.+|...++... .++.+.+..+++||+.||.|+|+.+|+||||||.|++++.+..+||||||+|+.....
T Consensus       101 vYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence            89999999 458988887654 6999999999999999999999999999999999999999999999999999876531


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                    ......+.++.|.+|+|||++. ...|+.+.||||+||||.||++|++.|.+.+...+...+....
T Consensus       179 --------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  179 --------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             --------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence                          0111346788999999999875 5679999999999999999999999999999888888888766


Q ss_pred             ccHHHHHHH-HhcC---------CCCC--cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 008220          295 YTEQQLTAA-VVSG---------GLRP--ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE  362 (573)
Q Consensus       295 ~~~~~~~~~-~~~~---------~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~~~  362 (573)
                      .++.+.... +.+.         ...|  .+...-++.++.+.+|+++||..||.+|+|++|.++|+..  +......++
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl--~~~hdp~dE  322 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL--APYHDPEDE  322 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh--hhhcCCccC
Confidence            555433222 2211         1111  1122235789999999999999999999999999999854  444444444


Q ss_pred             cc
Q 008220          363 DL  364 (573)
Q Consensus       363 ~~  364 (573)
                      +.
T Consensus       323 P~  324 (359)
T KOG0660|consen  323 PV  324 (359)
T ss_pred             CC
Confidence            43

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=375.91  Aligned_cols=292  Identities=22%  Similarity=0.340  Sum_probs=240.4

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|+++++||+|.||+|+++..  +++.+|||.++..   ..++.+..+.|.+++.... ||.++.++.+|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            45567899999999999999999986  5789999975433   3456788899999998885 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||++..+.  ....+++..++.|+..++.||.|||++|||+||||.+|||+|.+|++||+|||+++.--  
T Consensus       444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--  519 (694)
T ss_pred             EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence            99999999999954443  33479999999999999999999999999999999999999999999999999996322  


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                    ..+..+.+.+|||.|||||++.+..|+.++|.|||||+|||||.|..||.+.+.++....|+....
T Consensus       520 --------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~  585 (694)
T KOG0694|consen  520 --------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV  585 (694)
T ss_pred             --------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Confidence                          123357789999999999999999999999999999999999999999999888888777765332


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhccccccccccCCccccccc
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDD  375 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (573)
                                         ..|..+|.+..++|+++|+.+|++|....+=  .                           
T Consensus       586 -------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~--d---------------------------  617 (694)
T KOG0694|consen  586 -------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGER--D---------------------------  617 (694)
T ss_pred             -------------------CCCCcccHHHHHHHHHHhccCcccccCCCCC--C---------------------------
Confidence                               2466899999999999999999999876210  0                           


Q ss_pred             ccccccCCcccccccccccccccchhhhhccccccccchhcccccCccCcCCcc
Q 008220          376 KLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVL  429 (573)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~s~~~~~~~~~~~  429 (573)
                         ...-..|.++..++|.       ++......+|..|...++++...+-..|
T Consensus       618 ---~~~i~~hpFFr~i~w~-------~L~~r~i~PPf~P~i~~~~D~snFd~eF  661 (694)
T KOG0694|consen  618 ---AEDIKKHPFFRSIDWD-------DLLNRRIKPPFVPTIKGPEDVSNFDEEF  661 (694)
T ss_pred             ---chhhhhCCccccCCHH-------HHhhccCCCCCCcccCChhhhcccchhh
Confidence               0001345666777776       5666667777777777777755444433

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-46  Score=354.87  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=223.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .||++.+.||.|.||.|-+++.  .|+.||||.+...   ...+.-.+.+|+++|..|+||||+.+|++|++.+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            5899999999999999999975  6899999965433   3445667899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||..+|.|+|++...+ .+++.+++.+++||+.|+.|+|+++++|||||.+|||+|.++++||+|||++.++....    
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k----  207 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK----  207 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc----
Confidence            9999999999998766 89999999999999999999999999999999999999999999999999997765322    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   ...++||+|.|.+||++.|.+| ++.+|.||||++||-|+.|..||++.+......+|-.+.+-   
T Consensus       208 -------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---  271 (668)
T KOG0611|consen  208 -------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---  271 (668)
T ss_pred             -------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---
Confidence                         3578999999999999999998 67899999999999999999999998776666666544432   


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                       ++..|....-||++||..||++|.|+++|..|-|.....
T Consensus       272 -----------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  272 -----------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             -----------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence                             234567789999999999999999999999999876643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.4e-46  Score=368.52  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=217.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|.+.+.||+|.||.||+|+.  +.+.||+|.+...  ..++...+.+|+++++.|+||||+.++++|++..++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5899999999999999999975  6789999975433  44567889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.| +|..++...+ .++++.++.++++++.||.|||+.+|+|||+||+|||++..|.+|+||||+|+.+...      
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~------  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN------  153 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC------
Confidence            9988 9999998666 8999999999999999999999999999999999999999999999999999876531      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                ....+...|||.|||||++.+.+|+..+|+|||||++||+++|++||....-......|.          
T Consensus       154 ----------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~----------  213 (808)
T KOG0597|consen  154 ----------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL----------  213 (808)
T ss_pred             ----------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh----------
Confidence                      123566789999999999999999999999999999999999999997654333333332          


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                          .+..+     .|...+..+.+|++.+|.+||.+|.|..+++.|....
T Consensus       214 ----~d~v~-----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k  255 (808)
T KOG0597|consen  214 ----KDPVK-----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWK  255 (808)
T ss_pred             ----cCCCC-----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHh
Confidence                22222     2347899999999999999999999999999998543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=352.16  Aligned_cols=280  Identities=28%  Similarity=0.394  Sum_probs=229.0

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+.+..+.|++.+.||.|..++||+|+.  .++.||||++.... ..+.+.+.+|+..|+.++||||++++..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            34667778999999999999999999986  68999999977653 3346889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      +|+||.|+.+|++.+++.. ..+.+++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999999999864 345799999999999999999999999999999999999999999999999998755432


Q ss_pred             hhhhhcccccCCCCCCCCccc-cccccCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          215 LKEISLKNWRSSGKPTGGFHK-KNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                                 ++  ...... .+.+||++|||||++.  ...|+.|+||||||++..||.+|..||....+.......+
T Consensus       179 -----------~G--~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL  245 (516)
T KOG0582|consen  179 -----------SG--DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL  245 (516)
T ss_pred             -----------cC--ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence                       11  111122 7789999999999964  3568999999999999999999999999887766665555


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK  360 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~  360 (573)
                      +...+... .     +..+   ......++..+++++..||+.||.+|||+.++++|.++-........
T Consensus       246 qn~pp~~~-t-----~~~~---~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  246 QNDPPTLL-T-----SGLD---KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             cCCCCCcc-c-----ccCC---hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence            43332110 0     0000   00112467799999999999999999999999999988765544333

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-47  Score=339.03  Aligned_cols=258  Identities=26%  Similarity=0.333  Sum_probs=221.2

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ..+.|++.+.||+|.|+.|+++.+  +|+.+|+|.+....  ....+.+.+|+++.+.|+||||++|.+.+......|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            347899999999999999999976  78899999765432  23567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +|++.|++|..-+-.+ .-+++..+-.+++||+++|.|+|.+||||||+||+|+|+..   .-.+||+|||+|..+..  
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--  165 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--  165 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence            9999999996655433 25688889999999999999999999999999999999954   34599999999975541  


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                     +......+|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+......+|....+.
T Consensus       166 ---------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd  230 (355)
T KOG0033|consen  166 ---------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD  230 (355)
T ss_pred             ---------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC
Confidence                           11234568999999999999999999999999999999999999999998888777777765543


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..               +..+++++++.++|+++||..||.+|+|+.|.++|+|....
T Consensus       231 ~~---------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  231 YP---------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CC---------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            21               12456899999999999999999999999999999998654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=356.38  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=213.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--------------HHHHHHHHHHHHHHhCCCCcccee
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------------EELDNFHKELQLLCKLDHPGLAKF  126 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~l  126 (573)
                      ..-++|++.+.||+|.||.|-+|++  +++.||||++.....              ...+.+.+|+.+|+++.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3346899999999999999999987  688999997543211              124688999999999999999999


Q ss_pred             eeccccC--CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEe
Q 008220          127 VAAHAKP--PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       127 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                      +++..++  +.+|+|+|||..|.+...-. ....+++.++++|+++++.||+|||.+|||||||||+|+|++.+|++||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            9999875  57999999999988865432 22138999999999999999999999999999999999999999999999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                      |||.+.........           .........+|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||-+
T Consensus       253 DFGVs~~~~~~~~~-----------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDE-----------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             ccceeeecccCCcc-----------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99998755221000           0001133468999999999987632    46789999999999999999999998


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ........+|+......                 ...+.+.+.+++||++||.+||++|.++.+|..|+|....
T Consensus       322 ~~~~~l~~KIvn~pL~f-----------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  322 DFELELFDKIVNDPLEF-----------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             chHHHHHHHHhcCcccC-----------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            87777777666533321                 1123578999999999999999999999999999998765

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=364.63  Aligned_cols=267  Identities=33%  Similarity=0.539  Sum_probs=230.4

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..++|+.+...+.+.||+|.||+||+|.+.| .||||++...  ..+..+.|++|+.++++-+|.||+-++|++..++. 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            4588888999999999999999999999987 6899986554  45678899999999999999999999999988877 


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      .+|+.+|+|.+|+.+++.....|.+.+.+.|+.||++|+.|||.++|||||||..||++.+++.|||+|||++..-... 
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w-  541 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW-  541 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee-
Confidence            9999999999999999988888999999999999999999999999999999999999999999999999999754421 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                   .+........|...|||||++..   .+|++.+||||||+++|||+||..||.....          
T Consensus       542 -------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----------  598 (678)
T KOG0193|consen  542 -------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----------  598 (678)
T ss_pred             -------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----------
Confidence                         11223455678999999999863   5789999999999999999999999984432          


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                          +++++.+..|...|.+.....++++++++|+..||.+++++||.+.+|+..|..++..
T Consensus       599 ----dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  599 ----DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ----hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                3334445556566666666678899999999999999999999999999988777653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=338.11  Aligned_cols=268  Identities=25%  Similarity=0.272  Sum_probs=220.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHH--HHHHHHHHHHHHhCCCCccceeeecccc--CCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv  139 (573)
                      +.|+.+..|++|+||.||+|++  +++.||+|+++.....+  .-...+|+.+|.+++|||||.+-.+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4699999999999999999987  57899999876654322  1235689999999999999999877653  4579999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||||+. +|..+++....+|+..+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...    
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp----  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP----  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC----
Confidence            999987 999999988889999999999999999999999999999999999999999999999999999876531    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  ....+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++.|.+.....+..+|+.....+.
T Consensus       231 ------------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  231 ------------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS  298 (419)
T ss_pred             ------------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence                        1124567889999999999875 589999999999999999999999999999899888887654443


Q ss_pred             HHHHHHhcC---------------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSG---------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +..+.-...               .++..++.  ..+++...+|+..+|.+||.+|.||.|.++|-|+.
T Consensus       299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~--~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA--LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             cccCCCccccchhhccccCCCCchhhhhhccc--cccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence            322111000               00111111  12568899999999999999999999999988764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=361.75  Aligned_cols=253  Identities=31%  Similarity=0.512  Sum_probs=216.4

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .-|+|+-+...-++-||.|+.|.||+|+..++.||||+++.-       -..+++-|++|+||||+.+.++|.....+||
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            346777677777888999999999999999999999985322       2367888999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||||..|.|..+|+..+ .++......+..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++......  
T Consensus       190 iMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--  266 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--  266 (904)
T ss_pred             eeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence            999999999999997655 78889999999999999999999999999999999999999999999999987655321  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ....++||..|||||++.+++.+.|+|||||||+|||||||..||.+.+...+            
T Consensus       267 ---------------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------------  319 (904)
T KOG4721|consen  267 ---------------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------------  319 (904)
T ss_pred             ---------------hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------------
Confidence                           24567999999999999999999999999999999999999999987543322            


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                        ++.+....+.-.   .|..+|+.++-||++||+-.|.+||++.+|+.||+...
T Consensus       320 --IwGVGsNsL~Lp---vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  320 --IWGVGSNSLHLP---VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             --EEeccCCccccc---CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence              222222222222   34578999999999999999999999999999996643

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-44  Score=344.96  Aligned_cols=272  Identities=25%  Similarity=0.336  Sum_probs=224.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEECC--eeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..+.|++++.||.|.-|+||+++..+  ..+|+|++....   .+...+...|.+||+.++||.++.||..|+....
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            44556789999999999999999999854  789999865432   3456678889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .|++||||+||+|..+++++ +..++++.++.++.+++.||+|||-.|||.|||||+||||.++|++-|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999988765 46799999999999999999999999999999999999999999999999999754321


Q ss_pred             hhhhhc------------------ccc-----cCCC-----------------CCCCCccccccccCcccCChhhhccCC
Q 008220          215 LKEISL------------------KNW-----RSSG-----------------KPTGGFHKKNMVGTLIYMAPEILKKEI  254 (573)
Q Consensus       215 ~~~~~~------------------~~~-----~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~  254 (573)
                      ......                  ..+     ....                 ....+.....++||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            111000                  000     0000                 012234556789999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccC
Q 008220          255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG  334 (573)
Q Consensus       255 ~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  334 (573)
                      .+.++|+|+|||++|||+.|..||.+.+......+++.....                ++.. ..++..++|||+++|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~----------------Fp~~-~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK----------------FPEE-PEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc----------------CCCC-CcchhHHHHHHHHHhcc
Confidence            999999999999999999999999999998888888754332                2222 26789999999999999


Q ss_pred             CCCCCCC----HHHHHHHH
Q 008220          335 NPHNRPS----FSDIALEL  349 (573)
Q Consensus       335 dP~~Rpt----~~ell~~l  349 (573)
                      ||.+|..    +.||-+|+
T Consensus       375 dP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             ChhhhhccccchHHhhcCc
Confidence            9999998    88887666

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=356.54  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=219.0

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +...|+.++.||+|.||.||+|.+  +++.||+|++..... .+.+.+.+|+.+|..++++||.++|+.+..+..++++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            346799999999999999999987  688999999876644 35778899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |||.||++.+.+.... .+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.....   
T Consensus        91 ey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~---  166 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK---  166 (467)
T ss_pred             HHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence            9999999999997554 458888899999999999999999999999999999999999999999999976654222   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ...+++|||.|||||++.+..|+.++||||||++.+||++|.+||.+..+......|-+        
T Consensus       167 -------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------  225 (467)
T KOG0201|consen  167 -------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------  225 (467)
T ss_pred             -------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------
Confidence                         24788999999999999999999999999999999999999999998776443332221        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                             .   ..|.+...+++.+++|+..||+.||+.||+|.++++|-..
T Consensus       226 -------~---~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI  266 (467)
T KOG0201|consen  226 -------S---APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI  266 (467)
T ss_pred             -------C---CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence                   1   1223344789999999999999999999999999987643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-44  Score=356.44  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=211.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            3799999999999999999987  48899999865432   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC------
Confidence            9999999999987654 688999999999999999999999999999999999999999999999999865431      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....     
T Consensus       154 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----  215 (291)
T cd05612         154 -------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-----  215 (291)
T ss_pred             -------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----
Confidence                         12235689999999999999999999999999999999999999987655444333332111     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                                    ..+..+++.+.+||++||+.||.+||+     +.++++|.|..
T Consensus       216 --------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         216 --------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             --------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence                          123467899999999999999999995     99999998874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-44  Score=341.32  Aligned_cols=271  Identities=24%  Similarity=0.286  Sum_probs=221.1

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCc-cceeeeccccCC-----
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPG-LAKFVAAHAKPP-----  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~-----  134 (573)
                      ...|..+++||+|+||+||+|+.  +|+.||+|++.....+  ......+|+.+|+.|+|+| |+.|++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            35689999999999999999986  6889999998776543  3456789999999999999 999999998877     


Q ss_pred             -ceEEEEEeccCCChhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          135 -NYMFFFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       135 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                       .+++|+||+.. +|..++....   ..++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             79999999976 9999997655   357778999999999999999999999999999999999999999999999998


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      ...-                +....++.++|.+|+|||++.+. .|+...||||+|||+.||+++++.|.+.....+...
T Consensus       169 a~~i----------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~  232 (323)
T KOG0594|consen  169 AFSI----------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR  232 (323)
T ss_pred             HhcC----------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            5431                11124567899999999999886 789999999999999999999999999998888888


Q ss_pred             HHhccccHHHHHHHHhc--CCCCCccccc---------ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVS--GGLRPILASL---------ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +.+...++.+..+.-+.  ..+++..+..         .+..+++..+++.+||+.+|.+|.|+..++.|..+.
T Consensus       233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~  306 (323)
T KOG0594|consen  233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS  306 (323)
T ss_pred             HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence            87765554332221111  1222111111         123346899999999999999999999999987553

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-44  Score=322.41  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=220.7

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++|++.+.||+|.||.||+|+.  ++-.||+|++..+.   .....++.+|+++-..|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999986  45678999854432   22346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      +||..+|.|...|... ..++++.....++.|++.||.|+|..+|+||||||+|+|++..|.+||+|||.+....     
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-----  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-----
Confidence            9999999999998733 3468999999999999999999999999999999999999999999999999875432     


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+......  
T Consensus       176 -------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--  240 (281)
T KOG0580|consen  176 -------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--  240 (281)
T ss_pred             -------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--
Confidence                         12367899999999999999999999999999999999999999999988766666666544332  


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                       .|..++.++.++|.+||..+|.+|.+..|+++|+|...
T Consensus       241 -----------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  241 -----------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                             24579999999999999999999999999999998753

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-43  Score=359.31  Aligned_cols=263  Identities=27%  Similarity=0.437  Sum_probs=210.6

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      ++|+.++|++.++||.|+||.||+|.+       .++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            567889999999999999999999974       23579999865432 33456789999999999 8999999999887


Q ss_pred             cC-CceEEEEEeccCCChhhhhhccC------------------------------------------------------
Q 008220          132 KP-PNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------  156 (573)
Q Consensus       132 ~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  156 (573)
                      .. ..+++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 45889999999999999886421                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCC
Q 008220          157 -------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP  229 (573)
Q Consensus       157 -------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  229 (573)
                             ..+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........           
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----------  230 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----------  230 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-----------
Confidence                   23677888999999999999999999999999999999999999999999998754321110           


Q ss_pred             CCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                         .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+..........+             . .+
T Consensus       231 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-------------~-~~  293 (338)
T cd05102         231 ---VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-------------K-DG  293 (338)
T ss_pred             ---hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------h-cC
Confidence               01223456788999999999999999999999999999997 999998754322211111             1 11


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..+   ..+..+++++.+|+.+||+.||.+|||+.+|++.|..++.
T Consensus       294 ~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         294 TRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111   1245678999999999999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=350.68  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=225.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHH--HHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .-|.+.+.||+|.|+.|-++++  +|.+||||++.....+.  ...+.+|++.|+..+|||||+||++......+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4599999999999999999986  89999999876554443  3468899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE-cCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .-++|+|.|++-+....+.++.+.+|+.||+.|+.|+|+..+|||||||+||++ ..-|-|||+|||++..+.       
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-------  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-------  170 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-------
Confidence            999999999998888789999999999999999999999999999999999875 667899999999985443       


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                ++...++.+|+..|-|||++.|..|+ +++||||||||||-|++|++||+..++.+.+..|+...++   
T Consensus       171 ----------PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt---  237 (864)
T KOG4717|consen  171 ----------PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT---  237 (864)
T ss_pred             ----------CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---
Confidence                      23346788999999999999998874 6799999999999999999999999999988888877765   


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                      .|..++.++++||..||..||.+|.+.++|..+.|..
T Consensus       238 ----------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  238 ----------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             ----------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence                            3557899999999999999999999999999998875

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-44  Score=355.23  Aligned_cols=254  Identities=26%  Similarity=0.371  Sum_probs=225.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-eEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv  139 (573)
                      .+.|.+++++|+|+||.++++++  +++.+++|++....  ....+...+|+.+++++.|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36899999999999999998876  57899999876554  3445578899999999999999999999999988 9999


Q ss_pred             EEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+||+||++.+.+.+.+ ..++++.+..++.|++.|+.|||+..|+|||||+.||+++.++.|||+|||+|+.+..... 
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~-  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS-  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-
Confidence            99999999999997665 6789999999999999999999999999999999999999999999999999998875332 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ...+.+|||.||+||++.+.+|..++|||||||++|||++-+++|...+-.....++.+..+   
T Consensus       162 ---------------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~---  223 (426)
T KOG0589|consen  162 ---------------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY---  223 (426)
T ss_pred             ---------------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC---
Confidence                           24678999999999999999999999999999999999999999998877777666655432   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                     ..+|...+.+++.||+.||+.+|..||++.+|+.++...
T Consensus       224 ---------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  224 ---------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             ---------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                           234668899999999999999999999999999986544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-43  Score=360.04  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=211.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++|++.+.||+|+||.||+|++  +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            46899999999999999999987  5788999976432   223456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+++|.+.+...+ .++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....     
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence            99999999999987654 688999999999999999999999999999999999999999999999999864431     


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..       
T Consensus       171 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------  229 (329)
T PTZ00263        171 --------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------  229 (329)
T ss_pred             --------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------
Confidence                          12245799999999999999999999999999999999999999987654433333221       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                             +..     ..+..++..+.+||++||+.||.+||+     +.++++|+|..
T Consensus       230 -------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        230 -------GRL-----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             -------CCc-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence                   111     123457899999999999999999997     79999998764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-43  Score=350.43  Aligned_cols=268  Identities=24%  Similarity=0.269  Sum_probs=210.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.++||.|+||+||+|.+  +++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            5799999999999999999987  578999998654332 2344677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......      
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~------  157 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT------  157 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC------
Confidence            975 8988887666567899999999999999999999999999999999999999999999999986432100      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......+....
T Consensus       158 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07871         158 ----------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET  227 (288)
T ss_pred             ----------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence                      01234568999999999875 5689999999999999999999999988766655554443222111111


Q ss_pred             HHHh--cCC----CCCc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 AAVV--SGG----LRPI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~~~~--~~~----~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      +...  ...    ..+.     .......+++++.+||++||+.||.+|||++|+++|+|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            0000  000    0000     01112357889999999999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=354.86  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=222.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  138 (573)
                      ...|++.+.||+|.||.||+++.  +|+.+|+|.+.....   .....+.+|+.+|+++. ||||+.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            46899999999999999999987  588999997654432   34568999999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC----CCCeEeeeecchhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEYREN  214 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~----~~~kL~Dfg~a~~~~~  214 (573)
                      |||+|.||.|.+.+...  .+++..+..++.|++.+++|||+.||+||||||+|+|+...    +.+|++|||++.+...
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999766  39999999999999999999999999999999999999643    4799999999987653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                       +......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+....
T Consensus       192 -----------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~  254 (382)
T KOG0032|consen  192 -----------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD  254 (382)
T ss_pred             -----------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence                             223567899999999999999999999999999999999999999999987777666666554


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +.               .....++.++..++++|+.||..||.+|+|+.++++|+|.
T Consensus       255 ~~---------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi  296 (382)
T KOG0032|consen  255 FD---------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI  296 (382)
T ss_pred             CC---------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence            42               1223456789999999999999999999999999999993

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-43  Score=355.59  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=205.3

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||++.+  +++.||+|++...   .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986  5789999976432   2234556788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS  226 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~  226 (573)
                      +|.+++.... .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....            
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------  147 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------  147 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc------------
Confidence            9999887554 789999999999999999999999999999999999999999999999999864221            


Q ss_pred             CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhc
Q 008220          227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS  306 (573)
Q Consensus       227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (573)
                          .+......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..              
T Consensus       148 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------  209 (323)
T cd05571         148 ----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------  209 (323)
T ss_pred             ----CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------
Confidence                01113346799999999999999999999999999999999999999987654433333221              


Q ss_pred             CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                      +..     ..+..+++++.+||++||+.||++||     ++.++++|.|.
T Consensus       210 ~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         210 EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             CCC-----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence            111     13456899999999999999999999     89999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-43  Score=357.37  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=213.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC---CeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ..+..++|++.+.||+|+||.||+|.+.   +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3445578999999999999999999753   357999975432   2334567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999999999987654 789999999999999999999999999999999999999999999999999865431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                         ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+....
T Consensus       184 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~  244 (340)
T PTZ00426        184 -------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI  244 (340)
T ss_pred             -------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence                               1234579999999999999889999999999999999999999998765544433333211


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                                    .     ..+..+++.+.++|++||+.||++|+     ++.++++|+|.
T Consensus       245 --------------~-----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f  287 (340)
T PTZ00426        245 --------------I-----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF  287 (340)
T ss_pred             --------------C-----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence                          1     12456789999999999999999995     89999998876

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-42  Score=346.49  Aligned_cols=269  Identities=23%  Similarity=0.273  Sum_probs=209.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||+|++  +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            3799999999999999999987  46789999865432  2335677899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.++.+..+.. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........    
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN----  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence            999877665543 344789999999999999999999999999999999999999999999999999875432110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc--ccHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN--YTEQQ  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~~  299 (573)
                                 .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+....  .+...
T Consensus       156 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07848         156 -----------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             -----------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence                       01234568999999999999889999999999999999999999998765544443333221  11111


Q ss_pred             HHHHHhcCCC----CCcc-------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGL----RPIL-------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~----~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..........    .+..       ......+|.++.+||++||+.||++|||++++++|+|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            1110000000    0000       0112247889999999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-44  Score=324.10  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=219.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--------hHHHHHHHHHHHHHHhC-CCCccceeeeccccCC
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--------SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP  134 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  134 (573)
                      ..|.-.+.||+|..++|-++.+  ++..+|+|++....        .+-.+.-.+|+.+|+++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4688899999999999999865  67888998753321        12245567899999998 5999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++|+|.|+.|.|.|++...- .+++...+.+++|+++|+.|||..+|+||||||+|||++++-++||+|||++..+..
T Consensus        97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            9999999999999999997554 899999999999999999999999999999999999999999999999999987653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                                       |......||||.|+|||.+..      ..|+..+|+|++|+++|.|+.|++||..........
T Consensus       176 -----------------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR  238 (411)
T KOG0599|consen  176 -----------------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR  238 (411)
T ss_pred             -----------------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence                             223567899999999999853      457889999999999999999999999877777777


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .++++++...               ...+.+++...++||.+||+.||.+|.|++|.+.|+|++.-
T Consensus       239 ~ImeGkyqF~---------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  239 MIMEGKYQFR---------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHhcccccC---------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            7776665432               22356889999999999999999999999999999998643

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-42  Score=346.11  Aligned_cols=254  Identities=20%  Similarity=0.232  Sum_probs=207.0

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|++.+.||+|+||.||++.+  +++.||+|.+....   ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            378899999999999999986  68899999764332   2233457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+.+|+|.+.+... ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......    
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence            99999998887543 3368899999999999999999999999999999999999999999999999986542100    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.         
T Consensus       157 -------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---------  214 (285)
T cd05631         157 -------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---------  214 (285)
T ss_pred             -------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---------
Confidence                         1234568999999999999999999999999999999999999998654322111111         


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                       ..+.     ......+..+++++.+||++||+.||.+||+     ++++++|.|..
T Consensus       215 -~~~~-----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~  265 (285)
T cd05631         215 -RRVK-----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK  265 (285)
T ss_pred             -HHhh-----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence             0000     1111234568999999999999999999997     89999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=317.57  Aligned_cols=269  Identities=22%  Similarity=0.385  Sum_probs=214.5

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-  134 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  134 (573)
                      .....|+.+||++.++||+|||+.||+++.  ++..||+|++.....++.+..++|++..++++||||++++++...+. 
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            344678899999999999999999999984  78899999999998889999999999999999999999998875443 


Q ss_pred             ----ceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCCCeEee
Q 008220          135 ----NYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       135 ----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                          ..|++++|+..|+|.+.+..   .+..+++.+++.++.++++||++||+..  ++||||||.|||+..++.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence                48999999999999998864   3346899999999999999999999998  99999999999999999999999


Q ss_pred             eecchhhhh-----hhhhhcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCC
Q 008220          206 FGLAEYREN-----LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVP  277 (573)
Q Consensus       206 fg~a~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~P  277 (573)
                      ||.++...-     .+......|            ..-..|..|+|||.+.   +...+.++|||||||+||.|+.|..|
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~------------a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sP  240 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEW------------AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESP  240 (302)
T ss_pred             ccCccccceEeechHHHHHHHHH------------HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCc
Confidence            999864431     111111111            2235788999999985   45578999999999999999999999


Q ss_pred             CCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |...-..            ...+...+..+.+  .+|. ...+|..+.+||+.||+.||.+||++.+++.+++.+.
T Consensus       241 fe~~~~~------------GgSlaLAv~n~q~--s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  241 FERIYQQ------------GGSLALAVQNAQI--SIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             chHHhhc------------CCeEEEeeecccc--ccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            9642110            0000001111111  1111 1238999999999999999999999999999887653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.2e-42  Score=347.39  Aligned_cols=269  Identities=23%  Similarity=0.309  Sum_probs=214.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +..++|++.+.||+|+||.||++++  ++..+|+|.+... .......+.+|+++++.++||||+++++++...+..++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4568999999999999999999987  4778999986654 234456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......   
T Consensus        82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             eecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            99999999999987654 688999999999999999999986 6999999999999999999999999998644210   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc---
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY---  295 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---  295 (573)
                                     ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... +....   
T Consensus       158 ---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~  221 (331)
T cd06649         158 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI-FGRPVVDG  221 (331)
T ss_pred             ---------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-hccccccc
Confidence                           12345689999999999999999999999999999999999999976544332211 11000   


Q ss_pred             ------------------------------cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          296 ------------------------------TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       296 ------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                                                    ........+... ..+..+  ...+++++.+||.+||+.||++|||+.+|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~el  298 (331)
T cd06649         222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKML  298 (331)
T ss_pred             ccCCccccCcccccccccccccccccccchhHHHHHHHHHhC-CCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHH
Confidence                                          000011111111 111111  12478899999999999999999999999


Q ss_pred             HHHHHHHHH
Q 008220          346 ALELDLVLE  354 (573)
Q Consensus       346 l~~l~~~~~  354 (573)
                      ++|+|....
T Consensus       299 l~h~~~~~~  307 (331)
T cd06649         299 MNHTFIKRS  307 (331)
T ss_pred             hcChHHhhc
Confidence            999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-42  Score=341.33  Aligned_cols=251  Identities=19%  Similarity=0.297  Sum_probs=206.8

Q ss_pred             CCcccc--ccccccCceEEEEEEECCeeEEEeeccCCChH---HHHHHHHHHHHHHhCCCCccceeeecccc----CCce
Q 008220           66 SSYTLL--SPIARGAESVVYEATLDGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNY  136 (573)
Q Consensus        66 ~~y~~~--~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~  136 (573)
                      +++...  ..||+|++|.||+|..+++.||||.+......   ..+.+.+|+.+|++++||||+++++++.+    ....
T Consensus        18 ~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         18 DDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             HHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            344444  57899999999999999999999986543222   25678899999999999999999998866    4578


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ++||||+.+|+|.+++.... .+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.... 
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-  175 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-  175 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-
Confidence            99999999999999997654 788899999999999999999985 999999999999999999999999999865431 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                        ......|++.|+|||++.+  ..++.++|||||||++|||++|..||.+.+.......+.  
T Consensus       176 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~--  235 (283)
T PHA02988        176 ------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII--  235 (283)
T ss_pred             ------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--
Confidence                              0123468899999999976  678999999999999999999999998765443333222  


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  .+..++.   .+..+++++.+|+.+||+.||++|||+.++++.|..+.
T Consensus       236 ------------~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        236 ------------NKNNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ------------hcCCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                        2222222   23467899999999999999999999999998887654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-43  Score=354.44  Aligned_cols=256  Identities=24%  Similarity=0.325  Sum_probs=213.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||+|++  +++.||||++...   .......+..|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            3799999999999999999987  5789999986432   2234566889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....      
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc------
Confidence            9999999999997554 688999999999999999999999999999999999999999999999999865431      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+......    
T Consensus       154 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----  216 (333)
T cd05600         154 -------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----  216 (333)
T ss_pred             -------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----
Confidence                         123457999999999999999999999999999999999999999876555444333221100    


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                             ...|........+++++.+||.+||+.+|.+||++.++++|+|..
T Consensus       217 -------~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         217 -------LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             -------ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence                   011111111135789999999999999999999999999998764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-43  Score=335.82  Aligned_cols=265  Identities=25%  Similarity=0.343  Sum_probs=211.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-----ceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv  139 (573)
                      +|+-.+++|.|+||.||+|..  +++.||||+......    .-.+|+.+|+.++|||||+|.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            588899999999999999986  568999998644332    2247999999999999999988876422     34579


Q ss_pred             EEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhhhhh
Q 008220          140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENL  215 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~  215 (573)
                      |||++. +|..+++.   .+..++.-.++-+.+||++||+|||+.||+||||||+|+|+|.+ |.+||||||+|+.+.. 
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~-  178 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK-  178 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc-
Confidence            999976 88888863   24577888899999999999999999999999999999999986 8999999999987753 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                      +....++..|..|+|||.+.| ..|+.+.||||.||++.||+-|++-|.+.+...+...+++..
T Consensus       179 ----------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l  242 (364)
T KOG0658|consen  179 ----------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL  242 (364)
T ss_pred             ----------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence                            112456788999999999876 569999999999999999999999999988888888777654


Q ss_pred             ccHHHHHHHHhcCC----CCCccc-----c-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGG----LRPILA-----S-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~~~~~~~~~~~~~~----~~~~~~-----~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..+...........    ..|.+.     . .....++++.+|+.++|+.+|.+|.++.|++.|..+-.
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence            43322211111111    111111     1 23468999999999999999999999999999885543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=348.63  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=203.4

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||+|+||.||+|++  +++.||+|++...   .......+..|+.++++++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999987  5778999976432   233456778899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCC
Q 008220          149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK  228 (573)
Q Consensus       149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~  228 (573)
                      .+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....             
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------------  146 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------------  146 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-------------
Confidence            99987654 7899999999999999999999999999999999999999999999999998643210             


Q ss_pred             CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                         ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....              
T Consensus       147 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------  209 (312)
T cd05585         147 ---DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------  209 (312)
T ss_pred             ---CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--------------
Confidence               011234579999999999999999999999999999999999999998765444333332211              


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCC---CHHHHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRP---SFSDIALELDLV  352 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~l~~~  352 (573)
                           ...+..+++++.+||.+||+.||.+||   ++.+++.|+|..
T Consensus       210 -----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         210 -----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence                 123456889999999999999999997   578888888753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-42  Score=350.63  Aligned_cols=244  Identities=24%  Similarity=0.307  Sum_probs=204.4

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||++.+  +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999986  5789999986432   2334567888999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS  226 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~  226 (573)
                      +|.+.+.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....           
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-----------  148 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----------  148 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-----------
Confidence            9998886554 6899999999999999999999999999999999999999999999999998643210           


Q ss_pred             CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhc
Q 008220          227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS  306 (573)
Q Consensus       227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (573)
                           ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..              
T Consensus       149 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------  209 (328)
T cd05593         149 -----AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------  209 (328)
T ss_pred             -----ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--------------
Confidence                 0012345799999999999998999999999999999999999999987654433332221              


Q ss_pred             CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                      +.     ..++..+++++.+||++||+.||++||     ++.++++|.|.
T Consensus       210 ~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         210 ED-----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             CC-----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            11     113456899999999999999999997     89999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-42  Score=349.27  Aligned_cols=245  Identities=23%  Similarity=0.322  Sum_probs=204.9

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||++.+  +++.||+|++...   .......+.+|+.+++.++||||+++++++......|+||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999986  5789999986432   2234556778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS  226 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~  226 (573)
                      +|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......           
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-----------  148 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-----------  148 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-----------
Confidence            9998886554 7899999999999999999999999999999999999999999999999987532110           


Q ss_pred             CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhc
Q 008220          227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS  306 (573)
Q Consensus       227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (573)
                           ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..              
T Consensus       149 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------  209 (323)
T cd05595         149 -----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------  209 (323)
T ss_pred             -----CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------
Confidence                 0112345799999999999999999999999999999999999999987655443333321              


Q ss_pred             CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                      +..     ..+..+++++.+||.+||+.||.+||     ++.++++|.|..
T Consensus       210 ~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         210 EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             CCC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            111     12456899999999999999999998     899999988664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.3e-42  Score=347.96  Aligned_cols=271  Identities=23%  Similarity=0.322  Sum_probs=206.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----CceE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNYM  137 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~  137 (573)
                      +|++.++||+|+||.||+|.+  +++.||||++...  .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            699999999999999999987  5789999986532  223445688999999999999999999987543     3489


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 58988886544 689999999999999999999999999999999999999999999999999865421100


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                   .........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus       159 -------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         159 -------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             -------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence                         0011234579999999999876  6788999999999999999999999987654333222211110


Q ss_pred             -cHHHHHHHHh-----------cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 -TEQQLTAAVV-----------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 -~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       ........+.           .......+....+.+++.+.++|.+||+.||++|||+.|+++|.|..
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence             0111111100           00011111112235788999999999999999999999999999874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-42  Score=344.09  Aligned_cols=270  Identities=24%  Similarity=0.294  Sum_probs=205.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            6899999999999999999987  578999998654332 2234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +. ++|.+++......++++.++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......       
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-------  156 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-------  156 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-------
Confidence            96 5787877665557899999999999999999999999999999999999999999999999998643210       


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHHHhcccc--HH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYT--EQ  298 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~--~~  298 (573)
                               ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+......  ..
T Consensus       157 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (303)
T cd07869         157 ---------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED  227 (303)
T ss_pred             ---------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence                     011234568999999999875 457889999999999999999999998754322 11111111000  00


Q ss_pred             HHHHHHhcCCCCC---------cccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRP---------ILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~---------~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ............+         .+..  .....++++.+|+.+||+.||++|||+.|+++|.|+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence            0000000000000         0000  0113467899999999999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-41  Score=350.70  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeecc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAH  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  130 (573)
                      .+.++.++|++.+.||+|+||.||+|.+.       +..||+|++... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            35677789999999999999999999752       247999987544 334456788999999999 899999999999


Q ss_pred             ccCCceEEEEEeccCCChhhhhhccC------------------------------------------------------
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------  156 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  156 (573)
                      ......++||||+.+|+|.+++....                                                      
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999999875321                                                      


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          157 ---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       157 ---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                                     ..+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----  267 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----  267 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence                           2467888999999999999999999999999999999999999999999999865432110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.............         
T Consensus       268 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---------  328 (374)
T cd05106         268 ----------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---------  328 (374)
T ss_pred             ----------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---------
Confidence                      001122345678999999998899999999999999999997 999997654322222211         


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                           .....+.   .+..+++++.++|.+||+.||.+|||+.+|++.|..++
T Consensus       329 -----~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         329 -----KRGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -----HcccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                 1122221   23356899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-41  Score=333.23  Aligned_cols=256  Identities=22%  Similarity=0.351  Sum_probs=209.8

Q ss_pred             cCCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      |..++|++.+.||+|+||.||+|.+     .+..||+|...... ......+.+|+.++++++||||+++++++......
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            4567899999999999999999975     25689999865543 33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+++|+|.+++......+++.+++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            99999999999999997765578999999999999999999999999999999999999999999999999765322100


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     ........++..|+|||.+.+..++.++|||||||++||+++ |..||...........+.    
T Consensus       162 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~----  222 (266)
T cd05064         162 ---------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE----  222 (266)
T ss_pred             ---------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH----
Confidence                           001112345678999999999999999999999999999875 999998765443322221    


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 ....+   ..+..++..+.+++.+||+.+|.+||++.+|++.+..
T Consensus       223 -----------~~~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         223 -----------DGFRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----------CCCCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                       11111   1245688999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.8e-42  Score=359.38  Aligned_cols=265  Identities=28%  Similarity=0.450  Sum_probs=225.9

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeec
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAA  129 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (573)
                      ....+|+....++.+.||+|+||.||+|+..       ...||||.++..... ....|++|+++|..|+|||||+|+|+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3346778888999999999999999999752       357999987666555 67889999999999999999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhcc---------CC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVE---------EW----SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD  196 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~----~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~  196 (573)
                      |..++..|+|+||+..|+|.++|...         +.    .++..+.+.|+.||+.|++||-++.+|||||..+|+||.
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            99999999999999999999998632         11    277889999999999999999999999999999999999


Q ss_pred             CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CC
Q 008220          197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV  275 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~  275 (573)
                      ++..|||+|||+++-+...+...              ......-+.+|||||.+..+.++.+|||||+||+|||+++ |.
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk--------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~  703 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYK--------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGK  703 (774)
T ss_pred             cceEEEecccccchhhhhhhhhc--------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcccc
Confidence            99999999999998655322221              1123345789999999999999999999999999999999 99


Q ss_pred             CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .||.+..+.+.+..+..              +...    +.|+++|.++.+||..||+.+|.+||++.||-..|....+
T Consensus       704 QPy~glSn~EVIe~i~~--------------g~lL----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  704 QPYYGLSNQEVIECIRA--------------GQLL----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             CcccccchHHHHHHHHc--------------CCcc----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            99999877766665543              3221    2467999999999999999999999999999988877654

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-41  Score=341.71  Aligned_cols=270  Identities=24%  Similarity=0.319  Sum_probs=212.8

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ++..++|++.++||+|+||.||++.+  ++..+|+|.+... .......+.+|+++++.++||||+++++++......++
T Consensus         1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            35668999999999999999999987  4778999976554 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||||+.+++|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......  
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999999987654 688899999999999999999985 7999999999999999999999999998654310  


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH---hcc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL---EMN  294 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~~  294 (573)
                                      ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.   ...
T Consensus       158 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (333)
T cd06650         158 ----------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD  221 (333)
T ss_pred             ----------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCC
Confidence                            1233468999999999999889999999999999999999999997654322211110   000


Q ss_pred             cc---------------------------HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 008220          295 YT---------------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL  347 (573)
Q Consensus       295 ~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  347 (573)
                      ..                           .......+. ....+.++  ...++.++.+||.+||+.||++|||+.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIV-NEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccccccCcccCCccchhhhhcccccccccHHHHHHHHh-cCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence            00                           000001111 11111111  1236789999999999999999999999999


Q ss_pred             HHHHHH
Q 008220          348 ELDLVL  353 (573)
Q Consensus       348 ~l~~~~  353 (573)
                      |.|...
T Consensus       299 h~~~~~  304 (333)
T cd06650         299 HAFIKR  304 (333)
T ss_pred             CHHHhc
Confidence            998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.9e-41  Score=339.06  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=206.7

Q ss_pred             cCCCCccccccccccCceEEEEEEEC------------------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCcc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD------------------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGL  123 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI  123 (573)
                      ++..+|++.++||+|+||.||+|.+.                  +..||+|.+.... ......+.+|+.++..++||||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            45679999999999999999999742                  3369999865543 3345678999999999999999


Q ss_pred             ceeeeccccCCceEEEEEeccCCChhhhhhccC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008220          124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVH  185 (573)
Q Consensus       124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH  185 (573)
                      +++++++......++||||+.+++|.+++....                  ..+++.+++.++.||+.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999885421                  23577889999999999999999999999


Q ss_pred             ccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHH
Q 008220          186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG  265 (573)
Q Consensus       186 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  265 (573)
                      |||||+|||++.++.+||+|||+++.......              ........++..|+|||++.+..++.++||||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  227 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG  227 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCce--------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence            99999999999999999999999865432110              0012234567889999999888899999999999


Q ss_pred             HHHHHHHc--CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          266 ISINELLT--GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       266 ~il~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                      +++|+|++  +..||................           ...........+..++..+.+||.+||+.||++|||+.
T Consensus       228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         228 VTLWEILMLCKEQPYGELTDEQVIENAGEFF-----------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             HHHHHHHHccCCCCCCcCCHHHHHHHHHHHh-----------hhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            99999986  677888765444333221100           00011111122346789999999999999999999999


Q ss_pred             HHHHHHH
Q 008220          344 DIALELD  350 (573)
Q Consensus       344 ell~~l~  350 (573)
                      +|.+.|.
T Consensus       297 ~i~~~l~  303 (304)
T cd05096         297 DIHAFLT  303 (304)
T ss_pred             HHHHHHh
Confidence            9987653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-41  Score=350.64  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=211.7

Q ss_pred             CccccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceee
Q 008220           57 QSIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFV  127 (573)
Q Consensus        57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~  127 (573)
                      ....+.++.++|++.+.||+|+||.||+|++       .+..||||++.... ....+.+.+|+.+++.+ +||||++++
T Consensus        26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            3445677788999999999999999999963       34589999865432 34456788999999999 899999999


Q ss_pred             eccccCCceEEEEEeccCCChhhhhhccC---------------------------------------------------
Q 008220          128 AAHAKPPNYMFFFEFYESRNLAEKLHVEE---------------------------------------------------  156 (573)
Q Consensus       128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------  156 (573)
                      +++......++||||+++|+|.+++....                                                   
T Consensus       106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            99999999999999999999998885422                                                   


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          157 -----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       157 -----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                                             ..++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                   146778899999999999999999999999999999999999999999999986543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      .....              .......++..|+|||++.+..++.++|||||||++|||++ |..||............+.
T Consensus       266 ~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~  331 (375)
T cd05104         266 NDSNY--------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK  331 (375)
T ss_pred             Ccccc--------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence            21110              01122345678999999999999999999999999999998 9999976543332222211


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                    .+.++.   .+...+.++.+||.+||+.||++|||+.||++.|+.
T Consensus       332 --------------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         332 --------------EGYRML---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --------------hCccCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                          122221   223568899999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-41  Score=359.65  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=212.5

Q ss_pred             CCccccccccccCceEEEEEEE--C-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--D-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..|.+.+.||+|+||.||+|..  + ++.||+|............+..|+.+++.++||||+++++++..++.+|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4599999999999999999975  3 578899987666666667788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          143 YESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       143 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +++|+|.+.+..   ....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~--  224 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS--  224 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc--
Confidence            999999987753   234688999999999999999999999999999999999999999999999999875532110  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       
T Consensus       225 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-------  285 (478)
T PTZ00267        225 ------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-------  285 (478)
T ss_pred             ------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence                        0113456799999999999999999999999999999999999999987654433333322       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                             +...+    .+..+++++.+||.+||+.||++||++.+++.+.+.
T Consensus       286 -------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~  326 (478)
T PTZ00267        286 -------GKYDP----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL  326 (478)
T ss_pred             -------CCCCC----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence                   22221    234678999999999999999999999999987654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-42  Score=346.72  Aligned_cols=245  Identities=25%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             cccccccCceEEEEEEE-----CCeeEEEeeccCC----ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           71 LSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++.||+|+||.||+++.     .++.||+|.+...    .......+..|+.+|+.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999975     4678999976432    22334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++...+ .++++.+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....      
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------  153 (323)
T cd05584          81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------  153 (323)
T ss_pred             CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC------
Confidence            999999999987654 6788999999999999999999999999999999999999999999999998532210      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                ........||+.|+|||++.+..++.++|||||||++|||++|..||...........+..         
T Consensus       154 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------  214 (323)
T cd05584         154 ----------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------  214 (323)
T ss_pred             ----------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence                      0112345799999999999998899999999999999999999999987654443333322         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                           +.     ...+..+++++.+||++||+.||++||     ++.++++|.|.
T Consensus       215 -----~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         215 -----GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             -----CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence                 11     123456789999999999999999999     89999998875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=353.38  Aligned_cols=270  Identities=23%  Similarity=0.315  Sum_probs=211.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||.|+||+||+|++  +++.||||++...   .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999987  5789999986432   2234456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+........
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9999999999987654 689999999999999999999999999999999999999999999999999865432111000


Q ss_pred             ccccCCC----------CC------------CCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008220          221 KNWRSSG----------KP------------TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY  278 (573)
Q Consensus       221 ~~~~~~~----------~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf  278 (573)
                      .......          .+            .........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence            0000000          00            0000112357999999999999999999999999999999999999999


Q ss_pred             CCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHHH
Q 008220          279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDLV  352 (573)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~~  352 (573)
                      ...........+....              ....++ ....+++++.+||++||. +|.+|++   +.++++|.|..
T Consensus       240 ~~~~~~~~~~~i~~~~--------------~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         240 CSDNPQETYRKIINWK--------------ETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCHHHHHHHHHcCC--------------CccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            8766544433333211              011111 112578999999999997 9999998   99999998763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=357.18  Aligned_cols=269  Identities=23%  Similarity=0.279  Sum_probs=205.1

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccC-------
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-------  133 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------  133 (573)
                      ....+|++.+.||+|+||.||+|.+  +++.||||++....    ....+|+.+|+.++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4457899999999999999999986  57899999864332    2345799999999999999998876432       


Q ss_pred             -CceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeec
Q 008220          134 -PNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGL  208 (573)
Q Consensus       134 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~  208 (573)
                       ..+++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence             246789999976 66665532   344789999999999999999999999999999999999999765 699999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      ++.....                 .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.......
T Consensus       218 a~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  280 (440)
T PTZ00036        218 AKNLLAG-----------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL  280 (440)
T ss_pred             chhccCC-----------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9754321                 012345789999999998764 6899999999999999999999999887666655


Q ss_pred             HHHHhccccHHHHHHHHhcCCC-----C-----CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGL-----R-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..+......+...........+     .     .....++...++++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus       281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence            5554332211111000000000     0     0011124467889999999999999999999999999998743

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-41  Score=349.87  Aligned_cols=266  Identities=21%  Similarity=0.314  Sum_probs=204.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +...+|++++.||+|+||.||++.+  +++.||+|...      ...+.+|+.+++.++||||++++++|......++|+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4557899999999999999999987  57899999632      234678999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |++. ++|..++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........   
T Consensus       163 e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~---  237 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA---  237 (391)
T ss_pred             ecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc---
Confidence            9985 58888876544 688999999999999999999999999999999999999999999999999864321110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCch-------hHHHHHHHHhc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR-------AEAQAHTVLEM  293 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-------~~~~~~~~~~~  293 (573)
                                  .......||+.|+|||++.+..++.++|||||||++|||++|..||....       .......++..
T Consensus       238 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        238 ------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             ------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence                        01234579999999999999999999999999999999999998875321       11122222211


Q ss_pred             ccc--------H----HHHHHHHhcC-CC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYT--------E----QQLTAAVVSG-GL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~--------~----~~~~~~~~~~-~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...        .    .......... ..    ++... ....++.++.+||.+||+.||++|||+.|+++|.|+.
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence            100        0    0000011111 01    11111 0124677899999999999999999999999999873

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9e-42  Score=345.71  Aligned_cols=247  Identities=25%  Similarity=0.356  Sum_probs=203.9

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHH---HhCCCCccceeeeccccCCceEEE
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLL---CKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      |++.+.||+|+||.||+|.+  +++.||||++...   .....+.+..|++++   +.++||||+++++++......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999987  5789999986432   223345677776665   456799999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+++|...+..  ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......    
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~----  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF----  154 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC----
Confidence            999999999888754  36899999999999999999999999999999999999999999999999987532210    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  ........|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..       
T Consensus       155 ------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------  215 (324)
T cd05589         155 ------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------  215 (324)
T ss_pred             ------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence                        1113456799999999999999999999999999999999999999987655444333322       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                             +..     ..+..+++++.++|.+||+.||.+||     ++.++++|.|.
T Consensus       216 -------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f  260 (324)
T cd05589         216 -------DEV-----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF  260 (324)
T ss_pred             -------CCC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence                   111     12446899999999999999999999     68888888765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-41  Score=349.54  Aligned_cols=269  Identities=23%  Similarity=0.314  Sum_probs=208.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++...   .......+..|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4799999999999999999987  5789999986432   2233457888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            9999999999987654 789999999999999999999999999999999999999999999999999875432110000


Q ss_pred             c--------------cccCCCC-----CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008220          221 K--------------NWRSSGK-----PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL  281 (573)
Q Consensus       221 ~--------------~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  281 (573)
                      .              .......     ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence            0              0000000     00000123457999999999999999999999999999999999999999876


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCC---CCCCHHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH---NRPSFSDIALELDL  351 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rpt~~ell~~l~~  351 (573)
                      ........+.....              ...++. ...+++++.++|.+|+. +|.   .||+++||++|+|.
T Consensus       240 ~~~~~~~~i~~~~~--------------~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f  296 (363)
T cd05628         240 TPQETYKKVMNWKE--------------TLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF  296 (363)
T ss_pred             CHHHHHHHHHcCcC--------------cccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCC
Confidence            65554444432111              111111 12478999999998765 444   46899999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-41  Score=338.97  Aligned_cols=267  Identities=24%  Similarity=0.310  Sum_probs=205.2

Q ss_pred             CCccccccccccCceEEEEEEE---CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhC---CCCccceeeeccc-----c
Q 008220           66 SSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHA-----K  132 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----~  132 (573)
                      ++|++.+.||+|+||.||+|++   .++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4799999999999999999986   357899997654322  1233456677777766   6999999999874     3


Q ss_pred             CCceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ...+++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456899999997 5888888653 34588999999999999999999999999999999999999999999999999865


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ....                 .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.........+.
T Consensus       160 ~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         160 YSFQ-----------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             ccCC-----------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            4321                 11234568999999999998889999999999999999999999999877666555554


Q ss_pred             hccccH--HHHHHHH------hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          292 EMNYTE--QQLTAAV------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       292 ~~~~~~--~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......  .......      ........+......+++.+.+|+.+||+.||++|||+.++++|+|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            322111  1110000      0000111112223467889999999999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-41  Score=344.51  Aligned_cols=244  Identities=25%  Similarity=0.360  Sum_probs=202.6

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||+||+|++  +++.||||++...   .......+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999987  5788999976432   223455677888888876 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....           
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-----------  148 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-----------  148 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----------
Confidence            99999887554 789999999999999999999999999999999999999999999999999754211           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....          
T Consensus       149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------  213 (320)
T cd05590         149 -----NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------  213 (320)
T ss_pred             -----CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------
Confidence                 01113345799999999999999999999999999999999999999987765544443332111          


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~  351 (573)
                               ..+..+++++.+||++||+.||.+||++      +++++|.|.
T Consensus       214 ---------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         214 ---------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence                     1234678999999999999999999998      778877765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.9e-41  Score=350.96  Aligned_cols=270  Identities=21%  Similarity=0.282  Sum_probs=208.9

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|++++.||+|+||+||+|++  +++.||||++...   .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            689999999999999999987  5788999986543   23345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+++|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            999999999987654 6889999999999999999999999999999999999999999999999997643211000000


Q ss_pred             c---------------ccCC----------------CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHH
Q 008220          222 N---------------WRSS----------------GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE  270 (573)
Q Consensus       222 ~---------------~~~~----------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  270 (573)
                      .               +...                ............+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence            0               0000                00000001234679999999999999889999999999999999


Q ss_pred             HHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhc--cCCCCCCCCHHHHHHH
Q 008220          271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW--DGNPHNRPSFSDIALE  348 (573)
Q Consensus       271 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rpt~~ell~~  348 (573)
                      |++|..||...........+.....              ...++ ....+++++.+||.+|+  ..+|..||++.++++|
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWEN--------------TLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHcccc--------------ccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999987655443333321110              01111 12357899999999955  5556669999999999


Q ss_pred             HHHH
Q 008220          349 LDLV  352 (573)
Q Consensus       349 l~~~  352 (573)
                      .|..
T Consensus       306 p~f~  309 (381)
T cd05626         306 PFFS  309 (381)
T ss_pred             cccC
Confidence            8763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-41  Score=343.83  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=205.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCC-ccceeeeccccCCceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHP-GLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~  140 (573)
                      +|++.+.||+|+||.||+|.+  +++.||||++...   .....+.+..|.+++..+.|+ +|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            488999999999999999987  4578999986432   233456778899999999765 6888999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------  153 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------  153 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC------
Confidence            9999999999886554 688999999999999999999999999999999999999999999999998753211      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....      
T Consensus       154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------  217 (324)
T cd05587         154 ----------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------  217 (324)
T ss_pred             ----------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------
Confidence                      0011234579999999999999999999999999999999999999998765544443332211      


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                                   ...+..+++++.+++++||..||.+|++.     .++++|+|.
T Consensus       218 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~  260 (324)
T cd05587         218 -------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF  260 (324)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence                         12345688999999999999999999987     677777654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=352.23  Aligned_cols=270  Identities=23%  Similarity=0.309  Sum_probs=208.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++++.||.|+||+||++.+  +++.||||++...   .......+.+|+++++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4799999999999999999986  6789999976432   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999999987554 789999999999999999999999999999999999999999999999999864321110000


Q ss_pred             -ccccCCCCCC------------------------------CCccccccccCcccCChhhhccCCCCchhhHHHHHHHHH
Q 008220          221 -KNWRSSGKPT------------------------------GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN  269 (573)
Q Consensus       221 -~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  269 (573)
                       ..........                              ........+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence             0000000000                              000011357999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHH
Q 008220          270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIA  346 (573)
Q Consensus       270 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell  346 (573)
                      ||++|..||...........+.....              ...++ ....++.++.+||.+||. +|.+|   +|+.+++
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRE--------------TLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCC--------------ccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            99999999987655444333332110              01111 112578999999999998 77775   5999999


Q ss_pred             HHHHHH
Q 008220          347 LELDLV  352 (573)
Q Consensus       347 ~~l~~~  352 (573)
                      .|+|..
T Consensus       304 ~hp~~~  309 (377)
T cd05629         304 SHPFFR  309 (377)
T ss_pred             cCCCcC
Confidence            998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.6e-42  Score=347.33  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=203.9

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||++.+  +++.||+|.+...   .......+..|+++++.++||||+++++++......|+||||+.+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999986  6789999986432   2234556778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      +|..++.... .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++......          
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~----------  149 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD----------  149 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC----------
Confidence            9998886554 68999999999999999999997 79999999999999999999999999998642210          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..             
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------  210 (325)
T cd05594         150 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------  210 (325)
T ss_pred             ------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-------------
Confidence                  0112345799999999999999999999999999999999999999987654433333221             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                       +..     ..+..+++++.+||++||+.||++|+     ++.++++|.|..
T Consensus       211 -~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         211 -EEI-----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             -CCC-----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence             111     12456899999999999999999997     999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-42  Score=358.74  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=213.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CC-eeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccc-c----
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DG-RKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHA-K----  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~-~----  132 (573)
                      ++|...+++|.+.|.+|||+.||+|.+ .+ ..||+|+....+....+.+.+|+++|++|+ |+|||.+++... .    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            567777899999999999999999997 33 899999988888888999999999999997 999999999322 1    


Q ss_pred             --CCceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCCCeEeeee
Q 008220          133 --PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       133 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                        .-+++|+||||.||.|.|++..+ ..+|++.++++|++|+++|+++||...  |||||||-+||||+.+|+.||||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence              13578999999999999999743 346999999999999999999999997  9999999999999999999999999


Q ss_pred             cchhhhhhh-hhhcccccCCCCCCCCccccccccCcccCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          208 LAEYRENLK-EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       208 ~a~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      .|.-.-... ......+        -...-...-|+.|+|||++   .+.++++|+|||+|||+||-||....||++...
T Consensus       192 Satt~~~~~~~~~e~~~--------ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNY--------VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             ccccccCCCccHHHHHH--------HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            985221100 0000000        0001123568999999986   578899999999999999999999999987532


Q ss_pred             HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .    .|+..++..                |. .+.++..+++||+.||+.||++||++.|++.++..+...
T Consensus       264 l----aIlng~Y~~----------------P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 L----AILNGNYSF----------------PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             e----eEEeccccC----------------CC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            2    222222221                11 246899999999999999999999999999999887754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-41  Score=343.07  Aligned_cols=244  Identities=23%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|++  +++.||+|++...   .....+.+..|.+++..+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999987  4678999986432   223455677889998876 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|...+.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......          
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~----------  149 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN----------  149 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC----------
Confidence            99998886554 7889999999999999999999999999999999999999999999999988643210          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....          
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~----------  213 (321)
T cd05591         150 ------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV----------  213 (321)
T ss_pred             ------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence                  0112345799999999999999999999999999999999999999987765554444332111          


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-------CHHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-------SFSDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~ell~~l~~  351 (573)
                               ..+..++.++.+||++||+.||++||       ++.++++|+|.
T Consensus       214 ---------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         214 ---------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             ---------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence                     12345789999999999999999999       89999998875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.7e-41  Score=339.07  Aligned_cols=271  Identities=21%  Similarity=0.263  Sum_probs=211.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.++||+|+||.||+|++  +++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            6899999999999999999987  577899998654332 2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......      
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------  158 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT------  158 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc------
Confidence            976 8888876666568899999999999999999999999999999999999999999999999986432110      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...........
T Consensus       159 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07872         159 ----------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET  228 (309)
T ss_pred             ----------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence                      01223467899999999865 4578999999999999999999999987766555444433221111100


Q ss_pred             HH----------HhcCCCCC-cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          302 AA----------VVSGGLRP-ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       302 ~~----------~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      +.          .......+ ........+++++.+||.+||+.||.+|||+.|+++|.|...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            00          00000000 000112357889999999999999999999999999998854

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=345.77  Aligned_cols=269  Identities=23%  Similarity=0.279  Sum_probs=217.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-C-----CccceeeeccccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-H-----PGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~~~~~  137 (573)
                      .+|.+++.||+|+||.|-+|.+  +++.||||+++.. .....+...|+.+|..|+ |     -|+|+++++|...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            4799999999999999999987  6889999986544 444566778999999996 4     38999999999999999


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC--CCeEeeeecchhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL--CPHLADFGLAEYREN  214 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~--~~kL~Dfg~a~~~~~  214 (573)
                      ||+|.+.. +|.+++.... ..++...++.++.||+.||.+||+.||||+||||+|||+...+  .|||+|||++.+...
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            99998855 9999997654 4689999999999999999999999999999999999996543  699999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                         ...+++.+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.+...++..+.+..
T Consensus       344 -------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  344 -------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL  404 (586)
T ss_pred             -------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence                               1236788999999999999999999999999999999999999999998888888776644


Q ss_pred             ccHHHHHHHHhc---------------------------------------CCCCC-ccccc----ccCChHHHHHHHHH
Q 008220          295 YTEQQLTAAVVS---------------------------------------GGLRP-ILASL----ELGLPASILSLIQR  330 (573)
Q Consensus       295 ~~~~~~~~~~~~---------------------------------------~~~~~-~~~~~----~~~~~~~l~~li~~  330 (573)
                      ..+.........                                       ....| .....    +..-...+.++|++
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            332221111100                                       00001 00000    11223568999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          331 CWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       331 ~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ||.+||.+|+|+.+.++|+|.....
T Consensus       485 ~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             HhccCchhcCCHHHHhcCccccccc
Confidence            9999999999999999999987544

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.6e-42  Score=346.86  Aligned_cols=255  Identities=25%  Similarity=0.351  Sum_probs=204.8

Q ss_pred             CccccccccccCceEEEEEEE-----CCeeEEEeeccCC----ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      +|++.+.||+|+||.||+++.     +++.||+|++...    .....+.+..|+.+++.+ +||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999875     4688999975422    223345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+.+|+|.+++.... .+++++++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999986554 68999999999999999999999999999999999999999999999999986542110


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     ........||+.|+|||++.+. .++.++|||||||++|||++|..||...........      
T Consensus       160 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------  218 (332)
T cd05614         160 ---------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE------  218 (332)
T ss_pred             ---------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH------
Confidence                           0112345799999999999875 478899999999999999999999965322111111      


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                          ....+..  ..+   ..+..+++.+.++|.+||+.||++||     ++.++++|.|..
T Consensus       219 ----~~~~~~~--~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         219 ----VSRRILK--CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             ----HHHHHhc--CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence                1111111  111   23446899999999999999999999     788999998763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.8e-41  Score=351.45  Aligned_cols=268  Identities=21%  Similarity=0.298  Sum_probs=209.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +|+++++||+|+||+||+|++  +++.||+|++....   ......+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            689999999999999999987  57889999864322   2345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+++|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||++..+.........
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999987654 6889999999999999999999999999999999999999999999999997543211000000


Q ss_pred             ---------------cccC----------------CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHH
Q 008220          222 ---------------NWRS----------------SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE  270 (573)
Q Consensus       222 ---------------~~~~----------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  270 (573)
                                     .+..                .............+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                           0000                000000011234579999999999999999999999999999999


Q ss_pred             HHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 008220          271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIAL  347 (573)
Q Consensus       271 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~  347 (573)
                      |++|..||...+.......+.....              ....+ ....+++++.++|.+|+ .+|.+|++   +.++++
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQT--------------SLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCC--------------CcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            9999999987655444333332111              11111 12357899999999987 49999997   999999


Q ss_pred             HHHH
Q 008220          348 ELDL  351 (573)
Q Consensus       348 ~l~~  351 (573)
                      |.|.
T Consensus       305 hp~f  308 (382)
T cd05625         305 HPFF  308 (382)
T ss_pred             CCCc
Confidence            8875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.3e-41  Score=348.38  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=211.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.+.||+|+||.||++++  +++.||+|++...   .......+..|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            345567899999999999999999987  5789999986432   22334557789999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .|+||||+++|+|.+++...  .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999999988643  5788999999999999999999999999999999999999999999999998654311


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .               ........||+.|+|||++.+.    .++.++|||||||++|||++|..||...........+.
T Consensus       196 ~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  260 (370)
T cd05596         196 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             C---------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            0               0112345799999999998653    47889999999999999999999998765544433333


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV  352 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~  352 (573)
                      ...              ....++ ....++.++.+||++||+.+|.+  |+|+.++++|+|..
T Consensus       261 ~~~--------------~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         261 DHK--------------NSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             cCC--------------CcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            211              111111 12257899999999999999988  99999999998763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.4e-41  Score=355.27  Aligned_cols=260  Identities=23%  Similarity=0.319  Sum_probs=212.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC--
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  134 (573)
                      .+...++|++.+.||+|+||+||+|.+  +++.||||.+...  .......+.+|+.++..++|+||+++++.+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            345568999999999999999999986  6889999986543  3445667889999999999999999988765332  


Q ss_pred             ------ceEEEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEee
Q 008220          135 ------NYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       135 ------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                            .+++||||+.+|+|.+++...   ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  368999999999999988642   24688999999999999999999999999999999999999999999999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA  285 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~  285 (573)
                      ||+++.......              ........||+.|+|||++.+..++.++|||||||++|||++|..||...+...
T Consensus       187 FGls~~~~~~~~--------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~  252 (496)
T PTZ00283        187 FGFSKMYAATVS--------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE  252 (496)
T ss_pred             cccCeecccccc--------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999875432110              011345679999999999999999999999999999999999999998765443


Q ss_pred             HHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ....+.              .+...    ..+..+++++.+|+.+||+.||.+||++.+++++++..
T Consensus       253 ~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~  301 (496)
T PTZ00283        253 VMHKTL--------------AGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK  301 (496)
T ss_pred             HHHHHh--------------cCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence            333222              22222    23457899999999999999999999999999987643

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=349.19  Aligned_cols=269  Identities=23%  Similarity=0.339  Sum_probs=213.9

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|++.  ++.||||++...   .......+..|++++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999874  889999986432   1234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999766 4789999999999999999999999999999999999999999999999999876543210000


Q ss_pred             ccc-------------cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          221 KNW-------------RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       221 ~~~-------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      ...             ................||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence            000             0000000111234567999999999999999999999999999999999999999877654444


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL  351 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~  351 (573)
                      ..+.....            .  ..++. ...+++++.+||.+||. ||.+||+ +.++++|+|.
T Consensus       240 ~~i~~~~~------------~--~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~  288 (350)
T cd05573         240 NKIINWKE------------S--LRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF  288 (350)
T ss_pred             HHHhccCC------------c--ccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence            44332110            0  01111 12379999999999998 9999999 9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.8e-42  Score=352.77  Aligned_cols=270  Identities=21%  Similarity=0.262  Sum_probs=210.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++++.||+|+||.||++++  +++.||||++....   ......+.+|+++|+.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3699999999999999999986  57899999864321   223456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh-
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS-  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-  219 (573)
                      ||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999997654 68899999999999999999999999999999999999999999999999975332100000 


Q ss_pred             -------------cccccCC-------------CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          220 -------------LKNWRSS-------------GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       220 -------------~~~~~~~-------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                                   .......             ............+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                         0000000             00000011234579999999999999999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP---SFSDIALELD  350 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~l~  350 (573)
                      |..||.+.........+.....              ...++ ....+++++.++|.+|+ .+|.+|+   |+.++++|.|
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWET--------------TLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCc--------------cccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            9999987765444333322110              00111 12357899999999987 4999999   9999999987


Q ss_pred             HH
Q 008220          351 LV  352 (573)
Q Consensus       351 ~~  352 (573)
                      ..
T Consensus       304 ~~  305 (376)
T cd05598         304 FK  305 (376)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.8e-42  Score=347.66  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=211.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||++.+  +++.||+|++...   ..+....+..|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999987  5789999986533   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........   
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence            99999999999987655789999999999999999999999999999999999999999999999999865432110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                  .......||+.|+|||++.      +..++.++|||||||++|+|++|..||...........+....
T Consensus       158 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~  225 (330)
T cd05601         158 ------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ  225 (330)
T ss_pred             ------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence                        0123347899999999986      4567889999999999999999999998765554444333211


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                    .....+ ....+++++.+||.+||+ +|.+|||+.++++|.|..
T Consensus       226 --------------~~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         226 --------------RFLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             --------------CccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence                          001111 123578999999999998 999999999999998764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.6e-41  Score=339.46  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=210.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      |+++.++|++.+.||+|+||.||+|...       ++.||+|++.... ......+..|+.+++++ +||||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            6788899999999999999999999642       3679999865432 33456788899999999 7999999999876


Q ss_pred             c-CCceEEEEEeccCCChhhhhhccC------------------------------------------------------
Q 008220          132 K-PPNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------  156 (573)
Q Consensus       132 ~-~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  156 (573)
                      . ...+++++||+++++|.+++....                                                      
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 457889999999999998875321                                                      


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCC
Q 008220          157 ------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT  230 (573)
Q Consensus       157 ------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~  230 (573)
                            ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.....             
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-------------  228 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------------  228 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-------------
Confidence                  2578889999999999999999999999999999999999999999999999875532110             


Q ss_pred             CCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCC
Q 008220          231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL  309 (573)
Q Consensus       231 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (573)
                       ........++..|+|||++.+..++.++|||||||++|||++ |..||.+..........+              ....
T Consensus       229 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------~~~~  293 (337)
T cd05054         229 -YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------KEGT  293 (337)
T ss_pred             -hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------hccC
Confidence             001223456778999999999999999999999999999998 999997643222111111              1111


Q ss_pred             CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          310 RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       310 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ++   ..+...++++.+++.+||+.+|++||++.||+++|..+++
T Consensus       294 ~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         294 RM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11   1234678899999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=344.52  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=220.7

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +-|.|+..||.|+||.||++...  +-..|-|++.....++.+.+.-|+++|..++||+||+|++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            46899999999999999999764  3445778888888889999999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .||....++-.-+..++++++..+++|++.||.|||+.+|||||||..|||++-+|.++|+|||.+........      
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q------  185 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ------  185 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh------
Confidence            99999999887788899999999999999999999999999999999999999999999999998753322111      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhh-----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEIL-----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                ..-++.|||+|||||+.     ...+|+.++||||||++|.||..+.+|-.+.++...+..+....    
T Consensus       186 ----------kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe----  251 (1187)
T KOG0579|consen  186 ----------KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----  251 (1187)
T ss_pred             ----------hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC----
Confidence                      24568999999999986     46789999999999999999999999998887766655543211    


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                 .|.+ ..|..++..+.+++++||..||+.||++.+|++|+|..
T Consensus       252 -----------PPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  252 -----------PPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             -----------CCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence                       2222 12557899999999999999999999999999999764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.5e-41  Score=339.93  Aligned_cols=244  Identities=25%  Similarity=0.377  Sum_probs=198.6

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|++  +++.||+|.+...   .....+.+..|..++..+ +||||+++++++......++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  4678999976432   122344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......         
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------  150 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------  150 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---------
Confidence            99999887554 78999999999999999999999999999999999999999999999999986432100         


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                             .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..             
T Consensus       151 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------  210 (316)
T cd05592         151 -------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------  210 (316)
T ss_pred             -------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------
Confidence                   112345799999999999999999999999999999999999999987655443333221             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~  351 (573)
                       .  .+   ..+..++.++.+||.+||+.||.+||++. ++++|.|.
T Consensus       211 -~--~~---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05592         211 -D--RP---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF  251 (316)
T ss_pred             -C--CC---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence             1  11   23456889999999999999999999875 67676654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.1e-41  Score=340.69  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +|++.+.||+|+||.||+|.+  +++.||+|.+...   .......+..|..++..+ +||+|+.+++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            488999999999999999987  4678999976532   122344567788888877 5899999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++|+|.+.+.... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....      
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------  153 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------  153 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC------
Confidence            9999999999886554 689999999999999999999999999999999999999999999999999863221      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                .........||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....     
T Consensus       154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-----  218 (323)
T cd05616         154 ----------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----  218 (323)
T ss_pred             ----------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence                      01123356799999999999999999999999999999999999999987665544444332111     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                                    ..+..+++++.+|+.+||+.||.+|++.     .++++|.+.
T Consensus       219 --------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~  260 (323)
T cd05616         219 --------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  260 (323)
T ss_pred             --------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence                          1244689999999999999999999985     677766543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=342.91  Aligned_cols=266  Identities=26%  Similarity=0.440  Sum_probs=224.6

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEEC---C--ee-EEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeee
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLD---G--RK-VAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVA  128 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  128 (573)
                      ..+|++..++..+.++||+|+||.||+|+..   +  .. ||+|....   ...+....+.+|+++|++++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3458888888889999999999999999752   1  23 89998664   34667889999999999999999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                      +......+++|||+|.||+|.++|.+.+..++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999999998877799999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  287 (573)
                      ++.-.....                ......-+..|+|||.+....++.++|||||||++||+++ |..||.+.......
T Consensus       309 s~~~~~~~~----------------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~  372 (474)
T KOG0194|consen  309 SRAGSQYVM----------------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK  372 (474)
T ss_pred             ccCCcceee----------------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH
Confidence            864321000                0112235788999999999999999999999999999999 89999988666554


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ..+.              ..+++...   +...|.++..++.+||..||++|||+.++.+.+..+....
T Consensus       373 ~kI~--------------~~~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  373 AKIV--------------KNGYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             HHHH--------------hcCccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            4443              23333322   3367899999999999999999999999999998887643

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-41  Score=340.18  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|++  +++.||+|.+....   ......+..|..++..+ +||||+++++++...+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999987  57889999764321   22345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....           
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-----------  148 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-----------  148 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-----------
Confidence            99999886544 689999999999999999999999999999999999999999999999998753211           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           .........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..             
T Consensus       149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------  210 (316)
T cd05620         149 -----GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------  210 (316)
T ss_pred             -----CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence                 00113456799999999999999999999999999999999999999987654433332211             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-~ell~~l~~  351 (573)
                       .  .   +..+..++.++.+||++||+.||++||++ +++++|.|.
T Consensus       211 -~--~---~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         211 -D--T---PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             -C--C---CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence             1  1   12234678999999999999999999998 477777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.7e-41  Score=343.90  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ..+.|+++++||+|+||.||+|++  +++.||||++.... ......+.+|+++++.++|+||+++++++.....+++||
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            346799999999999999999987  57899999865443 334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+..     ..++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.....   
T Consensus       152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---  223 (353)
T PLN00034        152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---  223 (353)
T ss_pred             ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc---
Confidence            999999986532     346778889999999999999999999999999999999999999999999875432100   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                   ......||..|+|||++..     ...+.++|||||||++|||++|+.||.........        
T Consensus       224 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--------  282 (353)
T PLN00034        224 -------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA--------  282 (353)
T ss_pred             -------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH--------
Confidence                         1234579999999998743     33456899999999999999999999743211110        


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                         .....+... .   .+..+..++.++.+||.+||+.||++|||+.|+++|.|....
T Consensus       283 ---~~~~~~~~~-~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        283 ---SLMCAICMS-Q---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---HHHHHHhcc-C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence               011111101 1   112344688999999999999999999999999999987654

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.9e-41  Score=339.29  Aligned_cols=244  Identities=25%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||+||+|.+  +++.||||.+...   .......+..|..+++.+ +||||+++++++.....+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  4678999976532   223456677899999888 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|.+++.... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....           
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----------  148 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-----------  148 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----------
Confidence            99998887554 789999999999999999999999999999999999999999999999998853211           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           ........+|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..             
T Consensus       149 -----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------  210 (318)
T cd05570         149 -----GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------  210 (318)
T ss_pred             -----CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------------
Confidence                 00112345789999999999999999999999999999999999999987654443333221             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                       ..  +   ..+..+++++.+||++||+.||.+|||+     .++++|.|.
T Consensus       211 -~~--~---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~  255 (318)
T cd05570         211 -DE--V---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF  255 (318)
T ss_pred             -CC--C---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence             11  1   1234688999999999999999999999     999988766

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.2e-41  Score=340.68  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||++++  +++.||+|++...   .......+..|..+++.+ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999987  5788999986532   233456688999999998 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....           
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-----------  148 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-----------  148 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-----------
Confidence            99998886554 789999999999999999999999999999999999999999999999999853211           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           .........||+.|+|||++.+..++.++|+|||||++|+|++|..||..........     ..........+.
T Consensus       149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-----~~~~~~~~~~~~  218 (329)
T cd05588         149 -----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-----QNTEDYLFQVIL  218 (329)
T ss_pred             -----CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-----ccchHHHHHHHH
Confidence                 0112334679999999999999999999999999999999999999996421110000     000011111111


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC------HHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS------FSDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~~l~~  351 (573)
                      .+..     ..|..++.++.++|++||+.||.+|||      +.++++|.|.
T Consensus       219 ~~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         219 EKQI-----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             cCCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence            1111     234568899999999999999999997      7899988876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.9e-41  Score=331.33  Aligned_cols=248  Identities=19%  Similarity=0.256  Sum_probs=200.2

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||+|+||+||++.+  +++.||+|++.....   ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999986  578999998643322   2345677899999999999999999999999999999999999999


Q ss_pred             hhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          149 AEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       149 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      .+.+..   ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......         
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---------  151 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---------  151 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence            887643   23468999999999999999999999999999999999999999999999999986543210         


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                             .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............          ....
T Consensus       152 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----------~~~~  214 (280)
T cd05608         152 -------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------QRIL  214 (280)
T ss_pred             -------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----------Hhhc
Confidence                   01234578999999999999999999999999999999999999997643221111111          0000


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                      .    . ....+..+++++.+++.+||+.||++||     +++++++|.|..
T Consensus       215 ~----~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~  261 (280)
T cd05608         215 N----D-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR  261 (280)
T ss_pred             c----c-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence            0    0 0123446899999999999999999999     889999998873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-41  Score=333.92  Aligned_cols=255  Identities=20%  Similarity=0.231  Sum_probs=208.0

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|++.+.||+|+||+||++.+  +++.||+|++.....   .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            488999999999999999987  578999998654322   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+.+|+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence            999999998876433 368999999999999999999999999999999999999999999999999986543100    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......|++.|+|||++.+..++.++||||+||++|++++|..||.+.........+..        
T Consensus       157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--------  215 (285)
T cd05605         157 -------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--------  215 (285)
T ss_pred             -------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------
Confidence                         11234689999999999988899999999999999999999999986543322211111        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~~  353 (573)
                        .+.     ......+..+++.+.+||.+||..||.+||     +++++++|.|...
T Consensus       216 --~~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         216 --RVK-----EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             --Hhh-----hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence              010     111123346889999999999999999999     8999999887753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-40  Score=329.63  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=209.5

Q ss_pred             cCCCCccccccccccCceEEEEEEECC-------eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +..++|++.+.||+|+||.||+|...+       ..|++|...... ......+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            344689999999999999999997632       569999865443 334567899999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC
Q 008220          135 NYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL  199 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~  199 (573)
                      ..+++|||+++++|.+++....               ..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            9999999999999999886431               3578889999999999999999999999999999999999999


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY  278 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf  278 (573)
                      .++|+|||++........              ........+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       162 ~~~L~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~  227 (283)
T cd05048         162 TVKISDFGLSRDIYSADY--------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY  227 (283)
T ss_pred             cEEECCCcceeecccccc--------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999864421100              001233456889999999988889999999999999999998 99999


Q ss_pred             CCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+.........+.              .+..    ...+..+|+++.+|+.+||+.||.+||++.+|+++|..
T Consensus       228 ~~~~~~~~~~~i~--------------~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         228 YGFSNQEVIEMIR--------------SRQL----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCHHHHHHHHH--------------cCCc----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            8765433322221              1111    12345789999999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-40  Score=341.52  Aligned_cols=268  Identities=24%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      .++|++.+.||+|+||.||++.+  ++..||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            47899999999999999999987  5789999986432  3344567789999999999999999999886543      


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+||||+.+ +|...+..   .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            47999999976 56555532   478899999999999999999999999999999999999999999999999864321


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       176 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~  238 (359)
T cd07876         176 -----------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL  238 (359)
T ss_pred             -----------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence                             011234578999999999999999999999999999999999999998776554443333221


Q ss_pred             ccHH-HHH-------HH-HhcCCCCC--------------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTEQ-QLT-------AA-VVSGGLRP--------------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~~-~~~-------~~-~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+. ...       .. .......+              .........++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence            1110 000       00 00000000              0001112346789999999999999999999999999987


Q ss_pred             HH
Q 008220          352 VL  353 (573)
Q Consensus       352 ~~  353 (573)
                      ..
T Consensus       319 ~~  320 (359)
T cd07876         319 TV  320 (359)
T ss_pred             hh
Confidence            53

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.9e-40  Score=324.48  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             CCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +.++|++.+.||+|+||.||++... +..+|+|...... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            3467999999999999999999874 4589999754332 2345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++|+|.+++......+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++.......     
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-----  155 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-----  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-----
Confidence            999999999876555689999999999999999999999999999999999999999999999998865431110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+.......+...        
T Consensus       156 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~--------  217 (256)
T cd05114         156 ----------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG--------  217 (256)
T ss_pred             ----------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------
Confidence                      01122345678999999998889999999999999999999 99999876544443333221        


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                             .++.   .+...+.++.+++.+||+.+|++||++.++++.|
T Consensus       218 -------~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 -------FRLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -------CCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                   1111   1234678899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.4e-41  Score=345.92  Aligned_cols=260  Identities=21%  Similarity=0.291  Sum_probs=209.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.+.||+|+||.||++++  +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            345567899999999999999999987  4788999975421   22334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999999998643  5788999999999999999999999999999999999999999999999998654311


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .               .....+..||+.|+|||++.+.    .++.++|||||||++|+|++|..||...........+.
T Consensus       196 ~---------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         196 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             C---------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            0               0112356799999999999764    37889999999999999999999998765544433332


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV  352 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~  352 (573)
                      ...              ....++. ...++..+.+++..||+.+|.+  |+|+.|+++|+|..
T Consensus       261 ~~~--------------~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         261 DHK--------------NSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             hCC--------------cccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            211              1111111 1257899999999999865544  89999999998863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-41  Score=343.73  Aligned_cols=245  Identities=27%  Similarity=0.409  Sum_probs=202.3

Q ss_pred             cccccccCceEEEEEEE-----CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           71 LSPIARGAESVVYEATL-----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++.||+|+||.||++++     .++.||+|++....  ......+..|++++++++||||+++++++..+..+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999874     46889999865332  223456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.......       
T Consensus        81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------  152 (318)
T cd05582          81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------  152 (318)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence            9999999986544 68999999999999999999999999999999999999999999999999986432110       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....        
T Consensus       153 ---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------  215 (318)
T cd05582         153 ---------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------  215 (318)
T ss_pred             ---------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--------
Confidence                     012345789999999999998899999999999999999999999987655444333322111        


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL  351 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~  351 (573)
                                 ..+..+++++.+||++||+.||++||+     +.+++.|.|.
T Consensus       216 -----------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         216 -----------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence                       134468899999999999999999999     5667766654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-40  Score=343.34  Aligned_cols=270  Identities=27%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-----ceE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM  137 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~  137 (573)
                      .|++.+.||+|+||.||++.+  +++.||||++...  .......+.+|+++++.++||||+++++++..+.     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999986  6889999986432  2334567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|+||+. ++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence            9999996 47877775443 78999999999999999999999999999999999999999999999999986543211 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    ........+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+......
T Consensus       158 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         158 --------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             --------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence                          0112334688999999999874 4789999999999999999999999887766555554432111


Q ss_pred             --HHHH-------HHHHhcCCCC-Cccc---ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 --EQQL-------TAAVVSGGLR-PILA---SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 --~~~~-------~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                        ...+       ...+...... +...   ......++++.+||.+||+.||++|||+.|+++|+|...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence              1111       1111111111 1111   122456889999999999999999999999999998643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.5e-40  Score=324.68  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=211.4

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +.|..++|++.++||+|+||.||+|.. .++.||+|..... ....+.+.+|+.+++.++||||+++++.+......+++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            356778999999999999999999986 5677999975443 23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      +||+.+++|.+++... ...+++.+++.++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            9999999999998653 34678899999999999999999999999999999999999999999999999875532110 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..     
T Consensus       159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-----  219 (261)
T cd05072         159 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-----  219 (261)
T ss_pred             --------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----
Confidence                          01122345778999999988889999999999999999998 9999987654433332211     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                ..+.   .....++.++.+++.+||..+|++||+++++++.|+.
T Consensus       220 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 ----------GYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----------CCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                      1111   1223578999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-41  Score=340.51  Aligned_cols=244  Identities=26%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHH-HHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||+||+|.+  +++.||+|++....   ......+..|.. +++.++||||+++++.+......++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999987  57899999864321   222334455554 56789999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......          
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~----------  149 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH----------  149 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC----------
Confidence            99999887544 7899999999999999999999999999999999999999999999999998532110          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....           
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  212 (323)
T cd05575         150 ------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-----------  212 (323)
T ss_pred             ------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence                  011234579999999999999999999999999999999999999998765544433332211           


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH----HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF----SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~~l~~  351 (573)
                              ...+..+++++.++|++||+.||.+||++    .++++|+|.
T Consensus       213 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~  254 (323)
T cd05575         213 --------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF  254 (323)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence                    11234679999999999999999999998    577777664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.9e-41  Score=336.53  Aligned_cols=244  Identities=24%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|++  +++.||||.+....   ......+..|..+++.+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  46789999764331   22344566788888764 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....           
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----------  148 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML-----------  148 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-----------
Confidence            99999987543 688999999999999999999999999999999999999999999999998853211           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           .........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+..             
T Consensus       149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------  210 (316)
T cd05619         149 -----GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------  210 (316)
T ss_pred             -----CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence                 00112345789999999999999999999999999999999999999987654433332211             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~  351 (573)
                       .  .+   ..+..++.++.+||.+||+.||.+||++. ++++|.|.
T Consensus       211 -~--~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05619         211 -D--NP---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF  251 (316)
T ss_pred             -C--CC---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence             1  11   12345789999999999999999999997 77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.8e-40  Score=326.95  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=213.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      |....|.+.+.||+|+||.||++..       ++..+|+|.+..........+.+|+.++++++||||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            3456899999999999999999974       235689998766666667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeE
Q 008220          136 YMFFFEFYESRNLAEKLHVEE------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      .++|+||+.+++|.+++....            ..+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999999986432            24789999999999999999999999999999999999999999999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR  282 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  282 (573)
                      +|||++........              ........+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       162 ~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         162 GDFGMSRDVYSTDY--------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             ccCCccccccCCce--------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999864432110              001123346788999999998889999999999999999998 999998765


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .......+..              +...    ..+..++.++.+|+.+||+.||.+|||+.++++.+..+..
T Consensus       228 ~~~~~~~i~~--------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         228 NNEVIECITQ--------------GRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHHHHHc--------------CCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            4433333221              1111    1234578899999999999999999999999998887764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=319.27  Aligned_cols=252  Identities=22%  Similarity=0.387  Sum_probs=218.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +-|.++++||+|+||.||++.+  +|..+|||++...  .+.+.+..|+.+|++++.|+||++|+.|.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            4589999999999999999976  6899999986544  46778899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      ..|++.++++.++.+++++++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..+.....      
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA------  184 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA------  184 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH------
Confidence            99999999998888999999999999999999999999999999999999999999999999999976654322      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                                ...+..|||.|||||++..-.|+.++||||||+...||..|++||.+..+...+..+-.           
T Consensus       185 ----------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-----------  243 (502)
T KOG0574|consen  185 ----------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-----------  243 (502)
T ss_pred             ----------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-----------
Confidence                      25678999999999999999999999999999999999999999988655433222210           


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                          ...|.+ ..|...+.++.+++++||-.+|++|.|+.++++|...
T Consensus       244 ----~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi  286 (502)
T KOG0574|consen  244 ----KPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI  286 (502)
T ss_pred             ----CCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence                111111 2245678999999999999999999999999998743

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.5e-41  Score=343.75  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=208.8

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.+.||+|+||.||++.+  +++.+|+|.+...   .......+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            455668999999999999999999987  5788999975422   22334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            99999999999999988643  5788999999999999999999999999999999999999999999999998654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccC----CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .               ........||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.......+.
T Consensus       196 ~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         196 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             C---------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            0               0112346799999999998754    37889999999999999999999998765544444333


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL  351 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~  351 (573)
                      ....              ...++ ....++.++.+||..||+.++.+  |+++.++++|+|.
T Consensus       261 ~~~~--------------~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         261 NHKN--------------SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             cCCC--------------cccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            2110              01111 12368999999999999844433  7899999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-40  Score=327.75  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=207.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +.++|++.+.||+|+||.||+|.+  +++.||+|+...........+.+|+.+++.++||||+++++++......++|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            346899999999999999999986  678899998765555556678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......     
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-----  160 (267)
T cd06646          87 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-----  160 (267)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-----
Confidence            999999999887554 68999999999999999999999999999999999999999999999999986543100     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                 .......|++.|+|||.+.   ...++.++|+||+||++|+|++|..||...........+..      
T Consensus       161 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------  223 (267)
T cd06646         161 -----------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------  223 (267)
T ss_pred             -----------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------
Confidence                       0123346889999999884   34577899999999999999999999965433222111110      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                              ....+........++..+.++|++||+.+|++|||+++++++|+
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         224 --------SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             --------CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                    11111111112357889999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-40  Score=342.85  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=211.7

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCccceeeecc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAH  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  130 (573)
                      .++++.++|++.++||.|+||.||+|.+.       +..||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            46777889999999999999999999762       2469999875433 334567899999999996 99999999999


Q ss_pred             ccCCceEEEEEeccCCChhhhhhccC------------------------------------------------------
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------  156 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  156 (573)
                      ......|+||||+++|+|.+++....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999998875421                                                      


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE
Q 008220          157 -----------------------------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL  195 (573)
Q Consensus       157 -----------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill  195 (573)
                                                               ..+++.++..++.|++.||+|||+.+|+||||||+|||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     136778889999999999999999999999999999999


Q ss_pred             cCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-C
Q 008220          196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G  274 (573)
Q Consensus       196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g  274 (573)
                      +.++.+||+|||+++.......              ........+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g  336 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSN--------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG  336 (400)
T ss_pred             eCCCEEEEEeCCcceecccccc--------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999999875432111              001223457788999999999899999999999999999997 9


Q ss_pred             CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..||.............              ....++   ..+..++.++.+++.+||+.||++|||+.+|.+.|..++
T Consensus       337 ~~P~~~~~~~~~~~~~~--------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         337 GTPYPGMIVDSTFYNKI--------------KSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CCCCcccchhHHHHHHH--------------hcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            99997653322221111              111121   123467899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-40  Score=340.50  Aligned_cols=267  Identities=22%  Similarity=0.299  Sum_probs=205.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++.+.||+|+||.||++.+  .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999986  5789999986543  334456778899999999999999999987643      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.+ +|.+.+..   .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            57999999976 66665542   478899999999999999999999999999999999999999999999999864431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......++...
T Consensus       172 ~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         172 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             c-----------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            0                 11234578999999999999999999999999999999999999998766544444333221


Q ss_pred             ccH-HHH-------HHHHhcC---------------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTE-QQL-------TAAVVSG---------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~-~~~-------~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ... .+.       .......               ...+.-...+...+.++.+||.+||+.||++|||+.|+++|+|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence            110 000       0000000               00000011122346788999999999999999999999999987


Q ss_pred             H
Q 008220          352 V  352 (573)
Q Consensus       352 ~  352 (573)
                      .
T Consensus       315 ~  315 (355)
T cd07874         315 N  315 (355)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-40  Score=323.44  Aligned_cols=252  Identities=24%  Similarity=0.391  Sum_probs=206.4

Q ss_pred             CCCCccccccccccCceEEEEEEECC-eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..++|++.+.||+|+||+||++...+ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            45689999999999999999998754 459999765433 2345688999999999999999999999998999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.++.......     
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-----  155 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-----  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-----
Confidence            999999999876555789999999999999999999999999999999999999999999999998865432100     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+..         
T Consensus       156 ----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------  216 (256)
T cd05113         156 ----------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ---------  216 (256)
T ss_pred             ----------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc---------
Confidence                      00112345678999999998889999999999999999999 9999986654433332221         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                           + .++   ..+...+..+.+++.+||+.||.+|||+.+|++.+
T Consensus       217 -----~-~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         217 -----G-LRL---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -----C-CCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                 1 111   12234688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=329.17  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=215.7

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +.++|++.+.||.|+||.||++.+  ++..+|+|..........+.+..|+++++.++||||+++++.+..+...++|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            346899999999999999999987  578999998777766777889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+++++|.+++...+..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......     
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----  157 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-----  157 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-----
Confidence            999999999987766678999999999999999999999999999999999999999999999999875432110     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                 .......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||...........+..    
T Consensus       158 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----  222 (280)
T cd06611         158 -----------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----  222 (280)
T ss_pred             -----------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc----
Confidence                       0123456899999999975     34567899999999999999999999987654333222211    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                 ...+.+ ..+..++.++.++|.+||+.+|.+||++.++++|.|...
T Consensus       223 -----------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         223 -----------SEPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             -----------CCCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence                       111111 123467899999999999999999999999999988653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6e-40  Score=322.34  Aligned_cols=257  Identities=27%  Similarity=0.442  Sum_probs=211.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++....|.+.+.||+|+||.||+|.+  .++.|++|..... ......+.+|+++++.++||||+++++++.....++++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            45667899999999999999999986  4788999986533 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            9999999999998653 34578899999999999999999999999999999999999999999999999865432110 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.      
T Consensus       160 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~------  219 (263)
T cd05052         160 --------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------  219 (263)
T ss_pred             --------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence                          00112234668999999999999999999999999999998 999998764433322221      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                               ...++   ..+..++.++.+++.+||+.||++|||+.++++.|..+
T Consensus       220 ---------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 ---------KGYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------CCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                     11111   22456889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-40  Score=323.82  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=213.0

Q ss_pred             CCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +..+|++.++||.|+||.||+|.+ .++.+++|.+..........+..|+.+++.++||||+++++++.....+++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            446799999999999999999987 4678999987766665677889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++++|.+++... +..+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+.......     
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-----  158 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-----  158 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-----
Confidence            9999999998753 3468999999999999999999999999999999999999999999999999986543210     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+.         
T Consensus       159 -----------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---------  218 (261)
T cd05148         159 -----------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---------  218 (261)
T ss_pred             -----------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---------
Confidence                       01123346778999999998889999999999999999998 899998765443333222         


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                            ...++   ..+..+++.+.++|.+||+.||.+|||+.+|++.|+.
T Consensus       219 ------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 ------AGYRM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ------hCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                  11111   1234678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-40  Score=336.81  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +|++.+.||+|+||.||+|.+  +++.||+|++...   .....+.+..|..+++.+. ||+|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478889999999999999987  5789999986532   2234456778899998885 578888999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------  153 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------  153 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC------
Confidence            9999999999886554 689999999999999999999999999999999999999999999999999864321      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                .+.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....     
T Consensus       154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-----  218 (323)
T cd05615         154 ----------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-----  218 (323)
T ss_pred             ----------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence                      01112345699999999999999999999999999999999999999987765444444332111     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~  350 (573)
                                    ..+..++.++.+++.+||+.+|.+|++.     .++++|.|
T Consensus       219 --------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05615         219 --------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF  259 (323)
T ss_pred             --------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence                          1234678999999999999999999985     55665544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=337.73  Aligned_cols=257  Identities=25%  Similarity=0.282  Sum_probs=206.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||++++  +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999987  5789999986431   2234556889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG----  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence            9999999999997655578999999999999999999999999999999999999999999999999986443110    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                 ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||...........+...  
T Consensus       157 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--  223 (331)
T cd05597         157 -----------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--  223 (331)
T ss_pred             -----------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--
Confidence                       001223469999999999863     45788999999999999999999999876544333333211  


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~  351 (573)
                                  .....++.....+++++.++|++||..++++  |+++.++++|.|.
T Consensus       224 ------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         224 ------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             ------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence                        1111122223357999999999988764443  7899999999886

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-40  Score=338.21  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=199.7

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||++++  +++.||+|++...   .......+..|+.++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999987  5678999986532   334456678899988777 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....          
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~----------  149 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----------  149 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC----------
Confidence            99998886544 7899999999999999999999999999999999999999999999999998642210          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||..........     ..........+.
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-----~~~~~~~~~~i~  218 (329)
T cd05618         150 ------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVIL  218 (329)
T ss_pred             ------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-----cccHHHHHHHHh
Confidence                  011234679999999999999999999999999999999999999995321110000     000011111111


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC------HHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS------FSDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~~l~~  351 (573)
                      ....     ..|..++..+.+||++||+.||++||+      +.++++|+|.
T Consensus       219 ~~~~-----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         219 EKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             cCCC-----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            1111     234578899999999999999999998      4788887765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-40  Score=325.53  Aligned_cols=257  Identities=23%  Similarity=0.412  Sum_probs=207.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ++..++|++.+.||+|+||.||+|.+.       +..||+|+.... .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456789999999999999999999753       357999986433 233455688999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEe
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                      ...++||||+++++|.+++....         ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999986432         134678889999999999999999999999999999999999999999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchh
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA  283 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~  283 (573)
                      |||+++........              .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus       162 dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~  227 (277)
T cd05062         162 DFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN  227 (277)
T ss_pred             CCCCccccCCccee--------------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99998654321110              00112345788999999998889999999999999999999 7899987654


Q ss_pred             HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......+..              ...    ...+..++..+.+++.+||+.||++|||+.|+++++.
T Consensus       228 ~~~~~~~~~--------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         228 EQVLRFVME--------------GGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            433322211              111    1223467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=336.79  Aligned_cols=268  Identities=29%  Similarity=0.456  Sum_probs=204.4

Q ss_pred             CCccccccccccCceEEEEEEECC-eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-ceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-NYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e~~  143 (573)
                      +.|.-...||+|+||.||+|...+ +.||||+...........|.+|+.++.+++|||+|+|+|+|.+.+ +.+||+||+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym  154 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM  154 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence            467777899999999999998754 899999765544331344999999999999999999999999988 599999999


Q ss_pred             cCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          144 ESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG---IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       144 ~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ++|+|.+.++.... .++|.++.+|+.+++.||+|||+..   ||||||||+|||+|.++++||+|||+|+..... .  
T Consensus       155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~--  231 (361)
T KOG1187|consen  155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-D--  231 (361)
T ss_pred             CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-c--
Confidence            99999999987766 8899999999999999999999864   999999999999999999999999999543310 0  


Q ss_pred             cccccCCCCCCCCcccccc-ccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNM-VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   ....+. .||..|+|||.+..+..+.++||||||++|.|++||+.|........... +..+.  ..
T Consensus       232 -------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~~w~--~~  295 (361)
T KOG1187|consen  232 -------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LVEWA--KP  295 (361)
T ss_pred             -------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HHHHH--HH
Confidence                         011122 79999999999998889999999999999999999998877543111100 11110  00


Q ss_pred             HHHHHHhcCCCCCcccc--ccc-CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILAS--LEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~--~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+......+-.+|.+..  .+. ..-..+..+..+|++.+|.+||++.|+++.|..+
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            00000111222333221  010 1123366899999999999999999998888443

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=342.41  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=211.8

Q ss_pred             cccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChhh
Q 008220           73 PIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE  150 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  150 (573)
                      .||+|.||+||.|++  +...+|||.+........+.++.|+.+.++|+|.|||++++.+..++.+-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999987  456789999888888889999999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-CCCCCeEeeeecchhhhhhhhhhcccccCCC
Q 008220          151 KLHVEEWSP--SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSG  227 (573)
Q Consensus       151 ~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~  227 (573)
                      +++..=+++  .+.++-.+.+||++||.|||+..|||||||-+||||+ ..|.+||+|||.++.+.....          
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP----------  731 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP----------  731 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc----------
Confidence            998654456  7889999999999999999999999999999999995 589999999999877654332          


Q ss_pred             CCCCCccccccccCcccCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          228 KPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       228 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ...++.||.-|||||++..+  .|+.++|||||||++.||.||++||.....+....-.+              
T Consensus       732 ------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--------------  791 (1226)
T KOG4279|consen  732 ------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--------------  791 (1226)
T ss_pred             ------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--------------
Confidence                  35678999999999999754  48899999999999999999999998764332211111              


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                        +.-...|.+|..++.+++.+|.+|+..||.+||++.+++..+...
T Consensus       792 --GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  792 --GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             --cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence              112233445668899999999999999999999999999877543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-40  Score=329.36  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=212.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .+.+.|+++++||.|+||.||+|++  +++.+++|............+.+|+.+++.++||||+++++.+.....+++||
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            3457899999999999999999987  47889999877777777788999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|..++......+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++......     
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-----  163 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-----  163 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence            999999998887665557899999999999999999999999999999999999999999999999987543210     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                 ........+++.|+|||++.     ...++.++|+|||||++|+|++|..||...........+..   
T Consensus       164 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---  229 (292)
T cd06644         164 -----------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---  229 (292)
T ss_pred             -----------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---
Confidence                       00123456888999999984     34567899999999999999999999977544332222211   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                  ...+.. ..+..++.++.++|++||+.||++||++.++++|.+.
T Consensus       230 ------------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         230 ------------SEPPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             ------------CCCccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                        111111 1234678899999999999999999999999988774

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=323.11  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=209.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-----hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +.|++.+.||+|++|.||++.+  +++.|++|.+....     ......+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999976  57899999764332     2234578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+||+++++|.+.+.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            999999999999887654 6888999999999999999999999999999999999999999999999998654321100


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   ........|+..|+|||++.+..++.++||||||+++|++++|..||.............       
T Consensus       161 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------  220 (263)
T cd06625         161 -------------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-------  220 (263)
T ss_pred             -------------cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-------
Confidence                         000123467889999999999889999999999999999999999997654333222211       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                             .....   ...+..++..+.++|.+||..+|.+|||+.++++++|
T Consensus       221 -------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         221 -------TQPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             -------ccCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence                   11111   2234568899999999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9e-41  Score=338.52  Aligned_cols=243  Identities=26%  Similarity=0.328  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHH-HHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKEL-QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||+||+|++  +++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999987  46789999864321   12223344444 456788999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......          
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~----------  149 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----------  149 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----------
Confidence            99999987654 6888999999999999999999999999999999999999999999999998643210          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....           
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----------  212 (325)
T cd05602         150 ------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----------  212 (325)
T ss_pred             ------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence                  011334579999999999999999999999999999999999999998765544433332211           


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELD  350 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~  350 (573)
                              ...+..+++.+.++|++||+.||.+||++.    ++++|++
T Consensus       213 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~  253 (325)
T cd05602         213 --------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF  253 (325)
T ss_pred             --------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence                    012346899999999999999999999887    4544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=321.34  Aligned_cols=257  Identities=27%  Similarity=0.452  Sum_probs=211.2

Q ss_pred             CCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..++|++.+.||+|+||.||+|...     ...||+|...... ......+.+|+.+++.++||||+++++.+......+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            3468999999999999999999863     3479999865443 334567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ++|||+++++|.+++......+++.+++.++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++........
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            99999999999999977665789999999999999999999999999999999999999999999999999876541110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    ........+++.|+|||.+.+..++.++||||||+++|++++ |..||...........+.     
T Consensus       162 --------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----  222 (266)
T cd05033         162 --------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-----  222 (266)
T ss_pred             --------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-----
Confidence                          001112345678999999998889999999999999999998 999997655443322221     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                               .+ ...   ..+..+++.+.+|+.+||+.+|++||++.+|+++|..+
T Consensus       223 ---------~~-~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 ---------DG-YRL---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------cC-CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     11 111   12346789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=338.09  Aligned_cols=267  Identities=25%  Similarity=0.324  Sum_probs=206.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++++.||.|+||+||+|.+  +++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            47899999999999999999986  56789999865432  22345677899999999999999999988543      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|++++++ +++|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            578899987 6789887753  3689999999999999999999999999999999999999999999999999864431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus       171 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         171 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             -------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence                               1234578999999999877 56889999999999999999999999876555444444322


Q ss_pred             ccc-HHHHHHHHhcCC-------C----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYT-EQQLTAAVVSGG-------L----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~-~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ... .......+....       .    ...+.......++.+.+||.+||+.||.+|||+.|+++|.|...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence            111 111111110000       0    00011112346778999999999999999999999999998854

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=322.62  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=212.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|++.+.||.|+||.||+|.+  +++.+++|..........+.+.+|+.+++.++||||+++++++.....++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            46899999999999999999986  5678999987766666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++......+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........     
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-----  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-----  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-----
Confidence            999999999877645789999999999999999999999999999999999999999999999999865442110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                 ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||...........+..       
T Consensus       157 -----------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-------  218 (262)
T cd06613         157 -----------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-------  218 (262)
T ss_pred             -----------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence                       12345688899999999776   788999999999999999999999987654333222211       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                             ..+.+.....+..++.++.++|++||..+|.+|||+.+|+.|.
T Consensus       219 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         219 -------SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             -------ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence                   1111111112235678899999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.5e-41  Score=338.69  Aligned_cols=244  Identities=26%  Similarity=0.349  Sum_probs=197.9

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHH-HHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|.+  +++.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987  5789999986432   1223344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|..++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......          
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~----------  149 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----------  149 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC----------
Confidence            99998886544 7899999999999999999999999999999999999999999999999998532110          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....          
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~----------  213 (325)
T cd05604         150 ------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL----------  213 (325)
T ss_pred             ------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc----------
Confidence                  0112345799999999999999999999999999999999999999987655444333322110          


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~~  351 (573)
                               ..++..+..+.++|++||+.+|.+||++.    ++++|.|.
T Consensus       214 ---------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f  254 (325)
T cd05604         214 ---------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF  254 (325)
T ss_pred             ---------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence                     12335789999999999999999999875    67776654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-40  Score=330.75  Aligned_cols=270  Identities=23%  Similarity=0.277  Sum_probs=210.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||.|+||.||+|.+  +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            5899999999999999999987  57889999865432 22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++......+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++.......      
T Consensus        86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------  158 (301)
T cd07873          86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------  158 (301)
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC------
Confidence            974 8888887665578899999999999999999999999999999999999999999999999986432100      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH-HH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ-QL  300 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-~~  300 (573)
                                .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+........ ..
T Consensus       159 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  228 (301)
T cd07873         159 ----------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET  228 (301)
T ss_pred             ----------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence                      01223457889999999875 4578899999999999999999999987765554443332211110 00


Q ss_pred             HHHHhc-CCC---------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          301 TAAVVS-GGL---------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~-~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...... ...         ...+......+++.+.+||.+||+.||.+|||+.|+++|.|+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            000000 000         0111122346788999999999999999999999999999884

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-40  Score=342.86  Aligned_cols=269  Identities=23%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +.|++.+.||+|+||.||++.+  +++.||+|++...   .......+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3689999999999999999987  5789999986432   2334567888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||++||+|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            9999999999987654 689999999999999999999999999999999999999999999999999875432110000


Q ss_pred             c--------------cccCCC-----CCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008220          221 K--------------NWRSSG-----KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL  281 (573)
Q Consensus       221 ~--------------~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  281 (573)
                      .              ......     ...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence            0              000000     000000112457999999999999999999999999999999999999999877


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDL  351 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~  351 (573)
                      ........+....              ....++. ...+++++.+||.+|+. ||.+|++   +.++++|+|.
T Consensus       240 ~~~~~~~~i~~~~--------------~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f  296 (360)
T cd05627         240 TPQETYRKVMNWK--------------ETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF  296 (360)
T ss_pred             CHHHHHHHHHcCC--------------CceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCC
Confidence            6554444433211              0111111 12478999999999875 9999984   7899888864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-40  Score=338.66  Aligned_cols=267  Identities=22%  Similarity=0.298  Sum_probs=206.7

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++.+.||+|+||.||++.+  .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            47899999999999999999987  5788999986542  234456778999999999999999999987543      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+||||+.+ +|.+.+..   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            57999999976 67666642   478889999999999999999999999999999999999999999999999865431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......++...
T Consensus       179 ~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  241 (364)
T cd07875         179 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  241 (364)
T ss_pred             C-----------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            0                 11234578999999999999999999999999999999999999998876665555544321


Q ss_pred             ccH-HHHHH-------HHhcCC---------------CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTE-QQLTA-------AVVSGG---------------LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~-~~~~~-------~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+ .....       ......               ..+.........+..+.+||.+||+.||.+|||+.|+++|+|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            111 00000       000000               0000011112245688999999999999999999999999987


Q ss_pred             H
Q 008220          352 V  352 (573)
Q Consensus       352 ~  352 (573)
                      .
T Consensus       322 ~  322 (364)
T cd07875         322 N  322 (364)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-40  Score=325.58  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=208.9

Q ss_pred             CCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ...+|.+.+.||+|+||.||+|...       +..||+|........ ..+.+.+|+++++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4568999999999999999999752       367999986554433 45789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          136 YMFFFEFYESRNLAEKLHVEE-------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      .++||||+++++|.+++...+             ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.+|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            999999999999999986432             2467889999999999999999999999999999999999999999


Q ss_pred             EeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008220          203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL  281 (573)
Q Consensus       203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~  281 (573)
                      |+|||++.........              .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       163 l~d~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         163 IGDFGMSRDVYTTDYY--------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             ECCcccceecccCcce--------------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            9999998643211100              01123346788999999999999999999999999999998 99999776


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ........+.              .+..    ...+..++..+.+++.+||+.||++|||+.|+++.|.
T Consensus       229 ~~~~~~~~~~--------------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         229 SNEEVIECIT--------------QGRL----LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CHHHHHHHHH--------------cCCc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            5444333222              1111    1223468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-40  Score=336.80  Aligned_cols=244  Identities=27%  Similarity=0.341  Sum_probs=196.2

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHH-HHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|++  +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987  57889999864321   222334555554 67889999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|...+.... .+++.++..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......          
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----------  149 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP----------  149 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----------
Confidence            99988886543 6889999999999999999999999999999999999999999999999998642110          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            ........||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..             
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------  210 (321)
T cd05603         150 ------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------  210 (321)
T ss_pred             ------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-------------
Confidence                  0112345789999999999998999999999999999999999999987654433333221             


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~~  351 (573)
                       ..     ...+...+.++.++|.+||+.||.+||++.    ++++|+|.
T Consensus       211 -~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         211 -KP-----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             -CC-----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence             10     123446788999999999999999999764    66666554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-40  Score=324.82  Aligned_cols=257  Identities=24%  Similarity=0.365  Sum_probs=208.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .+.++|++.+.||+|+||.||+|.+  +++.||+|............+.+|+.+++.++||||+++++.+......++|+
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            3446899999999999999999987  57899999876665555667889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++++|.+++...+ .+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......    
T Consensus        86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----  160 (267)
T cd06645          86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI----  160 (267)
T ss_pred             eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----
Confidence            9999999999987554 78999999999999999999999999999999999999999999999999986443100    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                  .......|++.|+|||++.   ...++.++|+|||||++|+|++|..||..............     
T Consensus       161 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-----  223 (267)
T cd06645         161 ------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----  223 (267)
T ss_pred             ------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----
Confidence                        0123456899999999974   45678899999999999999999999975443222111111     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                               ....+........++..+.++|.+||+.+|++|||+.+|++|.|
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         224 ---------SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ---------cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                     11111111112246788999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.1e-39  Score=325.41  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             cCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +...+|.+.+.||+|+||.||+|..       .+..+++|............+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            3456799999999999999999974       235688998766666666789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC
Q 008220          136 YMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC  200 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~  200 (573)
                      .++||||+++++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999986432               24788999999999999999999999999999999999999999


Q ss_pred             CeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008220          201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT  279 (573)
Q Consensus       201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~  279 (573)
                      ++|+|||++........              ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       162 ~~l~dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY--------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             EEECCCCcccccCCCce--------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999864432110              001223456789999999999999999999999999999999 999997


Q ss_pred             CchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..........+.              .+. .   ...+..+|..+.+++.+||+.||++|||+.++++.+..+.+
T Consensus       228 ~~~~~~~~~~~~--------------~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         228 QLSNTEVIECIT--------------QGR-V---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCHHHHHHHHh--------------CCC-C---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            765443322221              111 1   11234578899999999999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-40  Score=330.36  Aligned_cols=264  Identities=25%  Similarity=0.349  Sum_probs=208.2

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccC--CChHHHHHHHHHHHHHHhCC-CCccceeeeccccCC
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPIL--STSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP  134 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (573)
                      .-+.+.+..|+++++||.||.+.||++.. +.+.||+|++..  ......+.+.+|+.+|.+|+ |.+|++|+++-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            34667788999999999999999999987 456788886433  34556788999999999995 999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+|+|||+- ..+|..+|......++.-.++.+..|++.|+.++|++||||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence            999999965 459999998776555555899999999999999999999999999999998 457899999999976653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-----------HSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                                    ........+.+||+.||+||.+....           .++++||||||||||+|+.|++||.....
T Consensus       512 --------------DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n  577 (677)
T KOG0596|consen  512 --------------DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN  577 (677)
T ss_pred             --------------cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence                          22334456779999999999985322           46799999999999999999999987643


Q ss_pred             HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .......+..             -...-.++..+  -..++.++++.||.+||++|||+.+||+|+....
T Consensus       578 ~~aKl~aI~~-------------P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  578 QIAKLHAITD-------------PNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHHHHhhcC-------------CCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            3222211110             00001111111  1234999999999999999999999999886544

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.6e-40  Score=326.01  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +-|++.+.||.|+||.||++.+  ++..+++|............+.+|+++++.++||||+++++.+......++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            3478999999999999999987  46788999876666666778899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+++|..++......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......       
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-------  157 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-------  157 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-------
Confidence            9999998887655578999999999999999999999999999999999999999999999999986432110       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                               .......+++.|+|||++.     +..++.++|+||+||++|+|++|..||...........+...     
T Consensus       158 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-----  223 (282)
T cd06643         158 ---------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----  223 (282)
T ss_pred             ---------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-----
Confidence                     0123346889999999984     455778999999999999999999999876543332222211     


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                ..+.+ ..+..++.++.+||.+||+.||.+||++.++++|.|...
T Consensus       224 ----------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         224 ----------EPPTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             ----------CCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence                      11111 123467899999999999999999999999999887654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.4e-40  Score=324.57  Aligned_cols=256  Identities=22%  Similarity=0.358  Sum_probs=207.8

Q ss_pred             cCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +...+|++.+.||.|+||.||+|.+.       +..||+|+...... ...+.+..|+.++..++||||+++++++....
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            34467999999999999999999763       36799998765433 33567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC
Q 008220          135 NYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL  199 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~  199 (573)
                      ..++++||+.+++|.+++...               ...+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            999999999999999987522               12467888999999999999999999999999999999999999


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY  278 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf  278 (573)
                      .+||+|||+++........              .......+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  227 (283)
T cd05091         162 NVKISDLGLFREVYAADYY--------------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY  227 (283)
T ss_pred             ceEecccccccccccchhe--------------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence            9999999998654321110              01123346788999999988889999999999999999998 88899


Q ss_pred             CCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .+.........+..              ....    ..+..++..+.+|+.+||+.+|++||++.+|+..|.
T Consensus       228 ~~~~~~~~~~~i~~--------------~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         228 CGYSNQDVIEMIRN--------------RQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             CCCCHHHHHHHHHc--------------CCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            87654433333222              1111    234578999999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-39  Score=328.36  Aligned_cols=259  Identities=23%  Similarity=0.397  Sum_probs=208.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCe----eEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +...+|++.+.||+|+||.||+|.+  +++    .||+|...... ....+.+..|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            4457899999999999999999975  333    48999865433 34556788999999999999999999998764 5


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++++||+.+|+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            77999999999999999876657889999999999999999999999999999999999999999999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..              ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....... .+..  
T Consensus       163 ~~--------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~--  225 (316)
T cd05108         163 EK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE--  225 (316)
T ss_pred             Cc--------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHh--
Confidence            11              001122234678999999999999999999999999999998 99999875433221 1111  


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  ....+   ..+..++.++.+++.+||..+|.+||++.+++.++..+..
T Consensus       226 ------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         226 ------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                        11111   1134578899999999999999999999999998877754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-40  Score=329.03  Aligned_cols=266  Identities=26%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhC---CCCccceeeecccc-----CC
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHAK-----PP  134 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~  134 (573)
                      +|++.+.||+|+||+||+|.+  +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            589999999999999999987  578899997654321  1223455677777665   79999999998764     34


Q ss_pred             ceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ..++++|++.+ +|.+++.... ..+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            58999999975 8888876533 358999999999999999999999999999999999999999999999999986543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...
T Consensus       160 ~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         160 CQM-----------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             Ccc-----------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            110                 122346899999999999888999999999999999999999999876555444444322


Q ss_pred             ccc--HHHHHHHH--hcCCC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          294 NYT--EQQLTAAV--VSGGL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       294 ~~~--~~~~~~~~--~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...  ........  ....+    ...+....+.++..+.+||.+||+.||++|||+.|++.|+|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            110  00000000  00000    01111223467889999999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=319.40  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             CCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ...+|++.+.||+|+||.||++.+. +..+|+|...... ...+.+.+|+++++.++||||+++++++......++||||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            3467999999999999999999874 4579999854332 2235678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|.+++......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.......     
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-----  155 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-----  155 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-----
Confidence            999999999876555789999999999999999999999999999999999999999999999999865431100     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+.          
T Consensus       156 ----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----------  215 (256)
T cd05059         156 ----------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS----------  215 (256)
T ss_pred             ----------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH----------
Confidence                      00111234567999999998899999999999999999999 899998665443322221          


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                           ...++   ..+..++.++.+++.+||..+|++|||+.++++.+
T Consensus       216 -----~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         216 -----AGYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----cCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 11111   12345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-40  Score=335.78  Aligned_cols=257  Identities=24%  Similarity=0.284  Sum_probs=207.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.++||+|+||.||++.+  .++.+|+|.+...   .......+..|+.++..++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4799999999999999999987  4678999975421   2223445788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+|+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......    
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~----  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG----  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence            9999999999998755578999999999999999999999999999999999999999999999999986432100    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                 ........||+.|+|||++.     ...++.++|||||||++|||++|..||...........+..   
T Consensus       157 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---  222 (332)
T cd05623         157 -----------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---  222 (332)
T ss_pred             -----------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC---
Confidence                       01123357999999999986     34578899999999999999999999987655444433322   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~  351 (573)
                                 ...+..++.....+++++.+||++||..+|.+  |+++.++++|.|.
T Consensus       223 -----------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f  269 (332)
T cd05623         223 -----------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF  269 (332)
T ss_pred             -----------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence                       11122222333468999999999999765544  6899999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.4e-40  Score=327.39  Aligned_cols=255  Identities=24%  Similarity=0.393  Sum_probs=212.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..+|++.+.||+|+||.||++.+  +++.|++|.+..........+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            36899999999999999999986  5789999987666555667788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|.+++...  .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........     
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-----  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-----
Confidence            9999999988543  578899999999999999999999999999999999999999999999998865432110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..............          
T Consensus       172 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~----------  230 (296)
T cd06654         172 -----------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----------  230 (296)
T ss_pred             -----------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc----------
Confidence                       12334688999999999988889999999999999999999999976543222111110          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                          .. .+.+ ..+..+++.+.++|.+||..||++|||+.+++++.|...
T Consensus       231 ----~~-~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         231 ----NG-TPEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             ----CC-CCCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence                11 1111 123467889999999999999999999999999888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=311.52  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=216.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +-.+.|.++++||+|.||.|-+++.  +++.+|+|+++..   ..++...-..|-++|+..+||.+..|-..|+..+++|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            4456899999999999999999975  6899999975432   3345566678999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||..||.|.-.+.+.. .++++..+.+-.+|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++.--    
T Consensus       245 FVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I----  319 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI----  319 (516)
T ss_pred             EEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc----
Confidence            9999999999998887655 79999999999999999999999999999999999999999999999999996321    


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                  ..+....+.||||.|+|||++....|+.++|.|.+||++|||++|+.||...+.......|+-...  
T Consensus       320 ------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--  385 (516)
T KOG0690|consen  320 ------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--  385 (516)
T ss_pred             ------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--
Confidence                        223346789999999999999999999999999999999999999999998877666655543222  


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                                       ..|..++++.+.|+..+|..||.+|.     .+.||.+|-.+
T Consensus       386 -----------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF  427 (516)
T KOG0690|consen  386 -----------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF  427 (516)
T ss_pred             -----------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence                             13568999999999999999999996     46666665533

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=356.40  Aligned_cols=263  Identities=30%  Similarity=0.474  Sum_probs=220.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC---C----eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD---G----RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      .++.+..++.+.||+|.||.||.|...   +    -.||||.+... +..+...|.+|..+|+.++|||||++++++.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            356678899999999999999999762   3    24888875443 456778999999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          134 PNYMFFFEFYESRNLAEKLHVE------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                      ...++++|||+||+|..+|+..      ...++..+.+.++.||+.|+.||+++++|||||..+|+|++....|||+|||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999999876      5578899999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ  286 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  286 (573)
                      +|+-+...+...     ..         ....-+..|||||.+....++.++|||||||+|||++| |..||.+.++...
T Consensus       848 lArDiy~~~yyr-----~~---------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v  913 (1025)
T KOG1095|consen  848 LARDIYDKDYYR-----KH---------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV  913 (1025)
T ss_pred             hhHhhhhchhee-----cc---------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence            998444322211     00         11234578999999999999999999999999999999 9999998765554


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ....              ..++..    ..|..+|..+.++|..||+.+|++||++..|++.+..+....
T Consensus       914 ~~~~--------------~~ggRL----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  914 LLDV--------------LEGGRL----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHHH--------------HhCCcc----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            4333              333311    135689999999999999999999999999999888777653

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-40  Score=335.79  Aligned_cols=257  Identities=24%  Similarity=0.271  Sum_probs=207.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||++++  +++.||+|.+...   .......+..|..++..++||||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999987  5678999976432   2233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.||+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........   
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT---  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence            99999999999987555789999999999999999999999999999999999999999999999999865432110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                  .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||...........+..   
T Consensus       158 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---  222 (331)
T cd05624         158 ------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---  222 (331)
T ss_pred             ------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc---
Confidence                        11233579999999999875     4578899999999999999999999987654433333221   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~  351 (573)
                                 ...+..++.....++.++.++|.+||..++++  |++++++++|.|.
T Consensus       223 -----------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         223 -----------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             -----------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence                       11122222223457899999999999876554  4689999998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.8e-40  Score=323.66  Aligned_cols=242  Identities=23%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||+|+||.||++..  +++.||+|.+....   ......+..|+++++.++||||+++++++..+..+++||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999986  58899999864321   11233456799999999999999999999999999999999999999


Q ss_pred             hhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCC
Q 008220          149 AEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG  227 (573)
Q Consensus       149 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~  227 (573)
                      .+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......            
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------  148 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------  148 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence            88875433 35788999999999999999999999999999999999999999999999998654321            


Q ss_pred             CCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcC
Q 008220          228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG  307 (573)
Q Consensus       228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (573)
                           .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+          .......
T Consensus       149 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~----------~~~~~~~  213 (277)
T cd05607         149 -----KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL----------KRRTLED  213 (277)
T ss_pred             -----ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH----------HHHhhcc
Confidence                 0122346899999999999888999999999999999999999999764322111111          1111111


Q ss_pred             CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 008220          308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA  346 (573)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell  346 (573)
                      .    +......+++++.+||.+||+.||++||++.|++
T Consensus       214 ~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         214 E----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             c----cccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence            1    1111236789999999999999999999995543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-39  Score=318.70  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=209.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .|.+.+.||+|++|.||++.+  +++.|++|.+...  .......+.+|+++++.++||||+++++++......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478899999999999999987  5789999976533  345567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......     
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-----  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-----  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-----
Confidence            9999999998764 4568899999999999999999999999999999999999999999999999986543211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                 .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..         
T Consensus       156 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------  215 (256)
T cd08529         156 -----------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---------  215 (256)
T ss_pred             -----------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------
Confidence                       012334688999999999998899999999999999999999999987654333332221         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                           +. .+   ..+..++.++.++|.+||+.+|++||++.+++++.|
T Consensus       216 -----~~-~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         216 -----GV-FP---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             -----CC-CC---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence                 11 11   123367899999999999999999999999998754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=319.72  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=209.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +++.++|++.+.||+|+||.||+|.+ .++.||+|...... ...+.+.+|+.++++++||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            56778999999999999999999986 45789999865433 23456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  158 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--  158 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc--
Confidence            9999999999986543 4689999999999999999999999999999999999999999999999999876542100  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+..      
T Consensus       159 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------  219 (261)
T cd05068         159 -------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------  219 (261)
T ss_pred             -------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------
Confidence                         00111223467999999999899999999999999999999 9999987654433322211      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                               ....   ..+..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       220 ---------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         220 ---------GYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---------CCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                     1111   1234678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-39  Score=322.53  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             CCCCccccccccccCceEEEEEEE------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .-+.|++.+.||+|+||+||+|..      .+..+++|..... .......+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            346899999999999999999974      3578999986533 334456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC
Q 008220          137 MFFFEFYESRNLAEKLHVEE----------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC  200 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~  200 (573)
                      |+||||+.+++|.+++....                ..+++.++..++.|++.||+|||++|++||||||+|||++.++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence            99999999999999885321                24678889999999999999999999999999999999999999


Q ss_pred             CeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008220          201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT  279 (573)
Q Consensus       201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~  279 (573)
                      +||+|||+++.......              ........++..|+|||.+.+..++.++|+|||||++|||++ |..||.
T Consensus       163 ~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         163 VKISDLGLSREIYSADY--------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             EEeccccccccccCCcc--------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            99999999875432110              001233446778999999988889999999999999999998 999997


Q ss_pred             CchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      +.........+..              ....    ..+..+++.+.+++.+||+.||.+||++.+|++++.
T Consensus       229 ~~~~~~~~~~~~~--------------~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         229 GFSNQEVIEMVRK--------------RQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             CCCHHHHHHHHHc--------------CCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            6544333222211              1111    134568899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=316.99  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=210.4

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +..++|++.+.||.|+||.||+|...++.||+|....... ..+.+.+|+.+++.++|+||+++++++......++||||
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            4567899999999999999999999999999998765544 567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+......      
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~------  155 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG------  155 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc------
Confidence            99999999987544 25899999999999999999999999999999999999999999999999998654210      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   .....++..|+|||.+....++.++|+||||+++|++++ |..||...........+.         
T Consensus       156 -------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---------  213 (256)
T cd05039         156 -------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE---------  213 (256)
T ss_pred             -------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---------
Confidence                         112234567999999988888999999999999999997 999997654333222211         


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                            ...++   ..+..+++++.++|.+||..+|++|||+.++++.|.
T Consensus       214 ------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         214 ------KGYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             ------cCCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence                  11111   223467899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-39  Score=321.86  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             cCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      |..++|.+.++||+|+||.||++..       ++..+++|............+.+|+++++.++||||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            4456899999999999999999963       356789998766666667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCC
Q 008220          136 YMFFFEFYESRNLAEKLHVEE--------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      .+++|||+.+++|.+++....              ..+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            999999999999999986532              247889999999999999999999999999999999999999999


Q ss_pred             eEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008220          202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD  280 (573)
Q Consensus       202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~  280 (573)
                      ||+|||++........              ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..
T Consensus       162 kL~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         162 KIGDFGMSRDIYSTDY--------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             EECCCCceeEcCCCce--------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999864421100              001123345788999999999999999999999999999998 9999976


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .........+..              +. .+   ..+..+++.+.+||.+||+.||.+||++.+|++.|.
T Consensus       228 ~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         228 LSNTEAIECITQ--------------GR-EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CCHHHHHHHHHc--------------Cc-cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            554433222211              11 11   123467899999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=335.70  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=216.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +.|.-++.||.|+||.||.+++  +.+.||||+...+   ..+.++.+..|+..|++++|||++.+-++|......|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4688899999999999999987  5788999987655   3456788999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |||-| +-.|++.....++.+.++..|+.+.+.||+|||+++.||||||.-|||++..|.|||+|||.|....       
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-------  177 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-------  177 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence            99976 7788887777789999999999999999999999999999999999999999999999999987654       


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                   +..+++|||.|||||++.   .+.|+-++||||||++..||.-.++|+-..+.....+-|-..    
T Consensus       178 -------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----  240 (948)
T KOG0577|consen  178 -------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----  240 (948)
T ss_pred             -------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----
Confidence                         357789999999999986   367899999999999999999999998777766655555332    


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 -.|.++  ....+..+.+|+..||+.-|.+|||.++++.|..-
T Consensus       241 -----------esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv  281 (948)
T KOG0577|consen  241 -----------ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV  281 (948)
T ss_pred             -----------CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence                       123333  24689999999999999999999999999987643

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-40  Score=322.69  Aligned_cols=249  Identities=36%  Similarity=0.541  Sum_probs=201.0

Q ss_pred             cccccccccCceEEEEEEEC------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           69 TLLSPIARGAESVVYEATLD------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .+.+.||.|.||.||+|.+.      +..|+||.+... ..+..+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35788999999999999876      678999987544 33457889999999999999999999999998888999999


Q ss_pred             eccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+++|+|.+++... ...+++.++..++.||+.||.|||+.+++|+||+++||+++.++.+||+|||++........   
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~---  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK---  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence            99999999999876 55789999999999999999999999999999999999999999999999999865521110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                 ........+...|+|||.+.+..++.++||||||+++||+++ |..||.+.+.......+....     
T Consensus       159 -----------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-----  222 (259)
T PF07714_consen  159 -----------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-----  222 (259)
T ss_dssp             -----------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-----
T ss_pred             -----------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence                       011233457788999999998889999999999999999999 789998775555444432211     


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                +   ...+..++..+.++|.+||..||++|||+.+|++.|
T Consensus       223 ----------~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 ----------R---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----------E---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----------c---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                      1   112456899999999999999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-39  Score=326.10  Aligned_cols=263  Identities=26%  Similarity=0.408  Sum_probs=212.6

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ++++.++|.+.+.||+|+||.||++.+.         ...+|+|..... .......+..|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            5666789999999999999999999752         246999986543 234456788899999999 79999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +......++||||+.+++|.+++....               ..+++.+++.++.|++.||+|||+.|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999986532               24788899999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||++..........              ......+++.|+|||++.+..++.++|+|||||++|+|++ 
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~  238 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYK--------------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL  238 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhh--------------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence            9999999999999986543211100              0112234578999999998889999999999999999998 


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |..||...........+.               ....+   ..+..++.++.+|+.+||..+|++|||+.+++++|..++
T Consensus       239 g~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         239 GGSPYPGVPVEELFKLLK---------------EGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             CCCCCCcCCHHHHHHHHH---------------cCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            899997654332222211               11111   223467899999999999999999999999999999988


Q ss_pred             HH
Q 008220          354 EH  355 (573)
Q Consensus       354 ~~  355 (573)
                      ..
T Consensus       301 ~~  302 (307)
T cd05098         301 AL  302 (307)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-39  Score=324.67  Aligned_cols=261  Identities=28%  Similarity=0.467  Sum_probs=209.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCe--eEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  138 (573)
                      -++|++.+.||+|+||.||+|.+  ++.  .+++|..... .......+.+|++++.++ +||||+++++++.....+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            35899999999999999999986  343  4577764432 334556788999999999 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeE
Q 008220          139 FFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      ||||+++++|.+++....               ..+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence            999999999999986432               24688999999999999999999999999999999999999999999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR  282 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  282 (573)
                      +|||++.......                 ......++..|+|||.+.+..++.++|||||||++|+|+| |..||....
T Consensus       166 ~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         166 ADFGLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             CccccCcccchhh-----------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            9999885321100                 0111234667999999988889999999999999999998 999997654


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK  360 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~  360 (573)
                      .......+.               ....+   ..+..+++++.+|+.+||+.+|++||++.+++..+..++...+...
T Consensus       229 ~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~  288 (303)
T cd05088         229 CAELYEKLP---------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  288 (303)
T ss_pred             hHHHHHHHh---------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence            433222111               11111   1233578899999999999999999999999999998887665443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.4e-40  Score=325.15  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=205.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|++.+.||+|+||.||++.+  +++.||+|.+....   ......+..|+.+++.++|+||+.+++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            478889999999999999987  57899999754332   2233457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+.+++|.+++... ...+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-----  155 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----  155 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence            99999999988543 235889999999999999999999999999999999999999999999999988543210     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......|++.|+|||++.+..++.++||||+||++|+|++|..||..............        
T Consensus       156 ------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~--------  215 (285)
T cd05630         156 ------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--------  215 (285)
T ss_pred             ------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh--------
Confidence                        011234789999999999998999999999999999999999999976432111111000        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                         ...    ......+..+++++.+|+++||+.||++|||     +.|+++|.|..
T Consensus       216 ---~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         216 ---LVK----EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             ---hhh----hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence               000    0001123467899999999999999999999     89999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-39  Score=323.01  Aligned_cols=256  Identities=28%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             CCccccccccccCceEEEEEEEC--C--eeEEEeeccC-CChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--G--RKVAVKKPIL-STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++|++.+.||.|+||.||+|...  +  ..+++|.+.. ......+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57999999999999999999763  3  2468887553 2344556788999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEe
Q 008220          140 FEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                      +||+++++|.+++....               ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999999986432               247888999999999999999999999999999999999999999999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchh
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA  283 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~  283 (573)
                      |||++......                 ........+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       162 dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~  224 (297)
T cd05089         162 DFGLSRGEEVY-----------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC  224 (297)
T ss_pred             CcCCCccccce-----------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99987532110                 00111223557999999998889999999999999999997 9999987654


Q ss_pred             HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ......+.               ....+   ..+..++.++.+|+.+||+.+|.+|||++++++.|..+....
T Consensus       225 ~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         225 AELYEKLP---------------QGYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHHHh---------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            43322221               11111   123468899999999999999999999999999998887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-39  Score=318.11  Aligned_cols=256  Identities=29%  Similarity=0.422  Sum_probs=206.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +++..+|++.++||+|+||.||+|.+. ...||+|+...... ..+.+.+|+.+++.++||||+++++.+. ....++||
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence            567789999999999999999999873 45799998654322 3456889999999999999999999875 45688999


Q ss_pred             EeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+++|.+++... ...++++.+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.+........  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--  157 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--  157 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence            999999999999753 33578899999999999999999999999999999999999999999999999865532110  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......++..|+|||+..+..++.++|+|||||++|+|++ |..||...........+.       
T Consensus       158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------  217 (262)
T cd05071         158 -------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------  217 (262)
T ss_pred             -------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------
Confidence                         01123346778999999988889999999999999999999 899997664433322221       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                             .+ ...   ..+..++..+.+|+.+||+.||++||++.++++.|+..
T Consensus       218 -------~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 -------RG-YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -------cC-CCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                   11 111   11346789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=320.78  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=209.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      +++..++|++.+.||+|+||.||+|...       +..||+|...... ......+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            3567789999999999999999999763       2679999865442 3445678899999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeE
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      ....++||||+.+++|.+++....         ..+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999986422         23678899999999999999999999999999999999999999999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR  282 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  282 (573)
                      +|||+++........              .......++..|+|||.+.+..++.++|||||||++||+++ |..||...+
T Consensus       161 ~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         161 GDFGMTRDIYETDYY--------------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             CCcccchhhccCccc--------------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            999998754321110              01223456788999999988889999999999999999998 999997665


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .......+.              .+. .+   ..+..++.++.++|.+||+.+|++|||+.++++.|.
T Consensus       227 ~~~~~~~~~--------------~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         227 NEEVLKFVI--------------DGG-HL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHHHHh--------------cCC-CC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            443332221              111 11   224457899999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.5e-39  Score=317.55  Aligned_cols=255  Identities=24%  Similarity=0.383  Sum_probs=206.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||+|+.  +++.||||.+..   ........+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999986  678999997543   23344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999988753   233578899999999999999999999999999999999999999999999999876542111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......            
T Consensus       162 ----------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------------  213 (267)
T cd08228         162 ----------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------------  213 (267)
T ss_pred             ----------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------------
Confidence                            1223468889999999988888999999999999999999999996542211            


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ......+......+.   .+..++..+.++|.+||..+|++||++.++++.+..
T Consensus       214 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         214 FSLCQKIEQCDYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             HHHHHHHhcCCCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            111111111222221   123567889999999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-39  Score=325.40  Aligned_cols=256  Identities=24%  Similarity=0.396  Sum_probs=214.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|++.+.||.|+||.||++.+  +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            36899999999999999999986  6789999987665555567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|..++...  .+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........     
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----  170 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-----  170 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-----
Confidence            9999999988643  588999999999999999999999999999999999999999999999998865432110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......+++.|+|||.+.+..++.++|+|||||++|++++|..||...........+..          
T Consensus       171 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~----------  229 (296)
T cd06655         171 -----------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------  229 (296)
T ss_pred             -----------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence                       12335688999999999988899999999999999999999999987654333222211          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                          .. .+.+ ..+..+++.+.++|++||..||.+|||+.+++.|.|....
T Consensus       230 ----~~-~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         230 ----NG-TPEL-QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             ----cC-Cccc-CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence                00 1111 1234678999999999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-39  Score=318.61  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=211.4

Q ss_pred             ccCCCCccccccccccCceEEEEEEECC-----eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDG-----RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ++..++|.+.+.||+|+||.||+|.+..     ..|+||...... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            4566789999999999999999998632     368999765544 4556789999999999999999999998875 55


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+++++|.+++......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            78999999999999999765556899999999999999999999999999999999999999999999999998655421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..               .......++..|+|||.+.+..++.++||||||+++|++++ |..||...........+..  
T Consensus       161 ~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~--  223 (270)
T cd05056         161 SY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN--  223 (270)
T ss_pred             cc---------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--
Confidence            10               00112234568999999988889999999999999999986 9999987654433322211  


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  + .++   ..+..++.++.++|.+||..+|++|||+.++++.|..+..
T Consensus       224 ------------~-~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         224 ------------G-ERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ------------C-CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                        1 111   1235678999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-39  Score=323.66  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=212.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      +++..++|++.+.||+|+||.||++...       ...+|+|..... .......+.+|+.+++.+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            6777889999999999999999999753       257899986543 334456788999999999 7999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD  196 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~  196 (573)
                      ....++++|||+.+|+|.+++...               ...+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999999999998532               23578899999999999999999999999999999999999


Q ss_pred             CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CC
Q 008220          197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV  275 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~  275 (573)
                      .++.+||+|||+++.........              ......++..|+|||++.+..++.++|||||||++|++++ |.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYR--------------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             CCCeEEeCcccccccccccccee--------------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence            99999999999987554211100              0112234678999999998889999999999999999998 99


Q ss_pred             CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .||...........+.               ....+   ..+...+.++.+|+.+||+.||++|||+.+++++|..++
T Consensus       233 ~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         233 SPYPGIPVEELFKLLK---------------EGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCCHHHHHHHHH---------------cCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            9998765443332221               11111   123467889999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-39  Score=320.02  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             cCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +..++|.+.+.||+|+||.||+|.+.       +..|++|...... ......+..|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            44578999999999999999999873       4678899765433 333456889999999999999999999999989


Q ss_pred             ceEEEEEeccCCChhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEee
Q 008220          135 NYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLAD  205 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~D  205 (573)
                      ..++||||+.+++|.+++....      ..+++.++..++.||+.||+|||+.+++||||||+||+++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999986543      2478899999999999999999999999999999999998765   589999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE  284 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~  284 (573)
                      ||+++........              .......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       163 fg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~  228 (277)
T cd05036         163 FGMARDIYRASYY--------------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ  228 (277)
T ss_pred             CccccccCCccce--------------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9998755311000              00112234568999999998889999999999999999997 99999876544


Q ss_pred             HHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .....+..               ..++   ..+..++..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       229 ~~~~~~~~---------------~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVMEFVTG---------------GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHc---------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            33222211               1111   124567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-39  Score=323.29  Aligned_cols=255  Identities=20%  Similarity=0.229  Sum_probs=207.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|+..+.||.|+||+||++.+  +++.||+|.+....   ......+.+|+.+++.++|+||+.+++.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            477889999999999999987  57899999864332   2233457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+.+++|.+.+.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-----  155 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-----  155 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence            999999998876433 36899999999999999999999999999999999999999999999999988543210     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+...       
T Consensus       156 ------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-------  216 (285)
T cd05632         156 ------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-------  216 (285)
T ss_pred             ------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------
Confidence                        0123456899999999999888999999999999999999999999865443322222110       


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~~  353 (573)
                         +.     ......+..++.++.+|+.+||+.||++||+     +.+++.|.|...
T Consensus       217 ---~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         217 ---VL-----ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             ---hh-----ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence               00     0011123467889999999999999999999     889998877644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-40  Score=332.84  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|.+  .++.||+|++...   .....+.+..|+.++.++ +||||+.+++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999986  5688999986543   233456688999999888 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......          
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----------  149 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP----------  149 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----------
Confidence            99998886544 6899999999999999999999999999999999999999999999999988632110          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                            .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.........       .........+.
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~  216 (327)
T cd05617         150 ------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-------NTEDYLFQVIL  216 (327)
T ss_pred             ------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-------ccHHHHHHHHH
Confidence                  01123467999999999999999999999999999999999999999643211000       00011111111


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~  351 (573)
                      ...     ...|..++..+.++|++||+.||.+|+++      .++++|.|.
T Consensus       217 ~~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f  263 (327)
T cd05617         217 EKP-----IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF  263 (327)
T ss_pred             hCC-----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence            111     11345688999999999999999999984      577777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-39  Score=323.18  Aligned_cols=267  Identities=25%  Similarity=0.262  Sum_probs=205.3

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||.|++|.||+|++  ++..||+|++.....  .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            488999999999999999987  578999998654322  2345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      +. ++|.+++....  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc----
Confidence            97 58888775432  468999999999999999999999999999999999999999999999999986433100    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+...................
T Consensus       156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  223 (285)
T cd07861         156 ------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE  223 (285)
T ss_pred             ------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence                        012234578899999998754 4688999999999999999999999876544433333221110000


Q ss_pred             H----------HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 L----------TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .          ............+......+++++.++|++||..||++|||+.+|++|.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence            0          00000000111111223457899999999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=355.31  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=204.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc--CC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  134 (573)
                      .+....+|+++++||+|+||+||+|.+  .+..||+|.+...  .......+..|+.+++.|+||||++++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            455567999999999999999999987  5678999976543  33456678999999999999999999998854  45


Q ss_pred             ceEEEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCceEEcC-------
Q 008220          135 NYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNL-------GIVHRDVKPANVLLDR-------  197 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-------~iiH~Dlkp~Nill~~-------  197 (573)
                      .+|+||||+.+++|.+++...   ...+++..++.|+.||+.||+|||+.       +||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999988642   24689999999999999999999985       4999999999999964       


Q ss_pred             ----------CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHH
Q 008220          198 ----------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFG  265 (573)
Q Consensus       198 ----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG  265 (573)
                                .+.+||+|||++......                 .......||+.|+|||++.+  ..++.++||||||
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~-----------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG  230 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIE-----------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG  230 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccc-----------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence                      334899999998654310                 01234579999999999864  4578999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       266 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                      |+||+|++|..||............+.             ..   +.++  ....+.++.+||..||+.+|.+||++.|+
T Consensus       231 ~ILYELLTGk~PF~~~~~~~qli~~lk-------------~~---p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~Ql  292 (1021)
T PTZ00266        231 CIIYELCSGKTPFHKANNFSQLISELK-------------RG---PDLP--IKGKSKELNILIKNLLNLSAKERPSALQC  292 (1021)
T ss_pred             HHHHHHHHCCCCCCcCCcHHHHHHHHh-------------cC---CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence            999999999999976543322221111             11   1111  13568999999999999999999999999


Q ss_pred             HHHHHHH
Q 008220          346 ALELDLV  352 (573)
Q Consensus       346 l~~l~~~  352 (573)
                      +.+.|..
T Consensus       293 L~h~~ik  299 (1021)
T PTZ00266        293 LGYQIIK  299 (1021)
T ss_pred             hccHHHh
Confidence            9887654

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3e-39  Score=316.78  Aligned_cols=255  Identities=29%  Similarity=0.444  Sum_probs=206.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++++.++|++.++||+|+||.||+|.. .+..+|+|....... ..+.+.+|+.++++++||||+++++++. ....+++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            356778999999999999999999986 456799997654332 3456889999999999999999999875 4568899


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+.+++|.+++... ...+++.+++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            9999999999998653 34578999999999999999999999999999999999999999999999999865432110 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..     
T Consensus       158 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----  218 (260)
T cd05070         158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-----  218 (260)
T ss_pred             --------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----
Confidence                          01122345678999999988889999999999999999999 9999987654433322211     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                ..++   ..+...+..+.+|+.+||..+|.+|||+.++.+.|.
T Consensus       219 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         219 ----------GYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             ----------CCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence                      1111   123467899999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-39  Score=329.96  Aligned_cols=263  Identities=27%  Similarity=0.439  Sum_probs=208.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      ++++.++|++.+.||.|+||.||+|.+       .++.||||++.... ......+.+|+.++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            567788999999999999999999973       35789999876543 33456788999999999 6899999999876


Q ss_pred             cC-CceEEEEEeccCCChhhhhhccC------------------------------------------------------
Q 008220          132 KP-PNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------  156 (573)
Q Consensus       132 ~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------  156 (573)
                      .. ...+++|||+.+|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 56789999999999999885421                                                      


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          157 ------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       157 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                                  ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------  235 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------  235 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence                        13577788899999999999999999999999999999999999999999998654211100      


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                              .......+++.|+|||.+.+..++.++||||||+++|++++ |..||............             
T Consensus       236 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------------  294 (343)
T cd05103         236 --------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------------  294 (343)
T ss_pred             --------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-------------
Confidence                    01122345678999999998889999999999999999997 99999764322211111             


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      +. .+.++.   .+...++++.+++..||+.||.+|||+.+|+++|..+++
T Consensus       295 ~~-~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         295 LK-EGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             Hh-ccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11 111111   223467899999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=323.10  Aligned_cols=263  Identities=26%  Similarity=0.381  Sum_probs=206.5

Q ss_pred             cCCCCccccccccccCceEEEEEEECC----------------eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDG----------------RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAK  125 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~  125 (573)
                      ++..+|++.+.||+|+||.||++++.+                ..||+|..... .......+.+|++++++++||||++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            456799999999999999999987532                25899986544 2334567899999999999999999


Q ss_pred             eeeccccCCceEEEEEeccCCChhhhhhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       126 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +++++......++||||+.+++|.+++....           ..+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999885432           13578889999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||++........              ........++..|+|||++.+..++.++|+|||||++|+|++ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDY--------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             EcCCCcEEecccccccccccCcc--------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence            99999999999999864421100              001123345778999999998889999999999999999988 


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                       |..||................           ...........+...++.+.+|+.+||+.||++|||+.+|++.|.
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFF-----------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhh-----------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             778888765444333221100           000011111223457899999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=344.46  Aligned_cols=287  Identities=25%  Similarity=0.417  Sum_probs=239.1

Q ss_pred             ccCCCcccCCCcCCCccccccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCCC-hHHHHHHHHHHHHHH
Q 008220           43 VLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLC  116 (573)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~  116 (573)
                      ..+|.+..........+..+|......|.+.||.|.||.|++|+.+     ...||||.++..- .+.+..|..|+.||-
T Consensus       606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG  685 (996)
T KOG0196|consen  606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG  685 (996)
T ss_pred             ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence            3344444444334444557888889999999999999999999863     3579999866553 445678999999999


Q ss_pred             hCCCCccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc
Q 008220          117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD  196 (573)
Q Consensus       117 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~  196 (573)
                      +++||||++|.++.......++|+|||++|+|+.+|+..+..|+..++..+++.|+.|++||-++++|||||..+||||+
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN  765 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN  765 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec
Confidence            99999999999999999999999999999999999999888999999999999999999999999999999999999999


Q ss_pred             CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CC
Q 008220          197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV  275 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~  275 (573)
                      .+..+|++|||+++++++...             ..+....-.-+.+|.|||.+....++.++||||+|++|||.++ |.
T Consensus       766 snLvCKVsDFGLSRvledd~~-------------~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE  832 (996)
T KOG0196|consen  766 SNLVCKVSDFGLSRVLEDDPE-------------AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE  832 (996)
T ss_pred             cceEEEeccccceeecccCCC-------------ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence            999999999999998864221             1111222234678999999999999999999999999999998 99


Q ss_pred             CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .||.+..+.+.+..+.              .+-..|    .|.++|..|.+||..||++|-.+||++.||+..|++++.+
T Consensus       833 RPYWdmSNQdVIkaIe--------------~gyRLP----pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  833 RPYWDMSNQDVIKAIE--------------QGYRLP----PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             CcccccchHHHHHHHH--------------hccCCC----CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            9999876666555443              222222    3568999999999999999999999999999999999876


Q ss_pred             hcccc
Q 008220          356 RKSLK  360 (573)
Q Consensus       356 ~~~~~  360 (573)
                      ..+++
T Consensus       895 P~SLk  899 (996)
T KOG0196|consen  895 PNSLK  899 (996)
T ss_pred             chhhc
Confidence            54443

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-39  Score=316.40  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=206.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +|++.+.||.|+||.||++.+  +++.+++|.+... .....+.+.+|+.+++.++||||+++++.+.....+++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            588999999999999999986  5788999986443 3445677889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          144 ESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       144 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      ++++|.+++... ...++++.++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......      
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~------  154 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG------  154 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc------
Confidence            999999988643 3457899999999999999999999999999999999999999999999999986543211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.           
T Consensus       155 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-----------  213 (255)
T cd08219         155 ----------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-----------  213 (255)
T ss_pred             ----------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-----------
Confidence                      11234568899999999998889999999999999999999999998654333322221           


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                         .+...+    .+..++..+.+||.+||+.||++|||+.+++..
T Consensus       214 ---~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 ---QGSYKP----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---cCCCCC----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               122222    234678899999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=308.90  Aligned_cols=275  Identities=19%  Similarity=0.270  Sum_probs=215.0

Q ss_pred             cccc-ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEec
Q 008220           68 YTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++. +.||+|+|+.|-.+..  ++..||||++.....-.+.++.+|++++.+.+ |+||++|+++|+++..+|+|||.+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            6654 5689999999988864  78999999987766667889999999999995 999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeeeecchhhhhhhhhhc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .||.|...+.+.. .|++.++..+.++|+.||.+||.+||.||||||+|||.....   .+|||||.+..-+....+.+ 
T Consensus       159 ~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s-  236 (463)
T KOG0607|consen  159 RGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS-  236 (463)
T ss_pred             cCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-
Confidence            9999999998766 799999999999999999999999999999999999997655   47999999976443222211 


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                              +.......+.+|+..|||||+..     ...|+.+.|.||||+|||-||+|.+||.+.-...--..-=+...
T Consensus       237 --------pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  237 --------PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             --------CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence                    22333466789999999999863     35689999999999999999999999976432110000000000


Q ss_pred             c-HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          296 T-EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       296 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      . ...+...+..+. -.....-+..+|.+.++||..+|..|+..|.++.++++|+|.-.
T Consensus       309 ~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  309 VCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             HHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence            0 112222222222 22223345678999999999999999999999999999998753

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4e-39  Score=324.01  Aligned_cols=265  Identities=22%  Similarity=0.326  Sum_probs=210.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||+|+||.||++.+  ++..+|+|..... .......+.+|++++++++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3699999999999999999987  5678899876544 333456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++......      
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc------
Confidence            99999999997654 68999999999999999999997 59999999999999999999999999987543210      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc-----
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT-----  296 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  296 (573)
                                  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...... .......     
T Consensus       154 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~  220 (308)
T cd06615         154 ------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA-MFGRPVSEGEAK  220 (308)
T ss_pred             ------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH-hhcCcccccccc
Confidence                        1234578999999999988889999999999999999999999997654322221 1111100     


Q ss_pred             ------------------HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 ------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                        ......... ....|.++  ...++.++.+|+.+||..||++|||+.++++++|...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         221 ESHRPVSGHPPDSPRPMAIFELLDYIV-NEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CCcccccCCCCCccchhhHHHHHHHHh-cCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                              000111111 11112211  1236889999999999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-39  Score=315.96  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecc-ccCCceEEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE  141 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e  141 (573)
                      +..++|++.+.||+|+||.||++...+..+++|.....  ...+.+.+|+.+++.++||||+++++++ ......++++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            34568999999999999999999999999999986433  3346788999999999999999999875 45567899999


Q ss_pred             eccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......     
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----  155 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----  155 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-----
Confidence            999999999987544 34788999999999999999999999999999999999999999999999988643210     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.        
T Consensus       156 --------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~--------  213 (256)
T cd05082         156 --------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------  213 (256)
T ss_pred             --------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------
Confidence                          112334568999999998889999999999999999998 999997654333222211        


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                             ....+   ..+..+++.+.+++.+||+.+|++|||+.++++.|..
T Consensus       214 -------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         214 -------KGYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -------cCCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                   11111   2234688999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.4e-39  Score=333.71  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=212.7

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  129 (573)
                      ..++++.++|.+.++||+|+||.||+|++.       ++.||+|++.... ....+.+.+|+.+|.++. ||||++++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            347788889999999999999999999853       3579999876542 333457889999999997 9999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC-----------------------------------------------------
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE-----------------------------------------------------  156 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------  156 (573)
                      +......++|+||+.+|+|.++++...                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999986432                                                     


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 008220          157 --------------------------------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN  192 (573)
Q Consensus       157 --------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  192 (573)
                                                                  ..+++..++.++.||+.||+|||+.+++||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                        135667788999999999999999999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                      ||++.++.+||+|||+++........              .......+++.|+|||.+.+..++.++|||||||++|||+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l  335 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNY--------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF  335 (401)
T ss_pred             EEEeCCCEEEEEecCcceeccccccc--------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence            99999999999999998754321100              0112345788999999999888999999999999999999


Q ss_pred             c-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       273 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      + |..||............+              ..+.++.   .+..++.++.+|+.+||..+|.+||++.+|++.|..
T Consensus       336 ~~g~~P~~~~~~~~~~~~~~--------------~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         336 TLGGTPYPELPMNEQFYNAI--------------KRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HcCCCCCCCCCchHHHHHHH--------------HcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            8 899997654322222111              1222222   234678999999999999999999999999998876


Q ss_pred             HH
Q 008220          352 VL  353 (573)
Q Consensus       352 ~~  353 (573)
                      ++
T Consensus       399 ~~  400 (401)
T cd05107         399 LL  400 (401)
T ss_pred             Hh
Confidence            54

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.6e-39  Score=320.48  Aligned_cols=260  Identities=24%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      +++..++|++.+.||+|+||.||+|...       +..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4567789999999999999999999642       3479999765433 2334567889999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeE
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      ....++||||+.+|+|.+++....         ..++...+..++.|++.||.|||+++|+||||||+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999986422         23456788999999999999999999999999999999999999999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR  282 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  282 (573)
                      +|||+++........              .......++..|+|||.+.+..++.++|+|||||++|||++ |..||....
T Consensus       161 ~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         161 GDFGMTRDIYETDYY--------------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             CcCCccccccccccc--------------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999998654321100              00122345678999999998889999999999999999998 899998755


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .......+.              .+...    ..+..+++.+.+++.+||+.||++|||+.++++.+...
T Consensus       227 ~~~~~~~~~--------------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         227 NEQVLKFVM--------------DGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHHHHHH--------------cCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            443322221              11111    12345689999999999999999999999998877654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.2e-39  Score=313.56  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=199.6

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      +.||+|+||.||+|++  +++.+|+|...... .+....+.+|+++++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999986  68889999754332 34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCC
Q 008220          149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK  228 (573)
Q Consensus       149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~  228 (573)
                      .+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........           
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----------  149 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-----------  149 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-----------
Confidence            999876555688999999999999999999999999999999999999999999999999864321000           


Q ss_pred             CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcC
Q 008220          229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG  307 (573)
Q Consensus       229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (573)
                         ........++..|+|||.+.+..++.++||||||+++|++++ |..||...........+.               .
T Consensus       150 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---------------~  211 (252)
T cd05084         150 ---ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------------Q  211 (252)
T ss_pred             ---cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---------------c
Confidence               000011123567999999998889999999999999999998 999997654332222111               1


Q ss_pred             CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..++   ..+..++..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       212 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1111   123467899999999999999999999999987663

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=336.86  Aligned_cols=273  Identities=24%  Similarity=0.316  Sum_probs=207.6

Q ss_pred             cccCCCCccccccccccCceEEEEEEE----CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..+...+|++++.||+|+||.||++..    .+..|++|.....     ....+|+++++.++||||+++++++......
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            344556899999999999999999975    3467999975432     2345899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |++||++. ++|.+++.. ...+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus       162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99999986 588888743 3478999999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH---HHHHHHhc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA---QAHTVLEM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~~  293 (573)
                      .              ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.....   ....+...
T Consensus       240 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        240 D--------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             c--------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            0              011234679999999999999999999999999999999999999997653221   11111111


Q ss_pred             c------ccH---HHHHHH--HhcCCCCCcc--ccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 N------YTE---QQLTAA--VVSGGLRPIL--ASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~------~~~---~~~~~~--~~~~~~~~~~--~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .      +..   ..+...  ......++..  +..  ...++.++.++|++||+.||++|||+.|++.|+|+...
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            0      000   000000  0011111111  100  12467789999999999999999999999999988654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.5e-39  Score=317.21  Aligned_cols=257  Identities=26%  Similarity=0.352  Sum_probs=208.6

Q ss_pred             CccccccccccCceEEEEEEE-CCeeEEEeeccCCC------hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +|++.+.||.|+||.||+|.. +++.+|+|.+....      ......+.+|+++++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588999999999999999986 67889999765432      22345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-  158 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH-  158 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence            99999999999987554 6789999999999999999999999999999999999999999999999998754321100 


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                               ...........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..       
T Consensus       159 ---------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------  222 (265)
T cd06631         159 ---------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-------  222 (265)
T ss_pred             ---------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-------
Confidence                     0000112345689999999999988899999999999999999999999976543322211111       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                            ..   ...+..+..++.++.++|++||+.+|.+||++.++++|.|
T Consensus       223 ------~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         223 ------HR---GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             ------cc---CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence                  01   1122344578999999999999999999999999998765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=352.55  Aligned_cols=260  Identities=23%  Similarity=0.278  Sum_probs=221.4

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +.+..++|.+++.||+|+||.|.++++  +++.||+|++..   -...+..-|..|-++|..-+.+-|+.++-.|+++.+
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            456778999999999999999999987  578899998543   123345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||++||+|..++.+.+ .++++.++.|+..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-.+.. 
T Consensus       150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-  227 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-  227 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence            999999999999999999888 899999999999999999999999999999999999999999999999999876552 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhc----c-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK----K-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                                    .+.......+|||.|.+||++.    + +.|++..|.||+||++|||+.|..||....-.....+|
T Consensus       228 --------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI  293 (1317)
T KOG0612|consen  228 --------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI  293 (1317)
T ss_pred             --------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence                          1222355679999999999985    3 56899999999999999999999999988777777777


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDLV  352 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~~  352 (573)
                      +...-.              -.+| ....+|+++++||++.+. +|+.|..   ++++..|+++.
T Consensus       294 m~hk~~--------------l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  294 MNHKES--------------LSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             hchhhh--------------cCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence            643211              0111 123589999999999887 6899998   99999888654

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-39  Score=319.71  Aligned_cols=254  Identities=31%  Similarity=0.459  Sum_probs=205.2

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHH--HHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELD--NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++.+.||+|+||+||++..  +++.||+|...........  ....|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78999999999999999998  4568999997776554433  3456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+++|.+++.... .+++.+++.++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+......        
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--------  151 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--------  151 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--------
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence            9999999997333 7899999999999999999999999999999999999999999999999998643110        


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                              ........+++.|+|||++. +..++.++|+||||+++|+|++|..||...........+........... 
T Consensus       152 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-  222 (260)
T PF00069_consen  152 --------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-  222 (260)
T ss_dssp             --------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-
T ss_pred             --------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-
Confidence                    01234567899999999998 88889999999999999999999999987622222222211111000000 


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                 .......++++.++|++||+.||++|||+.++++|+|
T Consensus       223 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  223 -----------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             -----------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             -----------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence                       0001123589999999999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=328.04  Aligned_cols=266  Identities=28%  Similarity=0.449  Sum_probs=221.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC----Ce--eEEEeeccC-CChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD----GR--KVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      .++..+...+.++||.|.||.||+|...    |+  .||||.-+. ...+..+.|..|+.+|+.++||||++|+|++.+ 
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            4455555667789999999999999763    33  477786444 345568899999999999999999999999865 


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ...|+|||.++-|.|..++......++......+++||+.||+|||+..+|||||..+|||+.....|||+|||++++++
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            56789999999999999999888899999999999999999999999999999999999999999999999999999887


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      ......               .....-+.-|||||.+.-..++.++|||.|||.+||++. |..||.+..+...+..+. 
T Consensus       543 d~~yYk---------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-  606 (974)
T KOG4257|consen  543 DDAYYK---------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-  606 (974)
T ss_pred             ccchhh---------------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-
Confidence            533321               222334678999999999999999999999999999998 999999875544433332 


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK  360 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~  360 (573)
                                   .|...|    .|+++|+.+..|+.+||.++|.+||++.+|...|..++++.+...
T Consensus       607 -------------nGeRlP----~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~  657 (974)
T KOG4257|consen  607 -------------NGERLP----CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS  657 (974)
T ss_pred             -------------CCCCCC----CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence                         222222    456899999999999999999999999999999999887544433

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.6e-39  Score=316.28  Aligned_cols=255  Identities=26%  Similarity=0.470  Sum_probs=208.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++|+.++|++.++||+|+||.||+|.. .++.||+|.+.... .....+.+|+.+++.++||||+++++++. ....+++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            357788999999999999999999986 56889999865433 23467889999999999999999999874 4678999


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+.+++|.+++... +..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999999988653 34678899999999999999999999999999999999999999999999999865431100 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||++.+..++.++||||||+++|++++ |..||.+.........+.      
T Consensus       158 --------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------  217 (260)
T cd05067         158 --------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE------  217 (260)
T ss_pred             --------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH------
Confidence                          01123345778999999998889999999999999999999 999998765443332221      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                               ...++   ..+...+.++.+++.+||+.+|++|||++++++.|.
T Consensus       218 ---------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         218 ---------RGYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ---------cCCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence                     11111   123467889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.3e-39  Score=316.37  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=209.2

Q ss_pred             CCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ...+|++.+.||+|+||.||+|.+.     +..+|+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            3468999999999999999999762     3378999765432 344567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||+++++|.+++......+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            99999999999999987665789999999999999999999999999999999999999999999999999875532110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .             ........++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+..    
T Consensus       162 ~-------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~----  224 (267)
T cd05066         162 A-------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE----  224 (267)
T ss_pred             e-------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC----
Confidence            0             000111233568999999998889999999999999999887 9999987654333222211    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                 ..++   ..+..+++.+.+++.+||+.+|.+||++.++++.|..+
T Consensus       225 -----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 -----------GYRL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----------CCcC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                       1111   12346789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.6e-39  Score=318.52  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             CccccccccccCceEEEEEEECC-------eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           67 SYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +|++.+.||+|+||.||+|....       ..+++|...... ......+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47899999999999999997632       468888755433 3445678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE
Q 008220          139 FFEFYESRNLAEKLHVE-----------------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL  195 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill  195 (573)
                      ++||+.+++|.+++...                       ...+++.+++.++.|++.||.|||+.|++||||||+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999987532                       1246788999999999999999999999999999999999


Q ss_pred             cCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-C
Q 008220          196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G  274 (573)
Q Consensus       196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g  274 (573)
                      +.++.+||+|||+++........              .......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSY--------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             cCCCcEEeccccccccccCccch--------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            99999999999998654321110              00122345678999999988889999999999999999998 9


Q ss_pred             CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..||.+...........               ...++   ..+..++.++.+++.+||+.+|++||++.++++.|..++.
T Consensus       227 ~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         227 GNPYPGIAPERLFNLLK---------------TGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCCCCHHHHHHHHh---------------CCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            99998764433222111               11111   1234678999999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-39  Score=320.13  Aligned_cols=255  Identities=30%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.++||+|+||.||+|.+  +++.||+|.+... .......+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3688999999999999999986  6788999986544 334456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|..+.     .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++......       
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-------  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-------  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-------
Confidence            9999986542     4678889999999999999999999999999999999999999999999998644210       


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..........       .......
T Consensus       149 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~  210 (279)
T cd06619         149 -----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQ  210 (279)
T ss_pred             -----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHHH
Confidence                       1234578999999999999889999999999999999999999997532211100       0001111


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ...... .+.+  .....++++.++|.+||+.+|++||++.++++|.|...
T Consensus       211 ~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         211 CIVDED-PPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             HHhccC-CCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            111111 1111  12357889999999999999999999999999988754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-38  Score=316.50  Aligned_cols=258  Identities=20%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCe----eEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ...+|++.+.||+|+||+||+|.+  +++    .+++|...... ......+..|+..++.++||||+++++++. ....
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            346899999999999999999986  343    47888754332 233467788888999999999999999875 4567


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++++||+++|+|.+++......+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            88999999999999998766678999999999999999999999999999999999999999999999999986543110


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .              ........++..|+|||.+.+..++.++|||||||++||+++ |..||.+.........+     
T Consensus       164 ~--------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----  224 (279)
T cd05111         164 K--------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-----  224 (279)
T ss_pred             c--------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence            0              011223457778999999998889999999999999999998 99999876433221111     


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                ..+..+.   .+..++.++.+++.+||..||++|||+.|+++.+..+..
T Consensus       225 ----------~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 ----------EKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----------HCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                      1111111   123467889999999999999999999999988777654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.1e-39  Score=315.15  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=206.3

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc-CCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e  141 (573)
                      +|++.+.||+|++|.||++.+  +++.|++|++...  .....+.+.+|+++++.++||||+++++.+.. ...+++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            589999999999999999986  5678999986543  23445678899999999999999999988764 446789999


Q ss_pred             eccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |+++++|.+++... ...+++.+++.++.|++.||++||+.|++||||||+||+++.++.++|+|||++........   
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC---
Confidence            99999999988753 34589999999999999999999999999999999999999999999999999865532110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......+++.|+|||++.+..++.++|+||||+++|++++|..||...+.......+..        
T Consensus       158 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------  216 (257)
T cd08223         158 -------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------  216 (257)
T ss_pred             -------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------
Confidence                         12345688999999999999899999999999999999999999986544333222221        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                            +. .   +..+..+++++.+++.+||+.||++|||+.++++|.|
T Consensus       217 ------~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         217 ------GK-L---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             ------cC-C---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence                  11 1   1233468899999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=334.61  Aligned_cols=244  Identities=23%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhC---CCCccceeeeccccCCceEEEEEeccC
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL---DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      ||+|+||+||+|++  +++.||||++....   .........|..++..+   .||||+++++++.....+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999987  57899999864321   22333455677777665   699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......          
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------  149 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------  149 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC----------
Confidence            99998887544 7899999999999999999999999999999999999999999999999998543210          


Q ss_pred             CCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                            .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..            
T Consensus       150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------------  211 (330)
T cd05586         150 ------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------------  211 (330)
T ss_pred             ------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------------
Confidence                  0112346799999999998764 478999999999999999999999987654433332221            


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC----CHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP----SFSDIALELDLV  352 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~ell~~l~~~  352 (573)
                        +..+.    ....+++++.+||++||+.||.+||    ++.++++|.|..
T Consensus       212 --~~~~~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         212 --GKVRF----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             --CCCCC----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence              11111    1124789999999999999999998    789999988764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.3e-39  Score=322.64  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=212.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      +.++..+|.+.++||+|+||.||++++.         ...+|+|..... .......+..|+.+++.+ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            5667789999999999999999999742         346899976543 334566788999999999 69999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +.....++++|||+.+|+|.+++....               ..+++.++..++.|++.||.|||++|++||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            999999999999999999999986432               24788899999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||+++........              .......++..|+|||++.+..++.++||||||+++|+|++ 
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~  232 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYY--------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL  232 (314)
T ss_pred             EcCCCcEEEccccccccccccccc--------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence            999999999999998754321110              00112234567999999998889999999999999999999 


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |..||...........+..              + ...   ..+..++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       233 g~~p~~~~~~~~~~~~~~~--------------~-~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         233 GGSPYPGIPVEELFKLLRE--------------G-HRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             CCCCCCCCCHHHHHHHHHc--------------C-CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            8999976644333322211              1 111   123467889999999999999999999999999998877


Q ss_pred             HH
Q 008220          354 EH  355 (573)
Q Consensus       354 ~~  355 (573)
                      ..
T Consensus       295 ~~  296 (314)
T cd05099         295 AA  296 (314)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.7e-39  Score=316.15  Aligned_cols=252  Identities=24%  Similarity=0.421  Sum_probs=209.9

Q ss_pred             CCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|++.+.||.|+||.||++...  ++.+++|.+....  ..+.+.+|+++++.++||||+++++.+......|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            468999999999999999999873  6889999865432  267899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++......+++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++........     
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-----  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-----  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-----
Confidence            999999999976666789999999999999999999999999999999999999999999999999865532110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..          
T Consensus       155 -----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----------  213 (256)
T cd06612         155 -----------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----------  213 (256)
T ss_pred             -----------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----------
Confidence                       12334578899999999998999999999999999999999999986543322211110          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                           ...+. ...+..++.++.++|.+||+.||++|||+.|++++.|
T Consensus       214 -----~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         214 -----KPPPT-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             -----CCCCC-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence                 00111 1123357789999999999999999999999998765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=318.15  Aligned_cols=253  Identities=27%  Similarity=0.424  Sum_probs=211.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||.|+||.||+|.+  +++.|++|...... ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4799999999999999999986  57899999865543 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++...  .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++......      
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~------  152 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM------  152 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc------
Confidence            9999999998754  68899999999999999999999999999999999999999999999999987654211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..          
T Consensus       153 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----------  212 (274)
T cd06609         153 ----------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK----------  212 (274)
T ss_pred             ----------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------
Confidence                      012345688899999999988899999999999999999999999976543322221111          


Q ss_pred             HHhcCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                           ...+.+   +.. ++.++.+++.+||..+|++|||++++++|.|....
T Consensus       213 -----~~~~~~---~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         213 -----NNPPSL---EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             -----cCCCCC---cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence                 111221   223 78899999999999999999999999999887543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-39  Score=322.20  Aligned_cols=267  Identities=24%  Similarity=0.273  Sum_probs=202.9

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||+|.+  +++.|++|.+.....  .....+.+|+.+++.++||||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            589999999999999999987  578999998654322  2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......      
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~------  153 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------  153 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC------
Confidence            975 7877776555578999999999999999999999999999999999999999999999999986443100      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCC-CCchhHHHHHHHHhccccHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPY-TDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf-~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                .......+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+.......+..........
T Consensus       154 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07839         154 ----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  223 (284)
T ss_pred             ----------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence                      012234578899999998764 4689999999999999999988885 4333333333332211111100


Q ss_pred             HHHHhcC--CC--CCcc------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSG--GL--RPIL------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~--~~--~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .......  ..  .+..      ......+++++.+||.+||+.||.+|||++++++|+|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            0000000  00  0000      1112357899999999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-39  Score=337.40  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=201.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ...+|.+.+.||+|+||.||++.+  .++.||||....      ..+.+|+++|++++||||+++++++......++|||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            345899999999999999999987  467899996322      235689999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      ++. ++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~----  315 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS----  315 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc----
Confidence            995 588888866555789999999999999999999999999999999999999999999999999875432110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-------HHHHHHHHhc-
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA-------EAQAHTVLEM-  293 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~~~~~-  293 (573)
                                ........||+.|+|||++.+..++.++|||||||+||||++|..|+-....       .....+++.. 
T Consensus       316 ----------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        316 ----------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             ----------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence                      0012245799999999999999999999999999999999998765432110       1111222111 


Q ss_pred             cccH--------HHHHHHHh---cCCCCCcccc----cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTE--------QQLTAAVV---SGGLRPILAS----LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~--------~~~~~~~~---~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ....        ..+.....   ....++....    ....++.++.+||.+||+.||.+|||+.|+++|.|+
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            1100        00000000   0111111000    001356789999999999999999999999999876

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-38  Score=346.71  Aligned_cols=274  Identities=24%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.++||+|+||.||+|.+  +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5899999999999999999987  5789999986543   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          141 EFYESRNLAEKLHVE----------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       141 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ||++|++|.+++...          ....+...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999999988531          1234567788999999999999999999999999999999999999999999997


Q ss_pred             hhhhhhhhhcc-cccCCCC-CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          211 YRENLKEISLK-NWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       211 ~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      ........... .....+. ..........+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            66321110000 0000000 000111234579999999999999999999999999999999999999997643222111


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEH  355 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~~~  355 (573)
                      ...  .              ..|........+|+.+.+++.+||+.||++|| +++++++.+...++.
T Consensus       242 ~~~--i--------------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 RDV--I--------------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh--c--------------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            100  0              00000011236789999999999999999996 566677777666653

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-39  Score=325.18  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=211.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++.+.||.|+||.||++.+  .++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6899999999999999999986  68899999876655556677889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      ++++|.+++...  .+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......       
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-------  169 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-------  169 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-------
Confidence            999999988543  57889999999999999999999999999999999999999999999999886443110       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               .......+++.|+|||.+.+..++.++|+|||||++|++++|..||...+.......+..           
T Consensus       170 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-----------  229 (297)
T cd06656         170 ---------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-----------  229 (297)
T ss_pred             ---------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-----------
Confidence                     012345688999999999998899999999999999999999999976543221111100           


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                         .. .+.+ ..+..+++.+.+|+.+||+.+|++||++.++++|.|...
T Consensus       230 ---~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (297)
T cd06656         230 ---NG-TPEL-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL  274 (297)
T ss_pred             ---CC-CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence               00 1111 123467889999999999999999999999999987754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-39  Score=316.58  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=207.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---------HHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +|.+.+.||.|+||.||+|.+  .++.+|+|.+.....         ...+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999986  568899997543321         123568899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            999999999999999997654 6888999999999999999999999999999999999999999999999998765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ...          ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+..   
T Consensus       160 ~~~----------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---  226 (267)
T cd06628         160 SLS----------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---  226 (267)
T ss_pred             ccc----------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---
Confidence            100          0000112335688999999999988889999999999999999999999987544332222111   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                  ...   +..+..++..+.++|++||+.||.+||++.+++++.|
T Consensus       227 ------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         227 ------------NAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ------------cCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence                        111   2234568899999999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.9e-39  Score=326.91  Aligned_cols=275  Identities=24%  Similarity=0.308  Sum_probs=204.1

Q ss_pred             ccccccccc--CceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           69 TLLSPIARG--AESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        69 ~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +++++||+|  +|++||++.+  +++.||+|++....  ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            367889999  6789999976  67899999865442  33456788899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+.........   
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~---  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR---  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc---
Confidence            9999999998643 335889999999999999999999999999999999999999999999999865432210000   


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc---
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT---  296 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---  296 (573)
                            ............++..|+|||++.+  ..++.++|||||||++|+|++|..||..................   
T Consensus       158 ------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (327)
T cd08227         158 ------LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  231 (327)
T ss_pred             ------ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence                  0000001223457788999999976  45889999999999999999999999865543333222221110   


Q ss_pred             ------HHHHHHHHhcCC-------------CCC-----cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 ------EQQLTAAVVSGG-------------LRP-----ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ------~~~~~~~~~~~~-------------~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                            ............             .++     ........+++++.+||++||+.||++|||+.|+++|+|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                  000000000000             000     00111234678999999999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.1e-39  Score=312.83  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=198.8

Q ss_pred             cccccCceEEEEEEE----CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           73 PIARGAESVVYEATL----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      .||+|+||.||+|.+    ++..+|+|++....  ....+.+..|+.+++.++||||+++++++. ...+++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964    46789999865432  334567889999999999999999999875 45778999999999


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS  226 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~  226 (573)
                      +|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........        
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~--------  151 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY--------  151 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--------
Confidence            9999987554 6899999999999999999999999999999999999999999999999998654321110        


Q ss_pred             CCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                           ........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...........+.              
T Consensus       152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~--------------  212 (257)
T cd05116         152 -----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE--------------  212 (257)
T ss_pred             -----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------
Confidence                 000122344678999999988888999999999999999998 999998764433322221              


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+. .+   ..+..+++++.++|.+||+.||++||++.+|...|..
T Consensus       213 ~~~-~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         213 SGE-RM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCC-CC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            111 11   2345689999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-39  Score=316.33  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=202.9

Q ss_pred             ccccccccccCceEEEEEEEC-----CeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-----
Q 008220           68 YTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-----  135 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  135 (573)
                      |++.+.||+|+||.||+|...     +..||+|++...  .......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            678899999999999999752     367999986543  23456678999999999999999999998765544     


Q ss_pred             -eEEEEEeccCCChhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          136 -YMFFFEFYESRNLAEKLHVE-----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       136 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                       .++++||+++++|..++...     ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999887432     235788999999999999999999999999999999999999999999999998


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH  288 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~  288 (573)
                      +........              .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+........
T Consensus       161 ~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05035         161 KKIYSGDYY--------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD  226 (273)
T ss_pred             eeccccccc--------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            754321100              00112234678999999988889999999999999999999 999998765433322


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+.              .+. .   ...+..++.++.+++.+||+.||++|||+.+++++|..+
T Consensus       227 ~~~--------------~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 YLR--------------HGN-R---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHH--------------cCC-C---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            221              111 1   123456889999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.9e-39  Score=314.59  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=209.3

Q ss_pred             cCCCCccccccccccCceEEEEEEEC--C---eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      |...+|+..+.||+|+||.||+|...  +   ..+++|..... .....+.+..|+++++.++||||+++++++......
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            44568999999999999999999863  3   36899986544 334466788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            99999999999999997665578999999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..             .........++.|+|||++.+..++.++|||||||++||+++ |..||...........+.    
T Consensus       162 ~~-------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~----  224 (268)
T cd05063         162 EG-------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN----  224 (268)
T ss_pred             cc-------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh----
Confidence            10             000111223567999999988888999999999999999998 999997654433332221    


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                .....+    .+..++.++.+++.+||+.+|++||++.++++.|..+
T Consensus       225 ----------~~~~~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 ----------DGFRLP----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----------cCCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      111111    1235788999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.3e-39  Score=321.59  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=212.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEE---------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL---------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      +++...+|.+.+.||+|+||.||+++.         .+..||+|..... .......+.+|+.+++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            566778999999999999999999974         1346899976533 234567789999999999 79999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +......+++|||+.+++|.+++....               ..+++.++..++.||+.||.|||+.|++||||||+||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            999999999999999999999986532               24677889999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||+++........              .......+++.|+|||++.+..++.++||||||+++|++++ 
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  235 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYY--------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  235 (304)
T ss_pred             EcCCCcEEECCCccceeccccccc--------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999998755321110              01122345678999999998889999999999999999998 


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |..||...........+..              + .+.   ..+..++.++.+|+.+||+.+|.+|||+.++++.|..++
T Consensus       236 g~~p~~~~~~~~~~~~~~~--------------~-~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         236 GGSPYPGIPVEELFKLLKE--------------G-HRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             CCCCcccCCHHHHHHHHHc--------------C-CcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            8889976654433332211              1 111   123467899999999999999999999999999998876


Q ss_pred             H
Q 008220          354 E  354 (573)
Q Consensus       354 ~  354 (573)
                      .
T Consensus       298 ~  298 (304)
T cd05101         298 T  298 (304)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.2e-39  Score=319.58  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             CCCCccccccccccCceEEEEEEECC------------------eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLDG------------------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLA  124 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv  124 (573)
                      ..++|++.+.||+|+||.||++.+..                  ..||+|.+.... ....+.+.+|+++++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            45689999999999999999997632                  458999866543 34567788999999999999999


Q ss_pred             eeeeccccCCceEEEEEeccCCChhhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       125 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      ++++++......++++|++.+++|.+++....          ..+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999999999999999999999999986543          25789999999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.++|+|||++.........              .......+++.|+|||.+.+..++.++|||||||++|+|++ 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  228 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYY--------------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL  228 (296)
T ss_pred             ecCCCceEEccccceeecccCcce--------------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence            999999999999998654321100              01223456788999999988889999999999999999998 


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                       |..||................          ......... ..+..++.++.+++.+||+.||.+|||+.+|++.|.
T Consensus       229 ~~~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         229 CREQPYEHLTDQQVIENAGHFF----------RDDGRQIYL-PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCCcChHHHHHHHHhcc----------ccccccccC-CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             788887655443333222110          000111111 123457899999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.8e-39  Score=321.30  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=210.8

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      +.+..++|.+.+.||+|+||.||++.+       .+..||+|...... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            456667899999999999999999974       23479999765432 34456789999999999 7999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ..+..+++|||+.+++|.+++.... ..+++.++..++.|++.||+|||+.+|+|+||||+|||++.++.++|+|||++.
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999987543 247999999999999999999999999999999999999999999999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  289 (573)
                      .......              ........+++.|+|||.+.+..++.++||||+||++|+|++ |..||...........
T Consensus       190 ~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~  255 (302)
T cd05055         190 DIMNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK  255 (302)
T ss_pred             cccCCCc--------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence            5432110              001223356788999999999889999999999999999998 9999987543332222


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...              ...++   ..+...++++.+++.+||+.+|++|||+.++++.+...
T Consensus       256 ~~~--------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 LIK--------------EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHH--------------cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            211              11111   12345789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.2e-39  Score=325.37  Aligned_cols=264  Identities=20%  Similarity=0.244  Sum_probs=189.9

Q ss_pred             cccccccCceEEEEEEE----CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc--CCceEEEEEecc
Q 008220           71 LSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFFEFYE  144 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~  144 (573)
                      .++||+|+||+||+|++    .++.||+|.+....  ....+.+|+.+++.++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            46899999999999985    35789999865432  22346789999999999999999998854  456889999986


Q ss_pred             CCChhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----cCCCCCeEeeeecchhh
Q 008220          145 SRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR  212 (573)
Q Consensus       145 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----~~~~~~kL~Dfg~a~~~  212 (573)
                      + +|.+++...        ...+++..++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+|||+++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            5 787776422        2257889999999999999999999999999999999999    45678999999999755


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-------
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAE-------  284 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------  284 (573)
                      .....             .........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||......       
T Consensus       163 ~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~  229 (317)
T cd07868         163 NSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  229 (317)
T ss_pred             CCCCc-------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence            32100             0111234578999999999977 45899999999999999999999999643221       


Q ss_pred             --HHHHHHHhccccHHHH--------------HHHHhcCCC-----CCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          285 --AQAHTVLEMNYTEQQL--------------TAAVVSGGL-----RPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       285 --~~~~~~~~~~~~~~~~--------------~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                        .....+......+...              .........     ...+.......+.++.+||++||+.||.+|||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~  309 (317)
T cd07868         230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence              1111111111000000              000000000     0000111123456789999999999999999999


Q ss_pred             HHHHHHH
Q 008220          344 DIALELD  350 (573)
Q Consensus       344 ell~~l~  350 (573)
                      |+++|+|
T Consensus       310 e~l~hp~  316 (317)
T cd07868         310 QAMQDPY  316 (317)
T ss_pred             HHhcCCC
Confidence            9999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-39  Score=318.40  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=203.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccC------C
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------~  134 (573)
                      +...|++.+.||+|+||.||+|..  .++.||+|...... .....+..|+.+++.+ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            346799999999999999999986  57889999865443 3345678899999998 699999999988652      4


Q ss_pred             ceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      .++++|||+.+++|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            689999999999999998763 3468999999999999999999999999999999999999999999999999986543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      ...                .......|++.|+|||++.     +..++.++|+||+||++|+|++|..||..........
T Consensus       163 ~~~----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~  226 (272)
T cd06637         163 RTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  226 (272)
T ss_pred             ccc----------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            100                0123457899999999986     3457889999999999999999999997654332222


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...              ....+.   ..+..++.++.+||.+||..||.+|||+.++++|.|
T Consensus       227 ~~~--------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         227 LIP--------------RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             HHh--------------cCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence            111              011111   122357889999999999999999999999998876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-40  Score=330.90  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=219.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ..|.+.+.||.|.|+.|.++++  ++..||||.+....  ....+.+.+|+++|+.|+|||||+++.+.+....+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4699999999999999999987  78999999765442  3344668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+|.+.+++.+.+ +..+..++.++.|++.|++|||+++|+|||||++|||++.+-++||+|||++.++..       
T Consensus       136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-------  207 (596)
T KOG0586|consen  136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-------  207 (596)
T ss_pred             eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-------
Confidence            999999999998777 666799999999999999999999999999999999999999999999999987763       


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                +....+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|.+||.+.+-.......+...      
T Consensus       208 ----------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------  271 (596)
T KOG0586|consen  208 ----------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------  271 (596)
T ss_pred             ----------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee------
Confidence                      123578899999999999998776 678999999999999999999999865444433333322      


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                              ++     ++..++.++.+||+++|-.+|.+|++.+++.++.|.....
T Consensus       272 --------~r-----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  272 --------YR-----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             --------ec-----ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence                    22     3446789999999999999999999999999999887654

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=312.54  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=210.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++++.++|++.+.||.|+||.||++.. .+..++||.+.... .....+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            357788999999999999999999986 45678999765433 3346788999999999999999999999988999999


Q ss_pred             EEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++++|.+++.... ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........ 
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            99999999999987543 4689999999999999999999999999999999999999999999999999865532110 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+..     
T Consensus       159 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-----  219 (261)
T cd05034         159 --------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-----  219 (261)
T ss_pred             --------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence                          00112234678999999998889999999999999999998 9999977654433333221     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                ..+.   ..+...+.++.+++.+||+.+|.+||++.++++.|+
T Consensus       220 ----------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         220 ----------GYRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ----------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence                      1111   123456889999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-38  Score=315.37  Aligned_cols=259  Identities=21%  Similarity=0.345  Sum_probs=207.3

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCe----eEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +...+|++.++||+|+||+||+|++  +++    .||+|..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            3457899999999999999999975  343    4899986543 33445678899999999999999999998865 45


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++++||+++|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            77999999999999999765557899999999999999999999999999999999999999999999999998755421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..              ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.   
T Consensus       163 ~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---  225 (279)
T cd05109         163 ET--------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---  225 (279)
T ss_pred             cc--------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence            11              001112235678999999998889999999999999999998 999997654433222111   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 .. ..+   ..+..++.++.+++.+||..||++||++.++++.+..+..
T Consensus       226 -----------~~-~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         226 -----------KG-ERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -----------CC-CcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                       11 111   1234678999999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.9e-39  Score=317.72  Aligned_cols=268  Identities=27%  Similarity=0.412  Sum_probs=206.4

Q ss_pred             CCccccccccccCceEEEEEEE------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc--CCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~  137 (573)
                      .+|++.+.||+|+||.||++..      .+..||+|++..........+.+|+++++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5799999999999999999873      467899999776666667789999999999999999999987643  45689


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|+||+++++|.+++......+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  163 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE  163 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence            99999999999999976555689999999999999999999999999999999999999999999999999875532111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc--
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY--  295 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--  295 (573)
                      ..             .......++..|+|||++.+..++.++|||||||++|||++|..|+....... .........  
T Consensus       164 ~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~  229 (284)
T cd05081         164 YY-------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQ  229 (284)
T ss_pred             ce-------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccc
Confidence            00             00111234456999999998889999999999999999999887765432211 110000000  


Q ss_pred             -cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          296 -TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       296 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                       ....+.. ......+.   ..+..++.++.+|+.+||+.+|++|||+.+|++.|..
T Consensus       230 ~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         230 MIVYHLIE-LLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             cchHHHHH-HHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence             0011111 11111111   1234688999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-38  Score=311.38  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             cccccCceEEEEEEEC----CeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCC
Q 008220           73 PIARGAESVVYEATLD----GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN  147 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~  147 (573)
                      .||+|+||.||+|.+.    +..||+|....... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999752    45699998655433 34567899999999999999999999875 457899999999999


Q ss_pred             hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCC
Q 008220          148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG  227 (573)
Q Consensus       148 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~  227 (573)
                      |.+++......+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..........        
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~--------  152 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY--------  152 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce--------
Confidence            999987655678999999999999999999999999999999999999999999999999986443211100        


Q ss_pred             CCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhc
Q 008220          228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS  306 (573)
Q Consensus       228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (573)
                           .......+++.|+|||.+.+..++.++|||||||++|++++ |..||...........+.               
T Consensus       153 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------  212 (257)
T cd05115         153 -----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE---------------  212 (257)
T ss_pred             -----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---------------
Confidence                 00112234678999999988889999999999999999996 999998765443322221               


Q ss_pred             CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+.++   ..+...++++.++|.+||..||++||++.+|++.|..+
T Consensus       213 ~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         213 QGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11111   12346789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=342.42  Aligned_cols=269  Identities=20%  Similarity=0.208  Sum_probs=200.1

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC------CccceeeeccccC-
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH------PGLAKFVAAHAKP-  133 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~-  133 (573)
                      +...+|++.++||+|+||+||+|.+  .++.||||++... .........|+.+++.++|      ++|+.+++++... 
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            3457899999999999999999987  5788999986432 2223445667777777654      4588888888764 


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCC-------------
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNL-------------  199 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~-------------  199 (573)
                      .++|+|||++ +++|.+++...+ .+++..++.++.||+.||+|||+ .||+||||||+|||++.++             
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            5788899987 668888886554 78999999999999999999998 5999999999999998765             


Q ss_pred             ---CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Q 008220          200 ---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV  276 (573)
Q Consensus       200 ---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  276 (573)
                         .+||+|||.+.....                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       283 ~~~~vkl~DfG~~~~~~~-------------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH-------------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             CCceEEECCCCccccCcc-------------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence               489999998743211                   1245689999999999999999999999999999999999999


Q ss_pred             CCCCchhHHHHHHHHhccccH-HHHHH---------H-HhcCCCCCcccc------------cccCChHHHHHHHHHhcc
Q 008220          277 PYTDLRAEAQAHTVLEMNYTE-QQLTA---------A-VVSGGLRPILAS------------LELGLPASILSLIQRCWD  333 (573)
Q Consensus       277 Pf~~~~~~~~~~~~~~~~~~~-~~~~~---------~-~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~  333 (573)
                      ||...+.......+....... ..+..         . ...+..++....            .....++.+.+||.+||+
T Consensus       344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  423 (467)
T PTZ00284        344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH  423 (467)
T ss_pred             CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence            998776554444333221110 00000         0 000111111000            000124668899999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHH
Q 008220          334 GNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       334 ~dP~~Rpt~~ell~~l~~~~  353 (573)
                      +||++|||+.|+++|+|...
T Consensus       424 ~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        424 YDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             cChhhCCCHHHHhcCccccc
Confidence            99999999999999999853

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-39  Score=332.05  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=198.7

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..+|++.+.||+|+||.||+|.+  +++.||+|.....      ....|+.+++.++||||+++++++......++|+|+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            35799999999999999999987  4568999974322      234689999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......       
T Consensus       139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-------  210 (357)
T PHA03209        139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-------  210 (357)
T ss_pred             cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-------
Confidence            95 5888888766667899999999999999999999999999999999999999999999999998643210       


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhH---------HHHHHHHh
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDLRAE---------AQAHTVLE  292 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~Pf~~~~~~---------~~~~~~~~  292 (573)
                                .......||+.|+|||++.+..++.++|||||||++|||+++ ..+|......         .....++.
T Consensus       211 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~  280 (357)
T PHA03209        211 ----------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS  280 (357)
T ss_pred             ----------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence                      012345689999999999999999999999999999999985 4444432111         01111111


Q ss_pred             c-cccHH--------HHHHHHhc--CCCCCccc---c-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 M-NYTEQ--------QLTAAVVS--GGLRPILA---S-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~-~~~~~--------~~~~~~~~--~~~~~~~~---~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      . .....        ........  ...+....   . ....++.++.+||.+||+.||++|||+.|+++|+|+.
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence            0 00000        00000000  00000000   0 0125677888999999999999999999999998863

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-38  Score=314.36  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=199.8

Q ss_pred             ccccccccccCceEEEEEEEC--C--eeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc------CCc
Q 008220           68 YTLLSPIARGAESVVYEATLD--G--RKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPN  135 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~  135 (573)
                      |.+.+.||+|+||.||+|...  +  ..+|+|.....  .....+.+..|+.+++.++||||+++++.+..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            457789999999999999863  2  26899975543  34556788999999999999999999987643      235


Q ss_pred             eEEEEEeccCCChhhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          136 YMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .++++||+.+|+|.+++..     ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            7899999999999887742     22347899999999999999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  289 (573)
                      .......              ........+++.|++||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus       161 ~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  226 (272)
T cd05075         161 KIYNGDY--------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY  226 (272)
T ss_pred             ccCcccc--------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            5532110              000122346778999999999999999999999999999999 8999987544332222


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +.              .+.. +   ..+..++..+.++|.+||+.||++|||+.+|+++|..+
T Consensus       227 ~~--------------~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LR--------------QGNR-L---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HH--------------cCCC-C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            21              1111 1   12346788999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-38  Score=314.52  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=207.8

Q ss_pred             CCCccccccccccCceEEEEEEEC--C---eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ...|++.+.||+|+||.||+|...  +   ..||||..... .......+..|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            356899999999999999999863  2   36999986544 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+++|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            99999999999998766657899999999999999999999999999999999999999999999999998655321110


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                 ...........+..|+|||.+.+..++.++|||||||++||+++ |..||...........+.      
T Consensus       163 -----------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~------  225 (269)
T cd05065         163 -----------PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE------  225 (269)
T ss_pred             -----------cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH------
Confidence                       00000011122457999999998889999999999999999887 999998765433322221      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                               ...+.   ..+..++..+.+++.+||+.+|.+||++.+|+..|..+
T Consensus       226 ---------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 ---------QDYRL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------cCCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     11111   11346788999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=316.91  Aligned_cols=268  Identities=24%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             CCc-cccccccccCceEEEEEEE------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccC--Cc
Q 008220           66 SSY-TLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PN  135 (573)
Q Consensus        66 ~~y-~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~  135 (573)
                      +|| ++.+.||+|+||+||++..      ++..||+|...... ......+.+|+++++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            355 9999999999999988652      46789999865543 23456788999999999999999999987653  45


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .+++|||+.+++|.+++...  .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            88999999999999998653  5899999999999999999999999999999999999999999999999998755321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-HHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT-VLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~-~~~~~  294 (573)
                      ....             .......++..|+|||.+.+..++.++||||||+++|+|++|..||........... .....
T Consensus       161 ~~~~-------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (283)
T cd05080         161 HEYY-------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ  227 (283)
T ss_pred             chhh-------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence            1100             001123456679999999888899999999999999999999999865432111000 00000


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ......... ......+   ..+..++.++.+++.+||+.+|++|||+.++++.+..+
T Consensus       228 ~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         228 MTVVRLIEL-LERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cchhhhhhh-hhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111111111 1111111   12456789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.1e-39  Score=320.39  Aligned_cols=269  Identities=26%  Similarity=0.313  Sum_probs=211.0

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||.|+||.||+|.+  .++.|++|+.....  ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            589999999999999999986  57899999865543  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      + +++|.+++......+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........     
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-----  154 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-----  154 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-----
Confidence            9 9999999876666789999999999999999999999999999999999999999999999999865532110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||...........+...........
T Consensus       155 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07832         155 ----------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET  224 (286)
T ss_pred             ----------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence                      012334689999999998654 468899999999999999999989977665554444333211110000


Q ss_pred             HHH-------hcCCC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 AAV-------VSGGL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~~~-------~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +..       .....    ...+.......+.++.+||.+||+.+|++|||++++++|+|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            000       00000    000111223567899999999999999999999999998874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-39  Score=318.90  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++++.||+|+||.||++.+  .++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3699999999999999999987  4889999976543 334456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          143 YESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       143 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +++++|..++...  ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence            9999999888653  2368999999999999999999997 59999999999999999999999999988644210    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccC------CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE------IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                    ......+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||...........+.  
T Consensus       157 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--  220 (286)
T cd06622         157 --------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS--  220 (286)
T ss_pred             --------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH--
Confidence                          12334688899999998654      34789999999999999999999997643322211110  


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                               .+..+ ..   +..+..+++++.++|.+||+.+|++||++.+++++.|....
T Consensus       221 ---------~~~~~-~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         221 ---------AIVDG-DP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             ---------HHhhc-CC---CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                     01111 11   12344689999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-38  Score=312.35  Aligned_cols=254  Identities=30%  Similarity=0.447  Sum_probs=205.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +++.++|++.+.||+|+||.||++.+. +..+++|.+.... ...+.+.+|+.+++.++||||+++++++. ....+++|
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            466788999999999999999999874 4579999754332 23456888999999999999999999875 45688999


Q ss_pred             EeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--  157 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--  157 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence            9999999999986533 3578899999999999999999999999999999999999999999999999865432110  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.       
T Consensus       158 -------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------  217 (260)
T cd05069         158 -------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------  217 (260)
T ss_pred             -------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence                         01122345678999999988889999999999999999999 999998765433322221       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                              ....+   ..+...+..+.+++++||..||++||+++++++.|.
T Consensus       218 --------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         218 --------RGYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             --------cCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence                    11111   123467899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.6e-39  Score=312.40  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=209.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++++.||.|+||.||.++.  +++.+++|.+...  .......+.+|+.++++++|+||+++++++......+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            589999999999999988876  5788999976543  344556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++........    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~----  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS----  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc----
Confidence            9999999998765 34689999999999999999999999999999999999999999999999999865432110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..         
T Consensus       157 ------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---------  215 (256)
T cd08221         157 ------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---------  215 (256)
T ss_pred             ------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------
Confidence                        12345689999999999888889999999999999999999999976554433333322         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                           +...+    .+..++.++.++|.+||..+|.+||++.+++++++
T Consensus       216 -----~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         216 -----GNYTP----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             -----CCCCC----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence                 22222    12467899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.8e-39  Score=320.69  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||++.+  .++.+|+|.....   .......+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4799999999999999999987  5789999975432   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......     
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence            9999999999987654 7899999999999999999999999999999999999999999999999998654321     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                    .....|++.|+|||.+.+...+.++||||||+++|+|++|..||...........+..        
T Consensus       155 --------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  212 (290)
T cd05580         155 --------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------  212 (290)
T ss_pred             --------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence                          2234688999999999888889999999999999999999999987653333222221        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                            +.  +   ..+..+++.+.++|.+||+.||.+|+     +++|+++|.|.
T Consensus       213 ------~~--~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         213 ------GK--V---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             ------CC--c---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence                  11  1   12346789999999999999999999     89999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-38  Score=318.03  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             cCCCCccccccccccCceEEEEEEEC------------------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCcc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD------------------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGL  123 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI  123 (573)
                      ++.++|++.++||+|+||.||++.+.                  +..+|+|...... ......+.+|+.+++.++||||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            56678999999999999999998532                  3368999865443 3345678999999999999999


Q ss_pred             ceeeeccccCCceEEEEEeccCCChhhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      +++++++......+++|||+.+++|.+++....          ..+++.++..++.|++.||+|||+.|++||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999886532          1356788999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      +++.++.++|+|||++.........              .......+++.|++||...+..++.++|+|||||++|||++
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~  227 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYY--------------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT  227 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcce--------------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence            9999999999999998654321000              01122345678999999888889999999999999999998


Q ss_pred             --CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          274 --GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       274 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                        |..||..............       ..   ....... ....+..+++.+.+|+.+||+.||++||++.+|++.|.
T Consensus       228 ~~~~~p~~~~~~~~~~~~~~~-------~~---~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         228 LCKEQPYSQLSDEQVIENTGE-------FF---RDQGRQV-YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hCCCCCccccChHHHHHHHHH-------HH---hhccccc-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              7889976554433222111       00   0000000 11123457899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=311.37  Aligned_cols=246  Identities=31%  Similarity=0.495  Sum_probs=205.8

Q ss_pred             ccccccCceEEEEEEEC-----CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATLD-----GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|...     +..|++|........ ....+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            47999999999999874     778999986655433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          146 RNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       146 g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ++|.+++...        ...+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            9999999775        35789999999999999999999999999999999999999999999999999876543111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    ........+++.|+|||.+....++.++||||||+++|+|++ |..||...........+..    
T Consensus       161 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----  222 (262)
T cd00192         161 --------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK----  222 (262)
T ss_pred             --------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----
Confidence                          011234457889999999988889999999999999999999 6999987744433332221    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                + .+   ...+..++.++.+++.+||+.+|.+|||+.|++++|
T Consensus       223 ----------~-~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         223 ----------G-YR---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             ----------C-CC---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                      1 11   123456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-38  Score=311.23  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=208.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++++.++|++.++||+|+||.||++.+ .+..+++|..... ....+.+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            467789999999999999999999986 4567999975533 3345678899999999999999999999887 788999


Q ss_pred             EEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++++|.+++... ...+++.++..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999999998653 34578889999999999999999999999999999999999999999999999865432100 


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......++..|+|||++.+..++.++|+|||||++|++++ |..||...........+.      
T Consensus       158 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------  217 (260)
T cd05073         158 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE------  217 (260)
T ss_pred             --------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh------
Confidence                          01122345678999999998889999999999999999999 999998765443332221      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                               .....   ..+...+.++.+++.+||+.+|++||++.++++.|.
T Consensus       218 ---------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         218 ---------RGYRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             ---------CCCCC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence                     11111   123467889999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-38  Score=313.07  Aligned_cols=238  Identities=24%  Similarity=0.335  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEEC--------------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           72 SPIARGAESVVYEATLD--------------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +.||+|+||.||+|+..              ...|++|............+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999742              2358888865555555667888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC-------CeEeeeecch
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-------PHLADFGLAE  210 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~-------~kL~Dfg~a~  210 (573)
                      +||||+++++|..++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.       ++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            999999999999988766557899999999999999999999999999999999999987664       8999999875


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCchhHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELL-TGVVPYTDLRAEAQAH  288 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-tg~~Pf~~~~~~~~~~  288 (573)
                      ....                    .....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ .
T Consensus       161 ~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~  219 (262)
T cd05077         161 TVLS--------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-E  219 (262)
T ss_pred             cccC--------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-H
Confidence            4321                    22345788899999886 567899999999999999998 58899876432221 1


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      ....              ....     .....++++.+||.+||+.||++||++.+|++++
T Consensus       220 ~~~~--------------~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYE--------------GQCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHh--------------cCcc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1110              1111     1123467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.1e-39  Score=318.25  Aligned_cols=268  Identities=24%  Similarity=0.317  Sum_probs=206.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++....  ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4799999999999999999987  47899999764332  1223567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |++++.|..++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........    
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD----  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence            999988887765443 689999999999999999999999999999999999999999999999999875532110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..........
T Consensus       156 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07847         156 ------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR  223 (286)
T ss_pred             ------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence                        1223457889999999876 457889999999999999999999998765544433322111000000


Q ss_pred             HHHHh-cCC-----CCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVV-SGG-----LRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~-~~~-----~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..... ...     ..+      .+......++..+.+|+.+||+.+|++|||+.|++.|.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            00000 000     000      001112356889999999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-38  Score=312.41  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=206.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .+|++.+.||+|+||.||++..  +++.++||.+...   .......+.+|+.+++.++||||+++++++..+...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4799999999999999999985  6889999975432   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+.+++|.+++..   ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998763   234578999999999999999999999999999999999999999999999998865432110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........           
T Consensus       162 ----------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----------  214 (267)
T cd08229         162 ----------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----------  214 (267)
T ss_pred             ----------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----------
Confidence                            12234688999999999988899999999999999999999999965422110           


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       .....+......+.   .+..+++++.+++.+||..||.+|||+.+|++.+..+
T Consensus       215 -~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         215 -SLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -HHhhhhhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             11111111111111   1235788999999999999999999999998877553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-38  Score=315.95  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=206.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ++.++|++.+.||+|+||.||++.+       .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            4457899999999999999999976       35789999865543 334567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          135 NYMFFFEFYESRNLAEKLHVEE---------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      ..++++||+++++|.+++....                     ..+++.+++.++.|++.||+|||+.+++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999986321                     2367788999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      +++.++.++|+|||++........              ........++..|+|||.+.+..++.++|||||||++|+|++
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  227 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADY--------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  227 (288)
T ss_pred             EecCCCceEECccccceecccCcc--------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence            999999999999998864321110              000122334677999999998889999999999999999998


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                       |..||.+.........+.              .+...    ..+..++.++.+||.+||+.||.+|||+.|+++.|.
T Consensus       228 ~~~~p~~~~~~~~~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         228 YGMQPYYGMAHEEVIYYVR--------------DGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHh--------------cCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence             888997654443322221              11111    123467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-38  Score=311.86  Aligned_cols=250  Identities=23%  Similarity=0.391  Sum_probs=208.8

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||++..  .++.|++|.+...  .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            589999999999999999986  5789999976543  234456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +.+++|.+.+.... ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........    
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~----  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE----  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh----
Confidence            99999999886543 3578899999999999999999999999999999999999999999999999865432111    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ......|++.|+|||++.+..++.++|+|||||++|++++|..||...........+..         
T Consensus       157 ------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---------  215 (256)
T cd08218         157 ------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR---------  215 (256)
T ss_pred             ------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------
Confidence                        12234588899999999988899999999999999999999999976544433332221         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                           +..    +..+..++.++.++|.+||+.+|.+||++.++++|.|
T Consensus       216 -----~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         216 -----GSY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             -----CCC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence                 211    1224467899999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=321.77  Aligned_cols=266  Identities=26%  Similarity=0.412  Sum_probs=220.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEECC-eeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .+++.++..+.++||+|.||.|.+|...+ .+||||.++..... ....|.+|+++|.+|+||||+.|+++|..++.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            36777889999999999999999998765 99999987765444 45789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      |+||+++|+|.+++.....+ +.......|+.||+.|++||.+.++|||||.++|+|+++++++||+|||+++.+...+.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999999999766422 24456677999999999999999999999999999999999999999999975442111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc--CCCCCCCchhHHHHHHHHhccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT--GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..              .....+-+..|||||.+..+.++.++|+|+||+++||+++  ...||....++......-..  
T Consensus       693 y~--------------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~--  756 (807)
T KOG1094|consen  693 YR--------------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF--  756 (807)
T ss_pred             ee--------------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh--
Confidence            10              1223456789999999999999999999999999999876  88999988776655443221  


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                               ....-+......|.-+|..+.++|.+||+.+-++||++++|..+|..
T Consensus       757 ---------~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  757 ---------FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ---------cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                     12222334445567899999999999999999999999999776654

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-38  Score=313.40  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=209.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc-C
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-P  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~  133 (573)
                      .+..++|++.+.||+|+||.||+|.+.      +..|++|..... .......+.+|+.+++.++||||+++++++.. +
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            456789999999999999999999863      477899876533 34456778899999999999999999998665 5


Q ss_pred             CceEEEEEeccCCChhhhhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeee
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEE-------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF  206 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Df  206 (573)
                      ...+++++|+.+++|.+++....       ..+++.+++.++.|++.||+|||+.+++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            67899999999999999986532       35789999999999999999999999999999999999999999999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA  285 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~  285 (573)
                      |+++.+......              .......++..|+|||++.+..++.++|||||||++|++++ |..||...+...
T Consensus       162 g~~~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  227 (280)
T cd05043         162 ALSRDLFPMDYH--------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE  227 (280)
T ss_pred             CCcccccCCceE--------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence            998654321100              00112345678999999998889999999999999999999 999998764433


Q ss_pred             HHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ....+.               ...++.   .+..+++++.+++.+||+.||++|||+.++++.|..+.+
T Consensus       228 ~~~~~~---------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         228 MAAYLK---------------DGYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHH---------------cCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222111               111111   123578899999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-38  Score=314.90  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +.|+..+.||.|+||.||+|.+  .++.||+|...... ....+.+.+|+.+++.++||||+++++++......++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            4688999999999999999986  57889999865443 34556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++..  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........     
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-----  156 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-----  156 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence            999999998854  3678999999999999999999999999999999999999999999999999865432110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+            
T Consensus       157 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------  213 (277)
T cd06642         157 -----------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------  213 (277)
T ss_pred             -----------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------------
Confidence                       122346788999999999988999999999999999999999999765433222111            


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                         .....+   ..+..++.++.++|.+||+.+|++||++.++++|.|...
T Consensus       214 ---~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         214 ---PKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             ---hcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence               011111   223457889999999999999999999999999988653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-38  Score=306.83  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=200.3

Q ss_pred             ccccccCceEEEEEEE-CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChh
Q 008220           72 SPIARGAESVVYEATL-DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA  149 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  149 (573)
                      ++||.|+||.||+|.. .++.+|+|...... ......+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999976 56789999865443 333456889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCC
Q 008220          150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP  229 (573)
Q Consensus       150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  229 (573)
                      +++......+++..+..++.|++.+|.|||+.|++||||||+||+++.++.+||+|||++........            
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------------  148 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------------  148 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc------------
Confidence            99876555688999999999999999999999999999999999999999999999998864321000            


Q ss_pred             CCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                         .......+++.|+|||++.+..++.++||||||+++|++++ |..||...........+..               .
T Consensus       149 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---------------~  210 (250)
T cd05085         149 ---SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---------------G  210 (250)
T ss_pred             ---ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------------C
Confidence               00112234678999999998889999999999999999998 9999987654433222211               1


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      .+.   ..+..++..+.+++.+||+.+|++||++.++++.+
T Consensus       211 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         211 YRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             CCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            111   12346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.3e-38  Score=309.69  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||+|..  +++.|++|.+..   ........+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4799999999999999999987  588999997543   22334667899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+++++|.+++..   ....+++.+++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence            99999999998853   23457899999999999999999999999999999999999999999999999986543210 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||......            .
T Consensus       161 ---------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~  213 (267)
T cd08224         161 ---------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------L  213 (267)
T ss_pred             ---------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------------H
Confidence                           0122346888999999999888999999999999999999999999654211            0


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .........+...+. +  ...++..+.++|.+||..+|++|||+.+|++.+..+
T Consensus       214 ~~~~~~~~~~~~~~~-~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         214 YSLCKKIEKCDYPPL-P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             HHHHhhhhcCCCCCC-C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            011111111111111 1  125788999999999999999999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.6e-39  Score=318.99  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .+.|.....||.|+||.||++.+  ++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            35677788899999999999986  5789999987666556667789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|.+++...  .++++++..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......      
T Consensus       101 ~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------  172 (292)
T cd06658         101 LEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV------  172 (292)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc------
Confidence            9999999987543  57899999999999999999999999999999999999999999999999986442110      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......|++.|+|||.+.+..++.++|+||||+++|||++|..||...........+..          
T Consensus       173 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----------  232 (292)
T cd06658         173 ----------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD----------  232 (292)
T ss_pred             ----------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence                      012345689999999999988899999999999999999999999986544332221110          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                           ...+.+. ....++..+.+++.+||..||.+|||+.+++++.|....
T Consensus       233 -----~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         233 -----NLPPRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             -----cCCCccc-cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence                 1111111 123568899999999999999999999999999877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-38  Score=322.09  Aligned_cols=263  Identities=27%  Similarity=0.409  Sum_probs=212.5

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeee
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA  128 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  128 (573)
                      .+++...+|++.+.||+|+||.||++.+.         ...||+|..... .....+.+.+|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            36777789999999999999999999752         236899976543 234567889999999999 7999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      ++......++++||+.+|+|.+++....               ..+++.++..++.|++.||+|||+.|++||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            9999999999999999999999986432               2467788999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      |++.++.+||+|||+++........              .......++..|+|||++.+..++.++||||||+++|||++
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  231 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYY--------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT  231 (334)
T ss_pred             EEcCCCcEEECCcccceeccccccc--------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence            9999999999999998654321100              00112234567999999999999999999999999999998


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       |..||...........+..              + ..+   ..+..++.++.+|+.+||+.+|++|||+.+++++|..+
T Consensus       232 ~g~~p~~~~~~~~~~~~~~~--------------~-~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         232 LGGSPYPGIPVEELFKLLKE--------------G-HRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             cCCCCCCCCCHHHHHHHHHc--------------C-CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             8999987654443332211              1 111   12346788999999999999999999999999999888


Q ss_pred             HH
Q 008220          353 LE  354 (573)
Q Consensus       353 ~~  354 (573)
                      ..
T Consensus       294 ~~  295 (334)
T cd05100         294 LT  295 (334)
T ss_pred             hh
Confidence            75

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=300.91  Aligned_cols=256  Identities=21%  Similarity=0.285  Sum_probs=204.9

Q ss_pred             CCcccc-ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeecccc----CCceE
Q 008220           66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~~~  137 (573)
                      ++|++. ++||-|-.|.|-.+.+  +++++|+|++.-     .....+|+++.-.. .|||||.++++|++    ...+.
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            456654 4689999999999976  688999998532     24456888886555 59999999999875    34677


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +|||.++||.|...+..++ ..+++.++..|++||..|+.|||+.+|.||||||+|+|...   +..+||+|||+|+.-.
T Consensus       136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            8999999999999997655 46899999999999999999999999999999999999975   4468999999997543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .                 .....+.+-||.|.|||++..+.|+...|+||+||++|-|++|.+||........       
T Consensus       216 ~-----------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------  271 (400)
T KOG0604|consen  216 E-----------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------  271 (400)
T ss_pred             C-----------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence            2                 1124667889999999999999999999999999999999999999986532111       


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                         ...+..++..+.+. +....+..+|+..+++|+.+|+.+|.+|.|+.++++|+|....
T Consensus       272 ---spgMk~rI~~gqy~-FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  272 ---SPGMKRRIRTGQYE-FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             ---ChhHHhHhhccCcc-CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence               11122222223221 2223356789999999999999999999999999999997653

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=320.20  Aligned_cols=270  Identities=24%  Similarity=0.345  Sum_probs=213.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|.+  +++.||+|.+.....   .....+..|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4799999999999999999987  478999998654432   34567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998753 3468999999999999999999999999999999999999999999999999986543211100


Q ss_pred             ccccc-------------CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          220 LKNWR-------------SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       220 ~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      .....             ...............|+..|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence            00000             00000111122345789999999999988899999999999999999999999987655443


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC----HHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS----FSDIALELDLV  352 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~l~~~  352 (573)
                      ...+....                +..+. ...+++++.++|.+||..||++|||    +.+++.|.|..
T Consensus       241 ~~~~~~~~----------------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         241 FSNILKKE----------------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             HHHHhcCC----------------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            33322111                11111 1237899999999999999999999    99999988764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.8e-38  Score=308.56  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=198.0

Q ss_pred             ccccccCceEEEEEEEC-----CeeEEEeeccC-CChHHHHHHHHHHHHHHhCCCCccceeeeccc-cCCceEEEEEecc
Q 008220           72 SPIARGAESVVYEATLD-----GRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAHA-KPPNYMFFFEFYE  144 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~  144 (573)
                      +.||+|+||.||+|.+.     ...+|+|.... ......+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999752     35799998643 33455678889999999999999999999765 4556889999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++......+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.........     
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~-----  155 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS-----  155 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee-----
Confidence            999999997655567788889999999999999999999999999999999999999999999986543211000     


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                             ........++..|+|||.+.+..++.++|||||||++|||++ |.+||...........+             
T Consensus       156 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-------------  215 (262)
T cd05058         156 -------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-------------  215 (262)
T ss_pred             -------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------------
Confidence                   000123346778999999988889999999999999999999 56677654333222211             


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       ..+ ..+.   .+..+++.+.+++.+||..+|++||++.++++.+..+.
T Consensus       216 -~~~-~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         216 -LQG-RRLL---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -hcC-CCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             111 1111   13357889999999999999999999999999987765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.6e-38  Score=309.29  Aligned_cols=252  Identities=27%  Similarity=0.439  Sum_probs=206.0

Q ss_pred             CCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ...+|++.+.||+|+||.||++.+. ++.+++|.+..... ....+.+|++++++++||||+++++++......++|+||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            3468999999999999999999874 77899997653322 235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++......++++.++.++.|++.+|+|||+.+++|+||||+||+++.++.++|+|||++........     
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-----  155 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-----  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-----
Confidence            999999999876655688999999999999999999999999999999999999999999999998864421000     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.          
T Consensus       156 ----------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------  215 (256)
T cd05112         156 ----------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN----------  215 (256)
T ss_pred             ----------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh----------
Confidence                      00112335678999999998889999999999999999998 999998655433332221          


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                           ...++.   .+...+..+.+|+.+||+.+|++|||+.++++++
T Consensus       216 -----~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         216 -----AGFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 111111   1234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-38  Score=314.16  Aligned_cols=268  Identities=25%  Similarity=0.366  Sum_probs=205.8

Q ss_pred             CCccccccccccCceEEEEEEE------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccC--Cce
Q 008220           66 SSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~  136 (573)
                      +-|++++.||+|+||.||++..      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4579999999999999999973      46789999865442 34456789999999999999999999988765  568


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            99999999999999987655568999999999999999999999999999999999999999999999999987553211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH---hc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL---EM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~  293 (573)
                      ..             ........++..|+|||.+.+..++.++|||||||++|+|+++..|+.......  ....   ..
T Consensus       164 ~~-------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~--~~~~~~~~~  228 (284)
T cd05079         164 EY-------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF--LKMIGPTHG  228 (284)
T ss_pred             cc-------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh--hhhcccccc
Confidence            10             001123456778999999988889999999999999999999877654321110  0000   00


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .............+. +.   ..+..++..+.+|+.+||+.||++|||+.++++.+..+
T Consensus       229 ~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         229 QMTVTRLVRVLEEGK-RL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccHHHHHHHHHcCc-cC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            011111111111111 11   12346889999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-38  Score=313.27  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=207.8

Q ss_pred             cCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ++.++|++.+.||+|+||.||+|+..       .+.|++|........ ..+.+.+|++++++++||||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            34578999999999999999999852       357899976554433 4677899999999999999999999999989


Q ss_pred             ceEEEEEeccCCChhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeee
Q 008220          135 NYMFFFEFYESRNLAEKLHVEE--------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF  206 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Df  206 (573)
                      ..++||||+++++|.+++....        ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999986543        15789999999999999999999999999999999999999999999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA  285 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~  285 (573)
                      |++.......               ........++..|+|||.+.+..++.++||||||+++|++++ |..||.......
T Consensus       162 ~~~~~~~~~~---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~  226 (275)
T cd05046         162 SLSKDVYNSE---------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE  226 (275)
T ss_pred             ccccccCccc---------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence            9875432110               011223456778999999988888999999999999999999 889997654433


Q ss_pred             HHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .......              +....   ..+..++..+.+++.+||+.+|.+|||+.+++..++
T Consensus       227 ~~~~~~~--------------~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         227 VLNRLQA--------------GKLEL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHHc--------------CCcCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            3222211              11111   123467899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.5e-38  Score=311.79  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=202.8

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .......||+|+||.||+|.+  ++..|++|..........+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            334446899999999999986  467899998776666677789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhhhhhcc
Q 008220          145 SRNLAEKLHVEEWSP--SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +++|.+++......+  ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++........    
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~----  164 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----  164 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC----
Confidence            999999987653345  78889999999999999999999999999999999976 67899999998864431100    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  ......|++.|+|||.+.+..  ++.++|+||+|+++|+|++|..||............         
T Consensus       165 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---------  223 (268)
T cd06624         165 ------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---------  223 (268)
T ss_pred             ------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---------
Confidence                        112345789999999986543  788999999999999999999999754321111100         


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                          ....   ...+..+..+++++.+++++||+.+|.+|||+.+++.|+|
T Consensus       224 ----~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         224 ----VGMF---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             ----hhhh---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence                0000   1112234568899999999999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-38  Score=316.92  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=211.1

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +..++|++.+.||+|+||+||++.+  .++.||+|+..... ......+.+|+++++.++||||+++++.+.....+++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            3456899999999999999999987  47889999765433 33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      +||+++++|.+++...+ .+++..+..++.+++.+|.|||+ .+++||||||+||+++.++.++|+|||++......   
T Consensus        82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             EecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999999887644 68999999999999999999997 69999999999999999999999999987543210   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ......|+..|+|||++.+..++.++|+|||||++|++++|..||............   .....
T Consensus       158 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~  219 (284)
T cd06620         158 ---------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---PMGIL  219 (284)
T ss_pred             ---------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---hhHHH
Confidence                           112346899999999998888899999999999999999999999865432110000   00000


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .......... .+.++  ...++.++.+|+.+||+.||++|||+.|++++++.+..
T Consensus       220 ~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         220 DLLQQIVQEP-PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHhhcc-CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            1111111111 11111  12378899999999999999999999999998877543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-38  Score=311.40  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-----ChHHHHHHHHHHHHHHhCCCCccceeeecccc--CCce
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~  136 (573)
                      ..|++.+.||+|+||.||++.+  +++.|++|++...     .......+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4699999999999999999986  5789999975432     22345678899999999999999999998865  3568


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            89999999999999987654 58889999999999999999999999999999999999999999999999986543110


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .             .........++..|+|||.+.+..++.++|+||+||++|+|++|..||.............     
T Consensus       161 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----  222 (266)
T cd06651         161 M-------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----  222 (266)
T ss_pred             c-------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----
Confidence            0             0001123458899999999998889999999999999999999999998654332222111     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                               .....   +..+..+++.+.+++ +||..+|++||+++||++|.+.
T Consensus       223 ---------~~~~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         223 ---------TQPTN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA  264 (266)
T ss_pred             ---------cCCCC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence                     11111   223345788899999 6888899999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-38  Score=310.89  Aligned_cols=259  Identities=22%  Similarity=0.362  Sum_probs=210.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CC----eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DG----RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +...+|++.+.||+|+||.||+|.+  ++    ..+|+|...... ......+.+|+.+++.++||||+++++++.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            4557899999999999999999975  23    258999765443 3445678899999999999999999999887 78


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++|+||+.+|+|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999999876667899999999999999999999999999999999999999999999999998765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..              ........++..|+|||.+....++.++|+||||+++||+++ |..||...........+.   
T Consensus       163 ~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---  225 (279)
T cd05057         163 EK--------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---  225 (279)
T ss_pred             cc--------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---
Confidence            11              000112234678999999988889999999999999999998 999998765443322221   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 .+...    ..+...+..+.+++.+||..||.+|||+.++++.+..+..
T Consensus       226 -----------~~~~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         226 -----------KGERL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -----------CCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                       11111    1234577899999999999999999999999998887754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-38  Score=313.27  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=210.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..|+..+.||.|+||.||+|.+  .++.||+|...... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            4688999999999999999986  57899999865443 34567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++...  .+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......      
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~------  155 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ------  155 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc------
Confidence            9999999988643  57889999999999999999999999999999999999999999999999986543211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.           
T Consensus       156 ----------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-----------  214 (277)
T cd06640         156 ----------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-----------  214 (277)
T ss_pred             ----------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------
Confidence                      01233467889999999998889999999999999999999999998654433222111           


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                          ....   +..+..++..+.+++.+||+.+|++||++.+++.|.+....
T Consensus       215 ----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         215 ----KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ----cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                1111   12334578899999999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3e-38  Score=310.67  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=203.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-----ChHHHHHHHHHHHHHHhCCCCccceeeeccccC--Cce
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~  136 (573)
                      +.|++.+.||+|+||.||++.+  +++.|++|.+...     .......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5799999999999999999986  5789999975432     123456788999999999999999999988764  467


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            89999999999999987554 67889999999999999999999999999999999999999999999999886543210


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .             .........|+..|+|||++.+..++.++|+|||||++|+|++|..||.............     
T Consensus       161 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----  222 (265)
T cd06652         161 L-------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----  222 (265)
T ss_pred             c-------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----
Confidence            0             0001223468899999999988888999999999999999999999997654333222211     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                               .....   +..+..++..+.++|.+||. +|++||++++|++|.|
T Consensus       223 ---------~~~~~---~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         223 ---------TQPTN---PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             ---------cCCCC---CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence                     11111   22344678889999999995 9999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=309.67  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=197.7

Q ss_pred             ccccccCceEEEEEEEC--Ce--eEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATLD--GR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~--~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|+||.||+|.+.  +.  .+++|..... .....+.+.+|+.+++++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999863  32  4688876533 344556788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          146 RNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       146 g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ++|.+++....               ..+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99999986432               246889999999999999999999999999999999999999999999999875


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  289 (573)
                      ......                 .......+..|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus       161 ~~~~~~-----------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  223 (270)
T cd05047         161 GQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  223 (270)
T ss_pred             ccchhh-----------------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence            221100                 0111233567999999988889999999999999999997 9999976543332222


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      +.              . ..+.   ..+..++.++.+|+.+||..||.+|||+.+++..|..++
T Consensus       224 ~~--------------~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LP--------------Q-GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             Hh--------------C-CCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11              1 1111   123357889999999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-38  Score=312.89  Aligned_cols=237  Identities=26%  Similarity=0.345  Sum_probs=190.5

Q ss_pred             cccccCceEEEEEEEC--------------------------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcccee
Q 008220           73 PIARGAESVVYEATLD--------------------------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF  126 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  126 (573)
                      +||+|+||.||+|...                          ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998631                          13588888655544455678889999999999999999


Q ss_pred             eeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-------
Q 008220          127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-------  199 (573)
Q Consensus       127 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-------  199 (573)
                      ++++......++||||+++|+|..++......+++..+..++.|++.||+|||+.||+||||||+|||++..+       
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999999876555789999999999999999999999999999999999997654       


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHH-cCCCC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELL-TGVVP  277 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-tg~~P  277 (573)
                      .+||+|||++.....                    .....++..|+|||.+.+ ..++.++|||||||++||++ +|..|
T Consensus       162 ~~kl~d~g~~~~~~~--------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         162 FIKLSDPGVSFTALS--------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             eeeecCCcccccccc--------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            379999998743211                    122357788999998865 56789999999999999995 69999


Q ss_pred             CCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      |.......... ...              ..  .   ..+...++.+.++|.+||+.+|++|||+.+|+++|
T Consensus       222 ~~~~~~~~~~~-~~~--------------~~--~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         222 LKERTPSEKER-FYE--------------KK--H---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ccccChHHHHH-HHH--------------hc--c---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            97654332211 110              00  0   11223567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-38  Score=312.61  Aligned_cols=238  Identities=24%  Similarity=0.325  Sum_probs=192.7

Q ss_pred             ccccccCceEEEEEEEC---------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           72 SPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +.||.|+||.||+|...         ...+++|..........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999752         234888876554445567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--------CeEeeeecchhhhh
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--------PHLADFGLAEYREN  214 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--------~kL~Dfg~a~~~~~  214 (573)
                      +.+|+|.+++...+..+++..++.++.||+.||+|||+.||+||||||+||+++.++.        ++++|||.+.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            9999999999876657899999999999999999999999999999999999988765        58999998753321


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHHHh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTG-VVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~  292 (573)
                                          .....+++.|+|||++.+ ..++.++||||||+++|+|++| ..||.......... ...
T Consensus       161 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~  219 (258)
T cd05078         161 --------------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE  219 (258)
T ss_pred             --------------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH
Confidence                                223467889999999986 4578899999999999999998 56665443322111 110


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                    .  +   ...+...+.++.+||.+||+.||++|||+++|++.|
T Consensus       220 --------------~--~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 --------------D--R---HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --------------c--c---ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                          0  0   112335678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-38  Score=312.26  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC------hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +|+..+.||+|+||.||++.+  +++.||+|.+....      ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            488899999999999999986  67899999865432      1235678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~  217 (573)
                      |+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++........
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            999999999999987544 688999999999999999999999999999999999998876 599999999866542100


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                  ..........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+       
T Consensus       160 ------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------  220 (268)
T cd06630         160 ------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-------  220 (268)
T ss_pred             ------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-------
Confidence                        0011123456889999999998888999999999999999999999999754321111111       


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                          .........   +..+..+++++.+++.+||+.+|.+|||+.++++|.+.
T Consensus       221 ----~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         221 ----FKIASATTA---PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             ----HHHhccCCC---CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence                111111111   22344678999999999999999999999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-38  Score=316.85  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=209.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      .-|.....||+|+||.||++.+  +++.||+|.+..........+.+|+.+++.++||||+++++++..+...++++||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            3466677899999999999986  57899999876554445567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      ++++|..++..  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......       
T Consensus       101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------  171 (297)
T cd06659         101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------  171 (297)
T ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-------
Confidence            99999987754  358899999999999999999999999999999999999999999999999886443110       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..           
T Consensus       172 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----------  231 (297)
T cd06659         172 ---------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-----------  231 (297)
T ss_pred             ---------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------
Confidence                     012345689999999999988899999999999999999999999976544333222211           


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                          . .+.....+..++..+.++|.+||+.+|.+||++.+++++.+...
T Consensus       232 ----~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         232 ----S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             ----c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence                0 01111123467889999999999999999999999999987664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.8e-38  Score=308.85  Aligned_cols=246  Identities=29%  Similarity=0.450  Sum_probs=203.0

Q ss_pred             CCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .++|++.+.||+|+||.||++...++.||+|......  ..+.+.+|+.+++.++||||+++++++... ..+++|||+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3679999999999999999999899999999865432  345788999999999999999999998654 5789999999


Q ss_pred             CCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          145 SRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       145 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      +++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......        
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--------  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--------  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--------
Confidence            999999987543 35788999999999999999999999999999999999999999999999988543210        


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.           
T Consensus       154 -----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----------  211 (254)
T cd05083         154 -----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-----------  211 (254)
T ss_pred             -----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----------
Confidence                       112234567999999988889999999999999999998 999998765433322221           


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                          .+.++.   .+..++..+.+++.+||+.+|++||++.++++.+.
T Consensus       212 ----~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         212 ----KGYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ----CCCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                111221   23467899999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-38  Score=309.18  Aligned_cols=249  Identities=27%  Similarity=0.433  Sum_probs=206.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC-----hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +|+..+.||+|+||.||+|..  +++.|++|.+....     .+..+.+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            588889999999999999986  57899999754432     23456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......   
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---
Confidence            99999999999987554 68899999999999999999999999999999999999999999999999886543211   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    ......|++.|++||.+.... ++.++|+||||+++|+|++|..||...........+.       
T Consensus       157 --------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------  215 (258)
T cd06632         157 --------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG-------  215 (258)
T ss_pred             --------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH-------
Confidence                          123456889999999987766 8899999999999999999999997654222221111       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                             ...   ..+..+..+++.+.+++++||+.+|.+||++.+++.+.|
T Consensus       216 -------~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         216 -------RSK---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             -------hcc---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence                   101   112234568899999999999999999999999998764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-38  Score=314.45  Aligned_cols=254  Identities=23%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeecccc------C
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK------P  133 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~------~  133 (573)
                      .+...|++.+.||.|+||.||+|.+  .++.+|+|...... .....+..|+.+++++ +||||+++++++..      .
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            3557899999999999999999987  57889999865443 3445688899999998 69999999999853      4


Q ss_pred             CceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ..++++|||+.+|+|.+++... ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            5789999999999999988653 345788889999999999999999999999999999999999999999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      ....                .......|++.|+|||.+.     +..++.++|+|||||++|+|++|..||.........
T Consensus       172 ~~~~----------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         172 DRTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             hccc----------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            3110                0123456899999999986     345788999999999999999999999765433222


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..+..              . ..+  ......++.++.+||.+||+.||.+|||+.||++|.|
T Consensus       236 ~~~~~--------------~-~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         236 FLIPR--------------N-PPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             hhHhh--------------C-CCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            21110              0 011  1112357899999999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.7e-38  Score=316.56  Aligned_cols=270  Identities=26%  Similarity=0.264  Sum_probs=208.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChH-----HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-----ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +|++.+.||.|+||.||+|.+  +++.|++|.+......     ....+..|+++++.++||||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999987  5789999986544322     334567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+ +++|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN---  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence            9999 889999987655478999999999999999999999999999999999999999999999999986543211   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+........
T Consensus       157 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~  223 (298)
T cd07841         157 -------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT  223 (298)
T ss_pred             -------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence                         01223356888999999865 4578899999999999999999888877655444333332111110


Q ss_pred             HHHHHHhcC---------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSG---------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .........         .............+.++.++|.+||+.||++|||+.|++++.|+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            000000000         0000111122356789999999999999999999999999887643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=307.01  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=199.2

Q ss_pred             ccccccCceEEEEEEEC-----CeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATLD-----GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      ++||+|+||.||+|.+.     +..+|+|....... ...+.+.+|+.+++.+.||||+++++++. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999752     26799998654433 34567889999999999999999999875 5578999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||+++........       
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~-------  151 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-------  151 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc-------
Confidence            99999997655 7899999999999999999999999999999999999999999999999998755321100       


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                            ........++..|+|||.+.+..++.++||||||+++|++++ |..||...+.......+..            
T Consensus       152 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------  213 (257)
T cd05060         152 ------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------  213 (257)
T ss_pred             ------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------
Confidence                  000111234567999999998889999999999999999998 9999987654333222211            


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                        .. ..   ..+..++..+.++|.+||+.+|++||++.++++.|..+
T Consensus       214 --~~-~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         214 --GE-RL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CC-cC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              11 11   12346789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-38  Score=315.79  Aligned_cols=268  Identities=23%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.++||+|+||.||+|.+  .++.||+|+.....  ....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4799999999999999999987  47899999754322  2234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.++.|..+..... .+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-----  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-----  154 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence            999988887765443 58999999999999999999999999999999999999999999999999986543211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+..........
T Consensus       155 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07846         155 -----------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR  223 (286)
T ss_pred             -----------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence                       01233567899999999875 446889999999999999999999997665444333332211110000


Q ss_pred             HHH------HhcCCCCCc------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAA------VVSGGLRPI------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~------~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...      .......+.      .....+.++..+.+|+.+||+.+|++||++.++++|.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            000      000000010      01123467899999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-38  Score=309.93  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=206.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||++..  +++.+|+|.+...  .......+.+|+++++.++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            589999999999999999976  6788999986543  234567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      +++++|.+++.... ..+++..+..++.|++.+|+|||++|++|+||+|+||+++.++ .+||+|||++.......    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~----  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----
Confidence            99999999997643 3578999999999999999999999999999999999998654 57999999986543210    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..        
T Consensus       157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--------  215 (256)
T cd08220         157 -------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--------  215 (256)
T ss_pred             -------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------
Confidence                         12235688999999999988889999999999999999999999977654333322221        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                            +...    ..+..+++++.+++.+||+.+|.+|||+.|+++|++
T Consensus       216 ------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         216 ------GTFA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             ------cCCC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence                  1111    233467899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.2e-38  Score=313.18  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccc-----cCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHA-----KPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-----~~~  134 (573)
                      ...++|++.+.||+|+||.||++.+  .++.+|+|+..... .....+.+|+.+++.+ +||||+++++++.     ...
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            3457999999999999999999987  57889999754322 2235677899999999 6999999999873     456


Q ss_pred             ceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          135 NYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence            78999999999999988752   234678899999999999999999999999999999999999999999999999865


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      .....                .......|++.|+|||++..     ..++.++||||+||++|+|++|..||........
T Consensus       174 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         174 LTSTR----------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             cccCC----------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            43110                01234468999999999853     4578899999999999999999999986543322


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .....               ....+.. ..+..++..+.+||.+||+.||++|||+.|+++|+|
T Consensus       238 ~~~~~---------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         238 LFKIP---------------RNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             Hhhcc---------------ccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            21111               0111111 123346788999999999999999999999999876

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-38  Score=316.41  Aligned_cols=267  Identities=26%  Similarity=0.356  Sum_probs=207.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|++.+.||.|+||.||++.+  .++.|++|.+....   ......+.+|+++++.++||||+++++.+..+...++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            689999999999999999987  56789999765443   2345578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |++|++|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999999997654 6899999999999999999999999999999999999999999999999988642110000000


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                      . ................++..|+|||.+.+..++.++|+|||||++|++++|..||.+............         
T Consensus       161 ~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~---------  230 (305)
T cd05609         161 E-GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---------  230 (305)
T ss_pred             c-cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence            0 000000001112234678899999999888899999999999999999999999986544333332221         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDL  351 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~  351 (573)
                           +...  .+.....+++++.++|.+||+.||++||+   +.+++++.|.
T Consensus       231 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         231 -----DDIE--WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             -----cccC--CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence                 1110  11112357899999999999999999998   6777777665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=313.93  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=204.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCC------
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~------  134 (573)
                      +.++|++.+.||.|++|.||+|.+  .++.+++|....... ..+.+.+|+.+++++ .||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            347899999999999999999987  467899998655443 346788999999999 6999999999986544      


Q ss_pred             ceEEEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          135 NYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      .+++||||+.+++|.+++...   +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            489999999999999988642   35789999999999999999999999999999999999999999999999999865


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ......                ......|++.|+|||++..     ..++.++|||||||++|++++|..||........
T Consensus       163 ~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  226 (275)
T cd06608         163 LDSTLG----------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA  226 (275)
T ss_pred             cccchh----------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence            432110                1234568999999998854     3467889999999999999999999976544333


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...+...               ..+.+. .+..++.++.+||.+||..||++|||+.++++|.|
T Consensus       227 ~~~~~~~---------------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         227 LFKIPRN---------------PPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             HHHhhcc---------------CCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence            3222211               111111 12347789999999999999999999999998875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-38  Score=310.86  Aligned_cols=255  Identities=25%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh----------HHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS----------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +|.+.+.||.|+||.||+|..  +++.+|+|.+.....          ...+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588999999999999999975  578999997543211          12346788999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++|+||+.+++|.+++...+ .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            9999999999999999987654 788999999999999999999999999999999999999999999999999864331


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ..              .........|+..|+|||.+....  ++.++|+||||+++|++++|..||...........+. 
T Consensus       161 ~~--------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  225 (272)
T cd06629         161 IY--------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG-  225 (272)
T ss_pred             cc--------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-
Confidence            10              011123456889999999987654  7889999999999999999999997543322221111 


Q ss_pred             ccccHHHHHHHHhcCCCCC-cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRP-ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                   .....+ ........++.++.++|.+||..+|++|||+.++++|+|
T Consensus       226 -------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         226 -------------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             -------------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence                         111111 112233467899999999999999999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-38  Score=310.37  Aligned_cols=257  Identities=28%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||.|+||.||++.+.  ++.+++|.+.... ......+.+|+++++.++||||+++++.+.....+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36889999999999999999874  7889999765543 34556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +.+++|.+++......+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.......     
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----
Confidence            99999999997664578999999999999999999999 999999999999999999999999999986553211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........         ...+..
T Consensus       156 -------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------~~~~~~  213 (265)
T cd06605         156 -------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---------GIFELL  213 (265)
T ss_pred             -------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---------cHHHHH
Confidence                         1125688899999999999999999999999999999999999975421000         000011


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .... ....+.++.  ..+++++.++|.+||..||++|||+.+++.+.|..
T Consensus       214 ~~~~-~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         214 QYIV-NEPPPRLPS--GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             HHHh-cCCCCCCCh--hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            1111 111122111  12788999999999999999999999999998873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-37  Score=306.97  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=193.4

Q ss_pred             ccccccCceEEEEEEE----CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||+|..    ....+++|.+.... ......+.+|+.+++.++||||+++++.+.....+++||||+.+|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            3699999999999964    23578888755433 334556889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          147 NLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       147 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +|.+++....    ...++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.........    
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----  156 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY----  156 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe----
Confidence            9999986543    23467788999999999999999999999999999999999999999999988543211000    


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                .......+++.|+|||++..       ..++.++|||||||++|||++ |..||............... 
T Consensus       157 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-  225 (269)
T cd05042         157 ----------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-  225 (269)
T ss_pred             ----------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-
Confidence                      00122346778999998743       456789999999999999999 88999876544333322211 


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                  .......+..+..+++.+.+++..|| .||++|||+++|++.+
T Consensus       226 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         226 ------------QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ------------cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                        11111222334568899999999999 5999999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.8e-38  Score=318.14  Aligned_cols=271  Identities=25%  Similarity=0.272  Sum_probs=208.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccC--CceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l  138 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++......  ....+.+|+.++++++||||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46899999999999999999987  5789999986543221  123456799999999999999999998654  56899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+ +|.+++......+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......  
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--
Confidence            9999975 8888887655678999999999999999999999999999999999999999999999999986543210  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.......
T Consensus       163 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         163 --------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             --------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence                          01122345788999999865 557899999999999999999999998877666555554322111


Q ss_pred             HHHHHHHh-----cCCC------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVV-----SGGL------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~-----~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ....+...     .+..      ...+.......++++.+||.+||+.||++|||+.+++.|.|..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            11000000     0000      0000111123688999999999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-38  Score=322.54  Aligned_cols=267  Identities=23%  Similarity=0.318  Sum_probs=205.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999986  6789999986432  334455677899999999999999999987643      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+||||+.+ +|.+.+..   .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999965 78777753   278899999999999999999999999999999999999999999999999865432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus       171 ~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         171 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             C-----------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            0                 01223467899999999999999999999999999999999999998766544444433221


Q ss_pred             ccH-HHHHHH-------HhcCCC---------------CCcc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          295 YTE-QQLTAA-------VVSGGL---------------RPIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       295 ~~~-~~~~~~-------~~~~~~---------------~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..+ .++...       ......               .+.. ...+...++.+.++|.+||+.||++|||+.|++.|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~  313 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY  313 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence            111 111000       000000               0000 0001235778999999999999999999999999998


Q ss_pred             HH
Q 008220          351 LV  352 (573)
Q Consensus       351 ~~  352 (573)
                      ..
T Consensus       314 ~~  315 (353)
T cd07850         314 IN  315 (353)
T ss_pred             Hh
Confidence            75

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-38  Score=313.46  Aligned_cols=266  Identities=24%  Similarity=0.284  Sum_probs=206.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .|++.+.||.|++|.||+|.+  +++.|+||++....  ......+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            488999999999999999987  57899999865432  22335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +. ++|..++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......     
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-----  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-----
Confidence            96 5888887643 3468899999999999999999999999999999999999999999999999986443110     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......+++.|+|||++.+.. ++.++||||||+++|+|+||..||..........++..........
T Consensus       155 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07860         155 -----------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  223 (284)
T ss_pred             -----------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence                       0112335688999999887644 5889999999999999999999998765554444443322111110


Q ss_pred             H-----------HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 T-----------AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .           .... ......+......+++++.++|.+||+.||.+|||+.++++|+|
T Consensus       224 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         224 VWPGVTSLPDYKPSFP-KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             hhhhhhHHHHHHhhcc-cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence            0           0000 00011111223457889999999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.6e-38  Score=315.07  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..+.++|++.+.||+|+||+||+|..  .++.||+|++...   ..+....+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            34457899999999999999999986  5789999976432   234456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++|+||+.+ ++.+.+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....  
T Consensus        91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--  167 (307)
T cd06607          91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--  167 (307)
T ss_pred             EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence            999999975 77777665455789999999999999999999999999999999999999999999999998754321  


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                        .....+++.|+|||++.   ...++.++||||||+++|+|++|..||...+.......+.. 
T Consensus       168 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-  228 (307)
T cd06607         168 ------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-  228 (307)
T ss_pred             ------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-
Confidence                              22346788999999874   35678899999999999999999999977654433222211 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                    ...+.+  .+..++..+.++|.+||+.||++||++.+|+.|+|...
T Consensus       229 --------------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         229 --------------NDSPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             --------------CCCCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                          011111  12346789999999999999999999999999988654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=304.26  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             ccccccCceEEEEEEEC-CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChh
Q 008220           72 SPIARGAESVVYEATLD-GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA  149 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  149 (573)
                      ++||+|+||.||++.+. ++.|++|........ ....+.+|++++++++||||+++++++......++|+||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999874 889999986554333 5667899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCC
Q 008220          150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP  229 (573)
Q Consensus       150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  229 (573)
                      +++......+++..+..++.+++.+|+|||+.+++||||||+||+++.++.+||+|||++........            
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~------------  148 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY------------  148 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc------------
Confidence            99876555788999999999999999999999999999999999999999999999999864431000            


Q ss_pred             CCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                        ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.               ..
T Consensus       149 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---------------~~  211 (251)
T cd05041         149 --TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---------------SG  211 (251)
T ss_pred             --eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---------------cC
Confidence              000112234567999999998889999999999999999999 899997765433222221               11


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...   ..+..++.++.+++.+||+.+|.+|||+.|+++.|.
T Consensus       212 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 YRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            111   123467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-37  Score=304.41  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             ccccccCceEEEEEEEC---C--eeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATLD---G--RKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~---~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||+|++|.||+|.+.   +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            46899999999999862   2  3689998766555 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          146 RNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       146 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      ++|.+.+.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.........      
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~------  153 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH------  153 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc------
Confidence            99999987654 46789999999999999999999999999999999999999999999999998765421110      


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                             ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+..           
T Consensus       154 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----------  215 (257)
T cd05040         154 -------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-----------  215 (257)
T ss_pred             -------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------
Confidence                   001123456788999999998889999999999999999998 9999976655443333221           


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                         .....   ..+..+|..+.+++.+||+.+|++|||+.++++.|
T Consensus       216 ---~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         216 ---EGERL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             ---cCCcC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence               00011   12345788999999999999999999999998766

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.4e-38  Score=307.90  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||.|+||+||+|..  ++..+++|+..... ......+.+|+.+++.++||||+++++.+......++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4799999999999999999986  57789999865432 33567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      +.+++|.+++....  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~--  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR--  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc--
Confidence            99999999987542  36889999999999999999999999999999999999999999999999998765421110  


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                .........|+..|+|||++... .++.++|+|||||++|+|++|..||................     
T Consensus       159 ----------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-----  223 (267)
T cd06610         159 ----------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-----  223 (267)
T ss_pred             ----------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-----
Confidence                      00112345689999999998776 78899999999999999999999998665443333222111     


Q ss_pred             HHHHHhcCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                .+.++..  ...+++++.+++.+||..||++|||+.+|++|+|
T Consensus       224 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         224 ----------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             ----------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence                      1111111  1367899999999999999999999999998865

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.9e-38  Score=307.57  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=205.9

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc--CCceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~  140 (573)
                      +|++.+.||.|+||.||++.+  +++.+++|.+...  .....+.+..|+.+++.++||||+++++.+..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999986  5788999976533  34456678899999999999999999997753  45689999


Q ss_pred             EeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          141 EFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLH-----NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       141 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH-----~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ||+++++|.+++...   ...+++.+++.++.||+.||+|||     +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   347899999999999999999999     899999999999999999999999999998765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      .....                ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+  
T Consensus       161 ~~~~~----------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--  222 (265)
T cd08217         161 GHDSS----------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--  222 (265)
T ss_pred             cCCcc----------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH--
Confidence            42110                123346899999999999888999999999999999999999999876533222221  


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                  ..+.    .+..+..++..+.+++.+||+.+|++|||+.+|++|++
T Consensus       223 ------------~~~~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         223 ------------KEGK----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             ------------hcCC----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence                        1111    12234578899999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=314.79  Aligned_cols=268  Identities=24%  Similarity=0.288  Sum_probs=202.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||.|++|.||+|.+  .++.||+|.+...... ....+.+|+++++.++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            6899999999999999999986  5789999986543221 234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++......      
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------  157 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS------  157 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC------
Confidence            985 8998887655578999999999999999999999999999999999999999999999999985432100      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCch-hHHHHHHHHhccccH-HH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLR-AEAQAHTVLEMNYTE-QQ  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~~~~~~~~~-~~  299 (573)
                                .......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.+.. .......+....... ..
T Consensus       158 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07844         158 ----------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE  227 (291)
T ss_pred             ----------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence                      01122346889999999875 457899999999999999999999997654 222222221111000 00


Q ss_pred             HHHHHhc-CCC---------CCcccccccCCh--HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVS-GGL---------RPILASLELGLP--ASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~-~~~---------~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ....... ...         ...+......++  .++.+++.+||+.+|++|||+.+++.+.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            0000000 000         000001111234  88899999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.3e-38  Score=317.95  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=189.0

Q ss_pred             cccccccCceEEEEEEE----CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccc--cCCceEEEEEecc
Q 008220           71 LSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA--KPPNYMFFFEFYE  144 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~lv~e~~~  144 (573)
                      ..+||+|+||+||+|+.    ++..||+|.+....  ....+.+|+.+++.++||||+++++++.  .....++|+||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            35799999999999985    34689999765432  2235678999999999999999999884  3567899999987


Q ss_pred             CCChhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----cCCCCCeEeeeecchhh
Q 008220          145 SRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR  212 (573)
Q Consensus       145 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----~~~~~~kL~Dfg~a~~~  212 (573)
                      + +|.+++...        ...+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||+++..
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            5 777665421        2247889999999999999999999999999999999999    56678999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH------
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA------  285 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------  285 (573)
                      .....             .........||+.|+|||++.+ ..++.++|||||||++|||+||.+||.......      
T Consensus       163 ~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~  229 (317)
T cd07867         163 NSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF  229 (317)
T ss_pred             CCCcc-------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence            42110             0011234578999999999876 457899999999999999999999996533211      


Q ss_pred             ---HHHHHHhccc-cH-HHH------------HHHHhcCCC-----CCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          286 ---QAHTVLEMNY-TE-QQL------------TAAVVSGGL-----RPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       286 ---~~~~~~~~~~-~~-~~~------------~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                         ....+..... .. ...            .........     ...........+..+.+||.+||+.||.+|||+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~  309 (317)
T cd07867         230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE  309 (317)
T ss_pred             cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence               1111111000 00 000            000000000     0000111123466789999999999999999999


Q ss_pred             HHHHHHH
Q 008220          344 DIALELD  350 (573)
Q Consensus       344 ell~~l~  350 (573)
                      |+++|+|
T Consensus       310 e~l~hp~  316 (317)
T cd07867         310 QALQDPY  316 (317)
T ss_pred             HHhcCCC
Confidence            9999876

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=304.99  Aligned_cols=248  Identities=31%  Similarity=0.518  Sum_probs=204.2

Q ss_pred             ccccccccccCceEEEEEEECC------eeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           68 YTLLSPIARGAESVVYEATLDG------RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +++.+.||.|+||.||++.+..      ..||+|........ ....+..|+.+++.++||||+++++++.+....+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4578899999999999998743      78999987655433 5678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+++++|.+++...... +++.++..++.|++.||++||+.|++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-  159 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-  159 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc-
Confidence            999999999998765433 899999999999999999999999999999999999999999999999998755432110 


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..      
T Consensus       160 --------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------  219 (258)
T smart00219      160 --------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK------  219 (258)
T ss_pred             --------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------
Confidence                          0111236789999999988889999999999999999998 8999987544333332221      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                              +. .+   ..+...+.++.+++.+||+.||++|||+.|+++.
T Consensus       220 --------~~-~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      220 --------GY-RL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             --------CC-CC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence                    11 11   1233578999999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-37  Score=305.77  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=192.5

Q ss_pred             ccccccCceEEEEEEEC----CeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATLD----GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||+|...    +..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999753    35789998655432 33456888999999999999999999999999999999999999


Q ss_pred             ChhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          147 NLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       147 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++........     
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-----  155 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-----  155 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce-----
Confidence            9999986432    2456678889999999999999999999999999999999999999999998854321100     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-------IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                               ........+++.|+|||++.+.       .++.++||||||+++|||++ |..||.............   
T Consensus       156 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---  223 (269)
T cd05087         156 ---------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---  223 (269)
T ss_pred             ---------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---
Confidence                     0012234578889999998642       35789999999999999996 999997654433221111   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                .....+...+......++.+.+++.+|| .+|++|||+++|+..|
T Consensus       224 ----------~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         224 ----------REQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL  267 (269)
T ss_pred             ----------hcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence                      1111111122223357888999999999 6899999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.3e-38  Score=310.52  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ..|...+.||.|++|.||++.+  .++.+++|+.........+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            3566678999999999999986  57889999876655555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+++|.+++..  ..++++++..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.......       
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-------  169 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-------  169 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-------
Confidence            99999999876  368899999999999999999999999999999999999999999999999875432100       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..           
T Consensus       170 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-----------  229 (285)
T cd06648         170 ---------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-----------  229 (285)
T ss_pred             ---------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh-----------
Confidence                     012335688999999999988899999999999999999999999976544333222211           


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                         . ..+.+. .+..++..+.++|.+||+.+|++|||+.++++|.+...
T Consensus       230 ---~-~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         230 ---N-LPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             ---c-CCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence               1 111111 12347889999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.7e-38  Score=314.64  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=210.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ..+|++.+.||+|+||.||++..  +++.|++|..........+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46899999999999999999976  5788999987655555567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|.+++...  .+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......      
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~------  169 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------  169 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc------
Confidence            9999999988643  47889999999999999999999999999999999999999999999999876443211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......|++.|+|||.+.+..++.++|+||||+++|++++|..||...+.......+..          
T Consensus       170 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~----------  229 (293)
T cd06647         170 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------  229 (293)
T ss_pred             ----------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc----------
Confidence                      112345688999999999888889999999999999999999999976543222111100          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                          .. .+... .+..++..+.++|++||..+|.+||++.+++.|.|...
T Consensus       230 ----~~-~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~  274 (293)
T cd06647         230 ----NG-TPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI  274 (293)
T ss_pred             ----CC-CCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence                00 11111 23357889999999999999999999999999987754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=314.42  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=219.5

Q ss_pred             cCCCCccccccccccCceEEEEEEECCee--EEEee---ccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRK--VAVKK---PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--vavK~---~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +.-+.++++..||-|+||.|-++...++.  +|+|.   ..+-...+.+.+..|-.+|...+.|.||++|..|.+....|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            33457888899999999999999876554  67664   34456667788999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ++||-|-||.|+..++.++ .|...+++.++.-+++|++|||.+|||.|||||+|++++.+|-+||.|||+|+.+..   
T Consensus       497 mLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---  572 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---  572 (732)
T ss_pred             hhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence            9999999999999998766 899999999999999999999999999999999999999999999999999987753   


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    +....+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++......|+.+....
T Consensus       573 --------------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i  638 (732)
T KOG0614|consen  573 --------------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI  638 (732)
T ss_pred             --------------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence                          223678999999999999999999999999999999999999999999998888877777543211


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~  351 (573)
                                       ..|..++....+||+++...+|.+|..     +.+|.+|-|+
T Consensus       639 -----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  639 -----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             -----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence                             235678999999999999999999986     4555544443

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.1e-37  Score=310.85  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=205.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCe----eEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..++|+..+.||+|+||.||+|.+  ++.    .+|+|...... ......+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            346899999999999999999976  343    57888765433 23344688999999999999999999998654 56


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++++||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            78999999999999987666578899999999999999999999999999999999999999999999999987553211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .              ........++..|+|||.+.+..++.++|||||||++||+++ |..||.+........ +.    
T Consensus       164 ~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~----  224 (303)
T cd05110         164 K--------------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LL----  224 (303)
T ss_pred             c--------------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH----
Confidence            1              001122345778999999999899999999999999999997 999997653322211 11    


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                .....+.   .+...+..+.+++.+||..+|++||++.++++.+..+..
T Consensus       225 ----------~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         225 ----------EKGERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ----------HCCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      1111111   123567899999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-37  Score=310.07  Aligned_cols=267  Identities=25%  Similarity=0.312  Sum_probs=207.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +|++.+.||.|++|.||+|++  +++.||||++..... .....+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            588999999999999999987  588999998665432 23456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      .+ +|.+++....  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......     
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-----  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-----  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-----
Confidence            86 8888776443  468999999999999999999999999999999999999999999999999986443100     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......+++.|++||++.+. .++.++|+|||||++|+|++|..||.+.+.......+.+........
T Consensus       155 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07836         155 -----------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES  223 (284)
T ss_pred             -----------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence                       012234578899999998664 46889999999999999999999998876665555544332111111


Q ss_pred             HHHHhc--CCCCCc--------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVS--GGLRPI--------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~--~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......  ..+...        .....+.+++.+.+++.+||+.||.+||++.+++++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            111000  000000        01112346788999999999999999999999998765

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=291.36  Aligned_cols=253  Identities=24%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC-CChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL-STSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +..+++..||.|+-|.||+++.  +|...|||.... .+.++.+++...++++..-+ +|+||+++++|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3456788999999999999987  568999997544 46667788888999877765 9999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .+.. -+..++.+-..++++.-+-++...++.||.||.+ +||+|||+||+|||+|..|++||||||++..+.+...   
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---  247 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---  247 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence            8743 5666666666688888888999999999999985 5899999999999999999999999999876543211   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .+...|.+.|||||.+..   ..|+.++||||||+.++||.||+.||.+.+.+.....+       
T Consensus       248 --------------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk-------  306 (391)
T KOG0983|consen  248 --------------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK-------  306 (391)
T ss_pred             --------------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-------
Confidence                          234578999999999853   45888999999999999999999999986544333322       


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                            +.. ...|.++. ..++|+.+.+|+..||+.|+.+||.+.++++|...
T Consensus       307 ------vln-~ePP~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  307 ------VLN-EEPPLLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             ------HHh-cCCCCCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence                  222 22344443 23589999999999999999999999999988743

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-37  Score=306.68  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=208.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      -|++.+.||.|+||.||+|.+  +++.||+|...... ......+.+|+.+++.++||||+++++.+..+...++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            478899999999999999986  57899999865433 334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+++|.+++...  .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++........      
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~------  156 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI------  156 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh------
Confidence            999999988643  578999999999999999999999999999999999999999999999998865432110      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                                ......++..|+|||.+.+..++.++|+|||||++|++++|..||...........+.            
T Consensus       157 ----------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------  214 (277)
T cd06641         157 ----------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------  214 (277)
T ss_pred             ----------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------
Confidence                      1223467889999999988888999999999999999999999997654332222211            


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                         ....+   ..+..++.++.+++.+||+.+|.+||++.++++|.+....
T Consensus       215 ---~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         215 ---KNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ---cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence               11111   2334678999999999999999999999999999877653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.1e-38  Score=312.74  Aligned_cols=268  Identities=24%  Similarity=0.256  Sum_probs=206.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccC--CceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv  139 (573)
                      ++|++.+.||.|+||.||+|.+  +++.+++|.+......  ....+.+|+.+++.++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5799999999999999999987  4788999986543322  233567899999999999999999998777  889999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +||+.+ +|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......   
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL---  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc---
Confidence            999975 8988887655568999999999999999999999999999999999999999999999999886543210   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+........
T Consensus       161 -------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (293)
T cd07843         161 -------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT  227 (293)
T ss_pred             -------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence                         0112345788999999987644 68899999999999999999999987765555444432211111


Q ss_pred             HHHHHH-------h-c----CCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAV-------V-S----GGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~-------~-~----~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...+..       . .    ..........+.. +++.+.++|++||+.||++|||+.|++.|.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence            100000       0 0    0000001111222 5889999999999999999999999998765

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-39  Score=274.38  Aligned_cols=268  Identities=24%  Similarity=0.311  Sum_probs=216.0

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|.-.++||+|.||+||+++.  +.+.||+|.+.....+  ......+|+-+++.++|.|||+++++...+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            578889999999999999975  6789999987766543  246678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      |.. +|..+....+..+..+.++.++.|++.||.++|++++.||||||+|+||+.+|.+||+|||+++.+.-        
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--------  153 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--------  153 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--------
Confidence            976 89988887777899999999999999999999999999999999999999999999999999986642        


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                            |..  ....-+-|.+|++|.++.|. .|+...|+||.||++.|+.. |.+.|.+.+...+..+++....++.+.
T Consensus       154 ------pvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  154 ------PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED  225 (292)
T ss_pred             ------ceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence                  111  12334679999999998875 48999999999999999998 999999999888888887654333221


Q ss_pred             HHHHhc--CCCCC--cccc------cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVS--GGLRP--ILAS------LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~--~~~~~--~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+.-..  ..+.+  ..+.      +-+.++..-++|+.++|.-+|..|.++++.++|+.+
T Consensus       226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf  286 (292)
T KOG0662|consen  226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF  286 (292)
T ss_pred             cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence            111100  11111  1110      112334456899999999999999999999887643

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=312.16  Aligned_cols=269  Identities=22%  Similarity=0.277  Sum_probs=206.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||+|.+  +++.|++|++....  ......+.+|+++++.++||||+++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3799999999999999999987  47889999765432  2335678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.++.+..+... ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........    
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA----  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence            9998777665543 34689999999999999999999999999999999999999999999999999876542110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc--ccHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN--YTEQ  298 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~~  298 (573)
                                 .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...........+....  ....
T Consensus       156 -----------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T cd07833         156 -----------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS  224 (288)
T ss_pred             -----------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence                       012345688999999999887 78999999999999999999999998765443333222111  0100


Q ss_pred             HHHHHHhcCCCC-----Ccc------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          299 QLTAAVVSGGLR-----PIL------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       299 ~~~~~~~~~~~~-----~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ............     +..      ...+..++.++.+||++||..+|++|||+.+++++.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence            000000000000     000      0112345899999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-37  Score=308.12  Aligned_cols=264  Identities=24%  Similarity=0.257  Sum_probs=200.5

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCccceeeeccccC--CceEEEEE
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKP--PNYMFFFE  141 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~e  141 (573)
                      |++.++||+|+||.||+|.+  +++.||+|+..... ........+|+.++.++. ||||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            77899999999999999987  57889999765431 122223457888898885 99999999999887  88999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+ +|.+.+......+++.+++.++.|++.||+|||+.|++||||+|+||+++. +.+||+|||++.......     
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-----  153 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-----  153 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-----
Confidence            9975 787777655557899999999999999999999999999999999999999 999999999986543210     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH-HH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE-QQ  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~  299 (573)
                                  ......+++.|+|||.+. +..++.++|||||||++|||++|..||...+.......+....... ..
T Consensus       154 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
T cd07831         154 ------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE  221 (282)
T ss_pred             ------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence                        112345788999999765 4557889999999999999999999998766544433333211111 11


Q ss_pred             HHHHHhcCCCC-C--------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLR-P--------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ........... .        .+......++.++.+||.+||+.+|++|||+.++++|.|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            11111000000 0        011112357899999999999999999999999998876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-37  Score=308.97  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=212.9

Q ss_pred             CCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .+.|++.+.||.|++|.||++.+.  +..+++|++..... ....+.+|+++++.++||||+++++.+......++++||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            467999999999999999999874  78999998765544 556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........     
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----  171 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-----  171 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-----
Confidence            999999999986654789999999999999999999999999999999999999999999999998764432110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......+++.|++||.+.+..++.++|+||||+++|+|++|..||...........+..          
T Consensus       172 -----------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------  230 (286)
T cd06614         172 -----------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------  230 (286)
T ss_pred             -----------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence                       12334578899999999988899999999999999999999999986544333222211          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                          ... +... .+..++.++.++|.+||+.+|.+|||+.+++++.+...
T Consensus       231 ----~~~-~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         231 ----KGI-PPLK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ----cCC-CCCc-chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                111 1111 12347889999999999999999999999999887754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-37  Score=310.43  Aligned_cols=255  Identities=26%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccC-----Cc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP-----PN  135 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-----~~  135 (573)
                      ..++|.+.+.||.|+||.||++..  +++.+|+|...... .....+.+|+.+++.+ +||||+++++++...     ..
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            357899999999999999999987  57889999864332 2345677899999999 799999999988653     35


Q ss_pred             eEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          136 YMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      +++|+||+.+++|.+++..   ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            8999999999999998753   3346899999999999999999999999999999999999999999999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      .....                ......|+..|+|||++...     .++.++|||||||++|+|++|..||.........
T Consensus       179 ~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~  242 (291)
T cd06639         179 TSTRL----------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL  242 (291)
T ss_pred             ccccc----------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence            32110                12234688999999998643     3678999999999999999999999876443332


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+..              . ..+.+. .+...+..+.+||.+||+.+|++||++.++++|.|.
T Consensus       243 ~~~~~--------------~-~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         243 FKIPR--------------N-PPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             HHHhc--------------C-CCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            22211              1 011111 123567889999999999999999999999998764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.1e-38  Score=308.35  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=206.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +|++.+.||.|+||.||+|.+  +++.||+|.....   .....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            589999999999999999987  4789999976433   22446788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++... ..+++.++..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-----  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-----
Confidence            99999999998765 478899999999999999999999999999999999999999999999999886543210     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..+.          
T Consensus       155 ------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------  211 (258)
T cd05578         155 ------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIR----------  211 (258)
T ss_pred             ------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHH----------
Confidence                        12334688899999999988899999999999999999999999986643110 0000          


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH--HHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF--SDIALELD  350 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~ell~~l~  350 (573)
                      .. ...    .....+..++..+.++|.+||+.||.+||++  .|+++|.|
T Consensus       212 ~~-~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         212 AK-QET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             HH-hcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence            00 000    1112345678999999999999999999999  88877654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-37  Score=308.88  Aligned_cols=271  Identities=26%  Similarity=0.429  Sum_probs=208.1

Q ss_pred             CCCccccccccccCceEEEEEEEC------CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeecccc--CCc
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPN  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  135 (573)
                      .+.|++.+.||+|+||.||++...      +..+|+|........ ....+.+|+++++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            357899999999999999999753      678999986655443 56789999999999999999999998877  567


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .+++|||+++++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            99999999999999999766556899999999999999999999999999999999999999999999999998765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH-hcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL-EMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-~~~  294 (573)
                      ....             .......++..|++||.+.+..++.++||||||+++|+|++|..||............. ...
T Consensus       163 ~~~~-------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  229 (284)
T cd05038         163 KDYY-------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ  229 (284)
T ss_pred             Ccce-------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence            1100             00112245567999999988889999999999999999999999986543221100000 000


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ........... ...+.   ..+..++.++.+|+.+||+.+|++|||+.||++.|..+
T Consensus       230 ~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 MIVTRLLELLK-EGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccHHHHHHHHH-cCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00111111111 11111   12345778999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=304.87  Aligned_cols=236  Identities=25%  Similarity=0.369  Sum_probs=190.6

Q ss_pred             ccccccCceEEEEEEECCe------------eEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           72 SPIARGAESVVYEATLDGR------------KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +.||+|+||.||+|.+...            .+++|........ ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999987432            4777865444332 6778899999999999999999999887 778999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-------CCeEeeeecchhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-------CPHLADFGLAEYR  212 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-------~~kL~Dfg~a~~~  212 (573)
                      |||+.+++|.+++......+++..+..++.||+.||+|||+.||+||||||+||+++.++       .+||+|||++...
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            999999999999976655789999999999999999999999999999999999999888       7999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC--CCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT  289 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  289 (573)
                      ..                    .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||...........
T Consensus       159 ~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~  218 (259)
T cd05037         159 LS--------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF  218 (259)
T ss_pred             cc--------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH
Confidence            31                    1233567789999999876  78999999999999999999 6888876542221111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      ..              ....      .+......+.++|.+||..+|.+|||+.++++.|
T Consensus       219 ~~--------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         219 YQ--------------DQHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             Hh--------------cCCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            10              0000      1112237899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-38  Score=310.37  Aligned_cols=266  Identities=26%  Similarity=0.287  Sum_probs=206.3

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++.+.||.|++|.||+|.+  +++.|++|++.....  .....+.+|+++++.++||||+++++++.+....++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999986  688999998654432  22356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          144 ESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       144 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      . ++|.+++.... ..+++..++.++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++.......      
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------  153 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV------  153 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc------
Confidence            5 58988886543 368999999999999999999999999999999999999999999999999986443110      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+...........
T Consensus       154 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07835         154 ----------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV  223 (283)
T ss_pred             ----------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence                      011233568899999988664 568899999999999999999999987665544444433221111110


Q ss_pred             H-------HH---hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 A-------AV---VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~-------~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      +       ..   ......+........++.++.++|.+||+.||.+|||+.|++++.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            0       00   0000111122224567899999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-37  Score=309.69  Aligned_cols=270  Identities=22%  Similarity=0.273  Sum_probs=204.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||.|++|+||+|.+  +++.||+|++.....  .....+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5799999999999999999986  578899998654322  234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhhhhh
Q 008220          142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |+.+ +|.+.+... ...+++..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++.......   
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~---  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc---
Confidence            9965 777776443 334678889999999999999999999999999999999985 4578999999986443110   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+......+.
T Consensus       158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        158 -------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             -------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence                         01123457889999999876 4578899999999999999999999987655444443332111100


Q ss_pred             HHHH---------HHhcCCC-CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTA---------AVVSGGL-RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~---------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...+         ....... ........+.+++++.+++.+||+.+|++||++.++++|.|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence            0000         0000000 0111112346789999999999999999999999999988764

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-37  Score=303.26  Aligned_cols=253  Identities=27%  Similarity=0.414  Sum_probs=210.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      .|++.+.||.|++|.||++.+  +++.|++|+...... .....+.+|+..++.++||||+++++++......++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            688999999999999999987  478999998765544 45678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      ++++|.+++... ..+++..++.++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++........     
T Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-----  155 (264)
T cd06623          82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-----  155 (264)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-----
Confidence            999999999765 378999999999999999999999 9999999999999999999999999998865532111     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......           ...+...
T Consensus       156 -----------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----------~~~~~~~  213 (264)
T cd06623         156 -----------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----------SFFELMQ  213 (264)
T ss_pred             -----------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----------CHHHHHH
Confidence                       112456889999999999888999999999999999999999999776420           0111111


Q ss_pred             HHhcCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+....    .+..+.. ++..+.++|.+||..+|++|||+.+++++.|.
T Consensus       214 ~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~  259 (264)
T cd06623         214 AICDGP----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI  259 (264)
T ss_pred             HHhcCC----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence            111111    1122334 78999999999999999999999999998876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-37  Score=304.76  Aligned_cols=256  Identities=30%  Similarity=0.467  Sum_probs=207.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||++.+  +++.|++|.+.....  .....+..|+.+++.++||||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            689999999999999999986  578999998665543  3677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.........    
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~----  155 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT----  155 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----
Confidence            99999999987654 5788999999999999999999999999999999999999999999999998765421110    


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                              .........+++.|+|||++.+..   ++.++||||||+++|++++|..||............         
T Consensus       156 --------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~---------  218 (264)
T cd06626         156 --------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH---------  218 (264)
T ss_pred             --------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH---------
Confidence                    000012356788999999998766   789999999999999999999999765322111111         


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                          +. ....+.++. ...+++.+.++|.+||+.+|.+|||+.+++.+.|
T Consensus       219 ----~~-~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         219 ----VG-AGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             ----Hh-cCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence                11 111222221 1245899999999999999999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-37  Score=312.02  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +.+.|...+.||+|+||.||++.+  .+..+|+|++...   ..+....+.+|+.+++.++|||++++++++......++
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            345689999999999999999986  5788999986532   23345678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.| +|.+.+......+++.++..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....    
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            9999975 77777765555789999999999999999999999999999999999999999999999998754321    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      .....|++.|+|||.+.   ...++.++|+|||||++|+|++|..||...........+..   
T Consensus       178 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---  238 (317)
T cd06635         178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---  238 (317)
T ss_pred             ----------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh---
Confidence                            22346888999999974   45678899999999999999999999976544333333221   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 ....+   .....+++.+.+++.+||+.+|.+||++.+++++++....
T Consensus       239 -----------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         239 -----------NESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -----------ccCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                       11111   1123578899999999999999999999999999988664

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-37  Score=304.95  Aligned_cols=247  Identities=29%  Similarity=0.437  Sum_probs=198.1

Q ss_pred             ccccccCceEEEEEEECC--------eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           72 SPIARGAESVVYEATLDG--------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +.||.|+||.||+|+...        ..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997632        578999754432 23466788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-----CCeEeeeecchh
Q 008220          143 YESRNLAEKLHVE------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-----CPHLADFGLAEY  211 (573)
Q Consensus       143 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-----~~kL~Dfg~a~~  211 (573)
                      +++++|.+++...      ...+++.+++.++.|++.||+|||+.+++|+||||+||+++.++     .++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642      23468899999999999999999999999999999999999887     899999999865


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~  290 (573)
                      .......              .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus       161 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~  226 (269)
T cd05044         161 IYKSDYY--------------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV  226 (269)
T ss_pred             ccccccc--------------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence            4321100              01122345788999999998889999999999999999998 99999866543332222


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .              .+. .+   ..+..+|..+.++|.+||+.+|.+||++.++++.|.
T Consensus       227 ~--------------~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 T--------------AGG-RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             h--------------cCC-cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1              111 11   123467899999999999999999999999988764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=310.54  Aligned_cols=268  Identities=25%  Similarity=0.265  Sum_probs=199.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||+|+||.||+|.+  +++.|++|.+...... ....+.+|+.+++.++|+||+++++++..+...|+|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            6899999999999999999976  5789999986544322 223567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +. ++|.+.+......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||+++......      
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------  157 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS------  157 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC------
Confidence            96 57766665544467888999999999999999999999999999999999999999999999986432100      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHHHhccc-cHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNY-TEQQ  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~-~~~~  299 (573)
                                .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ....+..... ....
T Consensus       158 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         158 ----------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             ----------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence                      01123457889999999875 457889999999999999999999997654321 1111111000 0000


Q ss_pred             HHHHH----------hcCCCCCcccccc--cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAV----------VSGGLRPILASLE--LGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~----------~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .....          ........+....  ...++++.+++.+||..||++|||+.|++.|.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence            00000          0000000011111  123678999999999999999999999998765

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.1e-37  Score=302.72  Aligned_cols=250  Identities=27%  Similarity=0.418  Sum_probs=211.1

Q ss_pred             CccccccccccCceEEEEEEEC--CeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||++.+.  +..|++|++.....  .....+.+|+++++.++|||++++++.+......++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5889999999999999999874  88999998665432  5567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +++++|.+++...   ...+++.++..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc---
Confidence            9999999998764   3578999999999999999999999999999999999999999999999999986543211   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.............        
T Consensus       158 -------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------  216 (258)
T cd08215         158 -------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL--------  216 (258)
T ss_pred             -------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------
Confidence                         11234568899999999998889999999999999999999999997664333222221        


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                            ...    ...++..++.++.+++.+||..+|++|||+.+++++.|
T Consensus       217 ------~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         217 ------KGQ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             ------cCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence                  111    12234478899999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-37  Score=316.73  Aligned_cols=274  Identities=20%  Similarity=0.277  Sum_probs=209.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeecccc----CCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~  137 (573)
                      .+|++.+.||+|+||.||+|.+  +++.||+|++....  ......+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6899999999999999999986  58899999865432  2345667789999999999999999998763    35689


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|+||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 58988886554 589999999999999999999999999999999999999999999999999865432110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                  ..........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus       163 ------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         163 ------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             ------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence                        01111234578999999999865 45789999999999999999999999876554444333322111


Q ss_pred             -HHHHHHHHh---------c-C-CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 -EQQLTAAVV---------S-G-GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 -~~~~~~~~~---------~-~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       .........         . . .............++++.++|++||+.+|++|||+.+++.|+|...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence             111111000         0 0 0001111223457899999999999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-37  Score=307.45  Aligned_cols=247  Identities=21%  Similarity=0.250  Sum_probs=200.2

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||+|+||+||++.+  +++.|++|.+....   ......+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999976  57899999764332   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCC
Q 008220          149 AEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG  227 (573)
Q Consensus       149 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~  227 (573)
                      .+++.... ..+++.+++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+......            
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------  148 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------  148 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence            99886543 36899999999999999999999999999999999999999999999999988654320            


Q ss_pred             CCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcC
Q 008220          228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG  307 (573)
Q Consensus       228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (573)
                           .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+....             
T Consensus       149 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  210 (277)
T cd05577         149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-------------  210 (277)
T ss_pred             -----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-------------
Confidence                 01223467889999999988889999999999999999999999997654321111111100             


Q ss_pred             CCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          308 GLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                        .......+..+++.+.++|++||+.||.+||     ++.++++|+|..
T Consensus       211 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         211 --LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             --ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence              0111123456799999999999999999999     888899888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-38  Score=334.43  Aligned_cols=272  Identities=22%  Similarity=0.278  Sum_probs=194.7

Q ss_pred             CCCccccccccccCceEEEEEEEC---CeeEEEe------------------eccCCChHHHHHHHHHHHHHHhCCCCcc
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD---GRKVAVK------------------KPILSTSEELDNFHKELQLLCKLDHPGL  123 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~hpnI  123 (573)
                      .++|+++++||+|+||+||+|...   +...++|                  .. .........+.+|+.+|++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCCCc
Confidence            368999999999999999998642   1111111                  11 1122334568899999999999999


Q ss_pred             ceeeeccccCCceEEEEEeccCCChhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC
Q 008220          124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL  199 (573)
Q Consensus       124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~  199 (573)
                      +++++++......|+|++++.+ +|.+++....    ......+++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999865 6666654321    1234667889999999999999999999999999999999999


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCC-CC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV-PY  278 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-Pf  278 (573)
                      .+||+|||++..+.....               .......||+.|+|||++.+..++.++|||||||++|||++|.. ||
T Consensus       305 ~vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        305 KIVLGDFGTAMPFEKERE---------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             CEEEEeCCCceecCcccc---------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            999999999875542110               11234679999999999999999999999999999999999775 44


Q ss_pred             CCch--hHHHHHHHHhcc-ccH-------HHHHHHHhcCCC---CCccccc--ccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          279 TDLR--AEAQAHTVLEMN-YTE-------QQLTAAVVSGGL---RPILASL--ELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       279 ~~~~--~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~---~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                      ....  .......++... ...       ..+...+....+   ...++..  ...++.++.++|.+||+.||.+|||+.
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            3321  112222222110 000       011111111000   0011110  124677889999999999999999999


Q ss_pred             HHHHHHHHHH
Q 008220          344 DIALELDLVL  353 (573)
Q Consensus       344 ell~~l~~~~  353 (573)
                      |++.|+|+..
T Consensus       450 elL~hp~f~~  459 (501)
T PHA03210        450 ELLALPLFSA  459 (501)
T ss_pred             HHhhChhhhc
Confidence            9999998744

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.5e-37  Score=303.48  Aligned_cols=244  Identities=25%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             ccccCceEEEEEEEC--CeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||.|+||.||++.+.  ++.+++|.+....   ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999985  8899999864332   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCC
Q 008220          149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK  228 (573)
Q Consensus       149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~  228 (573)
                      .+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......            
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------  147 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------  147 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------------
Confidence            99997654 68899999999999999999999999999999999999999999999999986553211            


Q ss_pred             CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCch--hHHHHHHHHhccccHHHHHHHHhc
Q 008220          229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR--AEAQAHTVLEMNYTEQQLTAAVVS  306 (573)
Q Consensus       229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  306 (573)
                           ......|++.|++||.+.+..++.++|+||||+++|++++|..||....  .......              +..
T Consensus       148 -----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------~~~  208 (262)
T cd05572         148 -----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND--------------ILK  208 (262)
T ss_pred             -----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH--------------Hhc
Confidence                 1223468889999999988888999999999999999999999998654  2211111              111


Q ss_pred             CCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                      +...+   ..+...++++.++|.+||+.+|++||+     +.|+++|.|+.
T Consensus       209 ~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         209 GNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            11111   123456899999999999999999999     99999998864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-37  Score=316.48  Aligned_cols=271  Identities=25%  Similarity=0.330  Sum_probs=207.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----Cc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PN  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  135 (573)
                      ..+|.+.+.||+|+||+||++.+  +++.||||.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35899999999999999999986  5789999986532  233345677899999999999999999987654     35


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .|+|+||+. ++|.+++...+ .+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            899999996 58888886544 7899999999999999999999999999999999999999999999999998654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus       162 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         162 G----------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             c----------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            0                11234467889999998865 468899999999999999999999998765433333222211


Q ss_pred             c--cHHHH--------HHHH--hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 Y--TEQQL--------TAAV--VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~--~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .  .....        ...+  .....++......+.+++++.+||++||+.+|++|||+.++++|.|...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            0  00000        0000  0011112222233568899999999999999999999999999988754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-37  Score=303.62  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|.+.+.||.|+||.||++..  .+..+|+|.+....  ....+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            588999999999999999987  57889999864431  23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC-CeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      +.+++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.+........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc---
Confidence            99999999986543 35789999999999999999999999999999999999998864 69999998865432110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......|++.|+|||++.+..++.++|+||||+++|++++|..||...........+.         
T Consensus       158 -------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------  215 (257)
T cd08225         158 -------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC---------  215 (257)
T ss_pred             -------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---------
Confidence                         1223468899999999988889999999999999999999999997654333222221         


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                           .+..    ......++.++.++|.+||..+|++|||+.+++++.|
T Consensus       216 -----~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         216 -----QGYF----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             -----cccC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence                 1111    1223467889999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-40  Score=351.41  Aligned_cols=254  Identities=29%  Similarity=0.417  Sum_probs=210.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      -+++....||.|.||.||-|..  +|...|+|.+.....  .....+.+|..++..|+|||+|+++++-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            4678888999999999999975  788999997655433  234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      ||.+|+|.+.+...+ ...+.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|..+.....    
T Consensus      1315 yC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~---- 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ---- 1389 (1509)
T ss_pred             HhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh----
Confidence            999999999987544 456667778999999999999999999999999999999999999999999987654211    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                              .-+.....++||+.|||||++.+.   ....++|||||||+..||+||+.||...+.+..+...        
T Consensus      1390 --------~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-------- 1453 (1509)
T KOG4645|consen 1390 --------TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-------- 1453 (1509)
T ss_pred             --------cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH--------
Confidence                    111235678999999999999764   3567999999999999999999999887655443322        


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                           + ..+..|.+|   ..++++-.++|..||..||++|.++.||++|-
T Consensus      1454 -----V-~~gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1454 -----V-AAGHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             -----H-hccCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                 2 233444443   46999999999999999999999999988764

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-37  Score=303.11  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-----ChHHHHHHHHHHHHHHhCCCCccceeeeccccC--Cce
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~  136 (573)
                      .+|++.+.||+|+||.||++.+  +++.|++|.....     .......+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999986  5789999975432     233456788999999999999999999998664  458


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            89999999999999987554 57889999999999999999999999999999999999999999999999987543210


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                   ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||..........++..    
T Consensus       161 -------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----  223 (264)
T cd06653         161 -------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT----  223 (264)
T ss_pred             -------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc----
Confidence                         000112345688999999999988889999999999999999999999986543333222211    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                .   +..+..+..+++++.++|.+||+ +|..||++.+++.|+
T Consensus       224 ----------~---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         224 ----------Q---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ----------C---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                      1   11223456789999999999999 579999999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=312.78  Aligned_cols=263  Identities=26%  Similarity=0.433  Sum_probs=218.5

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..|+..........+||-|.||.||.|.++  .-.||||.++. ...+.+.|..|+.+|+.++|||+|+|+++|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            456666667777889999999999999885  45789997543 456788999999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      |||+|||..|+|.++|+..+. .++.-..+.++.||..|++||..+++|||||..+|+|+.++..||++|||+++++...
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            999999999999999986543 3455677889999999999999999999999999999999999999999999987642


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ....               .....-+.-|.|||-+....++.++|||+|||+|||+.| |..||.+.+...... +++..
T Consensus       419 TYTA---------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~-LLEkg  482 (1157)
T KOG4278|consen  419 TYTA---------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG-LLEKG  482 (1157)
T ss_pred             ceec---------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-HHhcc
Confidence            2210               111234678999999999999999999999999999999 999999875443332 22222


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                    ++-   .-|.++|+.+.+||+.||+++|.+||++.|+-+.++.++..
T Consensus       483 --------------yRM---~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  483 --------------YRM---DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             --------------ccc---cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence                          221   12568999999999999999999999999999888877643

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=305.87  Aligned_cols=251  Identities=28%  Similarity=0.480  Sum_probs=204.9

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCC---CCccceeeeccccCCceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .|++.+.||+|+||.||+|.+  +++.|++|.+... .......+.+|+.+++.++   ||||+++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            588999999999999999986  5789999986544 2344567889999999996   999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++...  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS----  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc----
Confidence            999999999988643  68899999999999999999999999999999999999999999999999986553211    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.        
T Consensus       156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------  215 (277)
T cd06917         156 ------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------  215 (277)
T ss_pred             ------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--------
Confidence                        01233468899999999865 456889999999999999999999997654322211110        


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                             ....+.++  ...++.++.+++.+||+.||++||++.+++.+.|..
T Consensus       216 -------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~  259 (277)
T cd06917         216 -------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK  259 (277)
T ss_pred             -------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence                   01111111  123788999999999999999999999999988773

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.8e-37  Score=310.07  Aligned_cols=269  Identities=23%  Similarity=0.250  Sum_probs=202.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCC-CCccceeeeccccCCc-----
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPN-----  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~-----  135 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|+.......  ....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3699999999999999999987  5789999975543222  2356788999999995 6999999999877665     


Q ss_pred             eEEEEEeccCCChhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecch
Q 008220          136 YMFFFEFYESRNLAEKLHVE----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAE  210 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~  210 (573)
                      .|+||||+.+ +|.+++...    ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 788877543    235799999999999999999999999999999999999998 8899999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      ......                .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...........
T Consensus       160 ~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~  223 (295)
T cd07837         160 AFSIPV----------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH  223 (295)
T ss_pred             ecCCCc----------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            442100                01123356889999998865 4578999999999999999999999987665554444


Q ss_pred             HHhccccHHHHHH-H-------HhcCCCC-CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTA-A-------VVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       290 ~~~~~~~~~~~~~-~-------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +............ .       ....... ..+....+.+++++.++|.+||..||.+||++.|++.|.|.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence            3321110000000 0       0000000 01111124578999999999999999999999999988764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=315.53  Aligned_cols=271  Identities=25%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----Cce
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNY  136 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~  136 (573)
                      .++|++.++||+|+||.||+|.+  +++.||+|++... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            36899999999999999999986  5789999986532 233456678899999999999999999876543     357


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++++||+.+ +|.+.+..  ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            999999975 78777743  368999999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .            ..+ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       161 ~------------~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~  227 (336)
T cd07849         161 D------------HTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG  227 (336)
T ss_pred             c------------ccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            0            000 1234578999999998754 5688999999999999999999999987654433333222111


Q ss_pred             --cHHHHHHHHhcC---------CCCCc--ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 --TEQQLTAAVVSG---------GLRPI--LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 --~~~~~~~~~~~~---------~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                        ..... ......         ...+.  ........++++.++|.+||+.||++|||+.++++|.|..
T Consensus       228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~  296 (336)
T cd07849         228 TPSQEDL-NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE  296 (336)
T ss_pred             CCCHHHH-HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence              11111 000000         00000  1111235688899999999999999999999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=318.32  Aligned_cols=263  Identities=27%  Similarity=0.398  Sum_probs=219.5

Q ss_pred             CccccccCCCCccccccccccCceEEEEEEEC---C--eeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeecc
Q 008220           57 QSIPLHLPPSSYTLLSPIARGAESVVYEATLD---G--RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAH  130 (573)
Q Consensus        57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (573)
                      .....-|+.++.++.++||+|.||.||+|.++   |  -.||||.+...... ..+.|.+|+.+|.+|+|||+++||++.
T Consensus       101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV  180 (1039)
T KOG0199|consen  101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV  180 (1039)
T ss_pred             CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence            33445677889999999999999999999874   3  36899987655433 678899999999999999999999998


Q ss_pred             ccCCceEEEEEeccCCChhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                      .+ ....+|+|.++.|+|.+.|++ ....|.......|+.||+.|+.||.++++|||||..+|+|+-....|||+|||+.
T Consensus       181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence            87 778899999999999999987 4456778899999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH  288 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~  288 (573)
                      +.+...++.-.             ......-+..|+|||.+....++.++|+|++||++|||++ |+-||.+.....+++
T Consensus       260 RaLg~ned~Yv-------------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~  326 (1039)
T KOG0199|consen  260 RALGENEDMYV-------------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK  326 (1039)
T ss_pred             eccCCCCcceE-------------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH
Confidence            87765333210             1122334678999999999999999999999999999999 999999987766655


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+....              .   + ..|+.++..+.++++.||..+|.+|||+..|.+.+-.
T Consensus       327 ~iD~~e--------------r---L-pRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  327 NIDAGE--------------R---L-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             hccccc--------------c---C-CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            553211              1   1 1256799999999999999999999999999865543

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-38  Score=316.33  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=208.5

Q ss_pred             CCc-cccccccccCceEEEEEEECCeeEEEe--ec----cCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc--e
Q 008220           66 SSY-TLLSPIARGAESVVYEATLDGRKVAVK--KP----ILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN--Y  136 (573)
Q Consensus        66 ~~y-~~~~~lg~G~~g~V~~~~~~~~~vavK--~~----~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~  136 (573)
                      .|| ++...||+|+|-+||+|.++.+-+.|-  .+    .....+..++|..|+.+|+.|+||||+++|+++.+...  +
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            455 567789999999999998854443332  11    23455667899999999999999999999999987665  7


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCceEEcC-CCCCeEeeeecchhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--GIVHRDVKPANVLLDR-NLCPHLADFGLAEYRE  213 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~  213 (573)
                      .+|+|.+..|+|..++.+.+ ..+...++.|++||+.||.|||++  .|||||||-+||+|++ .|.|||+|+|+|+...
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            78999999999999998766 788899999999999999999998  4999999999999976 5899999999998776


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ..                  ...+..|||.|||||++. ..|+..+||||||++++||+|+..||....+..++++.+..
T Consensus       198 ~s------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S  258 (632)
T KOG0584|consen  198 KS------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS  258 (632)
T ss_pred             cc------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence            31                  245579999999999997 78899999999999999999999999988777666655443


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ...+..                +..--.+++++||.+||.. ..+|||+.|+|.+..+...
T Consensus       259 GiKP~s----------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  259 GIKPAA----------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CCCHHH----------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            332222                1123478999999999999 9999999999998866554

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.1e-37  Score=308.51  Aligned_cols=256  Identities=29%  Similarity=0.378  Sum_probs=201.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|+..+.||+|+||.||++.+  +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4678889999999999999987  57899999865432 344567889999999996 9999999999999999999999


Q ss_pred             eccCCChhhhh---h-ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          142 FYESRNLAEKL---H-VEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       142 ~~~~g~L~~~l---~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+.. ++.++.   . .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            9865 554432   2 2234689999999999999999999975 99999999999999999999999999986543210


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccC---CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                       ......|++.|+|||++.+.   .++.++|||||||++|+|++|..||......  ...+.  
T Consensus       163 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~--  221 (288)
T cd06616         163 -----------------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--FDQLT--  221 (288)
T ss_pred             -----------------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--HHHHh--
Confidence                             12234688899999999776   6889999999999999999999999754311  11110  


Q ss_pred             cccHHHHHHHHhcCCCCCcc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               ....+ ..+.+ ...+..++.++.+||.+||+.||++|||+.+|+.+.|...
T Consensus       222 ---------~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         222 ---------QVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             ---------hhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence                     01111 11111 1122458899999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-37  Score=304.99  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=203.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeecccc--CCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~  140 (573)
                      ++|+..+.||.|++|.||++.+  .++.+|+|....... .....+.+|+++++.++||||+++++++..  ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3688999999999999999987  578999998654432 345678899999999999999999998854  34689999


Q ss_pred             EeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--
Confidence            99999999887643   2346788999999999999999999999999999999999999999999999997543210  


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......         ...
T Consensus       159 ----------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~  213 (287)
T cd06621         159 ----------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---------LGP  213 (287)
T ss_pred             ----------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---------CCh
Confidence                            0123457889999999998899999999999999999999999997652200         000


Q ss_pred             HHHHHHHhcCCCCCcccccc---cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLE---LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+....... ...+.++..+   ...++.+.++|.+||+.+|.+|||+.|+++|.|..
T Consensus       214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         214 IELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             HHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence            011111111 1111111111   23578899999999999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.8e-37  Score=299.72  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=209.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .|++.+.||+|++|.||++.+  +++.+++|+...........+.+|+.+++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            478899999999999999987  478899998766655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++......+++..+..++.|++.+|++||+.|++||||+|+||+++.++.++|+|||.+.......        
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--------  152 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--------  152 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc--------
Confidence            999999987764578999999999999999999999999999999999999999999999999886543211        


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                               ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..........            
T Consensus       153 ---------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  211 (253)
T cd05122         153 ---------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------------  211 (253)
T ss_pred             ---------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------------
Confidence                     02345688999999999888889999999999999999999999987643222222111            


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                         ...+.++ .+..++..+.++|.+||+.||++|||+.++++|.|
T Consensus       212 ---~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         212 ---NGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---cCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               0011111 11224889999999999999999999999998754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=307.14  Aligned_cols=266  Identities=26%  Similarity=0.313  Sum_probs=208.9

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++.+.||.|++|.||++.+  +++.+++|.+.....  .....+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999986  578899998654432  24567888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+ +|.+++......+++.++..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||.+.......       
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-------  152 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-------  152 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-------
Confidence            76 8888887655678999999999999999999999999999999999999999999999999886543211       


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH-HHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE-QQLT  301 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~  301 (573)
                               .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....... ....
T Consensus       153 ---------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd05118         153 ---------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW  223 (283)
T ss_pred             ---------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence                     011234578899999998876 78899999999999999999999998776655444433221110 0000


Q ss_pred             HHH----------hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          302 AAV----------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       302 ~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...          ...............++.++.++|.+||+.||.+||++.+++.|.|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence            000          0001111112233457889999999999999999999999998876

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.6e-37  Score=300.46  Aligned_cols=250  Identities=21%  Similarity=0.370  Sum_probs=191.4

Q ss_pred             ccccccCceEEEEEEE-CC---eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCC
Q 008220           72 SPIARGAESVVYEATL-DG---RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      +.||+|+||.||++.. .+   ..+++|...... ......+.+|+.+++.++||||+++++.+......++||||+.+|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999964 22   346677654433 345678899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          147 NLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       147 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      +|.+++....   ...++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.........     
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~-----  155 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI-----  155 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh-----
Confidence            9999987542   23566778899999999999999999999999999999999999999999987532210000     


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                               .......++..|+|||++..       ..++.++|||||||++|||++ |..||...........+...  
T Consensus       156 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--  224 (268)
T cd05086         156 ---------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD--  224 (268)
T ss_pred             ---------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh--
Confidence                     01223567889999998743       235778999999999999997 67788765544333332211  


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                 .......+..+..+++.+.+++..|| .+|++||++.+|++.|
T Consensus       225 -----------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         225 -----------QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             -----------cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence                       11111112233457889999999999 6799999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-37  Score=307.74  Aligned_cols=255  Identities=28%  Similarity=0.424  Sum_probs=199.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHH-HHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQL-LCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||++.+  +++.||+|.+.... ......+..|+.+ ++.++||||+++++++......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            3689999999999999999987  58899999865442 2233445556665 666789999999999999999999999


Q ss_pred             eccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          142 FYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       142 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      |++ ++|.+++..   ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            997 577776643   234689999999999999999999997 99999999999999999999999999986543100 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHHHHHHh
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK----EIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTVLE  292 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~~~~  292 (573)
                                      ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||...... ....... 
T Consensus       159 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-  221 (283)
T cd06617         159 ----------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-  221 (283)
T ss_pred             ----------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-
Confidence                            1123467889999998865    44688999999999999999999999753211 1111111 


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                   . ...+.++  ...+|.++.++|.+||..+|.+||++.++++|.|.....
T Consensus       222 -------------~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         222 -------------E-EPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -------------h-cCCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                         1 1111111  235789999999999999999999999999999887653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=306.34  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=204.8

Q ss_pred             cCCCCccccccccccCceEEEEEE--ECCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +..+.|+.-+.||+|+||.||-++  .+|+.+|+|++..+   .........+|-.+|.+++.+.||.+-..|++++.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            445678999999999999999885  58999999975332   2223345678999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +|+..|+||+|.-.+.+.+ ..+++..++.++.+|+.||++||..+||.|||||+|||+|+.|+++|+|+|+|..+... 
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-  340 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-  340 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence            9999999999988876544 46899999999999999999999999999999999999999999999999999765421 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                      -.....+||..|||||++.++.|+...|.|||||+||||+.|..||.........         
T Consensus       341 ----------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---------  395 (591)
T KOG0986|consen  341 ----------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---------  395 (591)
T ss_pred             ----------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---------
Confidence                            1234458999999999999999999999999999999999999999754322111         


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                       +++...+...     -..++..+|+++++|.+.+|+.||.+|....
T Consensus       396 -eEvdrr~~~~-----~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  396 -EEVDRRTLED-----PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -HHHHHHHhcc-----hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence             1111111111     1234568999999999999999999998755

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=313.86  Aligned_cols=272  Identities=26%  Similarity=0.329  Sum_probs=213.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCC-----ceE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM  137 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~  137 (573)
                      +|++.+.||.|++|.||+|..  .++.|+||++....  ....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            689999999999999999987  47899999865433  344567889999999999999999999988775     789


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ++|||+.+ +|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus        81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999974 8888886554 789999999999999999999999999999999999999999999999999875542110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .             ........+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+......
T Consensus       159 ~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         159 E-------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             c-------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            0             0112344688999999999887 7899999999999999999999999887766555544432211


Q ss_pred             HHH----------HHHHHhcC--CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 EQQ----------LTAAVVSG--GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 ~~~----------~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ...          ....+...  .....+......+++++.++|.+||+.+|.+|||+.+++.|.|...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence            110          00000000  0011111223457899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.1e-37  Score=305.97  Aligned_cols=267  Identities=16%  Similarity=0.200  Sum_probs=190.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCCChHH-----------HHHHHHHHHHHHhCCCCccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILSTSEE-----------LDNFHKELQLLCKLDHPGLA  124 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv  124 (573)
                      .++..++|++.++||+|+||+||+|...     +..+++|.........           ......+...+..+.|+||+
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            4567789999999999999999999863     3466777533322111           01122334456667899999


Q ss_pred             eeeeccccCC----ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC
Q 008220          125 KFVAAHAKPP----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC  200 (573)
Q Consensus       125 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~  200 (573)
                      ++++++....    ..+++++++.. ++.+.+.... ..++..++.++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence            9998765443    34667777644 6666655432 4578889999999999999999999999999999999999999


Q ss_pred             CeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                      ++|+|||+++.+.......         ...........||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       165 ~~l~DFGla~~~~~~~~~~---------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHI---------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             EEEEEcCCceeeccCCccc---------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999987653211000         0000112334699999999999999999999999999999999999999987


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      .............     +....+..+..      .....++++.++++.||+.+|++||++.+|++.+
T Consensus       236 ~~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        236 FGHNGNLIHAAKC-----DFIKRLHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             cccchHHHHHhHH-----HHHHHhhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            6332221111110     11111111111      1235689999999999999999999999998754

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-37  Score=313.02  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=208.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      .++|++.+.||.|+||.||++.+  ++..||||+....  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            57899999999999999999986  5789999986432  2233456889999999999999999999987654      


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++||||+ +++|.+++..  ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            468999998 6789888753  3689999999999999999999999999999999999999999999999999864321


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+...
T Consensus       171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07880         171 -------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV  231 (343)
T ss_pred             -------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                               1123457889999999876 45788999999999999999999999877655444444332


Q ss_pred             cccH-HHHHHHHhc-----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTE-QQLTAAVVS-----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .... ..+...+..           ...+..+......+++.+.++|.+||..||.+|||+.+++.|.|+..-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            2111 111111000           011111222335678899999999999999999999999999887543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.8e-37  Score=315.13  Aligned_cols=272  Identities=24%  Similarity=0.366  Sum_probs=206.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccC---------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP---------  133 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---------  133 (573)
                      ..+|++.+.||.|+||.||+|.+  +++.||+|++........+.+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            47899999999999999999987  5789999987666666667788999999999999999999876553         


Q ss_pred             -----CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeee
Q 008220          134 -----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFG  207 (573)
Q Consensus       134 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg  207 (573)
                           ...++|+||+. ++|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 35789999997 488887753  36889999999999999999999999999999999999975 5578999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ++........            . ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||........
T Consensus       161 ~~~~~~~~~~------------~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  227 (342)
T cd07854         161 LARIVDPHYS------------H-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ  227 (342)
T ss_pred             cceecCCccc------------c-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9865432110            0 001123357889999998754 5678899999999999999999999987665554


Q ss_pred             HHHHHhcccc-HHH--------HHHHHh--cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          287 AHTVLEMNYT-EQQ--------LTAAVV--SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       287 ~~~~~~~~~~-~~~--------~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...+...... ...        ......  ....+.........++.++.+||.+||+.||.+|||+.+++.|.|..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            4444322110 000        000000  00111111122346789999999999999999999999999998874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.7e-37  Score=305.79  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .|....+||+|+||.||++..  +++.||+|++..........+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            355567899999999999976  678999998765555566778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++...  .+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......        
T Consensus       101 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--------  170 (292)
T cd06657         101 GGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--------  170 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--------
Confidence            99999887533  57889999999999999999999999999999999999999999999999875432100        


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                              .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+..            
T Consensus       171 --------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~------------  230 (292)
T cd06657         171 --------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------  230 (292)
T ss_pred             --------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence                    012334688999999999888889999999999999999999999986544332222111            


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                         ...+.+.. ...+++.+.+++.+||+.+|.+||++.++++|.|....
T Consensus       231 ---~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         231 ---NLPPKLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             ---hCCcccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence               11111111 23578899999999999999999999999998877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.3e-37  Score=300.68  Aligned_cols=249  Identities=24%  Similarity=0.435  Sum_probs=202.6

Q ss_pred             CccccccccccCceEEEEEEEC---CeeEEEeeccCC----------ChHHHHHHHHHHHHHHh-CCCCccceeeecccc
Q 008220           67 SYTLLSPIARGAESVVYEATLD---GRKVAVKKPILS----------TSEELDNFHKELQLLCK-LDHPGLAKFVAAHAK  132 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  132 (573)
                      .|++.+.||+|+||.||++.+.   ++.+|+|.+...          .......+..|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4889999999999999999873   578999975432          22344567788888865 799999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          133 PPNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                      ....+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743   34468899999999999999999996 6899999999999999999999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      +.......                 ......|+..|++||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus       161 ~~~~~~~~-----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~  223 (269)
T cd08528         161 AKQKQPES-----------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT  223 (269)
T ss_pred             eeeccccc-----------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence            86543211                 1234568899999999998889999999999999999999999997654433332


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      .+.              .....+.   ....+++++.++|.+||+.||++||++.|+..++
T Consensus       224 ~~~--------------~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         224 KIV--------------EAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             HHh--------------hccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence            222              1222221   1225789999999999999999999999998876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.8e-37  Score=309.59  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=206.1

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +.+.|...+.||.|+||.||+|++  .++.+++|.+..   ........+.+|+++++.++|||++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            345799999999999999999987  577899997643   233445678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+||+. |++.+.+......+++.++..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....    
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            999997 578777765555689999999999999999999999999999999999999999999999998754321    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      .....|++.|+|||.+.   ...++.++|||||||++|+|++|..||...........+..   
T Consensus       168 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---  228 (308)
T cd06634         168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---  228 (308)
T ss_pred             ----------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---
Confidence                            22346888999999975   34578899999999999999999999976543333222211   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 + ..+..  ....++..+.+||++||+.+|++||++.+++++.|....
T Consensus       229 -----------~-~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         229 -----------N-ESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             -----------c-CCCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                       1 11111  123578899999999999999999999999999887653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=300.15  Aligned_cols=244  Identities=25%  Similarity=0.333  Sum_probs=195.3

Q ss_pred             ccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHH-HhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLL-CKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      +.||.|+||.||+|.+  .++.||+|.......   .....+..|..++ ...+||||+++++++...+.+++|+||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999987  578999998654321   2223344555544 445899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      ++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....           
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----------  149 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----------  149 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----------
Confidence            99999987554 688999999999999999999999999999999999999999999999998754321           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                               .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+....           
T Consensus       150 ---------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  209 (260)
T cd05611         150 ---------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------  209 (260)
T ss_pred             ---------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------
Confidence                     223467889999999988888999999999999999999999998765443333222111           


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELDL  351 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~~  351 (573)
                         .. ........+++++.+++.+||+.+|++||++   .|++.|+|.
T Consensus       210 ---~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         210 ---IN-WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             ---cC-CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence               10 1111223578999999999999999999955   688888766

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=312.67  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=212.4

Q ss_pred             cccc--ccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           68 YTLL--SPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        68 y~~~--~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      |++.  +.||.|.||+||-|.+  +|+.||||++..-  ..+..+.+.+|+.+|+.+.||.||.+.-.|++++..++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            5554  6899999999999976  7999999975332  22334788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~  218 (573)
                      .+.|.-|.-++.....++++.....++.||+.||.|||.++|+|.||||+|||+....   ++||||||+|+++....  
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            9988777777777778999999999999999999999999999999999999996543   59999999999887422  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ...+.+|||.|+|||++.+..|...-|+||+|+|+|--++|..||.+..+.....+.-...+   
T Consensus       722 ---------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy---  783 (888)
T KOG4236|consen  722 ---------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY---  783 (888)
T ss_pred             ---------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc---
Confidence                           35678999999999999999999999999999999999999999986533322222111111   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                    .+..+..++++..+||..+|+..=++|-+.++-+.|+|..-
T Consensus       784 --------------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  784 --------------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             --------------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence                          12345679999999999999999999999999999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=301.20  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=211.5

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (573)
                      .|...+|.++..||.|+||.|-++...  .+.+|||++...   ..++.+--+.|-++|... +-|.++++..+|++.+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            455578999999999999999999764  467999975433   233444456677888776 47899999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|...+..-+ .+.+..+..++.+|+-||-+||++|||.||||.+|||+|.+|++||+|||+++.-   
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn---  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---  500 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc---
Confidence            999999999999998887666 7888999999999999999999999999999999999999999999999998532   


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                   ..++....+.+|||.|+|||++..++|+.++|.||+||+||||+.|++||.+.+..+....|.+.+.
T Consensus       501 -------------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv  567 (683)
T KOG0696|consen  501 -------------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV  567 (683)
T ss_pred             -------------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC
Confidence                         1223356789999999999999999999999999999999999999999999998888888876554


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF  342 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  342 (573)
                      +                   .|..+|.++.++.+..|...|.+|...
T Consensus       568 s-------------------yPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  568 S-------------------YPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             c-------------------CcccccHHHHHHHHHHhhcCCccccCC
Confidence            3                   456899999999999999999999754

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.7e-37  Score=310.04  Aligned_cols=273  Identities=24%  Similarity=0.276  Sum_probs=201.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      .++|++.++||+|+||.||+|.+  +++.||||.+.....  .....+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            36899999999999999999987  578999997643321  12334568999999999999999999876543      


Q ss_pred             --ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          135 --NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       135 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                        ..++||||+.+ +|.+.+......+++.+++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              45999999965 888887766557899999999999999999999999999999999999999999999999998755


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .....            ..........++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.
T Consensus       170 ~~~~~------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         170 SLSKN------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             cCCcc------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            32111            000112334678899999988764 46889999999999999999999998765544333222


Q ss_pred             hcc--ccHHH--------HHHHHh-cCCCCCcc-ccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          292 EMN--YTEQQ--------LTAAVV-SGGLRPIL-ASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       292 ~~~--~~~~~--------~~~~~~-~~~~~~~~-~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...  .+...        ...... ........ ..+ +...+..+.+||.+||..||.+|||++++++|.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            211  00000        000000 00000000 000 1123567889999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-37  Score=332.65  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=194.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccc-----------
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHA-----------  131 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----------  131 (573)
                      ..|+.++.||+||||.||+++.  +|+.||||++.... ......+.+|+.+|.+|+|||||+++..+.           
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3578899999999999999986  79999999977663 445678999999999999999999764320           


Q ss_pred             -------------------------------------------------------------------cC-----------
Q 008220          132 -------------------------------------------------------------------KP-----------  133 (573)
Q Consensus       132 -------------------------------------------------------------------~~-----------  133 (573)
                                                                                         ++           
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                               00           


Q ss_pred             ------------------------------CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 008220          134 ------------------------------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI  183 (573)
Q Consensus       134 ------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  183 (573)
                                                    ..+||-||||+...|.++++.....-..+..+.++++|++||+|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                          12578899999988888887654221467899999999999999999999


Q ss_pred             eeccCCCCceEEcCCCCCeEeeeecchhhhh-hhhh--hcccccCCCCCCCCccccccccCcccCChhhhccCC---CCc
Q 008220          184 VHRDVKPANVLLDRNLCPHLADFGLAEYREN-LKEI--SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSE  257 (573)
Q Consensus       184 iH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~  257 (573)
                      |||||||.||+++.++.|||+|||+|+.... ..+.  ....+..... ......+..+||..|+|||++.+..   |+.
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g-~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAG-SNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccC-CCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999987331 1111  1111111111 1111356789999999999998755   999


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHHHhccccHHHHHHHHhcCCCCCcccc---cccCChHHHHHHHHHhcc
Q 008220          258 KSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTEQQLTAAVVSGGLRPILAS---LELGLPASILSLIQRCWD  333 (573)
Q Consensus       258 ~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~  333 (573)
                      |+|+||||+||+||+.   ||...-... .+..+.                  ++.+|.   +..+--+.-..+|++||+
T Consensus       798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR------------------~g~iP~~~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLR------------------KGSIPEPADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc------------------cCCCCCCcccccccchHHHHHHHHHhc
Confidence            9999999999999986   676532211 111111                  112222   123334556799999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 008220          334 GNPHNRPSFSDIALE  348 (573)
Q Consensus       334 ~dP~~Rpt~~ell~~  348 (573)
                      .||.+||||.|+|+.
T Consensus       857 hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCccCCCHHHHhhc
Confidence            999999999999863

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-36  Score=299.76  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=199.8

Q ss_pred             ccccccccccCceEEEEEEE-----CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           68 YTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      |++.+.||+|+||.||+|..     ++..||||.+...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            67889999999999999975     3578999976543  3445677889999999999999999999876432      


Q ss_pred             ceEEEEEeccCCChhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          135 NYMFFFEFYESRNLAEKLHVE-----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                      ..+++++|+.+|+|.+++...     ...++...++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247889999999998876422     224688899999999999999999999999999999999999999999999998


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH  288 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~  288 (573)
                      +.......              ........+++.|++||.+.+..++.++|||||||++|+|++ |.+||..........
T Consensus       161 ~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05074         161 KKIYSGDY--------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN  226 (273)
T ss_pred             ccccCCcc--------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence            75432110              001122345678999999998889999999999999999999 899998765433322


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+..              .. ..   ..+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus       227 ~~~~--------------~~-~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 YLIK--------------GN-RL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHc--------------CC-cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2221              11 00   11235788999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=306.68  Aligned_cols=267  Identities=26%  Similarity=0.320  Sum_probs=206.0

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccC--CceEEEEE
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFE  141 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e  141 (573)
                      |++.+.||.|+||.||+|..  .++.+|+|......  ......+.+|+.+++.++||||+++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            67899999999999999987  46899999876552  33445678899999999999999999999887  88999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+ +|.+++......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........    
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~----  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS----  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc----
Confidence            9975 88888876545789999999999999999999999999999999999999999999999999875542110    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..........
T Consensus       156 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07840         156 -----------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE  224 (287)
T ss_pred             -----------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Confidence                       01123356788999998765 457899999999999999999999998876655544443321110000


Q ss_pred             HHHH-----------hcCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAV-----------VSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~-----------~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .+..           ........+...... +++++.+++++||+.+|.+||++.+++++.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence            0000           000000001111122 4889999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-39  Score=288.15  Aligned_cols=282  Identities=24%  Similarity=0.311  Sum_probs=216.7

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccC--
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP--  133 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  133 (573)
                      |.-.....|+-..+||+|.||.||+|+.  ++++||+|++...+..  ......+|+++|..|+|+|++.++++|...  
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3444557899999999999999999975  6788999976543322  233467899999999999999999887642  


Q ss_pred             ------CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          134 ------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       134 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                            ..+|+|+.+|+. +|..++.....+++..++.+++.+++.||.|+|...|+|||+||.|+||+.+|.+||+|||
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                  248999999987 9999998877789999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      +++.+.......            ....+..+-|.+|++||.+.| ..|+++.|||+.||++.||++|.+-+++.....+
T Consensus       170 lar~fs~~~n~~------------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq  237 (376)
T KOG0669|consen  170 LARAFSTSKNVV------------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ  237 (376)
T ss_pred             cccceecccccC------------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH
Confidence            997665322211            112455678999999999876 4589999999999999999999999998876666


Q ss_pred             HHHHHhc--cccHH--------HHHHHHhcC-----CCCCccccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          287 AHTVLEM--NYTEQ--------QLTAAVVSG-----GLRPILASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       287 ~~~~~~~--~~~~~--------~~~~~~~~~-----~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ...|-..  ..+.+        .+...+..+     .++...... |..-.++..+|+.++|..||.+|+++.++++|-+
T Consensus       238 l~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  238 LHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             HHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence            5544322  11111        111111111     011000000 1123568899999999999999999999999988


Q ss_pred             HHHH
Q 008220          351 LVLE  354 (573)
Q Consensus       351 ~~~~  354 (573)
                      +..+
T Consensus       318 F~kd  321 (376)
T KOG0669|consen  318 FWKD  321 (376)
T ss_pred             hhcC
Confidence            8764

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-36  Score=306.93  Aligned_cols=248  Identities=27%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .|...+.||+|+||+||+|++  +++.|++|++...   .......+.+|+.+++.++|||++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            477788899999999999986  6789999986533   23345678889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+ +|.+.+......+++.+++.++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++....        
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------  172 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------  172 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------
Confidence            9964 7877776655578999999999999999999999999999999999999999999999999874321        


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+....    
T Consensus       173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----  236 (313)
T cd06633         173 ------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----  236 (313)
T ss_pred             ------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Confidence                        123456889999999984   4567889999999999999999999997765443333222111    


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                 .+.  .....++..+.+|+.+||+.+|.+||++.+++.|.|..
T Consensus       237 -----------~~~--~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         237 -----------SPT--LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             -----------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                       111  11235678899999999999999999999999987764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.9e-37  Score=305.00  Aligned_cols=265  Identities=24%  Similarity=0.367  Sum_probs=211.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++|.+.+.||.|+||.||++..  +++.|++|+....   .......+..|+.++++++ ||||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4799999999999999999987  6789999975432   2334567889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||++.+++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99999999999997655 78999999999999999999999999999999999999999999999999987654321100


Q ss_pred             cccc----cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          220 LKNW----RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       220 ~~~~----~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ....    ................++..|+|||++.+..++.++|+||||++++++++|..||...........+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-  238 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE-  238 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-
Confidence            0000    00000001122344568899999999988888999999999999999999999998765333322222110 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH----HHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF----SDIALELD  350 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~~l~  350 (573)
                                        ...+..+++.+.++|.+||+.+|.+|||+    .++++|+|
T Consensus       239 ------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         239 ------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             ------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence                              11234678999999999999999999999    99988765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-36  Score=307.33  Aligned_cols=272  Identities=21%  Similarity=0.264  Sum_probs=204.4

Q ss_pred             CccccccccccCceEEEEEEEC----CeeEEEeeccCC--ChHHHHHHHHHHHHHHhC-CCCccceeeecccc----CCc
Q 008220           67 SYTLLSPIARGAESVVYEATLD----GRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK----PPN  135 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----~~~  135 (573)
                      +|++.+.||+|+||.||++.+.    +..||+|++...  .......+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5889999999999999999874    568999975432  222345678899999999 59999999986432    245


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .+++++++. ++|.+.+.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            778888885 58888886443 7899999999999999999999999999999999999999999999999998754321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..            ..........|++.|+|||++.+ ..++.++||||+||++|++++|..||...........++...
T Consensus       159 ~~------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~  226 (332)
T cd07857         159 PG------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL  226 (332)
T ss_pred             cc------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence            10            00111234578999999998765 568899999999999999999999998766554444443321


Q ss_pred             ccH-HHHHHHH-----------hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTE-QQLTAAV-----------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ... .+....+           ........+......++..+.+|+.+||+.||.+|||+.+++.+.|..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence            111 1110000           001111122223345688999999999999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.5e-37  Score=303.95  Aligned_cols=245  Identities=24%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             cccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHH---HhCCCCccceeeeccccCCceEEEEEecc
Q 008220           73 PIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLL---CKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .||+|+||.||++.+  +++.+|+|......   ......+..|..++   ...+||||+.+++.+..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987  57899999754321   11222334444433   33479999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++...+ .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++......         
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---------  150 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------  150 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---------
Confidence            999999887554 6899999999999999999999999999999999999999999999999988543210         


Q ss_pred             CCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               ......|++.|+|||.+. +..++.++||||+||++|+|++|..||........ ..+....         
T Consensus       151 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~---------  211 (279)
T cd05633         151 ---------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMT---------  211 (279)
T ss_pred             ---------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHh---------
Confidence                     112346899999999986 45678999999999999999999999975432111 0000000         


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                         ....   ..++..+++++.++|++||+.||.+||     |+.++++|+|..
T Consensus       212 ---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         212 ---LTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             ---hcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence               0011   123456889999999999999999999     699999988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=297.38  Aligned_cols=249  Identities=30%  Similarity=0.492  Sum_probs=208.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||.|++|.||++.+  .++.|++|.......  ...+.+.+|++++++++|||++++++++.+....++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            588999999999999999986  567899998655443  4567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----  154 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-----  154 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence            99999999987653 789999999999999999999999999999999999999999999999999875542111     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                 ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............           
T Consensus       155 -----------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------  212 (254)
T cd06627         155 -----------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----------  212 (254)
T ss_pred             -----------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----------
Confidence                       1233467889999999988888999999999999999999999997654322222111           


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                         ....    +..+..++..+.+++.+||..+|++|||+.+++.+.+
T Consensus       213 ---~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         213 ---QDDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             ---ccCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence               1111    1234567899999999999999999999999987643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-37  Score=309.11  Aligned_cols=277  Identities=20%  Similarity=0.235  Sum_probs=205.2

Q ss_pred             ccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      |.+.+.+|.|+++.|+++..+++.||+|++...  .......+.+|+.+++.++||||+++++++......+++|||+.+
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            456666677777777777778999999986544  345667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          146 RNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       146 g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      ++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+.........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~------  157 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR------  157 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc------
Confidence            9999998753 346789999999999999999999999999999999999999999999999988644321110      


Q ss_pred             CCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH----H
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE----Q  298 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~  298 (573)
                         ............++..|+|||++.+  ..++.++|+||+||++|+|++|..||...................    .
T Consensus       158 ---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         158 ---QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             ---ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence               0001111234567889999999876  357889999999999999999999998764433322211111000    0


Q ss_pred             HHHHHH--hcC----CCC-----CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAV--VSG----GLR-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~--~~~----~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ......  ...    ...     .........++.++.+|+.+||+.||++|||+.++++|+|...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~  300 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ  300 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence            000000  000    000     0000112245678999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-36  Score=297.40  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +|++.+.||+|+||.||++.+  +++.+++|.....  .......+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999976  5778999986543  234456778899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      +++++|.+++...   ...++++.++.++.|++.||+|||+.|++|+||+|.||+++.++.+||+|||++......    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence            9999999988652   246788999999999999999999999999999999999999999999999998655421    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.        
T Consensus       157 --------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------  214 (256)
T cd08530         157 --------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------  214 (256)
T ss_pred             --------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------
Confidence                          1123457889999999999889999999999999999999999998765443322221        


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                            .+..    +..+..++.++.+++.+||+.+|++|||+.++++|+
T Consensus       215 ------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         215 ------RGKY----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             ------cCCC----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence                  1111    122346789999999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.4e-37  Score=302.58  Aligned_cols=245  Identities=22%  Similarity=0.241  Sum_probs=194.1

Q ss_pred             CCccccccc--cccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPI--ARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~l--g~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +.|++.+.+  |.|+||.||++..  ++..+|+|.........     .|+.....+ +||||+++++.+...+..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            456777766  9999999999986  57789999754332211     123233223 7999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+++++|.+++.... .+++++++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....     
T Consensus        89 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-----  162 (267)
T PHA03390         89 DYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-----  162 (267)
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-----
Confidence            9999999999997655 789999999999999999999999999999999999999998 999999998864431     


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                     .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||...........         .
T Consensus       163 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---------~  218 (267)
T PHA03390        163 ---------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE---------S  218 (267)
T ss_pred             ---------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH---------H
Confidence                           1234588999999999998899999999999999999999999975432221111         1


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~  351 (573)
                      +....  .    .....+..+++.+.++|.+||+.+|.+||+ ++++++|.|.
T Consensus       219 ~~~~~--~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~  265 (267)
T PHA03390        219 LLKRQ--Q----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL  265 (267)
T ss_pred             HHHhh--c----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence            11110  0    011123468999999999999999999996 6999998875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-37  Score=312.52  Aligned_cols=266  Identities=24%  Similarity=0.370  Sum_probs=208.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-----
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-----  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-----  135 (573)
                      .++|++.+.||.|++|.||+|++  +++.||+|++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            46899999999999999999987  4788999986542  23344567789999999999999999998876554     


Q ss_pred             -eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 -YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                       .++|+||+ +++|.+++..  ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence             89999998 5699888864  3689999999999999999999999999999999999999999999999999864431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......++..|+|||.+.+ ..++.++|||||||++|++++|..||...........+...
T Consensus       171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         171 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             -------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence                               1233467889999999865 36788999999999999999999999877655544444332


Q ss_pred             ccc-HHHHHHHHh-----------cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYT-EQQLTAAVV-----------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ... ...+...+.           ....++.+......+++.+.++|.+||+.||.+|||+.+|++|.|..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence            111 111111110           01111122222345689999999999999999999999999998775

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.6e-37  Score=307.58  Aligned_cols=272  Identities=24%  Similarity=0.275  Sum_probs=204.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCC----
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----  134 (573)
                      ...++|++.+.||.|+||.||+|.+  +++.||+|.+....  ......+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            3446899999999999999999987  57889999865432  222345678999999999999999999887654    


Q ss_pred             ------ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          135 ------NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       135 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                            .+++|+||+.+ ++.+.+......+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999986 77777765555789999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      +........               .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.........
T Consensus       163 ~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~  227 (302)
T cd07864         163 ARLYNSEES---------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL  227 (302)
T ss_pred             cccccCCcc---------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            875542110               01122346788999998865 45688999999999999999999999876554444


Q ss_pred             HHHHhccccHHHHHH-HHhc----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTA-AVVS----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..+............ .+..          ......+......+|..+.+++.+||+.||.+|||+.+++.+.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            333322111000000 0000          00000111112357899999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-36  Score=310.27  Aligned_cols=273  Identities=26%  Similarity=0.356  Sum_probs=207.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC--CChHHHHHHHHHHHHHHhC-CCCccceeeeccccC--CceEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP--PNYMF  138 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~l  138 (573)
                      ++|++.+.||+|+||.||+|.+  +++.+|+|++..  ........+.+|+.+++++ +||||+++++++...  ..+++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            6899999999999999999987  578999997643  2333455677899999999 999999999987643  46899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+ +|..++...  .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        87 v~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          87 VFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             Eeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            9999975 898887654  6788899999999999999999999999999999999999999999999998755321110


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc-
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT-  296 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-  296 (573)
                                 ..........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...... 
T Consensus       164 -----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         164 -----------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             -----------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence                       00012234578999999998765 55788999999999999999999999876555444433322110 


Q ss_pred             -HH-----------HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 -EQ-----------QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 -~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       ..           .+..... ......+......++.++.++|.+||+.||++|||+.+++++.|...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLP-SRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcc-cccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence             00           0000011 11111122223347899999999999999999999999999876644

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-36  Score=308.16  Aligned_cols=276  Identities=22%  Similarity=0.255  Sum_probs=202.9

Q ss_pred             ccccccc--CceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           71 LSPIARG--AESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        71 ~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      ...||+|  +||+||++.+  .++.||+|.....  .....+.+.+|+.+++.++||||++++++|..+...++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3467766  9999999987  6899999986543  33445788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          145 SRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       145 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      +++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++||+.+.........     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~-----  157 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK-----  157 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence            999999887542 35788999999999999999999999999999999999999999999999865432210000     


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc-H---
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT-E---  297 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-~---  297 (573)
                          ............++..|+|||++.+.  .++.++|||||||++|+|++|..||.................. +   
T Consensus       158 ----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         158 ----AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             ----ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence                00000001122356779999999764  4688999999999999999999999876544433332221100 0   


Q ss_pred             -----HHHH-------------HHHhcCCC------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          298 -----QQLT-------------AAVVSGGL------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       298 -----~~~~-------------~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                           ....             ........      .......+..+++.+.+||++||+.||++|||+.|+++|.|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                 0000             00000000      00001112346788999999999999999999999999999865


Q ss_pred             HH
Q 008220          354 EH  355 (573)
Q Consensus       354 ~~  355 (573)
                      ..
T Consensus       314 ~~  315 (328)
T cd08226         314 VK  315 (328)
T ss_pred             HH
Confidence            53

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-36  Score=308.05  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=203.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccC------
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------  133 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------  133 (573)
                      ..++|++.+.||+|+||.||++.+  +++.||+|++....  ....+.+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            347899999999999999999986  57899999865432  22345678899999999999999999987543      


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ...+++++++ +++|.+++...  .++++.++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            3467788876 77998877543  58899999999999999999999999999999999999999999999999986432


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      .                   ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus       172 ~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         172 D-------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             c-------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            1                   1233467899999999876 5678899999999999999999999976655444433332


Q ss_pred             cccc-HHHHHHHHhc-----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 MNYT-EQQLTAAVVS-----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .... .......+..           ......+.......++++.++|.+||+.||.+||++.+++.|.|..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence            2111 1111100000           0000111111224688899999999999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.5e-37  Score=308.88  Aligned_cols=280  Identities=24%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccC-------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP-------  133 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------  133 (573)
                      .++|++.++||.|+||.||+|.+  +++.+++|++......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            36899999999999999999987  5788999976443222  233567899999999999999999887543       


Q ss_pred             -CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          134 -PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       134 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                       ..+++|+||+.+ +|...+......+++.+++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence             346999999875 677777655557999999999999999999999999999999999999999999999999998755


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ........     ..............+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.........+.
T Consensus       166 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         166 DGPPPNPK-----GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cCCCcccc-----cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            42111000     0000011112345678999999988654 57889999999999999999999998776655444433


Q ss_pred             hccccH--HHHH-HHHhc--------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          292 EMNYTE--QQLT-AAVVS--------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       292 ~~~~~~--~~~~-~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......  .... .....        ....+.+......+++.+.++|.+||+.||.+|||+.+++.|.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            221110  0000 00000        00011111111245678999999999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-36  Score=295.54  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=209.9

Q ss_pred             CccccccccccCceEEEEEEEC--CeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccC--CceEEEE
Q 008220           67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFF  140 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~  140 (573)
                      +|++.+.||+|++|.||+|.+.  ++.|++|+......  ...+.+.+|+.++++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999874  88999998655442  4567889999999999999999999999888  8899999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--  157 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence            9999999999987665 7899999999999999999999999999999999999999999999999998765431110  


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......++..|+|||.+.+...+.++|+||||+++|+|++|..||..........            
T Consensus       158 ------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------  213 (260)
T cd06606         158 ------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL------------  213 (260)
T ss_pred             ------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------------
Confidence                        01234568899999999988889999999999999999999999998764111110            


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                       ......   ...+..+..++..+.++|.+||+.||++||++.+++.|.|
T Consensus       214 -~~~~~~---~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         214 -YKIGSS---GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             -Hhcccc---CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence             111111   1122334567899999999999999999999999998876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-36  Score=298.97  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=202.6

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||.|+||.||++.+  +++.+++|.+.....   .....+.+|++++++++||||+++++.+......|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999987  488999998654433   3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCC
Q 008220          149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK  228 (573)
Q Consensus       149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~  228 (573)
                      .+++...+ .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........        .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--------~  151 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN--------L  151 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc--------c
Confidence            99997655 78999999999999999999999999999999999999999999999999986443211100        0


Q ss_pred             CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                      ...........++..|++||.+.+...+.++|+||||+++|++++|..||...........+..              +.
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------~~  217 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--------------GK  217 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------CC
Confidence            0011122345688899999999888889999999999999999999999987654433333221              11


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELDL  351 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~~  351 (573)
                      ..  .+. ...++..+.+++++||+.+|.+|||+   .+++++.|+
T Consensus       218 ~~--~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         218 IE--WPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             cC--CCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            11  111 11248999999999999999999999   888877765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=307.60  Aligned_cols=270  Identities=23%  Similarity=0.282  Sum_probs=199.4

Q ss_pred             CccccccccccCceEEEEEEE----CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccC--CceE
Q 008220           67 SYTLLSPIARGAESVVYEATL----DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYM  137 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~  137 (573)
                      +|++.++||+|+||.||+|.+    .++.||+|.+....   ......+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            588999999999999999987    46899999865532   33345678899999999999999999999888  7899


Q ss_pred             EEEEeccCCChhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC----CCCCeEeeeecc
Q 008220          138 FFFEFYESRNLAEKLHVE----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR----NLCPHLADFGLA  209 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~----~~~~kL~Dfg~a  209 (573)
                      +||||+.+ +|.+.+...    ...+++..++.++.|++.||+|||+.+|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 666655322    236789999999999999999999999999999999999999    999999999998


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHH---
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEA---  285 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---  285 (573)
                      ........             .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.......   
T Consensus       160 ~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~  226 (316)
T cd07842         160 RLFNAPLK-------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS  226 (316)
T ss_pred             cccCCCcc-------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence            75532111             00112345688999999988764 57899999999999999999999997654322   


Q ss_pred             ------HHHHHHhccc-cHH----------HHHHHHhcCCCCC----ccc-ccc--cCChHHHHHHHHHhccCCCCCCCC
Q 008220          286 ------QAHTVLEMNY-TEQ----------QLTAAVVSGGLRP----ILA-SLE--LGLPASILSLIQRCWDGNPHNRPS  341 (573)
Q Consensus       286 ------~~~~~~~~~~-~~~----------~~~~~~~~~~~~~----~~~-~~~--~~~~~~l~~li~~~l~~dP~~Rpt  341 (573)
                            ....++.... ...          +...........+    .+. ..+  ...+.++.+++.+||+.||++|||
T Consensus       227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps  306 (316)
T cd07842         227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT  306 (316)
T ss_pred             chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence                  1111111000 000          0000000000000    000 011  156788999999999999999999


Q ss_pred             HHHHHHHHH
Q 008220          342 FSDIALELD  350 (573)
Q Consensus       342 ~~ell~~l~  350 (573)
                      +.|+++|.|
T Consensus       307 ~~eil~~~~  315 (316)
T cd07842         307 AEEALEHPY  315 (316)
T ss_pred             HHHHhcCCC
Confidence            999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-36  Score=300.43  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=191.7

Q ss_pred             cccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHH---HHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           73 PIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKEL---QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .||+|+||.||++.+  +++.||+|.+.....   .....+..|.   ..++...||||+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999986  578999997543321   1112233343   34455689999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      |++|.+++...+ .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+...         
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---------  150 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------  150 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---------
Confidence            999998886544 7899999999999999999999999999999999999999999999999998643210         


Q ss_pred             CCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                               ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||..........           ....
T Consensus       151 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----------~~~~  210 (278)
T cd05606         151 ---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----------IDRM  210 (278)
T ss_pred             ---------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----------HHHH
Confidence                     1223468999999999875 468899999999999999999999997652211100           0000


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                      .  ....   ...+..+++++.+++.+||..+|.+||     ++.++++|.|..
T Consensus       211 ~--~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         211 T--LTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             h--hccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            0  0011   123445789999999999999999999     999999888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=301.79  Aligned_cols=265  Identities=26%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhC---CCCccceeeeccccCCc-----
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHAKPPN-----  135 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~-----  135 (573)
                      |++.+.||+|+||.||+|.+  +++.||+|.+.....  .....+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67899999999999999987  478999998654322  2234566788777666   59999999999988776     


Q ss_pred             eEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999999975 7888876543 3689999999999999999999999999999999999999999999999998865432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..                 ......++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+....
T Consensus       160 ~~-----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07838         160 EM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI  222 (287)
T ss_pred             Cc-----------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence            10                 1122357889999999999889999999999999999999999998876655555444321


Q ss_pred             ccHHHHHHH--------HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          295 YTEQQLTAA--------VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       295 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .........        ................+++.+.++|.+||+.||.+||++.+++.|.|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence            110000000        00000001111112346788899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=301.47  Aligned_cols=266  Identities=28%  Similarity=0.339  Sum_probs=207.7

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++.+.||+|+||.||+|..  +++.|++|......  ......+..|+.+++.++||||+++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67788999999999999987  47899999865542  233456778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      .+ +|.+++......+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||.+........      
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~------  153 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR------  153 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc------
Confidence            74 89999987645789999999999999999999999999999999999999999999999999865432110      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                ......++..|+|||.+.+. .++.++|+|||||++|++++|..||...........+...........+
T Consensus       154 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (282)
T cd07829         154 ----------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW  223 (282)
T ss_pred             ----------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence                      11233467789999998766 7889999999999999999999999887655554444432211111100


Q ss_pred             HHhcCC--CC---Cc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          303 AVVSGG--LR---PI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       303 ~~~~~~--~~---~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......  ..   +.     .....+.++..+.++|++||+.||++||++.+++.|+|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            000000  00   00     00112245789999999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-36  Score=296.55  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             CccccccccccCceEEEEEEEC--CeeEEEeecc---CC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPI---LS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~---~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +|.+.+.||+|+||.||++.+.  +..+++|...   ..  .......+..|+.+++.++||||+++++.+......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6899999999999999999874  3334444322   11  122334567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||+.+++|.+++..   ....+++.+++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988753   2346899999999999999999999999999999999999975 569999999886543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .                ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..    
T Consensus       160 ~----------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~----  219 (260)
T cd08222         160 D----------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE----  219 (260)
T ss_pred             c----------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----
Confidence            0                12234578899999999888889999999999999999999999976543332222211    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                                 ...   +..+..++.++.++|.+||+.||++||++.++++|.|
T Consensus       220 -----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         220 -----------GPT---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             -----------CCC---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence                       111   1234567899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-37  Score=288.48  Aligned_cols=277  Identities=23%  Similarity=0.250  Sum_probs=206.1

Q ss_pred             CCccccccccccCceEEEEEEEC------CeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeecccc-CCce
Q 008220           66 SSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~  136 (573)
                      ..|++...||+|+||.||+|..+      .+.+|||++......  -....-+|+.+++.++||||+.|..+|.+ ....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46999999999999999999532      236899986554221  12345689999999999999999999988 7789


Q ss_pred             EEEEEeccCCChhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC----CCCeEeeeec
Q 008220          137 MFFFEFYESRNLAEKLHVE----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN----LCPHLADFGL  208 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~----~~~kL~Dfg~  208 (573)
                      ++++||.+. +|..+++..    ...++...++.++.||+.|+.|||++=|+||||||.||||..+    |.|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999987 888888643    2467889999999999999999999999999999999999888    8999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchh----
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRA----  283 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~----  283 (573)
                      ++.+.+.-             .+-......+-|.+|+|||.+.|. .|+.+.|||++|||+.||+|-++.|.+...    
T Consensus       183 aR~~~~pl-------------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~  249 (438)
T KOG0666|consen  183 ARLFNNPL-------------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT  249 (438)
T ss_pred             HHHhhccc-------------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence            99876311             011123345789999999999875 589999999999999999999988865321    


Q ss_pred             -----HHHHHHHHhccccHHH--------------HHHHHhcCCCCCc-ccc---cccCChHHHHHHHHHhccCCCCCCC
Q 008220          284 -----EAQAHTVLEMNYTEQQ--------------LTAAVVSGGLRPI-LAS---LELGLPASILSLIQRCWDGNPHNRP  340 (573)
Q Consensus       284 -----~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dP~~Rp  340 (573)
                           ..+..+|++....+.+              ...........+. +..   ....-++...+|+.+||+.||.+|.
T Consensus       250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI  329 (438)
T KOG0666|consen  250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI  329 (438)
T ss_pred             CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence                 2233334332211111              1111111111110 100   1122355688999999999999999


Q ss_pred             CHHHHHHHHHHHHHHh
Q 008220          341 SFSDIALELDLVLEHR  356 (573)
Q Consensus       341 t~~ell~~l~~~~~~~  356 (573)
                      |+++.++|..+....+
T Consensus       330 ta~qAleh~yF~~d~l  345 (438)
T KOG0666|consen  330 TAEQALEHPYFTEDPL  345 (438)
T ss_pred             cHHHHhcccccccCCC
Confidence            9999999887765543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=301.50  Aligned_cols=265  Identities=26%  Similarity=0.299  Sum_probs=202.9

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |++.+.||+|++|+||+|..  .++.|+||++..... .......+|+..++.++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            67889999999999999987  568899998544322 22334557999999999 999999999999999999999999


Q ss_pred             cCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          144 ESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       144 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                       +++|.+.+.... ..+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......      
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~------  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP------  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC------
Confidence             779988886543 467999999999999999999999999999999999999999999999999986543210      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH--HH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE--QQ  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~  299 (573)
                                 ......++..|+|||++. +..++.++|+||||+++|+|++|..||...........+.......  ..
T Consensus       154 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         154 -----------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             -----------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence                       112346788999999875 4457889999999999999999999998776555444433211110  00


Q ss_pred             HHHHH-hcCCCC--------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          300 LTAAV-VSGGLR--------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       300 ~~~~~-~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ..... ......        ..+.......+..+.++|++||+.||++|||+.|++.+.|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            00000 000000        1111112234788999999999999999999999998765

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=308.72  Aligned_cols=283  Identities=21%  Similarity=0.199  Sum_probs=207.2

Q ss_pred             CCcc-ccccccccCceEEEEEEE--CCeeEEEeeccCCChHH--------------HHHHHHHHHHHHhCCCCccceeee
Q 008220           66 SSYT-LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--------------LDNFHKELQLLCKLDHPGLAKFVA  128 (573)
Q Consensus        66 ~~y~-~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l~~  128 (573)
                      ++|. +.+.||.|+||+||+|.+  .++.||||+........              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5676 457799999999999986  57899999764332211              124678999999999999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                      ++......++||||+. ++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999999999997 58988886543 689999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      +.............  ...............+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.....
T Consensus       166 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        166 ARRYGYPPYSDTLS--KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             eeeccccccccccc--ccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            87554211000000  00000001112234578899999998764 4688999999999999999999999877665544


Q ss_pred             HHHHhccccHHH--HHHHHhc-------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQ--LTAAVVS-------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       288 ~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+.........  +......       ....+.+.......+.++.++|.+||+.+|++|||++|++.|.|..
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            444322111100  0000000       0001111112235688899999999999999999999999998884

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-36  Score=308.28  Aligned_cols=266  Identities=22%  Similarity=0.331  Sum_probs=202.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      ..+|.+.+.||.|+||.||+|.+  +++.||+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36899999999999999999986  5789999986432  2223456789999999999999999999886543      


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++|+||+.. +|..++   +..++++.+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            46899999864 676654   23688999999999999999999999999999999999999999999999999864321


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||...+.......+...
T Consensus       170 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~  230 (342)
T cd07879         170 -------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  230 (342)
T ss_pred             -------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                               1123467889999999876 46788999999999999999999999876554444443332


Q ss_pred             c-ccHHHHHHHHhcC-------C----CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 N-YTEQQLTAAVVSG-------G----LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~-~~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      . .............       .    .+..+....+..++.+.+||.+||+.||.+||++.+++.|.|+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence            1 1111111111000       0    001111112356788999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=295.04  Aligned_cols=269  Identities=20%  Similarity=0.288  Sum_probs=207.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC--CC----ccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD--HP----GLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp----nIv~l~~~~~~  132 (573)
                      .+....||.+++.+|+|+||.|-.+.+  .+..||||+++. -....+..+-|+++|+++.  .|    -++.+.++|+-
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            345568999999999999999999987  467899998543 2344566778999999993  23    37888899999


Q ss_pred             CCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC--------------
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--------------  197 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~--------------  197 (573)
                      .++.|+|+|.+ |.++.+++...+ .+++.+.++.+++|+++++++||+.+++|.||||+|||+..              
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999987 669999998654 46899999999999999999999999999999999999931              


Q ss_pred             ------CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHH
Q 008220          198 ------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL  271 (573)
Q Consensus       198 ------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  271 (573)
                            +..++|+|||.|++-..                   ...+.+.|..|+|||++.+-.++.++||||+||||+|+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e-------------------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE-------------------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc-------------------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                  33589999999976542                   23567889999999999999999999999999999999


Q ss_pred             HcCCCCCCCchhHH---HHHHHHhccccHHHHHHHH------hcCCC------------------CCccccc--ccCChH
Q 008220          272 LTGVVPYTDLRAEA---QAHTVLEMNYTEQQLTAAV------VSGGL------------------RPILASL--ELGLPA  322 (573)
Q Consensus       272 ltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~------------------~~~~~~~--~~~~~~  322 (573)
                      .+|...|+.-++.+   ..+.++. ..+ ..+..+.      ..+.+                  +|.-...  ......
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlG-p~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~  380 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILG-PIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV  380 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhC-CCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence            99999998765444   2233322 221 1111111      00100                  0000000  011234


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          323 SILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       323 ~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +|.+||++||.+||.+|+|+.|++.|+++.
T Consensus       381 ~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  381 QLFDLLRRMLEFDPARRITLREALSHPFFA  410 (415)
T ss_pred             HHHHHHHHHHccCccccccHHHHhcCHHhh
Confidence            688999999999999999999999998774

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-36  Score=330.54  Aligned_cols=145  Identities=26%  Similarity=0.391  Sum_probs=131.4

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.++||+|+||+||+|.+.  ++.||||++...   .......+..|+.+++.++||||+++++++.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            68999999999999999999984  889999986432   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ||+.+++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            9999999999987654 678899999999999999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5e-36  Score=299.81  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=203.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  136 (573)
                      ..+..+.|++.+.||.|+||.||+|.+.  ++.||||.+.... ......+..|+.++..+. ||||+++++++......
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   89 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV   89 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence            4455678999999999999999999985  8899999865432 233455667777776664 99999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +++|||+.+ +|.+++......+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++..+...
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999999854 7777776545578999999999999999999997 59999999999999999999999999998654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTV  290 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~  290 (573)
                      .                 ......+++.|+|||.+.+..    ++.++||||||+++|+|++|..||....... ....+
T Consensus       169 ~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  231 (296)
T cd06618         169 K-----------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI  231 (296)
T ss_pred             C-----------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence            0                 012235788999999987553    7889999999999999999999997532211 11111


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .              ... .+.++ ....++.++.+|+.+||..||.+||++.+++.+.|...
T Consensus       232 ~--------------~~~-~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         232 L--------------QEE-PPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             h--------------cCC-CCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            1              111 11111 11247889999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-36  Score=301.89  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             CccccccccccCceEEEEEEE-----CCeeEEEeeccCCC----hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      .|++.+.||.|+||.||++.+     +++.||+|.+....    ....+.+.+|+.+++.+ +||||+.+++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            488999999999999999975     57889999865322    22345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999987654 68899999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .               .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+    
T Consensus       160 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----  220 (290)
T cd05613         160 V---------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI----  220 (290)
T ss_pred             c---------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH----
Confidence            0               012235688999999998753  4678999999999999999999999643221111111    


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                            ...+...     .+..+..+++.+.+++++||+.||++||     ++.+++.|.+.
T Consensus       221 ------~~~~~~~-----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         221 ------SRRILKS-----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             ------HHHhhcc-----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence                  1111111     1122446789999999999999999997     78888887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.6e-36  Score=303.53  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=203.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc-CCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l  138 (573)
                      ..++|++.+.||.|+||.||++.+  +++.||+|++...  .......+..|+.+++.++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            346899999999999999999986  5788999975432  22344667789999999999999999998865 567889


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ++||+ +++|..++...  .+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||.+.....    
T Consensus        88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----  160 (328)
T cd07856          88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----  160 (328)
T ss_pred             Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence            99998 55888877532  578888999999999999999999999999999999999999999999998864321    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc-c
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY-T  296 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~  296 (573)
                                     ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.+... .
T Consensus       161 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~  225 (328)
T cd07856         161 ---------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP  225 (328)
T ss_pred             ---------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                           1123467889999998765 5688999999999999999999999977654333222221110 0


Q ss_pred             HHHHHHHHhcC-----------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSG-----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+.......+           ..........+.+++++.++|++||+.+|++|||+.+++.+.|..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence            11111100000           000111112245789999999999999999999999999888764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=309.98  Aligned_cols=242  Identities=25%  Similarity=0.327  Sum_probs=200.1

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ...|.+...+|.|+|+.|-.+.+  +++..++|++....    ....+|+.++... +||||+++.+++.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            46799999999999999999976  67889999865442    1223567666555 79999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE-cCCCCCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .+.|+.+.+.+.... .+. .++..|+.+|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++..+..     
T Consensus       397 ~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----  469 (612)
T ss_pred             hccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence            999999888876554 233 6778899999999999999999999999999999 69999999999998765531     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                    ..+.+-|..|.|||++....|+.++||||||++||+||+|+.||........+..-+.        
T Consensus       470 --------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~--------  527 (612)
T KOG0603|consen  470 --------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ--------  527 (612)
T ss_pred             --------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc--------
Confidence                          1234568899999999999999999999999999999999999987554422221111        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                           .+       .....+|.++++||.+||+.||.+||++.++..|.|.
T Consensus       528 -----~~-------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 -----MP-------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -----CC-------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                 11       1114789999999999999999999999999999998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=290.36  Aligned_cols=241  Identities=26%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             ccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCCh
Q 008220           74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL  148 (573)
Q Consensus        74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  148 (573)
                      ||.|+||.||++.+  .++.+++|.+....   ......+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999987  47899999755432   23456788999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCC
Q 008220          149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK  228 (573)
Q Consensus       149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~  228 (573)
                      .+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......            
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------  147 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------  147 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------------
Confidence            99987654 68999999999999999999999999999999999999999999999999986543211            


Q ss_pred             CCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                          .......++..|+|||.+.+...+.++|+||||+++|++++|..||...........+..              ..
T Consensus       148 ----~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------~~  209 (250)
T cd05123         148 ----SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------------DP  209 (250)
T ss_pred             ----CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------------CC
Confidence                012345688899999999888889999999999999999999999976654332222221              11


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELD  350 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~  350 (573)
                           ...+...+..+.++|++||..||++||++   .++++|+|
T Consensus       210 -----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         210 -----LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence                 11344568999999999999999999999   78887765

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.8e-36  Score=298.12  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=198.0

Q ss_pred             CccccccccccCceEEEEEEE-----CCeeEEEeeccCCC----hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      .|++.+.||.|+||.||++..     +++.||||.+....    ......+.+|+.+++++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            488999999999999999874     45789999754321    22345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+.+++|.+.+.... .+++..++.++.|++.+|.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            99999999999999886544 68899999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .               .......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||.........       
T Consensus       160 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------  217 (288)
T cd05583         160 E---------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-------  217 (288)
T ss_pred             c---------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-------
Confidence            0               0122346889999999987654  688999999999999999999999643211111       


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH---HHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI---ALELD  350 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el---l~~l~  350 (573)
                         ..+...+....     ...+..++.++.++|.+||+.||++|||+.++   ++++|
T Consensus       218 ---~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         218 ---SEISRRILKSK-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             ---HHHHHHHHccC-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence               11111111111     12234578999999999999999999996554   54443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=281.00  Aligned_cols=260  Identities=26%  Similarity=0.345  Sum_probs=205.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      +++.....+-+..||+|.||+|++..+  .|+..|||++...+. .+..++..|.+...+- ++||||++|+....++..
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            455566777888999999999999987  689999999877655 5677888898875554 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          137 MFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      |+.||.+.- +|..+..    .....++++-+-.|..-.+.||.||.+. .|||||+||+|||++..|.+||||||++..
T Consensus       139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999999864 6654432    2344788888888999999999999865 899999999999999999999999999976


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      +.+.                 ...+.-.|...|||||.+..  ..|+-++|+||||++|||+.||..||...+..  ..+
T Consensus       218 Lv~S-----------------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feq  278 (361)
T KOG1006|consen  218 LVDS-----------------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQ  278 (361)
T ss_pred             HHHH-----------------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHH
Confidence            6531                 12345578999999999853  45889999999999999999999999875432  111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCccccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +           ..++.+......... ..+++..+..+|..||.+|-+.||.+.++.++...
T Consensus       279 l-----------~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy  330 (361)
T KOG1006|consen  279 L-----------CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY  330 (361)
T ss_pred             H-----------HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence            1           122223222222221 24589999999999999999999999999876543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=278.98  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=211.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeecc---CCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPI---LSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  134 (573)
                      +-+...+|.++..||+|+|+.|.++++  +.+.+|+|+++   .+..++++-+..|-.+..+. +||.+|.+..+|+++.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            344556899999999999999999976  56789998643   34556677788888888887 6999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++|.||++||+|.-.+.+++ .++++.++.+..+|+.||.|||++|||.||||.+|||+|..|++||+|+|+++.-- 
T Consensus       325 rlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            9999999999999988876655 78999999999999999999999999999999999999999999999999986321 


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCc--hhHHHHHHHHh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL--RAEAQAHTVLE  292 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~  292 (573)
                                     .++....+++|||.|.|||++.+..|...+|.|+||++++||+.|+.||.--  ++..       
T Consensus       403 ---------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-------  460 (593)
T KOG0695|consen  403 ---------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-------  460 (593)
T ss_pred             ---------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-------
Confidence                           2334567899999999999999999999999999999999999999999532  1110       


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC------CHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP------SFSDIALEL  349 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------t~~ell~~l  349 (573)
                       ..+++.+...+.....+     +|..+|-....+++.-|+.||.+|.      .+.++..|.
T Consensus       461 -~ntedylfqvilekqir-----iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~  517 (593)
T KOG0695|consen  461 -MNTEDYLFQVILEKQIR-----IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA  517 (593)
T ss_pred             -cchhHHHHHHHhhhccc-----ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence             11222233333333332     3456788888999999999999995      456666655

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=289.19  Aligned_cols=271  Identities=28%  Similarity=0.392  Sum_probs=218.3

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhC--CCCccceeeeccccCC----ceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL--DHPGLAKFVAAHAKPP----NYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~~----~~~lv  139 (573)
                      ...++.++||+|.||.||+|..+++.||||++..   .+.+.+.+|-++++..  +|+||+++++.-....    .++||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3577889999999999999999999999998643   4566788888887765  7999999999877665    89999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---------GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ++|.+.|+|.++|...  .+++....+++..+++||+|||+.         .|+|||||.+||||..+++.-|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            9999999999999754  689999999999999999999964         59999999999999999999999999997


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC-CC-----chhhHHHHHHHHHHHHcCCCCCC-Cchh
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HS-----EKSDVYSFGISINELLTGVVPYT-DLRA  283 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~elltg~~Pf~-~~~~  283 (573)
                      .+....            +.+  .....+||.+|||||++.+.. +.     .+.||||+|.+|||+++...-+. +.-+
T Consensus       365 ~~~p~~------------~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  365 RLEPGK------------PQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             EecCCC------------CCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            765211            111  233478999999999997642 11     36899999999999999765543 1111


Q ss_pred             --HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccC--ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          284 --EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG--LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       284 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                        ..-...-+....+.+++...++..+.||.++..+..  -..-+++.++.||..||+.|.|+.=+.++++.+...
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence              111222344456677888888899999988876543  345688999999999999999999999888887653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=308.84  Aligned_cols=271  Identities=25%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             ccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------ceEE
Q 008220           68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------NYMF  138 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~l  138 (573)
                      |...+.||+|+||.||++++  +|+.||||..+.. .....+...+|+++|++|+|||||+++++-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            55678899999999999986  7999999975442 3445677889999999999999999999866543      5789


Q ss_pred             EEEeccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc--CCCC--CeEeeeecchhh
Q 008220          139 FFEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNLC--PHLADFGLAEYR  212 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~--~~~~--~kL~Dfg~a~~~  212 (573)
                      |||||.||+|..++....  ..+++.+++.++.++..||.|||++||+||||||.||++-  .+|+  -||+|||.|+-+
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999999997643  5789999999999999999999999999999999999983  3343  699999999876


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH----HH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA----QA  287 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~  287 (573)
                      ....                 ...+.+||+.|.+||++.. ..|+..+|.|||||++|++.||..||.......    ..
T Consensus       175 ~d~s-----------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~  237 (732)
T KOG4250|consen  175 DDNS-----------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM  237 (732)
T ss_pred             CCCC-----------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence            5322                 3567899999999999984 888999999999999999999999996543331    22


Q ss_pred             HHHHhccccHHHHHHHH-hcC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAV-VSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRP--SFSDIALELDLVLEH  355 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--t~~ell~~l~~~~~~  355 (573)
                      ..+...+.+........ .++     ...|....+...+-..+...+..+|..+|++|.  .+.+....+..++..
T Consensus       238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            22222211110000000 000     111111111112223455788889999999999  888877777777654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=288.08  Aligned_cols=264  Identities=27%  Similarity=0.404  Sum_probs=211.4

Q ss_pred             CCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHh--CCCCccceeeeccccC----CceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAKP----PNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~----~~~~l  138 (573)
                      ..+.++.+.||+|.||.||+|.+.|+.||||++....   .....+|.++++.  |+|+||+.+++.-...    .++||
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4678899999999999999999999999999864433   2345577777766  5999999999876543    36899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      |++|.+.|+|.|+|.+  ..++.+..+++++.++.||++||..        .|.|||||+.||||..+|.+-|+|+|+|.
T Consensus       287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            9999999999999976  4789999999999999999999954        59999999999999999999999999997


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC----C-C-chhhHHHHHHHHHHHHcC----------
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----H-S-EKSDVYSFGISINELLTG----------  274 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwslG~il~elltg----------  274 (573)
                      ......+            .-....+..+||.+|||||++...-    + + ..+||||||.++||++..          
T Consensus       365 ~h~~~t~------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  365 RHDSDTD------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             EecccCC------------cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            6553211            1112245679999999999986432    1 2 358999999999999863          


Q ss_pred             CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCCh--HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ++||.+.         .....+.+++...+....++|.++..+...+  ..+..||+.||..||.-|.|+--|-+.+..+
T Consensus       433 ~~Pyyd~---------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  433 QLPYYDV---------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             cCCcccC---------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            4677653         2233455666667777888998887766544  3577999999999999999999888877776


Q ss_pred             HH
Q 008220          353 LE  354 (573)
Q Consensus       353 ~~  354 (573)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            64

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=292.14  Aligned_cols=270  Identities=25%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-------HHHHHHHHHHHHHHhCCCCccceeeecc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------EELDNFHKELQLLCKLDHPGLAKFVAAH  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (573)
                      ......+||-++.+||+|+|+.||++-+  ..+.||||+......       .......+|.++.+.|+||.||++|++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            3556678999999999999999999976  578999997443321       1233467899999999999999999998


Q ss_pred             cc-CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCceEEc---CCCCCeEe
Q 008220          131 AK-PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--GIVHRDVKPANVLLD---RNLCPHLA  204 (573)
Q Consensus       131 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiH~Dlkp~Nill~---~~~~~kL~  204 (573)
                      .- ...+|-|+|||+|.+|.-+|.... .+++.+++.|+.||+.||.||.+.  .|||-||||.|||+-   ..|.+||+
T Consensus       537 slDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  537 SLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             eeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            74 567899999999999998887655 789999999999999999999977  599999999999984   45789999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK----EIHSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                      |||++++++.....+         ..+-.......||.||++||.+.-    ...+.++||||+|||+|+++.|+.||..
T Consensus       616 DFGLSKIMdddSy~~---------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNS---------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ecchhhhccCCccCc---------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            999999887543321         111222445689999999998752    2357899999999999999999999986


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ....   +.|++.+--       +...  .-.+| .-+.++.+..+||++||.+--+.|.+..++..++.++
T Consensus       687 nqsQ---QdILqeNTI-------lkAt--EVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  687 NQSQ---QDILQENTI-------LKAT--EVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             chhH---HHHHhhhch-------hcce--eccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            4322   222221100       0000  00111 1236899999999999999999999999987766444

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-35  Score=286.19  Aligned_cols=226  Identities=22%  Similarity=0.173  Sum_probs=183.2

Q ss_pred             cCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChhhhhhc
Q 008220           77 GAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV  154 (573)
Q Consensus        77 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  154 (573)
                      |.+|.||++.+  +++.||+|.+....     .+..|...+....||||+++++++......+++|||+.+++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999987  67889999865432     223455556666799999999999999999999999999999999865


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCcc
Q 008220          155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH  234 (573)
Q Consensus       155 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~  234 (573)
                      .. .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||.+.....                   .
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-------------------~  138 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-------------------S  138 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-------------------c
Confidence            54 689999999999999999999999999999999999999999999999998754331                   0


Q ss_pred             ccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCccc
Q 008220          235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA  314 (573)
Q Consensus       235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (573)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........                    ....   .
T Consensus       139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------------~~~~---~  195 (237)
T cd05576         139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------------THTT---L  195 (237)
T ss_pred             cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------------cccc---c
Confidence            1223456789999999888889999999999999999999988754211100                    0000   0


Q ss_pred             ccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHH
Q 008220          315 SLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELD  350 (573)
Q Consensus       315 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~  350 (573)
                      ..+..+++.+.++|.+||+.||++||++     +++++|+|
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence            1344678999999999999999999996     77776654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-35  Score=297.94  Aligned_cols=270  Identities=22%  Similarity=0.301  Sum_probs=210.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +..-|..++.||-|+||.|.+++.  +...||+|.+...   .......++.|-+||...+.+-||+||-.|.+.+.+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            344577889999999999999964  6677899965433   22345568889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh----
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN----  214 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~----  214 (573)
                      ||+|++||++..+|.+.+ -|.++.++.++.++..|+++.|+.|+|||||||+|||||.+|++||+|||+|+-+.=    
T Consensus       707 VMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999999998777 789999999999999999999999999999999999999999999999999853320    


Q ss_pred             --------hhhhhccc---ccCCCCC-----------CCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          215 --------LKEISLKN---WRSSGKP-----------TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       215 --------~~~~~~~~---~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                              .+.-++..   |.+.+..           .........+||+.|+|||++....|+...|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                    00011111   1111111           0111234578999999999999999999999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCccc-ccccCChHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 008220          273 TGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA-SLELGLPASILSLIQRCWDGNPHNRP---SFSDIALE  348 (573)
Q Consensus       273 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~  348 (573)
                      .|++||-...+.....+++.+...                +. ....++++++.++|.++.. +++.|.   .++||-.|
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~----------------l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH  928 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNF----------------LHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH  928 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhc----------------cccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence            999999888777776666543211                11 1234789999999987654 567775   45567666


Q ss_pred             HHH
Q 008220          349 LDL  351 (573)
Q Consensus       349 l~~  351 (573)
                      .|+
T Consensus       929 pfF  931 (1034)
T KOG0608|consen  929 PFF  931 (1034)
T ss_pred             ccc
Confidence            655

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=311.54  Aligned_cols=262  Identities=30%  Similarity=0.447  Sum_probs=215.4

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeee
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA  128 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  128 (573)
                      .++++.++..+.+.||+|.||.||+|...         ...||||..... ...+.+.+..|+++|+.+ .||||+.+++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            68888888889999999999999999642         356999976543 335678899999999999 5999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      ++......++|+||+..|+|.++++..+               ..++....+.++.||+.|++||++..++||||..+||
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            9999999999999999999999998665               3488899999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCcccccccc--CcccCChhhhccCCCCchhhHHHHHHHHHHH
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG--TLIYMAPEILKKEIHSEKSDVYSFGISINEL  271 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~el  271 (573)
                      |+..+..+||+|||+|+........               ......|  +..|||||.+....|+.++||||+|++|||+
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y---------------~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei  514 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYY---------------RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEI  514 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCce---------------EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHH
Confidence            9999999999999999754321111               1112222  4459999999999999999999999999999


Q ss_pred             Hc-CCCCCCCch-hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          272 LT-GVVPYTDLR-AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       272 lt-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      ++ |..||.+.. ......               ....+.+..   .|..+++++.++|+.||+.+|++||++.++.+.+
T Consensus       515 fsLG~~PYp~~~~~~~l~~---------------~l~~G~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~  576 (609)
T KOG0200|consen  515 FTLGGTPYPGIPPTEELLE---------------FLKEGNRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF  576 (609)
T ss_pred             hhCCCCCCCCCCcHHHHHH---------------HHhcCCCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence            99 999998743 222211               122233322   3557899999999999999999999999999988


Q ss_pred             HHHHH
Q 008220          350 DLVLE  354 (573)
Q Consensus       350 ~~~~~  354 (573)
                      ...+.
T Consensus       577 ~~~l~  581 (609)
T KOG0200|consen  577 EKHLQ  581 (609)
T ss_pred             HHHHH
Confidence            88554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-36  Score=272.09  Aligned_cols=268  Identities=25%  Similarity=0.342  Sum_probs=208.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-----ceE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM  137 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~  137 (573)
                      +.+--+.||.|+||.||.+++  +|+.|++|++..-  +.....++.+|+++|..++|.|++..+++..-+.     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345567899999999999987  6899999985432  3334567889999999999999999998876543     467


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +++|.+.. +|..++-.. ..++.+.++-+++||++||+|||+.+|.||||||.|+|++.+..+||||||+++.-+..+.
T Consensus       134 V~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            78887754 777766543 4788999999999999999999999999999999999999999999999999987654332


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .               ..+.-+-|..|+|||++.|. .|+.+.||||+|||+.||+..+..|....+..+...+.....+
T Consensus       212 ~---------------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT  276 (449)
T KOG0664|consen  212 L---------------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT  276 (449)
T ss_pred             h---------------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence            2               23455778999999999875 5899999999999999999999999988888887777665555


Q ss_pred             HHHHHHHHhc---------CCCC-Cccccc-----ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          297 EQQLTAAVVS---------GGLR-PILASL-----ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~---------~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +.....+...         +..+ |.++.+     +..-..+...++..+|..||++|.+.++.+.++..
T Consensus       277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            4433222222         2222 222211     11233467789999999999999999998776643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=299.65  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=211.8

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeecccc-----CC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK-----PP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-----~~  134 (573)
                      .+...|+|.+.||.|.+|.||+++.  .++..|+|+....... .+.++.|.++|+.+ .|||++.++++|..     ++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            3456899999999999999999864  7889999986554433 35677899999988 59999999999864     56


Q ss_pred             ceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      .+|||||||.||+..|++... +.++.|+.+..|++.++.||.+||...++|||||-.|||++.++.|||+|||.+..+.
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            899999999999999998643 5678999999999999999999999999999999999999999999999999986554


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      .                +-....+..|||.|||||++..     ..|+..+|+||||++..||.-|.+|+-+..+.....
T Consensus       175 s----------------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  175 S----------------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             c----------------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            2                1123678899999999999864     346778999999999999999999999876655544


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+.+..               +|.+. -|...++++.++|..||..|-++||+..++++|+..
T Consensus       239 ~IpRNP---------------PPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  239 LIPRNP---------------PPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             cCCCCC---------------Ccccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence            443211               11111 245688999999999999999999999999988743

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.6e-34  Score=256.66  Aligned_cols=265  Identities=21%  Similarity=0.319  Sum_probs=202.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCC--ceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP--NYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~lv~  140 (573)
                      ++|++.+++|+|-|+.||.|..  ++++++||.+..-   ....+.+|+.+|..|. ||||++|+++..++.  ...+|+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            6899999999999999999984  6789999986433   3456889999999997 999999999988754  577999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+.+...+..    .++.-.++.++.+++.||.|+|++||+|||+||.|++||... .++|+|+|+|.+.....   
T Consensus       115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---  187 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---  187 (338)
T ss_pred             hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc---
Confidence            9999877766543    567788999999999999999999999999999999999754 59999999998765322   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CchhHHHHHHHHhccccH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYT-DLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~~~~  297 (573)
                                    .....+.+..|--||.+.. +.|+.+-|+|||||+|..|+..+.||- +.++..+.-++.....+.
T Consensus       188 --------------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  188 --------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             --------------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence                          1334567888999999875 568899999999999999999888874 444444444443222111


Q ss_pred             H-------------HHHHHHhcCCCCCcc----ccccc-CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          298 Q-------------QLTAAVVSGGLRPIL----ASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       298 ~-------------~~~~~~~~~~~~~~~----~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .             .....+.....+..+    ..-.. -+++++.+|+.++|..|-.+|+|+.|.+.|+++...
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            1             001111111112111    11111 256999999999999999999999999999987543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-33  Score=302.69  Aligned_cols=268  Identities=21%  Similarity=0.206  Sum_probs=176.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE--C----CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeec------c
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--D----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA------H  130 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~  130 (573)
                      +..++|.+.++||+|+||.||+|++  +    +..||+|+.......  +....|  .++...+.++..++..      .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            3457899999999999999999987  3    678999985432221  111111  1222233333333222      2


Q ss_pred             ccCCceEEEEEeccCCChhhhhhccCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHVEEWSP-------------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA  191 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~  191 (573)
                      .....+++|+||+.+++|.+++.......                   ....+..++.||+.||+|||+++|+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            45667999999999999999886443111                   23446689999999999999999999999999


Q ss_pred             ceEEcC-CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-----------------
Q 008220          192 NVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----------------  253 (573)
Q Consensus       192 Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------------  253 (573)
                      |||++. ++.+||+|||+++.+....               ........+++.|+|||.+...                 
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~---------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp  349 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGI---------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP  349 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCcccccccc---------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence            999986 5789999999997543210               1123456789999999976432                 


Q ss_pred             -----CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh-ccccHHHHHHHHhcCCCCCccc---ccccCChHHH
Q 008220          254 -----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQQLTAAVVSGGLRPILA---SLELGLPASI  324 (573)
Q Consensus       254 -----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  324 (573)
                           .++.++|||||||+||||+++..|+...  .......+. .......+..... ....+.+.   ......+...
T Consensus       350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~~  426 (566)
T PLN03225        350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVE-PRASPDLRRGFEVLDLDGGAG  426 (566)
T ss_pred             hhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhc-cccchhhhhhhhhccccchHH
Confidence                 1334569999999999999977765432  112222221 1122111111111 11111100   0111234456


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          325 LSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       325 ~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+||.+||+.||++|||+.++++|+|..
T Consensus       427 ~dLi~~mL~~dP~kR~ta~e~L~Hpff~  454 (566)
T PLN03225        427 WELLKSMMRFKGRQRISAKAALAHPYFD  454 (566)
T ss_pred             HHHHHHHccCCcccCCCHHHHhCCcCcC
Confidence            7999999999999999999999998873

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=293.66  Aligned_cols=258  Identities=24%  Similarity=0.366  Sum_probs=214.6

Q ss_pred             CccccccccccCceEEEEEEE--CC----eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DG----RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ..+..++||.|+||+||+|.+  ++    -+||+|++... ..+....+..|+-+|..++|||+++|++++.... ..||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            456678999999999999976  33    36899975443 3445677899999999999999999999997765 8899


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ++|++.|.|.++++..+..+-....+.|+.||++|+.|||+++++||||..+||||..-..+||+|||+++.......  
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~--  853 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK--  853 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc--
Confidence            999999999999998888898999999999999999999999999999999999999999999999999987653211  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  .+......-.+.|||-|.+....|+.++||||+||++||++| |..|+.+....++...+..      
T Consensus       854 ------------ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------  915 (1177)
T KOG1025|consen  854 ------------EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------  915 (1177)
T ss_pred             ------------cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc------
Confidence                        112233345678999999999999999999999999999999 9999998766554433321      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                              +. |  + ..|+.++.++..++.+||..|+..||+++++...+..+....+
T Consensus       916 --------ge-R--L-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  916 --------GE-R--L-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             --------cc-c--C-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence                    11 1  1 2356789999999999999999999999999988877765433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-33  Score=325.08  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=191.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .|...+.||+|+||.||+|++  .+..||||++.....    ....|++.+++++||||+++++++.+....++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            456677899999999999986  678999998643322    12356889999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +|+|.++++    .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||......        
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--------  833 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--------  833 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc--------
Confidence            999999985    3788999999999999999999   6699999999999999999888775 66543211        


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~  300 (573)
                                  ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .............. 
T Consensus       834 ------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  900 (968)
T PLN00113        834 ------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH-  900 (968)
T ss_pred             ------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc-
Confidence                        0123368899999999999999999999999999999999999995421110 00000000000000 


Q ss_pred             HHHHhcCCCCCcccc---cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILAS---LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                          .....+|.+..   .+.....++.+++.+||+.||++|||+.|+++.+..+..
T Consensus       901 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 ----LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ----hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence                00011121111   111233467899999999999999999999999987765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=288.22  Aligned_cols=270  Identities=17%  Similarity=0.187  Sum_probs=187.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE------------------CCeeEEEeeccCCChHHHHH--------------HH
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL------------------DGRKVAVKKPILSTSEELDN--------------FH  109 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~------------------~~~~vavK~~~~~~~~~~~~--------------~~  109 (573)
                      .+..++|++.++||+|+||+||+|..                  .++.||||++........+.              ..
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            35567999999999999999999963                  24579999876543322222              33


Q ss_pred             HHHHHHHhCCCCcc-----ceeeecccc--------CCceEEEEEeccCCChhhhhhccC--------------------
Q 008220          110 KELQLLCKLDHPGL-----AKFVAAHAK--------PPNYMFFFEFYESRNLAEKLHVEE--------------------  156 (573)
Q Consensus       110 ~E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~--------------------  156 (573)
                      .|+.++.+++|.++     ++++++|..        ....++|+||+.+++|.++++...                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46677777766554     566666543        356899999999999999886421                    


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCc
Q 008220          157 ---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF  233 (573)
Q Consensus       157 ---~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~  233 (573)
                         ..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++.......               ..
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------------~~  365 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------------NF  365 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC---------------cc
Confidence               123567788999999999999999999999999999999999999999999985432100               00


Q ss_pred             cccccccCcccCChhhhccCC--------------------C--CchhhHHHHHHHHHHHHcCCC-CCCCchhHHHHHHH
Q 008220          234 HKKNMVGTLIYMAPEILKKEI--------------------H--SEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTV  290 (573)
Q Consensus       234 ~~~~~~gt~~y~aPE~~~~~~--------------------~--~~~~DiwslG~il~elltg~~-Pf~~~~~~~~~~~~  290 (573)
                      ......+++.|+|||.+....                    +  ..+.|+||+||++|+|++|.. ||.+..........
T Consensus       366 ~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~  445 (507)
T PLN03224        366 NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ  445 (507)
T ss_pred             CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh
Confidence            111234588999999875422                    1  124699999999999999875 77643221111110


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCC---CCCCCHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP---HNRPSFSDIALELDLV  352 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~ell~~l~~~  352 (573)
                      .    ......+....+ ....++ .....++...+|+.+||..+|   .+|+|+.|+++|+|+.
T Consensus       446 ~----~~~~~~~r~~~~-~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        446 Y----DNDLNRWRMYKG-QKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             c----cchHHHHHhhcc-cCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            0    000000111111 111111 234678999999999999876   6899999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-33  Score=270.65  Aligned_cols=133  Identities=26%  Similarity=0.335  Sum_probs=111.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-----CC---ccceeeecc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----HP---GLAKFVAAH  130 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hp---nIv~l~~~~  130 (573)
                      -.+...||-+.++||+|.|++||++.+  ..+.||+|+.+.. .-..+....|+++|++++     |+   .||+|++.|
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            345558999999999999999999998  4688999985432 334567789999999983     33   699999999


Q ss_pred             cc----CCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEE
Q 008220          131 AK----PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLL  195 (573)
Q Consensus       131 ~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill  195 (573)
                      ..    +.+.|+|+|++ |.+|..++.... ..++...++.|++||+.||.|||.. ||||.||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            74    56899999988 558888876544 4689999999999999999999965 99999999999999

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.3e-32  Score=264.20  Aligned_cols=240  Identities=28%  Similarity=0.398  Sum_probs=195.9

Q ss_pred             CceEEEEEEEC--CeeEEEeeccCCChHH-HHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChhhhhhc
Q 008220           78 AESVVYEATLD--GRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV  154 (573)
Q Consensus        78 ~~g~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  154 (573)
                      +||.||+|...  ++.+++|+........ .+.+.+|++.+++++|+||+++++.+......++++|++.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999874  6899999876654444 67899999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCcc
Q 008220          155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH  234 (573)
Q Consensus       155 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~  234 (573)
                      .. .++...++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.......                 .
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------------~  142 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------------L  142 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------c
Confidence            54 38899999999999999999999999999999999999999999999999987654211                 1


Q ss_pred             ccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCccc
Q 008220          235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA  314 (573)
Q Consensus       235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (573)
                      .....++..|++||.+.+..++.++|+||||+++|++++|..||..............              ....+ ..
T Consensus       143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------------~~~~~-~~  207 (244)
T smart00220      143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG--------------KPKPP-FP  207 (244)
T ss_pred             cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--------------ccCCC-Cc
Confidence            2345678899999999988889999999999999999999999976322222222111              01011 00


Q ss_pred             ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       315 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .....++.++.+++.+||..+|++||++.+++++.|
T Consensus       208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence            011117889999999999999999999999998654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.7e-34  Score=280.63  Aligned_cols=271  Identities=23%  Similarity=0.273  Sum_probs=211.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC------Cccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH------PGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~  132 (573)
                      +++.-.+|.+....|.|-|++|.+|.+  .+..||||++..+.... ..=..|+++|++|+.      -+.++|+..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            456778999999999999999999987  47799999976654433 334579999999953      389999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecc
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLA  209 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a  209 (573)
                      .+++|||+|.+.- +|.++|.+.+.  .+....++.|+.|++.||..|-..||+|.||||+||||++.. .+||||||.|
T Consensus       506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence            9999999998854 99999987653  567789999999999999999999999999999999998754 5899999999


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      .+....                  ..+-+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|++.++...+..
T Consensus       585 ~~~~en------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  585 SFASEN------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             cccccc------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            765421                  12334556789999999999999999999999999999999999999888777766


Q ss_pred             HHhcc--ccHHHHHHHH-hcCCC--------------------------CCc---------cccccc---CChHHHHHHH
Q 008220          290 VLEMN--YTEQQLTAAV-VSGGL--------------------------RPI---------LASLEL---GLPASILSLI  328 (573)
Q Consensus       290 ~~~~~--~~~~~~~~~~-~~~~~--------------------------~~~---------~~~~~~---~~~~~l~~li  328 (573)
                      .+...  ++...+.... ....+                          .|.         .+.++.   .+-.+|.+|+
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence            65443  2222111100 00000                          110         000111   1234688999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHH
Q 008220          329 QRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       329 ~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+||..||++|.|..+.|.|+..
T Consensus       727 dkml~LdP~KRit~nqAL~HpFi  749 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALKHPFI  749 (752)
T ss_pred             HHHhccChhhcCCHHHHhcCCcc
Confidence            99999999999999999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=263.74  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=206.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      ..||.-++.+|.|.- .|..+-+  .+++||+|+....  +.....+..+|+.++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            368999999999998 6766755  6899999974332  333456778999999999999999999998643      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+|||++.. +|...+..   .+.-.++..+++|++.|++|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus        95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            58999999976 88887763   456688999999999999999999999999999999999999999999999964332


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 ...+.++.|..|+|||++.+..+...+||||+||++.||++|...|.+.+...+..++.+..
T Consensus       171 ~-----------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l  233 (369)
T KOG0665|consen  171 D-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL  233 (369)
T ss_pred             c-----------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence            1                 23456788999999999999889999999999999999999999999888877777776554


Q ss_pred             ccHHHHHHHHhcC-------------------CCCCc-c---cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSG-------------------GLRPI-L---ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~~~~~~~~~~~-------------------~~~~~-~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .++..-.......                   .+... +   ..-++--+..+.+|+.+||..||++|.+++++|+|+-.
T Consensus       234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence            3332211111000                   00000 0   00011123457899999999999999999999998854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=292.61  Aligned_cols=250  Identities=27%  Similarity=0.392  Sum_probs=195.0

Q ss_pred             ccccccccccCceE-EEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEeccC
Q 008220           68 YTLLSPIARGAESV-VYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        68 y~~~~~lg~G~~g~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      |.-.+.+|.|..|+ ||+|...++.||||++...   ......+|+..|+.- .|||||++++.-.+....|+..|.|.-
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~  587 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC  587 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence            34456789999996 6999999999999985432   334567999999988 599999999999999999999999965


Q ss_pred             CChhhhhhcc--CCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---C--CCCeEeeeecchhhhhhhh
Q 008220          146 RNLAEKLHVE--EWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---N--LCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       146 g~L~~~l~~~--~~~~-~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~--~~~kL~Dfg~a~~~~~~~~  217 (573)
                       +|.+++...  .... .....+.++.|++.||++||+.+||||||||+||||+.   +  ..++|+|||+++.......
T Consensus       588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence             999999763  1111 11456789999999999999999999999999999976   3  4689999999987653221


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .             -....+..||-+|+|||++....-+.++|||||||++|+.++ |..||.+...  ...+|+..++.
T Consensus       667 S-------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~  731 (903)
T KOG1027|consen  667 S-------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYT  731 (903)
T ss_pred             h-------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccc
Confidence            0             112456789999999999999888889999999999999999 6999987532  22233333322


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .                ..+......+..+||.+|+..+|..||+|.+|+.|+.+.
T Consensus       732 L----------------~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  732 L----------------VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             e----------------eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            1                111111122889999999999999999999999998554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=242.19  Aligned_cols=204  Identities=27%  Similarity=0.406  Sum_probs=172.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      ++++.+...-+..||+|+||.|-+.++  +|+..|+|.+... +.....++.+|+++..+. .+|++|.+|+.+......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            788888899999999999999877765  7899999986544 345567788899886665 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          137 MFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ++.||.+.- +|..+..   ..+..+++..+-+|+..++.||.|||++ .+||||+||+||||+.+|++|+||||++.++
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999865 7765543   3566889999999999999999999987 8999999999999999999999999999776


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHcCCCCCCCch
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK----EIHSEKSDVYSFGISINELLTGVVPYTDLR  282 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~  282 (573)
                      .+.-.                 .+...|...|||||.+..    ..|+-++||||||+.++||.+++.||....
T Consensus       200 ~dSiA-----------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  200 VDSIA-----------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hhhhH-----------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            54221                 223568889999999853    368899999999999999999999997643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-33  Score=280.47  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=215.5

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +..+|.++..+|.|+||.||++++  +++..|+|.++....++...+.+|+-+++..+||||+.+++.+......++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            457899999999999999999987  688999999888888888889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      ||.||+|++..+..+ .+++.++..++++.+.||+|||+.|-+|||||-.|||++..|.+||.|||.+..+...      
T Consensus        93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat------  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT------  165 (829)
T ss_pred             ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh------
Confidence            999999999887655 8899999999999999999999999999999999999999999999999987654421      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                ........||+.|||||+.   ....|...+|||++|+...|+---++|--+..+.....          
T Consensus       166 ----------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~----------  225 (829)
T KOG0576|consen  166 ----------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF----------  225 (829)
T ss_pred             ----------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH----------
Confidence                      1125678999999999986   45678999999999999999988888865543322211          


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                          .....++.|.--.-+...++.+.+|++.+|..+|++|||++.++.|.
T Consensus       226 ----LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~  272 (829)
T KOG0576|consen  226 ----LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP  272 (829)
T ss_pred             ----HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence                11223333332222446789999999999999999999999998765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=271.60  Aligned_cols=195  Identities=29%  Similarity=0.426  Sum_probs=168.2

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCCC--------hHHHHHHHHHHHHHHhCC---CCccceeeecccc
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST--------SEELDNFHKELQLLCKLD---HPGLAKFVAAHAK  132 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~  132 (573)
                      ..|..++.||.|+||.|++|.++  ...|+||.+....        ....-.+..|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46999999999999999999884  4568888643321        112234667999999997   9999999999999


Q ss_pred             CCceEEEEEec-cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          133 PPNYMFFFEFY-ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       133 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      .+.+|++||.- +|-+|.+++.... ++++.++..|++|++.|+++||+.||||||||-+||+++.+|.+||+|||.+.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99999999975 4568999998766 899999999999999999999999999999999999999999999999999876


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~  279 (573)
                      ....                  +.-.++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus       720 ~ksg------------------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSG------------------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCC------------------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            5421                  2356789999999999999887 677899999999999999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=249.37  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc-
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  132 (573)
                      .+...|+++..++-+|.||.||.|.+.       .+.|.+|.+... +.-+...+..|.-.+..+.|||+..+.++... 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            344567888999999999999999652       245667754333 33356778899999999999999999988754 


Q ss_pred             CCceEEEEEeccCCChhhhhhc-----c--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEee
Q 008220          133 PPNYMFFFEFYESRNLAEKLHV-----E--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~-----~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                      ....++++.+..-|+|..++..     .  ...++..+...++.|++.|++|||++||||.||..+|.+||+..++||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence            4567788888888999999872     1  12456678889999999999999999999999999999999999999999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhH
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE  284 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~  284 (573)
                      =.+++-+-.      .++..-|        -.-..+..||+||.+.+..|+.++|+||||++||||+| |+.||.+.++.
T Consensus       440 saLSRDLFP------~DYhcLG--------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf  505 (563)
T KOG1024|consen  440 SALSRDLFP------GDYHCLG--------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF  505 (563)
T ss_pred             chhccccCc------ccccccC--------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence            998864321      1111110        11234678999999999999999999999999999999 99999988776


Q ss_pred             HHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      +....+..               ++|-   ..|.++|+++..+|..||..+|++||+++|+..-|..+-.+
T Consensus       506 Em~~ylkd---------------GyRl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  506 EMEHYLKD---------------GYRL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             HHHHHHhc---------------ccee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            65554432               2221   13568999999999999999999999999998877766543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=7.6e-29  Score=233.75  Aligned_cols=210  Identities=37%  Similarity=0.568  Sum_probs=182.0

Q ss_pred             ccccCceEEEEEEEC--CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChhh
Q 008220           74 IARGAESVVYEATLD--GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE  150 (573)
Q Consensus        74 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  150 (573)
                      ||.|.+|.||++...  ++.+++|+....... ..+.+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999986  899999986655432 35678999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhhhhhcccccCCCCC
Q 008220          151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKP  229 (573)
Q Consensus       151 ~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  229 (573)
                      ++......++...++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........            
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------------  148 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------------  148 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------------
Confidence            98765346889999999999999999999999999999999999999 89999999999865432110            


Q ss_pred             CCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCC
Q 008220          230 TGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG  308 (573)
Q Consensus       230 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (573)
                          ......+...|++||.+... .++.++|+|++|++++++                                     
T Consensus       149 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------  187 (215)
T cd00180         149 ----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------  187 (215)
T ss_pred             ----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence                12234578889999999877 788999999999999999                                     


Q ss_pred             CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                   ..+.+++.+|++.+|.+||++.++++++
T Consensus       188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                         3367999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-29  Score=233.40  Aligned_cols=278  Identities=20%  Similarity=0.281  Sum_probs=228.7

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCC
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP  134 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (573)
                      .....+.+-.|++.++||+|.||.++.|+.  .+++||||.-..  ..+.-++..|.+..+.|. .++|+.+|-+...+.
T Consensus        20 ~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   20 SSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             CCCceEecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            334557778999999999999999999975  899999996322  233456788999999995 799999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-----CCeEeeeecc
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-----CPHLADFGLA  209 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-----~~kL~Dfg~a  209 (573)
                      +-.||+|.+ |.+|.|++.-.+.+|+..++..++.|++.-++|+|++.+|.|||||+|+||...+     .+.|+|||+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            999999987 7799999998888999999999999999999999999999999999999997654     4789999999


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      +.+.+........+         ....+..||..||+-..+.|..-+...|+-|||-+++++|-|.+||.+........+
T Consensus       177 K~YrDp~TkqHIPY---------rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPY---------REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             hhhcCccccccCcc---------ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            87765444322221         234677899999999999999999999999999999999999999999765443333


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS  358 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~  358 (573)
                      .           +++........+..+..++|.++..-++..-+.+-.+-|+++-+...+..++.....
T Consensus       248 Y-----------eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  248 Y-----------EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             H-----------HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            2           333333334445556678999999999999999999999999888877777765443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.1e-29  Score=245.93  Aligned_cols=283  Identities=25%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             CCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (573)
                      ..+.|.++.+||.|.|++||++.+     ..+.||+|.+...+  ...++.+|++.|..+. +.||+++.+++..+++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            346799999999999999999964     45789999765543  3456889999999995 899999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +|+||++...-.++..    .++..+++.+++.++.||+++|..|||||||||.|+|.+. .+.-.|+|||+|...+...
T Consensus       112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            9999999988877765    4567899999999999999999999999999999999975 4556899999997433211


Q ss_pred             hhhcccc-------------------cCCCCC---------CCCccccccccCcccCChhhhccCC-CCchhhHHHHHHH
Q 008220          217 EISLKNW-------------------RSSGKP---------TGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGIS  267 (573)
Q Consensus       217 ~~~~~~~-------------------~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  267 (573)
                      .......                   .....+         ..........||++|+|||++...+ -+.++||||.|+|
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence            1000000                   000000         0111223458999999999987644 5789999999999


Q ss_pred             HHHHHcCCCCCCCchhHH----HHHHHHh-----------cc---cc------HHHHH---HHHhcCCCCC-----cccc
Q 008220          268 INELLTGVVPYTDLRAEA----QAHTVLE-----------MN---YT------EQQLT---AAVVSGGLRP-----ILAS  315 (573)
Q Consensus       268 l~elltg~~Pf~~~~~~~----~~~~~~~-----------~~---~~------~~~~~---~~~~~~~~~~-----~~~~  315 (573)
                      +.-++++..||-...+..    .+..++.           +.   +.      ..+..   ..+..+...+     ....
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            999999999984332111    1111100           00   00      00000   0000011111     0111


Q ss_pred             -cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          316 -LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       316 -~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       ..+..+..+.+|+.+||..||.+|.|+++.|+|+.+-
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence             1123566899999999999999999999999988654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=229.17  Aligned_cols=253  Identities=20%  Similarity=0.251  Sum_probs=188.8

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeec-cccCCceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAA-HAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~  140 (573)
                      .+.|.+.+.||+|-||.+-++++  +++.+++|-+... ......|.+|...--.| .|.||+.-|++ |++.+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            36799999999999999999998  4578999965433 23456788888776666 48999997765 67778888999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-C-CCCCeEeeeecchhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-R-NLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~-~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||++.|+|..-+...  .+.+.....++.|++.||.|||+.++||||||.+||||- . ...+||||||..+....    
T Consensus       102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~----  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT----  175 (378)
T ss_pred             ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc----
Confidence            999999999887653  578889999999999999999999999999999999983 2 33699999998754331    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc---C--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---E--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                     ......-+..|.+||+...   +  ...+.+|+|.||+++|.++||++||+......        
T Consensus       176 ---------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--------  232 (378)
T KOG1345|consen  176 ---------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--------  232 (378)
T ss_pred             ---------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--------
Confidence                           1122234567999997642   2  23678999999999999999999997321111        


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIALELD  350 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell~~l~  350 (573)
                         .....+..=.++..+.+|..-..+++.+..+.++-|..+|++|   .++......+|
T Consensus       233 ---~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  233 ---KPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             ---chHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence               1111111112334444555555689999999999999999999   44444444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-28  Score=219.58  Aligned_cols=272  Identities=19%  Similarity=0.285  Sum_probs=220.1

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCce
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~  136 (573)
                      +-.|...+|+++++||.|+||.+|+|..  .|..||||.-...  .....+..|.++...|+ ...|+.+..++.+...-
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            3456678999999999999999999976  7899999973222  22345678999999997 57888888888888999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC---CCCeEeeeecchhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEYRE  213 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~---~~~kL~Dfg~a~~~~  213 (573)
                      .+||+.+ |.+|.+++......++..+++.++-|++.-++|+|.+++|||||||+|+|+.-+   ..+.|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999987 779999998877799999999999999999999999999999999999999644   357899999998776


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      +.......         +........||..|.+-..+.+..-+...|+-|+|.+|.++.-|..||++.......++.   
T Consensus       166 d~~t~~HI---------pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy---  233 (341)
T KOG1163|consen  166 DIRTRQHI---------PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY---  233 (341)
T ss_pred             cccccccC---------ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH---
Confidence            54332221         222345678999999999988888899999999999999999999999998655443322   


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                              +++........+..+..++|.++.-.+..|-..--++-|+..-|.+.+..++.
T Consensus       234 --------EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  234 --------EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             --------HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence                    23333334445556677899999999999999999999999887766655554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=8.5e-28  Score=229.64  Aligned_cols=198  Identities=35%  Similarity=0.524  Sum_probs=172.2

Q ss_pred             ccccccccccCceEEEEEEEC--CeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           68 YTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      |.+.+.||.|++|.||++...  ++.+++|........ ..+.+.+|++.++.++|+|++++++.+......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            677889999999999999874  689999987665544 67788999999999999999999999998899999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......        
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~--------  152 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL--------  152 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--------
Confidence            999999987655227899999999999999999999999999999999999999999999999886554211        


Q ss_pred             CCCCCCCCccccccccCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                             +.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       153 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 -------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   0012345678899999998 667778899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.1e-29  Score=280.69  Aligned_cols=216  Identities=16%  Similarity=0.133  Sum_probs=147.8

Q ss_pred             HhCCC-Cccceeeeccc-------cCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 008220          116 CKLDH-PGLAKFVAAHA-------KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD  187 (573)
Q Consensus       116 ~~l~h-pnIv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~D  187 (573)
                      +.++| +||++++++|.       ....+++++|++ +++|.+++......+++.+++.+++||+.||+|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            34556 58888888872       234577788876 5699999976555789999999999999999999999999999


Q ss_pred             CCCCceEEcCCCCCeEeeeecchhhhhhhhh--hccccc-----------------CCCCCCCCccccccccCcccCChh
Q 008220          188 VKPANVLLDRNLCPHLADFGLAEYRENLKEI--SLKNWR-----------------SSGKPTGGFHKKNMVGTLIYMAPE  248 (573)
Q Consensus       188 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~-----------------~~~~~~~~~~~~~~~gt~~y~aPE  248 (573)
                      |||+||||+..|.+|++|||++.........  ....+.                 ..............+||+.|||||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            9999999976555555555544322110000  000000                 000000011122357899999999


Q ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHH
Q 008220          249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI  328 (573)
Q Consensus       249 ~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  328 (573)
                      ++.+..++.++|||||||+||||++|.+|+.....  ....+..              ....+.    .....+...+++
T Consensus       186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~--------------~~~~~~----~~~~~~~~~~~~  245 (793)
T PLN00181        186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH--------------RVLPPQ----ILLNWPKEASFC  245 (793)
T ss_pred             hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH--------------hhcChh----hhhcCHHHHHHH
Confidence            99999999999999999999999999888753211  1111100              000010    011234567899


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHHH
Q 008220          329 QRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       329 ~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+||+.+|.+||++.|+++|+|..
T Consensus       246 ~~~L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             HHhCCCChhhCcChHHHhhchhhh
Confidence            999999999999999999998864

>PLN03145 Protein phosphatase 2c; Provisional

Probab=99.95  E-value=5.6e-28  Score=242.09  Aligned_cols=140  Identities=36%  Similarity=0.620  Sum_probs=116.2

Q ss_pred             CcCCcceEEEEeeccCCCCCceeEEecccCCC--------CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCC-CCCh
Q 008220          424 TYYPVLSWGSFATCGRRETMEDTHFLMPHMYN--------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRP  494 (573)
Q Consensus       424 ~~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~--------~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~-~~~~  494 (573)
                      .+...+++|..|++|.|+.|||++++..++..        .....||||||||||+.+|+||++++++.+.+... ..++
T Consensus        60 ~~~~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~~~~~~~~lf~V~DGhGG~~age~as~~l~~~i~~~~~~~~~~  139 (365)
T PLN03145         60 EFIPVVRSGAWADIGSRSSMEDVYICVDNFMSDFGLKNSEDGPSAFYGVFDGHGGKHAADFACYHLPRFIVEDEDFPREI  139 (365)
T ss_pred             hccCceEEEEEccccCCCCCCCceEecccccccccccccCCCCceEEEEEeCCCCHHHHHHHHHHHHHHHHhhhccchhH
Confidence            44567899999999999999999987665321        23368999999999999999999999998876532 3456


Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          495 TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       495 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .++|.++|.++|.++.+.....        ....+|||+++++|.++.+|||||||||||++++|++++||+||+|.
T Consensus       140 ~~al~~af~~~d~~~~~~~~~~--------~~~~~GTTavv~li~~~~l~vaNvGDSRayl~r~g~~~~LT~DH~~~  208 (365)
T PLN03145        140 EKVVSSAFLQTDTAFAEACSLD--------ASLASGTTALAALVVGRSLVVANAGDCRAVLCRRGKAIEMSRDHKPM  208 (365)
T ss_pred             HHHHHHHHHHHhHHHHhhhccc--------cCCCCcCcEEEEEEECCeEEEEecCCceEEEEcCCeEEEecCCCCCC
Confidence            7899999999999986543211        11236999999999999999999999999999999999999999995

>KOG0697 consensus Protein phosphatase 1B (formerly 2C) [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=221.97  Aligned_cols=143  Identities=24%  Similarity=0.385  Sum_probs=120.0

Q ss_pred             ccCcCCcceEEEEeeccCCCCCceeEEecccCCC-CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-C-----C---
Q 008220          422 ALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-S-----T---  491 (573)
Q Consensus       422 ~~~~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~-----~---  491 (573)
                      .......++||+.|+||||.+|||+|.....+.+ -.+++||||||||.|+..|.+|+++|.+.+.+.. +     .   
T Consensus        15 ~~G~GNglryg~SSMQGWR~eMEDah~A~~~l~~~l~dWSfFAVfDGHAGs~va~~c~~hLlehi~sse~F~~~~k~gsv   94 (379)
T KOG0697|consen   15 AEGEGNGLRYGVSSMQGWRVEMEDAHTAVAGLPSPLEDWSFFAVFDGHAGSQVANHCAEHLLEHIISSEEFRGMTKNGSV   94 (379)
T ss_pred             ccCcCCceeeeeccccchhhhhhhhhhhhhcCCCCccCceEEEEEcCccchHHHHHHHHHHHHHhhhhHHHhhhccCCcH
Confidence            3344678999999999999999999988666542 3679999999999999999999999988775431 1     1   


Q ss_pred             CChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          492 TRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       492 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .+.+..|+..|+++|+.++.......       ...++|||||+++|...++|++|+|||||+|||+|.++.-|.|||||
T Consensus        95 ~~~~~GIrtGFL~iDE~mr~~~~~~~-------~~drsGsTAVcv~vsp~h~y~~NcGDSRavl~rng~~~f~TqDHKP~  167 (379)
T KOG0697|consen   95 ENVEKGIRTGFLSIDEIMRTLSDISK-------GSDRSGSTAVCVFVSPTHIYIINCGDSRAVLCRNGEVVFSTQDHKPY  167 (379)
T ss_pred             HHHHhhHhhcceeHHHHHhhhhhhhc-------ccccCCceEEEEEecCceEEEEecCcchhheecCCceEEeccCCCCC
Confidence            25677899999999998876544322       22347999999999999999999999999999999999999999998

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.2e-27  Score=218.25  Aligned_cols=169  Identities=23%  Similarity=0.307  Sum_probs=131.0

Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++...+..+++++++.++.|++.||+|||+.+      ||+|||++.++.+|+  ||++.....           
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-----------   61 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-----------   61 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence            6899999876667999999999999999999999998      999999999999999  998865431           


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH-HHHHHhccccHHHHHHHH
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ-AHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  304 (573)
                                ....||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+.....         
T Consensus        62 ----------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---------  122 (176)
T smart00750       62 ----------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---------  122 (176)
T ss_pred             ----------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---------
Confidence                      112588999999999999999999999999999999999999976432211 111111000         


Q ss_pred             hcCCCCCcccccccCChH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPA--SILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~--~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                        . ..+.....+..++.  ++.++|.+||..||.+|||+.++++|++.....
T Consensus       123 --~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      123 --A-DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             --c-CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence              0 00000001122333  699999999999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=226.86  Aligned_cols=266  Identities=22%  Similarity=0.243  Sum_probs=201.4

Q ss_pred             CccccccccccCceEEEEEEECC---eeEEEeeccCCChHHHHHHHHHHHHHHhCCC----Cccceeeecc-ccCCceEE
Q 008220           67 SYTLLSPIARGAESVVYEATLDG---RKVAVKKPILSTSEELDNFHKELQLLCKLDH----PGLAKFVAAH-AKPPNYMF  138 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~l  138 (573)
                      +|++.++||+|+||.||++.+..   ..+|+|............+..|..++..+..    ++++.+++.+ ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999999744   4688987544332222367789999998863    6899999999 47778899


Q ss_pred             EEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-----CCCeEeeeecchhh
Q 008220          139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-----LCPHLADFGLAEYR  212 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-----~~~kL~Dfg~a~~~  212 (573)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+++..
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99977 779999885544 689999999999999999999999999999999999999865     35899999999833


Q ss_pred             hhhhhhhcccccCCCCC-CCCcc-ccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKP-TGGFH-KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      .....        .+.. ..... .....||..|+++.++.+...+++.|+||++.++.+++.|..||............
T Consensus       178 ~~~~~--------~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  178 KYVGD--------SGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             cccCC--------CCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            21111        0000 01111 23456999999999999999999999999999999999999999765433222221


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ......           .   .........+.++.+++..+-..+...+|.+..+...+......
T Consensus       250 ~~~~~~-----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  250 EKDPRK-----------L---LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHhhh-----------h---ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111100           0   00002234567888999988899999999999999887666653

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=99.94  E-value=1e-24  Score=231.12  Aligned_cols=341  Identities=16%  Similarity=0.127  Sum_probs=207.0

Q ss_pred             HHHHHHHhCC---CCccceeeeccccCCceEEEEEeccC-CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008220          110 KELQLLCKLD---HPGLAKFVAAHAKPPNYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH  185 (573)
Q Consensus       110 ~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH  185 (573)
                      ..+..+-+|.   +.||+++|+++..+..-++++|+... ..|.+.....  ..+.-+.+.++.||+.--.-|...|+.-
T Consensus       166 ~~~~~Yl~L~~~~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~--~~~~l~~l~Wl~q~~~LW~~l~~~~~~~  243 (645)
T PRK14559        166 ALAIPYLALQDQFPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQ--TLPTLQILYWLNQMTQLWKALEPWGCCQ  243 (645)
T ss_pred             HHhhhHHhccccccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhc--CCcHHHHHHHHHHHHHHHHHHHhcCeeh
Confidence            3444444452   34599999999988888888887643 2333333221  3456788899999999999999999999


Q ss_pred             ccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHH
Q 008220          186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG  265 (573)
Q Consensus       186 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  265 (573)
                      -=|.++|+-|+++..+.|-.|-.-                                    .|+    .+    .-+=.||
T Consensus       244 sll~~~nlrv~~~~~~~l~~l~~~------------------------------------~~~----~~----~~l~~Lg  279 (645)
T PRK14559        244 SLLELENLRVDEDQTLGLQQLYQD------------------------------------PPE----QP----PSLQDLG  279 (645)
T ss_pred             hccchhheeeCCCceehHhhhhcC------------------------------------CCc----CC----CCHHHHH
Confidence            999999999987766555544210                                    000    01    1122445


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       266 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                      -+.-.++....|                                         .+...+..|+..+-+   .+=.++++|
T Consensus       280 ~~w~~l~~~~~~-----------------------------------------~~~~~l~~l~~~l~~---~~~~~~~~l  315 (645)
T PRK14559        280 QVWQQLFTQSQR-----------------------------------------TQFESLIPLLQDLQS---GKIQTIAQL  315 (645)
T ss_pred             HHHHHHHhhcCh-----------------------------------------hhHHHHHHHHHHHHh---cCCCCHHHH
Confidence            444444442211                                         122334555555532   233478888


Q ss_pred             HHHHHHHHHHhccccccccccCCcccccccccccccCCcccccc-cccccccccchhhhhccccccccchhcccccCccC
Q 008220          346 ALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHE-SINWTAQGEHSSKKASHAAESDVKLWLESANDALT  424 (573)
Q Consensus       346 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~~~~~~~~s~~~~~~  424 (573)
                      ...|+.+.............+.      .+.....+...+.... ...+                    ...+.+...+.
T Consensus       316 ~~~l~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~lp  369 (645)
T PRK14559        316 RLRLQELATELEAEGEAEFEST------EGETTLAPSILQSDDSESPIH--------------------ETEDAPTAVLP  369 (645)
T ss_pred             HHHHHHHHHHhccccccccccc------ccccccccccccccccccccc--------------------ccccCcccccc
Confidence            8888887765433221111000      0000000000000000 0000                    00001111111


Q ss_pred             -cCCcceEEEEeeccC-CCCCceeEEecccCC-----CC---CceEEEEEEcCCCcHHHHHHHHHHhHHHHHh----cCC
Q 008220          425 -YYPVLSWGSFATCGR-RETMEDTHFLMPHMY-----NQ---KEIHMFGIFDGHRGSAAAEFSARALPGFLQN----LGS  490 (573)
Q Consensus       425 -~~~~~~~~~~s~~G~-R~~neD~~~~~~~~~-----~~---~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~----~~~  490 (573)
                       ..-.+.++..|++|. |+.|||++.+..++.     ..   ....+|+|||||||+.+|++||+.+.+.|.+    ...
T Consensus       370 ~~l~~l~~a~~Td~G~~R~~NEDa~~i~~~~~~~~~~~~~~~~~~~L~aVaDGmGGh~~GevAS~lAv~~L~~~~~~~~~  449 (645)
T PRK14559        370 MQLVSLEDAGRTDVGRQRHHNEDYFGINTRIQKLENPHGRIVQARGLYILCDGMGGHAAGEVASALAVETLQQYFQQHWQ  449 (645)
T ss_pred             ccceeEEEEEECCCCCCCcccCCcccccccccccccccccccccceEEEEEeCCCCchhHHHHHHHHHHHHHHHHHhhhc
Confidence             113577899999997 999999987754321     01   1357999999999999888888766665543    211


Q ss_pred             -CCChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEE-eCCeeeeCCCCC
Q 008220          491 -TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILC-RGGHPFALSRVR  568 (573)
Q Consensus       491 -~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~-~~~~~~~lt~dH  568 (573)
                       .....+.|.++|..+|..+.+........     ....+|||+++++|.++.+|||||||||+|++ |+|++++||+||
T Consensus       450 ~~~~~~~~L~~ai~~AN~~I~~~~~~~~~~-----~~~~MGTTlv~alI~~~~l~ianVGDSRaYli~r~g~l~QLT~DH  524 (645)
T PRK14559        450 DELPDEETIREAIYLANEAIYDLNQQNARS-----GSGRMGTTLVMALVQDTQVAVAHVGDSRLYRVTRKGGLEQLTVDH  524 (645)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhhhcccc-----cCCCCCceeeeEEEECCEEEEEEecCceEEEEecCCeEEEeCCCC
Confidence             12346789999999999997654332210     11136999999999999999999999999988 678999999999


Q ss_pred             CCC
Q 008220          569 QEF  571 (573)
Q Consensus       569 ~p~  571 (573)
                      ++.
T Consensus       525 s~~  527 (645)
T PRK14559        525 EVG  527 (645)
T ss_pred             CHH
Confidence            973

>COG0631 PTC1 Serine/threonine protein phosphatase [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=216.30  Aligned_cols=138  Identities=27%  Similarity=0.344  Sum_probs=113.8

Q ss_pred             CCcceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCC-----CC--hhHH
Q 008220          426 YPVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST-----TR--PTDA  497 (573)
Q Consensus       426 ~~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~-----~~--~~~~  497 (573)
                      ...+.++..++.|. |..|||++.+..+..+.. ..||+||||||||.+|++|++.+++.|.+....     ..  ..+.
T Consensus         5 ~~~~~~~~~s~~g~~R~~NeD~~~~~~~~~~~~-~~l~~V~DG~GGh~~ge~aS~~~v~~l~~~~~~~~~~~~~~~~~~~   83 (262)
T COG0631           5 ILSLKVAGLSDVGTVRKHNEDAFLIKPNENGNL-LLLFAVADGMGGHAAGEVASKLAVEALARLFDETNFNSLNESLEEL   83 (262)
T ss_pred             cceeeeeeeccCCCccCCCCcceeeccccCCcc-eeEEEEEeCccchhHHHHHHHHHHHHHHHHHHhccccccchhHHHH
Confidence            34566778888887 999999999987543333 679999999999999999999999988775211     11  5789


Q ss_pred             HHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          498 LLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       498 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      |.+++..++..+...........       .+|||++++++.++++||||||||||||+|+|.+.+||+||+++
T Consensus        84 l~~~~~~~n~~i~~~~~~~~~~~-------~mgtTl~~~~~~~~~l~~a~vGDSR~yl~~~~~~~~lT~DH~~~  150 (262)
T COG0631          84 LKEAILKANEAIAEEGQLNEDVR-------GMGTTLVLLLIRGNKLYVANVGDSRAYLLRDGELKQLTEDHSLV  150 (262)
T ss_pred             HHHHHHHHHHHHHHhhhcccccC-------CCceeEEEEEEECCeEEEEEccCCeEEEEcCCceEEeccCCcHH
Confidence            99999999999987754222333       35999999999999999999999999999999999999999974

>PTZ00224 protein phosphatase 2C; Provisional

Probab=99.92  E-value=7.9e-25  Score=220.04  Aligned_cols=130  Identities=26%  Similarity=0.419  Sum_probs=109.3

Q ss_pred             CcCCcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCCCChhHHHHHHHH
Q 008220          424 TYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFI  503 (573)
Q Consensus       424 ~~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~~~  503 (573)
                      .....+.+|..+++|.|++|||++++...    .+..+|||||||||..||++++++|++.+.+.... ...++|.++|.
T Consensus        17 ~~~~~~~~g~~s~~G~R~~nED~~~v~~~----~~~~lfgVfDGHgG~~~S~~~~~~l~~~l~~~~~~-~~~~~l~~a~~   91 (381)
T PTZ00224         17 AGNSIFRCASACVNGYRESMEDAHLLYLT----DDWGFFGVFDGHVNDECSQYLARAWPQALEKEPEP-MTDERMEELCL   91 (381)
T ss_pred             CCCccEEEEEEeCCCCCCCCCCeeEeccC----CCceEEEEEeCCCcHHHHHHHHHHHHHHHHhcccc-ccHHHHHHHHH
Confidence            35678999999999999999999886543    34579999999999999999999999888654322 23466999999


Q ss_pred             HHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEE-CCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV-RNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~-~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .+|.++.+...             .+|||+++++|. +++++||||||||||++|+|++++||+||+|.
T Consensus        92 ~~d~~i~~~~~-------------~~GsTatv~lI~~~~~l~vaNVGDSRayl~r~g~~~~LT~DH~~~  147 (381)
T PTZ00224         92 EIDEEWMDSGR-------------EGGSTGTFCVIMKDVHLQVGNVGDSRVLVCRDGKLVFATEDHKPN  147 (381)
T ss_pred             HHHHHHHhccc-------------CCCCeEEEEEEEECCEEEEEEcccceEEEEECCEEEEcccCCCCC
Confidence            99998864321             259999999886 57999999999999999999999999999996

>KOG0698 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms]

Probab=99.92  E-value=9e-25  Score=218.53  Aligned_cols=136  Identities=35%  Similarity=0.527  Sum_probs=111.6

Q ss_pred             Ccce-EEEEeeccCCCCCceeEEecccCC----CCC-ceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCC-C---ChhH
Q 008220          427 PVLS-WGSFATCGRRETMEDTHFLMPHMY----NQK-EIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST-T---RPTD  496 (573)
Q Consensus       427 ~~~~-~~~~s~~G~R~~neD~~~~~~~~~----~~~-~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~-~---~~~~  496 (573)
                      ..+. .+.++.+|+|..|||++....++.    ... ..+||||||||||+.+|+||+++|+..+.+.... .   ...+
T Consensus        37 ~~~~~~~~~~~~~~r~~med~~~~~~~~~~~~~~~~~~~~ffgVfDGHGG~~~A~~~~~~L~~~l~~~~~~~~~~~~~~~  116 (330)
T KOG0698|consen   37 ESYRLGSLLSIRGRRRKMEDRHVQLPDFLEEDVGGEQDTAFFGVFDGHGGDLAAKFAAKHLHKNLLEQLAFPKDRQDVKD  116 (330)
T ss_pred             ccccceEEEecCCCCCccCcceeecccccccccCCCCceEEEEEEeCCCCHHHHHHHHHHHHHHHHhhhhcccchHHHHH
Confidence            3444 455588899999999999877743    233 5899999999999999999999999999876432 2   3789


Q ss_pred             HHHHHHH-HHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECC-eEEEEEccccceeEEeCC-eeeeCCCCCCCCC
Q 008220          497 ALLEAFI-RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGDCRAILCRGG-HPFALSRVRQEFW  572 (573)
Q Consensus       497 ~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~-~l~vanvGDSRa~l~~~~-~~~~lt~dH~p~~  572 (573)
                      ++.++|. .+|.++....          .....+||||+++++.++ +|||||+||||||||+.| ++++||.||||.+
T Consensus       117 a~~~~F~~~~D~~~~~~~----------~~~~~~gstav~~vi~~~~~l~vaN~GDSRaVl~~~~~~a~~Ls~DHkP~~  185 (330)
T KOG0698|consen  117 ALRRAFLTKTDSEFLEKR----------EDNRSGGSTAVVALIKKGRKLYVANVGDSRAVLSRKGGVAVQLSVDHKPDR  185 (330)
T ss_pred             HHHHHHHHHHHHHHHhhc----------cCCCCCcceeeeeeEecCCEEEEEEcCCCcEEEecCCCeeeeCCCCCCCCc
Confidence            9999999 6999987650          112357999999999865 999999999999999766 8999999999976

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=204.05  Aligned_cols=250  Identities=22%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      |..++..+.-+|.+...|..|+|+++|..+++|++....  ......|..|.-.|+-+.||||+.+++.|..++++.++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            444567788899999999999999999999998765432  233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC-ceec-cCCCCceEEcCCCCCeEe--eeecchhhhhh
Q 008220          141 EFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG-IVHR-DVKPANVLLDRNLCPHLA--DFGLAEYRENL  215 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~-iiH~-Dlkp~Nill~~~~~~kL~--Dfg~a~~~~~~  215 (573)
                      .|++.|+|..+++.... -....++.+++.++++|++|||+.. ++-| -|.+..++||++.+.+|.  |--++.     
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            99999999999986542 2356789999999999999999984 4433 688899999999887764  222211     


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCC---chhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS---EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                                        ......-.|.||+||.+...+-+   .++|+|||.+++|||.|...||.+..+         
T Consensus       342 ------------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp---------  394 (448)
T KOG0195|consen  342 ------------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP---------  394 (448)
T ss_pred             ------------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc---------
Confidence                              12223457899999999876543   579999999999999999999997644         


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           .++..++.-+++++.   +|++++..+..|+.-|+..||.+||.+..|+-.|+.+
T Consensus       395 -----mecgmkialeglrv~---ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  395 -----MECGMKIALEGLRVH---IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -----hhhhhhhhhcccccc---CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                 334444455666664   4568999999999999999999999999998776654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.9e-25  Score=219.05  Aligned_cols=173  Identities=18%  Similarity=0.168  Sum_probs=131.2

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE---CCeeEEEeeccCC-----ChHHHHHHHHHHHHHHhCCCCccce-eeecc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAK-FVAAH  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~  130 (573)
                      +......+|.+.+.||+|+||+||+|++   +++.+|||++...     .......+.+|+++|+.++|+||+. +++. 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            3455668899999999999999999976   4677899975422     2234567999999999999999985 5543 


Q ss_pred             ccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCceEEcCCCCCeEeeeecc
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV-KPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl-kp~Nill~~~~~~kL~Dfg~a  209 (573)
                         ...|+||||++|++|... ..    ..   ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus        91 ---~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence               457999999999999632 11    11   1467899999999999999999999 999999999999999999999


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK  252 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  252 (573)
                      +.+.......        .........+..+++.|+|||.+..
T Consensus       160 ~~~~~~~~~~--------~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALY--------RIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchh--------hhhhhhhhhhhhccCccCCcccCCh
Confidence            8664311100        0000011246678889999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2e-25  Score=238.67  Aligned_cols=264  Identities=22%  Similarity=0.247  Sum_probs=194.3

Q ss_pred             Cc-cccccccccCceEEEEEEE--CCeeEEEeecc-----CCChHHH-HHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           67 SY-TLLSPIARGAESVVYEATL--DGRKVAVKKPI-----LSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        67 ~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .| .....+|.|++|.|+.+..  ..+.++.|...     ....... ..+..|+-+-..+.|||++..+..+.+.....
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            35 4667889999997777754  23333333221     1111222 22667888888899999999888887777666


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      -+||||++ +|..++.... .++..++..++.|++.|++|||+.||.|||||++|++++.+|.+||+|||.+..+...-.
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            66999999 9999987653 678889999999999999999999999999999999999999999999999876543111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .            ........+|+..|+|||++.+..|. ...||||.|+++..|.+|+.||..........  ....+.
T Consensus       476 ~------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~  541 (601)
T KOG0590|consen  476 K------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYS  541 (601)
T ss_pred             h------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccc
Confidence            0            01234567899999999999988875 46899999999999999999997654333221  000000


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                          .+.....+..    .+...++.+.+.+|.+||++||.+|.|+++|++..|...-
T Consensus       542 ----~~~~~~~~~~----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  542 ----DQRNIFEGPN----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             ----cccccccChH----HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence                0000001111    1223578889999999999999999999999999988653

>PF00481 PP2C: Protein phosphatase 2C; InterPro: IPR001932 This domain is found in protein phosphatase 2C, as well as other proteins eg

Probab=99.91  E-value=2.8e-24  Score=209.09  Aligned_cols=135  Identities=37%  Similarity=0.620  Sum_probs=109.7

Q ss_pred             eEEEEeeccCCCCCceeEEecccCC---CCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCC--CC-ChhHHHHHHHH
Q 008220          430 SWGSFATCGRRETMEDTHFLMPHMY---NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS--TT-RPTDALLEAFI  503 (573)
Q Consensus       430 ~~~~~s~~G~R~~neD~~~~~~~~~---~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~--~~-~~~~~l~~~~~  503 (573)
                      .+|+.+.+|+|..|||++++..++.   ......+|||||||||+.+|+++++++++.+.+...  .. ...++|.++|.
T Consensus         1 ~~~~~~~~g~r~~~eD~~~~~~~~~~~~~~~~~~l~~V~DGhgG~~~a~~~~~~l~~~l~~~~~~~~~~~~~~al~~a~~   80 (254)
T PF00481_consen    1 DYGVSSMQGVRKEMEDRHLIIQNFNSNSGNDNVSLFGVFDGHGGSEAAEYASQNLPEFLKENLSFNDGNDIEEALRQAFL   80 (254)
T ss_dssp             EEEEEEEECTSSSHHEEEEEEEEETCCTTEEEEEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred             CcCeecCCCCCCcccCEEEEecCccccCCCCCcEEEEEecCCCChhhHHHHHHHHHHHHHhhcccccccchhhcccceee
Confidence            3789999999999999999988653   346789999999999999999999999988876522  22 57899999999


Q ss_pred             H-HHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeee-eCCCCCCCCC
Q 008220          504 R-TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPF-ALSRVRQEFW  572 (573)
Q Consensus       504 ~-~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~-~lt~dH~p~~  572 (573)
                      . ++..+....... .       ...+||||++++|.++++||||||||||||++++... +||+||+|..
T Consensus        81 ~~~~~~~~~~~~~~-~-------~~~~GsTa~v~li~~~~l~vanvGDSravl~~~~~~~~~Lt~dH~~~~  143 (254)
T PF00481_consen   81 AFTDESLYSDSENN-E-------SSKSGSTATVALIDGNKLYVANVGDSRAVLCRNGGIIKQLTRDHKPSN  143 (254)
T ss_dssp             HHHHHHHHHHHHHH-T-------HTTSEEEEEEEEEETTEEEEEEESS-EEEEEETTEEEEESS---STTS
T ss_pred             eccccccccccccc-c-------cccccccccccccccceeEEEeeeeeeeeeeeccccccccccccccch
Confidence            9 888887632221 1       1247999999999999999999999999999999988 9999999964

pyruvate dehydrogenase (lipoamide)-phosphatase (3.1.3.43 from EC), adenylate cyclase (4.6.1.1 from EC) and some bacterial stage II sporulation E proteins (3.1.3.16 from EC). Protein phosphatase 2C (PP2C) is one of the four major classes of mammalian serine/threonine specific protein phosphatases (3.1.3.16 from EC). PP2C [] is a monomeric enzyme of about 42 Kd which shows broad substrate specificity and is dependent on divalent cations (mainly manganese and magnesium) for its activity. Its exact physiological role is still unclear. Three isozymes are currently known in mammals: PP2C-alpha, -beta and -gamma. In yeast, there are at least four PP2C homologs: phosphatase PTC1 [], which has weak tyrosine phosphatase activity in addition to its activity on serines, phosphatases PTC2 and PTC3, and hypothetical protein YBR125c. Isozymes of PP2C are also known from Arabidopsis thaliana (ABI1, PPH1), Caenorhabditis elegans (FEM-2, F42G9.1, T23F11.1), Leishmania chagasi and Paramecium tetraurelia. In A. thaliana, the kinase associated protein phosphatase (KAPP) [] is an enzyme that dephosphorylates the Ser/Thr receptor-like kinase RLK5 and which contains a C-terminal PP2C domain. PP2C does not seem to be evolutionary related to the main family of serine/ threonine phosphatases: PP1, PP2A and PP2B. However, it is significantly similar to the catalytic subunit of pyruvate dehydrogenase phosphatase 3.1.3.43 from EC (PDPC) [], which catalyzes dephosphorylation and concomitant reactivation of the alpha subunit of the E1 component of the pyruvate dehydrogenase complex. PDPC is a mitochondrial enzyme and, like PP2C, is magnesium-dependent.; GO: 0003824 catalytic activity; PDB: 2I0O_A 2POP_C 2POM_A 2J4O_A 2I44_B 3MQ3_A 3N3C_A 2PNQ_B 2P8E_A 2IQ1_A ....

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.4e-22  Score=204.84  Aligned_cols=257  Identities=31%  Similarity=0.454  Sum_probs=197.8

Q ss_pred             ccccccccccCceEEEEEEECCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCC-ccceeeeccccCCceEEEEEec
Q 008220           68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHP-GLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      |.+.+.||.|+||.||++.+. ..+++|.+.....   .....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            788899999999999999887 7788887544322   2467789999999999988 7999999997777789999999


Q ss_pred             cCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhhc
Q 008220          144 ESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       144 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .++++.+++....  ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~-  159 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS-  159 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc-
Confidence            9999997766543  2688899999999999999999999999999999999999998 69999999987443211100 


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHHHhcc
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRA---EAQAHTVLEMN  294 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~  294 (573)
                               ..........|+..|++||.+.+   ..+....|+|++|++++++++|..||.....   .......+...
T Consensus       160 ---------~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         160 ---------SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ---------cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence                     00012456789999999999987   5788899999999999999999999876643   11111111111


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccC----ChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELG----LPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                      ..             ..........    ....+.+++..|+..+|..|.+..+...+
T Consensus       231 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PT-------------PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CC-------------cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00             0000011111    13578999999999999999999988766

>KOG0699 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms]

Probab=99.90  E-value=1e-23  Score=198.03  Aligned_cols=82  Identities=34%  Similarity=0.609  Sum_probs=71.3

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC--CCCChhHHHHHHHHH
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG--STTRPTDALLEAFIR  504 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~--~~~~~~~~l~~~~~~  504 (573)
                      .-+.||..++||||-.|||+|-++.++  +.++++|+|||||||.++|.||+..|+.+|++..  ...++..+|.+||+.
T Consensus        20 ~lL~yg~s~MQGWRvsqEDAHNci~~l--d~~t~mF~VYDGHGG~EVa~yca~kLPdflK~~k~yk~g~~~~aL~~AFl~   97 (542)
T KOG0699|consen   20 NLLSYGCSTMQGWRVSQEDAHNCIVDL--DTDTHMFGVYDGHGGTEVAKYCAAKLPDFLKERKFYKAGDVAEALQKAFLD   97 (542)
T ss_pred             ccchhchhhhhccccchhhhhcccccc--cCcceEEEEecCCCcHHHHHHHHHhhhHHHHhHHhhhcccHHHHHHHHHhc
Confidence            458899999999999999999998887  4789999999999999999999999999998764  346778888888888


Q ss_pred             HHHHHH
Q 008220          505 TDVAFR  510 (573)
Q Consensus       505 ~~~~~~  510 (573)
                      .|..++
T Consensus        98 fD~~l~  103 (542)
T KOG0699|consen   98 FDDFLR  103 (542)
T ss_pred             hhhhhc
Confidence            766554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=8.8e-24  Score=225.30  Aligned_cols=249  Identities=22%  Similarity=0.197  Sum_probs=184.6

Q ss_pred             CccccccccccCceEEEEEEECCeeEEEeeccCCCh-HHHHHHH---HHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTS-EELDNFH---KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .|...+.||.+.|=.|.+|++....|+||+.....+ -..+.+.   .|++ ...+++||.+.+.-+.....-.|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            688899999999999999998766699998544432 1233333   3444 5556899999999888888888999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh--hhhhhhc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE--NLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~--~~~~~~~  220 (573)
                      ... +|.|++..+. .+..-+.+.|+.|++.||.-+|..||+|||||.+||||+.-+.+.|+||...+...  ..+..+.
T Consensus       103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            976 9999998765 56778888999999999999999999999999999999999999999999764221  1111110


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----------I-HSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH  288 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~  288 (573)
                                 .+..-+...-.+|.|||.+...          + .+++-||||+||++.||++ |++||.-.    +..
T Consensus       181 -----------~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~  245 (1431)
T KOG1240|consen  181 -----------TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLL  245 (1431)
T ss_pred             -----------eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHH
Confidence                       1111222334589999988531          2 5678999999999999999 89999531    222


Q ss_pred             HHHhc-cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          289 TVLEM-NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       289 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                      ....+ ....++..+.               -.+..+++||..|++.||.+|.+++++|+.
T Consensus       246 aYr~~~~~~~e~~Le~---------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLEK---------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccCccCHHHHHHh---------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            22222 2222222221               224578899999999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.8e-24  Score=217.85  Aligned_cols=224  Identities=30%  Similarity=0.362  Sum_probs=182.8

Q ss_pred             cccccCceEEEEEE-----ECCeeEEEeeccCCChH--HHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEecc
Q 008220           73 PIARGAESVVYEAT-----LDGRKVAVKKPILSTSE--ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        73 ~lg~G~~g~V~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .+|+|.||.|++++     +.+..+|+|........  .......|..++...+ ||.++++...++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874     35677888864433211  1114556778888887 9999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      ||.|...+.... .+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..         
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~---------  150 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE---------  150 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence            999998887655 6778888899999999999999999999999999999999999999999998765431         


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                                 ...+||..|||||++.  ....++|.||+|++++||+||..||..    +....|.....         
T Consensus       151 -----------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------  204 (612)
T KOG0603|consen  151 -----------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------  204 (612)
T ss_pred             -----------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc---------
Confidence                       1228999999999998  456789999999999999999999987    33333332111         


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF  342 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  342 (573)
                                ..|..++..+.+++..++..+|.+|...
T Consensus       205 ----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 ----------EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                      2345678899999999999999999765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=4e-23  Score=192.78  Aligned_cols=173  Identities=15%  Similarity=0.155  Sum_probs=134.4

Q ss_pred             ccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHH---HHH------HHHHHHHHHhCCCCccceeeecccc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDN------FHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ++...+|++.+.||.|+||.||+...++..+|||.+.......   ...      +.+|+..+.++.||+|..+.+++..
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4556899999999999999999987778899999865432222   222      6899999999999999999888654


Q ss_pred             C--------CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEe
Q 008220          133 P--------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       133 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                      .        ...+++|||++|.+|.+..     .+++    ....+++.+|..||+.|++|||+||.||+++.+| ++|+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            3        3588999999999998763     2333    2456999999999999999999999999999998 9999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                      |||..........                            ....+....+..++|+|+||+.+..+.
T Consensus       177 Dfg~~~~~~e~~a----------------------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKA----------------------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhh----------------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            9998754321111                            011334445667899999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.2e-21  Score=181.21  Aligned_cols=138  Identities=20%  Similarity=0.170  Sum_probs=106.6

Q ss_pred             cccccccCceEEEEEEE-CCeeEEEeeccCCChH--H------------------------HHHHHHHHHHHHhCCCCcc
Q 008220           71 LSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--E------------------------LDNFHKELQLLCKLDHPGL  123 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnI  123 (573)
                      ...||+|+||.||+|.+ +|+.||||+.......  .                        ......|+.+++.+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            56899999999999987 6899999986543210  0                        1123459999999988776


Q ss_pred             ceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCceEEcCCCCCe
Q 008220          124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL-HNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      .....+..  ...++||||++|+++...... ...++..++..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            44332211  233899999998777654322 23688999999999999999999 799999999999999998 57899


Q ss_pred             Eeeeecchhh
Q 008220          203 LADFGLAEYR  212 (573)
Q Consensus       203 L~Dfg~a~~~  212 (573)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=186.02  Aligned_cols=203  Identities=26%  Similarity=0.337  Sum_probs=146.0

Q ss_pred             CCCccceeeecccc---------------------------CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHH
Q 008220          119 DHPGLAKFVAAHAK---------------------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL  171 (573)
Q Consensus       119 ~hpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi  171 (573)
                      +|||||++..+|.+                           +..+|+||..+.. +|..++..+.  .+......++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            69999999887743                           2347889988765 8888886553  5667788899999


Q ss_pred             HHHHHHHHhCCceeccCCCCceEEc--CCC--CCeEeeeecchhhhhhhhhhcccccCCCCCCC-CccccccccCcccCC
Q 008220          172 AKALQYLHNLGIVHRDVKPANVLLD--RNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTG-GFHKKNMVGTLIYMA  246 (573)
Q Consensus       172 ~~~l~~LH~~~iiH~Dlkp~Nill~--~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~a  246 (573)
                      ++|+.|||++||.|||+|++|||+.  .++  .+.|+|||.+-.-+.           .+...+ ....-..-|.-.-||
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~-----------hGlqlpy~S~~Vd~GGNa~lmA  419 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN-----------HGLQLPYESDEVDLGGNAKLMA  419 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccc-----------cccccccccccccCCCcceecc
Confidence            9999999999999999999999984  333  478999998732111           000000 001223457778899


Q ss_pred             hhhhccCCC------CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCC
Q 008220          247 PEILKKEIH------SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL  320 (573)
Q Consensus       247 PE~~~~~~~------~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (573)
                      ||+....+-      -.++|.|+.|.+.||+++...||........-..    .+.             ...++.+|..+
T Consensus       420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----~Yq-------------e~qLPalp~~v  482 (598)
T KOG4158|consen  420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----TYQ-------------ESQLPALPSRV  482 (598)
T ss_pred             hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh----hhh-------------hhhCCCCcccC
Confidence            999864321      2489999999999999999999986321111000    111             12345567789


Q ss_pred             hHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          321 PASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       321 ~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ++.+.+|+..+|+.||.+|++..=..+.+...
T Consensus       483 pp~~rqlV~~lL~r~pskRvsp~iAANvl~Ls  514 (598)
T KOG4158|consen  483 PPVARQLVFDLLKRDPSKRVSPNIAANVLNLS  514 (598)
T ss_pred             ChHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence            99999999999999999999987666555444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=3.9e-21  Score=184.86  Aligned_cols=230  Identities=21%  Similarity=0.310  Sum_probs=145.1

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCC---C-------ccceeeeccc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDH---P-------GLAKFVAAHA  131 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---p-------nIv~l~~~~~  131 (573)
                      .+...+.||.|+++.||.+++  +++.+|+|+.....   ....+.+++|.-....+.+   |       .++--++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            456778999999999999998  56999999744332   2346667776655544322   1       1222122111


Q ss_pred             ---------cC---C-----ceEEEEEeccCCChhhhhhc---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 008220          132 ---------KP---P-----NYMFFFEFYESRNLAEKLHV---EEWS---PSVDQVLMIAAQLAKALQYLHNLGIVHRDV  188 (573)
Q Consensus       132 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~---~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl  188 (573)
                               ..   .     +.+++|+-+. ++|.+++..   ....   +.......+..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     2466777664 488777542   2211   122333556699999999999999999999


Q ss_pred             CCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--------CCCCchhh
Q 008220          189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--------EIHSEKSD  260 (573)
Q Consensus       189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D  260 (573)
                      +|+|++++.+|.++|+||+........                   ......+..|.+||....        ..++.+.|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-------------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR-------------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE-------------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce-------------------eeccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence            999999999999999999977544320                   111334577999998743        24688999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC
Q 008220          261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR  339 (573)
Q Consensus       261 iwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  339 (573)
                      .|+||+++|.|++|..||...........                      .+.... ++|+.++.||+.+|+.||++|
T Consensus       233 aW~LG~~ly~lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  233 AWQLGITLYSLWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999999999986543221110                      111222 789999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=5.7e-22  Score=211.51  Aligned_cols=218  Identities=28%  Similarity=0.385  Sum_probs=158.5

Q ss_pred             CCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      .+|..++.|..|+||.||.++++  .+++|+|+ +.++.-    +++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee-------------------
Confidence            67999999999999999999875  78899954 221110    001   22222333333                   


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                        |+-...+...+ .++.+        ++.+++|||+.||+|||+||+|++|+.-|++|++|||+.+..-.....   +.
T Consensus       136 --gDc~tllk~~g-~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at---nl  201 (1205)
T KOG0606|consen  136 --GDCATLLKNIG-PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT---NL  201 (1205)
T ss_pred             --chhhhhcccCC-CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc---hh
Confidence              34444444333 33332        378999999999999999999999999999999999998654321111   11


Q ss_pred             cCCC--CCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          224 RSSG--KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       224 ~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                      ....  .....+.....+|||.|.|||++..+.|+..+|+|++|+|+||++.|+.||.+.++++.+.+++.....+.+  
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE--  279 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE--  279 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc--
Confidence            1110  012233456679999999999999999999999999999999999999999999888887777654433221  


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP  340 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  340 (573)
                                    -...++++++++|.++|+.+|..|.
T Consensus       280 --------------~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 --------------EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence                          1235789999999999999999995

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.2e-20  Score=172.24  Aligned_cols=197  Identities=16%  Similarity=0.100  Sum_probs=140.8

Q ss_pred             cccccccccCceEEEEEEECCeeEEEeeccCCChH----HHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEec
Q 008220           69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      .+...|++|+||+|+++...+.+++.+.+.....-    ....+.+|+++|++|. |++|++++++    ...+++|||+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            35678999999999998888888887764443221    1235789999999995 5889999886    4579999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV-KPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl-kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      .|.+|...+..        ....++.|++.+|.++|+.||+|||| ||+|||++.+|.++|+|||+|.......... ..
T Consensus        81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-r~  151 (218)
T PRK12274         81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-RL  151 (218)
T ss_pred             cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-HH
Confidence            99988654321        12357889999999999999999999 7999999999999999999997443211000 00


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHS-EKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltg~~Pf~~  280 (573)
                      +..  .........-...++.|++|+...-. ..+ ...+.++.|+-+|.++|+..|+.+
T Consensus       152 L~~--rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        152 LAR--EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHH--HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            000  00000001112367889999865432 223 567889999999999998888754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.6e-20  Score=172.86  Aligned_cols=140  Identities=23%  Similarity=0.238  Sum_probs=108.8

Q ss_pred             ccccccccCceEEEEEEE-CCeeEEEeeccCCChH--------------------------HHHHHHHHHHHHHhCCCCc
Q 008220           70 LLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--------------------------ELDNFHKELQLLCKLDHPG  122 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpn  122 (573)
                      +.+.||+|+||.||+|.+ +|+.||||+.......                          ....+..|.+.+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            357899999999999987 5999999986543210                          0123467999999999998


Q ss_pred             cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCC
Q 008220          123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       123 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      |.....+...  ..++||||++|+++...... ...++..++..++.|++.++.++|+ .||+||||||+|||++ ++.+
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            7543333222  24899999998755433222 2357788999999999999999999 9999999999999999 8899


Q ss_pred             eEeeeecchhhh
Q 008220          202 HLADFGLAEYRE  213 (573)
Q Consensus       202 kL~Dfg~a~~~~  213 (573)
                      +|+|||++....
T Consensus       157 ~liDFG~a~~~~  168 (190)
T cd05145         157 YIIDVSQAVELD  168 (190)
T ss_pred             EEEEcccceecC
Confidence            999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=2.9e-20  Score=189.98  Aligned_cols=216  Identities=30%  Similarity=0.507  Sum_probs=166.8

Q ss_pred             HHhCCCCccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCce
Q 008220          115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI-VHRDVKPANV  193 (573)
Q Consensus       115 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-iH~Dlkp~Ni  193 (573)
                      |+.+.|.|+.++++.+.+++..+.|.+||..|+|.|.+......+++-....++++|+.||+|||...| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999998877778888888999999999999999876 9999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC-------CCchhhHHHHHH
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-------HSEKSDVYSFGI  266 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~  266 (573)
                      ++|....+||+|||+..........              .......-...|.|||.+.+..       .+.+.||||+|+
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~--------------~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i  146 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEP--------------EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI  146 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccc--------------cccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence            9999999999999998765420000              0011122345799999997631       356799999999


Q ss_pred             HHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhc---CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS---GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       267 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                      +++|+++...||.........          .++...+..   ..++|.+.... .+++++..+++.||..+|.+||+++
T Consensus       147 i~~ei~~r~~~~~~~~~~~~~----------~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  147 IMYEILFRSGPFDLRNLVEDP----------DEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             HHHHHHhccCccccccccCCh----------HHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHH
Confidence            999999999999764322111          111111222   22455444332 5667899999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 008220          344 DIALELDLVLEH  355 (573)
Q Consensus       344 ell~~l~~~~~~  355 (573)
                      ++-..+..+...
T Consensus       216 ~i~~~~~~~~~~  227 (484)
T KOG1023|consen  216 QIRSKLLTINKG  227 (484)
T ss_pred             HHHhhhhhhccc
Confidence            998777666553

>smart00332 PP2Cc Serine/threonine phosphatases, family 2C, catalytic domain

Probab=99.82  E-value=2.6e-19  Score=174.84  Aligned_cols=135  Identities=39%  Similarity=0.631  Sum_probs=111.8

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCC-----CChhHHHHHH
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST-----TRPTDALLEA  501 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~-----~~~~~~l~~~  501 (573)
                      ..+.++..+.+|.|..|||++.+....  ..+..+|+|||||||+.+|+++++.+.+.+.+....     ..+.+.|.++
T Consensus         4 ~~~~~~~~~~~~~r~~neD~~~~~~~~--~~~~~~~~v~DG~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~   81 (255)
T smart00332        4 LGLRYGLSSMQGVRKPMEDAHVITPDL--SDSGAFFGVFDGHGGSEAAKFLSKNLPEILAEELIKHKDELEDVEEALRKA   81 (255)
T ss_pred             CceeEEEecCCCCCCCCcceEEEeccC--CCCeEEEEEEeCCCcHHHHHHHHHHHHHHHHHhHhhcccchhHHHHHHHHH
Confidence            346677778888899999999886542  245789999999999999999999999888765321     2477889999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          502 FIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                      +..++.++..........       ..+|||++++++.++.++++|+||||+|++|+++..+||+||+|
T Consensus        82 ~~~~~~~~~~~~~~~~~~-------~~~gtT~~~~~~~~~~l~~~~vGDsr~y~~~~~~~~~lt~dh~~  143 (255)
T smart00332       82 FLKTDEEILEELESLEED-------AGSGSTAVVALISGNKLYVANVGDSRAVLCRNGKAVQLTEDHKP  143 (255)
T ss_pred             HHHHHHHHHHhhhhccCC-------CCCCccEEEEEEECCEEEEEeccCceEEEEeCCceeEcCCCCCC
Confidence            999999987765443311       13699999999999999999999999999999999999999998

The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity.

>cd00143 PP2Cc Serine/threonine phosphatases, family 2C, catalytic domain; The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity

Probab=99.82  E-value=2e-19  Score=175.59  Aligned_cols=134  Identities=37%  Similarity=0.562  Sum_probs=109.9

Q ss_pred             eEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCC------CCChhHHHHHHHH
Q 008220          430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS------TTRPTDALLEAFI  503 (573)
Q Consensus       430 ~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~------~~~~~~~l~~~~~  503 (573)
                      .++..+..|.|+.|||++.+...... .+..+|+|||||||+..|+++++.+.+.+.+...      ...+...|..+|.
T Consensus         2 ~~~~~~~~g~r~~neD~~~~~~~~~~-~~~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~   80 (254)
T cd00143           2 SAGVSDKGGDRKTNEDAVVIKPNLNN-EDGGLFGVFDGHGGHAAGEFASKLLVEELLEELEETLTLSEEDIEEALRKAFL   80 (254)
T ss_pred             ceeeecCCCCCCCCcceEEEeccCCC-CCcEEEEEEcCCChHHHHHHHHHHHHHHHHHHHhhccccchHHHHHHHHHHHH
Confidence            46777888889999999998664210 2578999999999999999999999988876532      2356678999999


Q ss_pred             HHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .++..+.........       ...+|||++++++.++.++++|+||||+|++++++.+++|+||++.
T Consensus        81 ~~~~~l~~~~~~~~~-------~~~~gtT~~~~~~~~~~l~~~~vGDsr~~~~~~~~~~~lt~dh~~~  141 (254)
T cd00143          81 RADEEILEEAQDEPD-------DARSGTTAVVALIRGNKLYVANVGDSRAVLCRNGEAVQLTKDHKPV  141 (254)
T ss_pred             HHHHHHHHhhhhccC-------CCCCCCcEEEEEEECCEEEEEEecCcEEEEEcCCceeEcCCCCCCc
Confidence            999988766543211       1246999999999999999999999999999999999999999975

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.1e-19  Score=196.11  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=183.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC---CCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~  136 (573)
                      .++-++.|.|-+.||+|+||.||+|.. +++.||+|+-...+.-+   |.--.+++.+|+   -+.|..+...+.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            556678899999999999999999986 68999999744433221   111123344444   24556666666677888


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-------CCCCeEeeeecc
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------NLCPHLADFGLA  209 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-------~~~~kL~Dfg~a  209 (573)
                      ++|+||.+-|+|.+++... ..+++..+..+..|++..++.||..+|||+||||+|+||..       .--++|+|||-+
T Consensus       770 ~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            9999999999999999744 47889999999999999999999999999999999999943       334899999987


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      .-+.-..              .+......++|-.+-.+|+..|.++++.+|.|.|..+++-||.|+.-=           
T Consensus       849 iDm~lfp--------------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------  903 (974)
T KOG1166|consen  849 IDMKLFP--------------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------  903 (974)
T ss_pred             eeeeEcC--------------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------
Confidence            5443221              122345668899999999999999999999999999999999986321           


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHH-HHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASI-LSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                    +..+..+.....++.....++ .+++..+|+.|-..=|...+|...+...+..
T Consensus       904 --------------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  904 --------------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             --------------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence                          011111111111112222333 4788888885555557788887777776654

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.2e-19  Score=169.08  Aligned_cols=134  Identities=24%  Similarity=0.306  Sum_probs=105.2

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhC-----CCCccceeeeccccCC---c-eEEEE
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-----DHPGLAKFVAAHAKPP---N-YMFFF  140 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~-~~lv~  140 (573)
                      -.+.||+|+||.||.-...+.. +||+.........+.+.+|+.+++.+     +||||++++++++++.   . +.+|+
T Consensus         6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             CcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            4568999999999962223444 79986655444566789999999999     5799999999998864   3 34789


Q ss_pred             Ee--ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCceEEcC----CCCCeEeeeec
Q 008220          141 EF--YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL-QYLHNLGIVHRDVKPANVLLDR----NLCPHLADFGL  208 (573)
Q Consensus       141 e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~iiH~Dlkp~Nill~~----~~~~kL~Dfg~  208 (573)
                      ||  +.+++|.+++...  .++++  ..++.|++.++ +|||+++|+||||||+|||++.    ++.++|+||+-
T Consensus        85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            99  5579999999653  45555  35678888887 8999999999999999999974    34799999443

>KOG0700 consensus Protein phosphatase 2C/pyruvate dehydrogenase (lipoamide) phosphatase [Signal transduction mechanisms]

Probab=99.80  E-value=1.8e-19  Score=174.92  Aligned_cols=122  Identities=27%  Similarity=0.339  Sum_probs=94.6

Q ss_pred             CceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc-------------C--------------------
Q 008220          443 MEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-------------G--------------------  489 (573)
Q Consensus       443 neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~-------------~--------------------  489 (573)
                      -||++.+....  ..++.|+||||||||.+|++|++++|...+..+             .                    
T Consensus        85 ~edrv~~~~s~--~~~~~fvGIyDGhgGp~as~~v~~~L~~~v~~~L~~~~~~~~~~f~~e~~~~~~~~~~~~~~~~~~~  162 (390)
T KOG0700|consen   85 EEDRVSVAVSE--ENGWLFVGIYDGHGGPDASRFLSDHLYPYVARELQGLLWQDEERFPSEYKSEELEHLLVYWKQLSSA  162 (390)
T ss_pred             ccCcceeeeec--cCCeEEEEEecCCCCccHHHHHHHHHHHHHHHHhhhhhhhhccccccccccchhhhhhhhhhccccc
Confidence            35665543332  467889999999999999999999998876511             0                    


Q ss_pred             -C-CCChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEe---CC---ee
Q 008220          490 -S-TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR---GG---HP  561 (573)
Q Consensus       490 -~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~---~~---~~  561 (573)
                       . ...+.++|.+||.++|+++.+........   ....-.+|+||++++|.+..|||||+|||||||++   +|   .+
T Consensus       163 ~~~~~~v~~al~~Af~~tee~fl~~v~~~~~~---~p~lA~~GSC~Lv~~i~~~~LyVaN~GDSRAVLG~~~~~~~~~~A  239 (390)
T KOG0700|consen  163 DQRHGDVLEALSKAFEATEEDFLEMVDKQLQE---NPELALVGSCCLVGLIKGGDLYVANVGDSRAVLGVVENNGSWLVA  239 (390)
T ss_pred             CccchhHHHHHHHHHHHHHHHHHHHHHHhhcc---chhhhhhcceEEEEEEeCCeEEEEecCcchhhhceecCCCCeEEE
Confidence             0 34567899999999999998776443332   22233579999999999999999999999999973   33   58


Q ss_pred             eeCCCCCC
Q 008220          562 FALSRVRQ  569 (573)
Q Consensus       562 ~~lt~dH~  569 (573)
                      +|||.||.
T Consensus       240 ~qLS~dHn  247 (390)
T KOG0700|consen  240 VQLSTDHN  247 (390)
T ss_pred             EecChhhc
Confidence            89999996

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=1.5e-18  Score=165.99  Aligned_cols=140  Identities=21%  Similarity=0.209  Sum_probs=110.2

Q ss_pred             CccccccccccCceEEEEEE-E--CCeeEEEeeccCCChH------------------------HHHHHHHHHHHHHhCC
Q 008220           67 SYTLLSPIARGAESVVYEAT-L--DGRKVAVKKPILSTSE------------------------ELDNFHKELQLLCKLD  119 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~-~--~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  119 (573)
                      -|++.+.||.|+||.||+|. +  +|+.||+|+.......                        ....+..|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48999999999999999998 3  6899999976533210                        1123578999999997


Q ss_pred             CC--ccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCceEEc
Q 008220          120 HP--GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLD  196 (573)
Q Consensus       120 hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiH~Dlkp~Nill~  196 (573)
                      +.  .++++++.    ...++||||+.|.+|....... ..+...++..++.|++.+|++||+.| |+||||||+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            53  34455543    2358999999998887654322 24566677899999999999999999 99999999999999


Q ss_pred             CCCCCeEeeeecchhh
Q 008220          197 RNLCPHLADFGLAEYR  212 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~  212 (573)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999988643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.2e-18  Score=162.11  Aligned_cols=135  Identities=24%  Similarity=0.438  Sum_probs=113.7

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCCh--H------HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTS--E------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++.||+|++|.||+|.+.+..+++|+......  .      ....+.+|+.++..+.|++|+....++......+++|||
T Consensus         1 ~~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             CcccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            35799999999999999999999997443211  1      134578899999999999987776666677788999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ++|++|.+.+....    . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432    1 7889999999999999999999999999999999 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=2.4e-18  Score=161.39  Aligned_cols=131  Identities=25%  Similarity=0.430  Sum_probs=106.7

Q ss_pred             cccccCceEEEEEEECCeeEEEeeccCCC---h-----HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           73 PIARGAESVVYEATLDGRKVAVKKPILST---S-----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .||+|+||.||++...+..+++|......   .     ....++.+|++++..+.|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            48999999999999999999999743321   1     123567889999999998875554444455667799999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      |++|.+.+.....        .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988754221        7899999999999999999999999999999 889999999988643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=9.5e-19  Score=175.36  Aligned_cols=246  Identities=23%  Similarity=0.359  Sum_probs=158.2

Q ss_pred             CccccccccccCceEEEEEEE-C----CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeee-------ccc---
Q 008220           67 SYTLLSPIARGAESVVYEATL-D----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA-------AHA---  131 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-------~~~---  131 (573)
                      .+.+.+..+...++.+....- .    ...+.-+.....+........+++-.+....|-+..-+.+       .+.   
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            455556666666666654431 1    1223333322222222333344444444444433333322       111   


Q ss_pred             --cCCceEEEEEeccCCChhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          132 --KPPNYMFFFEFYESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       132 --~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                        ....+|+.|++|.-.+|.+++...  ....+....+.++.|+..|++|   +|.+|+|+||.||....+..+||.|||
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhh
Confidence              123578999999999999999633  3356778899999999999999   999999999999999999999999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ  286 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  286 (573)
                      +..........          .......+...||.+||+||.+.+..|+.++||||||++|+|++. -..+|....... 
T Consensus       402 l~ts~~~~~~~----------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~-  470 (516)
T KOG1033|consen  402 LVTSQDKDETV----------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT-  470 (516)
T ss_pred             heeecccCCcc----------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh-
Confidence            98655432200          011113456789999999999999999999999999999999998 344443221111 


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA  346 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell  346 (573)
                        .+.              .+.+.|.   ...+ -+.-..|+.++|...|.+||++.+..
T Consensus       471 --d~r--------------~g~ip~~---~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  471 --DIR--------------DGIIPPE---FLQD-YPEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             --hhh--------------cCCCChH---Hhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence              111              1111110   0011 23345899999999999999665543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.4e-17  Score=179.30  Aligned_cols=136  Identities=23%  Similarity=0.356  Sum_probs=113.2

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCC--C-h-----HHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--T-S-----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~-~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..|...++||+|+||+||++.+.+..+++|+....  . .     ...+.+.+|+++++.++|++|+....++......+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            34567899999999999999987777766642211  1 1     12356889999999999999988777777777889


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      +||||++|++|.+++.         ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999998875         356789999999999999999999999999999 678899999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=3.5e-17  Score=153.18  Aligned_cols=136  Identities=21%  Similarity=0.185  Sum_probs=107.8

Q ss_pred             CccccccccccCceEEEEEEE-CCeeEEEeeccCCCh----------------------HHHHHHHHHHHHHHhCCCC--
Q 008220           67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS----------------------EELDNFHKELQLLCKLDHP--  121 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp--  121 (573)
                      .|.+.+.||.|+||.||++.. +++.||||+......                      ........|+.++..+.|+  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            388899999999999999987 689999997543220                      0112367789999999877  


Q ss_pred             ccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCC
Q 008220          122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       122 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      .++..++.    ...++||||++|++|......       .....++.+++.++.++|+.||+||||||.||+++.++.+
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence            44555542    345899999999998765421       3456788999999999999999999999999999999999


Q ss_pred             eEeeeecchhhh
Q 008220          202 HLADFGLAEYRE  213 (573)
Q Consensus       202 kL~Dfg~a~~~~  213 (573)
                      +|+|||++....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999985443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=8.9e-19  Score=187.73  Aligned_cols=263  Identities=25%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             CCCCccccccccccCceEEEEEEE---CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILST--SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (573)
                      +...|.+.+.||+|+|+.|-....   ....+|+|.+....  .........|..+-+.+. |+|++.+++....+...+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            356799999999999999987754   33456666544332  334455667888888887 999999999999999999


Q ss_pred             EEEEeccCCChhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCceEEcCCC-CCeEeeeecchhhhh
Q 008220          138 FFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYREN  214 (573)
Q Consensus       138 lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~  214 (573)
                      +++++..|+++.+.+ +......+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999988 544335667788899999999999999 99999999999999999999 999999999976543


Q ss_pred             hhhhhcccccCCCCCCCCcccccccc-CcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVG-TLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ..             .........+| ++.|+|||.+.+. ......|+||.|+++.-+++|..||............+ 
T Consensus       178 ~~-------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-  243 (601)
T KOG0590|consen  178 KN-------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-  243 (601)
T ss_pred             cC-------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-
Confidence            11             11112344577 9999999999884 55778999999999999999999997653322111000 


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                 ....  ...-...+..++....+++.+++..+|..|.+.+++-.+.|...
T Consensus       244 -----------~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  244 -----------KSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------cccc--cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       0000  01111234578889999999999999999999999988887766

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=3.4e-16  Score=139.48  Aligned_cols=133  Identities=24%  Similarity=0.285  Sum_probs=114.0

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC--CccceeeeccccCCceEEEEEeccCCC
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPPNYMFFFEFYESRN  147 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~  147 (573)
                      +.+.||.|.++.||++...+..+++|.......  ...+..|+.+++.+.|  +++++++.++...+..++++||+.++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            467899999999999998888999998654433  4578899999999976  589999999888889999999999877


Q ss_pred             hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---GIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       148 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      +..+        +......++.+++.+|++||..   +++|+|++|.||+++..+.++++|||.+...
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            7654        4456678899999999999985   6999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=9e-16  Score=147.15  Aligned_cols=134  Identities=21%  Similarity=0.250  Sum_probs=103.6

Q ss_pred             cccc-ccCceEEEEEEECCeeEEEeeccCCC-------------hHHHHHHHHHHHHHHhCCCCcc--ceeeeccccCC-
Q 008220           72 SPIA-RGAESVVYEATLDGRKVAVKKPILST-------------SEELDNFHKELQLLCKLDHPGL--AKFVAAHAKPP-  134 (573)
Q Consensus        72 ~~lg-~G~~g~V~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~~-  134 (573)
                      ..|| .|+.|+||.+...+..++||......             ......+.+|+.++.+|.|++|  +..+++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            3576 78888999998888899998653211             1234568889999999998775  66666543322 


Q ss_pred             ---ceEEEEEeccC-CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          135 ---NYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       135 ---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                         ..++|||+++| .+|.+++...  .+++.    .+.+++.+|.+||+.||+||||||.|||++.++.++|+|||.+.
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence               23599999997 6888887542  44543    35789999999999999999999999999999999999999875


Q ss_pred             h
Q 008220          211 Y  211 (573)
Q Consensus       211 ~  211 (573)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            3

>KOG1323 consensus Serine/threonine phosphatase [Signal transduction mechanisms]

Probab=99.65  E-value=5.9e-16  Score=144.65  Aligned_cols=106  Identities=34%  Similarity=0.471  Sum_probs=86.8

Q ss_pred             CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCC-----------------------------------------CCCh
Q 008220          456 QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-----------------------------------------TTRP  494 (573)
Q Consensus       456 ~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~-----------------------------------------~~~~  494 (573)
                      ..+.++|.+||||.|..+|-.|++.+++.+.+...                                         ...+
T Consensus       141 ~~~~~~~slfdghags~~avvAsrll~~hI~~ql~~vvd~i~~~~~~~~~~~g~~~~~s~~s~~~~~~~~ek~Ir~E~LV  220 (493)
T KOG1323|consen  141 RADGALFSLFDGHAGSAVAVVASRLLHRHIKEQLCEVVDTILHMDRHENLNFGKHRSESSYSMSEMSREDEKRIRHEHLV  220 (493)
T ss_pred             CCcceeeeeecCCCcchHHHHHHHHHHHhhhHHHHHHHHHHhhhccccccccccccccCCcccccccchhhccCchHHhh
Confidence            35678999999999999999999887666543210                                         0123


Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          495 TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       495 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                      ..||..||+.+|+.|.........         ..||||+++++.-++|||||+|||||+|+|+|..++||+|.+|
T Consensus       221 iGAlEsAFqemDeqiarer~~~~~---------~GGCtalvvi~llGKlYvaNAGDsRAIlVrndeirplS~efTP  287 (493)
T KOG1323|consen  221 IGALESAFQEMDEQIARERQVWRL---------PGGCTALVVIVLLGKLYVANAGDSRAILVRNDEIRPLSKEFTP  287 (493)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhcC---------CCCceEEEeeeeccceEEccCCCceEEEEecCCeeecccccCc
Confidence            469999999999998765544322         2699999999999999999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.2e-15  Score=141.44  Aligned_cols=135  Identities=23%  Similarity=0.228  Sum_probs=97.2

Q ss_pred             ccccccccCceEEEEEEEC-CeeEEEeeccCCChH--HHHH----------------------HHHHHHHHHhCCCC--c
Q 008220           70 LLSPIARGAESVVYEATLD-GRKVAVKKPILSTSE--ELDN----------------------FHKELQLLCKLDHP--G  122 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hp--n  122 (573)
                      +.+.||+|+||+||+|.+. ++.||||+.......  ....                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            3568999999999999875 899999975432211  1111                      13566666666433  3


Q ss_pred             cceeeeccccCCceEEEEEeccCCChhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCC
Q 008220          123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLC  200 (573)
Q Consensus       123 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~  200 (573)
                      +++.+++    ...++||||++++.+... +....  .. +++..++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            4555543    246899999999544321 11111  11 6788999999999999999 9999999999999999 899


Q ss_pred             CeEeeeecchhh
Q 008220          201 PHLADFGLAEYR  212 (573)
Q Consensus       201 ~kL~Dfg~a~~~  212 (573)
                      ++|+|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=5e-14  Score=144.44  Aligned_cols=258  Identities=21%  Similarity=0.178  Sum_probs=189.9

Q ss_pred             cccCCCCccccccccc--cCceEEEEEEE----CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhC-CCCccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIAR--GAESVVYEATL----DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  131 (573)
                      ..+....+.+.+.+|.  |.+|.||.+..    ++..+|+|+....  .......-.+|+...+.+ .|+|.++.+..++
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3444567888899999  99999998865    5678999973332  222333334677777777 4999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCceEEcCC-CCCeEeee
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK----ALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADF  206 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Df  206 (573)
                      ..+..++-+|+|. .+|..+.+.....++...++..+.+...    ||.++|..+++|-|+||.||++..+ ...+++||
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            9999999999985 6898888877777888999999999999    9999999999999999999999999 88999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      |+...+.......           .........|...|++||...+. ++..+||+++|.++.+..++..+....... .
T Consensus       268 ~~v~~i~~~~~~~-----------~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~  334 (524)
T KOG0601|consen  268 GLVSKISDGNFSS-----------VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS-S  334 (524)
T ss_pred             ceeEEccCCcccc-----------ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC-C
Confidence            9987654322110           00011223577889999998765 478999999999999999887665432100 0


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      ..++.               ..+  +..++..+.+.++...+..|++.+|..|+++..+..+.
T Consensus       335 W~~~r---------------~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~  380 (524)
T KOG0601|consen  335 WSQLR---------------QGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN  380 (524)
T ss_pred             ccccc---------------ccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence            00000               000  11112234567777899999999999999998876543

>PF13672 PP2C_2: Protein phosphatase 2C; PDB: 2JFT_A 2JFS_A 2V06_A 2JFR_A 2J86_A 2J82_A 2Y09_A 2XZV_A 2CM1_A 1TXO_B

Probab=99.46  E-value=4.7e-13  Score=126.68  Aligned_cols=128  Identities=19%  Similarity=0.218  Sum_probs=71.1

Q ss_pred             EeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHH----HhcCCCCChhHHHHHHHHHHHHHH
Q 008220          434 FATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL----QNLGSTTRPTDALLEAFIRTDVAF  509 (573)
Q Consensus       434 ~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l----~~~~~~~~~~~~l~~~~~~~~~~~  509 (573)
                      .++.|.|..|||++.+...    .+..+++|+||+||...++.+++.+++.+    .......... .....+..+..++
T Consensus         3 ~sh~~~~~~nqD~~~~~~~----~~~~~~aVaDG~g~~~~~~~aa~~av~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~   77 (212)
T PF13672_consen    3 RSHRGRGAPNQDAFGIRTD----DDGNLAAVADGVGGSPYGEEAAQLAVETFINYLKKLLSQESPS-SIEALIRAIKKEI   77 (212)
T ss_dssp             ----TTSSS--EEEEEE-T----CCTCEEEEEEEESTTTHHHHHHHHHHHHHHHHHHHSCCCHHHH-HHHHHHHHHHHHH
T ss_pred             ccccCCCCCCCCCEEeeeC----CCCEEEEEEECCCCCchhHHHHHHHHHHHHHHHHhcccccchH-HHHHHHHHHHHHH
Confidence            5788999999999986543    44567799999998777776666665544    3333221111 0222333333333


Q ss_pred             HHHH---HHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeE-EeCCeeeeCCCCCC
Q 008220          510 RNEL---DSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAIL-CRGGHPFALSRVRQ  569 (573)
Q Consensus       510 ~~~~---~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l-~~~~~~~~lt~dH~  569 (573)
                      ....   ........   .....+||++++++.++.++++|+||||+|+ .++|....+|.||.
T Consensus        78 ~~~~~~~~~~~~~~~---~~~~~~tTl~~~v~~~~~~~~~~iGD~~i~~~~~~g~~~~l~~~~~  138 (212)
T PF13672_consen   78 LSIVRAFQSAKQADL---ELRDYGTTLLALVIDPDKVYIFNIGDSRIYVIRRNGEIQQLTDDHS  138 (212)
T ss_dssp             HHHH----HHHHHSG---GGTT-EE-EEEEEEETTEEEEEEESS-EEEEEEETTEEEE-S---B
T ss_pred             HHHhhhhhhhhhccc---cccccCceEEEEEEECCEEEEEEECCCeEEEEECCCEEEEcCCCcc
Confidence            3211   00000000   1113599999999999999999999999965 58999999999986

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=6.3e-14  Score=150.73  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=188.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ....+.+.+.+.+-+|.++.++.+.-  .+...+.|.....   .....+....+-.++-.-.+|-++.....+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            44556788888999999999998864  2323333321110   111122222333333334557777666666667789


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +++++|+.+++|...++..+ ..+.+-++.++..+..++++||...+.|+|++|.|+++..+|+.++.|||.........
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            99999999999999998766 56777788899999999999999999999999999999999999999998543222110


Q ss_pred             ---hhh-------cccc-cCCCCCCC----CccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008220          217 ---EIS-------LKNW-RSSGKPTG----GFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL  281 (573)
Q Consensus       217 ---~~~-------~~~~-~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  281 (573)
                         ..+       .... .....+.-    ........||+.|.+||.+.+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence               000       0000 00000000    11234568999999999999999999999999999999999999999988


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS  343 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  343 (573)
                      ........+......                ++.-+...+++..+++...|..+|.+|..+.
T Consensus      1039 tpq~~f~ni~~~~~~----------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIP----------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhhhccccCCCC----------------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            777766665544332                2233456789999999999999999998876

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=7.8e-13  Score=137.84  Aligned_cols=137  Identities=22%  Similarity=0.320  Sum_probs=96.6

Q ss_pred             ccccccCceEEEEEEE-CCeeEEEeeccCCChHHHH----------------------------------------HHHH
Q 008220           72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEELD----------------------------------------NFHK  110 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~----------------------------------------~~~~  110 (573)
                      +.||.|++|.||+|+. +|+.||||+......+...                                        .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999987 7899999985443211100                                        1444


Q ss_pred             HHHHHHhC----C-CCc--cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 008220          111 ELQLLCKL----D-HPG--LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK-ALQYLHNLG  182 (573)
Q Consensus       111 E~~~l~~l----~-hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~  182 (573)
                      |+..+.++    + +++  |++++..+  ....++||||++|++|.+..........   ...++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            55555555    2 333  23333322  3457899999999999887653322222   3345556655 467899999


Q ss_pred             ceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       183 iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ++|+|++|.||+++.++.++|+|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.1e-12  Score=119.53  Aligned_cols=128  Identities=25%  Similarity=0.263  Sum_probs=97.4

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc-cceeeeccccCCceEEEEEeccCCChh
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEFYESRNLA  149 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g~L~  149 (573)
                      ++.|+.|.++.||+++..+..|++|....... ....+..|+.+++.+.+.+ +++++....  ...++||||++|.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            45788999999999999899999998543321 1234578999999986544 445665543  3457999999998876


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI-----VHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-----iH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ..    .     .....++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            43    0     1123456799999999999985     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=1.1e-11  Score=128.49  Aligned_cols=164  Identities=20%  Similarity=0.237  Sum_probs=125.2

Q ss_pred             ECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHH
Q 008220           87 LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM  166 (573)
Q Consensus        87 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  166 (573)
                      .++.+|.|......+....+...+-++.|+.++||||+++++.++..+..|+|+|.+.  .|..++...+    ...+..
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~  108 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL  108 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence            3577888877655555556677888999999999999999999999999999999885  4666665433    567778


Q ss_pred             HHHHHHHHHHHHH-hCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccC
Q 008220          167 IAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM  245 (573)
Q Consensus       167 i~~qi~~~l~~LH-~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  245 (573)
                      -++||+.||.||| +.+++|++|.-+.|+|+..|..||++|.++........                ......--..|.
T Consensus       109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----------------~~~~~~~~~s~~  172 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----------------PAKSLYLIESFD  172 (690)
T ss_pred             HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----------------ccccchhhhccc
Confidence            8999999999997 56899999999999999999999999998754332110                011111222356


Q ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 008220          246 APEILKKEIHSEKSDVYSFGISINELLTG  274 (573)
Q Consensus       246 aPE~~~~~~~~~~~DiwslG~il~elltg  274 (573)
                      .|+.+....  -..|.|.|||++++++.|
T Consensus       173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  173 DPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            666543332  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=8.3e-12  Score=114.34  Aligned_cols=135  Identities=18%  Similarity=0.147  Sum_probs=99.1

Q ss_pred             cccccccCceEEEEEEEC--------CeeEEEeeccCCC----------------------hHHHHH----HHHHHHHHH
Q 008220           71 LSPIARGAESVVYEATLD--------GRKVAVKKPILST----------------------SEELDN----FHKELQLLC  116 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~  116 (573)
                      ...||.|-.+.||.|...        +..+|||+.....                      ......    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999753        3689999632210                      011222    338999999


Q ss_pred             hCC--CCccceeeeccccCCceEEEEEeccCCChhh-hhhccCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCc
Q 008220          117 KLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLHVEEWSPSVDQVLMIAAQLAKALQYL-HNLGIVHRDVKPAN  192 (573)
Q Consensus       117 ~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~iiH~Dlkp~N  192 (573)
                      ++.  .-+++..+++    ...++||||+.++.+.. .+.  ...++.+++..+..+++.+|..| |+.|++|+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            995  3567777765    56789999997754422 222  12345567778889999999999 89999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhh
Q 008220          193 VLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~  212 (573)
                      ||++ ++.+.|+|||.+...
T Consensus       156 IL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEE-CCcEEEEECCCceeC
Confidence            9997 467999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=4.7e-12  Score=111.63  Aligned_cols=133  Identities=26%  Similarity=0.428  Sum_probs=100.8

Q ss_pred             ccccccCceEEEEEEECCeeEEEeeccCC---ChH-----HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           72 SPIARGAESVVYEATLDGRKVAVKKPILS---TSE-----ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ..+++|+-+.+|.+.+.+.++++|.-..+   .++     ..++-.+|++++.++.--.|..-+=++.++....++|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46789999999999888878888851111   111     1345678999999986544443333334677788999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +|..|.+.+...        ...++..+-.-+.-||..||+|+||.++||++...+ +.++|||++.+-+
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999888654        135677777888889999999999999999997765 9999999986543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=1.1e-11  Score=108.60  Aligned_cols=142  Identities=23%  Similarity=0.302  Sum_probs=107.6

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeeccCC---C-----hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPILS---T-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .+..|-+|+.+.|+++.+.|+..+||.-..+   .     .-...+..+|+++|.++.--.|.--.-+|.+...-.++||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            5678889999999999999999999952221   1     1134567889999998864444443334556667789999


Q ss_pred             eccC-CChhhhhhccCCCCCHHHH-HHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchh
Q 008220          142 FYES-RNLAEKLHVEEWSPSVDQV-LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEY  211 (573)
Q Consensus       142 ~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~  211 (573)
                      |++| .++.+++........++.. ..++..|-+.+.-||..+|+|+||..+||++..++.   +.|+|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9987 5777777654433444444 789999999999999999999999999999976653   47999999753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=4.3e-12  Score=133.74  Aligned_cols=140  Identities=17%  Similarity=0.162  Sum_probs=90.6

Q ss_pred             CccccccccccCceEEEEEEE-C-CeeEEEeeccCCChH----------------------------------HHHH---
Q 008220           67 SYTLLSPIARGAESVVYEATL-D-GRKVAVKKPILSTSE----------------------------------ELDN---  107 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~-~~~vavK~~~~~~~~----------------------------------~~~~---  107 (573)
                      .|.. +.||.|++|.||+|+. + |+.||||+......+                                  ..+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 7899999999999987 3 899999986533111                                  1112   


Q ss_pred             ---HHHHHHHHHhCC----CCccceeeecccc-CCceEEEEEeccCCChhhhh--hccCC---CCCHHHHHHHHHHHHHH
Q 008220          108 ---FHKELQLLCKLD----HPGLAKFVAAHAK-PPNYMFFFEFYESRNLAEKL--HVEEW---SPSVDQVLMIAAQLAKA  174 (573)
Q Consensus       108 ---~~~E~~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~qi~~~  174 (573)
                         +.+|+..+.++.    +.+.+.+-.++.+ ....++||||+.|+.+.++-  ...+.   .+....+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence               233443333331    2222222222221 34567999999999998753  22221   133334444555554  


Q ss_pred             HHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhhhh
Q 008220          175 LQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYREN  214 (573)
Q Consensus       175 l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~~~  214 (573)
                           ..|++|+|+||.||+++.+|    .++++|||++..+..
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 58999999999999999988    899999999876543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.6e-12  Score=120.65  Aligned_cols=208  Identities=20%  Similarity=0.246  Sum_probs=142.5

Q ss_pred             HHHHHHhCCCCccceeeeccccC-----CceEEEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 008220          111 ELQLLCKLDHPGLAKFVAAHAKP-----PNYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNL-  181 (573)
Q Consensus       111 E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-  181 (573)
                      -...|-++.|.||++++.++.+.     ....+++||+..|++..+|++.   ...+......+++-||+.||.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34556677899999999887653     4578999999999999998753   33567778889999999999999988 


Q ss_pred             -CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhh
Q 008220          182 -GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD  260 (573)
Q Consensus       182 -~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  260 (573)
                       -|+|+++..+.|++..+|-+|+.--...........            ..........+-+.|.+||.=.-...+.++|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~------------~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~d  264 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS------------TREAEKSVNTSLPGFSAPESGTTTNTTGASD  264 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhh------------hhHhhhhccccCCccccCCcCcccccccchh
Confidence             499999999999999998887653222111110000            0001122345678899999866666677999


Q ss_pred             HHHHHHHHHHHHcCCCC-CCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC
Q 008220          261 VYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR  339 (573)
Q Consensus       261 iwslG~il~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  339 (573)
                      ||++|+...+|..+..- -...........+-           .+..        .+   ..+--++++.+|++-.|..|
T Consensus       265 Iy~fgmcAlemailEiq~tnseS~~~~ee~ia-----------~~i~--------~l---en~lqr~~i~kcl~~eP~~r  322 (458)
T KOG1266|consen  265 IYKFGMCALEMAILEIQSTNSESKVEVEENIA-----------NVII--------GL---ENGLQRGSITKCLEGEPNGR  322 (458)
T ss_pred             hhhhhHHHHHHHHheeccCCCcceeehhhhhh-----------hhee--------ec---cCccccCcCcccccCCCCCC
Confidence            99999999999887654 22221111100000           0000        00   01112478999999999999


Q ss_pred             CCHHHHHHHHHHH
Q 008220          340 PSFSDIALELDLV  352 (573)
Q Consensus       340 pt~~ell~~l~~~  352 (573)
                      |++.+++.|+-.+
T Consensus       323 p~ar~llfHpllf  335 (458)
T KOG1266|consen  323 PDARLLLFHPLLF  335 (458)
T ss_pred             cchhhhhcCceee
Confidence            9999999887554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=1.3e-11  Score=126.78  Aligned_cols=245  Identities=23%  Similarity=0.240  Sum_probs=175.5

Q ss_pred             CCccccccccccCceEEEEEEE---CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTS--EELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .+|..+..||.|.|+.|+.+..   .+..|++|.......  .....-..|+.+...+ .|.++++++..+....+.|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            4688899999999999998854   467788886433221  2222234566666666 599999999888888888899


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      .|||.++++....... ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.+.-    
T Consensus       345 ~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~----  419 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF----  419 (524)
T ss_pred             hhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce----
Confidence            9999999887766322 256778899999999999999999999999999999999886 7889999998753211    


Q ss_pred             hcccccCCCCCCCCccccccccCcccC--ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYM--APEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                     ........-++.  +|+......+..+.|++|||.-+.+.+++.+--....   ....+..    
T Consensus       420 ---------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~----  477 (524)
T KOG0601|consen  420 ---------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRS----  477 (524)
T ss_pred             ---------------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeec----
Confidence                           111222333344  5555566778899999999999999999764322110   1111110    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                 +.-+.    ....+.++..+.+.++..++..||.+.++..+....
T Consensus       478 -----------~~~p~----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  478 -----------GDTPN----LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -----------ccccC----CCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                       11111    123457888999999999999999999887665544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=9.8e-10  Score=110.68  Aligned_cols=212  Identities=15%  Similarity=0.221  Sum_probs=153.5

Q ss_pred             ceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc----CCceEEEEEeccC-CChhhh
Q 008220           79 ESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYMFFFEFYES-RNLAEK  151 (573)
Q Consensus        79 ~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  151 (573)
                      -.+.|++..  +|..|++|++.............-++.++++.|+|||.+-++|..    ...+++|++|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            346789975  789999999855544444444566889999999999999998873    4468999999986 566665


Q ss_pred             hhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          152 LHV--------------EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       152 l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      .-.              .+...+++.+|.++.|+..||.++|+.|..-+-|.|.+||++++-+++|...|....+.... 
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence            321              12245789999999999999999999999999999999999999888888877664433200 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCC-CCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P-f~~~~~~~~~~~~~~~~~~  296 (573)
                                                 .  |-+..   -.+-|.=.||.+++.|.||..- +..........        
T Consensus       448 ---------------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~--------  487 (655)
T KOG3741|consen  448 ---------------------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL--------  487 (655)
T ss_pred             ---------------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHH--------
Confidence                                       0  11111   2367999999999999998643 11111111000        


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                                       ..+...++.++++++......++++ -++.+++.+.
T Consensus       488 -----------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  488 -----------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -----------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                             0122357889999999999999997 6788887655

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=3e-10  Score=108.18  Aligned_cols=138  Identities=24%  Similarity=0.349  Sum_probs=105.4

Q ss_pred             ccccccCceEEEEEEECC-eeEEEeeccCCCh-HHHHHHHHHHHHHHhCCC--CccceeeeccccC---CceEEEEEecc
Q 008220           72 SPIARGAESVVYEATLDG-RKVAVKKPILSTS-EELDNFHKELQLLCKLDH--PGLAKFVAAHAKP---PNYMFFFEFYE  144 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~~lv~e~~~  144 (573)
                      +.|+.|.++.||++...+ +.+++|....... .....+..|+.+++.+.+  .++++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998765 8999998544322 134567899999999965  4567777776654   36789999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------------------------------------------  180 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  180 (573)
                      |.++.+.+..  ..++.++...++.+++.+|..||+                                            
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888776532  245666777777788888877773                                            


Q ss_pred             ------------CCceeccCCCCceEEcC--CCCCeEeeeecchh
Q 008220          181 ------------LGIVHRDVKPANVLLDR--NLCPHLADFGLAEY  211 (573)
Q Consensus       181 ------------~~iiH~Dlkp~Nill~~--~~~~kL~Dfg~a~~  211 (573)
                                  ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        23699999999999998  56689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=2.9e-09  Score=103.27  Aligned_cols=131  Identities=19%  Similarity=0.162  Sum_probs=95.7

Q ss_pred             eEEEEEEECCeeEEEeeccCCChHH-H----------HHHHHHHHHHHhCCCCcc--ceeeecccc-----CCceEEEEE
Q 008220           80 SVVYEATLDGRKVAVKKPILSTSEE-L----------DNFHKELQLLCKLDHPGL--AKFVAAHAK-----PPNYMFFFE  141 (573)
Q Consensus        80 g~V~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~~~~~lv~e  141 (573)
                      ..|.+....|+.|.||......... .          ..+.+|...+..|..-+|  +..+.+++.     ....++|+|
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            3466777888999999754333111 1          137789999988843333  334444432     235789999


Q ss_pred             eccCC-Chhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-------CCCCeEeeeecch
Q 008220          142 FYESR-NLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------NLCPHLADFGLAE  210 (573)
Q Consensus       142 ~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-------~~~~kL~Dfg~a~  210 (573)
                      ++++. +|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99886 788887531 224566778899999999999999999999999999999975       4678999999774

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=6.9e-09  Score=102.08  Aligned_cols=264  Identities=20%  Similarity=0.216  Sum_probs=163.4

Q ss_pred             cccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHh-CCCCccce--------eeeccccCCceEEE
Q 008220           69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK-LDHPGLAK--------FVAAHAKPPNYMFF  139 (573)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~--------l~~~~~~~~~~~lv  139 (573)
                      .....||+|+.+.+|-.-.-+..| -|+..........+   .+..|.. -.||-+-.        |++-- .....-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchhhchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEe
Confidence            356789999999999653322222 34333222221111   1222333 35664333        22211 12236678


Q ss_pred             EEeccCC-Chhhhhhc----cC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          140 FEFYESR-NLAEKLHV----EE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       140 ~e~~~~g-~L~~~l~~----~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      |..+.|. .+..++.-    +. ....++.++..++.++.+.+.||..|.+-+|+.++|+|++.++.|.|.|=.....-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence            8877764 23333321    11 134678899999999999999999999999999999999999999999865432211


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTG-VVPYTDLRAEAQA  287 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~  287 (573)
                                       .+......+|.+.|.+||.-.     +-.-+...|.|.||+++++++.| +.||.+.......
T Consensus       169 -----------------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         169 -----------------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             -----------------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence                             112244568999999999754     34456778999999999999984 9999864211100


Q ss_pred             ----H-HHHhccccHHHHHHHHhcCCCCCcccc-cccCChHHHHHHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhcc
Q 008220          288 ----H-TVLEMNYTEQQLTAAVVSGGLRPILAS-LELGLPASILSLIQRCWDGN--PHNRPSFSDIALELDLVLEHRKS  358 (573)
Q Consensus       288 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~d--P~~Rpt~~ell~~l~~~~~~~~~  358 (573)
                          . .|-.+.+...    .....+++|..-. ...-+++.+..|..+|+...  +.-|||++..+..|..+.++...
T Consensus       232 p~p~E~~Ia~g~f~ya----~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         232 PNPLETDIAHGRFAYA----SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             CCcchhhhhcceeeec----hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence                0 1111111110    0011222332222 22357889999999999653  56899999999998888776543

>smart00331 PP2C_SIG Sigma factor PP2C-like phosphatases

Probab=99.03  E-value=1.7e-09  Score=100.63  Aligned_cols=110  Identities=20%  Similarity=0.033  Sum_probs=79.1

Q ss_pred             CCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCCCChhHHHHHHHHHHHHHHHHHHHHhhhhh
Q 008220          441 ETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSK  520 (573)
Q Consensus       441 ~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  520 (573)
                      ...-|.+.+...   +++..+++|+||||+..+|.+++..+...+.+.....   ..+.+.+..+++.+....     . 
T Consensus        15 ~~~GD~~~~~~~---~~~~~~~~v~Dg~G~G~~aa~~s~~~~~~~~~~~~~~---~~~~~~l~~~n~~l~~~~-----~-   82 (193)
T smart00331       15 QVGGDFYDVVKL---PEGRLLIAIADVMGKGLAAALAMSMARSALRTLLSEG---ISLSQILERLNRAIYENG-----E-   82 (193)
T ss_pred             hcCccEEEEEEe---CCCeEEEEEEecCCCChHHHHHHHHHHHHHHHHhhcC---CCHHHHHHHHHHHHHhcC-----C-
Confidence            455677766554   2457899999999988888888888888776553221   125566667777765431     1 


Q ss_pred             hccCCccCccceeEEEEE--ECCeEEEEEccccceeEEe-CCeeeeCCCCC
Q 008220          521 RVVQKDWHPGCTAIAALI--VRNRLFVANAGDCRAILCR-GGHPFALSRVR  568 (573)
Q Consensus       521 ~~~~~~~~~GtT~~~~~i--~~~~l~vanvGDSRa~l~~-~~~~~~lt~dH  568 (573)
                            ...|+|++++++  ..++++++|+||+|+|+++ +|..++++.+-
T Consensus        83 ------~~~~~T~~~~~id~~~~~l~~~~~Gd~~~~~~~~~~~~~~~~~~~  127 (193)
T smart00331       83 ------DGMFATLFLALYDFAGGTLSYANAGHSPPYLLRADGGLVEDLDDL  127 (193)
T ss_pred             ------CCcEEEEEEEEEECCCCEEEEEeCCCCceEEEECCCCeEEEcCCC
Confidence                  135999999998  5779999999999999998 66555555543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=1.9e-09  Score=98.52  Aligned_cols=123  Identities=26%  Similarity=0.266  Sum_probs=81.8

Q ss_pred             EEEEEEE-CCeeEEEeeccCCC--------------------------hHHHHHHHHHHHHHHhCCCC--ccceeeeccc
Q 008220           81 VVYEATL-DGRKVAVKKPILST--------------------------SEELDNFHKELQLLCKLDHP--GLAKFVAAHA  131 (573)
Q Consensus        81 ~V~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~  131 (573)
                      .||.|.. ++..+|||......                          .-......+|.+.|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899986 68899999632210                          00133577899999999754  677777663 


Q ss_pred             cCCceEEEEEecc--CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          132 KPPNYMFFFEFYE--SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY-LHNLGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       132 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                         ..++||||+.  |..+..+....   ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               4579999998  65554433221   1134566778888885555 579999999999999999887 899999998


Q ss_pred             chh
Q 008220          209 AEY  211 (573)
Q Consensus       209 a~~  211 (573)
                      +..
T Consensus       153 av~  155 (188)
T PF01163_consen  153 AVD  155 (188)
T ss_dssp             EEE
T ss_pred             cee
Confidence            753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=3.5e-09  Score=99.26  Aligned_cols=133  Identities=26%  Similarity=0.219  Sum_probs=102.8

Q ss_pred             ccccccccccCceEEEEEEE-CCeeEEEeeccCCCh----------------------HHHHHHHHHHHHHHhCCCC--c
Q 008220           68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS----------------------EELDNFHKELQLLCKLDHP--G  122 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp--n  122 (573)
                      +.+..+||-|--+.||.|.+ .|.++|||.-.....                      -......+|.++|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            56788999999999999987 599999995322110                      1133467899999999644  7


Q ss_pred             cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       123 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      |++.+++    +...+|||+++|-.|...-      +..+....++..|++-+.-+-..||||+|+++-||+++.+|.+.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            7777765    5678999999996665432      13345556777777777777799999999999999999999999


Q ss_pred             Eeeeecch
Q 008220          203 LADFGLAE  210 (573)
Q Consensus       203 L~Dfg~a~  210 (573)
                      ++||-.+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99998764

>KOG1379 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms]

Probab=98.81  E-value=2.6e-08  Score=94.40  Aligned_cols=112  Identities=22%  Similarity=0.321  Sum_probs=81.8

Q ss_pred             CCceeEEecccCCCCCceEEEEEEcCCCcH-----HHHHHHHHHhHH---HHHhcC-CCCChhHHHHHHHHHHHHHHHHH
Q 008220          442 TMEDTHFLMPHMYNQKEIHMFGIFDGHRGS-----AAAEFSARALPG---FLQNLG-STTRPTDALLEAFIRTDVAFRNE  512 (573)
Q Consensus       442 ~neD~~~~~~~~~~~~~~~~~~V~DGhgG~-----~a~~~~~~~l~~---~l~~~~-~~~~~~~~l~~~~~~~~~~~~~~  512 (573)
                      .=||++.+..+    ....+.|||||.||.     ..+.|.++.+..   .+.+.. ...++...|..|+.++-..    
T Consensus        90 ~GEDa~Fvss~----~~~~v~GVADGVGGWa~~GiDpg~fS~eLM~~ce~~v~~~~~~~~~P~~lL~~ay~~l~~~----  161 (330)
T KOG1379|consen   90 GGEDAWFVSSN----PHAIVMGVADGVGGWAEYGIDPGAFSRELMSNCERLVQNSDFNPSDPVNLLEKAYAELKSQ----  161 (330)
T ss_pred             CCCcceeeccC----cccceEEEccccchHhhcCcCHHHHHHHHHHHHHHHhcccccCCCChHHHHHHHHHHHhhc----
Confidence            45799988665    456789999999975     577777765533   333332 3457888888888776211    


Q ss_pred             HHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCCCC
Q 008220          513 LDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQEFW  572 (573)
Q Consensus       513 ~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~~  572 (573)
                                 ....-.+|||+++.+.  +++|++||+|||=..++|+|+.+.-|..+..|+
T Consensus       162 -----------~~~~vGSSTAcI~~l~~~~~~Lh~aNLGDSGF~VvR~G~vv~~S~~Q~H~F  212 (330)
T KOG1379|consen  162 -----------KVPIVGSSTACILALDRENGKLHTANLGDSGFLVVREGKVVFRSPEQQHYF  212 (330)
T ss_pred             -----------CCCCCCcceeeeeeeecCCCeEEEeeccCcceEEEECCEEEEcCchheecc
Confidence                       0001248899999988  889999999999999999999998888765543

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=5.1e-08  Score=89.57  Aligned_cols=136  Identities=14%  Similarity=0.068  Sum_probs=102.9

Q ss_pred             cccCceEEEEEEECCeeEEEeeccCCC------hHHHHHHHHHHHHHHhCCCC--ccceeeeccc---c--CCceEEEEE
Q 008220           75 ARGAESVVYEATLDGRKVAVKKPILST------SEELDNFHKELQLLCKLDHP--GLAKFVAAHA---K--PPNYMFFFE  141 (573)
Q Consensus        75 g~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~---~--~~~~~lv~e  141 (573)
                      |+||-+-|+.....|..+-+|+.....      +-....|.+|+..+++|..-  .+++.+ ++.   .  .-..+||+|
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence            568999999998888889999743111      22456789999999998532  355554 222   1  124679999


Q ss_pred             eccC-CChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--CeEeeeecchh
Q 008220          142 FYES-RNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGLAEY  211 (573)
Q Consensus       142 ~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--~kL~Dfg~a~~  211 (573)
                      -+.| .+|.+++.... .+.+......++.+++..+.-||+.|+.|+|+-+.||+++.+|.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            8865 58888875432 24567777899999999999999999999999999999987777  99999997653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=2.1e-09  Score=112.34  Aligned_cols=161  Identities=19%  Similarity=0.259  Sum_probs=110.0

Q ss_pred             HHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCccc
Q 008220          166 MIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY  244 (573)
Q Consensus       166 ~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  244 (573)
                      .=+.+++.|+.|+|.. ++||++|.|++|.++.++..||+.|+++.........-...|.       ........-...|
T Consensus       103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd-------~~lp~~~~~~~~f  175 (700)
T KOG2137|consen  103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYD-------PPLPLLLQPHLNF  175 (700)
T ss_pred             hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCC-------CCCChhhccCccc
Confidence            3344556999999976 8999999999999999999999999998765542221111110       0112223456789


Q ss_pred             CChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHH
Q 008220          245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS  323 (573)
Q Consensus       245 ~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (573)
                      .|||.+.+...+.++|++|+|+++|.+.. |+.-+........ ..+..              ....-........+|.+
T Consensus       176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~--------------~~~~~~~~~~s~~~p~e  240 (700)
T KOG2137|consen  176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSR--------------NLLNAGAFGYSNNLPSE  240 (700)
T ss_pred             ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhh--------------cccccccccccccCcHH
Confidence            99999999888999999999999999995 5544433211111 11000              00011111223578999


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          324 ILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       324 l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                      +.+-+.+++..++..||++.++...
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcc
Confidence            9999999999999999988777543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=3.5e-08  Score=92.65  Aligned_cols=106  Identities=23%  Similarity=0.246  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHHHhCCCC--ccceeeeccccC----CceEEEEEeccCC-ChhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Q 008220          105 LDNFHKELQLLCKLDHP--GLAKFVAAHAKP----PNYMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQY  177 (573)
Q Consensus       105 ~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~  177 (573)
                      ..+..+|...+..|..-  .++..+.+.+..    ...++|+|++++. +|.+++.... .++......++.+++..++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence            44677888888887433  334445544432    2458999999884 7888886533 25667788999999999999


Q ss_pred             HHhCCceeccCCCCceEEcCCC---CCeEeeeecchh
Q 008220          178 LHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEY  211 (573)
Q Consensus       178 LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~  211 (573)
                      ||+.||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999999887   799999997753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.67  E-value=2.5e-07  Score=85.32  Aligned_cols=138  Identities=19%  Similarity=0.274  Sum_probs=93.4

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHH---------HHHHHHHHHhCCC---Cccceeeec-
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN---------FHKELQLLCKLDH---PGLAKFVAA-  129 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---pnIv~l~~~-  129 (573)
                      +....|.+.+.+-......|-+...+++.+++|..........+.         ..+++..+..+..   .....++-+ 
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            445678888888888888888888899999999865443322222         2233443444322   222222222 


Q ss_pred             ----cccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEee
Q 008220          130 ----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       130 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                          +.-....+++|||++|..|.+...     +++    .+...+.+++.-||+.|++|+|..|.|++++.++ ++++|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence                222345678999999988876542     222    2445677889999999999999999999998655 99999


Q ss_pred             eecch
Q 008220          206 FGLAE  210 (573)
Q Consensus       206 fg~a~  210 (573)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.3e-06  Score=81.44  Aligned_cols=133  Identities=27%  Similarity=0.276  Sum_probs=93.4

Q ss_pred             cccccCceEEEEEEE-CCeeEEEeeccCCChHH------------------------HHHHHHHHHHHHhCC--CCccce
Q 008220           73 PIARGAESVVYEATL-DGRKVAVKKPILSTSEE------------------------LDNFHKELQLLCKLD--HPGLAK  125 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~--hpnIv~  125 (573)
                      .|+.|--+.||+|.. ++..+|+|+........                        ..-..+|+..|+++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            567788889999975 68899999754332111                        012456777777774  344555


Q ss_pred             eeeccccCCceEEEEEeccCC-ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeE
Q 008220          126 FVAAHAKPPNYMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       126 l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      -+.+.    +-.|||||+... .-.-.|  ....+..+++..+..++++.+.-|-. .++||+||+.=|||+. ++.+.+
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            55553    457999998653 111112  12234444788888999999998877 8999999999999999 888999


Q ss_pred             eeeecchhh
Q 008220          204 ADFGLAEYR  212 (573)
Q Consensus       204 ~Dfg~a~~~  212 (573)
                      +|||.|...
T Consensus       208 ID~~QaV~~  216 (268)
T COG1718         208 IDVSQAVTI  216 (268)
T ss_pred             EECcccccc
Confidence            999988644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.42  E-value=3.1e-06  Score=80.52  Aligned_cols=134  Identities=11%  Similarity=0.104  Sum_probs=83.7

Q ss_pred             ccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC--ccceeeeccccCCceEEEEEeccCCC-h
Q 008220           72 SPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAHAKPPNYMFFFEFYESRN-L  148 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~-L  148 (573)
                      .+||.|..+.||+.  .+..+++|......  ....+.+|.++++.+..-  .+++.+.+....+...+|||+++|.. +
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            57899999999984  35577888754322  234468899999998533  35777888777777889999999963 1


Q ss_pred             hhh---------------------hhccC-CCCCHHHH-HHHHH----------HHHHH-HHHHHh----CCceeccCCC
Q 008220          149 AEK---------------------LHVEE-WSPSVDQV-LMIAA----------QLAKA-LQYLHN----LGIVHRDVKP  190 (573)
Q Consensus       149 ~~~---------------------l~~~~-~~~~~~~~-~~i~~----------qi~~~-l~~LH~----~~iiH~Dlkp  190 (573)
                      ...                     ++... ........ ..+..          .+... ..+|..    ..++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            111                     11110 01111100 00100          01111 112221    1478999999


Q ss_pred             CceEEcCCCCCeEeeeecch
Q 008220          191 ANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       191 ~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .||+++.++ +.|+||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999988 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=2.3e-06  Score=90.14  Aligned_cols=138  Identities=20%  Similarity=0.289  Sum_probs=88.3

Q ss_pred             ccccccCceEEEEEEE-CCeeEEEeeccCCChHHH----------------------------------H------HHHH
Q 008220           72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEEL----------------------------------D------NFHK  110 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~----------------------------------~------~~~~  110 (573)
                      ..|+.++-|.||+|+. +|+.||||+....-.+..                                  +      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            4688999999999997 599999997544321110                                  0      1334


Q ss_pred             HHHHHHhCC-----CCc--cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 008220          111 ELQLLCKLD-----HPG--LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI  183 (573)
Q Consensus       111 E~~~l~~l~-----hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  183 (573)
                      |+..+.++.     .|+  |++++.  +-...-.++|||++|-.+.+........++...+...+.++.  +..+-..|+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            444444441     222  222222  223567899999999888888543333454333322222111  223334799


Q ss_pred             eeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          184 VHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       184 iH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +|.|..|-||+++.+|.+.+.|||+...+.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCC
Confidence            999999999999999999999999986554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=3.4e-06  Score=81.63  Aligned_cols=136  Identities=15%  Similarity=0.129  Sum_probs=85.4

Q ss_pred             cccccCc-eEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEeccCCChhh
Q 008220           73 PIARGAE-SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAE  150 (573)
Q Consensus        73 ~lg~G~~-g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  150 (573)
                      .|..|.+ +.||+....+..+++|......   ...+.+|+++++.+. +--+++++.+....+..++|||+++|.++..
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3445555 7899998777788999754332   335678999988884 4557778888777677899999999977653


Q ss_pred             hh-------------------hccC---CCCCH--HHHHHH-----------------------HHHHHHHHHHH----H
Q 008220          151 KL-------------------HVEE---WSPSV--DQVLMI-----------------------AAQLAKALQYL----H  179 (573)
Q Consensus       151 ~l-------------------~~~~---~~~~~--~~~~~i-----------------------~~qi~~~l~~L----H  179 (573)
                      ..                   +...   ..+..  ......                       ..+++..|...    .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            31                   1110   01110  000000                       11111111111    1


Q ss_pred             hCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       180 ~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ...++|+|+.|.|||++.++.+.|+||+.+.+
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            22489999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=1.2e-07  Score=98.29  Aligned_cols=189  Identities=17%  Similarity=0.192  Sum_probs=140.7

Q ss_pred             CCCccccccccccCceEEEEEEECCee-EEEeeccCCChHHHHHHHHHHHHHHhCCCCc-cceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATLDGRK-VAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~  142 (573)
                      .+-|....-+++|+++.+++.+.+.+. ...+.+...     ....-++++|.+++||| .+..++-++.+...++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            355788889999999999999875443 234432222     23446889999999999 77777777888889999999


Q ss_pred             ccCC-ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          143 YESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       143 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +.++ +-..........+..-+...+++.-.++++++|+..-+|+|    ||+..+ +..++.||+....+...      
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~------  384 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT------  384 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc------
Confidence            9887 33332222222344455666778888999999998778998    776655 67899999987654421      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                                 ....+..+++.++|||+.....+....|.|++|.-..++.-|.+|-..
T Consensus       385 -----------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  385 -----------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             -----------cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence                       124667899999999999999999999999999887788778777543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.32  E-value=1.6e-05  Score=72.59  Aligned_cols=125  Identities=27%  Similarity=0.362  Sum_probs=90.8

Q ss_pred             CCccccccccccCc-eEEEEEEECCeeEEEeecc---CCCh------------------HHHHHHHHHHHHHHhCC---C
Q 008220           66 SSYTLLSPIARGAE-SVVYEATLDGRKVAVKKPI---LSTS------------------EELDNFHKELQLLCKLD---H  120 (573)
Q Consensus        66 ~~y~~~~~lg~G~~-g~V~~~~~~~~~vavK~~~---~~~~------------------~~~~~~~~E~~~l~~l~---h  120 (573)
                      ..+++++.||.|.- |.||+++..|+.+|+|...   ....                  ...+.|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            68999999999999 9999999999999999811   1110                  12345788888877774   4


Q ss_pred             Ccc--ceeeecccc------------------CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008220          121 PGL--AKFVAAHAK------------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN  180 (573)
Q Consensus       121 pnI--v~l~~~~~~------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~  180 (573)
                      .++  ++++++..-                  ...+.||-||++...          .++.    .-+.+|++-|..+|.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK  182 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence            456  888887621                  123456777765532          1222    234677788888999


Q ss_pred             CCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          181 LGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       181 ~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                      .||+-+|+++.|..     .-||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999996     3489999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=3.4e-06  Score=74.33  Aligned_cols=133  Identities=22%  Similarity=0.256  Sum_probs=96.0

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcc-ceeeeccccCCceEEEEEecc
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~  144 (573)
                      ...+..+.|++|.+|.||+|.+.+..+|+|+-...  .....+..|+++|..+...++ ++++.+..+    ++.|||+.
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            34567789999999999999999999999984433  345678899999999987665 446665432    34599999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCceEEcCCCCCeEeeeecchhh
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK-PANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlk-p~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      |..|.+.-...    .    ++-+..+++.---|-..||-|+.|. |...++..++.+.|+||..|++-
T Consensus        96 G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98887654321    1    2234456666556677899999986 44444445558999999998643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.29  E-value=5.4e-06  Score=79.40  Aligned_cols=138  Identities=21%  Similarity=0.255  Sum_probs=82.5

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC--Cccceeeecc---ccCCceEEEEEeccC
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAAH---AKPPNYMFFFEFYES  145 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~---~~~~~~~lv~e~~~~  145 (573)
                      ++.|+.|..+.||++...+..+++|.....  .....+..|..+++.+..  ..+++++...   ......+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            457899999999999987789999985433  455677889999888842  2356666533   223457899999999


Q ss_pred             CChhh----------------hh---hccC---CCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 008220          146 RNLAE----------------KL---HVEE---WSPSVDQ---------VLMI------------AAQLAK-ALQYLHN-  180 (573)
Q Consensus       146 g~L~~----------------~l---~~~~---~~~~~~~---------~~~i------------~~qi~~-~l~~LH~-  180 (573)
                      ..+..                .+   +...   ..+....         ....            ...+.. .++.+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                11   1110   0111000         0000            111222 2333332 


Q ss_pred             ------CCceeccCCCCceEEc-CCCCCeEeeeecch
Q 008220          181 ------LGIVHRDVKPANVLLD-RNLCPHLADFGLAE  210 (573)
Q Consensus       181 ------~~iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~  210 (573)
                            ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                  3599999999999999 55656799999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=3.5e-05  Score=87.62  Aligned_cols=147  Identities=18%  Similarity=0.309  Sum_probs=92.5

Q ss_pred             cccccccCceEEEEEEECC----eeEEEeeccCCC-hHHHHHHHHHHHHHHhCC-CCcc--ceeeeccccC---CceEEE
Q 008220           71 LSPIARGAESVVYEATLDG----RKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGL--AKFVAAHAKP---PNYMFF  139 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv  139 (573)
                      ++.|+.|.++.+|+....+    ..+++|+..... ......+.+|+++|+.+. |++|  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            5678999999999987643    467888743322 123356889999999995 6654  7788877664   467899


Q ss_pred             EEeccCCChhhh-----------------------hhccCC---CC-----C----HHHHHHHHHH--------------
Q 008220          140 FEFYESRNLAEK-----------------------LHVEEW---SP-----S----VDQVLMIAAQ--------------  170 (573)
Q Consensus       140 ~e~~~~g~L~~~-----------------------l~~~~~---~~-----~----~~~~~~i~~q--------------  170 (573)
                      |||++|..+.+.                       |+.-..   .+     +    ..++..+..+              
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999988643211                       111110   00     0    1122211111              


Q ss_pred             -HHHHHHHHHh-----------CCceeccCCCCceEEcCC-CC-CeEeeeecchhhhhhhh
Q 008220          171 -LAKALQYLHN-----------LGIVHRDVKPANVLLDRN-LC-PHLADFGLAEYRENLKE  217 (573)
Q Consensus       171 -i~~~l~~LH~-----------~~iiH~Dlkp~Nill~~~-~~-~kL~Dfg~a~~~~~~~~  217 (573)
                       +...+.+|..           ..++|+|+++.|||++.+ +. +-|.||+++..-....+
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl~D  263 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQMCD  263 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChHHH
Confidence             2233455632           249999999999999853 33 57999999876655444

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.95  E-value=2.7e-05  Score=86.58  Aligned_cols=235  Identities=16%  Similarity=0.205  Sum_probs=151.5

Q ss_pred             ccccCceEEEEEEEC------CeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc----eEEEE
Q 008220           74 IARGAESVVYEATLD------GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN----YMFFF  140 (573)
Q Consensus        74 lg~G~~g~V~~~~~~------~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~lv~  140 (573)
                      |..-.+|+++...+.      -+++-++....+   ...++.....|++.+.++.|+|++.++.+......    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            555566667666541      122333321111   12344556677888888999999999887654322    22345


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC---ceEEcCCCCCeEe--eeecchhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA---NVLLDRNLCPHLA--DFGLAEYRENL  215 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~---Nill~~~~~~kL~--Dfg~a~~~~~~  215 (573)
                      ++|..-++...+..-. .++.++.+.+..++++||+|+|+....|.-+..+   +..++..+.+..+  ||+........
T Consensus       266 ~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~  344 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN  344 (1351)
T ss_pred             hhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCc
Confidence            7787778877776544 6788999999999999999999996655555444   4444556666655  88776544321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCc--hhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE--KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ..                 .....-+..+.+||.........  ..|+|.+|..+..+..|..+-.......        
T Consensus       345 ~~-----------------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~--------  399 (1351)
T KOG1035|consen  345 EK-----------------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV--------  399 (1351)
T ss_pred             cc-----------------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh--------
Confidence            11                 12223455677888776665544  4799999999999998765432110000        


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                       +.   ++.....+..+...+|+..++++|+++.+++.+......
T Consensus       400 -----------------~~---l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  400 -----------------SL---LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             -----------------hh---hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence                             00   111122267899999999999999999999988866543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.94  E-value=7.3e-05  Score=78.65  Aligned_cols=138  Identities=20%  Similarity=0.237  Sum_probs=89.5

Q ss_pred             ccccccCceEEEEEEE-CCeeEEEeeccCCChHH-------------------------------HH------HHHHHHH
Q 008220           72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEE-------------------------------LD------NFHKELQ  113 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~  113 (573)
                      +.|+.-+.|.|++|+. .|+.||||+.+..-...                               .+      .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5789999999999986 68899999743321110                               01      1444544


Q ss_pred             HHHhC----CCCc------cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 008220          114 LLCKL----DHPG------LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI  183 (573)
Q Consensus       114 ~l~~l----~hpn------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  183 (573)
                      ...+.    .|-+      |++++-.+  .....|+|||++|..+.|.-.-....++...+..-+.++..  +-|=..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            44333    3434      44444332  34678999999998877765444445666544333333222  22335689


Q ss_pred             eeccCCCCceEEcC----CCCCeEeeeecchhhh
Q 008220          184 VHRDVKPANVLLDR----NLCPHLADFGLAEYRE  213 (573)
Q Consensus       184 iH~Dlkp~Nill~~----~~~~kL~Dfg~a~~~~  213 (573)
                      +|.|=.|-||+++.    ++.+.+.|||+...+.
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999999984    6789999999986554

>TIGR02865 spore_II_E stage II sporulation protein E

Probab=97.93  E-value=7.1e-05  Score=83.48  Aligned_cols=116  Identities=11%  Similarity=-0.005  Sum_probs=81.2

Q ss_pred             eccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCC-CCChhHHHHHHHHHHHHHHHHHHH
Q 008220          436 TCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRPTDALLEAFIRTDVAFRNELD  514 (573)
Q Consensus       436 ~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~  514 (573)
                      .++.+..+.|.+.+...   +++..+++|+||+|+...|..++..+.+.+.+... ..+    ...++..+|..+.... 
T Consensus       560 ~k~g~~vsGD~y~~~~l---~~g~~~~~laDGmGhG~~Aa~~S~~~~~ll~~~~~~g~~----~~~ai~~lN~~L~~~~-  631 (764)
T TIGR02865       560 AKDGELVSGDSYSFGKL---SAGKYAVAISDGMGSGPEAAQESSACVRLLEKFLESGFD----REVAIKTVNSILSLRS-  631 (764)
T ss_pred             cCCCCcccCceEEEEEE---CCCEEEEEEEcccCCCHHHHHHHHHHHHHHHHHHHcCCC----HHHHHHHHHHHHHhCC-
Confidence            34557889999887654   24557889999999666666666666665544211 112    2455666666653221 


Q ss_pred             HhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          515 SLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       515 ~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                          ..       .+++|+.+++|+  .+.+.++|+|++++|+.|+|...+++..+.|
T Consensus       632 ----~~-------~~faTl~l~~IDl~~g~~~~~~aG~~p~~i~r~~~v~~i~s~~lP  678 (764)
T TIGR02865       632 ----TD-------EKFSTLDLSVIDLYTGQAEFVKVGAVPSFIKRGAKVEVIRSSNLP  678 (764)
T ss_pred             ----CC-------CeEEEEEEEEEECCCCeEEEEecCCCceEEEECCEEEEecCCCce
Confidence                11       248999999995  5789999999999999999998888877766

Stage II sporulation protein E (SpoIIE) is a multiple membrane spanning protein with two separable functions. It plays a role in the switch to polar cell division during sporulation. By means of it protein phosphatase activity, located in the C-terminal region, it activates sigma-F. All proteins that score above the trusted cutoff to this model are found in endospore-forming Gram-positive bacteria. Surprisingly, a sequence from the Cyanobacterium-like (and presumably non-spore-forming) photosynthesizer Heliobacillus mobilis is homologous, and scores between the trusted and noise cutoffs.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=9.8e-05  Score=70.91  Aligned_cols=73  Identities=15%  Similarity=0.258  Sum_probs=46.5

Q ss_pred             ccccccCce-EEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC---ccceeeeccccC---CceEEEEEecc
Q 008220           72 SPIARGAES-VVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKFVAAHAKP---PNYMFFFEFYE  144 (573)
Q Consensus        72 ~~lg~G~~g-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~e~~~  144 (573)
                      +.|+.|+.. .||+.   +..+++|.....  .....+.+|++++..+...   .++.++......   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            456766666 58876   345778864332  2345788999999888532   355555554332   23578999999


Q ss_pred             CCChh
Q 008220          145 SRNLA  149 (573)
Q Consensus       145 ~g~L~  149 (573)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.79  E-value=4.3e-05  Score=73.85  Aligned_cols=132  Identities=20%  Similarity=0.210  Sum_probs=97.0

Q ss_pred             ccccccccccCceEEEEEEE-CCeeEEEeeccCCCh--------H--------------HHHHHHHHHHHHHhCCC--Cc
Q 008220           68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS--------E--------------ELDNFHKELQLLCKLDH--PG  122 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--------~--------------~~~~~~~E~~~l~~l~h--pn  122 (573)
                      +.++.+||-|--+.||.+-+ .|++.++|.......        .              .+-...+|...|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56788999999999999987 589999995322110        0              01124578888888842  23


Q ss_pred             cceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       123 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      |++.+++    +..++|||++.|-.|...-+...       +..+...+..-+.-|..+|+||+|..-=||+++.++.++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d-------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVED-------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecCC-------hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            5555554    56789999999988866543322       234555666677788999999999999999999999999


Q ss_pred             Eeeeecch
Q 008220          203 LADFGLAE  210 (573)
Q Consensus       203 L~Dfg~a~  210 (573)
                      ++||-.+.
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99998663

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.76  E-value=0.00018  Score=70.06  Aligned_cols=134  Identities=16%  Similarity=0.200  Sum_probs=79.3

Q ss_pred             cccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc-cceeeeccccCCceEEEEEeccCCChhhh
Q 008220           73 PIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEFYESRNLAEK  151 (573)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  151 (573)
                      .+..|-.+.+|+....++.+++|........-.-...+|..+++.+.... .++++....    -++|+||++|..+...
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            35568888999998888889999743322111012467899999885432 344554432    3689999998665321


Q ss_pred             -----------------hhccC---CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccCCCCce
Q 008220          152 -----------------LHVEE---WSPSV-DQVLMIAAQL---------AKALQYLHN--------LGIVHRDVKPANV  193 (573)
Q Consensus       152 -----------------l~~~~---~~~~~-~~~~~i~~qi---------~~~l~~LH~--------~~iiH~Dlkp~Ni  193 (573)
                                       ++...   ..++. ..+..+..++         ...+..+-.        ..++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111   11121 1122222111         111222211        2489999999999


Q ss_pred             EEcCCCCCeEeeeecchh
Q 008220          194 LLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~  211 (573)
                      +++.++ +.|+||+.+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 79999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.75  E-value=0.00011  Score=67.65  Aligned_cols=101  Identities=20%  Similarity=0.153  Sum_probs=80.0

Q ss_pred             HHHHHHHHhCCC-CccceeeeccccCCceEEEEEeccCCChhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 008220          109 HKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHN---LG  182 (573)
Q Consensus       109 ~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~  182 (573)
                      ..|.-+|+.+++ +++++++|+|-    .+++.||...+++......  .-...++..+.+++.++++.+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888899976 69999999983    3678999987766432100  11246889999999999999999987   34


Q ss_pred             ceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       183 iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +.-.|++|+|+-++.+|.+|++|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7778999999999999999999999876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.66  E-value=5.2e-05  Score=82.13  Aligned_cols=128  Identities=23%  Similarity=0.424  Sum_probs=98.4

Q ss_pred             CCcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHH
Q 008220          426 YPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIR  504 (573)
Q Consensus       426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~  504 (573)
                      ...+++|++..-|.|..+==+.+...++.. .....||++||-+-.....++...+..++.++. ..++-.+.|+.+|..
T Consensus       519 ~~~~t~Gv~~~~gqrnk~c~~~~~v~nf~~-~~~a~~g~~dgs~n~~v~~~vq~~ma~~L~eev~~~~~et~~mr~~fl~  597 (1081)
T KOG0618|consen  519 AFLWTYGVAGVSGQRNKVCSRAVWVENFFL-NPQATFGCFDGSRNSRVLSLVQDTMASYLAEEVQLYGNETEQMRNTFLR  597 (1081)
T ss_pred             eeheeeccchhcccccchhhhhhhhhhccc-CCcceEEEEcCCCchhHHHHHHHHHHHHHHHHHHhccChHHHHHHHHHH
Confidence            345569999999998887666665566553 445689999999999999999999999988763 344556669999999


Q ss_pred             HHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECC--------eEEEEEccccceeEEeCCeeeeCCCC
Q 008220          505 TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN--------RLFVANAGDCRAILCRGGHPFALSRV  567 (573)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~--------~l~vanvGDSRa~l~~~~~~~~lt~d  567 (573)
                      .++++-+...             .-|..++.+.|..+        ++++||||+|-|++|++|+..++|+-
T Consensus       598 ~~rklg~~g~-------------~lg~~~~~~~i~~d~~~~asS~~l~~Anvg~c~avls~ng~~~p~t~~  655 (1081)
T KOG0618|consen  598 LNRKLGEEGQ-------------VLGGSVVLCQIVEDSLSPASSKTLFAANVGTCMAVLSRNGKPLPTTRS  655 (1081)
T ss_pred             Hhhhhhhhhc-------------cccchhhheeecccccCcccchhhhHhhhccchhhhhhcCCcCccccc
Confidence            9998833321             13666677776654        78999999999999999998887764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00039  Score=66.67  Aligned_cols=73  Identities=19%  Similarity=0.198  Sum_probs=47.7

Q ss_pred             cccccccCceEEEEEEEC---CeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEeccCC
Q 008220           71 LSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      ++.|..|-...+|++...   ++.|++|+...... ..-...+|+.+++.+. +.-.++++..+..    .++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence            356778888899999764   57888997543221 1122347888888884 3334556554432    3799999986


Q ss_pred             Ch
Q 008220          147 NL  148 (573)
Q Consensus       147 ~L  148 (573)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.64  E-value=0.00067  Score=62.67  Aligned_cols=128  Identities=20%  Similarity=0.269  Sum_probs=88.4

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCC----------------hHHHHHHHHHHHHHHhCC------CCccceeee
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILST----------------SEELDNFHKELQLLCKLD------HPGLAKFVA  128 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~l~~  128 (573)
                      ...||+|+.-.||.-- .+...+||+.....                ........+|+.....+.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            3578999999998642 23456777654443                112345566776666665      788999999


Q ss_pred             ccccCCceEEEEEeccC------CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---
Q 008220          129 AHAKPPNYMFFFEFYES------RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---  199 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---  199 (573)
                      +.+++.-.-+|+|.+..      .+|.+++...  .++. .   +...+-+-..||-+.+|+.+|++|.||++....   
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            99999999999998743      2577777433  3443 3   333444555688899999999999999996433   


Q ss_pred             -CCeEee
Q 008220          200 -CPHLAD  205 (573)
Q Consensus       200 -~~kL~D  205 (573)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             466777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.54  E-value=0.00067  Score=67.59  Aligned_cols=137  Identities=23%  Similarity=0.207  Sum_probs=84.2

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC--ccceeeecc------ccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH------AKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~------~~~~~~~lv~e~  142 (573)
                      .+.|..|....+|+....+..+++|+...   .....+..|+.++..|.+.  .+++++...      ...+..++|+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            55677788889999877777899997543   2234566788888888432  245554421      224467899999


Q ss_pred             ccCCChhh--------------hhhccCCCC----------CHHHH--H--------HHHHHHHHHHHHHHh-------C
Q 008220          143 YESRNLAE--------------KLHVEEWSP----------SVDQV--L--------MIAAQLAKALQYLHN-------L  181 (573)
Q Consensus       143 ~~~g~L~~--------------~l~~~~~~~----------~~~~~--~--------~i~~qi~~~l~~LH~-------~  181 (573)
                      ++|..+..              .++.....+          .+...  .        .....+..++.++.+       .
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99866432              011100000          00000  0        011112334444443       3


Q ss_pred             CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          182 GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       182 ~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      +++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            79999999999999998777899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.47  E-value=0.00065  Score=68.09  Aligned_cols=139  Identities=24%  Similarity=0.269  Sum_probs=82.4

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC--ccceeeecc------ccCCceEEEEE
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH------AKPPNYMFFFE  141 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~------~~~~~~~lv~e  141 (573)
                      .++.++.|....+|+....+..+++|+.....  ..+.+..|++++..|...  .+++++...      ...+..+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            35667888888999987666678888743321  123445677777777322  244544421      12456789999


Q ss_pred             eccCCChhh--------------hhhccCCCC-----------CHHHHH------------HHHHHHHHHHHHHHh----
Q 008220          142 FYESRNLAE--------------KLHVEEWSP-----------SVDQVL------------MIAAQLAKALQYLHN----  180 (573)
Q Consensus       142 ~~~~g~L~~--------------~l~~~~~~~-----------~~~~~~------------~i~~qi~~~l~~LH~----  180 (573)
                      |++|..+..              .++.....+           .+....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321              012110000           000000            011123334555542    


Q ss_pred             ---CCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          181 ---LGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       181 ---~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                         .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               589999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.37  E-value=0.0034  Score=64.44  Aligned_cols=74  Identities=16%  Similarity=0.093  Sum_probs=53.5

Q ss_pred             cccccccCceEEEEEEECC--eeEEEeeccCC-----C--hHHHHHHHHHHHHHHhCC---CCccceeeeccccCCceEE
Q 008220           71 LSPIARGAESVVYEATLDG--RKVAVKKPILS-----T--SEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l  138 (573)
                      .+.||.|.+..||++...+  +.++||.....     .  ....++...|.+.|+.+.   ..++++++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4578999999999998754  48999973211     1  123556777888888863   3468888887  4466889


Q ss_pred             EEEeccCC
Q 008220          139 FFEFYESR  146 (573)
Q Consensus       139 v~e~~~~g  146 (573)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998764

>PRK05231 homoserine kinase; Provisional

Probab=97.35  E-value=0.0033  Score=63.38  Aligned_cols=137  Identities=20%  Similarity=0.185  Sum_probs=76.5

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC--Cccceeeec------cccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAA------HAKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~------~~~~~~~~lv~e~  142 (573)
                      .+.|+.|....+|+....+..+++|+.....   .+.+..|+.++..|..  -.+++.+..      ....+..+++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567778888999998766688999754212   2334456666666531  123343321      1224567899999


Q ss_pred             ccCCChhh-----------h---hhccCCCC--------C--H-HHHH------------HHHHH-HHHHHHHHH-----
Q 008220          143 YESRNLAE-----------K---LHVEEWSP--------S--V-DQVL------------MIAAQ-LAKALQYLH-----  179 (573)
Q Consensus       143 ~~~g~L~~-----------~---l~~~~~~~--------~--~-~~~~------------~i~~q-i~~~l~~LH-----  179 (573)
                      ++|..+..           .   ++.....+        .  + ....            ..+.+ +-..++.+.     
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            98864311           1   11110000        0  1 1100            11111 111222222     


Q ss_pred             --hCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          180 --NLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       180 --~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                        ..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              2389999999999999876556899999874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.31  E-value=0.0011  Score=66.27  Aligned_cols=73  Identities=29%  Similarity=0.284  Sum_probs=46.7

Q ss_pred             ccccccCceEEEEEEEC--------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC-ccceeeeccccCCceEEEEEe
Q 008220           72 SPIARGAESVVYEATLD--------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHP-GLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +.|..|-...||+....        ++.+++|+..... .......+|.++++.+... -.++++..+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            45566777789988754        4788999844332 2233456888888888532 24556666542    358899


Q ss_pred             ccCCChh
Q 008220          143 YESRNLA  149 (573)
Q Consensus       143 ~~~g~L~  149 (573)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            8886553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.28  E-value=0.003  Score=62.48  Aligned_cols=144  Identities=20%  Similarity=0.261  Sum_probs=91.5

Q ss_pred             ccccccccccCceEEEEEEECCeeEEEeecc-CCChHHHHHHHHHHHHHHhCCC--CccceeeeccccCC--ceEEEEEe
Q 008220           68 YTLLSPIARGAESVVYEATLDGRKVAVKKPI-LSTSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPP--NYMFFFEF  142 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~e~  142 (573)
                      ..+++.+..|....+|....+++++++.+.. ...........+|+.+++.+.-  .-+...++.+.++.  ..+.||+|
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDTGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             CceeeeccCCcccceEEEecCCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            4455555555555667776668888888432 2344556677889999988843  34455566666555  67999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHH-HHHHHHHHHH------------------------------------------
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAA-QLAKALQYLH------------------------------------------  179 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~-qi~~~l~~LH------------------------------------------  179 (573)
                      +.|..+.+.+....      ....++. .+...|+.||                                          
T Consensus       107 veGe~~~~~~~~~~------~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         107 VEGEVVWSALPPES------LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ecceeccCcCCccc------chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            99854433221110      0011111 3344444444                                          


Q ss_pred             --------hC--------CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          180 --------NL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       180 --------~~--------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                              .+        .++|+|+.+.|++++..+.+-|.||+++..-....+
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D  234 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED  234 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence                    22        489999999999999999999999999876554443

>PF07228 SpoIIE: Stage II sporulation protein E (SpoIIE); InterPro: IPR001932 This domain is found in protein phosphatase 2C, as well as other proteins eg

Probab=97.19  E-value=0.004  Score=57.56  Aligned_cols=99  Identities=19%  Similarity=0.065  Sum_probs=62.2

Q ss_pred             CceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEE
Q 008220          457 KEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIA  535 (573)
Q Consensus       457 ~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~  535 (573)
                      ++..+++|+|+.|..-.|.+.+..+...+.... ...+    ..+.+..+++.+.......           ..++|+++
T Consensus         2 ~~~~~~~v~D~~GhG~~aa~~~~~~~~~~~~~~~~~~~----p~~~l~~ln~~l~~~~~~~-----------~~~~t~~~   66 (193)
T PF07228_consen    2 DGRYFIIVGDVSGHGVSAALLSAALASAIRELLDEGLD----PEELLEALNRRLYRDLKGD-----------NRYATACY   66 (193)
T ss_dssp             TTEEEEEEEEESSSSHHHHHHHHHHHHHHHHHHHTTTS----HHHHHHHHHHHHHHHTTTT-----------STTEEEEE
T ss_pred             CCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHHcCCC----HHHHHHHHHHHHHHHhhhc-----------cccceEEE
Confidence            346788999999955555555555555544331 1112    4555556666664433221           14889998


Q ss_pred             EEEE--CCeEEEEEccccceeEEeC--CeeeeCCCCCCC
Q 008220          536 ALIV--RNRLFVANAGDCRAILCRG--GHPFALSRVRQE  570 (573)
Q Consensus       536 ~~i~--~~~l~vanvGDSRa~l~~~--~~~~~lt~dH~p  570 (573)
                      +.+.  .+.++++|+|+++++++++  +....+.....|
T Consensus        67 ~~~d~~~~~l~~~~aG~~~~l~~~~~~~~~~~~~~~~~~  105 (193)
T PF07228_consen   67 AIIDPETGTLTYANAGHPPPLLLRPGGREIEQLESEGPP  105 (193)
T ss_dssp             EEEETTTTEEEEEEESSSEEEEEETTCTEEEEETCSSBB
T ss_pred             EEecccceEEEEeCCCCCCEEEEeccccceeecccCccc
Confidence            8876  4589999999999999998  445555444333

pyruvate dehydrogenase (lipoamide)-phosphatase (3.1.3.43 from EC), adenylate cyclase (4.6.1.1 from EC) and some bacterial stage II sporulation E proteins (3.1.3.16 from EC). Protein phosphatase 2C (PP2C) is one of the four major classes of mammalian serine/threonine specific protein phosphatases (3.1.3.16 from EC). PP2C [] is a monomeric enzyme of about 42 Kd which shows broad substrate specificity and is dependent on divalent cations (mainly manganese and magnesium) for its activity. Its exact physiological role is still unclear. Three isozymes are currently known in mammals: PP2C-alpha, -beta and -gamma. In yeast, there are at least four PP2C homologs: phosphatase PTC1 [], which has weak tyrosine phosphatase activity in addition to its activity on serines, phosphatases PTC2 and PTC3, and hypothetical protein YBR125c. Isozymes of PP2C are also known from Arabidopsis thaliana (ABI1, PPH1), Caenorhabditis elegans (FEM-2, F42G9.1, T23F11.1), Leishmania chagasi and Paramecium tetraurelia. In A. thaliana, the kinase associated protein phosphatase (KAPP) [] is an enzyme that dephosphorylates the Ser/Thr receptor-like kinase RLK5 and which contains a C-terminal PP2C domain. PP2C does not seem to be evolutionary related to the main family of serine/ threonine phosphatases: PP1, PP2A and PP2B. However, it is significantly similar to the catalytic subunit of pyruvate dehydrogenase phosphatase 3.1.3.43 from EC (PDPC) [], which catalyzes dephosphorylation and concomitant reactivation of the alpha subunit of the E1 component of the pyruvate dehydrogenase complex. PDPC is a mitochondrial enzyme and, like PP2C, is magnesium-dependent.; GO: 0003824 catalytic activity; PDB: 3KE6_B 3ZT9_A 3RNR_A 3EQ2_A 3F7A_B 3F79_A 3ES2_B 3PU9_B 3T91_B 3T9Q_B ....

>PLN02236 choline kinase

Probab=97.04  E-value=0.0047  Score=62.76  Aligned_cols=135  Identities=19%  Similarity=0.299  Sum_probs=79.0

Q ss_pred             ccccccCceEEEEEEEC------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc-cceeeeccccCCceEEEEEecc
Q 008220           72 SPIARGAESVVYEATLD------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      ..|..|-...+|++...      ++.|++|..........++ .+|..+++.+..-+ -+++++.+..+    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            34545888899998742      3678999754433222232 67899998885333 34566666433    5789987


Q ss_pred             CCChhhh-----------------hhccCCC----C-CHHHHHHHHHHH-----------------HHHHHHH----H--
Q 008220          145 SRNLAEK-----------------LHVEEWS----P-SVDQVLMIAAQL-----------------AKALQYL----H--  179 (573)
Q Consensus       145 ~g~L~~~-----------------l~~~~~~----~-~~~~~~~i~~qi-----------------~~~l~~L----H--  179 (573)
                      +.++...                 +|....+    + ..+++..++.++                 ...+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7655311                 1211111    1 123333332221                 1111122    1  


Q ss_pred             --hCCceeccCCCCceEEcC-CCCCeEeeeecchh
Q 008220          180 --NLGIVHRDVKPANVLLDR-NLCPHLADFGLAEY  211 (573)
Q Consensus       180 --~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~  211 (573)
                        ...++|+|+++.|||++. ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              225899999999999986 46899999998753

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.99  E-value=0.00014  Score=82.87  Aligned_cols=158  Identities=13%  Similarity=0.001  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHhCCCCccceeeecccc--CCceEEEEEeccCCChhhhhhccCCC---CCHHHHHHHHHHHHHHHHHHHh
Q 008220          106 DNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFFEFYESRNLAEKLHVEEWS---PSVDQVLMIAAQLAKALQYLHN  180 (573)
Q Consensus       106 ~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~LH~  180 (573)
                      +....|.+.++...|+++.....-...  ...-+.+++++.+|.+.+.+.+....   +...-+.....+.+....-+|.
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            334456666667789998877665443  34567889999999999998654322   2222333333333666666665


Q ss_pred             C-----CceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC
Q 008220          181 L-----GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH  255 (573)
Q Consensus       181 ~-----~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  255 (573)
                      .     -.+|++||+-|.+|..+.++|+.++|+.+.......                ..+...+++.|+.|++...-.+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s----------------f~Gl~l~sp~~v~qli~N~ik~ 1417 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS----------------FFGLELCSPIYVLQLIKNEIKF 1417 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHh----------------hhhhhhCCHHHHHHHHHHHHhh
Confidence            4     268999999999999999999999999984432221                2456678899999999988888


Q ss_pred             CchhhHHHHHHHHHHHHcCCCCCC
Q 008220          256 SEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       256 ~~~~DiwslG~il~elltg~~Pf~  279 (573)
                      +.++|+|..|+.+|+..-|..+|-
T Consensus      1418 t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1418 TKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             hhHHHHHHHHHHHHHHhcccHHHH
Confidence            888999999999999999988874

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.0093  Score=58.57  Aligned_cols=31  Identities=29%  Similarity=0.494  Sum_probs=25.6

Q ss_pred             CceeccCCCCceEEcCCCC-CeEeeeecchhh
Q 008220          182 GIVHRDVKPANVLLDRNLC-PHLADFGLAEYR  212 (573)
Q Consensus       182 ~iiH~Dlkp~Nill~~~~~-~kL~Dfg~a~~~  212 (573)
                      .++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997555 459999988543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.83  E-value=0.0038  Score=64.28  Aligned_cols=166  Identities=22%  Similarity=0.321  Sum_probs=101.5

Q ss_pred             HHHHHHHHHHhCCCCccceeeecccc-CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008220          107 NFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH  185 (573)
Q Consensus       107 ~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH  185 (573)
                      ++......++.+.|+|...++++... .....+|+|++ +.+|.+.+....  +-...       ++       .+++.|
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~~-------~~~~~~   90 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------LL-------AHGVLH   90 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------hc-------ccccce
Confidence            45566788999999999999998764 34577889988 459999886543  11111       11       223322


Q ss_pred             ccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHH
Q 008220          186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG  265 (573)
Q Consensus       186 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  265 (573)
                      -.            ..+.+| -++..                                |  |     .+..+++||||+|
T Consensus        91 ~~------------~~~~td-~~~t~--------------------------------~--~-----~~~~pKsdVwsl~  118 (725)
T KOG1093|consen   91 LN------------IIYITD-HFLTK--------------------------------Y--P-----SPIGPKSDVWSLG  118 (725)
T ss_pred             eh------------hhhccc-ccccc--------------------------------C--C-----CCCCcchhhhhHH
Confidence            21            123333 11100                                0  0     0112499999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       266 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                      .++.++..|...|...........+......+..........       .....++.-+.++.+.|+...|..||...++
T Consensus       119 ~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  119 FIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH-------LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-------HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            999999999988887766655555544333333222111111       0112456778899999999999999977766


Q ss_pred             HHH
Q 008220          346 ALE  348 (573)
Q Consensus       346 l~~  348 (573)
                      .++
T Consensus       192 ~k~  194 (725)
T KOG1093|consen  192 SKR  194 (725)
T ss_pred             hcC
Confidence            543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	573
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-25
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-25
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-25
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-25
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-25
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-25
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-25
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-25
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-25
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-21
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-21
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-21
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-20
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-20
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-20
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-20
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-20
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-19
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-18
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-18
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-14
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-13
3soa_A	444	Full-Length Human Camkii Length = 444		9e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-13
2i0o_A	304	Crystal Structure Of Anopheles Gambiae SerTHR PHOSP		9e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-12
3nmv_B	324	Crystal Structure Of Pyrabactin-Bound Abscisic Acid		8e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
3kdj_B	316	Complex Structure Of (+)-Aba-Bound Pyl1 And Abi1 Le		2e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
3nmn_B	319	Crystal Structure Of Pyrabactin-Bound Abscisic Acid		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-10
3jrq_A	326	Crystal Structure Of (+)-aba-bound Pyl1 In Complex		3e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-08
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		8e-08
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		8e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-07
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
4da1_A	389	Crystal Structure Of Branched-Chain Alpha-Ketoacid		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-07
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-07
2iq1_A	274	Crystal Structure Of Human Ppm1k Length = 274		3e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-07
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 134/293 (45%), Gaps = 43/293 (14%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLC 116
           + +P     +   I  G+   V+ A   G  VAVK  IL      +E ++ F +E+ ++ 
Sbjct: 32  MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK--ILMEQDFHAERVNEFLREVAIMK 89
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV--LMIAAQLAKA 174
           +L HP +  F+ A  +PPN     E+    +L   LH       +D+   L +A  +AK 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 175 LQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + YLHN    IVHRD+K  N+L+D+     + DFGL+                  K +  
Sbjct: 150 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL----------------KASXF 193
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
              K   GT  +MAPE+L+ E  +EKSDVYSFG+ + EL T   P+ +L           
Sbjct: 194 LXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL----------- 242
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 Q+ AAV   G +     +   L   + ++I+ CW   P  RPSF+ I
Sbjct: 243 ---NPAQVVAAV---GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 135/293 (46%), Gaps = 43/293 (14%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLC 116
           + +P     +   I  G+   V+ A   G  VAVK  IL      +E ++ F +E+ ++ 
Sbjct: 32  MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK--ILMEQDFHAERVNEFLREVAIMK 89
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV--LMIAAQLAKA 174
           +L HP +  F+ A  +PPN     E+    +L   LH       +D+   L +A  +AK 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 175 LQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + YLHN    IVHR++K  N+L+D+     + DFGL+                  K +  
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL----------------KASTF 193
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
              K+  GT  +MAPE+L+ E  +EKSDVYSFG+ + EL T   P+ +L           
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL----------- 242
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 Q+ AAV   G +     +   L   + ++I+ CW   P  RPSF+ I
Sbjct: 243 ---NPAQVVAAV---GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 9   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 67
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH  E    + +++ IA Q A+ + YLH 
Sbjct: 68  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +    + DFGLA  +          W      +G    + + G
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 172
Query: 241 TLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++ +    +S +SDVY+FGI + EL+TG +PY+++    Q   ++EM    
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM---- 225
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                 V  G L P L+ +    P  +  L+  C       RPSF  I  E++
Sbjct: 226 ------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 138/293 (47%), Gaps = 34/293 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH  E    + +++ IA Q A+ + YLH 
Sbjct: 80  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +    + DFGLA  +          W      +G    + + G
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS--------RW------SGSHQFEQLSG 184
Query: 241 TLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++ +    +S +SDVY+FGI + EL+TG +PY+++    Q   ++EM    
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM---- 237
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                 V  G L P L+ +    P  +  L+  C       RPSF  I  E++
Sbjct: 238 ------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 139/293 (47%), Gaps = 34/293 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+  ++  P      ++ E  +L   LH  E    + +++ IA Q A+ + YLH 
Sbjct: 80  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +    + DFGLA  +          W      +G    + + G
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS--------RW------SGSHQFEQLSG 184
Query: 241 TLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++ +    +S +SDVY+FGI + EL+TG +PY+++    Q   ++EM    
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM---- 237
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                 V  G L P L+ +    P  +  L+  C       RPSF  I  E++
Sbjct: 238 ------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 33  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 92  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 196
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 243
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 32  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 90
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 91  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 195
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 242
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 243 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 140/303 (46%), Gaps = 34/303 (11%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKEL 112
           S  S    +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
            +L K  H  +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + + YLH   I+HRD+K  N+ L  +L   + DFGLA  +          W      +G 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGS 165
Query: 233 FHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
              + + G++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++        
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------- 218
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                    Q+   V  G L P L+ +    P ++  L+  C       RP F  I   +
Sbjct: 219 ------NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272
Query: 350 DLV 352
           +L+
Sbjct: 273 ELL 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 140/303 (46%), Gaps = 34/303 (11%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKEL 112
           S  S    +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+
Sbjct: 2   SDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
            +L K  H  +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 119
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + + YLH   I+HRD+K  N+ L  +L   + DFGLA  +          W      +G 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGS 165
Query: 233 FHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
              + + G++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++        
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------- 218
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                    Q+   V  G L P L+ +    P ++  L+  C       RP F  I   +
Sbjct: 219 ------NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272
Query: 350 DLV 352
           +L+
Sbjct: 273 ELL 275

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 25  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 83
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 84  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS--------RW------SGSHQFEQLSG 188
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 189 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 235
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 236 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 33  IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 92  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS--------RW------SGSHQFEQLSG 196
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 243
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 244 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 7   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 65
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 66  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 170
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 171 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 217
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 218 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 64  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 168
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 215
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    KP       ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 64  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKS--------RW------SGSHQFEQLSG 168
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 215
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 34/295 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK   ++  T ++L  F  E+ +L K  H
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+  ++  P      ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA  +          W      +G    + + G
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS--------RW------SGSHQFEQLSG 168
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 215
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 135/302 (44%), Gaps = 52/302 (17%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVK----KPILSTSEELDNFHKELQLLCKLDHP 121
           +  TL   I  G    VY A   G +VAVK     P    S+ ++N  +E +L   L HP
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN- 180
            +        K PN     EF     L   L  +   P  D ++  A Q+A+ + YLH+ 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARGMNYLHDE 124
Query: 181 --LGIVHRDVKPANVLLDR--------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
             + I+HRD+K +N+L+ +        N    + DFGLA           + W  + K +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----------REWHRTTKMS 173
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
                    G   +MAPE+++  + S+ SDV+S+G+ + ELLTG VP+  +   A A+ V
Sbjct: 174 AA-------GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
             MN     + +                  P     L++ CW+ +PH+RPSF++I  +L 
Sbjct: 227 -AMNKLALPIPSTC----------------PEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
Query: 351 LV 352
            +
Sbjct: 270 TI 271

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
           +  S   L + I  G+   VY+    G  VAVK  K +  T E+   F  E+ +L K  H
Sbjct: 33  IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+    K  N     ++ E  +L + LHV+E    + Q++ IA Q A+ + YLH 
Sbjct: 92  VNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L   L   + DFGLA  +          W      +G    +   G
Sbjct: 151 KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS--------RW------SGSQQVEQPTG 196
Query: 241 TLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++ + +   S +SDVYS+GI + EL+TG +PY+ +                
Sbjct: 197 SVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-------------NR 243
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
            Q+   V  G   P L+ L    P ++  L+  C       RP F  I   ++L L+H
Sbjct: 244 DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL-LQH 300

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 138/298 (46%), Gaps = 62/298 (20%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSE-------ELDNFHKELQLLCKLDHPGLA 124
           I +G   +V++  L  D   VA+K  IL  SE       +   F +E+ ++  L+HP + 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 125 KFVAAHAKPPNYMFFF----EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           K       PP  +  F    + Y    L +K H  +WS  +  +L IA      ++Y+ N
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLY--HRLLDKAHPIKWSVKLRLMLDIAL----GIEYMQN 140
Query: 181 LG--IVHRDVKPANVLL---DRN--LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
               IVHRD++  N+ L   D N  +C  +ADFGL++  +++  +S              
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVS-------------- 184
Query: 234 HKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
               ++G   +MAPE +  ++E ++EK+D YSF + +  +LTG  P+             
Sbjct: 185 ---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------------ 229
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
           E +Y + +    +   GLRP +       P  + ++I+ CW G+P  RP FS I  EL
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 45/279 (16%)
Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133
           + RGA  VV +A    + VA+K+  + +  E   F  EL+ L +++HP + K   A   P
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 134 PNYMFFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKALQYLHNL---GIVHRDV 188
                  E+ E  +L   LH  E  P  +    +    Q ++ + YLH++    ++HRD+
Sbjct: 74  --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 189 KPANVLL-DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           KP N+LL        + DFG A   +                    H  N  G+  +MAP
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQT-------------------HMTNNKGSAAWMAP 172
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307
           E+ +   +SEK DV+S+GI + E++T   P+ ++   A             ++  AV +G
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------------FRIMWAVHNG 220
Query: 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              P++ +    LP  I SL+ RCW  +P  RPS  +I 
Sbjct: 221 TRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 45/279 (16%)
Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133
           + RGA  VV +A    + VA+K+  + +  E   F  EL+ L +++HP + K   A   P
Sbjct: 17  VGRGAFGVVCKAKWRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 74
Query: 134 PNYMFFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKALQYLHNL---GIVHRDV 188
                  E+ E  +L   LH  E  P  +    +    Q ++ + YLH++    ++HRD+
Sbjct: 75  --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 132
Query: 189 KPANVLL-DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           KP N+LL        + DFG A   +                    H  N  G+  +MAP
Sbjct: 133 KPPNLLLVAGGTVLKICDFGTACDIQT-------------------HMTNNKGSAAWMAP 173
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307
           E+ +   +SEK DV+S+GI + E++T   P+ ++   A             ++  AV +G
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------------FRIMWAVHNG 221
Query: 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              P++ +    LP  I SL+ RCW  +P  RPS  +I 
Sbjct: 222 TRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 36/273 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 101
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 102 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 162 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 206
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 207 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 248
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
           +CW  +P  RP F+++  +L  +LE  K+ +EE
Sbjct: 249 KCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 281

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 36/273 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 102
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 103 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 163 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 207
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 208 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 249
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
           +CW  +P  RP F+++  +L  +LE  K+ +EE
Sbjct: 250 KCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 282

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 36/273 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 96
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 97  FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 157 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 201
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 202 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 243
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
           +CW  +P  RP F+++  +L  +LE  K+ +EE
Sbjct: 244 KCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE 276

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 62/298 (20%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSE-------ELDNFHKELQLLCKLDHPGLA 124
           I +G   +V++  L  D   VA+K  IL  SE       +   F +E+ ++  L+HP + 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 125 KFVAAHAKPPNYMFFF----EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           K       PP  +  F    + Y    L +K H  +WS  +  +L IA      ++Y+ N
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLY--HRLLDKAHPIKWSVKLRLMLDIAL----GIEYMQN 140
Query: 181 LG--IVHRDVKPANVLL---DRN--LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
               IVHRD++  N+ L   D N  +C  +ADFG ++  +++  +S              
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVS-------------- 184
Query: 234 HKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
               ++G   +MAPE +  ++E ++EK+D YSF + +  +LTG  P+             
Sbjct: 185 ---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------------ 229
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
           E +Y + +    +   GLRP +       P  + ++I+ CW G+P  RP FS I  EL
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 68  YTLLSPIARGAESVVY--EATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHPG 122
           Y ++  +  G  S VY  E T+   KVA+K    P     E L  F +E+    +L H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNL 181
           +   +    +   Y    E+ E   L+E  ++E   P SVD  +    Q+   +++ H++
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            IVHRD+KP N+L+D N    + DFG+A+    L E SL                +++GT
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTN------------HVLGT 175
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           + Y +PE  K E   E +D+YS GI + E+L G  P+          T + +     Q +
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF-------NGETAVSIAIKHIQDS 228
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
              V+  +R         +P S+ ++I R  + +  NR
Sbjct: 229 VPNVTTDVRK-------DIPQSLSNVILRATEKDKANR 259

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 62/298 (20%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSE-------ELDNFHKELQLLCKLDHPGLA 124
           I +G   +V++  L  D   VA+K  IL  SE       +   F +E+ ++  L+HP + 
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 125 KFVAAHAKPPNYMFFF----EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           K       PP  +  F    + Y    L +K H  +WS  +  +L IA      ++Y+ N
Sbjct: 87  KLYGLMHNPPRMVMEFVPCGDLY--HRLLDKAHPIKWSVKLRLMLDIAL----GIEYMQN 140
Query: 181 LG--IVHRDVKPANVLL---DRN--LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
               IVHRD++  N+ L   D N  +C  +ADF L++  +++  +S              
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVS-------------- 184
Query: 234 HKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
               ++G   +MAPE +  ++E ++EK+D YSF + +  +LTG  P+             
Sbjct: 185 ---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD------------ 229
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
           E +Y + +    +   GLRP +       P  + ++I+ CW G+P  RP FS I  EL
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 74  IARGAESVVYEATLDGRKVAVKK---PILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAA 129
           +  G   VVY+  ++   VAVKK    +  T+EEL   F +E++++ K  H  L + +  
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRD 187
            +   +    + +  + +L ++L   + +P +       IA   A  + +LH    +HRD
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +K AN+LLD      ++DFGLA              R+S K         +VGT  YMAP
Sbjct: 159 IKSANILLDEAFTAKISDFGLA--------------RASEKFAQTVMXSRIVGTTAYMAP 204
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
           E L+ EI + KSD+YSFG+ + E++TG +P  D   E Q
Sbjct: 205 EALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQ 241

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 74  IARGAESVVYEATLDGRKVAVKK---PILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAA 129
           +  G   VVY+  ++   VAVKK    +  T+EEL   F +E++++ K  H  L + +  
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRD 187
            +   +    + +  + +L ++L   + +P +       IA   A  + +LH    +HRD
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +K AN+LLD      ++DFGLA              R+S K         +VGT  YMAP
Sbjct: 159 IKSANILLDEAFTAKISDFGLA--------------RASEKFAQTVMXXRIVGTTAYMAP 204
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
           E L+ EI + KSD+YSFG+ + E++TG +P  D   E Q
Sbjct: 205 EALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQ 241

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 74  IARGAESVVYEATLDGRKVAVKK---PILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAA 129
           +  G   VVY+  ++   VAVKK    +  T+EEL   F +E++++ K  H  L + +  
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRD 187
            +   +    + +  + +L ++L   + +P +       IA   A  + +LH    +HRD
Sbjct: 93  SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 152
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +K AN+LLD      ++DFGLA              R+S K         +VGT  YMAP
Sbjct: 153 IKSANILLDEAFTAKISDFGLA--------------RASEKFAQXVMXXRIVGTTAYMAP 198
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
           E L+ EI + KSD+YSFG+ + E++TG +P  D   E Q
Sbjct: 199 EALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQ 235

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 36/269 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 127
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 128 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 188 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 232
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 233 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 274
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKS 358
           +CW  +P  RP F+++  +L  +LE  K+
Sbjct: 275 KCWAYDPSRRPRFTELKAQLSTILEEEKA 303

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 36/269 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 104
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 105 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 165 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 210 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 251
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKS 358
           +CW  +P  RP F+++  +L  +LE  K+
Sbjct: 252 KCWAYDPSRRPRFTELKAQLSTILEEEKA 280

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 99
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 100 FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 160 YMED----STXXKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 204
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 205 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 246
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 247 KCWAYDPSRRPRFTELKAQLSTILEEEK 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 99
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 100 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 160 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 204
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 205 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 246
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 247 KCWAYDPSRRPRFTELKAQLSTILEEEK 274

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 99
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 100 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 160 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 204
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 205 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 246
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 247 KCWAYDPSRRPRFTELKAQLSTILEEEK 274

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 19/223 (8%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           S +  ++ + +GA   V +A   LD R  A+KK I  T E+L     E+ LL  L+H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 AKFVAAHAKPPNY------------MFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
            ++ AA  +  N+            +F   E+ E+R L + +H E  +   D+   +  Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + +AL Y+H+ GI+HRD+KP N+ +D +    + DFGLA  +   + + +    S   P 
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA--KNVHRSLDILKLDSQNLPG 182
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELL 272
              +  + +GT +Y+A E+L    H +EK D+YS GI   E++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 32/296 (10%)
Query: 74  IARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132
           I  G    VY+  L DG KVA+K+    +S+ ++ F  E++ L    HP L   +    +
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 133 PPNYMFFFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
               +  +++ E+ NL   L+  +    S S +Q L I    A+ L YLH   I+HRDVK
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMAPE 248
             N+LLD N  P + DFG+++                G   G  H   +V GTL Y+ PE
Sbjct: 167 SINILLDENFVPKITDFGISK---------------KGTELGQTHLXXVVKGTLGYIDPE 211
Query: 249 ILKKEIHSEKSDVYSFGISINELL---TGVVPYTDLRAEAQAHTVLEMNYTEQ--QLTAA 303
              K   +EKSDVYSFG+ + E+L   + +V          A   +E +   Q  Q+   
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
            ++  +RP   SL      ++     +C   +  +RPS  D+  +L+  L  ++S+
Sbjct: 272 NLADKIRP--ESLRKFGDTAV-----KCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 479
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+  N C  L DFGL+ 
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 540 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 585 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 626
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 627 KCWAYDPSRRPRFTELKAQLSTILEEEK 654

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGLA   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 131
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+   N L+  N    +ADFGL+              R     T   H       + +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLS--------------RLMTGDTXTAHAGAKF-PIKW 176
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +     
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-SQVYELLEKDYRME----- 230
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 231 ------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 38/281 (13%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+   N L+  N    +ADFGL+          L    +   P G          + + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLS---------RLMTGDTYTAPAGAKF------PIKWT 181
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +      
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME------ 234
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 235 -----RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 38/281 (13%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+   N L+  N    +ADFGL+          L    +   P G          + + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLS---------RLMTGDTYTAPAGAKF------PIKWT 180
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +      
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME------ 233
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 234 -----RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 133
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HRD+   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 232
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 30/295 (10%)
Query: 74  IARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132
           I  G    VY+  L DG KVA+K+    +S+ ++ F  E++ L    HP L   +    +
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 133 PPNYMFFFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
               +  +++ E+ NL   L+  +    S S +Q L I    A+ L YLH   I+HRDVK
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
             N+LLD N  P + DFG+++    L +  L                 + GTL Y+ PE 
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELDQTHLXXV--------------VKGTLGYIDPEY 212
Query: 250 LKKEIHSEKSDVYSFGISINELL---TGVVPYTDLRAEAQAHTVLEMNYTEQ--QLTAAV 304
             K   +EKSDVYSFG+ + E+L   + +V          A   +E +   Q  Q+    
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
           ++  +RP   SL      ++     +C   +  +RPS  D+  +L+  L  ++S+
Sbjct: 273 LADKIRP--ESLRKFGDTAV-----KCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 140/283 (49%), Gaps = 39/283 (13%)
Query: 68  YTLLSPIARGA--ESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y  L  I  G+  ++++ ++T DGR+  +K+  +S  +S+E +   +E+ +L  + HP +
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
            ++  +  +  +     ++ E  +L ++++ ++      DQ+L    Q+  AL+++H+  
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+K  N+ L ++    L DFG+A    +  E++                +  +GT 
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----------------RACIGTP 189
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y++PEI + + ++ KSD+++ G  + EL T       L+   +A ++       + L  
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCT-------LKHAFEAGSM-------KNLVL 235
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            ++SG   P+     L     + SL+ + +  NP +RPS + I
Sbjct: 236 KIISGSFPPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 57  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 116
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 170
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 171 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 224 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 265
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 266 PKFEQIVSILDKLIRNPGSLK 286

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 187
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 188 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 240
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 241 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 282
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 283 PKFEQIVSILDKLIRNPGSLK 303

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 133
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HRD+   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 232
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 99
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+    C  L DFGL+ 
Sbjct: 100 FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 160 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 204
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 205 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 246
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 247 KCWAYDPSRRPRFTELKAQLSTILEEEK 274

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 75  ARGAESVVYEATLDGRKVAVKK---PILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAH 130
             G   VVY+  ++   VAVKK    +  T+EEL   F +E+++  K  H  L + +   
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFS 90
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRDV 188
           +   +    + +  + +L ++L   + +P +       IA   A  + +LH    +HRD+
Sbjct: 91  SDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDI 150
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K AN+LLD      ++DFGLA              R+S K         +VGT  Y APE
Sbjct: 151 KSANILLDEAFTAKISDFGLA--------------RASEKFAQXVXXSRIVGTTAYXAPE 196
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
            L+ EI + KSD+YSFG+ + E++TG +P  D   E Q
Sbjct: 197 ALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQ 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 133
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HRD+   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 232
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 84  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 144 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 197
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 198 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 250
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 251 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 292
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 293 PKFEQIVSILDKLIRNPGSLK 313

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 131
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+   N L+  N    +ADFGL+              R     T   H       + +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLS--------------RLMTGDTXTAHAGAKF-PIKW 176
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +     
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-SQVYELLEKDYRME----- 230
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 231 ------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL    E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 138
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HRD+   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 181
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 237
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 238 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 133
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HRD+   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 232
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 131
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+   N L+  N    +ADFGL+              R     T   H       + +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLS--------------RLMTGDTFTAHAGAKF-PIKW 176
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +     
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP-SQVYELLEKDYRME----- 230
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 231 ------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 38/281 (13%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+   N L+  N    +ADFGL+              R     T   H       + + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLS--------------RLMTGDTXTAHAGAKF-PIKWT 180
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +      
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME------ 233
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 234 -----RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T  +  +F  E  ++ + DHP + +      +    M   E+ E+ +L   L   +   +
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           + Q++ +   +   ++YL +LG VHRD+   NVL+D NL   ++DFGL+   E+      
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED------ 203
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +        + + APE +     S  SDV+SFG+ + E+L  G  PY 
Sbjct: 204 -------DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY- 255
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
                         N T + + ++V  G   P      +G P ++  L+  CW  +   R
Sbjct: 256 -------------WNMTNRDVISSVEEGYRLPA----PMGCPHALHQLMLDCWHKDRAQR 298
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P FS I   LD ++   +SL+
Sbjct: 299 PRFSQIVSVLDALIRSPESLR 319

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 48/305 (15%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
           + L     TLL  +  G   VV      G+     K I   S   D F +E Q + KL H
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH 62
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL--HVEEWSPSVDQVLMIAAQLAKALQYL 178
           P L KF    +K        E+  +  L   L  H +   PS  Q+L +   + + + +L
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFL 120
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
            +   +HRD+   N L+DR+LC  ++DFG+  Y  + + +S                   
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS------------------S 162
Query: 239 VGT---LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294
           VGT   + + APE+     +S KSDV++FGI + E+ + G +PY DL             
Sbjct: 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY-DL------------- 208
Query: 295 YTEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
           YT  ++   V  G    RP LAS       +I  ++  CW   P  RP+F  +   ++ +
Sbjct: 209 YTNSEVVLKVSQGHRLYRPHLAS------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
Query: 353 LEHRK 357
            E  K
Sbjct: 263 REKDK 267

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 19/223 (8%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           S +  ++ + +GA   V +A   LD R  A+KK I  T E+L     E+ LL  L+H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 AKFVAAHAKPPNY------------MFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
            ++ AA  +  N+            +F   E+ E+  L + +H E  +   D+   +  Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + +AL Y+H+ GI+HRD+KP N+ +D +    + DFGLA  +   + + +    S   P 
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA--KNVHRSLDILKLDSQNLPG 182
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELL 272
              +  + +GT +Y+A E+L    H +EK D+YS GI   E++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 36/268 (13%)
Query: 92  VAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VA+K     TS+ + + F +E   + + DHP + K +    + P ++   E      L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRS 479
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            L V ++S  +  +++ A QL+ AL YL +   VHRD+   NVL+    C  L DFGL+ 
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           Y E+    S     S GK             + +MAPE +     +  SDV+ FG+ + E
Sbjct: 540 YMED----STYYKASKGKL-----------PIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           +L  GV P+  ++                 +   + +G   P+  +     P ++ SL+ 
Sbjct: 585 ILMHGVKPFQGVK--------------NNDVIGRIENGERLPMPPN----CPPTLYSLMT 626
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW  +P  RP F+++  +L  +LE  K
Sbjct: 627 KCWAYDPSRRPRFTELKAQLSTILEEEK 654

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 182
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 237
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 238 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 38/281 (13%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+   N L+  N    +ADFGL+              R     T   H       + + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLS--------------RLMTGDTXTAHAGAKF-PIKWT 184
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
           APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME------ 237
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 238 -----RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E  E+ +L   L   +   +
Sbjct: 57  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 116
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 170
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 171 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 224 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 265
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 266 PKFEQIVSILDKLIRNPGSLK 286

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T  +  +F  E  ++ + DHP + +      +    M   E+ E+ +L   L   +   +
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           + Q++ +   +   ++YL +LG VHRD+   NVL+D NL   ++DFGL+   E+  + + 
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                    TGG         + + APE +     S  SDV+SFG+ + E+L  G  PY 
Sbjct: 210 TT-------TGGKIP------IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY- 255
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
                         N T + + ++V  G   P      +G P ++  L+  CW  +   R
Sbjct: 256 -------------WNMTNRDVISSVEEGYRLPA----PMGCPHALHQLMLDCWHKDRAQR 298
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P FS I   LD ++   +SL+
Sbjct: 299 PRFSQIVSVLDALIRSPESLR 319

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 182
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 237
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 238 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 179
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 234
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 235 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 179
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 234
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 235 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFEFYESR 146
           G  VAVK+   S  ++  +F +E+Q+L  L    + K+      P  P      E+  S 
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L + L          ++L+ ++Q+ K ++YL +   VHRD+   N+L++      +ADF
Sbjct: 96  CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 155
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GLA+     K+  +   R  G+             + + APE L   I S +SDV+SFG+
Sbjct: 156 GLAKLLPLDKDXXVV--REPGQ-----------SPIFWYAPESLSDNIFSRQSDVWSFGV 202
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASI 324
            + EL T    Y D      A   L M   E+ + A      L      L      PA +
Sbjct: 203 VLYELFT----YCDKSCSPSAE-FLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEV 257
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLV 352
             L++ CW  +P +RPSFS +  +LD++
Sbjct: 258 HELMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 177
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 232
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 177
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 232
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 233 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 181
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 236
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 237 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 182
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 237
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 238 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E  E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP + +      K    M   E  E+ +L   L   +   +
Sbjct: 86  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 199
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + +PE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 200 -------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              + Q +  AV  G   P      +  PA++  L+  CW  + +NR
Sbjct: 253 EM--------------SNQDVIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNR 294
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 295 PKFEQIVSILDKLIRNPGSLK 315

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           RD+   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 190
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 245
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  RP       G P  +  L++ CW  NP +RPSF++I
Sbjct: 246 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 112/221 (50%), Gaps = 22/221 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + +L  +  G+   VY+A     G+ VA+K+  +    +L    KE+ ++ + D P
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ--VPVESDLQEIIKEISIMQQCDSP 84
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K+  ++ K  +     E+  + ++++ + +   + + D++  I     K L+YLH +
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
             +HRD+K  N+LL+      LADFG+A                 G+ T    K+N ++G
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVA-----------------GQLTDXMAKRNXVIG 187
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           T  +MAPE++++  ++  +D++S GI+  E+  G  PY D+
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 74  IARGAESVVYEATL---DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFV 127
           +  G    VYE       G K+ V          LDN   F  E  ++  LDHP + K +
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
               + P ++   E Y    L   L   + S  V  +++ + Q+ KA+ YL ++  VHRD
Sbjct: 80  GIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI-YMA 246
           +   N+L+    C  L DFGL+ Y E+                  ++K ++    I +M+
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYIED----------------EDYYKASVTRLPIKWMS 182
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           PE +     +  SDV+ F + + E+L+ G  P+                + E +    V+
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENKDVIGVL 227
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
             G R  L   +L  P  + +L+ RCWD +P +RP F+++   L  V +  K +  E
Sbjct: 228 EKGDR--LPKPDL-CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 74  IARGAESVVYEATL---DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFV 127
           +  G    VYE       G K+ V          LDN   F  E  ++  LDHP + K +
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
               + P ++   E Y    L   L   + S  V  +++ + Q+ KA+ YL ++  VHRD
Sbjct: 92  GIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 150
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI-YMA 246
           +   N+L+    C  L DFGL+ Y E+                  ++K ++    I +M+
Sbjct: 151 IAVRNILVASPECVKLGDFGLSRYIED----------------EDYYKASVTRLPIKWMS 194
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           PE +     +  SDV+ F + + E+L+ G  P+                + E +    V+
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENKDVIGVL 239
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
             G R  L   +L  P  + +L+ RCWD +P +RP F+++   L  V +  K +  E
Sbjct: 240 EKGDR--LPKPDL-CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 293

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 44/307 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
               + P +    EF    NL + L   + +E S  V  +L +A Q++ A++YL     +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV--LLYMATQISSAMEYLEKKNFI 340
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--L 242
           HR++   N L+  N    +ADFGL+                    TG  +  +      +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPI 383
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +   
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME--- 439
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKE 361
                   RP       G P  +  L++ CW  NP +RPSF++I    + + +      E
Sbjct: 440 --------RP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 485
Query: 362 EDLCAGK 368
            +   GK
Sbjct: 486 VEKELGK 492

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     EF    
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L E L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 102 SLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 161
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 162 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 208
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 209 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 259
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 260 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 19/217 (8%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           S +  ++ + +GA   V +A   LD R  A+KK I  T E+L     E+ LL  L+H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVXLLASLNHQYV 64
Query: 124 AKFVAAHAKPPNYM-----------FFF--EFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
            ++ AA  +  N++            F   E+ E+R L + +H E  +   D+   +  Q
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + +AL Y+H+ GI+HR++KP N+ +D +    + DFGLA  +   + + +    S   P 
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLA--KNVHRSLDILKLDSQNLPG 182
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGI 266
              +  + +GT  Y+A E+L    H +EK D YS GI
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGI 219

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 43/297 (14%)
Query: 74  IARGAESVVYEATL---DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFV 127
           +  G    VYE       G K+ V          LDN   F  E  ++  LDHP + K +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
               + P ++   E Y    L   L   + S  V  +++ + Q+ KA+ YL ++  VHRD
Sbjct: 76  GIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 134
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI-YMA 246
           +   N+L+    C  L DFGL+ Y E+                  ++K ++    I +M+
Sbjct: 135 IAVRNILVASPECVKLGDFGLSRYIED----------------EDYYKASVTRLPIKWMS 178
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           PE +     +  SDV+ F + + E+L+ G  P+                + E +    V+
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFF---------------WLENKDVIGVL 223
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
             G R  L   +L  P  + +L+ RCWD +P +RP F+++   L  V +  K +  E
Sbjct: 224 EKGDR--LPKPDL-CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 277

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 41/305 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEATL---DGRK---VAVK--KPILSTSEELDNFHKELQLLC 116
           PS  T    I  G    VY+  L    G+K   VA+K  K   +  + +D F  E  ++ 
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMG 101
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +  H  + +     +K    M   E+ E+  L + L  ++   SV Q++ +   +A  ++
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YL N+  VHRD+   N+L++ NL   ++DFGL+   E+  E +     S GK        
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKI------- 212
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                + + APE +     +  SDV+SFGI + E++T G  PY +L      H V++   
Sbjct: 213 ----PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMK--- 261
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                    ++ G R       +  P++I  L+ +CW      RP F+DI   LD ++  
Sbjct: 262 --------AINDGFR---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
Query: 356 RKSLK 360
             SLK
Sbjct: 311 PDSLK 315

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 65  PSSYTLLSPIARGAESVVYEATL----DGRKV----AVKKPILSTSEELDNFHKELQLLC 116
           PS + LL  + +G+   V+        D R++     +KK  L   + +     E  +L 
Sbjct: 24  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILV 82
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +++HP + K   A           +F    +L  +L  E      D V    A+LA AL 
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALD 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+LGI++RD+KP N+LLD      L DFGL+  +E++                  H+K
Sbjct: 142 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESID-----------------HEK 182
Query: 237 ---NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              +  GT+ YMAPE++ +  H++ +D +SFG+ + E+LTG +P+
Sbjct: 183 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 65  PSSYTLLSPIARGAESVVYEATL----DGRKV----AVKKPILSTSEELDNFHKELQLLC 116
           PS + LL  + +G+   V+        D R++     +KK  L   + +     E  +L 
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILV 81
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +++HP + K   A           +F    +L  +L  E      D V    A+LA AL 
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALD 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+LGI++RD+KP N+LLD      L DFGL+  +E++                  H+K
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESID-----------------HEK 181
Query: 237 ---NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              +  GT+ YMAPE++ +  H++ +D +SFG+ + E+LTG +P+
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 32/225 (14%)
Query: 65  PSSYTLLSPIARGAESVVYEATL----DGRKV----AVKKPILSTSEELDNFHKELQLLC 116
           PS + LL  + +G+   V+        D R++     +KK  L   + +     E  +L 
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILV 81
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +++HP + K   A           +F    +L  +L  E      D V    A+LA AL 
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALALD 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+LGI++RD+KP N+LLD      L DFGL+  +E++                  H+K
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESID-----------------HEK 181
Query: 237 ---NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
              +  GT+ YMAPE++ +  H++ +D +SFG+ + E+LTG +P+
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGL 123
            + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  +
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 124 AKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
            KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +G
Sbjct: 68  VKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIG 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           I HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M GT
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCGT 170
Query: 242 LIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           L Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGL 123
            + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  +
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 124 AKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
            KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +G
Sbjct: 67  VKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGIG 124
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           I HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M GT
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCGT 169
Query: 242 LIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           L Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 42/306 (13%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           T+   +  G    VYE       + V  K +   + E++ F KE  ++ ++ HP L + +
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVH 185
               + P +    EF    NL + L  E     V+ V+++  A Q++ A++YL     +H
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 380
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LI 243
           R++   N L+  N    +ADFGL+                    TG  +  +      + 
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLM-----------------TGDTYTAHAGAKFPIK 423
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           + APE L     S KSDV++FG+ + E+ T G+ PY  +   +Q + +LE +Y  +    
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRME---- 478
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEE 362
                  RP       G P  +  L++ CW  NP +RPSF++I    + + +      E 
Sbjct: 479 -------RP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 525
Query: 363 DLCAGK 368
           +   GK
Sbjct: 526 EKELGK 531

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMXG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 114/266 (42%), Gaps = 19/266 (7%)
Query: 91  KVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149
           +V V K ++   EE    F KE++++  L+HP + KF+    K     F  E+ +   L 
Sbjct: 36  EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95
Query: 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
             +   +      Q +  A  +A  + YLH++ I+HRD+   N L+  N    +ADFGLA
Sbjct: 96  GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155
Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269
               + K    +  RS  KP     +  +VG   +MAPE++    + EK DV+SFGI + 
Sbjct: 156 RLMVDEK-TQPEGLRSLKKPDRK-KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           E++  V    D         +    + ++                      P S   +  
Sbjct: 214 EIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP----------------NCPPSFFPITV 257
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEH 355
           RC D +P  RPSF  +   L+ +  H
Sbjct: 258 RCCDLDPEKRPSFVKLEHWLETLRMH 283

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 131/312 (41%), Gaps = 41/312 (13%)
Query: 58  SIPLHLPPSSYTLLSPIARG----AESVVYEATLD--GRKVAVKKPILSTSEELDNFHKE 111
           S P          L  + +G     E   Y+   D  G  VAVKK   ST E L +F +E
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 112 LQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +++L  L H  + K+  V   A   N     E+    +L + L   +      ++L   +
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+ K ++YL     +HRD+   N+L++      + DFGL +     KE            
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE------------ 169
Query: 230 TGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
              F K    G   + + APE L +   S  SDV+SFG+ + EL T +      ++++  
Sbjct: 170 ---FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKSPP 221
Query: 288 HTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
              + M   ++Q       L   + + G  P       G P  I  ++  CW+ N + RP
Sbjct: 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRP 277
Query: 341 SFSDIALELDLV 352
           SF D+AL +D +
Sbjct: 278 SFRDLALRVDQI 289

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 40/301 (13%)
Query: 58  SIPLHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLC 116
           S+ + + PS  T +  I  G   +V+    L+  KVA+K  I   S   D+F +E +++ 
Sbjct: 19  SLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IKEGSMSEDDFIEEAEVMM 77
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           KL HP L +      +       FEF E   L++ L  +    + + +L +   + + + 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YL    ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K
Sbjct: 138 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK 189
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + +PE+     +S KSDV+SFG+ + E+ + G +PY               N 
Sbjct: 190 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NR 228
Query: 296 TEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
           +  ++   + +G    +P LAS        +  ++  CW   P +RP+FS +  +L  + 
Sbjct: 229 SNSEVVEDISTGFRLYKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 282
Query: 354 E 354
           E
Sbjct: 283 E 283

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 22/234 (9%)
Query: 56  SQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRK--VAVKKPILSTSE-ELDNFHKEL 112
           S ++P  +    Y L   I  GA +VV  A    +K  VA+K+  L   +  +D   KE+
Sbjct: 5   SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEI 64
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HV----EEWSPSVDQ--VL 165
           Q + +  HP +  +  +           +     ++ + + H+    E  S  +D+  + 
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            I  ++ + L+YLH  G +HRDVK  N+LL  +    +ADFG++ +     +I+    R 
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR- 183
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPY 278
                     K  VGT  +MAPE++++   +  K+D++SFGI+  EL TG  PY
Sbjct: 184 ----------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMXG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 65  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 167
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMXG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 37/310 (11%)
Query: 58  SIPLHLPPSSYTLLSPIARG----AESVVYEATLD--GRKVAVKKPILSTSEELDNFHKE 111
           S P          L  + +G     E   Y+   D  G  VAVKK   ST E L +F +E
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 112 LQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +++L  L H  + K+  V   A   N     E+    +L + L   +      ++L   +
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+ K ++YL     +HRD+   N+L++      + DFGL +     KE      +  G+ 
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX--KVKEPGE- 178
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
                       + + APE L +   S  SDV+SFG+ + EL T +      ++++    
Sbjct: 179 ----------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKSPPAE 223
Query: 290 VLEMNYTEQQ-------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            + M   ++Q       L   + + G  P       G P  I  ++  CW+ N + RPSF
Sbjct: 224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSF 279
Query: 343 SDIALELDLV 352
            D+AL +D +
Sbjct: 280 RDLALRVDQI 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 103 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 162
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 163 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 209
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 210 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 260
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
            P  I  ++  CW+ N + RPSF D+AL +D + ++   L
Sbjct: 261 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGL 300

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFEFYESR 146
           G  VAVK+   S  ++  +F +E+Q+L  L    + K+      P   +     E+  S 
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L + L          ++L+ ++Q+ K ++YL +   VHRD+   N+L++      +ADF
Sbjct: 100 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 159
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GLA+     K+  +   R  G+             + + APE L   I S +SDV+SFG+
Sbjct: 160 GLAKLLPLDKDYYVV--REPGQ-----------SPIFWYAPESLSDNIFSRQSDVWSFGV 206
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASI 324
            + EL T    Y D      A   L M   E+ + A      L      L      PA +
Sbjct: 207 VLYELFT----YCDKSCSPSAE-FLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEV 261
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLV 352
             L++ CW  +P +RPSFS +  +LD++
Sbjct: 262 HELMKLCWAPSPQDRPSFSALGPQLDML 289

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 124
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMCG 169
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 22/268 (8%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFEFYESR 146
           G  VAVK+   S  ++  +F +E+Q+L  L    + K+      P   +     E+  S 
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L + L          ++L+ ++Q+ K ++YL +   VHRD+   N+L++      +ADF
Sbjct: 99  CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 158
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GLA+     K+  +   R  G+             + + APE L   I S +SDV+SFG+
Sbjct: 159 GLAKLLPLDKDYYVV--REPGQ-----------SPIFWYAPESLSDNIFSRQSDVWSFGV 205
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASI 324
            + EL T    Y D      A   L M  +E+ + A      L      L      PA +
Sbjct: 206 VLYELFT----YCDKSCSPSAE-FLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEV 260
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLV 352
             L++ CW  +P +RPSFS +  +LD++
Sbjct: 261 HELMKLCWAPSPQDRPSFSALGPQLDML 288

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMXG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 131/313 (41%), Gaps = 37/313 (11%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARG----AESVVYEATLD--GRKVAVKKPILSTSEELDNF 108
           S    P          L  + +G     E   Y+   D  G  VAVKK   ST E L +F
Sbjct: 2   SEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 109 HKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
            +E+++L  L H  + K+  V   A   N     E+    +L + L   +      ++L 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 121
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
             +Q+ K ++YL     +HRD+   N+L++      + DFGL +     KE      +  
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX--KVKEP 179
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
           G+             + + APE L +   S  SDV+SFG+ + EL T +      ++++ 
Sbjct: 180 GE-----------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKSP 223
Query: 287 AHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
               + M   ++Q       L   + + G  P       G P  I  ++  CW+ N + R
Sbjct: 224 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQR 279
Query: 340 PSFSDIALELDLV 352
           PSF D+AL +D +
Sbjct: 280 PSFRDLALRVDQI 292

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 190 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 237 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 287
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 288 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD---NFHKELQLLCKLDHPG 122
             + L+  +  GA   V  A     + AV   I+     +D   N  KE+ +   L+H  
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 123 LAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           + KF   H +  N  + F E+     L +++  +   P  D       QL   + YLH +
Sbjct: 66  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-QLMAGVVYLHGI 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           GI HRD+KP N+LLD      ++DFGLA  +R N +E  L                 M G
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL---------------NKMXG 168
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           TL Y+APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 117 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 176
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 177 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 223
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 224 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 274
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 275 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 104 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 163
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 164 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 210
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 211 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 261
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 262 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 31/276 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 106 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 165
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 166 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 212
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 213 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 263
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
            P  I  ++  CW+ N + RPSF D+AL +D + ++
Sbjct: 264 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 299

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 99  SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 159 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 205
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 206 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 256
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 257 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 105 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 164
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 165 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 211
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 212 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 262
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 263 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 117 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 176
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 177 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 223
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 224 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 274
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 275 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 123
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAE--------XTAREGAKFPIK 175
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 227
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 228 RM-----------VRPD------NCPEELYQLMRLCWKERPEDRPTFD 258

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 98  SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 157
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 158 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 204
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 205 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 255
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 256 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L          ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 102 SLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 161
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 162 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 208
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 209 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 259
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 260 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HRD+   N+L++      + DF
Sbjct: 97  SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 156
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL +     KE      +  G+             + + APE L +   S  SDV+SFG+
Sbjct: 157 GLTKVLPQDKEXX--KVKEPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 203
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLELG 319
            + EL T +      ++++     + M   ++Q       L   + + G  P       G
Sbjct: 204 VLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G 254
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 255 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 22/232 (9%)
Query: 58  SIPLHLPPSSYTLLSPIARGAESVVYEATLDGRK--VAVKKPILSTSE-ELDNFHKELQL 114
           ++P  +    Y L   I  GA +VV  A    +K  VA+K+  L   +  +D   KE+Q 
Sbjct: 2   ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 61
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HV----EEWSPSVDQ--VLMI 167
           + +  HP +  +  +           +     ++ + + H+    E  S  +D+  +  I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             ++ + L+YLH  G +HRDVK  N+LL  +    +ADFG++ +     +I+    R   
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR--- 178
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPY 278
                   K  VGT  +MAPE++++   +  K+D++SFGI+  EL TG  PY
Sbjct: 179 --------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFEFYESR 146
           G  VAVK+   S  ++  +F +E+Q+L  L    + K+      P   +     E+  S 
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L + L          ++L+ ++Q+ K ++YL +   VHRD+   N+L++      +ADF
Sbjct: 112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GLA+     K+  +   R  G+             + + APE L   I S +SDV+SFG+
Sbjct: 172 GLAKLLPLDKDYYVV--REPGQ-----------SPIFWYAPESLSDNIFSRQSDVWSFGV 218
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASI 324
            + EL T    Y D      A   L M   E+ + A      L      L      PA +
Sbjct: 219 VLYELFT----YCDKSCSPSAE-FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEV 273
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLV 352
             L++ CW  +P +RPSFS +  +LD++
Sbjct: 274 HELMKLCWAPSPQDRPSFSALGPQLDML 301

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 121/263 (46%), Gaps = 34/263 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   EF E+ +L   L   +   +
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++  VHRD+   N+L++ NL   ++DFGL+ + E+      
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED------ 187
Query: 221 KNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                +  PT   +   + G +   + APE ++    +  SDV+S+GI + E+++ G  P
Sbjct: 188 ----DTSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y D+              T Q +  A+      P      +  P+++  L+  CW  + +
Sbjct: 241 YWDM--------------TNQDVINAIEQDYRLP----PPMDCPSALHQLMLDCWQKDRN 282
Query: 338 NRPSFSDIALELDLVLEHRKSLK 360
           +RP F  I   LD ++ +  SLK
Sbjct: 283 HRPKFGQIVNTLDKMIRNPNSLK 305

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 70  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 124
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 125 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 176
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 177 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 228
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 229 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 259

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 123
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 175
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 227
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 228 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 258

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
           G  VAVKK   ST E L +F +E+++L  L H  + K+  V   A   N     E+    
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
           +L + L   +      ++L   +Q+ K ++YL     +HR++   N+L++      + DF
Sbjct: 100 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDF 159
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSF 264
           GL +     KE               ++K    G   + + APE L +   S  SDV+SF
Sbjct: 160 GLTKVLPQDKE---------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 204
Query: 265 GISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-------LTAAVVSGGLRPILASLE 317
           G+ + EL T +      ++++     + M   ++Q       L   + + G  P      
Sbjct: 205 GVVLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD--- 256
Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            G P  I  ++  CW+ N + RPSF D+AL +D +
Sbjct: 257 -GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 71  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 125
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 126 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 177
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 178 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 229
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 230 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 50/327 (15%)
Query: 52  GCCSSQSIP--------------LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKP 97
           G C   S+P                +P  S  L   +  G    V+ AT +       K 
Sbjct: 160 GLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 98  ILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEW 157
           +   S  ++ F  E  ++  L H  L K  A   K P Y+   EF    +L + L  +E 
Sbjct: 220 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG 278
Query: 158 SPS-VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
           S   + +++  +AQ+A+ + ++     +HRD++ AN+L+  +L   +ADFGLA   E+ +
Sbjct: 279 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                    + +    F  K       + APE +     + KSDV+SFGI + E++T G 
Sbjct: 339 --------YTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
           +PY  + +  +    LE  Y              RP         P  + +++ RCW   
Sbjct: 384 IPYPGM-SNPEVIRALERGYRMP-----------RP------ENCPEELYNIMMRCWKNR 425
Query: 336 PHNRPSFSDIALELDLVLEHRKSLKEE 362
           P  RP+F  I   LD      +S  EE
Sbjct: 426 PEERPTFEYIQSVLDDFYTATESQXEE 452

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 123
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 175
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 227
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 228 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 258

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 115/256 (44%), Gaps = 32/256 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   E+ E+ +L   L   +   +
Sbjct: 63  TEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   ++  ++YL ++G VHRD+   N+L++ NL   ++DFGL+   E+      
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED------ 176
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + APE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 177 -------DPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYW 229
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           ++              T Q +  AV  G   P      +  PA++  L+  CW    ++R
Sbjct: 230 EM--------------TNQDVIKAVEEGYRLP----SPMDCPAALYQLMLDCWQKERNSR 271
Query: 340 PSFSDIALELDLVLEH 355
           P F +I   LD ++ +
Sbjct: 272 PKFDEIVNMLDKLIRN 287

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 123
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 175
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 176 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 227
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 228 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 258

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 74  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 128
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 129 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 180
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 181 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 232
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 233 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 129
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 181
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 182 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 233
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 234 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 78  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 132
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 133 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 185 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 236
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 237 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 267

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 46/289 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDH 120
            +P  +  L+  +  G    V+    +G  KVAVK  +   S   D F  E  L+ +L H
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQH 75
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKAL 175
             L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ +
Sbjct: 76  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGM 130
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  
Sbjct: 131 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPI 182
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294
           K       + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  
Sbjct: 183 K-------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERG 234
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           Y             +RP         P  +  L++ CW   P +RP+F 
Sbjct: 235 YR-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 266

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK  ++T+        E+ +L +LDHP + K         NY    E Y    L +++ 
Sbjct: 37  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII 96
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAE 210
           + +    VD  + I  Q+     YLH   IVHRD+KP N+LL+   R+    + DFGL+ 
Sbjct: 97  LRQKFSEVDAAV-IMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 155
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           + E                 GG  K+ + GT  Y+APE+L+K+ + EK DV+S G+ +  
Sbjct: 156 HFE----------------VGGKMKERL-GTAYYIAPEVLRKK-YDEKCDVWSCGVILYI 197
Query: 271 LLTGVVPY 278
           LL G  P+
Sbjct: 198 LLCGYPPF 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 64  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 118
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 119 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 170
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 171 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 222
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 223 RM-----------VRPD------NCPEELYQLMRLCWKERPEDRPTFD 253

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 129
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------XTAREGAKFPIK 181
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 182 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 233
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 234 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 264

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 84  EATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFF 139
           E    G +VAVK  KP  S    + +  KE+++L  L H  + K+  +            
Sbjct: 45  EGDNTGEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 103
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            EF  S +L E L   +   ++ Q L  A Q+ K + YL +   VHRD+   NVL++   
Sbjct: 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163
Query: 200 CPHLADFGLAEYRENLKE-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK 258
              + DFGL +  E  KE  ++K+ R S               + + APE L +      
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDS--------------PVFWYAPECLMQSKFYIA 209
Query: 259 SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRP-ILASLE 317
           SDV+SFG++++ELLT    Y D  +   A  +  +  T  Q+T   +   L+        
Sbjct: 210 SDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDI 345
              P  +  L+++CW+  P NR SF ++
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNL 293

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK  ++T+        E+ +L +LDHP + K         NY    E Y    L +++ 
Sbjct: 54  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII 113
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAE 210
           + +    VD  + I  Q+     YLH   IVHRD+KP N+LL+   R+    + DFGL+ 
Sbjct: 114 LRQKFSEVDAAV-IMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA 172
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           + E                 GG  K+ + GT  Y+APE+L+K+ + EK DV+S G+ +  
Sbjct: 173 HFE----------------VGGKMKERL-GTAYYIAPEVLRKK-YDEKCDVWSCGVILYI 214
Query: 271 LLTGVVPY 278
           LL G  P+
Sbjct: 215 LLCGYPPF 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 84  EATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFF 139
           E    G +VAVK  KP  S    + +  KE+++L  L H  + K+  +            
Sbjct: 33  EGDNTGEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 91
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            EF  S +L E L   +   ++ Q L  A Q+ K + YL +   VHRD+   NVL++   
Sbjct: 92  MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 151
Query: 200 CPHLADFGLAEYRENLKE-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK 258
              + DFGL +  E  KE  ++K+ R S               + + APE L +      
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDS--------------PVFWYAPECLMQSKFYIA 197
Query: 259 SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRP-ILASLE 317
           SDV+SFG++++ELLT    Y D  +   A  +  +  T  Q+T   +   L+        
Sbjct: 198 SDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 253
Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDI 345
              P  +  L+++CW+  P NR SF ++
Sbjct: 254 PNCPDEVYQLMRKCWEFQPSNRTSFQNL 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 100 STSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAE---KLHVE 155
           ++ ++  +F  EL++LCKL H P +   + A           E+    NL +   K  V 
Sbjct: 64  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 123
Query: 156 EWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203
           E  P            S  Q+L  AA +A+ + YL     +HRD+   N+L+  N    +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDV 261
           ADFGL+  +E                    + K  +G L   +MA E L   +++  SDV
Sbjct: 184 ADFGLSRGQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 262 YSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
           +S+G+ + E+++ G  PY  +   A+ +  L   Y  ++                  L  
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLNC 266
Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
              +  L+++CW   P+ RPSF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 320

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVC-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 240 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  +               ++    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---------------RQGAKF 343
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 389
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P         P S+  L+ +CW   P  RP+F
Sbjct: 390 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 428

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 240 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  +               ++    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---------------RQGAKF 343
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 389
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P         P S+  L+ +CW   P  RP+F
Sbjct: 390 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 428

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+     L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 40/296 (13%)
Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+    L+  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +       FEF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K     
Sbjct: 123 CVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK----- 169
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + +PE+     +S KSDV+SFG+ + E+ + G +PY               N +  ++
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NRSNSEV 213
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              + +G    +P LAS        +  ++  CW   P +RP+FS +  +L  + E
Sbjct: 214 VEDISTGFRLYKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 128/287 (44%), Gaps = 42/287 (14%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKL 118
            +P  S  L+  +  G    V+  T +G  KVA+K  KP   + E   +F +E Q++ KL
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIMKKL 61
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQY 177
            H  L +  A  ++ P Y+   E+    +L + L   E     +  ++ +AAQ+A  + Y
Sbjct: 62  KHDKLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 120
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           +  +  +HRD++ AN+L+   L   +ADFGLA   E+ +  + +  +   K         
Sbjct: 121 IERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK--------- 171
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
                 + APE       + KSDV+SFGI + EL+T G VPY  +        VLE    
Sbjct: 172 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREVLEQ--- 218
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                   V  G R          P S+  L+  CW  +P  RP+F 
Sbjct: 219 --------VERGYR---MPCPQDCPISLHELMIHCWKKDPEERPTFE 254

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 100 STSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAE---KLHVE 155
           ++ ++  +F  EL++LCKL H P +   + A           E+    NL +   K  V 
Sbjct: 54  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 113
Query: 156 EWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203
           E  P            S  Q+L  AA +A+ + YL     +HRD+   N+L+  N    +
Sbjct: 114 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 173
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDV 261
           ADFGL+  +E                    + K  +G L   +MA E L   +++  SDV
Sbjct: 174 ADFGLSRGQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 214
Query: 262 YSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
           +S+G+ + E+++ G  PY  +   A+ +  L   Y  ++                  L  
Sbjct: 215 WSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLNC 256
Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
              +  L+++CW   P+ RPSF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 257 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 310

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 79  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 133
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HRD++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 134 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 185
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 186 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 237
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 238 R-----------MVRPD------NCPEELYQLMRLCWKERPEDRPTFD 268

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 240 KLVQLYAVVSEEPIYIVG-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  +               ++    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---------------RQGAKF 343
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 389
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P         P S+  L+ +CW   P  RP+F
Sbjct: 390 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 428

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 110/250 (44%), Gaps = 46/250 (18%)
Query: 105 LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---HVEEWSPSV 161
           ++    E+++L  LDHP + K         N     E  E   L E++        + S 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKE 217
             V  +  Q+  AL Y H+  +VH+D+KP N+L  ++  PH    + DFGLAE       
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAEL------ 176
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                ++S        H  N  GT +YMAPE+ K+++ + K D++S G+ +  LLTG +P
Sbjct: 177 -----FKSDE------HSTNAAGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLP 224
Query: 278 Y--TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
           +  T L    Q  T  E NY  +           RP        L    + L+++    +
Sbjct: 225 FTGTSLEEVQQKATYKEPNYAVE----------CRP--------LTPQAVDLLKQMLTKD 266
Query: 336 PHNRPSFSDI 345
           P  RPS + +
Sbjct: 267 PERRPSAAQV 276

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 40/296 (13%)
Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+    L+  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 60
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +       FEF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K     
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK----- 167
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + +PE+     +S KSDV+SFG+ + E+ + G +PY               N +  ++
Sbjct: 168 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NRSNSEV 211
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              + +G    +P LAS        +  ++  CW   P +RP+FS +  +L  + E
Sbjct: 212 VEDISTGFRLYKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 64
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 65  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 171
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 172 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 214
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 215 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 254

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ ++AQ+A  + Y+  
Sbjct: 71  KLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+        W +         ++    
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIED------NEWTA---------RQGAKF 174
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 220
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW   P  RP+F 
Sbjct: 221 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFE 260

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 63  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 169
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 170 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 212
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 213 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 252

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+    L+  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +       FEF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K     
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK----- 169
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + +PE+     +S KSDV+SFG+ + E+ + G +PY               N +  ++
Sbjct: 170 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NRSNSEV 213
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
              + +G    +P LAS        +  ++  CW   P +RP+FS +  +L
Sbjct: 214 VEDISTGFRLYKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 40/296 (13%)
Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+    L+  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 7   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 65
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +       FEF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K     
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK----- 172
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + +PE+     +S KSDV+SFG+ + E+ + G +PY               N +  ++
Sbjct: 173 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NRSNSEV 216
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              + +G    +P LAS        +  ++  CW   P +RP+FS +  +L  + E
Sbjct: 217 VEDISTGFRLYKPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 36/291 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   +  G    V+ AT +       K +   S  ++ F  E  ++  L H 
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-VDQVLMIAAQLAKALQYLHN 180
            L K  A   K P Y+   EF    +L + L  +E S   + +++  +AQ+A+ + ++  
Sbjct: 71  KLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ AN+L+  +L   +ADFGLA   E+ +         + +    F  K    
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--------YTAREGAKFPIK---- 177
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE +     + KSDV+SFGI + E++T G +PY  + +  +    LE  Y    
Sbjct: 178 ---WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP- 232
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                     RP         P  + +++ RCW   P  RP+F  I   LD
Sbjct: 233 ----------RP------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 323 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  +               ++    
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---------------RQGAKF 426
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 472
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P         P S+  L+ +CW   P  RP+F
Sbjct: 473 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 511

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 66
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 67  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 173
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 174 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 216
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW   P  RP+F 
Sbjct: 217 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFE 256

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ K+ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+     L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVT-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   E+ E+ +L   L   +   +
Sbjct: 55  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 114
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +   ++YL ++  VHRD+   N+L++ NL   ++DFG++   E+      
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED------ 168
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + APE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 169 -------DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 221
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           D+              + Q +  A+  G   P      +  P ++  L+  CW     +R
Sbjct: 222 DM--------------SNQDVIKAIEEGYRLP----PPMDCPIALHQLMLDCWQKERSDR 263
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 264 PKFGQIVNMLDKLIRNPNSLK 284

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   E+ E+ +L   L   +   +
Sbjct: 49  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 108
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +   ++YL ++  VHRD+   N+L++ NL   ++DFG++   E+      
Sbjct: 109 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED------ 162
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + APE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 163 -------DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 215
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           D+              + Q +  A+  G   P      +  P ++  L+  CW     +R
Sbjct: 216 DM--------------SNQDVIKAIEEGYRLP----PPMDCPIALHQLMLDCWQKERSDR 257
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 258 PKFGQIVNMLDKLIRNPNSLK 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   E+ E+ +L   L   +   +
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +   ++YL ++  VHRD+   N+L++ NL   ++DFG++   E+      
Sbjct: 130 VIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED------ 183
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
                   P   +  +     + + APE +     +  SDV+S+GI + E+++ G  PY 
Sbjct: 184 -------DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 236
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           D+              + Q +  A+  G   P      +  P ++  L+  CW     +R
Sbjct: 237 DM--------------SNQDVIKAIEEGYRLP----PPMDCPIALHQLMLDCWQKERSDR 278
Query: 340 PSFSDIALELDLVLEHRKSLK 360
           P F  I   LD ++ +  SLK
Sbjct: 279 PKFGQIVNMLDKLIRNPNSLK 299

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 74  KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD+  AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 133 MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 180
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 181 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 223
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW  +P  RP+F 
Sbjct: 224 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 34/263 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T ++  +F  E  ++ + DHP +        K    M   EF E+ +L   L   +   +
Sbjct: 48  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 107
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL ++  VHR +   N+L++ NL   ++DFGL+ + E+      
Sbjct: 108 VIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED------ 161
Query: 221 KNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                +  PT   +   + G +   + APE ++    +  SDV+S+GI + E+++ G  P
Sbjct: 162 ----DTSDPT---YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y D+              T Q +  A+      P      +  P+++  L+  CW  + +
Sbjct: 215 YWDM--------------TNQDVINAIEQDYRLP----PPMDCPSALHQLMLDCWQKDRN 256
Query: 338 NRPSFSDIALELDLVLEHRKSLK 360
           +RP F  I   LD ++ +  SLK
Sbjct: 257 HRPKFGQIVNTLDKMIRNPNSLK 279

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 74  IARGAESVVYEAT--LDGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAA- 129
           + RG   VV+EA   +D    A+K+  L   E   +   +E++ L KL+HPG+ ++  A 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 130 ----------HAKPPNYMFF-FEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKA 174
                      + P  Y++   +     NL +    +  +EE   SV   L I  Q+A+A
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV--CLHIFLQIAEA 130
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL--AEYRENLKEISLKNWRSSGKPTGG 232
           +++LH+ G++HRD+KP+N+    +    + DFGL  A  ++  ++  L    +  + TG 
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG- 189
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
                 VGT +YM+PE +    +S K D++S G+ + ELL
Sbjct: 190 -----QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHE 240
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 241 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 299
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGL    E+ +  +               ++    
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA---------------RQGAKF 344
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 345 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 390
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           +   V  G   P         P S+  L+ +CW  +P  RP+F
Sbjct: 391 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKDPEERPTF 429

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 44/259 (16%)
Query: 92  VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           VAVK  +   + E++ F KE  ++ ++ HP L + +      P +    E+    NL + 
Sbjct: 60  VAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDY 118
Query: 152 L---HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
           L   + EE +  V  +L +A Q++ A++YL     +HRD+   N L+  N    +ADFGL
Sbjct: 119 LRECNREEVTAVV--LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGL 176
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGI 266
           +                    TG  +  +      + + APE L     S KSDV++FG+
Sbjct: 177 SRLM-----------------TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGV 219
Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
            + E+ T G+ PY  +   +Q + +LE  Y  +Q                   G P  + 
Sbjct: 220 LLWEIATYGMSPYPGIDL-SQVYDLLEKGYRMEQPE-----------------GCPPKVY 261
Query: 326 SLIQRCWDGNPHNRPSFSD 344
            L++ CW  +P +RPSF++
Sbjct: 262 ELMRACWKWSPADRPSFAE 280

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 137/314 (43%), Gaps = 55/314 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATL---DGR--KVAVK--KPILSTSEELDNFHKELQLL 115
           +P   +TL   + +G    V EA L   DG   KVAVK  K  +  S +++ F +E   +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 116 CKLDHPGLAKFVA------AHAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQV 164
            + DHP +AK V       A  + P  M    F +  +L     A ++    ++  +  +
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           +     +A  ++YL +   +HRD+   N +L  ++   +ADFGL                
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL---------------- 183
Query: 225 SSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
           S    +G ++++     L   ++A E L   +++  SDV++FG+++ E++T G  PY  +
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
                 + ++  N  +Q                         +  L+ +CW  +P  RPS
Sbjct: 244 ENAEIYNYLIGGNRLKQPPECM------------------EEVYDLMYQCWSADPKQRPS 285
Query: 342 FSDIALELDLVLEH 355
           F+ + +EL+ +L H
Sbjct: 286 FTCLRMELENILGH 299

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ ++AQ+A  + Y+  
Sbjct: 71  KLVQLYAVVSEEPIYIVT-EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------------ 177
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 178 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 220
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW   P  RP+F 
Sbjct: 221 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFE 260

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  +  L+  +  G    V+    +G      K +   S   D F  E  L+ +L H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----VDQVLMIAAQLAKALQ 176
            L +  A   + P Y+   E+ E+ +L + L     +PS     ++++L +AAQ+A+ + 
Sbjct: 65  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMA 119
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++     +HR+++ AN+L+   L   +ADFGLA   E+ +         + +    F  K
Sbjct: 120 FIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE--------YTAREGAKFPIK 171
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                  + APE +     + KSDV+SFGI + E++T G +PY  +    +    LE  Y
Sbjct: 172 -------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGY 223
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                        +RP         P  +  L++ CW   P +RP+F 
Sbjct: 224 RM-----------VRPD------NCPEELYQLMRLCWKERPEDRPTFD 254

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 35/273 (12%)
Query: 90  RKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146
           R VAV    L    T ++  +F  E  ++ + DHP +        +    M   EF E+ 
Sbjct: 70  RDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENG 129
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L   L   +   +V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DF
Sbjct: 130 ALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDF 189
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           GL+   E+  E            TGG         + + APE ++    +  SDV+S+GI
Sbjct: 190 GLSRVIEDDPEAVYTT-------TGGKI------PVRWTAPEAIQYRKFTSASDVWSYGI 236
Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
            + E+++ G  PY D+              + Q +  A+  G   P      +  PA + 
Sbjct: 237 VMWEVMSYGERPYWDM--------------SNQDVIKAIEEGYRLP----APMDCPAGLH 278
Query: 326 SLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
            L+  CW      RP F  I   LD ++ +  S
Sbjct: 279 QLMLDCWQKERAERPKFEQIVGILDKMIRNPNS 311

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 100 STSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAE---KLHVE 155
           ++ ++  +F  EL++LCKL H P +   + A           E+    NL +   K  V 
Sbjct: 61  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 120
Query: 156 EWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203
           E  P            S  Q+L  AA +A+ + YL     +HR++   N+L+  N    +
Sbjct: 121 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKI 180
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDV 261
           ADFGL+  +E                    + K  +G L   +MA E L   +++  SDV
Sbjct: 181 ADFGLSRGQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 221
Query: 262 YSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
           +S+G+ + E+++ G  PY  +   A+ +  L   Y  ++                  L  
Sbjct: 222 WSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLNC 263
Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
              +  L+++CW   P+ RPSF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 264 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 317

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A      V     ++ T   EEL+++  E+ +L   DHP
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A     N     EF     +   +   E   +  Q+ ++  Q   AL YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+L   +    LADFG          +S KN R+  +      + + +GT
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFG----------VSAKNTRTIQR------RDSFIGT 198
Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
             +MAPE++  E   +     K+DV+S GI++ E+     P+ +L
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 75  ARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133
           +  A  V+ ++  D GR     K I    EE+ N   E+ LL  LDHP + K        
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN---EISLLKSLDHPNIIKLFDVFEDK 118
Query: 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
             +    EFYE   L E++         D    I  Q+   + YLH   IVHRD+KP N+
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAA-NIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 194 LLDRN---LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL 250
           LL+     L   + DFGL+ +                  +  +  ++ +GT  Y+APE+L
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF-----------------FSKDYKLRDRLGTAYYIAPEVL 220
Query: 251 KKEIHSEKSDVYSFGISINELLTGVVPY 278
           KK+ ++EK DV+S G+ +  LL G  P+
Sbjct: 221 KKK-YNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 139/325 (42%), Gaps = 63/325 (19%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           +P  S  LL   ARG    V++A L    VAVK   L   +   +  +E+     + H  
Sbjct: 12  VPRGSLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHEN 70
Query: 123 LAKFVAAHAKPPNY----MFFFEFYESRNLAEKL--HVEEWSPSVDQVLMIAAQLAKALQ 176
           L +F+AA  +  N          F++  +L + L  ++  W    +++  +A  +++ L 
Sbjct: 71  LLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITW----NELCHVAETMSRGLS 126
Query: 177 YLH-----------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           YLH              I HRD K  NVLL  +L   LADFGLA   E            
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFE------------ 174
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTG------ 274
            GKP G  H +  VGT  YMAPE+L+  I+ ++      D+Y+ G+ + EL++       
Sbjct: 175 PGKPPGDTHGQ--VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232
Query: 275 -----VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSL 327
                ++P+ +   E   H  LE      +L   VV   +RP +    L  P  A +   
Sbjct: 233 PVDEYMLPFEE---EIGQHPSLE------ELQEVVVHKKMRPTIKDHWLKHPGLAQLCVT 283
Query: 328 IQRCWDGNPHNRPSFSDIALELDLV 352
           I+ CWD +   R S   +   + L+
Sbjct: 284 IEECWDHDAEARLSAGCVEERVSLI 308

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 68/327 (20%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 28  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 87
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 88  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 146
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 147 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 203
Query: 205 DFGLAE--YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSD 260
           DFG+A   YR                   G+++K     L   +M PE   + I + K+D
Sbjct: 204 DFGMARDIYR------------------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 245
Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLEL 318
            +SFG+ + E+ + G +PY               + + Q++   V SGG + P       
Sbjct: 246 TWSFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PK 286
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDI 345
             P  +  ++ +CW   P +RP+F+ I
Sbjct: 287 NCPGPVYRIMTQCWQHQPEDRPNFAII 313

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 65  PSSYTLLSPIARGAESVVY---------EATLDGRKVAVKKPILSTSEELDNFHKELQLL 115
           PS + LL  + +G+   V+            L   KV +KK  L   + +     E  +L
Sbjct: 27  PSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV-LKKATLKVRDRVRT-KMERDIL 84
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
             ++HP + K   A           +F    +L  +L  E      D V    A+LA  L
Sbjct: 85  ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALGL 143
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            +LH+LGI++RD+KP N+LLD      L DFGL+  +E +                  H+
Sbjct: 144 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KEAID-----------------HE 184
Query: 236 K---NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           K   +  GT+ YMAPE++ ++ HS  +D +S+G+ + E+LTG +P+
Sbjct: 185 KKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 36/284 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L   + +G    V+  T +G      K +   +   + F +E Q++ KL H 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P      E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 64  KLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA   E+ +  + +  +   K            
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK------------ 170
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 171 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 213
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
           +   V  G   P         P S+  L+ +CW   P  RP+F 
Sbjct: 214 VLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTFE 253

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A      V     ++ T   EEL+++  E+ +L   DHP
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A     N     EF     +   +   E   +  Q+ ++  Q   AL YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+L   +    LADFG          +S KN R   +      + + +GT
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFG----------VSAKNTRXIQR------RDSFIGT 198
Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
             +MAPE++  E   +     K+DV+S GI++ E+     P+ +L
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 68/327 (20%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 51  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 111 EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 169
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 170 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 226
Query: 205 DFGLAE--YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSD 260
           DFG+A   YR                   G+++K     L   +M PE   + I + K+D
Sbjct: 227 DFGMARDIYR------------------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLEL 318
            +SFG+ + E+ + G +PY               + + Q++   V SGG + P       
Sbjct: 269 TWSFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PK 309
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDI 345
             P  +  ++ +CW   P +RP+F+ I
Sbjct: 310 NCPGPVYRIMTQCWQHQPEDRPNFAII 336

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 23/226 (10%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           ++K  +STS       +E+ +L  LDHP + K         NY    E Y+   L +++ 
Sbjct: 70  IRKTSVSTSSN-SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAE 210
                  VD  ++I  Q+   + YLH   IVHRD+KP N+LL   +++    + DFGL+ 
Sbjct: 129 HRMKFNEVDAAVIIK-QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
             EN K++                 K  +GT  Y+APE+L+K+ + EK DV+S G+ +  
Sbjct: 188 VFENQKKM-----------------KERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFI 229
Query: 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
           LL G  P+     +     V +  YT        VS G + ++  +
Sbjct: 230 LLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 60/315 (19%)
Query: 52  GCCSSQSIP--------------LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKP 97
           G C   S+P                +P  S  L   +  G    V+ AT +       K 
Sbjct: 154 GLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 213
Query: 98  ILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEW 157
           +   S  ++ F  E  ++  L H  L K  A   K P Y+   EF    +L + L  +E 
Sbjct: 214 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG 272
Query: 158 SPS-VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
           S   + +++  +AQ+A+ + ++     +HRD++ AN+L+  +L   +ADFGLA       
Sbjct: 273 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKF- 331
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                                    + + APE +     + KSDV+SFGI + E++T G 
Sbjct: 332 ------------------------PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
           +PY  + +  +    LE  Y              RP         P  + +++ RCW   
Sbjct: 368 IPYPGM-SNPEVIRALERGYRMP-----------RP------ENCPEELYNIMMRCWKNR 409
Query: 336 PHNRPSFSDIALELD 350
           P  RP+F  I   LD
Sbjct: 410 PEERPTFEYIQSVLD 424

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A      V     ++ T   EEL+++  E+ +L   DHP
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A     N     EF     +   +   E   +  Q+ ++  Q   AL YLH+ 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+L   +    LADFG          +S KN R   +      +   +GT
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFG----------VSAKNTRXIQR------RDXFIGT 198
Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
             +MAPE++  E   +     K+DV+S GI++ E+     P+ +L
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 137/325 (42%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 25  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ KL+H  + + +    +        E     +L   L    
Sbjct: 85  EVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 200
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 201 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 245 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 285
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAII 310

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 40/296 (13%)
Query: 63  LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+    L+  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +        EF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +        L +  +S   T  F  K     
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSSTGT-KFPVK----- 170
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             + +PE+     +S KSDV+SFG+ + E+ + G +PY               N +  ++
Sbjct: 171 --WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------------NRSNSEV 214
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              + +G    +P LAS        +  ++  CW   P +RP+FS +  +L  + E
Sbjct: 215 VEDISTGFRLYKPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK------------ 201
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 247
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 248 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKK-PILSTSEELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   +    +E+++  +E+ +L + D
Sbjct: 5   PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K        E+     + +L E   ++E      Q+  I  ++ K L 
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 118
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K ANVLL  +    LADFG+A                 G+ T    K+
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 161
Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKK-PILSTSEELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   +    +E+++  +E+ +L + D
Sbjct: 5   PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K        E+     + +L E   ++E      Q+  I  ++ K L 
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 118
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K ANVLL  +    LADFG+A                 G+ T    K+
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 161
Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKK-PILSTSEELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   +    +E+++  +E+ +L + D
Sbjct: 20  PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K        E+     + +L E   ++E      Q+  I  ++ K L 
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 133
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K ANVLL  +    LADFG+A                 G+ T    K+
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 176
Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 177 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 146
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 194
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 240
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 241 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 25  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 85  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 143
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 200
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 201 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 245 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 285
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAII 310

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 202
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 248
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 249 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 31/226 (13%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKK-PILSTSEELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   +    +E+++  +E+ +L + D
Sbjct: 25  PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 83
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            P + K+  ++ K        E+     + +L E   ++E      Q+  I  ++ K L 
Sbjct: 84  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 138
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YLH+   +HRD+K ANVLL  +    LADFG+A                 G+ T    K+
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 181
Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 27  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 86
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 87  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 145
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 146 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 202
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 203 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 246
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 247 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 287
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 288 PGPVYRIMTQCWQHQPEDRPNFAII 312

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 197
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 243
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 244 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 2   PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 61
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 62  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 120
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 121 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 177
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 178 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 221
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 222 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 262
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 263 PGPVYRIMTQCWQHQPEDRPNFAII 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 172
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 220
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 266
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 267 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 152
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 200
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 246
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 247 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 202
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 248
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 249 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 70  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 128
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 185
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 186 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 230 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 270
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAII 295

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 201
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 247
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 248 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 151
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 199
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 245
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 246 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 25  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 85  EVYSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 200
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 201 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 245 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 285
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 286 PGPVYRIMTQCWQHQPEDRPNFAII 310

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK ++YL +   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKF 173
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK------------ 221
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------DITV 267
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 268 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 70  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 185
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 186 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 230 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 270
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAII 295

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 90/320 (28%), Positives = 137/320 (42%), Gaps = 71/320 (22%)
Query: 57  QSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLC 116
           QS+PL L       L   ARG    V++A L    VAVK   +   +   N + E+  L 
Sbjct: 22  QSMPLQL-------LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY-EVYSLP 73
Query: 117 KLDHPGLAKFVAAHAKPP----NYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQ 170
            + H  + +F+ A  +      +      F+E  +L++  K +V  W    +++  IA  
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSW----NELCHIAET 129
Query: 171 LAKALQYLH----------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           +A+ L YLH             I HRD+K  NVLL  NL   +ADFGLA   E       
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE------- 182
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTG- 274
                +GK  G  H +  VGT  YMAPE+L+  I+ ++      D+Y+ G+ + EL +  
Sbjct: 183 -----AGKSAGDTHGQ--VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 275 ----------VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL---ELGLP 321
                     ++P+ +   E   H  LE       +   VV    RP+L        G+ 
Sbjct: 236 TAADGPVDEYMLPFEE---EIGQHPSLE------DMQEVVVHKKKRPVLRDYWQKHAGM- 285
Query: 322 ASILSLIQRCWDGNPHNRPS 341
           A +   I+ CWD +   R S
Sbjct: 286 AMLCETIEECWDHDAEARLS 305

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
            E ++ +  + G++ AVK   K  +    + ++  +E+QLL +LDHP + K         
Sbjct: 63  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 122
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
            +    E Y    L +++   +    VD   +I  Q+   + Y+H   IVHRD+KP N+L
Sbjct: 123 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QVLSGITYMHKNKIVHRDLKPENLL 181
Query: 195 LD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           L+   ++    + DFGL+ + E  K++                 K+ +GT  Y+APE+L 
Sbjct: 182 LESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKIGTAYYIAPEVLH 224
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
              + EK DV+S G+ +  LL+G  P+
Sbjct: 225 G-TYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
            E ++ +  + G++ AVK   K  +    + ++  +E+QLL +LDHP + K         
Sbjct: 64  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 123
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
            +    E Y    L +++   +    VD   +I  Q+   + Y+H   IVHRD+KP N+L
Sbjct: 124 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QVLSGITYMHKNKIVHRDLKPENLL 182
Query: 195 LD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           L+   ++    + DFGL+ + E  K++                 K+ +GT  Y+APE+L 
Sbjct: 183 LESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKIGTAYYIAPEVLH 225
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
              + EK DV+S G+ +  LL+G  P+
Sbjct: 226 G-TYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 34/263 (12%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T  +   F  E  ++ + +HP + +           M   EF E+  L   L + +   +
Sbjct: 55  TERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFT 114
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL  +  VHRD+   N+L++ NL   ++DFGL+ + E       
Sbjct: 115 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE------ 168
Query: 221 KNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
               +S  PT   +  ++ G +   + APE +     +  SD +S+GI + E+++ G  P
Sbjct: 169 ----NSSDPT---YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y D+ +       +E +Y             L P         P S+  L+  CW  + +
Sbjct: 222 YWDM-SNQDVINAIEQDYR------------LPP-----PPDCPTSLHQLMLDCWQKDRN 263
Query: 338 NRPSFSDIALELDLVLEHRKSLK 360
            RP F  +   LD ++ +  SLK
Sbjct: 264 ARPRFPQVVSALDKMIRNPASLK 286

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAH 130
           I RG    V+   L  D   VAVK    +   +L   F +E ++L +  HP + + +   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
            +        E  +  +    L  E     V  +L +    A  ++YL +   +HRD+  
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 191 ANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL 250
            N L+       ++DFG++  RE    +           +GG  +  +  T    APE L
Sbjct: 242 RNCLVTEKNVLKISDFGMS--REEADGVX--------AASGGLRQVPVKWT----APEAL 287
Query: 251 KKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL 309
               +S +SDV+SFGI + E  + G  PY +L              + QQ    V  GG 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNL--------------SNQQTREFVEKGGR 333
Query: 310 RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P     EL  P ++  L+++CW   P  RPSFS I  EL  +
Sbjct: 334 LP---CPEL-CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
            E ++ +  + G++ AVK   K  +    + ++  +E+QLL +LDHP + K         
Sbjct: 46  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 105
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
            +    E Y    L +++   +    VD   +I  Q+   + Y+H   IVHRD+KP N+L
Sbjct: 106 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QVLSGITYMHKNKIVHRDLKPENLL 164
Query: 195 LD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           L+   ++    + DFGL+ + E  K++                 K+ +GT  Y+APE+L 
Sbjct: 165 LESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKIGTAYYIAPEVLH 207
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
              + EK DV+S G+ +  LL+G  P+
Sbjct: 208 G-TYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
            E ++ +  + G++ AVK   K  +    + ++  +E+QLL +LDHP + K         
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
            +    E Y    L +++   +    VD   +I  Q+   + Y+H   IVHRD+KP N+L
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QVLSGITYMHKNKIVHRDLKPENLL 158
Query: 195 LD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           L+   ++    + DFGL+ + E  K++                 K+ +GT  Y+APE+L 
Sbjct: 159 LESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKIGTAYYIAPEVLH 201
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
              + EK DV+S G+ +  LL+G  P+
Sbjct: 202 G-TYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 72  SPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           S + RGA S+VY     G +      +L  + +      E+ +L +L HP + K      
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
            P       E      L +++ VE+   S         Q+ +A+ YLH  GIVHRD+KP 
Sbjct: 119 TPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 192 NVLL-----DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           N+L      D  L   +ADFGL++  E+                     K + GT  Y A
Sbjct: 178 NLLYATPAPDAPL--KIADFGLSKIVEH-----------------QVLMKTVCGTPGYCA 218
Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
           PEIL+   +  + D++S GI    LL G  P+ D R +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 36/283 (12%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAH 130
           I RG    V+   L  D   VAVK    +   +L   F +E ++L +  HP + + +   
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
            +        E  +  +    L  E     V  +L +    A  ++YL +   +HRD+  
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 191 ANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL 250
            N L+       ++DFG++  RE    +           +GG  +  +  T    APE L
Sbjct: 242 RNCLVTEKNVLKISDFGMS--REEADGVY--------AASGGLRQVPVKWT----APEAL 287
Query: 251 KKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL 309
               +S +SDV+SFGI + E  + G  PY +L              + QQ    V  GG 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNL--------------SNQQTREFVEKGGR 333
Query: 310 RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
            P     EL  P ++  L+++CW   P  RPSFS I  EL  +
Sbjct: 334 LP---CPEL-CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 179
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +MAPE++ ++ +  K D++S GI   E++ G  PY
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------EMVGT 179
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +MAPE++ ++ +  K D++S GI   E++ G  PY
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS---TSEELDNFHKELQLLCKLDH 120
           P   +T L  I +G+   VY+   +  K  V   I+      +E+++  +E+ +L + D 
Sbjct: 17  PEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 76
Query: 121 PGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           P + ++  ++ K        E+     + +L +   +EE       +  I  ++ K L Y
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE-----TYIATILREILKGLDY 131
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH+   +HRD+K ANVLL       LADFG+A                 G+ T    K+N
Sbjct: 132 LHSERKIHRDIKAANVLLSEQGDVKLADFGVA-----------------GQLTDTQIKRN 174
Query: 238 -MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
             VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P +DL
Sbjct: 175 XFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 38/288 (13%)
Query: 74  IARGAESVVYEAT-LDGRKVAVKKPILSTS-----EELDNFHKELQLLCKLDHPGLAKFV 127
           I +G   VVY    +D  +  ++  I S S     ++++ F +E  L+  L+HP +   +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 AAHAKPPNYMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
                P         Y    +L + +   + +P+V  ++    Q+A+ ++YL     VHR
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR 148
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+   N +LD +    +ADFGLA    + +  S++  R +  P              + A
Sbjct: 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK------------WTA 196
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
            E L+    + KSDV+SFG+ + ELLT G  PY  +      H + +     Q       
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC--- 253
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
                          P S+  ++Q+CW+ +P  RP+F  +  E++ ++
Sbjct: 254 ---------------PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN    G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 11  PNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ KL+H  + + +    +        E     +L   L    
Sbjct: 71  EVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 186
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 187 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 231 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 271
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAII 296

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 36/264 (13%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
           T  +   F  E  ++ + +HP + +           M   EF E+  L   L + +   +
Sbjct: 57  TERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFT 116
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
           V Q++ +   +A  ++YL  +  VHRD+   N+L++ NL   ++DFGL+ + E       
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE------ 170
Query: 221 KNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
               +S  PT    + + +G  I   + APE +     +  SD +S+GI + E+++ G  
Sbjct: 171 ----NSSDPT----ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 222
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY D+ +       +E +Y             L P         P S+  L+  CW  + 
Sbjct: 223 PYWDM-SNQDVINAIEQDYR------------LPP-----PPDCPTSLHQLMLDCWQKDR 264
Query: 337 HNRPSFSDIALELDLVLEHRKSLK 360
           + RP F  +   LD ++ +  SLK
Sbjct: 265 NARPRFPQVVSALDKMIRNPASLK 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 203
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 249
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 250 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------XMVGT 179
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +MAPE++ ++ +  K D++S GI   E++ G  PY
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 88  DGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
           +GR  A+K   K I+   +++++ + E  +L  + HP + +               ++ E
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
              L   L   +  P+       AA++  AL+YLH+  I++RD+KP N+LLD+N    + 
Sbjct: 90  GGELFSLLRKSQRFPN-PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKIT 148
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSF 264
           DFG A+Y  ++                      + GT  Y+APE++  + +++  D +SF
Sbjct: 149 DFGFAKYVPDV-------------------TYXLCGTPDYIAPEVVSTKPYNKSIDWWSF 189
Query: 265 GISINELLTGVVPYTD 280
           GI I E+L G  P+ D
Sbjct: 190 GILIYEMLAGYTPFYD 205

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 48/293 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 202
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 248
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
            ++ G   L+P         P  +  ++ +CW      RPSFS++   +  + 
Sbjct: 249 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 159
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 207
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 253
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 254 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 40/248 (16%)
Query: 105 LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQ 163
           ++  ++E+ +L KLDHP + K V      PN    +  +E  N    + V    P S DQ
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKN 222
                  L K ++YLH   I+HRD+KP+N+L+  +    +ADFG++ E++ +   +S   
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS--- 195
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKS-DVYSFGISINELLTGVVPYT 279
                         N VGT  +MAPE L   ++I S K+ DV++ G+++   + G  P+ 
Sbjct: 196 --------------NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           D R          +     ++ +  +    +P +A         +  LI R  D NP +R
Sbjct: 242 DER----------IMCLHSKIKSQALEFPDQPDIAE-------DLKDLITRMLDKNPESR 284
Query: 340 PSFSDIAL 347
               +I L
Sbjct: 285 IVVPEIKL 292

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 152
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 200
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 246
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 247 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 202
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 248
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 249 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 19  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 78
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------XMVGT 180
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +MAPE++ ++ +  K D++S GI   E++ G  PY
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 137/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T E+L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)
Query: 74  IARGAESVVYEAT-LDGRKV----AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           + +G  +  YE T +D ++V     V K +L    + +    E+ +   LD+P +  F  
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
                       E    R+L E LH    + +  +      Q  + +QYLHN  ++HRD+
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 152
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K  N+ L+ ++   + DFGLA   E                  G  KK++ GT  Y+APE
Sbjct: 153 KLGNLFLNDDMDVKIGDFGLATKIE----------------FDGERKKDLCGTPNYIAPE 196
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           +L K+ HS + D++S G  +  LL G  P+          + L+  Y   +     V   
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET--------SCLKETYIRIKKNEYSVPRH 248
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           + P+ +           +LI+R    +P  RPS +++
Sbjct: 249 INPVAS-----------ALIRRMLHADPTLRPSVAEL 274

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 48/293 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK------------ 261
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 307
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
            ++ G   L+P         P  +  ++ +CW      RPSFS++   +  + 
Sbjct: 308 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 88  DGRKVAVKKPILSTSEELD-----NFHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MF 138
           D R VAVK  +L      D      F +E Q    L+HP + A +    A+ P       
Sbjct: 36  DHRDVAVK--VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93
Query: 139 FFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
             E+ +   L + +H E   +P   + + + A   +AL + H  GI+HRDVKPAN+L+  
Sbjct: 94  VMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
                + DFG+A         ++ +  +S   T       ++GT  Y++PE  + +    
Sbjct: 152 TNAVKVVDFGIAR--------AIADSGNSVXQTAA-----VIGTAQYLSPEQARGDSVDA 198
Query: 258 KSDVYSFGISINELLTGVVPYT 279
           +SDVYS G  + E+LTG  P+T
Sbjct: 199 RSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 74  IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL   DG+K+  AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 128 A----AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                +   P   + + +  + RN       E  +P+V  ++    Q+AK +++L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           VHRD+   N +LD      +ADFGLA    + +  S+ N   +  P              
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK------------ 203
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+                  +T 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------------FDITV 249
Query: 303 AVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            ++ G   L+P         P  +  ++ +CW      RPSFS++ 
Sbjct: 250 YLLQGRRLLQPEYC------PDPLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQL---LCKL-D 119
           S Y L   + +GA SVV      L G++ A K  I++T +     H++L+    +C+L  
Sbjct: 22  SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAK--IINTKKLSARDHQKLEREARICRLLK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP + +   + ++  ++   F+      L E +   E+    D    I  Q+ +A+ + H
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH 138
Query: 180 NLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
            +G+VHRD+KP N+LL   L      LADFGLA   E             G+    F   
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-------------GEQQAWF--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
              GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P+ D
Sbjct: 183 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT    G++VAVKK  L   +  +    E+ ++    H  +    +++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL YLHN G++HRD+K  
Sbjct: 113 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 170
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 171 SILLTSDGRIKLSDFGFCA--QVSKEVP--------------KRKXLVGTPYWMAPEVIS 214
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)
Query: 74  IARGAESVVYEAT-LDGRKV----AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           + +G  +  YE T +D ++V     V K +L    + +    E+ +   LD+P +  F  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
                       E    R+L E LH    + +  +      Q  + +QYLHN  ++HRD+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K  N+ L+ ++   + DFGLA   E                  G  KK++ GT  Y+APE
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLATKIE----------------FDGERKKDLCGTPNYIAPE 212
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           +L K+ HS + D++S G  +  LL G  P+          + L+  Y   +     V   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET--------SCLKETYIRIKKNEYSVPRH 264
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           + P+ +           +LI+R    +P  RPS +++
Sbjct: 265 INPVAS-----------ALIRRMLHADPTLRPSVAEL 290

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A     G   A K     + EEL+++  E+++L   DHP
Sbjct: 17  PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A+          EF     +   +   +   +  Q+ ++  Q+ +AL +LH+ 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  NVL+       LADFG          +S KN ++  K      + + +GT
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFG----------VSAKNLKTLQK------RDSFIGT 180
Query: 242 LIYMAPEI-----LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
             +MAPE+     +K   +  K+D++S GI++ E+     P+ +L
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A     G   A K     + EEL+++  E+++L   DHP
Sbjct: 9   PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A+          EF     +   +   +   +  Q+ ++  Q+ +AL +LH+ 
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  NVL+       LADFG          +S KN ++  K      + + +GT
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFG----------VSAKNLKTLQK------RDSFIGT 172
Query: 242 LIYMAPEI-----LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
             +MAPE+     +K   +  K+D++S GI++ E+     P+ +L
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 133/325 (40%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN    G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 11  PNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 71  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 186
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A+            +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 187 DFGMAQ----------DIYRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 231 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 271
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAII 296

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN    G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 17  PNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 76
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 77  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 135
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 136 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 192
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 193 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 236
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 237 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 277
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 278 PGPVYRIMTQCWQHQPEDRPNFAII 302

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 74  IARGAESVVYEAT-LDGRKV----AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           + +G  +  YE T +D ++V     V K +L    + +    E+ +   LD+P +  F  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
                       E    R+L E LH    + +  +      Q  + +QYLHN  ++HRD+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K  N+ L+ ++   + DFGLA   E                  G  KK + GT  Y+APE
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLATKIE----------------FDGERKKTLCGTPNYIAPE 212
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           +L K+ HS + D++S G  +  LL G  P+          + L+  Y   +     V   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET--------SCLKETYIRIKKNEYSVPRH 264
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           + P+ +           +LI+R    +P  RPS +++
Sbjct: 265 INPVAS-----------ALIRRMLHADPTLRPSVAEL 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
            E ++ +  + G++ AVK   K  +    + ++  +E+QLL +LDHP + K         
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKG 99
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
            +    E Y    L +++   +    VD   +I  Q+   + Y H   IVHRD+KP N+L
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QVLSGITYXHKNKIVHRDLKPENLL 158
Query: 195 LD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           L+   ++    + DFGL+ + E  K+                  K+ +GT  Y+APE+L 
Sbjct: 159 LESKSKDANIRIIDFGLSTHFEASKK-----------------XKDKIGTAYYIAPEVLH 201
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
              + EK DV+S G+ +  LL+G  P+
Sbjct: 202 G-TYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 26/222 (11%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKK----PILSTSEELDNFHKELQLLCKLD 119
           +++ +   I RG  S VY A   LDG  VA+KK     ++      D   KE+ LL +L+
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLN 90
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQ--VLMIAAQLAKALQ 176
           HP + K+ A+  +        E  ++ +L+  + H ++    + +  V     QL  AL+
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++H+  ++HRD+KPANV +       L D GL  +              S K T      
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------------FSSKTTAA---H 194
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           ++VGT  YM+PE + +  ++ KSD++S G  + E+     P+
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 89/360 (24%), Positives = 147/360 (40%), Gaps = 69/360 (19%)
Query: 16  FVRKTQVLLSSKYGLQ-----FFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTL 70
           + RK Q L + +  LQ        L +   +    PN    G  SS S    +P  + TL
Sbjct: 2   YRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITL 61
Query: 71  LSPIARGAESVVYEATLDGR-------KVAVKK--PILSTSEELDNFHKELQLLCKLDHP 121
           +  +  GA   VYE  + G        +VAVK    + S  +ELD F  E  ++ K +H 
Sbjct: 62  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQ 120
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS------VDQVLMIAAQLAKAL 175
            + + +    +        E     +L   L      PS      +  +L +A  +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCP------HLADFGLAEYRENLKEISLKNWRSSGKP 229
           QYL     +HRD+   N LL    CP       + DFG+A      ++I    +R+S   
Sbjct: 181 QYLEENHFIHRDIAARNCLLT---CPGPGRVAKIGDFGMA------RDI----YRAS--- 224
Query: 230 TGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
              +++K     L   +M PE   + I + K+D +SFG+ + E+ + G +PY        
Sbjct: 225 ---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP------- 274
Query: 287 AHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                  + + Q++   V SGG + P         P  +  ++ +CW   P +RP+F+ I
Sbjct: 275 -------SKSNQEVLEFVTSGGRMDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFAII 322

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 108 FHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MFFFEFYESRNLAEKLHVE-EWSPSVD 162
           F +E Q    L+HP + A +    A+ P         E+ +   L + +H E   +P   
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-- 116
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + + + A   +AL + H  GI+HRDVKPAN+++       + DFG+A         ++ +
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------AIAD 168
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             +S   T       ++GT  Y++PE  + +    +SDVYS G  + E+LTG  P+T
Sbjct: 169 SGNSVTQTAA-----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 64/325 (19%)
Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKK-- 96
           PN    G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 11  PNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 70
Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE 156
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 71  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 129
Query: 157 WSPS------VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLA 204
             PS      +  +L +A  +A   QYL     +HRD+   N LL    CP       + 
Sbjct: 130 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT---CPGPGRVAKIG 186
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVY 262
           DFG+A      ++I    +R+S      +++K     L   +M PE   + I + K+D +
Sbjct: 187 DFGMA------RDI----YRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230
Query: 263 SFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGL 320
           SFG+ + E+ + G +PY               + + Q++   V SGG + P         
Sbjct: 231 SFGVLLWEIFSLGYMPYP--------------SKSNQEVLEFVTSGGRMDP-----PKNC 271
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
           P  +  ++ +CW   P +RP+F+ I
Sbjct: 272 PGPVYRIMTQCWQHQPEDRPNFAII 296

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 108/230 (46%), Gaps = 41/230 (17%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---------KPILSTSEELDNFHKELQLLC 116
           Y L   I +GA SVV        G++ AVK          P LST    ++  +E  +  
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST----EDLKREASICH 81
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----WSPSVDQVLMIAAQL 171
            L HP + + +  ++        FEF +  +L  ++         +S +V    M   Q+
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM--RQI 139
Query: 172 AKALQYLHNLGIVHRDVKPANVLL--DRNLCP-HLADFGLAEYRENLKEISLKNWRSSGK 228
            +AL+Y H+  I+HRDVKP NVLL    N  P  L DFG+A        I L     SG 
Sbjct: 140 LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--------IQLGE---SGL 188
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             GG      VGT  +MAPE++K+E + +  DV+  G+ +  LL+G +P+
Sbjct: 189 VAGG-----RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +E++LL KLDHP + K         ++    E Y    L +++ ++    S      I  
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAE-YRENLKEISLKNWRS 225
           Q+   + Y+H   IVHRD+KP N+LL   +++    + DFGL+  +++N K         
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--------- 179
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                     K+ +GT  Y+APE+L+   + EK DV+S G+ +  LL+G  P+
Sbjct: 180 ---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 137/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 60  PLHLPPSSYTLLSPIARGAESVVYE---------ATLDGRKVAVKKPILSTSEELDNFHK 110
           P  + P  + LL  + +G    V++           +   KV  K  I+  +++  +   
Sbjct: 11  PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           E  +L ++ HP +   + A           E+     L  +L  E      D      A+
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-DTACFYLAE 129
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           ++ AL +LH  GI++RD+KP N++L+      L DFGL   +E++ + ++ +        
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTH-------- 179
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
                    GT+ YMAPEIL +  H+   D +S G  + ++LTG  P+T
Sbjct: 180 ------TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 88  DGRKVAVKKPILSTSEELD-----NFHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MF 138
           D R VAVK  +L      D      F +E Q    L+HP + A +    A+ P       
Sbjct: 36  DHRDVAVK--VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93
Query: 139 FFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
             E+ +   L + +H E   +P   + + + A   +AL + H  GI+HRDVKPAN+++  
Sbjct: 94  VMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
                + DFG+A         ++ +  +S   T       ++GT  Y++PE  + +    
Sbjct: 152 TNAVKVMDFGIAR--------AIADSGNSVTQTAA-----VIGTAQYLSPEQARGDSVDA 198
Query: 258 KSDVYSFGISINELLTGVVPYT 279
           +SDVYS G  + E+LTG  P+T
Sbjct: 199 RSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 88  DGRKVAVKKPILSTSEELD-----NFHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MF 138
           D R VAVK  +L      D      F +E Q    L+HP + A +    A+ P       
Sbjct: 36  DHRDVAVK--VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93
Query: 139 FFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
             E+ +   L + +H E   +P   + + + A   +AL + H  GI+HRDVKPAN+++  
Sbjct: 94  VMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
                + DFG+A         ++ +  +S   T       ++GT  Y++PE  + +    
Sbjct: 152 TNAVKVMDFGIAR--------AIADSGNSVTQTAA-----VIGTAQYLSPEQARGDSVDA 198
Query: 258 KSDVYSFGISINELLTGVVPYT 279
           +SDVYS G  + E+LTG  P+T
Sbjct: 199 RSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 146/320 (45%), Gaps = 37/320 (11%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVK--KPILSTSEELDNFHKELQLLCK 117
           L +   +++  + + RG    VY+  L DG  VAVK  K       EL  F  E++++  
Sbjct: 33  LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEVEMISM 91
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-EWSPSVD--QVLMIAAQLAKA 174
             H  L +       P   +  + +  + ++A  L    E  P +D  +   IA   A+ 
Sbjct: 92  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 151
Query: 175 LQYLHNL---GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
           L YLH+     I+HRDVK AN+LLD      + DFGLA+         L +++       
Sbjct: 152 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---------LMDYKDX----- 197
Query: 232 GFHKKNMV-GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
             H    V GT+ ++APE L     SEK+DV+ +G+ + EL+TG   + DL   A    V
Sbjct: 198 --HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDV 254
Query: 291 LEMNYT----EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
           + +++     +++   A+V   L+      E+     ++ +   C   +P  RP  S++ 
Sbjct: 255 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV---EQLIQVALLCTQSSPMERPKMSEVV 311
Query: 347 --LELDLVLEHRKSLKEEDL 364
             LE D + E  +  ++E++
Sbjct: 312 RMLEGDGLAERWEEWQKEEM 331

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 74  IARGAESVVYEAT-LDGRKV----AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           + +G  +  YE T +D ++V     V K +L    + +    E+ +   LD+P +  F  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
                       E    R+L E LH    + +  +      Q  + +QYLHN  ++HRD+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 168
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           K  N+ L+ ++   + DFGLA   E                  G  KK + GT  Y+APE
Sbjct: 169 KLGNLFLNDDMDVKIGDFGLATKIE----------------FDGERKKXLCGTPNYIAPE 212
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           +L K+ HS + D++S G  +  LL G  P+          + L+  Y   +     V   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET--------SCLKETYIRIKKNEYSVPRH 264
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           + P+ +           +LI+R    +P  RPS +++
Sbjct: 265 INPVAS-----------ALIRRMLHADPTLRPSVAEL 290

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +E++LL KLDHP + K         ++    E Y    L +++ ++    S      I  
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAE-YRENLKEISLKNWRS 225
           Q+   + Y+H   IVHRD+KP N+LL   +++    + DFGL+  +++N K         
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--------- 179
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                     K+ +GT  Y+APE+L+   + EK DV+S G+ +  LL+G  P+
Sbjct: 180 ---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 133/321 (41%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  G       AE+V  +       V V   +L   +T ++L +   E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 137
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 198 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 242 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 283
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 284 HAVPSQRPTFKQLVEDLDRIL 304

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 19  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 78
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L +   V E      Q+  +  +  +AL++LH+ 
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 136
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HR++K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 180
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             +MAPE++ ++ +  K D++S GI   E++ G  PY
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +E++LL KLDHP + K         ++    E Y    L +++ ++    S      I  
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIK 128
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAE-YRENLKEISLKNWRS 225
           Q+   + Y+H   IVHRD+KP N+LL   +++    + DFGL+  +++N K         
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--------- 179
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                     K+ +GT  Y+APE+L+   + EK DV+S G+ +  LL+G  P+
Sbjct: 180 ---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 60  PLHLPPSSYTLLSPIARGAESVVYE---------ATLDGRKVAVKKPILSTSEELDNFHK 110
           P  + P  + LL  + +G    V++           +   KV  K  I+  +++  +   
Sbjct: 11  PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           E  +L ++ HP +   + A           E+     L  +L  E      D      A+
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME-DTACFYLAE 129
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           ++ AL +LH  GI++RD+KP N++L+      L DFGL   +E++ +         G  T
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHD---------GTVT 178
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             F      GT+ YMAPEIL +  H+   D +S G  + ++LTG  P+T
Sbjct: 179 HXF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 133/321 (41%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  G       AE+V  +       V V   +L   +T ++L +   E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 139
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 200 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 244 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 285
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 286 HAVPSQRPTFKQLVEDLDRIL 306

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 137/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 133/321 (41%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  G       AE+V  +       V V   +L   +T ++L +   E
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 83  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 142
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 203 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 247 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 288
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 289 HAVPSQRPTFKQLVEDLDRIL 309

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVY------EATLDGRKVAVKKPILSTSEELDNFHKELQLL 115
           H  PS +  L  I +G+   V       E      KV  KK IL   EE     +   LL
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAK 173
             + HP L     +        F  ++     L   L  E     P   +    AA++A 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIAS 150
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           AL YLH+L IV+RD+KP N+LLD      L DFGL   +EN++  S  +           
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTS----------- 197
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                 GT  Y+APE+L K+ +    D +  G  + E+L G+ P+
Sbjct: 198 ---TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 133/321 (41%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  G       AE+V  +       V V   +L   +T ++L +   E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 257 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 301 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 342
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 343 HAVPSQRPTFKQLVEDLDRIL 363

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 137/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 108 FHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MFFFEFYESRNLAEKLHVE-EWSPSVD 162
           F +E Q    L+HP + A +    A+ P         E+ +   L + +H E   +P   
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-- 116
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + + + A   +AL + H  GI+HRDVKPAN+++       + DFG+A         ++ +
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------AIAD 168
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             +S   T       ++GT  Y++PE  + +    +SDVYS G  + E+LTG  P+T
Sbjct: 169 SGNSVTQTAA-----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 35/291 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L+  +  G    V+    +       K +   +  +  F +E  L+  L H 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV-DQVLMIAAQLAKALQYLHN 180
            L +  A   +        E+    +L + L  +E    +  +++  +AQ+A+ + Y+  
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 128
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ ANVL+  +L   +ADFGLA   E+ +         + +    F  K    
Sbjct: 129 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--------YTAREGAKFPIK---- 176
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE +     + KSDV+SFGI + E++T G +PY   R  A   T L   Y   +
Sbjct: 177 ---WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPG-RTNADVMTALSQGYRMPR 232
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +                    P  +  +++ CW      RP+F  +   LD
Sbjct: 233 VE-----------------NCPDELYDIMKMCWKEKAEERPTFDYLQSVLD 266

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKK-PILSTSEELDNFHKELQLLCKLD 119
           P   +T L  I +G+   V++  +D R    VA+K   +    +E+++  +E+ +L + D
Sbjct: 21  PEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
              + K+  ++ K        E+    +  + L    +     Q+  +  ++ K L YLH
Sbjct: 80  SSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF--QIATMLKEILKGLDYLH 137
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-M 238
           +   +HRD+K ANVLL       LADFG+A                 G+ T    K+N  
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVA-----------------GQLTDTQIKRNTF 180
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           VGT  +MAPE++++  +  K+D++S GI+  EL  G  P +D+
Sbjct: 181 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 108 FHKELQLLCKLDHPGL-AKFVAAHAKPPNY---MFFFEFYESRNLAEKLHVE-EWSPSVD 162
           F +E Q    L+HP + A +    A+ P         E+ +   L + +H E   +P   
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-- 133
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + + + A   +AL + H  GI+HRDVKPAN+++       + DFG+A         ++ +
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------AIAD 185
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             +S   T       ++GT  Y++PE  + +    +SDVYS G  + E+LTG  P+T
Sbjct: 186 SGNSVTQTAA-----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 68  YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLA 124
           Y  L  +  G   VVY+A    GR VA+K+  L   +E       +E+ LL +L HP + 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
             +            FEF E ++L + L   +      Q+ +   QL + + + H   I+
Sbjct: 83  SLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+L++ +    LADFGLA              R+ G P   +  +  V TL Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLA--------------RAFGIPVRSYTHE--VVTLWY 185
Query: 245 MAPEILK-KEIHSEKSDVYSFGISINELLTG 274
            AP++L   + +S   D++S G    E++TG
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 68  YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLA 124
           Y  L  +  G   VVY+A    GR VA+K+  L   +E       +E+ LL +L HP + 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
             +            FEF E ++L + L   +      Q+ +   QL + + + H   I+
Sbjct: 83  SLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+L++ +    LADFGLA              R+ G P   +  +  V TL Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLA--------------RAFGIPVRSYTHE--VVTLWY 185
Query: 245 MAPEILK-KEIHSEKSDVYSFGISINELLTG 274
            AP++L   + +S   D++S G    E++TG
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 74  IARGAESVVYEATLDG-------RKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAK 125
           I  GA   V++A   G         VAVK      S ++  +F +E  L+ + D+P + K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 F--VAAHAKPPNYMFFFEFYESRN------------------LAEKLHVEEWSP---SVD 162
              V A  KP   +F +  Y   N                  L+ +  V    P   S  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + L IA Q+A  + YL     VHRD+   N L+  N+   +ADFGL+         S   
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSADY 229
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
           +++ G         N    + +M PE +    ++ +SDV+++G+ + E+ + G+ PY  +
Sbjct: 230 YKADG---------NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
             E   + V + N                 ILA  E   P  + +L++ CW   P +RPS
Sbjct: 281 AHEEVIYYVRDGN-----------------ILACPE-NCPLELYNLMRLCWSKLPADRPS 322
Query: 342 FSDI 345
           F  I
Sbjct: 323 FCSI 326

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 59/261 (22%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFF--EFYESRNLA--------EKLHVEEWSPS 160
           E+ LL +L HP + ++        N   +   E+ E  +LA        E+ +++E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE---- 110
Query: 161 VDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
            + VL +  QL  AL+  H        ++HRD+KPANV LD      L DFGLA    + 
Sbjct: 111 -EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
           ++ +                K  VGT  YM+PE + +  ++EKSD++S G  + EL   +
Sbjct: 170 EDFA----------------KEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR--PILASLELGLPASILSLIQRCWD 333
            P+T               +++++L   +  G  R  P   S EL        +I R  +
Sbjct: 214 PPFT--------------AFSQKELAGKIREGKFRRIPYRYSDELN------EIITRMLN 253
Query: 334 GNPHNRPSFSDIALELDLVLE 354
              ++RPS  +I LE  L+LE
Sbjct: 254 LKDYHRPSVEEI-LENPLILE 273

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 118/291 (40%), Gaps = 35/291 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            +P  S  L+  +  G    V+    +       K +   +  +  F +E  L+  L H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV-DQVLMIAAQLAKALQYLHN 180
            L +  A   K        EF    +L + L  +E    +  +++  +AQ+A+ + Y+  
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ ANVL+  +L   +ADFGLA   E+ +         + +    F  K    
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--------YTAREGAKFPIK---- 175
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE +     + KS+V+SFGI + E++T G +PY   R  A   + L   Y   +
Sbjct: 176 ---WTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPG-RTNADVMSALSQGYRMPR 231
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +                    P  +  +++ CW      RP+F  +   LD
Sbjct: 232 ME-----------------NCPDELYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 59/261 (22%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFF--EFYESRNLA--------EKLHVEEWSPS 160
           E+ LL +L HP + ++        N   +   E+ E  +LA        E+ +++E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE---- 110
Query: 161 VDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
            + VL +  QL  AL+  H        ++HRD+KPANV LD      L DFGLA      
Sbjct: 111 -EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----- 164
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
               + N  +S         K  VGT  YM+PE + +  ++EKSD++S G  + EL   +
Sbjct: 165 ----ILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR--PILASLELGLPASILSLIQRCWD 333
            P+T               +++++L   +  G  R  P   S EL        +I R  +
Sbjct: 214 PPFT--------------AFSQKELAGKIREGKFRRIPYRYSDELN------EIITRMLN 253
Query: 334 GNPHNRPSFSDIALELDLVLE 354
              ++RPS  +I LE  L+LE
Sbjct: 254 LKDYHRPSVEEI-LENPLILE 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 129/310 (41%), Gaps = 45/310 (14%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELD 106
            SQS+   +      LL  +  G+  VV     D   G+ V+V     K  +LS  E +D
Sbjct: 1   GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 60
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +F +E+  +  LDH  L +       PP  M   E     +L ++L   +    +  +  
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRS 225
            A Q+A+ + YL +   +HRD+   N+LL       + DFGL     +N     ++    
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--- 176
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE 284
                   H+K       + APE LK    S  SD + FG+++ E+ T G  P+  L   
Sbjct: 177 --------HRKV---PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 225
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
              H +   +   ++L         RP         P  I +++ +CW   P +RP+F  
Sbjct: 226 QILHKI---DKEGERLP--------RP------EDCPQDIYNVMVQCWAHKPEDRPTF-- 266
Query: 345 IALELDLVLE 354
           +AL  D +LE
Sbjct: 267 VALR-DFLLE 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 129/310 (41%), Gaps = 45/310 (14%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELD 106
            SQS+   +      LL  +  G+  VV     D   G+ V+V     K  +LS  E +D
Sbjct: 1   GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 60
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +F +E+  +  LDH  L +       PP  M   E     +L ++L   +    +  +  
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRS 225
            A Q+A+ + YL +   +HRD+   N+LL       + DFGL     +N     ++    
Sbjct: 120 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--- 176
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE 284
                   H+K       + APE LK    S  SD + FG+++ E+ T G  P+  L   
Sbjct: 177 --------HRKV---PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 225
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
              H +   +   ++L         RP         P  I +++ +CW   P +RP+F  
Sbjct: 226 QILHKI---DKEGERLP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF-- 266
Query: 345 IALELDLVLE 354
           +AL  D +LE
Sbjct: 267 VALR-DFLLE 275

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 140/307 (45%), Gaps = 37/307 (12%)
Query: 74  IARGAESVVYEATL-DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH 130
           + RG    VY+  L DG  VAVK  K   +   EL  F  E++++    H  L +     
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 96
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVE-EWSPSVD--QVLMIAAQLAKALQYLHN---LGIV 184
             P   +  + +  + ++A  L    E  P +D  +   IA   A+ L YLH+     I+
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLI 243
           HRDVK AN+LLD      + DFGLA+         L +++         H    V G + 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAK---------LMDYKDX-------HVXXAVRGXIG 200
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT----EQQ 299
           ++APE L     SEK+DV+ +G+ + EL+TG   + DL   A    V+ +++     +++
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGLLKEK 259
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA--LELDLVLEHRK 357
              A+V   L+      E+     ++ +   C   +P  RP  S++   LE D + E  +
Sbjct: 260 KLEALVDVDLQGNYKDEEV---EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
Query: 358 SLKEEDL 364
             ++E++
Sbjct: 317 EWQKEEM 323

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 74  IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G   +VY      +  ++A+K+     S      H+E+ L   L H  + +++ + +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA---AQLAKALQYLHNLGIVHRDV 188
           +      F E     +L+  L   +W P  D    I     Q+ + L+YLH+  IVHRD+
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 189 KPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           K  NVL++  +    ++DFG ++    +   +                +   GTL YMAP
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCT----------------ETFTGTLQYMAP 192
Query: 248 EILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           EI+ K    + + +D++S G +I E+ TG  P+ +L  E Q               AA+ 
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL-GEPQ---------------AAMF 236
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357
             G+  +   +   + A   + I +C++ +P  R   +D+ ++  L +  +K
Sbjct: 237 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 59/261 (22%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFF--EFYESRNLA--------EKLHVEEWSPS 160
           E+ LL +L HP + ++        N   +   E+ E  +LA        E+ +++E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE---- 110
Query: 161 VDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
            + VL +  QL  AL+  H        ++HRD+KPANV LD      L DFGLA      
Sbjct: 111 -EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----- 164
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
               + N  +S         K  VGT  YM+PE + +  ++EKSD++S G  + EL   +
Sbjct: 165 ----ILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR--PILASLELGLPASILSLIQRCWD 333
            P+T               +++++L   +  G  R  P   S EL        +I R  +
Sbjct: 214 PPFT--------------AFSQKELAGKIREGKFRRIPYRYSDELN------EIITRMLN 253
Query: 334 GNPHNRPSFSDIALELDLVLE 354
              ++RPS  +I LE  L+LE
Sbjct: 254 LKDYHRPSVEEI-LENPLILE 273

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++K    G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPG 122
           +Y +   + +GA SVV         +     I++T    + +     +E ++  KL HP 
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   +  +   +   F+      L E +   E+    D    I  Q+ +++ Y H+ G
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSNG 148
Query: 183 IVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHR++KP N+LL    +     LADFGLA     ++    + W        GF      
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDSEAWH-------GF-----A 191
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +         +    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 42/278 (15%)
Query: 74  IARGAESVVY--EATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           + +G+ + VY  E+   G +VA+K   K  +  +  +     E+++ C+L HP + +   
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 129 AHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
            + +  NY++   E   +  +   L       S ++      Q+   + YLH+ GI+HRD
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +  +N+LL RN+   +ADFGLA     LK    K++   G P              Y++P
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLA---TQLKMPHEKHYTLCGTPN-------------YISP 181
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307
           EI  +  H  +SDV+S G     LL G  P+             + +  +  L   V++ 
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPF-------------DTDTVKNTLNKVVLAD 228
Query: 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              P   S+E         LI +    NP +R S S +
Sbjct: 229 YEMPSFLSIEAK------DLIHQLLRRNPADRLSLSSV 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +         +    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA    N+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
                            ++KK   G L   +MAPE L   +++ +SDV+SFG+ + E+ T
Sbjct: 211 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCW 296
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD +L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRIL 317

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 135/319 (42%), Gaps = 59/319 (18%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVE-----EWSPSVDQV- 164
           ++++  +  H  +   + A  +        E+    NL E L        E+S  +++V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 165 ---------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                    +    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA      
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 205
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
               + N     K T G         + +MAPE L   +++ +SDV+SFG+ + E+ T G
Sbjct: 206 ---DINNIDXXKKTTNGRL------PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  +  E     + E +  +            +P   + EL +      +++ CW  
Sbjct: 257 GSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCWHA 298
Query: 335 NPHNRPSFSDIALELDLVL 353
            P  RP+F  +  +LD +L
Sbjct: 299 VPSQRPTFKQLVEDLDRIL 317

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 84  EATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
           E  L G KVAVK   +  + + + +    +E+Q L    HP + K     + P ++    
Sbjct: 31  EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90
Query: 141 EFYESRNLAEKL----HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
           E+     L + +     VEE      +   +  Q+  A+ Y H   +VHRD+KP NVLLD
Sbjct: 91  EYVSGGELFDYICKHGRVEEM-----EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS 256
            ++   +ADFGL+            N  S G+       ++  G+  Y APE++   +++
Sbjct: 146 AHMNAKIADFGLS------------NMMSDGE-----FLRDSCGSPNYAAPEVISGRLYA 188
Query: 257 -EKSDVYSFGISINELLTGVVPYTD 280
             + D++S G+ +  LL G +P+ D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 58  SIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKV-----AVKKPILSTSEELDNFHKEL 112
           S+ + L    + L   + +G+   V+ A            A+KK ++   ++++    E 
Sbjct: 10  SLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 69
Query: 113 QLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQ 170
           ++L    +HP L           N  F  E+    +L    H++      + +    AA+
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFYAAE 127
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           +   LQ+LH+ GIV+RD+K  N+LLD++    +ADFG+   +EN+               
Sbjct: 128 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENM--------------L 171
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
           G        GT  Y+APEIL  + ++   D +SFG+ + E+L G  P+     E   H++
Sbjct: 172 GDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 74  IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G   +VY      +  ++A+K+     S      H+E+ L   L H  + +++ + +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA---AQLAKALQYLHNLGIVHRDV 188
           +      F E     +L+  L   +W P  D    I     Q+ + L+YLH+  IVHRD+
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 134
Query: 189 KPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           K  NVL++  +    ++DFG ++    +   +                +   GTL YMAP
Sbjct: 135 KGDNVLINTYSGVLKISDFGTSKRLAGINPCT----------------ETFTGTLQYMAP 178
Query: 248 EILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           EI+ K    + + +D++S G +I E+ TG  P+ +L  E Q               AA+ 
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL-GEPQ---------------AAMF 222
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
             G+  +   +   + A   + I +C++ +P  R   +D+ ++
Sbjct: 223 KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 265

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 58  SIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKV-----AVKKPILSTSEELDNFHKEL 112
           S+ + L    + L   + +G+   V+ A            A+KK ++   ++++    E 
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 113 QLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQ 170
           ++L    +HP L           N  F  E+    +L    H++      + +    AA+
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFYAAE 126
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           +   LQ+LH+ GIV+RD+K  N+LLD++    +ADFG+   +EN+               
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENM--------------L 170
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
           G        GT  Y+APEIL  + ++   D +SFG+ + E+L G  P+     E   H++
Sbjct: 171 GDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 45/308 (14%)
Query: 57  QSIPLHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELDNF 108
           QS+   +      LL  +  G+  VV     D   G+ V+V     K  +LS  E +D+F
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 109 HKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
            +E+  +  LDH  L +       PP  M   E     +L ++L   +    +  +   A
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSG 227
            Q+A+ + YL +   +HRD+   N+LL       + DFGL     +N     ++      
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE----- 182
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
                 H+K       + APE LK    S  SD + FG+++ E+ T G  P+  L     
Sbjct: 183 ------HRKV---PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            H +   +   ++L         RP         P  I +++ +CW   P +RP+F  +A
Sbjct: 234 LHKI---DKEGERLP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF--VA 274
Query: 347 LELDLVLE 354
           L  D +LE
Sbjct: 275 LR-DFLLE 281

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPG 122
           +Y +   + +GA SVV         +     I++T    + +     +E ++  KL HP 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   +  +   +   F+      L E +   E+    D    I  Q+ +++ Y H+ G
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSNG 125
Query: 183 IVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHR++KP N+LL    +     LADFGLA     ++    + W        GF      
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDSEAWH-------GF-----A 168
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 135/316 (42%), Gaps = 57/316 (18%)
Query: 63  LPPSSYTLLSPIARGAESVVYEA-------TLDGRKVAVKKPIL---STSEELDNFHKEL 112
            P     L  P+ RGA   V EA       T   R VAVK  +L   +T  E      EL
Sbjct: 24  FPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK--MLKEGATHSEHRALMSEL 81
Query: 113 QLLCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP--------- 159
           ++L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P         
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 142 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLA---------- 191
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 192 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 248 PGVKIDEEFXRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 290
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 291 RPTFSELVEHLGNLLQ 306

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 45/308 (14%)
Query: 57  QSIPLHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELDNF 108
           QS+   +      LL  +  G+  VV     D   G+ V+V     K  +LS  E +D+F
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 109 HKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
            +E+  +  LDH  L +       PP  M   E     +L ++L   +    +  +   A
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSG 227
            Q+A+ + YL +   +HRD+   N+LL       + DFGL     +N     ++      
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE----- 182
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
                 H+K       + APE LK    S  SD + FG+++ E+ T G  P+  L     
Sbjct: 183 ------HRKV---PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            H +   +   ++L         RP         P  I +++ +CW   P +RP+F  +A
Sbjct: 234 LHKI---DKEGERLP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF--VA 274
Query: 347 LELDLVLE 354
           L  D +LE
Sbjct: 275 LR-DFLLE 281

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 84  EATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
           E  L G KVAVK   +  + + + +    +E+Q L    HP + K     + P ++    
Sbjct: 31  EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90
Query: 141 EFYESRNLAEKL----HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
           E+     L + +     VEE      +   +  Q+  A+ Y H   +VHRD+KP NVLLD
Sbjct: 91  EYVSGGELFDYICKHGRVEEM-----EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145
Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS 256
            ++   +ADFGL+            N  S G+       +   G+  Y APE++   +++
Sbjct: 146 AHMNAKIADFGLS------------NMMSDGE-----FLRTSCGSPNYAAPEVISGRLYA 188
Query: 257 -EKSDVYSFGISINELLTGVVPYTD 280
             + D++S G+ +  LL G +P+ D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/317 (24%), Positives = 133/317 (41%), Gaps = 56/317 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 25  FPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 84
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 85  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 160 -SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
            +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA         
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA--------- 195
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  P
Sbjct: 196 -----RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  ++ + +    L+               G R  + + +   P    +++  CW G P 
Sbjct: 251 YPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEPS 293
Query: 338 NRPSFSDIALELDLVLE 354
            RP+FS++   L  +L+
Sbjct: 294 QRPTFSELVEHLGNLLQ 310

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 89  GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
           GR+VAVK   L   +  +    E+ ++    H  + +   ++          EF +   L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
            +   V +   + +Q+  +   + +AL YLH  G++HRD+K  ++LL  +    L+DFG 
Sbjct: 130 TDI--VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF 187
Query: 209 -AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
            A+  +++ +                 +K +VGT  +MAPE++ + +++ + D++S GI 
Sbjct: 188 CAQISKDVPK-----------------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 268 INELLTGVVPY 278
           + E++ G  PY
Sbjct: 231 VIEMVDGEPPY 241

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLCKLDHP 121
            +Y +   + +GA SVV         +     I++T    + +     +E ++  KL HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   +  +   +   F+      L E +   E+    D    I  Q+ +++ Y H+ 
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSN 123
Query: 182 GIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           GIVHR++KP N+LL    +     LADFGLA     ++    + W        GF     
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDSEAWH-------GF----- 166
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 53/314 (16%)
Query: 63  LPPSSYTLLSPIARGAESVVYEA-------TLDGRKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA       T   R VAVK     +T  E      EL++
Sbjct: 24  FPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP---------SV 161
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P         ++
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
           + ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA            
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA------------ 191
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
             R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY  
Sbjct: 192 --RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249
Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
           ++ + +    L+               G R  + + +   P    +++  CW G P  RP
Sbjct: 250 VKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEPSQRP 292
Query: 341 SFSDIALELDLVLE 354
           +FS++   L  +L+
Sbjct: 293 TFSELVEHLGNLLQ 306

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPG 122
           +Y +   + +GA SVV         +     I++T    + +     +E ++  KL HP 
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   +  +   +   F+      L E +   E+    D    I  Q+ +++ Y H+ G
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHSNG 125
Query: 183 IVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHR++KP N+LL    +     LADFGLA     ++    + W        GF      
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA-----IEVNDSEAWH-------GF-----A 168
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 74
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 186
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 187 ------RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 241 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 284 SQRPTFSELVEHLGNLLQ 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 133/316 (42%), Gaps = 55/316 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEA-------TLDGRKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA       T   R VAVK     +T  E      EL++
Sbjct: 26  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI 85
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFL 145
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 146 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA---------- 195
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 196 ----RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 252 PGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 294
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 295 RPTFSELVEHLGNLLQ 310

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQL---LCKL-DHP 121
           Y L   + +GA SVV      L G++ A    I++T +     H++L+    +C+L  HP
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICRLLKHP 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   + ++  ++   F+      L E +   E+    D    I  Q+ +A+ + H +
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCHQM 129
Query: 182 GIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           G+VHR++KP N+LL   L      LADFGLA   E             G+    F     
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-------------GEQQAWF---GF 173
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P+ D
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 23/195 (11%)
Query: 90  RKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146
           +KVA+K   + +L  S+      +E+  L  L HP + K       P + +   E Y   
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE-YAGG 93
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
            L + + VE+   + D+      Q+  A++Y H   IVHRD+KP N+LLD NL   +ADF
Sbjct: 94  ELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADF 152
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFG 265
           GL                 S   T G   K   G+  Y APE++  ++++  + DV+S G
Sbjct: 153 GL-----------------SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 266 ISINELLTGVVPYTD 280
           I +  +L G +P+ D
Sbjct: 196 IVLYVMLVGRLPFDD 210

>pdb|2I0O|A Chain A, Crystal Structure Of Anopheles Gambiae SerTHR PHOSPHATASE COMPLEXED With Zn2+ Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 74/146 (50%), Gaps = 11/146 (7%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
           L+ GS +  G R + ED H  + +  +Q     F ++DGH G+  A++ +  LP FL+ +
Sbjct: 23  LASGSSSMQGWRISQEDAHNCILNFDDQ--CSFFAVYDGHGGAEVAQYCSLHLPTFLKTV 80
Query: 489 GSTTRPT--DALLEAFIRTDVAFRNE--LDSLRK-SKRVVQKDWHPG----CTAIAALIV 539
            +  R     AL EAF+  D     E  ++ L+  S      D  PG    CTA+ AL+ 
Sbjct: 81  EAYGRKEFEKALKEAFLGFDATLLQEKVIEELKVLSGDSAGSDAEPGKDSGCTAVVALLH 140
Query: 540 RNRLFVANAGDCRAILCRGGHPFALS 565
              L+VANAGD R ++CR G    +S
Sbjct: 141 GKDLYVANAGDSRCVVCRNGKALEMS 166

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 144/328 (43%), Gaps = 64/328 (19%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEAT---LDGR----KVAVKKPILSTS-EELDNFHKELQ 113
             P  +  L   +  G    V +AT   L GR     VAVK    + S  EL +   E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEF----------YESRNLAEKL----------- 152
           +L +++HP + K   A ++    +   E+           ESR +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 153 --HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
             H +E + ++  ++  A Q+++ +QYL  + +VHRD+   N+L+       ++DFGL+ 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLS- 197
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            R+  +E S    RS G+             + +MA E L   I++ +SDV+SFG+ + E
Sbjct: 198 -RDVYEEDSXVK-RSQGRI-----------PVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           ++T G  PY  +  E +   +L+  +  +           RP   S E+        L+ 
Sbjct: 245 IVTLGGNPYPGIPPE-RLFNLLKTGHRME-----------RPDNCSEEM------YRLML 286
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW   P  RP F+DI+ +L+ ++  R+
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 70  LLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELDNFHKELQLLCKLDHP 121
           LL  +  G+  VV     D   G+ V+V     K  +LS  E +D+F +E+  +  LDH 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +       PP  M   E     +L ++L   +    +  +   A Q+A+ + YL + 
Sbjct: 72  NLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             +HRD+   N+LL       + DFGL     +N     ++            H+K    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----------HRKV--- 176
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE LK    S  SD + FG+++ E+ T G  P+  L      H +   +   ++
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGER 233
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           L         RP         P  I +++ +CW   P +RP+F  +AL  D +LE
Sbjct: 234 LP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF--VALR-DFLLE 271

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 132/319 (41%), Gaps = 59/319 (18%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDGRK----VAVKKPIL---STSEELDNFHKE 111
             P    TL  P+  GA  + V+ EA  +D  K    V V   +L   +T ++L +   E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---------------VE 155
           ++++  +  H  +   + A  +        E+    NL E L                V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVP 150
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   +   ++    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA      
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 205
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
               + N     K T G         + +MAPE L   +++ +SDV+SFG+ + E+ T G
Sbjct: 206 ---DINNIDXXKKTTNGRL------PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  +  E     + E +  +            +P   + EL +      +++ CW  
Sbjct: 257 GSPYPGIPVEELFKLLKEGHRMD------------KPANCTNELYM------MMRDCWHA 298
Query: 335 NPHNRPSFSDIALELDLVL 353
            P  RP+F  +  +LD +L
Sbjct: 299 VPSQRPTFKQLVEDLDRIL 317

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 61/320 (19%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPIL---STSEELDNFHKEL 112
            P     L  P+ RGA   V EA   G       R VAVK  +L   +T  E      EL
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSEL 81
Query: 113 QLLCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP--------- 159
           ++L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P         
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 160 ----SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
               +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA      
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------ 195
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
                   R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G
Sbjct: 196 --------RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  ++ + +    L+               G R  + + +   P    +++  CW G
Sbjct: 248 ASPYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHG 290
Query: 335 NPHNRPSFSDIALELDLVLE 354
            P  RP+FS++   L  +L+
Sbjct: 291 EPSQRPTFSELVEHLGNLLQ 310

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 144/328 (43%), Gaps = 64/328 (19%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEAT---LDGR----KVAVKKPILSTS-EELDNFHKELQ 113
             P  +  L   +  G    V +AT   L GR     VAVK    + S  EL +   E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEF----------YESRNLAEKL----------- 152
           +L +++HP + K   A ++    +   E+           ESR +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 153 --HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
             H +E + ++  ++  A Q+++ +QYL  + +VHRD+   N+L+       ++DFGL+ 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS- 197
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            R+  +E S    RS G+             + +MA E L   I++ +SDV+SFG+ + E
Sbjct: 198 -RDVYEEDSYVK-RSQGRI-----------PVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           ++T G  PY  +  E +   +L+  +  +           RP   S E+        L+ 
Sbjct: 245 IVTLGGNPYPGIPPE-RLFNLLKTGHRME-----------RPDNCSEEM------YRLML 286
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW   P  RP F+DI+ +L+ ++  R+
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 70  LLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELDNFHKELQLLCKLDHP 121
           LL  +  G+  VV     D   G+ V+V     K  +LS  E +D+F +E+  +  LDH 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +       PP  M   E     +L ++L   +    +  +   A Q+A+ + YL + 
Sbjct: 72  NLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             +HRD+   N+LL       + DFGL     +N     ++            H+K    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----------HRKV--- 176
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE LK    S  SD + FG+++ E+ T G  P+  L      H +   +   ++
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGER 233
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           L         RP         P  I +++ +CW   P +RP+F  +AL  D +LE
Sbjct: 234 LP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF--VALR-DFLLE 271

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 74
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 186
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 187 ------RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 241 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 284 SQRPTFSELVEHLGNLLQ 301

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 70  LLSPIARGAESVVYEATLD---GRKVAV-----KKPILSTSEELDNFHKELQLLCKLDHP 121
           LL  +  G+  VV     D   G+ V+V     K  +LS  E +D+F +E+  +  LDH 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +       PP  M   E     +L ++L   +    +  +   A Q+A+ + YL + 
Sbjct: 72  NLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             +HRD+   N+LL       + DFGL     +N     ++            H+K    
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE-----------HRKV--- 176
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE LK    S  SD + FG+++ E+ T G  P+  L      H +   +   ++
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGER 233
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           L         RP         P  I +++ +CW   P +RP+F  +AL  D +LE
Sbjct: 234 LP--------RPE------DCPQDIYNVMVQCWAHKPEDRPTF--VALR-DFLLE 271

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K            F   + ++  L + +       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK---IGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                    + VGT  Y++PE+L ++  S+ SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 144/328 (43%), Gaps = 64/328 (19%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEAT---LDGR----KVAVKKPILSTS-EELDNFHKELQ 113
             P  +  L   +  G    V +AT   L GR     VAVK    + S  EL +   E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEF----------YESRNLAEKL----------- 152
           +L +++HP + K   A ++    +   E+           ESR +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 153 --HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
             H +E + ++  ++  A Q+++ +QYL  + +VHRD+   N+L+       ++DFGL+ 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS- 197
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
            R+  +E S    RS G+             + +MA E L   I++ +SDV+SFG+ + E
Sbjct: 198 -RDVYEEDSXVK-RSQGRI-----------PVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           ++T G  PY  +  E +   +L+  +  +           RP   S E+        L+ 
Sbjct: 245 IVTLGGNPYPGIPPE-RLFNLLKTGHRME-----------RPDNCSEEM------YRLML 286
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +CW   P  RP F+DI+ +L+ ++  R+
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     GF   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMAGF--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 61/320 (19%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPIL---STSEELDNFHKEL 112
            P     L  P+ RGA   V EA   G       R VAVK  +L   +T  E      EL
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSEL 81
Query: 113 QLLCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP--------- 159
           ++L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P         
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 160 ----SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
               +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA      
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------ 195
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
                   R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G
Sbjct: 196 --------RDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  ++ + +    L+               G R  + + +   P    +++  CW G
Sbjct: 248 ASPYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHG 290
Query: 335 NPHNRPSFSDIALELDLVLE 354
            P  RP+FS++   L  +L+
Sbjct: 291 EPSQRPTFSELVEHLGNLLQ 310

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     GF   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMAGF--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 75
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     GF   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMAGF--- 178
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 179 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 52/303 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKKPILSTS--EELDNFHKELQ 113
            P ++      +  GA   V EAT  G        KVAVK  + ST+  +E +    EL+
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSELK 93
Query: 114 LLCKL-DHPGLAKFVAA--HAKP----PNYMFFFEF--YESRNLAEKLHVEEWSP-SVDQ 163
           ++  L  H  +   + A  H  P      Y  + +   +  R     L  E+  P  +  
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
           +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA              
Sbjct: 154 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------------- 199
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282
           R     +    K N    + +MAPE +   +++ +SDV+S+GI + E+ + G+ PY  + 
Sbjct: 200 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 259
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
             ++ + +++  Y   Q           P  A      P +I S++Q CW   P +RP+F
Sbjct: 260 VNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSIMQACWALEPTHRPTF 302
Query: 343 SDI 345
             I
Sbjct: 303 QQI 305

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 52/303 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVKKPILSTS--EELDNFHKELQ 113
            P ++      +  GA   V EAT  G        KVAVK  + ST+  +E +    EL+
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSELK 101
Query: 114 LLCKL-DHPGLAKFVAA--HAKP----PNYMFFFEF--YESRNLAEKLHVEEWSP-SVDQ 163
           ++  L  H  +   + A  H  P      Y  + +   +  R     L  E+  P  +  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
           +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA              
Sbjct: 162 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------------- 207
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282
           R     +    K N    + +MAPE +   +++ +SDV+S+GI + E+ + G+ PY  + 
Sbjct: 208 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 267
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
             ++ + +++  Y   Q           P  A      P +I S++Q CW   P +RP+F
Sbjct: 268 VNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSIMQACWALEPTHRPTF 310
Query: 343 SDI 345
             I
Sbjct: 311 QQI 313

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQL---LCKL-DHP 121
           Y L   I +GA SVV        G + A K  I++T +     H++L+    +C+L  H 
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAK--IINTKKLSARDHQKLEREARICRLLKHS 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   + ++   +   F+      L E +   E+    D    I  Q+ +A+ + H +
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCHQM 122
Query: 182 GIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           G+VHRD+KP N+LL    +     LADFGLA        I ++     G     F     
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLA--------IEVQ-----GDQQAWF---GF 166
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+L+KE + +  D+++ G+ +  LL G  P+ D
Sbjct: 167 AGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 125/295 (42%), Gaps = 58/295 (19%)
Query: 71  LSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-------HP 121
           L  I RGA   V +      G+ +AVK+ I ST +E     ++ QLL  LD        P
Sbjct: 27  LGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDE----KEQKQLLMDLDVVMRSSDCP 81
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL------MIAAQLAKAL 175
            + +F  A  +  +     E   +    +K +   +S  +D V+       I     KAL
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYS-VLDDVIPEEILGKITLATVKAL 138
Query: 176 QYL-HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
            +L  NL I+HRD+KP+N+LLDR+    L DFG+                 SG+      
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-----------------SGQLVDSIA 181
Query: 235 KKNMVGTLIYMAPEIL----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
           K    G   YMAPE +     ++ +  +SDV+S GI++ EL TG  PY            
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP----------- 230
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            + N    QLT  VV G    +  S E     S ++ +  C   +   RP + ++
Sbjct: 231 -KWNSVFDQLT-QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 138
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 192
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                    + VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 193 --------NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 139/321 (43%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-------WSPSVD- 162
           ++++  +  H  +   + A  +        E+    NL E L   E       ++PS + 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 163 -------QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
                   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 200
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 201 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 248 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 289
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 290 HAVPSQRPTFKQLVEDLDRIV 310

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 74
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 186
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 187 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 241 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 284 SQRPTFSELVEHLGNLLQ 301

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 27/241 (11%)
Query: 61  LHLPPSSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLL 115
           LH+   +Y LL  I +G  A+  +    L G++VAVK   K  L++S  L    +E++++
Sbjct: 4   LHI--GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIM 60
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
             L+HP + K               E+     + + L    W     +      Q+  A+
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKE-KEARAKFRQIVSAV 119
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           QY H   IVHRD+K  N+LLD ++   +ADFG                  S + T G   
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTFGNKL 162
Query: 236 KNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
               G+  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   
Sbjct: 163 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 222
Query: 295 Y 295
           Y
Sbjct: 223 Y 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 87/204 (42%), Gaps = 39/204 (19%)
Query: 149 AEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADF 206
           AEKL      P  +++L  +   + KAL YL    G++HRDVKP+N+LLD      L DF
Sbjct: 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDV 261
           G+                 SG+      K    G   YMAPE +      K  +  ++DV
Sbjct: 170 GI-----------------SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADV 212
Query: 262 YSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP 321
           +S GIS+ EL TG  PY + + + +   VL     E+            P L    +G  
Sbjct: 213 WSLGISLVELATGQFPYKNCKTDFE---VLTKVLQEE------------PPLLPGHMGFS 257
Query: 322 ASILSLIQRCWDGNPHNRPSFSDI 345
               S ++ C   +   RP ++ +
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKL 281

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 93  AVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
            +KK ++   ++++    E ++L    +HP L +       P    F  EF    +L   
Sbjct: 55  VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM-- 112
Query: 152 LHVEEWSPSVDQVL--MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
            H+++ S   D+      AA++  AL +LH+ GI++RD+K  NVLLD      LADFG+ 
Sbjct: 113 FHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269
                      K    +G  T  F      GT  Y+APEIL++ ++    D ++ G+ + 
Sbjct: 172 -----------KEGICNGVTTATF-----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 270 ELLTGVVPY 278
           E+L G  P+
Sbjct: 216 EMLCGHAPF 224

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 195
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 196 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 250 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 292
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 293 SQRPTFSELVEHLGNLLQ 310

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 26  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 85
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD 145
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 146 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 197
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 198 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 251
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 252 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 294
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 295 SQRPTFSELVEHLGNLLQ 312

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 15  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 74
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 186
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 187 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 240
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 241 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 284 SQRPTFSELVEHLGNLLQ 301

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 133/318 (41%), Gaps = 57/318 (17%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA   G       R VAVK     +T  E      EL++
Sbjct: 61  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 120
Query: 115 LCKLDHP-GLAKFVAAHAKPPN-YMFFFEFYESRNLAEKLHVE--EWSP----------- 159
           L  + H   +   + A  KP    M   EF +  NL+  L  +  E+ P           
Sbjct: 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 180
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 181 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 232
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  
Sbjct: 233 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  ++ + +    L+               G R  + + +   P    +++  CW G P
Sbjct: 287 PYPGVKIDEEFCRRLK--------------EGTR--MRAPDYTTPEMYQTMLD-CWHGEP 329
Query: 337 HNRPSFSDIALELDLVLE 354
             RP+FS++   L  +L+
Sbjct: 330 SQRPTFSELVEHLGNLLQ 347

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 74  IARGAESVVYEATLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I +G    VY     G +VA++   +    E  L  F +E+    +  H  +  F+ A  
Sbjct: 41  IGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
            PP+        + R L   +   +    V++   IA ++ K + YLH  GI+H+D+K  
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK 159
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           NV  D N    + DFGL          S+     +G+       +N  G L ++APEI++
Sbjct: 160 NVFYD-NGKVVITDFGL---------FSISGVLQAGRREDKLRIQN--GWLCHLAPEIIR 207
Query: 252 ---------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
                    K   S+ SDV++ G    EL     P+    AEA    + +M         
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIWQMGT------- 257
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                G++P L+  ++G+   I  ++  CW      RP+F+ +
Sbjct: 258 -----GMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKL 293

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 32/189 (16%)
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
           + S   +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA        
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------- 211
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
                 R     +    K N    + +MAPE +   +++ +SDV+S+GI + E+ + G+ 
Sbjct: 212 ------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           PY  +   ++ + +++  Y   Q           P  A      P +I S++Q CW   P
Sbjct: 266 PYPGILVNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSIMQACWALEP 308
Query: 337 HNRPSFSDI 345
            +RP+F  I
Sbjct: 309 THRPTFQQI 317

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K            F   +  ++N  E L       S D+      
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY--AKN-GELLKYIRKIGSFDETCTRFY 134
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 188
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                    + VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 189 --------NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 104 ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL----AEKLHVEEWSP 159
           E+ N  KELQ++  L+HP L     +     +     +     +L     + +H +E   
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--- 114
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
             + V +   +L  AL YL N  I+HRD+KP N+LLD +   H+ DF +A       +I+
Sbjct: 115 --ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVV 276
                             M GT  YMAPE+    K   +S   D +S G++  ELL G  
Sbjct: 173 -----------------TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 277 PY 278
           PY
Sbjct: 216 PY 217

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 140
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 141 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 194
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 195 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 135
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 189
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 190 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA 129
           LL  I +G    V      G KVAVK   +        F  E  ++ +L H  L + +  
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 130 HAKPPNYMFFF-EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
             +    ++   E+    +L + L     S    D +L  +  + +A++YL     VHRD
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   NVL+  +    ++DFGL       KE       SS + TG    K       + AP
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTAP 183
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E L+++  S KSDV+SFGI + E+ + G VPY  +  +     V E  Y           
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD----- 237
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
                       G P ++  +++ CW  +   RPSF    L+L   LEH K+
Sbjct: 238 ------------GCPPAVYEVMKNCWHLDAAMRPSF----LQLREQLEHIKT 273

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 138
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 192
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 193 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 32/187 (17%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           S   +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA          
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---------- 211
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R     +    K N    + +MAPE +   +++ +SDV+S+GI + E+ + G+ PY
Sbjct: 212 ----RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             +   ++ + +++  Y   Q           P  A      P +I S++Q CW   P +
Sbjct: 268 PGILVNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSIMQACWALEPTH 310
Query: 339 RPSFSDI 345
           RP+F  I
Sbjct: 311 RPTFQQI 317

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 135
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 189
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 190 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 47/277 (16%)
Query: 88  DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
           D   VAVK    ++     +F +E +LL  L H  + +F     +    +  FE+    +
Sbjct: 70  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 148 LAEKLHV-----------EEWSPS---VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
           L   L             E+ +P    + Q+L +A+Q+A  + YL  L  VHRD+   N 
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 189
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
           L+ + L   + DFG++      ++I   ++   G  T        +  + +M PE +   
Sbjct: 190 LVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRT--------MLPIRWMPPESILYR 235
Query: 254 IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPI 312
             + +SDV+SFG+ + E+ T G  P+  L        + +    E            RP 
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE------------RP- 282
Query: 313 LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                   P  + ++++ CW   P  R S  D+   L
Sbjct: 283 -----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 135
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 189
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 190 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 47/277 (16%)
Query: 88  DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
           D   VAVK    ++     +F +E +LL  L H  + +F     +    +  FE+    +
Sbjct: 47  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 106
Query: 148 LAEKLHV-----------EEWSPS---VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
           L   L             E+ +P    + Q+L +A+Q+A  + YL  L  VHRD+   N 
Sbjct: 107 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 166
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
           L+ + L   + DFG++      ++I   ++   G  T        +  + +M PE +   
Sbjct: 167 LVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRT--------MLPIRWMPPESILYR 212
Query: 254 IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPI 312
             + +SDV+SFG+ + E+ T G  P+  L        + +    E            RP 
Sbjct: 213 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE------------RP- 259
Query: 313 LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                   P  + ++++ CW   P  R S  D+   L
Sbjct: 260 -----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 47/277 (16%)
Query: 88  DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
           D   VAVK    ++     +F +E +LL  L H  + +F     +    +  FE+    +
Sbjct: 41  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 100
Query: 148 LAEKLHV-----------EEWSPS---VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
           L   L             E+ +P    + Q+L +A+Q+A  + YL  L  VHRD+   N 
Sbjct: 101 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 160
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
           L+ + L   + DFG++      ++I   ++   G  T        +  + +M PE +   
Sbjct: 161 LVGQGLVVKIGDFGMS------RDIYSTDYYRVGGRT--------MLPIRWMPPESILYR 206
Query: 254 IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPI 312
             + +SDV+SFG+ + E+ T G  P+  L        + +    E            RP 
Sbjct: 207 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE------------RP- 253
Query: 313 LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                   P  + ++++ CW   P  R S  D+   L
Sbjct: 254 -----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 137
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 191
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 192 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 142
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 143 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 196
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 197 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 32/188 (17%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           + + +L  A Q+AK +++L     VHRD+   NVL+       + DFGLA        +S
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMS 224
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
             N+   G         N    + +MAPE L + I++ KSDV+S+GI + E+ + GV PY
Sbjct: 225 DSNYVVRG---------NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             +  +A  + +++  +   Q           P  A+ E      I  ++Q CW  +   
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQ-----------PFYATEE------IYIIMQSCWAFDSRK 318
Query: 339 RPSFSDIA 346
           RPSF ++ 
Sbjct: 319 RPSFPNLT 326

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 135
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 189
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 190 NA--------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA 129
           LL  I +G    V      G KVAVK   +        F  E  ++ +L H  L + +  
Sbjct: 16  LLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 130 HAKPPNYMFFF-EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
             +    ++   E+    +L + L     S    D +L  +  + +A++YL     VHRD
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   NVL+  +    ++DFGL       KE       SS + TG    K       + AP
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTAP 174
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E L++   S KSDV+SFGI + E+ + G VPY  +  +     V E  Y           
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD----- 228
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
                       G P ++  +++ CW  +   RPSF    L+L   LEH K+
Sbjct: 229 ------------GCPPAVYEVMKNCWHLDAAMRPSF----LQLREQLEHIKT 264

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 123/292 (42%), Gaps = 56/292 (19%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHPG 122
           Y  L PI  GA+ +V  A  T+ G  VAVKK   P  + +      ++EL LL  ++H  
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-KRAYRELVLLKCVNHKN 82
Query: 123 LAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           +   +           F + Y        NL + +H+E     +  +L    Q+   +++
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY---QMLCGIKH 139
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH+ GI+HRD+KP+N+++  +    + DFGLA              R++   +  F    
Sbjct: 140 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTA---STNFMMTP 182
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
            V T  Y APE++    + E  D++S G  + EL+ G V +       Q + V+E     
Sbjct: 183 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE----- 237
Query: 298 QQLTAAVVSGGLRPILASLELGLP-ASILSLIQRCWDGNPHNRPSFSDIALE 348
                              +LG P A  ++ +Q        NRP++  IA E
Sbjct: 238 -------------------QLGTPSAEFMAALQPTVRNYVENRPAYPGIAFE 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 112
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 113 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 166
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 167 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 115
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 116 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 169
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 170 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 114
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 115 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 168
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 169 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 200
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 201 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 248 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 289
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 290 HAVPSQRPTFKQLVEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 192
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 193 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 240 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 281
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 282 HAVPSQRPTFKQLVEDLDRIV 302

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 136/320 (42%), Gaps = 63/320 (19%)
Query: 63  LPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKEL 112
           LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E+
Sbjct: 14  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 73
Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVEE 156
           +++  +  H  +   + A  +        E+    NL E L               H  E
Sbjct: 74  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
              S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++ 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDIH 190
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT- 273
            I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T 
Sbjct: 191 HID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 237
Query: 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
           G  PY  +  E     + E +  +            +P   + EL +      +++ CW 
Sbjct: 238 GGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCWH 279
Query: 334 GNPHNRPSFSDIALELDLVL 353
             P  RP+F  +  +LD ++
Sbjct: 280 AVPSQRPTFKQLVEDLDRIV 299

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K         +   +F    ++N  E L       S D+      
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN-GELLKYIRKIGSFDETCTRFY 113
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 167
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 168 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
           H  E   S   +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA   
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA--- 213
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
                      R     +    K N    + +MAPE +   +++ +SDV+S+GI + E+ 
Sbjct: 214 -----------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262
Query: 273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRC 331
           + G+ PY  +   ++ + +++  Y   Q           P  A      P +I S++Q C
Sbjct: 263 SLGLNPYPGILVNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSIMQAC 305
Query: 332 WDGNPHNRPSFSDI 345
           W   P +RP+F  I
Sbjct: 306 WALEPTHRPTFQQI 319

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 46/292 (15%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA 129
           LL  I +G    V      G KVAVK   +        F  E  ++ +L H  L + +  
Sbjct: 10  LLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 130 HAKPPNYMFFFEFYESR-NLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
             +    ++    Y ++ +L + L     S    D +L  +  + +A++YL     VHRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   NVL+  +    ++DFGL       KE       SS + TG    K       + AP
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTAP 168
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E L+++  S KSDV+SFGI + E+ + G VPY  +  +     V E  Y           
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD----- 222
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
                       G P ++  +++ CW  +   RPSF    L+L   LEH K+
Sbjct: 223 ------------GCPPAVYEVMKNCWHLDAAMRPSF----LQLREQLEHIKT 258

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 132/321 (41%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDG---------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA   V  A   G          KVAVK     +T ++L +   E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 241
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 242 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 289 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 330
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 331 HAVPSQRPTFKQLVEDLDRIV 351

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K            F   +  ++N  E L       S D+      
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY--AKN-GELLKYIRKIGSFDETCTRFY 134
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 188
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 189 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 136/320 (42%), Gaps = 63/320 (19%)
Query: 63  LPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKEL 112
           LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVEE 156
           +++  +  H  +   + A  +        E+    NL E L               H  E
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
              S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++ 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDIH 186
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT- 273
            I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T 
Sbjct: 187 HID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233
Query: 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
           G  PY  +  E     + E +  +            +P   + EL +      +++ CW 
Sbjct: 234 GGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCWH 275
Query: 334 GNPHNRPSFSDIALELDLVL 353
             P  RP+F  +  +LD ++
Sbjct: 276 AVPSQRPTFKQLVEDLDRIV 295

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 19/171 (11%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL--MI 167
           +E  ++ +LDHP   K            F   +  ++N  E L       S D+      
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY--AKN-GELLKYIRKIGSFDETCTRFY 119
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            A++  AL+YLH  GI+HRD+KP N+LL+ ++   + DFG A      K +S ++ ++  
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA------KVLSPESKQARA 173
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                      VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+
Sbjct: 174 --------NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 33/198 (16%)
Query: 150 EKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
           E L  E+  P  +  +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGL
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
           A              R     +    K N    + +MAPE +   +++ +SDV+S+GI +
Sbjct: 205 A--------------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250
Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
            E+ + G+ PY  +   ++ + +++  Y   Q           P  A      P +I S+
Sbjct: 251 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-----------PAFA------PKNIYSI 293
Query: 328 IQRCWDGNPHNRPSFSDI 345
           +Q CW   P +RP+F  I
Sbjct: 294 MQACWALEPTHRPTFQQI 311

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 96  LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 154
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 155 EVKIGDFGLATKVE----------------YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 199 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 245
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 246 ------SLIQKMLQTDPTARPTINEL 265

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 100 LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 158
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 159 EVKIGDFGLATKVE----------------YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 202
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 203 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 249
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 250 ------SLIQKMLQTDPTARPTINEL 269

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 37/191 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIYET 183
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
           +             +++K   G L   +MAPE LK  + +  SD++SFG+ + E+ +   
Sbjct: 184 A-------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
            PY  L  E     V++  Y +Q                      P  +  L++ CW  N
Sbjct: 231 QPYQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFN 272
Query: 336 PHNRPSFSDIA 346
           P  RP+F +I 
Sbjct: 273 PKMRPTFLEIV 283

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 85
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 188
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 45/267 (16%)
Query: 92  VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           VAVK    ++     +FH+E +LL  L H  + KF     +    +  FE+ +  +L + 
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 152 LH--------VEEWSPSVD----QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
           L         + E +P  +    Q+L IA Q+A  + YL +   VHRD+   N L+  NL
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFG++      +++   ++   G  T        +  + +M PE +     + +S
Sbjct: 166 LVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPIRWMPPESIMYRKFTTES 211
Query: 260 DVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL 318
           DV+S G+ + E+ T G  P+  L        + +    ++  T                 
Sbjct: 212 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC---------------- 255
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDI 345
             P  +  L+  CW   PH R +   I
Sbjct: 256 --PQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 193
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 194 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 241 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 282
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 283 HAVPSQRPTFKQLVEDLDRIV 303

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 96  LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 154
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 155 EVKIGDFGLATKVE----------------YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 199 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 245
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 246 ------SLIQKMLQTDPTARPTINEL 265

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 99
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 202
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 203 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 87  LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143
           L G KVAVK   +  + + + +    +E+Q L    HP + K     + P +     E+ 
Sbjct: 39  LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203
               L + +  +       +   +  Q+   + Y H   +VHRD+KP NVLLD ++   +
Sbjct: 99  SGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKI 157
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVY 262
           ADFGL+            N  S G+       +   G+  Y APE++   +++  + D++
Sbjct: 158 ADFGLS------------NMMSDGE-----FLRXSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQQLTAAVVS 306
           S G+ +  LL G +P+ D         + + + YT Q L  +V+S
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 42/289 (14%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA 129
           LL  I +G    V      G KVAVK   +        F  E  ++ +L H  L + +  
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 130 HAKPPNYMFFFEFYESR-NLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
             +    ++    Y ++ +L + L     S    D +L  +  + +A++YL     VHRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   NVL+  +    ++DFGL       KE       SS + TG    K       + AP
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTAP 355
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E L+++  S KSDV+SFGI + E+ + G VPY  +  +     V E  Y           
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD----- 409
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                       G P ++  +++ CW  +   RP+F  +  +L+ +  H
Sbjct: 410 ------------GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 75
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 178
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 179 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 36/277 (12%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEAT------LDGRKVAVKKPILSTSEELDNFHKELQLL 115
           H     + +  P+ +G    VY A       +   KV  K  I     E     +E+++ 
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE-HQLRREIEIQ 77
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ--VLMIAAQLAK 173
             L HP + +               E+     L ++L   + S + D+     I  +LA 
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELAD 134
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           AL Y H   ++HRD+KP N+LL       +ADFG + +  +L+                 
Sbjct: 135 ALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLR----------------- 177
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
            +K M GTL Y+ PE+++  +H+EK D++  G+   ELL G  P+     E+ +H     
Sbjct: 178 -RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF-----ESASHNETYR 231
Query: 294 NYTEQQLT-AAVVSGGLRPILASLELGLPASILSLIQ 329
              +  L   A V  G + +++ L    P+  L L Q
Sbjct: 232 RIVKVDLKFPASVPTGAQDLISKLLRHNPSERLPLAQ 268

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 40  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 98
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 201
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 202 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 63/321 (19%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 143
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 200
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
             I              ++KK   G L   +MAPE L   I++ +SDV+SFG+ + E+ T
Sbjct: 201 HHID-------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  PY  +  E     + E +  +            +P   + EL +      +++ CW
Sbjct: 248 LGGSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCW 289
Query: 333 DGNPHNRPSFSDIALELDLVL 353
              P  RP+F  +  +LD ++
Sbjct: 290 HAVPSQRPTFKQLVEDLDRIV 310

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 65  PSSYTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKL 118
           P     L P+  GA   V   Y+A L  +KVAVKK   P  S       + +EL+LL  L
Sbjct: 27  PQRLQGLRPVGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTY-RELRLLKHL 84
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKAL 175
            H  +   +       +   F E Y    L    L+  V+  + S + V  +  QL + L
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGL 144
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +Y+H+ GI+HRD+KP+NV ++ +    + DFGLA              R + +   G+  
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA--------------RQADEEMTGY-- 188
Query: 236 KNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
              V T  Y APEI+   +H  ++ D++S G  + ELL G
Sbjct: 189 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 75
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL--AEKLHVEEWSP-SVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L  A+  ++ + +  + D V  +  Q+ + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLK 135
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 178
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 179 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV--AVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           YTL + I RG+   V  A   G ++  A KK      E++D F +E++++  LDHP + +
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                    +     E      L E++ H   +  S      I   +  A+ Y H L + 
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAYCHKLNVA 145
Query: 185 HRDVKPANVLL--DRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           HRD+KP N L   D    P  L DFGLA               +  KP  G   +  VGT
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLA---------------ARFKP--GKMMRTKVGT 188
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             Y++P++L+  ++  + D +S G+ +  LL G  P++
Sbjct: 189 PYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS 225

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 92  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 149
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 150 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 193
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 126 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIYET 182
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
               +R  GK          +  + +MAPE LK  + +  SD++SFG+ + E+ +    P
Sbjct: 183 DY--YRKGGKG---------LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 231
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  L  E     V++  Y +Q                      P  +  L++ CW  NP 
Sbjct: 232 YQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFNPK 273
Query: 338 NRPSFSDIA 346
            RP+F +I 
Sbjct: 274 MRPTFLEIV 282

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSPI  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 26  PERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 84
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLA--------------RHTDDEMTGY--- 187
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 188 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTADEMTGY--- 189
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 85/191 (44%), Gaps = 37/191 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIYET 183
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +MAPE LK  + +  SD++SFG+ + E+ +   
Sbjct: 184 D-------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 230
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
            PY  L  E     V++  Y +Q                      P  +  L++ CW  N
Sbjct: 231 QPYQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFN 272
Query: 336 PHNRPSFSDIA 346
           P  RP+F +I 
Sbjct: 273 PKMRPTFLEIV 283

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTADEMTGY--- 189
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3NMV|B Chain B, Crystal Structure Of Pyrabactin-Bound Abscisic Acid Receptor Pyl2 Mutant A93f In Complex With Type 2c Protein Phosphatase Abi2 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 39/164 (23%)
Query: 431 WGSFATCGRRETMEDTHFLMPHMYNQKE-----------------IHMFGIFDGHRGSAA 473
           +G  + CGRR  MED+   +P                         H FG++DGH GS  
Sbjct: 14  YGVTSICGRRPEMEDSVSTIPRFLQVSSSSLLDGRVTNGFNPHLSAHFFGVYDGHGGSQV 73
Query: 474 AEFSARAL------------PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKR 521
           A +    +            P F        +   AL  +F+R D    +E++++  +  
Sbjct: 74  ANYCRERMHLALTEEIVKEKPEFCDGDTWQEKWKKALFNSFMRVD----SEIETVAHAPE 129
Query: 522 VVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALS 565
            V      G T++ A++    +FVAN GD RA+LCRG  P ALS
Sbjct: 130 TV------GSTSVVAVVFPTHIFVANCGDSRAVLCRGKTPLALS 167

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF  S +L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 74  IHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 129
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 173
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTADEMTGY--- 189
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV--AVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           YTL + I RG+   V  A   G ++  A KK      E++D F +E++++  LDHP + +
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                    +     E      L E++ H   +  S      I   +  A+ Y H L + 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAYCHKLNVA 128
Query: 185 HRDVKPANVLL--DRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           HRD+KP N L   D    P  L DFGLA               +  KP  G   +  VGT
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLA---------------ARFKP--GKMMRTKVGT 171
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             Y++P++L+  ++  + D +S G+ +  LL G  P++
Sbjct: 172 PYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS 208

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 99
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA + ++                      
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------------------EMX 200
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 99  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 156
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 157 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 200
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF  S +L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 73  IHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 128
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 172
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 44/285 (15%)
Query: 67  SYTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHP 121
           +Y ++  +  G+   V  A  T  G+KVA+K   K +L+ S+      +E+  L  L HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K           +   E Y    L + + V+    S  +      Q+  A++Y H  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIE-YAGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            IVHRD+KP N+LLD +L   +ADFGL                 S   T G   K   G+
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGL-----------------SNIMTDGNFLKTSCGS 174
Query: 242 LIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             Y APE++  ++++  + DV+S G+ +  +L   +P+ D     ++  VL  N      
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKN------ 223
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               +S G+  +   L  G       LI+R    NP NR S  +I
Sbjct: 224 ----ISNGVYTLPKFLSPGAAG----LIKRMLIVNPLNRISIHEI 260

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 88  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 145
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 146 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 189
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 37/190 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIXET 176
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R  GK          +  + +M+PE LK  + +  SDV+SFG+ + E+ T    P
Sbjct: 177 DXX--RKGGKG---------LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 225
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGN 335
           Y  L              + +Q+   V+ GGL  +P         P  +L L++ CW  N
Sbjct: 226 YQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLLELMRMCWQYN 265
Query: 336 PHNRPSFSDI 345
           P  RPSF +I
Sbjct: 266 PKMRPSFLEI 275

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 44/285 (15%)
Query: 67  SYTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHP 121
           +Y ++  +  G+   V  A  T  G+KVA+K   K +L+ S+      +E+  L  L HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K           +   E Y    L + + V+    S  +      Q+  A++Y H  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIE-YAGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            IVHRD+KP N+LLD +L   +ADFGL                 S   T G   K   G+
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGL-----------------SNIMTDGNFLKTSCGS 175
Query: 242 LIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             Y APE++  ++++  + DV+S G+ +  +L   +P+ D     ++  VL  N      
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKN------ 224
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               +S G+  +   L  G       LI+R    NP NR S  +I
Sbjct: 225 ----ISNGVYTLPKFLSPGAAG----LIKRMLIVNPLNRISIHEI 261

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 185
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 186 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 232
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 233 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 272
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 273 YNPKMRPSFLEI 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIXET 183
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R  GK          +  + +MAPE LK  + +  SD++SFG+ + E+ +    P
Sbjct: 184 DXX--RKGGKG---------LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  L  E     V++  Y +Q                      P  +  L++ CW  NP+
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFNPN 274
Query: 338 NRPSFSDIA 346
            RP+F +I 
Sbjct: 275 MRPTFLEIV 283

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 142 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 200 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 243
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 97  VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 154
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 155 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 198
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 85
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 188
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 44/286 (15%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y ++  +  G+   V  A  T  G+KVA+K   K +L+ S+      +E+  L  L H
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K           +   E Y    L + + V+    S  +      Q+  A++Y H 
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIE-YAGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+KP N+LLD +L   +ADFGL                 S   T G   K   G
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGL-----------------SNIMTDGNFLKTSCG 168
Query: 241 TLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           +  Y APE++  ++++  + DV+S G+ +  +L   +P+ D     ++  VL  N     
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKN----- 218
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                +S G+  +   L  G       LI+R    NP NR S  +I
Sbjct: 219 -----ISNGVYTLPKFLSPGAAG----LIKRMLIVNPLNRISIHEI 255

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 18  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 76
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 179
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 180 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 19  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 77
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 137
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 138 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 180
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 181 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 91
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 194
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 195 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 181
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 182 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 228
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 229 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 268
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 269 YNPKMRPSFLEI 280

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 91
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 194
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 195 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 182
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 183 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 229
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 230 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 269
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 270 YNPKMRPSFLEI 281

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 25/124 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL  N    +ADFG               W S   
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG---------------W-SVHA 162
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G+ P+       +AH
Sbjct: 163 PSS--RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF-------EAH 213
Query: 289 TVLE 292
           T  E
Sbjct: 214 TYQE 217

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 178
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 179 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 225
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 226 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 265
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 266 YNPKMRPSFLEI 277

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 40  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 98
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 201
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 202 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 32  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 90
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLA--------------RHTDDEMTGY--- 193
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 194 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF  S +L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 72  IHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 127
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 171
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 85
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 188
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 44/286 (15%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y ++  +  G+   V  A  T  G+KVA+K   K +L+ S+      +E+  L  L H
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K           +   E Y    L + + V+    S  +      Q+  A++Y H 
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIE-YAGNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+KP N+LLD +L   +ADFGL                 S   T G   K   G
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGL-----------------SNIMTDGNFLKTSCG 164
Query: 241 TLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           +  Y APE++  ++++  + DV+S G+ +  +L   +P+ D     ++  VL  N     
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-----ESIPVLFKN----- 214
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                +S G+  +   L  G       LI+R    NP NR S  +I
Sbjct: 215 -----ISNGVYTLPKFLSPGAAG----LIKRMLIVNPLNRISIHEI 251

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMK 91
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 194
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 195 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 99
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 202
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 203 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 86
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 189
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 44  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 102
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 205
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 206 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 84
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 187
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 188 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 18  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 76
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 179
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 180 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 20  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 78
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 138
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 139 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 181
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 182 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 63/124 (50%), Gaps = 25/124 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL  N    +ADFG               W S   
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG---------------W-SVHA 162
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G+ P+       +AH
Sbjct: 163 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF-------EAH 213
Query: 289 TVLE 292
           T  E
Sbjct: 214 TYQE 217

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 32  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 90
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 193
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 194 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 75
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 178
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 179 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 81
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 185 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 81
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 185 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 37/190 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 213
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
               +R  GK          +  + +M+PE LK  + +  SDV+SFG+ + E+ T    P
Sbjct: 214 DY--YRKGGKG---------LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 262
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGN 335
           Y  L              + +Q+   V+ GGL  +P         P  +  L++ CW  N
Sbjct: 263 YQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQYN 302
Query: 336 PHNRPSFSDI 345
           P  RPSF +I
Sbjct: 303 PKMRPSFLEI 312

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 184
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 185 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 231
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 232 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 271
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 272 YNPKMRPSFLEI 283

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 84
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 187
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 188 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 81
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 185 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 44  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 102
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMXGY--- 205
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 206 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 33/189 (17%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIXET 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R  GK          +  + +MAPE LK  + +  SD++SFG+ + E+ +    P
Sbjct: 181 DXX--RKGGKG---------LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 229
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  L  E     V++  Y +Q                      P  +  L++ CW  NP 
Sbjct: 230 YQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFNPK 271
Query: 338 NRPSFSDIA 346
            RP+F +I 
Sbjct: 272 MRPTFLEIV 280

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA + ++             + TG     
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------------EMTG----- 181
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 182 -XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N  +  +    + DFG+     ++ E 
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMT---RDIYET 178
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 179 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 225
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +L L++ CW 
Sbjct: 226 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLLELMRMCWQ 265
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 266 YNPKMRPSFLEI 277

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 33/189 (17%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIXET 183
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R  GK          +  + +MAPE LK  + +  SD++SFG+ + E+ +    P
Sbjct: 184 DXX--RKGGKG---------LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  L  E     V++  Y +Q                      P  +  L++ CW  NP 
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFNPK 274
Query: 338 NRPSFSDIA 346
            RP+F +I 
Sbjct: 275 MRPTFLEIV 283

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 84
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLA--------------RHTDDEMTGY--- 187
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 188 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF  S +L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 74  IHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 129
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 130 RDLKPENLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 173
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 118 LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 176
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 177 EVKIGDFGLATKVE----------------YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 221 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 267
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 268 ------SLIQKMLQTDPTARPTINEL 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 184
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 185 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 231
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 232 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 271
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 272 YNPKMRPSFLEI 283

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 94  LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 152
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 153 EVKIGDFGLATKVE----------------YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 197 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 243
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 244 ------SLIQKMLQTDPTARPTINEL 263

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 65  PSSYTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKL 118
           P     L P+  GA   V   Y+A L  +KVAVKK   P  S       + +EL+LL  L
Sbjct: 19  PQRLQGLRPVGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTY-RELRLLKHL 76
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKAL 175
            H  +   +       +   F E Y    L    L+  V+  + S + V  +  QL + L
Sbjct: 77  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGL 136
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +Y+H+ GI+HRD+KP+NV ++ +    + DFGLA              R + +   G+  
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--------------RQADEEMTGY-- 180
Query: 236 KNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
              V T  Y APEI+   +H  ++ D++S G  + ELL G
Sbjct: 181 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
            E    R+L E LH    + +  +      Q+    QYLH   ++HRD+K  N+ L+ +L
Sbjct: 120 LELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
              + DFGLA   E                  G  KK + GT  Y+APE+L K+ HS + 
Sbjct: 179 EVKIGDFGLATKVE----------------YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 260 DVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
           DV+S G  +  LL G  P+          + L+  Y   +     +   + P+ A     
Sbjct: 223 DVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSIPKHINPVAA----- 269
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
                 SLIQ+    +P  RP+ +++
Sbjct: 270 ------SLIQKMLQTDPTARPTINEL 289

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 191
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 192 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 239 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 278
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 279 YNPKMRPSFLEI 290

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 74  IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           I  G+  +V  AT+   G+ VAVKK  L   +  +    E+ ++    H  + +   ++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
                    EF E   L +   V     + +Q+  +   + +AL  LH  G++HRD+K  
Sbjct: 219 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
           ++LL  +    L+DFG     +  KE+                +K +VGT  +MAPE++ 
Sbjct: 277 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKXLVGTPYWMAPELIS 320
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
           +  +  + D++S GI + E++ G  PY
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 32/178 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + +L +   +HRD+   N+LL       + DFGLA + +N     +K        
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG------- 228
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                  N    + +MAPE +   +++ +SDV+S+GI + EL + G  PY  +  +++ +
Sbjct: 229 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            +++  +             L P  A      PA +  +++ CWD +P  RP+F  I 
Sbjct: 282 KMIKEGFRM-----------LSPEHA------PAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 191
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +M+PE LK  + +  SDV+SFG+ + E+ T   
Sbjct: 192 D-------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
            PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW 
Sbjct: 239 QPYQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 278
Query: 334 GNPHNRPSFSDI 345
            NP  RPSF +I
Sbjct: 279 YNPKMRPSFLEI 290

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS-TSEELDNFHK----ELQLLCKLDH 120
           Y  L  +  G  + VY+A      + VA+KK  L   SE  D  ++    E++LL +L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           P +   + A     N    F+F E+   +  K +    +PS  +  M+     + L+YLH
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLH 129
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              I+HRD+KP N+LLD N    LADFGLA              +S G P   +   + V
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLA--------------KSFGSPNRAY--XHQV 173
Query: 240 GTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
            T  Y APE+L    ++    D+++ G  + ELL  V
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK--PILSTSEELDNFHKELQLLCKLD-HPG 122
           Y L+  + +GA  +V+++     G  VAVKK       S +     +E+ +L +L  H  
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 123 LAKFVAAHAKPPNYMFFFEF-YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
           +   +       +   +  F Y   +L   +      P   Q   +  QL K ++YLH+ 
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ--YVVYQLIKVIKYLHSG 128
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK----- 236
           G++HRD+KP+N+LL+      +ADFGL+    N++ ++     S  + T  F        
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
           + V T  Y APEIL       K  D++S G  + E+L G
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  L+P+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 31  PERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 89
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 150 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 192
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 193 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRK-----VAVKKPILSTSEELDNFHKELQLLCKL-DH 120
            + LL  I RG+ + V    L           VKK +++  E++D    E  +  +  +H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P L    +         F  E+    +L   +  +   P  +     +A+++ AL YLH 
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHARFYSAEISLALNYLHE 139
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
            GI++RD+K  NVLLD      L D+G+   +E L+          G  T  F      G
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLR---------PGDTTSXF-----CG 183
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           T  Y+APEIL+ E +    D ++ G+ + E++ G  P+
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---------KPILSTSEELDNFHKELQLLC 116
           Y L   I +G  SVV        G++ AVK          P LST    ++  +E  +  
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST----EDLKREASICH 83
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----WSPSVDQVLMIAAQL 171
            L HP + + +  ++        FEF +  +L  ++         +S +V    M   Q+
Sbjct: 84  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM--RQI 141
Query: 172 AKALQYLHNLGIVHRDVKPANVLL--DRNLCP-HLADFGLAEYRENLKEISLKNWRSSGK 228
            +AL+Y H+  I+HRDVKP  VLL    N  P  L  FG+A        I L     SG 
Sbjct: 142 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--------IQLGE---SGL 190
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             GG      VGT  +MAPE++K+E + +  DV+  G+ +  LL+G +P+
Sbjct: 191 VAGG-----RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 85
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLA--------------RHTDDEMTGY--- 188
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 170
Query: 246 APEI-LKKEIHSEKSDVYSFGISINELLT 273
           APEI L  + +S   D++S G    E++T
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKV-----AVKKPILSTSEELDNFHKELQLLCKL-DH 120
            + LL  I RG+ + V    L           VKK +++  E++D    E  +  +  +H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P L    +         F  E+    +L   +  +   P  +     +A+++ AL YLH 
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHARFYSAEISLALNYLHE 171
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
            GI++RD+K  NVLLD      L D+G+   +E L+          G  T  F      G
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLR---------PGDTTSTF-----CG 215
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           T  Y+APEIL+ E +    D ++ G+ + E++ G  P+
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 92  VAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VAVK   +   E++D N  +E+     L HP + +F      P +     E+     L E
Sbjct: 47  VAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGL 208
           ++       S D+      QL   + Y H + + HRD+K  N LLD +  P L  ADFG 
Sbjct: 105 RI-CNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGY 163
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGIS 267
           +           K      +P      K+ VGT  Y+APE+ LKKE   + +DV+S G++
Sbjct: 164 S-----------KASVLHSQP------KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 268 INELLTGVVPYTD 280
           +  +L G  P+ D
Sbjct: 207 LYVMLVGAYPFED 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 65  PSSYTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKL 118
           P     L P+  GA   V   Y+A L  +KVAVKK   P  S       + +EL+LL  L
Sbjct: 27  PQRLQGLRPVGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTY-RELRLLKHL 84
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKAL 175
            H  +   +       +   F E Y    L    L+  V+  + S + V  +  QL + L
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGL 144
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +Y+H+ GI+HRD+KP+NV ++ +    + DFGLA              R + +   G+  
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLA--------------RQADEEMTGY-- 188
Query: 236 KNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
              V T  Y APEI+   +H  ++ D++S G  + ELL G
Sbjct: 189 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 82  VYEATLDG--RKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKF--VAAHAKPPNY 136
            Y+ T DG    VAVK        +L   + +E+++L  L H  + K+          + 
Sbjct: 29  CYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSV 88
Query: 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
               E+    +L +  ++      + Q+L+ A Q+ + + YLH    +HR +   NVLLD
Sbjct: 89  QLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLD 146
Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKE 253
            +    + DFGLA+                  P G  +   +++    + + APE LK+ 
Sbjct: 147 NDRLVKIGDFGLAK----------------AVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPIL 313
                SDV+SFG+++ ELLT    Y D            + +T+ Q+T       LR + 
Sbjct: 191 KFYYASDVWSFGVTLYELLT----YCDSNQSPHTKFTELIGHTQGQMTV------LR-LT 239
Query: 314 ASLELG--------LPASILSLIQRCWDGNPHNRPSFSDIA 346
             LE G         P  I  L++ CW+     RP+F ++ 
Sbjct: 240 ELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKDFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 60  PLHLPPSSYTLLSPIARGAESVVYEATLDGRK-----VAVKKPILSTSEELDNFHKELQL 114
           PL L    + LL  I RG+ + V    L           VKK +++  E++D    E  +
Sbjct: 5   PLGL--QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
             +  +HP L    +         F  E+    +L   +  +   P  +     +A+++ 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHARFYSAEISL 121
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           AL YLH  GI++RD+K  NVLLD      L D+G+   +E L+          G  T  F
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLR---------PGDTTSXF 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
                 GT  Y+APEIL+ E +    D ++ G+ + E++ G  P+
Sbjct: 171 -----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 82  VYEATLDG--RKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKF--VAAHAKPPNY 136
            Y+ T DG    VAVK        +L   + +E+++L  L H  + K+          + 
Sbjct: 28  CYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSV 87
Query: 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
               E+    +L +  ++      + Q+L+ A Q+ + + YLH    +HR +   NVLLD
Sbjct: 88  QLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLD 145
Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKE 253
            +    + DFGLA+                  P G  +   +++    + + APE LK+ 
Sbjct: 146 NDRLVKIGDFGLAK----------------AVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPIL 313
                SDV+SFG+++ ELLT    Y D            + +T+ Q+T       LR + 
Sbjct: 190 KFYYASDVWSFGVTLYELLT----YCDSNQSPHTKFTELIGHTQGQMTV------LR-LT 238
Query: 314 ASLELG--------LPASILSLIQRCWDGNPHNRPSFSDIA 346
             LE G         P  I  L++ CW+     RP+F ++ 
Sbjct: 239 ELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 78  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 133
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 177
Query: 246 APEI-LKKEIHSEKSDVYSFGISINELLT 273
           APEI L  + +S   D++S G    E++T
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 37/190 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           PS+ +++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+     ++ E 
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIXET 185
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
                R  GK          +  + +M+PE LK  + +  SDV+SFG+ + E+ T    P
Sbjct: 186 DXX--RKGGKG---------LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 234
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGN 335
           Y  L              + +Q+   V+ GGL  +P         P  +  L++ CW  N
Sbjct: 235 YQGL--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQYN 274
Query: 336 PHNRPSFSDI 345
           P  RPSF +I
Sbjct: 275 PKMRPSFLEI 284

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 81
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLA--------------RHTDDEMTGY--- 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 185 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQL---LCKL-DHP 121
             Y L   + +GA SVV               I++T +     H++L+    +C+L  HP
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   + ++   +   F+      L E +   E+    D    I  Q+ +++ ++H  
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH-QILESVNHIHQH 149
Query: 182 GIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
            IVHRD+KP N+LL    +     LADFGLA        I ++     G+    F     
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLA--------IEVQ-----GEQQAWF---GF 193
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P+ D
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWD 235

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 135/319 (42%), Gaps = 59/319 (18%)
Query: 62  HLPPSSYTLLSPIARGA--ESVVYEAT-LDG------RKVAVKK-PILSTSEELDNFHKE 111
            LP     L  P+  GA  + V+ EA  LD        KVAVK     +T ++L +   E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------------HVE 155
           ++++  +  H  +   + A  +        E+    NL E L               H  
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
           E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA    ++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA---RDI 200
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
             I      ++G+             + +MAPE L   I++ +SDV+SFG+ + E+ T G
Sbjct: 201 HHIDXXKKTTNGRL-----------PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 249
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
             PY  +  E     + E +  +            +P   + EL +      +++ CW  
Sbjct: 250 GSPYPGVPVEELFKLLKEGHRMD------------KPSNCTNELYM------MMRDCWHA 291
Query: 335 NPHNRPSFSDIALELDLVL 353
            P  RP+F  +  +LD ++
Sbjct: 292 VPSQRPTFKQLVEDLDRIV 310

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRK-----VAVKKPILSTSEELDNFHKELQLLCKL-D 119
             + LL  I RG+ + V    L           VKK +++  E++D    E  +  +  +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP L    +         F  E+    +L   +  +   P  +     +A+++ AL YLH
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-EHARFYSAEISLALNYLH 123
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
             GI++RD+K  NVLLD      L D+G+   +E L+          G  T  F      
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLR---------PGDTTSXF-----C 167
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           GT  Y+APEIL+ E +    D ++ G+ + E++ G  P+
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 72  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 127
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 171
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 40/284 (14%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H  
Sbjct: 6   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 65
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L +      K        E+  +  L   L          Q+L +   + +A++YL +  
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
            +HRD+   N L++      ++DFGL+ Y   + +    + R S  P             
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSRGSKFPVR----------- 171
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            +  PE+L     S KSD+++FG+ + E+ + G +PY                +T  + T
Sbjct: 172 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTNSE-T 215
Query: 302 AAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           A  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 216 AEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 253

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 70  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 169
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGL               R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLC--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H 
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      K        E+  +  L   L          Q+L +   + +A++YL + 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             +HRD+   N L++      ++DFGL+ Y  + +E S                   VG+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS------------------SVGS 181
Query: 242 ---LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
              + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T 
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTN 227
Query: 298 QQLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 228 SE-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 268

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLSFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 37/191 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHR++   N ++  +    + DFG+     ++ E 
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT---RDIYET 184
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                         +++K   G L   +MAPE LK  + +  SD++SFG+ + E+ +   
Sbjct: 185 D-------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 231
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
            PY  L  E     V++  Y +Q                      P  +  L++ CW  N
Sbjct: 232 QPYQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFN 273
Query: 336 PHNRPSFSDIA 346
           P+ RP+F +I 
Sbjct: 274 PNMRPTFLEIV 284

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 74  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 129
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 173
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 74  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 129
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 173
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 73  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 128
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 172
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 92  VAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VAVK   +   E++D N  +E+     L HP + +F      P +     E+     L E
Sbjct: 46  VAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 103
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGL 208
           ++       S D+      QL   + Y H + + HRD+K  N LLD +  P L   DFG 
Sbjct: 104 RI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 162
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGIS 267
           +           K+     +P      K+ VGT  Y+APE+ LKKE   + +DV+S G++
Sbjct: 163 S-----------KSSVLHSQP------KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 205
Query: 268 INELLTGVVPYTD 280
           +  +L G  P+ D
Sbjct: 206 LYVMLVGAYPFED 218

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 70  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 169
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 72  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 127
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 171
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 75  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 130
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 174
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 33/189 (17%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           P++ +++ +AA++A  + YL+    VHR++   N ++  +    + DFG+     ++ E 
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMT---RDIYET 183
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
               +R  GK          +  + +MAPE LK  + +  SD++SFG+ + E+ +    P
Sbjct: 184 DY--YRKGGKG---------LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
           Y  L  E     V++  Y +Q                      P  +  L++ CW  NP+
Sbjct: 233 YQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFNPN 274
Query: 338 NRPSFSDIA 346
            RP+F +I 
Sbjct: 275 MRPTFLEIV 283

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 70  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 169
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 72  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 127
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 171
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---------KPILSTSEELDNFHKELQLLC 116
           Y L   I +G  SVV        G++ AVK          P LST    ++  +E  +  
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST----EDLKREASICH 81
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----WSPSVDQVLMIAAQL 171
            L HP + + +  ++        FEF +  +L  ++         +S +V    M   Q+
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM--RQI 139
Query: 172 AKALQYLHNLGIVHRDVKPANVLL--DRNLCP-HLADFGLAEYRENLKEISLKNWRSSGK 228
            +AL+Y H+  I+HRDVKP  VLL    N  P  L  FG+A        I L     SG 
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--------IQLGE---SGL 188
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
             GG      VGT  +MAPE++K+E + +  DV+  G+ +  LL+G +P+
Sbjct: 189 VAGG-----RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKVVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLVGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G+ + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 70  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 169
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 72  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 127
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 171
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 73  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 128
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 172
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD 119
            +Y LL  I +G  A+  +    L GR+VA+K  I+  ++     L    +E++++  L+
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP + K               E+     + + L V        +      Q+  A+QY H
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              IVHRD+K  N+LLD ++   +ADFG                  S + T G       
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTVGGKLDTFC 171
Query: 240 GTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           G+  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + D+GLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDYGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 78  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 133
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 177
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKVVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLVGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G+ + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQL---LCKL-DHP 121
           Y L   + +GA SVV        G++ A K  I++T +     H++L+    +C+L  HP
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLLKHP 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   + ++   +   F+      L E +   E+    D    I  Q+ +++ + H  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILESVNHCHLN 122
Query: 182 GIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           GIVHRD+KP N+LL    +     LADFGLA        I ++     G     F     
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQ-----GDQQAWF---GF 166
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P+ D
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAVK   K  L++S  L    +E++++  L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD ++   +ADFG                  S + T G       G
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTFGNKLDTFCG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           +  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQL---LCKL-DHP 121
           Y L   + +GA SVV        G++ A K  I++T +     H++L+    +C+L  HP
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLLKHP 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + +   + ++   +   F+      L E +   E+    D    I  Q+ +++ + H  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILESVNHCHLN 122
Query: 182 GIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           GIVHRD+KP N+LL    +     LADFGLA        I ++     G     F     
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA--------IEVQ-----GDQQAWF---GF 166
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P+ D
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWD 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 73  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 128
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 172
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAVK   K  L++S  L    +E++++  L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD ++   +ADFG                  S + T G       G
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTFGNKLDTFCG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           +  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE-----ELDNFHKELQLLCKLDH 120
             + ++ P+ +G    VY A     K  +   +L  S+           +E+++   L H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + +               EF     L ++L  +       +      +LA AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYCHE 132
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP N+L+       +ADFG + +  +L+                  ++ M G
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------------------RRXMCG 174
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           TL Y+ PE+++ + H EK D++  G+   E L G+ P+
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 75  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 130
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y 
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWYR 174
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 49/279 (17%)
Query: 91  KVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVA-----AHAKPPNYMFFFEFY 143
           KVAVK   L  S+  E++ F  E   +    HP + + +      +    P  M    F 
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 144 ESRNLAEKLHVE--EWSPS---VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN 198
           +  +L   L     E  P    +  +L     +A  ++YL N   +HRD+   N +L  +
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHS 256
           +   +ADFGL+      K+I           +G ++++  +  +   ++A E L   +++
Sbjct: 184 MTVCVADFGLS------KKIY----------SGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 257 EKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
            KSDV++FG+++ E+ T G+ PY  ++       +L  +  +Q                 
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL------------ 275
Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
                   +  ++  CW  +P +RP+FS + L+L+ +LE
Sbjct: 276 ------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L   +     +    P +   L    QL + L + H+  ++H
Sbjct: 74  IHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 129
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWYR 173
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 67/119 (56%), Gaps = 17/119 (14%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           +V +   ++  AL++LH LGI++RD+K  N+LLD N    L DFGL+  +E + + + + 
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERA 217
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYT 279
           +             +  GT+ YMAP+I++     H +  D +S G+ + ELLTG  P+T
Sbjct: 218 Y-------------DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLL 115
           L +    Y ++  I RGA   V        +      +LS  E +       F +E  ++
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQL 171
              + P + +   A           E+    +L   +      E+W+          A++
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK------FYTAEV 183
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
             AL  +H++G++HRDVKP N+LLD++    LADFG     +                TG
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---------------TG 228
Query: 232 GFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPY 278
             H    VGT  Y++PE+LK +     +  + D +S G+ + E+L G  P+
Sbjct: 229 MVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 23/232 (9%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEEL---DNFHKELQLLCKLD 119
           P  Y +   I  G+   V EA   L+ R VA+KK IL   E+L       +E+ +L +L+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK-ILRVFEDLIDCKRILREIAILNRLN 110
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKAL 175
           H  + K +     P +   F E Y    +A+    KL       +   +  +   L   +
Sbjct: 111 HDHVVKVLDI-VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA---EYRENLKEISLKNWRSSGKPTGG 232
           +Y+H+ GI+HRD+KPAN L++++    + DFGLA   +Y EN       + R        
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 233 F-HKKNM-------VGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGV 275
           F H KN+       V T  Y APE IL +E ++E  DV+S G    ELL  +
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 32/205 (15%)
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
           S  + Q+L+ A Q+ + + YLH    +HRD+   NVLLD +    + DFGLA+      E
Sbjct: 130 SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV-- 275
                 R  G              + + APE LK+      SDV+SFG+++ ELLT    
Sbjct: 190 XY--RVREDGD-----------SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236
Query: 276 -----VPYTDLRAEAQAH-TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
                  + +L   AQ   TVL       +LT  +  G   P         PA +  L++
Sbjct: 237 SQSPPTKFLELIGIAQGQMTVL-------RLTELLERGERLPRPDK----CPAEVYHLMK 285
Query: 330 RCWDGNPHNRPSFSDIALELDLVLE 354
            CW+     RP+F ++   L  V E
Sbjct: 286 NCWETEASFRPTFENLIPILKTVHE 310

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +N  +E+     L HP + +F      P +     E+     L E++       S D+  
Sbjct: 61  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEAR 119
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNW 223
               QL   + Y H++ I HRD+K  N LLD +  P L   DFG +           K+ 
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-----------KSS 168
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
               +P      K+ VGT  Y+APE+ L++E   + +DV+S G+++  +L G  P+ D
Sbjct: 169 VLHSQP------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 68  YTLLSPIARGAESVVYEATLDGR---KVAVKKPILSTSEEL--DNFHKELQLLCKLDHPG 122
           Y  L P+  GA   V  A +DGR   KVA+KK       EL     ++EL+LL  + H  
Sbjct: 27  YRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 123 LAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           +   +           F +FY        +L + +  E+     D++  +  Q+ K L+Y
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE--DRIQFLVYQMLKGLRY 143
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           +H  GI+HRD+KP N+ ++ +    + DFGLA              R +     G     
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RQADSEMXG----- 184
Query: 238 MVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTG 274
            V T  Y APE++   + +++  D++S G  + E++TG
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + +L +   +HRD+   N+LL       + DFGLA   +N     +K        
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG------- 205
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                  N    + +MAPE +   +++ +SDV+S+GI + EL + G  PY  +  +++ +
Sbjct: 206 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            +++  +             L P  A      PA +  +++ CWD +P  RP+F  I 
Sbjct: 259 KMIKEGFRM-----------LSPEHA------PAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  +     G K+AVKK   P  S       + +EL+LL  + 
Sbjct: 50  PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 108
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DFGLA              R +     G+   
Sbjct: 169 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 211
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H   + D++S G  + ELLTG  + P TD
Sbjct: 212 --VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 45/279 (16%)
Query: 73  PIARGAESVVYEATLDGRK--VAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           P+ +G    VY A    RK  +A+K   K  L  +       +E+++   L HP + +  
Sbjct: 12  PLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 71
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ-VLMIAAQLAKALQYLHNLGIVHR 186
                        E+     +  +L  ++ S   +Q       +LA AL Y H+  ++HR
Sbjct: 72  GYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHR 129
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+KP N+LL       +ADFG               W S   P+    +  + GTL Y+ 
Sbjct: 130 DIKPENLLLGSAGELKIADFG---------------W-SVHAPSS--RRTTLCGTLDYLP 171
Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           PE+++  +H EK D++S G+   E L G  P+    A     T   ++  E      V  
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQETYKRISRVEFTFPDFVTE 228
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           G                   LI R    NP  RP   ++
Sbjct: 229 GA----------------RDLISRLLKHNPSQRPMLREV 251

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNF----HKELQLLCKL 118
           P +Y   + +  GA   V  A     G KVA+KK  LS   + + F    ++EL LL  +
Sbjct: 41  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHM 98
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
            H  +   +       +   F++FY        +L + + +E    S +++  +  Q+ K
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEF---SEEKIQYLVYQMLK 155
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L+Y+H+ G+VHRD+KP N+ ++ +    + DFGLA +             +  + TG  
Sbjct: 156 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-------------ADAEMTG-- 200
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
                V T  Y APE++   +H  ++ D++S G  + E+LTG
Sbjct: 201 ----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + +L +   +HRD+   N+LL       + DFGLA   +N     +K        
Sbjct: 169 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG------- 221
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                  N    + +MAPE +   +++ +SDV+S+GI + EL + G  PY  +  +++ +
Sbjct: 222 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 274
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            +++  +             L P  A      PA +  +++ CWD +P  RP+F  I 
Sbjct: 275 KMIKEGFRM-----------LSPEHA------PAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + +L +   +HRD+   N+LL       + DFGLA   +N     +K        
Sbjct: 176 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG------- 228
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                  N    + +MAPE +   +++ +SDV+S+GI + EL + G  PY  +  +++ +
Sbjct: 229 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            +++  +             L P  A      PA +  +++ CWD +P  RP+F  I 
Sbjct: 282 KMIKEGFRM-----------LSPEHA------PAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + +L +   +HRD+   N+LL       + DFGLA   +N     +K        
Sbjct: 171 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG------- 223
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                  N    + +MAPE +   +++ +SDV+S+GI + EL + G  PY  +  +++ +
Sbjct: 224 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 276
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
            +++  +             L P  A      PA +  +++ CWD +P  RP+F  I 
Sbjct: 277 KMIKEGFRM-----------LSPEHA------PAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD 119
            +Y LL  I +G  A+  +    L GR+VA+K  I+  ++     L    +E++++  L+
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP + K               E+     + + L V        +      Q+  A+QY H
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              IVHRD+K  N+LLD ++   +ADFG +            N  + G     F      
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFS------------NEFTVGGKLDAF-----C 174
Query: 240 GTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           G   Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAV+   K  L++S  L    +E++++  L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSS-LQKLFREVRIMKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD ++   +ADFG                  S + T G       G
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTFGNKLDTFCG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           +  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           K   KK +      ++N   E+ +L K+ HP +      +    +     +      L +
Sbjct: 49  KCIAKKALEGKEGSMEN---EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL---LDRNLCPHLADFG 207
           ++  + +    D   +I  Q+  A++YLH+LGIVHRD+KP N+L   LD +    ++DFG
Sbjct: 106 RIVEKGFYTERDASRLIF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 164
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
           L++  +    +S                    GT  Y+APE+L ++ +S+  D +S G+ 
Sbjct: 165 LSKMEDPGSVLS-----------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 268 INELLTGVVPYTDLRAEAQAHTVLEMNY 295
              LL G  P+ D         +L+  Y
Sbjct: 208 AYILLCGYPPFYDENDAKLFEQILKAEY 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 84
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 187
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 85
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 146 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMVPFV 188
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 110/244 (45%), Gaps = 32/244 (13%)
Query: 66  SSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           S Y  L P+  G   +V+ A  +   ++VA+KK +L+  + + +  +E++++ +LDH  +
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 124 AKFV-------------AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ-VLMIAA 169
            K                      N ++  + Y   +LA   +V E  P +++   +   
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA---NVLEQGPLLEEHARLFMY 127
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           QL + L+Y+H+  ++HRD+KPAN+ ++  +L   + DFGLA   +        ++   G 
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-------PHYSHKGH 180
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
            + G   K      + ++P    K I     D+++ G    E+LTG   +       Q  
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAI-----DMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 289 TVLE 292
            +LE
Sbjct: 236 LILE 239

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAV+   K  L++S  L    +E++++  L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSS-LQKLFREVRIMKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD ++   +ADFG                  S + T G       G
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTFGNKLDEFCG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           +  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAVK   K  L++S  L    +E++++  L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD ++   +ADFG +            N  + G     F      G
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFS------------NEFTFGNKLDAF-----CG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
              Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 159
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 160 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 214
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 215 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 255

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           +V+E +P   +   +   AQ+   L++LH   I++RD+KP NVLLD +    ++D GLA 
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA- 336
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                  + LK         G    K   GT  +MAPE+L  E +    D ++ G+++ E
Sbjct: 337 -------VELK--------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           ++    P+   R E   +  L+    EQ +T
Sbjct: 382 MIAARGPFR-ARGEKVENKELKQRVLEQAVT 411

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           +V+E +P   +   +   AQ+   L++LH   I++RD+KP NVLLD +    ++D GLA 
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA- 336
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                  + LK         G    K   GT  +MAPE+L  E +    D ++ G+++ E
Sbjct: 337 -------VELK--------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           ++    P+   R E   +  L+    EQ +T
Sbjct: 382 MIAARGPFR-ARGEKVENKELKQRVLEQAVT 411

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           +V+E +P   +   +   AQ+   L++LH   I++RD+KP NVLLD +    ++D GLA 
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA- 336
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                  + LK         G    K   GT  +MAPE+L  E +    D ++ G+++ E
Sbjct: 337 -------VELK--------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           ++    P+   R E   +  L+    EQ +T
Sbjct: 382 MIAARGPFR-ARGEKVENKELKQRVLEQAVT 411

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 184
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 185 PSS--RRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 239
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 240 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 280

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ HP +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITAVSYDFDEE 240

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 19/151 (12%)
Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
           +V+E +P   +   +   AQ+   L++LH   I++RD+KP NVLLD +    ++D GLA 
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA- 336
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                  + LK         G    K   GT  +MAPE+L  E +    D ++ G+++ E
Sbjct: 337 -------VELK--------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           ++    P+   R E   +  L+    EQ +T
Sbjct: 382 MIAARGPFR-ARGEKVENKELKQRVLEQAVT 411

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKVVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLVGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 56/292 (19%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHPG 122
           Y  L PI  GA+ +V  A  T+ G  VAVKK   P  + +      ++EL LL  ++H  
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-KRAYRELVLLKCVNHKN 84
Query: 123 LAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           +   +           F + Y        NL + +H+E     +  +L    Q+   +++
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY---QMLCGIKH 141
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH+ GI+HRD+KP+N+++  +    + DFGLA              R++      F    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTA---CTNFMMTP 184
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
            V T  Y APE++    ++   D++S G  + EL+ G V +       Q + V+E     
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIE----- 239
Query: 298 QQLTAAVVSGGLRPILASLELGLP-ASILSLIQRCWDGNPHNRPSFSDIALE 348
                              +LG P A  ++ +Q        NRP +  I  E
Sbjct: 240 -------------------QLGTPSAEFMAALQPTVRNYVENRPKYPGIKFE 272

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKXVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    +  FGLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILGFGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    + ++ GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 164 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 219 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 259

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + DF LA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFYLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFV-A 128
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIV 184
            H +   Y+ F   ++  +L   +     +    P +   L    QL + L + H+  ++
Sbjct: 70  IHTENKLYLVFEHVHQ--DLKTFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVL 124
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+L++      LADFGLA              R+ G P   +   + V TL Y
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTY--THEVVTLWY 168
Query: 245 MAPEILKK-EIHSEKSDVYSFGISINELLT 273
            APEIL   + +S   D++S G    E++T
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H 
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 70
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      K        E+  +  L   L          Q+L +   + +A++YL + 
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             +HRD+   N L++      ++DFGL+ Y      +    + SS            VG+
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSS------------VGS 172
Query: 242 ---LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
              + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T 
Sbjct: 173 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTN 218
Query: 298 QQLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 219 SE-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 259

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE-----ELDNFHKELQLLCKLDH 120
             + +  P+ +G    VY A     K  +   +L  S+           +E+++   L H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + +               EF     L ++L  +       +      +LA AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYCHE 133
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP N+L+       +ADFG + +  +L+                  ++ M G
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------------------RRXMCG 175
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           TL Y+ PE+++ + H EK D++  G+   E L G+ P+
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPEV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
            T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           N  +E+     L HP + +F      P +     E+     L E++       S D+   
Sbjct: 61  NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARF 119
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWR 224
              QL   + Y H + + HRD+K  N LLD +  P L   DFG +           K+  
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----------KSSV 168
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
              +P      K+ VGT  Y+APE+ LKKE   + +DV+S G+++  +L G  P+ D
Sbjct: 169 LHSQP------KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFV-A 128
           I  G   VVY+A   L G  VA+KK  L T  E       +E+ LL +L+HP + K +  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIV 184
            H +   Y+ F   +  ++L + +     +    P +   L    QL + L + H+  ++
Sbjct: 74  IHTENKLYLVFE--HVDQDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVL 128
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYXHE--VVTLWY 172
Query: 245 MAPEILKK-EIHSEKSDVYSFGISINELLT 273
            APEIL   + +S   D++S G    E++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H  
Sbjct: 6   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 65
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L +      K        E+  +  L   L          Q+L +   + +A++YL +  
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT- 241
            +HRD+   N L++      ++DFGL+ Y      +    + SS            VG+ 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSS------------VGSK 167
Query: 242 --LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298
             + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T  
Sbjct: 168 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTNS 213
Query: 299 QLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 214 E-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 253

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 74  IARGAESVV----YEATLDGRKVAVKKPILS----TSEELDNFH----KELQLLCKL-DH 120
           I RG  SVV    + AT  G + AVK   ++    + E+L+       +E  +L ++  H
Sbjct: 102 IGRGVSSVVRRCVHRAT--GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P +   + ++         F+      L + L  E+ + S  +   I   L +A+ +LH 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+KP N+LLD N+   L+DFG + + E                  G   + + G
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-----------------PGEKLRELCG 261
Query: 241 TLIYMAPEILK---KEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
           T  Y+APEILK    E H    ++ D+++ G+ +  LL G  P+   R       ++E  
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321
Query: 295 Y 295
           Y
Sbjct: 322 Y 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKXVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 159
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 160 PSS--RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 214
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 215 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 255

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKVVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLCGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H 
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      K        E+  +  L   L          Q+L +   + +A++YL + 
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             +HRD+   N L++      ++DFGL+ Y      +    + SS            VG+
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSS------------VGS 165
Query: 242 ---LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
              + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T 
Sbjct: 166 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTN 211
Query: 298 QQLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 212 SE-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 252

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLCGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+ K  L T  E       +E+ LL +L+HP + K +  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 71  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 126
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYTHE--VVTLWYR 170
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
           I  G   VVY+A   L G  VA+ K  L T  E       +E+ LL +L+HP + K +  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWS----PSVDQVLMIAAQLAKALQYLHNLGIVH 185
                     FEF   ++L + +     +    P +   L    QL + L + H+  ++H
Sbjct: 70  IHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF---QLLQGLAFCHSHRVLH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
           RD+KP N+L++      LADFGLA              R+ G P   +  +  V TL Y 
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYTHE--VVTLWYR 169
Query: 246 APEILKK-EIHSEKSDVYSFGISINELLT 273
           APEIL   + +S   D++S G    E++T
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
            + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H 
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      K        E+  +  L   L          Q+L +   + +A++YL + 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             +HRD+   N L++      ++DFGL+ Y      +    + SS            VG+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSS------------VGS 181
Query: 242 ---LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
              + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T 
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTN 227
Query: 298 QQLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
            + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 228 SE-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 268

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 28/230 (12%)
Query: 68  YTLLSPIARGAESVV------YEATLDGRKVAVKKPIL-STSEELDNF-HKELQLLCKLD 119
           Y LL+ I +G E ++      Y+ T  G  V V++  L + S E+  F   EL +    +
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQY 177
           HP +  + A      N ++    + +   A+ L    +   ++++ +  I   + KAL Y
Sbjct: 85  HPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-- 235
           +H++G VHR VK +++L+  +         L+  R NL  I      S G+     H   
Sbjct: 144 IHHMGYVHRSVKASHILISVD-----GKVYLSGLRSNLSMI------SHGQRQRVVHDFP 192
Query: 236 KNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
           K  V  L +++PE+L++ +  +  KSD+YS GI+  EL  G VP+ D+ A
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            +   +       +   F + Y        NL++ + +E     +  +L    Q+   ++
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY---QMLCGIK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA--------------RTAGT---SFMMT 183
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
             V T  Y APE++    + E  D++S G  + E++ G V  P TD
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 175
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 176 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 230
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 231 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 271

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 21/192 (10%)
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +   E+ +L K+ HP +      +    +     +      L +++  + +    D   +
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVL---LDRNLCPHLADFGLAEYRENLKEISLKNW 223
           I  Q+  A++YLH+LGIVHRD+KP N+L   LD +    ++DFGL++  +    +S    
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---- 176
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                           GT  Y+APE+L ++ +S+  D +S G+    LL G  P+ D   
Sbjct: 177 -------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223
Query: 284 EAQAHTVLEMNY 295
                 +L+  Y
Sbjct: 224 AKLFEQILKAEY 235

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 162
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 163 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 217
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 218 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 258

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 157
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 158 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 212
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 213 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 28/230 (12%)
Query: 68  YTLLSPIARGAESVV------YEATLDGRKVAVKKPIL-STSEELDNF-HKELQLLCKLD 119
           Y LL+ I +G E ++      Y+ T  G  V V++  L + S E+  F   EL +    +
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPT--GEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 68
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQY 177
           HP +  + A      N ++    + +   A+ L    +   ++++ +  I   + KAL Y
Sbjct: 69  HPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 127
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-- 235
           +H++G VHR VK +++L+  +         L+  R NL  I      S G+     H   
Sbjct: 128 IHHMGYVHRSVKASHILISVD-----GKVYLSGLRSNLSMI------SHGQRQRVVHDFP 176
Query: 236 KNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
           K  V  L +++PE+L++ +  +  KSD+YS GI+  EL  G VP+ D+ A
Sbjct: 177 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 226

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNF----HKELQLLCKL 118
           P +Y   + +  GA   V  A     G KVA+KK  LS   + + F    ++EL LL  +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHM 80
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK--LHVEEWSPSVDQVLMIAAQLAKALQ 176
            H  +   +       +   F++FY      +     +     S +++  +  Q+ K L+
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+ G+VHRD+KP N+ ++ +    + DFGLA +             +  + TG     
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-------------ADAEMTG----- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
             V T  Y APE++   +H  ++ D++S G  + E+LTG
Sbjct: 183 -YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 21/192 (10%)
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +   E+ +L K+ HP +      +    +     +      L +++  + +    D   +
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVL---LDRNLCPHLADFGLAEYRENLKEISLKNW 223
           I  Q+  A++YLH+LGIVHRD+KP N+L   LD +    ++DFGL++  +    +S    
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---- 176
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                           GT  Y+APE+L ++ +S+  D +S G+    LL G  P+ D   
Sbjct: 177 -------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223
Query: 284 EAQAHTVLEMNY 295
                 +L+  Y
Sbjct: 224 AKLFEQILKAEY 235

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 104
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 105 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 153
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 154 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 210 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 251
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 252 RPGFAAVELRL 262

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 112/237 (47%), Gaps = 35/237 (14%)
Query: 89  GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKP-------PNYM--F 138
           G +VA+K+     S +  + +  E+Q++ KL+HP +   V+A   P       PN +   
Sbjct: 40  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV---VSAREVPDGLQKLAPNDLPLL 96
Query: 139 FFEFYESRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
             E+ E  +L + L+  E    + +  +  + + ++ AL+YLH   I+HRD+KP N++L 
Sbjct: 97  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 156
Query: 197 ---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
              + L   + D G A      KE+        G+    F     VGTL Y+APE+L+++
Sbjct: 157 PGPQRLIHKIIDLGYA------KELD------QGELCTEF-----VGTLQYLAPELLEQK 199
Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR 310
            ++   D +SFG    E +TG  P+       Q H  +     E  +    ++G ++
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 256

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 106
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 155
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 156 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 212 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 253
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 254 RPGFAAVELRL 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 164 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 219 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 46/287 (16%)
Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           + P   T L  +  G   VV      G+     K I   S   D F +E +++  L H  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L +      K        E+  +  L   L          Q+L +   + +A++YL +  
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT- 241
            +HRD+   N L++      ++DFGL+ Y      +    + SS            VG+ 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRY------VLDDEYTSS------------VGSK 162
Query: 242 --LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298
             + +  PE+L     S KSD+++FG+ + E+ + G +PY                +T  
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------------RFTNS 208
Query: 299 QLTAAVVSGGL---RPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
           + TA  ++ GL   RP LAS        + +++  CW      RP+F
Sbjct: 209 E-TAEHIAQGLRLYRPHLAS------EKVYTIMYSCWHEKADERPTF 248

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 112/237 (47%), Gaps = 35/237 (14%)
Query: 89  GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKP-------PNYM--F 138
           G +VA+K+     S +  + +  E+Q++ KL+HP +   V+A   P       PN +   
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV---VSAREVPDGLQKLAPNDLPLL 95
Query: 139 FFEFYESRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
             E+ E  +L + L+  E    + +  +  + + ++ AL+YLH   I+HRD+KP N++L 
Sbjct: 96  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155
Query: 197 ---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
              + L   + D G A      KE+        G+    F     VGTL Y+APE+L+++
Sbjct: 156 PGPQRLIHKIIDLGYA------KELD------QGELCTEF-----VGTLQYLAPELLEQK 198
Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR 310
            ++   D +SFG    E +TG  P+       Q H  +     E  +    ++G ++
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKXVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 164 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 219 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 184
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 185 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 239
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 240 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 280

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + D GLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDAGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 90  RKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146
           R ++ +K  + ++ E D   N   E+++L KL+HP + K +       +Y    E  E  
Sbjct: 180 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGG 238
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHL 203
            L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +    +
Sbjct: 239 ELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 297
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSD 260
            DFG   + + L E SL               + + GT  Y+APE+L       ++   D
Sbjct: 298 TDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVD 340
Query: 261 VYSFGISINELLTGVVPYTDLRAEA 285
            +S G+ +   L+G  P+++ R + 
Sbjct: 341 CWSLGVILFICLSGYPPFSEHRTQV 365

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SCHA 159
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 160 PSS--RRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 214
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 215 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 255

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 110
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 111 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 159
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 160 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 216 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 257
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 258 RPGFAAVELRL 268

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 38/208 (18%)
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
           S  + Q+L+ A Q+ + + YLH+   +HR++   NVLLD +    + DFGLA+       
Sbjct: 113 SIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK------- 165
Query: 218 ISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
                      P G  +   +++    + + APE LK+      SDV+SFG+++ ELLT 
Sbjct: 166 ---------AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 275 V-------VPYTDLRAEAQAH-TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
                     + +L   AQ   TVL       +LT  +  G   P         P  +  
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVL-------RLTELLERGERLPRPDK----CPCEVYH 265
Query: 327 LIQRCWDGNPHNRPSFSDIALELDLVLE 354
           L++ CW+     RP+F ++   L  V E
Sbjct: 266 LMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + D GLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDRGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 21/192 (10%)
Query: 107 NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +   E+ +L K+ HP +      +    +     +      L +++  + +    D   +
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVL---LDRNLCPHLADFGLAEYRENLKEISLKNW 223
           I  Q+  A++YLH+LGIVHRD+KP N+L   LD +    ++DFGL++  +    +S    
Sbjct: 122 IF-QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---- 176
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                           GT  Y+APE+L ++ +S+  D +S G+    LL G  P+ D   
Sbjct: 177 -------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 223
Query: 284 EAQAHTVLEMNY 295
                 +L+  Y
Sbjct: 224 AKLFEQILKAEY 235

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 116
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 165
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 166 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 222 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 263
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 264 RPGFAAVELRL 274

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 137 SAGIIHRDLKPSNIVVKSDXTLKILDFGLA--------------RTAG---TSFMMTPYV 179
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 42  KVLEPNTCIRGC-CSSQSIPLHLPPSSYTLLSPIARGAESVVYEA------------TLD 88
           K +E +   R C   +  + +HL  + +++   I RG    VY               LD
Sbjct: 163 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 222
Query: 89  GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
            +++ +K+   L+ +E +      L L+   D P +     A   P    F  +     +
Sbjct: 223 KKRIKMKQGETLALNERI-----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 277
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           L   L         D +   AA++   L+++HN  +V+RD+KPAN+LLD +    ++D G
Sbjct: 278 LHYHLSQHGVFSEAD-MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGI 266
           LA       + S K   +S            VGT  YMAPE+L+K + +   +D +S G 
Sbjct: 337 LA------CDFSKKKPHAS------------VGTHGYMAPEVLQKGVAYDSSADWFSLGC 378
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
            + +LL G  P+   + + + H +  M  T     A  +     P L SL  GL
Sbjct: 379 MLFKLLRGHSPFRQHKTKDK-HEIDRMTLT----MAVELPDSFSPELRSLLEGL 427

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 27/237 (11%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD 119
            +Y L   I +G  A+  +    L GR+VAVK  I+  ++     L    +E++++  L+
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVK--IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP + K               E+     + + L V        +      Q+  A+QY H
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              IVHRD+K  N+LLD ++   +ADFG                  S + T G       
Sbjct: 132 QKYIVHRDLKAENLLLDGDMNIKIADFGF-----------------SNEFTVGNKLDTFC 174
Query: 240 GTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           G+  Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 160
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 161 PSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 215
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 216 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 256

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 42  KVLEPNTCIRGC-CSSQSIPLHLPPSSYTLLSPIARGAESVVYEA------------TLD 88
           K +E +   R C   +  + +HL  + +++   I RG    VY               LD
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 89  GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
            +++ +K+   L+ +E +      L L+   D P +     A   P    F  +     +
Sbjct: 224 KKRIKMKQGETLALNERI-----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           L   L         D +   AA++   L+++HN  +V+RD+KPAN+LLD +    ++D G
Sbjct: 279 LHYHLSQHGVFSEAD-MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGI 266
           LA       + S K   +S            VGT  YMAPE+L+K + +   +D +S G 
Sbjct: 338 LA------CDFSKKKPHAS------------VGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
            + +LL G  P+   + + + H +  M  T     A  +     P L SL  GL
Sbjct: 380 MLFKLLRGHSPFRQHKTKDK-HEIDRMTLT----MAVELPDSFSPELRSLLEGL 428

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 42  KVLEPNTCIRGC-CSSQSIPLHLPPSSYTLLSPIARGAESVVYEA------------TLD 88
           K +E +   R C   +  + +HL  + +++   I RG    VY               LD
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 89  GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
            +++ +K+   L+ +E +      L L+   D P +     A   P    F  +     +
Sbjct: 224 KKRIKMKQGETLALNERI-----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           L   L         D +   AA++   L+++HN  +V+RD+KPAN+LLD +    ++D G
Sbjct: 279 LHYHLSQHGVFSEAD-MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGI 266
           LA       + S K   +S            VGT  YMAPE+L+K + +   +D +S G 
Sbjct: 338 LA------CDFSKKKPHAS------------VGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
            + +LL G  P+   + + + H +  M  T     A  +     P L SL  GL
Sbjct: 380 MLFKLLRGHSPFRQHKTKDK-HEIDRMTLT----MAVELPDSFSPELRSLLEGL 428

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 90  RKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146
           R ++ +K  + ++ E D   N   E+++L KL+HP + K +       +Y    E  E  
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGG 224
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHL 203
            L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +    +
Sbjct: 225 ELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSD 260
            DFG   + + L E SL               + + GT  Y+APE+L       ++   D
Sbjct: 284 TDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 261 VYSFGISINELLTGVVPYTDLRAEA 285
            +S G+ +   L+G  P+++ R + 
Sbjct: 327 CWSLGVILFICLSGYPPFSEHRTQV 351

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 117/300 (39%), Gaps = 64/300 (21%)
Query: 68  YTLLSPIARGAESVVYEA------TLDGRKVAVKKPILSTS-EELDNFHKELQLLCKLDH 120
           Y L   I +G+  VV  A       +   K+  K  I   + ++++    E++L+ KL H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-------------------------E 155
           P +A+    +          E     +L +KL+V                         E
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 156 E--------WSPSVDQVLM------IAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--L 199
           E        +  S+D V        I  Q+  AL YLHN GI HRD+KP N L   N   
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 200 CPHLADFGLAEYRENLKEI-SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHS 256
              L DFGL+      KE   L N    G  T         GT  ++APE+L    E + 
Sbjct: 208 EIKLVDFGLS------KEFYKLNNGEYYGMTTKA-------GTPYFVAPEVLNTTNESYG 254
Query: 257 EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
            K D +S G+ ++ LL G VP+  +        VL      +     V+S   R +L++L
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNL 314

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
           P  Y  LSP+  GA   V  A  T  G +VAVKK   P  S       + +EL+LL  + 
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 79
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
           H  +   +       +   F + Y   +L    L+  V+    + D V  +  Q+ + L+
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H+  I+HRD+KP+N+ ++ +    + D GLA              R +     G+   
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDGGLA--------------RHTDDEMTGY--- 182
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
             V T  Y APEI+   +H  ++ D++S G  + ELLTG  + P TD
Sbjct: 183 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 121
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 224
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 42  KVLEPNTCIRGC-CSSQSIPLHLPPSSYTLLSPIARGAESVVYEA------------TLD 88
           K +E +   R C   +  + +HL  + +++   I RG    VY               LD
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD 223
Query: 89  GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
            +++ +K+   L+ +E +      L L+   D P +     A   P    F  +     +
Sbjct: 224 KKRIKMKQGETLALNERI-----MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
           L   L         D +   AA++   L+++HN  +V+RD+KPAN+LLD +    ++D G
Sbjct: 279 LHYHLSQHGVFSEAD-MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGI 266
           LA       + S K   +S            VGT  YMAPE+L+K + +   +D +S G 
Sbjct: 338 LA------CDFSKKKPHAS------------VGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
            + +LL G  P+   + + + H +  M  T     A  +     P L SL  GL
Sbjct: 380 MLFKLLRGHSPFRQHKTKDK-HEIDRMTLT----MAVELPDSFSPELRSLLEGL 428

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/266 (22%), Positives = 106/266 (39%), Gaps = 21/266 (7%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   +  GA  VV+  T    G   A K  +     + +   KE+Q +  L HP L  
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +  +EF     L EK+  E    S D+ +    Q+ K L ++H    VH
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278
Query: 186 RDVKPANVLL--DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++    R+    L DFGL  + +  + +                 K   GT  
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----------------KVTTGTAE 321
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           + APE+ + +     +D++S G+    LL+G+ P+     +     V   ++       +
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 381
Query: 304 VVSGGLRPILASLELGLPASILSLIQ 329
            +S   +  +  L L  P + +++ Q
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQ 407

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 21/266 (7%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   +  GA  VV+  T    G   A K  +     + +   KE+Q +  L HP L  
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +  +EF     L EK+  E    S D+ +    Q+ K L ++H    VH
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172
Query: 186 RDVKPANVLL--DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++    R+    L DFGL  + +  + + +                   GT  
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----------------TTGTAE 215
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           + APE+ + +     +D++S G+    LL+G+ P+     +     V   ++       +
Sbjct: 216 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 275
Query: 304 VVSGGLRPILASLELGLPASILSLIQ 329
            +S   +  +  L L  P + +++ Q
Sbjct: 276 GISEDGKDFIRKLLLADPNTRMTIHQ 301

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 48/284 (16%)
Query: 78  AESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137
           AE      T D   VAVK     T     +F +E +LL  L H  + KF          +
Sbjct: 34  AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93
Query: 138 FFFEFYESRNLAEKLHVE--------EWSP-------SVDQVLMIAAQLAKALQYLHNLG 182
             FE+ +  +L + L           +  P        + Q+L IA+Q+A  + YL +  
Sbjct: 94  MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
            VHRD+   N L+  NL   + DFG++      +++   ++   G  T        +  +
Sbjct: 154 FVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPI 199
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            +M PE +     + +SDV+SFG+ + E+ T G  P+  L        + +    E    
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE---- 255
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   RP +       P  +  ++  CW   P  R +  +I
Sbjct: 256 --------RPRVC------PKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 164 PSS--RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 219 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 259

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 126
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 127 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 175
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 176 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 232 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 273
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 274 RPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 126
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 127 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 175
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 176 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 232 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 273
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 274 RPGFAAVELRL 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 90  RKVAVK-----KPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
           +KVA+K     K  + ++ E D   N   E+++L KL+HP + K +       +Y    E
Sbjct: 42  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLE 100
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRN 198
             E   L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +
Sbjct: 101 LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 159
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIH 255
               + DFG   + + L E SL               + + GT  Y+APE+L       +
Sbjct: 160 CLIKITDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGY 202
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           +   D +S G+ +   L+G  P+++ R + 
Sbjct: 203 NRAVDCWSLGVILFICLSGYPPFSEHRTQV 232

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 124
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 125 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 173
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 174 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 230 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 271
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 272 RPGFAAVELRL 282

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 16/131 (12%)
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
            +  AA++A  L +L + GI++RD+K  NV+LD      +ADFG+   +EN+       W
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENI-------W 494
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                   G   K   GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+     
Sbjct: 495 -------DGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 284 EAQAHTVLEMN 294
           +    +++E N
Sbjct: 548 DELFQSIMEHN 558

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 24/193 (12%)
Query: 92  VAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VAVK   +   E++D N  +E+     L HP + +F      P +     E+     L E
Sbjct: 47  VAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGL 208
           ++       S D+      QL   + Y H + + HRD+K  N LLD +  P L    FG 
Sbjct: 105 RI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGY 163
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGIS 267
           +           K+     +P      K+ VGT  Y+APE+ LKKE   + +DV+S G++
Sbjct: 164 S-----------KSSVLHSQP------KDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 268 INELLTGVVPYTD 280
           +  +L G  P+ D
Sbjct: 207 LYVMLVGAYPFED 219

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 73  PIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLL--CKLDHPGLAKFVAAH 130
           P+  G+ S+  +        A    I+S   E  N  KE+  L  C+  HP + K     
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-NTQKEITALKLCE-GHPNIVKLHEVF 75
Query: 131 AKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
               +     E      L E++    H  E   S      I  +L  A+ ++H++G+VHR
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IMRKLVSAVSHMHDVGVVHR 130
Query: 187 DVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           D+KP N+L    + NL   + DFG A                  KP      K    TL 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL----------------KPPDNQPLKTPCFTLH 174
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           Y APE+L +  + E  D++S G+ +  +L+G VP+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 90  RKVAVK-----KPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
           +KVA+K     K  + ++ E D   N   E+++L KL+HP + K +       +Y    E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLE 94
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRN 198
             E   L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +
Sbjct: 95  LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIH 255
               + DFG   + + L E SL               + + GT  Y+APE+L       +
Sbjct: 154 CLIKITDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           +   D +S G+ +   L+G  P+++ R + 
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY-TD 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 84
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 187
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 51/229 (22%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----------------VDQVLMI 167
           +            FF+   E +++     V ++ P                  V  V + 
Sbjct: 77  RL---------RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSS 226
             QL ++L Y+H+ GI HRD+KP N+LLD +     L DFG                 S+
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SA 170
Query: 227 GKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            +   G    + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 171 KQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD 119
           L  P   + L+  +  G    VY+   +   ++A  K +  T +E +   +E+ +L K  
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 78
Query: 120 H-PGLAKFVAAHAK--PP----NYMFFFEFYES-------RNLAEKLHVEEWSPSVDQVL 165
           H   +A +  A  K  PP          EF  +       +N       EEW      + 
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW------IA 132
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            I  ++ + L +LH   ++HRD+K  NVLL  N    L DFG          +S +  R+
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG----------VSAQLDRT 182
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTD 280
            G+      +   +GT  +MAPE++  + + +     KSD++S GI+  E+  G  P  D
Sbjct: 183 VGR------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
Query: 281 L 281
           +
Sbjct: 237 M 237

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 84
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 187
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 180
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 90  RKVAVK-----KPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
           +KVA+K     K  + ++ E D   N   E+++L KL+HP + K +       +Y    E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLE 94
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRN 198
             E   L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +
Sbjct: 95  LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIH 255
               + DFG   + + L E SL               + + GT  Y+APE+L       +
Sbjct: 154 CLIKITDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           +   D +S G+ +   L+G  P+++ R + 
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 179
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 116
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 165
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 166 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 220 TKQETLAN-VSAVNY 233

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 90  RKVAVK-----KPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
           +KVA+K     K  + ++ E D   N   E+++L KL+HP + K +       +Y    E
Sbjct: 35  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLE 93
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRN 198
             E   L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +
Sbjct: 94  LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 152
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIH 255
               + DFG   + + L E SL               + + GT  Y+APE+L       +
Sbjct: 153 CLIKITDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGY 195
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           +   D +S G+ +   L+G  P+++ R + 
Sbjct: 196 NRAVDCWSLGVILFICLSGYPPFSEHRTQV 225

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 90  RKVAVK-----KPILSTSEELD---NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
           +KVA+K     K  + ++ E D   N   E+++L KL+HP + K +       +Y    E
Sbjct: 36  KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLE 94
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRN 198
             E   L +K+ V           +   Q+  A+QYLH  GI+HRD+KP NVLL   + +
Sbjct: 95  LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEED 153
Query: 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIH 255
               + DFG   + + L E SL               + + GT  Y+APE+L       +
Sbjct: 154 CLIKITDFG---HSKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
           +   D +S G+ +   L+G  P+++ R + 
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQV 226

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 82
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 143 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 185
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 158
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 159 PSS--RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQD 213
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 214 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 254

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK +   + +    ++ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----NRELQIMRKLDHCNIV 76
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A+                G+P   +  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------------QLVRGEPNVSY-- 182
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 183 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMTPYV 180
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A LD R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 121
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +           F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 224
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 116
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 165
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 166 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 220 TKQETLAN-VSAVNY 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 38/208 (18%)
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
           S  + Q+L+ A Q+ + + YLH    +HR++   NVLLD +    + DFGLA+       
Sbjct: 113 SIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK------- 165
Query: 218 ISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
                      P G  +   +++    + + APE LK+      SDV+SFG+++ ELLT 
Sbjct: 166 ---------AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 275 V-------VPYTDLRAEAQAH-TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
                     + +L   AQ   TVL       +LT  +  G   P         P  +  
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVL-------RLTELLERGERLPRPDK----CPCEVYH 265
Query: 327 LIQRCWDGNPHNRPSFSDIALELDLVLE 354
           L++ CW+     RP+F ++   L  V E
Sbjct: 266 LMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA 129
           LL  I RG    VY+ +LD R VAVK    +  +   N  K +  +  ++H  +A+F+  
Sbjct: 17  LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVG 75
Query: 130 HAKPP-----NYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQLAKALQYLHNL- 181
             +        Y+   E+Y + +L +   LH  +W  S      +A  + + L YLH   
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC----RLAHSVTRGLAYLHTEL 131
Query: 182 --------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+   NVL+  +    ++DFGL+     ++    +  R   +     
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS-----MRLTGNRLVRPGEEDNAAI 186
Query: 234 HKKNMVGTLIYMAPEILKKEIH-------SEKSDVYSFGISINELL---TGVVPYTDLRA 283
            +   VGT+ YMAPE+L+  ++        ++ D+Y+ G+   E+    T + P   +  
Sbjct: 187 SE---VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 284 EAQAHTVLEMNY-TEQQLTAAVVSGGLRPIL--ASLELGLPA-SILSLIQRCWDGNPHNR 339
              A      N+ T + +   V     RP    A  E  L   S+   I+ CWD +   R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 340 PSFS---DIALELDLVLEHRKSL 359
            +     +   EL ++ E  KS+
Sbjct: 304 LTAQXAEERMAELMMIWERNKSV 326

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK +   + +    ++ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----NRELQIMRKLDHCNIV 76
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A+                G+P   +  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------------QLVRGEPNVSY-- 182
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 183 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 24/193 (12%)
Query: 92  VAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           VAVK   +   E++D N  +E+     L HP + +F      P +     E+     L E
Sbjct: 47  VAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGL 208
           ++       S D+      QL   + Y H + + HRD+K  N LLD +  P L    FG 
Sbjct: 105 RI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGY 163
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGIS 267
           +           K+     +P      K+ VGT  Y+APE+ LKKE   + +DV+S G++
Sbjct: 164 S-----------KSSVLHSQP------KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 268 INELLTGVVPYTD 280
           +  +L G  P+ D
Sbjct: 207 LYVMLVGAYPFED 219

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 61/108 (56%), Gaps = 4/108 (3%)
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           L I  Q+A+A+++LH+ G++HRD+KP+N+    +    + DFGL    +  +E   +   
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE---EQTV 223
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            +  P    H    VGT +YM+PE +    +S K D++S G+ + ELL
Sbjct: 224 LTPMPAYATH-XGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+A+ +++L +   +HRD+   N+LL  N    + DFGLA          
Sbjct: 197 TMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLA---------- 246
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +  +I+S KSDV+S+G+ + E+ + G  PY
Sbjct: 247 ----RDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY 302
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ +    + L                G+R  + + E   P  I  ++  CW  +P  
Sbjct: 303 PGVQMDEDFCSRLR--------------EGMR--MRAPEYSTP-EIYQIMLDCWHRDPKE 345
Query: 339 RPSFSDIALELDLVL 353
           RP F+++  +L  +L
Sbjct: 346 RPRFAELVEKLGDLL 360

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 67/130 (51%), Gaps = 16/130 (12%)
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           +  AA++A  L +L + GI++RD+K  NV+LD      +ADFG+   +EN+       W 
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENI-------W- 173
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
                  G   K   GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+     +
Sbjct: 174 ------DGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227
Query: 285 AQAHTVLEMN 294
               +++E N
Sbjct: 228 ELFQSIMEHN 237

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 81
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 142 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 187
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 188 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 104
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A+                G+P   +  
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------------QLVRGEPNVSY-- 210
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 211 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 26/224 (11%)
Query: 78  AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134
           +E V+ E    G+  AVK   K  L   E   +   E+ +L K+ H  +      +  P 
Sbjct: 36  SEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEIAVLRKIKHENIVALEDIYESPN 93
Query: 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
           +     +      L +++  + +    D   +I  Q+  A+ YLH +GIVHRD+KP N+L
Sbjct: 94  HLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR-QVLDAVYYLHRMGIVHRDLKPENLL 152
Query: 195 L---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
               D      ++DFGL+              +  GK   G       GT  Y+APE+L 
Sbjct: 153 YYSQDEESKIMISDFGLS--------------KMEGK---GDVMSTACGTPGYVAPEVLA 195
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           ++ +S+  D +S G+    LL G  P+ D         +L+  Y
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEY 239

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 155
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 261
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 262 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 42/249 (16%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 110
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL+      K +   
Sbjct: 111 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS------KALRAD 164
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
                 +  G +  K       + APE +     S KSDV+SFG+ + E  + G  PY  
Sbjct: 165 ENXYKAQTHGKWPVK-------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217
Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
           ++                ++TA +  G      A    G P  +  L+  CW  +  NRP
Sbjct: 218 MKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVENRP 259
Query: 341 SFSDIALEL 349
            F+ + L L
Sbjct: 260 GFAAVELRL 268

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 216
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 217 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 182
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 183 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 89
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A+                G+P   +  
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK------------QLVRGEPNVSY-- 195
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 196 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 112
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 218
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 219 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|3KDJ|B Chain B, Complex Structure Of (+)-Aba-Bound Pyl1 And Abi1 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 37/160 (23%)
Query: 431 WGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGSAAAEFS 477
           +G  + CGRR  MED    +P                 Q   H FG++DGH GS  A + 
Sbjct: 11  YGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGSQVANYC 70
Query: 478 ARALPGFLQNLGSTTRP------------TDALLEAFIRTDVAFRNELDSLRKSKRVVQK 525
              +   L    +  +P              AL  +F+R D    +E++S+         
Sbjct: 71  RERMHLALAEEIAKEKPMLSDGDTWLEKWKKALFNSFLRVD----SEIESVAPET----- 121
Query: 526 DWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALS 565
               G T++ A++  + +FVAN GD RA+LCRG     LS
Sbjct: 122 ---VGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTALPLS 158

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     +ADFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 114
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A      K++        G+P   +  
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQL------VRGEPNVSY-- 220
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
              + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 221 ---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     +ADFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     +ADFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK +   + +    ++ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----NRELQIMRKLDHCNIV 76
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS-----------------VDQVLMI 167
           +            FF+   E ++      V ++ P+                 V  V + 
Sbjct: 77  RL---------RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY 127
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSS 226
             QL ++L Y+H+ GI HRD+KP N+LLD +     L DFG                 S+
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SA 170
Query: 227 GKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            +   G    + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 171 KQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     +ADFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NMN|B Chain B, Crystal Structure Of Pyrabactin-Bound Abscisic Acid Receptor Pyl1 In Complex With Type 2c Protein Phosphatase Abi1 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 37/160 (23%)
Query: 431 WGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGS------ 471
           +G  + CGRR  MED    +P                 Q   H FG++DGH GS      
Sbjct: 14  YGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGSQVANYC 73
Query: 472 ------AAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQK 525
                 A AE  A+  P          +   AL  +F+R D    +E++S+         
Sbjct: 74  RERMHLALAEEIAKEKPMLCDGDTWLEKWKKALFNSFLRVD----SEIESVAPET----- 124
Query: 526 DWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALS 565
               G T++ A++  + +FVAN GD RA+LCRG     LS
Sbjct: 125 ---VGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTALPLS 161

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAK 125
           +  L   I +G    V+     G +VAVK  I S+ EE   F + E+     L H  +  
Sbjct: 5   TIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILG 62
Query: 126 FVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-- 179
           F+AA  K            +++E  +L + L+   ++ +V+ ++ +A   A  L +LH  
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 120
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+K  N+L+ +N    +AD GLA   +            S   T   
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD------------SATDTIDI 168
Query: 234 HKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL-----LTGV-----VP 277
              + VGT  YMAPE+L   I+       +++D+Y+ G+   E+     + G+     +P
Sbjct: 169 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 228
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGN 335
           Y DL         +  + + +++   V    LRP + +      A   +  +++ CW  N
Sbjct: 229 YYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 279
Query: 336 PHNR 339
              R
Sbjct: 280 GAAR 283

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W  +G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLAG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAK 125
           +  L   I +G    V+     G +VAVK  I S+ EE   F + E+     L H  +  
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 126 FVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-- 179
           F+AA  K            +++E  +L + L+   ++ +V+ ++ +A   A  L +LH  
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+K  N+L+ +N    +AD GLA   +            S   T   
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD------------SATDTIDI 167
Query: 234 HKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL-----LTGV-----VP 277
              + VGT  YMAPE+L   I+       +++D+Y+ G+   E+     + G+     +P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGN 335
           Y DL         +  + + +++   V    LRP + +      A   +  +++ CW  N
Sbjct: 228 YYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 336 PHNR 339
              R
Sbjct: 279 GAAR 282

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 469
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 470 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 518
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 519 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 575 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 616
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 617 RPGFAAVELRL 627

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 90  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 144 IKITDFGLC--KEGISD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 188 WWGLGVVMYEMMCGRLPF 205

>pdb|3JRQ|A Chain A, Crystal Structure Of (+)-aba-bound Pyl1 In Complex With Abi1 Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 37/167 (22%)
Query: 424 TYYPVLSWGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRG 470
           ++  V  +G  + CGRR  MED    +P                 Q   H FG++DGH G
Sbjct: 19  SHMSVPLYGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGG 78
Query: 471 S------------AAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
           S            A AE  A+  P          +   AL  +F+R D    +E++S+  
Sbjct: 79  SQVANYCRERMHLALAEEIAKEKPMLCDGDTWLEKWKKALFNSFLRVD----SEIESVAP 134
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALS 565
                      G T++ A++  + +FVAN GD RA+LCRG     LS
Sbjct: 135 ET--------VGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTALPLS 173

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
           D    E  ++ +LD+P + + +    +  ++M   E  E    ++ L +  HV++     
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKD----- 468
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
             ++ +  Q++  ++YL     VHRD+   NVLL       ++DFGL++           
Sbjct: 469 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK----------- 517
Query: 222 NWRSSGKPTGGFHKKNMVGT--LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               + +    ++K    G   + + APE +     S KSDV+SFG+ + E  + G  PY
Sbjct: 518 ----ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++                ++TA +  G      A    G P  +  L+  CW  +  N
Sbjct: 574 RGMKG--------------SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVEN 615
Query: 339 RPSFSDIALEL 349
           RP F+ + L L
Sbjct: 616 RPGFAAVELRL 626

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAK 125
           +  L   I +G    V+     G +VAVK  I S+ EE   F + E+     L H  +  
Sbjct: 7   TIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILG 64
Query: 126 FVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-- 179
           F+AA  K            +++E  +L + L+   ++ +V+ ++ +A   A  L +LH  
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 122
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+K  N+L+ +N    +AD GLA   +            S   T   
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD------------SATDTIDI 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL-----LTGV-----VP 277
              + VGT  YMAPE+L   I+       +++D+Y+ G+   E+     + G+     +P
Sbjct: 171 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 230
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGN 335
           Y DL         +  + + +++   V    LRP + +      A   +  +++ CW  N
Sbjct: 231 YYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 281
Query: 336 PHNR 339
              R
Sbjct: 282 GAAR 285

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
           +KK ++   ++++    E ++L  LD P  L +  +         F  E+    +L    
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLM--Y 109
Query: 153 HVEEWSPSVD-QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
           H+++     + Q +  AA+++  L +LH  GI++RD+K  NV+LD      +ADFG+   
Sbjct: 110 HIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMC-- 167
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
           +E++ +              G   +   GT  Y+APEI+  + + +  D +++G+ + E+
Sbjct: 168 KEHMMD--------------GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 213
Query: 272 LTGVVPYTDLRAEAQAHTVLEMNYT 296
           L G  P+     +    +++E N +
Sbjct: 214 LAGQPPFDGEDEDELFQSIMEHNVS 238

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAK 125
           +  L   I +G    V+     G +VAVK  I S+ EE   F + E+     L H  +  
Sbjct: 10  TIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILG 67
Query: 126 FVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-- 179
           F+AA  K            +++E  +L + L+   ++ +V+ ++ +A   A  L +LH  
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 125
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+K  N+L+ +N    +AD GLA   +            S   T   
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD------------SATDTIDI 173
Query: 234 HKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL-----LTGV-----VP 277
              + VGT  YMAPE+L   I+       +++D+Y+ G+   E+     + G+     +P
Sbjct: 174 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 233
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGN 335
           Y DL         +  + + +++   V    LRP + +      A   +  +++ CW  N
Sbjct: 234 YYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 284
Query: 336 PHNR 339
              R
Sbjct: 285 GAAR 288

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 70/177 (39%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +ADFG               W S   
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG---------------W-SVHA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE ++   H EK D++S G+   E L G  P+    A     
Sbjct: 164 PSS--RRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 219 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPXLREV 259

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 68  YTLLSPIARGAESVV--YEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y  +  +  G  S V   E   DG   A+K+ +    ++ +   +E  +    +HP + +
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 126 FVA-----AHAKPPNYMF--FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            VA       AK   ++   FF+     N  E+L  +    + DQ+L +   + + L+ +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFG-----LAEYRENLKEISLKNWRSSGKPTGGF 233
           H  G  HRD+KP N+LL     P L D G           + + ++L++W +        
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ------- 203
Query: 234 HKKNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPY 278
                  T+ Y APE+   + H    E++DV+S G  +  ++ G  PY
Sbjct: 204 -----RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 76/319 (23%), Positives = 133/319 (41%), Gaps = 59/319 (18%)
Query: 55  SSQSIPLHLPPS---SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK- 110
           S   +PL +  +   +  L   I +G    V+     G +VAVK  I S+ EE   F + 
Sbjct: 15  SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREA 72
Query: 111 ELQLLCKLDHPGLAKFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
           E+     L H  +  F+AA  K            +++E  +L + L+   ++ +V+ ++ 
Sbjct: 73  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIK 130
Query: 167 IAAQLAKALQYLH--------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
           +A   A  L +LH           I HRD+K  N+L+ +N    +AD GLA   +     
Sbjct: 131 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD----- 185
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL- 271
                  S   T      + VGT  YMAPE+L   I+       +++D+Y+ G+   E+ 
Sbjct: 186 -------SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238
Query: 272 ----LTGV-----VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA 322
               + G+     +PY DL         +  + + +++   V    LRP + +      A
Sbjct: 239 RRCSIGGIHEDYQLPYYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 289
Query: 323 --SILSLIQRCWDGNPHNR 339
              +  +++ CW  N   R
Sbjct: 290 LRVMAKIMRECWYANGAAR 308

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 33  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 92
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 93  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 146
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 147 IKITDFGLC--KEGISD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVD 190
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 191 WWGLGVVMYEMMCGRLPF 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +A+FG               W S   
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG---------------W-SVHA 161
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 162 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 216
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 217 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 257

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 90  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 144 IKITDFGLC--KEGISD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 188 WWGLGVVMYEMMCGRLPF 205

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 80
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 183
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 184 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 72/177 (40%), Gaps = 37/177 (20%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            +LA AL Y H+  ++HRD+KP N+LL       +A+FG               W S   
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFG---------------W-SVHA 160
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P+    +  + GTL Y+ PE+++  +H EK D++S G+   E L G  P+    A     
Sbjct: 161 PSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQE 215
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           T   ++  E      V  G                   LI R    NP  RP   ++
Sbjct: 216 TYKRISRVEFTFPDFVTEGA----------------RDLISRLLKHNPSQRPMLREV 256

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 66  SSYTLLSPIARG--AESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
            +Y LL  I +G  A+  +    L G++VAVK   K  L++S  L    +E+++   L+H
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIXKVLNH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + K               E+     + + L V        +      Q+  A+QY H 
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             IVHRD+K  N+LLD +    +ADFG                  S + T G       G
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGF-----------------SNEFTFGNKLDAFCG 174
Query: 241 TLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
              Y APE+ + K+    + DV+S G+ +  L++G +P+     +     VL   Y
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 88
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 191
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 77
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 180
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAK 125
           +  L   I +G    V+     G +VAVK  I S+ EE   F + E+     L H  +  
Sbjct: 43  TIVLQESIGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 126 FVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-- 179
           F+AA  K            +++E  +L + L+   ++ +V+ ++ +A   A  L +LH  
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
                    I HRD+K  N+L+ +N    +AD GLA   +            S   T   
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD------------SATDTIDI 206
Query: 234 HKKNMVGTLIYMAPEILKKEIHS------EKSDVYSFGISINEL-----LTGV-----VP 277
              + VGT  YMAPE+L   I+       +++D+Y+ G+   E+     + G+     +P
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGN 335
           Y DL         +  + + +++   V    LRP + +      A   +  +++ CW  N
Sbjct: 267 YYDL---------VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 336 PHNR 339
              R
Sbjct: 318 GAAR 321

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 179
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFGLA      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 84
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 187
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 188 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAKFV 127
           TLL  + +G    V+  +  G  VAVK  I S+ +E   F + EL     L H  +  F+
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 128 AAHA----KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV--LMIAAQLAKALQYLH-- 179
           A+                ++E  +L + L +     ++D V  L I   +A  L +LH  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGG 232
                    I HRD+K  N+L+ +N    +AD GLA  + ++  ++ + N          
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN---------- 174
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSE------KSDVYSFGISINELLTGVVPYTDLRA-EA 285
                 VGT  YMAPE+L + I  +      + D+++FG+ + E+   +V    +   + 
Sbjct: 175 ---NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSLIQRCWDGNPHNR 339
             + V+  + + + +   V     RP + +     P   S+  L++ CW  NP  R
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 95
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 198
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 199 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 88
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 191
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 76
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 179
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAKFV 127
           TLL  + +G    V+  +  G  VAVK  I S+ +E   F + EL     L H  +  F+
Sbjct: 40  TLLECVGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRETELYNTVMLRHENILGFI 97
Query: 128 AAHA----KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV--LMIAAQLAKALQYLH-- 179
           A+                ++E  +L + L +     ++D V  L I   +A  L +LH  
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIE 153
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGG 232
                    I HRD+K  N+L+ +N    +AD GLA  + ++  ++ + N          
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN---------- 203
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSE------KSDVYSFGISINELLTGVVPYTDLRA-EA 285
                 VGT  YMAPE+L + I  +      + D+++FG+ + E+   +V    +   + 
Sbjct: 204 ---NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 260
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSLIQRCWDGNPHNR 339
             + V+  + + + +   V     RP + +     P   S+  L++ CW  NP  R
Sbjct: 261 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 133/320 (41%), Gaps = 47/320 (14%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDN--FHKELQLLCKLDHP 121
             Y  +  I  G+  VV++      G+ VA+KK + S  + +      +E+++L +L HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            L   +    +       FE+ +   L E   ++ +   V + L+  I  Q  +A+ + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHE---LDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
               +HRDVKP N+L+ ++    L DFG A              R    P+  +   + V
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA--------------RLLTGPSDYY--DDEV 163
Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH----TVLEMN 294
            T  Y +PE+L  +  +    DV++ G    ELL+GV  +       Q +    T+ ++ 
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 295 YTEQQL--TAAVVSGGLRP---ILASLELGLPA---SILSLIQRCWDGNPHNR------- 339
              QQ+  T    SG   P    +  LEL  P      L L++ C   +P  R       
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 340 --PSFSDIALELDLVLEHRK 357
             P F +I    DL  EH K
Sbjct: 284 HHPYFENIREIEDLAKEHDK 303

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK  +   +   N  +ELQ++ KLDH  + 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKN--RELQIMRKLDHCNIV 110
Query: 125 K-----FVAAHAKPPNYMFFFEFYESRNL---AEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +     + +   K   Y+     Y    +   A      + +  V  V +   QL ++L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG                 S+ +   G   
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-----------------SAKQLVRGEPN 213
Query: 236 KNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
            + + +  Y APE I     ++   DV+S G  + ELL G
Sbjct: 214 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAKFV 127
           TLL  + +G    V+  +  G  VAVK  I S+ +E   F + EL     L H  +  F+
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 128 AAHA----KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV--LMIAAQLAKALQYLH-- 179
           A+                ++E  +L + L +     ++D V  L I   +A  L +LH  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 180 ------NLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGG 232
                    I HRD+K  N+L+ +N    +AD GLA  + ++  ++ + N          
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN---------- 174
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSE------KSDVYSFGISINELLTGVVPYTDLRA-EA 285
                 VGT  YMAPE+L + I  +      + D+++FG+ + E+   +V    +   + 
Sbjct: 175 ---NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSLIQRCWDGNPHNR 339
             + V+  + + + +   V     RP + +     P   S+  L++ CW  NP  R
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLXG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 35  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 94
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 95  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 148
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 149 IKITDFGLC--KEGISD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVD 192
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 193 WWGLGVVMYEMMCGRLPF 210

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           ++  +E+ +L ++ HP +      +    + +   E      L + L  E+ S + ++  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEAT 117
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+L I H D+KP N+ LLDRN+      + DFGLA            
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 167 ------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 281 LRAEAQAHTVLEMNY 295
            + E  A+ V  +NY
Sbjct: 221 TKQETLAN-VSAVNY 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 90  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 144 IKITDFGLC--KEGISD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 188 WWGLGVVMYEMMCGRLPF 205

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 221
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 222 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 90  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 144 IKITDFGLC--KEGISD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 188 WWGLGVVMYEMMCGRLPF 205

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 67  SYTLLSPIARGAESVVY--EATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           ++  +  +  GA S V+  +  L G+  A+K    S +    +   E+ +L K+ H  + 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                +    +Y    +      L +++ +E    +     ++  Q+  A++YLH  GIV
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 185 HRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           HRD+KP N+L    + N    + DFGL++  +N                 G       GT
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-----------------GI-MSTACGT 170
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
             Y+APE+L ++ +S+  D +S G+    LL G  P+ +
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 142 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 195
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 196 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 47/205 (22%)
Query: 148 LAEKLHVEEW-----SPSVDQVLMIA--AQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             +K  +E+W        +D+VL +    Q+ K + Y+H+  ++HRD+KP+N+ L     
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ 174
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL          SLKN    GK T         GTL YM+PE +  + + ++ D
Sbjct: 175 VKIGDFGLV--------TSLKN---DGKRT------RSKGTLRYMSPEQISSQDYGKEVD 217
Query: 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL 320
           +Y+ G+ + ELL                 V +  +   +    +  G +  I    E   
Sbjct: 218 LYALGLILAELL----------------HVCDTAFETSKFFTDLRDGIISDIFDKKE--- 258
Query: 321 PASILSLIQRCWDGNPHNRPSFSDI 345
                +L+Q+     P +RP+ S+I
Sbjct: 259 ----KTLLQKLLSKKPEDRPNTSEI 279

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 58/111 (52%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFGLA      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 89  GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
           GR  A+K   K ++   +E+ +   E ++L    HP L     A        F  E+   
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 146 RNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
             L      E++  EE      +     A++  AL+YLH+  +V+RD+K  N++LD++  
Sbjct: 90  GELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
             + DFGL   +E + +              G   K   GT  Y+APE+L+   +    D
Sbjct: 144 IKITDFGLC--KEGISD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 261 VYSFGISINELLTGVVPY 278
            +  G+ + E++ G +P+
Sbjct: 188 WWGLGVVMYEMMCGRLPF 205

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 193
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 194 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 133 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWTLCG 186
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 187 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 193
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 194 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 221
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 222 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHPGLAK 125
           Y +L  +  GA  VV+               ++T   LD +    E+ ++ +L HP L  
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +   EF     L +++  E++  S  +V+    Q  + L+++H   IVH
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 186 RDVKPANVLLDRNLCP--HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++ +        + DFGLA  + N  EI                 K    T  
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV----------------KVTTATAE 215
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
           + APEI+ +E     +D+++ G+    LL+G+ P+ 
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 94  VKKPILSTSEE---LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           +KK  LS+S      +   +E+ +L ++ HP +           + +   E      L +
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADF 206
            L  E+ S + D+      Q+   + YLH+  I H D+KP N+ LLD+N+      L DF
Sbjct: 98  FL-AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           G+A                  K   G   KN+ GT  ++APEI+  E    ++D++S G+
Sbjct: 157 GIAH-----------------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNY 295
               LL+G  P+     +     +  +NY
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNY 228

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 196 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---------- 245
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 246 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 301
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 302 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 344
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 345 RPTFSELVEHLGNLLQ 360

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWTLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 189 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---------- 238
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 239 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 294
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 295 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 337
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 338 RPTFSELVEHLGNLLQ 353

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 84  EATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143
           E T  G K+A K       ++ +    E+ ++ +LDH  L +   A     + +   E+ 
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL-LDRNLCP- 201
           +   L +++  E ++ +    ++   Q+ + ++++H + I+H D+KP N+L ++R+    
Sbjct: 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI 228
Query: 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDV 261
            + DFGLA           + ++   K    F      GT  ++APE++  +  S  +D+
Sbjct: 229 KIIDFGLA-----------RRYKPREKLKVNF------GTPEFLAPEVVNYDFVSFPTDM 271
Query: 262 YSFGISINELLTGVVPY 278
           +S G+    LL+G+ P+
Sbjct: 272 WSVGVIAYMLLSGLSPF 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---------- 240
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 241 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 297 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 339
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 340 RPTFSELVEHLGNLLQ 355

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 18/229 (7%)
Query: 66  SSYTLLSPIARGAESVVYEATLD--GRKVAVKK--PILSTSEELDNFHKELQLLCKLDHP 121
           S + L S +  GA  VV  AT    G  VA+KK  P       L    +E+++L    H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHE 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLH--VEEWSPSVDQVLMIAAQLAKALQYL 178
            +        +P ++  F E Y  + L +  LH  +     S D +     Q  +A++ L
Sbjct: 70  NIITIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H   ++HRD+KP+N+L++ N    + DFGLA     + E +  N   +G+ +G       
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---IDESAADNSEPTGQQSG---MTEX 182
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELL--TGVVPYTDLRAE 284
           V T  Y APE+ L    +S   DV+S G  + EL     + P  D R +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
           +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA          
Sbjct: 198 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---------- 247
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
               R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ + G  PY
Sbjct: 248 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 303
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             ++ + +    L+               G R  + + +   P    +++  CW G P  
Sbjct: 304 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 346
Query: 339 RPSFSDIALELDLVLE 354
           RP+FS++   L  +L+
Sbjct: 347 RPTFSELVEHLGNLLQ 362

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 18/229 (7%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDHP 121
           S + L S +  GA  VV  AT    G  VA+KK  P       L    +E+++L    H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHE 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLH--VEEWSPSVDQVLMIAAQLAKALQYL 178
            +        +P ++  F E Y  + L +  LH  +     S D +     Q  +A++ L
Sbjct: 70  NIITIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H   ++HRD+KP+N+L++ N    + DFGLA     + E +  N   +G+ +G       
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---IDESAADNSEPTGQQSGMV---EF 182
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELL--TGVVPYTDLRAE 284
           V T  Y APE+ L    +S   DV+S G  + EL     + P  D R +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 36/264 (13%)
Query: 61  LHLPPSSYTLLSPIARGA--ESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLL 115
           + L    + +L  I RGA  E  V +    G+  A+K   K  +    E+  F +E  +L
Sbjct: 56  VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL 115
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
              D   + +   A  +  NY++   E+Y   +L   L         +      A++  A
Sbjct: 116 VNGDRRWITQLHFAF-QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           +  +H LG VHRD+KP N+LLDR  C H  LADFG           S    R+ G     
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDR--CGHIRLADFG-----------SCLKLRADGT---- 217
Query: 233 FHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
                 VGT  Y++PEIL+          +  + D ++ G+   E+  G  P+    A++
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY---ADS 274
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGL 309
            A T  ++ + ++ L+  +V  G+
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGV 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D      + DFG A      K +  + W   G
Sbjct: 134 AAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFA------KRVKGRTWXLCG 187
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 188 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 92/234 (39%), Gaps = 25/234 (10%)
Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FH 109
           +S+   + L    + +L  I RGA   V    L          IL+  E L       F 
Sbjct: 63  TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 122
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +E  +L   D   +     A     N     ++Y   +L   L   E     +      A
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA 182
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           ++  A+  +H L  VHRD+KP N+L+D N    LADFG       LK +           
Sbjct: 183 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-----LKLME---------- 227
Query: 230 TGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPY 278
            G       VGT  Y++PEIL+     K  +  + D +S G+ + E+L G  P+
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 18/229 (7%)
Query: 66  SSYTLLSPIARGAESVVYEATLD--GRKVAVKK--PILSTSEELDNFHKELQLLCKLDHP 121
           S + L S +  GA  VV  AT    G  VA+KK  P       L    +E+++L    H 
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHE 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLH--VEEWSPSVDQVLMIAAQLAKALQYL 178
            +        +P ++  F E Y  + L +  LH  +     S D +     Q  +A++ L
Sbjct: 70  NIITIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H   ++HRD+KP+N+L++ N    + DFGLA     + E +  N   +G+ +G       
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---IDESAADNSEPTGQQSG---MTEY 182
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELL--TGVVPYTDLRAE 284
           V T  Y APE+ L    +S   DV+S G  + EL     + P  D R +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F  +  V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMEPEV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 94  VKKPILSTSEE---LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
           +KK  LS+S      +   +E+ +L ++ HP +           + +   E      L +
Sbjct: 45  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 104
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADF 206
            L  E+ S + D+      Q+   + YLH+  I H D+KP N+ LLD+N+      L DF
Sbjct: 105 FL-AEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 163
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
           G+A                  K   G   KN+ GT  ++APEI+  E    ++D++S G+
Sbjct: 164 GIAH-----------------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNY 295
               LL+G  P+     +     +  +NY
Sbjct: 207 ITYILLSGASPFLGETKQETLTNISAVNY 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 64/117 (54%), Gaps = 22/117 (18%)
Query: 167 IAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           IA  + KAL++LH+ L ++HRDVKP+NVL++      + DFG++ Y   L +   K+  +
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDA 170
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPY 278
             KP              YMAPE +  E+    +S KSD++S GI++ EL     PY
Sbjct: 171 GCKP--------------YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + +  AA++   L+ LH   IV+RD+KP N+LLD +    ++D GLA +    + I    
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---- 342
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
                        K  VGT+ YMAPE++K E ++   D ++ G  + E++ G  P+   +
Sbjct: 343 -------------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 283 AEAQAHTV 290
            + +   V
Sbjct: 390 KKIKREEV 397

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + +  AA++   L+ LH   IV+RD+KP N+LLD +    ++D GLA +    + I    
Sbjct: 287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---- 342
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
                        K  VGT+ YMAPE++K E ++   D ++ G  + E++ G  P+   +
Sbjct: 343 -------------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 283 AEAQAHTV 290
            + +   V
Sbjct: 390 KKIKREEV 397

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH-LADFGLAEYRENLK 216
           S S  +V      L KAL+ +H  GIVHRDVKP+N L +R L  + L DFGLA+   + K
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 217 EISLKNWRSSGKPTGGFHKKNMV------------GTLIYMAPEILKKEIHSEKS-DVYS 263
              LK  +S  +       K  +            GT  + APE+L K  +   + D++S
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 264 FGISINELLTGVVPY----TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
            G+    LL+G  P+     DL A AQ   ++ +  + + + AA   G  + IL S E  
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQ---IMTIRGSRETIQAAKTFG--KSILCSKE-- 285
Query: 320 LPASILSLIQRCWDGNPHNRPSF-SDI 345
           +PA  L  +     G   + P   SDI
Sbjct: 286 VPAQDLRKLCERLRGMDSSTPKLTSDI 312

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I ++  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 122/304 (40%), Gaps = 53/304 (17%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
           P   ++ L  I  G+   VY A    +   VA+KK   S   ++E+  +  KE++ L KL
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ-- 176
            HP   ++   + +        E+     L     + E      Q + IAA    ALQ  
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 177 -YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            YLH+  ++HRDVK  N+LL       L DFG A               S   P   F  
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------SIMAPANXF-- 210
Query: 236 KNMVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
              VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A +  + +  
Sbjct: 211 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-- 265
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
                Q  + A+ SG                  + +  C    P +RP+ S++ L+   V
Sbjct: 266 ----AQNESPALQSGHWSEYFR-----------NFVDSCLQKIPQDRPT-SEVLLKHRFV 309
Query: 353 LEHR 356
           L  R
Sbjct: 310 LRER 313

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 122/304 (40%), Gaps = 53/304 (17%)
Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
           P   ++ L  I  G+   VY A    +   VA+KK   S   ++E+  +  KE++ L KL
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ-- 176
            HP   ++   + +        E+     L     + E      Q + IAA    ALQ  
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYC----LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 177 -YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            YLH+  ++HRDVK  N+LL       L DFG A               S   P   F  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------SIMAPANXF-- 171
Query: 236 KNMVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
              VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++ A +  +    
Sbjct: 172 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---- 224
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
             +  Q  + A+ SG                  + +  C    P +RP+ S++ L+   V
Sbjct: 225 --HIAQNESPALQSGHWSEYFR-----------NFVDSCLQKIPQDRPT-SEVLLKHRFV 270
Query: 353 LEHR 356
           L  R
Sbjct: 271 LRER 274

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +    W   G
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGATWTLCG 221
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 222 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 88
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 149 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 191
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 75/297 (25%)
Query: 74  IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH----------- 120
           I  G    V++A   +DG+   +K+   +  +      +E++ L KLDH           
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHYNGCWD 74
Query: 121 -----PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEW-----SPSVDQVLMIA-- 168
                P  +   ++ +K        EF       +K  +E+W        +D+VL +   
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEF------CDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+ K + Y+H+  +++RD+KP+N+ L       + DFGL          SLKN    GK
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV--------TSLKN---DGK 177
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
                 +    GTL YM+PE +  + + ++ D+Y+ G+ + ELL                
Sbjct: 178 ------RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---------------- 215
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            V +  +   +    +  G +  I    E        +L+Q+     P +RP+ S+I
Sbjct: 216 HVCDTAFETSKFFTDLRDGIISDIFDKKE-------KTLLQKLLSKKPEDRPNTSEI 265

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ HP +           + +   E      L + L  E+ S + D+  
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEAT 132
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNLCP---HLADFGLAEYRENLKEISLK 221
               Q+   + YLH+  I H D+KP N+ LLD+N+      L DFG+A            
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH----------- 181
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
                 K   G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+   
Sbjct: 182 ------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 235
Query: 282 RAEAQAHTVLEMNY 295
             +     +  +NY
Sbjct: 236 TKQETLTNISAVNY 249

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+++D+     + DFG A      K +  + W   G
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKGRTWXLCG 201
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 202 TPE-------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 67  SYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
            Y  L  I  G   VVY+A  + G   A+KK  L   +E       +E+ +L +L H  +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K           +  FE  + ++L + L V E             QL   + Y H+  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++R     +ADFGLA              R+ G P   +  +  V TL 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLA--------------RAFGIPVRKYTHE--VVTLW 165
Query: 244 YMAPEILK-KEIHSEKSDVYSFGISINELLTG 274
           Y AP++L   + +S   D++S G    E++ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 67  SYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
            Y  L  I  G   VVY+A  + G   A+KK  L   +E       +E+ +L +L H  +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K           +  FE  + ++L + L V E             QL   + Y H+  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++R     +ADFGLA              R+ G P   +  +  V TL 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLA--------------RAFGIPVRKYTHE--VVTLW 165
Query: 244 YMAPEILK-KEIHSEKSDVYSFGISINELLTG 274
           Y AP++L   + +S   D++S G    E++ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 25/193 (12%)
Query: 110 KELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           KE+ +L K+  HP + +    +     +   F+  +   L + L  E+ + S  +   I 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
             L + +  LH L IVHRD+KP N+LLD ++   L DFG                  S +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF-----------------SCQ 173
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLR 282
              G   +++ GT  Y+APEI++  +      + ++ D++S G+ +  LL G  P+   +
Sbjct: 174 LDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 283 AEAQAHTVLEMNY 295
                  ++  NY
Sbjct: 234 QMLMLRMIMSGNY 246

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 60/244 (24%)
Query: 61  LHLPPSSYTLLSPIARGA----ESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKE 111
           L +    Y ++  I RGA    + V +++T   RKV   K +LS  E +       F +E
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMK-LLSKFEMIKRSDSAFFWEE 119
Query: 112 LQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA--- 168
             ++   + P + +             F+ F + R L     V E+ P  D V +++   
Sbjct: 120 RDIMAFANSPWVVQL------------FYAFQDDRYL---YMVMEYMPGGDLVNLMSNYD 164
Query: 169 ----------AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
                     A++  AL  +H++G +HRDVKP N+LLD++    LADFG           
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--------- 215
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTG 274
                       G       VGT  Y++PE+LK +     +  + D +S G+ + E+L G
Sbjct: 216 ------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 275 VVPY 278
             P+
Sbjct: 270 DTPF 273

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 63/117 (53%), Gaps = 22/117 (18%)
Query: 167 IAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           IA  + KAL++LH+ L ++HRDVKP+NVL++      + DFG++ Y   L +   K   +
Sbjct: 158 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDSVAKTIDA 214
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPY 278
             KP              YMAPE +  E+    +S KSD++S GI++ EL     PY
Sbjct: 215 GCKP--------------YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 257

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 60/244 (24%)
Query: 61  LHLPPSSYTLLSPIARGA----ESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKE 111
           L +    Y ++  I RGA    + V +++T   RKV   K +LS  E +       F +E
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMK-LLSKFEMIKRSDSAFFWEE 124
Query: 112 LQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA--- 168
             ++   + P + +             F+ F + R L     V E+ P  D V +++   
Sbjct: 125 RDIMAFANSPWVVQL------------FYAFQDDRYL---YMVMEYMPGGDLVNLMSNYD 169
Query: 169 ----------AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
                     A++  AL  +H++G +HRDVKP N+LLD++    LADFG           
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--------- 220
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTG 274
                       G       VGT  Y++PE+LK +     +  + D +S G+ + E+L G
Sbjct: 221 ------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274
Query: 275 VVPY 278
             P+
Sbjct: 275 DTPF 278

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++++CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMRKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F  +  V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TSFMMEPEV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 60/244 (24%)
Query: 61  LHLPPSSYTLLSPIARGA----ESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKE 111
           L +    Y ++  I RGA    + V +++T   RKV   K +LS  E +       F +E
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMK-LLSKFEMIKRSDSAFFWEE 124
Query: 112 LQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA--- 168
             ++   + P + +             F+ F + R L     V E+ P  D V +++   
Sbjct: 125 RDIMAFANSPWVVQL------------FYAFQDDRYL---YMVMEYMPGGDLVNLMSNYD 169
Query: 169 ----------AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
                     A++  AL  +H++G +HRDVKP N+LLD++    LADFG           
Sbjct: 170 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--------- 220
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTG 274
                       G       VGT  Y++PE+LK +     +  + D +S G+ + E+L G
Sbjct: 221 ------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274
Query: 275 VVPY 278
             P+
Sbjct: 275 DTPF 278

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 110 KELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           KE+ +L K+  HP + +    +     +   F+  +   L + L  E+ + S  +   I 
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 117
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
             L + +  LH L IVHRD+KP N+LLD ++   L DFG                  S +
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF-----------------SCQ 160
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLR 282
              G   + + GT  Y+APEI++  +      + ++ D++S G+ +  LL G  P+   +
Sbjct: 161 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 220
Query: 283 AEAQAHTVLEMNY 295
                  ++  NY
Sbjct: 221 QMLMLRMIMSGNY 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ H  +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITAVSYDFDEE 240

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 65  PSSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           P +Y +   I RG+   VY A      + VA+KK +    E+L +  + L+ +  L+   
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKK-VNRMFEDLIDCKRILREITILNRLK 85
Query: 123 LAKFVAAH--AKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQ 176
               +  H    P + + F E Y    +A+    KL       +   V  I   L    +
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEK 145
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN--WRSSGKPTGGFH 234
           ++H  GI+HRD+KPAN LL+++    + DFGLA    + K+I + N           G H
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 235 KKNM-------VGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
            KN+       V T  Y APE IL +E ++   D++S G    ELL 
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 134 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 179
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 180 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 238
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++++CW  +  +RP F ++ +
Sbjct: 239 SSILEKGERLPQ-----------PPICTID------VYMIMRKCWMIDADSRPKFRELII 281
Query: 348 EL 349
           E 
Sbjct: 282 EF 283

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 68  YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
           Y  L PI  GA+ +V   Y+A L+ R VA+KK   P  + +      ++EL L+  ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
            +   +       +   F + Y    L +    +     +D   M  +  Q+   +++LH
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           + GI+HRD+KP+N+++  +    + DFGLA              R++G     F     V
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 180
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
            T  Y APE++    + E  D++S G  + E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 172
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 231
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++++CW  +  +RP F ++ +
Sbjct: 232 SSILEKGERLPQ-----------PPICTID------VYMIMRKCWMIDADSRPKFRELII 274
Query: 348 EL 349
           E 
Sbjct: 275 EF 276

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 65  PSSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELD--NFHKELQLLCKLDH 120
           P +Y +   I RG+   VY A      + VA+KK      + +D     +E+ +L +L  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQ 176
             + +       P + + F E Y    +A+    KL       + + +  I   L     
Sbjct: 85  DYIIRLYDL-IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           ++H  GI+HRD+KPAN LL+++    + DFGLA    + K+ ++ N     +  G  H K
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP-HNK 202
Query: 237 NM-------VGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
           N+       V T  Y APE IL +E +++  D++S G    ELL 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 89  GRKVAVKKPILSTSEELDN--FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146
           GR VA+KK + S  +++      +E++LL +L H  L   +    K   +   FEF +  
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109
Query: 147 NLAEKLHVEEWSPSVD-QVLM-IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
            L +   +E +   +D QV+     Q+   + + H+  I+HRD+KP N+L+ ++    L 
Sbjct: 110 ILDD---LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLC 166
Query: 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYS 263
           DFG A              R+   P  G    + V T  Y APE+L  ++   K+ DV++
Sbjct: 167 DFGFA--------------RTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 264 FGISINELLTG 274
            G  + E+  G
Sbjct: 211 IGCLVTEMFMG 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 110 KELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           KE+ +L K+  HP + +    +     +   F+  +   L + L  E+ + S  +   I 
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 130
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
             L + +  LH L IVHRD+KP N+LLD ++   L DFG                  S +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF-----------------SCQ 173
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLR 282
              G   + + GT  Y+APEI++  +      + ++ D++S G+ +  LL G  P+   +
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 283 AEAQAHTVLEMNY 295
                  ++  NY
Sbjct: 234 QMLMLRMIMSGNY 246

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 48/256 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-----HVEEWSPS 160
           + F  E  L  +L HP +   +    K       F +    +L E L     H +  S  
Sbjct: 57  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 161 VDQVLM----------IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            D+ +           + AQ+A  ++YL +  +VH+D+   NVL+   L   ++D GL  
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL-- 174
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           +RE       K   +S  P            + +MAPE +     S  SD++S+G+ + E
Sbjct: 175 FREVYAADYYKLLGNSLLP------------IRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           + + G+ PY                Y+ Q +   + +  + P         PA + +L+ 
Sbjct: 223 VFSYGLQPYC--------------GYSNQDVVEMIRNRQVLPCPDD----CPAWVYALMI 264
Query: 330 RCWDGNPHNRPSFSDI 345
            CW+  P  RP F DI
Sbjct: 265 ECWNEFPSRRPRFKDI 280

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 67  SYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
            Y  L  I  G   VVY+A  + G   A+KK  L   +E       +E+ +L +L H  +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K           +  FE  + ++L + L V E             QL   + Y H+  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++R     +ADFGLA              R+ G P   +  +  + TL 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLA--------------RAFGIPVRKYTHE--IVTLW 165
Query: 244 YMAPEILK-KEIHSEKSDVYSFGISINELLTG 274
           Y AP++L   + +S   D++S G    E++ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 34/194 (17%)
Query: 99  LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
           +S   + D+F  ELQ++  + +      +       NY   +  YE       L  +E+ 
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYC---LTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 159 PSVDQ----------VLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFG 207
             +D+          +  I   +  +  Y+HN   I HRDVKP+N+L+D+N    L+DFG
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG 197
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFG 265
            +EY  + K   +K  R               GT  +M PE    E   +  K D++S G
Sbjct: 198 ESEYMVDKK---IKGSR---------------GTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 266 ISINELLTGVVPYT 279
           I +  +   VVP++
Sbjct: 240 ICLYVMFYNVVPFS 253

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 53/186 (28%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
            Q+  A+Q+ H+ G+VHRD+K  N+L+D R  C  L DFG      +             
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD------------- 192
Query: 228 KPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
           +P   F      GT +Y  PE I + + H+  + V+S GI + +++ G +P+        
Sbjct: 193 EPYTDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE------- 240
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSF 342
                     +Q++  A             EL  PA +     +LI+RC    P +RPS 
Sbjct: 241 ---------RDQEILEA-------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 343 SDIALE 348
            +I L+
Sbjct: 279 EEILLD 284

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 240
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 241 RER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 297
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 298 EGIKD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
Query: 273 TGVVPY 278
            G +P+
Sbjct: 344 CGRLPF 349

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ H  +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITAVSYDFDEE 240

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 184 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 243
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 244 RER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 300
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 301 EGIKD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 346
Query: 273 TGVVPY 278
            G +P+
Sbjct: 347 CGRLPF 352

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 120/300 (40%), Gaps = 54/300 (18%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAKFVA 128
           L+  + +G    V+     G  VAVK  I S+ +E   F + E+     L H  +  F+A
Sbjct: 12  LVECVGKGRYGEVWRGLWHGESVAVK--IFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 129 AHAKPPN----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH----- 179
           +     N          ++E  +L + L  +   P +   L +A   A  L +LH     
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL--ALRLAVSAACGLAHLHVEIFG 127
Query: 180 ---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
                 I HRD K  NVL+  NL   +AD GLA               S G         
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVM------------HSQGSDYLDIGNN 175
Query: 237 NMVGTLIYMAPEILKKEIHSE------KSDVYSFGISINE-----LLTGVV-----PYTD 280
             VGT  YMAPE+L ++I ++       +D+++FG+ + E     ++ G+V     P+ D
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYD 235
Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSG-GLRPILASLELGLPASILSLIQRCWDGNPHNR 339
           +     +   ++      Q T  + +     P+L+ L          +++ CW  NP  R
Sbjct: 236 VVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLA--------QMMRECWYPNPSAR 287

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 48/256 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-----HVEEWSPS 160
           + F  E  L  +L HP +   +    K       F +    +L E L     H +  S  
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 161 VDQVLM----------IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
            D+ +           + AQ+A  ++YL +  +VH+D+   NVL+   L   ++D GL  
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL-- 191
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           +RE       K   +S  P            + +MAPE +     S  SD++S+G+ + E
Sbjct: 192 FREVYAADYYKLLGNSLLP------------IRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
           + + G+ PY                Y+ Q +   + +  + P         PA + +L+ 
Sbjct: 240 VFSYGLQPYC--------------GYSNQDVVEMIRNRQVLPCPDD----CPAWVYALMI 281
Query: 330 RCWDGNPHNRPSFSDI 345
            CW+  P  RP F DI
Sbjct: 282 ECWNEFPSRRPRFKDI 297

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ H  +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITSVSYDFDEE 240

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P              Y+AP I+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPE-------------YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AAQ+    +YLH+L +++RD+KP N+L+D+     + DFG A      K +  + W   G
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWXLCG 200
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            P               +APEI+  + +++  D ++ G+ I E+  G  P+
Sbjct: 201 TPEA-------------LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 222
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + ++++ +      ++ +CW  +  +RP F ++ +
Sbjct: 223 SSILEKGERLPQ-----------PPICTIDVYM------IMVKCWMIDADSRPKFRELII 265
Query: 348 EL 349
           E 
Sbjct: 266 EF 267

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ H  +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITSVSYDFDEE 240

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 172
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 231
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 232 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 274
Query: 348 EL 349
           E 
Sbjct: 275 EF 276

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 176
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 235
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 236 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 278
Query: 348 EL 349
           E 
Sbjct: 279 EF 280

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 149 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 194
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 195 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 253
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 254 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 296
Query: 348 EL 349
           E 
Sbjct: 297 EF 298

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 173
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 232
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 233 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 275
Query: 348 EL 349
           E 
Sbjct: 276 EF 277

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 170
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 171 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 229
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 230 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 272
Query: 348 EL 349
           E 
Sbjct: 273 EF 274

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           +   +E+ +L ++ H  +      +    + +   E      L + L  +E S S ++  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEAT 118
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANV-LLDRNL-CPH--LADFGLAEYRENLKEISLK 221
               Q+   + YLH   I H D+KP N+ LLD+N+  PH  L DFGLA   E+       
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED------- 171
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-D 280
                     G   KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+  D
Sbjct: 172 ----------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 281 LRAEAQAH-TVLEMNYTEQ 298
            + E  A+ T +  ++ E+
Sbjct: 222 TKQETLANITSVSYDFDEE 240

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 171
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 230
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 231 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 273
Query: 348 EL 349
           E 
Sbjct: 274 EF 275

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 176
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 235
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 236 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 278
Query: 348 EL 349
           E 
Sbjct: 279 EF 280

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 130 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 175
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 176 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 234
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 235 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 277
Query: 348 EL 349
           E 
Sbjct: 278 EF 279

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 172
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 231
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 232 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 274
Query: 348 EL 349
           E 
Sbjct: 275 EF 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 22/176 (12%)
Query: 110 KELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           +E+++L +   HP +      +    +     E      L +K+  +++  S  +   + 
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFF-SEREASFVL 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVL-LDRN---LCPHLADFGLAEYRENLKEISLKNWR 224
             + K ++YLH+ G+VHRD+KP+N+L +D +    C  + DFG A      K++  +N  
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFA------KQLRAEN-- 179
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
             G      +  N V      APE+LK++ + E  D++S GI +  +L G  P+ +
Sbjct: 180 --GLLMTPCYTANFV------APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 176
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 235
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 236 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 278
Query: 348 EL 349
           E 
Sbjct: 279 EF 280

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 170
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 171 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 229
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 230 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 272
Query: 348 EL 349
           E 
Sbjct: 273 EF 274

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 171
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 230
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 231 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 273
Query: 348 EL 349
           E 
Sbjct: 274 EF 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 22/176 (12%)
Query: 110 KELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           +E+++L +   HP +      +    +     E      L +K+  +++  S  +   + 
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFF-SEREASFVL 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVL-LDRN---LCPHLADFGLAEYRENLKEISLKNWR 224
             + K ++YLH+ G+VHRD+KP+N+L +D +    C  + DFG A      K++  +N  
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFA------KQLRAEN-- 179
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
             G      +  N V      APE+LK++ + E  D++S GI +  +L G  P+ +
Sbjct: 180 --GLLMTPCYTANFV------APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 32/240 (13%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH-KELQLLCKLDHPG 122
           S +  L  +  G  + VY+      G  VA+K+  L + E   +   +E+ L+ +L H  
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 123 LAKFVAAHAKPPNYMFFFEFYE--------SRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           + +              FEF +        SR +       E    ++ V     QL + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE----LNLVKYFQWQLLQG 120
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L + H   I+HRD+KP N+L+++     L DFGLA              R+ G P   F 
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA--------------RAFGIPVNTFS 166
Query: 235 KKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
            +  V TL Y AP++L     +S   D++S G  + E++TG   +     E Q   + ++
Sbjct: 167 SE--VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 158 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 203
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 262
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 263 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 305
Query: 348 EL 349
           E 
Sbjct: 306 EF 307

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 172
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 173 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 231
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 232 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 274
Query: 348 EL 349
           E 
Sbjct: 275 EF 276

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 42  LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 101
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 102 RERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 158
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 159 EGIKD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 204
Query: 273 TGVVPY 278
            G +P+
Sbjct: 205 CGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 41  LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 100
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 101 RERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 157
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 158 EGIKD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 203
Query: 273 TGVVPY 278
            G +P+
Sbjct: 204 CGRLPF 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94  VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
           +KK ++   +E+ +   E ++L    HP L     +        F  E+     L   L 
Sbjct: 43  LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 102
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
            E    S D+     A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +
Sbjct: 103 RERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 159
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
           E +K+              G   K   GT  Y+APE+L+   +    D +  G+ + E++
Sbjct: 160 EGIKD--------------GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 205
Query: 273 TGVVPY 278
            G +P+
Sbjct: 206 CGRLPF 211

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 116/284 (40%), Gaps = 41/284 (14%)
Query: 74  IARGAESVVYEATLDGRKVAVKKPIL------STSEELD-NFHKELQLLCKLDHPGLAKF 126
           +  GA   VY+         VK P+       +T  + +  F  E  ++  +DHP L + 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
           +      P      +      L E +H  + +     +L    Q+AK + YL    +VHR
Sbjct: 106 LGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 164
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+   NVL+       + DFGLA     L E   K + + G   G    K       +MA
Sbjct: 165 DLAARNVLVKSPNHVKITDFGLA----RLLEGDEKEYNADG---GKMPIK-------WMA 210
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
            E +     + +SDV+S+G++I EL+T G  PY  +    +   +LE      Q      
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLLEKGERLPQ------ 263
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                P + +++      +  ++ +CW  +  +RP F ++A E 
Sbjct: 264 -----PPICTID------VYMVMVKCWMIDADSRPKFKELAAEF 296

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 171
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 230
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++++CW  +  +RP F ++ +
Sbjct: 231 SSILEKGERLPQ-----------PPICTID------VYMIMRKCWMIDADSRPKFRELII 273
Query: 348 EL 349
           E 
Sbjct: 274 EF 275

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 171
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 230
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++++CW  +  +RP F ++ +
Sbjct: 231 SSILEKGERLPQ-----------PPICTID------VYMIMRKCWMIDADSRPKFRELII 273
Query: 348 EL 349
           E 
Sbjct: 274 EF 275

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 114/263 (43%), Gaps = 37/263 (14%)
Query: 74  IARGAESVVY--EATLDGRKVAVKKPILSTSEELDNFHKELQLLCK-LDHPGLAKFVAAH 130
           + RG+   V+  E    G + AVKK        L+ F  E  + C  L  P +     A 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
            + P    F E  E  +L + +  +   P  D+ L    Q  + L+YLH+  I+H DVK 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPE-DRALYYLGQALEGLEYLHSRRILHGDVKA 213
Query: 191 ANVLLDRNLC-PHLADFGLAEYRENLKEISLKNWRSSGKP--TGGFHKKNMVGTLIYMAP 247
            NVLL  +     L DFG A        + L+     GK   TG +    + GT  +MAP
Sbjct: 214 DNVLLSSDGSHAALCDFGHA--------VCLQP-DGLGKSLLTGDY----IPGTETHMAP 260
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTD-------LRAEAQAHTVLEMNYTEQQL 300
           E++       K DV+S    +  +L G  P+T        L+  ++   V E+  +   L
Sbjct: 261 EVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPL 320
Query: 301 TAAVVSGGLR--PI--LASLELG 319
           TA  +  GLR  PI  +++ ELG
Sbjct: 321 TAQAIQEGLRKEPIHRVSAAELG 343

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 34/243 (13%)
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
           F  E  ++  +DHP L + +      P      +      L E +H  + +     +L  
Sbjct: 64  FMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW 122
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             Q+AK + YL    +VHRD+   NVL+       + DFGLA     L E   K + + G
Sbjct: 123 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA----RLLEGDEKEYNADG 178
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
                         + +MA E +     + +SDV+S+G++I EL+T G  PY  +    +
Sbjct: 179 GKM----------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-E 227
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
              +LE      Q           P + +++      +  ++ +CW  +  +RP F ++A
Sbjct: 228 IPDLLEKGERLPQ-----------PPICTID------VYMVMVKCWMIDADSRPKFKELA 270
Query: 347 LEL 349
            E 
Sbjct: 271 AEF 273

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+A+ + YL +  +VHRD+   NVL+       + DFGLA              +  G 
Sbjct: 121 VQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGA 166
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 167 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 225
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 226 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 268
Query: 348 EL 349
           E 
Sbjct: 269 EF 270

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 129
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 130 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 180
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 181 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 114/263 (43%), Gaps = 37/263 (14%)
Query: 74  IARGAESVVY--EATLDGRKVAVKKPILSTSEELDNFHKELQLLCK-LDHPGLAKFVAAH 130
           + RG+   V+  E    G + AVKK        L+ F  E  + C  L  P +     A 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
            + P    F E  E  +L + +  +   P  D+ L    Q  + L+YLH+  I+H DVK 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPE-DRALYYLGQALEGLEYLHSRRILHGDVKA 194
Query: 191 ANVLLDRNLC-PHLADFGLAEYRENLKEISLKNWRSSGKP--TGGFHKKNMVGTLIYMAP 247
            NVLL  +     L DFG A        + L+     GK   TG +    + GT  +MAP
Sbjct: 195 DNVLLSSDGSHAALCDFGHA--------VCLQP-DGLGKDLLTGDY----IPGTETHMAP 241
Query: 248 EILKKEIHSEKSDVYSFGISINELLTGVVPYTD-------LRAEAQAHTVLEMNYTEQQL 300
           E++       K DV+S    +  +L G  P+T        L+  ++   V E+  +   L
Sbjct: 242 EVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPL 301
Query: 301 TAAVVSGGLR--PI--LASLELG 319
           TA  +  GLR  PI  +++ ELG
Sbjct: 302 TAQAIQEGLRKEPIHRVSAAELG 324

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 173
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 232
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 233 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 275
Query: 348 EL 349
           E 
Sbjct: 276 EF 277

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 169
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 229 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 271
Query: 348 EL 349
           E 
Sbjct: 272 EF 273

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 171
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 172 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 230
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 231 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 273
Query: 348 EL 349
           E 
Sbjct: 274 EF 275

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 84/182 (46%), Gaps = 33/182 (18%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q+AK + YL +  +VHRD+   NVL+       + DFG A              +  G 
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA--------------KLLGA 176
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
               +H +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY  + A ++ 
Sbjct: 177 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEI 235
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
            ++LE      Q           P + +++      +  ++ +CW  +  +RP F ++ +
Sbjct: 236 SSILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELII 278
Query: 348 EL 349
           E 
Sbjct: 279 EF 280

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 20/134 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-----NLCPHLADFGLA-EY-- 211
           S+  VLMIA QL   ++Y+H+  +++RDVKP N L+ R         H+ DFGLA EY  
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYID 162
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
            E  K I  +  +S            + GT  YM+      +  S + D+ + G      
Sbjct: 163 PETKKHIPYREHKS------------LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210
Query: 272 LTGVVPYTDLRAEA 285
           L G +P+  L+A+ 
Sbjct: 211 LRGSLPWQGLKADT 224

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 87/228 (38%), Gaps = 25/228 (10%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLL 115
           + L    + ++  I RGA   V    +   +      IL+  E L       F +E  +L
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
              D   +     A     +     ++Y   +L   L   E     D       ++  A+
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
             +H L  VHRD+KP NVLLD N    LADFG            LK         G    
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC----------LKM-----NDDGTVQS 249
Query: 236 KNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPY 278
              VGT  Y++PEIL+        +  + D +S G+ + E+L G  P+
Sbjct: 250 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 120 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 172
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S  +P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 173 -SLTEP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 33/178 (18%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           + + I  Q+  AL   H  G  HRDVKP N+L+  +   +L DFG+A    + K   L  
Sbjct: 135 RAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-- 192
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-DL 281
                         N VGTL Y APE   +   + ++D+Y+    + E LTG  PY  D 
Sbjct: 193 -------------GNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
            +   AH           +  A+      P  +++  G+P +  ++I R    NP +R
Sbjct: 240 LSVXGAH-----------INQAI------PRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L   +  P  +++L  ++
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVS 120
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + + L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 121 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 171
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YMAPE L+   +S +SD++S G+S+ EL  G  P
Sbjct: 172 ---------SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 87/228 (38%), Gaps = 25/228 (10%)
Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLL 115
           + L    + ++  I RGA   V    +   +      IL+  E L       F +E  +L
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
              D   +     A     +     ++Y   +L   L   E     D       ++  A+
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
             +H L  VHRD+KP NVLLD N    LADFG            LK         G    
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC----------LKM-----NDDGTVQS 233
Query: 236 KNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPY 278
              VGT  Y++PEIL+        +  + D +S G+ + E+L G  P+
Sbjct: 234 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           S Y  L+ I +G    V++A     G+KVA+KK ++   +E   F     +E+++L  L 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLK 75
Query: 120 HPGLAKFVA---AHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           H  +   +      A P N         F+F E  +LA  L       ++ ++  +   L
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
              L Y+H   I+HRD+K ANVL+ R+    LADFGLA      +  SL       K + 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------RAFSL------AKNSQ 182
Query: 232 GFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLT 273
                N V TL Y  PE+L  E  +    D++  G  + E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 110
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 161
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 162 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 110
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 161
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 162 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 137
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 188
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 189 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 172
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 173 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 223
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 224 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 113
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++   + + E++        
Sbjct: 114 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDEMA-------- 163
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                      VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 164 --------NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           S Y  L+ I +G    V++A     G+KVA+KK ++   +E   F     +E+++L  L 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLK 75
Query: 120 HPGLAKFVA---AHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           H  +   +      A P N         F+F E  +LA  L       ++ ++  +   L
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
              L Y+H   I+HRD+K ANVL+ R+    LADFGLA      +  SL       K + 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------RAFSL------AKNSQ 182
Query: 232 GFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLT 273
                N V TL Y  PE+L  E  +    D++  G  + E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 127 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 179
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 180 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 128 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 180
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 181 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 110
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 161
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 162 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 110
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 161
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 162 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 126 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 178
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 179 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           S Y  L+ I +G    V++A     G+KVA+KK ++   +E   F     +E+++L  L 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLK 75
Query: 120 HPGLAKFVA---AHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           H  +   +      A P N         F+F E  +LA  L       ++ ++  +   L
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
              L Y+H   I+HRD+K ANVL+ R+    LADFGLA      +  SL       K + 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------RAFSL------AKNSQ 182
Query: 232 GFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLT 273
                N V TL Y  PE+L  E  +    D++  G  + E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 136 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 188
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 189 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
           +ELQ+L + + P +  F  A           E  +  +L + L      P  +Q+L  ++
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 110
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + K L YL     I+HRDVKP+N+L++      L DFG++    +    S+ N     
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN----- 161
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                    + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P
Sbjct: 162 ---------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 121 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 173
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 174 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 174
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 175 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 61/117 (52%), Gaps = 22/117 (18%)
Query: 167 IAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
           IA  + KAL++LH+ L ++HRDVKP+NVL++        DFG++ Y   L +   K+  +
Sbjct: 141 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGY---LVDDVAKDIDA 197
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPY 278
             KP              Y APE +  E+    +S KSD++S GI+  EL     PY
Sbjct: 198 GCKP--------------YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 120 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 172
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 173 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
           S Y  L+ I +G    V++A     G+KVA+KK ++   +E   F     +E+++L  L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLK 74
Query: 120 HPGLAKFVA---AHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           H  +   +      A P N         F+F E  +LA  L       ++ ++  +   L
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
              L Y+H   I+HRD+K ANVL+ R+    LADFGLA      +  SL       K + 
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA------RAFSL------AKNSQ 181
Query: 232 GFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLT 273
                N V TL Y  PE+L  E  +    D++  G  + E+ T
Sbjct: 182 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 68  YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE---LDNFHKE--LQLLCKLD 119
           Y  ++ I  GA   V++A      GR VA+K+  + T EE   L    +   L+ L   +
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 120 HPGLAKF-----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           HP + +      V+   +       FE  +         V E     + +  +  QL + 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L +LH+  +VHRD+KP N+L+  +    LADFGLA        ++               
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--------------- 177
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
             ++V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 33/240 (13%)
Query: 104 ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ 163
           + +   +E Q++ +LD+P + + +    +    M   E      L + L  +     V  
Sbjct: 53  DTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 111
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
           V  +  Q++  ++YL     VHRD+   NVLL       ++DFGL+  +    + S    
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTA 169
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282
           RS+GK             L + APE +     S +SDV+S+G+++ E L+ G  PY  ++
Sbjct: 170 RSAGK-----------WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
                               A +  G R          P  + +L+  CW     +RP F
Sbjct: 219 GPE---------------VMAFIEQGKR---MECPPECPPELYALMSDCWIYKWEDRPDF 260

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 66  SSYTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE---LDNFHKE--LQLLCK 117
             Y  ++ I  GA   V++A      GR VA+K+  + T EE   L    +   L+ L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 118 LDHPGLAKF-----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
            +HP + +      V+   +       FE  +         V E     + +  +  QL 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           + L +LH+  +VHRD+KP N+L+  +    LADFGLA        ++             
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT------------- 177
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
               ++V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 178 ----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 172 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHNS 225
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            ++              T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 226 LTTP-----------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHN- 218
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            S   P           T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 219 -SLTTP---------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHNS 175
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            ++              T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 176 LTTP-----------CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 21/231 (9%)
Query: 67  SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGL 123
           +Y  L  +  G  + VY+  + L    VA+K+  L   E       +E+ LL  L H  +
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                      +    FE Y  ++L + L       ++  V +   QL + L Y H   +
Sbjct: 63  VTLHDIIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++      LADFGLA              R+   PT  +   N V TL 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLA--------------RAKSIPTKTY--DNEVVTLW 165
Query: 244 YMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
           Y  P+IL     +S + D++  G    E+ TG   +     E Q H +  +
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 68  YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE---LDNFHKE--LQLLCKLD 119
           Y  ++ I  GA   V++A      GR VA+K+  + T EE   L    +   L+ L   +
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 120 HPGLAKF-----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           HP + +      V+   +       FE  +         V E     + +  +  QL + 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L +LH+  +VHRD+KP N+L+  +    LADFGLA        ++               
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--------------- 177
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
             ++V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 178 --SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           Y ++  I  GA  VV  A   L G++VA+KK I +  + + N  +   EL++L    H  
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKK-IPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LH--VEEWSP-SVDQVLMIAAQLAKALQYL 178
           +            Y  F   Y   +L E  LH  +    P +++ V     QL + L+Y+
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+L++ N    + DFG+A                +      +     
Sbjct: 175 HSAQVIHRDLKPSNLLVNENCELKIGDFGMA------------RGLCTSPAEHQYFMTEY 222
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLT 273
           V T  Y APE+ L    +++  D++S G    E+L 
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           Y ++  I  GA  VV  A   L G++VA+KK I +  + + N  +   EL++L    H  
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKK-IPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LH--VEEWSP-SVDQVLMIAAQLAKALQYL 178
           +            Y  F   Y   +L E  LH  +    P +++ V     QL + L+Y+
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+L++ N    + DFG+A                +      +     
Sbjct: 176 HSAQVIHRDLKPSNLLVNENCELKIGDFGMA------------RGLCTSPAEHQYFMTEY 223
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLT 273
           V T  Y APE+ L    +++  D++S G    E+L 
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 138 FFFEFYESR------NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
           F+  F + R      ++ ++ H  E   SV     +   +A AL +LHN GI HRD+KP 
Sbjct: 86  FYLVFEKMRGGSILSHIHKRRHFNELEASV-----VVQDVASALDFLHNKGIAHRDLKPE 140
Query: 192 NVLLD--RNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
           N+L +    + P  + DFGL          S         P          G+  YMAPE
Sbjct: 141 NILCEHPNQVSPVKICDFGLG---------SGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 249 IL-----KKEIHSEKSDVYSFGISINELLTGVVPYT 279
           ++     +  I+ ++ D++S G+ +  LL+G  P+ 
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 61/114 (53%), Gaps = 20/114 (17%)
Query: 171 LAKALQYLHNLGIVHRDVKPANVL-LDRNLCPH---LADFGLAEYRENLKEISLKNWRSS 226
           + K ++YLH  G+VHRD+KP+N+L +D +  P    + DFG A      K++  +N    
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA------KQLRAEN---- 174
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           G      +  N V      APE+L+++ +    D++S G+ +  +LTG  P+ +
Sbjct: 175 GLLMTPCYTANFV------APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLD-- 119
           S Y  ++ I  GA   VY+A     G  VA+K   +   EE       +E+ LL +L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 120 -HPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS---VDQVLMIAAQLAK 173
            HP + +   V A ++    +     +E  +   + ++++  P     + +  +  Q  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L +LH   IVHRD+KP N+L+       LADFGLA          + +++ +  P    
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---------IYSYQMALDP---- 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
               +V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 20/134 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-----LCPHLADFGLA-EY-- 211
           ++  VLMIA QL   ++Y+H+  +++RDVKP N L+ R         H+ DFGLA EY  
Sbjct: 95  TLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYID 154
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
            E  K I  +  +S            + GT  YM+      +  S + D+ + G      
Sbjct: 155 PETKKHIPYREHKS------------LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 202
Query: 272 LTGVVPYTDLRAEA 285
           L G +P+  L+A+ 
Sbjct: 203 LRGSLPWQGLKADT 216

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLA-EY-- 211
           ++  VLMIA QL   ++Y+H   +++RDVKP N L+      R    H+ DFGLA EY  
Sbjct: 98  TLKTVLMIAIQLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYID 157
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
            E  K I  +              K++ GT  YM+      +  S + D+ + G      
Sbjct: 158 PETKKHIPYRE------------HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 205
Query: 272 LTGVVPYTDLRAEA 285
           L G +P+  L+A+ 
Sbjct: 206 LRGSLPWQGLKADT 219

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLD-- 119
           S Y  ++ I  GA   VY+A     G  VA+K   +   EE       +E+ LL +L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 120 -HPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS---VDQVLMIAAQLAK 173
            HP + +   V A ++    +     +E  +   + ++++  P     + +  +  Q  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L +LH   IVHRD+KP N+L+       LADFGLA          + +++ +  P    
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---------IYSYQMALAP---- 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
               +V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 114/285 (40%), Gaps = 51/285 (17%)
Query: 74  IARGAESVVY-----EATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           I RG+   VY     E T++     ++   L+ SE    F +E + L  L HP + +F  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEXLKGLQHPNIVRFYD 92
Query: 129 AHAKPPN----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI-AAQLAKALQYLHNLG- 182
           +           +   E   S  L  K +++ +     +VL     Q+ K LQ+LH    
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTL--KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 183 -IVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
            I+HRD+K  N+ +        + D GLA     LK  S                K ++G
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFA--------------KAVIG 192
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           T  + APE  + E + E  DVY+FG    E  T   PY++ +  AQ +            
Sbjct: 193 TPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIY------------ 239
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               V+ G++P  AS +      +  +I+ C   N   R S  D+
Sbjct: 240 --RRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 48/229 (20%)
Query: 80  SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF 138
           +VV++ +  GR VAVK+ ++      D    E++LL + D HP + ++  +         
Sbjct: 48  TVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 104
Query: 139 FFEF--------YESRNLA-EKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
             E          ES+N++ E L ++ E++P     + +  Q+A  + +LH+L I+HRD+
Sbjct: 105 ALELCNLNLQDLVESKNVSDENLKLQKEYNP-----ISLLRQIASGVAHLHSLKIIHRDL 159
Query: 189 KPANVLLD-------------RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           KP N+L+               NL   ++DFGL +  +            SG+     + 
Sbjct: 160 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD------------SGQXXFRXNL 207
Query: 236 KNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLT-GVVPYTD 280
            N  GT  + APE+L++      +   D++S G     +L+ G  P+ D
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSS 226
             Q+AK + YL   G+VHR++   NVLL       +ADFG+A+    + K++     ++ 
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
            K               +MA E +    ++ +SDV+S+G+++ EL+T G  PY  LR  A
Sbjct: 181 IK---------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-A 224
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           +   +LE      Q           P + +++      +  ++ +CW  + + RP+F ++
Sbjct: 225 EVPDLLEKGERLAQ-----------PQICTID------VYMVMVKCWMIDENIRPTFKEL 267
Query: 346 ALEL 349
           A E 
Sbjct: 268 ANEF 271

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 48/229 (20%)
Query: 80  SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF 138
           +VV++ +  GR VAVK+ ++      D    E++LL + D HP + ++  +         
Sbjct: 48  TVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 104
Query: 139 FFEF--------YESRNLA-EKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
             E          ES+N++ E L ++ E++P     + +  Q+A  + +LH+L I+HRD+
Sbjct: 105 ALELCNLNLQDLVESKNVSDENLKLQKEYNP-----ISLLRQIASGVAHLHSLKIIHRDL 159
Query: 189 KPANVLLD-------------RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           KP N+L+               NL   ++DFGL +  +            SG+     + 
Sbjct: 160 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD------------SGQXXFRXNL 207
Query: 236 KNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLT-GVVPYTD 280
            N  GT  + APE+L++      +   D++S G     +L+ G  P+ D
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E      +   E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLA-------RVADPDHDHTGFLT------EY 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 88  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 145
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 192
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 89  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 146
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 193
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 80  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 137
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 184
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 35/184 (19%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSS 226
             Q+AK + YL   G+VHR++   NVLL       +ADFG+A+    + K++     ++ 
Sbjct: 139 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
            K               +MA E +    ++ +SDV+S+G+++ EL+T G  PY  LR  A
Sbjct: 199 IK---------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-A 242
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           +   +LE      Q           P + +++      +  ++ +CW  + + RP+F ++
Sbjct: 243 EVPDLLEKGERLAQ-----------PQICTID------VYMVMVKCWMIDENIRPTFKEL 285
Query: 346 ALEL 349
           A E 
Sbjct: 286 ANEF 289

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 81  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 138
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 185
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA   +                TG   +   
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-----------PDHDHTGFLXE--X 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 81  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 138
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 185
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 88  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 145
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA   +                TG   +   
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-----------PDHDHTGFLXE--X 192
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRK----VAVKKPILSTSEE--LDNFHKELQLLCKLD 119
             Y  L  I  G    V++A    R+    VA+K+  L   +E    +  +E+ LL +L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           H  + +              FEF + ++L +           + V     QL K L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +  ++HRD+KP N+L++RN    LADFGLA              R+ G P   +  +  V
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLA--------------RAFGIPVRCYSAE--V 162
Query: 240 GTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVP 277
            TL Y  P++L   +++S   D++S G    EL     P
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLA-------RVADPDHDHTGFLT------EY 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 33/205 (16%)
Query: 74  IARGAE-SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHA 131
           +  GAE ++VY    D R VAVK+ +       D   +E+QLL + D HP + ++     
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTE- 87
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
           K   + +      +  L E +  ++++    + + +  Q    L +LH+L IVHRD+KP 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147
Query: 192 NVLLDR-----NLCPHLADFGLAEYRENLKEISLKNW---RSSGKPTGGFHKKNMVGTLI 243
           N+L+        +   ++DFGL       K++++      R SG P          GT  
Sbjct: 148 NILISMPNAHGKIKAMISDFGLC------KKLAVGRHSFSRRSGVP----------GTEG 191
Query: 244 YMAPEILK---KEIHSEKSDVYSFG 265
           ++APE+L    KE  +   D++S G
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAG 216

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-----NLCPHLADFGLA-EY-- 211
           S+  VLMIA QL   ++Y+H+  +++RDVKP N L+ R         H+ DF LA EY  
Sbjct: 124 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 183
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
            E  K I  +  +S            + GT  YM+      +  S + D+ + G      
Sbjct: 184 PETKKHIPYREHKS------------LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 231
Query: 272 LTGVVPYTDLRAEA 285
           L G +P+  L+A+ 
Sbjct: 232 LRGSLPWQGLKADT 245

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-----NLCPHLADFGLA-EY-- 211
           S+  VLMIA QL   ++Y+H+  +++RDVKP N L+ R         H+ DF LA EY  
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
            E  K I  +  +S            + GT  YM+      +  S + D+ + G      
Sbjct: 163 PETKKHIPYREHKS------------LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210
Query: 272 LTGVVPYTDLRAEA 285
           L G +P+  L+A+ 
Sbjct: 211 LRGSLPWQGLKADT 224

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 125/302 (41%), Gaps = 58/302 (19%)
Query: 70  LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHK-ELQLLCKLDHPGLAKFVA 128
           ++  I +G    V+     G KVAVK  +  T+EE   F + E+     + H  +  F+A
Sbjct: 41  MVKQIGKGRYGEVWMGKWRGEKVAVK--VFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 129 AHAKPP----NYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNL- 181
           A  K            +++E+ +L + L     S ++D   +L +A      L +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 182 -------GIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGGF 233
                   I HRD+K  N+L+ +N    +AD GLA ++  +  E+ +             
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP------------ 202
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEK------SDVYSFGISINELLTGVVPYTDLRAEAQA 287
                VGT  YM PE+L + ++         +D+YSFG+ + E+    V    +  E Q 
Sbjct: 203 -PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-GGIVEEYQL 260
Query: 288 --HTVLEMNYTEQQLTAAVVSGGLRPILAS--------LELGLPASILSLIQRCWDGNPH 337
             H ++  + + + +   V    LRP   +         ++G       L+  CW  NP 
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG------KLMTECWAHNPA 314
Query: 338 NR 339
           +R
Sbjct: 315 SR 316

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 191
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 54/115 (46%), Gaps = 20/115 (17%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEISLKNW 223
           I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A      KE +  N 
Sbjct: 166 IXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTSHNS 219
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            ++              T  Y+APE+L  E + +  D +S G+    LL G  P+
Sbjct: 220 LTTP-----------CYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 105 G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 163 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 209
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|4DA1|A Chain A, Crystal Structure Of Branched-Chain Alpha-Ketoacid Dehydrogenase Phosphatase With Mg (Ii) Ions At The Active Site Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 10/136 (7%)
Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST 491
           G  +  G+R+  ED  F    + +  E+  F ++DGH G AAA+F    +   + +L   
Sbjct: 125 GCASQIGKRKENED-RFDFAQLTD--EVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPK 181
Query: 492 TRPTDALLE-AFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAG 549
            +  + LL  AF+  D AF +    L     ++      G TA  AL+     L VA+ G
Sbjct: 182 EKNLETLLTLAFLEIDKAFSSHA-RLSADATLLTS----GTTATVALLRDGIELVVASVG 236
Query: 550 DCRAILCRGGHPFALS 565
           D RAILCR G P  L+
Sbjct: 237 DSRAILCRKGKPMKLT 252

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 107 NFHKELQLLCKLDHPGLAKFVAA-HAKPPNYMFFFEFYESRNLAEKLH-VEEWSPSVDQV 164
           N  KE+QLL +L H  + + V   + +    M+    Y    + E L  V E    V Q 
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA 111
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
                QL   L+YLH+ GIVH+D+KP N+LL       ++  G+AE        +    R
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA--ADDTCR 169
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPY 278
           +S             G+  +  PEI          K D++S G+++  + TG+ P+
Sbjct: 170 TS------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLD-- 119
           S Y  ++ I  GA   VY+A     G  VA+K   +   EE       +E+ LL +L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 120 -HPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS---VDQVLMIAAQLAK 173
            HP + +   V A ++    +     +E  +   + ++++  P     + +  +  Q  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L +LH   IVHRD+KP N+L+       LADFGLA          + +++ +  P    
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---------IYSYQMALFP---- 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
               +V TL Y APE+L +  ++   D++S G    E+ 
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 67  SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--- 122
           +YT    I  G+  VV++A L +  +VA+KK  +   +   N  +ELQ++  + HP    
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKK--VLQDKRFKN--RELQIMRIVKHPNVVD 96
Query: 123 LAKFVAAHAKPPNYMFF---FEFYESRNLAEKLHVEEWSPSVDQVL--MIAAQLAKALQY 177
           L  F  ++    + +F     E+          H  +   ++  +L  +   QL ++L Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 178 LHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +H++GI HRD+KP N+LLD  +    L DFG A+               +G+P       
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI------------LIAGEPN-----V 199
Query: 237 NMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTG 274
           + + +  Y APE I     ++   D++S G  + EL+ G
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 33/240 (13%)
Query: 104 ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ 163
           + +   +E Q++ +LD+P + + +    +    M   E      L + L  +     V  
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 437
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
           V  +  Q++  ++YL     VHR++   NVLL       ++DFGL+  +    + S    
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTA 495
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282
           RS+GK             L + APE +     S +SDV+S+G+++ E L+ G  PY  ++
Sbjct: 496 RSAGK-----------WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
                               A +  G R          P  + +L+  CW     +RP F
Sbjct: 545 GPE---------------VMAFIEQGKR---MECPPECPPELYALMSDCWIYKWEDRPDF 586

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 93  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 197
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 189
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 189
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 52/233 (22%)
Query: 80  SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF 138
           +VV++ +  GR VAVK+ ++   +  D    E++LL + D HP + ++  +         
Sbjct: 30  TVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86
Query: 139 FFEF--------YESRNLA-EKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
             E          ES+N++ E L ++ E++P     + +  Q+A  + +LH+L I+HRD+
Sbjct: 87  ALELCNLNLQDLVESKNVSDENLKLQKEYNP-----ISLLRQIASGVAHLHSLKIIHRDL 141
Query: 189 KPANVLLD-------------RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           KP N+L+               NL   ++DFGL +  +            SG+ +   + 
Sbjct: 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD------------SGQSSFRTNL 189
Query: 236 KNMVGTLIYMAPEILK-------KEIHSEKSDVYSFGISINELLT-GVVPYTD 280
            N  GT  + APE+L+       K   +   D++S G     +L+ G  P+ D
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA+KK  +S  E         +E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKCQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 60/114 (52%), Gaps = 20/114 (17%)
Query: 171 LAKALQYLHNLGIVHRDVKPANVL-LDRNLCPH---LADFGLAEYRENLKEISLKNWRSS 226
           + K ++YLH  G+VHRD+KP+N+L +D +  P    + DFG A      K++  +N    
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA------KQLRAEN---- 174
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           G      +  N V      APE+L+++ +    D++S G+ +   LTG  P+ +
Sbjct: 175 GLLXTPCYTANFV------APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 46/264 (17%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF- 126
           Y+ +SP+  GA   V+ A    +   V    +   + L++        C ++ P L K  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED--------CWIEDPKLGKVT 77
Query: 127 ----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-----------PSVDQVLM--IAA 169
               + +  +  N +   + +E++   + +  +  S           P +D+ L   I  
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           QL  A+ YL    I+HRD+K  N+++  +    L DFG A Y E             GK 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER------------GKL 185
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
              F      GT+ Y APE+L    +   + +++S G+++  L+    P+ +L    +A 
Sbjct: 186 FYTF-----CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA- 239
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPI 312
             +   Y   +   ++VSG L+P+
Sbjct: 240 -AIHPPYLVSKELMSLVSGLLQPV 262

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 189
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPG 122
           YT LS I  GA  +V  A   L+  +VA++K  +S  E         +E+++L +  H  
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRK--ISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +   +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+
Sbjct: 87  IIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EY 191
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 189
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 50/239 (20%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLA 124
           Y +   I  G+  V++E T  L+ ++VA+K +P  S + +L + ++  +LL         
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL--------- 62
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-------------MIAAQL 171
              A     PN  +F +      L   L ++   PS++ +L             M A Q+
Sbjct: 63  ---AGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 115
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDR------NLCPHLADFGLAE-YRENLKEISLKNWR 224
              +Q +H   +V+RD+KP N L+ R      N+  ++ DFG+ + YR+ + +  +  +R
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIP-YR 173
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                     KKN+ GT  YM+         S + D+ + G      L G +P+  L+A
Sbjct: 174 E---------KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 50/239 (20%)
Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-KPILSTSEELDNFHKELQLLCKLDHPGLA 124
           Y +   I  G+  V++E T  L+ ++VA+K +P  S + +L + ++  +LL         
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL--------- 61
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-------------MIAAQL 171
              A     PN  +F +      L   L ++   PS++ +L             M A Q+
Sbjct: 62  ---AGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 114
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDR------NLCPHLADFGLAE-YRENLKEISLKNWR 224
              +Q +H   +V+RD+KP N L+ R      N+  ++ DFG+ + YR+ + +  +  +R
Sbjct: 115 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTKQHIP-YR 172
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
                     KKN+ GT  YM+         S + D+ + G      L G +P+  L+A
Sbjct: 173 E---------KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 222

>pdb|2IQ1|A Chain A, Crystal Structure Of Human Ppm1k Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 65/136 (47%), Gaps = 10/136 (7%)
Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST 491
           G  +  G+R+  ED  F    + +  E+  F ++DGH G AAA+F    +   + +L   
Sbjct: 11  GCASQIGKRKENED-RFDFAQLTD--EVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPK 67
Query: 492 TRPTDALLE-AFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAG 549
            +  + LL  AF+  D AF +    L     ++      G TA  AL+     L VA+ G
Sbjct: 68  EKNLETLLTLAFLEIDKAFSSHA-RLSADATLLTS----GTTATVALLRDGIELVVASVG 122
Query: 550 DCRAILCRGGHPFALS 565
           D RAILCR G P  L+
Sbjct: 123 DSRAILCRKGKPMKLT 138

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H  + 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 85  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLA-------RVADPDHDHTGFLT------EYVA 189
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 52/233 (22%)
Query: 80  SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF 138
           +VV++ +  GR VAVK+ ++      D    E++LL + D HP + ++  +         
Sbjct: 30  TVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86
Query: 139 FFEF--------YESRNLA-EKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
             E          ES+N++ E L ++ E++P     + +  Q+A  + +LH+L I+HRD+
Sbjct: 87  ALELCNLNLQDLVESKNVSDENLKLQKEYNP-----ISLLRQIASGVAHLHSLKIIHRDL 141
Query: 189 KPANVLLD-------------RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           KP N+L+               NL   ++DFGL +  +            SG+     + 
Sbjct: 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD------------SGQXXFRXNL 189
Query: 236 KNMVGTLIYMAPEILK-------KEIHSEKSDVYSFGISINELLT-GVVPYTD 280
            N  GT  + APE+L+       K   +   D++S G     +L+ G  P+ D
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L    H  + 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 191
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 96/232 (41%), Gaps = 20/232 (8%)
Query: 68  YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF 126
           Y +   + RG   +V+       +K  + K +     +     KE+ +L    H  +   
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
             +       +  FEF    ++ E+++   +  +  +++    Q+ +ALQ+LH+  I H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 187 DVKPANVLLD--RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           D++P N++    R+    + +FG A                  KP   F  + +     Y
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---------------QLKPGDNF--RLLFTAPEY 169
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
            APE+ + ++ S  +D++S G  +  LL+G+ P+     +     ++   YT
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 68
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W             + +A+  +
Sbjct: 69  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVHTI 123
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 124 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 168
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 228
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 229 LHAIIDPNH 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 116
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W             + +A+  +
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKS-----YWKNMLEAVHTI 171
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 216
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 277 LHAIIDPNH 285

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 17/122 (13%)
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNLCP-HLADFGLAEYRENLKEISLKN 222
           ++   +A AL +LHN GI HRD+KP N+L +    + P  + DF L          S   
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG---------SGIK 165
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEIL-----KKEIHSEKSDVYSFGISINELLTGVVP 277
                 P          G+  YMAPE++     +  I+ ++ D++S G+ +  LL+G  P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
Query: 278 YT 279
           + 
Sbjct: 226 FV 227

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 72
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W             + +A+  +
Sbjct: 73  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVHTI 127
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 128 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 172
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 232
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 233 LHAIIDPNH 241

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 33/181 (18%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           Q+AK + YL ++ +VHRD+   NVL+       + DFGLA     L +I    + + G  
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLA----RLLDIDETEYHADGGK 182
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                       + +MA E + +   + +SDV+S+G+++ EL+T G  PY  + A  +  
Sbjct: 183 V----------PIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIP 231
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
            +LE      Q           P + +++      +  ++ +CW  +   RP F ++  E
Sbjct: 232 DLLEKGERLPQ-----------PPICTID------VYMIMVKCWMIDSECRPRFRELVSE 274
Query: 349 L 349
Sbjct: 275 F 275

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 88
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W             + +A+  +
Sbjct: 89  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVHTI 143
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 144 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 188
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 249 LHAIIDPNH 257

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 69
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W             + +A+  +
Sbjct: 70  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-----SYWKNMLEAVHTI 124
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 125 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 169
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 230 LHAIIDPNH 238

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLA-EYRENL 215
           S+  VLM+A Q+   ++++H+   +HRD+KP N L+    R    ++ DFGLA +YR+  
Sbjct: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
               +  +R +         KN+ GT  Y +         S + D+ S G  +   L G 
Sbjct: 161 THQHIP-YREN---------KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
           +P+  L+A  +     ++  +E+++  ++          +L  G P    S    C    
Sbjct: 211 LPWQGLKAGTKKQKYEKI--SEKKVATSI---------EALCRGYPTEFASYFHYCRSLR 259
Query: 336 PHNRPSFS 343
             ++P +S
Sbjct: 260 FDDKPDYS 267

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 42/249 (16%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKV-AVKKPIL--STSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++   + +++ A+K   L  + ++ LD++  E+  L KL      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 116
Query: 125 KFVAAHAKPPNYMFFFEFYESRN------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           K +  +       + +   E  N      L +K  ++ W     +       + +A+  +
Sbjct: 117 KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW-----ERKSYWKNMLEAVHTI 171
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GIVH D+KPAN L+   +   L DFG+A   +                T    K + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ--------------PDTTSVVKDSQ 216
Query: 239 VGTLIYMAPEILKKEIHSEKS-----------DVYSFGISINELLTGVVPYTDLRAE-AQ 286
           VGT+ YM PE +K    S ++           DV+S G  +  +  G  P+  +  + ++
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 287 AHTVLEMNY 295
            H +++ N+
Sbjct: 277 LHAIIDPNH 285

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 46/308 (14%)
Query: 66  SSYTLLSPIARGAESVVYEATLDGRK----VAVKKPILSTSEE--LDNFHKELQLLCKLD 119
             Y  L  I  G    V++A    R+    VA+K+  L   +E    +  +E+ LL +L 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           H  + +              FEF + ++L +           + V     QL K L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +  ++HRD+KP N+L++RN    LA+FGLA              R+ G P   +  +  V
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLA--------------RAFGIPVRCYSAE--V 162
Query: 240 GTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG---VVPYTDLRAEAQAHTVLEMNY 295
            TL Y  P++L   +++S   D++S G    EL      + P  D+  + +    L    
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 296 TEQQLTAAVVSGGLRPI--------LASLELGLPASILSLIQRCWDGNPHNR-------- 339
           TE+Q  +       +P         L ++   L A+   L+Q     NP  R        
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 340 -PSFSDIA 346
            P FSD  
Sbjct: 283 HPYFSDFC 290

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 21/115 (18%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNW 223
           I   +  A+Q+LH+  I HRDVKP N+L    +++    L DFG A              
Sbjct: 114 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------------- 159
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
               K T     +    T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 160 ----KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 53/115 (46%), Gaps = 21/115 (18%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNW 223
           I   +  A+Q+LH+  I HRDVKP N+L    +++    L DFG A              
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------------- 178
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
               K T     +    T  Y+APE+L  E + +  D++S G+ +  LL G  P+
Sbjct: 179 ----KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L    H  + 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE----KLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +    + P      + Y  ++L E    KL ++    S D +     Q+ + L+Y+H+
Sbjct: 87  G-INDIIRAPTIEQMKDVYIVQDLMETDLYKL-LKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 191
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 153 HVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLA 209
           H E W  S+   QV         AL +LH+ G+VH DVKPAN+ L  R  C  L DFGL 
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC-KLGDFGL- 203
Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269
                L E+           T G  +    G   YMAPE+L+   +   +DV+S G++I 
Sbjct: 204 -----LVELG----------TAGAGEVQE-GDPRYMAPELLQGS-YGTAADVFSLGLTIL 246
Query: 270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
           E+   +    +L    +    L   Y   + TA  +S  LR +L  +
Sbjct: 247 EVACNM----ELPHGGEGWQQLRQGYLPPEFTAG-LSSELRSVLVMM 288

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHP--- 121
           YT L  I  GA  +V  A    RK  V    +S  E         +E+Q+L +  H    
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 122 GLAKFV-AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           G+   + A+  +    ++  +     +L + L  ++ S   D +     Q+ + L+Y+H+
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN--DHICYFLYQILRGLKYIHS 162
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+L++      + DFGLA        I+      +G  T        V 
Sbjct: 163 ANVLHRDLKPSNLLINTTCDLKICDFGLA-------RIADPEHDHTGFLT------EXVA 209
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLT 273
           T  Y APEI L  + +++  D++S G  + E+L+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLDHP--- 121
           YT LS I  GA  +V  A  +  KV V    +S  E         +E+++L +  H    
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 122 GLAKFV-AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           G+   + A   +    ++        +L + L  +  S   D +     Q+ + L+Y+H+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN--DHICYFLYQILRGLKYIHS 162
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA        ++  +   +G  T        V 
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLA-------RVADPDHDHTGFLT------EYVA 209
Query: 241 TLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	573
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-73
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-71
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-69
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-68
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-68
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-67
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-66
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-59
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-59
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-57
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-53
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-43
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-41
2i0o_A	304	Ser/Thr phosphatase; beta sandwich, structural gen	4e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
2iq1_A	274	Protein phosphatase 2C kappa, PPM1K; structural ge	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-39
2i44_A	324	Serine-threonine phosphatase 2C; PSI-2, 8817Z, str	6e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
3kdj_B	316	Protein phosphatase 2C 56; ABA, PYL1, abscisic aci	5e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-38
1a6q_A	382	Phosphatase 2C; catalytic mechanism, metalloenzyme	1e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-37
4da1_A	389	Protein phosphatase 1K, mitochondrial; metal-ION-a	1e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-37
3qn1_B	337	Protein phosphatase 2C 16; start domain, BET V dom	2e-37
2p8e_A	307	PPM1B beta isoform variant 6; structural genomics,	7e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-32
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-32
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-27
2j4o_A	401	Mitogen-activated protein kinase kinase kinase 7-i	1e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
2irm_A	358	Mitogen-activated protein kinase kinase kinase 7 i	6e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-25
3d8k_A	377	PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR	1e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-19
2isn_A	364	NYSGXRC-8828Z, phosphatase; pathogenic strain, pra	4e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-11
2pnq_A	467	[pyruvate dehydrogenase [lipoamide]]-phosphatase 1	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-09
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-08
2pk0_A	250	Serine/threonine protein phosphatase STP1; SI moti	3e-06
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-04
1txo_A	237	Putative bacterial enzyme; serine/threonine protei	3e-04
2j82_A	240	TPPHA, protein serine-threonine phosphatase; PP2C	5e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  236 bits (605), Expect = 1e-73
 Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 39/298 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
           P     +   I  G+   V+ A   G  VAVK        +E ++ F +E+ ++ +L HP
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLH 179
            +  F+ A  +PPN     E+    +L   LH       +D  + L +A  +AK + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 180 NLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           N    IVHR++K  N+L+D+     + DFGL+  R               K +     K+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS--RL--------------KASTFLSSKS 198

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
             GT  +MAPE+L+ E  +EKSDVYSFG+ + EL T   P+ +L                
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--------------NP 244

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
            Q+ AAV     R  +      L   + ++I+ CW   P  RPSF+ I   L  +++ 
Sbjct: 245 AQVVAAVGFKCKRLEIPR---NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  231 bits (590), Expect = 1e-71
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 45/298 (15%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
                 +   + RGA  VV +A    + VA+K+  + +  E   F  EL+ L +++HP +
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNI 63

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNL 181
            K   A   P       E+ E  +L   LH  E  P       +    Q ++ + YLH++
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 182 ---GIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
               ++HRD+KP N+LL        + DFG A            + ++        H  N
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQT--------HMTN 162

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
             G+  +MAPE+ +   +SEK DV+S+GI + E++T   P+ ++   A            
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---------- 212

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                  V  G RP L      LP  I SL+ RCW  +P  RPS  +I   +  ++ +
Sbjct: 213 ---IMWAVHNGTRPPLIK---NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  225 bits (576), Expect = 2e-69
 Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 41/309 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
           P     +   I +G    VY     G +VA++         ++L  F +E+    +  H 
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  F+ A   PP+        + R L   +   +    V++   IA ++ K + YLH  
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           GI+H+D+K  NV  D      + DFGL          S+     +G+       +   G 
Sbjct: 150 GILHKDLKSKNVFYDNGKV-VITDFGLF---------SISGVLQAGRREDKL--RIQNGW 197

Query: 242 LIYMAPEILK---------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
           L ++APEI++         K   S+ SDV++ G    EL     P+    AEA       
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------- 250

Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
                       +  G++P L+  ++G+   I  ++  CW      RP+F+ +   L+ +
Sbjct: 251 --------IIWQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

Query: 353 LEHRKSLKE 361
            +  + L  
Sbjct: 301 PKRNRRLSH 309

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  223 bits (571), Expect = 5e-69
 Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 34/292 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
           P    T+   I  G+   VY+    G  VAVK       T ++L  F  E+ +L K  H 
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  F+   +  P      ++ E  +L   LH  E    + +++ IA Q A+ + YLH  
Sbjct: 81  NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+ L  +    + DFGLA   E         W  S +           G+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLA--TE------KSRWSGSHQFEQL------SGS 185

Query: 242 LIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
           +++MAPE+++ +     S +SDVY+FGI + EL+TG +PY+++                 
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------------RD 232

Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           Q+   V  G L P L+ +    P  +  L+  C       RPSF  I  E++
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  223 bits (570), Expect = 2e-68
 Identities = 75/303 (24%), Positives = 118/303 (38%), Gaps = 20/303 (6%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
             PS       + +G      + T    G  + +K+ I    E    F KE++++  L+H
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
           P + KF+    K     F  E+ +   L   +   +      Q +  A  +A  + YLH+
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           + I+HRD+   N L+  N    +ADFGLA  R  + E +      S K      +  +VG
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLA--RLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
              +MAPE++    + EK DV+SFGI + E++  V    D                    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-------------RTMD 231

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
               V G L           P S   +  RC D +P  RPSF  +   L+ +  H     
Sbjct: 232 FGLNVRGFLDRYCPP---NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288

Query: 361 EED 363
              
Sbjct: 289 PLG 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  221 bits (565), Expect = 2e-68
 Identities = 82/305 (26%), Positives = 129/305 (42%), Gaps = 52/305 (17%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKK----PILSTSEELDNFHKELQLLC 116
           L +  +  TL   I  G    VY A   G +VAVK     P    S+ ++N  +E +L  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            L HP +        K PN     EF     L   L  +   P  D ++  A Q+A+ + 
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARGMN 119

Query: 177 YLHNLG---IVHRDVKPANVLLDRNLCPH--------LADFGLAEYRENLKEISLKNWRS 225
           YLH+     I+HRD+K +N+L+ + +           + DFGLA                
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----------- 168

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
                    K +  G   +MAPE+++  + S+ SDV+S+G+ + ELLTG VP+  +    
Sbjct: 169 -------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI---- 217

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                         +   V    L   + S     P     L++ CW+ +PH+RPSF++I
Sbjct: 218 ----------DGLAVAYGVAMNKLALPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNI 264

Query: 346 ALELD 350
             +L 
Sbjct: 265 LDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  216 bits (553), Expect = 1e-66
 Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 48/297 (16%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
                  L+ +       +++    G  + VK  K    ++ +  +F++E   L    HP
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 122 GLAKFVAAHAKPP--NYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
            +   + A   PP  +      +    +L   LH          Q +  A  +A+ + +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 179 HNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           H L   I    +   +V++D ++   ++   +                S       F   
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVK--------------FS-------FQSP 166

Query: 237 NMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
             +    ++APE L+K+    +   +D++SF + + EL+T  VP+ DL            
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------------ 214

Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
             +  ++   V   GLRP +     G+   +  L++ C + +P  RP F  I   L+
Sbjct: 215 --SNMEIGMKVALEGLRPTIPP---GISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  216 bits (552), Expect = 3e-66
 Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 54/306 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-------PILSTSEELDNFHKELQ 113
           L  +       I +G   +V++  L  D   VA+K              E+   F +E+ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
           ++  L+HP + K       PP  +   EF    +L  +L  +         L +   +A 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 174 ALQYLHNLG--IVHRDVKPANVLLD-----RNLCPHLADFGLAEYRENLKEISLKNWRSS 226
            ++Y+ N    IVHRD++  N+ L        +C  +ADFGL+  ++++           
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--QQSVHS--------- 182

Query: 227 GKPTGGFHKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
                      ++G   +MAPE +  ++E ++EK+D YSF + +  +LTG  P+ +    
Sbjct: 183 --------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---- 230

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                    +Y + +    +   GLRP +       P  + ++I+ CW G+P  RP FS 
Sbjct: 231 --------YSYGKIKFINMIREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSY 279

Query: 345 IALELD 350
           I  EL 
Sbjct: 280 IVKELS 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  197 bits (503), Expect = 6e-59
 Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 36/303 (11%)

Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           TLL  + +G    V+  +  G  VAVK    S  E+      EL     L H  +  F+A
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGENVAVKI-FSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 129 A----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--- 181
           +                ++E  +L + L +   +      L I   +A  L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 182 -----GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
                 I HRD+K  N+L+ +N    +AD GLA               S           
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VM----------HSQSTNQLDVGNN 175

Query: 237 NMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQA-HT 289
             VGT  YMAPE+L + I        ++ D+++FG+ + E+   +V    +       + 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235

Query: 290 VLEMNYTEQQLTAAVVSGGLRPIL--ASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
           V+  + + + +   V     RP +           S+  L++ CW  NP  R +   I  
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

Query: 348 ELD 350
            L 
Sbjct: 296 TLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  195 bits (498), Expect = 9e-58
 Identities = 65/308 (21%), Positives = 111/308 (36%), Gaps = 36/308 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
                 ++  I +G    V+     G KVAVK    +T E       E+     + H  +
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-FFTTEEASWFRETEIYQTVLMRHENI 93

Query: 124 AKFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
             F+AA  K            +++E+ +L + L     +     +L +A      L +LH
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH 151

Query: 180 NL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
                      I HRD+K  N+L+ +N    +AD GLA                S     
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK------------FISDTNEV 199

Query: 232 GFHKKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
                  VGT  YM PE+L + ++         +D+YSFG+ + E+    V    +    
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 286 QAH-TVLEMNYTEQQLTAAVVSGGLRPIL--ASLELGLPASILSLIQRCWDGNPHNRPSF 342
             +  ++  + + + +   V    LRP              +  L+  CW  NP +R + 
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 343 SDIALELD 350
             +   L 
Sbjct: 320 LRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  194 bits (495), Expect = 2e-57
 Identities = 68/313 (21%), Positives = 120/313 (38%), Gaps = 37/313 (11%)

Query: 69  TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
            L   I +G    V+     G +VAVK    S  E       E+     L H  +  F+A
Sbjct: 45  VLQESIGKGRFGEVWRGKWRGEEVAVKI-FSSREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 129 A----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH----- 179
           A    +          +++E  +L + L+    + +V+ ++ +A   A  L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 180 ---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
                 I HRD+K  N+L+ +N    +AD GLA                S   T      
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR------------HDSATDTIDIAPN 209

Query: 237 NMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT- 289
           + VGT  YMAPE+L   I        +++D+Y+ G+   E+                +  
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGNPHNRPSFSDIAL 347
           ++  + + +++   V    LRP + +      A   +  +++ CW  N   R +   I  
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

Query: 348 ELDLVLEHRKSLK 360
            L   L  ++ +K
Sbjct: 330 TLS-QLSQQEGIK 341

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  191 bits (486), Expect = 4e-56
 Identities = 79/313 (25%), Positives = 127/313 (40%), Gaps = 42/313 (13%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLD 119
           L+       LL   ARG    V++A L    VAVK  I    ++       E+  L  + 
Sbjct: 19  LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVK--IFPIQDKQSWQNEYEVYSLPGMK 76

Query: 120 HPGLAKFVAAHAKPPN----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
           H  + +F+ A  +  +          F+E  +L++ L       S +++  IA  +A+ L
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGL 134

Query: 176 QYLH----------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            YLH             I HRD+K  NVLL  NL   +ADFGLA        +  +  +S
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA--------LKFEAGKS 186

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIH-----SEKSDVYSFGISINELLTGVVPYTD 280
           +G   G       VGT  YMAPE+L+  I+       + D+Y+ G+ + EL +       
Sbjct: 187 AGDTHG------QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 281 LRAEAQA--HTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNP 336
              E        +  + + + +   VV    RP+L     +    A +   I+ CWD + 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 337 HNRPSFSDIALEL 349
             R S   +   +
Sbjct: 301 EARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  183 bits (465), Expect = 5e-53
 Identities = 71/332 (21%), Positives = 125/332 (37%), Gaps = 43/332 (12%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQ--LLCK 117
              L   +  LL  I RG    VY+ +LD R VAVK  + S +    NF  E     +  
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVK--VFSFANR-QNFINEKNIYRVPL 63

Query: 118 LDHPGLAKFVAAHAKPP-----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
           ++H  +A+F+    +        Y+   E+Y + +L + L +   +        +A  + 
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVT 121

Query: 173 KALQYLH---------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
           + L YLH            I HRD+   NVL+  +    ++DFGL+          ++  
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS--MRLTGNRLVRPG 179

Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-------HSEKSDVYSFGISINELL---T 273
                          VGT+ YMAPE+L+  +         ++ D+Y+ G+   E+    T
Sbjct: 180 EEDNAAIS------EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 274 GVVPYTDLRAEAQA-HTVLEMNYTEQQLTAAVVSGGLRPILA---SLELGLPASILSLIQ 329
            + P   +     A  T +  + T + +   V     RP              S+   I+
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKSLKE 361
            CWD +   R +       +  ++   +  K 
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKS 325

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  157 bits (400), Expect = 1e-43
 Identities = 76/361 (21%), Positives = 153/361 (42%), Gaps = 45/361 (12%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y  L  I  G+         T DGR+  +K+  +S  +S+E +   +E+ +L  + HP +
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
            ++  +  +  +     ++ E  +L ++++ ++      DQ+L    Q+  AL+++H+  
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+K  N+ L ++    L DFG+A      + ++          +     +  +GT 
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIA------RVLN----------STVELARACIGTP 189

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y++PEI + + ++ KSD+++ G  + EL T    +                 + + L  
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------------SMKNLVL 235

Query: 303 AVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
            ++SG   P+    S +L       SL+ + +  NP +RPS + I LE   + +  +   
Sbjct: 236 KIISGSFPPVSLHYSYDLR------SLVSQLFKRNPRDRPSVNSI-LEKGFIAKRIEKFL 288

Query: 361 EEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESAN 420
              L A +  +    K   S         S   +     + K    AA+  + L  +   
Sbjct: 289 SPQLIAEEFCLKTFSKF-GSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYG 347

Query: 421 D 421
           D
Sbjct: 348 D 348

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (396), Expect = 1e-43
 Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 46/318 (14%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP-- 121
           S +  ++ + +GA   V +A   LD R  A+KK I  T E+L     E+ LL  L+H   
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 122 ----------GLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
                               K  + +F   E+ E+  L + +H E  +   D+   +  Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           + +AL Y+H+ GI+HRD+KP N+ +D +    + DFGLA+      +I   + ++    +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 231 GGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
                   +GT +Y+A E+L     ++EK D+YS GI   E++      T          
Sbjct: 185 DNLTS--AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG--------- 231

Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                  E+      +           +         +I+   D +P+ RP    +    
Sbjct: 232 ------MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL---- 281

Query: 350 DLVLEH---RKSLKEEDL 364
              L         ++E +
Sbjct: 282 ---LNSGWLPVKHQDEVI 296

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  149 bits (379), Expect = 3e-41
 Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 42/302 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           +  +  + RG   VV+EA   +D    A+K+  + +     +   +E++ L KL+HPG+ 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 125 KFVAA---------HAKPPNYMFFF---EFYESRNLAEKLHVEEWS--PSVDQVLMIAAQ 170
           ++  A                ++ +   +     NL + ++             L I  Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           +A+A+++LH+ G++HRD+KP+N+    +    + DFGL    +  +E             
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ----TVLTPMP 182

Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
                   VGT +YM+PE +    +S K D++S G+ + ELL    P           T 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P---------FSTQ 230

Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +E   T   +     +    P+              ++Q     +P  RP   +I +E  
Sbjct: 231 MERVRTLTDV----RNLKFPPLFTQ----KYPCEYVMVQDMLSPSPMERPEAINI-IENA 281

Query: 351 LV 352
           + 
Sbjct: 282 VF 283

>2i0o_A Ser/Thr phosphatase; beta sandwich, structural genomics, PSI, protei structure initiative, NEW YORK SGX research center for STRU genomics; 1.70A {Anopheles gambiae} Length = 304

 Score =  149 bits (379), Expect = 4e-41
 Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 11/147 (7%)

Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
           L+ GS +  G R + ED H  + +  +  +   F ++DGH G+  A++ +  LP FL+ +
Sbjct: 23  LASGSSSMQGWRISQEDAHNCILNFDD--QCSFFAVYDGHGGAEVAQYCSLHLPTFLKTV 80

Query: 489 GS--TTRPTDALLEAFIRTDVAFRNEL---DSLRKSKRVVQKDWHP----GCTAIAALIV 539
            +        AL EAF+  D     E    +    S      D  P    GCTA+ AL+ 
Sbjct: 81  EAYGRKEFEKALKEAFLGFDATLLQEKVIEELKVLSGDSAGSDAEPGKDSGCTAVVALLH 140

Query: 540 RNRLFVANAGDCRAILCRGGHPFALSR 566
              L+VANAGD R ++CR G    +S 
Sbjct: 141 GKDLYVANAGDSRCVVCRNGKALEMSF 167

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (377), Expect = 1e-40
 Identities = 57/290 (19%), Positives = 109/290 (37%), Gaps = 35/290 (12%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y  +  +  G  S V       DG   A+K+ +    ++ +   +E  +    +HP + +
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 126 FVAAHAKPPN--YMFF--FEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYL 178
            VA   +     +  +    F++   L  ++     +    + DQ+L +   + + L+ +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  G  HRD+KP N+LL     P L D G           +  +   S +          
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSM-------NQACIHVEGSRQALTLQDWAAQ 203

Query: 239 VGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
             T+ Y APE+   + H    E++DV+S G  +  ++ G  PY             +M +
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-------------DMVF 250

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            +    A  V   L    +       +++  L+      +PH RP    +
Sbjct: 251 QKGDSVALAVQNQLSIPQSP---RHSSALWQLLNSMMTVDPHQRPHIPLL 297

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (372), Expect = 3e-40
 Identities = 81/312 (25%), Positives = 130/312 (41%), Gaps = 63/312 (20%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
           Y +L  I  G+     +     DG+ +  K+      T  E      E+ LL +L HP +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 124 AKFVAAHAKPPNYMFF--FEFYESRNLAEKL--------HVEEWSPSVDQVLMIAAQLAK 173
            ++        N   +   E+ E  +LA  +        +++E     + VL +  QL  
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-----EFVLRVMTQLTL 122

Query: 174 ALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           AL+  H        ++HRD+KPANV LD      L DFGLA      + ++         
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA------RILN--------- 167

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
                  K  VGT  YM+PE + +  ++EKSD++S G  + EL   + P+T         
Sbjct: 168 -HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-------- 218

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
                 +++++L   +  G  R I    S EL        +I R  +   ++RPS  +I 
Sbjct: 219 ------FSQKELAGKIREGKFRRIPYRYSDEL------NEIITRMLNLKDYHRPSVEEI- 265

Query: 347 LELDLVLEHRKS 358
           LE  L+LEH   
Sbjct: 266 LENPLILEHHHH 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (369), Expect = 1e-39
 Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 60/317 (18%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKL 118
             +++ +   I RG  S VY A   LDG  VA+KK     L  ++   +  KE+ LL +L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL--------HVEEWSPSVDQVLMIAAQ 170
           +HP + K+ A+  +        E  ++ +L+  +         + E       V     Q
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-----RTVWKYFVQ 144

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
           L  AL+++H+  ++HRD+KPANV +       L D GL       +  S K         
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG------RFFSSKTT------- 191

Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
                 ++VGT  YM+PE + +  ++ KSD++S G  + E+     P+           +
Sbjct: 192 ---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNL 243

Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRCWDGNPHNRPSFSDI 345
                    L   +      P+        P+   S     L+  C + +P  RP  + +
Sbjct: 244 Y-------SLCKKIEQCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

Query: 346 ALELDLVLEHRKSLKEE 362
             ++   +    +   E
Sbjct: 289 -YDVAKRMHACTASSLE 304

>2iq1_A Protein phosphatase 2C kappa, PPM1K; structural genomics, PSI-2, protein structure initiative, NEW YORK SGX research center for structural genomics; 2.25A {Homo sapiens} Length = 274

 Score =  143 bits (363), Expect = 4e-39
 Identities = 41/142 (28%), Positives = 59/142 (41%), Gaps = 10/142 (7%)

Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
            + + G  +  G+R+  ED            E+  F ++DGH G AAA+F    +   + 
Sbjct: 6   SLENVGCASQIGKRKENEDRFDFAQ---LTDEVLYFAVYDGHGGPAAADFCHTHMEKCIM 62

Query: 487 N-LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNR-LF 544
           + L         L  AF+  D AF +       +          G TA  AL+     L 
Sbjct: 63  DLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATL-----LTSGTTATVALLRDGIELV 117

Query: 545 VANAGDCRAILCRGGHPFALSR 566
           VA+ GD RAILCR G P  L+ 
Sbjct: 118 VASVGDSRAILCRKGKPMKLTI 139

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (363), Expect = 5e-39
 Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 74/319 (23%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---- 121
           +  +  I  G    V++A   +DG+   +K+         +   +E++ L KLDH     
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVH 68

Query: 122 -----------GLAKFVAAHAKPPNYMFFF-EFYESRNLAEKL------HVEEWSPSVDQ 163
                             +       +F   EF +   L + +       +++       
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-----VL 123

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
            L +  Q+ K + Y+H+  +++RD+KP+N+ L       + DFGL         +     
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV------TSLKNDGK 177

Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
           R+              GTL YM+PE +  + + ++ D+Y+ G+ + ELL       +   
Sbjct: 178 RTR-----------SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--- 223

Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                            T+   +     I++           +L+Q+     P +RP+ S
Sbjct: 224 -----------------TSKFFTDLRDGIISD---IFDKKEKTLLQKLLSKKPEDRPNTS 263

Query: 344 DIALELDLVLEHRKSLKEE 362
           +I L    V +      E 
Sbjct: 264 EI-LRTLTVWKKSPEKNER 281

>2i44_A Serine-threonine phosphatase 2C; PSI-2, 8817Z, structural genomics, protein structure initiative; 2.04A {Toxoplasma gondii} Length = 324

 Score =  144 bits (365), Expect = 6e-39
 Identities = 31/170 (18%), Positives = 54/170 (31%), Gaps = 34/170 (20%)

Query: 423 LTYYPVLSWGSFATCGRRETMEDTHFLMPHMY-NQKEIHMFGIFDGHRGSAAAEFSARAL 481
            T YP      F   G R+  ED   L P +   + +   FG+FDG  G  A+E     +
Sbjct: 16  PTSYPAFDAAIFTDIGGRKHQEDRFTLCPQLVPGRDDCAFFGVFDGTVGDFASENVKDLV 75

Query: 482 PGFLQN---------------------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSK 520
              L +                              A+ + +   D       + L K  
Sbjct: 76  VPQLISSPAWQEVTEMLRSDVPATEVDEKLPQLLDQAVDDMYKNADNELVKMCEQLNKD- 134

Query: 521 RVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR----GGHPFALSR 566
                  +   T++ A++ +  + V + GD R  +      G +   L+ 
Sbjct: 135 -------YASSTSVTAVLAKGFVAVGHLGDSRIAMGVETPNGLNCEFLTV 177

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  143 bits (364), Expect = 7e-39
 Identities = 72/286 (25%), Positives = 116/286 (40%), Gaps = 46/286 (16%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
           Y L   +  G  S V+ A    D R VAVK  +  L+        F +E Q    L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 123 LAK-----FVAAHAKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
           +            A P  Y  M   E+ +   L + +H  E   +  + + + A   +AL
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 129

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            + H  GI+HRDVKPAN+++       + DFG+A              R+         +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA--------------RAIADSGNSVTQ 175

Query: 236 KNMV-GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
              V GT  Y++PE  + +    +SDVYS G  + E+LTG  P+T    ++         
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAY--- 229

Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
              Q +    +        ++   GL A + +++ +    NP NR 
Sbjct: 230 ---QHVREDPIP------PSARHEGLSADLDAVVLKALAKNPENRY 266

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (367), Expect = 1e-38
 Identities = 73/312 (23%), Positives = 115/312 (36%), Gaps = 62/312 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVK--KPILSTSEELDNFHKELQLLCKL 118
           L      L   I RG    V+   L      VAVK  +      +    F +E ++L + 
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQY 169

Query: 119 DHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            HP + +   V    +P       E  +  +    L  E     V  +L +    A  ++
Sbjct: 170 SHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EY--RENLKEISLKNWRSSGK 228
           YL +   +HRD+   N L+       ++DFG++       Y     L+++ +K W     
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK-W----- 281

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
                            APE L    +S +SDV+SFGI + E  + G  PY +L      
Sbjct: 282 ----------------TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----SN 321

Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDI 345
               E            V  G R     L      P ++  L+++CW   P  RPSFS I
Sbjct: 322 QQTREF-----------VEKGGR-----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

Query: 346 ALELDLVLEHRK 357
             EL  + +  +
Sbjct: 366 YQELQSIRKRHR 377

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  143 bits (362), Expect = 1e-38
 Identities = 78/304 (25%), Positives = 118/304 (38%), Gaps = 62/304 (20%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
           Y L   + RG    VYEA  T+  R VA+K     LS+         +E +   +L  P 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 123 LAKFVAAH----AKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           +   V  H         Y  M         +LA  L   +   +  + + I  Q+  AL 
Sbjct: 96  V---VPIHDFGEIDGQLYVDM---RLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALD 148

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP----TGG 232
             H  G  HRDVKP N+L+  +   +L DFG+A               ++        G 
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIA--------------SATTDEKLTQLG- 193

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-DLRAEAQAHTVL 291
               N VGTL YMAPE   +   + ++D+Y+    + E LTG  PY  D  +   AH   
Sbjct: 194 ----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH--- 246

Query: 292 EMNYTEQQLTAAVVS-GGLRPILASLELGLPASILSLIQRCWDGNPHNR-PSFSDIALEL 349
                   +  A+     +RP       G+P +  ++I R    NP +R  +  D++   
Sbjct: 247 --------INQAIPRPSTVRP-------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291

Query: 350 DLVL 353
              L
Sbjct: 292 HAAL 295

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  142 bits (360), Expect = 2e-38
 Identities = 74/299 (24%), Positives = 129/299 (43%), Gaps = 42/299 (14%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
           Y ++  +  G  S VY A  T+   KVA+K         EE L  F +E+    +L H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 123 LAK-FVAAHAKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           +             Y  M   E+ E   L+E +       SVD  +    Q+   +++ H
Sbjct: 73  IVSMIDVDEEDDCYYLVM---EYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAH 128

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           ++ IVHRD+KP N+L+D N    + DFG+A      K +S  +   +          +++
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIA------KALSETSLTQTN---------HVL 173

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT+ Y +PE  K E   E +D+YS GI + E+L G  P+          T + +    + 
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-------GETAVSIAI--KH 224

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEHRK 357
           +  +V       +   +   +P S+ ++I R  + +  NR  +  ++  +L  VL   +
Sbjct: 225 IQDSVP-----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278

>3kdj_B Protein phosphatase 2C 56; ABA, PYL1, abscisic acid signaling pathway, cell membr hydrolase, magnesium, manganese, metal-binding, nucleus; HET: A8S; 1.88A {Arabidopsis thaliana} PDB: 3nmn_B* 3jrq_A* 3ujk_A 3nmv_B 3ujl_B* Length = 316

 Score =  141 bits (358), Expect = 5e-38
 Identities = 43/167 (25%), Positives = 62/167 (37%), Gaps = 37/167 (22%)

Query: 425 YYPVLSWGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGS 471
           +  V  +G  + CGRR  MED    +P                 Q   H FG++DGH GS
Sbjct: 5   FKSVPLYGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGS 64

Query: 472 AAAEFSARALPGFL------------QNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKS 519
             A +    +   L                   +   AL  +F+R D    +        
Sbjct: 65  QVANYCRERMHLALAEEIAKEKPMLSDGDTWLEKWKKALFNSFLRVDSEIES-------- 116

Query: 520 KRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
                     G T++ A++  + +FVAN GD RA+LCRG     LS 
Sbjct: 117 ----VAPETVGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTALPLSV 159

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (358), Expect = 8e-38
 Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 56/304 (18%)

Query: 68  YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++      +  A+K   L    ++ LD++  E+  L KL      
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 125 --KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
             +               E   + +L   L  ++ S    +       + +A+  +H  G
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           IVH D+KPAN L+   +   L DFG+A                    T    K + VGT+
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIA--------------NQMQPDTTSVVKDSQVGTV 173

Query: 243 IYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
            YM PE +K           K   S KSDV+S G  +  +  G  P+  +  +       
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 229

Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
                      A++                  +  +++ C   +P  R S  ++      
Sbjct: 230 ---------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPEL------ 271

Query: 352 VLEH 355
            L H
Sbjct: 272 -LAH 274

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (356), Expect = 8e-38
 Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 56/304 (18%)

Query: 68  YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLA 124
           Y++L  I  G  S V++      +  A+K   L    ++ LD++  E+  L KL      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89

Query: 125 --KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
             +               E   + +L   L  ++ S    +       + +A+  +H  G
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           IVH D+KPAN L+   +   L DFG+A                    T    K + VGT+
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIA--------------NQMQPDTTSVVKDSQVGTV 192

Query: 243 IYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
            YM PE +K           K   S KSDV+S G  +  +  G  P+  +  +       
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 248

Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
                      A++                  +  +++ C   +P  R S  ++      
Sbjct: 249 ---------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPEL------ 290

Query: 352 VLEH 355
            L H
Sbjct: 291 -LAH 293

>1a6q_A Phosphatase 2C; catalytic mechanism, metalloenzyme, transductuin, hydrolase; 2.00A {Homo sapiens} SCOP: a.159.1.1 d.219.1.1 PDB: 3fxk_A 3fxj_A 3fxl_A* 3fxm_A* 3fxo_A Length = 382

 Score =  142 bits (359), Expect = 1e-37
 Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 17/150 (11%)

Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKE-IHMFGIFDGHRGSAAAEFSARALPGFL 485
             L +G  +  G R  MED H  +  + +  E    F ++DGH GS  A++    L   +
Sbjct: 20  NGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHI 79

Query: 486 QN---------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAA 536
            N           S     + +   F+  D   R   +               G TA+  
Sbjct: 80  TNNQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEK-------KHGADRSGSTAVGV 132

Query: 537 LIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           LI     +  N GD R +LCR       ++
Sbjct: 133 LISPQHTYFINCGDSRGLLCRNRKVHFFTQ 162

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  139 bits (352), Expect = 1e-37
 Identities = 75/317 (23%), Positives = 126/317 (39%), Gaps = 61/317 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
           +      L   +  G    VYE            VAVK  K    T +  + F  E  ++
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIM 67

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
             LDHP + K +    + P ++   E Y    L   L   + S  V  +++ + Q+ KA+
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGK 228
            YL ++  VHRD+   N+L+    C  L DFGL+        Y+ ++  + +K W     
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-W----- 180

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
                           M+PE +     +  SDV+ F + + E+L+ G  P+  L      
Sbjct: 181 ----------------MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----N 220

Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDI 345
             V+ +           +  G R     L      P  + +L+ RCWD +P +RP F+++
Sbjct: 221 KDVIGV-----------LEKGDR-----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264

Query: 346 ALELDLVLEHRKSLKEE 362
              L  V +  K +  E
Sbjct: 265 VCSLSDVYQMEKDIAME 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (354), Expect = 1e-37
 Identities = 64/295 (21%), Positives = 104/295 (35%), Gaps = 44/295 (14%)

Query: 56  SQSIPLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKE 111
             S P      S+  LS +  G+   V++     DGR  AVK+ +      ++      E
Sbjct: 47  DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE 106

Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           +    K+  HP   +   A  +        E     +L +       S    QV      
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRD 165

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
              AL +LH+ G+VH DVKPAN+ L       L DFGL        E+            
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL------VELGTAGAGEV---- 215

Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
                    G   YMAPE+L+   +   +DV+S G++I E+   +               
Sbjct: 216 -------QEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMELPH------GGEGW 261

Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            ++             G L P   +   GL + + S++    + +P  R +   +
Sbjct: 262 QQL-----------RQGYLPPEFTA---GLSSELRSVLVMMLEPDPKLRATAEAL 302

>4da1_A Protein phosphatase 1K, mitochondrial; metal-ION-assisted catalysis, dehydrogenase phosphatase, hydrolase; 2.38A {Homo sapiens} PDB: 3qht_A 1l2n_A Length = 389

 Score =  142 bits (359), Expect = 1e-37
 Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 10/164 (6%)

Query: 405 SHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGI 464
           +H  +   +     A   +    + + G  +  G+R+  ED            E+  F +
Sbjct: 98  AHREQIGGENLYFQAGKPIPKISLENVGCASQIGKRKENEDRFDFAQL---TDEVLYFAV 154

Query: 465 FDGHRGSAAAEFSARALPGFLQN-LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVV 523
           +DGH G AAA+F    +   + + L         L  AF+  D AF +       +    
Sbjct: 155 YDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATL-- 212

Query: 524 QKDWHPGCTAIAALIVRNR-LFVANAGDCRAILCRGGHPFALSR 566
                 G TA  AL+     L VA+ GD RAILCR G P  L+ 
Sbjct: 213 ---LTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTI 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  142 bits (359), Expect = 2e-37
 Identities = 64/317 (20%), Positives = 112/317 (35%), Gaps = 56/317 (17%)

Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKE 111
           SS +  + +    Y++L  I  G  S V++      +  A+K   L    ++ LD++  E
Sbjct: 45  SSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 104

Query: 112 LQLLCKLDHPGLA--KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +  L KL        +               E   + +L   L  ++ S    +      
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWK 162

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
            + +A+  +H  GIVH D+KPAN L+   +   L DFG+A       ++           
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIA------NQMQ--------PD 207

Query: 230 TGGFHKKNMVGTLIYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPY 278
           T    K + VG + YM PE +K           K   S KSDV+S G  +  +  G  P+
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
             +  +                  A++                  +  +++ C   +P  
Sbjct: 268 QQIINQISK-------------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQ 311

Query: 339 RPSFSDIALELDLVLEH 355
           R S  ++       L H
Sbjct: 312 RISIPEL-------LAH 321

>3qn1_B Protein phosphatase 2C 16; start domain, BET V domain, PYR/PYL/RCAR, PP2C, abscisic ACI receptor, type 2C protein phosphatase; HET: A8S; 1.80A {Arabidopsis thaliana} PDB: 3ujg_B 3nmt_B* 3rt0_A 3kb3_B* Length = 337

 Score =  140 bits (355), Expect = 2e-37
 Identities = 38/176 (21%), Positives = 57/176 (32%), Gaps = 37/176 (21%)

Query: 428 VLSWGSFATCGRRETMEDTHFLMPHMYNQ------------------KEIHMFGIFDGHR 469
           +  WG+ +  G R  MED   + PH                         H FG++DGH 
Sbjct: 13  IPLWGTVSIQGNRSEMEDAFAVSPHFLKLPIKMLMGDHEGMSPSLTHLTGHFFGVYDGHG 72

Query: 470 GSAAAEFSARALPGFLQN---------------LGSTTRPTDALLEAFIRTDVAFRNELD 514
           G   A++    L   L                  G   +        F+  D     ++ 
Sbjct: 73  GHKVADYCRDRLHFALAEEIERIKDELCKRNTGEGRQVQWDKVFTSCFLTVDGEIEGKIG 132

Query: 515 SLRKSKRVVQKDWHP----GCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
                      +       G TA+ AL+  + + V+N GD RA+L RG     LS 
Sbjct: 133 RAVVGSSDKVLEAVASETVGSTAVVALVCSSHIVVSNCGDSRAVLFRGKEAMPLSV 188

>2p8e_A PPM1B beta isoform variant 6; structural genomics, hydrolase, PSI-2, protein structure initiative; 1.82A {Homo sapiens} Length = 307

 Score =  138 bits (349), Expect = 7e-37
 Identities = 34/153 (22%), Positives = 57/153 (37%), Gaps = 22/153 (14%)

Query: 429 LSWGSFATCGRRETMEDTHFLMPHM-YNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQN 487
           L +G  +  G R  MED H  +  + +  ++   F ++DGH GS  A + +  L   +  
Sbjct: 24  LRYGLSSMQGWRVEMEDAHTAVVGIPHGLEDWSFFAVYDGHAGSRVANYCSTHLLEHITT 83

Query: 488 --------------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTA 533
                           S     + +   F++ D   RN  D               G TA
Sbjct: 84  NEDFRAAGKSGSALELSVENVKNGIRTGFLKIDEYMRNFSDL-------RNGMDRSGSTA 136

Query: 534 IAALIVRNRLFVANAGDCRAILCRGGHPFALSR 566
           +  +I    ++  N GD RA+L R G     ++
Sbjct: 137 VGVMISPKHIYFINCGDSRAVLYRNGQVCFSTQ 169

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (347), Expect = 8e-37
 Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 50/304 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           L      LL  I +G    V      G KVAVK   +        F  E  ++ +L H  
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 75

Query: 123 LAKFVAAHAK-PPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
           L + +    +         E+    +L + L     S    D +L  +  + +A++YL  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRENLKEISLKNWRSSGKPTGGFHKKNM 238
              VHRD+   NVL+  +    ++DFGL                 + +GK       K  
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------QDTGK----LPVK-- 179

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
                + APE L+++  S KSDV+SFGI + E+ + G VPY  +                
Sbjct: 180 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PL 220

Query: 298 QQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           + +   V  G     P         P ++  +++ CW  +   RPSF  +  +L+ +  H
Sbjct: 221 KDVVPRVEKGYKMDAPDGC------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

Query: 356 RKSL 359
              L
Sbjct: 275 ELHL 278

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (350), Expect = 9e-37
 Identities = 75/312 (24%), Positives = 128/312 (41%), Gaps = 46/312 (14%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQL 114
            +  S   +   I  G    V    L         VA+K  K    T  +  +F  E  +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           + + DHP + +      +    M   E+ E+ +L   L   +   ++ Q++ +   +   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGF 233
           ++YL +LG VHRD+   NVL+D NL   ++DFGL+  R    +       + GK P    
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS--RVLEDDPDAAYTTTGGKIP---- 217

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
                   + + APE +     S  SDV+SFG+ + E+L  G  PY ++           
Sbjct: 218 --------IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----------- 258

Query: 293 MNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
              T + + ++V  G     P+        P ++  L+  CW  +   RP FS I   LD
Sbjct: 259 ---TNRDVISSVEEGYRLPAPMGC------PHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

Query: 351 LVLEHRKSLKEE 362
            ++   +SL+  
Sbjct: 310 ALIRSPESLRAT 321

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (352), Expect = 1e-36
 Identities = 78/334 (23%), Positives = 140/334 (41%), Gaps = 47/334 (14%)

Query: 40  GLKVL-EPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-----KVA 93
           GL+   +P+T      +       L  ++ ++   +  G    V    L         VA
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 77

Query: 94  VK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
           +K  K    T ++  +F  E  ++ + DHP + +      K    M   E+ E+ +L   
Sbjct: 78  IKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136

Query: 152 LHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
           L   +   +V Q++ +   +A  ++YL ++G VHRD+   N+L++ NL   ++DFGL   
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG-- 194

Query: 212 RENLKEISLKNWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
           R    +         GK P            + + +PE +     +  SDV+S+GI + E
Sbjct: 195 RVLEDDPEAAYTTRGGKIP------------IRWTSPEAIAYRKFTSASDVWSYGIVLWE 242

Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSL 327
           +++ G  PY ++              + Q +  AV  G     P      +  PA++  L
Sbjct: 243 VMSYGERPYWEM--------------SNQDVIKAVDEGYRLPPP------MDCPAALYQL 282

Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKE 361
           +  CW  + +NRP F  I   LD ++ +  SLK 
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (349), Expect = 1e-36
 Identities = 60/314 (19%), Positives = 121/314 (38%), Gaps = 63/314 (20%)

Query: 56  SQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDN 107
           +Q++   L  + +  +  +  GA   VY+             VA+K  +   ++ +    
Sbjct: 5   NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKE 63

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
              E  ++  +D+P + + +         +   +      L + +   + +     +L  
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEIS 219
             Q+AK + YL +  +VHRD+   NVL+       + DFGLA        EY     ++ 
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
           +K W                     MA E +   I++ +SDV+S+G+++ EL+T G  PY
Sbjct: 183 IK-W---------------------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNP 336
             +     A  +  +           +  G R     L         +  ++++CW  + 
Sbjct: 221 DGIP----ASEISSI-----------LEKGER-----LPQPPICTIDVYMIMRKCWMIDA 260

Query: 337 HNRPSFSDIALELD 350
            +RP F ++ +E  
Sbjct: 261 DSRPKFRELIIEFS 274

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  138 bits (349), Expect = 2e-36
 Identities = 42/330 (12%), Positives = 84/330 (25%), Gaps = 74/330 (22%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKL 118
                 L+ P+  G  SVV+           A+K       ++  EL+  H+      +L
Sbjct: 60  GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119

Query: 119 DHPGLAKFVAA--------------------------HAKPPNYMFFFEFYES-----RN 147
                 +                                   NY+              +
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179

Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
             + ++V      +  + ++ AQL +    L + G+VH    P N+ +  +    L D  
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFG 265
                              G              + Y   E L       +   + +  G
Sbjct: 240 AL--------------WKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
           +SI  +    +P+  +    +                     G   +       LP  + 
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP----------GTDSLAFGSCTPLPDFVK 330

Query: 326 SLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +LI R  + +   R    +        +E 
Sbjct: 331 TLIGRFLNFDRRRRLLPLEA-------MET 353

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (353), Expect = 3e-36
 Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 38/303 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  S  L   + +G    V+  T +G  +VA+K  +   +   + F +E Q++ KL H 
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 239

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 240 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA      + I    + +          K  + 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA------RLIEDNEYTARQ------GAKFPIK 346

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 347 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 389

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
           +   V  G   P         P S+  L+ +CW   P  RP+F  +   L+      +  
Sbjct: 390 VLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

Query: 360 KEE 362
            + 
Sbjct: 446 YQP 448

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (342), Expect = 3e-36
 Identities = 65/297 (21%), Positives = 124/297 (41%), Gaps = 50/297 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           + PS  T +  I  G   +V+      + KVA+K  +    + E+   F +E +++ KL 
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 61

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP L +      +        EF E   L++ L  +    + + +L +   + + + YL 
Sbjct: 62  HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
              ++HRD+   N L+  N    ++DFG+       + +    + SS             
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSST------------ 163

Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
           GT     + +PE+     +S KSDV+SFG+ + E+ + G +PY +               
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------------- 209

Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +  ++   + +G    +P LA         +  ++  CW   P +RP+FS +  +L 
Sbjct: 210 SNSEVVEDISTGFRLYKPRLA------STHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  136 bits (344), Expect = 3e-36
 Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 52/301 (17%)

Query: 69  TLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
                I RG    VY  TL          AVK    I +   E+  F  E  ++    HP
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHP 86

Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            +     +   ++    +    + +  +L   +  E  +P+V  ++    Q+AK ++YL 
Sbjct: 87  NVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +   VHRD+   N +LD      +ADFGLA      +++  K + S    TG        
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLA------RDMYDKEYYSVHNKTGA------- 192

Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
              +   +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+              
Sbjct: 193 --KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------------- 236

Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
               +T  ++ G    +P         P  +  ++ +CW      RPSFS++   +  + 
Sbjct: 237 NTFDITVYLLQGRRLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290

Query: 354 E 354
            
Sbjct: 291 S 291

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  136 bits (345), Expect = 4e-36
 Identities = 71/324 (21%), Positives = 137/324 (42%), Gaps = 59/324 (18%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
           +P   +TL   + +G    V EA L        KVAVK  K  +  S +++ F +E   +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 116 CKLDHPGLAKFVAA------HAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQV 164
            + DHP +AK V          + P  M    F +  +L     A ++    ++  +  +
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           +     +A  ++YL +   +HRD+   N +L  ++   +ADFGL+    +          
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS---------- 189

Query: 225 SSGKPTGGFHKKNMVGTL-I-YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
                 G ++++     L + ++A E L   +++  SDV++FG+++ E++T G  PY  +
Sbjct: 190 ------GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243

Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNR 339
                            ++   ++ G    +P            +  L+ +CW  +P  R
Sbjct: 244 --------------ENAEIYNYLIGGNRLKQPP------ECMEEVYDLMYQCWSADPKQR 283

Query: 340 PSFSDIALELDLVLEHRKSLKEED 363
           PSF+ + +EL+ +L H   L    
Sbjct: 284 PSFTCLRMELENILGHLSVLSTSQ 307

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (344), Expect = 4e-36
 Identities = 68/320 (21%), Positives = 124/320 (38%), Gaps = 70/320 (21%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
           +  +   L   +  G    V E  L        KVAVK  K   S+  E++ F  E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90

Query: 116 CKLDHPGLAKFVAA-----HAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVL 165
               HP + + +           P  M    F +  +L       +L        +  +L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK-E 217
                +A  ++YL N   +HRD+   N +L  ++   +ADFGL+        YR+    +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
           + +K W                     +A E L   +++ KSDV++FG+++ E+ T G+ 
Sbjct: 211 MPVK-W---------------------IAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248

Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDG 334
           PY  +                 ++   ++ G    +P            +  ++  CW  
Sbjct: 249 PYPGV--------------QNHEMYDYLLHGHRLKQPE------DCLDELYEIMYSCWRT 288

Query: 335 NPHNRPSFSDIALELDLVLE 354
           +P +RP+FS + L+L+ +LE
Sbjct: 289 DPLDRPTFSVLRLQLEKLLE 308

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 4e-36
 Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 54/332 (16%)

Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDN 107
           + Q + +            I RG    VY  TL          AVK    I    E    
Sbjct: 78  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ- 136

Query: 108 FHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
           F  E  ++    HP +     +   ++    +    + +  +L   +  E  +P+V  ++
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLI 195

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
               Q+AK +++L +   VHRD+   N +LD      +ADFGLA      +++  K + S
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RDMYDKEFDS 249

Query: 226 SGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
               TG           +   +MA E L+ +  + KSDV+SFG+ + EL+T G  PY D+
Sbjct: 250 VHNKTGA---------KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300

Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNR 339
                             +T  ++ G    +P         P  +  ++ +CW      R
Sbjct: 301 --------------NTFDITVYLLQGRRLLQP------EYCPDPLYEVMLKCWHPKAEMR 340

Query: 340 PSFSDIALELDLVLEHRKSLKEEDLCAGKSYV 371
           PSFS++   +  +      + E  +    +YV
Sbjct: 341 PSFSELVSRISAIF--STFIGEHYVHVNATYV 370

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (355), Expect = 5e-36
 Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 38/303 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  S  L   + +G    V+  T +G  +VA+K  +   +   + F +E Q++ KL H 
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 322

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHN 180
            L +  A  ++ P Y+   E+    +L + L  E      + Q++ +AAQ+A  + Y+  
Sbjct: 323 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           +  VHRD++ AN+L+  NL   +ADFGLA      + I    + +          K  + 
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLA------RLIEDNEYTARQ------GAKFPIK 429

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE       + KSDV+SFGI + EL T G VPY  +                ++
Sbjct: 430 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 472

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
           +   V  G   P         P S+  L+ +CW   P  RP+F  +   L+      +  
Sbjct: 473 VLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

Query: 360 KEE 362
            + 
Sbjct: 529 YQP 531

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (339), Expect = 9e-36
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 61/305 (20%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
           +      L   I  G    V++            VA+K  K   ++    + F +E   +
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTM 70

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            + DHP + K +    + P ++   E      L   L V ++S  +  +++ A QL+ AL
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGK 228
            YL +   VHRD+   NVL+  N C  L DFGL+        Y+ +  ++ +K W     
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-W----- 183

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
                           MAPE +     +  SDV+ FG+ + E+L  GV P+  +      
Sbjct: 184 ----------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------ 221

Query: 288 HTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                       +   + +G     P         P ++ SL+ +CW  +P  RP F+++
Sbjct: 222 --------KNNDVIGRIENGERLPMPP------NCPPTLYSLMTKCWAYDPSRRPRFTEL 267

Query: 346 ALELD 350
             +L 
Sbjct: 268 KAQLS 272

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (343), Expect = 9e-36
 Identities = 80/312 (25%), Positives = 133/312 (42%), Gaps = 47/312 (15%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKELQ 113
            + PS  T    I  G    VY+  L          VA+K  K    T ++  +F  E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAG 98

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
           ++ +  H  + +     +K    M   E+ E+  L + L  ++   SV Q++ +   +A 
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
            ++YL N+  VHRD+   N+L++ NL   ++DFGL+  R    +       S GK P   
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS--RVLEDDPEATYTTSGGKIP--- 213

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
                    + + APE +     +  SDV+SFGI + E++T G  PY +L          
Sbjct: 214 ---------IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------- 254

Query: 292 EMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
               +  ++  A+  G     P      +  P++I  L+ +CW      RP F+DI   L
Sbjct: 255 ----SNHEVMKAINDGFRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

Query: 350 DLVLEHRKSLKE 361
           D ++    SLK 
Sbjct: 305 DKLIRAPDSLKT 316

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  134 bits (340), Expect = 1e-35
 Identities = 68/310 (21%), Positives = 127/310 (40%), Gaps = 50/310 (16%)

Query: 69  TLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
                I +G   VVY      +     + A+K    I +  ++++ F +E  L+  L+HP
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHP 82

Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            +     +    +   ++    +    +L + +   + +P+V  ++    Q+A+ ++YL 
Sbjct: 83  NVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFHKKNM 238
               VHRD+   N +LD +    +ADFGLA    + +E          + P         
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-REYYSVQQHRHARLP--------- 191

Query: 239 VGTLI-YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
               + + A E L+    + KSDV+SFG+ + ELLT G  PY  +               
Sbjct: 192 ----VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--------------D 233

Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              LT  +  G    +P         P S+  ++Q+CW+ +P  RP+F  +  E++ ++ 
Sbjct: 234 PFDLTHFLAQGRRLPQP------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

Query: 355 HRKSLKEEDL 364
                    L
Sbjct: 288 ALLGDHYVQL 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 1e-35
 Identities = 71/313 (22%), Positives = 126/313 (40%), Gaps = 34/313 (10%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR------KVAVKKPILSTSEELDNFHKELQLLC 116
                   +S + +G    V     D         VAVK+   S  ++  +F +E+Q+L 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79

Query: 117 KLDHPGLAKF---VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
            L    + K+        +    +   E+  S  L + L          ++L+ ++Q+ K
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
            ++YL +   VHRD+   N+L++      +ADFGLA+     K+  +   R  G+ P   
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV--REPGQSP--- 193

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
                    + + APE L   I S +SDV+SFG+ + EL T      +      +     
Sbjct: 194 ---------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 292 EMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                  +L   +  G     P         PA +  L++ CW  +P +RPSFS +  +L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAP------PACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 350 DLVLEHRKSLKEE 362
           D++    +  +  
Sbjct: 299 DMLWSGSRGCETH 311

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (348), Expect = 2e-35
 Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 52/305 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           L      LL  I +G    V      G KVAVK   +        F  E  ++ +L H  
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 247

Query: 123 LAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
           L +   V    K   Y+   E+    +L + L     S    D +L  +  + +A++YL 
Sbjct: 248 LVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRENLKEISLKNWRSSGKPTGGFHKKN 237
               VHRD+   NVL+  +    ++DFGL                 + +GK       K 
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------QDTGK----LPVK- 351

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
                 + APE L+++  S KSDV+SFGI + E+ + G VPY  +               
Sbjct: 352 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------P 391

Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
            + +   V  G     P       G P ++  +++ CW  +   RP+F  +  +L+ +  
Sbjct: 392 LKDVVPRVEKGYKMDAP------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

Query: 355 HRKSL 359
           H   L
Sbjct: 446 HELHL 450

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (338), Expect = 2e-35
 Identities = 64/301 (21%), Positives = 113/301 (37%), Gaps = 50/301 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-RKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           + P   T L  +  G   VV      G   VA+K  K     S   D F +E +++  L 
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLS 77

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           H  L +      K        E+  +  L   L          Q+L +   + +A++YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +   +HRD+   N L++      ++DFGL+      + +    + SS             
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSV------------ 179

Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
           G+     +  PE+L     S KSD+++FG+ + E+ + G +PY                 
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------------- 225

Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
           T  +    +  G    RP LA         + +++  CW      RP+F  +   +  V+
Sbjct: 226 TNSETAEHIAQGLRLYRPHLA------SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279

Query: 354 E 354
           +
Sbjct: 280 D 280

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 3e-35
 Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 54/294 (18%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKF--- 126
           I RG+   VY+   T    +VA  +      T  E   F +E ++L  L HP + +F   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 127 -VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--NLGI 183
             +        +   E   S  L   L        +  +     Q+ K LQ+LH     I
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 184 VHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           +HRD+K  N+ +        + D GLA                          K ++GT 
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLA------------------TLKRASFAKAVIGTP 194

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            +MAPE+ +++ + E  DVY+FG+ + E+ T   PY++ +  AQ +              
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------------- 240

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
             V+ G++P  AS +      +  +I+ C   N   R S      +L   L H 
Sbjct: 241 -RVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDL---LNHA 284

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  132 bits (335), Expect = 3e-35
 Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 50/297 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
           L     TLL  +  G   VV      G+  VAVK  K    + +E   F +E Q + KL 
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE---FFQEAQTMMKLS 61

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP L KF    +K        E+  +  L   L          Q+L +   + + + +L 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +   +HRD+   N L+DR+LC  ++DFG+       + +    + SS             
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSV------------ 163

Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
           GT     + APE+     +S KSDV++FGI + E+ + G +PY                 
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-------------- 209

Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           T  ++   V  G    RP LA        +I  ++  CW   P  RP+F  +   ++
Sbjct: 210 TNSEVVLKVSQGHRLYRPHLA------SDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (350), Expect = 5e-35
 Identities = 75/364 (20%), Positives = 139/364 (38%), Gaps = 61/364 (16%)

Query: 4   YGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHL 63
           + ++P ++         ++  + K G++  T++        E            +    +
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEI 387

Query: 64  PPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLC 116
                 L   I  G    V++            VA+K  K   ++    + F +E   + 
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMR 446

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           + DHP + K +    + P ++   E      L   L V ++S  +  +++ A QL+ AL 
Sbjct: 447 QFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKP 229
           YL +   VHRD+   NVL+  N C  L DFGL+        Y+ +  ++ +K W      
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-W------ 558

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
                          MAPE +     +  SDV+ FG+ + E+L  GV P+  +       
Sbjct: 559 ---------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------- 596

Query: 289 TVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
                      +   + +G     P         P ++ SL+ +CW  +P  RP F+++ 
Sbjct: 597 -------KNNDVIGRIENGERLPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELK 643

Query: 347 LELD 350
            +L 
Sbjct: 644 AQLS 647

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  139 bits (351), Expect = 5e-35
 Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 60/302 (19%)

Query: 68  YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGL 123
           Y +   IA G    +Y A    ++GR V +K  + S   E       E Q L ++ HP +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 124 AK---FVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            +   FV    +  + + +   E+   ++L      +     V + +    ++  AL YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYL 198

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H++G+V+ D+KP N++L       L D G                       G      +
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV--------------SRINS-FG-----YL 237

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
            GT  + APEI++    +  +D+Y+ G ++  L   +                +      
Sbjct: 238 YGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPED------ 287

Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEHRK 357
                              L    S   L++R  D +P  R  +  +++ +L  VL    
Sbjct: 288 ----------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331

Query: 358 SL 359
           + 
Sbjct: 332 AQ 333

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (337), Expect = 6e-35
 Identities = 64/296 (21%), Positives = 98/296 (33%), Gaps = 45/296 (15%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
                T    + RG+   V+       G + AVKK  L          +EL     L  P
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSP 110

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            +     A  + P    F E  E  +L + +  ++      D+ L    Q  + L+YLH 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 181 LGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
             I+H DVK  NVLL  +     L DFG A              +  G          + 
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHA-----------LCLQPDGLGKSLLTGDYIP 217

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT  +MAPE++  +    K D++S    +  +L G  P+T                   +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----------------FR 261

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
               +      P +  +           IQ      P +R S    A+EL      
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS----AMEL---RRK 310

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (332), Expect = 1e-34
 Identities = 75/309 (24%), Positives = 117/309 (37%), Gaps = 64/309 (20%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KP-ILSTSEELDNFHKELQL 114
           +      LL  +  G+  VV     D        VAVK  KP +LS  E +D+F +E+  
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           +  LDH  L +       PP  M   E     +L ++L   +    +  +   A Q+A+ 
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EY--RENLKEISLKNWR 224
           + YL +   +HRD+   N+LL       + DFGL          Y  +E+ K +    W 
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-VPFA-W- 190

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA 283
                                APE LK    S  SD + FG+++ E+ T G  P+  L  
Sbjct: 191 --------------------CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN- 229

Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPS 341
                 +L            +   G R     L      P  I +++ +CW   P +RP+
Sbjct: 230 ---GSQILHK----------IDKEGER-----LPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

Query: 342 FSDIALELD 350
           F  +   L 
Sbjct: 272 FVALRDFLL 280

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (333), Expect = 1e-34
 Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 45/314 (14%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKE 111
           P H        +  +  G    V     D        +VAVK  KP  S    + +  KE
Sbjct: 15  PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKE 73

Query: 112 LQLLCKLDHPGLAKFVAA--HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +++L  L H  + K+                EF  S +L E L   +   ++ Q L  A 
Sbjct: 74  IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV 133

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK- 228
           Q+ K + YL +   VHRD+   NVL++      + DFGL +  E  KE      +     
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV--KDDRDS 191

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           P            + + APE L +      SDV+SFG++++ELLT    Y D  +   A 
Sbjct: 192 P------------VFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMAL 235

Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGL--------PASILSLIQRCWDGNPHNRP 340
            +  +  T  Q+T   +       + +L+ G         P  +  L+++CW+  P NR 
Sbjct: 236 FLKMIGPTHGQMTVTRL-------VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288

Query: 341 SFSDIALELDLVLE 354
           SF ++    + +L+
Sbjct: 289 SFQNLIEGFEALLK 302

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (343), Expect = 1e-34
 Identities = 73/315 (23%), Positives = 123/315 (39%), Gaps = 46/315 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVKKPILSTSEELDNFHKELQLLCKLDH 120
           +  +  T+   +  G    VYE         VAVK  +   + E++ F KE  ++ ++ H
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKH 275

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
           P L + +    + P +    EF    NL + L        S   +L +A Q++ A++YL 
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
               +HR++   N L+  N    +ADFGL+                     G  +  +  
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-----------------GDTYTAHAG 378

Query: 240 GTLIY--MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
                   APE L     S KSDV++FG+ + E+ T G+ PY  +               
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------------D 424

Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
             Q+   +       RP         P  +  L++ CW  NP +RPSF++I    + + +
Sbjct: 425 LSQVYELLEKDYRMERPEGC------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

Query: 355 HRKSLKEEDLCAGKS 369
                 E +   GK 
Sbjct: 479 ESSISDEVEKELGKR 493

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (332), Expect = 2e-34
 Identities = 60/325 (18%), Positives = 122/325 (37%), Gaps = 63/325 (19%)

Query: 56  SQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDN 107
           +Q++   L  + +  +  +  GA   VY+             VA+K  +   ++ +    
Sbjct: 5   NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKE 63

Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
              E  ++  +D+P + + +         +   +      L + +   + +     +L  
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEIS 219
             Q+AK + YL +  +VHRD+   NVL+       + DFGLA        EY     ++ 
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
           +K W                     MA E +   I++ +SDV+S+G+++ EL+T G  PY
Sbjct: 183 IK-W---------------------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNP 336
             +     A  +  +           +  G R     L         +  ++ +CW  + 
Sbjct: 221 DGIP----ASEISSI-----------LEKGER-----LPQPPICTIDVYMIMVKCWMIDA 260

Query: 337 HNRPSFSDIALELDLVLEHRKSLKE 361
            +RP F ++ +E   +    +    
Sbjct: 261 DSRPKFRELIIEFSKMARDPQRYLV 285

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  134 bits (338), Expect = 4e-34
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 48/308 (15%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  S  L   +  G    V+ AT +   KVAVK  +   S  ++ F  E  ++  L H 
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQHD 243

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L K  A   K P Y+   EF    +L + L  +E S   + +++  +AQ+A+ + ++  
Sbjct: 244 KLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ AN+L+  +L   +ADFGLA   E+        + +              G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIED------NEYTARE------------G 344

Query: 241 TLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
                 + APE +     + KSDV+SFGI + E++T G +PY  +              +
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------------S 390

Query: 297 EQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
             ++  A+  G    RP         P  + +++ RCW   P  RP+F  I   LD    
Sbjct: 391 NPEVIRALERGYRMPRPENC------PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444

Query: 355 HRKSLKEE 362
             +S  EE
Sbjct: 445 ATESQYEE 452

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  130 bits (328), Expect = 4e-34
 Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 48/291 (16%)

Query: 74  IARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
           + +G   +VY      +  ++A+K+     S      H+E+ L   L H  + +++ + +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVD---QVLMIAAQLAKALQYLHNLGIVHRDV 188
           +      F E     +L+  L   +W P  D    +     Q+ + L+YLH+  IVHRD+
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148

Query: 189 KPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           K  NVL++  +    ++DFG +      K ++                +   GTL YMAP
Sbjct: 149 KGDNVLINTYSGVLKISDFGTS------KRLA----------GINPCTETFTGTLQYMAP 192

Query: 248 EILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
           EI+ K    + + +D++S G +I E+ TG  P+ +L     A     M +        V 
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----M-F-------KVG 239

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
              + P    +   + A   + I +C++ +P  R      A +L   L   
Sbjct: 240 MFKVHP---EIPESMSAEAKAFILKCFEPDPDKRAC----ANDL---LVDE 280

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  130 bits (329), Expect = 6e-34
 Identities = 68/312 (21%), Positives = 111/312 (35%), Gaps = 42/312 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
             +   +A G  + VYEA     GR+ A+K+ + +  E+     +E+  + KL  HP + 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 125 KFVAAHAKPPNYM-------FFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKAL 175
           +F +A +                       L E L   E     S D VL I  Q  +A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 176 QYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           Q++H     I+HRD+K  N+LL       L DFG A               S+ +     
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA----TTISHYPDYSWSAQRRALVE 205

Query: 234 HKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
            +     T +Y  PEI+         EK D+++ G  +  L     P+            
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF------------ 253

Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                 E      +V+G         +        SLI+     NP  R S +++  +L 
Sbjct: 254 ------EDGAKLRIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

Query: 351 LVLEHRKSLKEE 362
            +   R    + 
Sbjct: 305 EIAAARNVNPKS 316

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (329), Expect = 7e-34
 Identities = 60/311 (19%), Positives = 114/311 (36%), Gaps = 49/311 (15%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKELQL 114
              +    L  +  G    V++             V +K  +   S  +        +  
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLA 68

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           +  LDH  + + +         +   ++    +L + +     +     +L    Q+AK 
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGF 233
           + YL   G+VHR++   NVLL       +ADFG+A+    L     +   S  K P    
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTP---- 180

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
                   + +MA E +    ++ +SDV+S+G+++ EL+T G  PY  LR       V +
Sbjct: 181 --------IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LAEVPD 228

Query: 293 MNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +           +  G R     L         +  ++ +CW  + + RP+F ++A E  
Sbjct: 229 L-----------LEKGER-----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272

Query: 351 LVLEHRKSLKE 361
            +         
Sbjct: 273 RMARDPPRYLV 283

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  129 bits (326), Expect = 7e-34
 Identities = 75/318 (23%), Positives = 124/318 (38%), Gaps = 52/318 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVK--KPILSTSEELDNFHKELQLLCKL 118
           +  +  T+   +  G    VYE         VAVK  K     + E++ F KE  ++ ++
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI 66

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQY 177
            HP L + +    + P +    EF    NL + L        S   +L +A Q++ A++Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           L     +HRD+   N L+  N    +ADFGL+             + +            
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHA---------- 170

Query: 238 MVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
             G      + APE L     S KSDV++FG+ + E+ T G+ PY  +            
Sbjct: 171 --GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------ 216

Query: 294 NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
                Q+   +       RP         P  +  L++ CW  NP +RPSF++I    + 
Sbjct: 217 --DLSQVYELLEKDYRMERPEGC------PEKVYELMRACWQWNPSDRPSFAEIHQAFET 268

Query: 352 VLEHRKSLKEEDLCAGKS 369
           + +      E +   GK 
Sbjct: 269 MFQESSISDEVEKELGKR 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 1e-33
 Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 43/313 (13%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSEELDNFHKELQ 113
           P          L  + +G    V     D  +      VAVKK   ST E L +F +E++
Sbjct: 35  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 114 LLCKLDHPGLAKFVA---AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           +L  L H  + K+     +  +    +   E+    +L + L   +      ++L   +Q
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-P 229
           + K ++YL     +HRD+   N+L++      + DFGL +     KE      +  G+ P
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV--KEPGESP 211

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
                       + + APE L +   S  SDV+SFG+ + EL T    Y +      A  
Sbjct: 212 ------------IFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEF 255

Query: 290 VLEM------NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPS 341
           +  +            L   + + G   RP       G P  I  ++  CW+ N + RPS
Sbjct: 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPS 309

Query: 342 FSDIALELDLVLE 354
           F D+AL +D + +
Sbjct: 310 FRDLALRVDQIRD 322

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  127 bits (322), Expect = 2e-33
 Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 42/293 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  +  L+  +  G    V+    +G  KVAVK  +   S   D F  E  L+ +L H 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQ 68

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHN 180
            L +  A   + P Y+   E+ E+ +L + L        +++++L +AAQ+A+ + ++  
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ AN+L+   L   +ADFGLA   E+ +  +    R   K    F  K    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA----REGAK----FPIK---- 175

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
              + APE +     + KSDV+SFGI + E++T G +PY  +              T  +
Sbjct: 176 ---WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------------TNPE 218

Query: 300 LTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
           +   +  G   +RP         P  +  L++ CW   P +RP+F  +   L+
Sbjct: 219 VIQNLERGYRMVRPDNC------PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (323), Expect = 2e-33
 Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 43/313 (13%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSEELDNFHKELQ 113
           P          L  + +G    V     D  +      VAVKK   ST E L +F +E++
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 114 LLCKLDHPGLAKFVA---AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           +L  L H  + K+     +  +    +   E+    +L + L   +      ++L   +Q
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-P 229
           + K ++YL     +HRD+   N+L++      + DFGL +     KE      +  G+ P
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV--KEPGESP 180

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
                       + + APE L +   S  SDV+SFG+ + EL T    Y +      A  
Sbjct: 181 ------------IFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEF 224

Query: 290 VLEM------NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPS 341
           +  +            L   + + G   RP       G P  I  ++  CW+ N + RPS
Sbjct: 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPS 278

Query: 342 FSDIALELDLVLE 354
           F D+AL +D + +
Sbjct: 279 FRDLALRVDQIRD 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  127 bits (322), Expect = 3e-33
 Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 47/299 (15%)

Query: 63  LPPSSYTLLS-PIARGAESVVYEATLDGRK----VAVK--KPILSTSEELDNFHKELQLL 115
           L     TL    +  G    V +     +K    VAVK  K   +     D    E  ++
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            +LD+P + + +         +   E  E   L + L         + + +   Q++  +
Sbjct: 73  QQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIEL-VHQVSMGM 130

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
           +YL     VHRD+   NVLL       ++DFGL+  +    + +    ++ GK P     
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS--KALRADENYYKAQTHGKWP----- 183

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
                  + + APE +     S KSDV+SFG+ + E  + G  PY  +    +   V  M
Sbjct: 184 -------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAM 232

Query: 294 NYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                      +  G R     +    G P  +  L+  CW  +  NRP F+ + L L 
Sbjct: 233 -----------LEKGER-----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 3e-33
 Identities = 73/311 (23%), Positives = 119/311 (38%), Gaps = 39/311 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRK------VAVK--KPILSTSEELDNFHKELQL 114
                   +  +  G    V     D         VAVK  K   +  +    + +E+ +
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDI 86

Query: 115 LCKLDHPGLAKFVAA---HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           L  L H  + K+             +   E+    +L + L     S  + Q+L+ A Q+
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143

Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PT 230
            + + YLH    +HRD+   NVLLD +    + DFGLA+      E      R  G  P 
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSP- 200

Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289
                      + + APE LK+      SDV+SFG+++ ELLT      +      +   
Sbjct: 201 -----------VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 290 VLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
           + +   T  +LT  +  G    RP         PA +  L++ CW+     RP+F ++  
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRP------DKCPAEVYHLMKNCWETEASFRPTFENLIP 303

Query: 348 ELDLVLEHRKS 358
            L  V E  + 
Sbjct: 304 ILKTVHEKYQG 314

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (322), Expect = 6e-33
 Identities = 77/344 (22%), Positives = 135/344 (39%), Gaps = 75/344 (21%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDG----RKVAVK--KPILSTSEELDNFHKELQLL 115
            L  +       I  G    V +A +         A+K  K   ++ ++  +F  EL++L
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 79

Query: 116 CKL-DHPGLAKFVAAHAKPPNYMFFFEF---------------YESRNLAEKLHVEEWSP 159
           CKL  HP +   + A           E+                E+       +    + 
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----EYRENL 215
           S  Q+L  AA +A+ + YL     +HRD+   N+L+  N    +ADFGL+     Y +  
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-- 197

Query: 216 KEISLKNWRSSGK-PTGGFHKKNMVGTLI-YMAPEILKKEIHSEKSDVYSFGISINELLT 273
                   ++ G+ P             + +MA E L   +++  SDV+S+G+ + E+++
Sbjct: 198 --------KTMGRLP-------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQR 330
            G  PY  +              T  +L   +  G    +P      L     +  L+++
Sbjct: 237 LGGTPYCGM--------------TCAELYEKLPQGYRLEKP------LNCDDEVYDLMRQ 276

Query: 331 CWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
           CW   P+ RPSF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 320

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (317), Expect = 1e-32
 Identities = 55/302 (18%), Positives = 119/302 (39%), Gaps = 34/302 (11%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL--STSEELDNFHKELQLLCKL-DH 120
           + +  L  I  G    V++    LDG   A+K+     + S +  N  +E+     L  H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 121 PGLAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQ 176
             + ++ +A A+  ++M    E+    +LA+ +       S     ++  +  Q+ + L+
Sbjct: 71  SHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H++ +VH D+KP+N+ + R   P+ A     E      ++  K     G  T     +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI-GDLGHVTRISSPQ 188

Query: 237 NMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
              G   ++A E+L++   H  K+D+++  +++           +           + + 
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWH- 238

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                   +  G L  I       L      L++     +P  RPS   + ++  ++L  
Sbjct: 239 -------EIRQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMAL-VKHSVLLSA 286

Query: 356 RK 357
            +
Sbjct: 287 SR 288

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  126 bits (318), Expect = 1e-32
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 41/231 (17%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDH 120
           P   +T L  I +G+   V++       + VA+K   +    +E+++  +E+ +L + D 
Sbjct: 20  PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79

Query: 121 PGLAKFVAAHAKPPNYMFFFEF---------YESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
           P + K+  ++ K        E+          E   L E            Q+  I  ++
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----------TQIATILREI 128

Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
            K L YLH+   +HRD+K ANVLL  +    LADFG+                 +G+ T 
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV-----------------AGQLTD 171

Query: 232 GFHKKN-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
              K+N  VGT  +MAPE++K+  +  K+D++S GI+  EL  G  P+++L
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  126 bits (319), Expect = 2e-32
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 41/301 (13%)

Query: 82  VYEATL-DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137
           VY+  L DG  VAVK+  L           F  E++++    H  L +       P   +
Sbjct: 46  VYKGRLADGTLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103

Query: 138 FFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLH---NLGIVHRDVKPA 191
             + +  + ++A  L     S       +   IA   A+ L YLH   +  I+HRDVK A
Sbjct: 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163

Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMAPEIL 250
           N+LLD      + DFGLA      K +               H    V GT+ ++APE L
Sbjct: 164 NILLDEEFEAVVGDFGLA------KLM----------DYKDTHVTTAVRGTIGHIAPEYL 207

Query: 251 KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL-----EMNYTEQQLTAAVV 305
                SEK+DV+ +G+ + EL+TG   +   R       +L      +   E++L  A+V
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-LKEKKLE-ALV 265

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI--ALELDLVLEHRKSLKEED 363
              L+      E+     ++ +   C   +P  RP  S++   LE D + E  +  ++E+
Sbjct: 266 DVDLQGNYKDEEV---EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322

Query: 364 L 364
           +
Sbjct: 323 M 323

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  125 bits (315), Expect = 3e-32
 Identities = 67/311 (21%), Positives = 118/311 (37%), Gaps = 47/311 (15%)

Query: 63  LPPSSYTLL-SPIARGAESVVYEATLDGR----KVAVK--KPILSTSEELDNFHKELQLL 115
           L   +  +    +  G    V +     R     VA+K  K   +   + +   +E Q++
Sbjct: 6   LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIM 64

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            +LD+P + + +         +   E      L + L  +     V  V  +  Q++  +
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
           +YL     VHRD+   NVLL       ++DFGL+  +    + S    RS+GK P     
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWP----- 176

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
                  L + APE +     S +SDV+S+G+++ E L+ G  PY  +    +   V+  
Sbjct: 177 -------LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAF 225

Query: 294 NYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
                      +  G R     +E     P  + +L+  CW     +RP F  +   +  
Sbjct: 226 -----------IEQGKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

Query: 352 VLEHRKSLKEE 362
                 S  E 
Sbjct: 270 CYYSLASKVEG 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (314), Expect = 4e-32
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 22/238 (9%)

Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKE 111
            S ++P  +    Y L   I  GA +VV  A       KVA+K+  +      +D   KE
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63

Query: 112 LQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM----I 167
           +Q + +  HP +  +  +           +     ++ + +            ++    I
Sbjct: 64  IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123

Query: 168 AA---QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           A    ++ + L+YLH  G +HRDVK  N+LL  +    +ADFG++        ++     
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS------AFLA----- 172

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           + G  T    +K  VGT  +MAPE + +   +  K+D++SFGI+  EL TG  PY   
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (313), Expect = 4e-32
 Identities = 56/318 (17%), Positives = 107/318 (33%), Gaps = 79/318 (24%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR---------KVAVK--KPILSTSEELDNFHK 110
            +          + +G  + +++               +V +K      +     ++F +
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFE 61

Query: 111 ELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
              ++ KL H  L            N +   EF +  +L   L   +   ++   L +A 
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQ-EFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDR--------NLCPHLADFGLA-------EYREN 214
           QLA A+ +L    ++H +V   N+LL R             L+D G++         +E 
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
           +       W                     + PE I   +  +  +D +SFG ++ E+ +
Sbjct: 181 IP------W---------------------VPPECIENPKNLNLATDKWSFGTTLWEICS 213

Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
            G  P + L     +   L+                 +     L     A + +LI  C 
Sbjct: 214 GGDKPLSAL----DSQRKLQF-----------YEDRHQ-----LPAPKAAELANLINNCM 253

Query: 333 DGNPHNRPSFSDIALELD 350
           D  P +RPSF  I  +L+
Sbjct: 254 DYEPDHRPSFRAIIRDLN 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  128 bits (323), Expect = 5e-32
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y     + +G+   V      + G++ AVK   K  +    + ++  +E+QLL +LDHP 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K          +    E Y    L +++ +     S      I  Q+   + Y+H   
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHRD+KP N+LL    ++    + DFGL+ + E  K++                 K+ +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKI 189

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT  Y+APE+L    + EK DV+S G+ +  LL+G  P+                  E  
Sbjct: 190 GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG--------------ANEYD 234

Query: 300 LTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +   V  G  +      +   +  S   LI++     P  R S    A +    L+H
Sbjct: 235 ILKKVEKG--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARD---ALDH 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (313), Expect = 7e-32
 Identities = 56/221 (25%), Positives = 111/221 (50%), Gaps = 22/221 (9%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + +L  +  G+   VY+A     G+ VA+K   +    +L    KE+ ++ + D P
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSP 84

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K+  ++ K  +     E+  + ++++ + +   + + D++  I     K L+YLH +
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
             +HRD+K  N+LL+      LADFG+                 +G+ T    K+N ++G
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGV-----------------AGQLTDTMAKRNTVIG 187

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           T  +MAPE++++  ++  +D++S GI+  E+  G  PY D+
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 9e-32
 Identities = 77/340 (22%), Positives = 133/340 (39%), Gaps = 90/340 (26%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
            P  +  L   +  G    V +AT            VAVK  K   ++  EL +   E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFN 78

Query: 114 LLCKLDHPGLAKFVAA--HAKP---------------------PNYMFFFEFYESRNLAE 150
           +L +++HP + K   A     P                          +     SRN + 
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA- 209
             H +E + ++  ++  A Q+++ +QYL  + +VHRD+   N+L+       ++DFGL+ 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 210 ------EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSD 260
                  Y                K + G          I   +MA E L   I++ +SD
Sbjct: 199 DVYEEDSYV---------------KRSQG---------RIPVKWMAIESLFDHIYTTQSD 234

Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLE 317
           V+SFG+ + E++T G  PY  +                ++L   + +G    RP   S E
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGI--------------PPERLFNLLKTGHRMERPDNCSEE 280

Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357
           +        L+ +CW   P  RP F+DI+ +L+ ++  R+
Sbjct: 281 MY------RLMLQCWKQEPDKRPVFADISKDLEKMMVKRR 314

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  123 bits (312), Expect = 1e-31
 Identities = 76/281 (27%), Positives = 117/281 (41%), Gaps = 26/281 (9%)

Query: 82  VYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
           VY+  L DG KVA+K+    +S+ ++ F  E++ L    HP L   +    +    +  +
Sbjct: 55  VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114

Query: 141 EFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
           ++ E+ NL   L+  +        +Q L I    A+ L YLH   I+HRDVK  N+LLD 
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174

Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMAPEILKKEIHS 256
           N  P + DFG+++                G      H   +V GTL Y+ PE   K   +
Sbjct: 175 NFVPKITDFGISK---------------KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219

Query: 257 EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQQLTAAVVSGGLRPILAS 315
           EKSDVYSFG+ + E+L               +     +          +V   L   +  
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279

Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI--ALELDLVLE 354
             L           +C   +  +RPS  D+   LE  L L+
Sbjct: 280 ESL---RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  123 bits (312), Expect = 1e-31
 Identities = 68/322 (21%), Positives = 127/322 (39%), Gaps = 72/322 (22%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKEL 112
            +     T+   + +G+  +VYE    G        +VA+K      S  E ++ F  E 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEA 79

Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------HVEEWSPSVDQ 163
            ++ + +   + + +   ++    +   E     +L   L         +     PS+ +
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK 216
           ++ +A ++A  + YL+    VHRD+   N ++  +    + DFG+         YR+  K
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199

Query: 217 E-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
             + ++ W                     M+PE LK  + +  SDV+SFG+ + E+ T  
Sbjct: 200 GLLPVR-W---------------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237

Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCW 332
             PY  L              + +Q+   V+ GGL  +P         P  +  L++ CW
Sbjct: 238 EQPYQGL--------------SNEQVLRFVMEGGLLDKP------DNCPDMLFELMRMCW 277

Query: 333 DGNPHNRPSFSDIALELDLVLE 354
             NP  RPSF +I   +   +E
Sbjct: 278 QYNPKMRPSFLEIISSIKEEME 299

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (312), Expect = 1e-31
 Identities = 78/340 (22%), Positives = 134/340 (39%), Gaps = 64/340 (18%)

Query: 46  PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--K 96
           PN C  G  SS S    +P  + TL+  +  GA   VYE  + G        +VAVK   
Sbjct: 10  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69

Query: 97  PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---- 152
            + S  +ELD F  E  ++ K +H  + + +    +        E     +L   L    
Sbjct: 70  EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128

Query: 153 --HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFG 207
               +  S ++  +L +A  +A   QYL     +HRD+   N LL          + DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188

Query: 208 LAEYRENLKEISLKNW-RSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYS 263
           +A      ++I   ++ R  G              ++   +M PE   + I + K+D +S
Sbjct: 189 MA------RDIYRASYYRKGGC------------AMLPVKWMPPEAFMEGIFTSKTDTWS 230

Query: 264 FGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGL 320
           FG+ + E+ + G +PY                 + Q++   V SGG    P         
Sbjct: 231 FGVLLWEIFSLGYMPYPSK--------------SNQEVLEFVTSGGRMDPP------KNC 270

Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
           P  +  ++ +CW   P +RP+F+ I   ++   +    + 
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  123 bits (311), Expect = 1e-31
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 28/224 (12%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P         I  G+  +V  A     GR+VAVK   L   +  +    E+ ++    H 
Sbjct: 43  PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102

Query: 122 GLAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            + +   ++          EF +     ++  ++ + E     +Q+  +   + +AL YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNE-----EQIATVCEAVLQALAYL 157

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
           H  G++HRD+K  ++LL  +    L+DFG                    + +    K+  
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGF-----------------CAQISKDVPKRKS 200

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           +VGT  +MAPE++ + +++ + D++S GI + E++ G  PY   
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (310), Expect = 1e-31
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 25/226 (11%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A     G   A K     + EEL+++  E+++L   DHP
Sbjct: 17  PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A+          EF     +   +   +   +  Q+ ++  Q+ +AL +LH+ 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
            I+HRD+K  NVL+       LADFG                  S K      K++  +G
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFG-----------------VSAKNLKTLQKRDSFIG 179

Query: 241 TLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
           T  +MAPE++  E   +     K+D++S GI++ E+     P+ +L
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  123 bits (311), Expect = 2e-31
 Identities = 48/252 (19%), Positives = 93/252 (36%), Gaps = 26/252 (10%)

Query: 96  KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-- 153
              LS+   +D    +++ +           +   +         +     NL + ++  
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155

Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
                      L I  Q+A+A+++LH+ G++HRD+KP+N+    +    + DFGL     
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV---T 212

Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
            + +   +    +  P    H    VGT +YM+PE +    +S K D++S G+ + ELL 
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQ-VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

Query: 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
                          T +E       +     +     +              ++Q    
Sbjct: 272 S------------FSTQMERVRIITDV----RNLKFPLLFTQ----KYPQEHMMVQDMLS 311

Query: 334 GNPHNRPSFSDI 345
            +P  RP  +DI
Sbjct: 312 PSPTERPEATDI 323

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (308), Expect = 2e-31
 Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 28/224 (12%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYL 178
            +  ++ ++          E+    +L + +    ++E      Q+  +  +  +AL++L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIAAVCRECLQALEFL 132

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
           H+  ++HRD+K  N+LL  +    L DFG                    + T    K++ 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----------------CAQITPEQSKRST 175

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
           MVGT  +MAPE++ ++ +  K D++S GI   E++ G  PY + 
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 2e-31
 Identities = 54/307 (17%), Positives = 110/307 (35%), Gaps = 46/307 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           + L   + +GA + V+       G   A+K    +S    +D   +E ++L KL+H  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 125 KFVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
           K  A   +          EF    +L   L     +  +   + L++   +   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 181 LGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
            GIVHR++KP N++            L DFG A   E+                      
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------------DEQFV 173

Query: 237 NMVGTLIYMAPEILKKEI--------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           ++ GT  Y+ P++ ++ +        +    D++S G++     TG +P+       +  
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 289 TVLE----------MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
            V+           ++  ++     +   G  P+  SL  GL   +  ++    + +   
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 339 RPSFSDI 345
              F   
Sbjct: 294 CWGFDQF 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (309), Expect = 3e-31
 Identities = 71/331 (21%), Positives = 123/331 (37%), Gaps = 82/331 (24%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
            P +  +    +  GA   V EAT  G         VAVK  KP  +   E +    EL+
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELK 78

Query: 114 LLCKL-DHPGLAKFVAAHAK-PPNYMFF----------------FEFYESRNLAEKLHVE 155
           +L  L +H  +   + A     P  +                    F  S+     +  +
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
           E +  ++ +L  + Q+AK + +L +   +HRD+   N+LL       + DFGLA      
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 210 -EYRENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
             Y                         K        +MAPE +   +++ +SDV+S+GI
Sbjct: 199 SNYV---------------VKGNARLPVK--------WMAPESIFNCVYTFESDVWSYGI 235

Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPAS 323
            + EL + G  PY  +  +++     +M          +  G     P  A  E+     
Sbjct: 236 FLWELFSLGSSPYPGMPVDSK---FYKM----------IKEGFRMLSPEHAPAEMY---- 278

Query: 324 ILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              +++ CWD +P  RP+F  I   ++  + 
Sbjct: 279 --DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (309), Expect = 3e-31
 Identities = 69/332 (20%), Positives = 121/332 (36%), Gaps = 85/332 (25%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
            P     L  P+ RGA   V EA   G       R VAVK  K   +T  E      EL+
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELK 82

Query: 114 LLCKLD-HPGLAKFVAA--HAKPPNYMFFFEF---------------YESRNLAEKLHVE 155
           +L  +  H  +   + A      P  +   EF                          + 
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141

Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
           +   +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA      
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 210 -EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFG 265
            +Y                +              +   +MAPE +   +++ +SDV+SFG
Sbjct: 202 PDYV---------------RKGDA---------RLPLKWMAPETIFDRVYTIQSDVWSFG 237

Query: 266 ISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPA 322
           + + E+ + G  PY  ++ + +                 +  G     P   + E+    
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEE---FCRR----------LKEGTRMRAPDYTTPEMY--- 281

Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
                +  CW G P  RP+FS++   L  +L+
Sbjct: 282 ---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 3e-31
 Identities = 65/353 (18%), Positives = 128/353 (36%), Gaps = 51/353 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           + L   + +GA + V+       G   A+K    +S    +D   +E ++L KL+H  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 125 KFVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
           K  A   +          EF    +L   L     +  +   + L++   +   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 181 LGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
            GIVHR++KP N++            L DFG A   E+                      
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------------DEQFV 173

Query: 237 NMVGTLIYMAPEILKKEI--------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
           ++ GT  Y+ P++ ++ +        +    D++S G++     TG +P+       +  
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

Query: 289 TVLE----------MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
            V+           ++  ++     +   G  P+  SL  GL   +  ++    + +   
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293

Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESI 391
              F     E   +L HR  +    L    ++  Y    I+S N    +HE +
Sbjct: 294 CWGFDQFFAETSDIL-HRMVIHVFSLQQMTAHKIY----IHSYNTATIFHELV 341

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  123 bits (311), Expect = 3e-31
 Identities = 40/330 (12%), Positives = 84/330 (25%), Gaps = 91/330 (27%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKE---LQLL 115
            P +    + + +       EAT    G    V          S  +    +E   L+LL
Sbjct: 71  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130

Query: 116 CKLDHPGLAKFVAAHAKP---------PNYMFFFEFYESRNLAEKLHVEEW--------- 157
             + +   AK       P            +          +  +  +            
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190

Query: 158 -----------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
                      S      L +  Q+ + L  LH+ G+VH  ++P +++LD+     L  F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250

Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----------KEIH 255
                                   G   +     +  +  PE+             + + 
Sbjct: 251 EHL------------------VRDG--ARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290

Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
           +   D ++ G+ I  +    +P T   A   +  +                         
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCK-------------------- 330

Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               +P  + +L++        +R      
Sbjct: 331 ---NIPQPVRALLEGFLRYPKEDRLLPLQA 357

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (312), Expect = 6e-31
 Identities = 70/311 (22%), Positives = 117/311 (37%), Gaps = 73/311 (23%)

Query: 67  SYTLLSPIARGAE-SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           S+     +  GAE ++VY    D R VAVK+ IL   E      +E+QLL + D      
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR-ILP--ECFSFADREVQLLRESDE----- 76

Query: 126 FVAAHAKPPNYMFFFEFYESRN------------LAEKLHVEEWSPSVDQVLMIAAQLAK 173
               H   PN + +F   + R             L E +  ++++    + + +  Q   
Sbjct: 77  ----H---PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTS 129

Query: 174 ALQYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            L +LH+L IVHRD+KP N+L+        +   ++DFGL +        S         
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRR----- 183

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLT-GVVPYTDLRAE 284
                    + GT  ++APE+L ++     +   D++S G     +++ G  P+      
Sbjct: 184 -------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK---- 232

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                         Q  A ++ G         E         LI++    +P  RPS   
Sbjct: 233 ------------SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKH 280

Query: 345 IALELDLVLEH 355
                  VL+H
Sbjct: 281 -------VLKH 284

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (309), Expect = 9e-31
 Identities = 68/340 (20%), Positives = 119/340 (35%), Gaps = 74/340 (21%)

Query: 64  PPSSYTLLSPIARGAES--VVYEA--TLDGRKVAVKKPIL--STSEELDNFHKELQLLCK 117
               Y LL+ I +G E    V  A     G  V V++  L   ++E +     EL +   
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82

Query: 118 LDHPGLAKFVAAHAKPPN------YMFF------FEFYESRNLAEKLHVEEWSPSVDQVL 165
            +HP +  + A             +M +         +    + E             + 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-----------LAIA 131

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            I   + KAL Y+H++G VHR VK +++L+  +   +L+             +S+ +   
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------LSMIS-HG 182

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTDL-- 281
             +       K  V  L +++PE+L++ +     KSD+YS GI+  EL  G VP+ D+  
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242

Query: 282 --------------------RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP 321
                                   +       +     L+ ++ +   RP          
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302

Query: 322 ASILS-----LIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
               S      +++C   NP  RPS    A  L   L H 
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARPS----ASTL---LNHS 335

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  121 bits (306), Expect = 2e-30
 Identities = 79/356 (22%), Positives = 137/356 (38%), Gaps = 64/356 (17%)

Query: 30  LQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDG 89
            +   L +   +    PN C  G  SS S    +P  + TL+  +  GA   VYE  + G
Sbjct: 35  YKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSG 94

Query: 90  R-------KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
                   +VAVK    + S  +ELD F  E  ++ K +H  + + +    +        
Sbjct: 95  MPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153

Query: 141 EFYESRNLAEKL------HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
           E     +L   L        +  S ++  +L +A  +A   QYL     +HRD+   N L
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 213

Query: 195 LDR---NLCPHLADFGLAEYRENLKEISLKNW-RSSGKPTGGFHKKNMVGTLI---YMAP 247
           L          + DFG+A      ++I    + R  G              ++   +M P
Sbjct: 214 LTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGC------------AMLPVKWMPP 255

Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E   + I + K+D +SFG+ + E+ + G +PY                 + Q++   V S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------------SNQEVLEFVTS 301

Query: 307 GGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
           GG    P         P  +  ++ +CW   P +RP+F+ I   ++   +    + 
Sbjct: 302 GGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  123 bits (311), Expect = 2e-30
 Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 52/297 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y  +  +  GA   V      +   + A+K   K  +STS       +E+ +L  LDHP 
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDHPN 97

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K         NY    E Y+   L +++ +     +     +I  Q+   + YLH   
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHRD+KP N+LL   +++    + DFGL+   EN K++                 K  +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-----------------KERL 199

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT  Y+APE+L+K+ + EK DV+S G+ +  LL G  P+                 T+Q+
Sbjct: 200 GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGG--------------QTDQE 244

Query: 300 LTAAVVSGGLRPILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +   V  G  +    S E   +      LI++    +   R S    A +    LEH
Sbjct: 245 ILRKVEKG--KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQ---ALEH 292

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (304), Expect = 2e-30
 Identities = 72/336 (21%), Positives = 124/336 (36%), Gaps = 80/336 (23%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
            P ++      +  GA   V EAT  G        KVAVK  K   + ++E +    EL+
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELK 101

Query: 114 LLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNL-------------AEKLHVEEWSP 159
           ++  L  H  +   + A       +   E+    +L                  +   + 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYR 212
           S   +L  ++Q+A+ + +L +   +HRDV   NVLL       + DFGLA        Y 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 213 ENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
                                   K        +MAPE +   +++ +SDV+S+GI + E
Sbjct: 222 ---------------VKGNARLPVK--------WMAPESIFDCVYTVQSDVWSYGILLWE 258

Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSL 327
           + + G+ PY  +   ++     ++          V  G    +P  A   +       S+
Sbjct: 259 IFSLGLNPYPGILVNSK---FYKL----------VKDGYQMAQPAFAPKNIY------SI 299

Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEED 363
           +Q CW   P +RP+F  I   L    +     +E D
Sbjct: 300 MQACWALEPTHRPTFQQICSFLQEQAQE--DRRERD 333

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (313), Expect = 3e-30
 Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 47/314 (14%)

Query: 61  LHLPPSSYTLLSP-IARGAESVVYEATLDGRK----VAVK--KPILSTSEELDNFHKELQ 113
           L L   +  +    +  G    V +     RK    VA+K  K   +   + +   +E Q
Sbjct: 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 388

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
           ++ +LD+P + + +         +   E      L + L  +     V  V  +  Q++ 
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 447

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
            ++YL     VHR++   NVLL       ++DFGL+  +    + S    RS+GK P   
Sbjct: 448 GMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWP--- 502

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
                    L + APE +     S +SDV+S+G+++ E L+ G  PY  +    +   V+
Sbjct: 503 ---------LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVM 549

Query: 292 EMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                        +  G R     +E     P  + +L+  CW     +RP F  +   +
Sbjct: 550 AF-----------IEQGKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593

Query: 350 DLVLEHRKSLKEED 363
                   S  E  
Sbjct: 594 RACYYSLASKVEGG 607

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (300), Expect = 3e-30
 Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 49/287 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y     + +G  +  +E +        A K   K +L    + +    E+ +   L H  
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           +  F              E    R+L E       + +  +      Q+    QYLH   
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNR 135

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           ++HRD+K  N+ L+ +L   + DFGLA   E                  G  KK + GT 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----------------YDGERKKVLCGTP 179

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+APE+L K+ HS + DV+S G  +  LL G  P+       +   + E          
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKET--------- 223

Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
                    I  + E  +P  I     SLIQ+    +P  RP+ +++
Sbjct: 224 ------YLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL 263

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  121 bits (304), Expect = 3e-30
 Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEAT-------LDGRKVAVKKPILSTSEELDNFHKELQ 113
             L      +   +  GA + VYEAT        + +K  +K    +   E     + ++
Sbjct: 60  FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLMIAA 169
            L         KF +AH      +   E Y    L   +    +  E       V+  A 
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH-----------LADFGLAEYRENLKEI 218
           ++   ++ +H+  I+H D+KP N +L                  L D G +        I
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------I 231

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
            +K +      T          T  +   E+L  +  + + D +    ++  +L G    
Sbjct: 232 DMKLFPKGTIFTA------KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285

Query: 279 TD 280
             
Sbjct: 286 VK 287

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  119 bits (301), Expect = 4e-30
 Identities = 72/329 (21%), Positives = 124/329 (37%), Gaps = 82/329 (24%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--KPILSTSEELDNFHKEL 112
           H+      L   +  GA   V+ A             VAVK  K   ++     +F +E 
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREA 94

Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF--------------YESRNLAEKLHVEEW 157
           +LL  L H  + +F     +  P  M F E+               +++ LA    V   
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EY 211
              + Q+L +A+Q+A  + YL  L  VHRD+   N L+ + L   + DFG++      +Y
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213

Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISI 268
                      +R  G+            T++   +M PE +     + +SDV+SFG+ +
Sbjct: 214 -----------YRVGGR------------TMLPIRWMPPESILYRKFTTESDVWSFGVVL 250

Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASIL 325
            E+ T G  P+  L              +  +    +  G    RP         P  + 
Sbjct: 251 WEIFTYGKQPWYQL--------------SNTEAIDCITQGRELERPR------ACPPEVY 290

Query: 326 SLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           ++++ CW   P  R S  D+   L  + +
Sbjct: 291 AIMRGCWQREPQQRHSIKDVHARLQALAQ 319

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (304), Expect = 5e-30
 Identities = 44/330 (13%), Positives = 86/330 (26%), Gaps = 92/330 (27%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKE---LQLL 115
            P +    + + +       EAT    G    V          S  +    +E   L+LL
Sbjct: 76  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 116 CKLDHPGLAKFVAAHAKP------------------------PNYMFFFEFYES------ 145
             + +   AK       P                         +  F +   +S      
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
             L       + S      L +  Q+ + L  LH+ G+VH  ++P +++LD+     L  
Sbjct: 196 EVLLSHSSTHK-SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254

Query: 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----------H 255
           F                    G                +  PE   + +           
Sbjct: 255 FEHL--------------VRDGASA------VSPIGRGFAPPETTAERMLPFGQHHPTLM 294

Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
           +   D ++ G++I  +    +P TD  A   +  +                         
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK-------------------- 334

Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
               +P  + +L++        +R      
Sbjct: 335 ---NIPQPVRALLEGFLRYPKEDRLLPLQA 361

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (300), Expect = 8e-30
 Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 49/287 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y     + +G  +  +E +        A K   K +L    + +    E+ +   L H  
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           +  F              E    R+L E       + +  +      Q+    QYLH   
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNR 161

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           ++HRD+K  N+ L+ +L   + DFGLA   E                  G  KK + GT 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----------------YDGERKKVLCGTP 205

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+APE+L K+ HS + DV+S G  +  LL G  P+       +   + E          
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKET--------- 249

Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
                    I  + E  +P  I     SLIQ+    +P  RP+ +++
Sbjct: 250 ------YLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL 289

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (300), Expect = 8e-30
 Identities = 74/346 (21%), Positives = 125/346 (36%), Gaps = 87/346 (25%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
            P  +      +  GA   V  AT  G        +VAVK  K   + S E +    EL+
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELK 100

Query: 114 LLCKL-DHPGLAKFVAA--HAKPP----NYM----------------FFFEFYESRNLAE 150
           ++ +L  H  +   + A   + P      Y                    E         
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA- 209
           +   +    + + +L  A Q+AK +++L     VHRD+   NVL+       + DFGLA 
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 210 ------EYRENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDV 261
                  Y                         K        +MAPE L + I++ KSDV
Sbjct: 221 DIMSDSNYV---------------VRGNARLPVK--------WMAPESLFEGIYTIKSDV 257

Query: 262 YSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG--LRPILASLEL 318
           +S+GI + E+ + GV PY  +  +A      ++          + +G    +P  A+ E+
Sbjct: 258 WSYGILLWEIFSLGVNPYPGIPVDAN---FYKL----------IQNGFKMDQPFYATEEI 304

Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDL 364
                   ++Q CW  +   RPSF ++   L   L   +    +++
Sbjct: 305 Y------IIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  118 bits (299), Expect = 9e-30
 Identities = 74/332 (22%), Positives = 124/332 (37%), Gaps = 85/332 (25%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKE 111
            P    TL  P+  GA   V  A   G           VAVK  K   +T ++L +   E
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSE 90

Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEF---------------YESRNLAEKLHVE 155
           ++++  +  H  +   + A  +        E+                      +   V 
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
           E   +   ++    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA      
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 210 -EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFG 265
             Y+               K T G          +   +MAPE L   +++ +SDV+SFG
Sbjct: 211 DYYK---------------KTTNG---------RLPVKWMAPEALFDRVYTHQSDVWSFG 246

Query: 266 ISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPA 322
           + + E+ T G  PY  +                ++L   +  G    +P   + EL    
Sbjct: 247 VLMWEIFTLGGSPYPGI--------------PVEELFKLLKEGHRMDKPANCTNELY--- 289

Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
               +++ CW   P  RP+F  +  +LD +L 
Sbjct: 290 ---MMMRDCWHAVPSQRPTFKQLVEDLDRILT 318

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  117 bits (295), Expect = 2e-29
 Identities = 64/327 (19%), Positives = 114/327 (34%), Gaps = 84/327 (25%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--KPILSTSEELDNFHKEL 112
            +  S+   +  +       VY+  L G         VA+K  K   +     + F  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEA 63

Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEE 156
            L  +L HP +   +    K  P  M F  +               +      +     +
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIF-SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------- 209
            +      + + AQ+A  ++YL +  +VH+D+   NVL+   L   ++D GL        
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGI 266
            Y+                   G        +L+   +MAPE +     S  SD++S+G+
Sbjct: 183 YYK-----------------LLG-------NSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218

Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPAS 323
            + E+ + G+ PY                 + Q +   + +  +   P         PA 
Sbjct: 219 VLWEVFSYGLQPYCGY--------------SNQDVVEMIRNRQVLPCP------DDCPAW 258

Query: 324 ILSLIQRCWDGNPHNRPSFSDIALELD 350
           + +L+  CW+  P  RP F DI   L 
Sbjct: 259 VYALMIECWNEFPSRRPRFKDIHSRLR 285

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 2e-29
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 26/289 (8%)

Query: 63  LPPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCKLD 119
           L    +  +S +  G   VV++      G  +A K   +       +   +ELQ+L + +
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            P +  F  A           E  +  +L + L      P    +  ++  + K L YL 
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTYLR 148

Query: 180 -NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
               I+HRDVKP+N+L++      L DFG++    +    S+ N              + 
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN--------------SF 190

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
           VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P     A+            + 
Sbjct: 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250

Query: 299 QLTAAVVSGGLRPI-LASLELGLPASILSLIQRCWDGNPHNRPS--FSD 344
             T        RP+    ++   P +I  L+    +  P   PS  FS 
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  117 bits (295), Expect = 2e-29
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 29/203 (14%)

Query: 82  VYEATLDGRKVAVKKPILSTSEELDN------FHKELQLLCKLDHPGLAKFVAAHAKPPN 135
           VY+  ++   VAVKK  L+   ++        F +E++++ K  H  L + +   +   +
Sbjct: 47  VYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104

Query: 136 YMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
               + +  + +L ++L   + +P +       IA   A  + +LH    +HRD+K AN+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164

Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMV-GTLIYMAPEILK 251
           LLD      ++DFGLA  R +                       + + GT  YMAPE L+
Sbjct: 165 LLDEAFTAKISDFGLA--RAS--------------EKFAQTVMTSRIVGTTAYMAPEALR 208

Query: 252 KEIHSEKSDVYSFGISINELLTG 274
            EI + KSD+YSFG+ + E++TG
Sbjct: 209 GEI-TPKSDIYSFGVVLLEIITG 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (294), Expect = 2e-29
 Identities = 71/326 (21%), Positives = 116/326 (35%), Gaps = 83/326 (25%)

Query: 62  HLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKEL 112
           H+      L   +  GA   V+ A             VAVK  K    T     +F +E 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREA 68

Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEE 156
           +LL  L H  + KF        P  M F E+                    +  +    +
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------E 210
               + Q+L IA+Q+A  + YL +   VHRD+   N L+  NL   + DFG++      +
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGIS 267
           Y           +R  G             T++   +M PE +     + +SDV+SFG+ 
Sbjct: 188 Y-----------YRVGGH------------TMLPIRWMPPESIMYRKFTTESDVWSFGVI 224

Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASI 324
           + E+ T G  P+  L              +  ++   +  G +  RP         P  +
Sbjct: 225 LWEIFTYGKQPWFQL--------------SNTEVIECITQGRVLERP------RVCPKEV 264

Query: 325 LSLIQRCWDGNPHNRPSFSDIALELD 350
             ++  CW   P  R +  +I   L 
Sbjct: 265 YDVMLGCWQREPQQRLNIKEIYKILH 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (298), Expect = 2e-29
 Identities = 82/390 (21%), Positives = 143/390 (36%), Gaps = 92/390 (23%)

Query: 11  QRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLE-PNTCIRGCCSSQSIPLH----LPP 65
            +     R+  V   S   +   T   ++  ++    +T +    S   +P       P 
Sbjct: 21  TKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR 80

Query: 66  SSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKELQL 114
              TL  P+  G    V  A   G           VAVK  K   +T ++L +   E+++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 139

Query: 115 LCKL-DHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEEW 157
           +  +  H  +   + A  +  P Y+   E+                      +   V E 
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------E 210
             +   ++    QLA+ ++YL +   +HRD+   NVL+  N    +ADFGLA        
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGIS 267
           Y+               K T G          +   +MAPE L   +++ +SDV+SFG+ 
Sbjct: 259 YK---------------KTTNG---------RLPVKWMAPEALFDRVYTHQSDVWSFGVL 294

Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASI 324
           + E+ T G  PY  +                ++L   +  G    +P   + EL      
Sbjct: 295 MWEIFTLGGSPYPGI--------------PVEELFKLLKEGHRMDKPANCTNELY----- 335

Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
             +++ CW   P  RP+F  +  +LD +L 
Sbjct: 336 -MMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (303), Expect = 2e-29
 Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 61/307 (19%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-------------KPILSTSEELDNFHKEL 112
           Y  +  +  GA   V          + A+K                 +  +  +  + E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
            LL  LDHP + K          +    EFYE   L E++ +            I  Q+ 
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQIL 156

Query: 173 KALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
             + YLH   IVHRD+KP N+LL   +  L   + DFGL+ +     ++           
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL----------- 205

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
                 ++ +GT  Y+APE+LKK+ ++EK DV+S G+ +  LL G  P+           
Sbjct: 206 ------RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGG--------- 249

Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALE 348
                  +Q +   V  G  +      +   +      LI+     + + R +    A E
Sbjct: 250 -----QNDQDIIKKVEKG--KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEE 298

Query: 349 LDLVLEH 355
               L  
Sbjct: 299 ---ALNS 302

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (302), Expect = 3e-29
 Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 52/297 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y ++  + +G+   V +    +  ++ AVK   K     +++     +E++LL KLDHP 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPN 82

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K         ++    E Y    L +++ ++    S      I  Q+   + Y+H   
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHRD+KP N+LL   +++    + DFGL+   +   ++                 K+ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-----------------KDRI 184

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           GT  Y+APE+L+   + EK DV+S G+ +  LL+G  P+                  E  
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG--------------KNEYD 229

Query: 300 LTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +   V +G  +      +   +      LI++    +P  R +    A +    LEH
Sbjct: 230 ILKRVETG--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQ---CLEH 277

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 5e-29
 Identities = 62/299 (20%), Positives = 115/299 (38%), Gaps = 40/299 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           + +   +  G    V        G +VA+K+     + +  + +  E+Q++ KL+HP + 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 125 K----FVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQ 176
                        PN +     E+ E  +L + L+  E    +    +  + + ++ AL+
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPH----LADFGLA-EYRENLKEISLKNWRSSGKPTG 231
           YLH   I+HRD+KP N++L           + D G A E  +                  
Sbjct: 136 YLHENRIIHRDLKPENIVLQPG-PQRLIHKIIDLGYAKELDQGELCTEF----------- 183

Query: 232 GFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
                  VGTL Y+APE+L+++ ++   D +SFG    E +TG  P+       Q H  +
Sbjct: 184 -------VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 292 EMNYTEQQLTAAVVSGGLR-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                E  +    ++G ++     P    L   L   +   +Q     +   R +    
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  117 bits (296), Expect = 5e-29
 Identities = 76/334 (22%), Positives = 125/334 (37%), Gaps = 87/334 (26%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKE 111
           LP     L  P+  GA   V  A   G          KVAVK  K   +  +  D    E
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISE 124

Query: 112 LQLLCKL-DHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHV 154
           ++++  +  H  +   + A  +  P Y+   E+                         H 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----- 209
            E   S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA     
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 210 --EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSF 264
              Y+               K T G          +   +MAPE L   I++ +SDV+SF
Sbjct: 244 IDYYK---------------KTTNG---------RLPVKWMAPEALFDRIYTHQSDVWSF 279

Query: 265 GISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLP 321
           G+ + E+ T G  PY  +                ++L   +  G    +P   + EL   
Sbjct: 280 GVLLWEIFTLGGSPYPGV--------------PVEELFKLLKEGHRMDKPSNCTNELY-- 323

Query: 322 ASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                +++ CW   P  RP+F  +  +LD ++  
Sbjct: 324 ----MMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (294), Expect = 6e-29
 Identities = 81/375 (21%), Positives = 139/375 (37%), Gaps = 89/375 (23%)

Query: 30  LQFFTLNSKMGLKVLEPN---TCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEAT 86
           +   TL S++ L  L PN     +    + + + L  P ++   +  I  GA   V++A 
Sbjct: 8   VTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQAR 67

Query: 87  LDG-------RKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA--HAKP-- 133
             G         VAVK  K   S   + D F +E  L+ + D+P + K +      KP  
Sbjct: 68  APGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIVKLLGVCAVGKPMC 126

Query: 134 -------------------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
                              P+ +      +    A          S  + L IA Q+A  
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK-EISLKNWRSS 226
           + YL     VHRD+   N L+  N+   +ADFGL+        Y+ +    I ++ W   
Sbjct: 187 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR-W--- 242

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
                             M PE +    ++ +SDV+++G+ + E+ + G+ PY  +    
Sbjct: 243 ------------------MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---- 280

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
                       +++   V  G +   P         P  + +L++ CW   P +RPSF 
Sbjct: 281 ----------AHEEVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFC 324

Query: 344 DIALELDLVLEHRKS 358
            I   L  + E  + 
Sbjct: 325 SIHRILQRMCERAEG 339

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (287), Expect = 1e-28
 Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 48/287 (16%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           + + + + +G+ + VY A     G +VA+K   K  +  +  +     E+++ C+L HP 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +               E   +  +   L       S ++      Q+   + YLH+ G
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+  +N+LL RN+   +ADFGLA   +                        + GT 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLK----------------MPHEKHYTLCGTP 176

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y++PEI  +  H  +SDV+S G     LL G  P+          TV            
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-------DTDTVKNT--------- 220

Query: 303 AVVSGGLRPILASLELGLPASILS----LIQRCWDGNPHNRPSFSDI 345
                 L  ++ + +  +P+ +      LI +    NP +R S S +
Sbjct: 221 ------LNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  116 bits (291), Expect = 4e-28
 Identities = 70/319 (21%), Positives = 127/319 (39%), Gaps = 70/319 (21%)

Query: 68  YTLLSPIARGAES-VVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAK 125
                 +  G+   VV++ +  GR VAVK+ +L   +  D    E++LL + D HP + +
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKR-MLI--DFCDIALMEIKLLTESDDHPNVIR 73

Query: 126 FVAAHAKPPN-YMF-------FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           +  +       Y+          +  ES+N++++    +   +   +L    Q+A  + +
Sbjct: 74  YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR---QIASGVAH 130

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPH-------------LADFGLAEYRENLKEISLKNWR 224
           LH+L I+HRD+KP N+L+  +                 ++DFGL       K++      
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC------KKL------ 178

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-------SEKSDVYSFGISINELLT-GVV 276
            SG+ +   +  N  GT  + APE+L++  +       +   D++S G     +L+ G  
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
           P+ D                E  +   + S      L    L   A    LI +  D +P
Sbjct: 239 PFGD------------KYSRESNIIRGIFSLDEMKCLHDRSLIAEA--TDLISQMIDHDP 284

Query: 337 HNRPSFSDIALELDLVLEH 355
             RP+          VL H
Sbjct: 285 LKRPTAMK-------VLRH 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (286), Expect = 4e-28
 Identities = 82/311 (26%), Positives = 123/311 (39%), Gaps = 61/311 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKL- 118
                   L  I RGA   V +      G+ +AVK+       +E      +L ++ +  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 119 DHPGLAKFVAAHAKPPN------YMF--FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           D P + +F  A  +  +       M   F +FY+         + E     + +  I   
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE-----EILGKITLA 133

Query: 171 LAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
             KAL +L  NL I+HRD+KP+N+LLDR+    L DFG+                 SG+ 
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-----------------SGQL 176

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIH----SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
                K    G   YMAPE +           +SDV+S GI++ EL TG  PY       
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW---- 232

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL-PASILSLIQRCWDGNPHNRPSFSD 344
             ++V +      QLT  VV G   P L++ E      S ++ +  C   +   RP    
Sbjct: 233 --NSVFD------QLT-QVVKGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPK--- 279

Query: 345 IALELDLVLEH 355
              EL   L+H
Sbjct: 280 -YKEL---LKH 286

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 1e-27
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 34/234 (14%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DH 120
           P   + L+  +  G    VY+      G+  A+K  +  T +E +   +E+ +L K   H
Sbjct: 22  PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHH 80

Query: 121 PGLAKFVAAHAKPPNYMFFF------EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAK 173
             +A +  A  K              EF  + ++ + +   + +    + +  I  ++ +
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
            L +LH   ++HRD+K  NVLL  N    L DFG+                 S +     
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV-----------------SAQLDRTV 183

Query: 234 HKKN-MVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
            ++N  +GT  +MAPE++  + + +     KSD++S GI+  E+  G  P  D+
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (281), Expect = 3e-27
 Identities = 68/341 (19%), Positives = 109/341 (31%), Gaps = 90/341 (26%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHKELQLLCKLDH 120
           Y L   I +G+  VV  A         A+K     K      ++++    E++L+ KL H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA----------- 169
           P +A+    +          E     +L +KL+V     +    + +             
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 170 ----------------------------QLAKALQYLHNLGIVHRDVKPANVLL--DRNL 199
                                       Q+  AL YLHN GI HRD+KP N L   +++ 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207

Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS--E 257
              L DFGL+                       +      GT  ++APE+L     S   
Sbjct: 208 EIKLVDFGLS------------KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 258 KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR---PILA 314
           K D +S G+ ++ LL G VP+                  +    + V++  L    P   
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPG--------------VNDADTISQVLNKKLCFENPNYN 301

Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                L      L+    + N   R             L+H
Sbjct: 302 V----LSPLARDLLSNLLNRNVDERFDAMR-------ALQH 331

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  111 bits (280), Expect = 3e-27
 Identities = 56/312 (17%), Positives = 107/312 (34%), Gaps = 58/312 (18%)

Query: 68  YTLLSPIARGAESVVYEATLDGRKVAVK-----------------KPILSTSEELDNFHK 110
           Y ++  + +G  + +     D +  A+K                    +S   + D+F  
Sbjct: 33  YRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92

Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-------VEEWSPSVDQ 163
           ELQ++  + +                   +E+ E+ ++ +                 +  
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 164 VLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
           +  I   +  +  Y+HN   I HRDVKP+N+L+D+N    L+DFG +EY  + K      
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK------ 206

Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                        K   GT  +M PE    +   +  K D++S GI +  +   VVP++ 
Sbjct: 207 ------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 281 LRAEAQAHTVLEM-------NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
                   +++E+       N          +              L    +  ++    
Sbjct: 255 ------KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308

Query: 334 GNPHNRPSFSDI 345
            NP  R +  D 
Sbjct: 309 KNPAERITSEDA 320

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (274), Expect = 7e-27
 Identities = 44/298 (14%), Positives = 78/298 (26%), Gaps = 76/298 (25%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y LL           ++A  T   R+VA+       +   + L         L ++D PG
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 123 LAK---FVAAHAKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
           +A+    V   A           E+    +L E     + SPS    +     LA A   
Sbjct: 93  VARVLDVVHTRAGG--LVVA---EWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADA 144

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
            H  G+      P+ V +  +    LA                                 
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------------------ 174

Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
                  M          + + D+   G S+  LL    P  +    +            
Sbjct: 175 ------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------ 215

Query: 298 QQLTAAVVS-GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           +      +    +          +P  I ++  R   G+   R + S +   +     
Sbjct: 216 RDTAGQPIEPADIDR-------DIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATA 265

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  110 bits (276), Expect = 8e-27
 Identities = 72/303 (23%), Positives = 111/303 (36%), Gaps = 50/303 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKL- 118
              +    L  +  G    V++      G  +AVK+       EE      +L ++ K  
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           D P + +         +     E   +     K  ++   P    +  +   + KAL YL
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIVKALYYL 140

Query: 179 H-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
               G++HRDVKP+N+LLD      L DFG+                 SG+      K  
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGI-----------------SGRLVDDKAKDR 183

Query: 238 MVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
             G   YMAPE +     ++     ++DV+S GIS+ EL TG  PY +        T  E
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC------KTDFE 237

Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
                  LT  +      P+L    +G      S ++ C   +   RP       +L   
Sbjct: 238 ------VLTKVL--QEEPPLLPG-HMGFSGDFQSFVKDCLTKDHRKRPK----YNKL--- 281

Query: 353 LEH 355
           LEH
Sbjct: 282 LEH 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (273), Expect = 9e-27
 Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 51/287 (17%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           + +  P+ +G    VY A        +A+K   K  L  +       +E+++   L HP 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +               E+     +  +L  +       +      +LA AL Y H+  
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           ++HRD+KP N+LL       +ADFG + +  + +                  + ++ GTL
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------------------RTDLCGTL 171

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+ PE+++  +H EK D++S G+   E L G  P+         +T  E          
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQET--------- 215

Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
                  + I   +E   P  +      LI R    NP  RP   ++
Sbjct: 216 ------YKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255

>2j4o_A Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TGF-beta, pseudo-phosphatase, TAK1 binding protein, protein binding; 2.25A {Homo sapiens} PDB: 2pom_A 2pop_A Length = 401

 Score =  111 bits (279), Expect = 1e-26
 Identities = 39/193 (20%), Positives = 70/193 (36%), Gaps = 47/193 (24%)

Query: 418 SANDALTYYPVLSWGSFATCGRR--------ETMEDTHFLMPHMYNQKEIHMFGIFDGHR 469
           S  D L    +   GS +                ED+        ++    ++G+F+G+ 
Sbjct: 16  SWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWL---KFRSENNCFLYGVFNGYD 72

Query: 470 GSAAAEFSARALPGFL--QNLGSTTRPTD---ALLEAFIRTDVAFRNELDSLRKSK---- 520
           G+    F A+ L   L    L +     D    LL+AF   + +F   +D     K    
Sbjct: 73  GNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQ 132

Query: 521 -----------------------RVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR 557
                                  + ++++   G  A+ A+++ N+L+VAN G  RA+LC+
Sbjct: 133 SQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCK 192

Query: 558 ----GGHPFALSR 566
               G     L+ 
Sbjct: 193 STVDGLQVTQLNV 205

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 1e-26
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 28/221 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y ++  + +G+   V +    +  ++ AVK   K     +++     +E++LL KLDHP 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPN 82

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K         ++    E Y    L +++ ++    S      I  Q+   + Y+H   
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHRD+KP N+LL   +++    + DFGL+   +   ++                 K+ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-----------------KDRI 184

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y+APE+L+   + EK DV+S G+ +  LL+G  P+  
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (274), Expect = 1e-26
 Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 64/238 (26%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           +  +  +  GA S V+     L G+  A+K   K        L+N   E+ +L K+ H  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHE- 66

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVL 165
                       N +   + YES                   + E+    E   S+    
Sbjct: 67  ------------NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---- 110

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKN 222
            +  Q+  A++YLH  GIVHRD+KP N+L    + N    + DFGL++  +N        
Sbjct: 111 -VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-------- 161

Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                   G        GT  Y+APE+L ++ +S+  D +S G+    LL G  P+ +
Sbjct: 162 --------GIM--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 3e-26
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 31/227 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL---STSEELDNFHKELQLLCKL 118
           P   ++ L  I  G+   VY A    +   VA+KK       ++E+  +  KE++ L KL
Sbjct: 52  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            HP   ++   + +        E+    + ++ L V +      ++  +     + L YL
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
           H+  ++HRDVK  N+LL       L DFG A                           N 
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------------SIMAPANS 209

Query: 238 MVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
            VGT  +MAPE+   + +  +  K DV+S GI+  EL     P  ++
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (273), Expect = 3e-26
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 33/228 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELD--NFHKELQLLCKLDH 120
           Y L   I +G  SVV        G++ AVK       ++S  L   +  +E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYE-----SRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
           P + + +  ++        FEF +        +        +S +V    M   Q+ +AL
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR--QILEAL 143

Query: 176 QYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
           +Y H+  I+HRDVKP  VLL   + +    L  FG+A                      G
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----------------SG 187

Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                 VGT  +MAPE++K+E + +  DV+  G+ +  LL+G +P+  
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>2irm_A Mitogen-activated protein kinase kinase kinase 7 interacting protein 1; TAK1-binding protein, TAB1; 3.00A {Anopheles gambiae} Length = 358

 Score =  108 bits (271), Expect = 6e-26
 Identities = 30/165 (18%), Positives = 59/165 (35%), Gaps = 33/165 (20%)

Query: 434 FATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTR 493
           +   GRR    ++        +     ++ I  GH G   AE + + +   L        
Sbjct: 25  YKDDGRRCEGYESRDKKCLCISDNNTSLYAILSGHNGVTVAENALQEMAAELLLGQLNVC 84

Query: 494 PTD-----ALLEAFIRTDVAFRNELDSLRKSKRVVQKD---------------------- 526
            TD      + ++F+  +  + + ++    +K  +Q                        
Sbjct: 85  NTDEAVKELIRQSFMSVEKGYFDSINPHVATKTAIQLHLSADGMNQYEISQQFENVLQKL 144

Query: 527 ------WHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALS 565
                    G +A+ ALI R+ L++ N G+CRA+LC+      L+
Sbjct: 145 DSLNNALSVGSSAVLALIHRSHLYLGNIGNCRALLCKTDEHDTLT 189

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 6e-26
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 28/220 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGL 123
           YTL + I RG+   V  A       + A K   +     E++D F +E++++  LDHP +
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            +         +     E      L E++ V +          I   +  A+ Y H L +
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 184 VHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
            HRD+KP N L      +    L DFGLA   +  K +                 +  VG
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-----------------RTKVG 170

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           T  Y++P++L+   +  + D +S G+ +  LL G  P++ 
Sbjct: 171 TPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (267), Expect = 7e-26
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 27/222 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           +     +  GA   V+       G +  +K      +   ++    E+++L  LDHP + 
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQYLHNL 181
           K         N     E  E   L E++   +      S   V  +  Q+  AL Y H+ 
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 182 GIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
            +VH+D+KP N+L      +    + DFGLAE  ++ +                    N 
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-----------------TNA 186

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            GT +YMAPE+ K++  + K D++S G+ +  LLTG +P+T 
Sbjct: 187 AGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTG 227

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (267), Expect = 7e-26
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y +   + +GA SVV        G + A K      LS + +     +E ++  KL HP 
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPN 66

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   +  +   +   F+      L E + V     S         Q+ +++ Y H+ G
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHR++KP N+LL    +     LADFGLA       E+           +  +      
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEV---------NDSEAW--HGFA 168

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (272), Expect = 1e-25
 Identities = 64/321 (19%), Positives = 116/321 (36%), Gaps = 90/321 (28%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHK---ELQLLCK 117
           Y +   +  GA   V  A      +KVA++     K  + ++ E D       E+++L K
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNL----------------AEKLHVEEWSPSV 161
           L+HP               +    F+++ +                      ++E     
Sbjct: 197 LNHP-------------CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE----- 238

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218
               +   Q+  A+QYLH  GI+HRD+KP NVLL   + +    + DFG ++       +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGV 275
                            + + GT  Y+APE+L        +   D +S G+ +   L+G 
Sbjct: 299 -----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDG 334
            P+++             + T+  L   + SG          E+   A  L L+++    
Sbjct: 342 PPFSE-------------HRTQVSLKDQITSGKYNFIPEVWAEVSEKA--LDLVKKLLVV 386

Query: 335 NPHNRPSFSDIALELDLVLEH 355
           +P  R +  +        L H
Sbjct: 387 DPKARFTTEE-------ALRH 400

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (267), Expect = 1e-25
 Identities = 39/214 (18%), Positives = 84/214 (39%), Gaps = 22/214 (10%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   + RG   +V+        +    K  +     +     KE+ +L    H  +  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILH 65

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              +       +  FEF    ++ E+++   +  +  +++    Q+ +ALQ+LH+  I H
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 186 RDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D++P N++        +   +FG A   +                      + +     
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----------------RLLFTAPE 168

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           Y APE+ + ++ S  +D++S G  +  LL+G+ P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (275), Expect = 2e-25
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 21/216 (9%)

Query: 66  SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
             Y +   +  GA  VV+  T    G   A K  +     + +   KE+Q +  L HP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
                A       +  +EF     L EK+  E    S D+ +    Q+ K L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 184 VHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           VH D+KP N++        L   DFGL  + +  + +                 K   GT
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----------------KVTTGT 319

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
             + APE+ + +     +D++S G+    LL+G+ P
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 2e-25
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 30/222 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
           Y +   +  G  ++V +      G++ A K   K  LS+S      +   +E+ +L ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP +           + +   E      L + L  E+ S + D+      Q+   + YLH
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH 125

Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +  I H D+KP N++L     P+    L DFG+A   E   E                  
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----------------- 168

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (271), Expect = 2e-25
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y L   + +GA SVV      L G++ A        LS  +      +E ++   L HP 
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHPN 71

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   + ++  ++   F+      L E + V     S         Q+ +A+ + H +G
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +VHR++KP N+LL    +     LADFGLA   E                   +      
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--------------EQQAWFG--FA 174

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           GT  Y++PE+L+K+ + +  D+++ G+ +  LL G  P
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  106 bits (267), Expect = 3e-25
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 21/214 (9%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +L  +  GA  VV+       GR    K        +      E+ ++ +L HP L  
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +   EF     L +++  E++  S  +V+    Q  + L+++H   IVH
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172

Query: 186 RDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++ +      +   DFGLA      + +                 K    T  
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-----------------KVTTATAE 215

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           + APEI+ +E     +D+++ G+    LL+G+ P
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 4e-25
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 27/221 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y +   + +GA SVV        G + A K      LS + +     +E ++  KL HP 
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPN 89

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +   +  +   +   F+      L E + V     S         Q+ +++ Y H+ G
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           IVHR++KP N+LL    +     LADFGLA    +             +           
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------------SEAW-----HGFA 191

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           GT  Y++PE+LKK+ +S+  D+++ G+ +  LL G  P+ D
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  104 bits (261), Expect = 4e-25
 Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCK 117
           + +       +  + RGA  VV +      G+ +AVK+      S+E      +L +  +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 118 L-DHPGLAKFVAAHAKPPN------YM--FFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
             D P    F  A  +  +       M     +FY+ + + +   + E     D +  IA
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK-QVIDKGQTIPE-----DILGKIA 115

Query: 169 AQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             + KAL++LH  L ++HRDVKP+NVL++      + DFG          IS        
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG----------ISGYLVDDVA 165

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIH----SEKSDVYSFGISINELLTGVVPYTDL 281
           K           G   YMAPE +  E++    S KSD++S GI++ EL     PY   
Sbjct: 166 KDI-------DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (263), Expect = 5e-25
 Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 30/222 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
           Y +   +  G  ++V +      G + A K   K     S      +   +E+ +L ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           H  +      +    + +   E      L + L  ++ S S ++      Q+   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH 132

Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
              I H D+KP N++L     P     L DFGLA   E+  E                  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----------------- 175

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (263), Expect = 7e-25
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 30/222 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEEL---DNFHKELQLLCKLD 119
           Y +   +  G  ++V +      G + A K   K     S      +   +E+ +L ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP +      +    + +   E      L + L  ++ S S ++      Q+   + YLH
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH 132

Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
              I H D+KP N++L     P     L DFGLA   E+  E                  
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----------------- 175

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3d8k_A PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR genomics, protein structure initiative, NEW YORK structural research consortium, nysgxrc; 2.71A {Toxoplasma gondii} Length = 377

 Score =  105 bits (262), Expect = 1e-24
 Identities = 31/181 (17%), Positives = 55/181 (30%), Gaps = 45/181 (24%)

Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYN-----QKEIHMFGIFDGHRGSAAAEFSARALPG 483
               S  +  RR T E  H     +       + E  +  +FDG +G  +A + A+ +  
Sbjct: 13  TVCASATSRNRRPTSESPHSDDVVVVEGMLRGRPETRVHAMFDGFQGRHSAMWLAQNVMN 72

Query: 484 FLQNLGSTTRPTDALLEAFIRTDVAFRNE---------LDSLRKSKRVVQ---------- 524
           +L +L       + +   F R D   R           +  +R  K+  +          
Sbjct: 73  YLNDLRDVNE--EEITRQFERMDGDLRAANLPGGSSALIIFVRYEKKPTEARVVGRQIVP 130

Query: 525 ---------KDWHPGCTAIAALIVRNR----------LFVANAGDCRAILCRGGHPFALS 565
                     +   G       +   R          + VA+ G+ R +L  G     LS
Sbjct: 131 EGAKEFTSVAEALGGPLMPVVAMNFRRDPRAAKGIYTIHVASLGNSRCVLKSGRTAIHLS 190

Query: 566 R 566
            
Sbjct: 191 T 191

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (259), Expect = 2e-24
 Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 30/222 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
           Y     +  G  +VV +      G + A K   K    +S      ++  +E+ +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP +      +    + +   E      L + L  E+ S + ++      Q+   + YLH
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131

Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +L I H D+KP N++L     P     + DFGLA   +   E                  
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----------------- 174

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  102 bits (257), Expect = 2e-24
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 24/218 (11%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           + +  P+ +G    VY A    +   +A+K   K  L          +E+++   L HP 
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +               EF     L ++L  +       +      +LA AL Y H   
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           ++HRD+KP N+L+       +ADFG + +  +L+                  ++ M GTL
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------------------RRTMCGTL 176

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            Y+ PE+++ + H EK D++  G+   E L G+ P+  
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (256), Expect = 5e-24
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 59/235 (25%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           + + S + RGA S+VY        +  A+K  +L  + +      E+ +L +L HP    
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHP---- 108

Query: 126 FVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMIA 168
                    N +   E +E+                   + EK +  E     D    + 
Sbjct: 109 ---------NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----RDAADAVK 155

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            Q+ +A+ YLH  GIVHRD+KP N+L      +    +ADFGL++  E+   +       
Sbjct: 156 -QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM------- 207

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                     K + GT  Y APEIL+   +  + D++S GI    LL G  P+ D
Sbjct: 208 ----------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (250), Expect = 2e-23
 Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 68/247 (27%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEEL----DNFHKELQLLC 116
           Y     + RG  SVV         ++ AVK          ++EE+    +   KE+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSP 159
           K+           H   PN +   + YE+                   L EK+ + E   
Sbjct: 79  KVSG---------H---PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE--- 123

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
              +   I   L + +  LH L IVHRD+KP N+LLD ++   L DFG +       ++ 
Sbjct: 124 --KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS------CQL- 174

Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLT 273
                    P      + + GT  Y+APEI++  +      + ++ D++S G+ +  LL 
Sbjct: 175 --------DPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

Query: 274 GVVPYTD 280
           G  P+  
Sbjct: 225 GSPPFWH 231

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (251), Expect = 2e-23
 Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 62/244 (25%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
           Y +   I  G+ SV           + AVK  I+  S+   +  +E+++L +   HP   
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVK--IIDKSKR--DPTEEIEILLRYGQHP--- 76

Query: 125 KFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMI 167
                     N +   + Y+                    +  +    E      +   +
Sbjct: 77  ----------NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-----REASAV 121

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCP-HLADFGLAEYRENLKEISLKNW 223
              + K ++YLH  G+VHRD+KP+N+L      N     + DFG A      K++     
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA------KQL----- 170

Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
               +   G        T  ++APE+L+++ +    D++S G+ +  +LTG  P+ +   
Sbjct: 171 ----RAENGLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 284 EAQA 287
           +   
Sbjct: 226 DTPE 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (252), Expect = 3e-23
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 48/192 (25%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             +L  AL YL N  I+HRD+KP N+LLD +   H+ DF +A        +  +   ++ 
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA------AMLPRETQITT- 173

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAE 284
                     M GT  YMAPE+        +S   D +S G++  ELL G  PY    + 
Sbjct: 174 ----------MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR---- 339
                      + +++     +  +  P   S E      ++SL+++  + NP  R    
Sbjct: 224 -----------SSKEIVHTFETTVVTYPSAWSQE------MVSLLKKLLEPNPDQRFSQL 266

Query: 340 ------PSFSDI 345
                 P  +DI
Sbjct: 267 SDVQNFPYMNDI 278

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 57/248 (22%), Positives = 95/248 (38%), Gaps = 58/248 (23%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
                P+  G+ S+  +       +  AVK  I+S      N  KE+  L   +      
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRM-EANTQKEITALKLCEG----- 64

Query: 126 FVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMIA 168
               H   PN +   E +  +                  + +K H  E   S      I 
Sbjct: 65  ----H---PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IM 112

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            +L  A+ ++H++G+VHRD+KP N+L    + NL   + DFG A  +             
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK------------- 159

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
              P     K     TL Y APE+L +  + E  D++S G+ +  +L+G VP+       
Sbjct: 160 --PPDNQPLKT-PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216

Query: 286 QAHTVLEM 293
              + +E+
Sbjct: 217 TCTSAVEI 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 67/245 (27%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHK---ELQLLCK 117
           Y +   +  GA   V  A      +KVA+K     K  + ++ E D       E+++L K
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNL----------------AEKLHVEEWSPSV 161
           L+HP               +    F+++ +                      ++E     
Sbjct: 72  LNHP-------------CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE----- 113

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218
               +   Q+  A+QYLH  GI+HRD+KP NVLL   + +    + DFG ++        
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGV 275
                           +  + GT  Y+APE+L       ++   D +S G+ +   L+G 
Sbjct: 170 ------------TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216

Query: 276 VPYTD 280
            P+++
Sbjct: 217 PPFSE 221

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 62/307 (20%), Positives = 110/307 (35%), Gaps = 89/307 (28%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHK---ELQLLCKLD 119
           Y +   +  G    VY      D   VA+K   K  +S   EL N  +   E+ LL K+ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRN------------------LAEKLHVEEWSPSV 161
                            +   +++E  +                  + E+  ++E     
Sbjct: 105 SG-----------FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----- 148

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISL 220
           +       Q+ +A+++ HN G++HRD+K  N+L+D N     L DFG       LK+   
Sbjct: 149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVY 205

Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYT 279
            ++                GT +Y  PE ++    H   + V+S GI + +++ G +P+ 
Sbjct: 206 TDF---------------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHN 338
                                   ++ G +      S E         LI+ C    P +
Sbjct: 251 HDE--------------------EIIRGQVFFRQRVSSEC------QHLIRWCLALRPSD 284

Query: 339 RPSFSDI 345
           RP+F +I
Sbjct: 285 RPTFEEI 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 44/243 (18%)

Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFH 109
                P    P  +     +  G+ S V  A      R+ A+K   K  +    ++    
Sbjct: 19  QPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78

Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPN-YM---------FFFEFYESRNLAEKLHVEEWSP 159
           +E  ++ +LDHP   K           Y                +  +  E         
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--------- 129

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKE 217
                    A++  AL+YLH  GI+HRD+KP N+LL+ ++  H  + DFG A      K 
Sbjct: 130 --TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTA------KV 179

Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           +S          +      + VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P
Sbjct: 180 LS--------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

Query: 278 YTD 280
           +  
Sbjct: 232 FRA 234

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.4 bits (248), Expect = 9e-23
 Identities = 46/218 (21%), Positives = 97/218 (44%), Gaps = 23/218 (10%)

Query: 66  SSYTLLSP--IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           S YT+     +  G    V++      G K+A K       ++ +    E+ ++ +LDH 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +   A     + +   E+ +   L +++  E ++ +    ++   Q+ + ++++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 182 GIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
            I+H D+KP N+L        +   DFGLA   +  +++                 K   
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-----------------KVNF 249

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
           GT  ++APE++  +  S  +D++S G+    LL+G+ P
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 45/228 (19%), Positives = 93/228 (40%), Gaps = 36/228 (15%)

Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
            +    ++      +         + +   +++ ++  + Q+AK +++L +   +HRD+ 
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 220

Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
             N+LL       + DFGLA  R+  K+    ++   G        K       +MAPE 
Sbjct: 221 ARNILLSEKNVVKICDFGLA--RDIYKD---PDYVRKGD--ARLPLK-------WMAPET 266

Query: 250 LKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
           +   +++ +SDV+SFG+ + E+ + G  PY  ++ + +                 +  G 
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR----------LKEGT 313

Query: 309 --LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
               P            +   +  CW G P  RP+FS++   L  +L+
Sbjct: 314 RMRAPDYT------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 57/295 (19%), Positives = 102/295 (34%), Gaps = 65/295 (22%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK--------KPILSTSEELDNFHKELQLLCK 117
           Y+ +SP+  GA   V+ A      ++V VK        +       +L     E+ +L +
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRN-----LAEKLHVEEWSPSVDQVLMIAAQLA 172
           ++H  + K +        +    E + S       +     ++E          I  QL 
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQLV 140

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
            A+ YL    I+HRD+K  N+++  +    L DFG                  +     G
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS-----------------AAYLERG 183

Query: 233 FHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
                  GT+ Y APE+L        + +++S G+++  L+    P+ +L          
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--------- 234

Query: 292 EMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                        V   +  P L S EL      +SL+       P  R +   +
Sbjct: 235 -----------ETVEAAIHPPYLVSKEL------MSLVSGLLQPVPERRTTLEKL 272

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 53/260 (20%), Positives = 95/260 (36%), Gaps = 37/260 (14%)

Query: 68  YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTS--EELDNFHKELQLLCKL-DHP 121
           Y L    +  GA + V      +  ++ AVK  I+            +E+++L +   H 
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVK--IIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 122 GLAKFVAAHAKPPNYMFFFEFYE-----SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
            + + +    +   +   FE        S  + ++ H  E   SV     +   +A AL 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSH-IHKRRHFNELEASV-----VVQDVASALD 125

Query: 177 YLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           +LHN GI HRD+KP N+L    ++     + DF L    +               P    
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL---------NGDCSPISTP 176

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVP-YTDLRAEAQA 287
                 G+  YMAPE+++             D++S G+ +  LL+G  P      ++   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 288 HTVLEMNYTEQQLTAAVVSG 307
                    +  L  ++  G
Sbjct: 237 DRGEACPACQNMLFESIQEG 256

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 46/285 (16%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHP 121
           Y LL  I +G  + V  A   L GR+VA+K  I+         L    +E++++  L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K               E+     + + L V        +      Q+  A+QY H  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            IVHRD+K  N+LLD ++   +ADFG                  S + T G       G 
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTVGGKLDAFCGA 176

Query: 242 LIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
             Y APE+ + K+    + DV+S G+ +  L++G +P+                   ++L
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------------QNLKEL 222

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              V+ G  R     +   +     +L++R    NP  R +   I
Sbjct: 223 RERVLRGKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 50/243 (20%), Positives = 83/243 (34%), Gaps = 77/243 (31%)

Query: 68  YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGL 123
           Y L    +  G    V E      G+K A+K  +L  S +     +E+    +    P  
Sbjct: 30  YQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKA---RQEVDHHWQASGGP-- 82

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLM--------------- 166
                      + +   + YE+ +  ++    + E         M               
Sbjct: 83  -----------HIVCILDVYENMHHGKRCLLIIME--------CMEGGELFSRIQERGDQ 123

Query: 167 ---------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYREN 214
                    I   +  A+Q+LH+  I HRDVKP N+L    +++    L DFG A+    
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183

Query: 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
                                     T  Y+APE+L  E + +  D++S G+ +  LL G
Sbjct: 184 ----------------NALQT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

Query: 275 VVP 277
             P
Sbjct: 226 FPP 228

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 63/271 (23%), Positives = 100/271 (36%), Gaps = 73/271 (26%)

Query: 45  EPNTCIRGCCSSQSIPLHLPPSS----YTLLSPIARGAESVVYEAT--LDGRKVAVK--- 95
             N   +       +P           Y     I RG  SVV        G + AVK   
Sbjct: 69  TENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128

Query: 96  KPILSTSEEL-----DNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRN-- 147
                 S E      +   +E  +L ++  HP             + +   + YES +  
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHP-------------HIITLIDSYESSSFM 175

Query: 148 ---------------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192
                          L EK+ + E      +   I   L +A+ +LH   IVHRD+KP N
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSE-----KETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230

Query: 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK 252
           +LLD N+   L+DFG +        +         +P      + + GT  Y+APEILK 
Sbjct: 231 ILLDDNMQIRLSDFGFS------CHL---------EPGEKL--RELCGTPGYLAPEILKC 273

Query: 253 EI------HSEKSDVYSFGISINELLTGVVP 277
            +      + ++ D+++ G+ +  LL G  P
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 64/298 (21%), Positives = 110/298 (36%), Gaps = 69/298 (23%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHK---ELQLLCKLD 119
           Y L   + +G    V+      D  +VA+K   +  +     L +      E+ LL K+ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 120 ----HPGLAKFVAAHAKPPNYMFFFEFYESRN-----LAEKLHVEEWSPSVDQVLMIAAQ 170
               HPG+ + +        +M   E           + EK  + E             Q
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-----GPSRCFFGQ 147

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           +  A+Q+ H+ G+VHRD+K  N+L+D R  C  L DFG      +               
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--------------- 192

Query: 230 TGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
              +      GT +Y  PE +   + H+  + V+S GI + +++ G +P+   +      
Sbjct: 193 -EPYTD--FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------ 243

Query: 289 TVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                          ++   L  P   S +        +LI+RC    P +RPS  +I
Sbjct: 244 --------------EILEAELHFPAHVSPDC------CALIRRCLAPKPSSRPSLEEI 281

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 5e-22
 Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 21/115 (18%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++   L+ LH   IV+RD+KP N+LLD +   H  ++D GLA        +       
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDH--GHIRISDLGLA------VHV------P 337

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G+   G      VGT+ YMAPE++K E ++   D ++ G  + E++ G  P+  
Sbjct: 338 EGQTIKGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 55/234 (23%)

Query: 68  YTLLS-PIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHP 121
           Y L S  + RG  +VV +      G++ A K   K              E+ +L      
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSC 88

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRN-------------LAEKLHVEEWSPSV--DQVLM 166
                       P  +   E YE+ +             +     + E +  V  + V+ 
Sbjct: 89  ------------PRVINLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIR 135

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNW 223
           +  Q+ + + YLH   IVH D+KP N+LL          + DFG++    +  E+     
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----- 190

Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                       + ++GT  Y+APEIL  +  +  +D+++ GI    LLT   P
Sbjct: 191 ------------REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 31/234 (13%)

Query: 61  LHLPPSSYTLLSPIARGAESVVY--EATLDGRKVAVK---KPILSTSEELDNFHKELQLL 115
           + L    + +L  I RGA S V   +    G+  A+K   K  +    E+  F +E  +L
Sbjct: 56  VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL 115

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
              D   + +   A           E+Y   +L   L         +      A++  A+
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
             +H LG VHRD+KP N+LLDR    H  LADFG         +          +  G  
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSC------LK---------LRADGTV 218

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVY-------SFGISINELLTGVVPYTD 280
                VGT  Y++PEIL+       +  Y       + G+   E+  G  P+  
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 44/115 (38%), Positives = 68/115 (59%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            A+LA AL +LH+LGI++RD+KP N+LLD     H  L DFGL+  +E++          
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEE--GHIKLTDFGLS--KESIDH-------- 179

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
             K    F      GT+ YMAPE++ +  H++ +D +SFG+ + E+LTG +P+  
Sbjct: 180 -EKKAYSF-----CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 50/257 (19%), Positives = 82/257 (31%), Gaps = 75/257 (29%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
                 +  G    V +        K A+K  +L    +     +E++L  +    P   
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA---RREVELHWRASQCP--- 115

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLM---------------- 166
                     + +   + YE+     K    V E         +                
Sbjct: 116 ----------HIVRIVDVYENLYAGRKCLLIVME--------CLDGGELFSRIQDRGDQA 157

Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENL 215
                   I   + +A+QYLH++ I HRDVKP N+L      N    L DFG A+     
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--- 214

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
                                    T  Y+APE+L  E + +  D++S G+ +  LL G 
Sbjct: 215 ------------TSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260

Query: 276 VPYTDLRAEAQAHTVLE 292
            P+      A +  +  
Sbjct: 261 PPFYSNHGLAISPGMKT 277

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.6 bits (238), Expect = 6e-21
 Identities = 34/115 (29%), Positives = 58/115 (50%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            AQ+   L++LH   I++RD+KP NVLLD +   +  ++D GLA       E+      +
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLA------VELK-----A 341

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
               T G+      GT  +MAPE+L  E +    D ++ G+++ E++    P+  
Sbjct: 342 GQTKTKGY-----AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 52/231 (22%)

Query: 65  PSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP-- 121
             +YT    I  G+  VV++A L +  +VA+KK +     +     +ELQ++  + HP  
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNV 94

Query: 122 -GLAKFVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA------Q 170
             L  F  ++    + +F     E+       E ++        + Q + +        Q
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLA----EYRENLKEISLKNWR 224
           L ++L Y+H++GI HRD+KP N+LLD      L   DFG A        N+  I      
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAGEPNVSYIC----- 203

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
                           +  Y APE++    + +   D++S G  + EL+ G
Sbjct: 204 ----------------SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.6 bits (233), Expect = 1e-20
 Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 51/229 (22%)

Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--- 121
           SYT    I  G+  VVY+A L   G  VA+KK +     +     +ELQ++ KLDH    
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110

Query: 122 GLAKFVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA------QL 171
            L  F  +  +  + ++     ++       E ++ V        Q L +        QL
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165

Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKP 229
            ++L Y+H+ GI HRD+KP N+LLD +    L   DFG A      K++        G+P
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSA------KQL------VRGEP 212

Query: 230 TGGFHKKNMVG---TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
                    V    +  Y APE++      +   DV+S G  + ELL G
Sbjct: 213 --------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 64/314 (20%), Positives = 115/314 (36%), Gaps = 49/314 (15%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
              Y  L PI  GA+ +V  A   +  R VA+KK              ++EL L+  ++H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
             +   +           F + Y    L +  L          +++  +  Q+   +++L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F     
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPY 223

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD---------------- 280
           V T  Y APE++    + E  D++S G  + E++   +  P  D                
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283

Query: 281 ------LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
                 L+   + + V             +    L P  +       +    L+ +    
Sbjct: 284 PEFMKKLQPTVRNY-VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342

Query: 335 NPHNRPSFSDIALE 348
           +P  R S  D AL+
Sbjct: 343 DPAKRISVDD-ALQ 355

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            A+++ AL +LH  GI++RD+KP N++L+     H  L DFGL   +E++ +        
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLC--KESIHD-------- 174

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G  T  F      GT+ YMAPEIL +  H+   D +S G  + ++LTG  P+T 
Sbjct: 175 -GTVTHTF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 39/284 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           + L+  +  GA   V  A   +    VAVK  I+     +D       E+ +   L+H  
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + KF     +      F E+     L +++   +             QL   + YLH +G
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I HRD+KP N+LLD      ++DFGLA                        +K  M GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA------------TVFRYNNRERLLNK--MCGTL 171

Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            Y+APE+L ++E H+E  DV+S GI +  +L G +P+          +     Y++    
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-------PSDSCQEYSD---- 220

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                             + ++ L+L+ +    NP  R +  DI
Sbjct: 221 --WKEKKTYLNPWK---KIDSAPLALLHKILVENPSARITIPDI 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 36/228 (15%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
            S + L S +  GA  VV  A     G  VA+KK        ++ F K         E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMI 167
           +L    H  +        +P ++  F       E  ++ +L   +  +  S    Q  + 
Sbjct: 62  ILKHFKHENIITIFNIQ-RPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIY 119

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             Q  +A++ LH   ++HRD+KP+N+L++ N    + DFGLA   +     + +      
Sbjct: 120 --QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 228 KPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                      V T  Y APE+ L    +S   DV+S G  + EL   
Sbjct: 178 GMVE------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 22/212 (10%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHPGL 123
           Y  +  I  G+  VV++      G+ VA+KK + S  + +      +E+++L +L HP L
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
              +    +       FE+ +   +  +L   +       V  I  Q  +A+ + H    
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRDVKP N+L+ ++    L DFG A              R    P+  +   + V T  
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFA--------------RLLTGPSDYY--DDEVATRW 167

Query: 244 YMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
           Y +PE+L  +       DV++ G    ELL+G
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 53/247 (21%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK--------------------------KPIL 99
           YTL   I +G+  VV  A    D    A+K                             +
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 100 STSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEW 157
                ++  ++E+ +L KLDHP + K   V       +    FE          + V   
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ---GPVMEVPTL 131

Query: 158 SP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
            P S DQ       L K ++YLH   I+HRD+KP+N+L+  +    +ADFG++   +   
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--- 188

Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLT 273
                               N VGT  +MAPE L   +K    +  DV++ G+++   + 
Sbjct: 189 -------------GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

Query: 274 GVVPYTD 280
           G  P+ D
Sbjct: 236 GQCPFMD 242

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 23/119 (19%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            A++  AL  +H++G +HRDVKP N+LLD++   H  LADFG         ++       
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTC------MKM------- 218

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTD 280
                G       VGT  Y++PE+LK +     +  + D +S G+ + E+L G  P+  
Sbjct: 219 --NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.4 bits (232), Expect = 4e-20
 Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 19/114 (16%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
           AA++   L+++HN  +V+RD+KPAN+LLD +    ++D GLA       +        S 
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDF-------SK 344

Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTD 280
           K          VGT  YMAPE+L+K + +   +D +S G  + +LL G  P+  
Sbjct: 345 KKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 49/231 (21%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
              YT LS I  GA  +V  A   L+  +VA+KK        +  F           E++
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMI 167
           +L +  H  +        + P            +  E+ +L + L  +  S       + 
Sbjct: 78  ILLRFRHENIIGINDII-RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLY 135

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
             Q+ + L+Y+H+  ++HRD+KP+N+LL+      + DFGLA              R + 
Sbjct: 136 --QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA--------------RVAD 179

Query: 228 KPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                 H   +   V T  Y APEI L  + +++  D++S G  + E+L+ 
Sbjct: 180 PDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 92.1 bits (229), Expect = 4e-20
 Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 30/237 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
           P +Y +   I RG+   VY A      + VA+KK +         F           E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK-VN------RMFEDLIDCKRILREIT 77

Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAA 169
           +L +L    + +       P + + F E Y    +A+  L     +P   + + +  I  
Sbjct: 78  ILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA---EYRENLKEISLKNWRSS 226
            L     ++H  GI+HRD+KPAN LL+++    + DFGLA      ++   ++       
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 227 GKPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYT 279
             P     KK +   V T  Y APE+ L +E +++  D++S G    ELL  +  + 
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 24/120 (20%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            A++  A+  +H L  VHRD+KP N+L+D N   H  LADFG         +        
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMN--GHIRLADFGSC------LK-------- 224

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVPYTD 280
                G       VGT  Y++PEIL+     +       D +S G+ + E+L G  P+  
Sbjct: 225 -LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 26/217 (11%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
           P +Y   + +  GA   V  A     G KVA+KK      +       ++EL LL  + H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP-SVDQVLMIAAQLAKALQYL 178
             +   +       +   F++FY      +  L        S +++  +  Q+ K L+Y+
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+ G+VHRD+KP N+ ++ +    + DFGLA              R +     G+     
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------------RHADAEMTGY----- 183

Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           V T  Y APE+ L    +++  D++S G  + E+LTG
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 49/229 (21%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK-----ELQLLCK 117
              Y L+  + RG  S V+EA    +  KV VK         L    K     E+++L  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILEN 86

Query: 118 L-DHP---GLAKFVAAHAKPP---NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
           L   P    LA  V    K P        FE   + +   K   +  +    +  M   +
Sbjct: 87  LRGGPNIITLADIV----KDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMY--E 138

Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKP 229
           + KAL Y H++GI+HRDVKP NV++D       L D+GLAE+    +E +++        
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-------- 190

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVP 277
                    V +  +  PE+L      + S D++S G  +  ++    P
Sbjct: 191 ---------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 38/229 (16%)

Query: 65  PSSYTLLSPIARGAESVVYEAT-LDGRKVAVKK--PILSTSEELDNFHK---------EL 112
            S YT+   I+ G+   V      +G  VA+K+    +S    ++             E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLM 166
           +LL    HP +                       E   + +LA+ +H +    S   +  
Sbjct: 81  RLLNHFHHPNILGLRDIF-VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
               +   L  LH  G+VHRD+ P N+LL  N    + DF LA  RE+  + +  ++   
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA--REDTADANKTHY--- 193

Query: 227 GKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                       V    Y APE+ ++ +  ++  D++S G  + E+   
Sbjct: 194 ------------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 43/115 (37%), Positives = 61/115 (53%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++A AL YLH+L IV+RD+KP N+LLD     H  L DFGL   +EN++         
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLC--KENIEH-------- 192

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
               T  F      GT  Y+APE+L K+ +    D +  G  + E+L G+ P+  
Sbjct: 193 -NSTTSTF-----CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 41/285 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
           + L+  +  GA   V  A   +    VAVK  I+     +D       E+ +   L+H  
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + KF     +      F E+     L +++   +             QL   + YLH +G
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGL-AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           I HRD+KP N+LLD      ++DFGL   +R N +E  L                   GT
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---------------CGT 170

Query: 242 LIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           L Y+APE+L ++E H+E  DV+S GI +  +L G +P+       Q        Y++   
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSD--- 220

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                              + ++ L+L+ +    NP  R +  DI
Sbjct: 221 ---WKEKKTYLNPWK---KIDSAPLALLHKILVENPSARITIPDI 259

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 44/202 (21%), Positives = 84/202 (41%), Gaps = 45/202 (22%)

Query: 91  KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YM---------FFF 140
           K+  K+ ++   + +++   E ++L  ++ P L K   +     N YM          F 
Sbjct: 72  KILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
                   +E                 AAQ+    +YLH+L +++RD+KP N+L+D+   
Sbjct: 131 HLRRIGRFSE-----------PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-- 177

Query: 201 PH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK 258
            +  + DFG A      K +  + W              + GT   +APEI+  + +++ 
Sbjct: 178 GYIQVTDFGFA------KRVKGRTW-------------TLCGTPEALAPEIILSKGYNKA 218

Query: 259 SDVYSFGISINELLTGVVPYTD 280
            D ++ G+ I E+  G  P+  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 26/224 (11%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK----KPILSTSEELDNFHKELQLLCKLDHP 121
           Y +   +  G+   V E        + AVK    K +        N  KE+QLL +L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYL 178
            + +   V  + +        E Y    + E L  V E    V Q      QL   L+YL
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVME-YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+ GIVH+D+KP N+LL       ++  G+AE              S G P         
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQGSPA-------- 176

Query: 239 VGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
                +  PEI          K D++S G+++  + TG+ P+  
Sbjct: 177 -----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 27/218 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKL 118
              Y  L PI  GA+ +V  A   +  R VA+KK  LS   +     K    EL L+  +
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCV 81

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP-SVDQVLMIAAQLAKALQ 176
           +H  +   +       +   F + Y    L +  L          +++  +  Q+   ++
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           +LH+ GI+HRD+KP+N+++  +    + DFGLA              R++G     F   
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMT 184

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
             V T  Y APE++    + E  D++S G  + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 58/229 (25%), Positives = 81/229 (35%), Gaps = 42/229 (18%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE-LDNFH-------KELQLL 115
           S Y  ++ I  GA   VY+A     G  VA+K   +                    L+ L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 116 CKLDHP---GLAKFVAAHAKPPNYMFF--FEFYES--RNLAEKLHVEEWSPSVDQVLMIA 168
              +HP    L    A             FE  +   R   +K           + LM  
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR- 127

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            Q  + L +LH   IVHRD+KP N+L+       LADFGLA              R    
Sbjct: 128 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------------RIYSY 172

Query: 229 P---TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
               T       +V TL Y APE+L +  ++   D++S G    E+   
Sbjct: 173 QMALT------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
            A++  AL+YLH+  +V+RD+K  N++LD++   H  + DFGL   +E + +        
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLC--KEGISD-------- 158

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G     F      GT  Y+APE+L+   +    D +  G+ + E++ G +P+ +
Sbjct: 159 -GATMKTF-----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 32/225 (14%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHP 121
           S Y  L+ I +G    V++A     G+KVA+KK ++   +E       +E+++L  L H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 122 ---GLAKFVAAHAKPPN------YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
               L +     A P N      Y+ F +F E  +LA  L       ++ ++  +   L 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVF-DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
             L Y+H   I+HRD+K ANVL+ R+    LADFGLA              R+       
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA--------------RAFSLAKNS 180

Query: 233 FHKK--NMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
              +  N V TL Y  PE+L  E       D++  G  + E+ T 
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++  AL +LH+ GI++RD+K  NVLLD     H  LADFG+   +E +          
Sbjct: 130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMC--KEGICN-------- 177

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G  T  F      GT  Y+APEIL++ ++    D ++ G+ + E+L G  P+  
Sbjct: 178 -GVTTATF-----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 41/115 (35%), Positives = 64/115 (55%), Gaps = 23/115 (20%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++  AL+YLH+  I++RD+KP N+LLD+N   H  + DFG A      K +    +  
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKN--GHIKITDFGFA------KYVPDVTY-- 161

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
               T       + GT  Y+APE++  + +++  D +SFGI I E+L G  P+ D
Sbjct: 162 ----T-------LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 32/175 (18%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           +A+++ AL YLH  GI++RD+K  NVLLD     H  L D+G+   +E L+         
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMC--KEGLRP-------- 163

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
            G  T  F      GT  Y+APEIL+ E +    D ++ G+ + E++ G  P+  + +  
Sbjct: 164 -GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR 339
                     TE  L   ++   +R P        L     S+++   + +P  R
Sbjct: 218 NPD-----QNTEDYLFQVILEKQIRIPR------SLSVKAASVLKSFLNKDPKER 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 32/175 (18%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           +A+++ AL YLH  GI++RD+K  NVLLD     H  L D+G+   +E L+         
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMC--KEGLRP-------- 206

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
            G  T  F      GT  Y+APEIL+ E +    D ++ G+ + E++ G  P+  + +  
Sbjct: 207 -GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR 339
                     TE  L   ++   +R P        L     S+++   + +P  R
Sbjct: 261 NPD-----QNTEDYLFQVILEKQIRIPR------SLSVKAASVLKSFLNKDPKER 304

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++   LQ+LH+ GIV+RD+K  N+LLD++   H  +ADFG+   +EN+          
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHIKIADFGMC--KENMLG-------- 171

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
               T  F      GT  Y+APEIL  + ++   D +SFG+ + E+L G  P+  
Sbjct: 172 -DAKTNTF-----CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++A  L +L + GI++RD+K  NV+LD     H  +ADFG+   +EN+ +        
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE--GHIKIADFGMC--KENIWD-------- 174

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G  T  F      GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+  
Sbjct: 175 -GVTTKTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 21/240 (8%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
           P  Y +   I  G+   V EA   L+ R VA+KK +    + +D     +E+ +L +L+H
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQ 176
             + K +     P +   F E Y    +A+        +P   +   +  +   L   ++
Sbjct: 112 DHVVKVLDI-VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEISLKNWRSSGK 228
           Y+H+ GI+HRD+KPAN L++++    + DFGLA           +        +      
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 229 PTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
           P     K+ +   V T  Y APE+ L +E ++E  DV+S G    ELL  +       A+
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
            + Y  L P+  GA   V  A     G KVA+KK      +       ++EL+LL  + H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 121 PGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
             +   +           F        F  + +L + +  E+      Q L+   Q+ K 
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVY--QMLKG 140

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L+Y+H  GI+HRD+KP N+ ++ +    + DFGLA              R +     G+ 
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RQADSEMTGY- 185

Query: 235 KKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
               V T  Y APE+ L    +++  D++S G  + E++TG
Sbjct: 186 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>2isn_A NYSGXRC-8828Z, phosphatase; pathogenic strain, praseodymium, sulfate structural genomics, PSI-2, protein structure initiative; 1.90A {Toxoplasma gondii} Length = 364

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 28/189 (14%), Positives = 51/189 (26%), Gaps = 53/189 (28%)

Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
            +  +    GRR T ED   +     ++  + +  +FDGH G A +++ A+     L   
Sbjct: 13  TTTVAATMLGRRPTDEDAILVSAPATSRPNVRIKAVFDGHAGEATSQYCAKHAAKHLGK- 71

Query: 489 GSTTRPTDALLEAFIRTDVAFRNEL-----DSLRKSKRVVQKDWHP-------------- 529
             +      + +A +  D     +L              +++   P              
Sbjct: 72  -LSEFTFAEVKKACLSLDAEIIRKLGPKHVAGSTGIIVAIERLSAPVVENVVGREIVPRA 130

Query: 530 ------------------------GCTAIAALIV-------RNRLFVANAGDCRAILCR- 557
                                   G       +           +   N GD RA L   
Sbjct: 131 HEETFVPLEKLIQEEEEAEHPELVGRYPRVPDVQQKTIPAGSFLVTAINIGDSRATLIHS 190

Query: 558 GGHPFALSR 566
            G    LS+
Sbjct: 191 DGGLTRLSK 199

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 52/231 (22%), Positives = 99/231 (42%), Gaps = 40/231 (17%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP- 121
            S Y  L P+  G   +V+ A      ++VA+KK +L+  + + +  +E++++ +LDH  
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 122 --GL-----AKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
              +                +           E+ E+ +LA  L          ++ M  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY- 127

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSG 227
            QL + L+Y+H+  ++HRD+KPAN+ ++       + DFGLA              R   
Sbjct: 128 -QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA--------------RIMD 172

Query: 228 KPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
                 HK ++   + T  Y +P + L    +++  D+++ G    E+LTG
Sbjct: 173 PHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHPGL 123
           Y  L  +  G+  +V +      GR VA+KK + S  +++      +E++LL +L H  L
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
              +    K   +   FEF +   + + L +         V     Q+   + + H+  I
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L+ ++    L DFG A              R+   P   +   + V T  
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFA--------------RTLAAPGEVY--DDEVATRW 189

Query: 244 YMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
           Y APE+L  ++   K+ DV++ G  + E+  G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 24/130 (18%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
             ++  AL++LH LGI++RD+K  N+LLD N   H  L DFGL+      KE        
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLS------KE----FVAD 212

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
             +    F      GT+ YMAP+I++     H +  D +S G+ + ELLTG  P+T    
Sbjct: 213 ETERAYDF-----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT---V 264

Query: 284 EAQAHTVLEM 293
           + + ++  E+
Sbjct: 265 DGEKNSQAEI 274

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 24/219 (10%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y L   +  G    V      L G KVAVK   +  + + + +    +E+Q L    HP 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K     + P ++    E+     L + +  +       +   +  Q+  A+ Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           +VHRD+KP NVLLD ++   +ADFGL                 S   + G   +   G+ 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGL-----------------SNMMSDGEFLRTSCGSP 174

Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            Y APE++  +     + D++S G+ +  LL G +P+ D
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.8 bits (217), Expect = 2e-18
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 20/115 (17%)

Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
           AA++A  L +L + GI++RD+K  NV+LD     H  +ADFG+   +EN+ +        
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE--GHIKIADFGMC--KENIWD-------- 495

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            G  T  F      GT  Y+APEI+  + + +  D ++FG+ + E+L G  P+  
Sbjct: 496 -GVTTKTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLA 124
           Y  +  I  G   V       L    VAVK   +     +D N  +E+     L HP + 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIV 79

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           +F      P +     E+     L E++       S D+      QL   + Y H++ I 
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 185 HRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           HRD+K  N LLD +  P L   DFG +           K+     +P      K+ VGT 
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYS-----------KSSVLHSQP------KSTVGTP 181

Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            Y+APE+L ++E   + +DV+S G+++  +L G  P+ D
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 35/231 (15%)

Query: 55  SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEE------LDN 107
             +++        Y  L  +  G   VVY+A    GR VA+K+  L   +E      +  
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI-- 67

Query: 108 FHKELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV 164
             +E+ LL +L HP    L   +  H++    + F EF E  +L + L   +      Q+
Sbjct: 68  --REISLLKELHHPNIVSLIDVI--HSERCLTLVF-EFMEK-DLKKVLDENKTGLQDSQI 121

Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
            +   QL + + + H   I+HRD+KP N+L++ +    LADFGLA              R
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA--------------R 167

Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
           + G P   +   + V TL Y AP++L   + +S   D++S G    E++TG
Sbjct: 168 AFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 30/220 (13%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
           Y  L  I  G    V++A        VA+K+  L   +E      L    +E+ LL +L 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELK 59

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           H  + +              FEF +  +L +           + V     QL K L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           +  ++HRD+KP N+L++RN    LA+FGLA              R+ G P   +     V
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLA--------------RAFGIPVRCY--SAEV 162

Query: 240 GTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPY 278
            TL Y  P++L   +++S   D++S G    EL     P 
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
           P  Y  LSP+  GA   V  A  T  G +VAVKK        +      +EL+LL  + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 121 PGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
             +   +       +   F           + +L   +  ++ +    Q L+   Q+ + 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIY--QILRG 144

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L+Y+H+  I+HRD+KP+N+ ++ +    + DFGLA  R    E++               
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMT--------------- 187

Query: 235 KKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
               V T  Y APEI L    +++  D++S G  + ELLTG
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 44/227 (19%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCK 117
             Y  ++ +  G    VY+A  T+    VA+K+  L   EE      +    +E+ LL +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKE 89

Query: 118 LDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAK 173
           L H     L   +  H     ++ F E+ E+ +L + +    + S  V +  +   QL  
Sbjct: 90  LQHRNIIELKSVI--HHNHRLHLIF-EYAEN-DLKKYMDKNPDVSMRVIKSFLY--QLIN 143

Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPH-----LADFGLAEYRENLKEISLKNWRSSGK 228
            + + H+   +HRD+KP N+LL  +         + DFGLA              R+ G 
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA--------------RAFGI 189

Query: 229 PTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
           P   F   + + TL Y  PEIL     +S   D++S      E+L  
Sbjct: 190 PIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.2 bits (209), Expect = 7e-18
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 31/221 (14%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFH----KELQLLCKL 118
             Y  L  +  G  + VY+A      + VA+KK  +   SE  D  +    +E++LL +L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 119 DHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            HP   GL        K    + F +F E+ +L   +       +   +        + L
Sbjct: 70  SHPNIIGLLDAF--GHKSNISLVF-DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +YLH   I+HRD+KP N+LLD N    LADFGLA              +S G P   +  
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA--------------KSFGSPNRAY-- 169

Query: 236 KNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
            + V T  Y APE+L    ++    D+++ G  + ELL  V
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 32/231 (13%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
              Y L+  + +GA  +V+++     G  VAVKK I       D F           E+ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK-IF------DAFQNSTDAQRTFREIM 60

Query: 114 LLCKL-DHPGLAKFVAAHAKPPNYM---FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           +L +L  H  +   +    +  N       F++ E+ +L   +      P   Q ++   
Sbjct: 61  ILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVY-- 116

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           QL K ++YLH+ G++HRD+KP+N+LL+      +ADFGL+    N++ ++     S  + 
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 230 TGGFHKKNM-----VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
           T  F          V T  Y APEI L    +++  D++S G  + E+L G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 74  IARGAESVVYEA----TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKF 126
           + RG    VY+A      D +  A+K+ I  T   +    +E+ LL +L HP    L K 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQ-IEGTGISMSAC-REIALLRELKHPNVISLQKV 86

Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA--------QLAKALQYL 178
             +HA    ++ F ++ E  +L   +     S +  + + +          Q+   + YL
Sbjct: 87  FLSHADRKVWLLF-DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 179 HNLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGF- 233
           H   ++HRD+KPAN+L+           +AD G A              R    P     
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA--------------RLFNSPLKPLA 190

Query: 234 HKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
               +V T  Y APE+L    H ++  D+++ G    ELLT 
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 37/220 (16%)

Query: 67  SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE------LDNFHKELQLLCKL 118
           +Y  L  +  G  + VY+    L    VA+K+ I    EE      +    +E+ LL  L
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKE-IRLEHEEGAPCTAI----REVSLLKDL 57

Query: 119 DHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            H     L   +  H +    + F E+ +  +L + L       ++  V +   QL + L
Sbjct: 58  KHANIVTLHDII--HTEKSLTLVF-EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            Y H   ++HRD+KP N+L++      LADFGLA              R+   PT  +  
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLA--------------RAKSIPTKTY-- 157

Query: 236 KNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
            N V TL Y  P+IL     +S + D++  G    E+ TG
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 57/235 (24%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y +   +  G+   V  AT     +KVA+K   + +L  S+      +E+  L  L HP 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP- 69

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRN----------------LAEKLHVEEWSPSVDQVLM 166
                       + +  ++   +                  + EK  + E     D+   
Sbjct: 70  ------------HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----DEGRR 112

Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
              Q+  A++Y H   IVHRD+KP N+LLD NL   +ADFGL                 S
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL-----------------S 155

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTD 280
              T G   K   G+  Y APE++  K     + DV+S GI +  +L G +P+ D
Sbjct: 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 17/114 (14%)

Query: 168 AAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
            A++  AL YLH+   +V+RD+K  N++LD++    + DFGL   +E +K+         
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKD--------- 302

Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           G     F      GT  Y+APE+L+   +    D +  G+ + E++ G +P+ +
Sbjct: 303 GATMKTF-----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 57/233 (24%), Positives = 89/233 (38%), Gaps = 52/233 (22%)

Query: 66  SSYTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEE-----------LDNFHKE 111
             Y  ++ I  GA   V++A      GR VA+K+  + T EE           +      
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV------ 64

Query: 112 LQLLCKLDHP---GLAKFVAAHAKPPNYMFF--FEFYES--RNLAEKLHVEEWSPSVDQV 164
           L+ L   +HP    L                  FE  +       +K+          + 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124

Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
           +M   QL + L +LH+  +VHRD+KP N+L+  +    LADFGLA              R
Sbjct: 125 MMF--QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------------R 168

Query: 225 SSGKP---TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
                   T      ++V TL Y APE+L +  ++   D++S G    E+   
Sbjct: 169 IYSFQMALT------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.0 bits (201), Expect = 4e-17
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 33/217 (15%)

Query: 68  YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKL 118
           Y  L  I  G   VVY+A      G   A+KK  L   +E      +    +E+ +L +L
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNY--GETFALKKIRLEKEDEGIPSTTI----REISILKEL 57

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            H  + K           +  FE  +  +L + L V E             QL   + Y 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRD+KP N+L++R     +ADFGLA              R+ G P   +   + 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLA--------------RAFGIPVRKY--THE 160

Query: 239 VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
           + TL Y AP++L   + +S   D++S G    E++ G
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 47/237 (19%), Positives = 79/237 (33%), Gaps = 59/237 (24%)

Query: 66  SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD 119
             + +     +G    V        G  VA+KK ++        EL    + +Q L  L 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNREL----QIMQDLAVLH 77

Query: 120 HPGLAK----FVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA-- 169
           HP + +    F     +    ++     E+       + LH                   
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIK 132

Query: 170 ----QLAKALQYLHN--LGIVHRDVKPANVLLDRNLCP-HLADFGLA----EYRENLKEI 218
               QL +++  LH   + + HRD+KP NVL++       L DFG A        N+  I
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
                                 +  Y APE++    H +   D++S G    E++ G
Sbjct: 193 C---------------------SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)

Query: 66  SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCK 117
           S +  L  +  G  + VY+      G  VA+K+ +   SEE      +    +E+ L+ +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE-VKLDSEEGTPSTAI----REISLMKE 59

Query: 118 LDHP---GLAKFVAAHAKPPNYMFFFEFYES------RNLAEKLHVEEWSPSVDQVLMIA 168
           L H     L   +  H +    + F EF ++       +            ++ +     
Sbjct: 60  LKHENIVRLYDVI--HTENKLTLVF-EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW- 115

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
            QL + L + H   I+HRD+KP N+L+++     L DFGLA              R+ G 
Sbjct: 116 -QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA--------------RAFGI 160

Query: 229 PTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
           P   F   + V TL Y AP++L     +S   D++S G  + E++TG
Sbjct: 161 PVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 50/259 (19%), Positives = 91/259 (35%), Gaps = 75/259 (28%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP- 121
              Y+L   +  G+  +V E      G++ A+KK +     +     +EL ++  LDH  
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----RELDIMKVLDHVN 61

Query: 122 -------------------------------GLAKFVAAHAKPPNYMFF------FEFYE 144
                                                   +   N           E+  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 145 SRNLAEKLH-VEEWSPSVDQVL------MIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
                + LH V +      + +      +   QL +A+ ++H+LGI HRD+KP N+L++ 
Sbjct: 122 -----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 198 NLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH- 255
                 L DFG A      K++         +P+  +     + +  Y APE++      
Sbjct: 177 KDNTLKLCDFGSA------KKL------IPSEPSVAY-----ICSRFYRAPELMLGATEY 219

Query: 256 SEKSDVYSFGISINELLTG 274
           +   D++S G    EL+ G
Sbjct: 220 TPSIDLWSIGCVFGELILG 238

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 30/230 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
           + +   I  G    +           VA+K  +          H E +   +L    G+ 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           +          Y          +L +   + + + S+  VLMIA QL   ++Y+H+  ++
Sbjct: 69  QVYY-FGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127

Query: 185 HRDVKPANVLLDRNLCP-----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFH----- 234
           +RDVKP N L+ R         H+ DF LA           K +     P    H     
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALA-----------KEYID---PETKKHIPYRE 173

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
            K++ GT  YM+      +  S + D+ + G      L G +P+  L+A+
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 46/253 (18%), Positives = 89/253 (35%), Gaps = 58/253 (22%)

Query: 68  YTLLSPIARGAESVVYEAT----------LDGRKVAVK-----KPILSTSEELDNFHKEL 112
           + L S   R  + ++YEA              +K ++K       + +         K L
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 113 QL-----LCKLDHPGLAKFVA--AHAKPPNYMFF----------FEFYESRNLAEKLHVE 155
           Q+     L       +   +    H     ++             +      L+E+    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS--- 160

Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLA-EY 211
                   VL +A +L  AL++LH    VH +V   N+ +   D++    LA +G A  Y
Sbjct: 161 --------VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRY 211

Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
             + K ++               +    G L +++ ++ K    S +SD+ S G  + + 
Sbjct: 212 CPSGKHVAYVEGS----------RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261

Query: 272 LTGVVPYTDLRAE 284
           L G +P+T+    
Sbjct: 262 LYGFLPWTNCLPN 274

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 24/219 (10%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y L   +  G    V      L G KVAVK   +  + + + +    +E+Q L    HP 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + K     + P +     E+     L + +  +       +   +  Q+   + Y H   
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           +VHRD+KP NVLLD ++   +ADFGL                 S   + G   +   G+ 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGL-----------------SNMMSDGEFLRTSCGSP 179

Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
            Y APE++  +     + D++S G+ +  LL G +P+ D
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 30/230 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
           Y +   I  G+  V++E T  L+ ++VA+K        +      E +    L    G+ 
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIP 69

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                  +   +          +L + L +     SV  V M A Q+   +Q +H   +V
Sbjct: 70  NVYY-FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128

Query: 185 HRDVKPANVLLDRNLCP-----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFH----- 234
           +RD+KP N L+ R         ++ DFG+            K +R    P    H     
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMV-----------KFYRD---PVTKQHIPYRE 174

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
           KKN+ GT  YM+         S + D+ + G      L G +P+  L+A 
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 75.2 bits (185), Expect = 9e-15
 Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 17/126 (13%)

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP--HLADFGLA-EYREN--LKEI 218
           VL ++ ++   L+Y+H    VH D+K +N+LL+       +L D+GLA  Y      K  
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
           +               K+   GT+ + + +       S + D+   G  + + LTG +P+
Sbjct: 214 AADP------------KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Query: 279 TDLRAE 284
            D   +
Sbjct: 262 EDNLKD 267

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 28/228 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
           Y L   I  G+   +Y  T    G +VA+K        +    H E ++   +    G+ 
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIP 68

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                     +Y          +L +  +      S+  VL++A Q+   ++Y+H+   +
Sbjct: 69  TIRW-CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127

Query: 185 HRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNWRSSGKPTGGFH-----KK 236
           HRDVKP N L+      +   + DFGLA           K +R         H      K
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLA-----------KKYRD---ARTHQHIPYRENK 173

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
           N+ GT  Y +         S + D+ S G  +     G +P+  L+A 
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 45/257 (17%), Positives = 76/257 (29%), Gaps = 96/257 (37%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
                 +  G    V +        K A+K  +L    +     +E++L  +    P   
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR---REVELHWRASQCP--- 71

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEK-LH-VEEWSPSVDQVLM---------------- 166
                     + +   + YE+     K L  V E         +                
Sbjct: 72  ----------HIVRIVDVYENLYAGRKCLLIVME--------CLDGGELFSRIQDRGDQA 113

Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENL 215
                   I   + +A+QYLH++ I HRDVKP N+L      N    L DFG        
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
                                         A E   ++ + +  D++S G+ +  LL G 
Sbjct: 167 ------------------------------AKETTGEK-YDKSCDMWSLGVIMYILLCGY 195

Query: 276 VPYTDLRAEAQAHTVLE 292
            P+      A +  +  
Sbjct: 196 PPFYSNHGLAISPGMKT 212

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 13/124 (10%)

Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP--HLADFGLA-EYRENLKEISL 220
           VL +  ++   L+Y+H    VH D+K AN+LL        +LAD+GL+  Y  N      
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
           +             +K   GT+ + + +  K    S +SDV   G  +   L G +P+  
Sbjct: 213 Q-ENP---------RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262

Query: 281 LRAE 284
              +
Sbjct: 263 NLKD 266

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.2 bits (176), Expect = 6e-14
 Identities = 43/281 (15%), Positives = 81/281 (28%), Gaps = 57/281 (20%)

Query: 53  CCSSQSIPLH--LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN--- 107
           C     +P    LP         I  G    V++   D   VA+K   +   + ++    
Sbjct: 5   CSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 108 -----FHKELQLLCKL---------DHPGLAKFVAAH----AKPPNYMFFFEFYESRNLA 149
                   E+ +  +L            G     + H    + PP  +  ++ Y S   +
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 150 EK------------------------LHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIV 184
                                       +     S+     I  QL  +L      L   
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFE 184

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRE---NLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           HRD+   NVLL +     L      +         ++S+ ++  S     G     +V  
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFC 240

Query: 242 LIYMAPEILKKEIHSEKSDVYSF-GISINELLTGVVPYTDL 281
            + M  ++   +    + D+Y       N       PY+++
Sbjct: 241 DVSMDEDLFTGD-GDYQFDIYRLMKKENNNRWGEYHPYSNV 280

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 28/228 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
           + L   I  G+   +Y  T      +VA+K    +   +      E ++   L    G+ 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE--NVKTKHPQLLYESKIYRILQGGTGIP 66

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                     +Y          +L +  +      S+  VLM+A Q+   ++++H+   +
Sbjct: 67  NVRW-FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125

Query: 185 HRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNWRSSGKPTGGFH-----KK 236
           HRD+KP N L+      +   + DFGLA           K +R     +   H      K
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLA-----------KKYRD---TSTHQHIPYRENK 171

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
           N+ GT  Y +         S + D+ S G  +   L G +P+  L+A 
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 60/234 (25%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKE-------LQLLCKL 118
           Y +L  I +G+   V +A      + VA+K  ++   +    FH++       L+ L K 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALK--MVRNEK---RFHRQAAEEIRILEHLRKQ 153

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYE---------SRNLAEKLHVEEWSP-SVDQVLMIA 168
           D       +       + +  F F           S NL E +   ++   S+  V   A
Sbjct: 154 DKDNTMNVI-------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSS 226
             + + L  LH   I+H D+KP N+LL +       + DFG +                 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----------------- 249

Query: 227 GKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
                  ++   V T I    Y APE++    +    D++S G  + ELLTG  
Sbjct: 250 ------CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>2pnq_A [pyruvate dehydrogenase [lipoamide]]-phosphatase 1; pyruvate dehydrogenase phosphatase 1, catalytic subunit, PDP1C, hydrolase; 1.81A {Rattus norvegicus} PDB: 3n3c_A 3mq3_A Length = 467

 Score = 64.0 bits (155), Expect = 4e-11
 Identities = 25/135 (18%), Positives = 40/135 (29%), Gaps = 10/135 (7%)

Query: 437 CGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPT- 495
                 +E  + +         +      + +    A++     L  + Q L        
Sbjct: 97  LPHETLLEIENAVESGRALLPILQWHKHPNDYFSKEASKLYFNGLRTYWQELIDLNTGES 156

Query: 496 ------DALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHP---GCTAIAALIVRNRLFVA 546
                 +AL+ AF R D     E      +  +          G TA  A +    L VA
Sbjct: 157 ADIDVKEALINAFKRLDNDISLEAQVGDPNSFLNYLVLRVAFSGATACVAHVDGVDLHVA 216

Query: 547 NAGDCRAILCRGGHP 561
           N GD RA+L      
Sbjct: 217 NTGDSRAMLGVQEED 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 60/241 (24%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-STSEELDNFHKELQLLCKL------ 118
           Y L+  +  G  S V+ A   ++   VA+K  I+       +    E++LL ++      
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 119 --DHPGLAKFVAAHAKPPNYMFFFEF-----------YE--SRNLAEKLHVEEWSP-SVD 162
             D  G    +         +  F             +E    NL   +   E     + 
Sbjct: 79  KEDSMGANHIL-------KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131

Query: 163 QVLMIAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPH------LADFGLAEYRENL 215
            V  I+ QL   L Y+H   GI+H D+KP NVL++    P       +AD G A + +  
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190

Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
                             H  N + T  Y +PE+L        +D++S    I EL+TG 
Sbjct: 191 ------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

Query: 276 V 276
            
Sbjct: 233 F 233

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 19/140 (13%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
            +  V  +A QL  AL++LH   + H D+KP N+L   +    L +   +   +++K  S
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 220 LK--NWRSSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLT 273
           ++  ++ S+              T++    Y  PE++ +   ++  DV+S G  + E   
Sbjct: 181 IRVADFGSA------TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 274 GVVPYTDLRAEAQAHTVLEM 293
           G   +       Q H   E 
Sbjct: 235 GFTLF-------QTHENREH 247

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 62/236 (26%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKE-------LQLLCKL 118
           Y + S I +G+   V +A   ++   VA+K  I+   +    F  +       L+L+ K 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKK---AFLNQAQIEVRLLELMNKH 110

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYE---------SRNLAEKLHVEEWSP-SVDQVLMIA 168
           D       V       +    F F           S NL + L    +   S++     A
Sbjct: 111 DTEMKYYIV-------HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163

Query: 169 AQLAKALQYLHN--LGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWR 224
            Q+  AL +L    L I+H D+KP N+LL         + DFG +               
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--------------- 208

Query: 225 SSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
                         +   I    Y +PE+L    +    D++S G  + E+ TG  
Sbjct: 209 --------CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 3e-09
 Identities = 79/503 (15%), Positives = 150/503 (29%), Gaps = 136/503 (27%)

Query: 87  LDGRKVA-VKKPILSTSEELDNFHKE----------LQLLCKLDHPGLAKFVAAHAKPPN 135
            D + V  + K IL + EE+D+                 L       + KFV    +  N
Sbjct: 33  FDCKDVQDMPKSIL-SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI-N 90

Query: 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL 195
           Y F         L   +  E+  PS+   +           Y+     ++ D +      
Sbjct: 91  YKF---------LMSPIKTEQRQPSMMTRM-----------YIEQRDRLYNDNQV---FA 127

Query: 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG--FHKKNMVG----TLIYMAPEI 249
             N+            R       L+      +P          ++G     +   A ++
Sbjct: 128 KYNVS-----------RLQPYL-KLRQALLELRPAKNVLID--GVLGSGKTWV---ALDV 170

Query: 250 LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL 309
                  +      F I           + +L+      TVLEM    Q+L   +     
Sbjct: 171 CLSY---KVQCKMDFKIF----------WLNLKNCNSPETVLEM---LQKLLYQIDPNWT 214

Query: 310 RPILASLELGLPA-SILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLKEEDL- 364
                S  + L   SI + ++R     P+         L   LVL +    K+    +L 
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYEN------CL---LVLLNVQNAKAWNAFNLS 265

Query: 365 CAGKSYVTYDDK-LINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDAL 423
           C  K  +T   K + +  +   T H S++  +      +      +S +  +L+     L
Sbjct: 266 C--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE-----VKSLLLKYLDCRPQDL 318

Query: 424 TYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPG 483
                           RE +  T+     +  +        +D  +     + +   +  
Sbjct: 319 ---------------PRE-VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT-TIIES 361

Query: 484 FLQNLGST-TR---------PTDA-----LLEAF----IRTDVAFRNELDSLRKSKRVVQ 524
            L  L     R         P  A     LL       I++DV     ++ L K   +V+
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--MVVVNKLHK-YSLVE 418

Query: 525 KDWHPGCTAIAALIVRNRLFVAN 547
           K       +I ++ +  ++ + N
Sbjct: 419 KQPKESTISIPSIYLELKVKLEN 441

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 1e-08
 Identities = 64/464 (13%), Positives = 134/464 (28%), Gaps = 143/464 (30%)

Query: 110 KELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
           + LQ L  ++D    ++  + H+                   KL +      + + L+ +
Sbjct: 200 EMLQKLLYQIDPNWTSR--SDHSSNI----------------KLRIHSIQAELRR-LLKS 240

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHL--------ADFGLAEYRENLKEIS 219
                 L       +V  +V+ A      NL C  L         DF  A        IS
Sbjct: 241 KPYENCL-------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT---THIS 290

Query: 220 LKNWRSSGKPTGGFHKKNMVGTL---IYMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
           L         +       +   L   +   P+ L +E+ +            N     ++
Sbjct: 291 LD------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-----------TNPRRLSII 333

Query: 277 P------------YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL-----G 319
                        +  +  +    T++E +    +          R +   L +      
Sbjct: 334 AESIRDGLATWDNWKHVNCDKL-TTIIESSLNVLE------PAEYRKMFDRLSVFPPSAH 386

Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD--DKL 377
           +P  +LSLI   W     +      +  +L     H+ SL E+        +      +L
Sbjct: 387 IPTILLSLI---WFDVIKSDVM--VVVNKL-----HKYSLVEKQPKESTISI-PSIYLEL 435

Query: 378 INSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATC 437
                N +  H SI      +H +   +  ++  +  +L+       Y+       +   
Sbjct: 436 KVKLENEYALHRSIV-----DHYNIPKTFDSDDLIPPYLDQ------YF-------Y--- 474

Query: 438 GRRETMEDTHFLMPHMYNQKEIHMFGIF-----DGH------RGSAAAEFSARALPGFLQ 486
                      +  H+ N +      +F     D        R  + A  ++ ++   LQ
Sbjct: 475 ---------SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525

Query: 487 NL---GSTTRPTDALLEAFIRTDVAF--RNELDSLR-KSKRVVQ 524
            L          D   E  +   + F  + E + +  K   +++
Sbjct: 526 QLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 2e-05
 Identities = 47/332 (14%), Positives = 90/332 (27%), Gaps = 84/332 (25%)

Query: 305 VSGGLRPILASLE----LGLPASILSLIQRCW---DGNPHNRPSFSDIALELD---LVLE 354
           V    + IL+  E    +    ++   ++  W            F +  L ++   L+  
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97

Query: 355 HRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKA--SHAAESDV 412
            +   ++  +   + Y+   D+L N       Y+ S     Q     ++A        +V
Sbjct: 98  IKTEQRQPSMMT-RMYIEQRDRLYNDNQVFAKYNVSR---LQPYLKLRQALLELRPAKNV 153

Query: 413 ---------KLWLESANDALTYYPVLS-------WGSFATCGRRET----MEDTHFLMPH 452
                    K W+  A D    Y V         W +   C   ET    ++   + +  
Sbjct: 154 LIDGVLGSGKTWV--ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 453 MYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALL-----------EA 501
            +  +  H   I          +    ++   L+ L  +    + LL            A
Sbjct: 212 NWTSRSDHSSNI----------KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261

Query: 502 F---IRTDVAFRNE--LDSL--RKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRA- 553
           F    +  +  R +   D L    +  +         T          L      DCR  
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----SLL-LKYLDCRPQ 316

Query: 554 ---ILCRGGHPFALS---------RVRQEFWL 573
                    +P  LS             + W 
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 44/264 (16%), Positives = 78/264 (29%), Gaps = 70/264 (26%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-STSEELDNFHKELQLLCKL-----D 119
           Y ++  +  G  S V+ +      + VA+K  ++ S     +    E++LL  +     +
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 120 HPGLAKFVAA-----HAKP-------------PNYMFFFEFYESRNLAEKLHVEEWSPSV 161
            P     V        +                + + +      + L            +
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGL-----------PL 145

Query: 162 DQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
             V  I  Q+ + L YLH    I+H D+KP N+LL  N          A   +       
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 221 KNWRSSGKPT------------------------------GGFHKKNMVGTLIYMAPEIL 250
                S  P                                  H    + T  Y + E+L
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265

Query: 251 KKEIHSEKSDVYSFGISINELLTG 274
               ++  +D++S      EL TG
Sbjct: 266 IGSGYNTPADIWSTACMAFELATG 289

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 30/140 (21%), Positives = 57/140 (40%), Gaps = 19/140 (13%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
            +D +  +A Q+ K++ +LH+  + H D+KP N+L  ++      +  +      L    
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 220 LK--NWRSSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLT 273
           +K  ++ S+       +      TL+    Y APE++     S+  DV+S G  + E   
Sbjct: 176 IKVVDFGSA------TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 274 GVVPYTDLRAEAQAHTVLEM 293
           G   +         H   E 
Sbjct: 230 GFTVF-------PTHDSKEH 242

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 27/150 (18%), Positives = 54/150 (36%), Gaps = 19/150 (12%)

Query: 74  IARGAESVVYEATLDGRKVAVKKPILST--SEELDNF------HKELQLLCKLDHPGLAK 125
           I +GAE+ +   +     V +K+ +      E LD         +E + L  +   G+  
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
                    N      +   +   + +       ++D    I   + K    LH   ++H
Sbjct: 404 PYIFDVDLDNKRIMMSYINGKLAKDVI-----EDNLDIAYKIGEIVGK----LHKNDVIH 454

Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENL 215
            D+  +N + D++L   + DFGL +     
Sbjct: 455 NDLTTSNFIFDKDLY--IIDFGLGKISNLD 482

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 29/126 (23%), Positives = 48/126 (38%), Gaps = 16/126 (12%)

Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
            ++ + +   ++ KAL YL  + + H D+KP N+LLD                  + +  
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI-----TVRRVTDGK 189

Query: 220 LKNWRSSGKPT------GG--FHKKNM---VGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
                 +          G   F        + T  Y APE++        SD++SFG  +
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249

Query: 269 NELLTG 274
            EL TG
Sbjct: 250 AELYTG 255

>2pk0_A Serine/threonine protein phosphatase STP1; SI motif, signaling protein; 2.65A {Streptococcus agalactiae} Length = 250

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 22/128 (17%), Positives = 41/128 (32%), Gaps = 17/128 (13%)

Query: 439 RRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTRPTDA 497
           RR   +D         N+  + +  + DG  G  A    S   +     +   T     +
Sbjct: 17  RRSNNQDFINQFE---NKAGVPLIILADGMGGHRAGNIASEMTVTDLGSDWAETDFSELS 73

Query: 498 LLEAFIRTDVAFRNELDSLRKSKRVVQKDWHP-----GCTAIAALIVRNRLFVANAGDCR 552
            +  ++   +   N         ++ +          G T  A  IV + +  A+ GD R
Sbjct: 74  EIRDWMLVSIETENR--------KIYELGQSDDYKGMGTTIEAVAIVGDNIIFAHVGDSR 125

Query: 553 AILCRGGH 560
             + R G 
Sbjct: 126 IGIVRQGE 133

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 26/161 (16%), Positives = 51/161 (31%), Gaps = 32/161 (19%)

Query: 68  YTLLSPIARGAESVVYEA-TLDGRKVAVKKPILSTSE--------ELDNFH--------- 109
             +   +  G ES V+   +    +  VK   +  +         +  + H         
Sbjct: 92  DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151

Query: 110 -KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
             E + L KL    + K  A            E  +++ L            V+    + 
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVL 199

Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
             + + +   ++ GIVH D+   NVL+       + DF  +
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 239

>1txo_A Putative bacterial enzyme; serine/threonine protein phosphatases, PSTP/PPP, structural genomics, PSI, protein structure initiative; 1.95A {Mycobacterium tuberculosis} SCOP: d.219.1.1 PDB: 2cm1_A Length = 237

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 13/31 (41%), Positives = 15/31 (48%)

Query: 530 GCTAIAALIVRNRLFVANAGDCRAILCRGGH 560
           G T  A L   NRL + + GD R  L R G 
Sbjct: 95  GTTLTAILFAGNRLGLVHIGDSRGYLLRDGE 125

>2j82_A TPPHA, protein serine-threonine phosphatase; PP2C family phosphatase, hydrolase; 1.28A {Synechococcus elongatus} PDB: 2j86_A 2y09_A 2xzv_A Length = 240

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 25/124 (20%), Positives = 45/124 (36%), Gaps = 10/124 (8%)

Query: 439 RRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTRPTDA 497
            R++ +D  +      ++K    F + DG  G A  E  S  A+    Q L +       
Sbjct: 12  IRKSNQDAFY-----IDEKHQRFFIVADGMGGHAGGEEASRLAVDHIRQYLETHLEDLQH 66

Query: 498 LLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVR--NRLFVANAGDCRAIL 555
                +R      N    + + ++   +    G TA+  L+    +R + A+ GD R   
Sbjct: 67  DPVTLLRQAFLAANH-AIVEQQRQNSARA-DMGTTAVVILLDEKGDRAWCAHVGDSRIYR 124

Query: 556 CRGG 559
            R  
Sbjct: 125 WRKD 128

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	573
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
2i0o_A	304	Ser/Thr phosphatase; beta sandwich, structural gen	99.94
2p8e_A	307	PPM1B beta isoform variant 6; structural genomics,	99.94
3qn1_B	337	Protein phosphatase 2C 16; start domain, BET V dom	99.93
3kdj_B	316	Protein phosphatase 2C 56; ABA, PYL1, abscisic aci	99.93
1a6q_A	382	Phosphatase 2C; catalytic mechanism, metalloenzyme	99.93
2isn_A	364	NYSGXRC-8828Z, phosphatase; pathogenic strain, pra	99.93
2iq1_A	274	Protein phosphatase 2C kappa, PPM1K; structural ge	99.93
2j4o_A	401	Mitogen-activated protein kinase kinase kinase 7-i	99.92
2i44_A	324	Serine-threonine phosphatase 2C; PSI-2, 8817Z, str	99.92
4da1_A	389	Protein phosphatase 1K, mitochondrial; metal-ION-a	99.92
2irm_A	358	Mitogen-activated protein kinase kinase kinase 7 i	99.92
2pnq_A	467	[pyruvate dehydrogenase [lipoamide]]-phosphatase 1	99.92
3d8k_A	377	PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR	99.91
1txo_A	237	Putative bacterial enzyme; serine/threonine protei	99.91
2pk0_A	250	Serine/threonine protein phosphatase STP1; SI moti	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
2j82_A	240	TPPHA, protein serine-threonine phosphatase; PP2C	99.89
2jfr_A	234	Ser-Thr phosphatase MSPP; hydrolase, PPM phosphata	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
3rnr_A	211	Stage II sporulation E family protein; structural	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3t91_A	242	Stage II sporulation protein E; SPOIIE, phosphatas	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3pu9_A	242	Protein serine/threonine phosphatase; PSI-biology,	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
3f79_A	255	Probable two-component response regulator; adaptor	98.44
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3zt9_A	193	Serine phosphatase; hydrolase, signal transduction	98.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.28
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.36
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.2
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.17
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.11
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.05
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.02
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.81
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.6
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.52
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.39
3ke6_A	399	Protein RV1364C/MT1410; anti-sigma factor, anti-si	96.11
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.08
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.58
3eq2_A	394	Probable two-component response regulator; adaptor	86.99
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.58

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-58  Score=462.38  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=217.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .++|+++++||+|+||+||+|++  +++.||||++...  .....+.+.+|+.+|++|+|||||++++++.+++.+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999997  5899999986543  3456778999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+||+|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......  
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--
Confidence            9999999999997543 4579999999999999999999999999999999999999999999999999987653222  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    ...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+.......+....     
T Consensus       181 --------------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----  241 (350)
T 4b9d_A          181 --------------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-----  241 (350)
T ss_dssp             --------------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred             --------------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----
Confidence                          1345689999999999999999999999999999999999999999876666555554322     


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               ..    ..+..+|+++.+||.+||+.||++|||+.|+++|.|...
T Consensus       242 ---------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 ---------FP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---------CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                     21    234578999999999999999999999999999998753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-58  Score=457.15  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=219.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++|++++.||+|+||+||+|++  +++.||||++...   .....+.+.+|+++|+.++|||||+++++|++++.+|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999997  5889999986432   123356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.....  
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~--  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT--
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC--
Confidence            99999999999997665 799999999999999999999999999999999999999999999999999986542111  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  .....+.+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.+......++....+    
T Consensus       188 ------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----  251 (311)
T 4aw0_A          188 ------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY----  251 (311)
T ss_dssp             ------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             ------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Confidence                        1124567999999999999999999999999999999999999999998776666555544322    


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                     .+|..+++++++||.+||+.||++|||+.|++.+.|.
T Consensus       252 ---------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i  288 (311)
T 4aw0_A          252 ---------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL  288 (311)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH
T ss_pred             ---------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHH
Confidence                           1345789999999999999999999999998766554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-57  Score=447.24  Aligned_cols=267  Identities=30%  Similarity=0.478  Sum_probs=222.6

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..++|+.+++++.++||+|+||+||+|++.+ .||||++...  ..+..+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            3478999999999999999999999998765 5899986533  45567889999999999999999999998754 578


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++|||||+||+|.+++......+++.++..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+......
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999999998777789999999999999999999999999999999999999999999999999997654311


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .              .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.+........   
T Consensus       187 ~--------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---  249 (307)
T 3omv_A          187 G--------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---  249 (307)
T ss_dssp             ---------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---
T ss_pred             c--------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---
Confidence            1              112345689999999999964   45899999999999999999999999876543333222   


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                +..+...|.++..+.++|+++.+||.+||+.||++|||+.||+++|+.+..
T Consensus       250 ----------~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          250 ----------VGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----------HHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----------HhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                      223334555666677899999999999999999999999999999987654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-58  Score=459.84  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=219.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +.|+++++||+|+||+||+|++  +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5799999999999999999998  58899999876554445567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      +||+|.+++...  .+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+...        
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--------  223 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--------  223 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--------
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--------
Confidence            999999998653  6899999999999999999999999999999999999999999999999999765421        


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                              .....+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.......+...          
T Consensus       224 --------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------  285 (346)
T 4fih_A          224 --------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------  285 (346)
T ss_dssp             --------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred             --------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----------
Confidence                    11245678999999999999999999999999999999999999999887655554444321          


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           ..+.+ ..+..+|+++.+||.+||+.||++|||+.|+++|+|..
T Consensus       286 -----~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          286 -----LPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             -----SCCCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             -----CCCCC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence                 11111 12346899999999999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.3e-57  Score=439.35  Aligned_cols=249  Identities=26%  Similarity=0.363  Sum_probs=203.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|++  +++.||||++...   .......+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999987  5899999986543   2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||| +|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......    
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence            999 679999987655 79999999999999999999999999999999999999999999999999997654211    


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   ...+.+||+.|||||++.+..+ +.++|||||||++|+|+||..||.+.+.......+.....    
T Consensus       167 -------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~----  229 (275)
T 3hyh_A          167 -------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY----  229 (275)
T ss_dssp             ---------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             -------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC----
Confidence                         1345789999999999998876 5899999999999999999999988765554444432211    


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                     ..|..+|+++.+||.+||+.||++|||+.|+++|.|.-
T Consensus       230 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          230 ---------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence                           13457899999999999999999999999999999984

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-56  Score=443.90  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=222.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .|..++|.+.++||+|+||+||+|++       ++..||||++........+.|.+|+++|++++|||||++++++.+++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            56678899999999999999999986       36789999987777777888999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          135 NYMFFFEFYESRNLAEKLHVE------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      .+|+|||||++|+|.++++..            ...+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999999753            24689999999999999999999999999999999999999999999


Q ss_pred             EeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008220          203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL  281 (573)
Q Consensus       203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~  281 (573)
                      |+|||+|+.........              ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus       169 i~DFGla~~~~~~~~~~--------------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYR--------------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             ECCCSCHHHHTGGGCEE--------------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ECCcccceecCCCCcee--------------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999998664322110              1234579999999999999999999999999999999999 99999887


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      +.......+..              +.. +   ..|..+|+++.+||.+||+.||++|||+.||++.|..+.+
T Consensus       235 ~~~~~~~~i~~--------------~~~-~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          235 SNNEVIECITQ--------------GRV-L---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             CHHHHHHHHHH--------------TCC-C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHc--------------CCC-C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            65544443332              221 1   2356789999999999999999999999999988877654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.5e-57  Score=461.44  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=220.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +.|+++++||+|+||+||+|++  +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            5799999999999999999998  58999999987665555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      +||+|.+++...  .+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...        
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--------  300 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--------  300 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--------
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--------
Confidence            999999998653  5899999999999999999999999999999999999999999999999999765421        


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA  303 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  303 (573)
                              .....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+...          
T Consensus       301 --------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------  362 (423)
T 4fie_A          301 --------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN----------  362 (423)
T ss_dssp             --------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred             --------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----------
Confidence                    11245679999999999999999999999999999999999999999887655554444321          


Q ss_pred             HhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           ..+.+ ..+..+|+++.+||.+||+.||++|||+.|+++|.|+.
T Consensus       363 -----~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          363 -----LPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             -----CCCCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             -----CCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence                 11111 12357899999999999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-56  Score=447.21  Aligned_cols=263  Identities=24%  Similarity=0.243  Sum_probs=219.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ..+.|++.++||+|+||+||+|++  +++.||||++.....     ..+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            345789999999999999999998  588999998765432     2469999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhhc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+||+|.+++...+ .+++.+++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+......  
T Consensus       131 y~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~--  207 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG--  207 (336)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc--
Confidence            999999999997665 799999999999999999999999999999999999999998 5999999999866431110  


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                               .........+||+.|||||++.+..|+.++|||||||+||||++|..||.+.........+....      
T Consensus       208 ---------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------  272 (336)
T 4g3f_A          208 ---------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------  272 (336)
T ss_dssp             ---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------
T ss_pred             ---------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------
Confidence                     01112345689999999999999999999999999999999999999998765544444443221      


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL  359 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~  359 (573)
                                +.+...+..+|+++.+||.+||+.||++|||+.||+++++..+.....+
T Consensus       273 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l  321 (336)
T 4g3f_A          273 ----------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL  321 (336)
T ss_dssp             ----------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred             ----------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence                      2223456789999999999999999999999999999999988765443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-56  Score=443.71  Aligned_cols=262  Identities=24%  Similarity=0.403  Sum_probs=218.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..|..++|.+.++||+|+||+||+|++       +++.||||++........+.|.+|+++|++++|||||++++++.++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            456667899999999999999999985       3678999998777777788899999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEE--------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL  199 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~  199 (573)
                      ..+|+|||||++|+|.++++...              ..+++.+++.++.||+.||+|||+++||||||||+|||++.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            99999999999999999986532              3589999999999999999999999999999999999999999


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY  278 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf  278 (573)
                      .+||+|||+++........              .......||+.|||||++.+..++.++|||||||+||||+| |+.||
T Consensus       196 ~~Ki~DFGla~~~~~~~~~--------------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf  261 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYY--------------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW  261 (329)
T ss_dssp             EEEECCCC------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cEEEcccccceeccCCCcc--------------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence            9999999999865432111              11234679999999999999999999999999999999999 99999


Q ss_pred             CCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .+.........+..              +. ++   ..|..+|+++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       262 ~~~~~~~~~~~i~~--------------g~-~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          262 YQLSNTEAIDCITQ--------------GR-EL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             CSSCHHHHHHHHHH--------------TC-CC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHc--------------CC-CC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            88765544433322              21 22   2345789999999999999999999999999999988765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-57  Score=447.73  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=210.5

Q ss_pred             cCCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      +.+++|++++.||+|+||+||+|++     +++.||||++....  ......+.+|+++|++++|||||++++++.+++.
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            3457899999999999999999986     36789999864332  1223467889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999999997665 7999999999999999999999999999999999999999999999999999754321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .                ....+.+||+.|||||++.+..|+.++|||||||+||||+||..||.+.+.......+.....
T Consensus       180 ~----------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  243 (304)
T 3ubd_A          180 E----------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL  243 (304)
T ss_dssp             -----------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             C----------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence            1                123467899999999999999999999999999999999999999998776666555543221


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                                         ..|..+|+++.+||++||+.||++|||+     +|+++|+|+
T Consensus       244 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          244 -------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence                               1345789999999999999999999984     688877764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-55  Score=433.88  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=208.5

Q ss_pred             CCc-cccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc----CCce
Q 008220           66 SSY-TLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNY  136 (573)
Q Consensus        66 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~  136 (573)
                      .+| ++.++||+|+||+||+|.+  ++..||+|++...  .....+.+.+|+++|++++|||||+++++|.+    ...+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 7888999999999999998  4788999986432  34556789999999999999999999999865    3568


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcC-CCCCeEeeeecchhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDR-NLCPHLADFGLAEYRE  213 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~  213 (573)
                      |+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+...
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999999997655 7899999999999999999999998  999999999999985 7999999999997432


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .                  ....+.+||+.|||||++.+ .|+.++|||||||+||||+||..||.+..........+  
T Consensus       184 ~------------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i--  242 (290)
T 3fpq_A          184 A------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--  242 (290)
T ss_dssp             T------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--
T ss_pred             C------------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH--
Confidence            1                  12356789999999999875 58999999999999999999999997654433322222  


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 ..+ ..|  +..+..+++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       243 -----------~~~-~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          243 -----------TSG-VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             -----------TTT-CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             -----------HcC-CCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                       111 111  22345688999999999999999999999999999886

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-55  Score=436.58  Aligned_cols=259  Identities=23%  Similarity=0.374  Sum_probs=217.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      .+|+...+++.++||+|+||+||+|++       +++.||||++.... ....+.|.+|+.+|++++|||||++++++.+
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            356667899999999999999999985       35789999875433 2345789999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR  197 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~  197 (573)
                      ++.+++|||||++|+|.+++...               ...+++.++..++.||+.||+|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999643               235889999999999999999999999999999999999999


Q ss_pred             CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCC
Q 008220          198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV  276 (573)
Q Consensus       198 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~  276 (573)
                      ++.+||+|||+++........              .......||+.|||||++.+..++.++|||||||+||||+| |..
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~--------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~  246 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYY--------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ  246 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCB--------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCEEECCcccceeccCCCce--------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCC
Confidence            999999999999866432211              11345679999999999999999999999999999999999 899


Q ss_pred             CCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       277 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ||.+.+.......+              ..+...|    .|..+|+++.+||.+||+.||++|||+.||+++|..
T Consensus       247 Pf~~~~~~~~~~~i--------------~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          247 PYCGYSNQDVVEMI--------------RNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             TTTTCCHHHHHHHH--------------HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHH--------------HcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            99887655443333              2222222    356799999999999999999999999999998853

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-54  Score=435.84  Aligned_cols=267  Identities=27%  Similarity=0.417  Sum_probs=221.9

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEECC-------eeEEEeeccCCC-hHHHHHHHHHHHHHHhCCC-Cccceeee
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKLDH-PGLAKFVA  128 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pnIv~l~~  128 (573)
                      ...++|+.++|++.++||+|+||+||+|.+.+       +.||||.+.... ....+.+.+|+.+|++++| ||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            34578999999999999999999999998632       579999875543 4456789999999999965 99999999


Q ss_pred             cccc-CCceEEEEEeccCCChhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 008220          129 AHAK-PPNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN  192 (573)
Q Consensus       129 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  192 (573)
                      +|.. +..+++|||||++|+|.++++..               ...+++.++..++.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9866 45789999999999999999643               2347899999999999999999999999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                      ||++.++.+||+|||+|+.+.....              .....+..||+.|||||++.+..|+.++|||||||+||||+
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~--------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~  281 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  281 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             eeeCCCCCEEECcchhhhhcccCCC--------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHH
Confidence            9999999999999999986542111              11234568999999999999999999999999999999999


Q ss_pred             c-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       273 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      | |..||.+..........+             . .+.++   ..|..+++++.+||.+||+.||++|||+.||+++|..
T Consensus       282 t~G~~Pf~~~~~~~~~~~~i-------------~-~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          282 SLGASPYPGVKIDEEFCRRL-------------K-EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             TTSCCSSTTCCCSHHHHHHH-------------H-HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHH-------------H-cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            8 999998764333322222             1 12222   2345789999999999999999999999999999998


Q ss_pred             HHHH
Q 008220          352 VLEH  355 (573)
Q Consensus       352 ~~~~  355 (573)
                      +++.
T Consensus       345 llq~  348 (353)
T 4ase_A          345 LLQA  348 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8763

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-53  Score=432.66  Aligned_cols=274  Identities=22%  Similarity=0.283  Sum_probs=219.7

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc------CC
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PP  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~  134 (573)
                      +++|++++.||+|+||+||+|++  +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            46899999999999999999998  5899999987543  33456678899999999999999999998653      46


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+|+|||||. |+|.+++...+ .+++.+++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            7899999996 58999987654 799999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...            .......+.+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.+.......+...
T Consensus       211 ~~~------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          211 SPA------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             -----------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             Ccc------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            111            111224567999999999998875 5699999999999999999999999998887777777654


Q ss_pred             cccHHHH----------HHHHhc--CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYTEQQL----------TAAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~~~~~----------~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...+...          ......  ......+....+.+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            3322110          000000  0111112223456899999999999999999999999999999874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.8e-53  Score=417.32  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=193.4

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC---------
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP---------  134 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---------  134 (573)
                      +|++++.||+|+||+||+|++  +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            589999999999999999997  58899999876543 345678999999999999999999999987544         


Q ss_pred             ---ceEEEEEeccCCChhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          135 ---NYMFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       135 ---~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                         .+|+|||||.||+|.+++.....  ..++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence               37899999999999999975432  2355678999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH-HH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ-AH  288 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~  288 (573)
                      +...........    ...........+.+||+.|||||++.+..|+.++|||||||+||||++   ||........ ..
T Consensus       166 ~~~~~~~~~~~~----~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          166 TAMDQDEEEQTV----LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             ------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             eecCCCcccccc----ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            876542221100    000001112345689999999999999999999999999999999996   8865322111 11


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+              ....+.    ..+...++.+.+||++||+.||++|||+.|+++|.|.
T Consensus       239 ~~--------------~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          239 DV--------------RNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             HH--------------HTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HH--------------hcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            11              111111    1122346778899999999999999999999988764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.5e-53  Score=419.50  Aligned_cols=274  Identities=22%  Similarity=0.284  Sum_probs=210.9

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC----ceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~e  141 (573)
                      ++|.+.++||+|+||+||+|+++|+.||||++..... .......|+..+.+++|||||++++++..+.    .+|+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            5789999999999999999999999999998754322 2223345666667889999999999987653    5799999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ||++|+|.++++..  .++++.+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            99999999999754  588999999999999999999987        99999999999999999999999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC------CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE------IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      .....            ........+||+.|||||++.+.      .++.++|||||||+||||+||.+||.........
T Consensus       160 ~~~~~------------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          160 SATDT------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             TTTTE------------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             CCCCc------------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            32110            01113356899999999999764      3577999999999999999998887543221111


Q ss_pred             H-HHHhccccHHHHHHHHhcCCCCCcccccccC--ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          288 H-TVLEMNYTEQQLTAAVVSGGLRPILASLELG--LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       288 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      . ...........+...+..+..+|.++.....  .+..+.+||.+||+.||++|||+.||++.|..+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1 1111122334445555666777766654332  45688999999999999999999999999987765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-51  Score=443.34  Aligned_cols=255  Identities=24%  Similarity=0.323  Sum_probs=225.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++++.||+|+||+||+|++  +|+.||+|++........+.+.+|+.+|+.++||||++++++|.+...+|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5899999999999999999997  58899999987777777788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC--CCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--LCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~--~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      .||+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.+....     
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-----  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-----  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-----
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-----
Confidence            9999999997666689999999999999999999999999999999999999854  899999999998654211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+.......+....+.     
T Consensus       312 ------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-----  374 (573)
T 3uto_A          312 ------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-----  374 (573)
T ss_dssp             ------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-----
T ss_pred             ------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-----
Confidence                        234568999999999999999999999999999999999999999988776666655543321     


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                .....+..+|+++.+||++||+.||.+|||+.|+++|.|+.
T Consensus       375 ----------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~  415 (573)
T 3uto_A          375 ----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  415 (573)
T ss_dssp             ----------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred             ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence                      11223457899999999999999999999999999999863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.5e-51  Score=416.48  Aligned_cols=281  Identities=25%  Similarity=0.291  Sum_probs=207.7

Q ss_pred             CCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .++|++.++||+|+||+||+|++     +++.||||++....  ....+.+|+++|+.+ +||||++++++|.+.+++|+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            36899999999999999999986     35789999865443  335678999999998 69999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||||++||+|.+++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999999999884    58999999999999999999999999999999999999877 7999999999976543211


Q ss_pred             hhcccccCCC------------CCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCc-hh
Q 008220          218 ISLKNWRSSG------------KPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDL-RA  283 (573)
Q Consensus       218 ~~~~~~~~~~------------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~-~~  283 (573)
                      .......+..            .........+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||... +.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence            1000000000            00011123456899999999999875 5899999999999999999999999544 33


Q ss_pred             HHHHHHHHhccccHHHHHH------------------------HHhcC-CCCC----------cccccccCChHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQLTA------------------------AVVSG-GLRP----------ILASLELGLPASILSLI  328 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~------------------------~~~~~-~~~~----------~~~~~~~~~~~~l~~li  328 (573)
                      ......+.....+......                        ..... ...|          ........+|+++.+||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            3344443332211111100                        00000 0000          00112346889999999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHH
Q 008220          329 QRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       329 ~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ++||+.||++|||++|+++|+|+
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHCcCChhHCcCHHHHhcCccc
Confidence            99999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4e-50  Score=429.85  Aligned_cols=254  Identities=23%  Similarity=0.276  Sum_probs=208.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC------ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS------TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..++|++++.||+|+||.||+|++  +|+.||||++...      ..........++.+++.++|||||+++++|.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            346899999999999999999997  6889999986422      11112223345677778899999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+|||||+||+|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.. 
T Consensus       267 lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~-  344 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-  344 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC-
Confidence            999999999999999998665 799999999999999999999999999999999999999999999999999975432 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                       ....+.+||+.|||||++. +..|+.++|||||||+||||++|.+||.+....... .     
T Consensus       345 -----------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~-----  401 (689)
T 3v5w_A          345 -----------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-----  401 (689)
T ss_dssp             -----------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-H-----
T ss_pred             -----------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H-----
Confidence                             1134578999999999996 467999999999999999999999999764322111 1     


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                           +...+....     ...|..+|+++.+||.+||+.||.+|++     ++||++|+|+-
T Consensus       402 -----i~~~i~~~~-----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          402 -----IDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             -----HHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             -----HHHhhcCCC-----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence                 111111111     1235678999999999999999999998     79999999763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-47  Score=387.36  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=217.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ..+|++.+.||+|+||.||+|.+  +++.||||++...  .....+.+.+|+.+|+.++||||+++++++.+....|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            36899999999999999999997  6889999986433  4456678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......     
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-----  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-----  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-----
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-----
Confidence            9999999999997655 7899999999999999999999999999999999999999999999999998654321     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....+    
T Consensus       168 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----  231 (328)
T 3fe3_A          168 ------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY----  231 (328)
T ss_dssp             ------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----
T ss_pred             ------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----
Confidence                        123456899999999999888765 789999999999999999999988765555444433221    


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                     ..|..+++++.+||++||+.||.+|||+.|+++|+|...
T Consensus       232 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          232 ---------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             ---------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence                           124468999999999999999999999999999988743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-47  Score=379.92  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=216.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999986  6889999987655444567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++...  .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......      
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------  170 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT------
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc------
Confidence            9999999998754  58999999999999999999999999999999999999999999999999986543211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....        
T Consensus       171 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------  232 (297)
T 3fxz_A          171 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------  232 (297)
T ss_dssp             ----------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------
T ss_pred             ----------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence                      12345679999999999999999999999999999999999999998765544433332111        


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                           .  +.+ ..+..+++.+.+||.+||+.||++|||+.|+++|.|...
T Consensus       233 -----~--~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          233 -----T--PEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             -----S--CCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -----C--CCC-CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence                 1  111 123468999999999999999999999999999887643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.9e-46  Score=375.91  Aligned_cols=264  Identities=31%  Similarity=0.496  Sum_probs=215.5

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ...+++..+|++.+.||+|+||+||+|++.++.||||++...  .....+.+.+|+.++++++||||+++++++......
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            346777889999999999999999999999999999986544  344567889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ++||||+.+|+|.+++.....  .+++..++.++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999976432  3899999999999999999999999  999999999999999999999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....                .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..
T Consensus       190 ~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  253 (309)
T 3p86_A          190 ASTF----------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF  253 (309)
T ss_dssp             ----------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred             cccc----------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            3211                113446799999999999999999999999999999999999999987655443332211


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                    ...+   ...+..+++++.+||.+||+.||.+|||+.++++.|..+++.
T Consensus       254 --------------~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          254 --------------KCKR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --------------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --------------cCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                          1111   123457899999999999999999999999999999888764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-47  Score=380.25  Aligned_cols=256  Identities=18%  Similarity=0.275  Sum_probs=221.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+...+++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            47899999999999999999998  57899999876543 4456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC--CCCCeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ++|++|.+++......+++.+++.++.||+.||.|||+.||+||||||+|||++.  ++.+||+|||++......     
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-----  157 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-----  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-----
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-----
Confidence            9999999999876667999999999999999999999999999999999999987  789999999998765321     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......   
T Consensus       158 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---  222 (321)
T 1tki_A          158 ------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---  222 (321)
T ss_dssp             ------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---
T ss_pred             ------------CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---
Confidence                        11345679999999999999889999999999999999999999998876665555554433221   


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  ....+..+++++.+||.+||..||.+|||+.|+++|+|...
T Consensus       223 ------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          223 ------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence                        11223578999999999999999999999999999999753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.9e-47  Score=382.11  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=216.4

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++++.||+|+||.||+|++  +++.||+|++...   .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            346899999999999999999987  5889999986432   12235678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....    
T Consensus        83 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~----  157 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----  157 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc----
Confidence            999999999999987654 789999999999999999999999999999999999999999999999999864321    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  .+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....    
T Consensus       158 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----  221 (337)
T 1o6l_A          158 ------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----  221 (337)
T ss_dssp             ------------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred             ------------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----
Confidence                        1112356789999999999999999999999999999999999999998776554444433211    


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                                .     ..+..+++++.+||.+||+.||++||     ++.|+++|.|+.
T Consensus       222 ----------~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          222 ----------I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ----------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ----------C-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence                      1     13457899999999999999999999     999999998763

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-46  Score=384.77  Aligned_cols=255  Identities=21%  Similarity=0.279  Sum_probs=218.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH------HHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||+|.+......      ..+.+.+|+.+|+.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            36899999999999999999998  5889999976543221      356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYR  212 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~  212 (573)
                      ++||||+.||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            99999999999999997654 789999999999999999999999999999999999998877    7999999998754


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ...                 ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       170 ~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~  232 (361)
T 2yab_A          170 EDG-----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA  232 (361)
T ss_dssp             CTT-----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             CCC-----------------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            321                 113456799999999999999999999999999999999999999988766655555543


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+..               .+..+..+++++.+||.+||..||.+|||+.|+++|+|..
T Consensus       233 ~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          233 VSYDF---------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             TCCCC---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             cCCCC---------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            33221               1223457899999999999999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=385.36  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=212.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|++++.||+|+||.||+|++  +++.||||++...   .......+..|..+++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            35567999999999999999999987  5789999986432   223456678999999988 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-  176 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-  176 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence            999999999999999997655 799999999999999999999999999999999999999999999999999864321 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     ......+.+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.....
T Consensus       177 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  241 (353)
T 3txo_A          177 ---------------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV  241 (353)
T ss_dssp             ------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             ---------------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence                           11123456899999999999999999999999999999999999999998776665555543221


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~~  352 (573)
                                         ..+..+++++.+||++||+.||.+||++      .++++|+|+.
T Consensus       242 -------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          242 -------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence                               1234689999999999999999999999      8899998763

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=375.50  Aligned_cols=268  Identities=26%  Similarity=0.428  Sum_probs=222.9

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ...++..++|++.+.||+|+||.||+|.+.     +..||||++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            345677889999999999999999999872     456999987654 44556789999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ....++||||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999999776668999999999999999999999999999999999999999999999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  291 (573)
                      ......             ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus       202 ~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  268 (325)
T 3kul_A          202 EDDPDA-------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE  268 (325)
T ss_dssp             C----C-------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred             ccCccc-------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            432110             111223456889999999999899999999999999999999 999998765554443332


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                      .              + .++   ..+..+++++.+||.+||+.||++|||+.+|++.|..+.....
T Consensus       269 ~--------------~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          269 E--------------G-YRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             T--------------T-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             c--------------C-CCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            2              1 111   1245789999999999999999999999999999999887543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-45  Score=363.06  Aligned_cols=261  Identities=23%  Similarity=0.395  Sum_probs=222.5

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .+.+..++|++.+.||+|+||.||+|.+ .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            3567788999999999999999999998 678899998764432 23568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+++++|.+++......+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999999999877667899999999999999999999999999999999999999999999999999765432211


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...    
T Consensus       163 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~----  223 (269)
T 4hcu_A          163 ---------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----  223 (269)
T ss_dssp             ---------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----
T ss_pred             ---------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC----
Confidence                           1233457889999999999999999999999999999999 99999876655444333221    


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 ..+   ..+..+++++.+++.+||+.||++|||+.+++++|..+.+
T Consensus       224 -----------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 -----------FRL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------ccC---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                       111   1234678999999999999999999999999999998875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-46  Score=373.64  Aligned_cols=273  Identities=25%  Similarity=0.292  Sum_probs=215.6

Q ss_pred             ccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +-..++|+++++||+|+||+||+|++ +++.||+|++.....  .....+.+|+.+++.++||||+++++++.+....++
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            34457999999999999999999998 688999998654432  234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+ +|.+.+......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......   
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---  172 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP---  172 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC---
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC---
Confidence            9999985 888888776667999999999999999999999999999999999999999999999999998754321   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus       173 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  239 (311)
T 3niz_A          173 -------------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP  239 (311)
T ss_dssp             -------------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred             -------------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence                         011234578999999999876 568999999999999999999999998876655555443321110


Q ss_pred             HH-------HHHHHhcCC----CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQ-------LTAAVVSGG----LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~-------~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..       .........    ...........+++++.+||++||+.||++|||+.|+++|+|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence            00       000000000    0111122345678999999999999999999999999999876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-45  Score=377.74  Aligned_cols=263  Identities=26%  Similarity=0.405  Sum_probs=219.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      +++..++|++.+.||+|+||.||+|++.         +..||||++.... ....+.+.+|+.+|+.+ +||||++++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4667789999999999999999999862         3569999875543 34567899999999999 89999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +.....+|+||||+.+|+|.+++....               ..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999987543               24788999999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||+++.......              ........+|+.|+|||++.+..++.++|||||||++|||++ 
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~  301 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  301 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCT--------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ECCCCCEEEccccCCcccCcccc--------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence            99999999999999975542111              011233467889999999999999999999999999999999 


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |..||.+.........+.               .+.++   ..+..+++++.+||.+||+.||.+|||+.|++++|..++
T Consensus       302 g~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          302 GGSPYPGIPVEELFKLLK---------------EGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             SCCSSTTCCGGGHHHHHH---------------TTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHh---------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            999998765443332221               11122   234578999999999999999999999999999999988


Q ss_pred             HH
Q 008220          354 EH  355 (573)
Q Consensus       354 ~~  355 (573)
                      ..
T Consensus       364 ~~  365 (370)
T 2psq_A          364 TL  365 (370)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=374.86  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=215.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++|++.+.||+|+||.||+|++  +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46899999999999999999987  58899999864321   12356678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....     
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence            99999999999997654 789999999999999999999999999999999999999999999999999865431     


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    ...+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....    
T Consensus       159 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----  220 (318)
T 1fot_A          159 --------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----  220 (318)
T ss_dssp             --------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----
T ss_pred             --------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----
Confidence                          12356799999999999999999999999999999999999999988765555444433211    


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                                     ..+..+++++.+||.+||+.||.+||     +++++++|+|.
T Consensus       221 ---------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f  262 (318)
T 1fot_A          221 ---------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  262 (318)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             ---------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence                           12456899999999999999999999     99999998876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=379.22  Aligned_cols=265  Identities=23%  Similarity=0.389  Sum_probs=221.3

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      ..++..++|++.+.||+|+||+||+|..       .++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3567778999999999999999999984       3568999987543 3455667889999999999999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCe
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPH  202 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~k  202 (573)
                      .....++||||+.+|+|.+++....      ..+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999997543      3588999999999999999999999999999999999999655   499


Q ss_pred             EeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008220          203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL  281 (573)
Q Consensus       203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~  281 (573)
                      |+|||+++........              .......||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       225 L~DFG~a~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~  290 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYY--------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  290 (367)
T ss_dssp             ECCCHHHHHHHHHSSC--------------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ECCCcccccccccccc--------------ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999765432110              11234568999999999999999999999999999999998 99999876


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ........+..              +. ++   ..+..+++++.+||.+||+.||.+|||+.+|+++|+.+....
T Consensus       291 ~~~~~~~~i~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          291 SNQEVLEFVTS--------------GG-RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             CHHHHHHHHHT--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             CHHHHHHHHHc--------------CC-CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            55444333322              11 11   124578999999999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.7e-46  Score=368.44  Aligned_cols=278  Identities=26%  Similarity=0.390  Sum_probs=219.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-  132 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  132 (573)
                      +.++..++|++.++||+|+||+||+|++      +++.||||++........+.+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4567778999999999999999999984      578999999877777777889999999999999999999998754 


Q ss_pred             -CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          133 -PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       133 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                       ...+++||||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             4568999999999999999987666799999999999999999999999999999999999999999999999999976


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .......             ........+++.|+|||++.+..++.++||||||+++|+|++|..||......... ...
T Consensus       164 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~  229 (295)
T 3ugc_A          164 LPQDKEF-------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIG  229 (295)
T ss_dssp             -------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH-HHC
T ss_pred             ccCCcce-------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh-hhc
Confidence            5432110             00123345778899999999999999999999999999999999999765332211 111


Q ss_pred             hccc---cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          292 EMNY---TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       292 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ....   ...........+...    ..+..+++++.+||.+||+.||++|||+.|+++.|..+.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          230 NDKQGQMIVFHLIELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CccccchhHHHHHHHHhccCcC----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1000   011122222222222    12457899999999999999999999999999999888764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=387.37  Aligned_cols=257  Identities=23%  Similarity=0.308  Sum_probs=216.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            5799999999999999999987  68999999865543  3455678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc---CCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.||+|.+.+.... .+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.......  
T Consensus        91 ~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--  167 (444)
T 3soa_A           91 LVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--  167 (444)
T ss_dssp             CCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--
Confidence            999999999987655 789999999999999999999999999999999999998   46789999999986544211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......  
T Consensus       168 --------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--  231 (444)
T 3soa_A          168 --------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--  231 (444)
T ss_dssp             --------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--
T ss_pred             --------------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--
Confidence                          1124567999999999999999999999999999999999999999887665555544432221  


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  . .......+++++.+||.+||+.||.+|||+.|+++|+|....
T Consensus       232 ------------~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 ------------F-PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------C-CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------C-CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                        1 111234689999999999999999999999999999987543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-45  Score=365.63  Aligned_cols=263  Identities=26%  Similarity=0.435  Sum_probs=215.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      .++..++|++.+.||+|+||.||+|.+  .++.||+|.+..   ......+.+.+|+.+++.++||||+++++++.....
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            455568999999999999999999987  578999997643   234556789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +++||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            999999999999999997655 7899999999999999999999999999999999999999999999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..               .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.............  
T Consensus       165 ~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--  227 (294)
T 4eqm_A          165 SL---------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--  227 (294)
T ss_dssp             -------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--
T ss_pred             cc---------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--
Confidence            11               1123457999999999999999999999999999999999999999887654443333221  


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVL  353 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~  353 (573)
                                  ...+.....+..+|+.+.++|.+||+.||.+|| ++.++.+.+..++
T Consensus       228 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          228 ------------SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ------------CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ------------cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                        112222234567899999999999999999999 7888777665543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-45  Score=377.45  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=216.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++...  .....+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            5799999999999999999998  5789999986543  34556789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.+|+|.+.+.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++   .+||+|||++......   
T Consensus       109 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~---  184 (362)
T 2bdw_A          109 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---  184 (362)
T ss_dssp             CCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC---
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC---
Confidence            999999999887554 689999999999999999999999999999999999998654   5999999998654321   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+   
T Consensus       185 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~---  247 (362)
T 2bdw_A          185 --------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY---  247 (362)
T ss_dssp             --------------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred             --------------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---
Confidence                          012346799999999999999999999999999999999999999988765554444433221   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                 .. .......+++++.+||.+||+.||++|||+.++++|+|...
T Consensus       248 -----------~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          248 -----------DY-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             -----------CC-CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             -----------CC-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                       11 11123468999999999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-45  Score=373.32  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=209.1

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCC----hHHHHHHHHHHHHHHhCCCCccceeeecc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPGLAKFVAAH  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  130 (573)
                      +..+..++|++.+.||+|+||.||++++     +++.||+|++....    ......+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            3456678999999999999999999986     57899999865432    23455678999999999999999999999


Q ss_pred             ccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .....+|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999999997655 68999999999999999999999999999999999999999999999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      ......                .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus       170 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  233 (327)
T 3a62_A          170 ESIHDG----------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI  233 (327)
T ss_dssp             -------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccccCC----------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            432111                1134567999999999999999999999999999999999999999887655554444


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                      .....                   ..+..+++++.+||.+||+.||.+||     ++.|+++|+|+
T Consensus       234 ~~~~~-------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          234 LKCKL-------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             HHTCC-------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             HhCCC-------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            33211                   12456899999999999999999999     88899998876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-46  Score=381.38  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=219.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++..........+.+|+.+|+.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            5899999999999999999987  57899999877666666778999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC--CCCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      .+|+|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++.  .+.+||+|||++.......     
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-----  205 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----  205 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-----
Confidence            999999999876667999999999999999999999999999999999999974  5679999999987553211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....+.     
T Consensus       206 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----  268 (387)
T 1kob_A          206 ------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----  268 (387)
T ss_dssp             ------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred             ------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence                        123457999999999999999999999999999999999999999887655554444332211     


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                ........+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       269 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          269 ----------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             ----------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             ----------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence                      11122346899999999999999999999999999988763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=370.66  Aligned_cols=276  Identities=26%  Similarity=0.372  Sum_probs=221.2

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +..++|++.+.||+|+||+||+|.+  +++.||+|++........+.+.+|+++++.++||||+++++++.+....++||
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            4457899999999999999999998  48899999877767777889999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99999999999987666899999999999999999999999999999999999999999999999999976543221100


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                      . .. ..............||+.|+|||++.+..++.++||||||+++|+|++|..||...........     ......
T Consensus       167 ~-~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-----~~~~~~  239 (310)
T 3s95_A          167 G-LR-SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----LNVRGF  239 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----BCHHHH
T ss_pred             c-cc-cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----hhhhcc
Confidence            0 00 0000011112356899999999999999999999999999999999999999875432111000     000000


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ..           ...+..+++++.+||.+||+.||++|||+.++++.|..+....
T Consensus       240 ~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          240 LD-----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HH-----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cc-----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00           0124578889999999999999999999999999998887654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-45  Score=362.14  Aligned_cols=262  Identities=21%  Similarity=0.352  Sum_probs=220.0

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .+++..++|++.+.||+|+||+||++.+. +..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            46788899999999999999999999884 56899998764432 23568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+++|.+++......+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            99999999999999875567999999999999999999999999999999999999999999999999999765432211


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...    
T Consensus       177 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----  237 (283)
T 3gen_A          177 ---------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----  237 (283)
T ss_dssp             ---------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----
T ss_pred             ---------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc----
Confidence                           1223456888999999999999999999999999999998 99999877655444433321    


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                 .++   ..+..+++.+.+||.+||+.||.+|||+.+++++|..+.++
T Consensus       238 -----------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          238 -----------LRL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -----------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------cCC---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                       111   12346789999999999999999999999999999988764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.9e-46  Score=378.46  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=214.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|++.+.||+|+||.||+|++  +++.||||++....   ....+.+..|..+++.+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            45567999999999999999999998  58899999864321   12345678899999877 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  170 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-  170 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence            999999999999999997654 789999999999999999999999999999999999999999999999999864321 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.... 
T Consensus       171 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-  234 (345)
T 1xjd_A          171 ---------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-  234 (345)
T ss_dssp             ---------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred             ---------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-
Confidence                           0112356789999999999999999999999999999999999999998876555544443211 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~  351 (573)
                                     +   ..+..+++++.+||.+||+.||++||++. +|++|+|+
T Consensus       235 ---------------~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f  273 (345)
T 1xjd_A          235 ---------------P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  273 (345)
T ss_dssp             ---------------C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             ---------------C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence                           1   12456899999999999999999999998 88888765

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3e-45  Score=362.30  Aligned_cols=263  Identities=26%  Similarity=0.443  Sum_probs=210.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..++..++|++.+.||+|+||.||+|.+.     +..||+|..... .....+.+.+|+.+++.++||||+++++++. .
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            35777889999999999999999999873     356999986543 3445678999999999999999999999984 5


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +..++||||+.+++|.+++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998776679999999999999999999999999999999999999999999999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....               .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+. 
T Consensus       168 ~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-  231 (281)
T 1mp8_A          168 DSTY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-  231 (281)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred             cccc---------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-
Confidence            2111               01223457889999999999999999999999999999997 999998765444333322 


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                   .+...    ..+..+++++.++|.+||+.||++|||+.+++++|..+.+..
T Consensus       232 -------------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          232 -------------NGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -------------TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------------cCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                         11111    234578999999999999999999999999999999988753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=372.39  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=215.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH------HHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            5799999999999999999998  4889999976543221      3567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+|||++.++    .+||+|||++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            9999999999999997544 789999999999999999999999999999999999999887    79999999987553


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus       170 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~  232 (326)
T 2y0a_A          170 FGN-----------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV  232 (326)
T ss_dssp             TTS-----------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred             CCC-----------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence            210                 123457999999999999999999999999999999999999999877655544444332


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...               .....+..+++.+.+||.+||+.||++|||+.|+++|+|.
T Consensus       233 ~~~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  275 (326)
T 2y0a_A          233 NYE---------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  275 (326)
T ss_dssp             CCC---------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             CCC---------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence            211               1122335789999999999999999999999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-45  Score=381.21  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=211.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|++++.||+|+||.||+|++  +++.||+|++...   .....+.+..|..+++++ +||||+++++++.+...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            34457899999999999999999987  5789999976432   233445678899999887 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence            999999999999999987655 799999999999999999999999999999999999999999999999999864221 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     .+....+.+||+.|+|||++.+..++.++|||||||++|||++|..||..........     ..
T Consensus       206 ---------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-----~~  265 (396)
T 4dc2_A          206 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QN  265 (396)
T ss_dssp             ---------------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------C
T ss_pred             ---------------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-----hh
Confidence                           1112456789999999999999999999999999999999999999996432111100     00


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~  351 (573)
                      ....+...+.....     ..|..+++++.+||++||+.||.+||++      .||++|+|+
T Consensus       266 ~~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff  322 (396)
T 4dc2_A          266 TEDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  322 (396)
T ss_dssp             CHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred             hHHHHHHHHhcccc-----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence            11112222222221     2345789999999999999999999995      789998876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-45  Score=363.84  Aligned_cols=271  Identities=29%  Similarity=0.503  Sum_probs=211.3

Q ss_pred             cCCCccccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           54 CSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        54 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      ......+.+|+.++|++.++||+|+||+||+|++.+ .||+|++...  .....+.+.+|+.+++.++||||++++++. 
T Consensus        12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             ------CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            344556789999999999999999999999998765 4999976543  445667899999999999999999999965 


Q ss_pred             cCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      .....++||||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence            56678999999999999999977766899999999999999999999999999999999999999999999999999875


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      ......              ........||+.|+|||++.   +..++.++||||||+++|+|++|..||..........
T Consensus       170 ~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          170 KSRWSG--------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             ----------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             cccccc--------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            432111              11233457999999999986   5678889999999999999999999998754433322


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..             +..+...+.+......+|+++.+||.+||+.||.+|||+.++++.|..+.
T Consensus       236 ~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          236 EM-------------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HH-------------HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HH-------------hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            22             22333444444555678999999999999999999999999999887654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-45  Score=375.99  Aligned_cols=250  Identities=19%  Similarity=0.275  Sum_probs=216.0

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++++.||+|+||.||+|++  +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            346899999999999999999998  58899999864321   1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....    
T Consensus       119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~----  193 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----  193 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred             EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence            999999999999997655 689999999999999999999999999999999999999999999999999875431    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....   
T Consensus       194 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---  255 (350)
T 1rdq_E          194 ---------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---  255 (350)
T ss_dssp             ---------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred             ---------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---
Confidence                           12356899999999999999999999999999999999999999987765554444433211   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~  352 (573)
                                      ..+..+++++.+||.+||+.||.+||+     +.+|++|.|+.
T Consensus       256 ----------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          256 ----------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence                            134578999999999999999999998     99999988763

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-46  Score=378.70  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=210.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .+|++.+.||+|+||.||+|.+  +++.||||++.....   .....+.+|+.+++.++||||+++++++.++...++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5899999999999999999998  688999998643211   12346889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+ +|+|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......     
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-----  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-----  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-----
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-----
Confidence            999 678988886654 7899999999999999999999999999999999999999999999999998754321     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........          
T Consensus       162 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------  219 (336)
T 3h4j_B          162 ------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------  219 (336)
T ss_dssp             ------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------
T ss_pred             ------------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------
Confidence                        12345679999999999988776 7899999999999999999999986533222111          


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               ........+..+++++.+||++||+.||.+|||+.|+++|+|...
T Consensus       220 ---------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          220 ---------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ---------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ---------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                     111122235578999999999999999999999999999999854

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.9e-45  Score=372.56  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=213.3

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      +..++|++.+.||+|+||.||+|++  +++.||+|++..   ......+.+.+|..+++++ +||||+++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            3446899999999999999999997  478999998643   2445567788999999988 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....  
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--  162 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--  162 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence            99999999999999987654 789999999999999999999999999999999999999999999999999864321  


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    .+......+||+.|+|||++.+..++.++|||||||++|||++|..||..........     ...
T Consensus       163 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~  223 (345)
T 3a8x_A          163 --------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNT  223 (345)
T ss_dssp             --------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------C
T ss_pred             --------------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-----ccc
Confidence                          0112345689999999999999999999999999999999999999996532111000     001


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~  351 (573)
                      .......+.....     ..+..+++++.+||++||+.||.+||++      .|+++|+|+
T Consensus       224 ~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f  279 (345)
T 3a8x_A          224 EDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  279 (345)
T ss_dssp             HHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred             HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence            1111122222221     1345789999999999999999999995      789988876

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-45  Score=364.98  Aligned_cols=269  Identities=24%  Similarity=0.310  Sum_probs=212.4

Q ss_pred             CCccccccccccCceEEEEEEE-CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++++.||+|+||+||+|++ +++.||+|++......  ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5899999999999999999998 4889999987554332  246788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........     
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-----  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-----
Confidence            986 99998877666899999999999999999999999999999999999999999999999999876532110     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH--
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ--  299 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--  299 (573)
                                 ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.........  
T Consensus       156 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          156 -----------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (288)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             -----------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence                       12345789999999999764 5899999999999999999999999887666555554432111000  


Q ss_pred             HHHHHhcCCCCC--------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRP--------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .........+.+        ........+++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            000000000111        1112234689999999999999999999999999998875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-45  Score=376.09  Aligned_cols=254  Identities=21%  Similarity=0.314  Sum_probs=214.6

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC---hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|++++.||+|+||.||+|++.  ++.||||++....   ....+.+..|..++..+ +||||+++++++.+...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            345579999999999999999999984  5789999864321   12356678899999988 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  173 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-  173 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence            999999999999999997655 689999999999999999999999999999999999999999999999999864221 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     .+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus       174 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  238 (353)
T 2i0e_A          174 ---------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV  238 (353)
T ss_dssp             ---------------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             ---------------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence                           11124466899999999999999999999999999999999999999988766555555443221


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~  351 (573)
                                         ..+..+++++.+||++||+.||.+||+     +.+|++|+|+
T Consensus       239 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          239 -------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence                               134578999999999999999999995     6899988875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-45  Score=376.54  Aligned_cols=253  Identities=26%  Similarity=0.347  Sum_probs=204.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHH-HHhCCCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQL-LCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      .+..++|++++.||+|+||.||+|++  +++.||||++...   .......+..|..+ ++.++||||+++++++.+...
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            34557899999999999999999998  4778999976432   22334556677776 577899999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999997654 7899999999999999999999999999999999999999999999999998643210


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus       193 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  256 (373)
T 2r5t_A          193 ----------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL  256 (373)
T ss_dssp             ----------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC
T ss_pred             ----------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Confidence                            1123467899999999999999999999999999999999999999988766655555443211


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELD  350 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~  350 (573)
                                         ..+..+++++.+||++||+.||.+||++.    ++++|.|
T Consensus       257 -------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~  296 (373)
T 2r5t_A          257 -------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF  296 (373)
T ss_dssp             -------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence                               12457899999999999999999999974    5555554

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.2e-45  Score=375.00  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=205.1

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +.....++|++.+.||+|+||+||++++  +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus        14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            4455668999999999999999999998  588999998654322 2356789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--CeEeeeecchhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGLAEYRENL  215 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~  215 (573)
                      +||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        93 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999999987655 7999999999999999999999999999999999999987765  999999998643211


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK-SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                       .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+............  
T Consensus       172 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--  232 (361)
T 3uc3_A          172 -----------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--  232 (361)
T ss_dssp             --------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH--
T ss_pred             -----------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH--
Confidence                             01234579999999999988877655 8999999999999999999987543322222211  


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                              .+......  ++ ....+++++.+||.+||+.||++|||+.|+++|+|...
T Consensus       233 --------~~~~~~~~--~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          233 --------RILSVKYS--IP-DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             --------HHHTTCCC--CC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             --------HHhcCCCC--CC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence                    11111111  11 12357899999999999999999999999999999853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-45  Score=375.07  Aligned_cols=267  Identities=25%  Similarity=0.440  Sum_probs=212.2

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ...++...+|++.+.||+|+||.||+|++.     +..||||++... .....+.+.+|+.++++++||||+++++++..
T Consensus        38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            345677789999999999999999999763     567999987654 34456789999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ....++||||+++++|.+++...+..+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999999999877667999999999999999999999999999999999999999999999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  291 (573)
                      ......             ........+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.
T Consensus       198 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~  264 (373)
T 2qol_A          198 EDDPEA-------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD  264 (373)
T ss_dssp             -----------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred             ccCCcc-------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            432110             001122346788999999999999999999999999999998 999998765544333322


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .               ..+.   ..+..++.++.+||.+||+.||++||++.+|++.|..+....
T Consensus       265 ~---------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 E---------------GYRL---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             T---------------TEEC---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             c---------------CCCC---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            1               1111   123468999999999999999999999999999999887643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=376.64  Aligned_cols=256  Identities=20%  Similarity=0.288  Sum_probs=214.2

Q ss_pred             CCccc--cccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTL--LSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~--~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ..|.+  .+.||+|+||.||+|.+  +++.||+|++........+.+.+|+.+|++++||||+++++++......++|||
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            34555  67899999999999987  588999999877766777889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE--cCCCCCeEeeeecchhhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL--DRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |+++++|.+++......+++..++.++.||+.||+|||+.||+||||||+|||+  +.++.+||+|||+++......   
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            999999999987666678999999999999999999999999999999999999  567789999999987553211   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....+.   
T Consensus       244 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---  306 (373)
T 2x4f_A          244 --------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD---  306 (373)
T ss_dssp             --------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---
T ss_pred             --------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---
Confidence                          123457999999999999999999999999999999999999999887766655555433221   


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  ........+++++.+||.+||+.||.+|||+.|+++|+|...
T Consensus       307 ------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          307 ------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             ------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             ------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence                        111223568999999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-45  Score=361.34  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=218.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++..++|++.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            4567789999999999999999999884 56899998654432 345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........  
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  159 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--  159 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE--
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh--
Confidence            999999999999987666799999999999999999999999999999999999999999999999999875532111  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..      
T Consensus       160 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------  220 (268)
T 3sxs_A          160 -------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------  220 (268)
T ss_dssp             -------------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------
T ss_pred             -------------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc------
Confidence                         11223456788999999999889999999999999999999 9999987655544333321      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                              + ..+   ..+...++++.++|.+||+.||.+|||+.+++++|..+.+
T Consensus       221 --------~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          221 --------G-HRL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --------T-CCC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --------C-CCC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                    1 111   1234578999999999999999999999999999876654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=366.40  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=205.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--------------------------HHHHHHHHHHHH
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------------------------EELDNFHKELQL  114 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~  114 (573)
                      +..++|++.+.||+|+||.||+|++  +++.||||++.....                          ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            3447999999999999999999987  578999998654321                          123568899999


Q ss_pred             HHhCCCCccceeeecccc--CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 008220          115 LCKLDHPGLAKFVAAHAK--PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN  192 (573)
Q Consensus       115 l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  192 (573)
                      ++.++||||+++++++.+  ....++||||+++++|.+++..  ..+++.+++.++.||+.||+|||+.||+||||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999886  5679999999999999887643  368999999999999999999999999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC---CCchhhHHHHHHHHH
Q 008220          193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISIN  269 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~  269 (573)
                      ||++.++.+||+|||++.......                .......||+.|+|||++.+..   ++.++|||||||++|
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~  231 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSD----------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY  231 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSS----------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEecCCCcccccccc----------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence            999999999999999987543211                1123457999999999998765   378899999999999


Q ss_pred             HHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       270 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      +|++|..||.+.........+..              .....   .....+++++.+||.+||+.||++|||+.|+++|+
T Consensus       232 ~l~~g~~pf~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          232 CFVFGQCPFMDERIMCLHSKIKS--------------QALEF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHH--------------CCCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             HHHHCCCCCCCccHHHHHHHHhc--------------ccCCC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            99999999987654433322221              11111   11246899999999999999999999999999999


Q ss_pred             HH
Q 008220          350 DL  351 (573)
Q Consensus       350 ~~  351 (573)
                      |.
T Consensus       295 ~~  296 (298)
T 2zv2_A          295 WV  296 (298)
T ss_dssp             HH
T ss_pred             cc
Confidence            86

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-45  Score=378.78  Aligned_cols=265  Identities=25%  Similarity=0.366  Sum_probs=221.2

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+++..++|++.+.||+|+||.||+|.+  +++.||||.+... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            34677888999999999999999999998  5889999986544 23445678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+++|+|.+++...+..+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999999876667899999999999999999999999999999999999999999999999998653321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ...              .......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.   
T Consensus       267 ~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~---  329 (377)
T 3cbl_A          267 VYA--------------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---  329 (377)
T ss_dssp             EEE--------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH---
T ss_pred             cee--------------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            000              00122346778999999998889999999999999999998 999998765443322221   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                 .+ .+.   ..+..+|+++.+||.+||+.||++|||+.+|++.|..+.+.
T Consensus       330 -----------~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          330 -----------KG-GRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -----------TT-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------cC-CCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                       11 111   12456899999999999999999999999999999887653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=372.49  Aligned_cols=267  Identities=27%  Similarity=0.395  Sum_probs=223.7

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceee
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFV  127 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~  127 (573)
                      ..++++.++|++.+.||+|+||.||+|++.         +..||||++... .......+.+|+++++.+ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            346788899999999999999999999862         257999987554 344567899999999999 899999999


Q ss_pred             eccccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 008220          128 AAHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN  192 (573)
Q Consensus       128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  192 (573)
                      +++......++||||+.+|+|.+++....               ..+++.+++.++.||+.||+|||+.||+||||||+|
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            99999999999999999999999997543               358999999999999999999999999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                      ||++.++.+||+|||+++.......              ........+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell  287 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  287 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCT--------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccc--------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence            9999999999999999875542111              01123446788999999999999999999999999999999


Q ss_pred             c-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       273 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      + |..||...........+..               ..++   ..+..+++++.+||.+||+.||++|||+.||+++|..
T Consensus       288 t~g~~p~~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          288 TLGGSPYPGVPVEELFKLLKE---------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             TTSCCSSTTCCHHHHHHHHHT---------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hCCCCCCCCCCHHHHHHHHHc---------------CCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9 9999987655443333221               1111   1245789999999999999999999999999999999


Q ss_pred             HHHHhc
Q 008220          352 VLEHRK  357 (573)
Q Consensus       352 ~~~~~~  357 (573)
                      +.....
T Consensus       350 ~~~~~~  355 (382)
T 3tt0_A          350 IVALTS  355 (382)
T ss_dssp             HHHHSC
T ss_pred             HHHHHh
Confidence            987543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-45  Score=370.66  Aligned_cols=279  Identities=27%  Similarity=0.335  Sum_probs=221.7

Q ss_pred             ccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC----c
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----N  135 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~  135 (573)
                      .+.+..++|++.++||+|+||+||+|++.++.||||++.... ........|+.+++.++||||+++++++....    .
T Consensus        18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            355777899999999999999999999999999999875443 33445667999999999999999999998754    3


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCceEEcCCCCCeEee
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL----------GIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                      +++||||+++|+|.+++...  .+++..++.++.|++.||+|||+.          ||+||||||+|||++.++.+||+|
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            79999999999999999654  589999999999999999999999          999999999999999999999999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTD  280 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~Pf~~  280 (573)
                      ||+++.......              ........||+.|+|||++.+.     .++.++|||||||++|||++|..||.+
T Consensus       175 Fg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          175 FGLALKFEAGKS--------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             CTTCEEECTTSC--------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             CCcccccccccC--------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            999976542111              0112345799999999999873     456688999999999999999999976


Q ss_pred             chhHHHH--HHHHhccccHHHHHHHHhcCCCCCccccccc--CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          281 LRAEAQA--HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       281 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .......  ................+.....++.++....  ..++++.+||.+||+.||++|||+.|+++.|..+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            4332111  1111222233444445555555665544322  3456799999999999999999999999999988753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.2e-46  Score=386.54  Aligned_cols=263  Identities=24%  Similarity=0.279  Sum_probs=219.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.++||+|+||+||+|++  +++.||+|++.....   .....+.+|..+++.++||||+++++++.+...
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            345667999999999999999999998  478999998643211   112237889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.||+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            99999999999999999876668999999999999999999999999999999999999999999999999998654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      .               .......+||+.|+|||++.     ...++.++|||||||++|||++|..||.+.+.......+
T Consensus       229 ~---------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          229 G---------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             S---------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             C---------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            1               11233468999999999987     456899999999999999999999999987766665555


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV  352 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~  352 (573)
                      +....              +..++.....+++++.+||++||..+|++  ||+++|+++|+|+.
T Consensus       294 ~~~~~--------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          294 MNHKE--------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HTHHH--------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             hhccc--------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            43211              11122223468999999999999998888  99999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-45  Score=373.79  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=212.1

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-----hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||||++....     ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999987  57899999754321     113567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchh
Q 008220          138 FFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEY  211 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~  211 (573)
                      +||||+.+++|.+.+...   +..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877542   335899999999999999999999999999999999999987655   99999999875


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ....                ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .....+.
T Consensus       183 ~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~  245 (351)
T 3c0i_A          183 LGES----------------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII  245 (351)
T ss_dssp             CCTT----------------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH
T ss_pred             ecCC----------------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH
Confidence            5421                1113445799999999999999999999999999999999999999987532 2222222


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .              +... ..+..+..+++++.+||.+||+.||++|||+.|+++|.|...
T Consensus       246 ~--------------~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          246 K--------------GKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             H--------------TCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             c--------------CCCC-CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            2              1111 111223568999999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-45  Score=371.69  Aligned_cols=257  Identities=26%  Similarity=0.359  Sum_probs=209.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            36899999999999999999987  588999998654433 234668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++.... .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........    
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----  160 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----  160 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE----
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc----
Confidence            999999999987554 689999999999999999999999999999999999999999999999999975532111    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..............        
T Consensus       161 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------  222 (323)
T 3tki_A          161 ----------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------  222 (323)
T ss_dssp             ----------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--------
T ss_pred             ----------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------
Confidence                      011345679999999999987765 7789999999999999999999986543322111111        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           .....   ......+++++.+||.+||+.||++|||+.|+++|.|..
T Consensus       223 -----~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          223 -----EKKTY---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             -----TTCTT---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             -----ccccc---CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence                 01100   111246789999999999999999999999999998874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-45  Score=369.09  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=220.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEECC-------eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      .+++..++|++.+.||+|+||.||+|++.+       +.||||.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            356778899999999999999999998753       78999987654 3445678999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV  188 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl  188 (573)
                      .....++||||+.+++|.+++....                       ..+++.+++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            9999999999999999999987532                       46899999999999999999999999999999


Q ss_pred             CCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHH
Q 008220          189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI  268 (573)
Q Consensus       189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  268 (573)
                      ||+|||++.++.+||+|||++.........              .......||+.|+|||++.+..++.++|||||||++
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il  266 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYY--------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL  266 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCB--------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccc--------------cccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence            999999999999999999999765432110              012345688999999999999999999999999999


Q ss_pred             HHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 008220          269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL  347 (573)
Q Consensus       269 ~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  347 (573)
                      |+|++ |..||.+.........+..              +..    ...+..+++++.+||++||+.||++|||+.++++
T Consensus       267 ~el~t~g~~p~~~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          267 WEIFSYGLQPYYGMAHEEVIYYVRD--------------GNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHT--------------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCcCCCCChHHHHHHHhC--------------CCc----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999 9999987655444333322              211    1234578999999999999999999999999999


Q ss_pred             HHHHHHHH
Q 008220          348 ELDLVLEH  355 (573)
Q Consensus       348 ~l~~~~~~  355 (573)
                      +|..+.+.
T Consensus       329 ~L~~~~~~  336 (343)
T 1luf_A          329 ILQRMCER  336 (343)
T ss_dssp             HHHHTTC-
T ss_pred             HHHHHHhh
Confidence            99877653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-45  Score=385.27  Aligned_cols=255  Identities=23%  Similarity=0.345  Sum_probs=217.3

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .+...+|.+.+.||+|+||.||+|++  +++.||||++.....   .....+.+|+.+++.++||||+++++++.+....
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            44457899999999999999999998  589999998643321   2346788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+.+|+|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...... 
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            99999999999999997554 7999999999999999999999999999999999999999999999999998754321 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+.... 
T Consensus       170 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-  232 (476)
T 2y94_A          170 ----------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-  232 (476)
T ss_dssp             ----------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-
T ss_pred             ----------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-
Confidence                            12345679999999999988765 689999999999999999999998765544444333211 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                   .     ..+..+++++.+||++||+.||.+|||+.|+++|.|...
T Consensus       233 -------------~-----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 -------------F-----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -------------C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -------------c-----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                         1     124468999999999999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-44  Score=355.00  Aligned_cols=253  Identities=32%  Similarity=0.503  Sum_probs=205.4

Q ss_pred             ccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCCh----HHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTS----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ++..++|++.+.||+|+||.||+|.+.++.||||+......    ...+.+.+|+++++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            56678999999999999999999999999999998654432    23567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCceEEcC--------CCCCeEeee
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG---IVHRDVKPANVLLDR--------NLCPHLADF  206 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiH~Dlkp~Nill~~--------~~~~kL~Df  206 (573)
                      +||||+.+++|.+++..  ..+++..++.++.|++.||+|||+.|   |+||||||+||+++.        ++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999999853  36899999999999999999999999   899999999999986        778999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      |++......                  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+......
T Consensus       161 g~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  222 (271)
T 3dtc_A          161 GLAREWHRT------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV  222 (271)
T ss_dssp             CC-------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             Ccccccccc------------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998754321                  12245689999999999999999999999999999999999999987655443


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ......              .....   ..+..+++++.++|.+||+.||.+|||+.|++++|..
T Consensus       223 ~~~~~~--------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          223 AYGVAM--------------NKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHHHT--------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHhhhc--------------CCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            333221              22111   2345789999999999999999999999999998863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-45  Score=362.69  Aligned_cols=269  Identities=24%  Similarity=0.263  Sum_probs=210.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.++||+|+||+||+|.+  +++.||||++....  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5899999999999999999998  57899999865432  3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+ +|.+.+......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......      
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~------  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP------  154 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC------
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc------
Confidence            9986 666666555568999999999999999999999999999999999999999999999999998654311      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCC-CCCchhHHHHHHHHhccccHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                ........||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...........+.........
T Consensus       155 ----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          155 ----------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             ----------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ----------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence                      11234457899999999998765 79999999999999999987777 5555444444444332111100


Q ss_pred             HH--HHHhcCCC--------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 LT--AAVVSGGL--------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 ~~--~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..  ........        ...+......+++++.+||++||+.||++|||+.|+++|+|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence            00  00000000        001111234578999999999999999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.9e-45  Score=372.26  Aligned_cols=266  Identities=27%  Similarity=0.432  Sum_probs=218.8

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..++++.++|++.+.||+|+||.||+|++       +++.||||++... .....+.+.+|+++++++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            35778889999999999999999999984       3478999987654 344567799999999999 79999999999


Q ss_pred             cccCC-ceEEEEEeccCCChhhhhhccCC---------------------------------------------------
Q 008220          130 HAKPP-NYMFFFEFYESRNLAEKLHVEEW---------------------------------------------------  157 (573)
Q Consensus       130 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------  157 (573)
                      +.... .+++||||+.+|+|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            88755 48999999999999999875432                                                   


Q ss_pred             --------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          158 --------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       158 --------------~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                                    .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........      
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------  248 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------  248 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT------
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc------
Confidence                          188999999999999999999999999999999999999999999999999975532111      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                              ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+............          
T Consensus       249 --------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----------  310 (359)
T 3vhe_A          249 --------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----------  310 (359)
T ss_dssp             --------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----------
T ss_pred             --------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----------
Confidence                    112345678999999999999999999999999999999998 9999987543332222221          


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                         .+. .+   ..+..+++++.++|.+||+.||.+|||+.|++++|..+++.
T Consensus       311 ---~~~-~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          311 ---EGT-RM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---HTC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cCC-CC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence               111 11   23456899999999999999999999999999999988864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-44  Score=353.17  Aligned_cols=260  Identities=23%  Similarity=0.398  Sum_probs=221.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +.+..++|++.+.||+|+||.||+|.+ .++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            567778999999999999999999998 678899998655432 346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+++++|.+++......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  160 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  160 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence            9999999999999877667899999999999999999999999999999999999999999999999998765422111 


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+..      
T Consensus       161 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~------  220 (267)
T 3t9t_A          161 --------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------  220 (267)
T ss_dssp             --------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------
T ss_pred             --------------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc------
Confidence                          1223457889999999999999999999999999999999 9999987655444333321      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                              + .++   ..+..+++.+.+++.+||+.||++|||+.+++++|..+.+
T Consensus       221 --------~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 --------G-FRL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --------T-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------C-CcC---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    1 111   1234678999999999999999999999999999988875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=375.97  Aligned_cols=257  Identities=25%  Similarity=0.349  Sum_probs=211.5

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++++.||+|+||.||+|.+  +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            455667999999999999999999987  57889999754321   1235678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .|+||||+.||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999999997654 7999999999999999999999999999999999999999999999999999754321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                                       ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||..........    
T Consensus       169 -----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----  227 (384)
T 4fr4_A          169 -----------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----  227 (384)
T ss_dssp             -----------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----
T ss_pred             -----------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----
Confidence                             12356789999999999964   458999999999999999999999997543221111    


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~  351 (573)
                             ....+....     ...+..+++++.+||.+||+.||.+||+ +.++++|+|+
T Consensus       228 -------~~~~~~~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f  275 (384)
T 4fr4_A          228 -------IVHTFETTV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM  275 (384)
T ss_dssp             -------HHHHHHHCC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred             -------HHHHHhhcc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence                   111111111     1234578999999999999999999998 8888877755

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.7e-45  Score=377.48  Aligned_cols=283  Identities=22%  Similarity=0.273  Sum_probs=215.5

Q ss_pred             cccCCCCcccccccccc--CceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARG--AESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +....++|++.++||+|  +||.||+|++  +++.||||++...  .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34455799999999999  9999999998  4889999986543  3455678889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      .+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999998754 2468999999999999999999999999999999999999999999999999886443


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ......         ...........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.........+.
T Consensus       180 ~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  250 (389)
T 3gni_B          180 SHGQRQ---------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  250 (389)
T ss_dssp             ETTEEC---------SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred             cccccc---------cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            211100         001112334579999999999987  678999999999999999999999998765544443333


Q ss_pred             hccccHHH---------HH-------------HHHhcC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHH
Q 008220          292 EMNYTEQQ---------LT-------------AAVVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD  344 (573)
Q Consensus       292 ~~~~~~~~---------~~-------------~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  344 (573)
                      ........         ..             ......     .........+..+++++.+||++||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            22111000         00             000000     0000011134568899999999999999999999999


Q ss_pred             HHHHHHHH
Q 008220          345 IALELDLV  352 (573)
Q Consensus       345 ll~~l~~~  352 (573)
                      +++|+|..
T Consensus       331 ll~hp~f~  338 (389)
T 3gni_B          331 LLNHSFFK  338 (389)
T ss_dssp             HTTSGGGG
T ss_pred             HhcCHHHH
Confidence            99998763

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-44  Score=355.14  Aligned_cols=255  Identities=21%  Similarity=0.369  Sum_probs=216.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC--Cce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~  136 (573)
                      ..+..++|++.+.||+|+||.||+|+++++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            3566689999999999999999999999999999986654  345567899999999999999999999999877  788


Q ss_pred             EEEEEeccCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+.|  |+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999999976543 5899999999999999999999999  9999999999999999999999999864322


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCc---hhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE---KSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                                           .....||+.|+|||++.+..++.   ++|||||||++|+|++|..||.+.........+
T Consensus       165 ---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          165 ---------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             ---------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             ---------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence                                 23456899999999998765444   899999999999999999999876554443333


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .              ....++   ..+..+++++.++|.+||+.||++|||+.++++.|..+.
T Consensus       224 ~--------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 A--------------LEGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             H--------------HSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             H--------------hcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2              222222   234578999999999999999999999999999887764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-44  Score=363.18  Aligned_cols=262  Identities=25%  Similarity=0.337  Sum_probs=210.4

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc---
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN---  135 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---  135 (573)
                      ..++|++.+.||+|+||.||+|++  +++.||||++...   .......+.+|+.+++.++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            347899999999999999999997  6889999987543   33445678999999999999999999999876554   


Q ss_pred             -eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 -YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                       .|+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence             499999999999999997655 789999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ....             ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..............
T Consensus       169 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~  235 (311)
T 3ork_A          169 SGNS-------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED  235 (311)
T ss_dssp             --------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred             cccc-------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            1110             011234579999999999999999999999999999999999999998876555444433322


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..              + ....+..+++++.+||.+||+.||.+||++.+++.+.+....
T Consensus       236 ~~--------------~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          236 PI--------------P-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CC--------------C-HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CC--------------C-cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            11              1 112245689999999999999999999999998888776654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.3e-45  Score=367.63  Aligned_cols=271  Identities=23%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .++|++++.||+|+||.||+|.+  +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            36899999999999999999987  588999998654432 234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          142 FYESRNLAEKLHVEE-----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+.+ +|.+++....     ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            9984 9988886432     358999999999999999999999999999999999999999999999999987543210


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       163 ----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  226 (317)
T 2pmi_A          163 ----------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG  226 (317)
T ss_dssp             ----------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ----------------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence                            01234578999999999976 4689999999999999999999999998776666555543211


Q ss_pred             cHHHHHH-HH-hcCCCCCc-------------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 TEQQLTA-AV-VSGGLRPI-------------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~-~~-~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ......+ .+ ....+.+.             .+..+..+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence            1000000 00 00000000             0112236789999999999999999999999999998763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=368.95  Aligned_cols=266  Identities=26%  Similarity=0.390  Sum_probs=218.5

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..++++.++|++.+.||+|+||.||+|.+       .+..||||++.... ....+.+.+|+.+++++ +||||++++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34788889999999999999999999986       34679999875432 33456789999999999 89999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEEW----------------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRD  187 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~iiH~D  187 (573)
                      +......++||||+++|+|.+++.....                      .+++..++.++.||+.||+|||+.||+|||
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  197 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD  197 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            9999999999999999999999976542                      378899999999999999999999999999


Q ss_pred             CCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHH
Q 008220          188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS  267 (573)
Q Consensus       188 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  267 (573)
                      |||+|||++.++.+||+|||++........              ........||+.|+|||++.+..++.++|||||||+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i  263 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSN--------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL  263 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCcc--------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHH
Confidence            999999999999999999999976542111              112334568899999999999999999999999999


Q ss_pred             HHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 008220          268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA  346 (573)
Q Consensus       268 l~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell  346 (573)
                      +|+|++ |..||.+..........+.              ....+   ..+..+++++.+||.+||+.||.+|||+.+++
T Consensus       264 l~el~t~g~~p~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  326 (344)
T 1rjb_A          264 LWEIFSLGVNPYPGIPVDANFYKLIQ--------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  326 (344)
T ss_dssp             HHHHTTTSCCSSTTCCCSHHHHHHHH--------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHcCCCCCcccCCcHHHHHHHHh--------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            999998 9999987654333222221              12222   22446899999999999999999999999999


Q ss_pred             HHHHHHHHH
Q 008220          347 LELDLVLEH  355 (573)
Q Consensus       347 ~~l~~~~~~  355 (573)
                      ++|+.++..
T Consensus       327 ~~l~~~~~~  335 (344)
T 1rjb_A          327 SFLGCQLAD  335 (344)
T ss_dssp             HHHHHHC--
T ss_pred             HHHHHHHHH
Confidence            999888764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-44  Score=380.16  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=217.3

Q ss_pred             ccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC-ceEE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-NYMF  138 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~l  138 (573)
                      .+++..++|++.+.||+|+||.||+|.+.++.||||.+....  ..+.+.+|+.+|++++||||+++++++.... ..++
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            457788899999999999999999999999999999876543  4567899999999999999999999976654 7999


Q ss_pred             EEEeccCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||||+.+|+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....   
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc---
Confidence            9999999999999986553 368999999999999999999999999999999999999999999999999864321   


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                      ......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.     
T Consensus       342 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----  400 (450)
T 1k9a_A          342 ----------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----  400 (450)
T ss_dssp             ---------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-----
T ss_pred             ----------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence                            0122357889999999999999999999999999999998 999998765443332221     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                .+.++   ..+..+|+++.+||.+||+.||++|||+.+|++.|..+...
T Consensus       401 ----------~~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          401 ----------KGYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                      12222   23457899999999999999999999999999999887653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=381.82  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=216.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .+..++|++.+.||+|+||.||+|++  +++.||||++....   ....+.+.+|..++..++||||+++++++.+...+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            45567999999999999999999998  58899999864321   12234578899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+||||++||+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998766679999999999999999999999999999999999999999999999999987543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                                     .......+||+.|+|||++.       ...++.++|||||||++|||++|..||...+.......
T Consensus       217 ---------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          217 ---------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             ---------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             ---------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                           11123468999999999987       35689999999999999999999999988776665555


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell~~l~~~  352 (573)
                      +.....              ...++..+..+|+++.+||++||. +|.+|   |+++|+++|.|+.
T Consensus       282 i~~~~~--------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          282 IVHYKE--------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             HHTHHH--------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             HHhccc--------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            543210              011122235789999999999999 99998   5999999998863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3e-44  Score=360.59  Aligned_cols=266  Identities=26%  Similarity=0.390  Sum_probs=222.2

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..++++.++|++.+.||+|+||.||+|.+       .++.||+|++.... ....+.+.+|+.+++++ +||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            34678889999999999999999999985       35789999876443 34567899999999999 89999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEEW-----------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN  192 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~N  192 (573)
                      +......++||||+++|+|.+++.....                 .+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            9999999999999999999999876542                 48999999999999999999999999999999999


Q ss_pred             eEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                      |+++.++.+||+|||++........              ........||+.|+|||++.+..++.++||||||+++|+|+
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  241 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF  241 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTT--------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEcCCCCEEEcccccccccccccc--------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence            9999999999999999876542111              11123456788999999999999999999999999999999


Q ss_pred             c-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       273 t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      + |..||...............              ..++   ..+..+++++.+||.+||+.||.+|||+.+++++|..
T Consensus       242 t~g~~p~~~~~~~~~~~~~~~~--------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          242 SLGSSPYPGMPVDSKFYKMIKE--------------GFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             TTTCCSSTTCCSSHHHHHHHHH--------------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hCCCCCCCcccchhHHHHHhcc--------------CCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            9 99999876443332222211              1111   1234689999999999999999999999999999998


Q ss_pred             HHHH
Q 008220          352 VLEH  355 (573)
Q Consensus       352 ~~~~  355 (573)
                      ++..
T Consensus       305 ~~~~  308 (313)
T 1t46_A          305 QISE  308 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-44  Score=362.74  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=220.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      .+++..++|++.+.||+|+||.||+|.+       .++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            4677788999999999999999999986       2378999987544 3455678999999999999999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV  188 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dl  188 (573)
                      .....++||||+.+++|.+++....                       ..+++.+++.++.||+.||+|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            9999999999999999999997543                       23789999999999999999999999999999


Q ss_pred             CCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHH
Q 008220          189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI  268 (573)
Q Consensus       189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  268 (573)
                      ||+||+++.++.+||+|||++........              ........+|+.|+|||++.+..++.++|||||||++
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  242 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDS--------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL  242 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSC--------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             chheEEEcCCCCEEEcccccccccccccc--------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence            99999999999999999999875542111              0112344678899999999998899999999999999


Q ss_pred             HHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 008220          269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL  347 (573)
Q Consensus       269 ~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  347 (573)
                      |+|++ |..||.+.........+..              + ..   ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       243 ~el~t~g~~p~~~~~~~~~~~~~~~--------------~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          243 WEIVTLGGNPYPGIPPERLFNLLKT--------------G-HR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             HHHHTTSCCSSTTCCGGGHHHHHHT--------------T-CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHhhc--------------C-Cc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999 9999987654433322211              1 11   1234578999999999999999999999999999


Q ss_pred             HHHHHHHH
Q 008220          348 ELDLVLEH  355 (573)
Q Consensus       348 ~l~~~~~~  355 (573)
                      +|..++..
T Consensus       305 ~l~~~~~~  312 (314)
T 2ivs_A          305 DLEKMMVK  312 (314)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHhh
Confidence            99988764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-44  Score=359.09  Aligned_cols=271  Identities=21%  Similarity=0.277  Sum_probs=219.8

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..+..++|++.+.||+|+||.||+|.+  +++.||||++....  ..+.+.+|+.+++.+ +|+||+++++++......+
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            355678999999999999999999996  68999999864332  234577899999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC-----CeEeeeecchhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-----PHLADFGLAEYR  212 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~-----~kL~Dfg~a~~~  212 (573)
                      +||||+ +++|.+++...+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||++...
T Consensus        83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999999 99999999876667999999999999999999999999999999999999987776     999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH---HHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE---AQAHT  289 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~  289 (573)
                      .......         ...........||+.|+|||++.+..++.++|||||||++|+|++|..||......   .....
T Consensus       162 ~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          162 RDPVTKQ---------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             BCTTTCC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             ccccccc---------cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            4321100         00011234567999999999999999999999999999999999999999874322   11111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                      +...              ...+..+.....+|+++.+||.+||+.||++|||+.+|++.|..+.+...
T Consensus       233 ~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          233 IGEK--------------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHH--------------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhh--------------ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            1111              11122223345789999999999999999999999999999999887543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-45  Score=385.74  Aligned_cols=267  Identities=22%  Similarity=0.285  Sum_probs=207.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++++.||+|+||+||+|.+  +++.||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            37899999999999999999987  5889999986543  445567888999999999999999999998654      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+||||+.+ +|.+.+..   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            57999999987 46555532   488999999999999999999999999999999999999999999999999975432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                       .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......++...
T Consensus       217 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l  279 (464)
T 3ttj_A          217 -----------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  279 (464)
T ss_dssp             -----------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             -----------------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence                             112345689999999999999999999999999999999999999999887777766665432


Q ss_pred             ccHHHH--------HHHHhcCCC-C--Cccccc-c-----------cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          295 YTEQQL--------TAAVVSGGL-R--PILASL-E-----------LGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       295 ~~~~~~--------~~~~~~~~~-~--~~~~~~-~-----------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+...        ......... .  ..++.. +           ...++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence            221100        000111100 0  000000 0           0126789999999999999999999999999987


Q ss_pred             H
Q 008220          352 V  352 (573)
Q Consensus       352 ~  352 (573)
                      .
T Consensus       360 ~  360 (464)
T 3ttj_A          360 N  360 (464)
T ss_dssp             G
T ss_pred             h
Confidence            5

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-44  Score=364.80  Aligned_cols=252  Identities=22%  Similarity=0.351  Sum_probs=214.2

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEecc
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      .|...++||+|+||.||+|++  +++.||||++........+.+.+|+.+++.++||||+++++++......++||||+.
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            477888999999999999987  589999998766655566788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccccc
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR  224 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~  224 (573)
                      +++|.+++..  ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......         
T Consensus       126 ~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---------  194 (321)
T 2c30_A          126 GGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---------  194 (321)
T ss_dssp             SCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---------
T ss_pred             CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC---------
Confidence            9999999864  36899999999999999999999999999999999999999999999999998654321         


Q ss_pred             CCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                             ........||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....          
T Consensus       195 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------  257 (321)
T 2c30_A          195 -------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----------  257 (321)
T ss_dssp             -------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS----------
T ss_pred             -------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------
Confidence                   011345679999999999999999999999999999999999999998765544333322111          


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           .+.+. .+..+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       258 -----~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          258 -----PPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             -----CCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             -----CCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence                 11111 1335789999999999999999999999999998874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.9e-44  Score=355.68  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=215.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++.+.||+|+||.||+|.+  ++..||+|++........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            5799999999999999999998  45689999865544445678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhhhhhc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .+++|.+++.... .+++.+++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||++......     
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-----  162 (277)
T 3f3z_A           89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-----  162 (277)
T ss_dssp             CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-----
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-----
Confidence            9999999887654 68999999999999999999999999999999999999   78899999999998654321     


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......    
T Consensus       163 ------------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  225 (277)
T 3f3z_A          163 ------------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT----  225 (277)
T ss_dssp             ------------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred             ------------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----
Confidence                        113445799999999998765 899999999999999999999999887665554444432221    


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 ........+++++.+||.+||+.||.+|||+.++++|.|....
T Consensus       226 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          226 -----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             -----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                       1111223689999999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=368.79  Aligned_cols=255  Identities=25%  Similarity=0.337  Sum_probs=199.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ...++|++.+.||+|+||.||+|++  +++.||||++....  ..+.+.+|+.+++.++||||+++++++......++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3446899999999999999999998  46789999865432  3456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+.+++|.+++...+ .+++.+++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+++...... 
T Consensus       128 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  205 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-  205 (349)
T ss_dssp             CCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence            9999999999987654 6899999999999999999999999999999999999975   8899999999987554211 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH-HHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~~  296 (573)
                                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.     
T Consensus       206 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~-----  264 (349)
T 2w4o_A          206 ----------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-----  264 (349)
T ss_dssp             -----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH-----
T ss_pred             ----------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH-----
Confidence                            1234579999999999999999999999999999999999999997654333 222221     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                               .... .........++.++.+||++||+.||++|||+.|+++|+|..
T Consensus       265 ---------~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          265 ---------NCEY-YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             ---------TTCC-CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             ---------hCCC-ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                     1111 112223457899999999999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=369.74  Aligned_cols=271  Identities=24%  Similarity=0.269  Sum_probs=210.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHH-HHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++++.||+|+||+||+|.+  +++.||+|++....... ...+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5899999999999999999998  57899999865443221 12455799999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+ +|.+++...+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......      
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~------  154 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------  154 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc------
Confidence            975 8999888776679999999999999999999999999999999999999999999999999986543211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH---
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ---  298 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---  298 (573)
                                .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......+.   
T Consensus       155 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          155 ----------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET  224 (324)
T ss_dssp             ------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence                      11234578999999999876 5689999999999999999999999998776666555543211110   


Q ss_pred             --------HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 --------QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                              ..............+......+++++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence                    0000000000011111223468899999999999999999999999999998854

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=369.12  Aligned_cols=266  Identities=21%  Similarity=0.320  Sum_probs=211.7

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------C
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~  134 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            47899999999999999999997  5889999986432  344567789999999999999999999998765      3


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+|+||||+ +++|.+++..  ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            469999999 7899999875  3689999999999999999999999999999999999999999999999999865431


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus       181 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~  241 (367)
T 1cm8_A          181 -------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV  241 (367)
T ss_dssp             -------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             -------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence                               1234578999999999887 67899999999999999999999999988777666666543


Q ss_pred             cccHHH-HHH-----------HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYTEQQ-LTA-----------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~~~~-~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...+.. ...           ..........+.......++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence            222111 100           00111112233344457899999999999999999999999999998863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-44  Score=364.25  Aligned_cols=272  Identities=28%  Similarity=0.433  Sum_probs=218.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ...++|++.+.||+|+||.||+|.+ +++.||||+.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            3457999999999999999999987 478999998776666677889999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.+|+|.+++....   ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  193 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--  193 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS--
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence            999999999986543   358999999999999999999999999999999999999999999999999986543211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  .........||+.|+|||++.+..++.++|||||||++|+|++|..||............. .     
T Consensus       194 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~-~-----  255 (321)
T 2qkw_B          194 ------------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-W-----  255 (321)
T ss_dssp             ------------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH-H-----
T ss_pred             ------------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH-H-----
Confidence                        0111234568999999999998899999999999999999999999997653322111000 0     


Q ss_pred             HHHHHHhcCCCC----Ccc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLR----PIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       299 ~~~~~~~~~~~~----~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                       .......+...    +.+ ...+...+..+.+++.+||+.||++|||+.|++++|+.++..
T Consensus       256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          256 -AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             -THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence             00001111111    111 112334677899999999999999999999999999988763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-44  Score=366.21  Aligned_cols=278  Identities=25%  Similarity=0.367  Sum_probs=221.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccc--cCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA--KPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~  134 (573)
                      +..++|++.+.||+|+||.||+|++      .++.||||++........+.+.+|+++++.++||||+++++++.  +..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            4457999999999999999999984      57899999988777777888999999999999999999999876  456


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            68999999999999999987555799999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ....             ........||+.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus       180 ~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  246 (327)
T 3lxl_A          180 DKDY-------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD  246 (327)
T ss_dssp             TCSE-------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred             CCcc-------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence            1110             011234568889999999999889999999999999999999999997654433222111111


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      ...............++.   .+..+++++.+||.+||+.||.+|||+.+++++|..+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          247 VPALSRLLELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             CCHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccHHHHHHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111111222222222222   24578999999999999999999999999999998876643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.7e-45  Score=385.59  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=208.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .+..++|++.+.||+|+||.||+|.+  +++.||||++...   .......+.+|+.+++.++||||+++++++...+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            34557899999999999999999987  5789999986432   233456678899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ++||||+++|+|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.....
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999987655 78999999999999999999998 99999999999999999999999999998643211


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.... 
T Consensus       303 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-  365 (446)
T 4ejn_A          303 ----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-  365 (446)
T ss_dssp             --------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred             ----------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-
Confidence                            112345789999999999999999999999999999999999999998876555444443221 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                                   .     ..+..+++++.+||.+||+.||.+||     |+.|+++|+|+.
T Consensus       366 -------------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          366 -------------I-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             -------------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             -------------C-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence                         1     13456899999999999999999999     999999988764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-44  Score=363.37  Aligned_cols=265  Identities=25%  Similarity=0.429  Sum_probs=205.7

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC--Ce---eEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD--GR---KVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ...++.++|++.+.||+|+||.||+|.+.  +.   .||||++...  .....+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            35677889999999999999999999863  22   7999986544  34456789999999999999999999999987


Q ss_pred             CCce------EEEEEeccCCChhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCC
Q 008220          133 PPNY------MFFFEFYESRNLAEKLHVEE-----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       133 ~~~~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      ....      ++||||+.+++|.+++....     ..+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            6655      99999999999999985432     258999999999999999999999999999999999999999999


Q ss_pred             eEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008220          202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD  280 (573)
Q Consensus       202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~  280 (573)
                      ||+|||++.........              .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       177 kl~Dfg~a~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYY--------------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             EECCCCC-------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEeeccccccccccccc--------------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            99999999765421110              01223457889999999999999999999999999999999 9999987


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .........+..              +..    ...+..+++++.+||.+||+.||++|||+.++++.+..++.+.
T Consensus       243 ~~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          243 IENAEIYNYLIG--------------GNR----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CCGGGHHHHHHT--------------TCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cChHHHHHHHhc--------------CCC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            655444333322              111    1224578999999999999999999999999999999988754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.3e-44  Score=353.77  Aligned_cols=256  Identities=24%  Similarity=0.312  Sum_probs=216.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++...  .....+.+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            47899999999999999999987  4789999986433  4455678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+.+++|.+.+.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.   +||+|||++......  
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence            9999999998887654 6899999999999999999999999999999999999987665   999999998654321  


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.....  
T Consensus       162 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--  224 (284)
T 3kk8_A          162 ---------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--  224 (284)
T ss_dssp             ---------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred             ---------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc--
Confidence                           112345799999999999999999999999999999999999999987765554444332221  


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  ... ......+++++.+||.+||+.||++|||+.|+++|.|...
T Consensus       225 ------------~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          225 ------------DYP-SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             ------------CCC-TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             ------------cCC-chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence                        111 1123468999999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-44  Score=363.51  Aligned_cols=268  Identities=19%  Similarity=0.266  Sum_probs=215.5

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      +.+++|++.+.||+|+||.||+|.+  +++.||||++.....  .+.+.+|+.+++.+ +||||+++++++......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            4457899999999999999999996  689999998654332  24578999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC-----CeEeeeecchhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-----PHLADFGLAEYREN  214 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~-----~kL~Dfg~a~~~~~  214 (573)
                      |||+ +++|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++.++.     +||+|||++.....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999 89999999876668999999999999999999999999999999999999998887     99999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH---HHHH
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA---HTVL  291 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~  291 (573)
                      .....         ...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.......   ..+.
T Consensus       163 ~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~  233 (330)
T 2izr_A          163 PETKK---------HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG  233 (330)
T ss_dssp             TTTCC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred             CCCCc---------cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence            11110         00011134568999999999999999999999999999999999999999875332221   1111


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                      ....              ..........+| ++.+||..||+.||.+||++.+|++.|..+.+...
T Consensus       234 ~~~~--------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          234 DTKR--------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHH--------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhhc--------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            1110              001111223456 99999999999999999999999999988776543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=360.21  Aligned_cols=270  Identities=23%  Similarity=0.302  Sum_probs=210.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++++.||+|+||+||+|.+  +++.||+|++....  ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            6899999999999999999998  48899999765443  2345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........    
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD----  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc----
Confidence            999999988876544 689999999999999999999999999999999999999999999999999875542111    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH-
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-  299 (573)
                                  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+......... 
T Consensus       158 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (311)
T 4agu_A          158 ------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR  225 (311)
T ss_dssp             --------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence                        1234578999999999976 66899999999999999999999999887666555444322111000 


Q ss_pred             HHHHHhcC-----CCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          300 LTAAVVSG-----GLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       300 ~~~~~~~~-----~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ........     ...+      .+......+++++.+||.+||+.||.+|||+.|+++|+|..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            00000000     0000      00111246889999999999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-45  Score=382.21  Aligned_cols=260  Identities=21%  Similarity=0.276  Sum_probs=216.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++++.||+|+||+||+|++  +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            345667999999999999999999998  578999998542111   112347789999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||++||+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            99999999999999998653  5899999999999999999999999999999999999999999999999999754321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      .               .....+.+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+.
T Consensus       222 ~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          222 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             S---------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             C---------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            1               01234568999999999998765    7889999999999999999999999877666666554


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV  352 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~  352 (573)
                      .....              ...+ .+..+++++.+||++||+.+|.+  ||++.||++|+|+.
T Consensus       287 ~~~~~--------------~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          287 NHKNS--------------LTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             THHHH--------------CCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             hcccc--------------ccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            32210              0011 12368999999999999999988  99999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.5e-44  Score=368.72  Aligned_cols=270  Identities=20%  Similarity=0.264  Sum_probs=216.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-----CCccceeeeccccC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----HPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~  133 (573)
                      ..+..++|++.++||+|+||+||+|++  +++.||||++.. .......+..|+.+++.+.     ||||+++++++...
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            456678999999999999999999998  678999998653 3445567788999999996     99999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---------------
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---------------  197 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---------------  197 (573)
                      ...++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+.||+||||||+|||++.               
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999999 889999987654 35899999999999999999999999999999999999975               


Q ss_pred             ----------CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHH
Q 008220          198 ----------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS  267 (573)
Q Consensus       198 ----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  267 (573)
                                ++.+||+|||++.....                   ......||+.|+|||++.+..++.++|||||||+
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSD-------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTS-------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccccCCCCEEEEeccCceecCC-------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                      78899999999865331                   1234578999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCchhHHHHHHHHhccccHHH-HHHHHhcC---------CCC-----------------CcccccccCC
Q 008220          268 INELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-LTAAVVSG---------GLR-----------------PILASLELGL  320 (573)
Q Consensus       268 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---------~~~-----------------~~~~~~~~~~  320 (573)
                      +|+|++|..||...........+......... ........         ...                 ..++..+...
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            99999999999887666555544432221111 11000000         000                 0011112234


Q ss_pred             hHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          321 PASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       321 ~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ++.+.+||.+||+.||++|||+.|+++|+|.
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhcCccc
Confidence            5788999999999999999999999998874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.2e-45  Score=360.17  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=211.3

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--C-------eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--G-------RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ++..++|++.+.||+|+||+||+|.+.  +       ..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            466789999999999999999999863  2       5699998766555667889999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--------CeEe
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--------PHLA  204 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--------~kL~  204 (573)
                      +...++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.        +||+
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999999877656999999999999999999999999999999999999998887        9999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcC-CCCCCCch
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTG-VVPYTDLR  282 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg-~~Pf~~~~  282 (573)
                      |||++.....                    .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||....
T Consensus       164 Dfg~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          164 DPGISITVLP--------------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             CCCSCTTTSC--------------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cCcccccccC--------------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            9999865432                    223458899999999987 7789999999999999999995 55555443


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      ..... ....              .  .   ...+...++++.+||.+||+.||++|||+.+++++|..++.
T Consensus       224 ~~~~~-~~~~--------------~--~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          224 SQRKL-QFYE--------------D--R---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHH-HHHH--------------T--T---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hHHHH-HHhh--------------c--c---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            32221 1111              0  0   11234567889999999999999999999999999977654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=359.67  Aligned_cols=266  Identities=27%  Similarity=0.424  Sum_probs=216.4

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ..++..++|++.+.||+|+||.||+|.+.      +..||||.+... .......+.+|+.+++.++||||+++++++..
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            35778899999999999999999999763      235999987654 33456678999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ....++||||+.+++|.+++......+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999876668999999999999999999999999999999999999999999999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  291 (573)
                      ......             ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus       198 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  264 (333)
T 1mqb_A          198 EDDPEA-------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  264 (333)
T ss_dssp             --------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             cccccc-------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            431110             011223356889999999999999999999999999999999 999998765544333222


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                    .+ .++   ..+..+++++.+||.+||+.||.+||++.+++++|..+....
T Consensus       265 --------------~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          265 --------------DG-FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --------------TT-CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------------CC-CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                          11 111   123478999999999999999999999999999999888643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.6e-44  Score=355.10  Aligned_cols=253  Identities=21%  Similarity=0.361  Sum_probs=212.8

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            346899999999999999999987  467899998543221   124568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......   
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence            999999999999987654 6899999999999999999999999999999999999999999999999988543311   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....   
T Consensus       163 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---  224 (279)
T 3fdn_A          163 ---------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---  224 (279)
T ss_dssp             --------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---
T ss_pred             ---------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---
Confidence                           12345789999999999999999999999999999999999999987655544433322111   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                      ..+..+++++.+||.+||+.||.+|||+.|+++|+|....
T Consensus       225 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          225 ----------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ----------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence                            1244688999999999999999999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-44  Score=365.93  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=211.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|++  +++.||||++...   .....+.+.+|+++++.++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4699999999999999999987  6889999986543   2334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+. |+|.+.+......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9997 588888866666899999999999999999999999999999999999999999999999999865431      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .....||+.|+|||++.   +..++.++|||||||++|||++|..||...........+..     
T Consensus       207 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-----  267 (348)
T 1u5q_A          207 --------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----  267 (348)
T ss_dssp             --------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred             --------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----
Confidence                          23457999999999985   56789999999999999999999999987655443333322     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               ... +.  ..+..+++.+.+||.+||+.||++|||+.++++|+|...
T Consensus       268 ---------~~~-~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          268 ---------NES-PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             ---------SCC-CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---------cCC-CC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence                     111 11  123467899999999999999999999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-44  Score=353.95  Aligned_cols=266  Identities=22%  Similarity=0.332  Sum_probs=221.4

Q ss_pred             cccCCCCccccc-cccccCceEEEEEEE----CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +.+..++|.+.+ .||+|+||.||+|.+    .+..||||++... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            456677898888 999999999999975    4778999987654 345677899999999999999999999999 556


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.+++|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            79999999999999999976666799999999999999999999999999999999999999999999999999876542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ....             ........||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.. 
T Consensus       163 ~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-  228 (287)
T 1u59_A          163 DDSY-------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-  228 (287)
T ss_dssp             CSCE-------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-
T ss_pred             Ccce-------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-
Confidence            1110             001223457899999999998889999999999999999998 9999987654443332221 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS  358 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~  358 (573)
                                   + .++   ..+..+++++.+||.+||+.||++|||+.+++++|+.+......
T Consensus       229 -------------~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          229 -------------G-KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             -------------T-CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -------------C-CcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                         1 111   23457899999999999999999999999999999999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-44  Score=362.89  Aligned_cols=260  Identities=22%  Similarity=0.382  Sum_probs=209.6

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCe----eEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .+..++|++.+.||+|+||+||+|++  +++    +||+|.+.... ......+.+|+.++++++||||+++++++... 
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            35567899999999999999999987  333    46888754332 23456789999999999999999999999875 


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++|+||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            47899999999999999987777899999999999999999999999999999999999999999999999999976643


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...              ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.  
T Consensus       170 ~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~--  233 (327)
T 3poz_A          170 EEK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE--  233 (327)
T ss_dssp             TCC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH--
T ss_pred             Ccc--------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH--
Confidence            111              111233457889999999999999999999999999999999 999998765433322221  


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  .+. +.   ..+..++.++.+|+.+||+.||.+|||+.+++++|..+..
T Consensus       234 ------------~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          234 ------------KGE-RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------------TTC-CC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ------------cCC-CC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                        111 11   1234678999999999999999999999999999988765

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-44  Score=364.15  Aligned_cols=277  Identities=20%  Similarity=0.277  Sum_probs=208.2

Q ss_pred             CCCcccc-ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEE
Q 008220           65 PSSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .++|++. +.||+|+||.||+|.+  +++.||||++........+.+.+|+.+++++ +||||+++++++.+.+.+++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4689985 7899999999999986  6889999987665555567889999999985 7999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            9999999999997654 7899999999999999999999999999999999999998776   89999999875542111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ..         ...........||+.|+|||++.+     ..++.++|||||||++|+|++|..||..............
T Consensus       170 ~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          170 CS---------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             ---------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             cc---------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            00         000111234569999999999875     5578899999999999999999999976532110000000


Q ss_pred             cc-ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 MN-YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .. .....+...+..+... ........+++++.+||++||+.||++|||+.|+++|+|..
T Consensus       241 ~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             cchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            00 0011112222222221 11112346899999999999999999999999999998864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=361.30  Aligned_cols=274  Identities=24%  Similarity=0.275  Sum_probs=209.5

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-----hHHHHHHHHHHHHHHhC---CCCccceeeeccc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKL---DHPGLAKFVAAHA  131 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~  131 (573)
                      .+..++|++.++||+|+||+||+|++  +++.||||++....     ......+.+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            34567999999999999999999996  68899999864322     11123456777777666   5999999999987


Q ss_pred             cCC-----ceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEee
Q 008220          132 KPP-----NYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       132 ~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                      ...     ..++||||+.+ +|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            755     48999999974 9999987654 2489999999999999999999999999999999999999999999999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA  285 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~  285 (573)
                      ||++......                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus       164 fg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  226 (308)
T 3g33_A          164 FGLARIYSYQ-----------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD  226 (308)
T ss_dssp             CSCTTTSTTC-----------------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred             CccccccCCC-----------------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9998754321                 11345679999999999999999999999999999999999999998877666


Q ss_pred             HHHHHHhccccHHHHHH--------HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTA--------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ....+...........+        ..........+......+++++.+||.+||+.||++|||+.|+++|.|...
T Consensus       227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            65555432111000000        000000011112234568899999999999999999999999999988754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-44  Score=365.46  Aligned_cols=276  Identities=21%  Similarity=0.242  Sum_probs=205.6

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..+.....++|++.++||+|+||+||+|.+  +++.||||++......  ....+.+|+.+++.++||||+++++++.+.
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            334445557999999999999999999987  6889999987654332  345678999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-----CCCCCeEeeeec
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-----RNLCPHLADFGL  208 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-----~~~~~kL~Dfg~  208 (573)
                      ..+++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++     ..+.+||+|||+
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999999999985 9999987655 689999999999999999999999999999999999995     445599999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      +........                ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus       184 a~~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  247 (329)
T 3gbz_A          184 ARAFGIPIR----------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL  247 (329)
T ss_dssp             HHHHC---------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccccCCccc----------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence            976542111                12345789999999999874 4899999999999999999999999887766655


Q ss_pred             HHHHhccccHHHHHH--HHhcCCCCCc---------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTA--AVVSGGLRPI---------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+...........+  ..........         ....+..+++++.+||.+||+.||++|||+.|+++|+|+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence            555432111000000  0000000000         001122378999999999999999999999999998875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5e-44  Score=357.19  Aligned_cols=277  Identities=26%  Similarity=0.359  Sum_probs=217.3

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      +..+...+|++.+.||+|+||.||+|++      +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3455667899999999999999999984      57899999865433 2345678999999999999999999999987


Q ss_pred             C--CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          133 P--PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       133 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .  ..+++||||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  67899999999999999997666679999999999999999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      ........             ........||+.|+|||++.+..++.++||||||+++|+|++|..|+............
T Consensus       175 ~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  241 (302)
T 4e5w_A          175 AIETDKEY-------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG  241 (302)
T ss_dssp             ECCTTCCE-------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred             cccCCCcc-------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC
Confidence            65431110             01133456888999999999998999999999999999999999997643221111100


Q ss_pred             -HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          291 -LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       291 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       ................+...    ..+..+++++.+||.+||+.||.+|||+.++++.|..++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          242 PTHGQMTVTRLVNTLKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             SCCGGGHHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccccCHHHHHHHHhccCCC----CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence             00111112222222222221    134578999999999999999999999999999998765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-44  Score=362.35  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=215.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH------HHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            5799999999999999999998  5789999976543221      3567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++    .+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            9999999999999997644 789999999999999999999999999999999999999888    79999999986543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ..                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus       171 ~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  233 (321)
T 2a2a_A          171 DG-----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV  233 (321)
T ss_dssp             TT-----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred             cc-----------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            21                 1123457999999999999999999999999999999999999999877655544444332


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...               ..+..+..+++.+.+||.+||+.||++|||+.|+++|+|.
T Consensus       234 ~~~---------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          234 SYD---------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             CCC---------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             ccc---------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            211               1122335789999999999999999999999999999876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.3e-44  Score=359.53  Aligned_cols=268  Identities=24%  Similarity=0.389  Sum_probs=217.9

Q ss_pred             CCccccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceee
Q 008220           56 SQSIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFV  127 (573)
Q Consensus        56 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~  127 (573)
                      +.....++..++|++.+.||+|+||.||+|++       ++..||||.+... .......+.+|+.+++.++||||++++
T Consensus        20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence            33344567889999999999999999999983       4568999987543 345566789999999999999999999


Q ss_pred             eccccCCceEEEEEeccCCChhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---C
Q 008220          128 AAHAKPPNYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---N  198 (573)
Q Consensus       128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~  198 (573)
                      +++......++||||+++++|.+++....      ..+++.+++.++.||+.||.|||+.||+||||||+|||++.   +
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence            99999999999999999999999997653      34889999999999999999999999999999999999984   4


Q ss_pred             CCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCC
Q 008220          199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP  277 (573)
Q Consensus       199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~P  277 (573)
                      ..+||+|||++.........              .......||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  245 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYY--------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP  245 (327)
T ss_dssp             CCEEECCCHHHHHHHC--------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ceEEECcccccccccccccc--------------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            46999999998755421110              01234568999999999999999999999999999999998 9999


Q ss_pred             CCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      |...........+..              +. .+   ..+..+++.+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus       246 ~~~~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          246 YPSKSNQEVLEFVTS--------------GG-RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             STTCCHHHHHHHHHT--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCcCHHHHHHHHhc--------------CC-CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            987654433332221              11 11   12457899999999999999999999999999999988764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-44  Score=372.27  Aligned_cols=284  Identities=23%  Similarity=0.329  Sum_probs=206.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccC--CChHHHHHHHHHHHHHHhCC-CCccceeeeccccCC--ceEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP--NYMF  138 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~~~l  138 (573)
                      ++|++++.||+|+||.||+|.+  +++.||||++..  ........+.+|+.+++.+. ||||+++++++...+  .+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            6899999999999999999987  588999998643  34556677889999999997 999999999987543  7899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+. ++|..++...  .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus        89 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             EecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence            999997 4898888653  6899999999999999999999999999999999999999999999999999765321110


Q ss_pred             hccc-----ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          219 SLKN-----WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       219 ~~~~-----~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....     ................+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            0000     000000011122455689999999999986 6789999999999999999999999998877777666653


Q ss_pred             ccccHHHHHH-------------HHh------cCCCCCccc---------ccccCChHHHHHHHHHhccCCCCCCCCHHH
Q 008220          293 MNYTEQQLTA-------------AVV------SGGLRPILA---------SLELGLPASILSLIQRCWDGNPHNRPSFSD  344 (573)
Q Consensus       293 ~~~~~~~~~~-------------~~~------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  344 (573)
                      ....+.....             ...      .......++         ..+..+++++.+||++||+.||++|||+.|
T Consensus       246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e  325 (388)
T 3oz6_A          246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND  325 (388)
T ss_dssp             HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence            2211111000             000      000000000         012367899999999999999999999999


Q ss_pred             HHHHHHHH
Q 008220          345 IALELDLV  352 (573)
Q Consensus       345 ll~~l~~~  352 (573)
                      +++|+|..
T Consensus       326 ~l~Hp~~~  333 (388)
T 3oz6_A          326 ALKHPFVS  333 (388)
T ss_dssp             HTTSTTTT
T ss_pred             HhCCHHHH
Confidence            99998864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5e-44  Score=377.57  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=218.5

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..++++.++|++.+.||+|+||.||+|.+ .+..||||++.... ...+.+.+|+.+|+.++||||+++++++. ....+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            45778889999999999999999999998 47889999876443 34678999999999999999999999986 66789


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999999999997542 367889999999999999999999999999999999999999999999999997654321


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..               ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+..   
T Consensus       339 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---  400 (454)
T 1qcf_A          339 YT---------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---  400 (454)
T ss_dssp             HH---------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH---
T ss_pred             ee---------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            11               0123356789999999998999999999999999999999 9999987655444333321   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 + .+.   ..+..+++++.+||.+||+.||++|||+.+|++.|..+..
T Consensus       401 -----------~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          401 -----------G-YRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -----------T-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -----------C-CCC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                       1 111   1245789999999999999999999999999988876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.1e-44  Score=352.81  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=215.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ..+..++|++.+.||+|+||+||+|.+.     +..||+|..... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            4566789999999999999999999862     235999986554 34566789999999999999999999999865 4


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.+++|.+++......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            56899999999999999987766799999999999999999999999999999999999999999999999999876542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...               .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.. 
T Consensus       166 ~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-  229 (281)
T 3cc6_A          166 EDY---------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-  229 (281)
T ss_dssp             ----------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-
T ss_pred             ccc---------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-
Confidence            111               01233457889999999999999999999999999999998 9999976544333222211 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                   +...    ..+..+++.+.+||.+||+.||++|||+.+++++|..+.+..
T Consensus       230 -------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          230 -------------GDRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------------CCCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                         1111    123468899999999999999999999999999999887643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=360.43  Aligned_cols=274  Identities=20%  Similarity=0.330  Sum_probs=210.0

Q ss_pred             cCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC--ceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~  137 (573)
                      +..++|++.+.||+|+||+||+|.+.  ++.||||++.... ....+.+.+|+++++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            44578999999999999999999984  8899999865432 233567789999999999999999999987655  789


Q ss_pred             EEEEeccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----cCCCCCeEeeeecchh
Q 008220          138 FFFEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEY  211 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----~~~~~~kL~Dfg~a~~  211 (573)
                      +||||+.+++|.+++....  ..+++.+++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+|||+++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999999997643  238999999999999999999999999999999999999    7888899999999875


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--------KEIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      .....                 ......||+.|+|||++.        +..++.++|||||||++|||++|..||.....
T Consensus       166 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  228 (319)
T 4euu_A          166 LEDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (319)
T ss_dssp             CCTTC-----------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             cCCCC-----------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            54211                 123457999999999986        56789999999999999999999999975432


Q ss_pred             HH----HHHHHHhccccHHHH-HHHHhcC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          284 EA----QAHTVLEMNYTEQQL-TAAVVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       284 ~~----~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..    ....+.......... .......     ...+....++..+++.+.+||++||+.||++|||+.|+++|+....
T Consensus       229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             GGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            22    222222111000000 0000000     0001111222346778999999999999999999999999997654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3e-44  Score=368.25  Aligned_cols=265  Identities=23%  Similarity=0.307  Sum_probs=198.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC------Cc
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PN  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~  135 (573)
                      ++|++++.||+|+||.||+|.+  +++.||||++...  .......+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            7899999999999999999987  5889999986543  344567888999999999999999999998654      56


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +++|+|++ +++|.+++..  ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-  184 (367)
T ss_dssp             CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence            89999998 6799988865  3689999999999999999999999999999999999999999999999999875432 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       185 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  246 (367)
T 2fst_X          185 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  246 (367)
T ss_dssp             ------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence                              1234679999999999987 678999999999999999999999999887766666655432


Q ss_pred             ccHHHH----------HHHHh--cCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQL----------TAAVV--SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~----------~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+...          ...+.  .......+.......++++.+||.+||+.||.+|||+.|+++|+|..
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence            221110          00000  00111122223346789999999999999999999999999998864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-43  Score=362.92  Aligned_cols=275  Identities=18%  Similarity=0.216  Sum_probs=212.5

Q ss_pred             cCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCChHHH-----------HHHHHHHHHHHhCCCCccc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSEEL-----------DNFHKELQLLCKLDHPGLA  124 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv  124 (573)
                      +..++|++.++||+|+||.||+|.+.       ++.||||+.........           ..+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            45579999999999999999999873       46899998665543211           1234466677788999999


Q ss_pred             eeeeccccC----CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc--CC
Q 008220          125 KFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RN  198 (573)
Q Consensus       125 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~--~~  198 (573)
                      ++++++...    ...++||||+ +++|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    4589999999 9999999987766899999999999999999999999999999999999999  88


Q ss_pred             CCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008220          199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY  278 (573)
Q Consensus       199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf  278 (573)
                      +.+||+|||+++.+......         ............||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVH---------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCC---------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             CeEEEEECCcceecccCCcc---------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999999999766432111         001111224557999999999999999999999999999999999999999


Q ss_pred             CCchhHHHHHHHHhccc--cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          279 TDLRAEAQAHTVLEMNY--TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       279 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .+...............  ....+....        +  ....+|+++.+||..||+.||.+||++.+|++.|..++...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          262 EDNLKDPKYVRDSKIRYRENIASLMDKC--------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             GGGTTCHHHHHHHHHHHHHCHHHHHHHH--------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccCHHHHHHHHHHhhhhHHHHHHHh--------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            86433322222211111  111111000        0  01467999999999999999999999999999999988754


Q ss_pred             c
Q 008220          357 K  357 (573)
Q Consensus       357 ~  357 (573)
                      .
T Consensus       332 ~  332 (364)
T 3op5_A          332 G  332 (364)
T ss_dssp             T
T ss_pred             C
Confidence            3

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-43  Score=352.08  Aligned_cols=254  Identities=30%  Similarity=0.534  Sum_probs=209.0

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChH---H----HHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE---E----LDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      .+..++|++.+.||+|+||+||+|++  +++.||+|++......   .    .+.+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45668999999999999999999998  5889999986543321   1    1678899999999999999999999876


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCC-----CeEee
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLC-----PHLAD  205 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~-----~kL~D  205 (573)
                      ..  ++||||+.+++|.+.+......+++..++.++.|++.||+|||+.|  |+||||||+|||++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            55  6999999999999998777778999999999999999999999999  999999999999988776     99999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      ||++.....                   ......||+.|+|||++.  ...++.++|||||||++|+|++|..||.....
T Consensus       173 fg~~~~~~~-------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          173 FGLSQQSVH-------------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             CTTCBCCSS-------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCccccccc-------------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            999863321                   134467999999999984  45578899999999999999999999976543


Q ss_pred             HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...            ...........++   ..+..+++++.+||.+||+.||.+|||+.++++.|..
T Consensus       234 ~~~------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          234 GKI------------KFINMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CHH------------HHHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cHH------------HHHHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            221            1111122223333   2345789999999999999999999999999988753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=363.44  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=207.3

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCC--CccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~  135 (573)
                      +.+.+++|++.+.||+|+||.||++.+ +++.||||++...  .....+.+.+|+.+|+.++|  |||+++++++.....
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            456678999999999999999999987 5788999986543  34456788999999999976  999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||| +.+++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++......
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            999999 56789999997654 789999999999999999999999999999999999997 678999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAE  284 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~  284 (573)
                      ..              ........||+.|+|||++.+           ..++.++|||||||++|+|++|..||......
T Consensus       161 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          161 TT--------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             -----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             cc--------------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            11              111335679999999999865           67889999999999999999999999764322


Q ss_pred             HHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ....             ..........   ..+...++++.+||.+||+.||.+|||+.|+++|+|...
T Consensus       227 ~~~~-------------~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          227 ISKL-------------HAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HHHH-------------HHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHH-------------HHHhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            1111             1111111111   233456789999999999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=375.80  Aligned_cols=287  Identities=22%  Similarity=0.259  Sum_probs=197.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccC--CChHHHHHHHHHHHHHHhCCCCccceeeeccc-----cCCc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVAAHA-----KPPN  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~  135 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++..  ......+.+.+|+.+|+.++||||+++++++.     ....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999987  578999998643  24455678999999999999999999999984     3457


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999999874 68998886544 7999999999999999999999999999999999999999999999999999866421


Q ss_pred             hhhhcccc----------cC-CCCCCCCccccccccCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHc----------
Q 008220          216 KEISLKNW----------RS-SGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLT----------  273 (573)
Q Consensus       216 ~~~~~~~~----------~~-~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt----------  273 (573)
                      ........          .. .............+||+.|+|||++ .+..++.++|||||||+||||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            11000000          00 0000000123456899999999986 56679999999999999999998          


Q ss_pred             -CCCCCCCchh--------------------HHHHHHHHhcccc--HHHH-------HHHHh---cCCCCCcccccccCC
Q 008220          274 -GVVPYTDLRA--------------------EAQAHTVLEMNYT--EQQL-------TAAVV---SGGLRPILASLELGL  320 (573)
Q Consensus       274 -g~~Pf~~~~~--------------------~~~~~~~~~~~~~--~~~~-------~~~~~---~~~~~~~~~~~~~~~  320 (573)
                       |.++|.+...                    ......+......  ...+       .....   .......+....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777765431                    1111111111100  0000       00000   011111222234567


Q ss_pred             hHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       321 ~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ++++.+||++||+.||++|||+.|+++|+|+..
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            999999999999999999999999999998753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-44  Score=366.35  Aligned_cols=261  Identities=26%  Similarity=0.333  Sum_probs=209.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-----ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||+|++...     .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46899999999999999999987  5778999975432     2345678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 008220          138 FFFEFYESRNLAEKLHVE---------------------------------------EWSPSVDQVLMIAAQLAKALQYL  178 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~L  178 (573)
                      +||||+++|+|.+++...                                       ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988521                                       11235678889999999999999


Q ss_pred             HhCCceeccCCCCceEEcCCC--CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CC
Q 008220          179 HNLGIVHRDVKPANVLLDRNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EI  254 (573)
Q Consensus       179 H~~~iiH~Dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~  254 (573)
                      |+.||+||||||+|||++.++  .+||+|||++..+......            .........||+.|+|||++.+  ..
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG------------EYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------CCCGGGCCHHHHTCSSSC
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc------------ccccccccCCCccccCchhhccCCCC
Confidence            999999999999999998776  8999999999765421110            0112345679999999999975  67


Q ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccC
Q 008220          255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG  334 (573)
Q Consensus       255 ~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  334 (573)
                      ++.++|||||||++|+|++|..||.+.........+.....              ... ......+++++.+||.+||+.
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--------------CFE-NPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------CTT-SGGGGGSCHHHHHHHHHHSCS
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc--------------ccC-CcccccCCHHHHHHHHHHcCC
Confidence            89999999999999999999999988766655554443221              111 112235789999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHH
Q 008220          335 NPHNRPSFSDIALELDLV  352 (573)
Q Consensus       335 dP~~Rpt~~ell~~l~~~  352 (573)
                      ||.+|||+.++++|+|..
T Consensus       318 ~p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          318 NVDERFDAMRALQHPWIS  335 (345)
T ss_dssp             CTTTSCCHHHHHHSHHHH
T ss_pred             ChhHCCCHHHHhcChhhc
Confidence            999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-43  Score=358.94  Aligned_cols=265  Identities=27%  Similarity=0.416  Sum_probs=220.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeee
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA  128 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  128 (573)
                      .++++.++|++.+.||+|+||.||+|.+.         +..||||++... .....+.+.+|+.+++.+ +||||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            46778899999999999999999999863         467999987544 344567899999999999 8999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      ++......++||||+.+++|.+++....               ..+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999997543               2478999999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      +++.++.+||+|||++.........              .......+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  254 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYY--------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  254 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSE--------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             EEcCCCCEEEccccccccccccccc--------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence            9999999999999998755421110              01223457889999999998889999999999999999999


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       |..||.+.........+..              +. ++   ..+..+++++.+||.+||+.||.+|||+.+++++|..+
T Consensus       255 ~g~~p~~~~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          255 LGGSPYPGIPVEELFKLLKE--------------GH-RM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             TSCCSSTTCCHHHHHHHHHH--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCcCCHHHHHHHHhc--------------CC-CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             9999987654443332221              11 11   12457899999999999999999999999999999999


Q ss_pred             HHHh
Q 008220          353 LEHR  356 (573)
Q Consensus       353 ~~~~  356 (573)
                      +...
T Consensus       317 ~~~~  320 (334)
T 2pvf_A          317 LTLT  320 (334)
T ss_dssp             HHHH
T ss_pred             Hhcc
Confidence            8754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=360.59  Aligned_cols=251  Identities=24%  Similarity=0.262  Sum_probs=203.0

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      .+..++|++.++||+|+||+||+|++  +++.||||++...  ..........|+..+..+ +||||+++++++.+....
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            34446899999999999999999998  5889999975443  333444555666665555 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+ +++|.+++...+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999999 669999887776679999999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                       ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.......   .+..    
T Consensus       212 -----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~----  266 (311)
T 3p1a_A          212 -----------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ----  266 (311)
T ss_dssp             --------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT----
T ss_pred             -----------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc----
Confidence                             1234569999999999886 68999999999999999999976665432211   1111    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                +.   ..+..+..+++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       267 ----------~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (311)
T 3p1a_A          267 ----------GY---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL  308 (311)
T ss_dssp             ----------TC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ----------cC---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence                      11   1122345789999999999999999999999999998875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-43  Score=362.35  Aligned_cols=274  Identities=22%  Similarity=0.293  Sum_probs=220.7

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++..++|++.+.||+|+||.||+|.+.  ++.||+|++... .....+.+.+|+.+++.++||||+++++++......+
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            4566789999999999999999999984  889999986654 3445678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++...... 
T Consensus       108 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            9999999999999997655 689999999999999999999996 9999999999999999999999999998755321 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc---
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM---  293 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~---  293 (573)
                                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...   
T Consensus       186 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  248 (360)
T 3eqc_A          186 -----------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG  248 (360)
T ss_dssp             -----------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----
T ss_pred             -----------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence                             123457899999999999999999999999999999999999999876544332211100   


Q ss_pred             -------------------------cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          294 -------------------------NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       294 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                                               ..........+..... +.  ..+..++.++.+||.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------------------CCCHHHHHHHHHHSCC-CC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-CC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                     0000111111121111 11  1123578999999999999999999999999999


Q ss_pred             HHHHHHHh
Q 008220          349 LDLVLEHR  356 (573)
Q Consensus       349 l~~~~~~~  356 (573)
                      +|......
T Consensus       326 p~~~~~~~  333 (360)
T 3eqc_A          326 AFIKRSDA  333 (360)
T ss_dssp             HHHHHHHH
T ss_pred             hHhhcchH
Confidence            99876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-43  Score=351.54  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=222.5

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .+++..++|++.+.||+|+||.||+|.+.  +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            46778889999999999999999999984  789999986544 345677899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999999997533 458999999999999999999999999999999999999999999999999987654211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                     ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..   
T Consensus       166 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---  227 (288)
T 3kfa_A          166 ---------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---  227 (288)
T ss_dssp             ---------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---
T ss_pred             ---------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---
Confidence                           112234567889999999999999999999999999999999 9999987654433222211   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                  ..++   ..+..+++++.+||.+||+.||.+|||+.++++.|..+....
T Consensus       228 ------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          228 ------------DYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             ------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------cCCC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                        1111   234578999999999999999999999999999998887753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-43  Score=358.86  Aligned_cols=267  Identities=26%  Similarity=0.391  Sum_probs=220.9

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECC-------eeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..+++..++|++.+.||+|+||.||+|.+.+       ..||+|.+... .....+.+.+|+.+++.+ +||||++++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            3478888999999999999999999998732       37999986544 344567899999999999 89999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVE-------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD  196 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~  196 (573)
                      +......++||||+++|+|.+++...             ...+++..++.++.||+.||+|||+.||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998643             23578999999999999999999999999999999999999


Q ss_pred             CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CC
Q 008220          197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV  275 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~  275 (573)
                      .++.+||+|||++........              ........||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  264 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSN--------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL  264 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTT--------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             CCCeEEECccccccccccccc--------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence            999999999999975542111              111234567889999999999999999999999999999999 99


Q ss_pred             CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .||.+.............              ...+   ..+..+++++.+||.+||+.||.+|||+.+++++|..+...
T Consensus       265 ~p~~~~~~~~~~~~~~~~--------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          265 NPYPGILVNSKFYKLVKD--------------GYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             CSSTTCCSSHHHHHHHHH--------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccchhHHHHHHHhc--------------CCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            999875443332222211              1111   12346789999999999999999999999999999888764


Q ss_pred             h
Q 008220          356 R  356 (573)
Q Consensus       356 ~  356 (573)
                      .
T Consensus       328 ~  328 (333)
T 2i1m_A          328 D  328 (333)
T ss_dssp             H
T ss_pred             h
Confidence            3

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.1e-44  Score=356.15  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=212.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++.+.||+|+||.||++++  +++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            5899999999999999999997  58899999876655445567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhhhhhc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      .+++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.....      
T Consensus        89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~------  161 (304)
T 2jam_A           89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN------  161 (304)
T ss_dssp             CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC------
T ss_pred             CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC------
Confidence            9999999987654 68999999999999999999999999999999999999   7889999999999854321      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....     
T Consensus       162 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----  224 (304)
T 2jam_A          162 ------------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY-----  224 (304)
T ss_dssp             ------------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-----
T ss_pred             ------------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----
Confidence                        012345689999999999999999999999999999999999999987655444433332211     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                +.....+..+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       225 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          225 ----------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             ----------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             ----------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence                      111123457899999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-43  Score=370.91  Aligned_cols=289  Identities=20%  Similarity=0.240  Sum_probs=207.5

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccC--CChHHHHHHHHHHHHHHhCCCCccceeeeccccC----
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP----  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----  133 (573)
                      -...++|++.+.||+|+||.||+|.+  +++.||||++..  ......+.+.+|+.+|+.++||||+++++++...    
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            33458999999999999999999987  578999998654  3445567899999999999999999999998766    


Q ss_pred             -CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          134 -PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       134 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                       ...|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence             57999999986 49999987543 7899999999999999999999999999999999999999999999999999866


Q ss_pred             hhhhhhhccc-ccCCC-----CCCCCccccccccCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCC-------
Q 008220          213 ENLKEISLKN-WRSSG-----KPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPY-------  278 (573)
Q Consensus       213 ~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf-------  278 (573)
                      .......... .....     ...........+||++|+|||++ .+..++.++|||||||++|||++|..||       
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            4322110000 00000     00000123567899999999986 5667999999999999999999854444       


Q ss_pred             ----CCch-----------------hHHHHHHHHhcccc----------HHHHHHHHhcCC--CCCcccccccCChHHHH
Q 008220          279 ----TDLR-----------------AEAQAHTVLEMNYT----------EQQLTAAVVSGG--LRPILASLELGLPASIL  325 (573)
Q Consensus       279 ----~~~~-----------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~  325 (573)
                          .+..                 .......+......          .......+..-.  ....+....+.+++++.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence                3321                 11112222111110          011111111111  11111222356899999


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          326 SLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       326 ~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +||++||+.||++|||+.|+++|+|..
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             HHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-43  Score=356.41  Aligned_cols=275  Identities=25%  Similarity=0.353  Sum_probs=216.6

Q ss_pred             CCCc-cccccccccCceEEEEEEE------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc--CC
Q 008220           65 PSSY-TLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PP  134 (573)
Q Consensus        65 ~~~y-~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~  134 (573)
                      .++| +++++||+|+||+||++..      +++.||||++.... ....+.+.+|+++++.++||||+++++++.+  ..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            3455 9999999999999998864      57899999876543 3456789999999999999999999999987  46


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++||||+++++|.+++...  .+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             eEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            789999999999999999654  489999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh-c
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-M  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-~  293 (573)
                      ....             ........||+.|+|||++.+..++.++||||||+++|+|++|..||.............. .
T Consensus       187 ~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          187 GHEY-------------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             TCSE-------------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             cccc-------------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            1110             0112345688899999999998899999999999999999999999976533221111100 0


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS  358 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~  358 (573)
                      ..........+..+ ..+   ..+..+++++.+||++||+.||++|||+.++++.|..+.+....
T Consensus       254 ~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          254 QMTVLRLTELLERG-ERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHHHHHHHHHHTT-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             chhHHHHHHHHhcc-cCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            11111122222222 222   23457899999999999999999999999999999998876654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=351.53  Aligned_cols=255  Identities=31%  Similarity=0.473  Sum_probs=207.0

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      +..++|++.+.||+|+||+||++++.++.||||++...  ...+.+.+|+.++++++||||+++++++.+  ..++||||
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            45678999999999999999999999999999986533  345778999999999999999999999874  58999999


Q ss_pred             ccCCChhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCceEEcCCCC-CeEeeeecchhhhhhh
Q 008220          143 YESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHN---LGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLK  216 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~iiH~Dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~  216 (573)
                      +++++|.+++.....  .++...++.++.|++.||+|||+   +||+||||||+|||++.++. +||+|||++.....  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--  158 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--  158 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--
Confidence            999999999975542  46889999999999999999999   89999999999999999887 79999999864432  


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                       ......||+.|+|||++.+..++.++||||||+++|+|++|..||........          
T Consensus       159 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------  211 (307)
T 2eva_A          159 -----------------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----------  211 (307)
T ss_dssp             -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----------
T ss_pred             -----------------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----------
Confidence                             12234689999999999999999999999999999999999999975432111          


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                        ........+. ++   ..+..+++.+.+||.+||+.||++|||+.+++++|..+....
T Consensus       212 --~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          212 --RIMWAVHNGT-RP---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             --HHHHHHHTTC-CC---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             --HHHHHHhcCC-CC---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence              1111111111 11   234578999999999999999999999999999998876544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-43  Score=380.36  Aligned_cols=255  Identities=25%  Similarity=0.323  Sum_probs=213.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-------------HHHHHHHHHHHHHHhCCCCccceeeec
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------------EELDNFHKELQLLCKLDHPGLAKFVAA  129 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (573)
                      .++|+++++||+|+||+||+|.+  +++.||+|++.....             ...+.+.+|+.+|+.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46899999999999999999997  478899998654321             234678899999999999999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeee
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADF  206 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Df  206 (573)
                      +.+...+++|||||.+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            999999999999999999999987654 789999999999999999999999999999999999998876   6899999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      |++......                 .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus       194 g~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          194 GLSSFFSKD-----------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             TTCEECCTT-----------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCCEEcCCC-----------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998755321                 11345679999999999874 589999999999999999999999998776665


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ...+....+.              .. ...+..+++++.+||++||+.||.+|||+.|+++|+|...
T Consensus       256 ~~~i~~~~~~--------------~~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          256 IKKVEKGKYY--------------FD-FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHHHHCCCC--------------CC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHcCCCC--------------CC-ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            5555433221              11 1123578999999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.8e-44  Score=360.74  Aligned_cols=273  Identities=22%  Similarity=0.303  Sum_probs=214.3

Q ss_pred             CCCccccccccccCceEEEEEEEC--CeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      .++|++.+.||+|+||.||+|++.  ++.||||++...  .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999984  789999976443  3334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........   
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---
Confidence            9999988888765444 789999999999999999999999999999999999999999999999999875542111   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.........
T Consensus       180 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (331)
T 4aaa_A          180 -------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP  246 (331)
T ss_dssp             -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             -------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence                         12345789999999999875 6899999999999999999999999887766655554432211100


Q ss_pred             -HHHHHh-----cCCCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          300 -LTAAVV-----SGGLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       300 -~~~~~~-----~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                       ......     .+...+      ......+.+++++.+||.+||+.||++|||+.|+++|.|+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             000000     000111      1111234679999999999999999999999999999998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.7e-44  Score=379.93  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=210.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++++.||+|+||+||+|++  ++..||+|++....  ......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4799999999999999999998  57889999865432  2235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC---CCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.+|+|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++..   +.+||+|||++.......  
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--  193 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence            999999999887654 78999999999999999999999999999999999999764   459999999987654211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....+   
T Consensus       194 ---------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---  254 (494)
T 3lij_A          194 ---------------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---  254 (494)
T ss_dssp             ---------------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred             ---------------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence                           1345679999999999864 589999999999999999999999998766555544433222   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                 .. ....+..+++++.+||++||+.||.+|||+.|+++|+|....
T Consensus       255 -----------~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          255 -----------TF-DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -----------CC-CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -----------CC-CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                       11 112235789999999999999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.2e-44  Score=352.49  Aligned_cols=254  Identities=21%  Similarity=0.354  Sum_probs=215.8

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +..++|++.+.||+|+||.||+|.+  +++.||+|++.....   ...+.+.+|+++++.++||||+++++++.+....+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            3446899999999999999999998  478899998643211   12457889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||+.+++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....   
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---  166 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---  166 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred             EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence            9999999999999987655 689999999999999999999999999999999999999999999999998854321   


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....  
T Consensus       167 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  229 (284)
T 2vgo_A          167 ---------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--  229 (284)
T ss_dssp             ---------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred             ---------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--
Confidence                           012345789999999999999999999999999999999999999987655444333322111  


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                       ..+..+++++.+||.+||+.||.+|||+.++++|.|....
T Consensus       230 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          230 -----------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -----------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                             1235689999999999999999999999999999988654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-44  Score=364.43  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=207.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++.....    ...+|++++.++ +||||+++++++.+....|+||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            5799999999999999999998  588999998654332    234688888887 799999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-C---CCeEeeeecchhhhhhhhh
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-L---CPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~---~~kL~Dfg~a~~~~~~~~~  218 (573)
                      +.||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+... +   .+||+|||++.......  
T Consensus        98 ~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--  174 (342)
T 2qr7_A           98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--  174 (342)
T ss_dssp             CCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--
Confidence            99999999987654 78999999999999999999999999999999999998543 3   49999999987543211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......           ...
T Consensus       175 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----------~~~  229 (342)
T 2qr7_A          175 --------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----------TPE  229 (342)
T ss_dssp             --------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----------CHH
T ss_pred             --------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----------CHH
Confidence                          1134567899999999999888899999999999999999999999763211           111


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ++...+..+.+. .....+..+++++.+||++||+.||++|||+.++++|+|..
T Consensus       230 ~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          230 EILARIGSGKFS-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             HHHHHHHHCCCC-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHHccCCcc-cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            122222222222 11223457899999999999999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7e-44  Score=379.99  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=212.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.++||+|+||+||+|.+  +++.||||++...  .......+.+|+.++++++||||+++++++.+...+++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            6899999999999999999998  5889999985322  12235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc---CCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.+++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......  
T Consensus       102 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--  178 (486)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence            999999999887654 789999999999999999999999999999999999995   45679999999987543211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....    
T Consensus       179 ---------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----  238 (486)
T 3mwu_A          179 ---------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----  238 (486)
T ss_dssp             ------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred             ---------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Confidence                           1234579999999999976 48999999999999999999999998876655544443322    


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                .....+ .+..+|+++.+||++||+.||.+|||+.++++|+|...
T Consensus       239 ----------~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          239 ----------YAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             ----------CCSCSG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             ----------CCCCCc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence                      222111 23468999999999999999999999999999999854

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-43  Score=357.32  Aligned_cols=262  Identities=23%  Similarity=0.402  Sum_probs=218.7

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      .+++..++|++.+.||+|+||.||+|.+.       ++.||||.+... .......+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            46777889999999999999999999753       578999986544 3345667899999999999999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      +....++||||+.+++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence            9999999999999999999986532         3568999999999999999999999999999999999999999999


Q ss_pred             EeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCc
Q 008220          203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL  281 (573)
Q Consensus       203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~  281 (573)
                      |+|||++.........              .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       179 l~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             ECCTTCCCGGGGGGCE--------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             ECcCcccccccccccc--------------ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            9999998765432110              01234467899999999999999999999999999999999 89999876


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ........+..              +..    ...+..+++.+.+||.+||+.||.+|||+.|++++|....
T Consensus       245 ~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          245 SNEQVLRFVME--------------GGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             CHHHHHHHHHT--------------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CHHHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            55444333322              111    1234578999999999999999999999999999886543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.1e-44  Score=351.03  Aligned_cols=256  Identities=26%  Similarity=0.411  Sum_probs=209.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-CCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv  139 (573)
                      +.+..++|++.+.||+|+||+||++.++++.||||.+....  ..+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            45667899999999999999999999999999999865443  45678899999999999999999998654 4579999


Q ss_pred             EEeccCCChhhhhhccCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++++|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......   
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999999875432 3788999999999999999999999999999999999999999999999998644321   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                      .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.      
T Consensus       171 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~------  228 (278)
T 1byg_A          171 ----------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------  228 (278)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT------
T ss_pred             ----------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------
Confidence                            123357889999999999999999999999999999998 999998764433322221      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                               ...++   ..+..+++++.++|++||+.||++|||+.++++.|..+...
T Consensus       229 ---------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          229 ---------KGYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------cCCCC---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                     11111   23457899999999999999999999999999999888764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-44  Score=362.01  Aligned_cols=260  Identities=21%  Similarity=0.340  Sum_probs=209.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCee----EEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRK----VAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .+..++|++.+.||+|+||+||+|.+  +++.    ||+|...... ......+.+|+.+++.++||||+++++++. ..
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            45567999999999999999999987  3443    7788653322 222345678999999999999999999886 56


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.+|+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            78999999999999999987655789999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...              ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.. 
T Consensus       168 ~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-  232 (325)
T 3kex_A          168 DDK--------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-  232 (325)
T ss_dssp             CTT--------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-
T ss_pred             ccc--------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-
Confidence            111              112234568889999999999999999999999999999999 9999987654433332221 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                   + .++   ..+..+++++.+||.+||+.||.+|||+.+++++|..+..
T Consensus       233 -------------~-~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          233 -------------G-ERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------------T-CBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------------C-CCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                         1 111   1234577889999999999999999999999999988764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-44  Score=382.63  Aligned_cols=257  Identities=26%  Similarity=0.317  Sum_probs=217.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++.+.||+|+||.||+|.+  +++.||||++....   ....+.+.+|+.++++++||||+++++++.+...+++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            346899999999999999999998  58899999864332   3346778999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ||||+.+++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999987654 78999999999999999999999999999999999999   56789999999998765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .                 ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+.... 
T Consensus       183 ~-----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-  243 (484)
T 3nyv_A          183 K-----------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK-  243 (484)
T ss_dssp             C-----------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred             c-----------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-
Confidence            1                 1344579999999999977 58999999999999999999999999876655544443322 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                   .....+ .+..+++++.+||++||+.||.+|||+.|+++|+|....
T Consensus       244 -------------~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          244 -------------YTFELP-QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             -------------CCCCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             -------------CCCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                         222111 234689999999999999999999999999999998643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-44  Score=359.35  Aligned_cols=262  Identities=21%  Similarity=0.375  Sum_probs=209.8

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCee----EEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRK----VAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..+..++|++.+.||+|+||.||+|.+  +++.    |++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            345668999999999999999999987  4444    577765332 233467788999999999999999999999865


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      . .++|++++.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 889999999999999998777789999999999999999999999999999999999999999999999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....              ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. 
T Consensus       169 ~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-  233 (327)
T 3lzb_A          169 AEEK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-  233 (327)
T ss_dssp             -------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred             Cccc--------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-
Confidence            2111              111233457889999999999999999999999999999999 999998765443322221 


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                   .+...    ..+..+++++.+||.+||+.||.+|||+.|+++.|..+...
T Consensus       234 -------------~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          234 -------------KGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------------TTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------------cCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                         11111    12446889999999999999999999999999999888753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-44  Score=353.32  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=205.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.++||+|+||.||++.+  ++..+|+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5799999999999999999987  47899999764432 23457788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhh
Q 008220          143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +.+++|.+.+...   ...+++..++.++.|++.||+|||+.||+||||||+||++   +.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            9999999988542   3578999999999999999999999999999999999999   556789999999997554211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                       ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+..............  
T Consensus       182 -----------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--  241 (285)
T 3is5_A          182 -----------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--  241 (285)
T ss_dssp             ----------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--
T ss_pred             -----------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--
Confidence                             123457899999999986 457899999999999999999999998765544333222111  


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                    +........+++++.+||.+||+.||++|||+.|+++|.|.
T Consensus       242 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          242 --------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             --------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             --------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence                          11111223578999999999999999999999999998875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-43  Score=352.27  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=215.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++.+.||+|+||.||++.+  +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            346899999999999999999998  4788999975432   34566788999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+++|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......   
T Consensus        93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---  168 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---  168 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC---
Confidence            999999999999887554 7899999999999999999999999999999999999999999999999998654311   


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                   ........||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..      
T Consensus       169 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------  229 (294)
T 2rku_A          169 -------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------  229 (294)
T ss_dssp             -------------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------
T ss_pred             -------------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------
Confidence                         1113345789999999999999899999999999999999999999987654443332221      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                              ...     ..+..+++.+.+||.+||+.||++|||+.|+++|.|...
T Consensus       230 --------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          230 --------NEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             --------TCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             --------ccC-----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence                    111     134568899999999999999999999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.9e-44  Score=355.74  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=210.2

Q ss_pred             CCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +.++|++.+.||+|+||.||+|.+.  ++.||+|++........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3468999999999999999999984  78999998766655567789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........    
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ----  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH----
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc----
Confidence            9999999999877666799999999999999999999999999999999999999999999999998764332111    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                  ......||+.|+|||++.     +..++.++||||||+++|+|++|..||...........+...   
T Consensus       173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---  237 (302)
T 2j7t_A          173 ------------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---  237 (302)
T ss_dssp             ------------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---
T ss_pred             ------------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---
Confidence                        123457899999999983     667889999999999999999999999876554433332221   


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 .. +. ...+..++.++.+||.+||+.||++|||+.++++|+|.
T Consensus       238 -----------~~-~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          238 -----------DP-PT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             -----------CC-CC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             -----------CC-cc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence                       11 11 11234678999999999999999999999999988765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-43  Score=359.69  Aligned_cols=254  Identities=24%  Similarity=0.302  Sum_probs=216.2

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..++|++.+.||+|+||.||++.+  +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            346899999999999999999998  4678999975432   34566788999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--  195 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--  195 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence            999999999999887554 78999999999999999999999999999999999999999999999999987543211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                    .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..      
T Consensus       196 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------  255 (335)
T 2owb_A          196 --------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------  255 (335)
T ss_dssp             --------------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------
T ss_pred             --------------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------
Confidence                          113445799999999999999999999999999999999999999987654443333221      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                              ...     ..+..+++++.+||.+||+.||++|||+.|+++|.|...
T Consensus       256 --------~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          256 --------NEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             --------TCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             --------CCC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                    111     124468899999999999999999999999999998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.7e-43  Score=349.89  Aligned_cols=257  Identities=21%  Similarity=0.304  Sum_probs=214.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh------HHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+.....      ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            5799999999999999999998  478999997544321      13567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            9999999999999997654 789999999999999999999999999999999999998877    79999999986543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...
T Consensus       164 ~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  226 (283)
T 3bhy_A          164 AGN-----------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV  226 (283)
T ss_dssp             -------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             CCC-----------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence            211                 123456899999999999999999999999999999999999999877655444433322


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ..               ......+..+++.+.+||.+||+.||++|||+.++++|.|...-.
T Consensus       227 ~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          227 NY---------------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CC---------------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cc---------------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            11               111223357889999999999999999999999999999876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.8e-44  Score=355.55  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=205.6

Q ss_pred             ccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHh--CCCCccceeeecccc----CCc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAK----PPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~----~~~  135 (573)
                      ++..++|++.+.||+|+||+||+|+++++.||||++...   ....+..|.+++..  ++||||+++++++..    ...
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            345679999999999999999999999999999986433   33455567777766  799999999998543    356


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--------NLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                      .++||||+.+|+|.+++..  ..+++..++.++.|++.||+|||        +.||+||||||+|||++.++.+||+|||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            8999999999999999954  36899999999999999999999        9999999999999999999999999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC------CCCchhhHHHHHHHHHHHHcC-------
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE------IHSEKSDVYSFGISINELLTG-------  274 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg-------  274 (573)
                      ++..........            ........||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       159 ~a~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          159 LAVMHSQSTNQL------------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             TCEEEETTTTEE------------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             Ceeecccccccc------------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            987554211100            0112345799999999999876      445789999999999999999       


Q ss_pred             ---CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          275 ---VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       275 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                         ..||........         ..............++.++.  .+..+++++.+||.+||+.||++|||+.++++.|
T Consensus       227 ~~~~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDP---------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             CCCCCTTTTTSCSSC---------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccccCCCCc---------chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence               788865322111         11111122222333333322  2334678999999999999999999999999988


Q ss_pred             HHH
Q 008220          350 DLV  352 (573)
Q Consensus       350 ~~~  352 (573)
                      ..+
T Consensus       298 ~~i  300 (301)
T 3q4u_A          298 TKI  300 (301)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4e-43  Score=350.01  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=212.7

Q ss_pred             CCccccccccccCceEEEEEEEC-----CeeEEEeeccC-CChHHHHHHHHHHHHHHhCCCCccceeeecc-ccCCceEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMF  138 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~l  138 (573)
                      .+|++.+.||+|+||+||+|.+.     ...+|+|.... ......+.+.+|+.++++++||||+++++++ ......++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            47999999999999999999862     23588887654 3445667899999999999999999999984 55678899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||||+.+++|.+++......+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            99999999999999876767899999999999999999999999999999999999999999999999999765432211


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                      .            ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...........+..     
T Consensus       185 ~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-----  247 (298)
T 3f66_A          185 S------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----  247 (298)
T ss_dssp             B------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-----
T ss_pred             c------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-----
Confidence            0            111334567899999999999999999999999999999999 6777776544333322221     


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                               +. .+   ..+..+++++.++|.+||+.||++|||+.++++.|..+....
T Consensus       248 ---------~~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          248 ---------GR-RL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             ---------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             ---------CC-CC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                     11 11   123468899999999999999999999999999999888643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-43  Score=349.28  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.+.||+|+||.||+|.+  +++.||||++.....   ...+.+.+|+.+++.++||||+++++++.....
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            455567999999999999999999998  488999998643221   224578899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+.+++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999999997654 6899999999999999999999999999999999999999999999999998654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .                 ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..  
T Consensus       165 ~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--  225 (276)
T 2h6d_A          165 E-----------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--  225 (276)
T ss_dssp             -----------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--
T ss_pred             c-----------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--
Confidence            1                 1234578999999999988765 6899999999999999999999987654443333221  


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                  +.     ...+..++.++.++|.+||+.||++|||+.++++|.|..
T Consensus       226 ------------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~  266 (276)
T 2h6d_A          226 ------------GV-----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK  266 (276)
T ss_dssp             ------------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             ------------Cc-----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence                        11     112446789999999999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-44  Score=361.94  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=190.1

Q ss_pred             Ccccc---ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           67 SYTLL---SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        67 ~y~~~---~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      +|++.   +.||+|+||+||+|.+  +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            46554   7899999999999998  4789999986432   3456778999999997 999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++....... 
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  163 (325)
T 3kn6_A           86 ELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-  163 (325)
T ss_dssp             CCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             EccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence            9999999999997654 799999999999999999999999999999999999998766   79999999986543211 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     .......||+.|+|||++.+..++.++|||||||++|+|++|..||........       ....
T Consensus       164 ---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~  221 (325)
T 3kn6_A          164 ---------------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-------CTSA  221 (325)
T ss_dssp             -----------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------CCCH
T ss_pred             ---------------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-------cccH
Confidence                           123455789999999999999999999999999999999999999986543211       0111


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+....+..+... .....+..+++++.+||.+||+.||.+|||+.|+++|.|..
T Consensus       222 ~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          222 VEIMKKIKKGDFS-FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HHHHHHHTTTCCC-CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             HHHHHHHHcCCCC-CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            1222222222221 12223356899999999999999999999999999988763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-43  Score=357.84  Aligned_cols=263  Identities=28%  Similarity=0.478  Sum_probs=214.0

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeE--EEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKV--AVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      +..++|++.+.||+|+||.||+|++  ++..+  ++|.+... .....+.+.+|+.+++++ +||||+++++++.+....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            4447899999999999999999986  56644  88876532 233456788999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCC
Q 008220          137 MFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      ++||||+++++|.+++....               ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence            99999999999999987543               368999999999999999999999999999999999999999999


Q ss_pred             eEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008220          202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD  280 (573)
Q Consensus       202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~  280 (573)
                      ||+|||++......                 .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       182 kL~Dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          182 KIADFGLSRGQEVY-----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             EECCTTCEESSCEE-----------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEcccCcCcccccc-----------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence            99999998633210                 01233457889999999998889999999999999999998 9999987


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK  360 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~  360 (573)
                      .........+..              + .++   ..+..+++++.+||.+||+.||.+|||+.+++++|..+++..+...
T Consensus       245 ~~~~~~~~~~~~--------------~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          245 MTCAELYEKLPQ--------------G-YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             CCHHHHHHHGGG--------------T-CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             CcHHHHHHHhhc--------------C-CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence            655443332221              1 111   1234688999999999999999999999999999999988655443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-43  Score=349.17  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=218.0

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      .++++.++|++.+.||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence            46788899999999999999999999984 5689999865433 23567889999999999999999999986 456899


Q ss_pred             EEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999999987542 2689999999999999999999999999999999999999999999999999876542110


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                     .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..    
T Consensus       165 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----  225 (279)
T 1qpc_A          165 ---------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----  225 (279)
T ss_dssp             ---------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----
T ss_pred             ---------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc----
Confidence                           01223457889999999998889999999999999999999 9999987655443333221    


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                 ..++   ..+..+++++.+||.+||+.||++|||+.++++.|..+....
T Consensus       226 -----------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          226 -----------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             -----------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----------ccCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                       1111   124578999999999999999999999999999999888653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.3e-44  Score=391.94  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=216.1

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      +..++|++++.||+|+||.||+|++  +++.||||++...   .....+.+..|..++..+ +||||+++++++.+...+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            4457899999999999999999997  5678999986432   122345678899999988 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....  
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--  494 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--  494 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred             EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence            99999999999999998665 799999999999999999999999999999999999999999999999999864321  


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    .+....+.+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.......+..... 
T Consensus       495 --------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-  559 (674)
T 3pfq_A          495 --------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-  559 (674)
T ss_dssp             --------------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-
T ss_pred             --------------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-
Confidence                          11124567899999999999999999999999999999999999999998776666555543221 


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                                        ..+..+++++.+||++||+.||++||++     .||++|.|+
T Consensus       560 ------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          560 ------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence                              1345789999999999999999999998     889888865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-44  Score=373.18  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=200.2

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--------hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||||++....        ......+.+|+.+|++++||||+++++++. ..
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            36899999999999999999987  57899999754321        112235789999999999999999999975 45


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC---CCeEeeeecchh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEY  211 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~---~~kL~Dfg~a~~  211 (573)
                      .+++||||+.+|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            6899999999999999887554 789999999999999999999999999999999999997544   599999999976


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      .....                 .....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||..........
T Consensus       292 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  354 (419)
T 3i6u_A          292 LGETS-----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  354 (419)
T ss_dssp             CC----------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred             cCCCc-----------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence            54211                 1345679999999999863   567889999999999999999999997653322211


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+             . ....+..+..+..+++.+.+||.+||+.||++|||+.|+++|+|..
T Consensus       355 ~~i-------------~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          355 DQI-------------T-SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             HHH-------------H-TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHH-------------h-cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            111             1 1112223334457899999999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-43  Score=355.88  Aligned_cols=267  Identities=27%  Similarity=0.429  Sum_probs=218.8

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..+++..++|++.+.||+|+||+||+|.+       +++.||||++.... ......+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            34677888999999999999999999985       34789999875543 34566789999999999 69999999999


Q ss_pred             cccCC-ceEEEEEeccCCChhhhhhccCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          130 HAKPP-NYMFFFEFYESRNLAEKLHVEEWS---------------PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       130 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      +...+ .+++||||+.+++|.+++......               +++..++.++.|++.||.|||+.||+||||||+||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 589999999999999999765422               78999999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      +++.++.+||+|||++........              ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             EECCCCCEEECCCccccccccCcc--------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence            999999999999999875532111              112334578899999999999999999999999999999998


Q ss_pred             -CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                       |..||............+             ..+. .+   ..+..+++++.++|.+||+.||.+|||+.+++++|..+
T Consensus       246 ~g~~p~~~~~~~~~~~~~~-------------~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          246 LGASPYPGVKIDEEFCRRL-------------KEGT-RM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             TSCCSSTTCCCSHHHHHHH-------------HHTC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcccchhHHHHHHh-------------ccCc-cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             999998754332222111             1111 11   12346899999999999999999999999999999998


Q ss_pred             HHHh
Q 008220          353 LEHR  356 (573)
Q Consensus       353 ~~~~  356 (573)
                      ++..
T Consensus       309 ~~~~  312 (316)
T 2xir_A          309 LQAN  312 (316)
T ss_dssp             HHHH
T ss_pred             Hhhh
Confidence            8643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=355.56  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=191.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||.+.....   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5799999999999999999997  688999998643221   12467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC---
Confidence            99999999999987666799999999999999999999999999999999999999999999999999865432110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..        
T Consensus       168 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  226 (278)
T 3cok_A          168 -------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--------  226 (278)
T ss_dssp             -------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--------
T ss_pred             -------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--------
Confidence                         12345789999999999998899999999999999999999999976543222111110        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                            ..     ...+..++.++.+||.+||+.||++|||+.++++|+|...
T Consensus       227 ------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          227 ------AD-----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             ------SC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             ------cc-----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence                  00     1124468899999999999999999999999999887643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-43  Score=374.72  Aligned_cols=261  Identities=29%  Similarity=0.413  Sum_probs=213.5

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..++++.++|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|++++||||+++++++.. ...+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            457788899999999999999999999985 4679999876443 234678999999999999999999999876 6789


Q ss_pred             EEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+.+|+|.+++... +..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            999999999999999753 3468999999999999999999999999999999999999999999999999997654211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .               .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.    
T Consensus       335 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----  395 (452)
T 1fmk_A          335 Y---------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----  395 (452)
T ss_dssp             -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----
T ss_pred             e---------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence            1               01223457889999999999999999999999999999999 999998765544333322    


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                . +.+.   ..+..+|+.+.+||.+||+.||++|||+.+|++.|..+..
T Consensus       396 ----------~-~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          396 ----------R-GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ----------T-TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----------c-CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                      1 1121   1245789999999999999999999999999988876654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-43  Score=351.67  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..+..++|++.+.||+|+||.||+|.+.     +..||+|.+...  .....+.+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            5567789999999999999999999762     357999986543  345567899999999999999999999998765


Q ss_pred             C-----ceEEEEEeccCCChhhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeE
Q 008220          134 P-----NYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL  203 (573)
Q Consensus       134 ~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL  203 (573)
                      .     ..++||||+.+++|.+++..     ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            4     45999999999999999842     2346899999999999999999999999999999999999999999999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCch
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR  282 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  282 (573)
                      +|||++.........              .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       189 ~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          189 ADFGLSKKIYSGDYY--------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             CSCSCC------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eecCcceeccccccc--------------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            999998765421110              01233457889999999999999999999999999999999 999998765


Q ss_pred             hHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .......+..              +. ++   ..+..+++++.+||.+||+.||.+|||+.+++++|..+.+..
T Consensus       255 ~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          255 NHEMYDYLLH--------------GH-RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             GGGHHHHHHT--------------TC-CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHc--------------CC-CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            4443332221              11 11   234578999999999999999999999999999999988754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=361.16  Aligned_cols=271  Identities=26%  Similarity=0.287  Sum_probs=210.1

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHH-----HHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-----LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.......     ...+.+|+.+++.++||||+++++++......+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            46899999999999999999987  47899999865432211     246789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +||||+.+ +|.+++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...... 
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  166 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  166 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence            99999986 8888887766678999999999999999999999999999999999999999999999999987553211 


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                     .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+......
T Consensus       167 ---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~  231 (346)
T 1ua2_A          167 ---------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  231 (346)
T ss_dssp             ---------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ---------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence                           11344678999999999976 45899999999999999999999999887766665555432211


Q ss_pred             HHHHHHH--------HhcCCC-CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAA--------VVSGGL-RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~--------~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .....+.        ...... ...+......+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence            1000000        000000 0001112356789999999999999999999999999998874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.5e-43  Score=363.52  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=207.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCC--CCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~  135 (573)
                      ..+...+|++.+.||+|+||.||++.+ .++.||||++...  .....+.+.+|+.+|+.++  ||||+++++++.....
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            345567899999999999999999987 4788999986543  3455678999999999996  5999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||| +.+++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999999 66789999997655 789999999999999999999999999999999999995 589999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAE  284 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~  284 (573)
                      ..              .......+||+.|+|||++.+           ..++.++|||||||+||+|++|..||......
T Consensus       208 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          208 TT--------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             --------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             Cc--------------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            11              011245679999999999875           46889999999999999999999999764322


Q ss_pred             -HHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          285 -AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       .....              +.......   ..+...+.++.+||.+||+.||.+|||+.|+++|+|...
T Consensus       274 ~~~~~~--------------~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          274 ISKLHA--------------IIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             HHHHHH--------------HHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHH--------------HhCccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence             11111              11111111   123456889999999999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-43  Score=349.11  Aligned_cols=260  Identities=25%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hH-HHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      +++..++|++.+.||+|+||+||+|.+  +++.||+|++.... .. ..+.+..+...++.++||||+++++++.++...
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            456778999999999999999999998  78999999865442 22 233445555668888999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          137 MFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ++||||+.+ +|.+++..   ....+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999975 88777643   345789999999999999999999998 9999999999999999999999999998765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhh----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhH-HHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQA  287 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~  287 (573)
                      ....                 ......||+.|+|||++    .+..++.++|||||||++|+|++|..||...... ...
T Consensus       161 ~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  223 (290)
T 3fme_A          161 VDDV-----------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL  223 (290)
T ss_dssp             --------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred             cccc-----------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence            4211                 12334689999999996    5567899999999999999999999999753222 111


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .....              ... +  ...+..+++++.+||.+||+.||++|||+.|+++|+|.....
T Consensus       224 ~~~~~--------------~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          224 KQVVE--------------EPS-P--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHH--------------SCC-C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHhc--------------cCC-C--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            11111              111 1  112346899999999999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-44  Score=365.03  Aligned_cols=270  Identities=24%  Similarity=0.375  Sum_probs=210.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChH-HHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      +.+..++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+|+.+++.++||||+++++++......++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            556778999999999999999999986 5889999986544322 22368899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          139 FFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNL---GIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ||||+.+|+|.+++....   ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997543   2489999999999999999999999   9999999999999999999999999998755


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....               ........||+.|+|||++.+..++.++|||||||++|+|++|..||.........     
T Consensus       185 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----  244 (326)
T 3uim_A          185 DYKD---------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-----  244 (326)
T ss_dssp             CSSS---------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS-----
T ss_pred             Cccc---------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc-----
Confidence            3211               11233456999999999999888999999999999999999999999632111000     


Q ss_pred             ccccHHHHHHHHhcC-CCCCc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSG-GLRPI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                       .............. .....     ....+...++.+.+++.+||+.||.+|||+.||+++|+.
T Consensus       245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          245 -DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             -CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             -chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence             00000000000000 00000     011122346789999999999999999999999999964

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=363.24  Aligned_cols=243  Identities=22%  Similarity=0.333  Sum_probs=206.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--------HHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++.....        .....+.+|+.+++.++||||+++++++.+...
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            5899999999999999999987  688999998654321        123456789999999999999999999999999


Q ss_pred             eEEEEEeccCC-ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          136 YMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       136 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      +++||||+.+| +|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            99999999776 9999887654 789999999999999999999999999999999999999999999999999875542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .                 .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......        
T Consensus       183 ~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------  237 (335)
T 3dls_A          183 G-----------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------  237 (335)
T ss_dssp             T-----------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------
T ss_pred             C-----------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------
Confidence            1                 11334679999999999988876 789999999999999999999997632110        


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                  ...     ...+..+++++.+||.+||+.||++|||+.++++|+|.
T Consensus       238 ------------~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          238 ------------EAA-----IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             ------------TTC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             ------------hhc-----cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                        000     11234689999999999999999999999999999876

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-43  Score=363.48  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=203.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------c
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------N  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~  135 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++...  .......+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            6899999999999999999987  5889999986542  3455677889999999999999999999987654      6


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+.+ +|.+.+..   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             eEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            8999999975 78777742   5889999999999999999999999999999999999999999999999998754321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       181 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  243 (371)
T 2xrw_A          181 -----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  243 (371)
T ss_dssp             --------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred             -----------------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence                             012346799999999999999999999999999999999999999998877666655544321


Q ss_pred             cHHH---------HHHHHhcC-CCC-------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 TEQQ---------LTAAVVSG-GLR-------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~---------~~~~~~~~-~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+..         ........ ...             |.....+...++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence            1100         00000000 000             000000111367899999999999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.9e-44  Score=356.70  Aligned_cols=276  Identities=24%  Similarity=0.386  Sum_probs=197.2

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ..++.+..++|++.+.||+|+||.||+|.+  +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            456788889999999999999999999986  68899999865443 234567889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          135 NYMFFFEFYESRNLAEKLHV-------EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                      ..++||||+.+++|.+++..       ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999999864       23468999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ++.........           ..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus       167 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  235 (303)
T 2vwi_A          167 VSAFLATGGDI-----------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV  235 (303)
T ss_dssp             HHHHCC--------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred             chheeccCCCc-----------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence            98765421110           00111334579999999999876 5689999999999999999999999987654433


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .............         ...........+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus       236 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          236 LMLTLQNDPPSLE---------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             HHHHHTSSCCCTT---------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             HHHHhccCCCccc---------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence            3322221111000         000011223468899999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-43  Score=367.63  Aligned_cols=255  Identities=21%  Similarity=0.285  Sum_probs=198.9

Q ss_pred             CCcccc-ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHH-hCCCCccceeeecccc----CCceE
Q 008220           66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~----~~~~~  137 (573)
                      ++|.+. +.||+|+||+||++.+  +++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            467776 7899999999999998  5789999986422     34668888874 4589999999998865    56789


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +||||+.||+|.+++.... ..+++.+++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||+++...
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            9999999999999997653 36899999999999999999999999999999999999998   7889999999987543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........     
T Consensus       216 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----  273 (400)
T 1nxk_A          216 SHN-----------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----  273 (400)
T ss_dssp             ----------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-----
T ss_pred             CCC-----------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-----
Confidence            211                 1345678999999999999999999999999999999999999997654321100     


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                           .....+..+.+... ...+..+++++.+||++||+.||++|||+.|+++|+|...
T Consensus       274 -----~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          274 -----GMKTRIRMGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             -----SHHHHHHHTCCCCC-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -----HHHHHHHcCcccCC-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence                 00111111222111 1123468999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.5e-44  Score=381.37  Aligned_cols=257  Identities=21%  Similarity=0.241  Sum_probs=212.6

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +..++|++.+.||+|+||.||+|++  +++.||||++....   ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            5567899999999999999999998  58899999864321   123456789999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||++||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-  339 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-  339 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence            9999999999999987544 35899999999999999999999999999999999999999999999999999754321 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........        
T Consensus       340 ----------------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--------  395 (576)
T 2acx_A          340 ----------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--------  395 (576)
T ss_dssp             ----------------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--------
T ss_pred             ----------------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--------
Confidence                            11234589999999999999899999999999999999999999998753211111        


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                        .+...+....     ...+..+++++.+||++||+.||.+||     ++.|+++|+|+
T Consensus       396 --~i~~~i~~~~-----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF  448 (576)
T 2acx_A          396 --EVERLVKEVP-----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF  448 (576)
T ss_dssp             --HHHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred             --HHHHHhhccc-----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence              1111111111     123457899999999999999999999     78999888765

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-43  Score=361.34  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=211.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--------hHHHHHHHHHHHHHHhC-CCCccceeeeccccCC
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--------SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP  134 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  134 (573)
                      ++|++.+.||+|+||.||+|.+  +|+.||||++....        ....+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999998  48899999865432        12245688999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            9999999999999999987554 789999999999999999999999999999999999999999999999999865432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      ..                 ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||..........
T Consensus       253 ~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  315 (365)
T 2y7j_A          253 GE-----------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR  315 (365)
T ss_dssp             TC-----------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             Cc-----------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            11                 1345679999999999864      357889999999999999999999998765544443


Q ss_pred             HHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .+....              .... ...+..+++++.+||.+||+.||++|||+.++++|+|+
T Consensus       316 ~i~~~~--------------~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          316 MIMEGQ--------------YQFS-SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             HHHHTC--------------CCCC-HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHhCC--------------CCCC-CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            333222              1111 11234678999999999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-43  Score=377.61  Aligned_cols=258  Identities=19%  Similarity=0.271  Sum_probs=211.4

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +..++|++.+.||+|+||.||+|++  +++.||||++.....   .....+.+|+.+++.++||||+++++++.+...+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            4457899999999999999999998  588999998643221   23457889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          138 FFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      +||||++||+|.+++...   ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999988653   23689999999999999999999999999999999999999999999999999975432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..                ......+||+.|+|||++.+..++.++|||||||++|||++|..||........        
T Consensus       342 ~~----------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--------  397 (543)
T 3c4z_A          342 GQ----------------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--------  397 (543)
T ss_dssp             TC----------------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--------
T ss_pred             CC----------------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--------
Confidence            11                112345899999999999999999999999999999999999999986532111        


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL  351 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~  351 (573)
                        ...+...+.....     ..+..+++++.+||++||+.||++||++     .+|++|+|+
T Consensus       398 --~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff  452 (543)
T 3c4z_A          398 --NKELKQRVLEQAV-----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF  452 (543)
T ss_dssp             --HHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred             --HHHHHHHHhhccc-----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence              1111111111111     2345789999999999999999999964     778777654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.9e-43  Score=368.60  Aligned_cols=273  Identities=22%  Similarity=0.242  Sum_probs=216.3

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC------CCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL------DHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~  131 (573)
                      +.+....+|++.+.||+|+||+||+|.+  +++.||||++... ......+.+|+.+++.+      +|+||+++++++.
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3445567899999999999999999987  4789999986543 34456777888888887      5789999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--CeEeeeec
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGL  208 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--~kL~Dfg~  208 (573)
                      .....++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999996 58988887654 35899999999999999999999999999999999999999987  99999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      +.....                   ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+......
T Consensus       249 a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~  309 (429)
T 3kvw_A          249 SCYEHQ-------------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA  309 (429)
T ss_dssp             CEETTC-------------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ceecCC-------------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            864331                   1234679999999999999999999999999999999999999999887766665


Q ss_pred             HHHhccccHH-HHHHH------Hhc-CCCC--------------------------------CcccccccCChHHHHHHH
Q 008220          289 TVLEMNYTEQ-QLTAA------VVS-GGLR--------------------------------PILASLELGLPASILSLI  328 (573)
Q Consensus       289 ~~~~~~~~~~-~~~~~------~~~-~~~~--------------------------------~~~~~~~~~~~~~l~~li  328 (573)
                      .+......+. .+...      ... .+..                                .....++...++++.+||
T Consensus       310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli  389 (429)
T 3kvw_A          310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL  389 (429)
T ss_dssp             HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred             HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence            5554321111 11100      000 0000                                000011223578899999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          329 QRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       329 ~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ++||+.||++|||+.|+++|+|...
T Consensus       390 ~~~L~~dP~~Rpta~e~L~Hpw~~~  414 (429)
T 3kvw_A          390 KQCLEWDPAVRMTPGQALRHPWLRR  414 (429)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred             HHHCCCChhhCCCHHHHhCChhhcc
Confidence            9999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.2e-43  Score=348.49  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=209.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc----C
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----P  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~  133 (573)
                      ...+..|++.+.||+|+||+||+|.+  ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..    .
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34556799999999999999999988  4678999975432  45567789999999999999999999998765    4


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEc-CCCCCeEeeeecch
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLD-RNLCPHLADFGLAE  210 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~  210 (573)
                      ..+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.|  |+||||||+|||++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            56899999999999999997654 6899999999999999999999999  99999999999998 78999999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      ....                  .......||+.|+|||++.+ .++.++|||||||++|+|++|..||............
T Consensus       181 ~~~~------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  241 (290)
T 1t4h_A          181 LKRA------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR  241 (290)
T ss_dssp             GCCT------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred             cccc------------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence            4331                  11334579999999998875 4899999999999999999999999875443332222


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..             .+ ..+  ...+...++++.+||.+||+.||.+|||+.|+++|+|.
T Consensus       242 ~~-------------~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          242 VT-------------SG-VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             HT-------------TT-CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             Hh-------------cc-CCc--cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            11             11 111  12345678999999999999999999999999998875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-42  Score=346.55  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=206.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccC---CChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ..+|++.+.||+|+||.||+|.+  +++.||||++..   ........+.+|+.+++.++||||+++++++......++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35899999999999999999987  588999998654   3455667889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |||+.+++|.+++..   ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            999999999998864   34468999999999999999999999999999999999999999999999999987554211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .                ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+....            
T Consensus       191 ~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------  242 (310)
T 2wqm_A          191 T----------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------  242 (310)
T ss_dssp             ------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------------
T ss_pred             c----------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------------
Confidence            1                123457899999999999999999999999999999999999999754211            


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS  358 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~  358 (573)
                      .......+......+.   .+..+++++.+||.+||+.||++|||+.++++.+..+......
T Consensus       243 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          243 LYSLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             HHHHHHHHHTTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHhhcccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            1111122222222221   1246899999999999999999999999999999988875443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-43  Score=358.91  Aligned_cols=272  Identities=23%  Similarity=0.285  Sum_probs=215.1

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----Cce
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNY  136 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~  136 (573)
                      ..+|++++.||+|+||.||+|.+  +++.||||++... .....+.+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            36899999999999999999987  5789999987543 344557889999999999999999999998654     468


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++|||++.+ +|.+++...  .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus       106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999999975 899888653  58999999999999999999999999999999999999999999999999997654311


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..             ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       183 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          183 DH-------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             CB-------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             Cc-------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            10             011244589999999998764 4589999999999999999999999988776666555543221


Q ss_pred             cHHHHH----------HHHhc--CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 TEQQLT----------AAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~----------~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+....          .....  .............+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            111100          00000  0111112223456889999999999999999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-43  Score=350.51  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=216.2

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            36799999999999999999987  57899999865443 3446788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+++|.+++..  ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......     
T Consensus       101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-----  173 (303)
T ss_dssp             CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-----
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-----
Confidence            9999999999864  368999999999999999999999999999999999999999999999999986543211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                 .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..         
T Consensus       174 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------  233 (303)
T 3a7i_A          174 -----------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---------  233 (303)
T ss_dssp             -----------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------
T ss_pred             -----------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---------
Confidence                       112345789999999999999999999999999999999999999987654433322211         


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                           .. .   +..+..++..+.+||.+||+.||.+|||+.++++|+|....
T Consensus       234 -----~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          234 -----NN-P---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----SC-C---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----CC-C---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                 11 1   12345789999999999999999999999999999998654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-43  Score=364.85  Aligned_cols=270  Identities=21%  Similarity=0.299  Sum_probs=209.5

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-------
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-------  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------  132 (573)
                      +...++|++.+.||+|+||+||+|.+  +++.||||++.....    ...+|+.+|+.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567999999999999999999987  688999998654322    22379999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHH
Q 008220          133 -------------------------------PPNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYL  178 (573)
Q Consensus       133 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L  178 (573)
                                                     ....++||||+++ +|.+.+..   .+..+++..++.++.||+.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999985 77766642   345789999999999999999999


Q ss_pred             HhCCceeccCCCCceEEc-CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCC
Q 008220          179 HNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHS  256 (573)
Q Consensus       179 H~~~iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  256 (573)
                      |+.||+||||||+|||++ .++.+||+|||+++......                 ......||+.|+|||++.+. .++
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~  220 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------------PSVAYICSRFYRAPELMLGATEYT  220 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------------CCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------------CCcCcccCCCccCHHHhcCCCCCC
Confidence            999999999999999998 68899999999997543211                 13345789999999998875 489


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCC----C------cccccccCChHHHHH
Q 008220          257 EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR----P------ILASLELGLPASILS  326 (573)
Q Consensus       257 ~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------~~~~~~~~~~~~l~~  326 (573)
                      .++|||||||++|+|++|..||.+.........+......+...........+.    +      .....+..+++++.+
T Consensus       221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            999999999999999999999998877776666654332221111111111110    0      011134568999999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          327 LIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       327 li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ||.+||+.||.+|||+.|+++|+|+..
T Consensus       301 li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             HHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-43  Score=376.41  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=218.6

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..+++...+|++.+.||+|+||.||+|.+.  +..||||.+.... ...+.+.+|+.+|++++||||+++++++.....+
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            346777889999999999999999999984  7899999875443 3457789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999999754 346899999999999999999999999999999999999999999999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..               .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.........+.   
T Consensus       372 ~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---  433 (495)
T 1opk_A          372 TY---------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---  433 (495)
T ss_dssp             CE---------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             ce---------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            10               01223456789999999999899999999999999999999 999998765443322221   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  ...+.   ..+..+++++.+||.+||+.||++|||+.+|++.|..++
T Consensus       434 ------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          434 ------------KDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------------cCCCC---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                        12222   234578999999999999999999999999998886554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-44  Score=372.63  Aligned_cols=246  Identities=18%  Similarity=0.204  Sum_probs=197.0

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeecc---CCChHHHHHHHHHHH---HHHhCCCCccceee-------
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPI---LSTSEELDNFHKELQ---LLCKLDHPGLAKFV-------  127 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~---~~~~~~~~~~~~E~~---~l~~l~hpnIv~l~-------  127 (573)
                      ...++|++.+.||+|+||+||+|++  +++.||||++.   .......+.+.+|+.   +++.++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            4457899999999999999999985  58999999865   234446678999994   55555899999998       


Q ss_pred             eccccCC-----------------ceEEEEEeccCCChhhhhhccCCCCC-------HHHHHHHHHHHHHHHHHHHhCCc
Q 008220          128 AAHAKPP-----------------NYMFFFEFYESRNLAEKLHVEEWSPS-------VDQVLMIAAQLAKALQYLHNLGI  183 (573)
Q Consensus       128 ~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~~i  183 (573)
                      +++..++                 ..|+||||+ +|+|.+++...+ .++       +..++.++.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5554443                 388999999 579999997543 233       47888899999999999999999


Q ss_pred             eeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC----------
Q 008220          184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----------  253 (573)
Q Consensus       184 iH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------  253 (573)
                      +||||||+|||++.++.+||+|||+++....                   ......| +.|+|||++.+.          
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~  287 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------RVVSSVS-RGFEPPELEARRATISYHRDRR  287 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCE
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-------------------cccCCCC-cCccChhhhccccccccccccc
Confidence            9999999999999999999999999874321                   1334567 999999999887          


Q ss_pred             -CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhc
Q 008220          254 -IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW  332 (573)
Q Consensus       254 -~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  332 (573)
                       .++.++|||||||++|||++|..||.+.........+.                       ..+..+++++.+||.+||
T Consensus       288 ~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~L  344 (377)
T 3byv_A          288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----------------------RSCKNIPQPVRALLEGFL  344 (377)
T ss_dssp             EECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------------------SSCCCCCHHHHHHHHHHT
T ss_pred             ccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------------------hhccCCCHHHHHHHHHHc
Confidence             89999999999999999999999997654322211111                       112468999999999999


Q ss_pred             cCCCCCCCCHHHHHHHHHHHH
Q 008220          333 DGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       333 ~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      +.||++|||+.|+++|+|...
T Consensus       345 ~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          345 RYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             CSSGGGCCCHHHHHTSHHHHH
T ss_pred             CCCchhCCCHHHHhhChHHHH
Confidence            999999999999999988753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-43  Score=349.67  Aligned_cols=252  Identities=28%  Similarity=0.401  Sum_probs=209.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecc--ccCCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~lv  139 (573)
                      ++|++.+.||+|+||.||++.+  +++.||+|.+...  .....+.+.+|+.+++.++||||+++++++  ......++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            5899999999999999999998  5789999986543  345567899999999999999999999987  446789999


Q ss_pred             EEeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          140 FEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||+.|     |+||||||+||+++.++.+||+|||++..
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            9999999999998643   235899999999999999999999999     99999999999999999999999999876


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ......                ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus       166 ~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  229 (279)
T 2w5a_A          166 LNHDTS----------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  229 (279)
T ss_dssp             C---CH----------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eccccc----------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence            542111                1234578999999999999999999999999999999999999998765444333332


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .              +...    ..+..+++++.++|.+||+.||.+|||+.||++++|.
T Consensus       230 ~--------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          230 E--------------GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             H--------------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             h--------------cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            2              2211    2345789999999999999999999999999987754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.9e-43  Score=358.16  Aligned_cols=264  Identities=21%  Similarity=0.293  Sum_probs=211.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce-----
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY-----  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-----  136 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++...  .......+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            6899999999999999999987  5899999986543  334467788999999999999999999999877654     


Q ss_pred             -EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 -MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                       ++||||+. ++|.+.+.   ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence             99999997 48877763   2589999999999999999999999999999999999999999999999999875432 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       197 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          197 ------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  258 (371)
T ss_dssp             ---------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ------------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence                              1234578999999999987 778999999999999999999999999877666655554322


Q ss_pred             ccHHH-H-----------HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQ-L-----------TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..... .           ............+...+..+++++.+||.+||+.||++|||+.|+++|+|+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence            11100 0           0001111112222333457899999999999999999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=351.96  Aligned_cols=275  Identities=21%  Similarity=0.324  Sum_probs=211.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccc--------
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA--------  131 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--------  131 (573)
                      ....++|++.+.||+|+||.||+|.+.  ++.||+|++........+.+.+|+.+++.++||||+++++++.        
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            344579999999999999999999984  8999999887777777888999999999999999999998863        


Q ss_pred             ------cCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-CCCCCeEe
Q 008220          132 ------KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLA  204 (573)
Q Consensus       132 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~~~~~kL~  204 (573)
                            .....++||||+. |+|.+++..  ..+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence                  4467899999998 599998864  3689999999999999999999999999999999999997 56789999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      |||++.........             ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus       164 Dfg~~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          164 DFGLARIMDPHYSH-------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             CCTTCBCC---------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCccccccCCCccc-------------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            99998765421110             011234567999999998865 6789999999999999999999999998776


Q ss_pred             HHHHHHHHhccccHHHH-HHHH----------hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQL-TAAV----------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ......+.......... ....          ........+...+..+++++.+||++||+.||++|||+.|+++|+|..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            66555554332111100 0000          001111122233457899999999999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=360.51  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             CccccccccccCceEEEEEEE--C-C--eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc-cCCceEEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--D-G--RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA-KPPNYMFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv  139 (573)
                      .|++.+.||+|+||+||+|.+  . +  ..||+|.+... .....+.+.+|+.++++++||||+++++++. .....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            588899999999999999985  2 2  35899976433 3456778999999999999999999999864 45688999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+|+|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........ 
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-  248 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD-  248 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc-
Confidence            9999999999999877767899999999999999999999999999999999999999999999999999765421110 


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                 .........+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+.       
T Consensus       249 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------  310 (373)
T 3c1x_A          249 -----------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------  310 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------
T ss_pred             -----------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------
Confidence                       0011234467889999999999999999999999999999999 788887654333222221       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                             .+. ++   ..+..+++++.++|.+||+.||++|||+.+++++|..+....
T Consensus       311 -------~~~-~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          311 -------QGR-RL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -------TTC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -------cCC-CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                   111 11   124568999999999999999999999999999999988754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-43  Score=359.60  Aligned_cols=274  Identities=24%  Similarity=0.245  Sum_probs=209.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeecccc--------C
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAK--------P  133 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~  133 (573)
                      ++|++.+.||+|+||.||+|++  +++.||||++.....  .....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            6899999999999999999998  578999998644322  224567799999999999999999999876        3


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ...++||||+.+ +|.+.+......+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            468999999986 7777777666679999999999999999999999999999999999999999999999999987554


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....            ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus       176 ~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  243 (351)
T 3mi9_A          176 LAKN------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  243 (351)
T ss_dssp             CCSS------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccc------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            2111            11112345678999999999976 4579999999999999999999999998766655554433


Q ss_pred             ccccHHHHHH-HHh----cCCCC---Cccccc-----ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          293 MNYTEQQLTA-AVV----SGGLR---PILASL-----ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       293 ~~~~~~~~~~-~~~----~~~~~---~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .......... ...    .....   ......     ....++++.+||.+||+.||++|||+.|+++|.|..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            2111000000 000    00000   000000     001367899999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=354.57  Aligned_cols=278  Identities=27%  Similarity=0.408  Sum_probs=220.9

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE------CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      +..+..++|++.+.||+|+||.||+|+.      +++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4556678899999999999999999984      5789999998777677778899999999999999999999988664


Q ss_pred             C--ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          134 P--NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       134 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      .  ..++||||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  78999999999999999987766799999999999999999999999999999999999999999999999999876


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ........             .......+++.|+|||++.+..++.++||||||+++|+|++|..||........  ...
T Consensus       195 ~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~--~~~  259 (326)
T 2w1i_A          195 LPQDKEYY-------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--RMI  259 (326)
T ss_dssp             CCSSCSEE-------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH--HHH
T ss_pred             cccccccc-------------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH--Hhh
Confidence            54211100             012234577889999999988899999999999999999999999875432211  111


Q ss_pred             hcccc----HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          292 EMNYT----EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       292 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .....    ...+...+..+. ++   ..+..+++++.+||++||+.||++|||+.++++.|..+.++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          260 GNDKQGQMIVFHLIELLKNNG-RL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTC-CC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccchhhhHHHHHHHhhcCC-CC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11100    111122222222 21   124578999999999999999999999999999998887653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.7e-43  Score=348.36  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=214.7

Q ss_pred             cccCCCCccccc-cccccCceEEEEEEE----CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..+..++|++.+ .||+|+||+||+|.+    .++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            456667999998 999999999999964    35789999865442  23467799999999999999999999998 56


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +..++||||+.+++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            78899999999999999997654 68999999999999999999999999999999999999999999999999987554


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      ......             .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+..
T Consensus       169 ~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  235 (291)
T 1xbb_A          169 ADENYY-------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK  235 (291)
T ss_dssp             TTCSEE-------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred             cCCCcc-------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            211100             01123356789999999998889999999999999999999 9999987655443332221


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                    + .++   ..+..+++++.++|.+||+.||.+|||+.++++.|..++...
T Consensus       236 --------------~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          236 --------------G-ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             --------------T-CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --------------C-CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                          1 111   234578999999999999999999999999999999888754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.5e-43  Score=350.96  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++...   .....+.+.+|+.+++.++||||+++++++......++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            36899999999999999999997  5889999986543   233457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+++++|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........  
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--  189 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--  189 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc--
Confidence            99999999999997654 689999999999999999999999999999999999999999999999999865542111  


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.        
T Consensus       190 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------  248 (309)
T 2h34_A          190 -------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN--------  248 (309)
T ss_dssp             --------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH--------
T ss_pred             -------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc--------
Confidence                         01234578999999999999999999999999999999999999998765432211111        


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEH  355 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~~~  355 (573)
                             .. .+.....+..+|+++.+||.+||+.||++|| +++++++.|...+..
T Consensus       249 -------~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          249 -------QA-IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             -------SC-CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             -------cC-CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                   11 1122234567899999999999999999999 999999888776543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=351.16  Aligned_cols=258  Identities=22%  Similarity=0.405  Sum_probs=209.8

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ..+.++|++.+.||+|+||.||+|.+.  ++.||||.+....  ..+.+.+|+.+++.++||||+++++++......++|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            345678999999999999999999984  8899999865432  345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......   
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM---  179 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB---
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc---
Confidence            99999999999997666689999999999999999999999999999999999999999999999999986543210   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                   .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..       
T Consensus       180 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------  239 (314)
T 3com_A          180 -------------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------  239 (314)
T ss_dssp             -------------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------
T ss_pred             -------------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------
Confidence                         012345789999999999999999999999999999999999999987654333222211       


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                             . ..+.+ ..+..+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus       240 -------~-~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          240 -------N-PPPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             -------S-CCCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             -------C-CCccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence                   1 11111 123457899999999999999999999999999998753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=344.81  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=211.9

Q ss_pred             CccccccccccCceEEEEEEE--CC---eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce-EEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DG---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY-MFF  139 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lv  139 (573)
                      .|++.++||+|+||+||+|.+  ++   ..||+|..... .....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            466779999999999999986  22   36999986543 345567899999999999999999999999876665 999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..........
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            99999999999998766688999999999999999999999999999999999999999999999999997654322110


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+.       
T Consensus       182 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------  242 (298)
T 3pls_A          182 ------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------  242 (298)
T ss_dssp             ------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------
T ss_pred             ------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------
Confidence                        112334568899999999999999999999999999999999 455555443332222221       


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                             .+. .   ...+..+++++.+||.+||+.||.+|||+.++++.|..+.+..
T Consensus       243 -------~~~-~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          243 -------QGR-R---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -------TTC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------cCC-C---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                   111 1   1124568999999999999999999999999999999988754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.6e-43  Score=360.39  Aligned_cols=273  Identities=22%  Similarity=0.272  Sum_probs=209.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCC-----------ChHHHHHHHHHHHHHHhCCCCccceeeec
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS-----------TSEELDNFHKELQLLCKLDHPGLAKFVAA  129 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (573)
                      ....++|++.+.||+|+||.||+|.+ .++.||||++...           .....+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            34457999999999999999999987 6889999975332           22334788999999999999999999999


Q ss_pred             cc-----cCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEe
Q 008220          130 HA-----KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       130 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                      +.     ....+++||||+. |+|.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            84     3446899999998 58888887766679999999999999999999999999999999999999999999999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      |||++.......                 ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus       177 Dfg~~~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          177 DFNLAREDTADA-----------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             CTTC--------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ecCccccccccc-----------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999986433211                 1334578999999999887 6789999999999999999999999998776


Q ss_pred             HHHHHHHHhccccHHHH---------HHHHhcCCC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          284 EAQAHTVLEMNYTEQQL---------TAAVVSGGL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       284 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      ......+..........         .........    ...........++.+.+||.+||+.||.+|||+.|+++|+|
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            66655554322111100         000011111    11122234567899999999999999999999999999988


Q ss_pred             HH
Q 008220          351 LV  352 (573)
Q Consensus       351 ~~  352 (573)
                      .-
T Consensus       320 f~  321 (362)
T 3pg1_A          320 FE  321 (362)
T ss_dssp             GT
T ss_pred             hh
Confidence            63

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7e-43  Score=347.69  Aligned_cols=270  Identities=20%  Similarity=0.292  Sum_probs=209.8

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecc-ccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e  141 (573)
                      .++|++.+.||+|+||.||+|++  +++.||||+.....  ....+.+|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            47899999999999999999996  68899999744332  223577899999999988777665554 66778899999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            99 889999998666679999999999999999999999999999999999999   78999999999999765432110


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                      .         ...........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...     
T Consensus       165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----  230 (296)
T 4hgt_A          165 Q---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-----  230 (296)
T ss_dssp             C---------BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH-----
T ss_pred             c---------cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh-----
Confidence            0         00011234567999999999999999999999999999999999999999865332211111100     


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                            .........+.....+|+++.+||.+||+.||++|||+.++++.|..+.....
T Consensus       231 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          231 ------SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             ------HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ------hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                  00000111222335689999999999999999999999999999999887543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-42  Score=346.53  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=211.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecc-ccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e  141 (573)
                      .++|++.+.||+|+||.||+|++  +++.||||++.....  .+.+.+|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            47899999999999999999996  689999998654432  23578999999999988866655554 56777899999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99 889999998666689999999999999999999999999999999999999   48899999999999765432110


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH---HHHHHHhccc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA---QAHTVLEMNY  295 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~~~~  295 (573)
                      .         ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+.... 
T Consensus       165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-  234 (296)
T 3uzp_A          165 Q---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-  234 (296)
T ss_dssp             C---------BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-
T ss_pred             c---------ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-
Confidence            0         000112345679999999999999999999999999999999999999998643221   111111100 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                   .....+..+..+|+++.+||.+||+.||++|||+.++++.|..+....
T Consensus       235 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          235 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             -------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence                         011122234578999999999999999999999999999999888754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-42  Score=351.97  Aligned_cols=263  Identities=20%  Similarity=0.292  Sum_probs=206.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeecccc--CCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAK--PPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv  139 (573)
                      .++|++.+.||+|+||+||+|.+  +++.||||++....   .+.+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36899999999999999999987  67899999875443   356889999999997 9999999999987  6678999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+.+++|.+++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......  
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  185 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence            99999999999875    478999999999999999999999999999999999999777 79999999987543211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHHHhcccc
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRA-EAQAHTVLEMNYT  296 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~~~~~~~~  296 (573)
                                     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.. ...
T Consensus       186 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~-~~~  249 (330)
T 3nsz_A          186 ---------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK-VLG  249 (330)
T ss_dssp             ---------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH-HHC
T ss_pred             ---------------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH-hcC
Confidence                           1234578999999999987 6789999999999999999999999954322 222222221 111


Q ss_pred             HHHHHHHHhcCC--------------CCCcc-----cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGG--------------LRPIL-----ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       297 ~~~~~~~~~~~~--------------~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .......+....              .....     ...+..+++++.+||.+||+.||++|||+.|+++|+|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            111111111111              00000     011223799999999999999999999999999998763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=356.95  Aligned_cols=282  Identities=24%  Similarity=0.346  Sum_probs=208.2

Q ss_pred             ccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHH--HHhCCCCccceeeecc-----ccCC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQL--LCKLDHPGLAKFVAAH-----AKPP  134 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~-----~~~~  134 (573)
                      .+..++|++.+.||+|+||.||+|+++++.||||++....   ...+..|.++  +..++||||+++++.+     ....
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            4566899999999999999999999999999999865432   2334444444  4558999999998743     3344


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCceEEcCCCCCeEee
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---------GIVHRDVKPANVLLDRNLCPHLAD  205 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~iiH~Dlkp~Nill~~~~~~kL~D  205 (573)
                      .+++||||+++|+|.+++...  ..++..++.++.||+.||+|||+.         ||+||||||+|||++.++.+||+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             eEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            678999999999999999654  358899999999999999999999         999999999999999999999999


Q ss_pred             eecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCC
Q 008220          206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLTGVVPY  278 (573)
Q Consensus       206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~Pf  278 (573)
                      ||++..........        ............||+.|+|||++.+       ..++.++|||||||++|||++|..||
T Consensus       164 FG~a~~~~~~~~~~--------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          164 FGLSMRLTGNRLVR--------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CTTCEECSSSSCC-----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             ccceeecccccccC--------ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99997654211100        0001112335579999999999987       45567899999999999999997776


Q ss_pred             CCchhHHHH----HHHHhccccHHHHHHHHhcCCCCCccccccc---CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          279 TDLRAEAQA----HTVLEMNYTEQQLTAAVVSGGLRPILASLEL---GLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       279 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .........    ................+.....++.++....   .+++++.+||.+||+.||++|||+.|+++.|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            432211110    0111111222333333344444554443222   256789999999999999999999999999999


Q ss_pred             HHHHh
Q 008220          352 VLEHR  356 (573)
Q Consensus       352 ~~~~~  356 (573)
                      ++...
T Consensus       316 ll~~~  320 (336)
T 3g2f_A          316 LMMIW  320 (336)
T ss_dssp             HHHCC
T ss_pred             HHHHH
Confidence            88643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-43  Score=349.82  Aligned_cols=268  Identities=25%  Similarity=0.388  Sum_probs=210.6

Q ss_pred             CccccccccccCceEEEEEEECCeeEEEeeccCC----ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .|...+.||+|+||.||+|.++++.||+|++...    .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            4666789999999999999999999999986432    234567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          143 YESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       143 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........   
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---  188 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ---  188 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS---
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc---
Confidence            9999999998643  34689999999999999999999999999999999999999999999999999865432110   


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 ........||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+..........
T Consensus       189 -----------~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (307)
T 2nru_A          189 -----------TVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT  256 (307)
T ss_dssp             -----------CEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred             -----------cccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence                       1112345799999999998764 7889999999999999999999998754433222221110000000


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .....    .+.+...+...+..+.+++.+||+.||.+|||+.+++++|..+.
T Consensus       257 ~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          257 IEDYI----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHS----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hhhhc----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            00111    11112223345788999999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-43  Score=356.30  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC--------
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--------  134 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--------  134 (573)
                      ++|++.+.||+|+||.||+|++  +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            4799999999999999999998  58899999875443 335678999999999999999999999875543        


Q ss_pred             -------------------------------------------------ceEEEEEeccCCChhhhhhccCC--CCCHHH
Q 008220          135 -------------------------------------------------NYMFFFEFYESRNLAEKLHVEEW--SPSVDQ  163 (573)
Q Consensus       135 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~  163 (573)
                                                                       ..++||||+.+++|.+++.....  ..++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             37999999999999999976432  345667


Q ss_pred             HHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcc
Q 008220          164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI  243 (573)
Q Consensus       164 ~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  243 (573)
                      ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............    ..............||+.
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----LTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc----cccccccccccccCCCcC
Confidence            8999999999999999999999999999999999999999999999765432110000    000000112344679999


Q ss_pred             cCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHH
Q 008220          244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS  323 (573)
Q Consensus       244 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (573)
                      |+|||++.+..++.++|||||||++|+|++|..|+....  ........              .    ..+......+++
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~--------------~----~~~~~~~~~~~~  301 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRN--------------L----KFPLLFTQKYPQ  301 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHT--------------T----CCCHHHHHHCHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhc--------------c----CCCcccccCChh
Confidence            999999999999999999999999999999877753211  11111111              1    111122345678


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          324 ILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       324 l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +.+||.+||+.||++|||+.|+++|.|.
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence            8999999999999999999999998763

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5e-43  Score=347.12  Aligned_cols=247  Identities=19%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999998  5899999986543  334566788999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-------------------
Q 008220          141 EFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-------------------  198 (573)
Q Consensus       141 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-------------------  198 (573)
                      ||+++++|.+++...   ...+++.+++.++.||+.||+|||++||+||||||+|||++.+                   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999998754   2468999999999999999999999999999999999999844                   


Q ss_pred             CCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCC
Q 008220          199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVP  277 (573)
Q Consensus       199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P  277 (573)
                      ..+||+|||++.....                    .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus       171 ~~~kl~Dfg~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS--------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             CCEEECCCTTCEETTC--------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             eEEEEcccccccccCC--------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence            4789999999865432                    1234589999999999876 566899999999999999999988


Q ss_pred             CCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      +.......   .+              ..+.    .+..+..+++++.+||.+||+.||++|||+.|+++|+|...
T Consensus       231 ~~~~~~~~---~~--------------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          231 PRNGDQWH---EI--------------RQGR----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             CSSSHHHH---HH--------------HTTC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             CcchhHHH---HH--------------HcCC----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            76543211   11              1111    12345578999999999999999999999999999988654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-44  Score=363.59  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=208.9

Q ss_pred             cCCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCC----hHHHHHHHHHHHHHHhC-CCCccceeeecccc
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHAK  132 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  132 (573)
                      +..++|++.+.||+|+||.||+|++     +++.||||++....    ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            3447899999999999999999987     67899999864321    12334567899999999 69999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ...+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999999997655 7899999999999999999999999999999999999999999999999999754


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      .....               .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||...........+
T Consensus       210 ~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  274 (355)
T 1vzo_A          210 VADET---------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  274 (355)
T ss_dssp             CGGGG---------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             ccCCC---------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence            32111               01234679999999999986  34788999999999999999999999754322111111


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV  352 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~  352 (573)
                      .          ..+...     .+..+..+++.+.+||.+||+.||.+||     |+.|+++|+|..
T Consensus       275 ~----------~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          275 S----------RRILKS-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             H----------HHHHHC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             H----------HHHhcc-----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            1          111111     1123457899999999999999999999     999999988764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.6e-43  Score=354.35  Aligned_cols=256  Identities=21%  Similarity=0.265  Sum_probs=210.9

Q ss_pred             CCCCcccc-ccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceE
Q 008220           64 PPSSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        64 ~~~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (573)
                      ..++|.+. +.||+|+||.||+|.+  +++.||+|++....  ......+.+|+.+++.+. ||||+++++++......+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            34578888 8899999999999988  48899999765432  233567889999999995 699999999999999999


Q ss_pred             EEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+|+|.+++... ...+++.+++.++.||+.||+|||+.||+||||||+|||++.   ++.+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999998643 347899999999999999999999999999999999999988   7899999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus       186 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  248 (327)
T 3lm5_A          186 HAC-----------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV  248 (327)
T ss_dssp             -------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             Ccc-----------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence            211                 123457999999999999999999999999999999999999999887655544443322


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...               ........+++.+.+||.+||+.||.+|||+.++++|+|.
T Consensus       249 ~~~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          249 NVD---------------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             CCC---------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             ccc---------------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            211               1112234689999999999999999999999999998876

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-42  Score=346.50  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=212.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---------hHHHHHHHHHHHHHHhCC-CCccceeeecccc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---------SEELDNFHKELQLLCKLD-HPGLAKFVAAHAK  132 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  132 (573)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....         ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            47899999999999999999998  57899999865442         123467889999999995 9999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ....++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            999999999999999999997654 7899999999999999999999999999999999999999999999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ...                 .......|++.|+|||++.      ...++.++||||||+++|+|++|..||........
T Consensus       175 ~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  237 (298)
T 1phk_A          175 DPG-----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  237 (298)
T ss_dssp             CTT-----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCC-----------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence            321                 1123457899999999985      45678899999999999999999999987655444


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...+....              .... ......+++++.+||.+||+.||.+|||+.|+++|.|.
T Consensus       238 ~~~~~~~~--------------~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          238 LRMIMSGN--------------YQFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             HHHHHHTC--------------CCCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHhcCC--------------cccC-cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence            33333221              1111 11224678999999999999999999999999998875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=377.66  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=214.2

Q ss_pred             cccCCCCccccc-cccccCceEEEEEEE----CCeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +.+..+++.+.+ .||+|+||.||+|.+    .+..||||++.... ....+.+.+|+++|+.++||||+++++++.. +
T Consensus       330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            344556666666 899999999999976    34679999876542 3356789999999999999999999999876 5


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++||||+.+|+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            69999999999999999977666799999999999999999999999999999999999999999999999999976542


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .....             .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+.. 
T Consensus       489 ~~~~~-------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-  554 (613)
T 2ozo_A          489 DDSYY-------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-  554 (613)
T ss_dssp             --------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-
T ss_pred             CCcee-------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-
Confidence            11100             01123346789999999999999999999999999999998 9999987655443333321 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                                   + .+.   ..+..+++++.+||.+||+.||++|||+.+|++.|..+.....
T Consensus       555 -------------~-~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          555 -------------G-KRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             -------------T-CCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             -------------C-CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence                         1 121   2345789999999999999999999999999999988876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=350.47  Aligned_cols=258  Identities=23%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeecccc-----
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK-----  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~-----  132 (573)
                      +....++|++.+.||+|+||.||+|++  +++.||||++.... ...+.+.+|+.+++.+ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            445568999999999999999999998  68899999865443 2346788999999999 79999999999876     


Q ss_pred             -CCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          133 -PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       133 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                       ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             467899999999999999987542 468999999999999999999999999999999999999999999999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA  285 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~  285 (573)
                      .......                ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.....
T Consensus       178 ~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          178 QLDRTVG----------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             -----------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             ecCcCcc----------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            5432110                123457899999999987     5668899999999999999999999998765443


Q ss_pred             HHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ....+..              ... +  ...+..+++.+.+||.+||..||.+|||+.++++|+|..
T Consensus       242 ~~~~~~~--------------~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          242 ALFLIPR--------------NPA-P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HHHHHHH--------------SCC-C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHhhc--------------Ccc-c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            3322221              111 1  112346899999999999999999999999999998874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.7e-43  Score=346.14  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=209.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            5799999999999999999987  4889999986433 233457789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.+++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........     
T Consensus        87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-----  160 (276)
T 2yex_A           87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-----  160 (276)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-----
T ss_pred             cCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-----
Confidence            99999999986543 689999999999999999999999999999999999999999999999999875432111     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                               ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.............          
T Consensus       161 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------  221 (276)
T 2yex_A          161 ---------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------  221 (276)
T ss_dssp             ---------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH----------
T ss_pred             ---------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh----------
Confidence                     011234578999999999987665 778999999999999999999998754322111111          


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                         ....  ... .....+++.+.+||.+||+.||++|||+.|+++|.|.
T Consensus       222 ---~~~~--~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          222 ---KEKK--TYL-NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             ---HTTC--TTS-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             ---hhcc--ccc-CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence               0010  000 1124678999999999999999999999999988775

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=377.80  Aligned_cols=261  Identities=29%  Similarity=0.415  Sum_probs=217.7

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..+++..++|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            457788899999999999999999999985 4679999876543 234678999999999999999999999876 6789


Q ss_pred             EEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+.+|+|.+++... +..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999999753 3468999999999999999999999999999999999999999999999999997654321


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..               ......++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+..   
T Consensus       418 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~---  479 (535)
T 2h8h_A          418 YT---------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---  479 (535)
T ss_dssp             HH---------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---
T ss_pred             ee---------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence            11               0123456789999999999999999999999999999999 9999987655443333221   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  +.+.   ..+..+++++.+||.+||+.||++|||+.+|++.|..++.
T Consensus       480 ------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 ------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ------------CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                        1121   1245789999999999999999999999999988876553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=355.58  Aligned_cols=269  Identities=19%  Similarity=0.190  Sum_probs=202.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEE-----CCeeEEEeeccCCChHH-----------HHHHHHHHHHHHhCCCCccce
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEE-----------LDNFHKELQLLCKLDHPGLAK  125 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~  125 (573)
                      ++..++|++.+.||+|+||.||+|.+     .+..+|+|+........           ...+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            45568999999999999999999998     45789999865543211           123667889999999999999


Q ss_pred             eeecccc----CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC--
Q 008220          126 FVAAHAK----PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL--  199 (573)
Q Consensus       126 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~--  199 (573)
                      +++++..    ....++||||+ +++|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||++.++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            9999887    77899999999 999999997665 789999999999999999999999999999999999999887  


Q ss_pred             CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008220          200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  279 (573)
                      .+||+|||+++.+......         ............||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNH---------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             SEEECCCTTCEESSGGGCC---------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             cEEEEeCCCceeccccccc---------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999999999766432110         0111112345689999999999999999999999999999999999999996


Q ss_pred             CchhHHHHHHHHhccccHHHHHHHHhcCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .................          ....+.+...  ...+++++.+||.+||+.||++|||+.+|++.|..
T Consensus       262 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          262 QNLKDPVAVQTAKTNLL----------DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             GGTTCHHHHHHHHHHHH----------HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             ccccccHHHHHHHHhhc----------ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            53221111111100000          0000000000  12688999999999999999999999999987754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.3e-43  Score=353.85  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=204.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--------hHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      ++|++.+.||+|+||.||+|.+  +++.||||++....        ......+.+|+.+++.++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            5799999999999999999987  57899999865432        122345789999999999999999999987654 


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYR  212 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~~  212 (573)
                      +++||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            899999999999999886544 7899999999999999999999999999999999999987664   999999998755


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      ....                 ......||+.|+|||++.   ...++.++|||||||++|+|++|..||...........
T Consensus       168 ~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  230 (322)
T 2ycf_A          168 GETS-----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD  230 (322)
T ss_dssp             CCCH-----------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH
T ss_pred             cccc-----------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH
Confidence            3211                 123457899999999974   46688999999999999999999999976543221111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .+             ..+. .+..+..+..+++++.+||.+||+.||++|||+.++++|.|..
T Consensus       231 ~~-------------~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~  279 (322)
T 2ycf_A          231 QI-------------TSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  279 (322)
T ss_dssp             HH-------------HHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred             HH-------------HhCc-cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence            11             1111 1223334457899999999999999999999999999988763

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.9e-43  Score=347.42  Aligned_cols=262  Identities=25%  Similarity=0.378  Sum_probs=207.0

Q ss_pred             cccCCCCccccccccccCceEEEEEEE---CC--eeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL---DG--RKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ..+..++|++.+.||+|+||+||+|++   .+  ..||||++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            456678999999999999999999985   22  26899986543   23456788999999999999999999999987


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      +. .++|+||+.+++|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            55 88999999999999999876557899999999999999999999999999999999999999999999999998765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  291 (573)
                      ......             ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus       172 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          172 PQNDDH-------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             CC-CCE-------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             cccccc-------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            421110             011234467889999999998889999999999999999999 999998775544433332


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .              ....+   ..+..+++++.++|.+||+.||.+|||+.+++++|..+.
T Consensus       239 ~--------------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          239 K--------------EGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             T--------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             c--------------cCCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            2              11111   123578999999999999999999999999999887654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=347.44  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .+...+|.....||+|+||.||+|.+  +++.||||.+........+.+.+|+.+++.++||||+++++++......++|
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            33445566667999999999999997  5789999987766666677899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-CCCCeEeeeecchhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999997653  24578899999999999999999999999999999999988 8999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                      .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||............    
T Consensus       178 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----  237 (295)
T 2clq_A          178 ----------------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK----  237 (295)
T ss_dssp             -------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH----
T ss_pred             ----------------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh----
Confidence                            0123457899999999997654  789999999999999999999999754322111100    


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               .......   +..+..+++++.+||.+||+.||++|||+.++++|.|...
T Consensus       238 ---------~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~  284 (295)
T 2clq_A          238 ---------VGMFKVH---PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV  284 (295)
T ss_dssp             ---------HHHHCCC---CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred             ---------hcccccc---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence                     0000111   2234578999999999999999999999999999887753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=345.17  Aligned_cols=254  Identities=23%  Similarity=0.276  Sum_probs=206.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC----hHHHHHHHHHHHHHHhCCCCccceeeecc--ccCCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~  137 (573)
                      ++|++.+.||+|+||.||++.+  +++.||+|++....    ......+.+|+.+++.++||||+++++++  .+....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            6899999999999999999987  57899999864332    23456789999999999999999999998  4556899


Q ss_pred             EEEEeccCCChhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+.++ |.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999886 6666654 34578999999999999999999999999999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCC--CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .              ........||+.|+|||++.+..  ++.++||||||+++|+|++|..||...........+..  
T Consensus       164 ~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--  227 (305)
T 2wtk_C          164 A--------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--  227 (305)
T ss_dssp             S--------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--
T ss_pred             c--------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--
Confidence            0              11223456999999999998654  37799999999999999999999987654443333322  


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  +..     ..+..+++++.+||.+||+.||.+|||+.|+++|.|...
T Consensus       228 ------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          228 ------------GSY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             ------------CCC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             ------------CCC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence                        111     124578999999999999999999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=363.81  Aligned_cols=276  Identities=20%  Similarity=0.333  Sum_probs=211.4

Q ss_pred             cCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeeccccCC--ceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~  137 (573)
                      +..++|++.+.||+|+||+||+|++.  ++.||||++.... ....+.+.+|+++++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            44678999999999999999999984  8899999865432 223567789999999999999999999987655  789


Q ss_pred             EEEEeccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----cCCCCCeEeeeecchh
Q 008220          138 FFFEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEY  211 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----~~~~~~kL~Dfg~a~~  211 (573)
                      +||||+.+|+|.+++....  ..+++..++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+|||+++.
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999999997543  238999999999999999999999999999999999999    7788899999999976


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCchh
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--------EIHSEKSDVYSFGISINELLTGVVPYTDLRA  283 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~  283 (573)
                      .....                 ......||+.|+|||++.+        ..++.++|||||||++|||++|..||.....
T Consensus       166 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~  228 (396)
T 4eut_A          166 LEDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (396)
T ss_dssp             CCCGG-----------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             ccCCC-----------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            54211                 1234579999999999875        5567899999999999999999999975332


Q ss_pred             ----HHHHHHHHhccccHHHH-HHHHhcC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          284 ----EAQAHTVLEMNYTEQQL-TAAVVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       284 ----~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                          ......+.......... ......+     ...+....++..+++.+.++|.+||+.||++|||+.++++++..++
T Consensus       229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             TTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence                12222222211100000 0000000     0001111122346778999999999999999999999999998887


Q ss_pred             HH
Q 008220          354 EH  355 (573)
Q Consensus       354 ~~  355 (573)
                      ..
T Consensus       309 ~~  310 (396)
T 4eut_A          309 HR  310 (396)
T ss_dssp             TC
T ss_pred             hc
Confidence            63

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=350.70  Aligned_cols=264  Identities=21%  Similarity=0.311  Sum_probs=210.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc------
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN------  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------  135 (573)
                      ++|.+.+.||+|+||.||+|.+  +++.||||++...  .......+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            6899999999999999999987  5899999986543  33446778899999999999999999999987654      


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +++||||+. ++|.+++..   .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence            599999997 488887642   589999999999999999999999999999999999999999999999999865431 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       179 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~  240 (353)
T 3coi_A          179 ------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  240 (353)
T ss_dssp             -----------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred             ------------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence                              1234578999999999887 678999999999999999999999999877655555544321


Q ss_pred             ccH-HHH--------HHHH---hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTE-QQL--------TAAV---VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~-~~~--------~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ... ...        ....   .....++.+......+++++.+||.+||+.||++|||+.++++|.|..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            111 000        0000   011112223334457899999999999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=353.58  Aligned_cols=272  Identities=21%  Similarity=0.299  Sum_probs=211.7

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccc----c
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA----K  132 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~  132 (573)
                      ..+.+..++|++.+.||+|+||.||++.+  +++.||||++........+.+.+|+.+++.++||||+++++++.    .
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            34567778999999999999999999997  68899999877666777888999999999999999999999986    3


Q ss_pred             CCceEEEEEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          133 PPNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                      ....++||||+.+++|.+++..   ....+++.+++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            4578999999999999998875   3457899999999999999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC---CCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      .............       ..........||+.|+|||++.+..   ++.++||||||+++|+|++|..||........
T Consensus       182 ~~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  254 (317)
T 2buj_A          182 NQACIHVEGSRQA-------LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD  254 (317)
T ss_dssp             EESCEEEESHHHH-------HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred             hhccccccccccc-------ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence            6543110000000       0000012346799999999987654   68899999999999999999999964211100


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                  ....... .....   ..+..+++++.+||.+||+.||.+|||+.+++++|+.+.
T Consensus       255 ------------~~~~~~~-~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          255 ------------SVALAVQ-NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ------------CHHHHHH-CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ------------hhhHHhh-ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                        0000111 11111   113467899999999999999999999999999887653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.8e-43  Score=364.51  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc------CCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~  137 (573)
                      .+|++.+.||+|+||.||+|++  +++.||||++....    ....+|+++|+.++||||+++++++..      ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4799999999999999999998  58899999865432    123479999999999999999998743      22367


Q ss_pred             EEEEeccCCChhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+ +|.+.+.   .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            89999986 5655543   234578999999999999999999999999999999999999965 568999999997543


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ..                 .......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.........++.
T Consensus       209 ~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~  271 (420)
T 1j1b_A          209 RG-----------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  271 (420)
T ss_dssp             TT-----------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cC-----------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            21                 012346789999999999764 789999999999999999999999998876666666554


Q ss_pred             ccccHH-HHHHHHhcCCCC-Cccc---------ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQ-QLTAAVVSGGLR-PILA---------SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~-~~~~~~~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ....+. +..... ...+. ..++         .++..+++++.+||.+||+.||.+|||+.|+++|.|+
T Consensus       272 ~lg~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          272 VLGTPTREQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHCSCCHHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhCCCCHHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            322111 111111 11111 0111         1234678999999999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=349.96  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=207.3

Q ss_pred             CCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhC--CCCccceeeeccccC----CceE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL--DHPGLAKFVAAHAKP----PNYM  137 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~----~~~~  137 (573)
                      ..++|++.+.||+|+||.||+|+++++.||||++...   .......|.+++..+  +||||+++++++...    ...+
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            3468999999999999999999999999999986433   223445566666554  899999999998876    6899


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCceEEcCCCCCeEeeeecc
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLA  209 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a  209 (573)
                      +||||+.+|+|.+++...  .+++..++.++.|++.||.|||+.        ||+||||||+|||++.++.+||+|||++
T Consensus       112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            999999999999999654  589999999999999999999999        9999999999999999999999999998


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCch------hhHHHHHHHHHHHHcC---------
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK------SDVYSFGISINELLTG---------  274 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~elltg---------  274 (573)
                      .........            .........||+.|+|||++.+......      +|||||||++|||++|         
T Consensus       190 ~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          190 VKFISDTNE------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             EECC---------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             eeecccccc------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            655421110            0111235579999999999988766554      9999999999999999         


Q ss_pred             -CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          275 -VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       275 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                       ..||.......         .........+.....++.++..  +..+++++.+||.+||+.||.+|||+.+++++|..
T Consensus       258 ~~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          258 YQLPYHDLVPSD---------PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccHhhhcCCC---------CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence             66665432111         1112222222333344433321  23567889999999999999999999999999999


Q ss_pred             HHHHh
Q 008220          352 VLEHR  356 (573)
Q Consensus       352 ~~~~~  356 (573)
                      +.+..
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            88743

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=352.85  Aligned_cols=271  Identities=25%  Similarity=0.312  Sum_probs=198.1

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeecc------
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAH------  130 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~------  130 (573)
                      .+++...+|++.++||+|+||.||+|++  +++.||||++..........+.+|+.+++++. ||||+++++++      
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            4567778999999999999999999998  68899999876666777788999999999996 99999999988      


Q ss_pred             --ccCCceEEEEEeccCCChhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEcCCCCCeEe
Q 008220          131 --AKPPNYMFFFEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLA  204 (573)
Q Consensus       131 --~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~~~~~~kL~  204 (573)
                        .....+++||||+. |+|.+++..  ....+++.+++.++.||+.||+|||+.|  |+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence              33445899999996 688888764  3446899999999999999999999999  9999999999999999999999


Q ss_pred             eeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhh---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Q 008220          205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL  281 (573)
Q Consensus       205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~Pf~~~  281 (573)
                      |||++.............    .............||+.|+|||++   .+..++.++|||||||++|+|++|..||...
T Consensus       181 Dfg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSA----QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             CCTTCBCCSSCC-----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             cCccceeccccCcccccc----cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999997654321110000    000000112245699999999998   5677899999999999999999999999754


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .......                  +....   ..+...+..+.+||++||+.||.+|||+.|++++|+.+....
T Consensus       257 ~~~~~~~------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          257 AKLRIVN------------------GKYSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ---------------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHHHhhc------------------CcccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            3221111                  11110   112456778999999999999999999999999999988754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.9e-43  Score=362.45  Aligned_cols=269  Identities=22%  Similarity=0.290  Sum_probs=206.7

Q ss_pred             cCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------c
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------N  135 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~  135 (573)
                      ....+|++.+.||+|+||+||+|++ .+..||+|++.....    ...+|+.+++.++||||+++++++....      .
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            3346899999999999999999998 456699997643321    1236999999999999999999985433      3


Q ss_pred             eEEEEEeccCCChhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-CCCCCeEeeeecchhh
Q 008220          136 YMFFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYR  212 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~  212 (573)
                      +++||||+.++.+.....  .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            889999998754443332  2244789999999999999999999999999999999999999 7999999999999754


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ...                 .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.
T Consensus       193 ~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~  255 (394)
T 4e7w_A          193 IAG-----------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII  255 (394)
T ss_dssp             CTT-----------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCC-----------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            321                 113356789999999998765 58999999999999999999999999887776666665


Q ss_pred             hccccHHHHHHHHhc-CCC---------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVS-GGL---------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .....+......... ...         .+.....+..+++++.+||.+||+.||.+|||+.|+++|+|+.
T Consensus       256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence            432221111111110 000         0111112345889999999999999999999999999998863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=352.74  Aligned_cols=269  Identities=25%  Similarity=0.396  Sum_probs=212.6

Q ss_pred             cccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ..+++..++|++.+.||+|+||.||+|.+.+ .+|+|++....  ....+.+.+|+.+++.++||||+++++++......
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            4578889999999999999999999999866 58999865432  22345577899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      ++||||+.+++|.+++...+..+++.+++.++.||+.||+|||+.||+||||||+||+++ ++.+||+|||++.......
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999999999987666789999999999999999999999999999999999998 6899999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhcc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      ..           ..........|++.|+|||++.+         ..++.++|||||||++|+|++|..||.........
T Consensus       184 ~~-----------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          184 AG-----------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             ---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cc-----------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            10           01112334568999999999874         45788999999999999999999999876554443


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                      ..+..              + ..+..  .+..++.++.+||.+||+.||++|||+.++++.|..+.....
T Consensus       253 ~~~~~--------------~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          253 WQMGT--------------G-MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             HHHHT--------------T-CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             HHhcc--------------C-CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            33221              1 12211  123678899999999999999999999999999887766443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=353.22  Aligned_cols=268  Identities=18%  Similarity=0.236  Sum_probs=209.6

Q ss_pred             CCCCccccccccccCceEEEEEEEC----------CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccce--------
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD----------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK--------  125 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------  125 (573)
                      ..++|++.+.||+|+||.||+|++.          ++.||||.....     +.+.+|+++++.++||||++        
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4579999999999999999999873          678999986543     35779999999999999998        


Q ss_pred             -------eeecccc-CCceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc
Q 008220          126 -------FVAAHAK-PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD  196 (573)
Q Consensus       126 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~  196 (573)
                             +++++.. ....++||||+ +++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                   4455544 67889999999 99999999865 34799999999999999999999999999999999999999


Q ss_pred             CCC--CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 008220          197 RNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG  274 (573)
Q Consensus       197 ~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  274 (573)
                      .++  .+||+|||+++.........         ...........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  264 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHV---------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG  264 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCC---------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCCceEEEecCcceeeccCCCccc---------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            998  89999999997665321100         0011122445899999999999999999999999999999999999


Q ss_pred             CCCCCCch-hHHHHHHHHhccccHHHHHHHHhcCCCCCcccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          275 VVPYTDLR-AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       275 ~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..||.... ..........          ... ....+....  ....+++++.+||.+||+.||++|||+.+|++.|..
T Consensus       265 ~~pf~~~~~~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          265 FLPWTNCLPNTEDIMKQKQ----------KFV-DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             CCTTGGGTTCHHHHHHHHH----------HHH-HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CCCcccCCcCHHHHHHHHH----------hcc-CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            99998753 1111111110          000 011111110  123578999999999999999999999999999999


Q ss_pred             HHHHhc
Q 008220          352 VLEHRK  357 (573)
Q Consensus       352 ~~~~~~  357 (573)
                      +.+...
T Consensus       334 ~~~~~~  339 (352)
T 2jii_A          334 LLQDLR  339 (352)
T ss_dssp             HHHHTT
T ss_pred             HHHhcC
Confidence            887654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-42  Score=350.33  Aligned_cols=271  Identities=21%  Similarity=0.286  Sum_probs=212.6

Q ss_pred             cccCCCCccccccccccCceEEEEEEE---CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC------ccceeeeccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP------GLAKFVAAHA  131 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~  131 (573)
                      .++..++|++.+.||+|+||+||+|.+   .++.||||++.. .....+.+.+|+.+++.++|+      +|+++++++.
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            455568999999999999999999987   578999998653 344567788999999998665      4999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-------------
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------------  197 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-------------  197 (573)
                      .....++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 889999987654 36889999999999999999999999999999999999987             


Q ss_pred             ------CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHH
Q 008220          198 ------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL  271 (573)
Q Consensus       198 ------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  271 (573)
                            ++.+||+|||++.....                   ......||+.|+|||++.+..++.++|||||||++|||
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCcc-------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence                  66899999999865331                   12345789999999999999999999999999999999


Q ss_pred             HcCCCCCCCchhHHHHHHHHhccccH-HHHHHHH----------------------hcCCCCCcc--cccccCChHHHHH
Q 008220          272 LTGVVPYTDLRAEAQAHTVLEMNYTE-QQLTAAV----------------------VSGGLRPIL--ASLELGLPASILS  326 (573)
Q Consensus       272 ltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~----------------------~~~~~~~~~--~~~~~~~~~~l~~  326 (573)
                      ++|..||...+.......+....... .......                      ......+..  ...+...++++.+
T Consensus       228 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             HHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            99999998776555443332211110 0000000                      000000000  0112234688999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          327 LIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       327 li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ||.+||+.||.+|||+.|+++|+|+.
T Consensus       308 li~~~L~~dP~~Rpt~~ell~hp~f~  333 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALKHPFFD  333 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred             HHHHHhCcCcccccCHHHHhcCHHHH
Confidence            99999999999999999999988763

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.6e-43  Score=361.57  Aligned_cols=259  Identities=17%  Similarity=0.203  Sum_probs=190.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhC--CCCccceee-------ecc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL--DHPGLAKFV-------AAH  130 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~hpnIv~l~-------~~~  130 (573)
                      ...|++.+.||+|+||+||+|.+  +++.||||++....   ....+.+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34699999999999999999997  58899999876543   24456778886555544  699988855       333


Q ss_pred             ccC-----------------CceEEEEEeccCCChhhhhhccCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecc
Q 008220          131 AKP-----------------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQV------LMIAAQLAKALQYLHNLGIVHRD  187 (573)
Q Consensus       131 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~iiH~D  187 (573)
                      ..+                 ..+|+||||+. |+|.+++...+..++...+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            322                 33899999998 7999999865434555555      67779999999999999999999


Q ss_pred             CCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHH
Q 008220          188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFG  265 (573)
Q Consensus       188 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG  265 (573)
                      |||+|||++.++.+||+|||+++....                   ......+|+.|+|||++.+  ..++.++||||||
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  280 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT-------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLG  280 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC-------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC-------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence            999999999999999999999975432                   1124567799999999987  7789999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       266 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                      |++|+|++|..||..........      +....   ........... ..+..+++++.+||.+||+.||++|||+.++
T Consensus       281 ~il~elltg~~Pf~~~~~~~~~~------~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  350 (371)
T 3q60_A          281 LSIYRVWCLFLPFGLVTPGIKGS------WKRPS---LRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA  350 (371)
T ss_dssp             HHHHHHHHSSCSTTBCCTTCTTC------CCBCC---TTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred             HHHHHHHhCCCCCCCcCcccccc------hhhhh---hhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            99999999999998753221100      00000   00000011111 1234789999999999999999999999999


Q ss_pred             HHHHHHHH
Q 008220          346 ALELDLVL  353 (573)
Q Consensus       346 l~~l~~~~  353 (573)
                      ++|+|+..
T Consensus       351 l~hp~f~~  358 (371)
T 3q60_A          351 METPEFLQ  358 (371)
T ss_dssp             TTSHHHHH
T ss_pred             hcCHHHHH
Confidence            99998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.2e-42  Score=351.19  Aligned_cols=280  Identities=22%  Similarity=0.217  Sum_probs=212.9

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----Cc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PN  135 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  135 (573)
                      ..++|++.+.||+|+||.||+|.+  +++.||||++... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            347899999999999999999998  4889999987543 344566788999999999999999999987654     67


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||||+. ++|.+++...  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            899999997 5898888653  6899999999999999999999999999999999999999999999999999765432


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ......      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus       166 ~~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          166 AADNSE------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             --------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccC------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            111000      0000011234579999999998764 678999999999999999999999998876555444333211


Q ss_pred             ccH-----------HHHHHHHhc--CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTE-----------QQLTAAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~-----------~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..+           .........  ......+......+++++.+||.+||+.||++|||+.|+++|+|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            000           000000000  0011122233457899999999999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-43  Score=358.87  Aligned_cols=271  Identities=22%  Similarity=0.282  Sum_probs=211.4

Q ss_pred             CCCCccccccccccCceEEEEEEECCeeEEEeeccCCChH-----------------HHHHHHHHHHHHHhCCCCcccee
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE-----------------ELDNFHKELQLLCKLDHPGLAKF  126 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpnIv~l  126 (573)
                      ..++|++.+.||+|+||.||+|.++++.||||.+......                 ..+.+.+|+.+++.++||||+++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            3468999999999999999999999999999975432111                 12778999999999999999999


Q ss_pred             eeccccCCceEEEEEeccCCChhhh------hhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCC
Q 008220          127 VAAHAKPPNYMFFFEFYESRNLAEK------LHVE-EWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRN  198 (573)
Q Consensus       127 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~  198 (573)
                      ++++.+.+..++||||+++++|.++      +... ...+++..++.++.|++.||.|||+ .||+||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999998      5542 4578999999999999999999999 999999999999999999


Q ss_pred             CCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCc-hhhHHHHHHHHHHHHcCCC
Q 008220          199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSE-KSDVYSFGISINELLTGVV  276 (573)
Q Consensus       199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltg~~  276 (573)
                      +.+||+|||++......                  ......||+.|+|||++.+. .++. ++|||||||++|+|++|..
T Consensus       189 ~~~kl~dfg~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             SCEEECCCTTCEECBTT------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcEEEeccccccccccc------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            99999999998654321                  13445789999999999887 5665 9999999999999999999


Q ss_pred             CCCCchh-HHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          277 PYTDLRA-EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       277 Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ||..... ......+.............................+++++.+||.+||+.||.+|||+.|+++|.|..
T Consensus       251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            9987654 333333322111100000000000000000011246899999999999999999999999999988763

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-42  Score=360.98  Aligned_cols=267  Identities=21%  Similarity=0.214  Sum_probs=204.8

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC--------CCccceeeecc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD--------HPGLAKFVAAH  130 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~  130 (573)
                      .++..++|++.++||+|+||+||+|++  +++.||||++.. .....+.+.+|+.+++.++        ||||+++++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            344568999999999999999999987  578999998653 3445677889999999985        78899999998


Q ss_pred             c----cCCceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCC-----
Q 008220          131 A----KPPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNL-----  199 (573)
Q Consensus       131 ~----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~-----  199 (573)
                      .    ....+++||||+. ++|.+.+... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            7    5668999999995 4665555433 35789999999999999999999998 999999999999999775     


Q ss_pred             --------------------------------------------CCeEeeeecchhhhhhhhhhcccccCCCCCCCCccc
Q 008220          200 --------------------------------------------CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK  235 (573)
Q Consensus       200 --------------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (573)
                                                                  .+||+|||++.....                   ..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------------~~  250 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------------HF  250 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------------------CS
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------------------cC
Confidence                                                        799999999875432                   12


Q ss_pred             cccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchh------HHHHHHHHhcccc-HHHHHHHHhcCC
Q 008220          236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA------EAQAHTVLEMNYT-EQQLTAAVVSGG  308 (573)
Q Consensus       236 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~  308 (573)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+...... +....   ..+.
T Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~  327 (397)
T 1wak_A          251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI---VAGK  327 (397)
T ss_dssp             CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH---HHCT
T ss_pred             ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh---hccc
Confidence            345789999999999999999999999999999999999999975432      1112222111100 00000   0000


Q ss_pred             CC-----------Ccc--------------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          309 LR-----------PIL--------------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       309 ~~-----------~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..           ...              ...+...++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence            00           000              00122346789999999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.9e-42  Score=341.00  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=211.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|++.+.||+|+||.||+|++  +++.||+|++...  .....+.+.+|+.++++++||||+++++++......++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            5899999999999999999998  5889999985432  22346678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC---CCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+.+++|.+.+.... .+++.+++.++.||+.||.|||+.||+||||||+||+++.+   +.+||+|||++.......  
T Consensus       102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--  178 (287)
T 2wei_A          102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--  178 (287)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence            999999999887554 68999999999999999999999999999999999999764   469999999986543210  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+..      
T Consensus       179 ---------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------  236 (287)
T 2wei_A          179 ---------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------  236 (287)
T ss_dssp             ---------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred             ---------------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------
Confidence                           12344689999999998765 78999999999999999999999987655444333322      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                              +......+ ....+++++.+||.+||+.||++|||+.|+++|+|...
T Consensus       237 --------~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          237 --------GKYAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             --------CCCCCCSG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             --------CCCCCCch-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence                    22221111 23468999999999999999999999999999988753

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9e-42  Score=374.59  Aligned_cols=262  Identities=26%  Similarity=0.444  Sum_probs=217.2

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccC
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP  133 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (573)
                      ..++..++|++.+.||+|+||.||+|.+.     +..||+|..... .....+.+.+|+.+++.++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            45677789999999999999999999873     357999986543 3445678999999999999999999999985 4


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      +..++||||+.+|+|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            67899999999999999998776678999999999999999999999999999999999999999999999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....               .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus       543 ~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~  607 (656)
T 2j0j_A          543 DSTY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  607 (656)
T ss_dssp             C-------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred             CCcc---------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence            2111               11223457889999999999999999999999999999997 9999987655444333321


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                    +...    ..+..+++.+.+||.+||+.||.+|||+.+|++.|..+++.
T Consensus       608 --------------~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          608 --------------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                          2111    13457899999999999999999999999999999988764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-42  Score=375.00  Aligned_cols=256  Identities=24%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             Ccccc-ccccccCceEEEEEEE----CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           67 SYTLL-SPIARGAESVVYEATL----DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        67 ~y~~~-~~lg~G~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .+.+. ++||+|+||.||+|.+    .++.||||++...  .....+.+.+|+.+|++++||||+++++++.. +.+++|
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  447 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV  447 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence            34443 3799999999999965    3578999986543  23346789999999999999999999999864 568899


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       448 ~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  525 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-  525 (635)
T ss_dssp             EECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-
Confidence            99999999999997554 7899999999999999999999999999999999999999999999999999866432110 


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                  ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..      
T Consensus       526 ------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~------  587 (635)
T 4fl3_A          526 ------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------  587 (635)
T ss_dssp             ---------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------
T ss_pred             ------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence                        001233457889999999999999999999999999999998 9999988765544333322      


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                              +. ++   ..+..+++++.+||.+||+.||++|||+.+|++.|..+...
T Consensus       588 --------~~-~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          588 --------GE-RM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             --------TC-CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --------CC-CC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    11 11   23457899999999999999999999999999999887754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-41  Score=360.18  Aligned_cols=270  Identities=20%  Similarity=0.288  Sum_probs=214.4

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC-CccceeeeccccCCceEEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~  140 (573)
                      ..++|++.++||+|+||.||+|.+  +++.||||+......  ...+..|+++++.++| ++|+.+..++......++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            357899999999999999999997  488999997544332  2347789999999986 55666666667788899999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE---cCCCCCeEeeeecchhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||+++.......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            999 889999998766689999999999999999999999999999999999999   6889999999999976543211


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                      ..         ...........||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+...    
T Consensus       162 ~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----  228 (483)
T 3sv0_A          162 HQ---------HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----  228 (483)
T ss_dssp             CC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----
T ss_pred             cc---------ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----
Confidence            10         00011233568999999999999999999999999999999999999999875432222211110    


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                             ........+..++..+++++.+||..||+.||++||++.+|++.|..++...
T Consensus       229 -------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          229 -------SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             -------HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                   0001112222334578999999999999999999999999999999888754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-42  Score=341.81  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=205.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-----------
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-----------  132 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----------  132 (573)
                      .+|++.+.||+|+||.||+|.+  +++.||+|++....    +.+.+|+++++.++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            5799999999999999999998  48899999876543    346689999999999999999998754           


Q ss_pred             -----CCceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeee
Q 008220          133 -----PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF  206 (573)
Q Consensus       133 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Df  206 (573)
                           ...+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence                 44589999999999999999754 347899999999999999999999999999999999999999999999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      |++.......                 ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....  .
T Consensus       167 g~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~  227 (284)
T 2a19_B          167 GLVTSLKNDG-----------------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--F  227 (284)
T ss_dssp             TTCEESSCCS-----------------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--H
T ss_pred             hhheeccccc-----------------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--H
Confidence            9986543210                 12345689999999999999999999999999999999999988753211  1


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ..              ....+.       .+..+++++.+||.+||+.||.+|||+.|++++|+.+...
T Consensus       228 ~~--------------~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          228 FT--------------DLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HH--------------HHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HH--------------Hhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            01              111111       2345789999999999999999999999999999887643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.9e-42  Score=347.37  Aligned_cols=269  Identities=23%  Similarity=0.296  Sum_probs=210.5

Q ss_pred             CCCccccccccccCceEEEEEEE---CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhC---CCCccceeeeccc-----
Q 008220           65 PSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILST--SEELDNFHKELQLLCKL---DHPGLAKFVAAHA-----  131 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~-----  131 (573)
                      .++|++.+.||+|+||.||+|.+   .++.||+|++....  ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            36899999999999999999987   36889999754322  11123455777777666   8999999999987     


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .....++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5667899999998 59999887543 358999999999999999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV  290 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  290 (573)
                      ......                 ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus       169 ~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  231 (326)
T 1blx_A          169 IYSFQM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  231 (326)
T ss_dssp             CCCGGG-----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccCCC-----------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            553211                 123457899999999999999999999999999999999999999987766655554


Q ss_pred             HhccccH--HHHH------HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          291 LEMNYTE--QQLT------AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       291 ~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .......  ..+.      ...........+......+++.+.+||.+||+.||.+|||+.|+++|.|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence            4321100  0000      00000011122233446789999999999999999999999999998876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.4e-42  Score=347.72  Aligned_cols=266  Identities=25%  Similarity=0.393  Sum_probs=211.4

Q ss_pred             CCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHh--CCCCccceeeeccccCC----ceEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAKPP----NYMF  138 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~~l  138 (573)
                      .++|++.+.||+|+||.||+|.++++.||||++...   ....+.+|+++++.  ++||||+++++++....    ..++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            468999999999999999999999999999986432   34567789999887  78999999999998776    7999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--------NLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ||||+.+|+|.+++...  .+++.+++.++.|++.||+|||        +.||+||||||+|||++.++.+||+|||++.
T Consensus       118 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999999999653  5899999999999999999999        8999999999999999999999999999987


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC------CCchhhHHHHHHHHHHHHcC----------
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTG----------  274 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg----------  274 (573)
                      .........            ........||+.|+|||++.+..      ++.++|||||||++|+|++|          
T Consensus       196 ~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          196 RHDSATDTI------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             EEETTTTEE------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             ecccccccc------------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            654211100            00123457999999999998753      33689999999999999999          


Q ss_pred             CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ..||.......         .....+...+.....++.++..  ....++.+.+||.+||+.||++|||+.+++++|..+
T Consensus       264 ~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          264 QLPYYDLVPSD---------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCccccCcCc---------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            77886542111         1112222223334444443321  224567899999999999999999999999999998


Q ss_pred             HHHh
Q 008220          353 LEHR  356 (573)
Q Consensus       353 ~~~~  356 (573)
                      .++.
T Consensus       335 ~~~~  338 (342)
T 1b6c_B          335 SQQE  338 (342)
T ss_dssp             HHTT
T ss_pred             HHHh
Confidence            7643

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=351.99  Aligned_cols=257  Identities=18%  Similarity=0.195  Sum_probs=209.8

Q ss_pred             ccccCCCCccccccccccCceEEEEEE-------ECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC---CCccceeeec
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEAT-------LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAA  129 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~  129 (573)
                      .+++..++|++.+.||+|+||+||+|.       ..++.||||++.....   ..+..|+.+++.++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            356777899999999999999999993       2678999998765543   35667888888876   9999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC--------
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHV----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--------  197 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~--------  197 (573)
                      +...+..++||||+++|+|.+++..    ....+++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999999974    3457899999999999999999999999999999999999998        


Q ss_pred             ---CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC
Q 008220          198 ---NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG  274 (573)
Q Consensus       198 ---~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  274 (573)
                         ++.+||+|||+++.+.....              .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPK--------------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCT--------------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCEEEeeCchhhhhhccCC--------------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence               89999999999975432111              1123456799999999999999999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHH
Q 008220          275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR-PSFSDIALELDLVL  353 (573)
Q Consensus       275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-pt~~ell~~l~~~~  353 (573)
                      ..||........         .            ....+..  ...++.+.+++..||+.+|.+| |++.++.+.+..++
T Consensus       282 ~~pf~~~~~~~~---------~------------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          282 TYMKVKNEGGEC---------K------------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             SCCCEEEETTEE---------E------------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCccccCCCCce---------e------------echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            999965422110         0            0011111  1347789999999999999999 57788888887777


Q ss_pred             HHh
Q 008220          354 EHR  356 (573)
Q Consensus       354 ~~~  356 (573)
                      ...
T Consensus       339 ~~~  341 (365)
T 3e7e_A          339 QQH  341 (365)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.4e-42  Score=340.51  Aligned_cols=267  Identities=26%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-----------
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-----------  132 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----------  132 (573)
                      ++|++.+.||+|+||.||+|++  +++.||||++.. .....+.+.+|+.+++.++||||+++++++.+           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            4799999999999999999997  588999998643 34456788999999999999999999998754           


Q ss_pred             --CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          133 --PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       133 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                        ....++||||+++++|.+++......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence              456899999999999999998766678889999999999999999999999999999999999999999999999987


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT  289 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~  289 (573)
                      ..........  ......+..........||+.|+|||++.+. .++.++|||||||++|+|++   ||...........
T Consensus       165 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          165 NVHRSLDILK--LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CTTC---------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hcccccchhc--cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            6542111000  0000000111123456799999999999865 68999999999999999998   6654322211111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .             +... .....+..+...++.+.+||++||+.||.+|||+.++++|+|..
T Consensus       240 ~-------------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          240 K-------------LRSV-SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             H-------------HHST-TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             h-------------cccc-ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence            1             1111 11112233456788999999999999999999999999988763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-41  Score=341.74  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=206.6

Q ss_pred             cccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCC--CCccceeeeccccCCc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPN  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~  135 (573)
                      ..+..++|++.+.||+|+||.||++.+ +++.||||++...  .....+.+.+|+.+++.++  ||||+++++++.....
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            566778999999999999999999987 5788999986543  4456678999999999997  5999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++. +.+||+|||++......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            999999 66789999997654 7899999999999999999999999999999999999964 88999999998765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhcc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhH
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAE  284 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~  284 (573)
                      ..              ........||+.|+|||++.+           ..++.++||||||+++|+|++|..||......
T Consensus       180 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          180 TT--------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             ------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             cc--------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            11              011234579999999999875           46788999999999999999999999764322


Q ss_pred             HHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ....             ..........   ..+...++++.+||.+||+.||++|||+.|+++|+|...
T Consensus       246 ~~~~-------------~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          246 ISKL-------------HAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHH-------------HHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHH-------------HHHHhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            1110             1111111111   123456889999999999999999999999999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.3e-42  Score=353.18  Aligned_cols=269  Identities=22%  Similarity=0.221  Sum_probs=209.3

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CC-----ccceeeeccccC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HP-----GLAKFVAAHAKP  133 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~~  133 (573)
                      +...++|++.+.||+|+||+||+|.+  +++.||||++.. .......+..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            33457999999999999999999987  578999998653 3344567788999988885 55     499999999999


Q ss_pred             CceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCceEEc--CCCCCeEeeeec
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLH--NLGIVHRDVKPANVLLD--RNLCPHLADFGL  208 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~iiH~Dlkp~Nill~--~~~~~kL~Dfg~  208 (573)
                      ...++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+|||+
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999999965 9999987654 46899999999999999999999  57999999999999994  578899999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      +.....                   ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+......
T Consensus       208 a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~  268 (382)
T 2vx3_A          208 SCQLGQ-------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN  268 (382)
T ss_dssp             CEETTC-------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ceeccc-------------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            865431                   1234678999999999999999999999999999999999999999887766666


Q ss_pred             HHHhccccHHHHHHH-------Hhc----CC------------CC-Cccccc---------------------ccCChHH
Q 008220          289 TVLEMNYTEQQLTAA-------VVS----GG------------LR-PILASL---------------------ELGLPAS  323 (573)
Q Consensus       289 ~~~~~~~~~~~~~~~-------~~~----~~------------~~-~~~~~~---------------------~~~~~~~  323 (573)
                      .+.............       ...    +.            +. +....+                     ....+++
T Consensus       269 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (382)
T 2vx3_A          269 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK  348 (382)
T ss_dssp             HHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHH
T ss_pred             HHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHH
Confidence            555432111111000       000    00            00 000000                     0001247


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          324 ILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       324 l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      +.+||.+||+.||++|||+.|+++|+|+
T Consensus       349 ~~dli~~mL~~dP~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          349 FKDLILRMLDYDPKTRIQPYYALQHSFF  376 (382)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             HHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence            8999999999999999999999999886

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.3e-42  Score=351.38  Aligned_cols=270  Identities=18%  Similarity=0.216  Sum_probs=197.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-------  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-------  135 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++.... .......+|+..++.++||||+++++++.....       
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            36899999999999999999998  47899999764332 223455678888899999999999999865433       


Q ss_pred             eEEEEEeccCCChhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCceEEcC-CCCCeEeeeecc
Q 008220          136 YMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLH--NLGIVHRDVKPANVLLDR-NLCPHLADFGLA  209 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiH~Dlkp~Nill~~-~~~~kL~Dfg~a  209 (573)
                      .++||||+.+ +|...+.   .....+++..++.++.|++.||.|||  +.||+||||||+|||++. ++.+||+|||++
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            7899999987 4444332   23447889999999999999999999  999999999999999997 899999999998


Q ss_pred             hhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 008220          210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH  288 (573)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  288 (573)
                      .......                 ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+........
T Consensus       180 ~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          180 KKLSPSE-----------------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             BCCCTTS-----------------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eecCCCC-----------------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence            7554211                 123457899999999987654 8999999999999999999999999887776666


Q ss_pred             HHHhccccH-HHHHHHHhcCCCCC------------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          289 TVLEMNYTE-QQLTAAVVSGGLRP------------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       289 ~~~~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      .+....... ..............            .++......++++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            665432221 11111111110000            011122346889999999999999999999999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-41  Score=343.40  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=192.3

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC-hHHHHHHHHHHH-HHHhCCCCccceeeeccccCCc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      .+++..++|++.+.||+|+||.||+|.+.  ++.||||++.... ......+..|+. +++.++||||+++++++...+.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            36677889999999999999999999984  8999999875543 334455566666 6777899999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          136 YMFFFEFYESRNLAEKLHV----EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      .++||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999986 77777653    245789999999999999999999999 99999999999999999999999999986


Q ss_pred             hhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhh----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ......                 ......||+.|+|||++    .+..++.++|||||||++|+|++|..||........
T Consensus       175 ~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  237 (327)
T 3aln_A          175 QLVDSI-----------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD  237 (327)
T ss_dssp             C-----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred             eccccc-----------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH
Confidence            553211                 12234689999999998    466789999999999999999999999986432111


Q ss_pred             -HHHHHhccccHHHHHHHHhcCCCCCcc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          287 -AHTVLEMNYTEQQLTAAVVSGGLRPIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       287 -~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                       ...+              . ....+.+ ...+..+++++.+||.+||+.||++|||+.++++|+|.....
T Consensus       238 ~~~~~--------------~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          238 QLTQV--------------V-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             --CCC--------------C-CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHH--------------h-cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence             0000              0 1111111 122346899999999999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-41  Score=346.78  Aligned_cols=270  Identities=20%  Similarity=0.270  Sum_probs=208.7

Q ss_pred             ccCCCCccccccccccCceEEEEEEEC--C-eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc------cceeeecccc
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLD--G-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPG------LAKFVAAHAK  132 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~  132 (573)
                      +...++|++.+.||+|+||+||+|.+.  + +.||+|++.. .....+.+.+|+.+++.++|++      ++.+++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            445689999999999999999999873  3 7899998653 3445677889999999997665      8999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----------------
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----------------  195 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----------------  195 (573)
                      ....++||||+ +++|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||+                
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999999 556666665443 468999999999999999999999999999999999999                


Q ss_pred             ---cCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 008220          196 ---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL  272 (573)
Q Consensus       196 ---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  272 (573)
                         +.++.+||+|||++.....                   ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  233 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY  233 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccCCCcEEEeecCccccccc-------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence               6788999999999865321                   123457999999999999999999999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHHHhccccH-HHHHHHHh----------------------cCCCCCccc--ccccCChHHHHHH
Q 008220          273 TGVVPYTDLRAEAQAHTVLEMNYTE-QQLTAAVV----------------------SGGLRPILA--SLELGLPASILSL  327 (573)
Q Consensus       273 tg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~----------------------~~~~~~~~~--~~~~~~~~~l~~l  327 (573)
                      +|..||...........+....... ..+.....                      .....+...  ......++++.+|
T Consensus       234 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (355)
T 2eu9_A          234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL  313 (355)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence            9999998876555444332221110 00000000                      000000000  0112236789999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          328 IQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       328 i~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      |.+||+.||++|||+.|+++|.|..
T Consensus       314 i~~~L~~dP~~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          314 MRRMLEFDPAQRITLAEALLHPFFA  338 (355)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred             HHHHhcCChhhCcCHHHHhcChhhc
Confidence            9999999999999999999988764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=352.79  Aligned_cols=272  Identities=19%  Similarity=0.244  Sum_probs=188.8

Q ss_pred             CCccc-cccccccCceEEEEEEEC----CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecc--ccCCceEE
Q 008220           66 SSYTL-LSPIARGAESVVYEATLD----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYMF  138 (573)
Q Consensus        66 ~~y~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~~~~~~l  138 (573)
                      +.|++ .++||+|+||+||+|++.    ++.||||++.....  ...+.+|+.+|+.++||||+++++++  ......++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45776 458999999999999863    67899998654322  24577999999999999999999999  45778999


Q ss_pred             EEEeccCCChhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEE----cCCCCCeEeee
Q 008220          139 FFEFYESRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADF  206 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill----~~~~~~kL~Df  206 (573)
                      ||||+.+ +|.+++...        ...+++..++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            9999975 777776422        1248999999999999999999999999999999999999    77889999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhH-
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAE-  284 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-  284 (573)
                      |+++.......             ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... 
T Consensus       177 g~a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  243 (405)
T 3rgf_A          177 GFARLFNSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  243 (405)
T ss_dssp             TCCC-----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred             CCceecCCCCc-------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence            99976542111             00123456899999999999874 5899999999999999999999999754331 


Q ss_pred             --------HHHHHHHhccccH--------------HHHHHHHhcCCCCC-----cccccccCChHHHHHHHHHhccCCCC
Q 008220          285 --------AQAHTVLEMNYTE--------------QQLTAAVVSGGLRP-----ILASLELGLPASILSLIQRCWDGNPH  337 (573)
Q Consensus       285 --------~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~  337 (573)
                              .....++.....+              ..............     .+.......++.+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~  323 (405)
T 3rgf_A          244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI  323 (405)
T ss_dssp             ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred             cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence                    1222221110000              00000000000000     00001123477899999999999999


Q ss_pred             CCCCHHHHHHHHHHHH
Q 008220          338 NRPSFSDIALELDLVL  353 (573)
Q Consensus       338 ~Rpt~~ell~~l~~~~  353 (573)
                      +|||+.|+++|+|+..
T Consensus       324 ~R~ta~e~L~hp~f~~  339 (405)
T 3rgf_A          324 KRITSEQAMQDPYFLE  339 (405)
T ss_dssp             GSCCHHHHHTSGGGTS
T ss_pred             cCCCHHHHhcChhhcc
Confidence            9999999999998853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=337.40  Aligned_cols=258  Identities=25%  Similarity=0.350  Sum_probs=192.1

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HH-HHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .+..++|++.+.||+|+||.||+|.+  +++.||||++..... .. .+.+..+..+++.++||||+++++++......+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            34456899999999999999999998  588999998755432 22 334455556788889999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+ ++.+..+.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999999 5566666655456789999999999999999999995 99999999999999999999999999986543211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHH
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRA-EAQAHTV  290 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~~  290 (573)
                                       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||..... ......+
T Consensus       180 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  242 (318)
T 2dyl_A          180 -----------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV  242 (318)
T ss_dssp             ------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             -----------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence                             123456899999999994     55688999999999999999999999986432 2222222


Q ss_pred             HhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      ..              + ..+.++ ....+++++.+||.+||+.||.+|||+.++++|+|...
T Consensus       243 ~~--------------~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          243 LQ--------------E-EPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HH--------------S-CCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             hc--------------c-CCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            11              1 111111 12368999999999999999999999999999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-42  Score=346.22  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh------HHHHHHHHHHHHHHhCC--CCccceeeecc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLD--HPGLAKFVAAH  130 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnIv~l~~~~  130 (573)
                      .+...++|++.+.||+|+||.||+|.+  +++.||||++.....      .....+.+|+.+++.++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            455678999999999999999999987  688999998543311      12245668999999996  59999999999


Q ss_pred             ccCCceEEEEEeccC-CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-CCCCCeEeeeec
Q 008220          131 AKPPNYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGL  208 (573)
Q Consensus       131 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~~~~~kL~Dfg~  208 (573)
                      ..+...++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+|||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999999986 89999987654 789999999999999999999999999999999999999 788999999999


Q ss_pred             chhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 008220          209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQA  287 (573)
Q Consensus       209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  287 (573)
                      +......                  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....    
T Consensus       197 ~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----  254 (320)
T 3a99_A          197 GALLKDT------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----  254 (320)
T ss_dssp             CEECCSS------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred             ccccccc------------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence            8654320                  1234569999999999987665 6889999999999999999999975421    


Q ss_pred             HHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                        +..              +.     ...+..+++++.+||++||+.||++|||+.|+++|+|.
T Consensus       255 --~~~--------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          255 --IIR--------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             --HHH--------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             --hhc--------------cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence              100              10     01234689999999999999999999999999998875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.5e-41  Score=348.01  Aligned_cols=270  Identities=23%  Similarity=0.267  Sum_probs=204.0

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-----------CCccceeee
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----------HPGLAKFVA  128 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~  128 (573)
                      .+...+|++.+.||+|+||+||+|.+  +++.||||++.. .....+.+.+|+.+++.++           ||||+++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            44567999999999999999999997  688999998653 3445567889999999886           899999999


Q ss_pred             ccccCC----ceEEEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCceEEc------
Q 008220          129 AHAKPP----NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLD------  196 (573)
Q Consensus       129 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiH~Dlkp~Nill~------  196 (573)
                      ++....    .+++|||++ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+|||++      
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987644    789999999 88999998753 34589999999999999999999998 999999999999995      


Q ss_pred             CCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Q 008220          197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV  276 (573)
Q Consensus       197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  276 (573)
                      ..+.+||+|||++.....                   ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  233 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE-------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF  233 (373)
T ss_dssp             TEEEEEECCCTTCEETTB-------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcceEEEcccccccccCC-------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            344799999999865432                   1234578999999999999999999999999999999999999


Q ss_pred             CCCCchhH------HHHHHHHhccccHHH-HHHH------H-hcC-CCCCc--------------ccccccCChHHHHHH
Q 008220          277 PYTDLRAE------AQAHTVLEMNYTEQQ-LTAA------V-VSG-GLRPI--------------LASLELGLPASILSL  327 (573)
Q Consensus       277 Pf~~~~~~------~~~~~~~~~~~~~~~-~~~~------~-~~~-~~~~~--------------~~~~~~~~~~~l~~l  327 (573)
                      ||......      .....+......... ....      . ... .....              ....+..+++++.+|
T Consensus       234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
T 1q8y_A          234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  313 (373)
T ss_dssp             CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence            99865321      111222111100000 0000      0 000 00000              001123457889999


Q ss_pred             HHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          328 IQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       328 i~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      |.+||+.||++|||+.|+++|+|..
T Consensus       314 i~~~L~~dP~~Rpt~~ell~hp~f~  338 (373)
T 1q8y_A          314 LSPMLQLDPRKRADAGGLVNHPWLK  338 (373)
T ss_dssp             HGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             HHHHhccCccccCCHHHHhhChhhh
Confidence            9999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-41  Score=342.86  Aligned_cols=256  Identities=21%  Similarity=0.258  Sum_probs=179.4

Q ss_pred             CCCccccc-cccccCceEEEEEEEC--CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc----CCceE
Q 008220           65 PSSYTLLS-PIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        65 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~  137 (573)
                      .++|++.+ .||+|+||+||+|.+.  ++.||||++... ...   .......++.+.||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46899965 5999999999999984  889999986443 221   1222334667799999999999876    44589


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++....
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            9999999999999997654 36899999999999999999999999999999999999976   4559999999986443


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ..                  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. 
T Consensus       183 ~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-  243 (336)
T 3fhr_A          183 QN------------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-  243 (336)
T ss_dssp             ---------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             cc------------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-
Confidence            21                  12345789999999999888889999999999999999999999976543322111110 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               .+..+.. .........+++++.+||.+||+.||.+|||+.|+++|+|...
T Consensus       244 ---------~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          244 ---------RIRLGQY-GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ---------hhhcccc-ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence                     0000110 1111123468999999999999999999999999999999854

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=339.08  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             cccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh------HHHHHHHHHHHHHHhC----CCCccceeee
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKL----DHPGLAKFVA  128 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~hpnIv~l~~  128 (573)
                      .+...++|++.+.||+|+||.||+|.+  +++.||||++.....      .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            445568999999999999999999987  678999998654432      1233456799999998    8999999999


Q ss_pred             ccccCCceEEEEEe-ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc-CCCCCeEeee
Q 008220          129 AHAKPPNYMFFFEF-YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADF  206 (573)
Q Consensus       129 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~-~~~~~kL~Df  206 (573)
                      ++...+..++|+|+ +.+++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++ .++.+||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999999 78899999997654 689999999999999999999999999999999999999 8899999999


Q ss_pred             ecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHH
Q 008220          207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEA  285 (573)
Q Consensus       207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~  285 (573)
                      |++......                  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....  
T Consensus       185 g~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--  244 (312)
T 2iwi_A          185 GSGALLHDE------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--  244 (312)
T ss_dssp             SSCEECCSS------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             chhhhcccC------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence            998654321                  1234568999999999987665 4589999999999999999999975321  


Q ss_pred             HHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                          +..              ..     ...+..+++++.+||.+||+.||++|||+.|+++|.|..
T Consensus       245 ----~~~--------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          245 ----ILE--------------AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             ----HHH--------------TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             ----Hhh--------------hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence                110              00     012356899999999999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=351.50  Aligned_cols=258  Identities=23%  Similarity=0.318  Sum_probs=196.0

Q ss_pred             cccCCCCccccccccccCceEE-EEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVV-YEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ..+...+|.+.+.||+|+||+| |++..+++.||||++.....   ..+.+|+.+|+.+ +||||+++++++.+....|+
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            3455567999999999999985 55566899999998654322   2356899999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---C--CCCeEeeeecchhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---N--LCPHLADFGLAEYRE  213 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~--~~~kL~Dfg~a~~~~  213 (573)
                      ||||+. |+|.+++......+++..++.++.||+.||+|||+.||+||||||+|||++.   +  ..+||+|||+++...
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            999996 4999999876656666678899999999999999999999999999999953   2  357799999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT  289 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  289 (573)
                      .....             ........||+.|+|||++.   ...++.++|||||||++|||++ |..||...........
T Consensus       175 ~~~~~-------------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~  241 (432)
T 3p23_A          175 VGRHS-------------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL  241 (432)
T ss_dssp             ------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred             CCCcc-------------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence            21110             01134467999999999997   4567889999999999999999 9999975433221111


Q ss_pred             HHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .                +.........+...+..+.+||.+||+.||.+|||+.++++|+|+
T Consensus       242 ~----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          242 L----------------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             T----------------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             h----------------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence            0                110110111122346778999999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-41  Score=364.07  Aligned_cols=270  Identities=21%  Similarity=0.274  Sum_probs=205.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeecccc------CCce
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPNY  136 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~  136 (573)
                      ++|++.+.||+|+||+||+|.+  +++.||||++... .....+.+.+|+.+++.++||||+++++++..      ....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999987  5889999986544 44556789999999999999999999998765      6778


Q ss_pred             EEEEEeccCCChhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC---CeEeeeecchh
Q 008220          137 MFFFEFYESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEY  211 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~---~kL~Dfg~a~~  211 (573)
                      ++||||+.||+|.+++....  ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.   +||+|||++..
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            99999999999999997643  25888999999999999999999999999999999999997765   89999999875


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ....                 .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus       174 ~~~~-----------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i  236 (676)
T 3qa8_A          174 LDQG-----------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV  236 (676)
T ss_dssp             TTSC-----------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred             cccc-----------------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence            4321                 11234679999999999999999999999999999999999999997653332211111


Q ss_pred             hccccHHHHHHHHhc-----CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVS-----GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ...............     ....+.....+..+++.+.+||.+||+.||++|||+.++++|.|+.
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence            000000000000000     0111112223345789999999999999999999999988777654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.8e-40  Score=345.66  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=191.1

Q ss_pred             CCCccccccccccCceEEEEE-EECCeeEEEeeccCCChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEA-TLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .+.|.+.+.||+|+||+||.+ ..+++.||||++...   ..+.+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            356777899999999999755 447899999986443   234677899999876 899999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCC------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-------------CCCeE
Q 008220          143 YESRNLAEKLHVEEWSP------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-------------LCPHL  203 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~------~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-------------~~~kL  203 (573)
                      +. |+|.+++.......      ++..++.++.||+.||+|||+.||+||||||+|||++.+             +.+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            96 59999987543211      223457899999999999999999999999999999754             47999


Q ss_pred             eeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHc-CC
Q 008220          204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GV  275 (573)
Q Consensus       204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~  275 (573)
                      +|||++.........            .........||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       170 ~DFG~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          170 SDFGLCKKLDSGQSS------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CCCTTCEECCC--------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccceecCCCCcc------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence            999999765421110            0001234579999999999976       668999999999999999999 99


Q ss_pred             CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccc-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .||.+.....  ..+......             .+.+.. .+..+++++.+||.+||+.||.+|||+.++++|+|..
T Consensus       238 ~Pf~~~~~~~--~~i~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          238 HPFGDKYSRE--SNIIRGIFS-------------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             CTTCSTTTHH--HHHHHTCCC-------------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             CCCCCchhhH--HHHhcCCCC-------------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            9997653322  111111110             011111 1224578999999999999999999999999998763

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-39  Score=320.46  Aligned_cols=236  Identities=19%  Similarity=0.156  Sum_probs=192.3

Q ss_pred             cc-cCCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LH-LPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~-~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .. +..++|++.+.||+|+||.||+|++.  ++.||||++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            44 66689999999999999999999984  8999999875442   345578899999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..|+||||+.|++|.+++..   .....++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|.      
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------  175 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------  175 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred             cEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence            99999999999999999853   246667899999999999999999999999999999999999999985542      


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                                    ++       +++.++|||||||++|+|++|..||.+............. 
T Consensus       176 ------------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-  217 (286)
T 3uqc_A          176 ------------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-  217 (286)
T ss_dssp             ------------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-
T ss_pred             ------------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-
Confidence                                          22       2688999999999999999999999875432211000000 


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                . ....+........+++++.+||.+||+.||++| |+.|+++.|..+...
T Consensus       218 ----------~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          218 ----------T-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             ----------T-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ----------h-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence                      0 000111223345789999999999999999999 999999999887653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.9e-41  Score=338.97  Aligned_cols=248  Identities=17%  Similarity=0.154  Sum_probs=194.0

Q ss_pred             cCCCCccccccccccCceEEEEEEECCeeEEEeeccCCC--------hHHHHHHHHHHHHHHhCC---------------
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--------SEELDNFHKELQLLCKLD---------------  119 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------------  119 (573)
                      +..++|++.+.||+|+||+||+|+++++.||||++....        ....+.+.+|+.+++.++               
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            456789999999999999999999999999999865432        223467889999998886               


Q ss_pred             -----------CCccceeeecccc-------------CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHH
Q 008220          120 -----------HPGLAKFVAAHAK-------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL  175 (573)
Q Consensus       120 -----------hpnIv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l  175 (573)
                                 ||||+++++++.+             ....|+||||+.+|++.+.+..  ..+++.+++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence                       6666666666665             7889999999999977666643  3689999999999999999


Q ss_pred             HHHH-hCCceeccCCCCceEEcCCC--------------------CCeEeeeecchhhhhhhhhhcccccCCCCCCCCcc
Q 008220          176 QYLH-NLGIVHRDVKPANVLLDRNL--------------------CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH  234 (573)
Q Consensus       176 ~~LH-~~~iiH~Dlkp~Nill~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~  234 (573)
                      +||| ++||+||||||+|||++.++                    .+||+|||+|+....                    
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------------------  234 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------------------  234 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------------------
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------------------
Confidence            9999 99999999999999999987                    899999999975541                    


Q ss_pred             ccccccCcccCChhhhccCCCCchhhHHHHHHH-HHHHHcCCCCCCCchhHH-HHHHHHhccccHHHHHHHHhcCCCCCc
Q 008220          235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS-INELLTGVVPYTDLRAEA-QAHTVLEMNYTEQQLTAAVVSGGLRPI  312 (573)
Q Consensus       235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (573)
                       ...+||+.|+|||++.+.. +.++||||||++ .+++++|..||....... ....+....            ......
T Consensus       235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~  300 (336)
T 2vuw_A          235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------TFKTKC  300 (336)
T ss_dssp             -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------CCSSCC
T ss_pred             -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------ccCccc
Confidence             2357999999999998877 889999998777 778888999995421101 111111000            000111


Q ss_pred             ccccccCChHHHHHHHHHhccCCCCCCCCHHHHH-HHHHH
Q 008220          313 LASLELGLPASILSLIQRCWDGNPHNRPSFSDIA-LELDL  351 (573)
Q Consensus       313 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell-~~l~~  351 (573)
                      ....+..+++++.+||++||+.|     |+.|++ +|+|.
T Consensus       301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred             chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCc
Confidence            12233467899999999999977     999999 88874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.7e-39  Score=319.67  Aligned_cols=235  Identities=20%  Similarity=0.265  Sum_probs=185.6

Q ss_pred             CCcccc-ccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHH-HhCCCCccceeeecccc----CCceE
Q 008220           66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLL-CKLDHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~~~  137 (573)
                      ++|.+. +.||+|+||.||+|.+  +++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ...++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            568777 7899999999999988  5789999986432     3466888887 66689999999999876    67799


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+||+++.   ++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999997653 36899999999999999999999999999999999999998   7889999999875322


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                                            +..++.++|||||||++|+|++|..||...............
T Consensus       172 --------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          172 --------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             --------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             --------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence                                                  133577999999999999999999999765433221111000


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                      .           .....+........+++++.+||.+||+.||++|||+.|+++|+|....
T Consensus       214 ~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          214 I-----------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             S-----------CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             H-----------hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            0           0000111111225689999999999999999999999999999988654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-39  Score=338.62  Aligned_cols=245  Identities=16%  Similarity=0.184  Sum_probs=188.5

Q ss_pred             CCCCccccccccccCceEEEEEEEC--CeeEEEeeccCCCh---HHHHHHHHHHHHHHhCCC-Cccceee----------
Q 008220           64 PPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTS---EELDNFHKELQLLCKLDH-PGLAKFV----------  127 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~l~----------  127 (573)
                      ....|++.+.||+|+||+||+|.+.  ++.||||++.....   ...+.+.+|+.+++.++| +|...+.          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456889999999999999999984  89999998663322   235678999999999977 3222111          


Q ss_pred             -----------ecccc-----CCceEEEEEeccCCChhhhhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008220          128 -----------AAHAK-----PPNYMFFFEFYESRNLAEKLH------VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH  185 (573)
Q Consensus       128 -----------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH  185 (573)
                                 .++..     ...++++|+.+ +++|.+++.      .....+++..++.++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                       11111     22456677755 579998884      22335677889999999999999999999999


Q ss_pred             ccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhh----------ccCCC
Q 008220          186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----------KKEIH  255 (573)
Q Consensus       186 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~  255 (573)
                      |||||+|||++.++.+||+|||+++....                   .....+| +.|+|||++          .+..+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~-------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTE-------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCC-------------------ccccCCC-CceeCchhhhccccccccccCcCC
Confidence            99999999999999999999999865432                   1234567 999999999          55567


Q ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCC
Q 008220          256 SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN  335 (573)
Q Consensus       256 ~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  335 (573)
                      +.++|||||||++|||++|+.||...........+                      +. ....+|+++.+||.+||+.|
T Consensus       295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~----------------------~~-~~~~~~~~~~~li~~~l~~d  351 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----------------------FR-SCKNIPQPVRALLEGFLRYP  351 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG----------------------GS-SCCCCCHHHHHHHHHHTCSS
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH----------------------Hh-hcccCCHHHHHHHHHHccCC
Confidence            88999999999999999999999875433221111                      11 12367899999999999999


Q ss_pred             CCCCCCHHHHHHHHHHH
Q 008220          336 PHNRPSFSDIALELDLV  352 (573)
Q Consensus       336 P~~Rpt~~ell~~l~~~  352 (573)
                      |++|||+.+++++.|..
T Consensus       352 P~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          352 KEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             GGGSCCHHHHTTSHHHH
T ss_pred             hhhCcCHHHHHhCHHHH
Confidence            99999999999987764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.7e-39  Score=354.11  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=195.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEE---CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc-
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-  135 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-  135 (573)
                      .++..++|++.+.||+|+||+||+|.+   +++.||||++... .......+.+|+.+++.++||||+++++++..... 
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            345568999999999999999999987   4789999986543 34556678999999999999999999999987665 


Q ss_pred             ----eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          136 ----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       136 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                          .|+||||++|++|.+++..   .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                7999999999999887654   68999999999999999999999999999999999999885 899999999865


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ...                    .....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+......     
T Consensus       231 ~~~--------------------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----  284 (681)
T 2pzi_A          231 INS--------------------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----  284 (681)
T ss_dssp             TTC--------------------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----
T ss_pred             ccc--------------------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----
Confidence            432                    13457999999999997765 8899999999999999999999875311100     


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH-HHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE-LDLVL  353 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~-l~~~~  353 (573)
                                        ....  .....++.+.+||.+||+.||.+||+..+.+.+ +..++
T Consensus       285 ------------------~~~~--~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 ------------------PEDD--PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------------------CTTC--HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------------------cccc--cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                              0000  011245789999999999999999965555444 44333

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.1e-31  Score=289.15  Aligned_cols=185  Identities=19%  Similarity=0.171  Sum_probs=130.9

Q ss_pred             cccccCceEEEEEE--ECCeeEEEeeccCCC----------hHHHHHHHHHHHHHHhC-CCCccceeeeccccCCceEEE
Q 008220           73 PIARGAESVVYEAT--LDGRKVAVKKPILST----------SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        73 ~lg~G~~g~V~~~~--~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      .++.|+.|.+..++  ..|+.+++|.+....          ....+.+.+|+++|+++ .|+||+++++++++....|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45667777666654  368899999754321          12345799999999999 699999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||++|++|.+++...+ .+++.   .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....    
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~----  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD----  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC----
Confidence            99999999999997654 66654   58899999999999999999999999999999999999999999755421    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY  278 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf  278 (573)
                                  .....+.+||+.|||||++.+. +..++|+||+|++++++.++..|+
T Consensus       393 ------------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 ------------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ------------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence                        1124567899999999999875 467899999999998887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.7e-27  Score=255.25  Aligned_cols=191  Identities=16%  Similarity=0.178  Sum_probs=146.2

Q ss_pred             cccccccccCceEEEEEEECCeeEEEeeccCCC---h-----HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           69 TLLSPIARGAESVVYEATLDGRKVAVKKPILST---S-----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ...++||+|+||.||+|...++.+++|+.....   .     ...+.+.+|++++++++||||+++..++......|+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            346689999999999998889999999743322   1     12456899999999999999995555555677789999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||++|++|.+++..         +..++.|++.||+|||++||+||||||+|||++.  .+||+|||+++..........
T Consensus       419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            99999999999865         5689999999999999999999999999999998  999999999987654322110


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~  279 (573)
                      ..         ........||+.|||||++..  ..|+...|+|+..+-..+-..++.+|.
T Consensus       488 ~~---------~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          488 DL---------IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HH---------HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ch---------hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            00         001245689999999999987  567788899999988888887776663

>2i0o_A Ser/Thr phosphatase; beta sandwich, structural genomics, PSI, protei structure initiative, NEW YORK SGX research center for STRU genomics; 1.70A {Anopheles gambiae}

Probab=99.94  E-value=2.5e-26  Score=228.31  Aligned_cols=144  Identities=30%  Similarity=0.472  Sum_probs=116.4

Q ss_pred             CCcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC--CCCChhHHHHHHHH
Q 008220          426 YPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG--STTRPTDALLEAFI  503 (573)
Q Consensus       426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~--~~~~~~~~l~~~~~  503 (573)
                      ...+.+|.++++|+|..|||++.+..++  ..+..+|+|||||||+.+|++|++++++.|.+..  ...++.++|.++|.
T Consensus        20 ~~~~~~~~~s~~G~R~~nED~~~~~~~~--~~~~~l~~V~DGhGG~~~a~~as~~~~~~l~~~~~~~~~~~~~~l~~a~~   97 (304)
T 2i0o_A           20 NEFLASGSSSMQGWRISQEDAHNCILNF--DDQCSFFAVYDGHGGAEVAQYCSLHLPTFLKTVEAYGRKEFEKALKEAFL   97 (304)
T ss_dssp             CSSEEEEEEEEEESSSCCCEEEEEEEEE--ETTEEEEEEEECSSCSHHHHHHHHHHHHHHHHSHHHHTTCHHHHHHHHHH
T ss_pred             CCceEEEEeecCCCCCCccCEEEEEecc--CCCeEEEEEEcCCCCHHHHHHHHHHHHHHHHhhhhcccccHHHHHHHHHH
Confidence            5678999999999999999999876543  2467899999999999999999999999887652  23567889999999


Q ss_pred             HHHHHHHHHHHHhhh--hhh-----ccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          504 RTDVAFRNELDSLRK--SKR-----VVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       504 ~~~~~~~~~~~~~~~--~~~-----~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      ++|+.+.+.......  ...     .......+|||++++++.++++||||||||||||+|+|++++||+||+|.
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~r~g~~~~LT~DH~~~  172 (304)
T 2i0o_A           98 GFDATLLQEKVIEELKVLSGDSAGSDAEPGKDSGCTAVVALLHGKDLYVANAGDSRCVVCRNGKALEMSFDHKPE  172 (304)
T ss_dssp             HHHHHTTSHHHHHHHHHHHCC-----CCTTTSCEEEEEEEEEETTEEEEEEESSCEEEEEETTEEEECCCCCCTT
T ss_pred             HHHHHHHhhhhHHHHhhhccccccccccCCCCCCccEEEEEEECCEEEEEEccCcEEEEEECCEEEEcCCCcCCc
Confidence            999988654321000  000     00112347999999999999999999999999999999999999999996

>2p8e_A PPM1B beta isoform variant 6; structural genomics, hydrolase, PSI-2, protein structure initiative; 1.82A {Homo sapiens}

Probab=99.94  E-value=1.9e-26  Score=229.34  Aligned_cols=139  Identities=24%  Similarity=0.361  Sum_probs=113.5

Q ss_pred             CCcceEEEEeeccCCCCCceeEEecccCCC-CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC--CC-----------
Q 008220          426 YPVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG--ST-----------  491 (573)
Q Consensus       426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~--~~-----------  491 (573)
                      ...+++|+++++|+|..|||++.+...+.. ..+..+|+|||||||+.+|++|++.+++.|.+..  ..           
T Consensus        21 ~~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~l~~V~DGhGG~~~a~~as~~~~~~l~~~~~~~~~~~~~~~~~~~  100 (307)
T 2p8e_A           21 GNGLRYGLSSMQGWRVEMEDAHTAVVGIPHGLEDWSFFAVYDGHAGSRVANYCSTHLLEHITTNEDFRAAGKSGSALELS  100 (307)
T ss_dssp             ETTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSTTTC-----------C
T ss_pred             CCCeeEEEEecCCCCCcccceEEEEecCCCCCCCeEEEEEECCCCCHHHHHHHHHHHHHHHHhhHhhhhccccccccccc
Confidence            357899999999999999999988654321 1357899999999999999999999999887531  11           


Q ss_pred             -CChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          492 -TRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       492 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                       ..+.++|.++|.++|+.+.+.......       ...+|||+++++|.++++||||||||||||+|+|++.+||+||+|
T Consensus       101 ~~~~~~~l~~a~~~~~~~i~~~~~~~~~-------~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~r~g~~~~lT~DH~~  173 (307)
T 2p8e_A          101 VENVKNGIRTGFLKIDEYMRNFSDLRNG-------MDRSGSTAVGVMISPKHIYFINCGDSRAVLYRNGQVCFSTQDHKP  173 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTSTTTC----------CCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhhccC-------CCCCCCeEEEEEEECCcEEEEEccCcEEEEEECCccccCCCCCCC
Confidence             124678999999999998764322111       123699999999999999999999999999999999999999998


Q ss_pred             C
Q 008220          571 F  571 (573)
Q Consensus       571 ~  571 (573)
                      .
T Consensus       174 ~  174 (307)
T 2p8e_A          174 C  174 (307)
T ss_dssp             T
T ss_pred             C
Confidence            6

>3qn1_B Protein phosphatase 2C 16; start domain, BET V domain, PYR/PYL/RCAR, PP2C, abscisic ACI receptor, type 2C protein phosphatase; HET: A8S; 1.80A {Arabidopsis thaliana} PDB: 3zvu_B* 3ujg_B 3nmt_B* 4ds8_B* 3rt0_A 3kb3_B*

Probab=99.93  E-value=1e-26  Score=233.95  Aligned_cols=145  Identities=26%  Similarity=0.400  Sum_probs=113.4

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCC------------------CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYN------------------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL  488 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~------------------~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~  488 (573)
                      ..-.||.+|++|+|.+|||++.+..++..                  ..+..||||||||||+.+|++|+++++..|.+.
T Consensus        12 ~~~~~G~~s~~G~R~~nEDa~~~~~~~~~~p~~~~~~~~~g~~~~~~~~~~~l~~V~DGhGG~~~~~~as~~~~~~l~~~   91 (337)
T 3qn1_B           12 CIPLWGTVSIQGNRSEMEDAFAVSPHFLKLPIKMLMGDHEGMSPSLTHLTGHFFGVYDGHGGHKVADYCRDRLHFALAEE   91 (337)
T ss_dssp             CSCCEEEEEECTTSSSCCEEEEEEEEEEEEEGGGTC----------CEEEEEEEEEEEEESSSHHHHHHHHHHHHHHHHH
T ss_pred             ccCceEEEEeeeCCchhhhHHHHHhhhhcccchhcccccccccccccCCCeEEEEEEeCCCChhHHHHHHHHHHHHHHHH
Confidence            34468999999999999999998765321                  125789999999999999999999998887653


Q ss_pred             CC---------------CCChhHHHHHHHHHHHHHHHHHHHHhhh----hhhccCCccCccceeEEEEEECCeEEEEEcc
Q 008220          489 GS---------------TTRPTDALLEAFIRTDVAFRNELDSLRK----SKRVVQKDWHPGCTAIAALIVRNRLFVANAG  549 (573)
Q Consensus       489 ~~---------------~~~~~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~GtT~~~~~i~~~~l~vanvG  549 (573)
                      ..               ...+.++|.++|.++|..+.........    ..........+|||++++++.++++||||||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~l~~a~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvG  171 (337)
T 3qn1_B           92 IERIKDELCKRNTGEGRQVQWDKVFTSCFLTVDGEIEGKIGRAVVGSSDKVLEAVASETVGSTAVVALVCSSHIVVSNCG  171 (337)
T ss_dssp             HHHTC------------CHHHHHHHHHHHHHHHHHHHTSSCBCCTTCSSCBCCCSSCTTCEECEEEEEECSSEEEEEEES
T ss_pred             HHhhhhhhhccccccchHHHHHHHHHHHHHHhhHHHHhhhhccccccccccccccccCCCCceEEEEEEECCEEEEEecc
Confidence            10               1245689999999999998764411000    0000112235799999999999999999999


Q ss_pred             ccceeEEeCCeeeeCCCCCCCC
Q 008220          550 DCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       550 DSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      |||+||+|+|++++||+||+|.
T Consensus       172 DSR~~l~r~g~~~~lT~DH~~~  193 (337)
T 3qn1_B          172 DSRAVLFRGKEAMPLSVDHKPD  193 (337)
T ss_dssp             SCEEEEEETTEEEESCCCCCTT
T ss_pred             CcEEEEEeCCEeeeecCCCCCC
Confidence            9999999999999999999985

>3kdj_B Protein phosphatase 2C 56; ABA, PYL1, abscisic acid signaling pathway, cell membr hydrolase, magnesium, manganese, metal-binding, nucleus; HET: A8S; 1.88A {Arabidopsis thaliana} PDB: 3nmn_B* 3jrq_A* 3ujk_A 3nmv_B 3ujl_B*

Probab=99.93  E-value=2.9e-26  Score=229.01  Aligned_cols=133  Identities=32%  Similarity=0.545  Sum_probs=107.6

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCC-------------CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC----
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG----  489 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~-------------~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~----  489 (573)
                      ..+.||.++++|+|..|||++.+..++..             ..+..+|||||||||+.+|++|++.+++.|.+..    
T Consensus         7 ~~~~~g~~s~~G~R~~nEDa~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~   86 (316)
T 3kdj_B            7 SVPLYGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGSQVANYCRERMHLALAEEIAKEK   86 (316)
T ss_dssp             ---CEEEEEECTTSSSCCEEEEEETTCC-----------CCGGGGCEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCeEEEEEeEeCCCCCccceeeecccccccccccccccccCCCCeEEEEEEeCCCcHHHHHHHHHHHHHHHHHHHHhhh
Confidence            45789999999999999999998665421             1357899999999999999999999998876531    


Q ss_pred             CC--------CChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCee
Q 008220          490 ST--------TRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHP  561 (573)
Q Consensus       490 ~~--------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~  561 (573)
                      ..        ..+.++|.++|.++|..+....            ...+|||++++++.++++|||||||||+|++|+|++
T Consensus        87 ~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~------------~~~~GtT~~~~~i~~~~l~vanvGDSR~yl~r~g~~  154 (316)
T 3kdj_B           87 PMLSDGDTWLEKWKKALFNSFLRVDSEIESVA------------PETVGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTA  154 (316)
T ss_dssp             CCGGGTHHHHHHHHHHHHHHHHHHHHHGGGTS------------CTTCEECEEEEEECSSEEEEEEESSCEEEEEETTEE
T ss_pred             cccccccchHHHHHHHHHHHHHHHHHHHhccc------------CCCCCCcEEEEEEECCEEEEEEccCCEEEEEECCEe
Confidence            10        1246788888888888773211            113699999999999999999999999999999999


Q ss_pred             eeCCCCCCCC
Q 008220          562 FALSRVRQEF  571 (573)
Q Consensus       562 ~~lt~dH~p~  571 (573)
                      ++||+||+|.
T Consensus       155 ~~lT~DH~~~  164 (316)
T 3kdj_B          155 LPLSVDHKPD  164 (316)
T ss_dssp             EESCCCCCTT
T ss_pred             cccCCCCCCC
Confidence            9999999986

>1a6q_A Phosphatase 2C; catalytic mechanism, metalloenzyme, transductuin, hydrolase; 2.00A {Homo sapiens} SCOP: a.159.1.1 d.219.1.1 PDB: 3fxk_A 3fxj_A 3fxl_A* 3fxm_A* 3fxo_A

Probab=99.93  E-value=4.4e-26  Score=232.17  Aligned_cols=138  Identities=24%  Similarity=0.381  Sum_probs=114.4

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCC-CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC---------CCCChhH
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG---------STTRPTD  496 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~---------~~~~~~~  496 (573)
                      ..+++|+++++|+|..|||++.+...+.. ..+..+|+|||||||+.+|++|++++++.|.+..         ....+.+
T Consensus        20 ~~l~~g~~s~~G~R~~nEDa~~~~~~~~~~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~~~~~~~~~~~~~~~~~   99 (382)
T 1a6q_A           20 NGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKN   99 (382)
T ss_dssp             TTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSHHHHCSSSSCCHHHHHH
T ss_pred             CceEEEEEecCCCCCCCCceeEEecCCCCCCCCeEEEEEEcCCCcHHHHHHHHHHHHHHHHhhhhhhccCCCCCHHHHHH
Confidence            57899999999999999999988665321 1356899999999999999999999999886421         0123467


Q ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          497 ALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       497 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      +|.++|..+|+.+.........       ...+|||+++++|.++++||||||||||||+|+|++++||+||+|.
T Consensus       100 ~l~~af~~~n~~i~~~~~~~~~-------~~~~GtT~~~~li~~~~l~vanvGDSRayl~r~g~~~~LT~DHs~~  167 (382)
T 1a6q_A          100 GIRTGFLEIDEHMRVMSEKKHG-------ADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPS  167 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC-------CCCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCTT
T ss_pred             HHHHHHHHHHHHHHhhhhhccC-------CCCCcceEEEEEEECCeEEEEEcCCCeEEEEECCceEEeCCCCCCC
Confidence            8999999999999766533221       1236999999999999999999999999999999999999999996

>2isn_A NYSGXRC-8828Z, phosphatase; pathogenic strain, praseodymium, sulfate structural genomics, PSI-2, protein structure initiative; 1.90A {Toxoplasma gondii}

Probab=99.93  E-value=7e-26  Score=229.37  Aligned_cols=131  Identities=24%  Similarity=0.296  Sum_probs=109.2

Q ss_pred             ceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCCCChhHHHHHHHHHHHHH
Q 008220          429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVA  508 (573)
Q Consensus       429 ~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~~~~~~~~  508 (573)
                      +.++..+++|+|..|||++++...+....+..||||||||||+.||++|+++|++.|.+..  ....++|+++|.++|+.
T Consensus        13 ~~~~~~s~~G~R~~nED~~~v~~~~~~~~~~~lf~VfDGHGG~~as~~a~~~l~~~l~~~~--~~~~~~l~~a~~~~d~~   90 (364)
T 2isn_A           13 TTTVAATMLGRRPTDEDAILVSAPATSRPNVRIKAVFDGHAGEATSQYCAKHAAKHLGKLS--EFTFAEVKKACLSLDAE   90 (364)
T ss_dssp             EEEEEEEECTTSSSCCEEEEEECC----CCEEEEEEEEEESCSHHHHHHHHHHHHHHTTCS--SCCHHHHHHHHHHHHHH
T ss_pred             eEEEEEEcCCCCCcCCCeeEEeccCCCCCCeEEEEEEECCCCHHHHHHHHHHHHHHHHHhh--cccHHHHHHHHHHHHHH
Confidence            6889999999999999999987665445678999999999999999999999999986542  23467899999999999


Q ss_pred             HHHHHHHhhhhhhccCCccCccceeEEEEEEC------------------------------------------------
Q 008220          509 FRNELDSLRKSKRVVQKDWHPGCTAIAALIVR------------------------------------------------  540 (573)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~------------------------------------------------  540 (573)
                      +.+.....          ..+|||+++++|.+                                                
T Consensus        91 i~~~~~~~----------~~~GtT~v~~~i~~~~~p~~~~~~g~~~~~~~~~~~f~~l~~~~~~~~~~~~~~~~~~~~~~  160 (364)
T 2isn_A           91 IIRKLGPK----------HVAGSTGIIVAIERLSAPVVENVVGREIVPRAHEETFVPLEKLIQEEEEAEHPELVGRYPRV  160 (364)
T ss_dssp             HHHHHCSS----------SCCEECEEEEEEEECSSCEEEEEETTEECCC-----CCCHHHHHHHHHHC-----CCSSCCC
T ss_pred             HHHhcccC----------CCCCcceehhhhhccccccccccccccccccccccchhhhhhhhhhhhhccccccccccccc
Confidence            87654221          13699999999852                                                


Q ss_pred             ------------CeEEEEEccccceeEE-eCCeeeeCCCCCCCC
Q 008220          541 ------------NRLFVANAGDCRAILC-RGGHPFALSRVRQEF  571 (573)
Q Consensus       541 ------------~~l~vanvGDSRa~l~-~~~~~~~lt~dH~p~  571 (573)
                                  +++||||||||||||+ |+|++++||+||+|.
T Consensus       161 ~~~~~~~~~~g~~~l~vanvGDSRayl~~r~g~~~~LT~DH~~~  204 (364)
T 2isn_A          161 PDVQQKTIPAGSFLVTAINIGDSRATLIHSDGGLTRLSKDHKPN  204 (364)
T ss_dssp             CCCEEEEECTTCEEEEEEEESSCEEEEECTTSCEEECCCCCCTT
T ss_pred             ccccccccccCccEEEEEECccCEEEEEeeCCEEEEcCcCCCCC
Confidence                        3899999999999999 789999999999996

>2iq1_A Protein phosphatase 2C kappa, PPM1K; structural genomics, PSI-2, protein structure initiative, NEW YORK SGX research center for structural genomics; 2.25A {Homo sapiens}

Probab=99.93  E-value=2.2e-25  Score=218.21  Aligned_cols=138  Identities=30%  Similarity=0.414  Sum_probs=113.9

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHH
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRT  505 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~  505 (573)
                      ....+|.+|++|.|+.|||++.+...   ..+..+|+|||||||+.+|++|++.+++.|.+.. ...++.++|.++|.++
T Consensus         6 ~~~~~g~~s~~G~R~~nED~~~~~~~---~~~~~l~~V~DG~GG~~~a~~as~~~~~~l~~~~~~~~~~~~~l~~a~~~~   82 (274)
T 2iq1_A            6 SLENVGCASQIGKRKENEDRFDFAQL---TDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEI   82 (274)
T ss_dssp             CGGGCEEEEECCSSSSCCEEEEEEEC---SSSEEEEEEEEEESSTHHHHHHHHHHHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred             cCCeEEEEecccCCCCccceEEEeeC---CCCeEEEEEECCCCCHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHH
Confidence            45578999999999999999988542   2567899999999999999999999998887653 2457789999999999


Q ss_pred             HHHHHHHHHHhhhhhhccCCccCccceeEEEEEEC-CeEEEEEccccceeEEeCCeeeeCCCCCCCCC
Q 008220          506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVR-NRLFVANAGDCRAILCRGGHPFALSRVRQEFW  572 (573)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~-~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~~  572 (573)
                      |+.+.+.......     .....+|||++++++.+ +++|+|||||||||++|+|++.+||+||+|.+
T Consensus        83 ~~~i~~~~~~~~~-----~~~~~~GtT~~~~~i~~~~~l~~anvGDSR~~l~r~g~~~~lT~DH~~~~  145 (274)
T 2iq1_A           83 DKAFSSHARLSAD-----ATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPER  145 (274)
T ss_dssp             HHHHHHHHHC--------CCGGGCEECEEEEEEETTTEEEEEEESSCEEEEEETTEEEECCCCCCTTS
T ss_pred             HHHHHHHhhhccc-----cCCCCCCCcEEEEEEECCCEEEEEEecCceEEEEeCCEeeECCCCCCCcC
Confidence            9999876532211     01123699999999985 59999999999999999999999999999963

>2j4o_A Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TGF-beta, pseudo-phosphatase, TAK1 binding protein, protein binding; 2.25A {Homo sapiens} PDB: 2pom_A 2pop_A

Probab=99.92  E-value=3.1e-25  Score=227.84  Aligned_cols=146  Identities=23%  Similarity=0.346  Sum_probs=113.8

Q ss_pred             CcCCcceEEEEeeccCCCC--------CceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc-CC----
Q 008220          424 TYYPVLSWGSFATCGRRET--------MEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-GS----  490 (573)
Q Consensus       424 ~~~~~~~~~~~s~~G~R~~--------neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~-~~----  490 (573)
                      .....+.+|+++++|+|..        |||++++...   ..+..||||||||||+.+|++|+++++..|.+. ..    
T Consensus        22 ~~~~~~~~G~~~~~G~r~~g~~~~r~~nED~~~~~~~---~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~~~~~~~   98 (401)
T 2j4o_A           22 PLCHLSGVGSASNRSYSADGKGTESHPPEDSWLKFRS---ENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHA   98 (401)
T ss_dssp             CBCTTEEEEEECCEEECSSSSCEECCCCCEEEEEEEE---TTTEEEEEEEEEESSSHHHHHHHHHHHHTTSSSSCCTTSC
T ss_pred             cccccCceeEEecccccccccccCCCCCCceEEEecC---CCCeEEEEEEcCCCCHHHHHHHHHHHHHHHHHhhhhcccc
Confidence            3345778999999999884        9999987642   356789999999999999999999999888643 11    


Q ss_pred             CCChhHHHHHHHHHHHHHHHHHHHHhhhhh-----hcc----------------------CCccCccceeEEEEEECCeE
Q 008220          491 TTRPTDALLEAFIRTDVAFRNELDSLRKSK-----RVV----------------------QKDWHPGCTAIAALIVRNRL  543 (573)
Q Consensus       491 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~----------------------~~~~~~GtT~~~~~i~~~~l  543 (573)
                      ..++.++|.++|..+|+.+.+.........     ...                      .....+||||++++|.++++
T Consensus        99 ~~~~~~~l~~af~~~~~~i~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~GtTa~~~li~~~~l  178 (401)
T 2j4o_A           99 EADVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKL  178 (401)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCTTCCSSCSCGGGHHHHHHHHHHHHHHCCEEEEEEEEEETTEE
T ss_pred             hhhHHHHHHHHHHHHHHHHHHHHHHHHhhhhcccccccccccccccccccchhhhhhhcccccCCCccCEEEEEEECCEE
Confidence            224678999999999999876432110000     000                      00124699999999999999


Q ss_pred             EEEEccccceeEEeCC----eeeeCCCCCCCCC
Q 008220          544 FVANAGDCRAILCRGG----HPFALSRVRQEFW  572 (573)
Q Consensus       544 ~vanvGDSRa~l~~~~----~~~~lt~dH~p~~  572 (573)
                      ||||||||||||+|+|    ++++||+||+|..
T Consensus       179 ~vanvGDSRa~l~r~~~~g~~~~~LT~DH~~~~  211 (401)
T 2j4o_A          179 YVANVGTNRALLCKSTVDGLQVTQLNVDHTTEN  211 (401)
T ss_dssp             EEEEESSCEEEEEEECSSSEEEEECSCCCSTTS
T ss_pred             EEEEccCceEEEEEcCCCCceEEECCCCCCCCC
Confidence            9999999999999998    9999999999963

>2i44_A Serine-threonine phosphatase 2C; PSI-2, 8817Z, structural genomics, protein structure initiative; 2.04A {Toxoplasma gondii}

Probab=99.92  E-value=2.5e-25  Score=223.52  Aligned_cols=137  Identities=21%  Similarity=0.270  Sum_probs=110.3

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCC-CCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc--CC-------------
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMY-NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--GS-------------  490 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~-~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~--~~-------------  490 (573)
                      ..+.+|+.|++|+|+.|||++.+..+.. ...+..+|+|||||||+.+|++|++++++.|.+.  ..             
T Consensus        20 ~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~l~~V~DGhGG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~   99 (324)
T 2i44_A           20 PAFDAAIFTDIGGRKHQEDRFTLCPQLVPGRDDCAFFGVFDGTVGDFASENVKDLVVPQLISSPAWQEVTEMLRSDVPAT   99 (324)
T ss_dssp             TTEEEEEEEECTTSSSCCEEEEEESCCSTTCSSEEEEEEEEEESSSHHHHHHHHHHHHHHHTCHHHHHHHHHHTSCCCHH
T ss_pred             cceEEEEEECCCCCCccCCeEEEEecCCCCCCCeEEEEEeCCCCchHHHHHHHHHHHHHHHhhhHHHHHHHHhhccCCcc
Confidence            4688999999999999999999875432 2356789999999999999999999999888653  10             


Q ss_pred             ------CCChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeC---C-e
Q 008220          491 ------TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRG---G-H  560 (573)
Q Consensus       491 ------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~---~-~  560 (573)
                            ..++.++|.++|.++|+.+.+.......        ..+|+|+++++|.++++||||||||||||+|+   | +
T Consensus       100 ~~~~~~~~~~~~~l~~a~~~~~~~i~~~~~~~~~--------~~~g~gtt~~~i~~~~l~vanvGDSRa~l~r~~~~g~~  171 (324)
T 2i44_A          100 EVDEKLPQLLDQAVDDMYKNADNELVKMCEQLNK--------DYASSTSVTAVLAKGFVAVGHLGDSRIAMGVETPNGLN  171 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTC--------SSCEECEEEEEEETTEEEEEEESSCEEEEEEEETTEEE
T ss_pred             ccccccchhHHHHHHHHHHHHHHHHHHHHhhcCC--------CCCCCCeEEEEEECCeEEEEEccCceEEEEeccCCCce
Confidence                  1234678999999999999876543211        12355666666999999999999999999997   7 8


Q ss_pred             eeeCCCCCCCC
Q 008220          561 PFALSRVRQEF  571 (573)
Q Consensus       561 ~~~lt~dH~p~  571 (573)
                      +++||+||+|.
T Consensus       172 ~~~LT~DH~~~  182 (324)
T 2i44_A          172 CEFLTVDHKPD  182 (324)
T ss_dssp             EEESCCCCCTT
T ss_pred             EEECCCCCCCc
Confidence            99999999996

>4da1_A Protein phosphatase 1K, mitochondrial; metal-ION-assisted catalysis, dehydrogenase phosphatase, hydrolase; 2.38A {Homo sapiens} PDB: 3qht_A 1l2n_A

Probab=99.92  E-value=8.3e-25  Score=224.09  Aligned_cols=137  Identities=30%  Similarity=0.432  Sum_probs=116.0

Q ss_pred             CcceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHH
Q 008220          427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRT  505 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~  505 (573)
                      ..+.+|..|++|.|+.|||++.+...   ..+..+|+|||||||+.+|++|++.+++.+.+.. ...+..++|.++|..+
T Consensus       120 ~~~~~g~~s~~G~R~~NED~~~~~~~---~~~~~l~~VaDG~GG~~~g~~as~~~~~~l~~~~~~~~~~~~~l~~a~~~~  196 (389)
T 4da1_A          120 SLENVGCASQIGKRKENEDRFDFAQL---TDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEI  196 (389)
T ss_dssp             CGGGCEEEEECTTSSSCCEEEEEEEC---SSSEEEEEEEEEESSTHHHHHHHHHHHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred             cceeEEEecCCCCCCCCcceeeeeec---CCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence            46779999999999999999988543   2567899999999999999999999999887653 3567889999999999


Q ss_pred             HHHHHHHHHHhhhhhhccCCccCccceeEEEEEECC-eEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~-~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      |..+...........     ...+|||++++++.++ ++|||||||||||++|+|++++||+||+|.
T Consensus       197 n~~i~~~~~~~~~~~-----~~~~GtT~~~~li~~~~~l~vanvGDSRayl~r~g~~~~LT~DHs~~  258 (389)
T 4da1_A          197 DKAFSSHARLSADAT-----LLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPE  258 (389)
T ss_dssp             HHHHHHHHHHSSCGG-----GGGCEECEEEEEEETTTEEEEEEESSCEEEEEETTEEEECCCCCCTT
T ss_pred             HHHHHHHhhhccccc-----cCCCCCeEEEEEEEcCCeEEEEEeeccEEEEEECCEeEEeCCCCCCC
Confidence            999987654432211     1136999999999876 999999999999999999999999999986

>2irm_A Mitogen-activated protein kinase kinase kinase 7 interacting protein 1; TAK1-binding protein, TAB1; 3.00A {Anopheles gambiae}

Probab=99.92  E-value=3.7e-25  Score=224.44  Aligned_cols=136  Identities=21%  Similarity=0.383  Sum_probs=106.7

Q ss_pred             EeeccCCC---CCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-----CCCChhHHHHHHHHHH
Q 008220          434 FATCGRRE---TMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-----STTRPTDALLEAFIRT  505 (573)
Q Consensus       434 ~s~~G~R~---~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-----~~~~~~~~l~~~~~~~  505 (573)
                      ++.+|+|.   .|||++++...   ..+..||||||||||+.||++|+++++..|.+..     ...++.++|.++|.++
T Consensus        25 ~~~~G~r~~~~~nED~~~~~~~---~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~l~~~~~~~~~~~~l~~a~~~~  101 (358)
T 2irm_A           25 YKDDGRRCEGYESRDKKCLCIS---DNNTSLYAILSGHNGVTVAENALQEMAAELLLGQLNVCNTDEAVKELIRQSFMSV  101 (358)
T ss_dssp             ECSSSCEEECSSCCEEEEEEEC---SSSEEEEEEEEEESCSHHHHHHHHHHHHHSSSSTTTTCCSHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCCCCCCCceEEEEEC---CCCEEEEEEEcCCCCHHHHHHHHHHHHHHHHHhhhccccchhhHHHHHHHHHHHH
Confidence            66799977   49999987642   3568899999999999999999999999887521     1224578999999999


Q ss_pred             HHHHHHHHHHhhh-----hhhc-----------------------cCCccCccceeEEEEEECCeEEEEEccccceeEEe
Q 008220          506 DVAFRNELDSLRK-----SKRV-----------------------VQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR  557 (573)
Q Consensus       506 ~~~~~~~~~~~~~-----~~~~-----------------------~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~  557 (573)
                      |+.+.+.......     ....                       ......+||||++++|.++++||||||||||||+|
T Consensus       102 d~~i~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~GtTav~~li~~~~l~vAnvGDSRa~l~r  181 (358)
T 2irm_A          102 EKGYFDSINPHVATKTAIQLHLSADGMNQYEISQQFENVLQKLDSLNNALSVGSSAVLALIHRSHLYLGNIGNCRALLCK  181 (358)
T ss_dssp             HHHHHHHSHHHHHHHHHHHHTTC---------------CCCTHHHHHTTTTCEEEEEEEEEESSEEEEEEESSCEEEEEE
T ss_pred             HHHHHHHHHhhhhccccccccccccccccccchhhccchhhhcccccCCCCCCCcEEEEEEECCEEEEEEcccCeEEEEE
Confidence            9999764321000     0000                       00122479999999999999999999999999999


Q ss_pred             C---C--eeeeCCCCCCCCC
Q 008220          558 G---G--HPFALSRVRQEFW  572 (573)
Q Consensus       558 ~---~--~~~~lt~dH~p~~  572 (573)
                      +   |  ++++||+||+|..
T Consensus       182 ~~~~g~~~~~~LT~DH~~~~  201 (358)
T 2irm_A          182 TDEHDTLTVTQLSVDHNLLN  201 (358)
T ss_dssp             CCTTCSCEEEECSCCCBTTS
T ss_pred             ecCCCceeeEeCCCCCCCCC
Confidence            8   8  9999999999963

>2pnq_A [pyruvate dehydrogenase [lipoamide]]-phosphatase 1; pyruvate dehydrogenase phosphatase 1, catalytic subunit, PDP1C, hydrolase; 1.81A {Rattus norvegicus} PDB: 3n3c_A 3mq3_A

Probab=99.92  E-value=1.3e-24  Score=226.30  Aligned_cols=134  Identities=25%  Similarity=0.277  Sum_probs=106.3

Q ss_pred             ceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc-------------------
Q 008220          429 LSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-------------------  488 (573)
Q Consensus       429 ~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~-------------------  488 (573)
                      ...++.|++|. |..|||++.+...+.  .+..||||||||||+.||++|+++|+..|.+.                   
T Consensus        37 ~v~~~~s~~g~~R~~nED~~~v~~~~~--~~~~lfgVfDGHGG~~aa~~as~~L~~~i~~~l~~~~~l~~~~~~~~~~~~  114 (467)
T 2pnq_A           37 SILGFDSNRLPANAPIEDRRSATTCLQ--TRGMLLGVFDGHAGCACSQAVSERLFYYIAVSLLPHETLLEIENAVESGRA  114 (467)
T ss_dssp             SEEEEEEEEECCSSSCCEEEEEEEESS--SSCEEEEEEEEESSSHHHHHHHHHHHHHHHHHHCCHHHHHHHHTTTC----
T ss_pred             ceEEEEeeccCCCCCCCCceeeeeccC--CCcEEEEEECCCCCHHHHHHHHHHHHHHHHHhhcchhhhhhhhhhhhcccc
Confidence            34555666665 999999998765432  35689999999999999999999998876421                   


Q ss_pred             ------------C-----------------------------CCCChhHHHHHHHHHHHHHHHHHHHHh----------h
Q 008220          489 ------------G-----------------------------STTRPTDALLEAFIRTDVAFRNELDSL----------R  517 (573)
Q Consensus       489 ------------~-----------------------------~~~~~~~~l~~~~~~~~~~~~~~~~~~----------~  517 (573)
                                  .                             ...++.++|.+||.++|..|.......          .
T Consensus       115 ~~~~l~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~aL~~af~~~d~~i~~~~~~~~~~~~~~~~~~  194 (467)
T 2pnq_A          115 LLPILQWHKHPNDYFSKEASKLYFNGLRTYWQELIDLNTGESADIDVKEALINAFKRLDNDISLEAQVGDPNSFLNYLVL  194 (467)
T ss_dssp             CCCCEEECCCTTCCCCSTTHHHHHHHHHHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHHHCCSSHHHHHHHH
T ss_pred             ccccccccccccccchhhhhhhhhcchhhhhhhhccccccccchhhHHHHHHHHHHHHHHHHHHhhhhcccccccccccc
Confidence                        0                             011577899999999999998765321          1


Q ss_pred             hhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEe---CC--eeeeCCCCCCCC
Q 008220          518 KSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR---GG--HPFALSRVRQEF  571 (573)
Q Consensus       518 ~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~---~~--~~~~lt~dH~p~  571 (573)
                      ...       .+||||++++|.++++||||||||||||+|   +|  .+++||+||+|.
T Consensus       195 ~~~-------~~GtTa~v~li~~~~l~vAnvGDSRa~l~r~~~~g~~~~~~LT~DH~~~  246 (467)
T 2pnq_A          195 RVA-------FSGATACVAHVDGVDLHVANTGDSRAMLGVQEEDGSWSAVTLSNDHNAQ  246 (467)
T ss_dssp             HHH-------HSEECEEEEEEETTEEEEEEESSCEEEEEEECTTSCEEEEECCCCCSTT
T ss_pred             cCC-------CCcceEEEEEEECCEEEEEECCCceEEEEEecCCCcEEEEECCCCCCCC
Confidence            111       269999999999999999999999999998   47  899999999995

>3d8k_A PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR genomics, protein structure initiative, NEW YORK structural research consortium, nysgxrc; 2.71A {Toxoplasma gondii}

Probab=99.91  E-value=6.1e-25  Score=223.13  Aligned_cols=131  Identities=21%  Similarity=0.280  Sum_probs=107.2

Q ss_pred             CcceEEEEeeccCCCCCcee-----EEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCCCChhHHHHHH
Q 008220          427 PVLSWGSFATCGRRETMEDT-----HFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEA  501 (573)
Q Consensus       427 ~~~~~~~~s~~G~R~~neD~-----~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~  501 (573)
                      ..+.+|.+|++|+|++|||+     +++...+....+..||||||||||+.+|++|++++++.|.+..  ....++|.++
T Consensus        11 ~~~~~~~~s~~G~R~~~ED~~neD~~~~~~~~~~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~--~~~~~al~~a   88 (377)
T 3d8k_A           11 GRTVCASATSRNRRPTSESPHSDDVVVVEGMLRGRPETRVHAMFDGFQGRHSAMWLAQNVMNYLNDLR--DVNEEEITRQ   88 (377)
T ss_dssp             HHHHHHHTTTCEEEEEECC---CEEEEEEEECSSCTTEEEEEEEEBSSSSHHHHHHHHHHHHHHTTCS--SSSHHHHHHH
T ss_pred             CcEEEEEEEccCCCCccccchhcceEEEecccCCCCCeEEEEEEcCCCcHHHHHHHHHHHHHHHHHhc--ccHHHHHHHH
Confidence            34677888999999988654     4454333334678899999999999999999999999997643  3457899999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEE------------------------------------------
Q 008220          502 FIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV------------------------------------------  539 (573)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~------------------------------------------  539 (573)
                      |.++|+.+.....             .+|||++++++.                                          
T Consensus        89 f~~~d~~l~~~~~-------------~~GtTa~~~~i~~~~~~~~~~~~g~~~~p~~~~~~~~~~~~~g~ta~a~vali~  155 (377)
T 3d8k_A           89 FERMDGDLRAANL-------------PGGSSALIIFVRYEKKPTEARVVGRQIVPEGAKEFTSVAEALGGPLMPVVAMNF  155 (377)
T ss_dssp             HHHHHHHHHHHTC-------------CCCBCEEEEEEEEESSCCCEEEETTEEECCC---CCCHHHHSSCCCCCCEEECG
T ss_pred             HHHHHHHHHhccc-------------CCCCceEEEEEeccccccccccccccccccccccccccccccccccccceeeec
Confidence            9999999976531             259999998885                                          


Q ss_pred             ---------CCeEEEEEccccceeEEeCCeeeeCCCCCCCCC
Q 008220          540 ---------RNRLFVANAGDCRAILCRGGHPFALSRVRQEFW  572 (573)
Q Consensus       540 ---------~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~~  572 (573)
                               ++++||||||||||||+|+|++++||+||+|..
T Consensus       156 ~~~p~~~~~~~~l~vanvGDSRa~l~r~g~~~~LT~DH~~~~  197 (377)
T 3d8k_A          156 RRDPRAAKGIYTIHVASLGNSRCVLKSGRTAIHLSTPHTASS  197 (377)
T ss_dssp             GGCGGGTTCEEEEEEEEESSCEEEEEETTEEEESSCCCSSSS
T ss_pred             ccccccccCCCeEEEEEcccceEEEEECCEEEECCcCCCCCC
Confidence                     148999999999999999999999999999964

>1txo_A Putative bacterial enzyme; serine/threonine protein phosphatases, PSTP/PPP, structural genomics, PSI, protein structure initiative; 1.95A {Mycobacterium tuberculosis} SCOP: d.219.1.1 PDB: 2cm1_A

Probab=99.91  E-value=6.4e-24  Score=203.57  Aligned_cols=129  Identities=23%  Similarity=0.269  Sum_probs=110.7

Q ss_pred             cceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC---CCCChhHHHHHHHH
Q 008220          428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG---STTRPTDALLEAFI  503 (573)
Q Consensus       428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~---~~~~~~~~l~~~~~  503 (573)
                      .++++..|++|+ |+.|||++.+.        ..+|+|||||||+.+|++|++.+++.+.+..   ...++.++|.++|.
T Consensus         4 ~~~~~~~s~~G~~r~~nED~~~~~--------~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~l~~a~~   75 (237)
T 1txo_A            4 VLRYAARSDRGLVRANNEDSVYAG--------ARLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVR   75 (237)
T ss_dssp             EEEEEEEEECCSSCSSCCEEEEEC--------SSEEEEEEEECTTTHHHHHHHHHHHHHGGGGSSCCCSCHHHHHHHHHH
T ss_pred             EEEEEEecCCCCCCCcCCCccccC--------CCEEEEEeCCCCcHHHHHHHHHHHHHHHHHhhhCCchhHHHHHHHHHH
Confidence            478999999997 99999999762        3589999999999999999999999887642   23467889999999


Q ss_pred             HHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .++..+.+.........       .+|||++++++.++++++||+||||+|++|+|++.+||+||+|.
T Consensus        76 ~~~~~i~~~~~~~~~~~-------~~gtT~~~~~i~~~~l~~a~vGDsr~~l~r~g~~~~lt~dh~~~  136 (237)
T 1txo_A           76 AGNSAIAAQVEMEPDLE-------GMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTFV  136 (237)
T ss_dssp             HHHHHHHHHHHHCGGGT-------TCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECSCCCBHH
T ss_pred             HHHHHHHHHHhhCCCCC-------CCcceEEEEEEECCEEEEEEEccCcEEEEeCCEeEEeCCCCCHH
Confidence            99999987655432222       25999999999999999999999999999999999999999974

>2pk0_A Serine/threonine protein phosphatase STP1; SI motif, signaling protein; 2.65A {Streptococcus agalactiae}

Probab=99.90  E-value=1.9e-23  Score=202.00  Aligned_cols=134  Identities=17%  Similarity=0.136  Sum_probs=112.5

Q ss_pred             CCcceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHH-hcCC-----CCChhHHH
Q 008220          426 YPVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ-NLGS-----TTRPTDAL  498 (573)
Q Consensus       426 ~~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~-~~~~-----~~~~~~~l  498 (573)
                      ...|+++..|++|. |+.|||++.+....   .+..+|+|||||||+.+|+++++.+++.|. +...     ..+..++|
T Consensus         3 k~~~~~~~~s~~G~~r~~neD~~~~~~~~---~~~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l   79 (250)
T 2pk0_A            3 KKYMEISLLTDIGQRRSNNQDFINQFENK---AGVPLIILADGMGGHRAGNIASEMTVTDLGSDWAETDFSELSEIRDWM   79 (250)
T ss_dssp             CCCEEEEEEEECCTTCSCCCEEEEEEECT---TCCEEEEEEEEECTTTHHHHHHHHHHHHHHHHHTTCCCCSHHHHHHHH
T ss_pred             cceEEEEEecCCCCCCCcCCCceEeccCC---CCcEEEEEEeCCCCcHHHHHHHHHHHHHHHHHHhhcccCChhhHHHHH
Confidence            35689999999999 99999999886642   357899999999999999999999988887 3221     12356789


Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          499 LEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                      .++|..+|..+.+...... .       ..+|||++++++.++++++||+||||+|++|+|++.+||.||+|
T Consensus        80 ~~~~~~~~~~l~~~~~~~~-~-------~~~gtT~~~~~i~~~~l~~anvGDsr~~l~r~g~~~~lt~dh~~  143 (250)
T 2pk0_A           80 LVSIETENRKIYELGQSDD-Y-------KGMGTTIEAVAIVGDNIIFAHVGDSRIGIVRQGEYHLLTSDHSL  143 (250)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-C-------TTCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECCCCCBH
T ss_pred             HHHHHHHHHHHHHHHhhCC-C-------CCCcceEEEEEEECCeEEEEEeCCCeEEEEcCCcEEEeCCCCCH
Confidence            9999999999987654322 1       13699999999999999999999999999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=7.4e-24  Score=208.22  Aligned_cols=131  Identities=19%  Similarity=0.222  Sum_probs=107.6

Q ss_pred             CccccccccccCceEEEEEEE-CCeeEEEeeccCCCh------------------HHHHHHHHHHHHHHhCCCCccceee
Q 008220           67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS------------------EELDNFHKELQLLCKLDHPGLAKFV  127 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~  127 (573)
                      .|.+.+.||+|+||.||+|.+ +++.||||.+.....                  .....+.+|+.+|+.++  | +++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            455669999999999999998 588999998654321                  23567889999999999  4 5555


Q ss_pred             eccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeee
Q 008220          128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG  207 (573)
Q Consensus       128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg  207 (573)
                      +++.. +..++||||++|++|.+ +..       .....++.|++.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            55433 56799999999999988 421       23557999999999999999999999999999999 9999999999


Q ss_pred             cch
Q 008220          208 LAE  210 (573)
Q Consensus       208 ~a~  210 (573)
                      +|+
T Consensus       238 ~a~  240 (282)
T 1zar_A          238 QSV  240 (282)
T ss_dssp             TCE
T ss_pred             CCe
Confidence            984

>2j82_A TPPHA, protein serine-threonine phosphatase; PP2C family phosphatase, hydrolase; 1.28A {Synechococcus elongatus} PDB: 2j86_A 2y09_A 2xzv_A

Probab=99.89  E-value=3.9e-23  Score=198.55  Aligned_cols=130  Identities=20%  Similarity=0.298  Sum_probs=103.9

Q ss_pred             ceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-----C-CCChhHHHHHH
Q 008220          429 LSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-----S-TTRPTDALLEA  501 (573)
Q Consensus       429 ~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-----~-~~~~~~~l~~~  501 (573)
                      |+++..|++|. |+.|||++ +...   ..+. +|+|||||||+.+|+++++.+.+.+.+..     . ..++.++|.++
T Consensus         1 ~~~~~~s~~G~~r~~neD~~-~~~~---~~~~-~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l~~~   75 (240)
T 2j82_A            1 MDVAGLTDCGLIRKSNQDAF-YIDE---KHQR-FFIVADGMGGHAGGEEASRLAVDHIRQYLETHLEDLQHDPVTLLRQA   75 (240)
T ss_dssp             CEEEEEEECCSSCSSCCEEE-EECT---TTCC-EEEEEEBC---CHHHHHHHHHHHHHHHHHHHHHHHHTTSHHHHHHHH
T ss_pred             CeEEEeCCCCCCCCcCCCcc-EecC---CCCe-EEEEEcCCCCchHHHHHHHHHHHHHHHHHHhcccccchhHHHHHHHH
Confidence            57899999999 99999999 6543   1344 99999999999999988888877664321     1 44678899999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          502 FIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                      |..+|..+.+.......       ...+|||++++++.  ++++++||+||||+|++|+|++.+||+||+|
T Consensus        76 ~~~~~~~l~~~~~~~~~-------~~~~gtT~~~~~i~~~~~~l~~anvGDsr~~l~r~~~~~~lt~dh~~  139 (240)
T 2j82_A           76 FLAANHAIVEQQRQNSA-------RADMGTTAVVILLDEKGDRAWCAHVGDSRIYRWRKDQLQQITSDHTW  139 (240)
T ss_dssp             HHHHHHHHHHHHTTSCS-------CTTCCBCEEEEEECTTSSEEEEEEESSCEEEEEETTEEEECSCCCBH
T ss_pred             HHHHHHHHHHHhhcccC-------CCCCCceEEEEEEEecCCEEEEEEEccCceEEEeCCEEEEECCCCcH
Confidence            99999999776433211       11359999999999  9999999999999999999999999999998

>2jfr_A Ser-Thr phosphatase MSPP; hydrolase, PPM phosphatase, manganese, phosphate; 0.83A {Mycobacterium smegmatis} PDB: 2jfs_A 2jft_A 2v06_A

Probab=99.86  E-value=7.9e-22  Score=188.58  Aligned_cols=124  Identities=23%  Similarity=0.240  Sum_probs=104.1

Q ss_pred             CcceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcH--HHHHHHHHHhHHHHHhcCCCCChhHHHHHHHH
Q 008220          427 PVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGS--AAAEFSARALPGFLQNLGSTTRPTDALLEAFI  503 (573)
Q Consensus       427 ~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~--~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~~~  503 (573)
                      ..++++..|++|. |+.|||++.+        +..+|+|||||||+  .||+++.+.+.+.+....   + .+.|.++|.
T Consensus         4 ~~~~~~~~s~~G~~r~~neD~~~~--------~~~~~~V~DG~Gg~G~~as~~~~~~l~~~~~~~~---~-~~~l~~~~~   71 (234)
T 2jfr_A            4 SVLSAATATDQGPVRENNQDACLA--------DGILYAVADGFGARGHHASATALKTLSAGFAAAP---D-RDGLLEAVQ   71 (234)
T ss_dssp             SEEEEEEEEECCSSCSSCCEEEEE--------ETTEEEEEEEESTTHHHHHHHHHHHHHHHHHHSC---S-HHHHHHHHH
T ss_pred             eeEEEEEecCCCCCCCcCCCccee--------CCcEEEEEeCCCccHHHHHHHHHHHHHHHHhcCC---c-HHHHHHHHH
Confidence            3578999999999 9999999965        24689999999966  888888888887776542   2 788999999


Q ss_pred             HHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCe---EEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNR---LFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~---l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .+|+.+.+.......         .+|||++++++.++.   ++++|+||||+|++|+|++.+||+||+|.
T Consensus        72 ~~~~~l~~~~~~~~~---------~~gtT~~~~~i~~~~~~~l~~anvGDsr~~l~r~g~~~~lt~dh~~~  133 (234)
T 2jfr_A           72 QANLRVFELLGDEPT---------VSGTTLTAVAVFEPGQGGPLVVNIGDSPLYRIRDGHMEQLTDDHSVA  133 (234)
T ss_dssp             HHHHHHHHHHTTSSS---------CCEECEEEEECCCGGGTSCEEEEESSCCEEEEETTEEEECSCCCBHH
T ss_pred             HHHHHHHHhhccCCC---------CCCccEEEEEEECCCccEEEEEEEccCceEEEECCEEEEeCCCCCHH
Confidence            999998765432111         159999999999998   99999999999999999999999999983

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=1.1e-20  Score=183.31  Aligned_cols=136  Identities=23%  Similarity=0.196  Sum_probs=106.4

Q ss_pred             CccccccccccCceEEEEEEE--CCee--EEEeeccCCChH------------------------HHHHHHHHHHHHHhC
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRK--VAVKKPILSTSE------------------------ELDNFHKELQLLCKL  118 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  118 (573)
                      -|++.+.||+|+||.||+|.+  +|+.  ||||+.......                        ....+.+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378899999999999999987  7888  999975432111                        123678999999999


Q ss_pred             CCCcc--ceeeeccccCCceEEEEEeccC-C----ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCC
Q 008220          119 DHPGL--AKFVAAHAKPPNYMFFFEFYES-R----NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-NLGIVHRDVKP  190 (573)
Q Consensus       119 ~hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiH~Dlkp  190 (573)
                      .|++|  +.+++.    ...++||||+.+ |    .|.+....    .++..+..++.|++.+|.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88754  444443    367899999942 3    56655432    234567889999999999999 99999999999


Q ss_pred             CceEEcCCCCCeEeeeecchhh
Q 008220          191 ANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       191 ~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  8999999998543

>3rnr_A Stage II sporulation E family protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: MSE; 2.00A {Thermanaerovibrio acidaminovorans}

Probab=99.80  E-value=1.1e-19  Score=170.31  Aligned_cols=104  Identities=20%  Similarity=0.164  Sum_probs=85.1

Q ss_pred             CceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEE
Q 008220          457 KEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIA  535 (573)
Q Consensus       457 ~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~  535 (573)
                      ++..+|+|||||||+.+|++|++.+.+.+.+.. ....    +.+++..++..+.+.........       .+|||+++
T Consensus         8 ~~~~l~~VaDG~GG~~~g~~AS~~~~~~l~~~~~~~~~----~~~~~~~an~~l~~~~~~~~~~~-------~~GtT~~~   76 (211)
T 3rnr_A            8 GDKAYCVVVDGMGGMIRGDEAAQRALSASVGVLDAGGS----PLDAVLAAQAAVHRWASQGGILG-------RTGATMAV   76 (211)
T ss_dssp             TTEEEEEEEEECTTSTTHHHHHHHHHHHHHHHHHTTCC----HHHHHHHHHHHHHHHHHHTTCTT-------SCCEEEEE
T ss_pred             CCccEEEEEeCCcCcHHHHHHHHHHHHHHHHHHhccCC----HHHHHHHHHHHHHHHHhhccCCC-------Ccchhhee
Confidence            567899999999999999999998888776531 1112    36888888888877655433332       35999999


Q ss_pred             EEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          536 ALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       536 ~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      +++.  ++++++|||||||+|++|+|++.+||+||+|.
T Consensus        77 ~~i~~~~~~~~~anvGDSr~yl~r~g~~~~lt~dh~~~  114 (211)
T 3rnr_A           77 AAVNLRDGTLEWASVGDCRVYLFKGGRLSRLSLDHNVS  114 (211)
T ss_dssp             EEEETTTTEEEEEEESSCEEEEEETTEEEECCCCCBHH
T ss_pred             eeeeeCCCEEEEEEEccCeEEEEeCCEEEEECCCcHHH
Confidence            9999  99999999999999999999999999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=4.8e-18  Score=171.14  Aligned_cols=132  Identities=19%  Similarity=0.236  Sum_probs=96.6

Q ss_pred             ccccccccccCceEEEEEEE-CCeeEEEeeccCCCh--------------HHHH--------HHHHHHHHHHhCCCCccc
Q 008220           68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS--------------EELD--------NFHKELQLLCKLDHPGLA  124 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~hpnIv  124 (573)
                      |++.++||.|+||.||+|.+ +|+.||||+......              ....        ...+|...|.++.++++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            89999999999999999987 689999997532100              0001        123456666666443332


Q ss_pred             --eeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCC--
Q 008220          125 --KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--  200 (573)
Q Consensus       125 --~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~--  200 (573)
                        ..++.    ...++||||+.|+.|..+...       +....++.||+.+|.+||+.|||||||||.|||++.+|.  
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              22222    234799999999888765432       234678899999999999999999999999999988774  


Q ss_pred             --------CeEeeeecch
Q 008220          201 --------PHLADFGLAE  210 (573)
Q Consensus       201 --------~kL~Dfg~a~  210 (573)
                              +.|+||+.+.
T Consensus       246 d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CTTSEEEEEEECCCTTCE
T ss_pred             cccccccceEEEEeCCcc
Confidence                    7899999774

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=7.1e-13  Score=128.54  Aligned_cols=139  Identities=12%  Similarity=0.141  Sum_probs=111.8

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEecc
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      ..|++...++.|+.+.||++...++.+++|............+.+|+.+++.+. +..++++++++...+..|+|||+++
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            368899999999999999998878899999865321122335789999999984 6788899999888889999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------------------------------------------  180 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  180 (573)
                      |.+|.+.+.      +......++.++..+|..||+                                            
T Consensus        94 G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           94 GVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            999877632      112344788899999999998                                            


Q ss_pred             ---------------CCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          181 ---------------LGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       181 ---------------~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                                     ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           448999999999999876556799999774

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1e-10  Score=118.83  Aligned_cols=142  Identities=15%  Similarity=0.207  Sum_probs=108.5

Q ss_pred             cccccccccCceEEEEEEECCeeEEEeecc--CCC-hHHHHHHHHHHHHHHhCC--CCccceeeeccccC---CceEEEE
Q 008220           69 TLLSPIARGAESVVYEATLDGRKVAVKKPI--LST-SEELDNFHKELQLLCKLD--HPGLAKFVAAHAKP---PNYMFFF  140 (573)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~  140 (573)
                      .-++.|+.|.++.||++...+..+++|+..  ... ......+.+|+.+++.|.  +..+++++.++.+.   +..++||
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            346778999999999998877889999754  221 123456788999999996  45688888887766   4589999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN----------------------------------------  180 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~----------------------------------------  180 (573)
                      ||++|..+.+...   ..++.++...++.++...|+.||+                                        
T Consensus       121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999987754221   146778888999999999999997                                        


Q ss_pred             ------------------CCceeccCCCCceEEcCCCC--CeEeeeecchhhh
Q 008220          181 ------------------LGIVHRDVKPANVLLDRNLC--PHLADFGLAEYRE  213 (573)
Q Consensus       181 ------------------~~iiH~Dlkp~Nill~~~~~--~kL~Dfg~a~~~~  213 (573)
                                        ..++|+|++|.|||++.++.  +.|+||+.+..-.
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                              35899999999999998764  5899999986544

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=7.8e-11  Score=113.75  Aligned_cols=132  Identities=16%  Similarity=0.208  Sum_probs=98.4

Q ss_pred             CccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc--cceeeeccccCCceEEEEEec
Q 008220           67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--LAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~  143 (573)
                      .|.+....+.|..+.||++.. +++.+++|.....   ....+..|+.+++.+.+.+  +++++.+...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            455555545677799999975 3678999985443   2245678999999885434  667888888878899999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-----------------------------------------  182 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----------------------------------------  182 (573)
                      +|.+|.  ...    ..   ...++.++...|..||+..                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    11   2256677778888888643                                         


Q ss_pred             -----------------ceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          183 -----------------IVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       183 -----------------iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                                       ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             9999999999999877667799999874

>3t91_A Stage II sporulation protein E; SPOIIE, phosphatase, manganese binding, PP2C PH domain; HET: GL0 MAN; 2.64A {Bacillus subtilis} PDB: 3t9q_A*

Probab=99.01  E-value=3.9e-10  Score=107.65  Aligned_cols=125  Identities=14%  Similarity=0.058  Sum_probs=81.4

Q ss_pred             cceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHH
Q 008220          428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRT  505 (573)
Q Consensus       428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~  505 (573)
                      .+.+++++.... +..+.|.+.+...   ..+..+++|+||+|+...|.+++..+...+.... ...+    +.+++..+
T Consensus         7 ~i~~~~~~~~~p~~~v~GD~y~~~~~---~~~~~~~~vaDg~G~G~~aa~~s~~~~~~l~~~~~~~~~----~~~~l~~~   79 (242)
T 3t91_A            7 RVSTGAAHAAKGGGLVSGDSYSMMEL---GARKYAAAISDGMGNGARAHFESNETIKLLEKILESGID----EKIAIKTI   79 (242)
T ss_dssp             EEEEEEEEECTTSCSCCSCEEEEEEE---TTTEEEEEEECC-----CCSEEECHHHHHHHHHHHHTCC----HHHHHHHH
T ss_pred             EEEEEeehhcCCccccCCcEEEEEEe---CCCeEEEEEEeeCCCCHHHHHHHHHHHHHHHHHHHhCCC----HHHHHHHH
Confidence            466777777554 7899999987553   2456679999999988877766665555443321 1112    34555566


Q ss_pred             HHHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      |+.+.....     .       .+++|++++++.  ++.++++|+||||+|++|+|++.+|+.++.|.
T Consensus        80 n~~l~~~~~-----~-------~~~~T~~~~~id~~~~~l~~~~aG~~~~~l~r~g~~~~l~~~~~~l  135 (242)
T 3t91_A           80 NSILSLRTT-----D-------EIYSTLDLSIIDLQDASCKFLKVGSTPSFIKRGDQVMKVQASNLPI  135 (242)
T ss_dssp             HHHHTTC----------------CCCCEEEEEEETTTCEEEEEEESCCCEEEEETTEEEECCCC----
T ss_pred             HHHHHhcCC-----C-------CeEeEEEEEEEECCCCEEEEEcCCCCceEEEECCEEEEecCCCcee
Confidence            666543211     1       248999999997  67999999999999999999999999988774

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=3.5e-10  Score=112.02  Aligned_cols=197  Identities=19%  Similarity=0.202  Sum_probs=123.8

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCc--cceeeeccccCC---ceEEEEEecc
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPG--LAKFVAAHAKPP---NYMFFFEFYE  144 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~e~~~  144 (573)
                      ++.++.|....||++.   ..+++|...  .......+.+|+.+|+.+. +..  +++++.......   ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999874   578999743  2345567889999998883 332  455555544333   3578999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------------------------------------------  180 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  180 (573)
                      |..|.+...   ..++.++...++.++...|+.||+                                            
T Consensus       100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            988865332   146777788888888888888885                                            


Q ss_pred             --------------CCceeccCCCCceEEcC--CCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCccc
Q 008220          181 --------------LGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY  244 (573)
Q Consensus       181 --------------~~iiH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  244 (573)
                                    ..++|+|++|.||+++.  .+.+.|+||+.+..-....+........  ...+.............
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~--~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD--EEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT--TSCCHHHHHHHHHHHTC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc--cccCHHHHHHHHHHcCC
Confidence                          13699999999999998  4567899999886543222211000000  00000000000000011


Q ss_pred             CC-hhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008220          245 MA-PEILKKEIHSEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       245 ~a-PE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  279 (573)
                      .. |+.....  ..-.+.|+++.++|.+.+|..+|.
T Consensus       255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            12 2222111  123689999999999999988874

>3pu9_A Protein serine/threonine phosphatase; PSI-biology, MCSG, structural genomics; HET: MSE; 1.55A {Sphaerobacter thermophilus}

Probab=98.99  E-value=5.9e-09  Score=99.25  Aligned_cols=125  Identities=14%  Similarity=0.007  Sum_probs=90.7

Q ss_pred             cceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHHH
Q 008220          428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIRT  505 (573)
Q Consensus       428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~~  505 (573)
                      .+.+++.+.... +....|.|.+...   ..+..+++|+||+|++.+|.+++..+...+.... ...+    ..+++..+
T Consensus        10 ~~~~~~~~~~~~~~~vgGD~y~~~~~---~~~~~~~~vaD~~G~G~~aa~~s~~~~~~l~~~~~~~~~----~~~~l~~~   82 (242)
T 3pu9_A           10 TIELAVAKTHKFGTRESGDTVELVER---PGGGFSAVLVDGQGSGAGAKRLSLLVAGAAVRLLNEGVR----DGAAARAA   82 (242)
T ss_dssp             EEEEEEEEECCTTCSSCSEEEEEEEC---TTSEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHTTCC----HHHHHHHH
T ss_pred             EEEEEEEecccCccccCCceEEEEEe---CCCEEEEEEEecCCCCHHHHHHHHHHHHHHHHHHHcCCC----HHHHHHHH
Confidence            345566665544 7788899987643   2345679999999999999988887666554321 1112    34566677


Q ss_pred             HHHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      |+.+....     ..       ..++|++++++.  .+.+.++|+||+|+|++|+|+..+|+.+|.|.
T Consensus        83 n~~l~~~~-----~~-------~~~~T~~~~~id~~~~~l~~~~aG~~~~~l~r~g~~~~l~~~~~~l  138 (242)
T 3pu9_A           83 HDFLYAMR-----DG-------KVSAALDILSVDLASRSVLVTRNSEVPMLLGRNGEFEQISESGGRI  138 (242)
T ss_dssp             HHHHHHHT-----TT-------CCCEEEEEEEEETTTTEEEEEEESCCCEEEEETTEEEEECCCCCCB
T ss_pred             HHHHHhcc-----CC-------CcEEEEEEEEEECCCCEEEEEeCCCCcEEEEECCEEEEeCCCCccc
Confidence            77764332     11       248999999996  56899999999999999999999999999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=7.4e-07  Score=87.96  Aligned_cols=133  Identities=20%  Similarity=0.228  Sum_probs=93.8

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC---ccceeeeccc-cCCceEEEEEeccCC
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKFVAAHA-KPPNYMFFFEFYESR  146 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~g  146 (573)
                      ++.++.|....||+.   +..+++|+.  ........+.+|+.+|+.+.+.   .|++++.+.. ..+..++|||+++|.
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE---CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456788999999988   678899974  2334556789999999999642   3566666653 445678999999998


Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---------------------------------------------  181 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------------  181 (573)
                      .+.+..-.   .++.++...++.++...|+.||+.                                             
T Consensus        99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             ECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            87653211   234445555555555555555532                                             


Q ss_pred             ---------------CceeccCCCCceEEcC---CCCC-eEeeeecchh
Q 008220          182 ---------------GIVHRDVKPANVLLDR---NLCP-HLADFGLAEY  211 (573)
Q Consensus       182 ---------------~iiH~Dlkp~Nill~~---~~~~-kL~Dfg~a~~  211 (573)
                                     .++|+|++|.|||++.   ++.+ .|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           3599999999999987   4554 7999998753

>3f79_A Probable two-component response regulator; adaptor, signaling protein; 2.80A {Pseudomonas aeruginosa} PDB: 3es2_A

Probab=98.44  E-value=1.1e-06  Score=84.29  Aligned_cols=127  Identities=16%  Similarity=0.037  Sum_probs=78.7

Q ss_pred             cceEEEEeeccCCCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc----CC-CCChhHHHHHHH
Q 008220          428 VLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL----GS-TTRPTDALLEAF  502 (573)
Q Consensus       428 ~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~----~~-~~~~~~~l~~~~  502 (573)
                      .+.+++..... +...-|.+.+...   ..+..+++|+||+|+...|.+++..+...+...    .. .........+.+
T Consensus        37 ~~~~~~~~~p~-~~vgGD~yd~~~~---~~~~~~~~vaD~~GhG~~aa~~s~~~~~~~~~~~~~~~~~~~~~~~~p~~~l  112 (255)
T 3f79_A           37 GLEFSHRIIPS-LYLSGDFVDYFRV---DERRVAFYLADVSGHGASSAFVTVLLKFMTTRLLYESRRNGTLPEFKPSEVL  112 (255)
T ss_dssp             TEEEEEEEECS-SSSCSEEEEEEEE---TTTEEEEEEEEESSCSHHHHHHHHHHHHHHHHHHHHHTTCCC----CHHHHH
T ss_pred             CEEEEEEEeEh-hhcCceEEeEEEe---CCCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCHHHHH
Confidence            44555544443 5566788755443   245678999999997777777776555444321    10 111122355666


Q ss_pred             HHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccc-cceeEEeCCeeeeCCCCCCCC
Q 008220          503 IRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGD-CRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGD-SRa~l~~~~~~~~lt~dH~p~  571 (573)
                      ..+|+.+.+.      ..       .+|+|++++++.  .+.++++|+|| ++.|+.++|...+++.+|.|.
T Consensus       113 ~~ln~~l~~~------~~-------~~~~T~~~~~id~~~~~l~~~~aGh~p~~~l~~~g~~~~l~~~~~~l  171 (255)
T 3f79_A          113 AHINRGLINT------KL-------GKHVTMLGGVIDLEKNSLTYSIGGHLPLPVLFVEGQAGYLEGRGLPV  171 (255)
T ss_dssp             HHHHHHHBTT------BS-------SCCEEEEEEEEETTTTEEEEEECSCSCCCEEEC--CEEECCC-----
T ss_pred             HHHHHHHHhc------CC-------CCEEEEEEEEEECCCCEEEEEeCCCCCceEEEeCCeEEEeCCCCceE
Confidence            6777777431      11       259999999995  56899999999 569999999999999998773

>3zt9_A Serine phosphatase; hydrolase, signal transduction, protein protein interaction,; HET: PEG; 1.75A {Moorella thermoacetica}

Probab=98.32  E-value=1.1e-05  Score=73.48  Aligned_cols=116  Identities=12%  Similarity=0.077  Sum_probs=83.8

Q ss_pred             cceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcCCCCChhHHHHHHHHHHH
Q 008220          428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTD  506 (573)
Q Consensus       428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~~~~~~~~~l~~~~~~~~  506 (573)
                      .+.+|+.+.... +..+.|.|.+...    ++..+++|+||+|....|..++..+...+.+.. ..++    .+.+..+|
T Consensus         3 ~~~~~~~~~p~~~~~v~GD~y~~~~~----~~~~~~~v~Dv~GhG~~Aa~~s~~~~~~l~~~~-~~~p----~~il~~ln   73 (193)
T 3zt9_A            3 KLEVGIYTRAREGEIACGDACLVKRV----EGVIFLAVGDGIGHGPEAARAAEIAIASMESSM-NTGL----VNIFQLCH   73 (193)
T ss_dssp             CCCEEEEEECCTTCSSCSEEEEEEEE----TTEEEEEEEEESSSHHHHHHHHHHHHHHHHHHT-TSCH----HHHHHHHH
T ss_pred             ccEEEEEEeccCCCCCCCCeEEEEEe----CCEEEEEEEeCCCCCHHHHHHHHHHHHHHHHcc-cCCH----HHHHHHHH
Confidence            466777777765 6788999987543    456789999999977777777777777776542 2233    33444556


Q ss_pred             HHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEeCCeeeeCCCCC
Q 008220          507 VAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRVR  568 (573)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~~~~~~~lt~dH  568 (573)
                      +.+..                ..|.|++++.+.  .+.+.++|+|+++.|++|+|....+...+
T Consensus        74 ~~l~~----------------~~~~t~~~~~id~~~~~l~~~~aGh~~~~l~~~~~~~~l~~~~  121 (193)
T 3zt9_A           74 RELRG----------------TRGAVAALCRVDRRQGLWQAAIVGNIHVKILSAKGIITPLATP  121 (193)
T ss_dssp             HHHTT----------------SSCEEEEEEEEETTTTEEEEEEESSCEEEEEETTEEECCCCBC
T ss_pred             HHHhc----------------cCceEEEEEEEECCCCEEEEEecCCceEEEEcCCcEEEecCCC
Confidence            55521                138899888887  45899999999999999999877665443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.28  E-value=2.6e-06  Score=82.34  Aligned_cols=129  Identities=17%  Similarity=0.130  Sum_probs=92.5

Q ss_pred             ccccCce-EEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEeccCCChh
Q 008220           74 IARGAES-VVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLA  149 (573)
Q Consensus        74 lg~G~~g-~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  149 (573)
                      +..|..| .||+...  .+..+++|+...   .....+.+|...|+.+. +--+++++.++.+++..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3445555 6898765  356789997432   23456788999998884 334778888888889999999999998876


Q ss_pred             hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 008220          150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL------------------------------------------------  181 (573)
Q Consensus       150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------------  181 (573)
                      +.....     ......+..++...|..||..                                                
T Consensus       109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            654321     122334555666666666621                                                


Q ss_pred             ----------CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          182 ----------GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       182 ----------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                                .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      26899999999999987777799999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=7.6e-07  Score=89.92  Aligned_cols=80  Identities=9%  Similarity=0.074  Sum_probs=55.7

Q ss_pred             ccccc-cccCceEEEEEEEC--------CeeEEEeeccCCC---hHHHHHHHHHHHHHHhCC-C--CccceeeeccccC-
Q 008220           70 LLSPI-ARGAESVVYEATLD--------GRKVAVKKPILST---SEELDNFHKELQLLCKLD-H--PGLAKFVAAHAKP-  133 (573)
Q Consensus        70 ~~~~l-g~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~-  133 (573)
                      ..+.| +.|..+.+|+....        ++.+++|......   ......+.+|+.+++.|. +  -.+++++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            45677 88999999998754        6789999743221   001235678888888884 2  3577788776554 


Q ss_pred             --CceEEEEEeccCCChh
Q 008220          134 --PNYMFFFEFYESRNLA  149 (573)
Q Consensus       134 --~~~~lv~e~~~~g~L~  149 (573)
                        +..++|||+++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3578999999986654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.08  E-value=3.3e-05  Score=70.19  Aligned_cols=135  Identities=19%  Similarity=0.110  Sum_probs=93.1

Q ss_pred             ChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      +|.++|...+.+++++++|.+++|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ ..+.               
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence            7999999989899999999999999999887621 1212333456889999999877664 1110               


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHHHHh
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV  305 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (573)
                                   .....+.|||... ...+.+.=|+|||+++|..+--..|=.                          
T Consensus        98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~--------------------------  137 (229)
T 2yle_A           98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN--------------------------  137 (229)
T ss_dssp             ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------------
T ss_pred             -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc--------------------------
Confidence                         1123456787763 344678889999999999987333311                          


Q ss_pred             cCCCCCcccccccCChHHHHHHHHHhccC-------------------------CCCCCCCHHHHHH
Q 008220          306 SGGLRPILASLELGLPASILSLIQRCWDG-------------------------NPHNRPSFSDIAL  347 (573)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~-------------------------dP~~Rpt~~ell~  347 (573)
                                .+..+|++|.+||..|...                         .+..|+++.+|++
T Consensus       138 ----------eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          138 ----------EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ----------EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ----------cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                      2347899999999999865                         3468889998874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.07  E-value=1.5e-05  Score=79.63  Aligned_cols=136  Identities=13%  Similarity=0.142  Sum_probs=79.5

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC--CCccceeeec------cccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD--HPGLAKFVAA------HAKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~------~~~~~~~~lv~e~  142 (573)
                      ++.|+.|..+.||++...+..+++|+.... .   ..+..|+.+++.|.  .-.+++++..      ....+..+++++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEETTEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEeCCCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            345666778899999887777999986542 2   23445666666553  1234444431      1235678899999


Q ss_pred             ccCCChh--------------hhhhccC--C--C---------CCHHH-------------------------------H
Q 008220          143 YESRNLA--------------EKLHVEE--W--S---------PSVDQ-------------------------------V  164 (573)
Q Consensus       143 ~~~g~L~--------------~~l~~~~--~--~---------~~~~~-------------------------------~  164 (573)
                      ++|..+.              ..++...  .  .         ..+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986442              1122110  0  0         01110                               1


Q ss_pred             HHHHHHHHHHHHHHHh-------------CCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          165 LMIAAQLAKALQYLHN-------------LGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       165 ~~i~~qi~~~l~~LH~-------------~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                      ..+..++..++++|++             .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223345666652             579999999999999888889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.01  E-value=8e-06  Score=83.68  Aligned_cols=75  Identities=13%  Similarity=0.122  Sum_probs=49.6

Q ss_pred             ccccccccCceEEEEEEE--CCeeEEEeeccCCCh-------HHHHHHHHHHHHHHhCCC--C-ccceeeeccccCCceE
Q 008220           70 LLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------EELDNFHKELQLLCKLDH--P-GLAKFVAAHAKPPNYM  137 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~l~~~~~~~~~~~  137 (573)
                      -.+.||.|.++.||++..  .++.++||.......       ...+++..|.++|+.+..  | .+++++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            356789999999999954  567899996432111       123456778899888732  3 45566654  345578


Q ss_pred             EEEEeccCC
Q 008220          138 FFFEFYESR  146 (573)
Q Consensus       138 lv~e~~~~g  146 (573)
                      +|||++.+.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=5.6e-05  Score=77.95  Aligned_cols=74  Identities=9%  Similarity=0.142  Sum_probs=46.6

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeecc-----CCCh----HHHHHHHHHHHHHHh-CCCCccceeeeccccCCceEEE
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPI-----LSTS----EELDNFHKELQLLCK-LDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~-----~~~~----~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      -.+.||.|..+.||++...++.++||...     ....    .....+..|+..+.. .....+++++.+.  .+..++|
T Consensus        38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            35678999999999998777889999311     1110    122333444433322 2234677777765  5678999


Q ss_pred             EEec-cC
Q 008220          140 FEFY-ES  145 (573)
Q Consensus       140 ~e~~-~~  145 (573)
                      ||++ +|
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=9.7e-05  Score=72.59  Aligned_cols=76  Identities=13%  Similarity=0.050  Sum_probs=61.0

Q ss_pred             ccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC---CCccceeeeccccCCceEEEEEeccCC
Q 008220           70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~g  146 (573)
                      -.+.|+.|....+|+....+..+++|.....   ....+..|+..|+.|.   ...+++++.+....+..++|||+++|.
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            3567899999999999887888999975422   3566889999998883   367888888887778899999999987


Q ss_pred             Ch
Q 008220          147 NL  148 (573)
Q Consensus       147 ~L  148 (573)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.00025  Score=70.06  Aligned_cols=138  Identities=17%  Similarity=0.180  Sum_probs=78.4

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCC--ccceeeecc------ccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH------AKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~------~~~~~~~lv~e~  142 (573)
                      ++.|+.|....+|+....+..+++|.....  ...+.+..|+.+++.|...  .+++++...      ...+..++++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            456778888999999876668899975442  1223455788888777321  234444321      123567899999


Q ss_pred             ccCCChhh--------------hhhcc--CC--C----CC---HHHHHH------------HHHHHHHHHHHHHh-----
Q 008220          143 YESRNLAE--------------KLHVE--EW--S----PS---VDQVLM------------IAAQLAKALQYLHN-----  180 (573)
Q Consensus       143 ~~~g~L~~--------------~l~~~--~~--~----~~---~~~~~~------------i~~qi~~~l~~LH~-----  180 (573)
                      ++|..+..              .++..  ..  .    ..   +.....            +...+...++.+.+     
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            98854321              11211  10  0    01   111000            00113344455542     


Q ss_pred             --CCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          181 --LGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       181 --~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                        .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              368999999999999987666899999774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.36  E-value=0.00025  Score=68.94  Aligned_cols=80  Identities=15%  Similarity=0.107  Sum_probs=57.7

Q ss_pred             CCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC---CccceeeeccccCCceEEE
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH---PGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~~~~~~lv  139 (573)
                      .+.+..-++.+|.|..+.||+.+. +|+.|++|+...........+..|+..|+.|.-   -.+++++.+.    ..++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            345566778899999999999987 688999998554433334467889999998842   2355666542    34789


Q ss_pred             EEeccCCC
Q 008220          140 FEFYESRN  147 (573)
Q Consensus       140 ~e~~~~g~  147 (573)
                      ||++.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.20  E-value=0.00048  Score=70.98  Aligned_cols=72  Identities=18%  Similarity=0.171  Sum_probs=48.9

Q ss_pred             cccccccCceEEEEEEEC---------CeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++.|+.|....||++...         ++.+++|+......  .+.+..|+.+++.|. +.-.+++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            456788889999999864         46899998633221  134557999998885 3234677776643    3899


Q ss_pred             EeccCCCh
Q 008220          141 EFYESRNL  148 (573)
Q Consensus       141 e~~~~g~L  148 (573)
                      ||++|..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.17  E-value=0.00053  Score=67.07  Aligned_cols=71  Identities=15%  Similarity=0.216  Sum_probs=44.8

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcc-ceeeeccccCCceEEEEEec-cCCCh
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFY-ESRNL  148 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~g~L  148 (573)
                      ++.|+.|....+|++    ..+++|+..... ...-...+|+.+++.+...++ ++++...  +..-++++||+ +|..+
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            778989999999999    678888754321 111123468888877742222 5666654  33456899999 66444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.11  E-value=0.00074  Score=68.14  Aligned_cols=135  Identities=18%  Similarity=0.258  Sum_probs=81.6

Q ss_pred             cccccccCceEEEEEEEC---------CeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++.|.-|-...+|++...         ++.+++|+.. ........+.+|..+++.|. +.-.+++++.+.++    +|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g-~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG-AILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC-CccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence            345666888899998763         3689999742 22223455668999998884 33346777776542    899


Q ss_pred             EeccCCChhhh-----------------hhccC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 008220          141 EFYESRNLAEK-----------------LHVEE----WSPS--VDQVLMIAAQLAK-------------------ALQYL  178 (573)
Q Consensus       141 e~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~qi~~-------------------~l~~L  178 (573)
                      ||++|..|..-                 ++...    ....  +.++..++.++-.                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988554311                 12111    1122  3455555544322                   23333


Q ss_pred             H----h----CCceeccCCCCceEEcCC----CCCeEeeeecch
Q 008220          179 H----N----LGIVHRDVKPANVLLDRN----LCPHLADFGLAE  210 (573)
Q Consensus       179 H----~----~~iiH~Dlkp~Nill~~~----~~~kL~Dfg~a~  210 (573)
                      .    .    ..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    2    258999999999999876    789999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.05  E-value=0.00074  Score=67.02  Aligned_cols=136  Identities=15%  Similarity=0.122  Sum_probs=70.5

Q ss_pred             ccccccCceE-EEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCC--CCccceeeeccccCCceEEEEEeccCCC
Q 008220           72 SPIARGAESV-VYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPNYMFFFEFYESRN  147 (573)
Q Consensus        72 ~~lg~G~~g~-V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g~  147 (573)
                      +.|+.|.... +|+.... +..+++|.......   ..+..|+.+++.+.  .-.+++++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554444 6677653 66777876332211   23445777777663  234566776533332  78999987765


Q ss_pred             hhhhhhc---------------------cC----CCCCHHHHH-------H-HH------------HHHHHHHHHH----
Q 008220          148 LAEKLHV---------------------EE----WSPSVDQVL-------M-IA------------AQLAKALQYL----  178 (573)
Q Consensus       148 L~~~l~~---------------------~~----~~~~~~~~~-------~-i~------------~qi~~~l~~L----  178 (573)
                      +.+.+..                     ..    ..+......       . +.            ..+...++.+    
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            5433211                     00    011111110       0 00            0111222222    


Q ss_pred             --HhCCceeccCCCCceEEcCC----CCCeEeeeecchhh
Q 008220          179 --HNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEYR  212 (573)
Q Consensus       179 --H~~~iiH~Dlkp~Nill~~~----~~~kL~Dfg~a~~~  212 (573)
                        +...++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              23469999999999999874    67899999987543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.02  E-value=0.00087  Score=67.60  Aligned_cols=72  Identities=14%  Similarity=0.114  Sum_probs=43.9

Q ss_pred             cccccccCceEEEEEEECC----------eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc-cceeeeccccCCceEEE
Q 008220           71 LSPIARGAESVVYEATLDG----------RKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv  139 (573)
                      .+.|+.|....+|++...+          +.+++|+.... .........|..+++.+...+ ++++++.+.    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            4567788889999998754          68889874332 222112357888888874323 456666542    3689


Q ss_pred             EEeccCCC
Q 008220          140 FEFYESRN  147 (573)
Q Consensus       140 ~e~~~~g~  147 (573)
                      +||++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.81  E-value=0.0024  Score=66.17  Aligned_cols=73  Identities=18%  Similarity=0.176  Sum_probs=47.1

Q ss_pred             cccccccCceEEEEEEECC--eeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcc-ceeeeccccCCceEEEEEeccCCC
Q 008220           71 LSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFYESRN  147 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~  147 (573)
                      ++.|+.|-...+|++...+  ..+++|+......... ....|+.+++.|...++ +++++++..    .+|+||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4567788889999998865  8899997532211111 12478999998864444 667777632    25999998744


Q ss_pred             h
Q 008220          148 L  148 (573)
Q Consensus       148 L  148 (573)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.60  E-value=0.0078  Score=59.30  Aligned_cols=135  Identities=21%  Similarity=0.231  Sum_probs=77.0

Q ss_pred             ccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC--Cccceeeec-----cccCCceEEEEEec
Q 008220           72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAA-----HAKPPNYMFFFEFY  143 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~-----~~~~~~~~lv~e~~  143 (573)
                      ..|+ |....||++.. +|+.+++|...... .....+..|..+++.|..  -.+++++..     ....+..+++++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3456 88889999875 45679999864221 123456678888887742  224555443     11234567899999


Q ss_pred             cCCChhh--------------hhhcc--C------CCCCHHHH----------------------HHHHHHHHHHHHHH-
Q 008220          144 ESRNLAE--------------KLHVE--E------WSPSVDQV----------------------LMIAAQLAKALQYL-  178 (573)
Q Consensus       144 ~~g~L~~--------------~l~~~--~------~~~~~~~~----------------------~~i~~qi~~~l~~L-  178 (573)
                      +|..+..              .++..  .      ...+....                      ...+.+++..+..+ 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754320              01110  0      01111110                      11112222222222 


Q ss_pred             ---HhCCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          179 ---HNLGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       179 ---H~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                         ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence               223589999999999998 4 78999999764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.52  E-value=0.0061  Score=60.57  Aligned_cols=68  Identities=10%  Similarity=0.082  Sum_probs=43.4

Q ss_pred             cccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC---CCccceeeecc------ccCCceEEEEEeccC
Q 008220           75 ARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAAH------AKPPNYMFFFEFYES  145 (573)
Q Consensus        75 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~------~~~~~~~lv~e~~~~  145 (573)
                      |.|....||+....+..+++|+......      ..|+.+++.|.   -|++++.+...      ...+..+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESKSYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSCEEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCCCEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444789999986545899997544331      35666666662   23355555431      234668899999998


Q ss_pred             CCh
Q 008220          146 RNL  148 (573)
Q Consensus       146 g~L  148 (573)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>3ke6_A Protein RV1364C/MT1410; anti-sigma factor, anti-sigma factor antagonist, phosphatase serine kinase, ATPase, unknown function; 2.60A {Mycobacterium tuberculosis}

Probab=96.11  E-value=0.032  Score=56.64  Aligned_cols=120  Identities=11%  Similarity=-0.024  Sum_probs=72.4

Q ss_pred             cceEEEEeeccC--CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-CCCChhHHHHHHHHH
Q 008220          428 VLSWGSFATCGR--RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFIR  504 (573)
Q Consensus       428 ~~~~~~~s~~G~--R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-~~~~~~~~l~~~~~~  504 (573)
                      .+.++.......  ...-=|.|.+...    ++..+++|+|++|....|.+++..+...+.... ...++.    +.+..
T Consensus        35 ~~~~~~~y~P~~~~~~vgGD~y~~~~~----~~~~~~~v~Dv~GhGv~AA~~~~~~~~~l~~~~~~~~~p~----~il~~  106 (399)
T 3ke6_A           35 GADIAAEYLVAAEDTAAGGDWFDALAL----GDRLVLVVGDVVGHGVEAAAVMSQLRTALRMQISAGYTVV----EALEA  106 (399)
T ss_dssp             TEEEEEEEECSSSSCSCCSEEEEEEEC----SSEEEEEEEECSSCSHHHHHHHHHHHHHHHHHHHTTCCHH----HHHHH
T ss_pred             CeEEEEEEEECCCCCCCCCceEEEEEE----CCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHhcCCCHH----HHHHH
Confidence            445555544443  2344688776554    236788999999844444444444444443321 112233    33344


Q ss_pred             HHHHHHHHHHHhhhhhhccCCccCccceeEEEEEE--CCeEEEEEccccceeEEe-CCeeeeCCCCC
Q 008220          505 TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCR-GGHPFALSRVR  568 (573)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSRa~l~~-~~~~~~lt~dH  568 (573)
                      +|. +....     ..       ..++|++++.+.  .+.+.++|+|..+.|+++ +|....+..++
T Consensus       107 ln~-~~~~~-----~~-------~~~~t~~~~~id~~~~~l~~~~aGh~~~~l~~~~g~~~~l~~~~  160 (399)
T 3ke6_A          107 VDR-FHKQV-----PG-------SKSATMCVGSLDFTSGEFQYCTAGHPPPLLVTADASARYVEPTG  160 (399)
T ss_dssp             HHH-HGGGS-----TT-------CTTCEEEEEEEETTTCEEEEEEESSCCCEEECTTSCEEECCCCS
T ss_pred             HHH-HHHhc-----CC-------CcEEEEEEEEEECCCCEEEEECCCCChhEEEeCCCCEEEeecCC
Confidence            454 22111     11       248999999886  468999999999999998 77777887665

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.08  E-value=0.0067  Score=62.00  Aligned_cols=73  Identities=12%  Similarity=0.097  Sum_probs=47.8

Q ss_pred             cccccccCceEEEEEEEC---------CeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++.|..|-...+|++...         ++.+++++..... ...-...+|..+++.|. +.-.+++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456777888899999875         5789999843322 11112347888888874 333456666442    27899


Q ss_pred             EeccCCCh
Q 008220          141 EFYESRNL  148 (573)
Q Consensus       141 e~~~~g~L  148 (573)
                      +|++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.58  E-value=0.015  Score=59.21  Aligned_cols=29  Identities=31%  Similarity=0.521  Sum_probs=24.8

Q ss_pred             ceeccCCCCceEE------cCCCCCeEeeeecchh
Q 008220          183 IVHRDVKPANVLL------DRNLCPHLADFGLAEY  211 (573)
Q Consensus       183 iiH~Dlkp~Nill------~~~~~~kL~Dfg~a~~  211 (573)
                      ++|+|+.+.|||+      +.+..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567799999998853

>3eq2_A Probable two-component response regulator; adaptor sigmas, signaling protein; 3.40A {Pseudomonas aeruginosa} PDB: 3f7a_A

Probab=86.99  E-value=5.1  Score=39.99  Aligned_cols=111  Identities=16%  Similarity=0.070  Sum_probs=61.9

Q ss_pred             ceeEEecccCCCCCceEEEEEEcCCC-cHHHHH---HHHHHhHHHHHhcCCC-CChhHHHHHHHHHHHHHHHHHHHHhhh
Q 008220          444 EDTHFLMPHMYNQKEIHMFGIFDGHR-GSAAAE---FSARALPGFLQNLGST-TRPTDALLEAFIRTDVAFRNELDSLRK  518 (573)
Q Consensus       444 eD~~~~~~~~~~~~~~~~~~V~DGhg-G~~a~~---~~~~~l~~~l~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~  518 (573)
                      =|.|.+...   ..+..+++|.|+.| |-.||-   .+...+...+...... ........+.+..+|..+...      
T Consensus       191 GD~yd~~~~---~~~~~~~~i~Dv~GhGv~aa~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~l~~ln~~l~~~------  261 (394)
T 3eq2_A          191 GDFVDYFRV---DERRVAFYLADVSGHGASSAFVTVLLKFMTTRLLYESRRNGTLPEFKPSEVLAHINRGLINT------  261 (394)
T ss_dssp             CCEEECCEE---TTTEEEEEEEEESSCSTTTHHHHHHHHHHHHHHHHHSCSSCSSSSCCHHHHHHHHHHHHHHT------
T ss_pred             ccEEeEEEe---CCCcEEEEEEECCCCChHHHHHHHHHHHHHHHHHHhhhccCCcccCCHHHHHHHHHHHHhcc------
Confidence            466655332   24457889999776 443333   2333333343332110 000111334455666666421      


Q ss_pred             hhhccCCccCccceeEEEEEE--CCeEEEEEccccc-eeEEeCCeeeeCCCCCCC
Q 008220          519 SKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCR-AILCRGGHPFALSRVRQE  570 (573)
Q Consensus       519 ~~~~~~~~~~~GtT~~~~~i~--~~~l~vanvGDSR-a~l~~~~~~~~lt~dH~p  570 (573)
                      ..       ....|++++++.  .+.+.++|+|-.- .++.++|....|....-|
T Consensus       262 ~~-------~~~~t~~~~~~d~~~~~l~~~~aGh~p~~~~~~~g~~~~l~~~~~p  309 (394)
T 3eq2_A          262 KL-------GKHVTMLGGVIDLEKNSLTYSIGGHLPLPVLFVEGQAGYLEGRGLP  309 (394)
T ss_dssp             TC-------CCCEEEEEEEEETTTTEEEEEECSSSCCCEEEETTEEEECCCC--C
T ss_pred             Cc-------CcEEEEEEEEEECCCCEEEEEcCCCCCCcEEecCCceEecCCCCce
Confidence            11       237899999886  4589999999854 677788988877765544

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.58  E-value=2.8  Score=37.84  Aligned_cols=84  Identities=11%  Similarity=0.114  Sum_probs=57.4

Q ss_pred             CCCccceeeeccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC
Q 008220          119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN  198 (573)
Q Consensus       119 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~  198 (573)
                      .||+++.. .+-.+.+.+.+.++.-.  +...+-.-.  ..+....++++.+|+....+++  .=+|--|.|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK--SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG--GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH--hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence            67888866 45455565555555433  222222111  4567888999999988774443  34778899999999999


Q ss_pred             CCCeEeeeecc
Q 008220          199 LCPHLADFGLA  209 (573)
Q Consensus       199 ~~~kL~Dfg~a  209 (573)
                      +.+++.=.|+-
T Consensus       116 ~~p~i~~RGik  126 (215)
T 4ann_A          116 GLPIAKTRGLQ  126 (215)
T ss_dssp             SCEEESCCEET
T ss_pred             CCEEEEEccCc
Confidence            99999988863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	573
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-26
d1a6qa2	295	d.219.1.1 (A:2-296) Protein serine/threonine phosp	1e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1txoa_	235	d.219.1.1 (A:) putative serine/threonine phosphata	5e-12

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 6e-64
 Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 34/298 (11%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
           +P    T+   I  G+   VY+    G  VAVK       T ++L  F  E+ +L K  H
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
             +  F+     P   +   ++ E  +L   LH+ E    + +++ IA Q A+ + YLH 
Sbjct: 64  VNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             I+HRD+K  N+ L  +L   + DFGLA                  + +G    + + G
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------------TVKSRWSGSHQFEQLSG 168

Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
           ++++MAPE+++   K  +S +SDVY+FGI + EL+TG +PY+++                
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 215

Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
            Q+   V  G L P L+ +    P ++  L+  C       RP F  I   ++L+   
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 9e-54
 Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 42/296 (14%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
           L      LL  I +G    V      G KVAVK   +        F  E  ++ +L H  
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 61

Query: 123 LAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
           L + +    +    ++   E+    +L + L     S    D +L  +  + +A++YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              VHRD+   NVL+  +    ++DFGL +   +                    +     
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-------------------TQDTGKL 162

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE L+++  S KSDV+SFGI + E+ + G VPY  +                + 
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PLKD 208

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +   V  G           G P ++  +++ CW  +   RPSF  +  +L+ +  H
Sbjct: 209 VVPRVEKGYKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (456), Expect = 1e-52
 Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 36/305 (11%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSE-ELDNFHKELQLLC 116
           +  S   +   I  G    V    L         VA+K      +E +  +F  E  ++ 
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           + DHP +        K    M   EF E+ +L   L   +   +V Q++ +   +A  ++
Sbjct: 83  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YL ++  VHRD+   N+L++ NL   ++DFGL+           +               
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-----------RFLEDDTSDPTYTSAL 191

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
                + + APE ++    +  SDV+S+GI + E+++ G  PY D+              
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------------- 237

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           T Q +  A+      P      +  P+++  L+  CW  + ++RP F  I   LD ++ +
Sbjct: 238 TNQDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293

Query: 356 RKSLK 360
             SLK
Sbjct: 294 PNSLK 298

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-52
 Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 39/289 (13%)

Query: 64  PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   + ++  +  GA   VY+A         A K     + EEL+++  E+ +L   DHP
Sbjct: 10  PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 69

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            + K + A     N     EF     +   +   E   +  Q+ ++  Q   AL YLH+ 
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            I+HRD+K  N+L   +    LADFG++                         + + +GT
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAK----------------NTRTIQRRDSFIGT 173

Query: 242 LIYMAPEIL-----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
             +MAPE++     K   +  K+DV+S GI++ E+     P+ +L               
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--------------N 219

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             ++   +       +  +      ++    +++C + N   R + S +
Sbjct: 220 PMRVLLKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 38/291 (13%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  +  L+  +  G    V+        KVAVK  +   S   D F  E  L+ +L H 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQ 68

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
            L +  A   + P Y+   E+ E+ +L + L        +++++L +AAQ+A+ + ++  
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
              +HRD++ AN+L+   L   +ADFGLA   E                     ++    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE---------------DNEYTAREGAKF 172

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
            + + APE +     + KSDV+SFGI + E++T G +PY  +        +         
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------- 225

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
                   G R +        P  +  L++ CW   P +RP+F  +   L+
Sbjct: 226 --------GYRMVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 61/284 (21%), Positives = 118/284 (41%), Gaps = 36/284 (12%)

Query: 64  PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           P   YT    I +GA   VY A     G++VA+++  L    + +    E+ ++ +  +P
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            +  ++ ++          E+    +L + +   E      Q+  +  +  +AL++LH+ 
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+K  N+LL  +    L DFG         +I+ +  + S           MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 179

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
             +MAPE++ ++ +  K D++S GI   E++ G  PY +                  +  
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------------ENPLRAL 225

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             + + G   +       L A     + RC D +   R S  ++
Sbjct: 226 YLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-50
 Identities = 61/293 (20%), Positives = 118/293 (40%), Gaps = 34/293 (11%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           + PS  T +  I  G   +V+     +  KVA+K  I   +   ++F +E +++ KL HP
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 60

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +      +       FEF E   L++ L  +    + + +L +   + + + YL   
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
            ++HRD+   N L+  N    ++DFG+  +  +                           
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---------------DQYTSSTGTKFP 165

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           + + +PE+     +S KSDV+SFG+ + E+ +      + R+ ++               
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------V 211

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
              +S G R     L       +  ++  CW   P +RP+FS +  +L  + E
Sbjct: 212 VEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-50
 Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 43/283 (15%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           + +  P+ +G    VY A        +A+K   K  L  +       +E+++   L HP 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +               E+     +  +L  +       +      +LA AL Y H+  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKR 126

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           ++HRD+KP N+LL       +ADFG +                         +  + GTL
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWS------------------VHAPSSRRTTLCGTL 168

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+ PE+++  +H EK D++S G+   E L G  P+     +     +  + +T      
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-- 226

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                            +      LI R    NP  RP   ++
Sbjct: 227 -----------------VTEGARDLISRLLKHNPSQRPMLREV 252

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-50
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 34/289 (11%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
           +P  S  L   + +G    V+  T     +VA+K  +   +   + F +E Q++ KL H 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 72

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L +  A  ++ P Y+      +   L            + Q++ +AAQ+A  + Y+  +
Sbjct: 73  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
             VHRD++ AN+L+  NL   +ADFGLA   E                     ++     
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIE---------------DNEYTARQGAKFP 177

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
           + + APE       + KSDV+SFGI + EL T                        +++ 
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------------GMVNREVL 224

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
             V  G   P         P S+  L+ +CW   P  RP+F  +   L+
Sbjct: 225 DQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 5e-50
 Identities = 65/309 (21%), Positives = 120/309 (38%), Gaps = 36/309 (11%)

Query: 67  SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF 126
           +  L   I +G    V+     G +VAVK    S  E       E+     L H  +  F
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWRGEEVAVKI-FSSREERSWFREAEIYQTVMLRHENILGF 62

Query: 127 VAA----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--- 179
           +AA    +          +++E  +L + L+   ++ +V+ ++ +A   A  L +LH   
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 180 -----NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
                   I HRD+K  N+L+ +N    +AD G            L     S   T    
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG------------LAVRHDSATDTIDIA 168

Query: 235 KKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTGVVPY-TDLRAEAQA 287
             + VGT  YMAPE+L   I+       +++D+Y+ G+   E+             +   
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS--ILSLIQRCWDGNPHNRPSFSDI 345
           + ++  + + +++   V    LRP + +      A   +  +++ CW  N   R +   I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 346 ALELDLVLE 354
              L  + +
Sbjct: 289 KKTLSQLSQ 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 59/283 (20%), Positives = 102/283 (36%), Gaps = 36/283 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
           P   T L  +  G   VV          VA+K  I   S   D F +E +++  L H  L
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            +      K        E+  +  L   L          Q+L +   + +A++YL +   
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+   N L++      ++DFGL+ Y  +                           + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---------------DEYTSSVGSKFPVR 166

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           +  PE+L     S KSD+++FG+ + E+ + G +PY        A  + +          
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------- 216

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                GLR     L       + +++  CW      RP+F  +
Sbjct: 217 -----GLRLYRPHL---ASEKVYTIMYSCWHEKADERPTFKIL 251

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-49
 Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 37/305 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG------RKVAVKK-PILSTSEELDNFHKELQLL 115
           + PS  T    I  G    VY+  L          VA+K      T ++  +F  E  ++
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
            +  H  + +     +K    M   E+ E+  L + L  ++   SV Q++ +   +A  +
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +YL N+  VHRD+   N+L++ NL   ++DFGL+   E+              P   +  
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------------DPEATYTT 170

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
                 + + APE +     +  SDV+SFGI + E++T                      
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------YWEL 217

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +  ++  A+  G   P      +  P++I  L+ +CW      RP F+DI   LD ++  
Sbjct: 218 SNHEVMKAINDGFRLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

Query: 356 RKSLK 360
             SLK
Sbjct: 274 PDSLK 278

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (431), Expect = 5e-49
 Identities = 64/309 (20%), Positives = 109/309 (35%), Gaps = 47/309 (15%)

Query: 64  PPSSYTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKL 118
           P   ++ L  I  G+   VY A    +   VA+K        ++E+  +  KE++ L KL
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
            HP   ++   + +        E+             +      ++  +     + L YL
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H+  ++HRDVK  N+LL       L DFG A                           + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------------------ANSF 171

Query: 239 VGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           VGT  +MAPE++    +  +  K DV+S GI+  EL     P  ++ A +  + + +   
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
              Q                          + +  C    P +RP+   + L+   VL  
Sbjct: 232 PALQ-----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVL-LKHRFVLRE 273

Query: 356 RKSLKEEDL 364
           R      DL
Sbjct: 274 RPPTVIMDL 282

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (433), Expect = 8e-49
 Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 36/282 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   +  GA  VV+  T    G   A K  +     + +   KE+Q +  L HP L  
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +  +EF     L EK+  E    S D+ +    Q+ K L ++H    VH
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 147

Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++          L DFGL  + +                      K   GT  
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLD-----------------PKQSVKVTTGTAE 190

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           + APE+ + +     +D++S G+    LL+G+ P+     +     V   ++        
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-------- 242

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                   +  S   G+       I++    +P+ R +    
Sbjct: 243 -------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-48
 Identities = 63/314 (20%), Positives = 114/314 (36%), Gaps = 48/314 (15%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEEL-DNFHKELQLLCK 117
           + L    +  +S +  G   VV++ +    G  +A K   L     + +   +ELQ+L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
            + P +  F  A           E  +  +L + L  +        +  ++  + K L Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTY 119

Query: 178 LHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           L     I+HRDVKP+N+L++      L DFG++    +                      
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------------AN 161

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY------------------ 278
           + VGT  YM+PE L+   +S +SD++S G+S+ E+  G  P                   
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 279 --TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRC 331
              +     +       +Y         +   L  I+      LP+ + S      + +C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 332 WDGNPHNRPSFSDI 345
              NP  R     +
Sbjct: 282 LIKNPAERADLKQL 295

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (429), Expect = 3e-48
 Identities = 54/282 (19%), Positives = 95/282 (33%), Gaps = 36/282 (12%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +L  +  GA  VV+       GR    K        +      E+ ++ +L HP L  
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              A       +   EF     L +++  E++  S  +V+    Q  + L+++H   IVH
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 150

Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D+KP N++ +        + DFGLA                          K    T  
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP-----------------DEIVKVTTATAE 193

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           + APEI+ +E     +D+++ G+    LL+G+ P+           V   ++        
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-------- 245

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                           +       I+      P  R +  D 
Sbjct: 246 -------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-47
 Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 39/302 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEEL-DNFHKELQLLC 116
           +      L   I  G    V++            VA+K     TS+ + + F +E   + 
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
           + DHP + K +    + P ++   E      L   L V ++S  +  +++ A QL+ AL 
Sbjct: 64  QFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           YL +   VHRD+   NVL+  N C  L DFGL+ Y E                +  +   
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---------------DSTYYKAS 167

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
                + +MAPE +     +  SDV+ FG+ + E+L   V                    
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------------GVK 214

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
              +   + +G   P+        P ++ SL+ +CW  +P  RP F+++  +L  +LE  
Sbjct: 215 NNDVIGRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

Query: 357 KS 358
           K+
Sbjct: 271 KA 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-47
 Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 45/301 (14%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           + L+  +  GA   V  A        VAVK   +    +  +N  KE+ +   L+H  + 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           KF     +      F E+     L +++   +             QL   + YLH +GI 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+LLD      ++DFGLA          L N               M GTL Y
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--------------KMCGTLPY 171

Query: 245 MAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           +APE+LK +E H+E  DV+S GI +  +L G +P+       Q ++  +           
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------- 222

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLK 360
                      +    + ++ L+L+ +    NP  R +  DI        +     K LK
Sbjct: 223 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDI-------KKDRWYNKPLK 268

Query: 361 E 361
           +
Sbjct: 269 K 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 71/303 (23%), Positives = 125/303 (41%), Gaps = 37/303 (12%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
           +  +  T+   +  G    VYE         VAVK  +   + E++ F KE  ++ ++ H
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKH 72

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
           P L + +    + P +    EF    NL + L        S   +L +A Q++ A++YL 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
               +HRD+   N L+  N    +ADFGL+         +                    
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---------------HAGAK 177

Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
             + + APE L     S KSDV++FG+ + E+ T  +        +Q + +LE +Y  ++
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237

Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
                              G P  +  L++ CW  NP +RPSF++I    + + +   S+
Sbjct: 238 PE-----------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE-SSI 279

Query: 360 KEE 362
            +E
Sbjct: 280 SDE 282

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-47
 Identities = 70/292 (23%), Positives = 113/292 (38%), Gaps = 48/292 (16%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGL 123
           Y +L  I  G+     +     DG+ +  K       T  E      E+ LL +L HP +
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 124 AKFVAAHAKPPNYMFF--FEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYL 178
            ++        N   +   E+ E  +LA  +     E      + VL +  QL  AL+  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 179 HNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
           H        ++HRD+KPANV LD      L DFGLA           +           F
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-----------RILNHDTSFAKAF 174

Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
                  T  YM+PE + +  ++EKSD++S G  + EL   + P+T              
Sbjct: 175 VG-----TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------------- 216

Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
            +++++L   +  G  R I           +  +I R  +   ++RPS  +I
Sbjct: 217 -FSQKELAGKIREGKFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 40/296 (13%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVK---KPILSTSEELDNFHKELQL 114
           +      LL  +  G+  VV     D        VAVK     +LS  E +D+F +E+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           +  LDH  L +       PP  M   E     +L ++L   +    +  +   A Q+A+ 
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           + YL +   +HRD+   N+LL       + DFGL                          
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-------------LPQNDDHYVM 170

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
           +++      + APE LK    S  SD + FG+++ E+ T G  P+  L            
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------------ 218

Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                Q+   +   G R          P  I +++ +CW   P +RP+F  +   L
Sbjct: 219 --NGSQILHKIDKEGERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 8e-47
 Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 64/326 (19%)

Query: 61  LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEEL-DNFHKEL 112
           L  P ++   +  I  GA   V++A             VAVK      S ++  +F +E 
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67

Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH------------------- 153
            L+ + D+P + K +   A        FE+    +L E L                    
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 154 ----VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
                     S  + L IA Q+A  + YL     VHRD+   N L+  N+   +ADFGL+
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269
                         R+           N    + +M PE +    ++ +SDV+++G+ + 
Sbjct: 188 --------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233

Query: 270 ELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI 328
           E+ + G+ PY  +                +++   V  G +     +     P  + +L+
Sbjct: 234 EIFSYGLQPYYGM--------------AHEEVIYYVRDGNILACPEN----CPLELYNLM 275

Query: 329 QRCWDGNPHNRPSFSDIALELDLVLE 354
           + CW   P +RPSF  I   L  + E
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRMCE 301

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  163 bits (413), Expect = 1e-46
 Identities = 59/302 (19%), Positives = 106/302 (35%), Gaps = 29/302 (9%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   I  G+  V++E T  L+ ++VA+K        +      E +    L       
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
            V    +   +          +L + L +     SV  V M A Q+   +Q +H   +V+
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 186 RDVKPANVLLDRNLCPH-----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
           RD+KP N L+ R    +     + DFG+ ++  +           + +      KKN+ G
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD---------PVTKQHIPYREKKNLSG 175

Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
           T  YM+         S + D+ + G      L G +P+  L+A         +   +Q  
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233

Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
                       L  L  G P      +    +      P +  +      VLE   + +
Sbjct: 234 ---------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284

Query: 361 EE 362
           +E
Sbjct: 285 DE 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-46
 Identities = 55/282 (19%), Positives = 103/282 (36%), Gaps = 38/282 (13%)

Query: 74  IARGAESVVYEATL----DGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
           +  G    V +           VA+K     +   + +   +E Q++ +LD+P + + + 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
              +    M   E      L + L  +     V  V  +  Q++  ++YL     VHRD+
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
              NVLL       ++DFGL++                   +    +      L + APE
Sbjct: 136 AARNVLLVNRHYAKISDFGLSK-------------ALGADDSYYTARSAGKWPLKWYAPE 182

Query: 249 ILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307
            +     S +SDV+S+G+++ E L+ G  PY  +                 ++ A +  G
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------------KGPEVMAFIEQG 228

Query: 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
                        P  + +L+  CW     +RP F  +   +
Sbjct: 229 KRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-46
 Identities = 57/301 (18%), Positives = 112/301 (37%), Gaps = 40/301 (13%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQL 114
           P    P  +     +  G+ S V  A      R+ A+K   K  +    ++    +E  +
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           + +LDHP   K            F   + ++  L + +  +  S          A++  A
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA 120

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L+YLH  GI+HRD+KP N+LL+ ++   + DFG A              +     +    
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA--------------KVLSPESKQAR 166

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
             + VGT  Y++PE+L ++   + SD+++ G  I +L+ G+ P+           ++++ 
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226

Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
           Y                               L+++    +   R    ++      +  
Sbjct: 227 Y-------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEM-EGYGPLKA 266

Query: 355 H 355
           H
Sbjct: 267 H 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-46
 Identities = 71/320 (22%), Positives = 114/320 (35%), Gaps = 63/320 (19%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
            P  +      +  GA   V  AT           +VAVK     + S E +    EL++
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD----------- 162
           + +L  H  +   + A          FE+    +L   L  +    S D           
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 163 -----------QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
                       +L  A Q+AK +++L     VHRD+   NVL+       + DFGLA  
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-- 211

Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
                       R     +    + N    + +MAPE L + I++ KSDV+S+GI + E+
Sbjct: 212 ------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259

Query: 272 LT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQR 330
            + GV PY  +                      ++  G +             I  ++Q 
Sbjct: 260 FSLGVNPYPGI--------------PVDANFYKLIQNGFKM---DQPFYATEEIYIIMQS 302

Query: 331 CWDGNPHNRPSFSDIALELD 350
           CW  +   RPSF ++   L 
Sbjct: 303 CWAFDSRKRPSFPNLTSFLG 322

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 8e-46
 Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 57/334 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATLDG----RKVAVKK-PILSTSEELDNFHKELQLLCK 117
           L  +       I  G    V +A +         A+K+    ++ ++  +F  EL++LCK
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 118 L-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---------------SV 161
           L  HP +   + A           E+    NL + L                      S 
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
            Q+L  AA +A+ + YL     +HRD+   N+L+  N    +ADFGL+  +E        
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------- 179

Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
                        K      + +MA E L   +++  SDV+S+G+ + E+++ G  PY  
Sbjct: 180 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229

Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
           +              T  +L   +  G          L     +  L+++CW   P+ RP
Sbjct: 230 M--------------TCAELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERP 271

Query: 341 SFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
           SF+ I + L+ +LE RK+     L    +Y   D
Sbjct: 272 SFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 8e-46
 Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 40/283 (14%)

Query: 74  IARGAESVVYEATL----DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           +  G    V +         + VAVK  K   +     D    E  ++ +LD+P + + +
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
               +  ++M   E  E   L + L  +        ++ +  Q++  ++YL     VHRD
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132

Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
           +   NVLL       ++DFGL++                        + +    + + AP
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKA-------------LRADENYYKAQTHGKWPVKWYAP 179

Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
           E +     S KSDV+SFG+ + E  + G  PY  +                 ++TA +  
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------------KGSEVTAMLEK 225

Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
           G      A    G P  +  L+  CW  +  NRP F+ + L L
Sbjct: 226 GERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 2e-45
 Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 27/283 (9%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y L   I  G+   +Y  T    G +VA+K  +     +    H E ++   +       
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
            +       +Y          +L +  +      S+  VL++A Q+   ++Y+H+   +H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 186 RDVKPANVL---LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           RDVKP N L     +    ++ DFGLA+   +           + +       KN+ GT 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD---------ARTHQHIPYRENKNLTGTA 177

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y +         S + D+ S G  +     G +P+  L+A  +      ++  +     
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 232

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                 +   +  L  G P+   + +  C      ++P +S +
Sbjct: 233 ------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-44
 Identities = 64/289 (22%), Positives = 105/289 (36%), Gaps = 47/289 (16%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKK--PILSTSEELDNFHKELQLLCKLDHPGL 123
                 I RG+   VY+        +VA  +      T  E   F +E ++L  L HP +
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 124 AKFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            +F  +           +   E   S  L   L        +  +     Q+ K LQ+LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 180 NLG--IVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
                I+HRD+K  N+ +        + D GLA  +                       K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------------------ASFAK 171

Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
            ++GT  +MAPE+ +++ + E  DVY+FG+ + E+ T   PY++                
Sbjct: 172 AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSE-------------CQN 217

Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             Q+   V SG       S +      +  +I+ C   N   R S  D+
Sbjct: 218 AAQIYRRVTSGVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-44
 Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 41/296 (13%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEE-LDNFHKELQLL 115
           L  + +  +  +  GA   VY+             VA+K+   +TS +       E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
             +D+P + + +         +   +      L + +   + +     +L    Q+AK +
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
            YL +  +VHRD+   NVL+       + DFGLA              +  G     +H 
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGAEEKEYHA 170

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294
           +     + +MA E +   I++ +SDV+S+G+++ EL+T G  PY                
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------------- 216

Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
               ++++ +  G   P            +  ++ +CW  +  +RP F ++ +E  
Sbjct: 217 IPASEISSILEKGERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 6e-44
 Identities = 45/282 (15%), Positives = 101/282 (35%), Gaps = 37/282 (13%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y +   + RG   +V+        +    K  +     +     KE+ +L    H  +  
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILH 65

Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
              +       +  FEF    ++ E+++   +  +  +++    Q+ +ALQ+LH+  I H
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
            D++P N++          + +FG A   +                  G + + +     
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP-----------------GDNFRLLFTAPE 168

Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
           Y APE+ + ++ S  +D++S G  +  LL+G+ P+     +     ++   YT       
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------- 221

Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                           +    +  + R       +R + S+ 
Sbjct: 222 --------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 40/306 (13%)

Query: 74  IARGAESVVYEATLD-----GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
           I RG    VY  TL          AVK    ++   E+  F  E  ++    HP +   +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 128 AAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
               +          + +  +L   +  E  +P+V  ++    Q+AK +++L +   VHR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
           D+   N +LD      +ADFGLA                  +     +K      + +MA
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLA------------RDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
            E L+ +  + KSDV+SFG+ + EL+T G  PY D+        +L+             
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLC 365
             G R +        P  +  ++ +CW      RPSFS++   +  +      + E  + 
Sbjct: 250 --GRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS--TFIGEHYVH 302

Query: 366 AGKSYV 371
              +YV
Sbjct: 303 VNATYV 308

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-43
 Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 42/287 (14%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLL-CKLDHP 121
           + L   + +G+   V+ A      +  A+K   K ++   ++++    E ++L    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
            L           N  F  E+    +L   +        + +    AA++   LQ+LH+ 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           GIV+RD+K  N+LLD++    +ADFG+ +                    G        GT
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENM----------------LGDAKTNTFCGT 166

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
             Y+APEIL  + ++   D +SFG+ + E+L G  P+     E   H++   N    +  
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR-- 224

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
                             L      L+ + +   P  R        +
Sbjct: 225 -----------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-42
 Identities = 64/314 (20%), Positives = 115/314 (36%), Gaps = 56/314 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
            P +  +    +  GA   V EAT            VAVK     +   E +    EL++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-----------------VEE 156
           L  L +H  +   + A       +   E+    +L   L                   +E
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
            +  ++ +L  + Q+AK + +L +   +HRD+   N+LL       + DFGLA   +N  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
              +K                    + +MAPE +   +++ +SDV+S+GI + EL +   
Sbjct: 200 NYVVKGN--------------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
                                      ++  G R +        PA +  +++ CWD +P
Sbjct: 246 SP-------------YPGMPVDSKFYKMIKEGFRMLSPE---HAPAEMYDIMKTCWDADP 289

Query: 337 HNRPSFSDIALELD 350
             RP+F  I   ++
Sbjct: 290 LKRPTFKQIVQLIE 303

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (381), Expect = 3e-42
 Identities = 70/292 (23%), Positives = 115/292 (39%), Gaps = 39/292 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           Y L   +  G  S V+ A      R VAVK     +         F +E Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 123 LAK----FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
           +        A     P      E+ +   L + +H  E   +  + + + A   +AL + 
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFS 127

Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
           H  GI+HRDVKPAN+++       + DFG+A                +           +
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------RAIADSGNSVTQTAAV 174

Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
           +GT  Y++PE  + +    +SDVYS G  + E+LTG  P+T                +  
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------------DSPV 220

Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALEL 349
            +    V     P  A  E GL A + +++ +    NP NR  + +++  +L
Sbjct: 221 SVAYQHVREDPIPPSARHE-GLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 1e-41
 Identities = 62/293 (21%), Positives = 110/293 (37%), Gaps = 46/293 (15%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           + +L  +  G+   V+      +GR  A+K   K I+   +++++ + E  +L  + HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           + +               ++ E   L   L  +            AA++  AL+YLH+  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I++RD+KP N+LLD+N    + DFG A+Y  +                       + GT 
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------------------VTYTLCGTP 165

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+APE++  + +++  D +SFGI I E+L G  P+ D         +L           
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--- 222

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
                                +  L+ R    +   R        E   V  H
Sbjct: 223 ----------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTE--DVKNH 257

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 63/310 (20%), Positives = 121/310 (39%), Gaps = 50/310 (16%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSE-ELDNFHKELQL 114
           +     T+   + +G+  +VYE             +VA+K    + S  E   F  E  +
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS---------PSVDQVL 165
           + + +   + + +   ++    +   E     +L   L     +         PS+ +++
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
            +A ++A  + YL+    VHRD+   N ++  +    + DFG+               R 
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM--------------TRD 182

Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV-VPYTDLRAE 284
             +          +  + +M+PE LK  + +  SDV+SFG+ + E+ T    PY  L   
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--- 239

Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                      + +Q+   V+ GGL     +     P  +  L++ CW  NP  RPSF +
Sbjct: 240 -----------SNEQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 284

Query: 345 IALELDLVLE 354
           I   +   +E
Sbjct: 285 IISSIKEEME 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (372), Expect = 5e-41
 Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 51/296 (17%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK---------PILSTSEELDNFHKELQLLC 116
           Y     + RG  SVV         ++ AVK                E  +   KE+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 117 KL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
           K+  HP + +    +     +   F+  +   L + L  E+ + S  +   I   L + +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVI 123

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
             LH L IVHRD+KP N+LLD ++   L DFG +   +                  G   
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------------GEKL 166

Query: 236 KNMVGTLIYMAPEIL------KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
           + + GT  Y+APEI+          + ++ D++S G+ +  LL G  P+   +       
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226

Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
           ++  NY                  +        ++  L+ R     P  R +  + 
Sbjct: 227 IMSGNY---------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (374), Expect = 6e-41
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 39/284 (13%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           Y     +  GA S V  A      + VA+K     +   +  +   E+ +L K+ HP + 
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
                +    +     +      L +++  E+   +      +  Q+  A++YLH+LGIV
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 185 HRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           HRD+KP N+L    D +    ++DFGL++  +                  G       GT
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----------------GSVLSTACGT 172

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
             Y+APE+L ++ +S+  D +S G+    LL G  P+ D         +L+  Y      
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------ 226

Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                       +     +  S    I+   + +P  R +    
Sbjct: 227 ---------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  147 bits (371), Expect = 8e-41
 Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 38/302 (12%)

Query: 68  YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLA 124
           Y  L  I  G   VVY+A    G   A+KK  L   +E       +E+ +L +L H  + 
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
           K           +  FE +  ++L + L V E             QL   + Y H+  ++
Sbjct: 64  KLYDVIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
           HRD+KP N+L++R     +ADFGLA                           + + TL Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGI----------------PVRKYTHEIVTLWY 166

Query: 245 MAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
            AP++L   + +S   D++S G    E++ G   +  +    Q   +  +  T       
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 304 VVSGGLR----------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
            V+   +              S   GL  S + L+ +    +P+ R +           L
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA-------L 279

Query: 354 EH 355
           EH
Sbjct: 280 EH 281

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-39
 Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 59/319 (18%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL---------DGRKVAVKK-PILSTSEELDNFHKEL 112
           LP     L  P+  GA   V  A              KVAVK     +T ++L +   E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP------------ 159
           +++  +  H  +   + A  +        E+    NL E L                   
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 160 ---SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
              S   ++  A Q+A+ ++YL +   +HRD+   NVL+  +    +ADFGLA       
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------- 182

Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
                  R            N    + +MAPE L   I++ +SDV+SFG+ + E+ T G 
Sbjct: 183 -------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
            PY  +                ++L   +  G      +         +  +++ CW   
Sbjct: 236 SPYPGV--------------PVEELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAV 277

Query: 336 PHNRPSFSDIALELDLVLE 354
           P  RP+F  +  +LD ++ 
Sbjct: 278 PSQRPTFKQLVEDLDRIVA 296

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 67/308 (21%), Positives = 118/308 (38%), Gaps = 45/308 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           +  L  + +G    V        GR  A+K   K ++   +E+ +   E ++L    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L     A        F  E+     L   L   E   + ++     A++  AL+YLH+  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           +V+RD+K  N++LD++    + DFGL            K   S G        K   GT 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLC-----------KEGISDGATM-----KTFCGTP 169

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
            Y+APE+L+   +    D +  G+ + E++ G +P+ +                 ++L  
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------------QDHERLFE 215

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR--KSLK 360
            ++   +R         L     SL+      +P  R        +   V+EHR   S+ 
Sbjct: 216 LILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK--EVMEHRFFLSIN 268

Query: 361 EEDLCAGK 368
            +D+   K
Sbjct: 269 WQDVVQKK 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 6e-39
 Identities = 65/293 (22%), Positives = 105/293 (35%), Gaps = 31/293 (10%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGL 123
           +  +  I  G   VVY+A   L G  VA+K  +    T        +E+ LL +L+HP +
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            K +            FEF                  +  +     QL + L + H+  +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++      LADFGLA                           + V TL 
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFG----------------VPVRTYTHEVVTLW 167

Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
           Y APEIL   + +S   D++S G    E++T    +       Q   +     T  ++  
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 303 AVVSG----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
             V+             R   + +   L     SL+ +    +P+ R S    
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 8e-39
 Identities = 61/290 (21%), Positives = 106/290 (36%), Gaps = 45/290 (15%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVK--KPILSTSEE----LDNFHKELQLLCKLD 119
           Y     +  G  +VV +      G + A K  K   + S       ++  +E+ +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
           HP +      +    + +   E      L +    E+ S + ++      Q+   + YLH
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 180 NLGIVHRDVKPANVLLDRNLCP----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           +L I H D+KP N++L     P     + DFGLA   +                  G   
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-----------------GNEF 173

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           KN+ GT  ++APEI+  E    ++D++S G+    LL+G  P+     +     V  +NY
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                                     A     I+R    +P  R +  D 
Sbjct: 234 ---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-38
 Identities = 62/298 (20%), Positives = 108/298 (36%), Gaps = 58/298 (19%)

Query: 60  PLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDN---FHKE 111
           PL    S Y +   +  G    VY      D   VA+K   K  +S   EL N      E
Sbjct: 1   PLE---SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57

Query: 112 LQLLCKLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
           + LL K+     G+ + +    +P +++   E  E          E  +   +       
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117

Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGK 228
           Q+ +A+++ HN G++HRD+K  N+L+D N     L DFG     ++              
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-------------- 163

Query: 229 PTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
                   +  GT +Y  PE ++    H   + V+S GI + +++ G +P+       + 
Sbjct: 164 ----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219

Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                                           + +    LI+ C    P +RP+F +I
Sbjct: 220 QVFFRQR-------------------------VSSECQHLIRWCLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 66/303 (21%), Positives = 112/303 (36%), Gaps = 37/303 (12%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           Y  L+ I +G    V++A     G+KVA+KK ++   +E       +E+++L  L H  +
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 124 AKFVAA-------HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
              +         + +    ++    +   +LA  L       ++ ++  +   L   L 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
           Y+H   I+HRD+K ANVL+ R+    LADFGLA               S  K +      
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARA------------FSLAKNSQPNRYT 179

Query: 237 NMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
           N V TL Y  PE+L  E  +    D++  G  + E+ T          + Q   + ++  
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASI-------------LSLIQRCWDGNPHNRPSF 342
           +        V          L  G    +             L LI +    +P  R   
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 343 SDI 345
            D 
Sbjct: 300 DDA 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-38
 Identities = 63/299 (21%), Positives = 104/299 (34%), Gaps = 38/299 (12%)

Query: 68  YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEELDNFH-----KELQLLCKLD 119
           Y  ++ I  GA   V++A      GR VA+K+  + T EE            L+ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 120 HPGLAKFVAAHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
           HP + +                   FE  +         V E     + +  +  QL + 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
           L +LH+  +VHRD+KP N+L+  +    LADFGLA                         
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-----------------A 171

Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
             ++V TL Y APE+L +  ++   D++S G    E+      +       Q   +L++ 
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

Query: 295 YT--------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                     +  L            +      +      L+ +C   NP  R S    
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 71/317 (22%), Positives = 116/317 (36%), Gaps = 55/317 (17%)

Query: 63  LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
            P     L  P+ RGA   V EA           R VAVK     +T  E      EL++
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 115 LCK-LDHPGLAKFVAAHAKPPNY-MFFFEFYESRNLAEKLHVEEWSP------------- 159
           L     H  +   + A  KP    M   EF +  NL+  L  +                 
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
             +++ ++  + Q+AK +++L +   +HRD+   N+LL       + DFGLA        
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 181

Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
                 R   K      K +    L +MAPE +   +++ +SDV+SFG+ + E+ +    
Sbjct: 182 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235

Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
                                +     +  G R             +   +  CW G P 
Sbjct: 236 PYP-------------GVKIDEEFCRRLKEGTRMRAPD---YTTPEMYQTMLDCWHGEPS 279

Query: 338 NRPSFSDIALELDLVLE 354
            RP+FS++   L  +L+
Sbjct: 280 QRPTFSELVEHLGNLLQ 296

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 54/290 (18%), Positives = 102/290 (35%), Gaps = 45/290 (15%)

Query: 68  YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGL 123
           Y + S  +  G    V +        K A+K       ++     +E++L  +    P +
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHI 67

Query: 124 AKFV----AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
            + V      +A     +   E  +   L  ++        +  +   I   + +A+QYL
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 179 HNLGIVHRDVKPANVLLDRNLCP---HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           H++ I HRDVKP N+L           L DFG A+   +   ++   +            
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------------ 175

Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
                T  Y+APE+L  E + +  D++S G+ +  LL G  P+      A +  +     
Sbjct: 176 -----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-- 228

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                    +  G           +   +  LI+      P  R + ++ 
Sbjct: 229 ---------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-37
 Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 34/293 (11%)

Query: 70  LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELD-----NFHKELQLLCKLDHPG 122
            L  +  G  + VY+A      + VA+KK  L    E          +E++LL +L HP 
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           +   + A     N    F+F E+      +       +   +        + L+YLH   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           I+HRD+KP N+LLD N    LADFGLA+   +                      + V T 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS----------------PNRAYTHQVVTR 164

Query: 243 IYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
            Y APE+L    ++    D+++ G  + ELL  V          Q   + E   T  +  
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224

Query: 302 AAVVSGGLRPI---------LASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              +      +         L  +       +L LIQ  +  NP  R + +  
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 46/297 (15%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKK------PILSTSEELDNFHKELQLLCKLD 119
           +++   I RG    VY       G+  A+K        +        N    L L+   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
            P +     A   P    F  +     +L   L  +    S   +   AA++   L+++H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMH 124

Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
           N  +V+RD+KPAN+LLD +    ++D GLA      K                      V
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------------------PHASV 166

Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
           GT  YMAPE+L+K + +   +D +S G  + +LL G  P+   + + +            
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226

Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
           +L                       + SL++     + + R        +   V E 
Sbjct: 227 ELPD----------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQ--EVKES 265

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 33/294 (11%)

Query: 68  YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
           Y  L  I  G    V++A        VA+K+  L   +E    +  +E+ LL +L H  +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
            +              FEF +                 + V     QL K L + H+  +
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSRNV 122

Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
           +HRD+KP N+L++RN    LA+FGLA              R+ G P         V TL 
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLA--------------RAFGIPVR--CYSAEVVTLW 166

Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQLT 301
           Y  P++L   +++S   D++S G    EL     P +     + Q   +  +  T  +  
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 302 AAVVSG----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
              ++                L ++   L A+   L+Q     NP  R S  + 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-36
 Identities = 60/298 (20%), Positives = 108/298 (36%), Gaps = 35/298 (11%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
           YT LS I  GA  +V  A   ++  +VA+KK              +E+++L +  H  + 
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 125 KFVAAHAKPP----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
                   P       ++        +L + L  +  S   D +     Q+ + L+Y+H+
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN--DHICYFLYQILRGLKYIHS 127

Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
             ++HRD+KP+N+LL+      + DFGLA               +             V 
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFLTEYVA 174

Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
           T  Y APEI+      ++  D++S G  + E+L+    +       Q + +L +  +  Q
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 300 LTAAVVSG------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
                +                +     L     +  L L+ +    NPH R      
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (337), Expect = 2e-35
 Identities = 49/294 (16%), Positives = 106/294 (36%), Gaps = 46/294 (15%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
           +  +  +  G+   V        G   A+K   K  +   +++++   E ++L  ++ P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
           L K   +     N     E+     +   L       S       AAQ+    +YLH+L 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
           +++RD+KP N+L+D+     + DFG A+  +                        + GT 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------------------RTWTLCGTP 202

Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
             +APEI+  + +++  D ++ G+ I E+  G  P+   +       ++           
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--- 259

Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
                              + +  L++     +   R  F ++   ++ +  H+
Sbjct: 260 ----------------HFSSDLKDLLRNLLQVDLTKR--FGNLKNGVNDIKNHK 295

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 43/301 (14%)

Query: 67  SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
           SYT    I  G+  VVY+A L   G  VA+KK +L         ++ELQ++ KLDH  + 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRF---KNRELQIMRKLDHCNIV 76

Query: 125 KFV-----AAHAKPPNYMFF-FEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQ 176
           +       +   K   Y+    ++          H    + +  V  V +   QL ++L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 177 YLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
           Y+H+ GI HRD+KP N+LLD +     L DFG A+                     G   
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----------------GEPN 179

Query: 236 KNMVGTLIYMAP-EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
            + + +  Y AP  I     ++   DV+S G  + ELL G   +       Q   ++++ 
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 295 YTEQQLTAAVVSGGL----------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
            T  +     ++              P         P   ++L  R  +  P  R +  +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 345 I 345
            
Sbjct: 300 A 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 4e-35
 Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 39/301 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
            + Y  L P+  GA   V  A     G KVA+K       +       ++EL+LL  + H
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQY 177
             +   +           F +FY             ++      D++  +  Q+ K L+Y
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           +H  GI+HRD+KP N+ ++ +    + DFGLA   ++                       
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------------------EMTG 177

Query: 238 MVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
            V T  Y APE IL    +++  D++S G  + E++TG   +       Q   ++++  T
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 297 EQQLTAAVVSGGL------------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                   +                +   AS+        ++L+++    +   R +  +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 345 I 345
            
Sbjct: 298 A 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-34
 Identities = 69/315 (21%), Positives = 116/315 (36%), Gaps = 47/315 (14%)

Query: 68  YTLLSPIARGAESVVYEATL-----DGRKVAVKK----PILSTSEELDNFHKELQLLCKL 118
           + LL  +  GA   V+          G+  A+K      I+  ++  ++   E Q+L  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 119 DH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
              P L     A           ++     L   L  +    +  +V +   ++  AL++
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEH 144

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           LH LGI++RD+K  N+LLD N    L DFGL++                          +
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV---------------ADETERAYD 189

Query: 238 MVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
             GT+ YMAP+I+      H +  D +S G+ + ELLTG  P+T    +     +     
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249

Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
             +                     + A    LIQR    +P  R        +   + EH
Sbjct: 250 KSEP---------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD--EIKEH 292

Query: 356 R--KSLKEEDLCAGK 368
              + +  +DL A K
Sbjct: 293 LFFQKINWDDLAAKK 307

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 60/307 (19%), Positives = 109/307 (35%), Gaps = 46/307 (14%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDHPGL 123
           Y  L PI  GA+ +V  A   +  R VA+KK              ++EL L+  ++H  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
              +           F + Y    L +     V +     +++  +  Q+   +++LH+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           GI+HRD+KP+N+++  +    + DFGLA                       F     V T
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----------------SFMMTPYVVT 181

Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT----- 296
             Y APE++    + E  D++S G  + E++   + +       Q + V+E   T     
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 297 ------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
                                    +    L P  +       +    L+ +    +P  
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

Query: 339 RPSFSDI 345
           R S  D 
Sbjct: 302 RISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 39/301 (12%)

Query: 65  PSSYTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
           P  Y  LSP+  GA   V  A  T  G +VAVK       +       ++EL+LL  + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEW---SPSVDQVLMIAAQLAKALQY 177
             +   +       +   F + Y   +L              + D V  +  Q+ + L+Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
           +H+  I+HRD+KP+N+ ++ +    + DFGLA +                          
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------------------DDEMTG 177

Query: 238 MVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
            V T  Y APEI L    +++  D++S G  + ELLTG   +       Q   +L +  T
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 297 EQQLTAAVVSGGL------------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
                   +S               +   A++ +G     + L+++    +   R + + 
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

Query: 345 I 345
            
Sbjct: 298 A 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 56/304 (18%), Positives = 111/304 (36%), Gaps = 50/304 (16%)

Query: 68  YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
           Y L+  + RG  S V+EA    +  KV VK        +     +E+++L  L   P + 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNII 93

Query: 125 KFVAAHAKPPNYMFF--FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
                   P +      FE   + +  +       + +   +     ++ KAL Y H++G
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG 149

Query: 183 IVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
           I+HRDVKP NV++D  +    L D+GLAE+    +E +                   V +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-----------------VRVAS 192

Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTVLEMNYTEQQ 299
             +  PE+ +  +++    D++S G  +  ++    P+        Q   + ++  TE  
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 300 ------------------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
                             L         R + +  +  +    L  + +    +  +R +
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 342 FSDI 345
             + 
Sbjct: 313 AREA 316

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 71/374 (18%), Positives = 122/374 (32%), Gaps = 77/374 (20%)

Query: 68  YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
           Y L+  +  G  S V+ A   ++   VA+K  +       +    E++LL +++     K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 126 ---------------FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
                          F        + +  FE      LA     E     +  V  I+ Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 171 LAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
           L   L Y+H   GI+H D+KP NVL++    P                I +K        
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-------------NLIQIKIADLGNAC 180

Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY---------TD 280
               H  N + T  Y +PE+L        +D++S    I EL+TG   +          D
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 281 LRAEAQAHTVL-----EMNYTEQQLTAAVVSGGLRPILASLEL---------------GL 320
               AQ   +L      +    +       S GL   ++ L+                  
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLKEEDLCAGKSYVTYDDKL 377
              I   +      +P  R     +       + H   + +L  E++         D +L
Sbjct: 301 AKEISDFLSPMLQLDPRKRADAGGL-------VNHPWLKDTLGMEEI------RVPDREL 347

Query: 378 INSGNNMHTYHESI 391
             SG+++  + E +
Sbjct: 348 YGSGSDIPGWFEEV 361

>d1a6qa2 d.219.1.1 (A:2-296) Protein serine/threonine phosphatase 2C, catalytic domain {Human (Homo sapiens) [TaxId: 9606]} Length = 295

class: Alpha and beta proteins (a+b)
fold: PP2C-like
superfamily: PP2C-like
family: PP2C-like
domain: Protein serine/threonine phosphatase 2C, catalytic domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.6 bits (208), Expect = 1e-18
 Identities = 33/135 (24%), Positives = 51/135 (37%), Gaps = 3/135 (2%)

Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKE-IHMFGIFDGHRGSAAAEFSARALPGFLQN 487
           L +G  +  G R  MED H  +  + +  E    F ++DGH GS  A++    L   + N
Sbjct: 21  LRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITN 80

Query: 488 LGSTTRPTDALLEAFIRTDV--AFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFV 545
                    A     ++  +   F    + +R            G TA+  LI     + 
Sbjct: 81  NQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEKKHGADRSGSTAVGVLISPQHTYF 140

Query: 546 ANAGDCRAILCRGGH 560
            N GD R +LCR   
Sbjct: 141 INCGDSRGLLCRNRK 155

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 1e-18
 Identities = 23/154 (14%), Positives = 49/154 (31%), Gaps = 18/154 (11%)

Query: 68  YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE----------ELDNFHKELQLLC 116
             +   +  G ES V+        +  VK   +  +              +F        
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKAL 175
           + +   L K      +       + +  +  L E +  +E     V+    +   + + +
Sbjct: 62  RNEFRALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
              ++ GIVH D+   NVL+       + DF  +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149

>d1txoa_ d.219.1.1 (A:) putative serine/threonine phosphatase pstp/ppp {Mycobacterium tuberculosis [TaxId: 1773]} Length = 235

class: Alpha and beta proteins (a+b)
fold: PP2C-like
superfamily: PP2C-like
family: PP2C-like
domain: putative serine/threonine phosphatase pstp/ppp
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 63.8 bits (154), Expect = 5e-12
 Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 13/140 (9%)

Query: 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
           VL + + +  G  R   ED+ +    +          + DG  G AA E +++ +   L 
Sbjct: 2   VLRYAARSDRGLVRANNEDSVYAGARL--------LALADGMGGHAAGEVASQLVIAALA 53

Query: 487 NLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVA 546
           +L       D       + D A R    ++     +       G T  A L   NRL + 
Sbjct: 54  HLDDDEPGGD----LLAKLDAAVRAGNSAIAAQVEMEPDLEGMGTTLTAILFAGNRLGLV 109

Query: 547 NAGDCRAILCRGGHPFALSR 566
           + GD R  L R G    +++
Sbjct: 110 HIGDSRGYLLRDGELTQITK 129

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	573
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1a6qa2	295	Protein serine/threonine phosphatase 2C, catalytic	99.95
d1txoa_	235	putative serine/threonine phosphatase pstp/ppp {My	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.48
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.14
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.98

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=430.14  Aligned_cols=266  Identities=29%  Similarity=0.513  Sum_probs=221.6

Q ss_pred             ccccCCCCccccccccccCceEEEEEEECCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|+.++|++.++||+|+||+||+|+..+ .||||++...  .....+.+.+|+.+|++++||||+++++++. .+.++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence            378999999999999999999999998755 5999986543  3456778999999999999999999999875 45789


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|||||++|+|.+++...+..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999999987766899999999999999999999999999999999999999999999999999976543211


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                    ........||+.|||||++.+   ..++.++|||||||+||||+||+.||.+..........    
T Consensus       160 --------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~----  221 (276)
T d1uwha_         160 --------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM----  221 (276)
T ss_dssp             --------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----
T ss_pred             --------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH----
Confidence                          112345679999999999964   35789999999999999999999999876544333222    


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                               +..+...|.+...+.++|+++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       222 ---------~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         222 ---------VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---------HHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------HhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     223444555666677899999999999999999999999999999988765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-56  Score=437.37  Aligned_cols=254  Identities=23%  Similarity=0.375  Sum_probs=218.6

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .++|+++++||+|+||+||+|++  +|+.||||++........+.+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            46899999999999999999987  5899999987655444567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      |+||+|.+++...  .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....      
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~------  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------  170 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT------
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc------
Confidence            9999999987643  68999999999999999999999999999999999999999999999999997653211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                                ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....        
T Consensus       171 ----------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--------  232 (293)
T d1yhwa1         171 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG--------  232 (293)
T ss_dssp             ----------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------
T ss_pred             ----------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence                      12345689999999999999999999999999999999999999998766554444333211        


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                           .  +.+ ..+..+|+++.+||.+||+.||++|||+.|+++|.|.-
T Consensus       233 -----~--~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         233 -----T--PEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             -----S--CCC-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             -----C--CCC-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence                 1  111 12457899999999999999999999999999998763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=429.46  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=217.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++.+.||+|+||+||+|++  +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999998  57899999864321   223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |||++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....      
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~------  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC------
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC------
Confidence            9999999999997655 799999999999999999999999999999999999999999999999999865432      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                  .......||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.......+.....     
T Consensus       159 ------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----  221 (263)
T d2j4za1         159 ------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----  221 (263)
T ss_dssp             ------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----
T ss_pred             ------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----
Confidence                        113456799999999999999999999999999999999999999988766555444432211     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                                    ..|..+|+++.+||.+||+.||++|||+.|+++|+|...
T Consensus       222 --------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 --------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                          134578999999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-56  Score=435.18  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=219.6

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      +.|++++.||+|+||+||+|++  +++.||||++........+.+.+|+++|++++||||+++++++.+++.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4699999999999999999997  57899999977666667778999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW  223 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  223 (573)
                      ++|+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......      
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~------  165 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------  165 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH------
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc------
Confidence            99999999876666799999999999999999999999999999999999999999999999999976543221      


Q ss_pred             cCCCCCCCCccccccccCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                ...+..||+.|+|||++.     +..|+.++|||||||++|||++|..||.+.+.......+....    
T Consensus       166 ----------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~----  231 (288)
T d2jfla1         166 ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----  231 (288)
T ss_dssp             ----------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC----
T ss_pred             ----------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----
Confidence                      124568999999999984     4568899999999999999999999998876555544443321    


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 .+.+ ..+..+|+++.+||.+||+.||++|||+.|+++|+|.
T Consensus       232 -----------~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         232 -----------PPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             -----------CCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             -----------CCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                       1111 2245789999999999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-56  Score=429.96  Aligned_cols=255  Identities=26%  Similarity=0.366  Sum_probs=211.2

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|++++.||+|+||+||+|++  +++.||||++..... +..+.+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5799999999999999999998  588999998755433 3346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      |++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........    
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~----  159 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----  159 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE----
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc----
Confidence            99999999996544 7999999999999999999999999999999999999999999999999999866432110    


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                ......+||+.|||||++.+..+ +.++|||||||+||||++|..||...............        
T Consensus       160 ----------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~--------  221 (271)
T d1nvra_         160 ----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------  221 (271)
T ss_dssp             ----------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT--------
T ss_pred             ----------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------
Confidence                      11345689999999999988775 67899999999999999999999765433222221111        


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                           .   +.....+..+|+++.+||.+||+.||++|||++|+++|+|.
T Consensus       222 -----~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         222 -----K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             -----T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             -----C---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence                 1   11111234689999999999999999999999999999886

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=431.45  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=215.6

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      +.+++|++.+.||+|+||+||+|++  +++.||||++....   ....+.+.+|+++|++++||||+++++++.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            3346899999999999999999998  57899999864321   223567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +|||||+||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        85 ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999999987665 799999999999999999999999999999999999999999999999999976642111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .....+.+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.......+.....  
T Consensus       164 --------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--  227 (288)
T d1uu3a_         164 --------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY--  227 (288)
T ss_dssp             --------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--
T ss_pred             --------------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--
Confidence                          1123456899999999999999999999999999999999999999998766655555443221  


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                       ..|..+++++.+||++||+.||++|||++|++++.|.
T Consensus       228 -----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i  264 (288)
T d1uu3a_         228 -----------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL  264 (288)
T ss_dssp             -----------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHH
T ss_pred             -----------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHH
Confidence                             1345789999999999999999999999998876653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=424.75  Aligned_cols=251  Identities=28%  Similarity=0.404  Sum_probs=204.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc--CCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv  139 (573)
                      ++|++++.||+|+||+||+|++  +|+.||||++...  .....+.+.+|+++|++++||||+++++++.+  ...+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999987  5889999986544  34456789999999999999999999998864  4568999


Q ss_pred             EEeccCCChhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCceEEcCCCCCeEeeeecchh
Q 008220          140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEY  211 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~  211 (573)
                      ||||++|+|.+++..   ....+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   3457999999999999999999999976     99999999999999999999999999987


Q ss_pred             hhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ......                ......||+.|+|||++.+..++.++|||||||++|||+||..||.+.+.......+.
T Consensus       164 ~~~~~~----------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         164 LNHDTS----------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             C---------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccCCC----------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            643111                1345689999999999999999999999999999999999999998876555444433


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                      .              +...    ..+..+|+++.+||.+||+.||++|||+.|+++|+|
T Consensus       228 ~--------------~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         228 E--------------GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             H--------------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             c--------------CCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            2              2221    234578999999999999999999999999999876

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=432.32  Aligned_cols=271  Identities=23%  Similarity=0.314  Sum_probs=217.4

Q ss_pred             ccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEE
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  138 (573)
                      ++..++|+++++||+|+||+||+|++  +++.||+|++... .....+.+.+|+.+|+.++|||||+++++|.++.++|+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56678999999999999999999997  5899999987544 23345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      ||||++||+|.+++...+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        82 VmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999999997665 79999999999999999999997 49999999999999999999999999999866431  


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc---c
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM---N  294 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~---~  294 (573)
                                      ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+...........   .
T Consensus       159 ----------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  222 (322)
T d1s9ja_         159 ----------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD  222 (322)
T ss_dssp             ----------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred             ----------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence                            134568999999999999999999999999999999999999999765433221111000   0


Q ss_pred             c-------------------------cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 008220          295 Y-------------------------TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL  349 (573)
Q Consensus       295 ~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l  349 (573)
                      .                         ...+...... ....+.++  ...+|+++.+||.+||+.||++|||++|+++|+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             -----------------------CCCCHHHHHHHHH-TSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cccCCcccccccccccccccccccchhHHHHHhhhh-ccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence            0                         0000111111 11111111  124689999999999999999999999999999


Q ss_pred             HHHHH
Q 008220          350 DLVLE  354 (573)
Q Consensus       350 ~~~~~  354 (573)
                      |....
T Consensus       300 f~~~~  304 (322)
T d1s9ja_         300 FIKRS  304 (322)
T ss_dssp             HHHHH
T ss_pred             hhCcC
Confidence            87543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=415.96  Aligned_cols=258  Identities=23%  Similarity=0.415  Sum_probs=210.6

Q ss_pred             cCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      |++++|++.+.||+|+||+||+|++ +++.||||++.... ...+.+.+|++++++++||||+++++++..++.+++|||
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            4568999999999999999999998 56789999876433 334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+++|+|.+++......++++.++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~----  156 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----  156 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc----
Confidence            9999999999887777889999999999999999999999999999999999999999999999999976543211    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...........+..        
T Consensus       157 -----------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------  217 (263)
T d1sm2a_         157 -----------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------  217 (263)
T ss_dssp             -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--------
T ss_pred             -----------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--------
Confidence                       11234578999999999999999999999999999999999 5777766544443333321        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                            + .++   ..|..+++++.+||.+||+.||++|||++||+++|..+.+
T Consensus       218 ------~-~~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         218 ------G-FRL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ------T-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------c-CCC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                  1 122   1245678999999999999999999999999999988765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.8e-54  Score=435.01  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=223.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++++.||+|+||+||+|++  +|+.||||++........+.+.+|+.+|++++||||+++++++.+.+.+|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5899999999999999999997  58999999987777777788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC--CCCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +||+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++.+....     
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-----  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-----  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-----
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-----
Confidence            999999999766667999999999999999999999999999999999999964  6789999999997654211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                  ...+..||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+....+..    
T Consensus       181 ------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----  244 (350)
T d1koaa2         181 ------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM----  244 (350)
T ss_dssp             ------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS----
T ss_pred             ------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----
Confidence                        2345789999999999999999999999999999999999999999877666665554433211    


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                 .......+|+++.+||.+||+.||++|||+.|+++|+|..
T Consensus       245 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         245 -----------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             -----------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             -----------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                       1123346899999999999999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-54  Score=423.81  Aligned_cols=267  Identities=24%  Similarity=0.396  Sum_probs=213.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC--C---eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      .++..++|++.++||+|+||+||+|++.  +   ..||||++... .....+.+.+|+.+|++++|||||++++++..++
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            3566789999999999999999999873  2   25888876543 4455678999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++|||||++|+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999887666799999999999999999999999999999999999999999999999999987653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .....           .........||+.|+|||++.+..++.++|||||||+||||+| |..||.+.........+.  
T Consensus       181 ~~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~--  247 (299)
T d1jpaa_         181 DTSDP-----------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--  247 (299)
T ss_dssp             --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--
T ss_pred             CCCcc-----------eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence            22110           0011223468999999999999999999999999999999998 899998775544433332  


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                                  .+ .++   ..+..+|+++.+||.+||+.||++|||+.||++.|..+++..
T Consensus       248 ------------~~-~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         248 ------------QD-YRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ------------TT-CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ------------cC-CCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                        12 222   134578999999999999999999999999999998887643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4e-54  Score=434.16  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=223.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++++.||+|+||+||+|++  +++.||||++..........+.+|+.+|++++||||++++++|.++..+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999997  58899999987776667778899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc--CCCCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~--~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +||+|.+.+...+..+++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|......      
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~------  182 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD------  182 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT------
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC------
Confidence            99999998877776899999999999999999999999999999999999998  5789999999999765421      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                 .......||+.|+|||++.+..++.++|||||||++|+|+||..||.+.+.......+......     
T Consensus       183 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----  246 (352)
T d1koba_         183 -----------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----  246 (352)
T ss_dssp             -----------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred             -----------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence                       1234568999999999999999999999999999999999999999987766665555443321     


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                .....+..+|+++.+||.+||+.||.+|||+.|+++|.|.
T Consensus       247 ----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~  286 (352)
T d1koba_         247 ----------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  286 (352)
T ss_dssp             ----------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                      1122345789999999999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-54  Score=426.38  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh-HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++..... .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            36799999999999999999998  578999998654432 234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEc---CCCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      ||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+++......  
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--  164 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence            999999999997654 799999999999999999999999999999999999995   57899999999997654211  


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                                     ...+.+||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+.....   
T Consensus       165 ---------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---  226 (307)
T d1a06a_         165 ---------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY---  226 (307)
T ss_dssp             -----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---
T ss_pred             ---------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---
Confidence                           13456799999999999999999999999999999999999999988766655555443222   


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                 . .....+..+|+++.+||.+||+.||++|||+.|+++|+|.
T Consensus       227 -----------~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         227 -----------E-FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             -----------C-CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             -----------C-CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence                       1 1122345789999999999999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=415.65  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=206.7

Q ss_pred             CccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc----CCceEE
Q 008220           67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYMF  138 (573)
Q Consensus        67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~l  138 (573)
                      -|++.++||+|+||+||+|++  +++.||+|++...  .....+.+.+|+++|++++||||+++++++.+    ...+|+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            347888999999999999998  4778999975433  34556789999999999999999999999864    456899


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCceEEc-CCCCCeEeeeecchhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLD-RNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ||||+++|+|.+++.... .+++++++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+.... 
T Consensus        90 vmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             EEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence            999999999999997654 7899999999999999999999998  99999999999996 478999999999975331 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                       ....+.+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..........+.   
T Consensus       168 -----------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~---  226 (270)
T d1t4ha_         168 -----------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---  226 (270)
T ss_dssp             -----------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---
T ss_pred             -----------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH---
Confidence                             12345689999999999876 589999999999999999999999986544333222221   


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                .+ ..|  ...+...++++.+||.+||+.||++|||+.|+++|+|+
T Consensus       227 ----------~~-~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         227 ----------SG-VKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             ----------TT-CCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ----------cC-CCC--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence                      11 111  22345688999999999999999999999999998874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-53  Score=422.14  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=212.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++....   ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3599999999999999999987  58899999865442   344567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      |||.+|+|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....      
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence            999999887665544 4799999999999999999999999999999999999999999999999999865431      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                    .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.........+...    
T Consensus       168 --------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~----  229 (309)
T d1u5ra_         168 --------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----  229 (309)
T ss_dssp             --------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----
T ss_pred             --------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----
Confidence                          244679999999999864   45889999999999999999999999876655544444322    


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                ...+ +  .+..+|+++.+||.+||+.||++|||+.|+++|+|..
T Consensus       230 ----------~~~~-~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         230 ----------ESPA-L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             ----------CCCC-C--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             ----------CCCC-C--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence                      1111 1  2346899999999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-53  Score=416.88  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=217.8

Q ss_pred             ccccCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|+.++|++.++||+|+||+||+|++  +++.||||++.... ...+.+.+|+.+|++++||||+++++++.+++.++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            4789999999999999999999999998  57899999865443 34567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999998653 4578999999999999999999999999999999999999999999999999997654211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                      .               .......|++.|+|||++.+..++.++|||||||++|||++|..||............+     
T Consensus       170 ~---------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-----  229 (287)
T d1opja_         170 Y---------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----  229 (287)
T ss_dssp             S---------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-----
T ss_pred             c---------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-----
Confidence            1               11234568999999999999999999999999999999999666554332222222222     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                               ..+.++   ..+..+|+++.+||.+||+.||++|||+.||++.|..+.
T Consensus       230 ---------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         230 ---------EKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ---------HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------hcCCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     122222   234578999999999999999999999999998776554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=425.18  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=218.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      -++|++++.||+|+||.||+|++  +++.||||++...   .....+.+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            45899999999999999999997  5889999986432   122456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||++||+|.+++...+ .++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....    
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~----  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC----
Confidence            99999999999987665 7899999999999999999999999999999999999999999999999999754321    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+.....    
T Consensus       159 ------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~----  222 (337)
T d1o6la_         159 ------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----  222 (337)
T ss_dssp             ------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----
T ss_pred             ------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC----
Confidence                        1124567899999999999999999999999999999999999999998776555444433221    


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~  351 (573)
                                     ..|..+|+++.+||++||+.||.+||+     +.|+++|+|+
T Consensus       223 ---------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f  264 (337)
T d1o6la_         223 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             ---------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence                           234578999999999999999999994     8999999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=417.80  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=218.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC------hHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      .++|++.+.||+|+||+||+|++  +|+.||||++....      ....+.+.+|+.+|++++||||+++++++.++..+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36899999999999999999997  58899999764321      12357789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC----CCeEeeeecchhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYR  212 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~  212 (573)
                      |+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||++...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            99999999999999997655 799999999999999999999999999999999999998877    4899999998765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ...                 ....+..||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..
T Consensus       168 ~~~-----------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  230 (293)
T d1jksa_         168 DFG-----------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  230 (293)
T ss_dssp             TTS-----------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             CCC-----------------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            421                 123456799999999999999999999999999999999999999998776666555544


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ....               .....+..+|+++.+||++||+.||++|||++|+++|+|.
T Consensus       231 ~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         231 VNYE---------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             TCCC---------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             cCCC---------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            3322               1122345789999999999999999999999999998876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=411.23  Aligned_cols=262  Identities=25%  Similarity=0.430  Sum_probs=216.6

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      ...++|+.++|++.++||+|+||+||+|.+. ++.||||++.... ...+.+.+|+++|++++||||+++++++.+ +..
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            3458899999999999999999999999985 6789999875433 345679999999999999999999998754 567


Q ss_pred             EEEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      ++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            89999999999999775433 35899999999999999999999999999999999999999999999999999765421


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ..               .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...........+.   
T Consensus       163 ~~---------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---  224 (272)
T d1qpca_         163 EY---------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---  224 (272)
T ss_dssp             CE---------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---
T ss_pred             cc---------------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            11               113345789999999999988999999999999999999995 55555544333322221   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                  .+.++.   .|..+|+++.+||.+||+.||++|||+.+|++.|+.++.
T Consensus       225 ------------~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         225 ------------RGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ------------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------hcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                        122222   345789999999999999999999999999998887664

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=404.34  Aligned_cols=254  Identities=22%  Similarity=0.369  Sum_probs=218.0

Q ss_pred             cCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      +++++|++.++||+|+||+||+|++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            3567899999999999999999998 467899998665433 34678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.+|+|.+++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......    
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~----  155 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----  155 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC----
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc----
Confidence            9999999999877766889999999999999999999999999999999999999999999999999976543111    


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.......+..        
T Consensus       156 -----------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~--------  216 (258)
T d1k2pa_         156 -----------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------  216 (258)
T ss_dssp             -----------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT--------
T ss_pred             -----------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh--------
Confidence                       11234578999999999999999999999999999999998 8999988766554443332        


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD  350 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~  350 (573)
                             +.++.   .|..+++++.+||.+||+.||++|||+.+|+++|.
T Consensus       217 -------~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         217 -------GLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             -------TCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -------CCCCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence                   22222   34578999999999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=422.31  Aligned_cols=263  Identities=27%  Similarity=0.403  Sum_probs=217.7

Q ss_pred             ccccccCCCCccccccccccCceEEEEEEECC-------eeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeee
Q 008220           58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA  128 (573)
Q Consensus        58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  128 (573)
                      ...++|+.++|++.++||+|+||+||+|++.+       ..||+|.+... .......+.+|+.+|+++ +|||||++++
T Consensus        29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            44578999999999999999999999998632       36899976543 333456788999999998 8999999999


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEE----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHR  186 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~  186 (573)
                      ++.+.+..++|||||++|+|.+++....                      ..+++..++.++.||+.||+|||++||+||
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999996543                      247889999999999999999999999999


Q ss_pred             cCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHH
Q 008220          187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI  266 (573)
Q Consensus       187 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  266 (573)
                      ||||+|||++.++.+||+|||+|+........              ....+..||+.|||||++.+..++.++|||||||
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gv  254 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY--------------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI  254 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS--------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCce--------------eeeccccCCCccCChHHHcCCCCCcceeccchhH
Confidence            99999999999999999999999765532211              1234567899999999999999999999999999


Q ss_pred             HHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 008220          267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI  345 (573)
Q Consensus       267 il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  345 (573)
                      +||||+| |..||.+.........++.              ++.++   ..|..+|+++.+||.+||+.||++|||++||
T Consensus       255 il~emlt~g~~Pf~~~~~~~~~~~~~~--------------~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         255 LLWEIFSLGVNPYPGIPVDANFYKLIQ--------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHH--------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHh--------------cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            9999998 8999987654444333332              22332   2345789999999999999999999999999


Q ss_pred             HHHHHH
Q 008220          346 ALELDL  351 (573)
Q Consensus       346 l~~l~~  351 (573)
                      +++|..
T Consensus       318 ~~~L~~  323 (325)
T d1rjba_         318 TSFLGC  323 (325)
T ss_dssp             HHHHHH
T ss_pred             HHHHhC
Confidence            999853

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=408.65  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=211.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      ++|+.++|++.+.||+|+||.||+|++.     +..||||.+... .....+.+.+|+.+|++++||||+++++++. .+
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            6788899999999999999999999873     346888876543 3445678999999999999999999999985 46


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            78999999999999998877777899999999999999999999999999999999999999999999999999976543


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...               .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+.. 
T Consensus       161 ~~~---------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-  224 (273)
T d1mp8a_         161 STY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-  224 (273)
T ss_dssp             -------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred             Ccc---------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence            211               11334568999999999999999999999999999999998 8999987765544433322 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                   +. ++   ..+.++|+++.+||.+||+.||++|||+.||+++|..+++.
T Consensus       225 -------------~~-~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 -------------GE-RL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------CC-CC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                         21 11   23557899999999999999999999999999999988764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=409.33  Aligned_cols=262  Identities=21%  Similarity=0.324  Sum_probs=217.6

Q ss_pred             ccCCCCcccccc-ccccCceEEEEEEE----CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCc
Q 008220           62 HLPPSSYTLLSP-IARGAESVVYEATL----DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN  135 (573)
Q Consensus        62 ~~~~~~y~~~~~-lg~G~~g~V~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (573)
                      -+..++|.+.+. ||+|+||+||+|.+    ++..||||++... .....+.+.+|+++|++++|||||++++++.+ +.
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            345567888884 99999999999975    3457999987544 44567789999999999999999999999865 56


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+++|+|.+++...+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            89999999999999998766668999999999999999999999999999999999999999999999999999866432


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      ...             ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........+.   
T Consensus       163 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---  226 (285)
T d1u59a_         163 DSY-------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---  226 (285)
T ss_dssp             SCE-------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---
T ss_pred             ccc-------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence            111             111234568999999999999999999999999999999998 999998765544333322   


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                  .+.++   ..|..+|+++.+||.+||+.||++|||+.+|++.|......
T Consensus       227 ------------~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         227 ------------QGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ------------TTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------cCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                        12222   23467999999999999999999999999999888766543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-53  Score=419.10  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=216.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++++.||+|+||+||+|++  +|+.||||++...   .....+.+.+|+.+|+.++||||+++++++.++..+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4799999999999999999997  4889999986432   1223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.||+|..++.... .++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....      
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc------
Confidence            9999999999887655 788999999999999999999999999999999999999999999999999976542      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ...+.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....     
T Consensus       157 -------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----  218 (316)
T d1fota_         157 -------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----  218 (316)
T ss_dssp             -------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----
T ss_pred             -------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----
Confidence                         13456899999999999999999999999999999999999999998766665555543221     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                                    ..+..+|+++.++|.+||+.||.+|+     |++++++|+|.
T Consensus       219 --------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         219 --------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             --------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence                          12457899999999999999999996     99999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=417.25  Aligned_cols=254  Identities=18%  Similarity=0.291  Sum_probs=220.9

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEec
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY  143 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  143 (573)
                      ++|++++.||+|+||+||+|.+  +++.||||++..... +...+.+|+++|+.++||||++++++|.+...+|+|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            6899999999999999999997  588999998766543 3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC--CCCeEeeeecchhhhhhhhhhcc
Q 008220          144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--LCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~--~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      +||+|.+++...+..+++++++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.....      
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~------  157 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------  157 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT------
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC------
Confidence            9999999998776679999999999999999999999999999999999999854  47999999998754321      


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                 .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+....+...   
T Consensus       158 -----------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---  223 (321)
T d1tkia_         158 -----------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---  223 (321)
T ss_dssp             -----------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---
T ss_pred             -----------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence                       123456799999999999999999999999999999999999999998877666666654433211   


Q ss_pred             HHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                                  ...+..+|+++.+||.+||..||++|||+.|+++|+|..
T Consensus       224 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         224 ------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             ------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence                        122346899999999999999999999999999999863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=405.44  Aligned_cols=263  Identities=27%  Similarity=0.413  Sum_probs=211.9

Q ss_pred             ccCCCCccccccccccCceEEEEEEECC------eeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           62 HLPPSSYTLLSPIARGAESVVYEATLDG------RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      +|.++.|++.++||+|+||+||+|.+.+      ..||||++... .......+.+|+.+|++++|||||++++++.+..
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            6778899999999999999999998632      46999987544 3345567899999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+.++++.+.+......+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999999998877777899999999999999999999999999999999999999999999999999987653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCC-CCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-Pf~~~~~~~~~~~~~~~  293 (573)
                      ....             ........||+.|+|||++.+..++.++|||||||++|||++|.. ||...........    
T Consensus       163 ~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----  225 (283)
T d1mqba_         163 DPEA-------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----  225 (283)
T ss_dssp             ------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----
T ss_pred             CCcc-------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH----
Confidence            2211             111234568999999999999999999999999999999999544 4544433322222    


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                                +. .+.++.   .+..+++++.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus       226 ----------i~-~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         226 ----------IN-DGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ----------HH-TTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----------Hh-ccCCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                      11 222322   3457899999999999999999999999999999887763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-52  Score=420.68  Aligned_cols=247  Identities=19%  Similarity=0.282  Sum_probs=216.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++|++++.||+|+||.||+|++  +|+.||||++....   ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999998  58899999864321   223567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhc
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL  220 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  220 (573)
                      ||+.+|+|..++...+ .+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....      
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~------  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS------
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc------
Confidence            9999999999987665 799999999999999999999999999999999999999999999999999976542      


Q ss_pred             ccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                   ...+..||+.|||||++.+..++.++|||||||++|||+||..||.+.+.......+.....     
T Consensus       194 -------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----  255 (350)
T d1rdqe_         194 -------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----  255 (350)
T ss_dssp             -------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred             -------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----
Confidence                         13456899999999999999999999999999999999999999988766555554443221     


Q ss_pred             HHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                                    ..+..+++++.+||++||+.||.+|+     |++++++|.|+
T Consensus       256 --------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         256 --------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             --------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence                          12457899999999999999999994     99999999886

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.9e-52  Score=403.43  Aligned_cols=254  Identities=24%  Similarity=0.322  Sum_probs=216.0

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh---------HHHHHHHHHHHHHHhCC-CCccceeeecccc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---------EELDNFHKELQLLCKLD-HPGLAKFVAAHAK  132 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  132 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++.....         ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999998  689999998654321         12346889999999997 9999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ++..|+||||+++|+|.+++...+ .+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            999999999999999999997655 7999999999999999999999999999999999999999999999999999765


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhcc------CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ  286 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  286 (573)
                      ...                 .......||+.|+|||++.+      ..++.++||||+||+||+|++|..||.+.+....
T Consensus       161 ~~~-----------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~  223 (277)
T d1phka_         161 DPG-----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM  223 (277)
T ss_dssp             CTT-----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCC-----------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence            421                 12345679999999999863      3468899999999999999999999998776665


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...+.....              .+. .....++|+++.+||.+||+.||++|||+.|+++|.|.
T Consensus       224 ~~~i~~~~~--------------~~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         224 LRMIMSGNY--------------QFG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             HHHHHHTCC--------------CCC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHhCCC--------------CCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence            555543322              111 11234789999999999999999999999999998875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=401.92  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=203.3

Q ss_pred             ccccccCceEEEEEEEC----CeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEeccC
Q 008220           72 SPIARGAESVVYEATLD----GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES  145 (573)
Q Consensus        72 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  145 (573)
                      ++||+|+||+||+|.+.    ++.||||++...  .....+.+.+|+++|++++||||+++++++.+ +.+++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            36999999999999752    467999986543  23346789999999999999999999999865 567899999999


Q ss_pred             CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccC
Q 008220          146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS  225 (573)
Q Consensus       146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  225 (573)
                      |+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........       
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-------  163 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-------  163 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence            99999987654 7999999999999999999999999999999999999999999999999999765421110       


Q ss_pred             CCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 008220          226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV  304 (573)
Q Consensus       226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (573)
                            ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........+.             
T Consensus       164 ------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------------  224 (277)
T d1xbba_         164 ------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------------  224 (277)
T ss_dssp             ------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------------
T ss_pred             ------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------------
Confidence                  011234578999999999999999999999999999999998 999998765544333322             


Q ss_pred             hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                       . +.++   ..|..+|+++.+||.+||+.||++|||+.+|++.|....
T Consensus       225 -~-~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         225 -K-GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -T-TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -c-CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence             1 2222   234578999999999999999999999999987776554

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=399.57  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=211.2

Q ss_pred             cccCCCCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc-CCceEEE
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFF  139 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv  139 (573)
                      ++|..++|++.+.||+|+||.||+|+++++.||||++...  ...+.+.+|++++++++||||+++++++.+ .+.+++|
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            6788899999999999999999999999999999987543  345678999999999999999999998854 5678999


Q ss_pred             EEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999999986543 3589999999999999999999999999999999999999999999999999875432    


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                     ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...........+.      
T Consensus       156 ---------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~------  214 (262)
T d1byga_         156 ---------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------  214 (262)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT------
T ss_pred             ---------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------
Confidence                           1234568899999999999999999999999999999998 799988765444433332      


Q ss_pred             HHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                               .+.++.   .+..+++++.+||.+||+.||++|||+.+|+++|..+..
T Consensus       215 ---------~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         215 ---------KGYKMD---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------cCCCCC---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                     223332   345789999999999999999999999999999987754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.4e-51  Score=399.08  Aligned_cols=259  Identities=26%  Similarity=0.358  Sum_probs=209.5

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC----c
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----N  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~  135 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++...   .......+.+|+++|+.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46899999999999999999997  5899999986543   3445668999999999999999999999987654    3


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||++|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            889999999999999887655 7899999999999999999999999999999999999999999999999988654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                      ..             ........+||+.|+|||++.+..++.++|||||||++|||+||..||.+.+......+++....
T Consensus       165 ~~-------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~  231 (277)
T d1o6ya_         165 GN-------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  231 (277)
T ss_dssp             ---------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             cc-------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC
Confidence            11             11124456899999999999999999999999999999999999999988766555444433221


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~  352 (573)
                                    .+ .......+|+++.+||.+||+.||.+|| |+++++..|..+
T Consensus       232 --------------~~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 --------------IP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             --------------CC-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------------CC-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                          11 1223457899999999999999999999 899988777654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=409.73  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=213.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---hHHHHHHHHHHHHHH-hCCCCccceeeeccccCCceEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv  139 (573)
                      ++|++.+.||+|+||+||+|++  +++.||||++....   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999998  68999999864321   223455667777665 68999999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      |||+++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....    
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~----  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc----
Confidence            99999999999997655 7899999999999999999999999999999999999999999999999999754321    


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~  299 (573)
                                  ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....     
T Consensus       157 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----  219 (320)
T d1xjda_         157 ------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-----  219 (320)
T ss_dssp             ------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred             ------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----
Confidence                        112345689999999999999999999999999999999999999999876665554443211     


Q ss_pred             HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 008220          300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL  351 (573)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~  351 (573)
                                 +   ..|..+|+++.+||.+||+.||++|||+. ++++|+|.
T Consensus       220 -----------~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         220 -----------P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             -----------C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             -----------C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence                       1   23457899999999999999999999995 89888875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=401.38  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=217.9

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhCCCCccceeeecccc
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK  132 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (573)
                      ++++.++|++.+.||+|+||+||+|++.       ++.||||++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            6788889999999999999999999864       3689999876543 3346679999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK  189 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlk  189 (573)
                      ....+++|||+.+|+|.+++....                       ..+++..++.++.|++.||+|||+++|+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999986422                       247888999999999999999999999999999


Q ss_pred             CCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHH
Q 008220          190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN  269 (573)
Q Consensus       190 p~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  269 (573)
                      |+|||++.++.+||+|||+++........              ....+..||+.|+|||.+.+..++.++|||||||++|
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYY--------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCB--------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ccceEECCCCcEEEccchhheeccCCccc--------------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence            99999999999999999999765432211              1134567899999999999999999999999999999


Q ss_pred             HHHcCC-CCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 008220          270 ELLTGV-VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE  348 (573)
Q Consensus       270 elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  348 (573)
                      ||++|. +||.+.+.......+.              .+. +   +..+..+|+++.+||.+||+.||++|||+.||++.
T Consensus       234 ell~~~~~p~~~~~~~e~~~~v~--------------~~~-~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~  295 (301)
T d1lufa_         234 EIFSYGLQPYYGMAHEEVIYYVR--------------DGN-I---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  295 (301)
T ss_dssp             HHHTTTCCTTTTSCHHHHHHHHH--------------TTC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCCCCCCCCHHHHHHHHH--------------cCC-C---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999974 6888765554443332              222 1   22355789999999999999999999999999998


Q ss_pred             HHHH
Q 008220          349 LDLV  352 (573)
Q Consensus       349 l~~~  352 (573)
                      |..+
T Consensus       296 L~~i  299 (301)
T d1lufa_         296 LQRM  299 (301)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            8765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=398.00  Aligned_cols=261  Identities=28%  Similarity=0.392  Sum_probs=209.3

Q ss_pred             cccccCCCCccccccccccCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      ..++|+.++|++.+.||+|+||+||+|++ .++.||||++.... ...+.+.+|+.+|++++|||||++++++.+ +.++
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            34788899999999999999999999998 45689999875443 334679999999999999999999999854 5688


Q ss_pred             EEEEeccCCChhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      +||||+++|+|..++... ...+++.+++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||+++......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999999999888643 3468999999999999999999999999999999999999999999999999997654211


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCC-CCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-Pf~~~~~~~~~~~~~~~~~  295 (573)
                      .               .......||+.|+|||++.+..++.++|||||||++|||++|.. ||...........+.    
T Consensus       168 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~----  228 (285)
T d1fmka3         168 Y---------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----  228 (285)
T ss_dssp             -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----
T ss_pred             c---------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence            1               11334679999999999999999999999999999999999554 455444333332222    


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                                . +.++   ..+..+|+++.+||.+||+.||++|||+.+|++.|...+.
T Consensus       229 ----------~-~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         229 ----------R-GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----------T-TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----------h-cCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                      1 1222   2345789999999999999999999999999887765543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=403.42  Aligned_cols=270  Identities=24%  Similarity=0.246  Sum_probs=213.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh--HHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++.....  ...+.+.+|+++|++++||||+++++++.++.++|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999998  488999998754432  235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      |+.++.+..........+++.+++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......     
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-----  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-----
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-----
Confidence            998755554444455679999999999999999999999999999999999999999999999999997654211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL  300 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  300 (573)
                                 .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+........+.
T Consensus       157 -----------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  225 (298)
T d1gz8a_         157 -----------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  225 (298)
T ss_dssp             -----------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             -----------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence                       1234568999999999987655 5889999999999999999999999877666665554332221111


Q ss_pred             HHHH--hcCCCC--------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          301 TAAV--VSGGLR--------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       301 ~~~~--~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ....  ......        .........+++++.+||++||+.||++|||+.|+++|.|.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence            0000  000011        11111234678999999999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=402.00  Aligned_cols=266  Identities=27%  Similarity=0.398  Sum_probs=209.7

Q ss_pred             cccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ..++|+.++|++.++||+|+||.||+|++.       ++.||||++... .....+.+.+|..++.++ +||||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            357788899999999999999999999862       367999986543 344566788888888777 68999999998


Q ss_pred             ccc-CCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCce
Q 008220          130 HAK-PPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV  193 (573)
Q Consensus       130 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Ni  193 (573)
                      +.. ...+++|||||++|+|.+++....               ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            765 456899999999999999986432               2478999999999999999999999999999999999


Q ss_pred             EEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc
Q 008220          194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT  273 (573)
Q Consensus       194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  273 (573)
                      |++.++.+||+|||+|+.......              ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt  231 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  231 (299)
T ss_dssp             EECGGGCEEECC------CCSCTT--------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eECCCCcEEEccCcchhhcccccc--------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence            999999999999999976542111              112345679999999999999999999999999999999998


Q ss_pred             C-CCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          274 G-VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       274 g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      | .+||............+.              .+.++   ..+..+++++.+||.+||+.||++|||+.||++||+.+
T Consensus       232 ~~~~p~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         232 LGASPYPGVKIDEEFCRRLK--------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             TSCCSSTTCCCSHHHHHHHH--------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHh--------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            5 668876544333322221              11222   23457899999999999999999999999999999988


Q ss_pred             HHH
Q 008220          353 LEH  355 (573)
Q Consensus       353 ~~~  355 (573)
                      ++.
T Consensus       295 lq~  297 (299)
T d1ywna1         295 LQA  297 (299)
T ss_dssp             HHH
T ss_pred             HhC
Confidence            753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-50  Score=410.88  Aligned_cols=252  Identities=23%  Similarity=0.283  Sum_probs=205.8

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCCh------HHHHHHHHHHHHHHhCCCCccceeeeccccCCce
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (573)
                      -++|++.+.||+|+||.||+|++  +|+.||||++.....      ........|+.+++.++||||+++++++.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            35899999999999999999998  588999998642211      1112233457777888999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhh
Q 008220          137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK  216 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  216 (573)
                      |+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            99999999999999997655 7899999999999999999999999999999999999999999999999999754321 


Q ss_pred             hhhcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                       .....+||+.|+|||++. +..++.++|||||||+||||+||..||.+........ +.... 
T Consensus       161 -----------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~-  221 (364)
T d1omwa3         161 -----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT-  221 (364)
T ss_dssp             -----------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHS-
T ss_pred             -----------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc-
Confidence                             134567999999999996 4568999999999999999999999997653222111 11100 


Q ss_pred             cHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 008220          296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL  351 (573)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~  351 (573)
                                    .......+..+|+++.+||.+||+.||++|||     ++|+++|+|+
T Consensus       222 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         222 --------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             --------------SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             --------------ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence                          01112235578999999999999999999999     7999988875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=401.72  Aligned_cols=257  Identities=21%  Similarity=0.373  Sum_probs=209.8

Q ss_pred             CCCccccccccccCceEEEEEEEC--Ce----eEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceE
Q 008220           65 PSSYTLLSPIARGAESVVYEATLD--GR----KVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM  137 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (573)
                      .++|+++++||+|+||+||+|.+.  ++    +||+|++... .....+.+.+|+++|++++||||+++++++.++ ..+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            357999999999999999999873  33    6899876543 233467899999999999999999999999764 567


Q ss_pred             EEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhh
Q 008220          138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE  217 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  217 (573)
                      +++|++.+|+|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            88899999999999887777899999999999999999999999999999999999999999999999999987643111


Q ss_pred             hhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhcccc
Q 008220          218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT  296 (573)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~  296 (573)
                                    ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.........+.     
T Consensus       167 --------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-----  227 (317)
T d1xkka_         167 --------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----  227 (317)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-----
T ss_pred             --------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----
Confidence                          111234568999999999999999999999999999999998 899998765443322222     


Q ss_pred             HHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                               .+ .++   ..+..+++++.+||.+||+.||++|||+.||+++|+.+..
T Consensus       228 ---------~~-~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 ---------KG-ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ---------HT-CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------cC-CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                     11 222   2345789999999999999999999999999999987764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=405.23  Aligned_cols=265  Identities=26%  Similarity=0.269  Sum_probs=207.7

Q ss_pred             ccccccccCceEEEEEEE--CCeeEEEeeccCCChHH-----HHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           70 LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-----LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      .+++||+|+||+||+|++  +++.||||++.......     ...+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999987  57899999865443221     24688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.++++..+.. ....+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++......      
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------  154 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------  154 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence            99877776654 34478999999999999999999999999999999999999999999999999997554211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+.+...++....
T Consensus       155 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~  224 (299)
T d1ua2a_         155 ----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ  224 (299)
T ss_dssp             ----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence                      12345689999999999865 4679999999999999999999999998877776666554321111000


Q ss_pred             HH-Hhc-------CCC-CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 AA-VVS-------GGL-RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~~-~~~-------~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .. ...       ... ...+......+++++.+||.+||+.||++|||+.|+++|.|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f  283 (299)
T d1ua2a_         225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  283 (299)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence            00 000       000 001111234678999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=394.24  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=206.0

Q ss_pred             cCCCCccccccccccCceEEEEEEEC-----CeeEEEeeccCC---ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP  134 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (573)
                      |..++|++.+.||+|+||+||+|++.     ...||||++...   ..+..+.+.+|+.+|++++||||+++++++.+ +
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            45578999999999999999999852     236899976433   23445789999999999999999999999976 4


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      ..++||||+++|++.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999999999998877666799999999999999999999999999999999999999999999999999986543


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ....             ........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+.. 
T Consensus       164 ~~~~-------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~-  229 (273)
T d1u46a_         164 NDDH-------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-  229 (273)
T ss_dssp             -CCE-------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-
T ss_pred             CCCc-------------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh-
Confidence            2111             112334568889999999999999999999999999999998 8999988766555444432 


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                                   ...++.   .+..+|+++.+||.+||+.||++|||+.||++.|..
T Consensus       230 -------------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         230 -------------EGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -------------SCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------------CCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                         333332   345789999999999999999999999999876643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=406.60  Aligned_cols=254  Identities=21%  Similarity=0.284  Sum_probs=203.4

Q ss_pred             CCccccc-cccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHh-CCCCccceeeecccc----CCceE
Q 008220           66 SSYTLLS-PIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCK-LDHPGLAKFVAAHAK----PPNYM  137 (573)
Q Consensus        66 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~----~~~~~  137 (573)
                      ++|++++ .||+|+||+||+|++  +++.||||++..     ...+.+|+.++.+ ++||||++++++|.+    ...+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5799886 599999999999997  578999998643     2356789998765 489999999999865    46789


Q ss_pred             EEEEeccCCChhhhhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhh
Q 008220          138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE  213 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~  213 (573)
                      +|||||+||+|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.   .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            9999999999999997643 46899999999999999999999999999999999999985   5579999999997554


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      ...                 .....+||+.|+|||++.+..|+.++|||||||+||+|+||..||.+.........+...
T Consensus       166 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~  228 (335)
T d2ozaa1         166 SHN-----------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  228 (335)
T ss_dssp             CCC-----------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred             CCC-----------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence            211                 134568999999999999999999999999999999999999999875443332222111


Q ss_pred             cccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      .          ..+.. .........+|+++.+||++||+.||++|||+.|+++|.|..
T Consensus       229 i----------~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         229 I----------RMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             C----------CSCSS-SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             H----------hcCCC-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            1          00111 011112235899999999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=393.26  Aligned_cols=262  Identities=26%  Similarity=0.396  Sum_probs=216.1

Q ss_pred             cccCCCCccccccccccCceEEEEEEEC---------CeeEEEeeccCCC-hHHHHHHHHHHHHHHhC-CCCccceeeec
Q 008220           61 LHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA  129 (573)
Q Consensus        61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (573)
                      ++|+.++|++.+.||+|+||.||+|++.         +..||||++.... ......+.+|...+.++ +||||++++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            7788899999999999999999999752         2479999876544 34567788999999888 79999999999


Q ss_pred             cccCCceEEEEEeccCCChhhhhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceE
Q 008220          130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL  194 (573)
Q Consensus       130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nil  194 (573)
                      +.++...++||||+.+|+|.+++....               ..+++.+++.++.||+.||+|||+.+|+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            999999999999999999999996543               35899999999999999999999999999999999999


Q ss_pred             EcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHc-
Q 008220          195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-  273 (573)
Q Consensus       195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-  273 (573)
                      ++.++.+||+|||+++.......              ........||+.|+|||.+.+..++.++|||||||++|||++ 
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~  233 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL  233 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCT--------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             ecCCCCeEeccchhhcccccccc--------------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence            99999999999999976653111              112344678999999999999999999999999999999998 


Q ss_pred             CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 008220          274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL  353 (573)
Q Consensus       274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~  353 (573)
                      |.+||.+.........+              . .+.++.   .+..+++++.+||.+||+.||++|||+.||++.|+.++
T Consensus       234 g~~p~~~~~~~~~~~~i--------------~-~~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         234 GGSPYPGVPVEELFKLL--------------K-EGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             SCCSSTTCCHHHHHHHH--------------H-TTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHH--------------H-cCCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            79999876544332222              1 222332   34578999999999999999999999999999998886


Q ss_pred             H
Q 008220          354 E  354 (573)
Q Consensus       354 ~  354 (573)
                      +
T Consensus       296 a  296 (299)
T d1fgka_         296 A  296 (299)
T ss_dssp             H
T ss_pred             h
Confidence            5

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=400.63  Aligned_cols=269  Identities=23%  Similarity=0.263  Sum_probs=213.1

Q ss_pred             CCccccccccccCceEEEEEEEC---CeeEEEeeccCCC--hHHHHHHHHHHHHHHhC---CCCccceeeecccc-----
Q 008220           66 SSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILST--SEELDNFHKELQLLCKL---DHPGLAKFVAAHAK-----  132 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----  132 (573)
                      ++|+++++||+|+||+||+|++.   ++.||||++....  ......+.+|+.+|+.|   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            68999999999999999999973   5679999864321  12223455777777666   79999999999853     


Q ss_pred             CCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhh
Q 008220          133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR  212 (573)
Q Consensus       133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  212 (573)
                      ....+++||++.++.+..........++++.++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~  166 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  166 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence            35689999999998777666666667899999999999999999999999999999999999999999999999998754


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....                 ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..
T Consensus       167 ~~~~-----------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  229 (305)
T d1blxa_         167 SFQM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  229 (305)
T ss_dssp             CGGG-----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccc-----------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            3211                 23466899999999999999999999999999999999999999998877776666554


Q ss_pred             ccccHHHHHH--------HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQQLTA--------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..........        ..............+..+++++.+||.+||+.||++|||+.|+++|+|.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence            3211110000        0000111122233455789999999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=394.87  Aligned_cols=273  Identities=25%  Similarity=0.383  Sum_probs=225.7

Q ss_pred             CCcCCCccccccCCCCccccccccccCceEEEEEEE-------CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCc
Q 008220           52 GCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPG  122 (573)
Q Consensus        52 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpn  122 (573)
                      +.......+++|+.++|++.++||+|+||.||+|++       .++.||||++... .......+.+|+.+++.+ +|||
T Consensus         9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn   88 (311)
T d1t46a_           9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN   88 (311)
T ss_dssp             TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence            333444456889999999999999999999999975       2468999987543 445566789999999999 6999


Q ss_pred             cceeeeccccCCceEEEEEeccCCChhhhhhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 008220          123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----------------WSPSVDQVLMIAAQLAKALQYLHNLGIVH  185 (573)
Q Consensus       123 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH  185 (573)
                      |+++++++.++...++|||||++|+|.+++....                 ..+++..++.++.||+.||+|||++|++|
T Consensus        89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH  168 (311)
T d1t46a_          89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH  168 (311)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            9999999999999999999999999999986532                 25789999999999999999999999999


Q ss_pred             ccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHH
Q 008220          186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG  265 (573)
Q Consensus       186 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  265 (573)
                      |||||+|||++.++.+||+|||+++.......              ........||+.|+|||++.+..++.++||||||
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G  234 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG  234 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTT--------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             cccccccccccccCcccccccchheeccCCCc--------------ceEeeecccChHHcCHHHhcCCCCCCcccccchH
Confidence            99999999999999999999999976543111              1123446899999999999999999999999999


Q ss_pred             HHHHHHHc-CCCCCCCchhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHH
Q 008220          266 ISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD  344 (573)
Q Consensus       266 ~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  344 (573)
                      |++|||+| |.+||...........++.              .+.++.   .+..+|+++.+||.+||+.||++|||+.|
T Consensus       235 ~~l~ellt~g~p~~~~~~~~~~~~~~i~--------------~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         235 IFLWELFSLGSSPYPGMPVDSKFYKMIK--------------EGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             HHHHHHHTTTCCSSTTCCSSHHHHHHHH--------------HTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHh--------------cCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            99999999 6777766544443333332              222332   23568999999999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 008220          345 IALELDLVLEH  355 (573)
Q Consensus       345 ll~~l~~~~~~  355 (573)
                      |++.|+..+.+
T Consensus       298 il~~L~~~i~~  308 (311)
T d1t46a_         298 IVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHhhcc
Confidence            99999877653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.3e-50  Score=395.35  Aligned_cols=269  Identities=22%  Similarity=0.243  Sum_probs=212.7

Q ss_pred             CCccccccccccCceEEEEEEE-CCeeEEEeeccCCChH--HHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEEe
Q 008220           66 SSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF  142 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  142 (573)
                      ++|+++++||+|+||+||+|++ +++.||||++......  ..+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999998 5789999987654332  256789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      +.++.+..+.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.......      
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~------  154 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV------  154 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc------
Confidence            98866666654 44589999999999999999999999999999999999999999999999999997654211      


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT  301 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  301 (573)
                                .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+......++...........
T Consensus       155 ----------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (286)
T d1ob3a_         155 ----------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (286)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ----------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence                      123445789999999998764 568999999999999999999999998776666555543221111000


Q ss_pred             H--HHhcC--------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          302 A--AVVSG--------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       302 ~--~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .  .....        ............+++++.+||++||+.||++|||+.|+++|+|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            0  00000        00111122345688999999999999999999999999998874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=398.17  Aligned_cols=260  Identities=28%  Similarity=0.462  Sum_probs=212.5

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCe--eEEEeeccCC-ChHHHHHHHHHHHHHHhC-CCCccceeeeccccCCce
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY  136 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  136 (573)
                      |+.++|++.++||+|+||+||+|++  ++.  .||||++... ..+..+.+.+|+++|+++ +||||+++++++.+++.+
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            4557899999999999999999986  444  4677775433 334566799999999999 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCC
Q 008220          137 MFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP  201 (573)
Q Consensus       137 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~  201 (573)
                      ++||||+++|+|.+++...               ...+++.++..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence            9999999999999998643               3468999999999999999999999999999999999999999999


Q ss_pred             eEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 008220          202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTD  280 (573)
Q Consensus       202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~Pf~~  280 (573)
                      ||+|||+++......                 ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+
T Consensus       167 kl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         167 KIADFGLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             EECCTTCEESSCEEC-----------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEccccccccccccc-----------------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence            999999987543211                 12345689999999999999999999999999999999996 567876


Q ss_pred             chhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 008220          281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK  357 (573)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~  357 (573)
                      .+.......+..               +.++   ..+..+++++.+||.+||+.||++|||+.||+++|..+++..+
T Consensus       230 ~~~~~~~~~i~~---------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         230 MTCAELYEKLPQ---------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             CCHHHHHHHGGG---------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCHHHHHHHHHh---------------cCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            654444333321               1222   2345789999999999999999999999999999999886543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=390.14  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=219.2

Q ss_pred             ccccCCCCccccccccccCceEEEEEEEC-------CeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccc
Q 008220           60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA  131 (573)
Q Consensus        60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (573)
                      .++|+.++|++.++||+|+||+||+|.+.       ++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            47899999999999999999999999763       468999987543 4445567899999999999999999999999


Q ss_pred             cCCceEEEEEeccCCChhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCe
Q 008220          132 KPPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH  202 (573)
Q Consensus       132 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~k  202 (573)
                      .+...++||||+.+|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence            9999999999999999999876421         2468899999999999999999999999999999999999999999


Q ss_pred             EeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCCc
Q 008220          203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDL  281 (573)
Q Consensus       203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~Pf~~~  281 (573)
                      |+|||+++........              .......||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.
T Consensus       174 l~DFGla~~~~~~~~~--------------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~  239 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  239 (308)
T ss_dssp             ECCTTCCCGGGGGGCE--------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             EeecccceeccCCcce--------------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence            9999999866532221              113345789999999999999999999999999999999997 5888776


Q ss_pred             hhHHHHHHHHhccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      +.......+.              .+..    +..+..+|+.+.+||.+||+.||++|||+.+|+++|...
T Consensus       240 ~~~~~~~~i~--------------~~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         240 SNEQVLRFVM--------------EGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             CHHHHHHHHH--------------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             CHHHHHHHHH--------------hCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            5554444332              2221    123457899999999999999999999999999887443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=395.93  Aligned_cols=243  Identities=23%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCC---h---HHHHHHHHHHHHHHhCC--CCccceeeeccccCC
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---S---EELDNFHKELQLLCKLD--HPGLAKFVAAHAKPP  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~---~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~  134 (573)
                      .++|++.+.||+|+||+||+|++  +++.||||++....   .   ....++.+|+.+|++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36899999999999999999998  58899999754321   1   11234668999999996  899999999999999


Q ss_pred             ceEEEEEeccC-CChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCC-CCCeEeeeecchhh
Q 008220          135 NYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYR  212 (573)
Q Consensus       135 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~  212 (573)
                      ..++||||+.+ +++.+++.... .+++++++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            99999999976 57777776554 79999999999999999999999999999999999999854 78999999998654


Q ss_pred             hhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 008220          213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL  291 (573)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  291 (573)
                      ..                  ....+..||+.|+|||++.+..+ +.++|||||||++|||++|..||.....      +.
T Consensus       162 ~~------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~  217 (273)
T d1xwsa_         162 KD------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II  217 (273)
T ss_dssp             CS------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH
T ss_pred             cc------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh
Confidence            31                  11345689999999999987665 6779999999999999999999976321      11


Q ss_pred             hccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .              +.     ...+..+|+++.+||++||+.||++|||++|+++|+|.
T Consensus       218 ~--------------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         218 R--------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             H--------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             h--------------cc-----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            1              11     01345789999999999999999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=393.47  Aligned_cols=265  Identities=22%  Similarity=0.323  Sum_probs=209.3

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC------
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------  134 (573)
                      .++|+++++||+|+||+||+|.+  +++.||||++...  .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47999999999999999999997  4899999987543  3445678899999999999999999999987654      


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .+|+||||+ +.+|..+....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence            579999999 55777776543  699999999999999999999999999999999999999999999999999975432


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...........
T Consensus       174 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~  234 (346)
T d1cm8a_         174 -------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV  234 (346)
T ss_dssp             -------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             -------------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence                               1345679999999999876 45689999999999999999999999887666555544432


Q ss_pred             cccHHH------------HHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQQ------------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ......            .............+......+++++.+||.+||..||++|||+.|+++|+|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             cCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence            221110            1111111222233344456789999999999999999999999999999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=383.77  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=209.5

Q ss_pred             ccccccccCceEEEEEEECC-----eeEEEeeccC-CChHHHHHHHHHHHHHHhCCCCccceeeecccc-CCceEEEEEe
Q 008220           70 LLSPIARGAESVVYEATLDG-----RKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF  142 (573)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~  142 (573)
                      +.++||+|+||+||+|++..     ..||||++.. ......+.+.+|+++|++++||||+++++++.. +...++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            46789999999999998732     3589998653 455667889999999999999999999999765 5678999999


Q ss_pred             ccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhccc
Q 008220          143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN  222 (573)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  222 (573)
                      |++|+|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......     
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~-----  185 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-----  185 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC-----
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc-----
Confidence            999999999987777788999999999999999999999999999999999999999999999999976543211     


Q ss_pred             ccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 008220          223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA  302 (573)
Q Consensus       223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  302 (573)
                             ..........||+.|+|||.+.+..++.++||||||+++|||+||..||........             ...
T Consensus       186 -------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------------~~~  245 (311)
T d1r0pa_         186 -------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITV  245 (311)
T ss_dssp             -------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------------CHH
T ss_pred             -------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------------HHH
Confidence                   111123345789999999999999999999999999999999997777764322211             111


Q ss_pred             HHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      .+.. +.++.   .|..+++++.+||.+||+.||++|||+.||+++|..+.+.
T Consensus       246 ~i~~-g~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         246 YLLQ-GRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             HHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHc-CCCCC---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1222 22332   3457899999999999999999999999999999888753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=389.29  Aligned_cols=271  Identities=23%  Similarity=0.283  Sum_probs=209.4

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC-ChHHHHHHHHHHHHHHhCCCCccceeeeccccCC----ceEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMF  138 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l  138 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++... .....+.+.+|+.+|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            6799999999999999999987  5899999987543 3455678899999999999999999999986543    2355


Q ss_pred             EEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhh
Q 008220          139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      +++++.+|+|.+++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            55667799999998654  6899999999999999999999999999999999999999999999999999765432110


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE  297 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  297 (573)
                                   .......+||+.|+|||++. +..++.++||||+||++|+|++|..||...................
T Consensus       166 -------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         166 -------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             -------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             -------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence                         11234567999999999985 4567899999999999999999999998776555444433221111


Q ss_pred             HHH----------HHHH--hcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQL----------TAAV--VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~----------~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ...          ....  ...............+++++.+||.+||+.||.+|||+.|+++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~  298 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  298 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            000          0000  01111122233445788999999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=384.83  Aligned_cols=275  Identities=23%  Similarity=0.289  Sum_probs=211.2

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeeccccCC----ceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~e  141 (573)
                      ++|.+.+.||+|+||.||+|+++|+.||||++..... .....+.|+..++.++||||+++++++....    .+|+|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            5788999999999999999999999999998654322 2222334555556789999999999987643    5899999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      |+++|+|.+++...  .+++++++.++.|++.||+|||+        .||+||||||+||||+.++.+||+|||+++...
T Consensus        82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            99999999999754  58899999999999999999996        599999999999999999999999999997664


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCC------CCchhhHHHHHHHHHHHHcCCCCCCCchhHHH-
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQ-  286 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-  286 (573)
                      .....            .........||+.|+|||++.+..      ++.++|||||||+||||+||..||........ 
T Consensus       160 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         160 SATDT------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             TTTTE------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             CCCcc------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            32211            011234568999999999987643      56789999999999999999988854322211 


Q ss_pred             HHHHHhccccHHHHHHHHhcCCCCCccccccc--CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 008220          287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH  355 (573)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~  355 (573)
                      ....................+..+|.++....  ..+..+.+|+.+||+.||++|||+.||+++|..+.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11111222344445555566667766554332  2446799999999999999999999999999887754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-47  Score=375.83  Aligned_cols=271  Identities=21%  Similarity=0.274  Sum_probs=216.5

Q ss_pred             cCCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCC-CccceeeeccccCCceEEE
Q 008220           63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFF  139 (573)
Q Consensus        63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv  139 (573)
                      +.+++|++.++||+|+||+||+|++  +++.||||+.....  ....+.+|++.++.++| +||+.+++++......++|
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            4468999999999999999999997  58899999864432  22356789999999975 8999999999999999999


Q ss_pred             EEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC-----CCCCeEeeeecchhhhh
Q 008220          140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-----NLCPHLADFGLAEYREN  214 (573)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~-----~~~~kL~Dfg~a~~~~~  214 (573)
                      |||+ +++|.+++...+..++..++..++.|++.||+|||+.||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9998 67999998877778999999999999999999999999999999999999974     57899999999987653


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                      .....         ...........||+.|||||++.+..++.++|||||||++|||++|..||.+..............
T Consensus       159 ~~~~~---------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~  229 (293)
T d1csna_         159 PVTKQ---------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  229 (293)
T ss_dssp             TTTCC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             Ccccc---------ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence            21111         111122456789999999999999999999999999999999999999997653322222111100


Q ss_pred             ccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 008220          295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR  356 (573)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~  356 (573)
                      .           ....+.++.+..++|+++.+++..|++.+|++||++..+.+.+..+++..
T Consensus       230 ~-----------~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         230 E-----------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             H-----------HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             h-----------ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0           00011223344578999999999999999999999999988887777643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=385.66  Aligned_cols=273  Identities=24%  Similarity=0.244  Sum_probs=206.0

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCC--hHHHHHHHHHHHHHHhCCCCccceeeecccc--------C
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAK--------P  133 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------~  133 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++....  ......+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6999999999999999999997  58899999864432  2234668899999999999999999998754        4


Q ss_pred             CceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhh
Q 008220          134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE  213 (573)
Q Consensus       134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  213 (573)
                      ...|+||||+.++.+.... .....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            5689999999876665444 444578999999999999999999999999999999999999999999999999997654


Q ss_pred             hhhhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      .....            ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..
T Consensus       169 ~~~~~------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~  236 (318)
T d3blha1         169 LAKNS------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ  236 (318)
T ss_dssp             C-----------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccc------------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence            21110            11123446799999999998765 689999999999999999999999988776666555443


Q ss_pred             ccccHHH----------HHHHHhcC-CCCCcccc-c-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          293 MNYTEQQ----------LTAAVVSG-GLRPILAS-L-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~----------~~~~~~~~-~~~~~~~~-~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      .......          ........ ...+.+.. + ....++++.+||.+||+.||++|||+.|+++|+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            2211110          00000000 00000000 0 01246788999999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-47  Score=382.02  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=203.5

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeecccc--CCceEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAK--PPNYMFFF  140 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~  140 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++....   .+.+.+|+.+|+.++ ||||++++++|..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999998  58999999875443   356789999999995 9999999999874  45699999


Q ss_pred             EeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhhhhhhh
Q 008220          141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEIS  219 (573)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~  219 (573)
                      ||+.+++|....    ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......   
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence            999999997764    2689999999999999999999999999999999999998765 58999999997654211   


Q ss_pred             cccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHH-HHHHhccccH
Q 008220          220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA-HTVLEMNYTE  297 (573)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~  297 (573)
                                    ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||......... ..+......+
T Consensus       185 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~  250 (328)
T d3bqca1         185 --------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  250 (328)
T ss_dssp             --------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             --------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence                          13456799999999998765 4799999999999999999999999765433222 2221111111


Q ss_pred             HHHHHHHhcCC--------------CCCcc-----cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          298 QQLTAAVVSGG--------------LRPIL-----ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       298 ~~~~~~~~~~~--------------~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                       ..........              .+...     ......+++++.+||++||+.||++|||++|+++|+|+
T Consensus       251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         251 -DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             -HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             -hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence             1100000000              00000     11123478999999999999999999999999999876

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=388.42  Aligned_cols=265  Identities=25%  Similarity=0.285  Sum_probs=206.1

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCccceeeecccc------CCceE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPNYM  137 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~  137 (573)
                      .+|+.+++||+|+||+||+|++  +++.||||++.....    ...+|+.+|++++||||++++++|..      ..++|
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            3799999999999999999998  588999998654332    23479999999999999999999853      33578


Q ss_pred             EEEEeccCCChhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCC-CCeEeeeecchhhhh
Q 008220          138 FFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYREN  214 (573)
Q Consensus       138 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~  214 (573)
                      +||||++++.+..+..  .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9999998764444332  2345789999999999999999999999999999999999999876 899999999875532


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhc
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM  293 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  293 (573)
                      .                 ....+..||+.|+|||++.+ ..++.++||||+||++|||++|..||...........+...
T Consensus       176 ~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~  238 (350)
T d1q5ka_         176 G-----------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV  238 (350)
T ss_dssp             T-----------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             C-----------------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence            1                 12345689999999998875 56899999999999999999999999888776666665543


Q ss_pred             cccHH-HHHHHHhcCCCCC---------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          294 NYTEQ-QLTAAVVSGGLRP---------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       294 ~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                      ..+.. +............         ........+++++.+||.+||+.||++|||+.|+++|.|+
T Consensus       239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            22211 1111111111111         1111234578999999999999999999999999999876

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-47  Score=374.15  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcc-ceeeeccccCCceEEEEE
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e  141 (573)
                      +++|++.++||+|+||.||+|++  +++.||||++.....  ...+..|+++++.++|+|+ +.+..++...+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            36899999999999999999997  488999998654432  2357789999999987664 555666677888999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcC---CCCCeEeeeecchhhhhhhhh
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEI  218 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~  218 (573)
                      |+ +++|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+......
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            98 55777777666668999999999999999999999999999999999999854   557999999999876532211


Q ss_pred             hcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccccHH
Q 008220          219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ  298 (573)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~  298 (573)
                      .         ...........||+.|+|||++.+..++.++|||||||++|||++|..||...........+......  
T Consensus       163 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--  231 (299)
T d1ckia_         163 Q---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--  231 (299)
T ss_dssp             C---------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--
T ss_pred             c---------ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--
Confidence            1         11112235668999999999999999999999999999999999999999876544433322211100  


Q ss_pred             HHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 008220          299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE  354 (573)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~  354 (573)
                               ...+..+....++|+++.+||..||+.||++||++.++.+.|..+..
T Consensus       232 ---------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         232 ---------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ---------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                     00112233455789999999999999999999999998877766654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=384.68  Aligned_cols=266  Identities=21%  Similarity=0.262  Sum_probs=201.8

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeecccc------CCc
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPN  135 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~  135 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++...  .......+.+|+.+|++++||||++++++|..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999998  4899999986543  34556778999999999999999999999853      467


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      +|+||||+.++.+. .+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus        97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            89999999775554 332   26899999999999999999999999999999999999999999999999988654321


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhccc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY  295 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  295 (573)
                                       ......+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.....
T Consensus       173 -----------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~  235 (355)
T d2b1pa1         173 -----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  235 (355)
T ss_dssp             -------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             -----------------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence                             123456799999999999999999999999999999999999999988776666555543222


Q ss_pred             cHHH--------HHHHHhcCCC-C--------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          296 TEQQ--------LTAAVVSGGL-R--------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       296 ~~~~--------~~~~~~~~~~-~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ....        .......+.. .              +.........++++.+||++||..||++|||++|+++|+|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~  315 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  315 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            1100        0000111110 0              000011123578899999999999999999999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=374.62  Aligned_cols=269  Identities=23%  Similarity=0.225  Sum_probs=211.3

Q ss_pred             CCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccCCceEEEEE
Q 008220           66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE  141 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  141 (573)
                      ++|+++++||+|+||+||+|++  +++.||||++...  .......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999998  5788999986543  33456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhhhhhhcc
Q 008220          142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK  221 (573)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  221 (573)
                      ++.+++|..++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......     
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-----  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-----  155 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-----
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-----
Confidence            99998888877654 478999999999999999999999999999999999999999999999999997554211     


Q ss_pred             cccCCCCCCCCccccccccCcccCChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHHHhccccHHH
Q 008220          222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDL-RAEAQAHTVLEMNYTEQQ  299 (573)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~  299 (573)
                                 .......+++.|+|||++.+.. ++.++|||||||++|||++|..||... +.......+.........
T Consensus       156 -----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (292)
T d1unla_         156 -----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             -----------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             -----------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence                       1223446788999999987655 689999999999999999999886443 333333333221111100


Q ss_pred             --HHHHHhc--------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 008220          300 --LTAAVVS--------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL  351 (573)
Q Consensus       300 --~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~  351 (573)
                        .......        .............+++++.+||++||+.||++|||++|+++|+|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence              0000000        000111222345678999999999999999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-47  Score=383.55  Aligned_cols=267  Identities=23%  Similarity=0.324  Sum_probs=210.9

Q ss_pred             CCCccccccccccCceEEEEEEE--CCeeEEEeeccCC--ChHHHHHHHHHHHHHHhCCCCccceeeeccccC-----Cc
Q 008220           65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PN  135 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~  135 (573)
                      ++||+++++||+|+||+||+|++  +++.||||++...  .....+.+.+|+++|+.++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            37899999999999999999997  5899999987543  344566789999999999999999999998643     33


Q ss_pred             eEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhhh
Q 008220          136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL  215 (573)
Q Consensus       136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  215 (573)
                      .+++++++.+|+|.+++...  .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... 
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            46667788899999998543  699999999999999999999999999999999999999999999999999865432 


Q ss_pred             hhhhcccccCCCCCCCCccccccccCcccCChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHhcc
Q 008220          216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN  294 (573)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  294 (573)
                                        ...+..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       174 ------------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         174 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             ------------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ------------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence                              23456799999999987765 46899999999999999999999999887766666655433


Q ss_pred             ccHHHH---------HHHHhc---CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 008220          295 YTEQQL---------TAAVVS---GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       295 ~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ......         ......   ......+.....++++++.+||++||+.||++|||+.|+++|+|..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence            221110         000000   1111112223356899999999999999999999999999998863

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=382.16  Aligned_cols=256  Identities=25%  Similarity=0.340  Sum_probs=210.4

Q ss_pred             CCCccccccccccCceEEEEEEE-----CCeeEEEeeccCC----ChHHHHHHHHHHHHHHhCCC-CccceeeeccccCC
Q 008220           65 PSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPP  134 (573)
Q Consensus        65 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~  134 (573)
                      -++|++++.||+|+||+||+|++     +|+.||||++...    .....+.+.+|+++|++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            36899999999999999999986     4688999976432    22234567899999999976 89999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeecchhhhh
Q 008220          135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN  214 (573)
Q Consensus       135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  214 (573)
                      .++++|||+.+|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+++.+..
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999999997666 678899999999999999999999999999999999999999999999999976543


Q ss_pred             hhhhhcccccCCCCCCCCccccccccCcccCChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHh
Q 008220          215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE  292 (573)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  292 (573)
                      ....               ...+..|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.+.........+..
T Consensus       182 ~~~~---------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~  246 (322)
T d1vzoa_         182 DETE---------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  246 (322)
T ss_dssp             GGGG---------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             cccc---------------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            2211               13456799999999999764  468899999999999999999999987654443333322


Q ss_pred             ccccHHHHHHHHhcCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 008220          293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL  351 (573)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~  351 (573)
                      ...          ..     .+..+..+++++.+||++||+.||++||     |++|+++|+|.
T Consensus       247 ~~~----------~~-----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         247 RIL----------KS-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             HHH----------HC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             hcc----------cC-----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence            111          11     1123457899999999999999999999     58999988875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-41  Score=339.78  Aligned_cols=269  Identities=22%  Similarity=0.238  Sum_probs=193.6

Q ss_pred             CCCCccccccccccCceEEEEEEE--CCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-----------CCccceeeecc
Q 008220           64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----------HPGLAKFVAAH  130 (573)
Q Consensus        64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~  130 (573)
                      ...||+++++||+|+||+||+|++  +++.||||++... ....+.+.+|+.+++.++           ||||+++++++
T Consensus        11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            346799999999999999999997  5899999987543 334567788999998875           47899998887


Q ss_pred             cc--CCceEEEEEeccCCChhh--hhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCceEEcCCCC-----
Q 008220          131 AK--PPNYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLC-----  200 (573)
Q Consensus       131 ~~--~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiH~Dlkp~Nill~~~~~-----  200 (573)
                      ..  ....+++++++..+....  ........+++..++.++.||+.||+|||+ .||+||||||+|||++.++.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            54  455667777665543322  223344578999999999999999999998 89999999999999987664     


Q ss_pred             -CeEeeeecchhhhhhhhhhcccccCCCCCCCCccccccccCcccCChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008220          201 -PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT  279 (573)
Q Consensus       201 -~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  279 (573)
                       ++|+|||.+.....                   .....+||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus       170 ~~kl~dfg~s~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             EEEECCCTTCEETTB-------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             eeeEeeccccccccc-------------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence             89999999864432                   1345679999999999999999999999999999999999999997


Q ss_pred             CchhHH------HHHHHHhccc-cHHHHHHH------Hhc-CCCCCc---------------ccccccCChHHHHHHHHH
Q 008220          280 DLRAEA------QAHTVLEMNY-TEQQLTAA------VVS-GGLRPI---------------LASLELGLPASILSLIQR  330 (573)
Q Consensus       280 ~~~~~~------~~~~~~~~~~-~~~~~~~~------~~~-~~~~~~---------------~~~~~~~~~~~l~~li~~  330 (573)
                      ......      .......... ........      ... ......               ....+...++++.+||.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            543211      1111111000 00110000      000 000000               000112357889999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHH
Q 008220          331 CWDGNPHNRPSFSDIALELDLV  352 (573)
Q Consensus       331 ~l~~dP~~Rpt~~ell~~l~~~  352 (573)
                      ||..||.+|||++|+++|+|+-
T Consensus       311 mL~~dP~~Rpta~e~L~Hp~f~  332 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVNHPWLK  332 (362)
T ss_dssp             GGCSSTTTCBCHHHHHTCGGGT
T ss_pred             HCCCChhHCcCHHHHhcCcccC
Confidence            9999999999999999998775

>d1a6qa2 d.219.1.1 (A:2-296) Protein serine/threonine phosphatase 2C, catalytic domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: PP2C-like
superfamily: PP2C-like
family: PP2C-like
domain: Protein serine/threonine phosphatase 2C, catalytic domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.3e-29  Score=243.82  Aligned_cols=140  Identities=23%  Similarity=0.359  Sum_probs=116.5

Q ss_pred             cCCcceEEEEeeccCCCCCceeEEecccCCC-CCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhcC-----C----CCCh
Q 008220          425 YYPVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-----S----TTRP  494 (573)
Q Consensus       425 ~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~~-----~----~~~~  494 (573)
                      ....++||+++++|+|++|||++.+..++.. ..+..||||||||||+.||++|++++++.|.+..     .    ..++
T Consensus        17 ~~~~~~~g~~s~~G~R~~~ED~~~~~~~~~~~~~~~~lf~V~DGhGG~~~s~~~~~~l~~~l~~~~~~~~~~~~~~~~~~   96 (295)
T d1a6qa2          17 QGNGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENV   96 (295)
T ss_dssp             EETTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSHHHHCSSSSCCHHHH
T ss_pred             cCCceEEEEEeCccCCCcccCeeEEEcccCCCCCceEEEEEEeCCCChHHHHHHHHHHHHHHHHhhhhccccccchHHHH
Confidence            3467899999999999999999988776532 2467899999999999999999999999886541     1    1245


Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCCC
Q 008220          495 TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQEF  571 (573)
Q Consensus       495 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p~  571 (573)
                      .++|.++|.++++.+.........       ...+||||++++|.++++|||||||||||++++|.+++||.||+|.
T Consensus        97 ~~al~~a~~~~~~~~~~~~~~~~~-------~~~~GtTa~~~~i~~~~l~vanvGDSR~~l~~~~~~~~lT~dH~~~  166 (295)
T d1a6qa2          97 KNGIRTGFLEIDEHMRVMSEKKHG-------ADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPS  166 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTC-------CCCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCTT
T ss_pred             HHHHHHHHHHHHHHHhhhhhhccC-------cCCCCCeEEEEEeeCCEEEEEecCCCeEEEeecccceeeccccCcc
Confidence            678999999999888655433222       2246999999999999999999999999999999999999999995

>d1txoa_ d.219.1.1 (A:) putative serine/threonine phosphatase pstp/ppp {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: PP2C-like
superfamily: PP2C-like
family: PP2C-like
domain: putative serine/threonine phosphatase pstp/ppp
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.93  E-value=1.5e-25  Score=212.24  Aligned_cols=127  Identities=23%  Similarity=0.264  Sum_probs=110.9

Q ss_pred             ceEEEEeeccC-CCCCceeEEecccCCCCCceEEEEEEcCCCcHHHHHHHHHHhHHHHHhc---CCCCChhHHHHHHHHH
Q 008220          429 LSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL---GSTTRPTDALLEAFIR  504 (573)
Q Consensus       429 ~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DGhgG~~a~~~~~~~l~~~l~~~---~~~~~~~~~l~~~~~~  504 (573)
                      ++||+.|++|. |++|||++.+..        .+|+|||||||+.+|++|++.+++.+.+.   ....+..+.|.+++.+
T Consensus         3 ~~~~~~s~~G~~R~~nEDa~~~~~--------~l~~V~DG~GG~~~g~~as~~~~~~l~~~~~~~~~~~~~~~l~~~~~~   74 (235)
T d1txoa_           3 LRYAARSDRGLVRANNEDSVYAGA--------RLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVRA   74 (235)
T ss_dssp             EEEEEEEECCSSCSSCCEEEEECS--------SEEEEEEEECTTTHHHHHHHHHHHHHGGGGSSCCCSCHHHHHHHHHHH
T ss_pred             EEEEEECCCCCCCCCCCCccccCC--------CEEEEEeCCCCcHHHHHHHHHHHHHHHHHhhccCcccHHHHHHHHHHH
Confidence            68999999997 999999998732        48999999999999999999999988764   3346778899999999


Q ss_pred             HHHHHHHHHHHhhhhhhccCCccCccceeEEEEEECCeEEEEEccccceeEEeCCeeeeCCCCCCC
Q 008220          505 TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRVRQE  570 (573)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~~~~~~~~lt~dH~p  570 (573)
                      ++..+.+.........       .+|||++++++.++++++|||||||+|++|+|++.+||+||+|
T Consensus        75 ~~~~l~~~~~~~~~~~-------~~gtt~~~~~~~~~~l~~anvGDSr~~l~r~g~~~~lt~dH~~  133 (235)
T d1txoa_          75 GNSAIAAQVEMEPDLE-------GMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTF  133 (235)
T ss_dssp             HHHHHHHHHHHCGGGT-------TCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECSCCCBH
T ss_pred             HHHHHHHHhhcccccc-------cceeeeeeeeeccceeEEEecCCccEEEecCCEEEEecCCCcH
Confidence            9999987765544332       3599999999999999999999999999999999999999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=3.6e-24  Score=195.87  Aligned_cols=133  Identities=19%  Similarity=0.202  Sum_probs=105.6

Q ss_pred             ccccccccccCceEEEEEEE-CCeeEEEeeccCCCh------------------HHHHHHHHHHHHHHhCCCCccceeee
Q 008220           68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS------------------EELDNFHKELQLLCKLDHPGLAKFVA  128 (573)
Q Consensus        68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpnIv~l~~  128 (573)
                      +.+.++||+|+||+||+|.+ +|+.||||+......                  ........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999987 689999997542211                  11234567889999999999999887


Q ss_pred             ccccCCceEEEEEeccCCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCceEEcCCCCCeEeeeec
Q 008220          129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL  208 (573)
Q Consensus       129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH~Dlkp~Nill~~~~~~kL~Dfg~  208 (573)
                      +.    ..+++|||+.+..+..        ++...+..++.|++.+|.|||++||+||||||+|||++.++ ++|+|||+
T Consensus        82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence            64    2379999998865533        23345678999999999999999999999999999999765 89999999


Q ss_pred             chhhh
Q 008220          209 AEYRE  213 (573)
Q Consensus       209 a~~~~  213 (573)
                      |....
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            86543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=1.7e-07  Score=87.94  Aligned_cols=139  Identities=12%  Similarity=0.131  Sum_probs=95.0

Q ss_pred             CCccccccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEEEecc
Q 008220           66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYE  144 (573)
Q Consensus        66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  144 (573)
                      +.|++.+..+-++.+.||+...+++.+++|+...........+.+|...+..+. +--+++++.+...++..++||++++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~   93 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence            456766665555567899998788888899754333333345678888888774 4446788888888889999999999


Q ss_pred             CCChhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 008220          145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------------------------------------------  180 (573)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------  180 (573)
                      |..+.+......      ....++.++...++.||+                                            
T Consensus        94 G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          94 GVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             cccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            987755432111      112233344444444441                                            


Q ss_pred             ---------C------CceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          181 ---------L------GIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       181 ---------~------~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                               .      .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     1      27899999999999987666799999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.60  E-value=6e-05  Score=69.49  Aligned_cols=73  Identities=12%  Similarity=0.118  Sum_probs=50.5

Q ss_pred             ccccCc-eEEEEEEEC-CeeEEEeeccCCChHHHHHHHHHHHHHHhCC--CCccceeeeccccCCceEEEEEeccCCChh
Q 008220           74 IARGAE-SVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNLA  149 (573)
Q Consensus        74 lg~G~~-g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  149 (573)
                      +..|.. +.||+...+ +..+++|.......   ..+..|...++.+.  .-.+++++.+..+++..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            344443 679999874 55678887543322   24567888887773  334677888888888899999999886553

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.48  E-value=9e-05  Score=73.10  Aligned_cols=75  Identities=13%  Similarity=0.105  Sum_probs=48.5

Q ss_pred             cccccccCceEEEEEEE--CCeeEEEeeccC----C---ChHHHHHHHHHHHHHHhCC-C--CccceeeeccccCCceEE
Q 008220           71 LSPIARGAESVVYEATL--DGRKVAVKKPIL----S---TSEELDNFHKELQLLCKLD-H--PGLAKFVAAHAKPPNYMF  138 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~~~~~l  138 (573)
                      .+.||.|....||++..  .++.++||....    .   -....++...|.+.|+.+. +  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45689999999999975  356789995221    1   0112344567888887763 2  346667655  4556789


Q ss_pred             EEEeccCCC
Q 008220          139 FFEFYESRN  147 (573)
Q Consensus       139 v~e~~~~g~  147 (573)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.73  E-value=0.0015  Score=64.00  Aligned_cols=72  Identities=18%  Similarity=0.182  Sum_probs=48.2

Q ss_pred             cccccccCceEEEEEEEC---------CeeEEEeeccCCChHHHHHHHHHHHHHHhCC-CCccceeeeccccCCceEEEE
Q 008220           71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF  140 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~  140 (573)
                      ++.|+-|-.-.+|++...         .+.|.+++.- .... .....+|..+++.+. +.-.+++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            356777888899999863         2456666643 2222 234558999999885 4445678888753    6889


Q ss_pred             EeccCCCh
Q 008220          141 EFYESRNL  148 (573)
Q Consensus       141 e~~~~g~L  148 (573)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.14  E-value=0.0025  Score=60.61  Aligned_cols=69  Identities=25%  Similarity=0.159  Sum_probs=43.0

Q ss_pred             cCceEEEEEEE-CCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCcc--ceeee-----ccccCCceEEEEEeccCC
Q 008220           77 GAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL--AKFVA-----AHAKPPNYMFFFEFYESR  146 (573)
Q Consensus        77 G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~-----~~~~~~~~~lv~e~~~~g  146 (573)
                      +....||+++. +|+.|++|+.... ....+.+..|...+..|....|  +..+.     .+...+..+.+++++.|.
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            44468999986 6888999985433 2234557788888888742222  21111     123355678889988764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.98  E-value=0.002  Score=60.90  Aligned_cols=138  Identities=18%  Similarity=0.115  Sum_probs=72.8

Q ss_pred             cccccccCceEEEEEEECCeeEEEeeccCCChHHHHHHHHHHHHHHhCCCCc--cceeeec------cccCCceEEEEEe
Q 008220           71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--LAKFVAA------HAKPPNYMFFFEF  142 (573)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e~  142 (573)
                      .+.|..|--.+.|+...++..+++|+....  ...+.+..|++++..|...+  ++..+..      .........++.+
T Consensus        23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eecCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence            345667777899999887778999985432  22344556777777774222  2221111      1123345556666


Q ss_pred             ccCCChhh--------------hhhcc--------CCCCCH------------------HHHHHHHHHHHHHHHHHHh--
Q 008220          143 YESRNLAE--------------KLHVE--------EWSPSV------------------DQVLMIAAQLAKALQYLHN--  180 (573)
Q Consensus       143 ~~~g~L~~--------------~l~~~--------~~~~~~------------------~~~~~i~~qi~~~l~~LH~--  180 (573)
                      ..+.....              .++..        ......                  ......+..+...+...+.  
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence            65532211              00100        000000                  0111222233333333332  


Q ss_pred             --CCceeccCCCCceEEcCCCCCeEeeeecch
Q 008220          181 --LGIVHRDVKPANVLLDRNLCPHLADFGLAE  210 (573)
Q Consensus       181 --~~iiH~Dlkp~Nill~~~~~~kL~Dfg~a~  210 (573)
                        .|+||+|+.++||+++.+...-|+||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence              379999999999999988777899999874